<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2016-01-07T02:00:27Z</responseDate><request verb="ListRecords" resumptionToken="oai%3Apubmedcentral.nih.gov%3A4700559!2016-01-06!2016-01-07!pmc!">http://www.ncbi.nlm.nih.gov/oai/oai.cgi</request><ListRecords><record><header><identifier>oai:pubmedcentral.nih.gov:4700559</identifier><datestamp>2016-01-06</datestamp><setSpec>virolj</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="http://jats.nlm.nih.gov/ns/archiving/1.0/ http://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Virol J</journal-id>
      <journal-id journal-id-type="iso-abbrev">Virol. J</journal-id>
      <journal-title-group>
        <journal-title>Virology Journal</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1743-422X</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC4700559</article-id>
      <article-id pub-id-type="pmcid">PMC4700559</article-id>
      <article-id pub-id-type="pmc-uid">4700559</article-id>
      <article-id pub-id-type="publisher-id">460</article-id>
      <article-id pub-id-type="doi">10.1186/s12985-015-0460-8</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Short Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>HPV 16E7 and 48E7 proteins use different mechanisms to target p130 to overcome cell cycle block</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Nor Rashid</surname>
            <given-names>Nurshamimi</given-names>
          </name>
          <address>
            <phone>+603-79677549</phone>
            <email>nurshamimi@um.edu.my</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yong</surname>
            <given-names>Zi Ling</given-names>
          </name>
          <address>
            <email>yongzlno1@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yusof</surname>
            <given-names>Rohana</given-names>
          </name>
          <address>
            <email>rohana@um.edu.my</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Watson</surname>
            <given-names>Roger J.</given-names>
          </name>
          <address>
            <email>r.watson@bham.ac.uk</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <aff id="Aff1"><label/>Section of Virology, Department of Medicine, Imperial College London, London, UK </aff>
        <aff id="Aff2"><label/>Department of Molecular Medicine, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia </aff>
        <aff id="Aff3"><label/>Institute of Biomedical Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>4</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>4</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <volume>13</volume>
      <elocation-id>2</elocation-id>
      <history>
        <date date-type="received">
          <day>23</day>
          <month>4</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>28</day>
          <month>12</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© Nor Rashid et al. 2016</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Retinoblastoma like protein 2 (RBL2) or p130 is a member of the pocket protein family, which is infrequently mutated in human tumours. Its expression is posttranscriptionally regulated and largely G0 restricted. We have previously shown that E6/E7 oncoproteins encoded by human papillomavirus (HPV) type 16, which is a high-risk type for cervical cancer development, must target p130 to promote the host cell to exit from quiescence (G0) state and enter S phase of the cell cycle. P130 is associated with the DREAM (DP, RB-like, E2F and MuvB) complex in G0/G1, which prevents S phase progression by repressing transcription of E2F-regulated genes. E7 proteins could potentially disrupt the p130-DREAM complex through two known mechanisms: direct interaction with p130 or induction of cyclin dependent kinase 2 (CDK2) phosphorylation by interacting with its inhibitor, p21<sup>CIP1</sup>.</p>
        </sec>
        <sec>
          <title>Methods</title>
          <p>In this study we have used p130 mutants deficient in binding the E7 LXCXE domain (p130mE7), unphosphorylatable by CDK2 (p130PM22) or a combination of both (p130PM22/mE7) to investigate these mechanisms used by E7 proteins to disrupt the p130-DREAM complex and promote cell cycle progression.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>We found that HPV16 E7 binding to p130 through its LXCXE domain was absolutely required to disrupt p130-DREAM to promote S phase of the cell cycle, as HPV16 E7 was unable to suppress p130mE7 but could suppress p130PM22. In contrast, the E7 protein encoded by a cutaneous HPV type that lacks a functional LXCXE domain, HPV 48 E7, was also able to disrupt p130-DREAM to promote cell cycling, but through the alternative mechanism. Thus, HPV48 E7 could suppress a cell cycle block imposed by p130mE7, but was unable to suppress p130PM22.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>Overall, these results indicate that suppression of p130 is required for HPV-induced cell cycling, and that different HPV E7 proteins can use alternative mechanisms to achieve this.</p>
        </sec>
        <sec>
          <title>Electronic supplementary material</title>
          <p>The online version of this article (doi:10.1186/s12985-015-0460-8) contains supplementary material, which is available to authorized users.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>p130</kwd>
        <kwd>Retinoblastoma like protein 2 (RBL2)</kwd>
        <kwd>DREAM complex</kwd>
        <kwd>Human papillomavirus E7 oncoprotein</kwd>
        <kwd>Cervical cancer</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>© The Author(s) 2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Background</title>
      <p>In women, cervical cancer is the second most frequent cancer worldwide and the leading cause of cancer related deaths in developing countries [<xref ref-type="bibr" rid="CR1">1</xref>]. As an example, cervical cancer ranks as the second most frequent cancer among women in Malaysia, in women between 15 and 44 years of age. Data are not yet available on the HPV burden in the general population of Malaysia [<xref ref-type="bibr" rid="CR2">2</xref>]. HPV are associated with over 99 % of all cervical cancer, 40-50 % of penile and vulvar cancers and greater than 20 % of head and neck cancers [<xref ref-type="bibr" rid="CR3">3</xref>]. HPV types which are associated with these mucocutaneous sites are classified as high risk (HR) or low risk (LR) depending on their ability to cause cancer. HPV16, 18, 31, 33 and 45 are HR types commonly associated with malignancies [<xref ref-type="bibr" rid="CR4">4</xref>], whereas HPV6, 11, 42 and 43 are classified as LR and can cause condyloma acuminata (genital warts) [<xref ref-type="bibr" rid="CR5">5</xref>]. Many other HPV types are associated only with cutaneous epithelia, and these include HPV4, 48, 50, 65 and 88 which are found predominantly in sites extensively exposed to sun, in both lesions and healthy skin samples [<xref ref-type="bibr" rid="CR6">6</xref>]. There are also several other cutaneous types of HPVs (1, 2, 3, 4, 10, 27, 28, 57) which are the major causes of skin warts.</p>
      <p>The E6 and E7 oncoproteins encoded by HR HPV types are responsible to immortalize human keratinocytes through inactivation of p53 and pRB tumour suppressor proteins, respectively [<xref ref-type="bibr" rid="CR7">7</xref>]. The E6 and E7 proteins are consistently expressed in cancer cells and inhibiting their expression blocks the malignant phenotype [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. They are independently able to immortalize various human cell types in tissue culture, but efficiency is increased when they are expressed together [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. However, E6 and E7 from low risk viruses lack immortalization activity, providing a direct correlation between their <italic>in vitro</italic> properties and the potential carcinogenicity of the HPV type. HR HPV E7 proteins contain a LXCXE motif and a C-terminal domain which synergistically form a high affinity bivalent interaction that both anchors the E7 protein to pRB and dissociates the associated E2F transcription factor [<xref ref-type="bibr" rid="CR12">12</xref>]. HPV16 E7 preferentially binds to p130 in serum-starved quiescent human fibroblasts [<xref ref-type="bibr" rid="CR13">13</xref>]. It is notable that the cutaneous HPV10, 48 and 60 types encode E7 proteins which have incomplete LXCXE motifs and a low affinity for the pocket proteins; however, all have some ability to stimulate proliferation and progression into S phase [<xref ref-type="bibr" rid="CR14">14</xref>], suggesting that direct interaction with pocket proteins is not required for this property.</p>
      <p>P130 and its related proteins, pRB and p107 are important regulators of cell cycle progression, senescence, development and differentiation. These proteins share a distinct pocket domain necessary for binding E2F transcription factors and LXCXE motif-containing cellular proteins, including the D-type cyclins and histone deacetylases (HDACs). In their hypo- or unphosphorylated forms, the pocket proteins negatively regulate cell cycle progression through interaction with E2F/DP heterodimers and the recruitment of HDACs that promote chromatin condensation and repress transcription [<xref ref-type="bibr" rid="CR15">15</xref>].</p>
      <p>A multiprotein unit has been identified in human complexes, termed DREAM whose composition is regulated at distinct phases of the cell cycle [<xref ref-type="bibr" rid="CR16">16</xref>]. The core DREAM complex contains Lin9, Lin37, Lin54, Lin52 and RbAp48 (the human homologues of <italic>Drosophila</italic> Mip130, Mip40, Mip120, dLin52 and Caf1p55, respectively). In G0/G1, DREAM binds to E2F4 and either p130 or p107 to repress transcription of E2F target genes regulating the G1/S transition. In S/G2, DREAM switches to B-myb to activate genes required for G2/M transition and mitosis.</p>
      <p>In this study, we investigated how representative E7 proteins from HR mucocutaneous and cutaneous HPV types target p130. We constructed a p130 mutant that is defective in binding the HPV E7 LXCXE motif (p130mE7) based on conserved amino acids shown previously to be critical for pRB binding to LXCXE-containing viral oncoproteins [<xref ref-type="bibr" rid="CR17">17</xref>] and took advantage of another mutant which cannot be phosphorylated by CDK (p130PM22) [<xref ref-type="bibr" rid="CR18">18</xref>] (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). In addition, a double mutant (p130mE7/PM22) was constructed. The p130 mutants and a control wild-type p130 were co-transfected with HPV16 and 48 E7 into cell lines. Our results suggest that HPV E7 proteins can use alternative mechanisms to overcome p130-DREAM function in order to promote cell cycling.<fig id="Fig1"><label>Fig. 1</label><caption><p>Schematic summary of the constructed p130 mutants based on the p130wt. <bold>a</bold> Schematic of the 1139 amino acid human p130 protein, showing the A and B domains of the pocket. Also indicated is the region of the B domain conserved between RB and p130 which was mutated in p130mE7. In p130mE7, amino acids Y1009 and N1010 were changed to alanines. <bold>b</bold> p130wt has two pocket domains which are A and B for viral oncoproteins binding and cyclin dependent kinase phosphorylation. The p130mE7 mutant was designed based on the work of Dick and Dyson (2002), who showed that a surface of the pRB B pocket was critical for binding proteins containing the L-X-C-X-E motif. This region of the pRB B pocket is partially conserved in p130, and two critical conserved amino acids (leucine and cysteine) in p130 were replaced with alanine by <italic>in vitro</italic> mutagenesis. The p130PM22 mutant has been mutated at the 22 CDK phosphorylation sites by replacing the phosphorylated serine and threonine with alanine (Farkas et al., 2002). The p130mE7/PM22 protein was mutated at both the HPV E7 binding and phosphorylation sites. All p130 mutants and a control wild-type p130 were tagged with HA to differentiate between endogenous and ectopically expressed p130</p></caption><graphic xlink:href="12985_2015_460_Fig1_HTML" id="MO1"/></fig></p>
    </sec>
    <sec id="Sec2" sec-type="results">
      <title>Results and discussion</title>
      <p>To construct a p130 mutant unable to bind the E7 LXCXE motif (p130mE7) we replaced two amino acids in the B pocket that are conserved in pRB and shown previously to be essential for LXCXE-binding [<xref ref-type="bibr" rid="CR17">17</xref>]. We first compared the properties of p130mE7 the unphosphorylatable p130PM22 mutant and the p130mE7/PM22 double mutant with wild type p130 (p130wt) in CaSki and C33a cervical carcinoma cell lines: CaSki cells express HPV16 E7 at high levels, whereas C33a cells are HPV-negative. The transfected p130 proteins were distinguished from endogenous p130 by virtue of an HA tag. Immunoblotting with the p130 antibody did not show increased expression of p130 in the transfected cells, suggesting that the HA-tagged wild-type p130 and the mutants were expressed at a relatively low level, compared to endogenous p130 (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S1a). We found that all p130 mutants and p130wt were equally expressed in the HPV-negative C33a cells, as none of the p130 proteins could be targeted by E7 in this cell line (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S1b). In contrast, neither p130 wt nor p130PM22 were detected in CaSki cells, whereas the p130mE7 and p130PM22/mE7 mutants were both detectable on the HA antibody blot (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S1b). This finding strongly suggested that the p130mE7 mutation prevented binding to 16E7 in Caski cells and thus protected it from degradation. Our <italic>in vitro</italic> binding data confirmed that 16E7 binds to wild type p130, but not to p130mE7 (Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Figure S2a). On the other hand, CDK phosphorylation of p130 did not appear to be a major factor in degradation of this protein in Caski cells, as the p130PM22 mutant was not protected.</p>
      <p>To investigate whether or not the p130mE7 and p130PM22/mE7 mutants could complex with DREAM in CaSki cells, the nuclear lysates from transfected cells were co-precipitated with Lin-9 antibody and probed on western blots using HA and p130 antibodies. As anticipated from the differential expression of p130 proteins (Fig. <xref rid="Fig2" ref-type="fig">2</xref>), the results showed that p130mE7 and p130PM22/mE7 were formed into p130-DREAM complexes (Fig. <xref rid="Fig2" ref-type="fig">2a</xref>), whereas no p130-DREAM complexes were detected on this blot with p130wt or the p130PM22 mutant. These results further showed that mutation of the B pocket in p130mE7 and p130PM22/mE7 did not affect interactions with DREAM. Unexpectedly, none of the HA-tagged p130 proteins could be detected in DREAM complexes using the p130 antibody on western blots (Fig. <xref rid="Fig2" ref-type="fig">2a</xref>), again suggesting they were expressed at relatively low levels.<fig id="Fig2"><label>Fig. 2</label><caption><p>Formation of the p130-DREAM complexes in CaSki expressing p130mE7 and p130PM22/mE7. <bold>a</bold> Nuclear lysates from the untrasfected CaSki cells (CaSki) or CaSki cells transfected with pMSCV puro constructed with p130 wt, p130 mE7, p130PM22 and p130mE7/PM22 were immunoprecipitated with pre-immune serum (PI) or Lin-9 antibodies and were blotted using p130 (Santa Cruz) and HA (Roche) antibodies. The input (In) control comprised of the lysates used for immunoprecipitation. The image is representative of four independent experiments. <bold>b</bold> Flow cytometry of propidium iodide stained CaSki cells transfected with pMSCV puro constructed with p130 wt, p130mE7, p130PM22 and p130mE7/PM22 and pMSCV puro vector only as a control. The estimated percentages of cells in G1, S and G2/M phase are shown</p></caption><graphic xlink:href="12985_2015_460_Fig2_HTML" id="MO2"/></fig></p>
      <p>To test whether transfection with p130wt or any of the mutants had effects on the cell cycle in CaSki cells, transfected cells were harvested, stained with propidium iodide and analysed by flow cytometry. The p130mE7 and p130PM22/mE7 mutants were both able to arrest CaSki cells at G0/G1, with 81 % and 85.4 % at this stage, respectively, compared to 56 % G0/G1 cells in control cells transfected with the empty vector. In contrast, neither p130wt nor p130PM22 had any effect on the cell cycle, with 55.7 % and 55 % at G0/G1, respectively. These results reflected the ability of p130mE7 and p130PM22/mE7 to form DREAM complexes (Fig. <xref rid="Fig2" ref-type="fig">2b</xref>), and demonstrated that the levels of complex formation achieved with these mutants was sufficient to cause cell cycle arrest. It is notable that p130mE7 was as efficient as the p130PM22/mE7 double mutant in this cell cycle arrest assay, suggesting that direct interaction of 16E7 with p130 through its LXCXE motif is the key determinant in promoting the cell cycle in CaSki cells.</p>
      <p>To confirm that HPV16 E7 targets p130 through its LXCXE motif, T98G (human glioblastoma) cells were transfected with pMSCVpuro vectors encoding HA-tagged p130wt, p130mE7, p130PM22 and p130PM22/mE7 together with 16E7. First, it was established that the p130 proteins were expressed equally and that expression of p130 had no effect upon 16E7 expression. The resultant western blot (Fig. <xref rid="Fig3" ref-type="fig">3a</xref>) showed expression of 16E7 with only minor variation. The p130wt and mutant proteins were also consistently expressed in T98G cells (Fig. <xref rid="Fig3" ref-type="fig">3b</xref>).<fig id="Fig3"><label>Fig. 3</label><caption><p>The LXCXE motif of HPV16 E7 binds to p130. <bold>a</bold> 20 μg of each pMSCVpuro-16E7-HA was calcium phosphate co-transfected with each type of p130 mutants for transient expression in T98G cells. In addition, the pMSCVpuro vector was transfected in T98G cells as a control. Transfected cells were puromycin selected and nuclear lysates were harvested 48 hours post transfection. Nuclear lysates were immunoprecipitated with HA (Roche) antibody, separated on a 15 % SDS-PAGE gel and western blotted onto a PVDF membrane. 16E7 proteins were detected using HA (Roche) antibody. The image is representative of three independent experiments. <bold>b</bold> Nuclear lysates from T98G cells transfected with pMSCV puro constructed with 16E7HA or p130 wt, p130 mE7, p130PM2, p130mE7/PM22 and a combination of 16E7 with each of the p130s. Transfected cells were puromycin selected and nuclear lysates were harvested 48 hours post transfection. Nuclear lysates were separated on a 10 % SDS-PAGE gel and western blotted onto a nitrocellulose membrane. p130 proteins were detected using HA (Roche) antibody. The image is representative of three independent experiments. <bold>c</bold> Detection of ectopically expressed p130 in immunoprecipitates of T98G cells transfected with pMSCV puro constructed with p130 wt, p130mE7, p130PM22, p130mE7/PM22 and a combination of 16E7 with each of the p130 constructs. Pre-immune serum (PI) and Lin-9 antibodies were used for immunoprecipitation and HA p130 was detected on western blots. The co-immunoprecipitation control, Lin-9 was detected using Lin-9 (Abcam) antibody. The image is representative of three independent experiments. (d) Flow cytometry of propidium iodide-stained T98G cells transfected with pMSCV puro constructed with p130wt, p130mE7, p130PM22, p130mE7/PM22 together with 16E7HA. The T98G cells transfected with pMSCV puro only was used as a control. The estimated percentages of cells in G1, S, and G2/M phase are shown</p></caption><graphic xlink:href="12985_2015_460_Fig3_HTML" id="MO3"/></fig></p>
      <p>We then investigated what effect co-expression of 16E7 would have on the co-transfected p130 proteins. Whereas, co-expression with 16E7 had no significant impact on detection of p130mE7 or p130PM22/mE7 (Fig. <xref rid="Fig3" ref-type="fig">3b</xref>), it resulted in the virtual elimination of p130wt and p130PM22 expression. The loss of p130wt and p130PM22 expression in this experiment suggests that binding to 16E7 through the LXCXE motif resulted in proteasomal degradation, whereby the p130 proteins are degraded by the ubiquitin-proteasome pathway [<xref ref-type="bibr" rid="CR19">19</xref>]. HPV16 E7 and p130 both interact with and are ubiquitylated by SCF<sup>Skp2</sup> complex [<xref ref-type="bibr" rid="CR20">20</xref>]. As anticipated, formation of the DREAM complex with p130wt and p130PM22 in T98G-transfected cells was significantly disrupted by 16E7, whereas this complex was abundantly expressed with p130mE7 and p130PM22/mE7 (Fig. <xref rid="Fig3" ref-type="fig">3c</xref>). Consistent with these results, analysis of T98G cell cycle status showed a profound G0/G1 arrest when p130mE7 and p130mE7/PM22 were co-transfected with 16E7, with 87.5 % and 82.5 % of cells in G0/G1, respectively, whereas 16E7 co-transfection abolished the ability of p130wt and p130PM22 to cause arrest (64 % and 68.1 % of cells in G0/G1) (Fig. <xref rid="Fig3" ref-type="fig">3d</xref>).</p>
      <p>Studies in our laboratory have shown that the cutaneous HPV48 E7 protein was competent to bind to the CDK inhibitor (Cdki), p21<sup>Cip1</sup><italic>in vitro</italic> (Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Figure S2b). It is known that p21 together with <sup>p27Kip1</sup> are involved in E2F/pocket protein-cyclin E/A-CDK2 pathways in G1 and S phase. By binding to p21, HPV 48E7 will abrogate its inhibition of CDK2 activity, therefore potentially resulting in p130 hyperphosphorylation, and a block in its association with E2F4 and DREAM. However, the <italic>in vitro</italic> binding assay of 48E7 to p130wt and p130mE7 was not performed since 48E7 lacks a functional LXCXE domain. Previously, this observation has been carried out by Caldeira et al. between 48E7 and pRB or p107.</p>
      <p>To explore whether our previous finding [<xref ref-type="bibr" rid="CR21">21</xref>] that 48E7 can disrupt the p130-DREAM complex reflects direct binding to p130 or alternatively an effect on CDK activity, T98G cells were transfected with 48E7 and the HA-tagged wt and mutant p130 proteins used in the previous experiments. We first established that HPV48 E7 was expressed consistently in each transfection (Fig. <xref rid="Fig4" ref-type="fig">4a</xref>). Next we demonstrated that both p130wt and p130mE7 were degraded when 48E7 was co-expressed, whereas p130PM22 and p130PM22/mE7 were unaffected by 48E7 (Fig. <xref rid="Fig4" ref-type="fig">4b</xref>). These findings indicated that 48E7 suppresses p130 expression through CDK phosphorylation. This activity most probably reflects binding of 48E7 to p21and degradation of the resultant hyperphosphorylated p130.<fig id="Fig4"><label>Fig. 4</label><caption><p>Co-expression of HPV 48E7 with p130wt and p130mE7 disrupt the p130-DREAM complexes. <bold>a</bold> 20 μg of each pMSCVpuro-48E7-HA was calcium phosphate co-transfected with each type of p130mutants for transient expression in T98G cells. In addition, the pMSCVpuro vector was transfected in T98G cells as a control.Transfected cells were puromycin selected and nuclear lysates were harvested 48 hours post transfection. Nuclear lysates were immunoprecipitated with HA (Roche) antibody, separated on a 15 % SDS-PAGE gel and western blotted onto a PVDF membrane. 48E7 proteins were detected using HA (Roche) antibody. The image is representative of four independent experiments. <bold>b</bold> Nuclear lysates from T98G cells transfected with pMSCV puro constructed with 48E7HA or p130 wt, p130 mE7, p130PM2, p130mE7/PM22 and a combination of 48E7 with each of the p130s. Transfected cells were puromycin selected and nuclear lysates were harvested 48 hours post transfection. Nuclear lysates were separated on a 10 % SDS-PAGE gel and western blotted onto a nitrocellulose membrane. HA p130 antibody was detected on western blots. The image is representative of three independent experiments. <bold>c</bold> Detection of ectopically expressed p130 in immunoprecipitates of T98G cells transfected with pMSCV puro constructed with p130 wt, p130mE7, p130PM22, p130mE7/PM22 and a combination of 48E7 with each of the p130 constructs. Pre-immune serum (PI) and Lin-9 antibodies were used for immunoprecipitation and HA p130 was detected on western blots. The image is representative of three independent experiments. <bold>d</bold> Flow cytometry of propidium iodide-stained T98G cells transfected with pMSCV puro constructed with p130wt, p130mE7, p130PM22, p130mE7/PM22 together with 48E7HA. The T98G cells transfected with pMSCV puro only was used as a control. The estimated percentages of cells in G1, S, and G2/M phase are shown</p></caption><graphic xlink:href="12985_2015_460_Fig4_HTML" id="MO4"/></fig></p>
      <p>We also found that the p130-DREAM complex was significantly reduced when p130wt and p130mE7 were co-expressed with 48E7, compared to formation of this complex with p130PM22 or p130PM22/mE7 (Fig. <xref rid="Fig4" ref-type="fig">4c</xref>). To determine what impact this would have on the ability of the various p130 proteins to arrest the T98G cell cycle, the transfected cells were harvested and subjected to propidium iodide staining. Flow cytometry analysis showed that cells arrested at G0/G1 when either p130PM22 or p130PM22/mE7 were co-expressed with 48E7 (80.2 % and 89.9 % cells in G0/G1, respectively), whereas cells expressing p130wt or p130mE7 were able to escape arrest in the presence of 48E7 (Fig. <xref rid="Fig4" ref-type="fig">4d</xref>).</p>
      <p>Taken together, our results show that both 16E7 and 48E7 proteins lead to decrease steady state levels of p130, diminish p130-DREAM complexes and promote the cell to enter S-phase, but that this occurs by completely different mechanisms. More specifically, the results suggest that HPV16 E7 targets p130 predominantly through direct interactions via the LXCXE motif whereas HPV48 E7 disrupts p130-DREAM via CDK2 phosphorylation of p130. It is significant that whereas different HPV E7 types have a wide range of affinity towards pocket protein binding, based on their LXCXE motif [<xref ref-type="bibr" rid="CR21">21</xref>], HPV48 E7 (which lacks a functional LXCXE motif) demonstrates similar effects on p130-DREAM formation and cell cycle progression compared to HPV16 E7. Pang et al. (2014) reported that the LXCXE motif of HPV16 E7 could promote mitotic gene expression by a pocket protein-independent mechanism; this was associated with 16E7 binding to B-Myb, FoxM1 and Lin9 which associate in a transcription activating form of the DREAM complex (dubbed B-Myb-MuvB) present during S-G2. It is to be expected that HPV48 E7 would be unable to activate B-Myb-MuvB, and would therefore lack the ability to induce mitotic gene expression as does HPV16 E7.</p>
    </sec>
    <sec id="Sec3" sec-type="conclusion">
      <title>Conclusions</title>
      <p>Our studies indicate that HPV E7 proteins which differ markedly in their ability to interact directly with pocket proteins can both cause p130 degradation and lead to p130-DREAM disruption, resulting in promotion of cell proliferation. Whereas HPV16 E7 directly interacts with p130 through its LXCXE motif, HPV48 E7 (which lacks a functional LXCXE motif) alternatively might suppresses p130 through CDK phosphorylation. That both mechanisms exist, demonstrates that targeting p130-DREAM is imperative for HPV types to induce cell cycle progression.</p>
    </sec>
  </body>
  <back>
    <app-group>
      <app id="App1">
        <sec id="Sec4">
          <title>Additional files</title>
          <p>
            <media position="anchor" xlink:href="12985_2015_460_MOESM1_ESM.jpg" id="MOESM1">
              <label>Additional file 1: Figure S1.</label>
              <caption>
                <p>Expression of various p130 mutants in C33a and CaSki cell lines. pMSCV puro (Clontech, Mountain View, CA) constructed with p130 wt and p130 mutants (p130mE7, p130PM22 and p130 mE7/PM22) were ‘FuGENE 6’ transfected in C33a and CaSki cells. The T98G cell lines (HPV 16 E7 negative cell line) were used as a control cells. Transfected cells were puromycin selected and nuclear lysates were harvested 48 hours post transfection. Nuclear lysates were separated on a 10 % SDS-PAGE gel and western blotted onto a nitrocellulose membrane. (a) Endogenous p130 were detected by p130 (Santa Cruz) and β-actin (Sigma Aldrich) was used as a loading control. (b) Ectopically expressed p130 were detected by p130 (Santa Cruz) and HA (Roche) antibodies, respectively. β-actin (Sigma Aldrich) was used as a loading control. The image is representative of three independent experiments. (JPG 51 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="12985_2015_460_MOESM2_ESM.jpg" id="MOESM2">
              <label>Additional file 2: Figure S2.</label>
              <caption>
                <p>The p130mE7 mutant is unable to bind 16E7 and HPV48 E7 binds to p21. (A) Nuclear extracts were prepared from T98G cells transfected with the pMSCVpuro vector encoding HA-tagged p130wt or p130mE7 and from cells transfected with the empty vector (con). Nuclear extracts (150 μg) were incubated with 20 μg 16E7 protein bound to glutathione-Sepaharose beads and the selected proteins were eluted and run on a western blot alongside inputs comprising 15 μg of each nuclear extract. The p130wt and p130mE7 were detected using an HA antibody probe. In addition to the p130 proteins, a non-specific (n.s.) band was seen with the input samples. (B) A GST binding assay was carried out using GST-tagged-E7- HA proteins and IVT [<sup>35</sup>S]-labelled p21. 25 μg of each GST16-E7-HA and GST48-E7-HA proteins were resolved by SDS-PAGE alongside inputs comprising 15 μg of nuclear extract and were detected using an HA antibody probe. Any bound p21 was visualised by autoradiography. The image is representative of three independent experiments. (JPG 35 kb)</p>
              </caption>
            </media>
          </p>
        </sec>
      </app>
    </app-group>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>HPV</term>
          <def>
            <p>Human papillomavirus</p>
          </def>
        </def-item>
        <def-item>
          <term>RBL2</term>
          <def>
            <p>Retinoblastoma like protein 2</p>
          </def>
        </def-item>
        <def-item>
          <term>CDK2</term>
          <def>
            <p>Cyclin dependent kinase 2</p>
          </def>
        </def-item>
        <def-item>
          <term>HDACs</term>
          <def>
            <p>Histone deacytelases</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The authors declare no conflict of interest.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors’ contributions</bold>
        </p>
        <p>RW contributed to the design of the study, NNR and ZLY performed the experiments, NNR and RW carried out the analysis and interpretation of data, NNR drafted the manuscript, RW and RY contributed to the revision of the manuscript. All authors read and approved the final manuscript.</p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgements</title>
      <p>NNR was supported by the Ministry of Higher Education Malaysia under the Malaysia-Imperial Doctoral Program and a grant number (FP026-2014A). We thank Klaus Hansen and Jiri Bartek for providing the p130/PM22 mutant.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xavier</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Mireia</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>de Sanjosé</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nubia</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rolando</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Silvia</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Worldwide Human Papillomavirus Etiology of Cervical Adenocarcinoma and Its Cofactors: Implications for Screening and Prevention</article-title>
          <source>JNCI</source>
          <year>2006</year>
          <volume>98</volume>
          <fpage>303</fpage>
          <lpage>315</lpage>
          <pub-id pub-id-type="doi">10.1093/jnci/djj067</pub-id>
          <pub-id pub-id-type="pmid">16507827</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zaridah</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>A review of cervical cancer research in Malaysia</article-title>
          <source>Med J Malaysia</source>
          <year>2014</year>
          <volume>69</volume>
          <fpage>33</fpage>
          <lpage>41</lpage>
          <?supplied-pmid 25417949?>
          <pub-id pub-id-type="pmid">25417949</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <mixed-citation publication-type="other">D’Souza G, Dempsey A. The role of HPV in head and neck cancer and review of the HPV Vaccine. NIH public access. 2011.</mixed-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burd</surname>
              <given-names>EM</given-names>
            </name>
          </person-group>
          <article-title>Human papillomavirus and cervical cancer</article-title>
          <source>Clin. Micro. Bio. Rev</source>
          <year>2003</year>
          <volume>16</volume>
          <fpage>1</fpage>
          <lpage>17</lpage>
          <pub-id pub-id-type="doi">10.1128/CMR.16.1.1-17.2003</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Longworth</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Laimins</surname>
              <given-names>LA</given-names>
            </name>
          </person-group>
          <article-title>Pathogenesis of human papillomaviruses in differentiating epithelia</article-title>
          <source>Microbiol. Mol. Biol. Rev.</source>
          <year>2004</year>
          <volume>68</volume>
          <fpage>362</fpage>
          <lpage>372</lpage>
          <pub-id pub-id-type="doi">10.1128/MMBR.68.2.362-372.2004</pub-id>
          <?supplied-pmid 15187189?>
          <pub-id pub-id-type="pmid">15187189</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Forslund</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Genetic diversity of cutaneous human papillomaviruses</article-title>
          <source>J. Gen. Virol.</source>
          <year>2007</year>
          <volume>88</volume>
          <fpage>2662</fpage>
          <lpage>2669</lpage>
          <pub-id pub-id-type="doi">10.1099/vir.0.82911-0</pub-id>
          <?supplied-pmid 17872517?>
          <pub-id pub-id-type="pmid">17872517</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Munger</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Howley</surname>
              <given-names>PM</given-names>
            </name>
          </person-group>
          <article-title>Human papillomavirus immortalization and transformation functions</article-title>
          <source>Virus Res.</source>
          <year>2002</year>
          <volume>89</volume>
          <fpage>213</fpage>
          <lpage>228</lpage>
          <pub-id pub-id-type="doi">10.1016/S0168-1702(02)00190-9</pub-id>
          <?supplied-pmid 12445661?>
          <pub-id pub-id-type="pmid">12445661</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zur Hausen</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Papillomaviruses and cancer: from basic studies to clinical application</article-title>
          <source>Nat. Rev. Cancer</source>
          <year>2002</year>
          <volume>2</volume>
          <fpage>342</fpage>
          <lpage>350</lpage>
          <pub-id pub-id-type="doi">10.1038/nrc798</pub-id>
          <?supplied-pmid 12044010?>
          <pub-id pub-id-type="pmid">12044010</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Munger</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Baldwin</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Edwards</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Hayakawa</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Nguyen</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Owens</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mechanisms of human papillomavirus-Induced oncogenesis</article-title>
          <source>J. Virol.</source>
          <year>2004</year>
          <volume>78</volume>
          <fpage>11451</fpage>
          <lpage>11460</lpage>
          <pub-id pub-id-type="doi">10.1128/JVI.78.21.11451-11460.2004</pub-id>
          <?supplied-pmid 15479788?>
          <pub-id pub-id-type="pmid">15479788</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hawley-Nelson</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Vousden</surname>
              <given-names>KH</given-names>
            </name>
            <name>
              <surname>Hubbert</surname>
              <given-names>NL</given-names>
            </name>
            <name>
              <surname>Lowy</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Schiller</surname>
              <given-names>JT</given-names>
            </name>
          </person-group>
          <article-title>HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes</article-title>
          <source>EMBO J.</source>
          <year>1989</year>
          <volume>8</volume>
          <fpage>3905</fpage>
          <lpage>3910</lpage>
          <?supplied-pmid 2555178?>
          <pub-id pub-id-type="pmid">2555178</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zur</surname>
              <given-names>HH</given-names>
            </name>
          </person-group>
          <article-title>Immortalization of human cells and their malignant conversion by high risk human papillomavirus genotypes</article-title>
          <source>Cancer Biol.</source>
          <year>1999</year>
          <volume>9</volume>
          <fpage>405</fpage>
          <lpage>411</lpage>
          <pub-id pub-id-type="doi">10.1006/scbi.1999.0144</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Helt</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Galloway</surname>
              <given-names>DA</given-names>
            </name>
          </person-group>
          <article-title>Destabilization of retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes</article-title>
          <source>J. Virol</source>
          <year>2001</year>
          <volume>75</volume>
          <fpage>6737</fpage>
          <lpage>6747</lpage>
          <pub-id pub-id-type="doi">10.1128/JVI.75.15.6737-6747.2001</pub-id>
          <?supplied-pmid 11435552?>
          <pub-id pub-id-type="pmid">11435552</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smith-McCune</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kalman</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Robbins</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Shivakumar</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yuschenkoff</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Bishop</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Intranuclear localization of human papillomavirus 16 E7 during transformation and preferential binding of E7 to the Rb family member p130</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <year>1999</year>
          <volume>96</volume>
          <fpage>6999</fpage>
          <lpage>7004</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.96.12.6999</pub-id>
          <?supplied-pmid 10359828?>
          <pub-id pub-id-type="pmid">10359828</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Caldeira</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>de Villiers</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Tommasino</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Human papillomavirus E7 proteins stimulate proliferation independently of their ability to associate with retinoblastoma protein</article-title>
          <source>Oncogene</source>
          <year>2000</year>
          <volume>19</volume>
          <fpage>821</fpage>
          <lpage>826</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.onc.1203375</pub-id>
          <?supplied-pmid 10698500?>
          <pub-id pub-id-type="pmid">10698500</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baker</surname>
              <given-names>GL</given-names>
            </name>
            <name>
              <surname>Landis</surname>
              <given-names>MW</given-names>
            </name>
            <name>
              <surname>Hinds</surname>
              <given-names>PW</given-names>
            </name>
          </person-group>
          <article-title>Multiple functions of D-type cyclins can antagonize pRb-mediated suppression of proliferation</article-title>
          <source>Cell Cycle</source>
          <year>2005</year>
          <volume>4</volume>
          <fpage>330</fpage>
          <lpage>338</lpage>
          <pub-id pub-id-type="doi">10.4161/cc.4.2.1485</pub-id>
          <?supplied-pmid 15684604?>
          <pub-id pub-id-type="pmid">15684604</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sadasivam</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Decaprio</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>The DREAM complex:master coordinator of cell-cycle dependent gene expression</article-title>
          <source>Nature Reviews Cancer</source>
          <year>2013</year>
          <volume>AOP</volume>
          <fpage>1</fpage>
          <lpage>11</lpage>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dick</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>Dyson</surname>
              <given-names>NJ</given-names>
            </name>
          </person-group>
          <article-title>Three regions of the pRB pocket domain affect its inactivation by human papillomavirus E7 proteins</article-title>
          <source>J. Virol</source>
          <year>2002</year>
          <volume>76</volume>
          <fpage>6224</fpage>
          <lpage>6234</lpage>
          <pub-id pub-id-type="doi">10.1128/JVI.76.12.6224-6234.2002</pub-id>
          <?supplied-pmid 12021356?>
          <pub-id pub-id-type="pmid">12021356</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Farkas</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Hansen</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Holm</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Lukas</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bartek</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Distinct phosphorylation events regulate p130 and p107 mediated repression of E2F4</article-title>
          <source>J. Biol Chem</source>
          <year>2002</year>
          <volume>277</volume>
          <fpage>26741</fpage>
          <lpage>26752</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M200381200</pub-id>
          <?supplied-pmid 12006580?>
          <pub-id pub-id-type="pmid">12006580</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Glickman</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Ciechanover</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>The ubiquitin-proteasome proteolytic pathway:destruction for the sake of construction</article-title>
          <source>Physiol Rev</source>
          <year>2002</year>
          <volume>82</volume>
          <fpage>373</fpage>
          <lpage>428</lpage>
          <pub-id pub-id-type="doi">10.1152/physrev.00027.2001</pub-id>
          <?supplied-pmid 11917093?>
          <pub-id pub-id-type="pmid">11917093</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lou</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>E3 ubiquitin ligases and human papillomavirus-induced carcinogenesis</article-title>
          <source>J. Int. Med. Res</source>
          <year>2014</year>
          <volume>42</volume>
          <fpage>247</fpage>
          <lpage>260</lpage>
          <pub-id pub-id-type="doi">10.1177/0300060513506655</pub-id>
          <?supplied-pmid 24445694?>
          <pub-id pub-id-type="pmid">24445694</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nor Rashid</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Yusof</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Watson</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
          <article-title>A B-myb–DREAM Complex Is Not Critical to Regulate the G2/M Genes in HPV-transformed Cell Lines</article-title>
          <source>Anticancer research</source>
          <year>2013</year>
          <volume>34</volume>
          <issue>11</issue>
          <fpage>6557</fpage>
          <lpage>6563</lpage>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:4700560</identifier><datestamp>2016-01-06</datestamp><setSpec>bmcph</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="http://jats.nlm.nih.gov/ns/archiving/1.0/ http://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Public Health</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Public Health</journal-id>
      <journal-title-group>
        <journal-title>BMC Public Health</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1471-2458</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC4700560</article-id>
      <article-id pub-id-type="pmcid">PMC4700560</article-id>
      <article-id pub-id-type="pmc-uid">4700560</article-id>
      <article-id pub-id-type="publisher-id">2629</article-id>
      <article-id pub-id-type="doi">10.1186/s12889-015-2629-x</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Acceptability of tick control interventions to prevent Lyme disease in Switzerland and Canada: a mixed-method study</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Aenishaenslin</surname>
            <given-names>Cécile</given-names>
          </name>
          <address>
            <email>cecile.aenishaenslin@umontreal.ca</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
          <xref ref-type="aff" rid="Aff6"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Michel</surname>
            <given-names>Pascal</given-names>
          </name>
          <address>
            <email>pascal.michel@phac-aspc.gc.ca</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ravel</surname>
            <given-names>André</given-names>
          </name>
          <address>
            <email>andre.ravel@umontreal.ca</email>
          </address>
          <xref ref-type="aff" rid="Aff6"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gern</surname>
            <given-names>Lise</given-names>
          </name>
          <address>
            <email>lise.gern@unine.ch</email>
          </address>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Waaub</surname>
            <given-names>Jean-Philippe</given-names>
          </name>
          <address>
            <email>waaub.jean-philippe@uqam.ca</email>
          </address>
          <xref ref-type="aff" rid="Aff5"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Milord</surname>
            <given-names>François</given-names>
          </name>
          <address>
            <email>francois.milord@usherbrooke.ca</email>
          </address>
          <xref ref-type="aff" rid="Aff4"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bélanger</surname>
            <given-names>Denise</given-names>
          </name>
          <address>
            <email>denise.belanger@umontreal.ca</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
          <xref ref-type="aff" rid="Aff6"/>
        </contrib>
        <aff id="Aff1"><label/>Research Group on Epidemiology of Zoonoses and Public Health, Pavillon de la santé publique, Faculté de médecine vétérinaire, Université de Montréal, CP 5000, Saint-Hyacinthe, J2S 7C6 Québec, Canada </aff>
        <aff id="Aff2"><label/>Laboratory for Foodborne Zoonoses, Public Health Agency of Canada, CP 5000, Saint-Hyacinthe, H2S 7C6 Québec, Canada </aff>
        <aff id="Aff3"><label/>Laboratoire d’Eco-Épidémiologie, Institut de Biologie, Université de Neuchâtel, 11 Émile-Argand, CP 158, 2009 Neuchâtel, Switzerland </aff>
        <aff id="Aff4"><label/>Institut national de santé publique du Québec, 1255 Beauregard, Longueuil, J4K 2M3 Québec, Canada </aff>
        <aff id="Aff5"><label/>Group for Research in Decision Analysis (GERAD), 3000 Côte-Sainte-Catherine, Montréal, H3T 2A7 Québec Canada </aff>
        <aff id="Aff6"><label/>Département de pathologie et microbiologie, Faculté de médecine vétérinaire, Université de Montréal, CP 5000, Saint-Hyacinthe, J2S 7C6 Québec, Canada </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>5</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>5</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2015</year>
      </pub-date>
      <volume>16</volume>
      <elocation-id>12</elocation-id>
      <history>
        <date date-type="received">
          <day>1</day>
          <month>10</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>16</day>
          <month>12</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© Aenishaenslin et al. 2015</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Lyme disease control strategies may include tick control interventions in high risk areas. Public authorities may be interested to assess how these types of interventions are perceived by the public which may then impact their acceptability. The aims of this paper are to compare socio-cognitive factors associated with high acceptability of tick control interventions and to describe perceived issues that may explain their low acceptability in populations living in two different regions, one being an endemic region for LD since the last 30 years, the Neuchâtel canton, in Switzerland, and another where the disease is emerging, the Montérégie region, in Canada.</p>
        </sec>
        <sec>
          <title>Methods</title>
          <p>A mixed methods’ design was chosen. Quantitative data were collected using web-surveys conducted in both regions (<italic>n</italic> = 814). Multivariable logistic regressions were used to compare socio-cognitive factors associated with high acceptability of selected interventions. Qualitative data were collected using focus group’s discussions to describe perceived issues relative to these interventions.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>Levels of acceptability in the studied populations were the lowest for the use of acaricides and landscaping and were under 50 % in both regions for six out of eight interventions, but were higher overall in Montérégie. High perceived efficacy of the intervention was strongly associated with high acceptability of tick control interventions. A high perceived risk about LD was also associated with a high acceptability of intervention under some models. High level of knowledge about LD was negatively associated with high acceptability of the use of acaricides in Neuchâtel. Perceived issues explaining low acceptability included environmental impacts, high costs to the public system, danger of individual disempowerment and perceptions that tick control interventions were disproportionate options for the level of LD risk.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>This study suggests that the perceived efficacy and LD risk perception may be key factors to target to increase the acceptability of tick control interventions. Community-level issues seem to be important considerations driving low acceptability of public health interventions. Results of this study highlight the importance for decision-makers to account for socio-cognitive factors and perceived issues that may affect the acceptability of public health interventions in order to maximize the efficacy of actions to prevent and control LD.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Tick control</kwd>
        <kwd>Lyme disease</kwd>
        <kwd>Borreliosis</kwd>
        <kwd>Prevention</kwd>
        <kwd>Acceptability</kwd>
        <kwd>Risk perception</kwd>
        <kwd>Mixed-methods</kwd>
        <kwd>Intervention acceptability</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000156</institution-id>
              <institution>Fonds de Recherche du Québec - Santé</institution>
            </institution-wrap>
          </funding-source>
          <award-id>25752</award-id>
          <principal-award-recipient>
            <name>
              <surname>Aenishaenslin</surname>
              <given-names>Cécile</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
      </funding-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>© The Author(s) 2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Background</title>
      <p>Lyme disease (LD) is the most frequently reported vector-borne disease in the temperate countries. Caused by the bacteria <italic>Borrelia burgdorferi</italic> and transmitted to humans by a tick bite, the incidence of this multisystemic disease is increasing in several regions around the world [<xref ref-type="bibr" rid="CR1">1</xref>–<xref ref-type="bibr" rid="CR3">3</xref>]. In the absence of a vaccine, preventive strategies adopted by affected countries mostly target the promotion of individual preventive behaviors against tick bites such as wearing protective clothing, applying tick repellent on skin and clothing, checking for and removing ticks after visiting wooded areas, and avoiding tick habitats during high-risk periods [<xref ref-type="bibr" rid="CR4">4</xref>]. Several studies demonstrated that these behaviors were effective to protect oneself against LD [<xref ref-type="bibr" rid="CR4">4</xref>–<xref ref-type="bibr" rid="CR10">10</xref>]. Nevertheless, few studies also underlined that even in regions where LD incidence is high and where the population had a good level of knowledge about the disease, the proportion of people that effectively adopted these behaviors could be quite low, and that these different behaviors were not adopted with the same success by the individuals [<xref ref-type="bibr" rid="CR11">11</xref>–<xref ref-type="bibr" rid="CR16">16</xref>]. Tick control interventions have been studied as well as complementary strategies to prevent LD (reviewed in Piesman and Eisen [<xref ref-type="bibr" rid="CR4">4</xref>]). Studies have shown that these interventions could effectively decrease the vector density in risk areas for LD. These strategies include direct actions on tick populations such as the use of acaricides [<xref ref-type="bibr" rid="CR17">17</xref>], landscaping [<xref ref-type="bibr" rid="CR18">18</xref>–<xref ref-type="bibr" rid="CR20">20</xref>] or biological control of ticks [<xref ref-type="bibr" rid="CR21">21</xref>], and actions that target wild animal species, which are the main hosts of the vector or the reservoirs of the agent, such as the reduction of deer density [<xref ref-type="bibr" rid="CR22">22</xref>], the treatment of deer against ticks [<xref ref-type="bibr" rid="CR23">23</xref>–<xref ref-type="bibr" rid="CR25">25</xref>], the treatment of small rodents against ticks [<xref ref-type="bibr" rid="CR26">26</xref>–<xref ref-type="bibr" rid="CR30">30</xref>] and the vaccination of rodents against <italic>Borrelia</italic> sp. [<xref ref-type="bibr" rid="CR31">31</xref>–<xref ref-type="bibr" rid="CR34">34</xref>]. But such interventions used by public health authorities can have true or perceived impacts that may affect the acceptability of these choices in the targeted population and can cause controversy, such as their negative consequences for the environment or their adverse health effects [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>]. One example of this kind of debate experimented in Canada was caused by the use of larvicide in order to reduce mosquito populations and the risk of West Nile Virus infection [<xref ref-type="bibr" rid="CR37">37</xref>]. Regarding LD, a previous study reported that stakeholders involved in decision-making toward LD prevention in Canada and Switzerland identified social acceptability as an important decision criterion to prioritize preventive interventions [<xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR39">39</xref>]. In policy research, it is well known that public opinion has an impact on policy choices (38). But despite its recognized importance, very few published studies reported empirical data on the acceptability of interventions to prevent and control LD. Gould and colleagues [<xref ref-type="bibr" rid="CR40">40</xref>] measured the acceptability of three environmental interventions against LD in three districts in Connecticut, United States, during two different periods. Their study suggested that the level of acceptability changes according to the intervention, the region of residency and through time. Populations living in districts with the higher LD incidence showed higher levels of acceptability of tick control interventions, but no formal statistical tests were applied to confirm this relationship [<xref ref-type="bibr" rid="CR40">40</xref>]. To our knowledge, no published study explored factors that may be associated with acceptability of these interventions, nor what could explain low acceptability of some interventions in different populations. A better understanding of these factors would be an important addition to the current knowledge on the efficacy of these interventions and would be of great use to enhance informed decision-making by public health authorities.</p>
      <p>The aims of this paper are 1) to measure and compare levels of acceptability of tick control interventions, as well as their associated socio-cognitive factors, and 2) to describe perceived issues that may explain their low acceptability in populations living in two different regions, one being an endemic region for LD since the last 30 years, the Neuchâtel canton, in Switzerland, and another where the disease is emerging, the Montérégie region, in Québec, Canada [<xref ref-type="bibr" rid="CR3">3</xref>]. The choice of these two contrasting regions in terms of their epidemiological situation toward LD gives the opportunity to explore more specifically the influence of the epidemiological situation, and of some socio-cognitive factors related to different contexts on acceptability, that are the level of knowledge on LD in the population and the level of risk perception. Aenishaenslin and colleagues have shown that levels of knowledge and risk perception about LD were higher in Neuchâtel than in Montérégie [<xref ref-type="bibr" rid="CR41">41</xref>]. In this context, we hypothesized that tick control interventions are more acceptable in regions with higher risk of LD (here in Neuchâtel), than in regions with lower risk (Montérégie). For this study, we defined the notion of acceptability as a self-reported positive attitude of individuals toward a hypothetical intervention, given that none of the tick control interventions evaluated in this study had been implemented in both regions before data collection.</p>
    </sec>
    <sec id="Sec2">
      <title>Methods</title>
      <p>A mixed methods’ design was undertaken for this comparative study. In both study regions, quantitative data were collected to measure levels of acceptability for different interventions as well as their potential associated factors, and qualitative data were collected concurrently to identify and describe perceived issues that may explain the low acceptability of the least accepted interventions. Results of both qualitative and quantitative analysis were interpreted together as complementary approaches to answer the study objectives. Informed written consent was obtained from all participants. This procedure and the study protocol were reviewed by the ethical committee for health research of the University of Montreal (Comité d’éthique de la recherche en santé, CERES) (certificate number 12-050-CERES-D), and the ethical certificate was approved by the Université de Neuchâtel.</p>
      <sec id="Sec3">
        <title>Quantitative data</title>
        <sec id="Sec4">
          <title>Data collection</title>
          <p>Quantitative data were collected using cross-sectional web-surveys conducted simultaneously in fall 2012 in both study regions, the Montérégie region (<italic>n</italic> = 401) and the Neuchâtel region (<italic>n</italic> = 413), as part of a larger study [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR41">41</xref>]. Respondents were selected randomly in representative web panels managed in each country by Léger and Marketing survey firm [<xref ref-type="bibr" rid="CR42">42</xref>]. The complete questionnaire was administered in French and included 58 questions (available in [<xref ref-type="bibr" rid="CR11">11</xref>]). Sixteen were specifically designed to measure levels of acceptability and levels of perceived efficacy of eight tick control interventions for LD in both studied populations, namely: using biologic control methods to reduce tick density, for example, the introduction of mushrooms capable of killing ticks (<italic>biological control</italic>), applying acaricides on public areas (<italic>acaricides</italic>), removing vegetation in public wooden areas (<italic>landscaping</italic>), protecting deer against ticks (<italic>deer protection</italic>), protecting rodents against ticks (<italic>rodent protection</italic>), vaccinating rodents against LD (<italic>rodent vaccination</italic>), controlling the number of deer (<italic>deer reduction</italic>) and excluding deer from public areas by fencing (<italic>fencing</italic>). Five-points Likert’s scales were used as measurement units to assess the acceptability levels: “How acceptable do you think this intervention is to control LD with respect to your values? (5) strongly acceptable, (4) somewhat acceptable, (3) neither acceptable or unacceptable, (2) somewhat unacceptable, (1) strongly unacceptable; as well as the levels of perceived efficacy: “Do you agree that this intervention is effective to reduce the risk of LD?”: (5) strongly agree, (4) somewhat agree, (3) neither agree nor disagree, (2) somewhat disagree, (1) strongly disagree.” Additional data collected and used in this study included: gender, age, education level, level of knowledge on LD, and the level of risk perception for LD. Details on the survey design and on data collection strategies are described in more detail in Aenishaenslin et al. [<xref ref-type="bibr" rid="CR41">41</xref>].</p>
        </sec>
        <sec id="Sec5">
          <title>Data analysis</title>
          <p>Descriptive and multivariable statistical analyses were conducted. For the descriptive analyses, we calculated the proportions of respondents with high acceptability (individual scores of 4 or 5 on the Likert’s scale) for each of the eight interventions by region. Confidence intervals for proportions (confidence level of 95 %) were calculated using Agresti-Coull method with R software [<xref ref-type="bibr" rid="CR43">43</xref>]. Pearson Chi-square statistics were calculated to assess significant differences (<italic>p</italic> &lt; 0.05) between regions. This was done to evaluate the levels of acceptability for each intervention in both populations.</p>
          <p>For the multivariable analysis, eight multivariable logistic regression models were built: one per region for each of these four interventions: <italic>landscaping</italic>, <italic>acaricide, rodent vaccination</italic> and <italic>fencing</italic>. These four interventions were selected for multivariable analyses because they were the interventions with the lowest levels of acceptability in both populations according to the descriptive analyses. This was done to study the relationships of three specific socio-cognitive factors: knowledge, risk perception, and perceived efficacy, on high acceptability of these interventions at the individual level. Dependent variables were the acceptability of the interventions (low <italic>vs</italic> high), dichotomized as ‘low’ acceptability (individual scores of 1 to 3), and ‘high’ acceptability (individual scores of 4 or 5). Independent variables were 1) the global LD knowledge level, 2) the global risk perception score, and 3) the perceived efficacy of the specific control interventions. The global LD knowledge level was dichotomized in low if 0 to 2 good answers, and high if 3 or 4 good answers, based on four LD knowledge related questions about the transmission mode, early symptoms, treatment, and risk zones [<xref ref-type="bibr" rid="CR41">41</xref>]. The global risk perception score was the calculated mean score of four observed perception variables about the disease (perceived severity, perceived individual susceptibility, perceived regional susceptibility and feelings of worry, as described in Aenishaenslin et al. [<xref ref-type="bibr" rid="CR41">41</xref>]) and was considered as a continuous variable in the multivariable analyses. The perceived efficacy of the specific control interventions was also dichotomized in low (scores 1 to 3) and high (scores 4 and 5) in the models. Gender, age and education level were considered as potential confounders and forced in all models. Only statistically significant associations are shown for these variables. Participants with missing values (“prefer not to answer”) for one of the included variables were excluded from the models (Montérégie: <italic>n</italic> = 8; Neuchâtel, <italic>n</italic> = 6). Multivariable analyses were performed using IBM SPSS Statistics 19.</p>
        </sec>
      </sec>
      <sec id="Sec6">
        <title>Qualitative data</title>
        <sec id="Sec7">
          <title>Data collection</title>
          <p>Qualitative data were collected during five focus group discussions (FGD) conducted between August and October 2012 (previously to the websurveys) in Neuchâtel city and La-Chaux-de Fond (Neuchâtel canton, Switzerland) and in Saint-Hyacinthe and Longueuil (Montérégie region, Québec, Canada). In each region, residents who were more than 18 years old were invited to participate. Recruitment of this convenience sample was done locally through posters displayed in grocery stores, train stations, universities, public parks and health centers. Advertisements were also posted on outdoor group websites and sent to their members via e-mail. Specific questions addressed were: “Since when did you know LD? What worries you about this disease? What do you think about these interventions to prevent LD? Are they acceptable according to you and why?”. Four environmental interventions were specifically addressed during FGD, based on their anticipated low level of acceptability in the targeted populations: <italic>landscaping, acaricides, rodent vaccination</italic> and <italic>fencing</italic>. Basic information on the interventions was given by the moderator, and participants were welcome to ask complementary questions if needed to allow a common understanding of the interventions. All participants also completed the questionnaire used in the websurveys prior to the discussions. The data collected with these questionnaires were used to compute the descriptive characteristics of participants per region. FGD were conducted in French and lasted one and a half hour. They were recorded and then transcribed entirely.</p>
        </sec>
        <sec id="Sec8">
          <title>Data analysis</title>
          <p>A thematic analysis was performed by the principal researcher (Aenishaenslin C) with the objective to identify and describe the perceived issues that may contribute to the low acceptability of the four selected interventions [<xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR45">45</xref>]. Thematic analysis can be divided in six phases: familiarisation with the data, generating initial codes, searching for themes, reviewing themes, defining and naming themes and producing the report [<xref ref-type="bibr" rid="CR44">44</xref>]. Records and transcripts were first used during the familiarisation phase of analysis. Then, transcripts were analysed to create initial codes representing categories of issues expressed by participants in an iterative process, using QRS NVivo version 10. Codes were then grouped into themes representing the perceived issues related to the acceptability of interventions. Themes were named and reviewed using original transcripts. Extract examples were finally selected in each region, based on their representability of the issue in question. Perceived issues relative to low acceptability were analysed globally rather than for each intervention in order to draw general observations. Details relative to the interviewer and to qualitative data collection, analyse and reporting are presented in the supplementary material, using the consolidated criteria for reporting qualitative studies (COREQ) [<xref ref-type="bibr" rid="CR46">46</xref>].</p>
        </sec>
      </sec>
    </sec>
    <sec id="Sec9">
      <title>Results</title>
      <p>The proportions of respondents with high level of acceptability were significantly higher in Montérégie for all interventions (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). The least accepted intervention was <italic>landscaping</italic> in both regions with 16 % (66/401, 95 % CI = 13–20) in Montérégie and 10 % (41/413, 95 % CI = 7–13) in Neuchâtel (Pearson Chi-square = 7.60, <italic>p</italic> = 0.006). Following by increasing order of acceptability and respectively in Montérégie and Neuchâtel: <italic>acaricides</italic> with 29 % (116/401, 95 % CI = 25–34) and 12 % (51/413, 95 % CI = 9–16) (Pearson Chi-square = 34.29, <italic>p</italic> &lt; 0.001), <italic>rodent vaccination</italic> with 33 % (131/401, 95 % CI = 28–37) and 26 % (108/401, 95 % CI = 22–31) (Pearson Chi-square = 4.17, <italic>p</italic> = 0.04), <italic>fencing</italic> with 37 % (150/401, 95 % CI = 33–42) and 14 % (56/413, 95 % CI = 11–17) (Pearson Chi-square = 61.21, <italic>p</italic> &lt;0.001), <italic>deer reduction</italic> with 47 % (187/401, 95 % CI = 42–52) and 31 % (126/413, 95 % CI = 26–35) (Pearson Chi-square = 22.35, <italic>p</italic> &lt;0.001), <italic>rodents protection</italic> with 51 % (204/401, 95 % CI = 46–56) and 42 % (172/413, 95 % CI = 37–46) (Pearson Chi-square = 6.97, <italic>p</italic> = 0.008), <italic>deer protection</italic> with 66 % (266/401, 95 % CI = 62–71) and 51 % (211/413, 95 % CI = 46–56) (Pearson Chi-square = 19.49, <italic>p</italic> &lt;0.001), and <italic>biological control</italic> with 86 % (345/401, 95 % CI = 82–89) and 76 % (315/413, 95 % CI = 72–80) (Pearson Chi-square = 12.64, <italic>p</italic> &lt;0.001).<fig id="Fig1"><label>Fig. 1</label><caption><p>Levels of acceptability of tick control interventions in Neuchâtel and Montérégie. This figure shows the proportions of respondents with high acceptability (scores of 4 or 5) for eight tick control interventions against LD in Neuchâtel (<italic>n</italic> = 413) and Montérégie (<italic>n</italic> = 401)</p></caption><graphic xlink:href="12889_2015_2629_Fig1_HTML" id="MO1"/></fig></p>
      <p>In the multivariable analyses, socio-cognitive factors that were statistically associated with high acceptability of <italic>landscaping, acaricides, rodent vaccination</italic> and <italic>fencing</italic> varied in both regions (Table <xref rid="Tab1" ref-type="table">1</xref>). High perceived efficacy of the intervention was strongly associated with high acceptability of all interventions in all models. Risk perception was positively associated with high acceptability of <italic>landscaping</italic> in both regions, and it was positively associated with high acceptability of <italic>acaricides</italic> and <italic>fencing</italic> in Montérégie. High level of knowledge about LD was negatively associated with high acceptability of <italic>acaricides</italic> in Neuchâtel. Being between 18 and 34 years old was negatively associated with high acceptability of <italic>acaricides</italic> in Montérégie, in comparison to those who were more than 55 years old. Having a university degree was negatively associated with high acceptability of <italic>landscaping</italic> in Neuchâtel. When considering confidence intervals of OR (confidence level: 95 %), there was no difference regarding the strength of association between knowledge, risk perception and perceived efficacy and high acceptability of interventions between regional models.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Factors associated with high acceptability (scores of 4 or 5) of <italic>landscaping</italic>, <italic>acaricide, rodent vaccination</italic> and <italic>fencing</italic> (Logistic regressions)</p></caption><table frame="hsides" rules="groups"><tbody><tr><td colspan="5">Factors associated with high acceptability of <italic>landscaping</italic>
</td></tr><tr><td/><td colspan="2">Montérégie (<italic>n</italic> = 393)</td><td colspan="2">Neuchâtel (<italic>n</italic> = 407)</td></tr><tr><td/><td>OR</td><td>95 % CI</td><td>OR</td><td>95 % CI</td></tr><tr><td>Age 18–34 years</td><td>0.32</td><td>(0.09–1.10)</td><td>0.51</td><td>(0.13–1.98)</td></tr><tr><td>35–54 years</td><td>0.77</td><td>(0.39–1.54)</td><td>2.70</td><td>(0.93–7.88)</td></tr><tr><td>55+ yr <sup>R</sup>
</td><td>1</td><td>na</td><td>1</td><td>na</td></tr><tr><td>Education (University)</td><td>0.83</td><td>(0.39–1.76)</td><td>0.36</td><td>(0.15–0.88)*</td></tr><tr><td>Knowledge of LD</td><td>1.02</td><td>(0.42–2.48)</td><td>0.72</td><td>(0.31–1.67)</td></tr><tr><td>Risk perception</td><td>1.64</td><td>(1.05–2.57)*</td><td>2.88</td><td>(1.45–5.74)**</td></tr><tr><td>Perceived efficacy</td><td>16.31</td><td>(8.50–31.28)***</td><td>37.48</td><td>(13.95–100.71)***</td></tr><tr><td colspan="5">Factors associated with high acceptability of the use of <italic>acaricides</italic>
</td></tr><tr><td/><td colspan="2">Montérégie (<italic>n</italic> = 393)</td><td colspan="2">Neuchâtel (<italic>n</italic> = 407)</td></tr><tr><td/><td>OR</td><td>95 % CI</td><td>OR</td><td>95 % CI</td></tr><tr><td>Age 18–34 years</td><td>0.16</td><td>(0.05–0.49)***</td><td>0.47</td><td>(0.18–1.23)</td></tr><tr><td>35–54 years</td><td>0.98</td><td>(0.54–1.80)</td><td>0.85</td><td>(0.37–1.95)</td></tr><tr><td>55+ yr <sup>R</sup>
</td><td>1</td><td>na</td><td>1</td><td>na</td></tr><tr><td>Knowledge of LD</td><td>0.47</td><td>(0.20–1.07)</td><td>0.33</td><td>(0.16–0.69)**</td></tr><tr><td>Risk perception</td><td>1.60</td><td>(1.08–2.36)*</td><td>1.48</td><td>(0.88–2.50)</td></tr><tr><td>Perceived efficacy</td><td>20.89</td><td>(11.41–38.22)***</td><td>12.28</td><td>(6.03–24.99)***</td></tr><tr><td colspan="5">Factors associated with high acceptability of <italic>rodent vaccination</italic>
</td></tr><tr><td/><td colspan="2">Montérégie (<italic>n</italic> = 393)</td><td colspan="2">Neuchâtel (<italic>n</italic> = 407)</td></tr><tr><td/><td>OR</td><td>95 % CI</td><td>OR</td><td>95 % CI</td></tr><tr><td>Education (University)</td><td>2.01</td><td>(1.11–3.66)*</td><td>0.69</td><td>(0.39–1.20)</td></tr><tr><td>Knowledge of LD</td><td>0.67</td><td>(0.32–1.42)</td><td>1.05</td><td>(0.61–1.81)</td></tr><tr><td>Risk perception</td><td>1.34</td><td>(0.92–1.96)</td><td>1.35</td><td>(0.91–2.00)</td></tr><tr><td>Perceived efficacy</td><td>21.37</td><td>(12.15–37.58)***</td><td>17.37</td><td>(9.69–31.15)***</td></tr><tr><td colspan="5">Factors associated with high acceptability of <italic>fencing</italic> to restrict deer from public areas</td></tr><tr><td/><td colspan="2">Montérégie (<italic>n</italic> = 393)</td><td colspan="2">Neuchâtel (<italic>n</italic> = 407)</td></tr><tr><td/><td>OR</td><td>95 % CI</td><td>OR</td><td>95 % CI</td></tr><tr><td>Age 18–34 years</td><td>0.65</td><td>(0.27–1.57)</td><td>1.48</td><td>(0.53–4.16)</td></tr><tr><td>35–54 years</td><td>0.56</td><td>(0.31–1.03)</td><td>2.60</td><td>(1.04–6.48)*</td></tr><tr><td>55+ yr <sup>R</sup>
</td><td>1</td><td>na</td><td>1</td><td>Na</td></tr><tr><td>Knowledge of LD</td><td>0.64</td><td>(0.29–1.43)</td><td>0.93</td><td>(0.48–1.79)</td></tr><tr><td>Risk perception</td><td>1.65</td><td>(1.13–2.41)**</td><td>1.07</td><td>(0.68–1.68)</td></tr><tr><td>Perceived efficacy</td><td>22,82</td><td>(12.83–40.59)***</td><td>10,17</td><td>(5.27–19.63)***</td></tr></tbody></table><table-wrap-foot><p>*<italic>p</italic> &lt;0.05. **<italic>p</italic> &lt; 0.01. ***<italic>p</italic> &lt; 0.001</p></table-wrap-foot></table-wrap></p>
      <p>Thirty-four participants were recruited for the five FGD (specific locations, number of participants and participant characteristics are presented in Table <xref rid="Tab2" ref-type="table">2</xref>). Women represented 71 % of the participants (24/34), and age groups from 18–24 years old to 75+ years old were represented by at least one participant. Most participants had a high level of knowledge about LD (58 % in Montérégie and 86 % in Neuchâtel). In Neuchâtel, 27 % (7/22) of participants had a high risk perception score, compared to 50 % (6/12) in Montérégie.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Distribution of participants by region for the five FGD</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Region</th><th>Focus groups (number of participants)</th><th>Descriptive characteristics of participants by region</th></tr></thead><tbody><tr><td rowspan="7">Neuchâtel</td><td>Focus group 1 (7)</td><td>22/22 (100 %) were aware of LD for more than one year</td></tr><tr><td>Focus group 2 (9)</td><td>7/22 (27 %) had a high risk perception (global risk perception score ≥4)</td></tr><tr><td>Focus group 3 (6)</td><td>19/22 (86 %) had a high level of knowledge on LD</td></tr><tr><td rowspan="4">Total = 22</td><td>3/22 (14 %) declared that they had LD in the past</td></tr><tr><td>17/22 (77 %) declared that they knew someone who has ever had LD</td></tr><tr><td>16/22 (73 %) were women</td></tr><tr><td>Age of participants was distributed between 18 and more than 75 years old.</td></tr><tr><td rowspan="7">Montérégie</td><td>Focus group 4 (6)</td><td>10/12 (83 %) were aware of LD for more than one year</td></tr><tr><td>Focus group 5 (6)</td><td>6/12 (50 %) had a high risk perception (global risk perception score ≥4)</td></tr><tr><td rowspan="5">Total = 12</td><td>7/12 (58 %) had a high level of knowledge on LD</td></tr><tr><td>0/12 (0 %) declared that they had LD in the past</td></tr><tr><td>1/12 (8 %) declared that they knew someone who has ever had LD</td></tr><tr><td>8/12 (67 %) were women</td></tr><tr><td>Age of participants was distributed between 25 and 64 years old</td></tr></tbody></table></table-wrap></p>
      <p>Through qualitative analysis, we identified eight common themes representing the perceived issues that may explain the low acceptability of the four selected interventions in the FGD performed in both regions. The recurrence of these themes into all focus groups suggests that a good level of data saturation was achieved. The first and commonly reported in both regions was the perception that the intervention would be disproportionate to manage the level of risk due to LD. Even with a good knowledge of LD and being aware that the risk of contracting the disease was present in their region, participants frequently mentioned that LD risk was not high enough for the population to justify the use of tick control interventions, as reported by a Montérégie participant: <italic>‘In the current situation, I do not feel it would be important to have such an impact, but in case it becomes a major public health problem, I would consider</italic> [rodent vaccination]’. In relation to this perception of disproportion, the fear of unknown consequences following the use of interventions to reduce the tick density was frequently mentioned, as illustrated by this Neuchâtel participant, while discussing about rodent vaccination: <italic>‘There is chemistry in this intervention. Maybe we eradicate an evil, but we recreate another’</italic>. More specifically, participants of both regions mentioned the fear of negative environmental impacts. This issue was both reported as a rational argument based on the potential impact on biodiversity or natural habitat: ‘[…] <italic>If we speak of destroying animal habitat in protected areas, it seems to me rather questionable … it depends upon the impact on other species.’</italic> (Montérégie participant about <italic>landscaping</italic>). This fear was also expressed as a conflict with more general personal values regarding both animal well-being and protection of natural environments. This dimension was often mentioned in both regions, but more clearly defined in Neuchâtel: <italic>‘I do not see why we should change the nature because of a little bug’</italic> (Neuchâtel participant about <italic>landscaping</italic>)<italic>.</italic> Another perception frequently mentioned was the economic impacts of implementing the interventions. Participants of both regions shared concerns about the high public costs of interventions, as stated by this Neuchâtel participant: ‘[…] <italic>To take rodents and vaccinate them… we can spend public money otherwise’</italic>.</p>
      <p>Implementing these tick control interventions to prevent LD was also perceived as a threat to individual empowerment. It was perceived that if public health authorities made the choice of using such interventions, individuals would be tempted to distance themselves from their responsibility to adopt preventive behaviors: <italic>‘To want to protect humans by destroying nature when they do nothing to protect themselves, to me, it is unacceptable</italic> ’(expressed by a Montérégie participant). Doubts about the feasibility of the interventions were also reported, regarding all presented interventions. Even after explanations from the FGD moderator about the feasibility of the interventions, participants had sometimes difficulties to believe that it was feasible, as stated by this Montérégie participant: <italic>‘I find it peculiar a little. How to prevent deer from going to places?</italic> […] <italic>Can you really control it? I don’t think that you can control the movement of deer.’</italic> Finally, some interventions, such as landscaping, were perceived as acceptable only if implemented at a smaller scale:<italic>‘It is also different concepts if it is to destroy half a forest to reduce the tick population</italic> [or] <italic>if it is to expand certain paths by removing a portion of the low vegetation</italic> […]. <italic>That is acceptable because it has less impact on the ecosystem.’</italic> (Neuchâtel participant about <italic>landscaping</italic>).</p>
      <p>We did not identify major differences through qualitative analysis in categories of issues explaining low acceptability of these tick control interventions between Neuchâtel and Montégérie participants. One observed difference was that Neuchâtel participants more frequently stated that public authorities should prioritize actions aiming to raise the population awareness on LD and promote individual preventive behaviors instead of considering the use of tick control interventions to reduce LD risk: <italic>‘I would go further.</italic> [Fencing] <italic>is indefensible. It is not always to the man to adapt the landscape to what he wants […] It is also up to us to learn to live with our environment.’</italic> (Neuchâtel participant). Moreover, the perception that individuals can and should protect themselves was stronger among participants of this region when compared to Montérégie, where participants more frequently asked questions on how to prevent Lyme disease in general. Nevertheless, it was perceived that access to information about LD was lacking in both regions.</p>
    </sec>
    <sec id="Sec10">
      <title>Discussion</title>
      <p>This study showed that the levels of acceptability of tick control interventions to prevent LD was low in Neuchâtel and Montérégie, with only two interventions out of eight (<italic>deer protection</italic> and <italic>biological control</italic>) reaching at least 50 % of the studied populations in both regions. These results contrast with those reported by Gould and colleagues in Connecticut (USA) [<xref ref-type="bibr" rid="CR40">40</xref>]. In this study, levels of acceptability for <italic>deer control</italic>, <italic>deer protection,</italic> and <italic>acaricides</italic> were measured at two periods in 1999 and in 2004. All three interventions reached levels of acceptability of more than 50 % of the population for the two periods and in all three studied districts [<xref ref-type="bibr" rid="CR40">40</xref>]. One partial explanation for this difference can be that the incidence of LD in the studied districts ranged from 240 to 411 cases per 100,000 people at the time of the study, which is considerably higher than our two study regions [<xref ref-type="bibr" rid="CR40">40</xref>]. Considering our results, the fact that respondents from Montérégie region in Canada had low levels of acceptability can be understood when considering that LD incidence in this region is still very low (estimated at 0.5 case per 100,000 inhabitants in Montérégie in 2012) [<xref ref-type="bibr" rid="CR47">47</xref>]. The population may not perceive the need for these kinds of interventions. This explanation is corroborated by the qualitative analysis, underlining that one major issue related to low acceptability was the perception that tick control interventions are disproportionate options for the level of LD risk to which the population is exposed.</p>
      <p>Surprisingly, the fact that levels of acceptability of all interventions were even lower in Neuchâtel canton was unexpected, given our initial hypothesis which stated that populations living in regions with higher incidence of LD would be more receptive to tick control interventions. Neuchâtel canton has an incidence estimated to be between 49 to 95 cases per 100,000 inhabitants per year (data from 1996 and 2001) [<xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR49">49</xref>] which is still lower than the three Connecticut districts studied in Gould et al. [<xref ref-type="bibr" rid="CR40">40</xref>], but much higher than in Montérégie, and comparable to some endemic regions of the East coast of the United States. Even if we cannot consider that FGD participants are representative of the surveyed population, results of the qualitative analysis provided information that may help to explain these findings: Neuchâtel participants seemed to put a high value on the environment and its conservation, and shared the perception that the risk of LD does not justify the use of interventions that can affect the environment. This is coherent with a recent study by Aenishaenslin and colleagues [<xref ref-type="bibr" rid="CR39">39</xref>] which reported that Swiss stakeholders involved in decision-making for implementing LD preventive strategies did not want to include as hypothetical interventions in a decision-model some tick control interventions such as application of acaricides or landscaping at large scales, because their potential impact on the environment was against their population’s values.</p>
      <p>Results from multivariable analyses showed that high perceived efficacy was strongly associated with high acceptability of interventions, and that risk perception was also a factor associated with it in several logistic models. These two socio-cognitive factors were associated with the adoption of individual preventive behaviors toward LD in a recent study which analyzed the same sampled populations [<xref ref-type="bibr" rid="CR11">11</xref>], and they are known predictors of health behaviors in a number of theoretical models, including the Health Belief Model [<xref ref-type="bibr" rid="CR50">50</xref>]. On the other hand, the negative relationship between high level of knowledge on LD and high acceptability of <italic>acaricides</italic> was unexpected. The relationship was also negative in Montérégie and in other intervention’s models, but not statistically significant. A high level of knowledge was positively associated with higher levels of adoption of preventive behaviors against LD as performing tick checks, wearing protective clothing and putting tick repellent in another study [<xref ref-type="bibr" rid="CR11">11</xref>]. Again, results of the qualitative analysis can help to understand this observation. In both regions, participants of the FGD had a higher level of knowledge than their respective population, as measured by Aenishaenslin in a previous study [<xref ref-type="bibr" rid="CR41">41</xref>]: in Montérégie, 58 % of the FGD participants had a good level of knowledge against only 15 % in the survey, and in Neuchâtel, 86 % of the FGD participants, compared to 51 % in the survey. This difference may be due to the recruitment process: FGD participants were recruited voluntarily by responding to a public invitation, so it is normal that this method selected individuals who were interested by the subject and who knew more about it than the population mean. Nevertheless, two important themes were omnipresent during discussions in Neuchâtel: 1) participants felt that individuals can protect themselves from LD by adopting preventive behaviors and should be responsible of their own protection, and then 2) they felt that LD risk was not high enough to use interventions with potential consequences on the environment. Indeed, our results suggest that a good level of knowledge may increase the perception of self-control on LD prevention, rather than increasing the acceptability of tick control interventions.</p>
      <p>We found no statistical difference in the strength of association between high perceived efficacy of the intervention, risk perception, high level of knowledge on LD and high acceptability between both regions. This result is interesting given that the studied population contexts differed on several aspects, including their LD epidemiological situation, their history with the disease and their socio-cultural context. We could not find other published studies that measured such an association over the past. Further research conducted in other countries or regions where LD is present would be needed to support these findings.</p>
      <p>The eight perceived issues identified to explain low acceptability of selected interventions have interesting similarities with the decision criteria identified by stakeholders involved in LD prevention and control in two previous studies conducted in Québec, Canada [<xref ref-type="bibr" rid="CR38">38</xref>] and in Switzerland [<xref ref-type="bibr" rid="CR39">39</xref>]. These studies respectively aimed at developing a multi-criteria decision model for LD prevention in Québec, and to adapt this model to the Swiss context, using a participatory approach with local stakeholders. These stakeholders participated in the elaboration of a list of important criteria to consider in order to prioritize LD preventive and control interventions, as well as a list of potential interventions. Most of the perceived issues explaining low acceptability find their equivalent in some of the criteria included in these two decision models. Conflict with personal values such as animal well-being and respect of natural environment, fear of environmental and other unknown consequences are issues addressed in the following criteria: “impacts on habitat”, “impacts on wildlife” and “adverse health effects” [<xref ref-type="bibr" rid="CR38">38</xref>]. Doubts about the feasibility of interventions are reflected by the inclusion of operational criteria such as the “complexity of the intervention’s implementation” [<xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR39">39</xref>] and the “durability of effects” [<xref ref-type="bibr" rid="CR39">39</xref>]. Concerns with public costs are directly addressed with the criterion “cost to the public sector’ [<xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR39">39</xref>]. Danger of disempowerment of the population is aligned with the criterion measuring the capacity of the intervention to raise the level of public awareness, which was added by Swiss stakeholders [<xref ref-type="bibr" rid="CR39">39</xref>]. Moreover, the distinction made by participants to the FGD regarding large <italic>vs</italic> small scales interventions is also taken into account in the decision models by separating some potential interventions (acaricide and landscaping) into small scale <italic>vs</italic> large scale interventions in order to measure their impacts if they were implemented [<xref ref-type="bibr" rid="CR38">38</xref>]. This observation suggests two interesting trends. First, issues expressed by individuals reflect community-level issues rather than only self-oriented considerations, such as adverse health effects on oneself or its close relatives. Second, these perceived issues are shared by stakeholders involved in LD management in public organisations and can be taken into account in the decision-making process by using tools such as multi-criteria decision analysis [<xref ref-type="bibr" rid="CR38">38</xref>].</p>
      <p>This study has some limitations. First, this study design was cross-sectional and cannot presume of any causal relationships between factors associated with high acceptability in the quantitative analyses. Moreover, quantitative data were collected using a web panel and the sample cannot be considered as probabilistic. Nevertheless, distributions of gender, age and level of education of both studied samples were representative of demographic characteristics of Montérégie and Neuchâtel, as described in further details in Aenishaenslin et al. 2014 [<xref ref-type="bibr" rid="CR41">41</xref>]. Another point to keep in mind is that several variables were measured with an ordinal scale in the survey, but were dichotomized for the analysis. This was done to allow a useful interpretation of the results in the public health context, to carry out multivariable logistic regression analyses and to maximise statistical power. But this methodological step results in a partial loss of information when compared to the raw survey data.</p>
      <p>Regarding qualitative analysis, it is important to underline that the perceived issues identified to explain the low acceptability represent the perceptions of two small groups of participants, and may change over time according to contextual factors such as modifications in LD epidemiological situation or in the media attention toward this subject. The qualitative analysis was performed to explore perceived issues in the general public, but this approach cannot produce results that can be directly generalised to both regional populations. Also, FGD participants were recruited on a voluntary basis, and fewer participants manifested their interest to participate in Montérégie than in Neuchâtel (12 participants in Montérégie <italic>vs</italic> 22 in Neuchâtel). This can be understood by the difference in the levels of knowledge and risk perception between both regions [<xref ref-type="bibr" rid="CR41">41</xref>], but may have affected the results. Moreover, it was noted that during the Montérégie FGD, participants had sometimes difficulties to express clear opinions on the acceptability of LD interventions given that they did not know enough about the disease, its consequences and individual preventive behaviors. This may reflect fluidity in the opinion expressed and, consequently, it would be worthwhile to follow-up on this study to assess variation in opinions as well as progress in the population’s knowledge and perceptions since 2012.</p>
    </sec>
    <sec id="Sec11">
      <title>Conclusion</title>
      <p>This study strongly suggests that the perceived efficacy of public health interventions and LD risk perception in populations may be factors to consider in communication and knowledge translation efforts to increase the acceptability of tick control interventions when appropriate. Public health authorities may expect a higher level of reluctance to accept some of these interventions in populations with a higher level of knowledge about the disease, which may orient the consideration of different preventive strategies. In addition, low acceptability cannot be explained only by issues that may closely affect individuals such as immediate adverse health effects. Individuals who participated in this study expressed multiple issues related to LD management at the community level, such as possible impacts on environment and wildlife, high public costs and disempowerment of the population. These concerns are shared by decision-makers and can be integrated to the decision-making process by using tools such as multi-criteria decision analysis. Results of this study highlight the importance for decision-makers to account for regional socio-cognitive factors and perceived issues that may affect the acceptability of interventions in the target populations in order maximize the efficacy of interventions to prevent and control LD. Moreover, the study underlines the importance for decision-makers to be explicit about the public costs, the scale at which the intervention will be implemented, and its known impacts on ecosystems, when presenting an intervention to the target populations, as these aspects can modify its acceptability.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The authors declare that they have no competing interests.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors’ contributions</bold>
        </p>
        <p>CA conceived and designed the study and drafted the manuscript. AR, PM and LG helped in the elaboration of the questionnaires and organisation of focus groups. AR, PM, LG, FM, JPW and DB helped in the conception of the study. All authors read, revised and approved the final manuscript.</p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgements</title>
      <p>The authors would like to acknowledge Caroline Burri, Leonore Lovis and Liselore Roeslstra, as well as the University of Neuchâtel and the Direction de la santé publique de la Montérégie for their help in the organisation of the focus groups. Funding was provided by the Fonds de la recherche du Québec, the Public Health Agency of Canada, the 4P Training program in health promotion, prevention and public policy, and the Ministère de l’Éducation, des Loisirs et des Sports du Québec.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <mixed-citation publication-type="other">Rizzoli A, Hauffe H, Carpi G, Vourc HG, Neteler M, Rosa R. Lyme borreliosis in Europe. Euro Surveill. 2011;16(27):1–8.</mixed-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Steere</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Coburn</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Glickstein</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>The emergence of Lyme disease</article-title>
          <source>J Clin Invest</source>
          <year>2004</year>
          <volume>113</volume>
          <issue>8</issue>
          <fpage>1093</fpage>
          <lpage>101</lpage>
          <pub-id pub-id-type="doi">10.1172/JCI21681</pub-id>
          <?supplied-pmid 15085185?>
          <pub-id pub-id-type="pmid">15085185</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ogden</surname>
              <given-names>NH</given-names>
            </name>
            <name>
              <surname>Lindsay</surname>
              <given-names>LR</given-names>
            </name>
            <name>
              <surname>Morshed</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sockett</surname>
              <given-names>PN</given-names>
            </name>
            <name>
              <surname>Artsob</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>The emergence of Lyme disease in Canada</article-title>
          <source>CMAJ</source>
          <year>2009</year>
          <volume>180</volume>
          <issue>12</issue>
          <fpage>1221</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="doi">10.1503/cmaj.080148</pub-id>
          <?supplied-pmid 19506281?>
          <pub-id pub-id-type="pmid">19506281</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Piesman</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Eisen</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Prevention of tick-borne diseases</article-title>
          <source>Annu Rev Entomol</source>
          <year>2008</year>
          <volume>53</volume>
          <fpage>323</fpage>
          <lpage>43</lpage>
          <pub-id pub-id-type="doi">10.1146/annurev.ento.53.103106.093429</pub-id>
          <?supplied-pmid 17877457?>
          <pub-id pub-id-type="pmid">17877457</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vazquez</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Muehlenbein</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Cartter</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hayes</surname>
              <given-names>EB</given-names>
            </name>
            <name>
              <surname>Ertel</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Shapiro</surname>
              <given-names>ED</given-names>
            </name>
          </person-group>
          <article-title>Effectiveness of personal protective measures to prevent Lyme disease</article-title>
          <source>Emerg Infect Dis</source>
          <year>2008</year>
          <volume>14</volume>
          <issue>2</issue>
          <fpage>210</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.3201/eid1402.070725</pub-id>
          <?supplied-pmid 18258112?>
          <pub-id pub-id-type="pmid">18258112</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Finch</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Al-Damluji</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Krause</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Niccolai</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Steeves</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>O’Keefe</surname>
              <given-names>CF</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Integrated assessment of behavioral and environmental risk factors for Lyme disease infection on Block Island, Rhode Island</article-title>
          <source>PLoS One</source>
          <year>2014</year>
          <volume>9</volume>
          <issue>1</issue>
          <fpage>e84758</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0084758</pub-id>
          <?supplied-pmid 24416278?>
          <pub-id pub-id-type="pmid">24416278</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lane</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Manweiler</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Stubbs</surname>
              <given-names>HA</given-names>
            </name>
            <name>
              <surname>Lennette</surname>
              <given-names>ET</given-names>
            </name>
            <name>
              <surname>Madigan</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Lavoie</surname>
              <given-names>PE</given-names>
            </name>
          </person-group>
          <article-title>Risk factors for Lyme disease in a small rural community in northern California</article-title>
          <source>Am J Epidemiol</source>
          <year>1992</year>
          <volume>136</volume>
          <issue>11</issue>
          <fpage>1358</fpage>
          <lpage>68</lpage>
          <?supplied-pmid 1488962?>
          <pub-id pub-id-type="pmid">1488962</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smith</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Wileyto</surname>
              <given-names>EP</given-names>
            </name>
            <name>
              <surname>Hopkins</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Cherry</surname>
              <given-names>BR</given-names>
            </name>
            <name>
              <surname>Maher</surname>
              <given-names>JP</given-names>
            </name>
          </person-group>
          <article-title>Risk factors for lyme disease in Chester County, Pennsylvania</article-title>
          <source>Public Health Rep</source>
          <year>2001</year>
          <volume>116</volume>
          <issue>Suppl 1</issue>
          <fpage>146</fpage>
          <lpage>56</lpage>
          <pub-id pub-id-type="doi">10.1093/phr/116.S1.146</pub-id>
          <?supplied-pmid 11889282?>
          <pub-id pub-id-type="pmid">11889282</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Malouin</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Winch</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Leontsini</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Glass</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Simon</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Hayes</surname>
              <given-names>EB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Longitudinal evaluation of an educational intervention for preventing tick bites in an area with endemic lyme disease in Baltimore County, Maryland</article-title>
          <source>Am J Epidemiol</source>
          <year>2003</year>
          <volume>157</volume>
          <issue>11</issue>
          <fpage>1039</fpage>
          <lpage>51</lpage>
          <pub-id pub-id-type="doi">10.1093/aje/kwg076</pub-id>
          <?supplied-pmid 12777368?>
          <pub-id pub-id-type="pmid">12777368</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mowbray</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Amlot</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Rubin</surname>
              <given-names>GJ</given-names>
            </name>
          </person-group>
          <article-title>Ticking all the boxes? A systematic review of education and communication interventions to prevent tick-borne disease</article-title>
          <source>Vector Borne Zoonotic Dis</source>
          <year>2012</year>
          <volume>12</volume>
          <issue>9</issue>
          <fpage>817</fpage>
          <lpage>25</lpage>
          <pub-id pub-id-type="doi">10.1089/vbz.2011.0774</pub-id>
          <?supplied-pmid 22607072?>
          <pub-id pub-id-type="pmid">22607072</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aenishaenslin</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Michel</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Ravel</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gern</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Milord</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Waaub</surname>
              <given-names>JP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Factors associated with preventive behaviors regarding Lyme disease in Canada and Switzerland: a comparative study</article-title>
          <source>BMC Public Health</source>
          <year>2015</year>
          <volume>15</volume>
          <fpage>1539</fpage>
          <pub-id pub-id-type="doi">10.1186/s12889-015-1539-2</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Herrington</surname>
              <given-names>JE</given-names>
            </name>
          </person-group>
          <article-title>Risk perceptions regarding ticks and Lyme disease: a national survey</article-title>
          <source>Am J Prev Med</source>
          <year>2004</year>
          <volume>26</volume>
          <issue>2</issue>
          <fpage>135</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="doi">10.1016/j.amepre.2003.10.010</pub-id>
          <?supplied-pmid 14751325?>
          <pub-id pub-id-type="pmid">14751325</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Phillips</surname>
              <given-names>CB</given-names>
            </name>
            <name>
              <surname>Liang</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Sangha</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Wright</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Fossel</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Lew</surname>
              <given-names>RA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Lyme disease and preventive behaviors in residents of Nantucket Island, Massachusetts</article-title>
          <source>Am J Prev Med</source>
          <year>2001</year>
          <volume>20</volume>
          <issue>3</issue>
          <fpage>219</fpage>
          <lpage>24</lpage>
          <pub-id pub-id-type="doi">10.1016/S0749-3797(00)00315-9</pub-id>
          <?supplied-pmid 11275450?>
          <pub-id pub-id-type="pmid">11275450</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hallman</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Weinstein</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kadakia</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Chess</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Precautions taken against Lyme disease at three recreational parks in endemic areas of New Jersey</article-title>
          <source>Environ Behav</source>
          <year>1995</year>
          <volume>27</volume>
          <issue>4</issue>
          <fpage>437</fpage>
          <lpage>53</lpage>
          <pub-id pub-id-type="doi">10.1177/0013916595274001</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mowbray</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Amlot</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Rubin</surname>
              <given-names>GJ</given-names>
            </name>
          </person-group>
          <article-title>Predictors of protective behaviour against ticks in the UK: a mixed methods study</article-title>
          <source>Ticks Tick Borne Dis</source>
          <year>2014</year>
          <volume>5</volume>
          <issue>4</issue>
          <fpage>392</fpage>
          <lpage>400</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ttbdis.2014.01.006</pub-id>
          <?supplied-pmid 24713278?>
          <pub-id pub-id-type="pmid">24713278</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <mixed-citation publication-type="other">Valente SL, Wemple D, Ramos S, Cashman SB, Savageau JA. Preventive behaviors and knowledge of tick-borne illnesses: results of a survey from an endemic area. J Public Health Manag Pract. 2014;21(3):16–23.</mixed-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Curran</surname>
              <given-names>KL</given-names>
            </name>
            <name>
              <surname>Fish</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Piesman</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Reduction of nymphal <italic>Ixodes dammini</italic> (Acari: Ixodidae) in a residential suburban landscape by area application of insecticides</article-title>
          <source>J Med Entomol</source>
          <year>1993</year>
          <volume>30</volume>
          <issue>1</issue>
          <fpage>107</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="doi">10.1093/jmedent/30.1.107</pub-id>
          <?supplied-pmid 8433317?>
          <pub-id pub-id-type="pmid">8433317</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stafford</surname>
              <given-names>KC</given-names>
              <suffix>3rd</suffix>
            </name>
            <name>
              <surname>Ward</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Magnarelli</surname>
              <given-names>LA</given-names>
            </name>
          </person-group>
          <article-title>Impact of controlled burns on the abundance of <italic>Ixodes scapularis</italic> (Acari: Ixodidae)</article-title>
          <source>J Med Entomol</source>
          <year>1998</year>
          <volume>35</volume>
          <issue>4</issue>
          <fpage>510</fpage>
          <lpage>3</lpage>
          <pub-id pub-id-type="doi">10.1093/jmedent/35.4.510</pub-id>
          <?supplied-pmid 9701937?>
          <pub-id pub-id-type="pmid">9701937</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schulze</surname>
              <given-names>TL</given-names>
            </name>
            <name>
              <surname>Jordan</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Potential influence of leaf litter depth on effectiveness of granular carbaryl against subadult <italic>Ixodes scapularis</italic> (Acari: Ixodidae)</article-title>
          <source>J Med Entomol</source>
          <year>1995</year>
          <volume>32</volume>
          <issue>2</issue>
          <fpage>205</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1093/jmedent/32.2.205</pub-id>
          <?supplied-pmid 7608930?>
          <pub-id pub-id-type="pmid">7608930</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schulze</surname>
              <given-names>TL</given-names>
            </name>
            <name>
              <surname>Jordan</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Hung</surname>
              <given-names>RW</given-names>
            </name>
          </person-group>
          <article-title>Suppression of subadult <italic>Ixodes scapularis</italic> (Acari: Ixodidae) following removal of leaf litter</article-title>
          <source>J Med Entomol</source>
          <year>1995</year>
          <volume>32</volume>
          <issue>5</issue>
          <fpage>730</fpage>
          <lpage>3</lpage>
          <pub-id pub-id-type="doi">10.1093/jmedent/32.5.730</pub-id>
          <?supplied-pmid 7473629?>
          <pub-id pub-id-type="pmid">7473629</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Samish</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rehacek</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Pathogens and predators of ticks and their potential in biological control</article-title>
          <source>Annu Rev Entomol</source>
          <year>1999</year>
          <volume>44</volume>
          <fpage>159</fpage>
          <lpage>82</lpage>
          <pub-id pub-id-type="doi">10.1146/annurev.ento.44.1.159</pub-id>
          <?supplied-pmid 9990719?>
          <pub-id pub-id-type="pmid">9990719</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deblinger</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Rimmer</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Spielman</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Reduced abundance of immature <italic>Ixodes dammini</italic> (Acari: Ixodidae) following incremental removal of deer</article-title>
          <source>J Med Entomol</source>
          <year>1993</year>
          <volume>30</volume>
          <issue>1</issue>
          <fpage>144</fpage>
          <lpage>50</lpage>
          <pub-id pub-id-type="doi">10.1093/jmedent/30.1.144</pub-id>
          <?supplied-pmid 8433321?>
          <pub-id pub-id-type="pmid">8433321</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hoen</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Rollen</surname>
              <given-names>LG</given-names>
            </name>
            <name>
              <surname>Papero</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Carroll</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Daniels</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Mather</surname>
              <given-names>TN</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Effects of tick control by acaricide self-treatment of white-tailed deer on host-seeking tick infection prevalence and entomologic risk for <italic>Ixodes scapularis-</italic>borne pathogens</article-title>
          <source>Vector-Borne Zoonotic Dis</source>
          <year>2009</year>
          <volume>9</volume>
          <issue>4</issue>
          <fpage>431</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1089/vbz.2008.0155</pub-id>
          <?supplied-pmid 19650738?>
          <pub-id pub-id-type="pmid">19650738</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schulze</surname>
              <given-names>TL</given-names>
            </name>
            <name>
              <surname>Jordan</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Hung</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Schulze</surname>
              <given-names>CJ</given-names>
            </name>
          </person-group>
          <article-title>Effectiveness of the 4-Poster passive topical treatment device in the control of <italic>Ixodes scapularis</italic> and <italic>Amblyomma americanum</italic> (Acari: Ixodidae) in New Jersey</article-title>
          <source>Vector Borne Zoonotic Dis</source>
          <year>2009</year>
          <volume>9</volume>
          <issue>4</issue>
          <fpage>389</fpage>
          <lpage>400</lpage>
          <pub-id pub-id-type="doi">10.1089/vbz.2008.0160</pub-id>
          <?supplied-pmid 19650733?>
          <pub-id pub-id-type="pmid">19650733</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brei</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Brownstein</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>George</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Pound</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Daniels</surname>
              <given-names>TJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Evaluation of the United States Department of Agriculture northeast area-wide tick control project by meta-analysis</article-title>
          <source>Vector Borne Zoonotic Dis</source>
          <year>2009</year>
          <volume>9</volume>
          <issue>4</issue>
          <fpage>423</fpage>
          <lpage>30</lpage>
          <pub-id pub-id-type="doi">10.1089/vbz.2008.0150</pub-id>
          <?supplied-pmid 19650737?>
          <pub-id pub-id-type="pmid">19650737</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Daniels</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Fish</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Falco</surname>
              <given-names>RC</given-names>
            </name>
          </person-group>
          <article-title>Evaluation of host-targeted acaricide for reducing risk of Lyme disease in southern New York state</article-title>
          <source>J Med Entomol</source>
          <year>1991</year>
          <volume>28</volume>
          <issue>4</issue>
          <fpage>537</fpage>
          <lpage>43</lpage>
          <pub-id pub-id-type="doi">10.1093/jmedent/28.4.537</pub-id>
          <?supplied-pmid 1941916?>
          <pub-id pub-id-type="pmid">1941916</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deblinger</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Rimmer</surname>
              <given-names>DW</given-names>
            </name>
          </person-group>
          <article-title>Efficacy of a permethrin-based acaricide to reduce the abundance of <italic>Ixodes dammini</italic> (Acari: Ixodidae)</article-title>
          <source>J Med Entomol</source>
          <year>1991</year>
          <volume>28</volume>
          <issue>5</issue>
          <fpage>708</fpage>
          <lpage>11</lpage>
          <pub-id pub-id-type="doi">10.1093/jmedent/28.5.708</pub-id>
          <?supplied-pmid 1941940?>
          <pub-id pub-id-type="pmid">1941940</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mather</surname>
              <given-names>TN</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Spielman</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Lyme disease and babesiosis: acaricide focused on potentially infected ticks</article-title>
          <source>Am J Trop Med Hyg</source>
          <year>1987</year>
          <volume>36</volume>
          <issue>3</issue>
          <fpage>609</fpage>
          <lpage>14</lpage>
          <?supplied-pmid 3555140?>
          <pub-id pub-id-type="pmid">3555140</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stafford</surname>
              <given-names>KC</given-names>
              <suffix>3rd</suffix>
            </name>
          </person-group>
          <article-title>Effectiveness of host-targeted permethrin in the control of <italic>Ixodes dammini</italic> (Acari: Ixodidae)</article-title>
          <source>J Med Entomol</source>
          <year>1991</year>
          <volume>28</volume>
          <issue>5</issue>
          <fpage>611</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.1093/jmedent/28.5.611</pub-id>
          <?supplied-pmid 1941927?>
          <pub-id pub-id-type="pmid">1941927</pub-id>
        </element-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stafford</surname>
              <given-names>KC</given-names>
              <suffix>3rd</suffix>
            </name>
          </person-group>
          <article-title>Third-year evaluation of host-targeted permethrin for the control of <italic>Ixodes dammini</italic> (Acari: Ixodidae) in southeastern Connecticut</article-title>
          <source>J Med Entomol</source>
          <year>1992</year>
          <volume>29</volume>
          <issue>4</issue>
          <fpage>717</fpage>
          <lpage>20</lpage>
          <pub-id pub-id-type="doi">10.1093/jmedent/29.4.717</pub-id>
          <?supplied-pmid 1495085?>
          <pub-id pub-id-type="pmid">1495085</pub-id>
        </element-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Richer</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Brisson</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Melo</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Ostfeld</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Zeidner</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Gomes-Solecki</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Reservoir targeted vaccine against <italic>Borrelia burgdorferi</italic>: a new strategy to prevent Lyme disease transmission</article-title>
          <source>J Infect Dis</source>
          <year>2014</year>
          <volume>209</volume>
          <issue>12</issue>
          <fpage>1972</fpage>
          <lpage>80</lpage>
          <pub-id pub-id-type="doi">10.1093/infdis/jiu005</pub-id>
          <?supplied-pmid 24523510?>
          <pub-id pub-id-type="pmid">24523510</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tsao</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Fish</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Galvani</surname>
              <given-names>AP</given-names>
            </name>
          </person-group>
          <article-title>Predicted outcomes of vaccinating wildlife to reduce human risk of Lyme disease</article-title>
          <source>Vector Borne Zoonotic Dis</source>
          <year>2012</year>
          <volume>12</volume>
          <issue>7</issue>
          <fpage>544</fpage>
          <lpage>51</lpage>
          <pub-id pub-id-type="doi">10.1089/vbz.2011.0731</pub-id>
          <?supplied-pmid 22251312?>
          <pub-id pub-id-type="pmid">22251312</pub-id>
        </element-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tsao</surname>
              <given-names>JI</given-names>
            </name>
            <name>
              <surname>Wootton</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Bunikis</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Luna</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Fish</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Barbour</surname>
              <given-names>AG</given-names>
            </name>
          </person-group>
          <article-title>An ecological approach to preventing human infection: vaccinating wild mouse reservoirs intervenes in the Lyme disease cycle</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2004</year>
          <volume>101</volume>
          <issue>52</issue>
          <fpage>18159</fpage>
          <lpage>64</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.0405763102</pub-id>
          <?supplied-pmid 15608069?>
          <pub-id pub-id-type="pmid">15608069</pub-id>
        </element-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gomes-Solecki</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Brisson</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Dattwyler</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
          <article-title>Oral vaccine that breaks the transmission cycle of the Lyme disease spirochete can be delivered via bait</article-title>
          <source>Vaccine</source>
          <year>2006</year>
          <volume>24</volume>
          <issue>20</issue>
          <fpage>4440</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1016/j.vaccine.2005.08.089</pub-id>
          <?supplied-pmid 16198456?>
          <pub-id pub-id-type="pmid">16198456</pub-id>
        </element-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Llewellyn</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Brazier</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Cocker</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Evans</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Hampton</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Occupational exposure to permethrin during its use as a public hygiene insecticide</article-title>
          <source>Ann Occup Hyg</source>
          <year>1996</year>
          <volume>40</volume>
          <issue>5</issue>
          <fpage>499</fpage>
          <lpage>509</lpage>
          <pub-id pub-id-type="doi">10.1093/annhyg/40.5.499</pub-id>
          <?supplied-pmid 8888633?>
          <pub-id pub-id-type="pmid">8888633</pub-id>
        </element-citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alavanja</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Hoppin</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Kamel</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Health effects of chronic pesticide exposure: cancer and neurotoxicity</article-title>
          <source>Annu Rev Public Health</source>
          <year>2004</year>
          <volume>25</volume>
          <fpage>155</fpage>
          <lpage>97</lpage>
          <pub-id pub-id-type="doi">10.1146/annurev.publhealth.25.101802.123020</pub-id>
          <?supplied-pmid 15015917?>
          <pub-id pub-id-type="pmid">15015917</pub-id>
        </element-citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sibbald</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Larvicide debate marks start of another West Nile virus summer</article-title>
          <source>CMAJ</source>
          <year>2003</year>
          <volume>168</volume>
          <issue>11</issue>
          <fpage>1455</fpage>
          <?supplied-pmid 12771083?>
          <pub-id pub-id-type="pmid">12771083</pub-id>
        </element-citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aenishaenslin</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Hongoh</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Cisse</surname>
              <given-names>HD</given-names>
            </name>
            <name>
              <surname>Hoen</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Samoura</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Michel</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Multi-criteria decision analysis as an innovative approach to managing zoonoses: results from a study on Lyme disease in Canada</article-title>
          <source>BMC Public Health</source>
          <year>2013</year>
          <volume>13</volume>
          <fpage>897</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-2458-13-897</pub-id>
          <?supplied-pmid 24079303?>
          <pub-id pub-id-type="pmid">24079303</pub-id>
        </element-citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aenishaenslin</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Gern</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Michel</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Ravel</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hongoh</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Waaub</surname>
              <given-names>JP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Adaptation and evaluation of a multi-criteria decision analysis model for Lyme disease prevention</article-title>
          <source>PLoS One</source>
          <year>2015</year>
          <volume>10</volume>
          <issue>8</issue>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0135171</pub-id>
          <?supplied-pmid 26295344?>
          <pub-id pub-id-type="pmid">26295344</pub-id>
        </element-citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gould</surname>
              <given-names>LH</given-names>
            </name>
            <name>
              <surname>Nelson</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Griffith</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Hayes</surname>
              <given-names>EB</given-names>
            </name>
            <name>
              <surname>Piesman</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Mead</surname>
              <given-names>PS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Knowledge, attitudes, and behaviors regarding Lyme disease prevention among Connecticut residents, 1999–2004</article-title>
          <source>Vector Borne Zoonotic Dis</source>
          <year>2008</year>
          <volume>8</volume>
          <issue>6</issue>
          <fpage>769</fpage>
          <lpage>76</lpage>
          <pub-id pub-id-type="doi">10.1089/vbz.2007.0221</pub-id>
          <?supplied-pmid 18637724?>
          <pub-id pub-id-type="pmid">18637724</pub-id>
        </element-citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aenishaenslin</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ravel</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Michel</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Gern</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Milord</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Waaub</surname>
              <given-names>JP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>From Lyme disease emergence to endemicity: a cross sectional comparative study of risk perceptions in different populations</article-title>
          <source>BMC Public Health</source>
          <year>2014</year>
          <volume>14</volume>
          <issue>1</issue>
          <fpage>1298</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-2458-14-1298</pub-id>
          <?supplied-pmid 25523355?>
          <pub-id pub-id-type="pmid">25523355</pub-id>
        </element-citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <mixed-citation publication-type="other">Léger Marketing. [<ext-link ext-link-type="uri" xlink:href="http://leger360.com/en-ca/legerwebpanel.asp">http://leger360.com/en-ca/legerwebpanel.asp</ext-link>]. Accessed 1 Sept 2015.</mixed-citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Scherer</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <source>PropCIs: various confidence interval methods for proportions</source>
          <year>2014</year>
        </element-citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Braun</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Clarke</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Using thematic analysis in psychology</article-title>
          <source>Qual Res Psychol</source>
          <year>2006</year>
          <volume>3</volume>
          <issue>2</issue>
          <fpage>77</fpage>
          <lpage>101</lpage>
          <pub-id pub-id-type="doi">10.1191/1478088706qp063oa</pub-id>
        </element-citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <mixed-citation publication-type="other">Vaismoradi M, Turunen H, Bondas T. Content analysis and thematic analysis: Implications for conducting a qualitative descriptive study. Nurs Health Sci. 2013;15(3):398–405. </mixed-citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <mixed-citation publication-type="other">Tong A, Sainsbury P, Craig J. Consolidated Criteria for Reporting Qualitative Research (COREQ): a 32-item checklist for interviews and focus groups. International J Qual Health Care. 2007;19(6):349–57.</mixed-citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <mixed-citation publication-type="other">Ferrouillet C, Lambert L, Milord F. Consultation sur l’état actuel de la surveillance des zoonoses au Québec et son adéquation avec les changements climatiques et écologique. Institut national de santé publique du Québec. 2012. <ext-link ext-link-type="uri" xlink:href="https://www.inspq.qc.ca/pdf/publications/1541_ConsulEtatActSurvZoonoQcAdeqChangClimEcolo.pdf">https://www.inspq.qc.ca/pdf/publications/1541_ConsulEtatActSurvZoonoQcAdeqChangClimEcolo.pdf</ext-link>. Accessed 1 Sept 2015.</mixed-citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nahimana</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Gern</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Peter</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Praz</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Moosmann</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Francioli</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Epidemiology of Lyme borreliosis in French-speaking Switzerland</article-title>
          <source>Schweiz Med Wochenschr</source>
          <year>2000</year>
          <volume>130</volume>
          <issue>41</issue>
          <fpage>1456</fpage>
          <lpage>61</lpage>
          <?supplied-pmid 11075409?>
          <pub-id pub-id-type="pmid">11075409</pub-id>
        </element-citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moosmann</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Brossard</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Raeber</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Gern</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Estimated Lyme borreliosis incidence in the canton of Neuchâtel (Switzerland)</article-title>
          <source>Bulletin de la Société neuchâteloise des Sciences Naturelles</source>
          <year>2012</year>
          <volume>132</volume>
          <fpage>47</fpage>
          <lpage>56</lpage>
        </element-citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Conner</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Norman</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <source>Predicting health behaviour</source>
          <year>2005</year>
          <publisher-loc>Whitby</publisher-loc>
          <publisher-name>Open University Press</publisher-name>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:4700562</identifier><datestamp>2016-01-06</datestamp><setSpec>retrovir</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="http://jats.nlm.nih.gov/ns/archiving/1.0/ http://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Retrovirology</journal-id>
      <journal-id journal-id-type="iso-abbrev">Retrovirology</journal-id>
      <journal-title-group>
        <journal-title>Retrovirology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1742-4690</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC4700562</article-id>
      <article-id pub-id-type="pmcid">PMC4700562</article-id>
      <article-id pub-id-type="pmc-uid">4700562</article-id>
      <article-id pub-id-type="publisher-id">234</article-id>
      <article-id pub-id-type="doi">10.1186/s12977-015-0234-9</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>HIV-1 latency and virus production from unintegrated genomes following direct infection of resting CD4 T cells</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Chan</surname>
            <given-names>Chi N.</given-names>
          </name>
          <address>
            <email>cnc7@nyu.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Trinité</surname>
            <given-names>Benjamin</given-names>
          </name>
          <address>
            <email>bt32@nyu.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Caroline S.</given-names>
          </name>
          <address>
            <email>csl303@nyu.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mahajan</surname>
            <given-names>Saurabh</given-names>
          </name>
          <address>
            <email>saurabh05@nyu.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Anand</surname>
            <given-names>Akanksha</given-names>
          </name>
          <address>
            <email>akank.anand@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wodarz</surname>
            <given-names>Dominik</given-names>
          </name>
          <address>
            <email>dwodarz@uci.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sabbaj</surname>
            <given-names>Steffanie</given-names>
          </name>
          <address>
            <email>sabbaj@uab.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bansal</surname>
            <given-names>Anju</given-names>
          </name>
          <address>
            <email>ABansal@uab.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Goepfert</surname>
            <given-names>Paul A.</given-names>
          </name>
          <address>
            <email>paulg@uab.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Levy</surname>
            <given-names>David N.</given-names>
          </name>
          <address>
            <phone>212 998-9287</phone>
            <email>dnlevy@nyu.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <aff id="Aff1"><label/>Department of Basic Science, New York University College of Dentistry, New York, NY 10010 USA </aff>
        <aff id="Aff2"><label/>Department of Ecology and Evolutionary Biology, University of California, Irvine, School of Biological, Sciences, Irvine, CA 92697 USA </aff>
        <aff id="Aff3"><label/>Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294 USA </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>5</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>5</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <volume>13</volume>
      <elocation-id>1</elocation-id>
      <history>
        <date date-type="received">
          <day>21</day>
          <month>10</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>21</day>
          <month>12</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© Chan et al. 2016</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>HIV-1 integration is prone to a high rate of failure, resulting in the accumulation of unintegrated viral genomes (uDNA) in vivo and in vitro. uDNA can be transcriptionally active, and circularized uDNA genomes are biochemically stable in non-proliferating cells. Resting, non-proliferating CD4 T cells are prime targets of HIV-1 infection and latently infected resting CD4 T cells are the major barrier to HIV cure. Our prior studies demonstrated that uDNA generates infectious virions when T cell activation follows rather than precedes infection.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>Here, we characterize in primary resting CD4 T cells the dynamics of integrated and unintegrated virus expression, genome persistence and sensitivity to latency reversing agents. Unintegrated HIV-1 was abundant in directly infected resting CD4 T cells. Maximal gene expression from uDNA was delayed compared with integrated HIV-1 and was less toxic, resulting in uDNA enrichment over time relative to integrated proviruses. Inhibiting integration with raltegravir shunted the generation of durable latency from integrated to unintegrated genomes. Latent uDNA was activated to de novo virus production by latency reversing agents that also activated latent integrated proviruses, including PKC activators, histone deacetylase inhibitors and P-TEFb agonists. However, uDNA responses displayed a wider dynamic range, indicating differential regulation of expression relative to integrated proviruses. Similar to what has recently been demonstrated for latent integrated proviruses, one or two applications of latency reversing agents failed to activate all latent unintegrated genomes. Unlike integrated proviruses, uDNA gene expression did not down modulate expression of HLA Class I on resting CD4 T cells. uDNA did, however, efficiently prime infected cells for killing by HIV-1-specific cytotoxic T cells.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>These studies demonstrate that contributions by unintegrated genomes to HIV-1 gene expression, virus production, latency and immune responses are inherent properties of the direct infection of resting CD4 T cells. Experimental models of HIV-1 latency employing directly infected resting CD4 T cells should calibrate the contribution of unintegrated HIV-1.</p>
        </sec>
        <sec>
          <title>Electronic supplementary material</title>
          <p>The online version of this article (doi:10.1186/s12977-015-0234-9) contains supplementary material, which is available to authorized users.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>HIV-1</kwd>
        <kwd>Latency</kwd>
        <kwd>Unintegrated DNA</kwd>
        <kwd>Raltegravir</kwd>
        <kwd>Integration</kwd>
        <kwd>Cytotoxic T cells</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000060</institution-id>
              <institution>National Institute of Allergy and Infectious Diseases</institution>
            </institution-wrap>
          </funding-source>
          <award-id>R01 AI078783</award-id>
          <award-id>R01 AI093998</award-id>
          <award-id>R01 AI093998</award-id>
          <award-id>R01 AI084772</award-id>
          <award-id>R01 AI112566</award-id>
          <award-id>P30 AI027767</award-id>
          <award-id>R56 AI118453</award-id>
          <principal-award-recipient>
            <name>
              <surname>Wodarz</surname>
              <given-names>Dominik</given-names>
            </name>
            <name>
              <surname>Goepfert</surname>
              <given-names>Paul A.</given-names>
            </name>
            <name>
              <surname>Levy</surname>
              <given-names>David N.</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
      </funding-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>© The Author(s) 2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Background</title>
      <p>The failure of the majority of HIV-1 reverse transcripts to integrate into cellular chromosomal DNA has been apparent since the initial molecular descriptions of infection in vivo and in vitro [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>] (reviewed in [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]). Unintegrated HIV-1 DNA (uDNA) can be transcriptionally active, and production of early viral RNA and proteins has been observed in several cell types including resting CD4 T cells [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. The number of transcriptionally active uDNA genomes can rival the number of active integrated proviruses [<xref ref-type="bibr" rid="CR7">7</xref>]. Integration-defective lentiviral vector systems exploit this transcriptional activity, as well as biochemical stability of circularized extrachromosomal genomes in non-replicating cells [<xref ref-type="bibr" rid="CR8">8</xref>–<xref ref-type="bibr" rid="CR11">11</xref>] to achieve sustained ectopic gene expression in multiple lineages in vitro and in vivo (reviewed in [<xref ref-type="bibr" rid="CR12">12</xref>]). uDNA gene expression is higher in non-proliferating cells compared with proliferating cells such as transformed cell lines and activated CD4 T cells, perhaps owing to a lack of dilution of uDNA templates and their RNA and protein products [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR13">13</xref>].</p>
      <p>We have previously reported that when cellular coinfection places an integrated provirus (iDNA) in a cell together with an unintegrated genome, viral complementation allows completion of the unintegrated virus’ replication cycle without integration [<xref ref-type="bibr" rid="CR14">14</xref>]. Recently, we reported that when HIV-1 infects resting T cells several days prior to T cell activation, uDNA alone generates infectious virions [<xref ref-type="bibr" rid="CR6">6</xref>]. This stands in contrast to infection of activated T cells or cell lines, which support only transient and reduced levels of gene expression from uDNA without de novo virus production. Also in contrast to activated T cells and cell lines, gene expression from uDNA in resting T cells required delivery of virion-associated Vpr, evidence of the uniqueness of uDNA gene regulation. The sequence of events which we found to induce production of infectious virions from uDNA mimics an in vivo situation where an infected resting CD4 T cell is activated following migration to lymphoid tissues, which has been proposed as a mechanism facilitating the establishment of HIV-1 infection [<xref ref-type="bibr" rid="CR15">15</xref>–<xref ref-type="bibr" rid="CR17">17</xref>].</p>
      <p>The predominant model for establishment of HIV-1 latency entails the infection of an activate CD4 T cell that returns to a resting state, thus removing support for viral transcription [<xref ref-type="bibr" rid="CR18">18</xref>]. On the other hand, during acute and early infection, resting CD4 T cells are frequent targets of infection, constituting up to 90 % of viral RNA+ cells in both HIV-1 infected humans and SIV infected macaques [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>]. The latent reservoir is also rapidly established during acute infection [<xref ref-type="bibr" rid="CR21">21</xref>–<xref ref-type="bibr" rid="CR23">23</xref>], supporting the notion that direct infection of resting CD4 T cells may also contribute to the latent reservoir [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. The majority of infected cells during untreated chronic infection also contain only unintegrated HIV–1 DNA [<xref ref-type="bibr" rid="CR26">26</xref>]. Although unstimulated peripheral blood T cells are resistant to infection in vitro [<xref ref-type="bibr" rid="CR27">27</xref>], in vivo, HIV-1 replicates in lymphoid (LT) and mucosal tissues that provide microenvironmental factors (cytokines, chemokines, DC and stromal cells) that support HIV-1 replication and maintain cell viability [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>]. Several important in vitro models of HIV-1 latency utilize these factors to promote survival of resting CD4 T cells in vitro and to increase their permissiveness to infection by HIV-1 [<xref ref-type="bibr" rid="CR30">30</xref>]. These systems are extensively utilized to test the response of latent HIV-1 to various compounds under scrutiny as latency reversing agents for curative therapies.</p>
      <p>To this end, we recently described a convenient and relevant model system [<xref ref-type="bibr" rid="CR6">6</xref>] in which resting peripheral blood CD4 T cells are treated with common gamma chain cytokines such as IL-4 that render them permissive to infection without inducing cell activation, though it is known that common gamma chain cytokines induce signaling pathways such as stat5 or stat6 and increase the expression of the survival protein Bcl-2 [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]. IL-4, which we employ here, has been implicated in facilitating HIV-1 replication in lymphoid tissues [<xref ref-type="bibr" rid="CR33">33</xref>] and, as a product of various immune cells including T cells [<xref ref-type="bibr" rid="CR34">34</xref>], assists HIV transcription [<xref ref-type="bibr" rid="CR35">35</xref>]. Recently we have shown that the primary function of primary gamma chain cytokines in assisting infection of resting CD4 T cells in vitro is to prevent HIV-1-induced cell death early after infection that is triggered by reverse transcription and virion Vpr, rather than to enhance specific replicative processes [<xref ref-type="bibr" rid="CR36">36</xref>]. With this system, we observed that latency persisted in resting CD4 T cells for several weeks, after which de novo virus production could be elicited by T cell activation. Importantly, using either the integrase inhibitor raltegravir or class I integrase mutants, we observed that durable, reversible latency was efficiently established by unintegrated HIV-1. Neither stimulation of cell activation nor virus expression induced proviral integration in this system. Virus production from uDNA was about one order of magnitude lower than from integrated proviruses but per-virion, was equally infectious [<xref ref-type="bibr" rid="CR6">6</xref>].</p>
      <p>In the present study we investigated the properties of uDNA and integrated proviruses (iDNA) in resting CD4 T cells, finding substantial and unexpected differences in the kinetics of their gene expression, persistence and virus production. We compared the responsiveness of latent unintegrated and latent integrated HIV-1 to a series latency reversing agents. Finally, we investigated the capacity of uDNA to down modulate Class I HLA expression and to prime infected cells for CTL killing. We conclude that unintegrated HIV-1 should be accounted for in models employing direct infection of non-proliferating cells such as resting CD4 T cells. Should these mechanisms pertain in vivo, the persistence of non-proliferating cells expressing HIV-1 proteins from uDNA may be threatened more by anti-HIV immunity than by biochemical degradation or viral cytopathic effects.</p>
    </sec>
    <sec id="Sec2">
      <title>Results</title>
      <sec id="Sec3">
        <title>Kinetics of gene expression by integrating and non-integrating HIV-1 in resting CD4 T cells</title>
        <p>This study utilizes envelope-defective single round GFP reporter viruses expressing GFP in place of Nef, with Nef expressed at wild type levels downstream of an IRES element [<xref ref-type="bibr" rid="CR37">37</xref>]. GFP fluorescence is generated during both the early and late gene expression phases, providing a sensitive measurement of overall HIV-1 gene expression that is highly correlated with virus production [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR38">38</xref>]. To examine the properties of unintegrated genomes, integration was inhibited either with raltegravir (RAL) or by mutation of HIV-1 integrase at the catalytic domain [<xref ref-type="bibr" rid="CR39">39</xref>], which we have previously demonstrated are functionally equivalent [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR14">14</xref>], inhibiting integration by at least 2–3 orders of magnitude.</p>
        <p>Given the long life span of resting CD4 T cells and the stability of circularized HIV-1 uDNA in them, we investigated the kinetics of gene expression from uDNA vs. iDNA in these cells after a single round of infection (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). In the absence of further stimulation, integration-competent HIV-1 (No RAL) attained peak numbers of productively infected (GFP+) cells 7–9 days post infection (p.i.), consistent with studies demonstrating slowed kinetics of infection processes in resting vs. activated T cells [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR40">40</xref>]. Unintegrated HIV-1 (+RAL) displayed even slower expression kinetics, with expression remaining very low during the first 7–9 days, consistent with prior studies examining short term infections [<xref ref-type="bibr" rid="CR41">41</xref>]. uDNA expression peaked around 2 weeks after infection, and parallel results were obtained using a class I integrase mutant (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S1A). At peak expression, nearly as many GFP+ cells were generated from unintegrated as from integration-competent HIV-1 (Fig. <xref rid="Fig1" ref-type="fig">1</xref>c), though uDNA GFP MFI was four fold lower (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S2A) and HIV-1 RNA levels were 6.3 fold lower (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S2B). No increase in the numbers of cells expressing GFP was observed after day 14–16, suggesting that by this time the majority of both integrated and unintegrated genomes which were destined to be spontaneously active had done so; therefore, this interval could be useful to study durable latency in the GFP-negative cells. In order to be particularly cautious regarding raltegravir efficacy [<xref ref-type="bibr" rid="CR42">42</xref>], we added this integrase inhibitor 3 times over the course of the experiment, achieving a reduction from 0.48 integrated genomes per GFP +cell to less than or equal to 0.002 iDNA copies per GFP+ cell, i.e. less than one in 500 GFP+ cells contained an integrated provirus. (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S2C). In addition, the conformity of the raltegravir and integrase mutant results confirms that reversal of raltegravir activity is not playing a role. To test the effect of virus inoculum size on expression from uDNA, we reduced the virus inoculum eightfold, yielding a peak of 2 % GFP+ cells with the integration competent virus, or increased it twofold, observing little or no alteration in the kinetics of virus expression or the relative expression from the No RAL vs. +RAL infections (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S3A). Important for subsequent latency studies in GFP-negative cells, little HIV-1 RNA was expressed (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S2B). As mentioned above, we recently reported that common gamma chain cytokines enhance in vitro infection of peripheral blood resting T cell primarily by allowing them to survive early reverse transcription- and Vpr-induced apoptosis rather than through enhancement of virus replication per se [<xref ref-type="bibr" rid="CR36">36</xref>]. Here and in prior work [<xref ref-type="bibr" rid="CR6">6</xref>] we found that GFP+ cells were almost exclusively found among the cells which did not proliferate. GFP+ cells showed identical cell cycle status as demonstrated by staining for pyronin Y/7AAD (not shown and [<xref ref-type="bibr" rid="CR36">36</xref>]). CD69 is increased in GFP+ No RAL cells as we previously demonstrated, secondary to HIV-induced suppression of Foxo1 activity [<xref ref-type="bibr" rid="CR43">43</xref>].<fig id="Fig1"><label>Fig. 1</label><caption><p>Kinetics of responsiveness to activating agents following initial infection of resting CD4 T cells. <bold>a</bold> Experimental design. After infection, samples of the IL-4-treated resting CD4 T cells were maintained in culture with or without raltegravir (RAL) for the indicated time period and were then stimulated by αCD3/CD28 activation beads or prostratin plus trichostatin (Pro/TSA) for 2 days before analysis by flow cytometry. IL-4 was replenished every 7 days. Raltegravir was added on the day of infection and on days 3, 7, 14 and 21. <bold>b</bold> Emergence of GFP+ productively infected cells. Pro/TSA or αCD3/CD28 beads were added 2 days prior to analysis. Only the GFP+ cells are displayed, and the areas under the curves represent the number of GFP+ cells present in each sample. Red arrows indicate subpopulations which we have previously shown to contain predominantly unintegrated HIV-1 (uDNA) or to contain at least one copy of integrated HIV-1 DNA (iDNA) [<xref ref-type="bibr" rid="CR6">6</xref>]. One representative of 5 experiments is shown. Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S1A in presents a similar experiment performed using an Int-D116N integrase active site mutant. <bold>c</bold> Percentage of cells that were GFP+. Experiment was performed in triplicate. To account for proliferation of GFP-negative cells, %GFP+ was calculated as the number of GFP+ cells divided by the number of total live cells, which was adjusted for proliferation using the Expansion Index in the Proliferation Platform of FlowJo 9. Cell divisions were measured by eFluor670 dilution. Typically ≤16 % of cells underwent division through day 14, with essentially all of them GFP-negative (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S4A). <bold>d</bold> Cell populations predominantly expressing HIV-1 from unintegrated (GFPlow) or integrated HIV-1 (GFPhi) can be parsed in αCD3/CD28 activated T cells by accounting for cellular heterogeneity (side scatter [SSC] profile). Equivalent results were obtained utilizing the Int-D116N active site mutant (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig S1B)</p></caption><graphic xlink:href="12977_2015_234_Fig1_HTML" id="MO1"/></fig></p>
        <p>Next, we stimulated the entire cell population consisting of both GFP+ cells that are productively infected as well as the GFP-negative cells that comprise both uninfected and non-productively infected cells (Fig. <xref rid="Fig1" ref-type="fig">1</xref>a–c). αCD3/CD28 beads induce T cell activation, while the combination of a PKC activator prostratin (Pro) and a histone deacetylase inhibitor trichostatin A (TSA) more directly activates virus transcription. Integration-competent HIV-1 (Int-WT, No RAL) responded strongly to each stimulus beginning 1 day after infection (assayed on day 3). However, induction of maximal uDNA expression was only achieved with stimulation from day 7 (assayed on day 9) onward, demonstrating the uDNA requires more time than iDNA to establish responsiveness to these virus stimuli. There was a stimulation-induced increase in the GFP fluorescence of pre-existing GFP+ cells for both No RAL and +RAL cultures. However, stimulation increased the number of GFP+ cells only in the +RAL cultures, while the No RAL cultures remained at similar percentages of GFP+ cells. As we will describe in Fig. <xref rid="Fig5" ref-type="fig">5</xref>, there is rapid death of GFP+ cells only in No RAL cultures and this is accelerated by further stimulation. As a result, stimulation-induced cell loss masks latency reversal in No RAL cultures here, necessitating removal of pre-existing GFP+ cells to specifically examine latency reversal, which is specifically explored in the following figures. Equivalent results were obtained using the Int-D116 N mutant (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S1A). Thus, not only does uDNA display slower expression kinetics, its availability for transactivation is delayed compared with integrating HIV-1 and indicates qualitative differences in gene regulation between iDNA and uDNA.</p>
        <p>Importantly, two distinct peaks of GFP expression appeared in the No RAL cultures treated with Pro/TSA days 5–7 (assay days 7–9, arrows in Fig. <xref rid="Fig1" ref-type="fig">1</xref>b). PCR analysis in our previous study indicated that the dimmer peak corresponds primarily to expression from unintegrated genomes, while cells in the brighter peak contain at least one integrated provirus [<xref ref-type="bibr" rid="CR6">6</xref>]. Consistent with this, the bright population was lost upon raltegravir treatment (Fig. <xref rid="Fig1" ref-type="fig">1</xref>d) or Int-D116N mutation (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig S1B). Pro/TSA increased HIV-1 expression with little change in cell phenotype, including size and scatter profile (Fig. <xref rid="Fig1" ref-type="fig">1</xref>d). As a result, these cells remained largely homogeneous, and variations in GFP expression were easily discerned. By contrast, αCD3/CD28 beads generated a high degree of cell heterogeneity, which we hypothesized to have masked these subpopulations in the histograms of Fig. <xref rid="Fig1" ref-type="fig">1</xref>b. In fact, these two subpopulations were revealed in the activated T cells when the side scatter (which reports cell heterogeneity) and GFP expression were plotted together (Fig. <xref rid="Fig1" ref-type="fig">1</xref>d, Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig S1B). Therefore, separate and distinct populations expressing HIV-1 from both integrated and unintegrated templates is a common phenomenon when resting CD4 T cells are stimulated several days after infection.</p>
      </sec>
    </sec>
    <sec id="Sec4">
      <title>Response of latent unintegrated vs. integrated HIV-1 to a series of latency reversing agents</title>
      <p>We next examined latent uDNA responses to several latency reversing agents (LRA) being considered as components of curative therapies. To this end, we established 14-day infections with the single round GFP reporter virus in the presence or absence of maximally effective raltegravir (Fig. <xref rid="Fig2" ref-type="fig">2</xref>a) and sorted eFluor670<sup>hi</sup>GFP-negative cells. Maintenance of the resting CD4 T state after sorting was evidenced by lack of expression of activation markers and G0-G1a cell cycle status in &gt;99.3 % of eFluor670<sup>hi</sup>GFP-negative cells (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S4). We then applied a panel of LRA or combinations of LRA, including PKC activators, HDAC inhibitors and P-TEFb agonists. We measured GFP fluorescence and virus release 24 h after stimulation (Fig. <xref rid="Fig2" ref-type="fig">2</xref>b). All LRA which were effective on integration-competent HIV-1 were also effective in reversing latency from uDNA. Prior studies, including our own, have found that unintegrated retroviral genomes are responsive to histone deacetylase inhibitors [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR44">44</xref>–<xref ref-type="bibr" rid="CR46">46</xref>], which we confirm. Similar results were obtained in multiple experiments with either raltegravir (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S5) or with the Int-D116N virus (not shown). Infection without spinoculation resulted in a reduced infection frequency but the responses of latently infected cells to LRA were similar to spinoculated cells (not shown). Sorted eFluor670<sup>low</sup>GFP-negative cells, the proliferated population, did not generate GFP+ cells either spontaneously or following addition of latency reversing agents (not shown). This is interesting because homeostatic proliferation does not substantially alter the latent reservoir in vitro [<xref ref-type="bibr" rid="CR47">47</xref>], thus neither productive infection nor latency in our system were efficiently established in cells which subsequently proliferated.<fig id="Fig2"><label>Fig. 2</label><caption><p>Activation of latent integration-competent HIV-1 and unintegrated HIV-1 with a panel of latency reversing agents (LRA). <bold>a</bold> Experimental design. Raltegravir was added on days 0, 3 and 7 and not removed until sorting. <bold>b</bold> The responses of latently infected cells to various LRAs under No RAL and +RAL conditions, expressed as the percentage of GFP+ cells 1 day after stimulation. Data from one experiment representative of &gt;3 independent experiments with cells from different donors is shown. Each condition was tested in triplicate. Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S5 shows an independent experiment (Experiment 2 in Fig. <xref rid="Fig3" ref-type="fig">3</xref>c, d, g, h) employing an expanded panel of LRA. Similar results were obtained with the Integrase D116N mutant (not shown). <bold>c</bold> The percentage of GFP+ cells generated in the No RAL vs. the +RAL cultures for each LRA in two independent experiments from <bold>b</bold> (Expt. 1) and in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S5 (Expt. 2). Each <italic>symbol</italic> represents one LRA from Fig. 2b (Experiment 1) and S5 (Experiment 2). <bold>d</bold> Virus production from No RAL vs. +RAL cultures for both experiments. <bold>e</bold> The percentage of GFP+ cells generated by various LRAs vs. virus release into the culture medium to compare virus production per GFP+ cell. The dynamic range is shown for the number of GFP+ cells and for virus production as fold induction of the maximum over the minimum value. Data are from Expt. 1 and is representative of 3 additional independent experiments. <bold>f</bold> GFP Mean fluorescence intensity (MFI) of the GFP+ cells vs. virus production for No RAL and +RAL cells in Expt. 1. Similar results were obtained from Expt. 2 (not shown). The dynamic ranges are shown as in <bold>e</bold>. <bold>g</bold> Relationship between the strength of the LRA in inducing virus production (X axis) and the +RAL output expressed as a percent of the No RAL output. +RAL output reached 66 % of No RAL output for Bryostatin+ SAHA. <bold>h</bold> Relationship between the strength of the LRA in inducing virus production (X axis) and the +RAL output per GFP+ cell expressed as a percent of the No RAL output per GFP+ cell. <bold>c</bold>–<bold>h</bold> All p ≤ 0.001</p></caption><graphic xlink:href="12977_2015_234_Fig2_HTML" id="MO2"/></fig></p>
      <p>Strikingly, but also consistent with Fig. <xref rid="Fig1" ref-type="fig">1</xref>, at least as many and usually more GFP+ cells were generated from the +RAL infections for each LRA than from the No RAL infections (Fig. <xref rid="Fig2" ref-type="fig">2</xref>b, c). This held true for infections at lower and higher MOI (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S3B) and for Int-D116 N viruses (not shown). An expanded panel of LRA produced similar results (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S5, and Expt. 2 in Fig. <xref rid="Fig3" ref-type="fig">3</xref>c, d, g, f). Fewer virions were generated from the +RAL cells in each culture (Fig. <xref rid="Fig2" ref-type="fig">2</xref>d), and fewer virions were released per GFP+ cell (Fig. <xref rid="Fig2" ref-type="fig">2</xref>h) that was consistent with the lower transcription from unintegrated genomes. Virus production was highly correlated with GFP fluorescence intensity similarly for the No RAL and +RAL infections (Fig. <xref rid="Fig2" ref-type="fig">2</xref>f). However, the dynamic range of the induction of both GFP+ cells and the GFP fluorescence intensities were greater for the +RAL infections (bracketing lines in Fig. <xref rid="Fig2" ref-type="fig">2</xref>e, f). This translated into the finding of Fig. <xref rid="Fig2" ref-type="fig">2</xref>g, where, as the strength of the activators increased (more virions were released), the +RAL virus production approached closer to the No RAL virus production (Fig. <xref rid="Fig2" ref-type="fig">2</xref>g). This increase in the relative output from the +RAL infections was the result of both more GFP+ cells being generated as well as an increase in the output per cell relative to the No RAL cells (Fig. <xref rid="Fig2" ref-type="fig">2</xref>h), consistent with the greater dynamic range seen in the GFP fluorescence (Fig. <xref rid="Fig2" ref-type="fig">2</xref>f). These results further indicate that uDNA latency and transactivation are regulated differently from integrated proviruses.<fig id="Fig3"><label>Fig. 3</label><caption><p>Kinetics of latency reversal and virus production from sorted GFP-negative cells following in vitro infection of resting CD4 T cells from 3 donors. The 14-day latency protocol from Fig. <xref rid="Fig2" ref-type="fig">2</xref>a was followed using cells from 3 HIV-negative donors following infection with equal amounts of HIV-1 in order to investigate kinetics of latent virus activation and donor variability. For added precaution against de novo infection, Indinavir was added at day 0 and 7 p.i., while efavirenz was added at day 5 p.i. for donors 2 and 3. <bold>a</bold> Percent GFP+ cells after Pro/TSA or DMSO carrier control treatment of sorted GFP-negative cells. Percent GFP+ cells prior to sort (No RAL, +RAL): Donor 1: 4.9 %, 3.3 %, Donor 2: 16.9 %, 22.4 %, Donor 3: 21.4 %, 17.3 %. <bold>b</bold> Virions released into culture medium measured by RT-qPCR for genomic viral RNA. Lower limit of quantitation was 1 virion/µl. <bold>c</bold> The difference in virus output from the No RAL and +RAL cultures decreases over time following latency reversal. Graphs present the ratio of No RAL virus output vs. +RAL virus output over the indicated interval. Output over each interval for No RAL and +RAL cells was calculated by subtracting the virions/µL at the earlier indicated time from the later time, then the ratio of No RAL/+RAL was graphed. For example, for Donor 1 during the first 14 h (“0–14”) the No RAL cells released 7.3 times as many virions as the +RAL cultures but over the 41–65 h interval, the No RAL cells release 2.2 times as many virions as the +RAL cells. <italic>Red line</italic> indicates equal output from the No RAL and +RAL cells. <bold>d</bold> The difference in virus output per GFP+ cell from the No RAL and +RAL cultures decreases over time following latency reversal. The ratio of No RAL virus output per GFP+ cell vs. +RAL virus output per GFP+ cell over the indicated interval. Output during each interval, calculated as in 3C was then divided by the percent GFP+ cells at the end of each interval. For example, for Donor 1 during the first 14 h (0–14) each GFP cell in the No RAL infections released 9.5 times as many virions as the +RAL GFP+ cells but during 41–65 h interval, the No RAL cells released 2.9 times as many virions per GFP+ cell. Red line indicates equal output from the No RAL and +RAL cells</p></caption><graphic xlink:href="12977_2015_234_Fig3_HTML" id="MO3"/></fig></p>
      <p>With regard to individual LRA and classes of LRA, the PKC agonists (prostratin, bryostatin) were overall the most effective, activating viruses within the most cells and inducing the most virus production from both integrating and unintegrated HIV-1 (Fig. <xref rid="Fig2" ref-type="fig">2</xref>b, Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig S5). Histone deacetylase inhibitors [TSA, SAHA (vorinostat), Scriptaid] and the P-TEFb agonists JQ1 and HMBA only weakly activated latent integrated or unintegrated viruses on their own, but they enhanced virus activation in combination with PKC activators, consistent with the possible enhancement of stochastic fluctuations in transcription [<xref ref-type="bibr" rid="CR48">48</xref>]. Disulfiram was ineffective in our system on either integrating or unintegrated HIV-1, consistent with other recent reports [<xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR50">50</xref>]. Interestingly, synergy between agents was obtained only with PKC activators plus HDACi or JQ1 and only in the raltegravir cultures (Table <xref rid="Tab1" ref-type="table">1</xref>). This provides further evidence that uDNA and iDNA are differentially regulated at the transcriptional level.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Synergy indices for combinations of latency reversing agents</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">No RAL</th><th align="left">+RAL</th></tr></thead><tbody><tr><td align="left" colspan="3">Bryostatin</td></tr><tr><td align="left"> +TSA</td><td char="±" align="char">1.06 ± 0.13</td><td char="±" align="char">
<italic>1.49</italic> <italic>±</italic> <italic>0.28</italic>
</td></tr><tr><td align="left"> +SAHA</td><td char="±" align="char">0.94 ± 0.07</td><td char="±" align="char">
<italic>1.09</italic> <italic>±</italic> <italic>0.05</italic>
</td></tr><tr><td align="left"> +Scriptaid</td><td char="±" align="char">0.95 ± 0.05</td><td char="±" align="char">
<italic>1.19</italic> <italic>±</italic> <italic>0.09</italic>
</td></tr><tr><td align="left"> +JQ1</td><td char="±" align="char">0.85 ± 0.06</td><td char="±" align="char">
<italic>1.14</italic> <italic>±</italic> <italic>0.10</italic>
</td></tr><tr><td align="left"> +HMBA</td><td char="±" align="char">0.92 ± 0.13</td><td char="±" align="char">1.12 ± 0.16</td></tr><tr><td align="left"> +Disulfiram</td><td char="±" align="char">0.83 ± 0.06</td><td char="±" align="char">0.79 ± 0.03</td></tr><tr><td align="left" colspan="3">Prostratin</td></tr><tr><td align="left"> +TSA</td><td char="±" align="char">1.02 ± 0.04</td><td char="±" align="char">
<italic>1.44</italic> <italic>±</italic> <italic>0.14</italic>
</td></tr><tr><td align="left"> +SAHA</td><td char="±" align="char">0.96 ± 0.08</td><td char="±" align="char">
<italic>1.30</italic> <italic>±</italic> <italic>0.19</italic>
</td></tr><tr><td align="left"> +Scriptaid</td><td char="±" align="char">0.97 ± 0.05</td><td char="±" align="char">
<italic>1.42</italic> <italic>±</italic> <italic>0.18</italic>
</td></tr><tr><td align="left"> +JQ1</td><td char="±" align="char">0.87 ± 0.07</td><td char="±" align="char">
<italic>1.19</italic> <italic>±</italic> <italic>0.16</italic>
</td></tr><tr><td align="left"> +HMBA</td><td char="±" align="char">0.63 ± 0.10</td><td char="±" align="char">0.77 ± 0.29</td></tr><tr><td align="left"> +Disulfiram</td><td char="±" align="char">0.55 ± 0.14</td><td char="±" align="char">0.68 ± 0.14</td></tr><tr><td align="left">JQ1</td><td align="left"/><td align="left"/></tr><tr><td align="left"> +TSA</td><td char="±" align="char">0.72 ± 0.08</td><td char="±" align="char">0.88 ± 0.22</td></tr><tr><td align="left"> +SAHA</td><td char="±" align="char">0.87 ± 0.11</td><td char="±" align="char">0.90 ± 0.11</td></tr><tr><td align="left"> +Scriptaid</td><td char="±" align="char">0.84 ± 0.15</td><td char="±" align="char">0.90 ± 0.10</td></tr><tr><td align="left" colspan="3">HMBA</td></tr><tr><td align="left"> +TSA</td><td char="±" align="char">0.63 ± 0.17</td><td char="±" align="char">0.78 ± 0.03</td></tr><tr><td align="left"> +SAHA</td><td char="±" align="char">0.62 ± 0.21</td><td char="±" align="char">0.81 ± 0.11</td></tr><tr><td align="left"> +Scriptaid</td><td char="±" align="char">0.69 ± 0.14</td><td char="±" align="char">0.91 ± 0.14</td></tr><tr><td align="left" colspan="3">Disulfiram</td></tr><tr><td align="left"> +TSA</td><td char="±" align="char">0.68 ± 0.11</td><td char="±" align="char">0.72 ± 0.13</td></tr><tr><td align="left"> +SAHA</td><td char="±" align="char">0.63 ± 0.06</td><td char="±" align="char">0.69 ± 0.06</td></tr><tr><td align="left"> +Scriptaid</td><td char="±" align="char">0.85 ± 0.17</td><td char="±" align="char">0.98 ± 0.19</td></tr></tbody></table><table-wrap-foot><p>Synergy indices were calculated from 3 independent experiments with different cell donors, based on the number of GFP+ cells. Synergy was calculated according to [<xref ref-type="bibr" rid="CR95">95</xref>] and synergy indices significantly &gt;1 are indicated in italicized text. Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S5 contributes data for one of the 3 experiments</p></table-wrap-foot></table-wrap></p>
      <p>A recent study indicated that HIV-1 constructs rendered incapable of replicating by mutations or deletions of the <italic>env</italic> gene can revert to wild type through recombination with envelope expression plasmids following co-transfection of producer cells [<xref ref-type="bibr" rid="CR51">51</xref>]. To test if replication competent viruses might be contributing to our results, we treated infected resting CD4 T cells with the protease inhibitor indinavir on the day of infection and on day 5 post infection with the non-nucleoside reverse transcriptase inhibitor efavirenz in order to block the spread of any reverted viruses. There was no effect on the generation of latently infected cells, indicating that reversion was not contributing to results (not shown).</p>
    </sec>
    <sec id="Sec5">
      <title>Kinetics of latency reversal</title>
      <p>Twenty-four hours after stimulation of latently infected cells is a convenient and frequently utilized time at which to analyze latency reversal [<xref ref-type="bibr" rid="CR30">30</xref>]. However, our data indicating differential regulation of uDNA and iDNA prompted us to test if uDNA also presents differential kinetics of latency reversal. To this end, we performed a latency experiment with cells from 3 donors, sorting eFluorhiGFP- cells 14 days after infection then stimulating them with Pro/TSA. We analyzed the emergence of GFP expression and virus production over the following 3 days (Fig. <xref rid="Fig3" ref-type="fig">3</xref>). During the initial 14 h the No RAL cells generated from 3.7 to 7.9 fold more virus than the +RAL cells (Fig. <xref rid="Fig3" ref-type="fig">3</xref>b, c). However, after this initial burst of production, the relative differences in virus output decreased (Fig. <xref rid="Fig3" ref-type="fig">3</xref>c). With Donor 3 cells, which had the highest initial infection frequency, the +RAL virus production even exceeded the No RAL production by 2 days after stimulation. We then calculated virus output per GFP+ cell, accounting for the differences in the number of GFP+ cells and changes in their numbers over time (Fig. <xref rid="Fig3" ref-type="fig">3</xref>d). On a per-cell basis the rate of virus production from the No RAL cells decreased relative to the +RAL cells. For Donor 3 cells, the output per GFP+ cell equaled the No RAL cells after 2 days. Thus, uDNA latency reversal initially displayed slower kinetics compared with integrated proviruses, but the differences in virus production between the No RAL and +RAL declined over time, indicating a more sustainable virus release from uDNA.</p>
    </sec>
    <sec id="Sec6">
      <title>Distribution of integrated and unintegrated genomes in productive infection and latency</title>
      <p>We next analyzed the content of cells for integrated and unintegrated HIV-1 before and after latency reversal. Fourteen days after direct infection of resting CD4 T cells, we sorted cells into 4 groups based on GFP fluorescence intensity (Fig. <xref rid="Fig4" ref-type="fig">4</xref>a). Using qPCR we then directly measured total HIV-1 genomes, integrated proviruses and 2-LTR circles (Fig. <xref rid="Fig4" ref-type="fig">4</xref>b). The primers to measure total DNA amplify all integrated and unintegrated species of HIV-1 DNA. 2-LTR circles have been observed to be formed as a minor fraction of the unintegrated species, forming about 1/30th of the total uDNA, with 1-LTR circles and linear uDNA constituting the remainder [<xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR53">53</xref>]. The overall amount of uDNA is calculated as total DNA minus integrated DNA.<fig id="Fig4"><label>Fig. 4</label><caption><p>Distribution of integrated and unintegrated HIV-1 DNA after infection resting CD4 T cells and following latency reversal. Data are representative of 5 experiments (see Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1 for all experiments). Mean of triplicate PCR and SD are shown. <italic>ND</italic> none detected. <bold>a</bold> At Day 14 p.i., eFluor<sup>hi</sup> cells from No RAL cultures were sorted based on 4 levels of GFP fluorescence (<italic>blue boxes</italic> indicate sorting gates). <bold>b</bold> Sorted cells were analyzed by qPCR for total HIV-1 DNA, 2-LTR circles and integrated proviruses. <bold>c</bold> GFP-negative cells were sorted, then stimulated with Pro/TSA for 1 day, and then sorted a second time based on GFP expression. <bold>d</bold> Sorted cells were analyzed for viral DNA as in <bold>b</bold>. <bold>e</bold>–<bold>h</bold> The procedures of <bold>a</bold>–<bold>e</bold> were performed on raltegravir treated cells</p></caption><graphic xlink:href="12977_2015_234_Fig4_HTML" id="MO4"/></fig></p>
      <p>The most obvious result, consistent with prior studies [<xref ref-type="bibr" rid="CR54">54</xref>, <xref ref-type="bibr" rid="CR55">55</xref>], was that uDNA was formed in excess of integrated proviruses. In this infection of resting T cells, uDNA was present on day 14 p.i. at nearly tenfold excess over iDNA (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1) amongst all cells (GFP+ and GFP-neg.). Cells with the highest GFP fluorescence (+++ cells corresponding to the prominent peak in Fig. <xref rid="Fig1" ref-type="fig">1</xref>b) contain at least one integrated genome consistent with prior results [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. By contrast, single + and double ++ cells contained less than one iDNA per cell (0.2 and 0.3 in the + and ++ cells, respectively), thus between 67 and 80 % of these dimmer cells expressed GFP from uDNA only. In 5 similar experiments utilizing 5 different cell donors, a substantial fraction of GFP+ cells (9–62 %) contained only uDNA (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S2).</p>
      <p>To examine the contribution of unintegrated DNA to latency we treated sorted GFP-negative cells with Pro/TSA (Fig. <xref rid="Fig4" ref-type="fig">4</xref>c), then performed a second sort and analyzed the DNA content of GFP-neg. and GFP+ cells (Fig. <xref rid="Fig4" ref-type="fig">4</xref>d). Similar to the initial infection, uDNA predominated in the GFP dim cells while there was at least one integrated provirus in the GFP bright cells. Interestingly, uDNA was still the majority population in the bright cells. A prior study in proliferating cells has shown that unintegrated genomes can constitute a similar proportion of transcriptionally active genomes as integrated proviruses [<xref ref-type="bibr" rid="CR7">7</xref>], however ours is the first study conducted in resting CD4 T cells and to directly parse cell subpopulations and analyze DNA content. There were 20 times more uDNA than iDNA genomes in the GFP-negative cells from the first sort, but only 5.5 times as many in the newly activated GFP+ cells from the second sort (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1) indicating that silent iDNA genomes were more likely to be activated by the Pro/TSA treatment than were silent uDNA genomes, a result consistent with the differential latency regulation. There could also be a higher proportion of defective or otherwise unresponsive uDNA than iDNA genomes. Importantly, no increase in integration resulted from this stimulation 15 days after infection (Fig. <xref rid="Fig4" ref-type="fig">4</xref>b vs. d, Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1), consistent with the short (1 day) half-life of pre-integration complexes [<xref ref-type="bibr" rid="CR56">56</xref>].</p>
      <p>Consistent with Fig. <xref rid="Fig1" ref-type="fig">1</xref>, raltegravir increased the generation of GFP+ cells from the latent pool (3.2 vs. 1.88 %) while inhibiting integration by ≥280 fold (Fig. <xref rid="Fig4" ref-type="fig">4</xref>e–h). Raltegravir also increased the appearance of 2-LTR circles by several fold (Fig. <xref rid="Fig4" ref-type="fig">4</xref>f), as expected [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR58">58</xref>]. As in the No RAL cultures, no increase in integration resulted from this stimulation 14 days after infection, in agreement with our prior study utilizing both raltegravir and integrase active site mutants [<xref ref-type="bibr" rid="CR6">6</xref>], but in contrast to a recent study in which removal of raltegravir 2–3 days after infection allowed integration to proceed [<xref ref-type="bibr" rid="CR42">42</xref>]. The difference in results from that study to ours is likely to be the considerable differences in the timing between infection and the removal of raltegravir. In the current study we left raltegravir in the culture for the duration of the 14 days prior to sorting and added it 2 additional times on days 3 and 7. The measured quantity of residual integration events in Fig. <xref rid="Fig4" ref-type="fig">4</xref>f and h, likely caused by an integrase-independent mechanism, cannot account for the expression of HIV-1 in the raltegravir-treated cultures.</p>
    </sec>
    <sec id="Sec7">
      <title>Persistence of cells expressing HIV-1 from unintegrated genomes</title>
      <p>The lower but more sustained gene expression and de novo virus production from uDNA vs. iDNA suggested the possibility that these are less cytopathic to cells when uDNA is the template. Lower cytopathicity could enhance uDNA persistence and allow more prolonged virus release from the uDNA template. To test this, at day 7 post infection we sorted GFP+ cells infected with an integrase WT HIV-1 or an Integrase active site mutant (Integrase D116N), then analyzed cell survival of the sorted GFP+ cells and virus production from them in the absence of further stimulation (Fig. <xref rid="Fig5" ref-type="fig">5</xref>a). As we predicted, the GFP+ cells productively infected with the integrase mutant died at a considerably lower rate than cells productively infected with the integrase WT virus, and they generated 27 % of the total de novo virus output from the Integrase WT virus over this time. After about 12 days in these cells the death curve of the Int-WT virus inflected to be approximately parallel with the Int-D116N virus, suggesting that cells expressing GFP from integrated viruses may have become depleted from the Int-WT infected cells, with relative enrichment of cells expressing GFP from uDNA (shown to arise in Fig. <xref rid="Fig4" ref-type="fig">4</xref>) in this non-replicating cell population.<fig id="Fig5"><label>Fig. 5</label><caption><p>Preferential loss of resting CD4 T cells infected with integrated proviruses. <bold>a</bold> Productively infected GFP+ cells containing Int-WT or Int-D116N HIV-1 were sorted by FACS 7 days after infection and placed back into culture. Survival of the GFP+ cells was assessed by flow cytometry on the indicated days, and virus production from the FACS purified GFP+ cells was measured by RT-qPCR for viral RNA present in the culture medium as described [<xref ref-type="bibr" rid="CR6">6</xref>]. In this experiment an Envelope+ virus was employed. <bold>b</bold> Experimental design for <bold>c</bold>–<bold>e</bold>. Resting CD4 T cells infected with HSA-reporter viruses were maintained in IL-4 ± RAL for 14 days. At the indicated time points HSA<sup>+</sup> cells in each sample were isolated using anti-HSA antibody coupled to magnetic beads. Efavirenz was added to all cells on day 8. HSA Positive and negative cells were separated using the MACS system. Cell survival was measured by forward and side scatter analysis. Data present one of two independent experiments. <bold>c</bold> Productively infected HSA<sup>+</sup> cells purified from No RAL cultures at day 5, 7 and 14 p.i. were analyzed for viral DNA. <bold>d</bold> The ratios of 2-LTR/total HIV-1 DNA in comparison with the ratio of integrated/total HIV-1 DNA for No RAL purified HSA<sup>+</sup> productively infected cells. <bold>e</bold> HSA<sup>+</sup> and HSA-neg. cells were purified at day 7 and 14 p.i. and placed into fresh medium. Cell viability of these individual populations was monitored by flow cytometry over 48 h</p></caption><graphic xlink:href="12977_2015_234_Fig5_HTML" id="MO5"/></fig></p>
      <p>To test this hypothesis, we sampled productively infected cells at 3 intervals after infection and analyzed their DNA content (Fig. <xref rid="Fig5" ref-type="fig">5</xref>b–d). Here we employed a reporter virus expressing the cell surface molecule Heat Stable Antigen (HSA, a.k.a. murine CD24) in place of GFP [<xref ref-type="bibr" rid="CR43">43</xref>] which allows purification of productively infected (HSA+) cells with anti-HSA magnetic beads. Between days 5 and day 7 there was no loss of either integrated or unintegrated HIV-1 DNA in these cells infected without raltegravir added (Fig. <xref rid="Fig5" ref-type="fig">5</xref>c, d). However, between days 7 and 14 there was a ninefold reduction in the integrated proviruses among the HSA+ cells but only a 2.6 fold reduction in total DNA at day 7 p.i., consistent with our hypothesis that the cells expressing virus solely from the uDNA template have a survival advantage over cells expressing virus from an integrated template. Confirming our model, HSA+ cells collected on day 7 from the No RAL condition died at a greater rate than either the HSA− cells or HSA+ cells from raltegravir treated culture (Fig. <xref rid="Fig5" ref-type="fig">5</xref>e). Cells expressing HIV-1 from uDNA (+RAL, HSA+ cells) died at a similar rate to the HSA-negative cells, confirming that uDNA gene expression is not particularly toxic. All of the cells from day 14 died at an equal rate, which is consistent with the observed depletion of cells expressing HIV from iDNA by this point. In separate experiments, αCD3/CD28 beads accelerated death of purified No RAL HSA+ (or GFP+) cells but not +RAL HSA+ (or GFP+) cells (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S6). Thus, owing to its reduced toxicity, genetically active uDNA can have a persistence advantage in resting, non-proliferating T cells compared with active integrated proviruses.</p>
    </sec>
    <sec id="Sec8">
      <title>One or two rounds of stimulation do not activate all unintegrated latent genomes</title>
      <p>The efficacy of any shock and kill regimen will require that essentially all replication competent HIV–1 genomes be activated. Prior studies, however, have demonstrated failure of single or repeated strong stimuli to accomplish this in ex vivo and in vitro systems [<xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR60">60</xref>]. Here, we investigated whether a single round of strong stimulation can activate all unintegrated latent genomes (Fig. <xref rid="Fig6" ref-type="fig">6</xref>). Fourteen days after infection, we treated sorted eFluor<sup>hi</sup>GFP-neg. Cells with Pro/TSA, or activated them with αCD3/CD28 beads plus IL-2, or left them untreated (First Stimulation) (Fig. <xref rid="Fig6" ref-type="fig">6</xref>b, c). The αCD3/CD28 beads induced cell enlargement and proliferation in ≥99 % of the cells, indicating essentially complete activation. Pro/TSA, which does not induce T cell activation, resulted in no cell enlargement or proliferation but similar HIV-1 induction. We counted the total number of GFP+ cells generated from the GFP-negative sorted cells, and calculated the percent GFP+ cells based on the number of cells placed in each well before the first stimulation (Fig. <xref rid="Fig6" ref-type="fig">6</xref>c). Three days later we sorted GFP-neg. cells a second time from each culture and (re)stimulated them with one of the agents or with nothing (Second Stimulation). This yielded 9 combinations of first and second stimuli (Fig. <xref rid="Fig6" ref-type="fig">6</xref>d). We calculated the percent GFP+ cells based on the number of cells placed in each well before the second stimulation (Fig. <xref rid="Fig6" ref-type="fig">6</xref>e). Stimulation in the first round reduced the number of GFP+ cells generated in the second round. However, a second stimulation nevertheless generated measurable numbers of GFP+ cells. These finding held true in both the raltegravir treated and untreated cultures. In fact, more GFP+ cells were generated in the raltegravir cultures in the first and second round stimulations, with the exception of cells that were activated by αCD3/CD28 beads in the first round. We previously demonstrated [<xref ref-type="bibr" rid="CR6">6</xref>] that cell proliferation antagonizes uDNA gene expression, so it seems likely that that this effect plus the partitioning of uDNA genomes as the cells divided reduced the number of uDNA genomes that could be activated in αCD3/CD28 activated cells.<fig id="Fig6"><label>Fig. 6</label><caption><p>A single round of maximum T cell activation does not induce the expression of all latent unintegrated or integrated viruses. <bold>a</bold> Experimental design. eFluor<sup>hi</sup>GFP-negative cells were sorted on day 14 p.i., then cells were stimulated with Pro/TSA, αCD3/CD28 beads or medium only control (Ø). Three days later (day 17) all GFP-negative cells were purified in a second sort and 30,000 cells per well were (re)stimulated in triplicate. Efavirenz was added on days 14 and 17 to sorted cells as an added precaution against virus spread. <bold>b</bold> Flow cytometric analysis of cells at the end of the first three day treatment. GFP<sup>+</sup> cells (<italic>light grey dots</italic>) are overlaid on GFP-negative cells (<italic>black dots</italic>). Undivided cells lie above the red lines. <bold>c</bold> The percentage of GFP<sup>+</sup> cells generated after the first round of stimulation calculated based on the total number of GFP+ of the cells placed in the wells on day 14. <bold>d</bold> Flow analysis of cells after the restimulation. Cells that remained GFP-negative after the first round of stimulation were sorted and equal numbers of these cells were re-stimulated with Pro/TSA, αCD3/CD28beads or medium alone (Ø). <bold>e</bold> The percentage of GFP<sup>+</sup> cells generated after the second round of stimulation calculated based on the total number of GFP+ of the cells placed in the wells on day 17. Mean and SD for each condition are shown</p></caption><graphic xlink:href="12977_2015_234_Fig6_HTML" id="MO6"/></fig></p>
      <p>In a variant of this experiment, we stimulated cells infected with the single round virus twice (day 8 and day 11 post infection) prior to sorting for GFP-negative cells. Similar to Fig. <xref rid="Fig6" ref-type="fig">6</xref>, we observed latent viruses emerge 2 days later with or without further stimulation, further confirming a strong stochastic component to latency reversal (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S7). Overall, these results indicate that both uDNA latency and integrated proviral latency can resist a single or even double exposure to stimuli intended to reverse the latent state.</p>
    </sec>
    <sec id="Sec9">
      <title>Failure to down modulate HLA Class I expression and CTL responses to HIV-1 epitopes expressed from integration competent and defective HIV-1</title>
      <p>Observations of gene expression from uDNA prompted the notion that this could expand the antigenic repertoire of HIV-1 and the number of cells vulnerable to CTL recognition [<xref ref-type="bibr" rid="CR61">61</xref>]. We first measured the ability of uDNA to down modulate receptors required for immune recognition. In our system, integration-competent HIV-1 efficiently down modulated CD4 (Fig. <xref rid="Fig7" ref-type="fig">7</xref>a) and HLA Class I (Fig. <xref rid="Fig7" ref-type="fig">7</xref>b) in the majority of either resting CD4 T cells or cells subsequently activated according to the post-infection activation (Post-activation) procedures utilized in this work and in our prior study [<xref ref-type="bibr" rid="CR6">6</xref>] which demonstrated that high level uDNA expression is only achieved by this sequence of events and not by infection of pre-activated T cells. Post-activation of the cells resulted in the death of more GFP+ cells than GFP-neg. cells, resulting in a decrease in the percent GFP+. HLA Class I down modulation by the integrating virus was biphasic and observed only in cells with GFP expression higher than achieved by uDNA. HIV-1 Nef-dependent HLA Class I down modulation (reviewed in [<xref ref-type="bibr" rid="CR62">62</xref>]) has been shown to inhibit CTL recognition [<xref ref-type="bibr" rid="CR63">63</xref>]. Similar to previous reports [<xref ref-type="bibr" rid="CR64">64</xref>] uDNA was able to down modulate CD4, though not as efficiently as integrating virus. On the other hand, HLA Class I was barely affected by uDNA gene expression, suggesting continued high vulnerability to CTL recognition might result.<fig id="Fig7"><label>Fig. 7</label><caption><p>Gene expression from uDNA fails to down modulate HLA Class I but is efficiently recognized by HIV-1-specific CTL. <bold>a</bold> Unintegrated HIV-1 down modulates CD4 in both resting (<italic>left</italic>) and activated (<italic>right</italic>) CD4 T cells. Resting IL-4 treated CD4 T cells were infected then analyzed 6 days after infection with Integrase wild type (Int-WT) or Integrase mutant (Int-D116N) HIV-1 GFP reporter viruses (<italic>left</italic>). One half of the cells were then activated with αCD3/CD28 beads then analyzed 2 days later (<italic>right</italic>). Activation caused a loss of a portion of GFP+ cells, resulting in fewer GFP+ at the time of analysis. The positive control CD4 down modulation data for the integrase WT virus was also a positive control in [<xref ref-type="bibr" rid="CR43">43</xref>]. <bold>b</bold> Only integration-competent HIV-1 down modulates HLA A2 in resting (<italic>left</italic>) and post-infection activated (<italic>right</italic>) CD4 T cells. Cells were treated as in A but stained with an anti-HLA A2 antibody. <bold>c</bold> CD8+ cytotoxic T cells that recognize defined Gag and Nef epitopes (see materials and methods) specifically kill GFP+ cells infected with Int-WT or Int-D116N HIV-1. Killing was measured by loss of GFP+ cells, with non-specific killing of HLA Class I mismatched controls subtracted from the total. One of two representative experiments is shown</p></caption><graphic xlink:href="12977_2015_234_Fig7_HTML" id="MO7"/></fig></p>
      <p>Next, we examined the ability of HIV-1-specific CTL to recognize and eliminate cells expressing HIV-1 proteins from unintegrated templates (Fig. <xref rid="Fig7" ref-type="fig">7</xref>c). CD8 cytotoxic T cell lines specific for HIV-1 Nef and Gag were developed from HIV-1 infected individuals as previously described [<xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR66">66</xref>]. These CTL lines were co-cultured with HIV-1-infected HLA Class I-matched target cells at varying CTL to target cell ratios. Negative controls included HLA Class I mismatched infected target cells. Killing of HIV-1 expressing cells was measured as a reduction in the percentage of GFP+ cells by flow cytometry, and non-specific killing of the HLA Class I mismatched cells was subtracted from these data. Both Gag-specific and Nef-specific CTL recognized and eliminated GFP+ cells expressing HIV-1 proteins from HIV-1 with wild-type integrase or from uDNA (Int-D116N) with the efficiency of killing titrating according to the CTL:target ratio. Perhaps not-surprisingly, given the weaker expression of Gag vs. Nef from uDNA [<xref ref-type="bibr" rid="CR6">6</xref>], CTL against Gag more efficiently killed Int-WT infected cells than Int-D116N infected cells. This would be consistent with a recent study indicating that 2-LTR uDNA is cleared less efficiently by CTL than integrated proviruses [<xref ref-type="bibr" rid="CR67">67</xref>]. On the other hand, Nef CTL more efficiently killed cells infected with the integrase deficient virus, so uDNA clearance could be epitope-specific. It is tempting to speculate that failure to down modulate HLA Class I could allow greater vulnerability to CTL killing of cells expressing early vs. late gene products from unintegrated HIV-1.</p>
    </sec>
    <sec id="Sec10">
      <title>Discussion</title>
      <p>The findings presented here and in our prior studies [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR68">68</xref>] challenge the notion that uDNA is inevitably a replicative dead end. Instead, latency, gene expression and virus production from unintegrated HIV-1 DNA are natural and possibly unavoidable consequences of the direct infection of resting CD4 T cells. In this in vitro setting, we found evidence that gene expression from uDNA is regulated somewhat differently from iDNA during productive infection, as only uDNA required an interval of several days after infection to obtain responsiveness to activating agents. Furthermore, latent uDNA demonstrated a wider dynamic range of responses to latency reversing agents and slower activation kinetics compared to latent integrated proviruses. Our prior work demonstrated that uDNA but not iDNA depends on virion-associated Vpr for expression in resting T cells further demonstrates qualitative differences in gene regulation between these forms of HIV-1 genomes [<xref ref-type="bibr" rid="CR6">6</xref>].</p>
      <p>HIV-1 uDNA surprisingly had a persistence advantage over integrated proviruses in resting CD4 T cells, which we attribute to reduced cytotoxicity resulting from uDNA’s lower gene expression. As a result, resting CD4 T cells expressed proteins and viruses from unintegrated genomes for longer than from integrated proviruses. The extended persistent expression from uDNA vs. iDNA was evident both during initial infection of cells and after reversal of latency. We also found that uDNA failed to down modulate HLA Class I surface expression on resting CD4 T cells, and HIV-1-specific CTL efficiently killed cells infected with unintegrated HIV-1. Thus, in vivo, uDNA may contribute to the development of anti-HIV-1 immune responses and to immune-dependent cell loss.</p>
      <p>The de novo synthesis of virions from unintegrated HIV-1 requires a particular set of conditions that is clearly not the majority circumstance in vivo, and virus production by unintegrated HIV-1 in resting CD4 T cells is usually about one order of magnitude lower than from viruses which were capable of integration. Importantly, in vivo, most viruses are generated from activated T cells, which generate several-fold more viruses than resting T cells [<xref ref-type="bibr" rid="CR69">69</xref>], and which we confirmed in [<xref ref-type="bibr" rid="CR6">6</xref>] do not support high level gene expression and de novo virus production from uDNA. Thus, the finding that uDNA is capable of latency and virus production do not challenge the accepted view that HIV-1 predominantly replicates via the successfully integrated provirus. These findings are also consistent with the documented efficacy of raltegravir in vivo. We have identified an exception to the rule regarding the necessity of integration for de novo virus production and persistence. Intriguingly a recent study observed persistence of an integrase-defective HIV-1 in a patient [<xref ref-type="bibr" rid="CR70">70</xref>], and infectious virus production from uDNA has recently been reported in T cell lines [<xref ref-type="bibr" rid="CR71">71</xref>].</p>
      <p>Investigations into the regulation of HIV-1 latency rely heavily on in vitro models, with several prominent systems utilizing direct infection of resting T cells (reviewed in [<xref ref-type="bibr" rid="CR30">30</xref>]). In light of the results presented here, the contribution of uDNA to systems employing direct infection of resting and/or non-proliferating cells warrants investigation, as these systems may generate some of their output (RNA, virions, GFP+ cells) from unintegrated HIV-1 DNA, especially when stimulation is provided at least 5 days after infection. In addition, the procedure we established to reveal HIV–1 replication from uDNA [<xref ref-type="bibr" rid="CR6">6</xref>] parallels the protocols developed to characterize in vivo latency: culture resting CD4 T cells from HIV+ individuals ex vivo for about 6 days, then activate them [<xref ref-type="bibr" rid="CR56">56</xref>, <xref ref-type="bibr" rid="CR72">72</xref>, <xref ref-type="bibr" rid="CR73">73</xref>]. This culture period was performed so that pre-integration complexes in recently infected cells, which have a half-life of 1 day [<xref ref-type="bibr" rid="CR40">40</xref>], would disintegrate and the cDNA would not integrate in response to T cell activation. Our studies suggest that these procedures would in fact optimize gene expression from any remaining unintegrated HIV-1. On the other hand, when infected cells proliferate, uDNA gene expression does not lead to de novo virus production [<xref ref-type="bibr" rid="CR6">6</xref>], so systems in which activated and dividing T cells are infected are unlikely to generate such high levels of uDNA gene expression [<xref ref-type="bibr" rid="CR74">74</xref>, <xref ref-type="bibr" rid="CR75">75</xref>]. The use of a proliferation tracking dye (eFluor670) allowed us to isolate only the non-proliferated cells for study of the in vitro generated latent reservoir, where we found the vast majority of latent infection. This technique is potentially useful in other models of HIV latency where the cells have been stimulated or activated prior to infection.</p>
      <p>The potential of shock and kill therapies to eliminate latent reservoirs will depend upon these cells dying after virus activation, either via viral cytopathic effects or by immune killing [<xref ref-type="bibr" rid="CR76">76</xref>], which has been cast into some doubt [<xref ref-type="bibr" rid="CR77">77</xref>]. Our data here indicate that gene expression from uDNA displays slower kinetics and is more benign to host cells than from integrated proviruses, so viral cytopathicity is a particularly unreliable mechanism for eliminating cells expressing HIV-1 from uDNA. The lack of uDNA cytopathicity in resting CD4 T cells counterintuitively translated into the aforementioned persistence of unintegrated vs. integrated genomes in our system. The generation of uDNA may bias against the kill portion of investigations performing direct infection of resting T cells.</p>
      <p>Success of shock and kill will also depend upon activating all latent replication competent genomes; however, this task is complicated by the multifactorial nature of HIV-1 latency [<xref ref-type="bibr" rid="CR78">78</xref>]. Among these factors, the availability and activity of transcription factors in cells of varying lineages and activation states, the installation of epigenetic controls, and virus integration into chromosomal regions that favor or disfavor gene expression can all complicate the development of universally effective LRA [<xref ref-type="bibr" rid="CR79">79</xref>, <xref ref-type="bibr" rid="CR80">80</xref>]. Additionally, cellular activation does not necessarily induce all latent genomes [<xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR81">81</xref>], and subpopulations of latently infected cells may display varying “degrees of latency” [<xref ref-type="bibr" rid="CR82">82</xref>] or are regulated with a strong stochastic component [<xref ref-type="bibr" rid="CR81">81</xref>, <xref ref-type="bibr" rid="CR83">83</xref>]. This variability obtains even to clonal latent cell lines [<xref ref-type="bibr" rid="CR38">38</xref>]. Here, we provide evidence for a further complication that can apply to, at least, in vitro models of latency: unintegrated HIV-1 genomes contribute to latency when resting CD4 T cells are directly infected, and, as has observed for integrated proviruses, a subset of latent uDNA genomes resist activation by single or double stimulation and contain a strong stochastic component to their expression. Our finding that uDNA gene expression is regulated by somewhat different rules than integrated proviruses could also complicate in vitro testing of therapeutics to purge viral reservoirs.</p>
      <p>Two basic and non-exclusive models for the establishment of HIV-1 latency have been proposed. Siliciano and Chun, after analyzing quiescent blood CD4 T cells, initially suggested that a rapid return to quiescence of recently infected activated cells can induce transcriptional silencing, as necessary transcription factors are withdrawn. This model has the logical benefits that (1) most in vivo latency in blood resides within previously activated memory CD4 T cells, and (2) it has been commonly accepted, based on studies of purified blood T cells, that quiescent (resting) CD4 T cells are poorly infectible, though infection and latency are possible even without stimulation [<xref ref-type="bibr" rid="CR24">24</xref>]. However, the blood contains only 2 % of the body’s lymphocytes, with 98 % resident in tissues. Lymphoid and mucosal tissues are the predominant sites of HIV-1 replication, depletion and latency [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR84">84</xref>]. Microenvironmental factors in tissues enable resting CD4 T cells to be directly infected by HIV-1, and these cells are the dominant targets of early infection [<xref ref-type="bibr" rid="CR29">29</xref>]. It has also been shown that infection of both resting cells from lymphoid tissues and activated T cells results in rapid establishment of latency [<xref ref-type="bibr" rid="CR25">25</xref>]. Thus, a possible second mechanism contributing to HIV-1 latency has been gaining traction, in which direct infection of resting but permissive cells allows HIV-1 to rapidly enter latency immediately or soon after reverse transcription and integration [<xref ref-type="bibr" rid="CR24">24</xref>]. Within this scenario, the present work demonstrates that latency and ultimately virus replication can be established in the absence of integration.</p>
      <p>The responses of latent uDNA to the panel of latency reversing agents, measured as the induction of GFP+ cells and virions from sorted GFP-negative cells treated with raltegravir, obeyed the same basic pattern as when integration was allowed to proceed. However, the dynamic range of de novo virus production was substantially greater from unintegrated HIV-1, with weak stimuli inducing roughly equal numbers of GFP+ cells and 7–20 % as many virions as when integration is not blocked, while strong stimuli induced 2–3 times as many GFP+ cells and 30–66 % as many virions within 24 h and up to &gt;200 % more virions over 3 days. Thus, as the strength of the stimulus increased, relatively more uDNA genomes were recruited out of latency compared with integrated proviruses. This greater dynamic range of uDNA responses to LRA suggests that uDNA transcription is regulated differently from iDNA. Chromatin structures that are proximal to the HIV-1 transcriptional regulatory regions, chief among these being promoter-proximal nucleosomes, regulate the susceptibility of HIV-1 to transcriptional activation. The ability of histone deacetylase inhibitors to reverse latency is thought to be due at least in part to the displacement of promoter-proximal nucleosomes following histone acetylation. The responsiveness of uDNA from HIV-1 and other retroviruses to HDACi, which has been observed before by others and by us [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR44">44</xref>–<xref ref-type="bibr" rid="CR46">46</xref>], is an indication that uDNA is also regulated by chromatin [<xref ref-type="bibr" rid="CR44">44</xref>]. HDACi also activate many cellular genes, so the influences of HDACi on HIV-1 expression are likely complex and include multiple indirect effects. Nevertheless, our conclusion that uDNA is transcriptionally regulated by a set of criteria somewhat different from iDNA is supported by the notion that uDNA would lack chromosomal positional effects that an integrated gene would be subjected to, such as integration sites which favor or disfavor transcription, and integration near transcriptional regulatory sequences of cellular genes. In addition, Vpr’s ability to transactivate uDNA [<xref ref-type="bibr" rid="CR85">85</xref>], and our prior demonstration that Vpr is the critical determining factor in establishing uDNA but not iDNA transcriptional competence in resting CD4 T cells, emphasizes the differential transcriptional regulation of uDNA and iDNA [<xref ref-type="bibr" rid="CR6">6</xref>]. Use of Δvpr HIV-1 vectors to infect resting CD4 T cells would fail to achieve expression from unintegrated viral DNA and could account for some of the variability among systems [<xref ref-type="bibr" rid="CR86">86</xref>]. How Vpr may contribute to latency regulation is not clear, but some prior studies, including those from one of us, have indicated that Vpr can reactivate latent proviruses [<xref ref-type="bibr" rid="CR87">87</xref>–<xref ref-type="bibr" rid="CR90">90</xref>]. More recently, the cellular protein family TASK and the viral accessory protein Vpu has been shown to specifically down-modulate HIV-1 uDNA transcription in a NF-κB-depended manner [<xref ref-type="bibr" rid="CR91">91</xref>].</p>
      <p>Antiviral immunity, particularly cytotoxic T cells, is envisioned to assist eradication of cells containing recently activated viruses. However, CTL killing in this scenario cannot necessarily be taken for granted [<xref ref-type="bibr" rid="CR77">77</xref>, <xref ref-type="bibr" rid="CR92">92</xref>], and CTL responses may not be efficient at sites of HIV-1 replication in lymphoid tissues [<xref ref-type="bibr" rid="CR93">93</xref>]. We observed that uDNA expression is unable to efficiently down modulate HLA Class I expression in resting or CD4 T cells that were subsequently activated, despite being able to down modulate CD4 expression [<xref ref-type="bibr" rid="CR64">64</xref>]. HLA Class I is targeted by HIV-1 Nef, which has been shown previously to be expressed from uDNA, however, relatively higher levels of Nef are required to induce HLA Class I down modulation than CD4 down modulation. We predicted that failure to down modulate HLA Class I might leave cells expressing HIV-1 from uDNA particularly vulnerable to CTL killing. We observed that both Nef-specific and Gag-specific CTL killed autologous target cells infected either with integrase wild type HIV-1 or integrase defective virus. Interestingly, cells infected with integrase defective virus were killed more efficiently than WT virus by the Nef-specific CLT but less efficiently by the Gag CTL. It is tempting to speculate that this relates to the relative inefficiency of Gag expression by uDNA, especially in replicating cells [<xref ref-type="bibr" rid="CR6">6</xref>]. Recent studies have shown that the viral reservoir is influenced by the susceptibility of cells to CTL killing [<xref ref-type="bibr" rid="CR67">67</xref>, <xref ref-type="bibr" rid="CR94">94</xref>], and it will be important to examine how uDNA expression sensitizes various cell types at different activation states to these processes.</p>
    </sec>
    <sec id="Sec11">
      <title>Methods</title>
      <sec id="Sec12">
        <title>Viruses</title>
        <p>Viruses have been described previously [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR43">43</xref>]. With the exception of Fig. <xref rid="Fig5" ref-type="fig">5</xref>a which employed an Env+ virus, infectious virions were generated by co-transfection of 293T cells with a plasmid expressing the <italic>env</italic> gene-defective reporter virus and a plasmid expressing the CXCR4 trophic HIV-1 NL4-3 envelope, as described previously [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR37">37</xref>]. Virus stocks were filtered through a 0.45 μm pore-sized filter and treated with benzonase (50 μ/ml, Novagen) to remove residual plasmid remaining from transfections, as described [<xref ref-type="bibr" rid="CR14">14</xref>].</p>
      </sec>
      <sec id="Sec13">
        <title>Cells and infections</title>
        <p>Peripheral blood buffy coats from HIV–1-negative adults were purchased from the New York Blood Center. Isolation, culture, IL–4 treatment, eFluor670 staining and infection of resting CD4 T cells have been described previously [<xref ref-type="bibr" rid="CR6">6</xref>]. p24gag ELISA analysis on viral stocks indicated a range of 175–320 ng p24gag/10<sup>6</sup> cells except as indicated in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig S3. The titers of the virus stocks were routinely determined by TaqMan RT-qPCR for HIV-1 RNA and normalized as previously described [<xref ref-type="bibr" rid="CR6">6</xref>]. Raltegravir (1 μM in water) was added immediately after infection and supplemented at day 3 and day 7 after infection. Maximally effective raltegravir dose in resting CD4 T cells was determined in [<xref ref-type="bibr" rid="CR6">6</xref>] to be 0.3 µM. The HIV-protease inhibitor indinavir (IND) was used at 2 μM in water and the NNRTi efavirenz (EFV) was used at 1 μg/ml in DMSO. All antiretrovirals were obtained from the NIH AIDS Research and Reference Reagent Program.</p>
      </sec>
      <sec id="Sec14">
        <title>Stimulation of cells with latency reversing agents</title>
        <p>The following conditions were utilized: αCD3/CD28 T cell activation beads (1 μl/40,000 cells; Life Technologies), PHA-L (3 μg/ml in PBS; Sigma), TNF-α (10 ng/ml in PBS; Invitrogen), PMA (16.2 μM in DMSO; Fisher Scientific), prostratin (Pro; 330 nM in DMSO; Santa Cruz Biotechnology), bryostatin-1 (30 nM in DMSO; Santa Cruz Biotechnology), trichostatin A (TSA; 130 nM in DMSO; Fisher Scientific), JQ1 (1 μM in DMSO; kindly provided by James E. Bradner, Dana Farber Cancer Institute, Boston, MA), disulfiram (50 nM in DMSO; Tocris Bioscience), HMBA (1 mM in dH<sub>2</sub>O; Sigma), valproic acid (5 mM in PBS, Sigma), SAHA (vorinostat; 335 nM in DMSO; Santa Cruz Biotechnology), scriptaid (1.8 μM in DMSO; Santa Cruz Biotechnology), oxamflatin (500 nM in DMSO; Santa Cruz Biotechnology) and DMSO carrier control (0.1 % [14 mM], specific to Pro/TSA; Sigma). In the latency activation experiments, GFP-negative cells were plated at 30,000 cells per well in 96-well plates for stimulation. A supernatant sample from each treatment was collected 24 h later or at the indicated time point and cell GFP expression was concurrently analyzed by flow cytometry. Synergy index was calculated based on published methods [<xref ref-type="bibr" rid="CR95">95</xref>]. Briefly: The percentage of GFP+ cells after stimulation by each drug was converted to fold induction by normalizing to the percentage of GFP+ cells in IL-4-only treatment. The fold induction of a combination treatment was then divided by the sum of the fold induction of each drug when used separately. A combination with an index of &gt;1 was considered synergistic, while an index of 1 was considered to be additive and &lt;1 was considered as inhibitory.</p>
      </sec>
      <sec id="Sec15">
        <title>Flow cytometry</title>
        <p>Flow cytometric analysis was performed on a FACSort flow cytometer (Becton–Dickinson) upgraded to 3 lasers and 5 color channels as previously described [<xref ref-type="bibr" rid="CR6">6</xref>]. Cell proliferation was calculated using the Proliferation platform of the FlowJo software based on eFluor670 intensity. Anti-CD4 (RPA-T4), Anti-HLA Class I (HLA A2) PerCP-Cy 5.5 (BB7.2), Anti-HLA-DR PerCP-Cy 5.5 (G46-6) and Anti-HSA-PE (M1/69) antibodies were purchased from BD Biosciences. Anti-CD69 PerCP-Cy5.5 (FN50), and isotype control mouse IgG1κ PerCP-Cy5.5 (MOPC-21) antibodies were purchased from BioLegend. Anti-CD25 PerCP-Cy 5.5 (BC96) antibody was from eBioscience. Cell sorting was performed using a BD FACSAria sorter at the NYU Langone Medical Centre Office of Collaborative Science Flow Cytometry Core Facility. Flow cytometry for the CTL killing assay was performed at the UAB Center for AIDS Research Flow Cytometry Core. Intracellular DNA and RNA were stained with 7-aminoactinomycin D (7-AAD) and pyronin Y (PY) as previously described [<xref ref-type="bibr" rid="CR96">96</xref>].</p>
      </sec>
      <sec id="Sec16">
        <title>MACS separation of productively infected and non-productively infected cells</title>
        <p>After infection with murine HSA (CD24)-expressing reporter virus, primary CD4 T cells were treated at 1 day p.i. with pronase (Fisher Scientific) to remove residual HSA molecules from the initial infection as in [<xref ref-type="bibr" rid="CR14">14</xref>]. At the indicated time points, live cells were purified on a Ficoll-Paque (GE Life Sciences) gradient, stained with a phycoerythrin (PE) labeled anti-mCD24 antibody (M1/69, BD Biosciences) and then bound to anti-PE magnetic microbeads (Miltenyi Biotec). HSA Positive and negative cells were separated using the MACS system (Miltenyi Biotec) according to manufacturer’s protocol. Purity was routinely &gt;95 %. Cell survival was measured by forward and side scatter analysis.</p>
      </sec>
      <sec id="Sec17">
        <title>PCR methods for quantification of HIV-1 DNA and RNA</title>
        <p>All methods, including primers and TaqMan probes have been previously described [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR43">43</xref>]. Briefly, DNA from cells was purified using the DNeasy Blood &amp; Tissue kit or the AllPrep kit (Qiagen). Cell associated RNA and viral RNA in culture medium were prepared using the RNeasy kit (Qiagen). DNA was analyzed using the QuantiTect Probe PCR kit (Qiagen) and RNA was analyzed by RT-qPCR using the QuantiTect Probe RT-PCR kit (Qiagen). Integrated HIV-1 was detect by Alu PCR as described [<xref ref-type="bibr" rid="CR6">6</xref>].</p>
      </sec>
      <sec id="Sec18">
        <title>CTL cell killing assay</title>
        <p>HLA I-restricted CD8<sup>+</sup> Cytotoxic T cell lines reactive against HIV-1 peptides were developed from HIV-1+ individuals as described [<xref ref-type="bibr" rid="CR97">97</xref>]. CTL clone 2B6 recognizes HLA B*5301 restricted Gagp24-QW9 (QASQEVKNW) epitope in Nef, while clone 2A3 recognizes HLA B*4002 restricted Nef-KL9 (KEKGGLEGL) epitope. Both these clones were obtained from a chronically HIV clade B infected patient expressing HLA-A*02(01, 09)/A*3201; B*4002/B*5301 and Cw*0202/Cw*0401. EBV transformed B lymphoblastoid cell-lines (BLCL) were developed from this patient’s PBMC for use as targets in the killing assay. An HLA-I mismatched BLCL was used as a negative control (HLA-A*2904/A*3002; B*1503/B*5802; Cw*0202/Cw*0602). Target cells were infected with VSV-G pseudotyped NLENG1-ES-IRES or NLENG1-ES-IRES-D116N as described [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR37">37</xref>], resulting in 5–20 % GFP+ cells. Two days after infection, 50,000 infected target cells were co-cultured for 4 h with the CTL a three CTL:target ratios indicated in Fig. <xref rid="Fig7" ref-type="fig">7</xref>c. Cells were then harvested and stained with anti-CD19-PE-Cy7, anti-CD3-Pacific Blue, and anti-CD8-PerCP-Cy5.5 (BD Biosciences). Flow cytometry was performed on a BD FACSAria at the University of Alabama at Birmingham Center for AIDS Research Flow Cytometry Core Facility. Live cells were identified by side scatter and forward scatter profile, and live CD19+ CD3−CD8− cells were analyzed for percent GFP expression. Specific CTL killing of GFP+ target cells was calculated in two steps: The GFP+ cells remaining after CTL exposure was calculated as a percentage of the number of CD19+ CD3−CD8−GFP+ cells present without CTL, then non-specific killing of HLA-mismatched target cells (&lt;10 % in all instances) was then subtracted from this number for each CTL:target ratio. This number was graphed as the Percent Specific Killing in Fig. <xref rid="Fig7" ref-type="fig">7</xref>c.</p>
      </sec>
    </sec>
  </body>
  <back>
    <app-group>
      <app id="App1">
        <sec id="Sec19">
          <title>Additional file</title>
          <p>
            <media position="anchor" xlink:href="12977_2015_234_MOESM1_ESM.pdf" id="MOESM1">
              <caption>
                <p>
10.1186/s12977-015-0234-9
<bold>Figure S1</bold> (supplement to Fig. 1). Integrase D116N mutant expression in resting CD4 T cells. An experiment performed independently from those in Figs. 1 and 2 was performed using a different donor. (A) Kinetics of virus expression with and without stimulation. (B) Loss of GFPhi  population similar to raltegravir treatment of WT virus.    <bold>Figure S2</bold> (supplement to Fig. 1). Protein, RNA and DNA in GFP+ and GFP- cells at day 14 post infection. (A) HIV-GFP expression in cells at day 14 for analysis in E. Data are representative of &gt;5 independent experiments using cells from different donors. MFI = mean fluorescence intensity of GFP. (B) Intracellular HIV-1 RNA in sorted cells from integration permissive (No RAL) and integration inhibited (+RAL) cultures. Early Rev-independent Fully spliced RNA, and late Rev-dependent unspliced RNA were quantified by RT-qPCR (see methods). Data are normalized to Fully spliced RNA in the GFP+ No RAL cells set as 100%. Data from one of two similar experiments is shown. Standard deviations are from PCR triplicates. Non-proliferated cells were sorted for this analysis (Fig S4A-B). (C) qPCR analysis of Total and Integrated HIV-1 DNA in cells from Fig. 1E-F. Infection in the presence of raltegravir resulted in less than 1 in 500 GFP+ cells containing an integrated provirus.    <bold>Figure S3</bold> (supplement to Fig. 1). Lack of influence of MOI on the timing of HIV-1 gene expression and on No RAL vs. + RAL latency in resting CD4 T cells. (A) Cells were infected as in Figure 1 except that different doses of HIV-1 were applied. Figure 1 employs 300ng p24gag per million cells. Note that the Y axis scales are adjusted to allow comparison of relative kinetics at different MOI. (B) Relative amounts of latency for No RAL and +RAL infections remain constant with varying MOI. GFP-negative cells from each infection were sorted at Day 14 p.i. by FACS and stimulated with Pro/TSA in triplicates or DMSO. Expression of GFP one day after stimulation is shown. Data representative of 3 independent experiments with 3 different donors.    <bold>Figure S4</bold> (supplement to Fig 1). Homeostatic proliferation of IL-4 treated cells and resting status of the non-productively infected cells. (A) eFluor670 and GFP expression on day 14 p.i. Sorting gates are indicated by red boxes. Data are representative of &gt;5 independent experiments using cells from different donors. (B) Analysis of cell proliferation on the day of sorting. The FlowJo Proliferation Platform was used to calculate the percentage of cells that had divided at least once. (C) Expression of T cell activation markers CD69, HLA-DR and CD25 on the eFluorhiGFP-negative cells one day after sorting. Data are representative of three independent experiments. (D) 7AAD-Pyronin Y staining of eFluorhiGFP-negative cells one day after sort. As a positive control for cell cycle progression, uninfected CD4 T cells were activated with αCD3/CD28 beads four days prior to analysis. The arrow with * indicates cells with increased DNA content but low RNA levels that are apparently preparing for homeostatic proliferation. Data are representative of two independent experiments. <bold>Figure S5</bold> (supplement to Fig 2). Expanded panel of latency reversing agents in a donor different from Fig. 2. Grey and black vertical lines represent expression levels from the IL-4-only negative controls for No RAL and +RAL conditions in order to better visualize induction from latency. (A) Percent GFP+ cells as in Fig. 2 for the expanded panel. (B) Mean fluorescence intensity (MFI) of the GFP+ cells. <bold>Table S1</bold> (supplement to Fig 4). Calculations of ratios of uDNA to iDNA in sorted No RAL cells. Calculations of the ratios of integrated to total DNA in sorted cell populations for Fig. 4A and C. <bold>Table S2</bold> (Supplement to Fig 4). Percentage of cells with only uDNA from 4 additional experiments. Results from 4 additional independent experiments utilizing different donor cells for comparison with Fig. 4. <bold>Figure S6</bold> (supplement to Fig 5). Activation of productively infected cells accelerates death only when integration is allowed. HSA+ cells were isolated 8 days after infection and stimulated or not with αCD3/CD28 activation beads. Viability was assessed at the indicated times by flow cytometry as in Fig. 5E. Similar results were obtained using the GFP virus and sorted GFP+ cells (not shown).   <bold>Figure S7 </bold>(supplement to Fig 6). Two rounds of stimulation by Pro/TSA did not reverse all HIV-1 latency. (A) Experimental design. Infected cells were treated with DMSO (B) or Pro/TSA (C) on day 8 p.i., then washed and re-treated with the same compounds on day 11 post infection. GFP-neg. cells were sorted on day 14 p.i. and treated with IL-4, Pro/TSA or αCD3/CD28 activation beads + IL-2 for 2 days before analysis. Indinavir was added at day 0 and 7 p.i. as an additional precaution against second round infection.</p>
              </caption>
            </media>
          </p>
        </sec>
      </app>
    </app-group>
    <ack>
      <title>Authors’ contributions</title>
      <p>CNC, BT, SM, AA and DNL carried out the molecular studies. DNL, SS and AB performed the CTL recognition study. DW and PAG assisted with data analysis. CNC and DNL drafted the manuscript. All authors read and approved the final manuscript.</p>
      <sec id="FPar1">
        <title>Acknowledgements</title>
        <p>This study was funded by NIH/NIAID AI078783 and AI118453 to DNL, AI093998 to DNL and DW and AI084772 and AI112566 to PAG. The UAB Center for AIDS Research Flow Cytometry Core was funded by NIH AI027767. We thank Guomiao Shen and Catarina Hioe (NYU Langone Medical Center) for p24 ELISA.</p>
      </sec>
      <sec id="FPar2">
        <title>Competing interests</title>
        <p>The authors declare that they have no competing interests.</p>
      </sec>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shaw</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Hahn</surname>
              <given-names>BH</given-names>
            </name>
            <name>
              <surname>Arya</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Groopman</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Gallo</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Wong-Staal</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome</article-title>
          <source>Science</source>
          <year>1984</year>
          <volume>226</volume>
          <issue>4679</issue>
          <fpage>1165</fpage>
          <lpage>1171</lpage>
          <pub-id pub-id-type="doi">10.1126/science.6095449</pub-id>
          <?supplied-pmid 6095449?>
          <pub-id pub-id-type="pmid">6095449</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pang</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Koyanagi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Miles</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wiley</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Vinters</surname>
              <given-names>HV</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>IS</given-names>
            </name>
          </person-group>
          <article-title>High levels of unintegrated HIV-1 DNA in brain tissue of AIDS dementia patients</article-title>
          <source>Nature</source>
          <year>1990</year>
          <volume>343</volume>
          <issue>6253</issue>
          <fpage>85</fpage>
          <lpage>89</lpage>
          <pub-id pub-id-type="doi">10.1038/343085a0</pub-id>
          <?supplied-pmid 2296295?>
          <pub-id pub-id-type="pmid">2296295</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cara</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Reitz</surname>
              <given-names>MS</given-names>
              <suffix>Jr</suffix>
            </name>
          </person-group>
          <article-title>New insight on the role of extrachromosomal retroviral DNA</article-title>
          <source>Leukemia</source>
          <year>1997</year>
          <volume>11</volume>
          <issue>9</issue>
          <fpage>1395</fpage>
          <lpage>1399</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.leu.2400776</pub-id>
          <?supplied-pmid 9305590?>
          <pub-id pub-id-type="pmid">9305590</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sloan</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Wainberg</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>The role of unintegrated DNA in HIV infection</article-title>
          <source>Retrovirology.</source>
          <year>2011</year>
          <volume>8</volume>
          <fpage>52</fpage>
          <pub-id pub-id-type="doi">10.1186/1742-4690-8-52</pub-id>
          <?supplied-pmid 21722380?>
          <pub-id pub-id-type="pmid">21722380</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Marsh</surname>
              <given-names>JW</given-names>
            </name>
          </person-group>
          <article-title>Selective transcription and modulation of resting T cell activity by preintegrated HIV DNA</article-title>
          <source>Science</source>
          <year>2001</year>
          <volume>293</volume>
          <issue>5534</issue>
          <fpage>1503</fpage>
          <lpage>1506</lpage>
          <pub-id pub-id-type="doi">10.1126/science.1061548</pub-id>
          <?supplied-pmid 11520990?>
          <pub-id pub-id-type="pmid">11520990</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Trinité</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Ohlson</surname>
              <given-names>EC</given-names>
            </name>
            <name>
              <surname>Voznesensky</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Rana</surname>
              <given-names>SP</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>CN</given-names>
            </name>
            <name>
              <surname>Mahajan</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Alster</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Burke</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Wodarz</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Levy</surname>
              <given-names>DN</given-names>
            </name>
          </person-group>
          <article-title>An HIV-1 replication pathway utilizing reverse transcription products that fail to integrate</article-title>
          <source>J Virol</source>
          <year>2013</year>
          <volume>87</volume>
          <issue>23</issue>
          <fpage>12701</fpage>
          <lpage>12720</lpage>
          <pub-id pub-id-type="doi">10.1128/JVI.01939-13</pub-id>
          <?supplied-pmid 24049167?>
          <pub-id pub-id-type="pmid">24049167</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Iyer</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Biancotto</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Margolis</surname>
              <given-names>LB</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Measurement of human immunodeficiency virus type 1 preintegration transcription by using Rev-dependent Rev-CEM cells reveals a sizable transcribing DNA population comparable to that from proviral templates</article-title>
          <source>J Virol.</source>
          <year>2009</year>
          <volume>83</volume>
          <issue>17</issue>
          <fpage>8662</fpage>
          <lpage>8673</lpage>
          <pub-id pub-id-type="doi">10.1128/JVI.00874-09</pub-id>
          <?supplied-pmid 19553325?>
          <pub-id pub-id-type="pmid">19553325</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Butler</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>EP</given-names>
            </name>
            <name>
              <surname>Bushman</surname>
              <given-names>FD</given-names>
            </name>
          </person-group>
          <article-title>Human immunodeficiency virus cDNA metabolism: notable stability of two-long terminal repeat circles</article-title>
          <source>J Virol</source>
          <year>2002</year>
          <volume>76</volume>
          <issue>8</issue>
          <fpage>3739</fpage>
          <lpage>3747</lpage>
          <pub-id pub-id-type="doi">10.1128/JVI.76.8.3739-3747.2002</pub-id>
          <?supplied-pmid 11907213?>
          <pub-id pub-id-type="pmid">11907213</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pierson</surname>
              <given-names>TC</given-names>
            </name>
            <name>
              <surname>Kieffer</surname>
              <given-names>TL</given-names>
            </name>
            <name>
              <surname>Ruff</surname>
              <given-names>CT</given-names>
            </name>
            <name>
              <surname>Buck</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Gange</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Siliciano</surname>
              <given-names>RF</given-names>
            </name>
          </person-group>
          <article-title>Intrinsic stability of episomal circles formed during human immunodeficiency virus type 1 replication</article-title>
          <source>J Virol</source>
          <year>2002</year>
          <volume>76</volume>
          <issue>8</issue>
          <fpage>4138</fpage>
          <lpage>4144</lpage>
          <pub-id pub-id-type="doi">10.1128/JVI.76.8.4138-4144.2002</pub-id>
          <?supplied-pmid 11907256?>
          <pub-id pub-id-type="pmid">11907256</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gillim-Ross</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Cara</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Klotman</surname>
              <given-names>ME</given-names>
            </name>
          </person-group>
          <article-title>HIV-1 extrachromosomal 2-LTR circular DNA is long-lived in human macrophages</article-title>
          <source>Viral Immunol</source>
          <year>2005</year>
          <volume>18</volume>
          <issue>1</issue>
          <fpage>190</fpage>
          <lpage>196</lpage>
          <pub-id pub-id-type="doi">10.1089/vim.2005.18.190</pub-id>
          <?supplied-pmid 15802963?>
          <pub-id pub-id-type="pmid">15802963</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pace</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Graf</surname>
              <given-names>EH</given-names>
            </name>
            <name>
              <surname>O’Doherty</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>HIV 2-long terminal repeat circular DNA is stable in primary CD4+ T Cells</article-title>
          <source>Virology</source>
          <year>2013</year>
          <volume>441</volume>
          <issue>1</issue>
          <fpage>18</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="doi">10.1016/j.virol.2013.02.028</pub-id>
          <?supplied-pmid 23537959?>
          <pub-id pub-id-type="pmid">23537959</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>KC</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>BS</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>HY</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Yan</surname>
              <given-names>HH</given-names>
            </name>
            <name>
              <surname>Yi</surname>
              <given-names>XF</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Que</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Lan</surname>
              <given-names>XP</given-names>
            </name>
          </person-group>
          <article-title>Integrase-deficient lentivirus: opportunities and challenges for human gene therapy</article-title>
          <source>Curr Gene Ther</source>
          <year>2014</year>
          <volume>14</volume>
          <issue>5</issue>
          <fpage>352</fpage>
          <lpage>364</lpage>
          <pub-id pub-id-type="doi">10.2174/1566523214666140825124311</pub-id>
          <?supplied-pmid 25174579?>
          <pub-id pub-id-type="pmid">25174579</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saenz</surname>
              <given-names>DT</given-names>
            </name>
            <name>
              <surname>Loewen</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Peretz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Whitwam</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Barraza</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Howell</surname>
              <given-names>KG</given-names>
            </name>
            <name>
              <surname>Holmes</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Good</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Poeschla</surname>
              <given-names>EM</given-names>
            </name>
          </person-group>
          <article-title>Unintegrated lentivirus DNA persistence and accessibility to expression in nondividing cells: analysis with class I integrase mutants</article-title>
          <source>J Virol</source>
          <year>2004</year>
          <volume>78</volume>
          <issue>6</issue>
          <fpage>2906</fpage>
          <lpage>2920</lpage>
          <pub-id pub-id-type="doi">10.1128/JVI.78.6.2906-2920.2004</pub-id>
          <?supplied-pmid 14990709?>
          <pub-id pub-id-type="pmid">14990709</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gelderblom</surname>
              <given-names>HC</given-names>
            </name>
            <name>
              <surname>Vatakis</surname>
              <given-names>DN</given-names>
            </name>
            <name>
              <surname>Burke</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Lawrie</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>Bristol</surname>
              <given-names>GC</given-names>
            </name>
            <name>
              <surname>Levy</surname>
              <given-names>DN</given-names>
            </name>
          </person-group>
          <article-title>Viral complementation allows HIV-1 replication without integration</article-title>
          <source>Retrovirology.</source>
          <year>2008</year>
          <volume>5</volume>
          <fpage>60</fpage>
          <pub-id pub-id-type="doi">10.1186/1742-4690-5-60</pub-id>
          <?supplied-pmid 18613957?>
          <pub-id pub-id-type="pmid">18613957</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haase</surname>
              <given-names>AT</given-names>
            </name>
          </person-group>
          <article-title>Perils at mucosal front lines for HIV and SIV and their hosts</article-title>
          <source>Nat Rev Immunol</source>
          <year>2005</year>
          <volume>5</volume>
          <issue>10</issue>
          <fpage>783</fpage>
          <lpage>792</lpage>
          <pub-id pub-id-type="doi">10.1038/nri1706</pub-id>
          <?supplied-pmid 16200081?>
          <pub-id pub-id-type="pmid">16200081</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Miller</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Abel</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>EY</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>ZM</given-names>
            </name>
            <name>
              <surname>Wietgrefe</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>La Franco-Scheuch</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Compton</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Duan</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Shore</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Zupancic</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Busch</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Carlis</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Wolinsky</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Haase</surname>
              <given-names>AT</given-names>
            </name>
          </person-group>
          <article-title>Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus</article-title>
          <source>J Virol</source>
          <year>2005</year>
          <volume>79</volume>
          <issue>14</issue>
          <fpage>9217</fpage>
          <lpage>9227</lpage>
          <pub-id pub-id-type="doi">10.1128/JVI.79.14.9217-9227.2005</pub-id>
          <?supplied-pmid 15994816?>
          <pub-id pub-id-type="pmid">15994816</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haase</surname>
              <given-names>AT</given-names>
            </name>
          </person-group>
          <article-title>Early events in sexual transmission of HIV and SIV and opportunities for interventions</article-title>
          <source>Annu Rev Med</source>
          <year>2011</year>
          <volume>62</volume>
          <fpage>127</fpage>
          <lpage>139</lpage>
          <pub-id pub-id-type="doi">10.1146/annurev-med-080709-124959</pub-id>
          <?supplied-pmid 21054171?>
          <pub-id pub-id-type="pmid">21054171</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eisele</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Siliciano</surname>
              <given-names>RF</given-names>
            </name>
          </person-group>
          <article-title>Redefining the viral reservoirs that prevent HIV-1 eradication</article-title>
          <source>Immunity.</source>
          <year>2012</year>
          <volume>37</volume>
          <issue>3</issue>
          <fpage>377</fpage>
          <lpage>388</lpage>
          <pub-id pub-id-type="doi">10.1016/j.immuni.2012.08.010</pub-id>
          <?supplied-pmid 22999944?>
          <pub-id pub-id-type="pmid">22999944</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Schuler</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Zupancic</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wietgrefe</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Staskus</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Reimann</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Reinhart</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Rogan</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Cavert</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Veazey</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Notermans</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Little</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Danner</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Richman</surname>
              <given-names>DD</given-names>
            </name>
            <name>
              <surname>Havlir</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Jordan</surname>
              <given-names>HL</given-names>
            </name>
            <name>
              <surname>Schacker</surname>
              <given-names>TW</given-names>
            </name>
            <name>
              <surname>Racz</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Tenner-Racz</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Letvin</surname>
              <given-names>NL</given-names>
            </name>
            <name>
              <surname>Wolinsky</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Haase</surname>
              <given-names>AT</given-names>
            </name>
          </person-group>
          <article-title>Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells</article-title>
          <source>Science</source>
          <year>1999</year>
          <volume>286</volume>
          <issue>5443</issue>
          <fpage>1353</fpage>
          <lpage>1357</lpage>
          <pub-id pub-id-type="doi">10.1126/science.286.5443.1353</pub-id>
          <?supplied-pmid 10558989?>
          <pub-id pub-id-type="pmid">10558989</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>ZQ</given-names>
            </name>
            <name>
              <surname>Wietgrefe</surname>
              <given-names>SW</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Shore</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Duan</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Reilly</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Lifson</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Haase</surname>
              <given-names>AT</given-names>
            </name>
          </person-group>
          <article-title>Roles of substrate availability and infection of resting and activated CD4+ T cells in transmission and acute simian immunodeficiency virus infection</article-title>
          <source>Proc Natl Acad Sci USA.</source>
          <year>2004</year>
          <volume>101</volume>
          <issue>15</issue>
          <fpage>5640</fpage>
          <lpage>5645</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.0308425101</pub-id>
          <?supplied-pmid 15064398?>
          <pub-id pub-id-type="pmid">15064398</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chun</surname>
              <given-names>TW</given-names>
            </name>
            <name>
              <surname>Engel</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Berrey</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Shea</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Corey</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Fauci</surname>
              <given-names>AS</given-names>
            </name>
          </person-group>
          <article-title>Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection</article-title>
          <source>Proc Natl Acad Sci USA.</source>
          <year>1998</year>
          <volume>95</volume>
          <issue>15</issue>
          <fpage>8869</fpage>
          <lpage>8873</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.95.15.8869</pub-id>
          <?supplied-pmid 9671771?>
          <pub-id pub-id-type="pmid">9671771</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <mixed-citation publication-type="other">Hatziioannou T, Del Prete GQ, Keele BF, Estes JD, McNatt MW, Bitzegeio J, Raymond A, Rodriguez A, Schmidt F, Mac Trubey C, Smedley J, Piatak M, Jr., KewalRamani VN, Lifson JD, Bieniasz PD. HIV-1-induced AIDS in monkeys. Science. 2014;344(6190):1401–5. doi: 10.1126/science.1250761.</mixed-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Whitney</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Hill</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Sanisetty</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Penaloza-MacMaster</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Shetty</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Parenteau</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Cabral</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Shields</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Blackmore</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Brinkman</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Peter</surname>
              <given-names>LE</given-names>
            </name>
            <name>
              <surname>Mathew</surname>
              <given-names>SI</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Borducchi</surname>
              <given-names>EN</given-names>
            </name>
            <name>
              <surname>Rosenbloom</surname>
              <given-names>DI</given-names>
            </name>
            <name>
              <surname>Lewis</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Hattersley</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Hesselgesser</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Geleziunas</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Robb</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Michael</surname>
              <given-names>NL</given-names>
            </name>
            <name>
              <surname>Barouch</surname>
              <given-names>DH</given-names>
            </name>
          </person-group>
          <article-title>Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys</article-title>
          <source>Nature</source>
          <year>2014</year>
          <volume>512</volume>
          <issue>7512</issue>
          <fpage>74</fpage>
          <lpage>77</lpage>
          <?supplied-pmid 25042999?>
          <pub-id pub-id-type="pmid">25042999</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Swiggard</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Baytop</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Dai</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Schretzenmair</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Theodosopoulos</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>O’Doherty</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>Human immunodeficiency virus type 1 can establish latent infection in resting CD4+ T cells in the absence of activating stimuli</article-title>
          <source>J Virol</source>
          <year>2005</year>
          <volume>79</volume>
          <issue>22</issue>
          <fpage>14179</fpage>
          <lpage>14188</lpage>
          <pub-id pub-id-type="doi">10.1128/JVI.79.22.14179-14188.2005</pub-id>
          <?supplied-pmid 16254353?>
          <pub-id pub-id-type="pmid">16254353</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chavez</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Calvanese</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Verdin</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>HIV Latency Is Established Directly and Early in Both Resting and Activated Primary CD4 T Cells</article-title>
          <source>PLoS Pathog</source>
          <year>2015</year>
          <volume>11</volume>
          <issue>6</issue>
          <fpage>e1004955</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.ppat.1004955</pub-id>
          <?supplied-pmid 26067822?>
          <pub-id pub-id-type="pmid">26067822</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bukrinsky</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Stanwick</surname>
              <given-names>TL</given-names>
            </name>
            <name>
              <surname>Dempsey</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Stevenson</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection</article-title>
          <source>Science</source>
          <year>1991</year>
          <volume>254</volume>
          <issue>5030</issue>
          <fpage>423</fpage>
          <lpage>427</lpage>
          <pub-id pub-id-type="doi">10.1126/science.1925601</pub-id>
          <?supplied-pmid 1925601?>
          <pub-id pub-id-type="pmid">1925601</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zack</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Arrigo</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Weitsman</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Go</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Haislip</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>IS</given-names>
            </name>
          </person-group>
          <article-title>HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure</article-title>
          <source>Cell</source>
          <year>1990</year>
          <volume>61</volume>
          <issue>2</issue>
          <fpage>213</fpage>
          <lpage>222</lpage>
          <pub-id pub-id-type="doi">10.1016/0092-8674(90)90802-L</pub-id>
          <?supplied-pmid 2331748?>
          <pub-id pub-id-type="pmid">2331748</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eckstein</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Penn</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Korin</surname>
              <given-names>YD</given-names>
            </name>
            <name>
              <surname>Scripture-Adams</surname>
              <given-names>DD</given-names>
            </name>
            <name>
              <surname>Zack</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Kreisberg</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Roederer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sherman</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Chin</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Goldsmith</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>HIV-1 actively replicates in naive CD4(+) T cells residing within human lymphoid tissues</article-title>
          <source>Immunity</source>
          <year>2001</year>
          <volume>15</volume>
          <issue>4</issue>
          <fpage>671</fpage>
          <lpage>682</lpage>
          <pub-id pub-id-type="doi">10.1016/S1074-7613(01)00217-5</pub-id>
          <?supplied-pmid 11672548?>
          <pub-id pub-id-type="pmid">11672548</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kinter</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Moorthy</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Jackson</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Fauci</surname>
              <given-names>AS</given-names>
            </name>
          </person-group>
          <article-title>Productive HIV infection of resting CD4+ T cells: role of lymphoid tissue microenvironment and effect of immunomodulating agents</article-title>
          <source>AIDS Res Hum Retroviruses</source>
          <year>2003</year>
          <volume>19</volume>
          <issue>10</issue>
          <fpage>847</fpage>
          <lpage>856</lpage>
          <pub-id pub-id-type="doi">10.1089/088922203322493012</pub-id>
          <?supplied-pmid 14585216?>
          <pub-id pub-id-type="pmid">14585216</pub-id>
        </element-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spina</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Archin</surname>
              <given-names>NM</given-names>
            </name>
            <name>
              <surname>Bosque</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Famiglietti</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Greene</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>Kashuba</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lewin</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Margolis</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Mau</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ruelas</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Saleh</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Shirakawa</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Siliciano</surname>
              <given-names>RF</given-names>
            </name>
            <name>
              <surname>Singhania</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Soto</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Terry</surname>
              <given-names>VH</given-names>
            </name>
            <name>
              <surname>Verdin</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Woelk</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Wooden</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Xing</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Planelles</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patients</article-title>
          <source>PLoS Pathog</source>
          <year>2013</year>
          <volume>9</volume>
          <issue>12</issue>
          <fpage>e1003834</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.ppat.1003834</pub-id>
          <?supplied-pmid 24385908?>
          <pub-id pub-id-type="pmid">24385908</pub-id>
        </element-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vella</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Teague</surname>
              <given-names>TK</given-names>
            </name>
            <name>
              <surname>Ihle</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kappler</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Marrack</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Interleukin 4 (IL-4) or IL-7 prevents the death of resting T cells: stat6 is probably not required for the effect of IL-4</article-title>
          <source>J Exp Med.</source>
          <year>1997</year>
          <volume>186</volume>
          <issue>2</issue>
          <fpage>325</fpage>
          <lpage>330</lpage>
          <pub-id pub-id-type="doi">10.1084/jem.186.2.325</pub-id>
          <?supplied-pmid 9221762?>
          <pub-id pub-id-type="pmid">9221762</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ducrey-Rundquist</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Guyader</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Trono</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Modalities of interleukin-7-induced human immunodeficiency virus permissiveness in quiescent T lymphocytes</article-title>
          <source>J Virol.</source>
          <year>2002</year>
          <volume>76</volume>
          <issue>18</issue>
          <fpage>9103</fpage>
          <lpage>9111</lpage>
          <pub-id pub-id-type="doi">10.1128/JVI.76.18.9103-9111.2002</pub-id>
          <?supplied-pmid 12186894?>
          <pub-id pub-id-type="pmid">12186894</pub-id>
        </element-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moutsopoulos</surname>
              <given-names>NM</given-names>
            </name>
            <name>
              <surname>Vazquez</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Greenwell-Wild</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ecevit</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Horn</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Orenstein</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Wahl</surname>
              <given-names>SM</given-names>
            </name>
          </person-group>
          <article-title>Regulation of the tonsil cytokine milieu favors HIV susceptibility</article-title>
          <source>J Leukoc Biol</source>
          <year>2006</year>
          <volume>80</volume>
          <issue>5</issue>
          <fpage>1145</fpage>
          <lpage>1155</lpage>
          <pub-id pub-id-type="doi">10.1189/jlb.0306142</pub-id>
          <?supplied-pmid 16943383?>
          <pub-id pub-id-type="pmid">16943383</pub-id>
        </element-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Horikoshi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kinomoto</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kurosu</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Komoto</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Shiraga</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Otake</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Mukai</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ikuta</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Resting CD4(+) T cells with CD38(+)CD62L(+) produce interleukin-4 which contributes to enhanced replication of T-tropic human immunodeficiency virus type 1</article-title>
          <source>Virology</source>
          <year>2002</year>
          <volume>293</volume>
          <issue>1</issue>
          <fpage>94</fpage>
          <lpage>102</lpage>
          <pub-id pub-id-type="doi">10.1006/viro.2001.1272</pub-id>
          <?supplied-pmid 11853403?>
          <pub-id pub-id-type="pmid">11853403</pub-id>
        </element-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Clausell</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Robinson</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Yin</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Weiss</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Sabbaj</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lowe</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Wagner</surname>
              <given-names>FH</given-names>
            </name>
            <name>
              <surname>Goepfert</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Kutsch</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Cron</surname>
              <given-names>RQ</given-names>
            </name>
          </person-group>
          <article-title>Host factor transcriptional regulation contributes to preferential expression of HIV type 1 in IL-4-producing CD4 T cells</article-title>
          <source>J Immunol.</source>
          <year>2012</year>
          <volume>189</volume>
          <issue>6</issue>
          <fpage>2746</fpage>
          <lpage>2757</lpage>
          <pub-id pub-id-type="doi">10.4049/jimmunol.1103129</pub-id>
          <?supplied-pmid 22875803?>
          <pub-id pub-id-type="pmid">22875803</pub-id>
        </element-citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Trinité</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>CN</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Levy</surname>
              <given-names>DN</given-names>
            </name>
          </person-group>
          <article-title>HIV-1 Vpr- and reverse transcription-induced apoptosis in resting peripheral blood CD4 T cells and protection by common gamma-chain cytokines</article-title>
          <source>J Virol.</source>
          <year>2012</year>
          <volume>90</volume>
          <issue>2</issue>
          <fpage>904</fpage>
          <lpage>916</lpage>
          <pub-id pub-id-type="doi">10.1128/JVI.01770-15</pub-id>
          <pub-id pub-id-type="pmid">26537673</pub-id>
        </element-citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Levy</surname>
              <given-names>DN</given-names>
            </name>
            <name>
              <surname>Aldrovandi</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Kutsch</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Shaw</surname>
              <given-names>GM</given-names>
            </name>
          </person-group>
          <article-title>Dynamics of HIV-1 recombination in its natural target cells</article-title>
          <source>Proc Natl Acad Sci USA.</source>
          <year>2004</year>
          <volume>101</volume>
          <issue>12</issue>
          <fpage>4204</fpage>
          <lpage>4209</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.0306764101</pub-id>
          <?supplied-pmid 15010526?>
          <pub-id pub-id-type="pmid">15010526</pub-id>
        </element-citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kutsch</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Benveniste</surname>
              <given-names>EN</given-names>
            </name>
            <name>
              <surname>Shaw</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Levy</surname>
              <given-names>DN</given-names>
            </name>
          </person-group>
          <article-title>Direct and quantitative single-cell analysis of human immunodeficiency virus type 1 reactivation from latency</article-title>
          <source>J Virol</source>
          <year>2002</year>
          <volume>76</volume>
          <issue>17</issue>
          <fpage>8776</fpage>
          <lpage>8786</lpage>
          <pub-id pub-id-type="doi">10.1128/JVI.76.17.8776-8786.2002</pub-id>
          <?supplied-pmid 12163598?>
          <pub-id pub-id-type="pmid">12163598</pub-id>
        </element-citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Engelman</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Craigie</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Identification of conserved amino acid residues critical for human immunodeficiency virus type 1 integrase function in vitro</article-title>
          <source>J Virol.</source>
          <year>1992</year>
          <volume>66</volume>
          <issue>11</issue>
          <fpage>6361</fpage>
          <lpage>6369</lpage>
          <?supplied-pmid 1404595?>
          <pub-id pub-id-type="pmid">1404595</pub-id>
        </element-citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pierson</surname>
              <given-names>TC</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kieffer</surname>
              <given-names>TL</given-names>
            </name>
            <name>
              <surname>Ruff</surname>
              <given-names>CT</given-names>
            </name>
            <name>
              <surname>Buck</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Siliciano</surname>
              <given-names>RF</given-names>
            </name>
          </person-group>
          <article-title>Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infection</article-title>
          <source>J Virol</source>
          <year>2002</year>
          <volume>76</volume>
          <issue>17</issue>
          <fpage>8518</fpage>
          <lpage>8531</lpage>
          <pub-id pub-id-type="doi">10.1128/JVI.76.17.8518-8513.2002</pub-id>
          <?supplied-pmid 12163571?>
          <pub-id pub-id-type="pmid">12163571</pub-id>
        </element-citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lassen</surname>
              <given-names>KG</given-names>
            </name>
            <name>
              <surname>Hebbeler</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Bhattacharyya</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Lobritz</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Greene</surname>
              <given-names>WC</given-names>
            </name>
          </person-group>
          <article-title>A flexible model of HIV-1 latency permitting evaluation of many primary CD4 T-cell reservoirs</article-title>
          <source>PLoS One</source>
          <year>2012</year>
          <volume>7</volume>
          <issue>1</issue>
          <fpage>e30176</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0030176</pub-id>
          <?supplied-pmid 22291913?>
          <pub-id pub-id-type="pmid">22291913</pub-id>
        </element-citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thierry</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Munir</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Thierry</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Subra</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Leh</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Zamborlini</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Saenz</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Levy</surname>
              <given-names>DN</given-names>
            </name>
            <name>
              <surname>Lesbats</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Saib</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Parissi</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Poeschla</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Deprez</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Delelis</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Integrase inhibitor reversal dynamics indicate unintegrated HIV-1 dna initiate de novo integration</article-title>
          <source>Retrovirology.</source>
          <year>2015</year>
          <volume>12</volume>
          <issue>1</issue>
          <fpage>24</fpage>
          <pub-id pub-id-type="doi">10.1186/s12977-015-0153-9</pub-id>
          <?supplied-pmid 25808736?>
          <pub-id pub-id-type="pmid">25808736</pub-id>
        </element-citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Trinité</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>CN</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Mahajan</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Luo</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Muesing</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Folkvord</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Pham</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Connick</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Levy</surname>
              <given-names>DN</given-names>
            </name>
          </person-group>
          <article-title>Suppression of Foxo1 activity and down-modulation of CD62L (L-selectin) in HIV-1 infected resting CD4 T cells</article-title>
          <source>PLoS One</source>
          <year>2014</year>
          <volume>9</volume>
          <issue>10</issue>
          <fpage>e110719</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0110719</pub-id>
          <?supplied-pmid 25330112?>
          <pub-id pub-id-type="pmid">25330112</pub-id>
        </element-citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <mixed-citation publication-type="other">Kantor B, Ma H, Webster-Cyriaque J, Monahan PE, Kafri T. Epigenetic activation of unintegrated HIV-1 genomes by gut-associated short chain fatty acids and its implications for HIV infection. Proc Natl Acad Sci USA. 2009;106(44):18786–91. doi: 10.1073/pnas.0905859106.</mixed-citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schneider</surname>
              <given-names>WM</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>DT</given-names>
            </name>
            <name>
              <surname>Amin</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Aiyer</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Roth</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>MuLV IN mutants responsive to HDAC inhibitors enhance transcription from unintegrated retroviral DNA</article-title>
          <source>Virology</source>
          <year>2012</year>
          <volume>426</volume>
          <issue>2</issue>
          <fpage>188</fpage>
          <lpage>196</lpage>
          <pub-id pub-id-type="doi">10.1016/j.virol.2012.01.034</pub-id>
          <?supplied-pmid 22365328?>
          <pub-id pub-id-type="pmid">22365328</pub-id>
        </element-citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pelascini</surname>
              <given-names>LP</given-names>
            </name>
            <name>
              <surname>Janssen</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Goncalves</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Histone deacetylase inhibition activates transgene expression from integration-defective lentiviral vectors in dividing and non-dividing cells</article-title>
          <source>Hum Gene Ther</source>
          <year>2013</year>
          <volume>24</volume>
          <issue>1</issue>
          <fpage>78</fpage>
          <lpage>96</lpage>
          <pub-id pub-id-type="doi">10.1089/hum.2012.069</pub-id>
          <?supplied-pmid 23140481?>
          <pub-id pub-id-type="pmid">23140481</pub-id>
        </element-citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bosque</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Famiglietti</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Weyrich</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Goulston</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Planelles</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Homeostatic proliferation fails to efficiently reactivate HIV-1 latently infected central memory CD4+ T cells</article-title>
          <source>PLoS Pathog</source>
          <year>2011</year>
          <volume>7</volume>
          <issue>10</issue>
          <fpage>e1002288</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.ppat.1002288</pub-id>
          <?supplied-pmid 21998586?>
          <pub-id pub-id-type="pmid">21998586</pub-id>
        </element-citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dar</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Hosmane</surname>
              <given-names>NN</given-names>
            </name>
            <name>
              <surname>Arkin</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Siliciano</surname>
              <given-names>RF</given-names>
            </name>
            <name>
              <surname>Weinberger</surname>
              <given-names>LS</given-names>
            </name>
          </person-group>
          <article-title>Screening for noise in gene expression identifies drug synergies</article-title>
          <source>Science</source>
          <year>2014</year>
          <volume>344</volume>
          <issue>6190</issue>
          <fpage>1392</fpage>
          <lpage>1396</lpage>
          <pub-id pub-id-type="doi">10.1126/science.1250220</pub-id>
          <?supplied-pmid 24903562?>
          <pub-id pub-id-type="pmid">24903562</pub-id>
        </element-citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bullen</surname>
              <given-names>CK</given-names>
            </name>
            <name>
              <surname>Laird</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Durand</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Siliciano</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Siliciano</surname>
              <given-names>RF</given-names>
            </name>
          </person-group>
          <article-title>New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo</article-title>
          <source>Nat Med</source>
          <year>2014</year>
          <volume>20</volume>
          <issue>4</issue>
          <fpage>425</fpage>
          <lpage>429</lpage>
          <pub-id pub-id-type="doi">10.1038/nm.3489</pub-id>
          <?supplied-pmid 24658076?>
          <pub-id pub-id-type="pmid">24658076</pub-id>
        </element-citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spivak</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Andrade</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Eisele</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Hoh</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Bacchetti</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Bumpus</surname>
              <given-names>NN</given-names>
            </name>
            <name>
              <surname>Emad</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Buckheit</surname>
              <given-names>R</given-names>
              <suffix>3rd</suffix>
            </name>
            <name>
              <surname>McCance-Katz</surname>
              <given-names>EF</given-names>
            </name>
            <name>
              <surname>Lai</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kennedy</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Chander</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Siliciano</surname>
              <given-names>RF</given-names>
            </name>
            <name>
              <surname>Siliciano</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Deeks</surname>
              <given-names>SG</given-names>
            </name>
          </person-group>
          <article-title>A pilot study assessing the safety and latency-reversing activity of disulfiram in HIV-1-infected adults on antiretroviral therapy</article-title>
          <source>Clin Infect Dis</source>
          <year>2014</year>
          <volume>58</volume>
          <issue>6</issue>
          <fpage>883</fpage>
          <lpage>890</lpage>
          <pub-id pub-id-type="doi">10.1093/cid/cit813</pub-id>
          <?supplied-pmid 24336828?>
          <pub-id pub-id-type="pmid">24336828</pub-id>
        </element-citation>
      </ref>
      <ref id="CR51">
        <label>51.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bonczkowski</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>De Spiegelaere</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Bosque</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>White</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Van Nuffel</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Malatinkova</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Kiselinova</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Trypsteen</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Witkowski</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Vermeire</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Verhasselt</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Martins</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Woelk</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Planelles</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Vandekerckhove</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Replication competent virus as an important source of bias in HIV latency models utilizing single round viral constructs</article-title>
          <source>Retrovirology.</source>
          <year>2014</year>
          <volume>11</volume>
          <fpage>70</fpage>
          <pub-id pub-id-type="doi">10.1186/s12977-014-0070-3</pub-id>
          <?supplied-pmid 25142072?>
          <pub-id pub-id-type="pmid">25142072</pub-id>
        </element-citation>
      </ref>
      <ref id="CR52">
        <label>52.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hazuda</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Felock</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Witmer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wolfe</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Stillmock</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Grobler</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Espeseth</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gabryelski</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Schleif</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Blau</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>MD</given-names>
            </name>
          </person-group>
          <article-title>Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells</article-title>
          <source>Science</source>
          <year>2000</year>
          <volume>287</volume>
          <issue>5453</issue>
          <fpage>646</fpage>
          <lpage>650</lpage>
          <pub-id pub-id-type="doi">10.1126/science.287.5453.646</pub-id>
          <?supplied-pmid 10649997?>
          <pub-id pub-id-type="pmid">10649997</pub-id>
        </element-citation>
      </ref>
      <ref id="CR53">
        <label>53.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Butler</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Hansen</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Bushman</surname>
              <given-names>FD</given-names>
            </name>
          </person-group>
          <article-title>A quantitative assay for HIV DNA integration in vivo</article-title>
          <source>Nat Med</source>
          <year>2001</year>
          <volume>7</volume>
          <issue>5</issue>
          <fpage>631</fpage>
          <lpage>634</lpage>
          <pub-id pub-id-type="doi">10.1038/87979</pub-id>
          <?supplied-pmid 11329067?>
          <pub-id pub-id-type="pmid">11329067</pub-id>
        </element-citation>
      </ref>
      <ref id="CR54">
        <label>54.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>SY</given-names>
            </name>
            <name>
              <surname>Byrn</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Groopman</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Baltimore</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression</article-title>
          <source>J Virol.</source>
          <year>1989</year>
          <volume>63</volume>
          <issue>9</issue>
          <fpage>3708</fpage>
          <lpage>3713</lpage>
          <?supplied-pmid 2760980?>
          <pub-id pub-id-type="pmid">2760980</pub-id>
        </element-citation>
      </ref>
      <ref id="CR55">
        <label>55.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spina</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Guatelli</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Richman</surname>
              <given-names>DD</given-names>
            </name>
          </person-group>
          <article-title>Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro</article-title>
          <source>J Virol.</source>
          <year>1995</year>
          <volume>69</volume>
          <issue>5</issue>
          <fpage>2977</fpage>
          <lpage>2988</lpage>
          <?supplied-pmid 7707524?>
          <pub-id pub-id-type="pmid">7707524</pub-id>
        </element-citation>
      </ref>
      <ref id="CR56">
        <label>56.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chun</surname>
              <given-names>TW</given-names>
            </name>
            <name>
              <surname>Carruth</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Finzi</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Shen</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>DiGiuseppe</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hermankova</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Chadwick</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Margolick</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Quinn</surname>
              <given-names>TC</given-names>
            </name>
            <name>
              <surname>Kuo</surname>
              <given-names>YH</given-names>
            </name>
            <name>
              <surname>Brookmeyer</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Zeiger</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Barditch-Crovo</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Siliciano</surname>
              <given-names>RF</given-names>
            </name>
          </person-group>
          <article-title>Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection</article-title>
          <source>Nature</source>
          <year>1997</year>
          <volume>387</volume>
          <issue>6629</issue>
          <fpage>183</fpage>
          <lpage>188</lpage>
          <pub-id pub-id-type="doi">10.1038/387183a0</pub-id>
          <?supplied-pmid 9144289?>
          <pub-id pub-id-type="pmid">9144289</pub-id>
        </element-citation>
      </ref>
      <ref id="CR57">
        <label>57.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Middleton</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Lim</surname>
              <given-names>HB</given-names>
            </name>
            <name>
              <surname>Montgomery</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Rockway</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Mo</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kohlbrenner</surname>
              <given-names>WE</given-names>
            </name>
            <name>
              <surname>Molla</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kati</surname>
              <given-names>WM</given-names>
            </name>
          </person-group>
          <article-title>Inhibition of human immunodeficiency virus type I integrase by naphthamidines and 2-aminobenzimidazoles</article-title>
          <source>Antiviral Res</source>
          <year>2004</year>
          <volume>64</volume>
          <issue>1</issue>
          <fpage>35</fpage>
          <lpage>45</lpage>
          <pub-id pub-id-type="doi">10.1016/j.antiviral.2004.04.007</pub-id>
          <?supplied-pmid 15451177?>
          <pub-id pub-id-type="pmid">15451177</pub-id>
        </element-citation>
      </ref>
      <ref id="CR58">
        <label>58.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Svarovskaia</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Barr</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Pais</surname>
              <given-names>GC</given-names>
            </name>
            <name>
              <surname>Marchand</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Pommier</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Burke</surname>
              <given-names>TR</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Pathak</surname>
              <given-names>VK</given-names>
            </name>
          </person-group>
          <article-title>Azido-containing diketo acid derivatives inhibit human immunodeficiency virus type 1 integrase in vivo and influence the frequency of deletions at two-long-terminal-repeat-circle junctions</article-title>
          <source>J Virol.</source>
          <year>2004</year>
          <volume>78</volume>
          <issue>7</issue>
          <fpage>3210</fpage>
          <lpage>3222</lpage>
          <pub-id pub-id-type="doi">10.1128/JVI.78.7.3210-3222.2004</pub-id>
          <?supplied-pmid 15016842?>
          <pub-id pub-id-type="pmid">15016842</pub-id>
        </element-citation>
      </ref>
      <ref id="CR59">
        <label>59.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Blazkova</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Chun</surname>
              <given-names>TW</given-names>
            </name>
            <name>
              <surname>Belay</surname>
              <given-names>BW</given-names>
            </name>
            <name>
              <surname>Murray</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Justement</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Funk</surname>
              <given-names>EK</given-names>
            </name>
            <name>
              <surname>Nelson</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hallahan</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Moir</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wender</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Fauci</surname>
              <given-names>AS</given-names>
            </name>
          </person-group>
          <article-title>Effect of histone deacetylase inhibitors on HIV production in latently infected, resting CD4(+) T cells from infected individuals receiving effective antiretroviral therapy</article-title>
          <source>J Infect Dis</source>
          <year>2012</year>
          <volume>206</volume>
          <issue>5</issue>
          <fpage>765</fpage>
          <lpage>769</lpage>
          <pub-id pub-id-type="doi">10.1093/infdis/jis412</pub-id>
          <?supplied-pmid 22732922?>
          <pub-id pub-id-type="pmid">22732922</pub-id>
        </element-citation>
      </ref>
      <ref id="CR60">
        <label>60.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ho</surname>
              <given-names>YC</given-names>
            </name>
            <name>
              <surname>Shan</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Hosmane</surname>
              <given-names>NN</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Laskey</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Rosenbloom</surname>
              <given-names>DI</given-names>
            </name>
            <name>
              <surname>Lai</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Blankson</surname>
              <given-names>JN</given-names>
            </name>
            <name>
              <surname>Siliciano</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Siliciano</surname>
              <given-names>RF</given-names>
            </name>
          </person-group>
          <article-title>Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure</article-title>
          <source>Cell</source>
          <year>2013</year>
          <volume>155</volume>
          <issue>3</issue>
          <fpage>540</fpage>
          <lpage>551</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2013.09.020</pub-id>
          <?supplied-pmid 24243014?>
          <pub-id pub-id-type="pmid">24243014</pub-id>
        </element-citation>
      </ref>
      <ref id="CR61">
        <label>61.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stevenson</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Haggerty</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lamonica</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Meier</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Welch</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Wasiak</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
          <article-title>Integration is not necessary for expression of human immunodeficiency virus type 1 protein products</article-title>
          <source>J Virol.</source>
          <year>1990</year>
          <volume>64</volume>
          <issue>5</issue>
          <fpage>2421</fpage>
          <lpage>2425</lpage>
          <?supplied-pmid 2157898?>
          <pub-id pub-id-type="pmid">2157898</pub-id>
        </element-citation>
      </ref>
      <ref id="CR62">
        <label>62.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Landi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Iannucci</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Nuffel</surname>
              <given-names>AV</given-names>
            </name>
            <name>
              <surname>Meuwissen</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Verhasselt</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>One protein to rule them all: modulation of cell surface receptors and molecules by HIV Nef</article-title>
          <source>Curr HIV Res.</source>
          <year>2011</year>
          <volume>9</volume>
          <issue>7</issue>
          <fpage>496</fpage>
          <lpage>504</lpage>
          <pub-id pub-id-type="doi">10.2174/157016211798842116</pub-id>
          <?supplied-pmid 22103833?>
          <pub-id pub-id-type="pmid">22103833</pub-id>
        </element-citation>
      </ref>
      <ref id="CR63">
        <label>63.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cohen</surname>
              <given-names>GB</given-names>
            </name>
            <name>
              <surname>Gandhi</surname>
              <given-names>RT</given-names>
            </name>
            <name>
              <surname>Davis</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Mandelboim</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>BK</given-names>
            </name>
            <name>
              <surname>Strominger</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Baltimore</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells</article-title>
          <source>Immunity</source>
          <year>1999</year>
          <volume>10</volume>
          <issue>6</issue>
          <fpage>661</fpage>
          <lpage>671</lpage>
          <pub-id pub-id-type="doi">10.1016/S1074-7613(00)80065-5</pub-id>
          <?supplied-pmid 10403641?>
          <pub-id pub-id-type="pmid">10403641</pub-id>
        </element-citation>
      </ref>
      <ref id="CR64">
        <label>64.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gillim-Ross</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Cara</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Klotman</surname>
              <given-names>ME</given-names>
            </name>
          </person-group>
          <article-title>Nef expressed from human immunodeficiency virus type 1 extrachromosomal DNA downregulates CD4 on primary CD4+ T lymphocytes: implications for integrase inhibitors</article-title>
          <source>J Gen Virol</source>
          <year>2005</year>
          <volume>86</volume>
          <issue>Pt 3</issue>
          <fpage>765</fpage>
          <lpage>771</lpage>
          <pub-id pub-id-type="doi">10.1099/vir.0.80570-0</pub-id>
          <?supplied-pmid 15722538?>
          <pub-id pub-id-type="pmid">15722538</pub-id>
        </element-citation>
      </ref>
      <ref id="CR65">
        <label>65.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bansal</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Carlson</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Yan</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Akinsiku</surname>
              <given-names>OT</given-names>
            </name>
            <name>
              <surname>Schaefer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sabbaj</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bet</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Levy</surname>
              <given-names>DN</given-names>
            </name>
            <name>
              <surname>Heath</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kaslow</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>BD</given-names>
            </name>
            <name>
              <surname>Ndung’u</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Goulder</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Heckerman</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Hunter</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Goepfert</surname>
              <given-names>PA</given-names>
            </name>
          </person-group>
          <article-title>CD8 T cell response and evolutionary pressure to HIV-1 cryptic epitopes derived from antisense transcription</article-title>
          <source>J Exp Med.</source>
          <year>2010</year>
          <volume>207</volume>
          <issue>1</issue>
          <fpage>51</fpage>
          <lpage>59</lpage>
          <pub-id pub-id-type="doi">10.1084/jem.20092060</pub-id>
          <?supplied-pmid 20065064?>
          <pub-id pub-id-type="pmid">20065064</pub-id>
        </element-citation>
      </ref>
      <ref id="CR66">
        <label>66.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Akinsiku</surname>
              <given-names>OT</given-names>
            </name>
            <name>
              <surname>Bansal</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sabbaj</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Heath</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Goepfert</surname>
              <given-names>PA</given-names>
            </name>
          </person-group>
          <article-title>Interleukin-2 production by polyfunctional HIV-1-specific CD8 T cells is associated with enhanced viral suppression</article-title>
          <source>J Acquir Immune Defic Syndr</source>
          <year>2011</year>
          <volume>58</volume>
          <issue>2</issue>
          <fpage>132</fpage>
          <lpage>140</lpage>
          <pub-id pub-id-type="doi">10.1097/QAI.0b013e318224d2e9</pub-id>
          <?supplied-pmid 21637109?>
          <pub-id pub-id-type="pmid">21637109</pub-id>
        </element-citation>
      </ref>
      <ref id="CR67">
        <label>67.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Graf</surname>
              <given-names>EH</given-names>
            </name>
            <name>
              <surname>Pace</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Peterson</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Lynch</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Chukwulebe</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Mexas</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Shaheen</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>JN</given-names>
            </name>
            <name>
              <surname>Deeks</surname>
              <given-names>SG</given-names>
            </name>
            <name>
              <surname>Connors</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Migueles</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>O’Doherty</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>Gag-positive reservoir cells are susceptible to HIV-specific cytotoxic T lymphocyte mediated clearance in vitro and can be detected in vivo [corrected]</article-title>
          <source>PLoS One</source>
          <year>2013</year>
          <volume>8</volume>
          <issue>8</issue>
          <fpage>e71879</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0071879</pub-id>
          <?supplied-pmid 23951263?>
          <pub-id pub-id-type="pmid">23951263</pub-id>
        </element-citation>
      </ref>
      <ref id="CR68">
        <label>68.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lau</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Levy</surname>
              <given-names>DN</given-names>
            </name>
            <name>
              <surname>Wodarz</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Contribution of HIV-1 genomes that do not integrate to the basic reproductive ratio of the virus</article-title>
          <source>J Theor Biol</source>
          <year>2015</year>
          <volume>367</volume>
          <fpage>222</fpage>
          <lpage>229</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jtbi.2014.12.004</pub-id>
          <?supplied-pmid 25496730?>
          <pub-id pub-id-type="pmid">25496730</pub-id>
        </element-citation>
      </ref>
      <ref id="CR69">
        <label>69.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reilly</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Wietgrefe</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sedgewick</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Haase</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Determination of simian immunodeficiency virus production by infected activated and resting cells</article-title>
          <source>AIDS.</source>
          <year>2007</year>
          <volume>21</volume>
          <issue>2</issue>
          <fpage>163</fpage>
          <lpage>168</lpage>
          <pub-id pub-id-type="doi">10.1097/QAD.0b013e328012565b</pub-id>
          <?supplied-pmid 17197806?>
          <pub-id pub-id-type="pmid">17197806</pub-id>
        </element-citation>
      </ref>
      <ref id="CR70">
        <label>70.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Trabaud</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Cotte</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Saison</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ramiere</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ronfort</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Venet</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Tardy</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Monneret</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Andre</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Persistent production of an integrase-deleted HIV-1 variant with no resistance mutation and wild-type proviral DNA in a treated patient</article-title>
          <source>AIDS Res Hum Retroviruses</source>
          <year>2015</year>
          <volume>31</volume>
          <issue>1</issue>
          <fpage>142</fpage>
          <lpage>149</lpage>
          <pub-id pub-id-type="doi">10.1089/aid.2014.0129</pub-id>
          <?supplied-pmid 25333615?>
          <pub-id pub-id-type="pmid">25333615</pub-id>
        </element-citation>
      </ref>
      <ref id="CR71">
        <label>71.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shimura</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Miyazato</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Oishi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Fujii</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Matsuoka</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Impact of HIV-1 infection pathways on susceptibility to antiviral drugs and on virus spread</article-title>
          <source>Virology</source>
          <year>2015</year>
          <volume>484</volume>
          <fpage>364</fpage>
          <lpage>376</lpage>
          <pub-id pub-id-type="doi">10.1016/j.virol.2015.06.029</pub-id>
          <?supplied-pmid 26186575?>
          <pub-id pub-id-type="pmid">26186575</pub-id>
        </element-citation>
      </ref>
      <ref id="CR72">
        <label>72.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Finzi</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Hermankova</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Pierson</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Carruth</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Buck</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Chaisson</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Quinn</surname>
              <given-names>TC</given-names>
            </name>
            <name>
              <surname>Chadwick</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Margolick</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Brookmeyer</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Gallant</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Markowitz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ho</surname>
              <given-names>DD</given-names>
            </name>
            <name>
              <surname>Richman</surname>
              <given-names>DD</given-names>
            </name>
            <name>
              <surname>Siliciano</surname>
              <given-names>RF</given-names>
            </name>
          </person-group>
          <article-title>Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy</article-title>
          <source>Science</source>
          <year>1997</year>
          <volume>278</volume>
          <issue>5341</issue>
          <fpage>1295</fpage>
          <lpage>1300</lpage>
          <pub-id pub-id-type="doi">10.1126/science.278.5341.1295</pub-id>
          <?supplied-pmid 9360927?>
          <pub-id pub-id-type="pmid">9360927</pub-id>
        </element-citation>
      </ref>
      <ref id="CR73">
        <label>73.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wong</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Hezareh</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gunthard</surname>
              <given-names>HF</given-names>
            </name>
            <name>
              <surname>Havlir</surname>
              <given-names>DV</given-names>
            </name>
            <name>
              <surname>Ignacio</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Spina</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Richman</surname>
              <given-names>DD</given-names>
            </name>
          </person-group>
          <article-title>Recovery of replication-competent HIV despite prolonged suppression of plasma viremia</article-title>
          <source>Science</source>
          <year>1997</year>
          <volume>278</volume>
          <issue>5341</issue>
          <fpage>1291</fpage>
          <lpage>1295</lpage>
          <pub-id pub-id-type="doi">10.1126/science.278.5341.1291</pub-id>
          <?supplied-pmid 9360926?>
          <pub-id pub-id-type="pmid">9360926</pub-id>
        </element-citation>
      </ref>
      <ref id="CR74">
        <label>74.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bosque</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Planelles</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Induction of HIV-1 latency and reactivation in primary memory CD4+ T cells</article-title>
          <source>Blood.</source>
          <year>2009</year>
          <volume>113</volume>
          <issue>1</issue>
          <fpage>58</fpage>
          <lpage>65</lpage>
          <pub-id pub-id-type="doi">10.1182/blood-2008-07-168393</pub-id>
          <?supplied-pmid 18849485?>
          <pub-id pub-id-type="pmid">18849485</pub-id>
        </element-citation>
      </ref>
      <ref id="CR75">
        <label>75.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xing</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bullen</surname>
              <given-names>CK</given-names>
            </name>
            <name>
              <surname>Shroff</surname>
              <given-names>NS</given-names>
            </name>
            <name>
              <surname>Shan</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>HC</given-names>
            </name>
            <name>
              <surname>Manucci</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Bhat</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Margolick</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Quinn</surname>
              <given-names>TC</given-names>
            </name>
            <name>
              <surname>Margolis</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Siliciano</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Siliciano</surname>
              <given-names>RF</given-names>
            </name>
          </person-group>
          <article-title>Disulfiram reactivates latent HIV-1 in a Bcl-2-transduced primary CD4+ T cell model without inducing global T cell activation</article-title>
          <source>J Virol</source>
          <year>2011</year>
          <volume>85</volume>
          <issue>12</issue>
          <fpage>6060</fpage>
          <lpage>6064</lpage>
          <pub-id pub-id-type="doi">10.1128/JVI.02033-10</pub-id>
          <?supplied-pmid 21471244?>
          <pub-id pub-id-type="pmid">21471244</pub-id>
        </element-citation>
      </ref>
      <ref id="CR76">
        <label>76.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deeks</surname>
              <given-names>SG</given-names>
            </name>
          </person-group>
          <article-title>HIV: Shock and kill</article-title>
          <source>Nature.</source>
          <year>2012</year>
          <volume>487</volume>
          <issue>7408</issue>
          <fpage>439</fpage>
          <lpage>440</lpage>
          <pub-id pub-id-type="doi">10.1038/487439a</pub-id>
          <?supplied-pmid 22836995?>
          <pub-id pub-id-type="pmid">22836995</pub-id>
        </element-citation>
      </ref>
      <ref id="CR77">
        <label>77.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shan</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Deng</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Shroff</surname>
              <given-names>NS</given-names>
            </name>
            <name>
              <surname>Durand</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Rabi</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>HC</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Margolick</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Blankson</surname>
              <given-names>JN</given-names>
            </name>
            <name>
              <surname>Siliciano</surname>
              <given-names>RF</given-names>
            </name>
          </person-group>
          <article-title>Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation</article-title>
          <source>Immunity</source>
          <year>2012</year>
          <volume>36</volume>
          <issue>3</issue>
          <fpage>491</fpage>
          <lpage>501</lpage>
          <pub-id pub-id-type="doi">10.1016/j.immuni.2012.01.014</pub-id>
          <?supplied-pmid 22406268?>
          <pub-id pub-id-type="pmid">22406268</pub-id>
        </element-citation>
      </ref>
      <ref id="CR78">
        <label>78.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lassen</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Siliciano</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Siliciano</surname>
              <given-names>RF</given-names>
            </name>
          </person-group>
          <article-title>The multifactorial nature of HIV-1 latency</article-title>
          <source>Trends Mol Med.</source>
          <year>2004</year>
          <volume>10</volume>
          <issue>11</issue>
          <fpage>525</fpage>
          <lpage>531</lpage>
          <pub-id pub-id-type="doi">10.1016/j.molmed.2004.09.006</pub-id>
          <?supplied-pmid 15519278?>
          <pub-id pub-id-type="pmid">15519278</pub-id>
        </element-citation>
      </ref>
      <ref id="CR79">
        <label>79.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Winslow</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Pomerantz</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Bagasra</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Trono</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>HIV-1 latency due to the site of proviral integration</article-title>
          <source>Virology</source>
          <year>1993</year>
          <volume>196</volume>
          <issue>2</issue>
          <fpage>849</fpage>
          <lpage>854</lpage>
          <pub-id pub-id-type="doi">10.1006/viro.1993.1545</pub-id>
          <?supplied-pmid 8372452?>
          <pub-id pub-id-type="pmid">8372452</pub-id>
        </element-citation>
      </ref>
      <ref id="CR80">
        <label>80.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shan</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Siliciano</surname>
              <given-names>RF</given-names>
            </name>
          </person-group>
          <article-title>From reactivation of latent HIV-1 to elimination of the latent reservoir: the presence of multiple barriers to viral eradication</article-title>
          <source>BioEssays</source>
          <year>2013</year>
          <volume>35</volume>
          <issue>6</issue>
          <fpage>544</fpage>
          <lpage>552</lpage>
          <pub-id pub-id-type="doi">10.1002/bies.201200170</pub-id>
          <?supplied-pmid 23613347?>
          <pub-id pub-id-type="pmid">23613347</pub-id>
        </element-citation>
      </ref>
      <ref id="CR81">
        <label>81.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Razooky</surname>
              <given-names>BS</given-names>
            </name>
            <name>
              <surname>Pai</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Aull</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Rouzine</surname>
              <given-names>IM</given-names>
            </name>
            <name>
              <surname>Weinberger</surname>
              <given-names>LS</given-names>
            </name>
          </person-group>
          <article-title>A hardwired HIV latency program</article-title>
          <source>Cell</source>
          <year>2015</year>
          <volume>160</volume>
          <issue>5</issue>
          <fpage>990</fpage>
          <lpage>1001</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2015.02.009</pub-id>
          <?supplied-pmid 25723172?>
          <pub-id pub-id-type="pmid">25723172</pub-id>
        </element-citation>
      </ref>
      <ref id="CR82">
        <label>82.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Donahue</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Wainberg</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Cellular and molecular mechanisms involved in the establishment of HIV-1 latency</article-title>
          <source>Retrovirology.</source>
          <year>2013</year>
          <volume>10</volume>
          <fpage>11</fpage>
          <pub-id pub-id-type="doi">10.1186/1742-4690-10-11</pub-id>
          <?supplied-pmid 23375003?>
          <pub-id pub-id-type="pmid">23375003</pub-id>
        </element-citation>
      </ref>
      <ref id="CR83">
        <label>83.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weinberger</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Weinberger</surname>
              <given-names>LS</given-names>
            </name>
          </person-group>
          <article-title>Stochastic fate selection in HIV-infected patients</article-title>
          <source>Cell</source>
          <year>2013</year>
          <volume>155</volume>
          <issue>3</issue>
          <fpage>497</fpage>
          <lpage>499</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2013.09.039</pub-id>
          <?supplied-pmid 24243007?>
          <pub-id pub-id-type="pmid">24243007</pub-id>
        </element-citation>
      </ref>
      <ref id="CR84">
        <label>84.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brenchley</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Schacker</surname>
              <given-names>TW</given-names>
            </name>
            <name>
              <surname>Ruff</surname>
              <given-names>LE</given-names>
            </name>
            <name>
              <surname>Price</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Beilman</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Nguyen</surname>
              <given-names>PL</given-names>
            </name>
            <name>
              <surname>Khoruts</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Larson</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Haase</surname>
              <given-names>AT</given-names>
            </name>
            <name>
              <surname>Douek</surname>
              <given-names>DC</given-names>
            </name>
          </person-group>
          <article-title>CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract</article-title>
          <source>J Exp Med</source>
          <year>2004</year>
          <volume>200</volume>
          <issue>6</issue>
          <fpage>749</fpage>
          <lpage>759</lpage>
          <pub-id pub-id-type="doi">10.1084/jem.20040874</pub-id>
          <?supplied-pmid 15365096?>
          <pub-id pub-id-type="pmid">15365096</pub-id>
        </element-citation>
      </ref>
      <ref id="CR85">
        <label>85.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Poon</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>IS</given-names>
            </name>
          </person-group>
          <article-title>Human immunodeficiency virus type 1 (HIV-1) Vpr enhances expression from unintegrated HIV-1 DNA</article-title>
          <source>J Virol.</source>
          <year>2003</year>
          <volume>77</volume>
          <issue>7</issue>
          <fpage>3962</fpage>
          <lpage>3972</lpage>
          <pub-id pub-id-type="doi">10.1128/JVI.77.7.3962-3972.2003</pub-id>
          <?supplied-pmid 12634356?>
          <pub-id pub-id-type="pmid">12634356</pub-id>
        </element-citation>
      </ref>
      <ref id="CR86">
        <label>86.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shen</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Baker</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Scott</surname>
              <given-names>GL</given-names>
            </name>
            <name>
              <surname>Davis</surname>
              <given-names>YP</given-names>
            </name>
            <name>
              <surname>Ho</surname>
              <given-names>YY</given-names>
            </name>
            <name>
              <surname>Siliciano</surname>
              <given-names>RF</given-names>
            </name>
          </person-group>
          <article-title>Endothelial cell stimulation overcomes restriction and promotes productive and latent HIV-1 infection of resting CD4+ T cells</article-title>
          <source>J Virol</source>
          <year>2013</year>
          <volume>87</volume>
          <issue>17</issue>
          <fpage>9768</fpage>
          <lpage>9779</lpage>
          <pub-id pub-id-type="doi">10.1128/JVI.01478-13</pub-id>
          <?supplied-pmid 23824795?>
          <pub-id pub-id-type="pmid">23824795</pub-id>
        </element-citation>
      </ref>
      <ref id="CR87">
        <label>87.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Levy</surname>
              <given-names>DN</given-names>
            </name>
            <name>
              <surname>Refaeli</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>MacGregor</surname>
              <given-names>RR</given-names>
            </name>
            <name>
              <surname>Weiner</surname>
              <given-names>DB</given-names>
            </name>
          </person-group>
          <article-title>Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1</article-title>
          <source>Proc Natl Acad Sci USA.</source>
          <year>1994</year>
          <volume>91</volume>
          <issue>23</issue>
          <fpage>10873</fpage>
          <lpage>10877</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.91.23.10873</pub-id>
          <?supplied-pmid 7971975?>
          <pub-id pub-id-type="pmid">7971975</pub-id>
        </element-citation>
      </ref>
      <ref id="CR88">
        <label>88.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Levy</surname>
              <given-names>DN</given-names>
            </name>
            <name>
              <surname>Refaeli</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Weiner</surname>
              <given-names>DB</given-names>
            </name>
          </person-group>
          <article-title>Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency</article-title>
          <source>J Virol.</source>
          <year>1995</year>
          <volume>69</volume>
          <issue>2</issue>
          <fpage>1243</fpage>
          <lpage>1252</lpage>
          <?supplied-pmid 7815499?>
          <pub-id pub-id-type="pmid">7815499</pub-id>
        </element-citation>
      </ref>
      <ref id="CR89">
        <label>89.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sherman</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Schubert</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>de Noronha</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Kreisberg</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Henklein</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Greene</surname>
              <given-names>WC</given-names>
            </name>
          </person-group>
          <article-title>HIV-1 Vpr displays natural protein-transducing properties: implications for viral pathogenesis</article-title>
          <source>Virology</source>
          <year>2002</year>
          <volume>302</volume>
          <issue>1</issue>
          <fpage>95</fpage>
          <lpage>105</lpage>
          <pub-id pub-id-type="doi">10.1006/viro.2002.1576</pub-id>
          <?supplied-pmid 12429519?>
          <pub-id pub-id-type="pmid">12429519</pub-id>
        </element-citation>
      </ref>
      <ref id="CR90">
        <label>90.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hoshino</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Konishi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mori</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Shimura</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nishitani</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kuroki</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Koyanagi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kano</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Itabe</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ishizaka</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>HIV-1 Vpr induces TLR4/MyD88-mediated IL-6 production and reactivates viral production from latency</article-title>
          <source>J Leukoc Biol</source>
          <year>2010</year>
          <volume>87</volume>
          <issue>6</issue>
          <fpage>1133</fpage>
          <lpage>1143</lpage>
          <pub-id pub-id-type="doi">10.1189/jlb.0809547</pub-id>
          <?supplied-pmid 20145198?>
          <pub-id pub-id-type="pmid">20145198</pub-id>
        </element-citation>
      </ref>
      <ref id="CR91">
        <label>91.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Emeagwali</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Hildreth</surname>
              <given-names>JE</given-names>
            </name>
          </person-group>
          <article-title>Human immunodeficiency virus type 1 Vpu and cellular TASK proteins suppress transcription of unintegrated HIV-1 DNA</article-title>
          <source>Virol J.</source>
          <year>2012</year>
          <volume>9</volume>
          <fpage>277</fpage>
          <pub-id pub-id-type="doi">10.1186/1743-422X-9-277</pub-id>
          <?supplied-pmid 23164059?>
          <pub-id pub-id-type="pmid">23164059</pub-id>
        </element-citation>
      </ref>
      <ref id="CR92">
        <label>92.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deng</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Pertea</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rongvaux</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Durand</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Ghiaur</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Lai</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>McHugh</surname>
              <given-names>HL</given-names>
            </name>
            <name>
              <surname>Hao</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Margolick</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Gurer</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Murphy</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Valenzuela</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Yancopoulos</surname>
              <given-names>GD</given-names>
            </name>
            <name>
              <surname>Deeks</surname>
              <given-names>SG</given-names>
            </name>
            <name>
              <surname>Strowig</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Siliciano</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Salzberg</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Flavell</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Shan</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Siliciano</surname>
              <given-names>RF</given-names>
            </name>
          </person-group>
          <article-title>Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations</article-title>
          <source>Nature</source>
          <year>2015</year>
          <volume>517</volume>
          <issue>7534</issue>
          <fpage>381</fpage>
          <lpage>385</lpage>
          <pub-id pub-id-type="doi">10.1038/nature14053</pub-id>
          <?supplied-pmid 25561180?>
          <pub-id pub-id-type="pmid">25561180</pub-id>
        </element-citation>
      </ref>
      <ref id="CR93">
        <label>93.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Connick</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Mattila</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Folkvord</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Schlichtemeier</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Meditz</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Ray</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>McCarter</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Mawhinney</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hage</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>White</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Skinner</surname>
              <given-names>PJ</given-names>
            </name>
          </person-group>
          <article-title>CTL fail to accumulate at sites of HIV-1 replication in lymphoid tissue</article-title>
          <source>J Immunol.</source>
          <year>2007</year>
          <volume>178</volume>
          <issue>11</issue>
          <fpage>6975</fpage>
          <lpage>6983</lpage>
          <pub-id pub-id-type="doi">10.4049/jimmunol.178.11.6975</pub-id>
          <?supplied-pmid 17513747?>
          <pub-id pub-id-type="pmid">17513747</pub-id>
        </element-citation>
      </ref>
      <ref id="CR94">
        <label>94.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Buzon</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ouyang</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Seiss</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Rogich</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Le Gall</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Pereyra</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Rosenberg</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>XG</given-names>
            </name>
            <name>
              <surname>Lichterfeld</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Susceptibility to CD8 T-cell-mediated killing influences the reservoir of latently HIV-1-infected CD4 T cells</article-title>
          <source>J Acquir Immune Defic Syndr</source>
          <year>2014</year>
          <volume>65</volume>
          <issue>1</issue>
          <fpage>1</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1097/QAI.0b013e3182a1bc81</pub-id>
          <?supplied-pmid 23846565?>
          <pub-id pub-id-type="pmid">23846565</pub-id>
        </element-citation>
      </ref>
      <ref id="CR95">
        <label>95.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Quivy</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Adam</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Collette</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Demonte</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Chariot</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Vanhulle</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Berkhout</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Castellano</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>de Launoit</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Burny</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Piette</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bours</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Van Lint</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies</article-title>
          <source>J Virol</source>
          <year>2002</year>
          <volume>76</volume>
          <issue>21</issue>
          <fpage>11091</fpage>
          <lpage>11103</lpage>
          <pub-id pub-id-type="doi">10.1128/JVI.76.21.11091-11103.2002</pub-id>
          <?supplied-pmid 12368351?>
          <pub-id pub-id-type="pmid">12368351</pub-id>
        </element-citation>
      </ref>
      <ref id="CR96">
        <label>96.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schmid</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Cole</surname>
              <given-names>SW</given-names>
            </name>
            <name>
              <surname>Korin</surname>
              <given-names>YD</given-names>
            </name>
            <name>
              <surname>Zack</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Giorgi</surname>
              <given-names>JV</given-names>
            </name>
          </person-group>
          <article-title>Detection of cell cycle subcompartments by flow cytometric estimation of DNA-RNA content in combination with dual-color immunofluorescence</article-title>
          <source>Cytometry</source>
          <year>2000</year>
          <volume>39</volume>
          <issue>2</issue>
          <fpage>108</fpage>
          <lpage>116</lpage>
          <pub-id pub-id-type="doi">10.1002/(SICI)1097-0320(20000201)39:2&lt;108::AID-CYTO3&gt;3.0.CO;2-4</pub-id>
          <?supplied-pmid 10679728?>
          <pub-id pub-id-type="pmid">10679728</pub-id>
        </element-citation>
      </ref>
      <ref id="CR97">
        <label>97.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sabbaj</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bansal</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ritter</surname>
              <given-names>GD</given-names>
            </name>
            <name>
              <surname>Perkins</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Edwards</surname>
              <given-names>BH</given-names>
            </name>
            <name>
              <surname>Gough</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Szinger</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Korber</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Kaslow</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Mulligan</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Goepfert</surname>
              <given-names>PA</given-names>
            </name>
          </person-group>
          <article-title>Cross-reactive CD8+ T cell epitopes identified in US adolescent minorities</article-title>
          <source>J Acquir Immune Defic Syndr</source>
          <year>2003</year>
          <volume>33</volume>
          <issue>4</issue>
          <fpage>426</fpage>
          <lpage>438</lpage>
          <pub-id pub-id-type="doi">10.1097/00126334-200308010-00003</pub-id>
          <?supplied-pmid 12869831?>
          <pub-id pub-id-type="pmid">12869831</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:4700563</identifier><datestamp>2016-01-06</datestamp><setSpec>aaci</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="http://jats.nlm.nih.gov/ns/archiving/1.0/ http://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Allergy Asthma Clin Immunol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Allergy Asthma Clin Immunol</journal-id>
      <journal-title-group>
        <journal-title>Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1710-1484</issn>
      <issn pub-type="epub">1710-1492</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC4700563</article-id>
      <article-id pub-id-type="pmcid">PMC4700563</article-id>
      <article-id pub-id-type="pmc-uid">4700563</article-id>
      <article-id pub-id-type="publisher-id">107</article-id>
      <article-id pub-id-type="doi">10.1186/s13223-015-0107-8</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Sensitization to common aeroallergens in a population of young adults in a sub-Saharan Africa setting: a cross-sectional study</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Mbatchou Ngahane</surname>
            <given-names>Bertrand Hugo</given-names>
          </name>
          <address>
            <phone>+237 697 06 88 99</phone>
            <email>mbatchou.ngahane@yahoo.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Noah</surname>
            <given-names>Diane</given-names>
          </name>
          <address>
            <email>vickynoah@yahoo.fr</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nganda Motto</surname>
            <given-names>Malea</given-names>
          </name>
          <address>
            <email>maleakings@yahoo.com</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mapoure Njankouo</surname>
            <given-names>Yacouba</given-names>
          </name>
          <address>
            <email>mapoure@yahoo.fr</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Njock</surname>
            <given-names>Louis Richard</given-names>
          </name>
          <address>
            <email>rnjock@yahoo.fr</email>
          </address>
          <xref ref-type="aff" rid="Aff3"/>
          <xref ref-type="aff" rid="Aff4"/>
        </contrib>
        <aff id="Aff1"><label/>Department of Internal Medicine, Douala General Hospital, PO Box 4856, Douala, Cameroon </aff>
        <aff id="Aff2"><label/>Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon </aff>
        <aff id="Aff3"><label/>Department of Ear Nose and Throat, Douala General Hospital, Douala, Cameroon </aff>
        <aff id="Aff4"><label/>Faculty of Medicine and Biomedical Sciences, University of Yaounde 1, Yaounde, Cameroon </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>4</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>4</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <volume>12</volume>
      <elocation-id>1</elocation-id>
      <history>
        <date date-type="received">
          <day>22</day>
          <month>8</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>17</day>
          <month>12</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© Mbatchou Ngahane et al. 2015</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Sensitization to aeroallergens increases the risk of developing asthma or allergic rhinitis. Data on sensitization to airborne allergens in the general population in sub-Saharan Africa are lacking. The aim of this study was to determine the prevalence and determinants of sensitization to common aeroallergens in a population of young adults.</p>
        </sec>
        <sec>
          <title>Methods</title>
          <p>A cross-sectional study was conducted among students of the Faculty of Medicine and Pharmaceutical Sciences of the University of Douala between 1st February and 30th April 2014. We consecutively recruited all the students present in class or in hospital during our visit. They filled an anonymous questionnaire and underwent skin prick tests with common aeroallergens. A logistic regression model of the SPSS.20 software was used to investigate factors associated with sensitization to common aeroallergens.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>Of the 600 students included in the study, 305 (50.8 %) were female. The mean age of participants was 22.6 ± 2.7 years. The prevalence of sensitization to aeroallergens was 42.8 % (95 % CI 38.8–46.8). <italic>Dermatophagoides pteronyssimus</italic> (24.2 %), <italic>Dermatophagoides farinae</italic> (22.8 %), <italic>Blomia tropicalis</italic> (23.3 %) and <italic>Blatella germanica</italic> (15.2 %) were the most common allergens found. Allergic rhinitis, asthma symptoms and family atopy were independently associated to sensitization to common aeroallergens.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>A significant proportion of young adults are sensitized to common aeroallergens. Dust mites and cockroach should be included in the panel of aeroallergens in Cameroon.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Allergic sensitization</kwd>
        <kwd>Skin prick test</kwd>
        <kwd>Asthma</kwd>
        <kwd>Allergic rhinitis</kwd>
        <kwd>Africa</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>© The Author(s) 2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Background</title>
      <p>The prevalence of allergic diseases is steadily increasing especially in middle- and low-income countries. The main manifestations of respiratory allergy which are asthma and allergic rhinitis are increasing rapidly these last 2 decades [<xref ref-type="bibr" rid="CR1">1</xref>]. The number of asthma and allergic rhinitis patients worldwide are estimated at 334 and 400 million respectively [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Asthma is associated with allergic rhinitis in 74–81 % of cases [<xref ref-type="bibr" rid="CR3">3</xref>] and is one of highest ranking specific diseases in terms of years lost to disability adjusted life years [<xref ref-type="bibr" rid="CR4">4</xref>]. Atopy or allergic sensitization is defined as the production of immunoglobulin E (IgE) in response to allergens, especially inhaled allergens and food allergens [<xref ref-type="bibr" rid="CR1">1</xref>]. It is an important step in the pathogenesis of IgE mediated allergic diseases and is therefore a major risk factor for the development of asthma and allergic rhinitis [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. In order to design efficient preventive measures, it is useful to assess the prevalence and risk factors of allergic sensitization.</p>
      <p>In industrialized countries, there has been an increase over time of the sensitization to aeroallergens in the general population with a prevalence ranging from 25 to 50 % [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. In Africa, most studies have been carried out in selected populations of asthma patients or allergic rhinitis patients. Nevertheless, Benzarti et al. in Tunisia found a 34 % sensitization to common aeroallergens in a population of 500 subjects of an unselected population [<xref ref-type="bibr" rid="CR9">9</xref>]. In another study carried out in Uganda, 14 and 20 % of participants were respectively sensitized to <italic>Blomia tropicalis</italic> (BP) and <italic>Dermatophagoides pteronyssinus</italic> [<xref ref-type="bibr" rid="CR10">10</xref>]. In Cameroon, we could not identify any studies on sensitization to aeroallergens in the general population. The objective of this study was to determine the prevalence and factors associated with sensitization to common allergens in a population of young adults.</p>
    </sec>
    <sec id="Sec2">
      <title>Methods</title>
      <sec id="Sec3">
        <title>Design and study setting</title>
        <p>We conducted a cross-sectional study from February 1st to April 30th, 2014 among students of the Faculty of Medicine and Pharmaceutical Sciences of the University of Douala, who represented a sub-set of young adults in Douala, the most populated city of Cameroon. This seaside city is characterized by an equatorial climate with temperatures ranging from 21 to 31 °C with high rainfall from June to October. The relative humidity varies between 80 and 90 % over the year.</p>
      </sec>
      <sec id="Sec4">
        <title>Participants</title>
        <p>The study population was made of students of the Faculty of Medicine and Pharmaceutical Sciences. We included students attending classes and those present in the hospitals for their internship during the study period. Pregnant students, those on antihistamines, those presenting with acute asthma and non consenting students were excluded. Based on an expected prevalence of sensitization to common aeroallergens of 34 % [<xref ref-type="bibr" rid="CR9">9</xref>] and considering an accepted error of 5 % and a 95 % confidence interval, a minimal sample size of 268 participants was required for this study.</p>
      </sec>
      <sec id="Sec5">
        <title>Data collection</title>
        <p>The recruitment of participants was completed at the university campus during break periods for students from grade 1 to grade 5 and in hospitals for grade 6 and grade 7 students. Using a self-administered questionnaire, the following data were collected: socio-demographic characteristics, home environment, smoking habits, personal and family history of atopy and asthma and allergic rhinitis symptoms. The questionnaires were returned to the investigator.</p>
        <p>Skin prick tests were performed by two trained investigators according to the recommendations of the European Academy of Allergy and Clinical Immunology [<xref ref-type="bibr" rid="CR11">11</xref>]. We used 8 standardized allergen extracts provided by ALK laboratories (Argonne in Varennes, France): the house dust mites <italic>Dermatophagoides pteronyssinus, Dermatophagoides farina</italic>e and <italic>Blomia tropicalis</italic>, the moulds <italic>Alternaria alternata</italic> and <italic>Aspergillus fumigates</italic>, cat dander, dog dander, and the cockroach <italic>Blatella germanica.</italic> Glycerosaline solution was used as the negative control and Histamine dihydrochloride 10 mg/ml as the positive control.</p>
        <p>After cleaning of the volar aspect of the forearm with alcohol, a single drop of each test solution was applied on the skin. A skin-prick test was performed within the drop by pressing a lancet through the drop of allergen extract and holding it against the skin for at least 1 s. The results of the tests were read 15 min following the application by measuring the largest diameter of the wheal of each allergen. The test was considered positive when the wheal diameter was greater or equal to 3 mm. Allergic sensitization was defined as at least one positive reaction to the 8 aeroallergens used.</p>
      </sec>
      <sec id="Sec6">
        <title>Statistical analysis</title>
        <p>Data were entered and analyzed using IBM SPSS Statistics version 20.0. (Armonk, NY, USA: IBM Corp). Quantitative variables were summarized as means and standard deviations and qualitative data as frequencies and percentages. Univariate and multivariate logistic regression was used to determine the association between independent variables and sensitization to common aeroallergens. Variables with p &lt; 0.2 in the univariate analysis were fitted into the final multiple logistic regression models. Variables with p &lt; 0.05 in the final model were taken as significant associated factors.</p>
      </sec>
      <sec id="Sec7">
        <title>Ethical clearance</title>
        <p>The study protocol was given ethical approval by the ethics committee of the Douala University and verbal consent was obtained from each participant before recruitment.</p>
      </sec>
    </sec>
    <sec id="Sec8">
      <title>Results</title>
      <p>Of the total of 680 students who received questionnaires, 608 returned the questionnaires to the investigator and underwent skin prick tests, giving a response rate of 89.4 %. Prick tests from eight subjects were not interpretable. The final study population consisted of 600 students of which 305 (58.8 %) were female. The mean age of participants was 22.7 ± 2.8 years (range 16–35). Symptoms suggestive of asthma and allergic rhinitis were found in 50 (8 %) and 301 (50.2 %) participants, respectively. The other characteristics of the study population are illustrated in Table <xref rid="Tab1" ref-type="table">1</xref>.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Baseline characteristics of participants (N = 600)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Variables</th><th align="left">Number</th><th align="left">Percentage</th></tr></thead><tbody><tr><td align="left">Gender</td><td align="left"/><td align="left"/></tr><tr><td align="left"> Male</td><td char="." align="char">295</td><td char="." align="char">49.2</td></tr><tr><td align="left"> Female</td><td char="." align="char">305</td><td char="." align="char">50.8</td></tr><tr><td align="left">Age (years)</td><td align="left"/><td align="left"/></tr><tr><td align="left"> &lt;20</td><td char="." align="char">79</td><td char="." align="char">13.2</td></tr><tr><td align="left"> 20–24</td><td char="." align="char">359</td><td char="." align="char">59.8</td></tr><tr><td align="left"> 25–29</td><td char="." align="char">158</td><td char="." align="char">26.3</td></tr><tr><td align="left"> ≥30</td><td char="." align="char">4</td><td char="." align="char">0.7</td></tr><tr><td align="left">Family atopy</td><td align="left"/><td align="left"/></tr><tr><td align="left"> Yes</td><td char="." align="char">221</td><td char="." align="char">36.8</td></tr><tr><td align="left"> No</td><td char="." align="char">379</td><td char="." align="char">63.2</td></tr><tr><td align="left">Diagnosed asthma</td><td align="left"/><td align="left"/></tr><tr><td align="left"> Yes</td><td char="." align="char">39</td><td char="." align="char">6.5</td></tr><tr><td align="left"> No</td><td char="." align="char">561</td><td char="." align="char">93.5</td></tr><tr><td align="left">Allergic rhinitis</td><td align="left"/><td align="left"/></tr><tr><td align="left"> Yes</td><td char="." align="char">87</td><td char="." align="char">14.5</td></tr><tr><td align="left"> No</td><td char="." align="char">513</td><td char="." align="char">85.5</td></tr><tr><td align="left">Atopic dermatitis</td><td align="left"/><td align="left"/></tr><tr><td align="left"> Yes</td><td char="." align="char">51</td><td char="." align="char">8.5</td></tr><tr><td align="left"> No</td><td char="." align="char">549</td><td char="." align="char">91.5</td></tr><tr><td align="left">Allergic conjunctivitis</td><td align="left"/><td align="left"/></tr><tr><td align="left"> Yes</td><td char="." align="char">37</td><td char="." align="char">6.2</td></tr><tr><td align="left"> No</td><td char="." align="char">563</td><td char="." align="char">93.8</td></tr><tr><td align="left">Smoking</td><td align="left"/><td align="left"/></tr><tr><td align="left"> Yes</td><td char="." align="char">11</td><td char="." align="char">1.8</td></tr><tr><td align="left"> No</td><td char="." align="char">589</td><td char="." align="char">98.2</td></tr><tr><td align="left">Alcohol consumption</td><td align="left"/><td align="left"/></tr><tr><td align="left"> Yes</td><td char="." align="char">46</td><td char="." align="char">7.7</td></tr><tr><td align="left"> No</td><td char="." align="char">554</td><td char="." align="char">92.3</td></tr><tr><td align="left">Moulds</td><td align="left"/><td align="left"/></tr><tr><td align="left"> Yes</td><td char="." align="char">352</td><td char="." align="char">58.7</td></tr><tr><td align="left"> No</td><td char="." align="char">248</td><td char="." align="char">41.3</td></tr><tr><td align="left">Carpet at home</td><td align="left"/><td align="left"/></tr><tr><td align="left"> Yes</td><td char="." align="char">397</td><td char="." align="char">66.2</td></tr><tr><td align="left"> No</td><td char="." align="char">203</td><td char="." align="char">33.8</td></tr><tr><td align="left">Allergic rhinitis symptoms</td><td align="left"/><td align="left"/></tr><tr><td align="left"> Yes</td><td char="." align="char">301</td><td char="." align="char">50.2</td></tr><tr><td align="left"> No</td><td char="." align="char">299</td><td char="." align="char">49.8</td></tr><tr><td align="left">Wheezing the last 12 months</td><td align="left"/><td align="left"/></tr><tr><td align="left"> Yes</td><td char="." align="char">50</td><td char="." align="char">8.3</td></tr><tr><td align="left"> No</td><td char="." align="char">550</td><td char="." align="char">91.7</td></tr></tbody></table></table-wrap></p>
      <p>The skin prick tests were positive for at least one allergen in 257 subjects, giving a prevalence of allergic sensitization of 42.8 % (95 % CI 38.8–46.8). <italic>D. farinae</italic> (24.2 %), <italic>B. tropicalis</italic> (23.3 %), <italic>D. pteronyssinus</italic> (22.8 %) and cockroach (15.2 %) were the most prevalent sensitizers (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). The skin prick tests were positive for the 3 mites in 87 (14.5 %) participants while positive to both <italic>D. farinae</italic> and <italic>D. pteronyssinus</italic> in 107 (17.8 %) participants. The reactions were negative for 57.2 % of participants. Sensitization to only one allergen was present in 79 (13.2 %) participants while the sensitization to 4 different allergens was observed in 4.5 % of participants (Fig. <xref rid="Fig2" ref-type="fig">2</xref>). Of the 79 subjects with a monosensitization, cockroach was most represented (36, 7 %) followed by <italic>D. pteronyssinus</italic> (19 %) and B<italic>. tropicalis</italic> (13.9 %).<fig id="Fig1"><label>Fig. 1</label><caption><p>Prevalence of sensitization to aeroallergens</p></caption><graphic xlink:href="13223_2015_107_Fig1_HTML" id="MO1"/></fig><fig id="Fig2"><label>Fig. 2</label><caption><p>Sensitization to one or more aeroallergens</p></caption><graphic xlink:href="13223_2015_107_Fig2_HTML" id="MO2"/></fig></p>
      <p>Univariate analysis indentified personal history of atopic dermatitis, family atopy, being exposed to cat at home, allergic rhinitis and wheezing during the 12 last months were significantly associated with sensitization to any aeroallergen (Table <xref rid="Tab2" ref-type="table">2</xref>). The multivariate analysis revealed that, family atopy (OR 1.47, 95 % CI 1–2.1), wheezing during the last 12 months (OR 3.12, 95 % CI 2.19–4, 42) and allergic rhinitis symptoms (2.43, 95 % CI 1.27–4.66) were the factors independently associated to sensitization with common aeroallergens.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Univariate and multivariate analysis of factors associated with sensitization to aeroallergens</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Variable</th><th align="left">Positive skin prick test</th><th align="left">P value</th><th align="left">Adjusted odds ratio</th><th align="left">Adjusted P value</th></tr></thead><tbody><tr><td align="left">Age (increase in)</td><td align="left"/><td char="." align="char">0.15</td><td align="left">1.06 (0.99–1.13)</td><td align="left">0.06</td></tr><tr><td align="left">BMI (increase in)</td><td align="left"/><td char="." align="char">0.46</td><td align="left">–</td><td align="left">–</td></tr><tr><td align="left" colspan="5">Sex</td></tr><tr><td align="left"> Male</td><td char="(" align="char">121 (41 %)</td><td char="." align="char">0.77</td><td align="left">–</td><td align="left">–</td></tr><tr><td align="left"> Female</td><td char="(" align="char">135 (44.6 %)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Family atopy</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left"> Yes</td><td char="(" align="char">114 (51.6 %)</td><td char="." align="char">0.001</td><td align="left">1.47 (1.02–2.10)</td><td align="left">0.03</td></tr><tr><td align="left"> No</td><td char="(" align="char">143 (37.7 %)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Atopic dermatitis</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left"> Yes</td><td char="(" align="char">29 (56.9 %)</td><td char="." align="char">0.03</td><td align="left">1.52 (0.81–2.86)</td><td align="left">0.18</td></tr><tr><td align="left"> No</td><td char="(" align="char">228 (41.5 %)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Carpet at home</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left"> Yes</td><td char="(" align="char">194 (44.7 %)</td><td char="." align="char">0.13</td><td align="left">1.21 (0.82–1.79)</td><td align="left">0.33</td></tr><tr><td align="left"> No</td><td char="(" align="char">63 (38 %)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Cat</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left"> Yes</td><td char="(" align="char">78 (49.7 %)</td><td char="." align="char">0.04</td><td align="left">1.41 (0.96–2.09)</td><td align="left">0.07</td></tr><tr><td align="left"> No</td><td char="(" align="char">179 (40.4 %)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Dog</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left"> Yes</td><td char="(" align="char">74 (43 %)</td><td char="." align="char">0.95</td><td align="left">–</td><td align="left">–</td></tr><tr><td align="left"> No</td><td char="(" align="char">183 (42.8 %)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Moulds</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left"> Yes</td><td char="(" align="char">159 (45.2 %)</td><td char="." align="char">0.16</td><td align="left">0.98 (0.68–1.41)</td><td align="left">0.94</td></tr><tr><td align="left"> No</td><td char="(" align="char">98 (39.5 %)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Allergic rhinitis symptoms</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left"> Yes</td><td char="(" align="char">174 (57.8 %)</td><td char="." align="char">&lt;0.001</td><td align="left">3.12 (2.19–4.42)</td><td align="left">&lt;0.001</td></tr><tr><td align="left"> No</td><td char="(" align="char">83 (27.8 %)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Wheezing during the last 12 months</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left"> Yes</td><td char="(" align="char">34 (68 %)</td><td char="." align="char">&lt;0.001</td><td align="left">2.43 (1.27–4.66)</td><td align="left">0.007</td></tr><tr><td align="left"> No</td><td char="(" align="char">223 (40.5 %)</td><td align="left"/><td align="left"/><td align="left"/></tr></tbody></table></table-wrap></p>
    </sec>
    <sec id="Sec9">
      <title>Discussion</title>
      <p>This is the first study reporting on the pattern of allergic sensitization on a sample of young adults in sub-Saharan Africa. The prevalence of sensitization to common aeroallergens in this study was 41.8 %. Dust mites and cockroach were the most frequent allergens. Monosensitization was observed in 13.2 % of the sample and cockroach was the most implicated allergen. We also found an independent association between positive skin prick tests and family atopy, allergic rhinitis symptoms and asthma symptoms.</p>
      <p>Many studies have been conducted worldwide showing a high prevalence of positive skin prick tests to common aeroallergens in the general population. In Europe, the Global Allergy and Asthma European Network survey showed that this prevalence varied from 31.4 to 52.9 % [<xref ref-type="bibr" rid="CR12">12</xref>] while in the United States, a similar trend was observed in 2 national surveys, with almost half of the population aged 6 years and over having at least one positive skin prick test to common allergens [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. Another study in Vietnam found that one-third of the population was sensitized to common allergens [<xref ref-type="bibr" rid="CR14">14</xref>]. In Africa, we found one study in Tunisia, showing a prevalence of 34 %. In sub-Saharan Africa, studies in general population are scarce. In Cameroon, a recent study showed that 32 % of a population of individuals with no allergic symptoms had one or more positive skin prick test to common aeroallergens [<xref ref-type="bibr" rid="CR15">15</xref>].</p>
      <p>In our study population, mites were the most common allergens. This is consistent with previous reports from different regions of the world [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. Similar results were also found in asthma patients in sub-Saharan Africa [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. Cockroach was the fourth most frequent allergen in our study after the 3 mites. This finding corroborates previous studies in sub-Saharan Africa [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. The high prevalence of sensitization to both mites and cockroaches in this study is explained by the high relative humidity and hot climate observed in the city of Douala. In western countries, there is a geographical variation of the prevalence of sensitization to aeroallergens, with cockroach sensitization generally less frequent [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. However, some studies conducted in Eastern Europe showed a high prevalence of cockroach sensitization [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>].</p>
      <p>Sensitization to the other allergens such as moulds, as well as cat and dog dander had relative low prevalence in this study. Conversely, in European and North American countries, sensitization to cat and dog dander have a more important place among common aeroallergens [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. In these countries, the two pets are present more frequently in homes than they are in subSaharan Africa.</p>
      <p>The independent association between sensitization to common aeroallergens and allergic rhinitis or asthma in the current study confirms previous findings [<xref ref-type="bibr" rid="CR1">1</xref>]. Positive skin prick tests are considered as a hallmark of atopy. Indeed, it is well known that this genetic predisposition to develop IgE-mediated sensitivity to common aeroallergens is the strongest identifiable predisposing factor to the development of allergic rhinitis and asthma [<xref ref-type="bibr" rid="CR21">21</xref>]. In sub-Saharan Africa, many studies had demonstrated the association between sensitization to mites and asthma. These mites are the main contributor to sensitization to common aeroallergens [<xref ref-type="bibr" rid="CR22">22</xref>–<xref ref-type="bibr" rid="CR24">24</xref>]. Having a family history of atopy was associated to sensitization to common aeroallergens. This finding which is in line with the results of Pallasaho et al. in Finland [<xref ref-type="bibr" rid="CR25">25</xref>] can be explained by the genetic factors that influence the expression of atopy. In fact, allergy and organ-based phenotypes have strong heritability, but the exact genes involved in the expression of different disease phenotypes are only just being revealed and studies are still ongoing [<xref ref-type="bibr" rid="CR26">26</xref>].</p>
      <p>We did not find any association between sensitization to commons allergens and age. This is probably due to the fact that our participants were all young adults, with a mean age of 22.7 years. We could not compare them with a younger or older population. Usually, the rate of allergic sensitization decreases with increasing age [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR27">27</xref>].</p>
      <p>This study has several limitations: first the measurement of serum specific IgE to help confirm sensitization was not performed in this study. Secondly, we did not perform skin prick tests to pollens. This was because the commercial extracts available are adapted to the vegetation of western countries which are not necessarily present in sub-Saharan Africa. Another limitation of this study is the fact that our results cannot be generalizable to the whole Cameroon population because we included a selected population of university students in this study.</p>
    </sec>
    <sec id="Sec10">
      <title>Conclusion</title>
      <p>This study revealed that a significant proportion of young adults in Cameroon are sensitized to common aeroallergens with dust mites identified as the most prevalent allergens. In order to recommend proper allergen avoidance and to prescribe allergen specific immunotherapy, skin prick tests containing mites and cockroach allergens should be considered in patients presenting with symptoms of asthma and allergic rhinitis.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Authors’ contributions</title>
      <p>BHMN conceived and designed the study, analyzed the data and drafted the manuscript. ND drafted the study protocol and collected the data. NMM, YMN and NLR revised the manuscript. All authors read and approved the final manuscript.</p>
      <sec id="FPar1">
        <title>Acknowledgements</title>
        <p>The authors thank all of the medical students who participated in this study. They also thank the Pan African Thoracic Society MECOR course staff for their suggestions during the preparation of the manuscript.</p>
      </sec>
      <sec id="FPar2">
        <title>Competing interests</title>
        <p>The authors declare that they have no competing interests.</p>
      </sec>
      <sec id="FPar3">
        <title>Funding</title>
        <p>This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.</p>
      </sec>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Pawankar</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Canonica</surname>
              <given-names>GW</given-names>
            </name>
            <name>
              <surname>Holgate</surname>
              <given-names>ST</given-names>
            </name>
            <name>
              <surname>Lockey</surname>
              <given-names>RF</given-names>
            </name>
            <name>
              <surname>Blaiss</surname>
              <given-names>MS</given-names>
            </name>
          </person-group>
          <source>The World Allergy Organization (WAO) White Book on Allergy: Update 2013</source>
          <year>2013</year>
          <publisher-loc>Wisconsin</publisher-loc>
          <publisher-name>Milwaukee</publisher-name>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <mixed-citation publication-type="other">Global Asthma Network. The Global Asthma Report 2014. <ext-link ext-link-type="uri" xlink:href="http://www.globalasthmareport.org">http://www.globalasthmareport.org</ext-link>. Accessed 24 May 2015.</mixed-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leynaert</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Neukirch</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kony</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Guenegou</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bousquet</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Aubier</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Neukirch</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Association between asthma and rhinitis according to atopic sensitization in a population-based study</article-title>
          <source>J Allergy Clin Immunol</source>
          <year>2004</year>
          <volume>113</volume>
          <issue>1</issue>
          <fpage>86</fpage>
          <lpage>93</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jaci.2003.10.010</pub-id>
          <?supplied-pmid 14713912?>
          <pub-id pub-id-type="pmid">14713912</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <mixed-citation publication-type="other">Masoli M, Fabian D, Holt S, Beasley R. The Global Burden of Asthma Report. <ext-link ext-link-type="uri" xlink:href="http://www.ginasthma.org">http://www.ginasthma.org</ext-link>. Accessed 24 May 2015.</mixed-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leung</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Ho</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Lam</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Lai</surname>
              <given-names>CK</given-names>
            </name>
          </person-group>
          <article-title>Sensitization to inhaled allergens as a risk factor for asthma and allergic diseases in Chinese population</article-title>
          <source>J Allergy Clin Immunol</source>
          <year>1997</year>
          <volume>99</volume>
          <fpage>594</fpage>
          <lpage>599</lpage>
          <pub-id pub-id-type="doi">10.1016/S0091-6749(97)70018-6</pub-id>
          <?supplied-pmid 9155823?>
          <pub-id pub-id-type="pmid">9155823</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Peat</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Britton</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Salome</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Woolcock</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
          <article-title>Bronchial hyperresponsiveness in two populations of Australian schoolchildren. III. Effect of exposure to environmental allergens</article-title>
          <source>Clinical Allergy</source>
          <year>1987</year>
          <volume>17</volume>
          <issue>4</issue>
          <fpage>291</fpage>
          <lpage>300</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-2222.1987.tb02017.x</pub-id>
          <?supplied-pmid 3621548?>
          <pub-id pub-id-type="pmid">3621548</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Salo</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Arbes</surname>
              <given-names>SJ</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Jaramillo</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Calatroni</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Weir</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Sever</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Hoppin</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Rose</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Gergen</surname>
              <given-names>PJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Prevalence of allergic sensitization in the United States: results from the National Health and Nutrition Examination Survey (NHANES) 2005–2006</article-title>
          <source>J Allergy Clin Immunol</source>
          <year>2014</year>
          <volume>134</volume>
          <issue>2</issue>
          <fpage>350</fpage>
          <lpage>359</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jaci.2013.12.1071</pub-id>
          <?supplied-pmid 24522093?>
          <pub-id pub-id-type="pmid">24522093</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dottorini</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Bruni</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Peccini</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Bottini</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Pini</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Donato</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Casucci</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Tantucci</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Skin prick-test reactivity to aeroallergens and allergic symptoms in an urban population of central Italy: a longitudinal study</article-title>
          <source>Clin Exp Allergy</source>
          <year>2007</year>
          <volume>37</volume>
          <issue>2</issue>
          <fpage>188</fpage>
          <lpage>196</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-2222.2007.02652.x</pub-id>
          <?supplied-pmid 17250691?>
          <pub-id pub-id-type="pmid">17250691</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Benzarti</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mezghani</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Jarray</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Garrouche</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Khirouni</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Klabi</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Skin test reactivity to seven aeroallergens in a Sousse area population sample</article-title>
          <source>La Tunisie Médicale</source>
          <year>2002</year>
          <volume>80</volume>
          <fpage>450</fpage>
          <lpage>454</lpage>
          <?supplied-pmid 12703123?>
          <pub-id pub-id-type="pmid">12703123</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mpairwe</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Muhangi</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Ndibazza</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Tumusiime</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Muwanga</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rodrigues</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Elliott</surname>
              <given-names>AM</given-names>
            </name>
          </person-group>
          <article-title>Skin prick test reactivity to common allergens among women in Entebbe, Uganda</article-title>
          <source>Trans R Soc Trop Med Hyg</source>
          <year>2008</year>
          <volume>102</volume>
          <issue>4</issue>
          <fpage>367</fpage>
          <lpage>373</lpage>
          <pub-id pub-id-type="doi">10.1016/j.trstmh.2008.01.017</pub-id>
          <?supplied-pmid 18321545?>
          <pub-id pub-id-type="pmid">18321545</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heinzerling</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Mari</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bergmann</surname>
              <given-names>K-C</given-names>
            </name>
            <name>
              <surname>Bresciani</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Burbach</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Darsow</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Durham</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Fokkens</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Gjomarkaj</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Haahtela</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The skin prick test—European standards</article-title>
          <source>Clin Trans Allergy</source>
          <year>2013</year>
          <volume>3</volume>
          <fpage>3</fpage>
          <pub-id pub-id-type="doi">10.1186/2045-7022-3-3</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Newson</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>van Ree</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Forsberg</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Janson</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Lötvall</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Dahlén</surname>
              <given-names>S-E</given-names>
            </name>
            <name>
              <surname>Toskala</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Baelum</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Brożek</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Kasper</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Geographical variation in the prevalence of sensitization to common aeroallergens in adults: the GA(2) LEN survey</article-title>
          <source>Allergy</source>
          <year>2014</year>
          <volume>69</volume>
          <fpage>643</fpage>
          <lpage>651</lpage>
          <pub-id pub-id-type="doi">10.1111/all.12397</pub-id>
          <?supplied-pmid 24654915?>
          <pub-id pub-id-type="pmid">24654915</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Arbes</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Gergen</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Elliott</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Zeldin</surname>
              <given-names>DC</given-names>
            </name>
          </person-group>
          <article-title>Prevalences of positive skin test responses to 10 common allergens in the US population: results from the Third National Health and Nutrition Examination Survey</article-title>
          <source>J Allergy Clin Immunol</source>
          <year>2005</year>
          <volume>116</volume>
          <fpage>377</fpage>
          <lpage>383</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jaci.2005.05.017</pub-id>
          <?supplied-pmid 16083793?>
          <pub-id pub-id-type="pmid">16083793</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lâm</surname>
              <given-names>HT</given-names>
            </name>
            <name>
              <surname>Ekerljung</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Bjerg</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Văn</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tng</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Lundbäck</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Rönmark</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Sensitization to airborne allergens among adults and its impact on allergic symptoms: a population survey in northern Vietnam</article-title>
          <source>Clin Trans Allergy</source>
          <year>2014</year>
          <volume>4</volume>
          <fpage>6</fpage>
          <pub-id pub-id-type="doi">10.1186/2045-7022-4-6</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <mixed-citation publication-type="other">Pefura-Yone EW, Mbele-Onana CL, Balkissou AD, Kenmegne-Noumsi EC, Boulleys-Nana JR, Kolontchang-Yomi BL, Theubo-Kamgang BJ, Ndjeutcheu-Moualeu PI, Ebouki ER, Kengne AP. Perennial aeroallergens sensitisation and risk of asthma in African children and adolescents: a case-control study. J Asthma 2014:1–5.</mixed-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <mixed-citation publication-type="other">Mbatchou Ngahane BH, Agodokpessi G, Mapoure NY, Akazong AC, Fonyam V, Barla E, Njock LR. Prévalence de la sensibilisation aux pneumallergènes chez des patients asthmatiques. Etude préliminaire à Douala, Cameroun. Revue de Médecine et de Pharmacie 2013; 3(2):354–58.</mixed-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <mixed-citation publication-type="other">Agodokpessi G, Ade G, Dovoedo N, Ade S, Wachinou AP, Fayomi B, Gninafon M. Sensitisation profile to airborne allergens of patients followed for asthma in Cotonou, Benin. A cross-sectional study using prick-tests. Rev Mal Respir. 2014.</mixed-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bousquet</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Chinn</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Janson</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kogevinas</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Burney</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Jarvis</surname>
              <given-names>D</given-names>
            </name>
            <collab>European Community Respiratory Health Survey I</collab>
          </person-group>
          <article-title>Geographical variation in the prevalence of positive skin tests to environmental aeroallergens in the European Community Respiratory Health Survey I</article-title>
          <source>Allergy</source>
          <year>2007</year>
          <volume>62</volume>
          <issue>3</issue>
          <fpage>301</fpage>
          <lpage>309</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1398-9995.2006.01293.x</pub-id>
          <?supplied-pmid 17298348?>
          <pub-id pub-id-type="pmid">17298348</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Raukas-Kivioja</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Raukas</surname>
              <given-names>E-S</given-names>
            </name>
            <name>
              <surname>Meren</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Loit</surname>
              <given-names>H-M</given-names>
            </name>
            <name>
              <surname>Rönmark</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Lundbäck</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Allergic sensitization to common airborne allergens among adults in Estonia</article-title>
          <source>Int Arch Allergy Immunol</source>
          <year>2007</year>
          <volume>142</volume>
          <fpage>247</fpage>
          <lpage>254</lpage>
          <pub-id pub-id-type="doi">10.1159/000097027</pub-id>
          <?supplied-pmid 17114890?>
          <pub-id pub-id-type="pmid">17114890</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eriksson</surname>
              <given-names>NE</given-names>
            </name>
            <name>
              <surname>Holmén</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Möller</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Wihl</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Sensitization according to skin prick testing in atopic patients with asthma or rhinitis at 24 allergy clinics in Northern Europe and Asia</article-title>
          <source>Allergol Int</source>
          <year>1998</year>
          <volume>47</volume>
          <fpage>187</fpage>
          <lpage>196</lpage>
          <pub-id pub-id-type="doi">10.2332/allergolint.47.187</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weinmayr</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Weiland</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Bjorksten</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Brunekreef</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Buchele</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Cookson</surname>
              <given-names>WO</given-names>
            </name>
            <name>
              <surname>Garcia-Marcos</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Gotua</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gratziou</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>van Hage</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Atopic sensitization and the international variation of asthma symptom prevalence in children</article-title>
          <source>Am J Respir Crit Care Med</source>
          <year>2007</year>
          <volume>176</volume>
          <issue>6</issue>
          <fpage>565</fpage>
          <lpage>574</lpage>
          <pub-id pub-id-type="doi">10.1164/rccm.200607-994OC</pub-id>
          <?supplied-pmid 17575099?>
          <pub-id pub-id-type="pmid">17575099</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Addo-yobo</surname>
              <given-names>EO</given-names>
            </name>
            <name>
              <surname>Custovic</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Taggart</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Craven</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bonnie</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Woodcock</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Risk factors for asthma in urban Ghana</article-title>
          <source>J Allergy Clin Immunol</source>
          <year>2001</year>
          <volume>108</volume>
          <issue>3</issue>
          <fpage>363</fpage>
          <lpage>368</lpage>
          <pub-id pub-id-type="doi">10.1067/mai.2001.117464</pub-id>
          <?supplied-pmid 11544454?>
          <pub-id pub-id-type="pmid">11544454</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>El Fekih</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Mjid</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Souissi</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Ben Hmida</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>El Gueddari</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Douagui</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ouedraogo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Dan Aouta</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Beji</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Sensitization to three house dust mites (<italic>Dermatophagoïdes pteronyssinus</italic>, <italic>Dermatophagoïdes farinae</italic>, <italic>Blomia tropicalis</italic>) in asthmatic and rhinitic patients living in the Maghreb and sub-Saharan Africa</article-title>
          <source>Revue Française d’Allergologie</source>
          <year>2014</year>
          <volume>54</volume>
          <fpage>107</fpage>
          <lpage>112</lpage>
          <pub-id pub-id-type="doi">10.1016/j.reval.2014.01.033</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pefura-Yone</surname>
              <given-names>EW</given-names>
            </name>
            <name>
              <surname>Kengne</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Kuaban</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Sensitisation to mites in a group of patients with asthma in Yaounde, Cameroon: a cross-sectional study</article-title>
          <source>BMJ Open</source>
          <year>2014</year>
          <volume>4</volume>
          <issue>1</issue>
          <fpage>e004062</fpage>
          <pub-id pub-id-type="doi">10.1136/bmjopen-2013-004062</pub-id>
          <?supplied-pmid 24390384?>
          <pub-id pub-id-type="pmid">24390384</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pallasaho</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Rönmark</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Haahtela</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Sovijärvi</surname>
              <given-names>ARA</given-names>
            </name>
            <name>
              <surname>Lundbäck</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Degree and clinical relevance of sensitization to common allergens among adults: a population study in Helsinki, Finland</article-title>
          <source>Clin Exp Allergy J Br Soc Allergy Clin Immunol</source>
          <year>2006</year>
          <volume>36</volume>
          <fpage>503</fpage>
          <lpage>509</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-2222.2006.02460.x</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ober</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Yao</surname>
              <given-names>T-C</given-names>
            </name>
          </person-group>
          <article-title>The genetics of asthma and allergic disease: a 21st century perspective: genetics of asthma and allergy</article-title>
          <source>Immunol Rev</source>
          <year>2011</year>
          <volume>242</volume>
          <fpage>10</fpage>
          <lpage>30</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1600-065X.2011.01029.x</pub-id>
          <?supplied-pmid 21682736?>
          <pub-id pub-id-type="pmid">21682736</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cline</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Burrows</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Distribution of allergy in a population sample residing in Tucson, Arizona</article-title>
          <source>Thorax</source>
          <year>1989</year>
          <volume>44</volume>
          <issue>5</issue>
          <fpage>425</fpage>
          <lpage>431</lpage>
          <pub-id pub-id-type="doi">10.1136/thx.44.5.425</pub-id>
          <?supplied-pmid 2763244?>
          <pub-id pub-id-type="pmid">2763244</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:4700564</identifier><datestamp>2016-01-06</datestamp><setSpec>bmcgeno</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="http://jats.nlm.nih.gov/ns/archiving/1.0/ http://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Genomics</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Genomics</journal-id>
      <journal-title-group>
        <journal-title>BMC Genomics</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1471-2164</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC4700564</article-id>
      <article-id pub-id-type="pmcid">PMC4700564</article-id>
      <article-id pub-id-type="pmc-uid">4700564</article-id>
      <article-id pub-id-type="publisher-id">2348</article-id>
      <article-id pub-id-type="doi">10.1186/s12864-015-2348-9</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Long read and single molecule DNA sequencing simplifies genome assembly and TAL effector gene analysis of <italic>Xanthomonas translucens</italic></article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Peng</surname>
            <given-names>Zhao</given-names>
          </name>
          <address>
            <email>zpeng@ksu.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hu</surname>
            <given-names>Ying</given-names>
          </name>
          <address>
            <email>huying@ksu.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Xie</surname>
            <given-names>Jingzhong</given-names>
          </name>
          <address>
            <email>xiejingzhong381@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Potnis</surname>
            <given-names>Neha</given-names>
          </name>
          <address>
            <email>npotnis@ufl.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Akhunova</surname>
            <given-names>Alina</given-names>
          </name>
          <address>
            <email>akhunova@ksu.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jones</surname>
            <given-names>Jeffrey</given-names>
          </name>
          <address>
            <email>jbjones@ufl.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>Zhaohui</given-names>
          </name>
          <address>
            <email>zhh.liu@ndsu.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff4"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>White</surname>
            <given-names>Frank F.</given-names>
          </name>
          <address>
            <email>ffwhite@ufl.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Liu</surname>
            <given-names>Sanzhen</given-names>
          </name>
          <address>
            <email>liu3zhen@ksu.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <aff id="Aff1"><label/>Department of Plant Pathology, Kansas State University, Manhattan, KS USA </aff>
        <aff id="Aff2"><label/>Department of Horticulture, Forestry and Recreation resources, Kansas State University, Manhattan, KS USA </aff>
        <aff id="Aff3"><label/>Department of Plant Pathology, University of Florida, Gainesville, FL USA </aff>
        <aff id="Aff4"><label/>Department of Plant Pathology, North Dakota State University, Fargo, ND USA </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>5</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>5</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <volume>17</volume>
      <elocation-id>21</elocation-id>
      <history>
        <date date-type="received">
          <day>8</day>
          <month>10</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>21</day>
          <month>12</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© Peng et al. 2015</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>The species <italic>Xanthomonas translucens</italic> encompasses a complex of bacterial strains that cause diseases and yield loss on grass species including important cereal crops. Three pathovars, <italic>X. translucens</italic> pv<italic>. undulosa</italic>, <italic>X. translucens</italic> pv<italic>. translucens</italic> and <italic>X. translucens</italic> pv<italic>.cerealis</italic>, have been described as pathogens of wheat, barley, and oats. However, no complete genome sequence for a strain of this complex is currently available.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>A complete genome sequence of <italic>X. translucens</italic> pv<italic>. undulosa</italic> strain XT4699 was obtained by using PacBio long read, single molecule, real time (SMRT) DNA sequences and Illumina sequences. Draft genome sequences of nineteen additional <italic>X. translucens</italic> strains, which were collected from wheat or barley in different regions and at different times, were generated by Illumina sequencing. Phylogenetic relationships among different <italic>Xanthomonas</italic> strains indicates that <italic>X. translucens</italic> are members of a distinct clade from so-called group 2 xanthomonads and three pathovars of this species, <italic>undulosa</italic>, <italic>translucens</italic> and <italic>cerealis</italic>, represent distinct subclades in the group 1 clade. Knockout mutation of type III secretion system of XT4699 eliminated the ability to cause water-soaking symptoms on wheat and barley and resulted in a reduction in populations on wheat in comparison to the wild type strain. Sequence comparison of <italic>X. translucens</italic> strains revealed the genetic variation on type III effector repertories among different pathovars or within one pathovar. The full genome sequence of XT4699 reveals the presence of eight members of the Transcription-Activator Like (TAL) effector genes, which are phylogenetically distant from previous known TAL effector genes of group 2 xanthomonads. Microarray and qRT-PCR analyses revealed TAL effector-specific wheat gene expression modulation.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>PacBio long read sequencing facilitates the assembly of <italic>Xanthomonas</italic> genomes and the multiple TAL effector genes, which are difficult to assemble from short read platforms. The complete genome sequence of <italic>X. translucens</italic> pv<italic>. undulosa</italic> strain XT4699 and draft genome sequences of nineteen additional <italic>X. translucens</italic> strains provides a resource for further genetic analyses of pathogenic diversity and host range of the <italic>X. translucens</italic> species complex. TAL effectors of XT4699 strain play roles in modulating wheat host gene expressions.</p>
        </sec>
        <sec>
          <title>Electronic supplementary material</title>
          <p>The online version of this article (doi:10.1186/s12864-015-2348-9) contains supplementary material, which is available to authorized users.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Bacterial leaf streak</kwd>
        <kwd>
          <italic>X. translucens</italic>
        </kwd>
        <kwd>PacBio</kwd>
        <kwd>TAL effectors</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000001</institution-id>
              <institution>National Science Foundation</institution>
            </institution-wrap>
          </funding-source>
          <award-id>IOS-1238189</award-id>
          <principal-award-recipient>
            <name>
              <surname>White</surname>
              <given-names>Frank F.</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
      </funding-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>© The Author(s) 2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Background</title>
      <p>Bacterial pathogens of the genus <italic>Xanthomonas</italic> cause disease symptoms in a wide range of plant species, including many economically important cereal crops [<xref ref-type="bibr" rid="CR1">1</xref>]. The species <italic>X. translucens</italic> represents a complex of strains that are pathogenic on various members of the <italic>Poaceae</italic>, including wheat, barley, oat, rye and other grass species. Bacterial leaf streak (BLS) and black chaff symptoms in the grain spikes on wheat are caused by <italic>X. translucens</italic> pv. <italic>undulosa</italic> strains. Outbreaks of BLS occur sporadically in central Great Plains and are associated with relatively warm and humid conditions, although the disease has been prevalent in recent recurrent years in the northern Great Plains [<xref ref-type="bibr" rid="CR2">2</xref>]. <italic>X. translucens</italic> strains have been classified by pathogenicity types and DNA fingerprinting technologies [<xref ref-type="bibr" rid="CR3">3</xref>]. Strains causing disease symptoms on barley and wheat are named as <italic>X. translucens</italic> pv. <italic>undulosa</italic>, while strains only pathogenic on barley are called <italic>X. translucens</italic> pv. <italic>translucens</italic> [<xref ref-type="bibr" rid="CR4">4</xref>]. Although some strains of <italic>X. translucens</italic> pv. <italic>cerealis</italic> behave similarly as <italic>X. translucens</italic> pv. <italic>undulosa</italic> in pathogenicity types, they are distinguishable by DNA fingerprinting [<xref ref-type="bibr" rid="CR3">3</xref>]. Phylogenic analyses of various <italic>X. translucens</italic>, do not align with the pathovar designations, and clarifications await genomic analyses on larger strain collections. In addition, many strains that were isolated from other species, often have been reported to cause disease symptoms on wheat [<xref ref-type="bibr" rid="CR3">3</xref>]. For example, thirty-three bacterial strains isolated from diseased ornamental asparagus were identified as <italic>X. translucens</italic> pv. <italic>undulosa</italic> using DNA fingerprinting and cross inoculation [<xref ref-type="bibr" rid="CR5">5</xref>].</p>
      <p>Next-generation sequencing technologies have made transformational changes over the Sanger sequencing by improving throughput and reducing cost [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. The draft genome sequences provide valuable information on major genome contents and enable genome comparison among strains of interest [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. Currently, draft genome sequences are available for four strains from the <italic>X. translucens</italic> group. Draft genomic data for <italic>X. translucens</italic> pv. <italic>undulosa</italic> strain DAR61454, <italic>X. translucens</italic> pv. <italic>transluencs</italic> strain DSM18974, <italic>X. translucens</italic> pv. <italic>cerealis</italic> CFBP2541, and <italic>X. translucens</italic> pv. <italic>graminis</italic> ART-Xtg29 were generated by using Illumina or Roche 454 short read sequencing platforms [<xref ref-type="bibr" rid="CR8">8</xref>–<xref ref-type="bibr" rid="CR10">10</xref>]. At the same time, genome assemblies based on Illumina and Roche 454 sequencing are fragmented, and most assemblies failed to assemble complex repetitive sequences, including Transcription Activator-Like (TAL) effector genes, which occur in multiple gene copies and contain multiple simple near-perfect repeats within each gene. TAL effector genes typically have highly conserved N- and C-terminal sequences, and harbor 12.5–28.5 units of 102 or 105 bp repeats in the central regions [<xref ref-type="bibr" rid="CR1">1</xref>]. Recently, a single-molecule real-time (SMRT) sequencing technology was developed by Pacific Bioscience (PacBio) and produces long sequence reads with no obvious sequencing biases and may allow better resolution of long repetitive DNA features in a genome. Due to a high error rate of PacBio reads, a high sequencing depth (e.g., 50× or higher) is usually required for a high-quality <italic>de novo</italic> assembly [<xref ref-type="bibr" rid="CR11">11</xref>–<xref ref-type="bibr" rid="CR13">13</xref>].</p>
      <p>In this study, the complete genome sequence of <italic>X. translucens</italic> pv. <italic>undulosa</italic> strain XT4699 was generated by using high-depth PacBio and Illumina data. The genome was compared to draft genomic sequences of nineteen additional <italic>X. translucens</italic> strains that were derived by Illumina. Comparisons of TAL effectors from three <italic>X. translucens</italic> strains and their relationship with TAL effectors from other <italic>Xanthomonas</italic> species were also performed, and evidence for TAL effector-dependent effects on host gene expression was assessed by microarray and qRT-PCR analyses.</p>
    </sec>
    <sec id="Sec2" sec-type="results">
      <title>Results</title>
      <sec id="Sec3">
        <title>Complete genome assembly of XT4699</title>
        <p>Illumina 2x250 bp MiSeq data for XT4699 provided approximately 60x coverage, comprising 267.5 Mbp total sequencing bases. The assembly <italic>via</italic> SOAPdenov2 resulted in 547 contigs of at least 400 bp in length. The total assembly length was 4.4 Mb and the N50 equals to 15,114 bp. Two PacBio SMRT cells of 10-kb library preparation for XT4699 generated 114,394 raw reads and a total of 446 Mb. The average length of reads was 3,898 bp. The reads were assembled into two long contigs using an optimized assembly pipeline, HGAP2 [<xref ref-type="bibr" rid="CR12">12</xref>]. The longest contig is 4,357,621 bp in length. Two contigs were merged into a single contig <italic>via</italic> combining with Illumina assembled contigs using the minimus2 module in AMOS (sourceforge.net/apps/mediawiki/amos). Alignments of PacBio raw reads to the resulting single contig identified multiple PacBio reads spanning the junction of two original Pacbio contigs, providing additional evidence for the contig merging. Two ends of the resulting single contig shared 8,439 bp with 99.33 % identity. The contig was circularized after removing the sharing sequence at one end. The circularized assembly draft was subjected to an additional two rounds of error correction using the PacBio resequencing pipeline that includes the error correction module [<xref ref-type="bibr" rid="CR12">12</xref>]. Consequently, a single finished genome sequence (<italic>N</italic> = 4,561,137 bp) was obtained (Fig. <xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p>Circular representation of <italic>X. translucens</italic> pv. <italic>undulosa</italic> strain XT4699 genome. The outer histogram (<italic>green</italic>) indicates gene density, while the inner histogram (<italic>blue</italic>) shows the GC content. From the outside to inside, layer 1 indicates the location of, the NRPS genes (<italic>grey</italic>), the T3SS genes cluster (<italic>yellow in a black rectangle</italic>), the genes with PIPs (<italic>blue</italic>), and TAL effector genes (<italic>red</italic>). In layer 2, all non-TAL type III effector genes are marked by orange color, and, in layer 3, IS elements are shown in purple</p></caption><graphic xlink:href="12864_2015_2348_Fig1_HTML" id="MO1"/></fig></p>
        <p>To assess the assembly quality, Illumina reads were mapped to the assembled sequence. 99.53 reads can be mapped and 95.46 % are uniquely mapped with the stringent mapping criteria (see <xref rid="Sec13" ref-type="sec">Methods</xref>). Respectively, 99.99 and 99.44 % of the assembled genome was covered by mapping reads and uniquely mapped reads. Based on the alignments, no mismatches were identified between reads and the assembled genome (see <xref rid="Sec13" ref-type="sec">Methods</xref>), indicating the high quality of the assembly sequence. The Illumina-only assembly contigs were also aligned <italic>via</italic> nucmer [<xref ref-type="bibr" rid="CR14">14</xref>] to the final assembly, and approximately 97 % of the final assembly was covered by the Illumina contigs. Of the 547 contigs, 98.54 % (539/547), accounting for 99.77 % total contig sequence, can be aligned to the sequence with four exceptions (see <xref rid="Sec13" ref-type="sec">Methods</xref>). Four single nucleotide variants, including two substitutions and two INDELs (insertion-and-deletions), were identified between the Illumina assembly contigs and the final assembly (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1). To assess the quality of the assembly in the repetitive regions, the eight TAL effector genes were cloned by high fidelity PCR and sequenced using the standard Sanger protocol. All the Sanger sequences were perfectly matched to the assembled genome sequence with 100 % identity (Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S2).</p>
      </sec>
      <sec id="Sec4">
        <title>XT4699 genome content</title>
        <p>The XT4699 genome is a single circular chromosome (4,561,137 bp) with an overall G + C content of 68.1 %. The complete genome, as annotated by the NCBI Prokaryotic Genome Automatic Annotation Pipeline (PGAAP), contains 3,528 coding DNA sequence (CDS) genes, 94 pseudogenes, and 54 genes with frameshift mutation that alters open reading frame. XT4699 has 2 ribosomal RNA operons and 54 tRNA genes. The genome contains 74 predicted insertion sequence (IS) elements and 56 partial IS elements using the ISfinder program (Table <xref rid="Tab1" ref-type="table">1</xref>). The genome encodes three long non-ribosomal peptide synthesis (NRPS) proteins of 4827, 7451, and 6419 amino acids, respectively, in a cluster of 80 kb regions flanked by IS elements (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). A plant inducible promoter (PIP) element is present in 49 genes, including some type III secretion system (Hrp) and effector genes (Fig. <xref rid="Fig1" ref-type="fig">1</xref>, Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Table S3).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Genome features of <italic>X. translucens</italic> pv. <italic>undulosa</italic> strain XT4699</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Features</th><th>Values</th></tr></thead><tbody><tr><td>Genome size (bp)</td><td>4,561,137</td></tr><tr><td>GC content (%)</td><td>68.1</td></tr><tr><td>Number of predicted CDS genes</td><td>3528</td></tr><tr><td>Pseudogenes</td><td>94</td></tr><tr><td>Genes with frameshift</td><td>54</td></tr><tr><td>TAL effector genes</td><td>8</td></tr><tr><td>Non-TAL T3E genes</td><td>32</td></tr><tr><td>rRNA operons</td><td>2</td></tr><tr><td>tRNA</td><td>54</td></tr><tr><td>CRISPR array</td><td>Not detected</td></tr><tr><td>PIP genes</td><td>49</td></tr><tr><td>Insertion sequence elements (complete/partial)</td><td>74/56</td></tr></tbody></table></table-wrap></p>
        <p>The XT4699 genome consists of 4.3 %, or approximately 0.2 Mb, of repetitive sequence. Among 252 genomic repetitive regions, 163 repeats are less than 1 kb and 89 repeats are longer than 1 kb. The longest repeats, located around FD63_00725 and FD63_01915 ribosome RNA genes, are approximately 6 kb with the 99.98 % identity between two copies. Eleven pairs of tandem repeats were identified, ranging in size from 107 to 537 bp. In terms of copy number, 42.5 of the repeats have two copies and 57.5 % repeats have three or more copies. Tandem repeats and high copy repeats (&gt;2) increase the complexity of the assembly. In the Illumina-based assembly, more than 90 % of the tandem repeats occurred at assembly gaps, even when relatively short (115–375 bp), and the vast majority of high-copy repeats were not resolved. With one exception, repetitive regions with length greater than 500 bp were not resolved in the Illumina-based assembly. Overall, 40 % of the gaps in the Illumina-only assembly were located at repetitive regions.</p>
        <p>The overall GC percentage of the XT4699 final assembly is 68.1 %, while the overall GC percentage of the Illumina-only assembly is 67.2 %, indicating GC-rich regions are not equally represented in the Illumina-based assembly. To assess Illumina and PacBio sequence results for GC-rich regions, the final assembly genome was scanned with non-overlapping 200 bp windows, and the GC% and sequencing coverage of both Illumina and PacBio sequences were determined at each window. Scatter plots showed a GC bias in sequencing coverage of Illumina but not PacBio, which at least partially explains high variation of Illumina sequencing coverage and uniform distribution of PacBio sequencing reads across the genome (Additional file <xref rid="MOESM4" ref-type="media">4</xref>: Figure S1). The vast majority (50/55) of extremely high GC regions, which exhibit &gt; 80 % GC content, overlap with assembly gaps in the Illumina-only assembly. Most gaps on GC rich regions are very small (&lt;100 bp). The flanking contigs of many of these gaps have overlaps, but the overlapping sequences between two adjacent contigs are not long enough to join them. On the contrary, gaps caused by repeats are generally longer than GC-rich gaps. The sizes of repeat-induced gaps are linearly correlated with repeat sizes (Additional file <xref rid="MOESM5" ref-type="media">5</xref>: Figure S2). Regardless of gaps in the Illumina-only assembly, the contig sequences exhibit high accuracy when compared with the final assembly (Additional file <xref rid="MOESM4" ref-type="media">4</xref>: Figure S1).</p>
      </sec>
      <sec id="Sec5">
        <title>Phylogenetic relationship and pathogenicity types of <italic>X. translucens</italic> strains</title>
        <p>Genome assembly using Illumina 2x250 bp reads for other 19 <italic>X. translucens</italic> strains was performed with contigs having 70–200x coverage. The N50, assembled genome size, maximum contig length, and contig number of each assembly are shown in Table <xref rid="Tab2" ref-type="table">2</xref>. Consistent with the classification results from previous studies [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>], multilocus sequence analysis (MLSA) revealed the <italic>X. translucens</italic> strains were closer to <italic>X. albilineans</italic> in xanthomonad group 1 than <italic>X. oryzae</italic> and <italic>X. campestris</italic> in group 2 (Fig. <xref rid="Fig2" ref-type="fig">2a</xref>). The <italic>X. translucens</italic> pv. <italic>undulosa</italic> strains, XT4699, XT-Rocky, LB10, P3, LG48, and DAR61454, which are all virulent on both wheat and barley, were separated from the <italic>X. translucens</italic> pv. <italic>translucens</italic> strains XT8, B1, B2 and DSM18974, which are only virulent on barley. In addition, the above strains were distinguishable from the <italic>X. translucens</italic> pv. <italic>cerealis</italic> strains CFBP2541 and XT123, and <italic>X. translucens</italic> pv. <italic>graminis</italic> ART-Xtg29, which is consistent with previous phylogenetic classifications based on AFLP analysis [<xref ref-type="bibr" rid="CR3">3</xref>]. The phylogenetic tree developed by a whole genome SNP comparison further corroborated MLSA results, providing higher resolution of evolutionary relationship among closely related strains (Fig. <xref rid="Fig2" ref-type="fig">2b</xref>, Additional file <xref rid="MOESM6" ref-type="media">6</xref>: Table S4). Strains LG54, XT5523, XT-Rocky, CS2, CS22, LB10, and DAR61454 are highly related, although they were isolated from different geographic origins and at different times (Table <xref rid="Tab2" ref-type="table">2</xref>). The strains have near identical housekeeping genes, ranging from 2 to 17 SNPs in individual strains out of a total of 9,836 SNPs among the strains (Additional file <xref rid="MOESM6" ref-type="media">6</xref>: Table S4). XT4699 and LG48 are another pair of highly related strains on the basis of MLSA and the whole genome SNP comparison (Fig. <xref rid="Fig2" ref-type="fig">2</xref>).<table-wrap id="Tab2"><label>Table 2</label><caption><p>Information of bacterial isolation, pathogenicity type and genome assembly statistics for <italic>X. translucens</italic> strains</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Strain name</th><th colspan="3">Isolation</th><th rowspan="2">Pathogenicity type<sup>c</sup>
</th><th colspan="4">Assembly statistics</th></tr><tr><th>Year</th><th>Host origin</th><th>Place</th><th>Contig number</th><th>Genome size (bp)</th><th>N50 (bp)</th><th>Maximum contig length (bp)</th></tr></thead><tbody><tr><td colspan="9">Strains used in this study</td></tr><tr><td> XT-4699<sup>a</sup>
</td><td>1999</td><td>Wheat</td><td>KS,USA</td><td>A</td><td>1</td><td>4,561,137</td><td>NA</td><td>NA</td></tr><tr><td> XT-Rocky</td><td>2009</td><td>Wheat</td><td>KS,USA</td><td>A</td><td>521</td><td>4,459,068</td><td>21,643</td><td>85,632</td></tr><tr><td> XT8</td><td>1942</td><td>Barley</td><td>Canada</td><td>B</td><td>152</td><td>4,617,556</td><td>79,563</td><td>279,321</td></tr><tr><td> XT123</td><td>1952</td><td>Barley</td><td>Canada</td><td>A</td><td>344</td><td>4,284,749</td><td>28,687</td><td>135,676</td></tr><tr><td> XT130</td><td>1939</td><td>NA</td><td>Canada</td><td>A</td><td>329</td><td>4,654,290</td><td>95,229</td><td>230,109</td></tr><tr><td> XT5523<sup>b</sup>
</td><td>1966</td><td>Wheat</td><td>Canada</td><td>A</td><td>330</td><td>4,665,768</td><td>111,158</td><td>270,930</td></tr><tr><td> XT5770</td><td>NA</td><td>NA</td><td>Canada</td><td>A</td><td>533</td><td>4,617,837</td><td>27,152</td><td>149,044</td></tr><tr><td> XT5791</td><td>1969</td><td>Wheat</td><td>Canada</td><td>A</td><td>738</td><td>4,719,363</td><td>62,926</td><td>185,369</td></tr><tr><td> B1</td><td>2013</td><td>Barley</td><td>ND,USA</td><td>B</td><td>642</td><td>4,824,098</td><td>28,186</td><td>96,565</td></tr><tr><td> B2</td><td>2013</td><td>Barley</td><td>ND,USA</td><td>B</td><td>283</td><td>4,503,259</td><td>38,929</td><td>154,569</td></tr><tr><td> P3</td><td>2009</td><td>Wheat</td><td>ND,USA</td><td>A</td><td>161</td><td>4,522,131</td><td>78,928</td><td>240,099</td></tr><tr><td> LW16</td><td>2009</td><td>Wheat</td><td>ND,USA</td><td>A</td><td>325</td><td>4,600,125</td><td>33,769</td><td>145,918</td></tr><tr><td> LB5</td><td>2009</td><td>Wheat</td><td>ND,USA</td><td>A</td><td>434</td><td>4,766,161</td><td>111,172</td><td>269,877</td></tr><tr><td> LB10</td><td>2009</td><td>Wheat</td><td>ND,USA</td><td>A</td><td>157</td><td>4,543,985</td><td>98,403</td><td>211,728</td></tr><tr><td> LG48</td><td>2009</td><td>Wheat</td><td>ND,USA</td><td>A</td><td>293</td><td>4,486,555</td><td>38,250</td><td>111,281</td></tr><tr><td> LG54</td><td>2009</td><td>Wheat</td><td>ND,USA</td><td>A</td><td>213</td><td>4,623,672</td><td>123,210</td><td>274,463</td></tr><tr><td> CS2</td><td>2009</td><td>Wheat</td><td>ND,USA</td><td>A</td><td>285</td><td>4,722,832</td><td>85,714</td><td>207,734</td></tr><tr><td> CS22</td><td>2009</td><td>Wheat</td><td>ND,USA</td><td>A</td><td>129</td><td>4,605,395</td><td>95,219</td><td>274,395</td></tr><tr><td> CR31</td><td>2009</td><td>Wheat</td><td>ND,USA</td><td>A</td><td>386</td><td>4,720,715</td><td>62,461</td><td>158,913</td></tr><tr><td> CS4</td><td>2009</td><td>Wheat</td><td>ND,USA</td><td>A</td><td>498</td><td>4,779,534</td><td>37,460</td><td>107,554</td></tr><tr><td colspan="9">Strains from references</td></tr><tr><td> CFBP2541<sup>b</sup>
</td><td>1941</td><td>Bromegrass</td><td>USA</td><td>A</td><td>31</td><td>4,515,938</td><td>1,399,657</td><td>1,809,000</td></tr><tr><td> DSM18974<sup>b</sup>
</td><td>1933</td><td>Barley</td><td>MN,USA</td><td>B</td><td>551</td><td>4,463,577</td><td>13,041</td><td>55,714</td></tr><tr><td> DAR61454</td><td>1988</td><td>Wheat</td><td>Australia</td><td>A</td><td>404</td><td>4,452,091</td><td>27,210</td><td>121,856</td></tr><tr><td> ART-Xtg29</td><td>NA</td><td>Forage grass</td><td>Switzerland</td><td>C</td><td>788</td><td>4,100,864</td><td>8376</td><td>37,754</td></tr></tbody></table><table-wrap-foot><p>NA means not available or not applicable</p><p>
<sup>a</sup>indicates genome assembly with PacBio long-read sequencing</p><p>
<sup>b</sup>Type strains </p><p>
<sup>c</sup>Strains virulent on wheat and barley are classified as pathogenicity type A, strains virulent only on barley are considered as type B and strains virulent on forage grass are assigned to type C</p></table-wrap-foot></table-wrap><fig id="Fig2"><label>Fig. 2</label><caption><p>Phylogenetic trees. <bold>a</bold> Phylogenetic tree in the genus of <italic>Xanthomonas</italic> using MLSA. Nucleotide sequence of four concatenated housekeeping genes (<italic>DnaK</italic>, <italic>gyrB</italic>, <italic>GroEL</italic> and <italic>RecA</italic>) was extracted from the draft or complete genomes. The tree was constructed by applying all the concatenated sequences into Geneious software Version 6 with the Tamura-Nei genetic distance model and the Neighbor-joining method, with <italic>Stenotrophomonas maltophilia</italic> K279a as an outgroup. The scale bar indicates number of nucleotide substitutions per site. The dark red represents <italic>undulosa</italic> pathovars, the green color indicates the <italic>translucens</italic> pathovar and the yellow color represents the <italic>cerealis</italic> pathovars; <bold>b</bold> Phylogenetic tree of <italic>X. translucens</italic> strains using whole-genome discovery of SNP. The scale bar indicates number of nucleotide substitutions per site. Details are described in Methods</p></caption><graphic xlink:href="12864_2015_2348_Fig2_HTML" id="MO2"/></fig></p>
        <p>Based on previous pathogenicity tests, <italic>X. translucens</italic> strains have been grouped into type A, pathogenic on both wheat and barley, type B, only pathogenic on barley, and type C, not pathogenic on either [<xref ref-type="bibr" rid="CR3">3</xref>]. Though strains from <italic>X. translucens</italic> pv. <italic>undulosa</italic> and <italic>X. translucens</italic> pv. <italic>cerealis</italic> are classified as pathogenicity type A, they are distant in the phylogenetic relationship (Fig. <xref rid="Fig2" ref-type="fig">2</xref>). Here, cultivars other than ‘Alondra’ wheat and ‘Corona’ barley were tested to determine possible pathogenicity differences between strains from each subgroup. Three representative strains, XT4699 (<italic>X. translucens</italic> pv. <italic>undulosa</italic>), XT8 (<italic>X. translucens</italic> pv. <italic>translucens</italic>) and XT123 (<italic>X. translucens</italic> pv. <italic>cerealis</italic>), from each subgroup were selected and inoculated on ‘Chinese Spring’, ‘Jagger’, ‘Hope’ and ‘Canthatch’ hexaploid wheat, one <italic>Triticum turgidum</italic> wheat (accession number 107 in WGRC at Kansas State University), ‘KS Southeast’ and ‘Morex’ barley. XT4699 induced water-soaking symptoms on ‘Chinese Spring’, ‘Jagger’, ‘Hope’, ‘Canthatch’ wheat and ‘KS Southeast’ barley, while inducing mixed symptoms of chlorosis and water soaking on ‘Morex’ barley. XT123 only triggered chlorosis symptoms at 4 DPI on ‘Chinese Spring’, ‘Jagger’, ‘Hope’ wheat and ‘KS Southeast’, and ‘Morex’ barley (Additional file <xref rid="MOESM7" ref-type="media">7</xref>: Figure S3). Though XT123 could cause water-soaking on ‘Canthatch’ and <italic>Triticum turgidum</italic> wheat cultivars, the strain exhibited different lesion symptoms from XT4699 (Additional file <xref rid="MOESM7" ref-type="media">7</xref>: Figures S3F and S3G). XT8 caused strong water soaking symptoms on ‘KS Southeast’ barley and less severe water soaking lesions on ‘Morex’ barley, while only inducing chlorosis on all the wheat cultivars (Additional file <xref rid="MOESM7" ref-type="media">7</xref>: Figure S3).</p>
      </sec>
      <sec id="Sec6">
        <title>CRISPR clusters are present in most <italic>X. translucens</italic> strains</title>
        <p>Clustered regularly interspaced short palindromic repeat (CRISPR) and CRISPR-associated genes (<italic>Cas</italic>) comprise an adaptive bacterial immune system against foreign DNA [<xref ref-type="bibr" rid="CR15">15</xref>]. The spacer sequences between repeats in the CRISPR loci typically correspond to sequences of perfect copies, called proto-spacer, of sequences in foreign DNA elements and direct the their cleavage [<xref ref-type="bibr" rid="CR16">16</xref>]. The sequencing and monitoring of repeat and spacer array of CRISPR in strains provides insight into the coevolution relationship between strains and invader phage DNA. The DNA elements of CRISPR loci contain a record of past immunity events and can reveal relationships between closely related strains and populations [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>].</p>
        <p>Genomic sequence data of the <italic>X. translucens</italic> strains in this study and previously sequenced strains revealed CRISPR loci are present in most <italic>X. translucens</italic> strains, except for XT4699, LG48, and XT123. If present, only one CRISPR locus is found in each strain. The CRISPR loci are often flanked by transposon gene elements. Annotation of CRISPR <italic>Cas</italic> genes of all <italic>X. translucens</italic> strains and <italic>X. oryzae</italic> pv. <italic>oryzae</italic> strain PXO99 indicates that the strains belong to the Type I-C (Dvulg or CASS1) in the classification of CRISPR-Cas systems [<xref ref-type="bibr" rid="CR19">19</xref>]. The phylogenetic relationship, based on the nucleotide sequences of <italic>Cas</italic> gene clusters, among these strains is different from the MLSA and whole genome SNP comparisons (Fig. <xref rid="Fig2" ref-type="fig">2</xref>, Additional file <xref rid="MOESM8" ref-type="media">8</xref>: Figure S4), suggesting the evolution of CRISPR-Cas system is somewhat independent of genome evolution. LW16 and CS4 strains are special variants in this subtype, harboring two <italic>Cas3</italic> helicase genes, while other strains only have one. The sequence of direct repeats in the CRISPR loci is conserved among <italic>X. oryzae</italic> pv. <italic>oryzae</italic> strain PXO99 and <italic>X. translucens</italic> strains, although CRISPR <italic>Cas</italic> loci are distinct.</p>
        <p>The comparison of spacer elements among strains revealed that <italic>X. translucens</italic> pv. <italic>undulosa</italic> and <italic>X. translucens</italic> pv. <italic>translucens</italic> have distinct spacers, with the exception that <italic>X. translucens</italic> pv. <italic>undulosa</italic> strain P3. P3 shares twenty-three identical spacers with <italic>X. translucens</italic> pv. <italic>translucens</italic> strain B1, while harboring no identical spacer element with any other <italic>X. translucens</italic> pv. <italic>undulosa</italic> strain. Strains P3 and B1, though distinct in phylogeny and pathogenicity types, may have experienced an overlapping history of immunity or, alternatively, the strains have acquired the CRISPR elements by lateral gene transfer. <italic>X. translucens</italic> pv. <italic>translucens</italic> strains XT8 and B2 have closely related CRISPR <italic>Cas</italic> loci and share fifty-five identical spacers (Fig. <xref rid="Fig3" ref-type="fig">3a</xref>, Additional file <xref rid="MOESM8" ref-type="media">8</xref>: Figure S4). LW16 and CS4 share thirty-two identical spacers, the highest observed among <italic>X. translucens</italic> pv. <italic>undulosa</italic> strains (Fig. <xref rid="Fig3" ref-type="fig">3b</xref>). Although the older spacer elements in the <italic>X. translucens</italic> strains are shared among some strains, the most recently acquired spacer sequences are unique to each strain. (Fig. <xref rid="Fig3" ref-type="fig">3</xref>). However, nine strains, XT-Rocky (collected from KS in 2009), XT5523 (collected from Canada in 1966), LG54, CR31, CS2, CS22, LB5, LB10 (collected from ND in 2009) and DAR61454 (collected from Australia in 1988), share identical elements of <italic>Cas</italic> cluster, repeats, and spacer array (Fig. <xref rid="Fig3" ref-type="fig">3b</xref>), implying that CRISPR <italic>Cas</italic> loci can be maintained over decades. The spacer sequences of <italic>X. translucens</italic> pv. <italic>cerealis</italic> CFBP2541 and <italic>X. translucens</italic> pv. <italic>graminis</italic> ART-Xtg29 strains were not detected in any other <italic>X. translucens</italic> strains.<fig id="Fig3"><label>Fig. 3</label><caption><p>Spacer comparison among different <italic>X. translucens</italic> strains. The leader sequence, spacer and direct repeat sequence are analyzed at <ext-link ext-link-type="uri" xlink:href="http://crispr.u-psud.fr/Server/">http://crispr.u-psud.fr/Server/</ext-link>. The identical spacer elements are linked together by blue lines. The strains of <italic>undulosa</italic> pathovar and <italic>translucens</italic> pathovar are marked with dark red and green, respectively. There is no identical spacer between panel (<bold>a</bold>) and (<bold>b</bold>). The XT-Rocky…DAR61454 represents 9 strains of LG54, XT5523, XT-Rocky, CR31, CS2, CS22, LB5, LB10 and DAR61454, which share the same <italic>Cas</italic> genes, leader sequence, direct repeat and spacer arrays</p></caption><graphic xlink:href="12864_2015_2348_Fig3_HTML" id="MO3"/></fig></p>
      </sec>
      <sec id="Sec7">
        <title>The type III secretion system of <italic>X. translucens</italic></title>
        <p>Comparative genomics have previously revealed extensive divergence of the type III secretion system (T3SS) between group 1 and group 2 of <italic>Xanthomonas</italic> species [<xref ref-type="bibr" rid="CR9">9</xref>]. <italic>X. albilineans</italic> does not possess the T3SS, which is usually present and crucial for pathogenicity in group 2 <italic>Xanthomonas</italic> species [<xref ref-type="bibr" rid="CR20">20</xref>]. Disruption of the T3SS in <italic>X. translucens</italic> pv. <italic>graminis</italic> strain ART-Xtg29 did not eliminate disease symptoms, and the survival of T3SS mutants inside of plant tissue was reported to be unaffected when compared to the wild type strain up to 14 days post infection (DPI) [<xref ref-type="bibr" rid="CR9">9</xref>]. The T3SS gene clusters in XT4699 and ART-Xtg29 strains are syntenic but have lower sequence identity in T3SS proteins compared to the identity between <italic>X. translucens</italic> pv. <italic>undulosa</italic> strains (Additional file <xref rid="MOESM9" ref-type="media">9</xref>: Figure S5). An insertion mutant of the conserved component gene <italic>hrcC</italic> in XT4699 (XT4699<italic>hrcC</italic><sup><italic>−</italic></sup>) resulted in loss of disease symptoms on ‘Chinese Spring’ wheat on the basis of water-soaking lesions, which were not visible by 10 DPI in the mutant, while wild type XT4699 caused extensive water-soaked lesion starting at 3 DPI (Fig. <xref rid="Fig4" ref-type="fig">4a</xref>). Re-introduction of the native <italic>hrcC</italic> gene into the mutant strain fully complemented the loss of disease symptoms (Fig. <xref rid="Fig4" ref-type="fig">4a</xref>). Using an alternative dip inoculation assay, no disease was present 10 DPI for XT4699<italic>hrcC</italic><sup><italic>−</italic></sup>, while the disease spots appeared at 4–5 DPI for the XT4699 (Fig. <xref rid="Fig4" ref-type="fig">4b</xref>). The ability to cause disease symptoms on barley was also lost in XT4699<italic>hrcC</italic><sup><italic>−</italic></sup>. Two different barley cultivars, ‘KS Southeast’ and ‘Morex’, were used in the inoculation assays. XT4699 formed sharply delineated water-soaked lesions and a mixed symptom of chlorosis and water soaking at 3 DPI on ‘KS Southeast’ and ‘Morex’, respectively, while XT4699<italic>hrcC</italic><sup><italic>−</italic></sup> failed to develop symptoms on either cultivar (Additional file <xref rid="MOESM7" ref-type="media">7</xref>: Figures S3B and S3C). In addition, XT4699<italic>hrcC</italic><sup><italic>−</italic></sup> failed to trigger a hypersensitive reaction (HR) and strong chlorosis on non-host KY14 tobacco, while the XT4699 and the <italic>hrcC</italic><sup><italic>−</italic></sup> complementation strains did induce an HR (Fig. <xref rid="Fig4" ref-type="fig">4c</xref>). Bacterial population assays in ‘Chinese Spring’ wheat indicated that the XT4699<italic>hrcC</italic><sup><italic>−</italic></sup> population was lower by approximately 450 fold in comparison to XT4699 at 6DPI (Additional file <xref rid="MOESM10" ref-type="media">10</xref>: Figure S6).<fig id="Fig4"><label>Fig. 4</label><caption><p>Phenotypic difference between XT4699 and <italic>hrcC</italic>
<sup>−</sup> mutant. Panel <bold>a</bold>, third leaves of one-month-old Chinese Spring wheat plants were separately inoculated with XT4699, water, <italic>hrcC</italic>
<sup>−</sup> and complementation strain of <italic>hrcC</italic>
<sup>−</sup> by needleless syringe. The photo was taken at 4DPI. <bold>b</bold> WT and <italic>hrcC</italic>
<sup>−</sup> (OD600 = 0.2) strains were coated with 0.02 % Silwet L-77 and applied for the dip inoculation assays. Second leaves of 14-day-old Chinese Spring wheat plants were used for experiment. The photo was taken at 8DPI. C, the same inoculum, as in panel <bold>a</bold>, was infiltrated into leaves of two-month-old KY-14 tobacco plants. It was photographed at 8DPI</p></caption><graphic xlink:href="12864_2015_2348_Fig4_HTML" id="MO4"/></fig></p>
      </sec>
      <sec id="Sec8">
        <title>Type III effector gene content</title>
        <p>Thirty-nine putative type III effectors (T3Es) genes were predicted from the genomic data, not including TAL effector genes, from diverse <italic>X. translucens</italic> strains (Fig. <xref rid="Fig5" ref-type="fig">5</xref>). Among them, twenty-three T3Es are conserved among the <italic>X. translucens</italic> pv. <italic>undulosa</italic>, <italic>X. translucens</italic> pv. <italic>translucens</italic>, and <italic>X. translucens</italic> pv. <italic>cerealis</italic>. The core set of T3Es includes AvrBs2, XopF, XopK, XopL, XopN, XopP, XopQ, XopR, XopX and XopZ, with the exception of two <italic>X. translucens</italic> pv. <italic>cerealis</italic> strains, which have frameshift mutation in XopR. Multiple copies of <italic>avrBs2, xopF, xopX, xopL</italic> and <italic>xopP</italic> are found in all three <italic>X. translucens</italic> pathovars, while strains from group 2 <italic>Xanthomonas</italic> species only harbor one.<fig id="Fig5"><label>Fig. 5</label><caption><p>Comparison of Type III effector repertories among four pathovars of <italic>X. translucens</italic>. Fifteen effectors (from HapH to XopAM), marked with gray color, are predicted to be conserved among <italic>undulosa</italic>, <italic>translucens</italic> and <italic>cerealis</italic> pathovars, while seventeen remaining effectors (from AvrBs1 to XopAP), marked with blue color, are shown to be variable among strains. Single copy of an effector is indicated by ‘+’ and multiple copies are indicated by multiple ‘+’. An effector that is not detected is indicated as ‘ND’. The frameshift mutation in an effector gene is marked with ‘F’ and highlighted with red box. The number of TAL effectors in each strain is predicted if a full genome or high quality draft genome available, or by Southern blot analysis. The blank indicates that the number of TAL effector genes is unknown</p></caption><graphic xlink:href="12864_2015_2348_Fig5_HTML" id="MO5"/></fig></p>
        <p>Effector composition varies between different and within pathovars. The presence and absence, copy number difference, and frameshift in coding sequences of T3E genes were observed (Fig. <xref rid="Fig5" ref-type="fig">5</xref>). The gene <italic>avrBs1</italic> is present in only <italic>X. translucens</italic> pv. <italic>undulosa</italic> strain CS4 and both <italic>X. translucens</italic> pv. <italic>cerealis</italic> strains. The <italic>xopJ1</italic> effector gene is present in XT5523, XT-Rocky, XT5770, and DAR61454, but absent in XT4699, LG48, LW16, and XT5791. The gene <italic>xopJ1</italic> is present in all four <italic>X. translucens</italic> pv. <italic>translucens</italic> strains but not in either of <italic>X. translucens</italic> pv. <italic>cerealis</italic> strains. The <italic>xopAH</italic> and <italic>xopAK</italic> genes are present in all <italic>X. translucens</italic> pv. <italic>undulosa</italic> and <italic>X. translucens</italic> pv. <italic>translucens</italic> strains but not in either of <italic>X. translucens</italic> pv. <italic>cerealis</italic> strains. Five different <italic>xopE</italic> effector genes are present in the four pathovars. All <italic>X. translucens</italic> pv. <italic>undulosa</italic> strains have <italic>xopE1</italic> and <italic>xopE5</italic>, and <italic>X. translucens</italic> pv. <italic>translucens</italic> strains harbor <italic>xopE2</italic> and <italic>xopE3</italic>, while <italic>X. translucens</italic> pv. <italic>cerealis</italic> strains have <italic>xopE1</italic>, <italic>xopE2</italic> and <italic>xopE5</italic>. The <italic>X. translucens</italic> pv. <italic>graminis</italic> strain Xtg29 has <italic>xopE1</italic>, <italic>xopE2</italic> and <italic>xopE4</italic>. Besides the difference on the presence and absence of T3Es, variability in gene copy number exists among pathovars or within a pathovar. Two <italic>xopAF</italic> in <italic>X. translucens</italic> pv. <italic>undulosa</italic> strains DAR61454, XT-Rocky, XT5523, and XT4699, but only one copy in <italic>X. translucens</italic> pv. <italic>undulosa</italic> strains LW16, CS4, and XT5791. All four <italic>X. translucens</italic> pv. <italic>translucens</italic> strains have two copies of <italic>xopAF,</italic> while <italic>X. translucens</italic> pv. <italic>cerealis</italic> strains harbor one. Two copies of <italic>xopL</italic> are present in all <italic>X. translucens</italic> pv. <italic>undulosa</italic> and <italic>X. translucens</italic> pv. <italic>translucens</italic> strains, while there are four copies in <italic>X. translucens</italic> pv. <italic>cerealis</italic> strains. Two copies of <italic>xopP</italic> are present in <italic>X. translucens</italic> pv. <italic>undulosa</italic> strains, and three copies in <italic>X. translucens</italic> pv. <italic>translucens</italic> and <italic>X. translucens</italic> pv. <italic>cerealis</italic> strains with the exception that <italic>X. translucens</italic> pv. <italic>translucens</italic> strain B1 only has two <italic>xopP</italic> genes Four <italic>X. translucens</italic> pv. <italic>undulosa</italic> strains have frameshift mutations in one <italic>xopP</italic>. Consistent with a previous study on T3E genes in <italic>X. axonopodis</italic> pv. <italic>manihotis</italic> [<xref ref-type="bibr" rid="CR21">21</xref>], frameshift mutations of T3Es is not rare in <italic>X. translucens</italic> strains. Frameshifts in the coding sequence of one <italic>avrBs2</italic> is present in <italic>X. translucens</italic> pv. <italic>undulosa</italic> strain P3. Two <italic>X. translucens</italic> pv. <italic>cerealis</italic> strains have frameshift mutations in <italic>xopR</italic> compared to <italic>X. translucens</italic> pv. <italic>undulosa</italic> and <italic>X. translucens</italic> pv. <italic>translucens</italic> strains. All four <italic>X. translucens</italic> pv. <italic>translucens</italic> strains harbor frameshift mutations in <italic>xopAP</italic> compared to <italic>X. translucens</italic> pv. <italic>undulosa</italic> and <italic>X. translucens</italic> pv. <italic>cerealis</italic> strains (Fig. <xref rid="Fig5" ref-type="fig">5</xref>).</p>
      </sec>
      <sec id="Sec9">
        <title>TAL effector gene content</title>
        <p>Eight TAL effector genes were identified in XT4699. The number and lengths of TAL effector genes of XT4699 were confirmed by DNA Southern hybridization, in which the size of <italic>Bam</italic>HI fragments with TAL effector genes was consistent with the size of blotted bands (Additional file <xref rid="MOESM11" ref-type="media">11</xref>: Figure S7). Moreover, Sanger sequences of all eight TAL effector genes cloned by PCR with high fidelity polymerase were identical to the sequences of corresponding TAL genes in the assembly genome of XT4699 (Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S2).</p>
        <p>Four TAL effector genes from strain XT-Rocky were cloned and sequenced. Alignment of the predicted TAL effector proteins as represented by the repeat variable di-residues (RVDs) indicated that all the four of the TAL effectors that were retrieved from strain XT-Rocky were identical to corresponding TAL effectors from XT4699 except XTRocky-3E3 effector had variation in the last 5 RVDs and one RVD in the 7<sup>th</sup> repeat compared to XT4699-Tal6 (Fig. <xref rid="Fig6" ref-type="fig">6</xref>). Two TAL effector genes from the <italic>X. translucens</italic> pv. <italic>cerealis</italic> strain CFBP2541 were previously identified [<xref ref-type="bibr" rid="CR10">10</xref>]. TAL effector genes were not identified in the genome of <italic>X. translucens</italic> pv. <italic>graminis</italic> ART-Xtg29 strain [<xref ref-type="bibr" rid="CR9">9</xref>]. The sequences of all RVDs available from these three strains reveal unusual RVDs, including YD, YK, QD, KG, Y*, NF, KI and GI, which are rarely or not found in <italic>X. oryzae</italic> and <italic>X. campestris</italic> strains of group 2 xanthomonads (Fig. <xref rid="Fig6" ref-type="fig">6</xref>, Additional file <xref rid="MOESM12" ref-type="media">12</xref>: Table S5). In addition, sequences of 32<sup>nd</sup>-35<sup>th</sup> amino acids of repeats in TAL effectors in <italic>X. translucens</italic> are variable. Also, both 34 and 35 amino acids predicted repeats were observed within most individual TAL effectors (Additional file <xref rid="MOESM12" ref-type="media">12</xref>: Table S5). XT4699-Tal4 is distant from other TAL effectors in <italic>X. translucens</italic> based on the phylogenetic relationship of N- and C-terminal amino acid sequences (Fig. <xref rid="Fig7" ref-type="fig">7</xref>). TAL effectors in <italic>X. translucens</italic> strains are more closely to the AvrBs3 and PthXo1 of group 2 xanthomonads than Brg11 in <italic>Ralstonia solanacearum</italic> GMI1000 (Fig. <xref rid="Fig7" ref-type="fig">7</xref>, Additional file <xref rid="MOESM13" ref-type="media">13</xref>: Figure S8). The two TAL effectors from <italic>X. translucens</italic> pv. <italic>cerealis</italic> strain CFBP2541 are distinct from TAL effectors of <italic>X. translucens</italic> pv. <italic>undulosa</italic> strains in both RVD alignment and homology of N- and C-terminal amino acid (Figs. <xref rid="Fig6" ref-type="fig">6</xref> and <xref rid="Fig7" ref-type="fig">7</xref>). The XT4699 genome annotation shows that most TAL effector genes are flanked by transposon elements (Additional file <xref rid="MOESM14" ref-type="media">14</xref>: Figure S9).<fig id="Fig6"><label>Fig. 6</label><caption><p>Alignment of RVDs of TAL effectors of <italic>X. translucens</italic> strains. The unusual RVDs are marked with red color. The RVDs of repeats with 34 amino acids are marked with gray color. The missing 13<sup>th</sup> amino acid in the repeat is represented by *. The conserved TAL effector Tal7 is marked with green color. Variable RVDs among highly similar TAL effectors are underlined</p></caption><graphic xlink:href="12864_2015_2348_Fig6_HTML" id="MO6"/></fig><fig id="Fig7"><label>Fig. 7</label><caption><p>Phylogenetic tree of the concatenated N-terminal and C-terminal amino acid sequences of TAL effectors. The tree was constructed with the Tamura-Nei genetic distance model and the Neighbor-joining method, with Brg11 TAL effector from <italic>Ralstonia solanacearum</italic> GMI1000 as an outgroup using Geneious software. The scale bar with 0.02 indicates number of nucleotide substitutions per site</p></caption><graphic xlink:href="12864_2015_2348_Fig7_HTML" id="MO7"/></fig></p>
        <p>Primer pairs used for amplification of the TAL genes in XT4699 were applied for eleven other <italic>X. translucens</italic> pv. <italic>undulosa</italic> strains to identify potentially conserved TAL effector genes in <italic>X. translucens</italic> pv. <italic>undulosa</italic>. PCR fragments with similar sizes to <italic>tal7</italic> of XT4699 were present in 7 of 11 strains and sequencing of four representative genes showed the same RVDs as XT4699-Tal7 except for one amino acid variation in corresponding TAL effectors of both CS4 and LB5 (Fig. <xref rid="Fig6" ref-type="fig">6</xref>, Additional file <xref rid="MOESM15" ref-type="media">15</xref>: Figure S10).</p>
      </sec>
      <sec id="Sec10">
        <title>TAL effectors from XT4699 are associated with modulations in host gene expression</title>
        <p>Microarray analyses of gene expression from wheat leaf samples that were inoculated with strains XT4699, XT-Rocky, and XT4699<italic>hrcC</italic><sup>−</sup> were performed to identify changes in host gene expression associated with pathogenicity. Gene expression profiles upon inoculation of wheat cultivar ‘Chinese Spring’ with strains XT4699 and XT4699<italic>hrcC</italic><sup>−</sup> mutant were found to be distinct from each other, revealing approximately 250 genes with at least a 10-fold difference of expression (Additional file <xref rid="MOESM16" ref-type="media">16</xref>: Table S6). Mutations were generated in TAL effector genes of XT4699 (Additional file <xref rid="MOESM17" ref-type="media">17</xref>: Figure S11), and analysis of host gene expression after inoculation of each TAL effector gene mutant revealed three differentially induced genes, corresponding to Affymetrix probes Ta.7291.1.S1_s_at, Ta.14824.1.S1_at and Ta.9765.1.S1_at, selected from the microarray analysis of XT4699 vs XT4699<italic>hrcC</italic><sup>−</sup> comparison (Additional file <xref rid="MOESM16" ref-type="media">16</xref>: Table S6), were not induced during infections of mutants M2 (<italic>tal6</italic><sup><italic>−</italic></sup>), M3 (<italic>tal7</italic><sup><italic>−</italic></sup>) and M4 (<italic>tal1</italic><sup><italic>−</italic></sup>), respectively (Additional file <xref rid="MOESM18" ref-type="media">18</xref>: Figure S12). The probes sets Ta.7291.1.S1_s_at, Ta.14824.1.S1_at and Ta.9765.1.S1_at corresponded to coding regions that were predicted to encode a succinate dehydrogenase subunit, a choline transporter related protein and a cell wall invertase, respectively.</p>
        <p>Two genes from the microarray analysis, corresponding with to probes Ta.7291.1.S1_s_at and Ta.14164.1.S1_x_at, were induced by infection with wild type XT4699 but not by strain XT-Rocky (Additional file <xref rid="MOESM16" ref-type="media">16</xref>: Table S6). M2, a mutant of <italic>tal6</italic>, failed to induce Ta.7291.1.S1_s_at (Fig. <xref rid="Fig8" ref-type="fig">8a</xref>, Additional file <xref rid="MOESM18" ref-type="media">18</xref>: Figure S12) and Ta.14164.1.S1_x_at, which is predicted to encode a bHLH family transcriptional factor (Fig. <xref rid="Fig8" ref-type="fig">8b</xref>). Comparison of RVDs of TAL effectors between XT4699 and XT-Rocky revealed one TAL effector, XTRocky-3E3, is highly similar to XT4699-Tal6 but has variations in 6 RVDs (Fig. <xref rid="Fig6" ref-type="fig">6</xref>). The qRT-PCR assays indicated these two genes were not induced by <italic>X. translucens</italic> pv. <italic>translucens</italic> XT8, <italic>X. translucens</italic> pv. <italic>cerealis</italic> XT123 or <italic>X. translucens</italic> pv. <italic>undulosa</italic> XT5523 (the latter being very close to XT-Rocky in phylogeny). The two genes were elevated in expression after infection of plants by three other <italic>X. translucens</italic> pv. <italic>undulosa</italic> strains (Additional file <xref rid="MOESM19" ref-type="media">19</xref>: Figure S13). Complementation of the M2 mutant with <italic>tal6</italic> resulted in restored expression of both genes (Fig. <xref rid="Fig8" ref-type="fig">8a and b</xref>). The transcriptional induction of the two genes by XT4699 occurred in the presence of the eukaryotic translation inhibitor cycloheximide (CHX) (Fig. <xref rid="Fig8" ref-type="fig">8c and d</xref>), which had been used for distinguishing direct or indirect target of TAL effectors from <italic>Xanthomonas</italic> strains in previous study [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>].<fig id="Fig8"><label>Fig. 8</label><caption><p>XT4699-Tal6 effector modulates gene expression in wheat. First leaves of 10-day-old Chinese Spring wheat plants were inoculated with XT4699, M2, M2 (empty vector, ev for short) and M2 (<italic>tal6</italic>), respectively. Inoculated leaves were collected 24 h post inoculation. Gene specific primers were used for qRT-PCR in each panel. Relative expressions of Ta.7291.1.S1_s_at (<bold>a</bold> and <bold>c</bold>) and Ta.14164.1.S1_s_at (<bold>b</bold> and <bold>d</bold>) were calculated; In (<bold>a</bold>) and (<bold>b</bold>), the fold change relative to M2 (ev) treatment was calculated with 2<sup>-∆∆Ct</sup> method. In (<bold>c</bold>) and (<bold>d</bold>), bacterial strains treated with 100 μm cycloheximide (CHX) were applied for inoculation. The fold change relative to <italic>hrcC</italic>
<sup>−</sup> + CHX treatment was calculated with 2<sup>-∆∆Ct</sup> method. The lowercase letters indicate significantly different groups with <italic>P</italic>-value &lt; 0.05 in the ANOVA statistics analysis. Two biological replicates were applied, and the experiments were repeated twice with consistent results</p></caption><graphic xlink:href="12864_2015_2348_Fig8_HTML" id="MO8"/></fig></p>
      </sec>
    </sec>
    <sec id="Sec11" sec-type="discussion">
      <title>Discussion</title>
      <p>A complete genome assembly provides an excellent foundation for further genetic and comparative analyses into the pathogenicity mechanisms of a pathogen. The advances of genome sequencing technologies and better assembly algorithms now facilitate assembly of genomes with highly repetitive regions [<xref ref-type="bibr" rid="CR24">24</xref>]. In this study, a complete genome sequence was generated for <italic>X. translucens</italic> pv. <italic>undulosa</italic> strain XT4699. The results demonstrated that PacBio data was sufficient to achieve a high-accuracy assembly of a bacterial genome with many IS elements and multiple copies of highly repetitive TAL effector genes. Intact sequences of TAL effector genes can be used to predict the potential targets in host genomes, thereby facilitating the identification of possible resistant or susceptible genes [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>]. Draft genome sequence data was also generated using Illumina short reads for 20 strains, including XT4699, to determine the relatedness and compare effector contents among them. The comparison between the XT4699 Illumina-only assembly and the complete XT4699 assembly shows that approximately 97 % the complete genome is covered by the Illumina-only assembled contigs. The characterization of assembly gaps on the Illumina-only assembly indicates that gaps are largely located at repetitive regions and high GC contents. The lengths of gaps at repetitive regions tend to be linearly correlated to repeat lengths while the gaps at high GC regions are typically small. Gaps due to a high GC content may, in the future, be reduced by using a new Illumina PCR-free library preparation protocol, which is expected to ameliorate amplification biases associated with high GC contents. TAL effector gene content was not resolved in the Illumina draft genome sequences. To resolve repeats, especially long and complex repeats, PacBio or other emerging long read sequencing technologies are needed [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR28">28</xref>]. The improvement of these long read sequencing technologies may dramatically reduce the sequencing cost per bacterial strain in the near future. The ability to sequence and completely assemble a large number of independent strains would greatly accelerate genome comparison and the identification of bacterial virulence factors. Although not examined here, PacBio sequence can also be used to characterize the methylomes of bacteria and enables the exploration of possible epigenetic features in bacterial gene expression and restriction modifications [<xref ref-type="bibr" rid="CR29">29</xref>].</p>
      <p>The comparison of type III effector (T3E) content in <italic>X. tranlucens</italic> strains identified both conservative (<italic>N</italic> = 23) and variable T3Es among three pathvors, <italic>X. translucens</italic> pv. <italic>undulosa, X. translucens</italic> pv. <italic>translucens</italic> and <italic>X. translucens</italic> pv. <italic>cerealis</italic>. Effector triggered immunity (ETI) is defined by T3S/R gene pairs, which are present in the pathogens and host plants, respectively [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>]. Highly conserved sets of T3Es provide a potential opportunity to deploy pyramided R genes for broad resistance to the bacterial leaf streak disease, although no T3Es-specific R genes are known in wheat at this time. Presence and absence variation, copy number variation, and frameshift mutations were all observed in T3Es among <italic>X. translucens</italic> strains, and TAL effector repertories are also highly variable. The <italic>X. translucens</italic> pv. <italic>cerealis</italic> strain CFBP2541 only contains two TAL effectors, sharing no similarity with TAL effectors from <italic>X. translucens</italic> pv. <italic>undulosa</italic> strains based on the RVD sequences. Variation in T3Es may be one factor accounting for pathogenic diversity and host range determinants of <italic>X. translucens</italic> strains. Pathogenic and genetic diversity are present in <italic>X. translucens</italic> strains collected from five different locations in North Dakota [<xref ref-type="bibr" rid="CR2">2</xref>], and host specific virulence genes have been reported to act as host range determinants [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. CFBP2541 (<italic>X. translucens</italic> pv. <italic>cerealis</italic>) is a phylogenetically close strain to XT123 (<italic>X. translucens</italic> pv. <italic>cerealis</italic>) and was reported to cause severe symptoms on ‘Morex’ barley [<xref ref-type="bibr" rid="CR10">10</xref>]. XT123 only induced chlorosis on ‘Morex’ barley. However, pathogenicity diversity among different <italic>X. translucens</italic> strains may also be derived from variation in other genetic elements related with bacterial fitness. Functional mutation and complementation in genes related with virulence is needed for detecting the virulence contribution of genes and explaining their roles leading to difference in pathogenicity types.</p>
      <p>The TAL effector triggered susceptibility has been demonstrated in several disease complexes. The TAL effectors are a large family of closely related type III effector proteins, which transcriptionally activate host gene expression by directly interacting with promoter elements of host genes and have a varying degree of contribution in bacterial virulence, proliferation, and other disease symptomatology [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref>]. So far, TAL effectors with virulence contribution have been detected in strains of <italic>X. oryzae</italic> pv. <italic>oryzae</italic>, <italic>X. citri</italic> pv. <italic>citri</italic>, <italic>X. campestris</italic> pv. <italic>vesicatoria</italic>, <italic>X. campestris</italic> pv. <italic>malvacearum</italic>, <italic>X. axonopodis</italic> pv. <italic>manihotis</italic> and <italic>X. oryzae</italic> pv. <italic>oryzicola</italic> [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR36">36</xref>–<xref ref-type="bibr" rid="CR44">44</xref>]. However, it is still an open question whether TAL effectors play roles in triggering susceptibility in bacterial leaf streak on wheat. In this study, we are confirmed that TAL effectors do modulate transcriptional profiling of wheat host. The XT4699-Tal6 effector affects the transcriptional level of two candidate target genes, encoding a bHLH transcriptional factor and a succinate dehydrogenase subunit, respectively. Whether or not they are directly targeted by Tal6 is unknown. Searching in the promoter regions of the two genes using the RVD sequence of Tal6 did not give positive EBE above the default cutoff value (<ext-link ext-link-type="uri" xlink:href="https://tale-nt.cac.cornell.edu/node/add/talef-off">https://tale-nt.cac.cornell.edu/node/add/talef-off</ext-link>). We also failed to detect the direct interaction between Tal6 and 400 bp promoter sequence upstream of translation start site of bHLH gene in the assays of <italic>Agrobacteria</italic>-mediated transient expression in <italic>Nicotiana tabacum</italic> KY-14 (data not shown). In this study, no <italic>tal</italic> mutants suffered an obvious loss of virulence when compared to the WT strain in the bacterial growth population assays (Additional file <xref rid="MOESM10" ref-type="media">10</xref>: Figure S6). It is not known if TAL effectors contribute to bacterial virulence in other ways. Previous studies showed AvrBs3 of <italic>X. campestris</italic> pv. <italic>vesicatoria</italic>, Tal2g of <italic>X. oryzae</italic> pv. <italic>oryzicola</italic> and Avrb6 from <italic>X. campestris</italic> pv. <italic>malvacearum</italic> did not affect bacterial growth but had roles in other types of virulence contributions [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR42">42</xref>].</p>
      <p>In this study, XT4699-<italic>tal7</italic> was identified as a conserved TAL effector gene among 8 of 12 <italic>X. translucens</italic> pv. <italic>undulosa</italic> strains. Cloning and sequencing of TAL effector genes in larger collection of <italic>X. translucens</italic> strains is needed to get more reliable information regarding with conservation of TAL effector genes. The insertion of DNA elements, specifically designed to be recognized by RVDs of conserved TAL effectors, in the promoter regions of effective R genes was applied for controlling bacterial blight and bacterial leaf streak of rice [<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR46">46</xref>]. Therefore, for controlling the bacterial leaf streak on cereal crops, use of the RVDs of conserved <italic>X. translucens</italic> TAL effectors may allow the engineering of specific super terminator R genes in cereal crops.</p>
    </sec>
    <sec id="Sec12" sec-type="conclusion">
      <title>Conclusions</title>
      <p>Complete genome assembly of repeat laden bacterial genomes can be facilitated by long read sequencing platforms. Genomic comparisons among strains from different pathovars of <italic>X. translucens</italic> or within one pathovar of <italic>X. translucens</italic> revealed variations in type III effector repertories, which may explain the pathogenic and genetic diversity of <italic>X. translucens</italic> strains and might relate with host range adaptations of specific strains [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. TAL effectors in <italic>X. translucens</italic> strains are distant from ones of group 2 xanthomonads in phylogeny and RVD sequences. Gene expression studies reveal specific TAL effectors in XT4699 function in modulating expression of specific genes in wheat plants.</p>
    </sec>
    <sec id="Sec13" sec-type="materials|methods">
      <title>Methods</title>
      <sec id="Sec14">
        <title>Bacterial strains and genomic DNA extraction</title>
        <p>The <italic>X. translucens</italic> strains used in this study are listed in Table <xref rid="Tab2" ref-type="table">2</xref>. <italic>Xanthomonas</italic> strains were grown on tryptone sucrose agar (tryptone, 10 g/l; sucrose, 10 g/l; glutamic acid, 1 g/l; Difco Bacto agar, 15 g/l) medium at 28 °C [<xref ref-type="bibr" rid="CR47">47</xref>]. Bacterial strains were stored in nutrient broth with 20 % glycerol at −80 °C. For genomic DNA extraction, fresh grown bacteria from medium was washed first by sterilized water and be treated with 1 % SDS and proteinase K (1 mg/ml) at 37 °C for 20–30 min. Samples were then treated with 0.5 M NaCl and incubated at 65 °C for 30 min for cell lysis. Phenol and chloroform extraction and 2.5 times 95 % ethanol precipitation were applied to isolate DNA. Samples were treated with RNase A (0.1 mg/ml) and incubated at 37 °C for 30 min for RNA removal.</p>
      </sec>
      <sec id="Sec15">
        <title>Genome sequencing and assembly</title>
        <p>Bacterial genomic DNAs were subjected to library preparation using the Illumina TruSeq DNA LT Sample Prep kit. 2x250 bp paired-end data for all sequenced strains were generated on an Illumina MiSeq at the Integrated Genomic Facility at Kansas State University. Reads were subjected to adaptor and quality trimming and assembled <italic>via</italic> CLC Genomics Workbench software, DISCOVAR <italic>de novo</italic> (<ext-link ext-link-type="uri" xlink:href="ftp://ftp.broadinstitute.org/pub/crd/DiscovarDeNovo/">ftp://ftp.broadinstitute.org/pub/crd/DiscovarDeNovo/</ext-link>), or SOAPdenov2 [<xref ref-type="bibr" rid="CR48">48</xref>]. For the whole genome assembly for XT4699 strain, the 10-kb libraries were constructed, quantitated, and sequenced on the two SMRT cells of PacBio RS II at the Interdisciplinary Center for Biotechnology Research (ICBR) at University of Florida. These reads were assembled into three contigs using an optimized PacBio pipeline, HGAP2 [<xref ref-type="bibr" rid="CR12">12</xref>]. As suggested by a PacBio HGAP instruction for bacterial assemblies, the parameter of “Target Coverage” was changed from 30 to 15. One short contig was discarded due to low coverage of PacBio reads. Two remaining contigs were merged into a single contig with Illumina assembled contigs using the minimus2 module in AMOS (sourceforge.net/apps/mediawiki/amos). The contig was further circularized through removing the overlap at two ends. To improve the quality of the draft assembly at the ends of the contig, a standard PacBio resequencing pipeline with PacBio reads was used for additional error correction.</p>
      </sec>
      <sec id="Sec16">
        <title>Alignment of XT4699 Illumina reads to the assembled genome to assess the assembly quality</title>
        <p>Trimmed Illumina reads were aligned to the assembly sequences with BWA-MEM [<xref ref-type="bibr" rid="CR49">49</xref>]. The alignment was subjected to stringent filtering criteria (minimum mapping score: 40; minimum overlap: 100 bp; minimum identity: 97; and minimum read coverage: 98 %) to obtain a set of uniquely and confidently mapped reads coverage. To identify mismatches between Illumina sequencing data and the assembly genome, GATK was applied to discover SNPs and INDELs [<xref ref-type="bibr" rid="CR50">50</xref>, <xref ref-type="bibr" rid="CR51">51</xref>]. A set of criteria for polymorphism filtering, including a minimum polymorphic site coverage set as five reads and minimum percentage of reads of the polymorphic allele set at 90 %, were used as the filter to identify the mismatches between Illumina sequences and the assembled genome.</p>
      </sec>
      <sec id="Sec17">
        <title>Genome annotation</title>
        <p>The finished assembled genome of XT4699 was annotated using the NCBI Prokaryotic Genome Automatic Annotation Pipeline (PGAAP) (ncbi.nlm.nih.gov/genome/annotation_prok). The annotated genome has been deposited in Genbank with accession number (CP_008714). The complete and draft genomic sequences were also annotated using the RAST (Rapid Annotation using Subsystem Technology) (<ext-link ext-link-type="uri" xlink:href="http://rast.nmpdr.org/">http://rast.nmpdr.org</ext-link>) [<xref ref-type="bibr" rid="CR52">52</xref>]. The sequence feature of TTCGN16TTCGN, where N represents A, T, G, and C, was used to search the 500-bp promoter region before each annotated gene to identify genes with the plant inducible promoter (PIP) element. IS elements of XT4699 genome was annotated by ISfinder (www-is.biotoul.fr) [<xref ref-type="bibr" rid="CR53">53</xref>].</p>
      </sec>
      <sec id="Sec18">
        <title>Phylogenetic tree construction</title>
        <p>Multilocus sequence analysis (MLSA) was used to build phylogenetic trees in <italic>Xanthomonas</italic> strains [<xref ref-type="bibr" rid="CR54">54</xref>]. To generate the phylogenetic relationship tree, concatenated sequences of four conserved loci (<italic>dnaK</italic>, <italic>gyrB</italic>, <italic>groEL</italic> and <italic>recA</italic>) were assembled. The distance matrix was constructed with the Tamura-Nei genetic distance model and the tree was built using the Neighbor-joining method in the Geneious software R6, with sequence of <italic>Stenotrophomonas maltophilia</italic> K279a as outgroup.</p>
        <p>Whole-genome discovery of single nucleotide polymorphisms (SNPs) was performed by using the assembly draft or finished assembly sequences with MUMmer 3.0 [<xref ref-type="bibr" rid="CR14">14</xref>]. The modules of nucmer, delta-filter, and show-snps were sequentially run to identify SNPs. At least 100 bp and 90 % identity of one-to-one match was required for the alignment between each assembled sequence and the XT4699 reference genome. After identifying all the SNPs of each strain, the XT4699 reference genome was modified at all the SNP sites to polymorphic bases. The resulting modified XT4699 sequence was used as the reference for the second run of the SNP discovery. Consequently, a matrix of the genotyping result of all the strains was obtained. The genotyping data at the SNP sites with no missing data were used to construct a phylogenetic tree using an R package APE [<xref ref-type="bibr" rid="CR55">55</xref>].</p>
      </sec>
      <sec id="Sec19">
        <title>Identification of type III effector genes</title>
        <p>A combined resource of Type III effector (T3E) in the genus of <italic>Xanthomonas</italic>, also called Xop effectors, was used as blastp query against the NCBI and RAST annotation protein database of XT4699 [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR56">56</xref>]. The cutoff e-value was set as 1e-10. For other <italic>X. translucens</italic> strains, the same query was applied using blastp against the RAST annotation database of each strain. In the second round of identification of T3Es, the same query was applied against genome sequence of each strains using tblastn to identify T3Es, which may be overlooked by annotation process. This tblastn search was also used to confirm the presence, absence and number of copies and frameshift mutation of T3Es in the genome. Assembled contigs with less than 5x sequencing coverage, which might contain relatively high sequence errors, were excluded. Frameshifts in T3Es were identified when multiple reading frames from different segments of a contig were matched to the separated regions of a protein. Premature termination codons were identified when translation was truncated. The missing proteins overlooked by the annotation but identified by tblastn were re-evaluated by performing blastp in the NCBI protein database.</p>
      </sec>
      <sec id="Sec20">
        <title>Southern blot analysis</title>
        <p>Genomic DNA manipulation was performed according to standard protocols [<xref ref-type="bibr" rid="CR57">57</xref>]. Genomic DNA of <italic>X. translucens</italic> strains was completely digested by <italic>Bam</italic>HI (New England Biolabs, MA). The digested DNA was separated in 0.9 % agarose gel <italic>via</italic> electrophoresis at 4 °C at 40 Volt overnight. The <italic>sphI</italic> fragment of TAL effector gene in <italic>X. oryzae</italic> pv. <italic>oryzae</italic> strain AXO1947 was used as the probe. AlkPhos Direct Labeling and Detection System with CDP-Star Kit (GE healthcare) was applied for the probe labeling, hybridization and detection procedures.</p>
      </sec>
      <sec id="Sec21">
        <title>Mutagenesis and mutant validation in XT4699</title>
        <p>A <italic>hrcC</italic><sup><italic>−</italic></sup> mutant of XT4699 was generated by gene transfer and homologous recombination of a mutant copy. The partial fragment of <italic>hrcC</italic> gene were amplified by PCR with primers XTThrcC-F and XTThrcC-R (Additional file <xref rid="MOESM20" ref-type="media">20</xref>: Table S7) and cloned into suicide vector pKNOCK-Km vector [<xref ref-type="bibr" rid="CR58">58</xref>]. The suicide vector with cloned fragment was transformed into <italic>E. Coli</italic> S17–1 pir strain for bacterial conjugation. The mixture of XT4699 and S17–1 strains was plated on NA at 28 °C for 24 h, then transferred to TSA plates containing 20 ug/ml Cephalexin and 50 ug/ml kanamycin for selection of XT4699<italic>hrcC</italic><sup><italic>−</italic></sup> mutants [<xref ref-type="bibr" rid="CR59">59</xref>]. The mutants were validated by PCR with primers XTThrcC-Out and 07KM-Val. The TAL mutants of XT4699 were generated in similar way. Partial fragment of N-terminal region of each TAL effector gene in XT4699 was individually amplified by PCR with primers 4699 N-TAL-F and 4699 N-TAL-R. The partial fragment was cloned into pKNOCK-Km vector for conjugation. Mutants were validated by PCR with specific primers located upstream of each TAL gene and the reverse primer Forall-Val in the vector (Additional file <xref rid="MOESM20" ref-type="media">20</xref>: Table S7).</p>
      </sec>
      <sec id="Sec22">
        <title>Pathogenicity assays</title>
        <p>Two-day old <italic>Xanthomonas</italic> cultures were scraped off the TSA plates and resuspended in sterilized water. For pathogenicity type assays, bacterial suspensions (OD600 = 0.2) were infiltrated onto same age leaves of wheat and barley plants by needleless syringe. Hexaploid wheat cultivars ‘Chinese Spring’, ‘Jagger’, ‘Hope’ and ‘Canthatch’, one <italic>Triticum turgidum</italic> wheat (accession number 107 in WGRC at KSU), ‘KS Southeast’ and ‘Morex’ barleys were applied. The symptoms were observed and photographed at 4DPI. For dip inoculation assays, second leaves of 14-day-old ‘Chinese Spring’ wheat plants were dipped into the bacterial suspensions (OD600 = 0.2) coated with 0.02 % Silwet L–77. The water soaking symptoms appeared at 4–5DPI and were photographed at 8DPI. For bacterial growth population assays, equal amount of inoculum of 4 × 10<sup>4</sup> dilutions of original bacterial suspension (OD600 = 0.25) was infiltrated on 2<sup>nd</sup> leaves of 3-week-old ‘Chinese Spring’ wheat plants by needleless syringe. At 6DPI, three biological replicates of inoculated leaves (3 cm) were pooled and ground together. Ground samples were serially diluted, and 100 μl of diluted samples were added onto TSA agar plates for colony counting three days later. 10–100 colonies per plate is considered as optimal and three plates were applied for calculating colony forming units (CFU).</p>
      </sec>
      <sec id="Sec23">
        <title>Microarray and qRT-PCR</title>
        <p>Fully expanded leaves of 10-day-old ‘Chinese Spring’ wheat plants were inoculated with three different bacterial suspensions (XT4699, XT-Rocky and XT4699<italic>hrcC</italic><sup><italic>−</italic></sup>), each at an optical density of 0.5 at 600 nm, using a needleless syringe. RNA samples were isolated 24 h after inoculation using Trizol reagent (Invitrogen) as described by the manufacturer. Three biological replicates, each of which was pooled from three independently inoculated leaves, were used for each treatment. RNA quality was assessed using an Agilent 2100 Bioanalyzer (Agilent Technologies). Processed samples were hybridized to GeneChip Wheat Genome Array (Affymetrix) at Integrated Genomics Facility at Kansas State University. MAS5 algorithm normalization was applied using Affymetrix default parameters. Microarray analyses were performed with the Bioconductor/R package Limma [<xref ref-type="bibr" rid="CR60">60</xref>]. Linear models and empirical Bayes methods were used for statistical tests of differential expression [<xref ref-type="bibr" rid="CR61">61</xref>]. The comparisons were as follows: XT4699 vs XT4699<italic>hrcC</italic><sup><italic>−</italic></sup> and XT-Rocky vs XT4699<italic>hrcC</italic><sup><italic>−</italic></sup>. The <italic>P</italic>-values of all probes were subjected to multiple tests correction to estimate false discovery rate (FDR) [<xref ref-type="bibr" rid="CR62">62</xref>]. Probes were considered differentially expressed if they had an adjusted <italic>P</italic>-value &lt;0.05 and a fold-change greater than two. Raw and processed data are accessible from Gene Expression Omnibus (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo">http://www.ncbi.nlm.nih.gov/geo</ext-link>) with accession number GSE73757. All probes were annotated using Blastx analysis (E-value &lt; e-30) against the GenBank nonredundant protein database. A few probes of interest, which show low <italic>p</italic>-values, were manually annotated. For qRT-PCR, 1 μg RNA samples were treated with DNaseI following the protocols provided by Invitrogen and subjected to reverse transcription reaction using iScript cDNA synthesis kits (Bio-rad). 10x diluted samples of the cDNA products were applied for real-time PCR in the CFX-96 machines at the Integrated Genomics Facility at Kansas State University. Relative gene expression level was calculated with 2<sup>-∆∆Ct</sup> method [<xref ref-type="bibr" rid="CR63">63</xref>]. The EF-1α gene was set as an internal control gene. Primer sequences are shown in the Additional file <xref rid="MOESM20" ref-type="media">20</xref>: Table S7.</p>
      </sec>
      <sec id="Sec24">
        <title>Availability of supporting data</title>
        <p>The complete genome sequence of <italic>X. translucens</italic> pv<italic>. undulosa</italic> XT4699 and its annotation are accessible in Genbank under the accession number CP_008714. The raw PacBio and Illumina reads of XT4699 were also submitted to Genbank Sequence Read Archive (SRA) under the BioProject number of PRJNA248137. The datasets of raw Illumina sequencing reads and draft genome assembly sequences of nineteen additional <italic>X. translucens</italic> strains were submitted to GenBank under the BioProject number of PRJNA302486. The raw and processed microarray data are available from Gene Expression Omnibus with accession number GSE73757. Additional files <xref rid="MOESM1" ref-type="media">1</xref>, <xref rid="MOESM2" ref-type="media">2</xref>, <xref rid="MOESM3" ref-type="media">3</xref>, <xref rid="MOESM6" ref-type="media">6</xref>, <xref rid="MOESM12" ref-type="media">12</xref>, <xref rid="MOESM16" ref-type="media">16</xref>, <xref rid="MOESM20" ref-type="media">20</xref>: Tables S1-S7 and Additional files <xref rid="MOESM4" ref-type="media">4</xref>, <xref rid="MOESM5" ref-type="media">5</xref>, <xref rid="MOESM7" ref-type="media">7</xref>, <xref rid="MOESM8" ref-type="media">8</xref>, <xref rid="MOESM9" ref-type="media">9</xref>, <xref rid="MOESM10" ref-type="media">10</xref>, <xref rid="MOESM11" ref-type="media">11</xref>, <xref rid="MOESM13" ref-type="media">13</xref>, <xref rid="MOESM14" ref-type="media">14</xref>, <xref rid="MOESM15" ref-type="media">15</xref>, <xref rid="MOESM17" ref-type="media">17</xref>, <xref rid="MOESM18" ref-type="media">18</xref>, <xref rid="MOESM19" ref-type="media">19</xref>: Figures S1-S13 are included in Additional files.</p>
      </sec>
    </sec>
  </body>
  <back>
    <app-group>
      <app id="App1">
        <sec id="Sec25">
          <title>Additional files</title>
          <p>
            <media position="anchor" xlink:href="12864_2015_2348_MOESM1_ESM.xlsx" id="MOESM1">
              <label>Additional file 1: Table S1.</label>
              <caption>
                <p>The sequence difference between the reference genome and the Illumina assembly for XT4699. (XLSX 9 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="12864_2015_2348_MOESM2_ESM.xlsx" id="MOESM2">
              <label>Additional file 2: Table S2.</label>
              <caption>
                <p>Summary of alignments of Sanger reads from TAL effector genes to the assembly genome of XT4699. (XLSX 10 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="12864_2015_2348_MOESM3_ESM.xlsx" id="MOESM3">
              <label>Additional file 3: Table S3.</label>
              <caption>
                <p>Genes with plant inducible promoter (PIP) box in XT4699. (XLSX 14 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="12864_2015_2348_MOESM4_ESM.pdf" id="MOESM4">
              <label>Additional file 4: Figure S1.</label>
              <caption>
                <p>Data coverage of XT4699 PacBio and Illumina sequences. A) Coverage of PacBio sequences (light blue) and Illumina sequences (orange) across the genome. B) The relationship between Illumina sequencing coverage and GC% of non-overlapping 200 bp windows. C) Visualization of the alignment of Illumina assembled contigs on the XT4699 reference genome. D) The relationship between PacBio sequencing coverage and GC% of non-overlapping 200 bp windows. (PDF 487 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="12864_2015_2348_MOESM5_ESM.pdf" id="MOESM5">
              <label>Additional file 5: Figure S2.</label>
              <caption>
                <p>The relationship between genome repeats and assembled gaps using XT4699 Illumina data. A) The repeat features (length, similarity between repeated copies, and copy number) of assembled repeats and unassembled repeats. B) The relationship between assembled gaps and repeat lengths. (PDF 247 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="12864_2015_2348_MOESM6_ESM.xlsx" id="MOESM6">
              <label>Additional file 6: Table S4.</label>
              <caption>
                <p>SNP difference count among <italic>Xanthomonas</italic> strains in a total of 9836 SNPs. (XLSX 13 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="12864_2015_2348_MOESM7_ESM.pdf" id="MOESM7">
              <label>Additional file 7: Figure S3.</label>
              <caption>
                <p>Different disease symptoms induced by pathovars of <italic>X. translucens</italic>. In A-G panels, different wheat and barley cultivars were inoculated. A, ‘Chinese Spring’ wheat; B, ‘KS Southeast’ barley; C, ‘Morex’ barley; D, ‘Jagger’ wheat; E, ‘Hope’ wheat; F, ‘Canthatch’ wheat; G, Triticum turgidum wheat #107. In A, B, C, plants are 3 weeks old and second leaves were inoculated. In D, E, F, G, leaves with similar age from 50-day-old plants were inoculated. (PDF 359 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="12864_2015_2348_MOESM8_ESM.pdf" id="MOESM8">
              <label>Additional file 8: Figure S4.</label>
              <caption>
                <p>Phylogenetic tree based on CRISPR <italic>Cas</italic> loci of <italic>X. translucens</italic> strains. The sequence of CRISPR <italic>Cas</italic> genes is annotated in RAST website <ext-link ext-link-type="uri" xlink:href="http://rast.nmpdr.org/">http://rast.nmpdr.org</ext-link>. The phylogenetic tree was generated using Geneious software Version 6 with the Tamura-Nei genetic distance model and the Neighbor-joining method, with PXO99 CRISPR <italic>Cas</italic> genes as outgroup. The scale bar indicates number of nucleotide substitutions per site. (PDF 149 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="12864_2015_2348_MOESM9_ESM.pdf" id="MOESM9">
              <label>Additional file 9: Figure S5.</label>
              <caption>
                <p>Syntenic gene clusters of type III secretion system among <italic>X. translucens</italic> strains. XT-Rocky and XT4699 are <italic>X. translucens</italic> pv. <italic>undulosa</italic> while ART-Xtg29 is <italic>X. translucens</italic> pv. <italic>gramins</italic>. White arrows (drawn to scale) represent orientation and position of Hrp genes. Black arrows indicate the two predicted IS elements in ART-Xtg29 strain. The names of Hrp genes are shown above or under the white arrows. The identity of homologous proteins of compared strains is shown between them. (PDF 155 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="12864_2015_2348_MOESM10_ESM.pdf" id="MOESM10">
              <label>Additional file 10: Figure S6.</label>
              <caption>
                <p>Bacterial population assay. Equal amount of 4x10<sup>4</sup> dilution of bacterial inoculum of different <italic>tal</italic> mutants, <italic>hrcC</italic> mutant and WT were inoculated on 3-week-old Chinese Spring wheat by needleless syringe. At 6DPI, three inoculated leaves (3 cm) were pooled and ground together in each treatment. Samples were serially diluted and 100 μl of diluted samples were added to TSA plates. Plates were incubated at 28 °C for colony formation. Data represents the mean of Log10 CFU/cm leaf ± standard deviation. The * indicates the significant difference of bacterial population of <italic>hrcC</italic>
<sup><italic>−</italic></sup> mutant compared to other <italic>tal</italic> mutants or WT at 6DPI under <italic>p</italic>-value &lt;0.001 in the ANOVA statistics analysis. (PDF 157 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="12864_2015_2348_MOESM11_ESM.pdf" id="MOESM11">
              <label>Additional file 11: Figure S7.</label>
              <caption>
                <p>Southern blot analysis of two <italic>X. translucens</italic> pv. <italic>undulosa</italic> strains from Kansas. Genomic DNA digested by <italic>Bam</italic>HI and hybridized by <italic>sph</italic>I fragment of TAL effector gene in <italic>X. oryzae</italic> pv. <italic>oryzae</italic> strain AXO1947. The size of blotted bands is consistent with assembly genome of XT4699. (PDF 182 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="12864_2015_2348_MOESM12_ESM.pdf" id="MOESM12">
              <label>Additional file 12: Table S5.</label>
              <caption>
                <p>Amino acid sequences of TAL effector proteins in <italic>X. translucens</italic> pv. <italic>undulosa</italic> strain XT4699. (PDF 135 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="12864_2015_2348_MOESM13_ESM.jpg" id="MOESM13">
              <label>Additional file 13: Figure S8.</label>
              <caption>
                <p>Alignment of concatenated N-terminal and C-terminal amino acid sequences of TAL effectors. The sequences of Tal2 and Tal4 of <italic>X. translucens</italic> XT4699, PthXo1 of <italic>X. oryzae</italic> PXO99, AvrBs3 of <italic>X. campestris</italic> 85–10 and Brg11 of <italic>Ralstonia Solanacearum</italic> GMI1000 are applied for alignment, which is generated by Geneious software. (JPG 737 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="12864_2015_2348_MOESM14_ESM.pdf" id="MOESM14">
              <label>Additional file 14: Figure S9.</label>
              <caption>
                <p>Most TAL effector genes are flanked by transposon elements. The blue arrows indicate the TAL effector genes and the dark red arrows show the transposase genes; the gray arrows indicate other genes. The genes are listed as following: 1, <italic>RpoD</italic>, encoding RNA polymerase subunit sigma-70; 2, Hypothetical genes; 3, Acetyltransferase and hypothetical genes; 4, Type III effector gene <italic>xopL</italic>; 5, <italic>vgrG</italic>, encoding type IV secretion protein. (PDF 168 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="12864_2015_2348_MOESM15_ESM.pdf" id="MOESM15">
              <label>Additional file 15: Figure S10.</label>
              <caption>
                <p>XT4699-<italic>tal7</italic> is a conserved TAL effector gene. Primer pair used for cloning <italic>tal7</italic> gene in XT4699 was applied in PCR with template DNA of other strains from North Dakota and Kansas. PCR bands with similar size as XT4699-<italic>tal7</italic> were shown in the blue box. (PDF 118 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="12864_2015_2348_MOESM16_ESM.xlsx" id="MOESM16">
              <label>Additional file 16: Table S6.</label>
              <caption>
                <p>Microarray analysis of gene expression from inoculated wheat leaves by XT4699, XT-Rocky and XT4699<italic>hrcC</italic>
<sup>−</sup>. (XLSX 153 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="12864_2015_2348_MOESM17_ESM.pdf" id="MOESM17">
              <label>Additional file 17: Figure S11.</label>
              <caption>
                <p>Validation of all eight TAL mutants in XT4699 by PCR. The sequence of specific primers for each TAL gene and the primer from the vector are provided in Table S6. The desired PCR product size is around 1.5 kb. The corresponding names of TAL genes are shown for all 8 mutants. A, M1 (<italic>tal2</italic> mutant), M2 (<italic>tal6</italic> mutant); B, M3 (<italic>tal7</italic> mutant), M4 (<italic>tal1</italic> mutant); C, M5 (<italic>tal5</italic> mutant), M6 (<italic>tal8</italic> mutant); D, M7 (<italic>tal3</italic> mutant), M8 (<italic>tal4</italic> mutant). (PDF 351 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="12864_2015_2348_MOESM18_ESM.pdf" id="MOESM18">
              <label>Additional file 18: Figure S12.</label>
              <caption>
                <p>Induction of host genes is impaired by mutation of specific TAL genes. M2 is lack of <italic>tal6</italic>, M3 is lack of <italic>tal7</italic> and M4 is the mutant of <italic>tal1</italic>. A, relative expression level of Ta.7291.1.S1_at, corresponding to succinate dehydrogenase subunit gene, was calculated compared to M2 treatment; B, relative expression level of Ta.14824.1.S1_at, corresponding to choline transporter related gene, was calculated compared to M3 treatment; C, relative expression level of Ta.9765.1.S1_at, corresponding to cell wall invertase gene, was calculated compared to M4 treatment. 2<sup>-∆∆Ct</sup> method was applied in calculation. The * indicates significant difference compared to other TAL mutants treated samples with <italic>P</italic>-value &lt; 0.05 in the ANOVA statistics analysis. (PDF 191 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="12864_2015_2348_MOESM19_ESM.pdf" id="MOESM19">
              <label>Additional file 19: Figure S13.</label>
              <caption>
                <p>Induction of Ta.14164.1.S1_s_at and Ta.7291.1.S1_s_at is strain specific. XT8 is <italic>X. translucens</italic> pv. <italic>translucens</italic>, XT123 is <italic>X. translucens</italic> pv. <italic>cerealis</italic>, XT130, XT5523, XT5770 and XT5791 are strains of <italic>X. translucens</italic> pv. <italic>undulosa</italic>. M2 is the mutant of XT4699 lack of <italic>tal6</italic>. The relative expression level is calculated relative to M2 treatment by with 2<sup>-∆∆Ct</sup> method. A, the relative expression of Ta.14164.1.S1_s_at, corresponding to <italic>bHLH</italic> gene, was calculated; B, the relative expression of Ta.7291.1.S1_s_at, corresponding to succinate dehydrogenase gene, was calculated. The lowercase letters indicate significantly different groups with <italic>P</italic>-value &lt; 0.05 in the ANOVA statistics analysis. (PDF 178 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="12864_2015_2348_MOESM20_ESM.xlsx" id="MOESM20">
              <label>Additional file 20: Table S7.</label>
              <caption>
                <p>Primers used in this study. (XLSX 8 kb)</p>
              </caption>
            </media>
          </p>
        </sec>
      </app>
    </app-group>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>BLS</term>
          <def>
            <p>Bacterial leaf streak</p>
          </def>
        </def-item>
        <def-item>
          <term>Cas</term>
          <def>
            <p>CRISPR-associated genes</p>
          </def>
        </def-item>
        <def-item>
          <term>CDS</term>
          <def>
            <p>Coding DNA sequence</p>
          </def>
        </def-item>
        <def-item>
          <term>CHX</term>
          <def>
            <p>Cycloheximide</p>
          </def>
        </def-item>
        <def-item>
          <term>CRISPR</term>
          <def>
            <p>Clustered regularly interspaced short palindromic repeat</p>
          </def>
        </def-item>
        <def-item>
          <term>DPI</term>
          <def>
            <p>Days post infection</p>
          </def>
        </def-item>
        <def-item>
          <term>HR</term>
          <def>
            <p>Hypersensitive reaction</p>
          </def>
        </def-item>
        <def-item>
          <term>INDELs</term>
          <def>
            <p>Insertion-and-deletions</p>
          </def>
        </def-item>
        <def-item>
          <term>IS</term>
          <def>
            <p>Insertion Sequence</p>
          </def>
        </def-item>
        <def-item>
          <term>MLSA</term>
          <def>
            <p>Multilocus sequence analysis</p>
          </def>
        </def-item>
        <def-item>
          <term>NRPS</term>
          <def>
            <p>Non-ribosomal peptide synthesis</p>
          </def>
        </def-item>
        <def-item>
          <term>PacBio</term>
          <def>
            <p>Pacific Bioscience</p>
          </def>
        </def-item>
        <def-item>
          <term>PGAAP</term>
          <def>
            <p>Prokaryotic Genome Automatic Annotation Pipeline</p>
          </def>
        </def-item>
        <def-item>
          <term>PIP</term>
          <def>
            <p>Plant inducible promoter</p>
          </def>
        </def-item>
        <def-item>
          <term>RVDs</term>
          <def>
            <p>Repeat variable di-residues</p>
          </def>
        </def-item>
        <def-item>
          <term>SMRT</term>
          <def>
            <p>Single molecule, real time</p>
          </def>
        </def-item>
        <def-item>
          <term>SNPs</term>
          <def>
            <p>Single nucleotide polymorphisms</p>
          </def>
        </def-item>
        <def-item>
          <term>T3Es</term>
          <def>
            <p>Type III effectors</p>
          </def>
        </def-item>
        <def-item>
          <term>T3SS</term>
          <def>
            <p>Type III secretion system</p>
          </def>
        </def-item>
        <def-item>
          <term>TAL</term>
          <def>
            <p>Transcription-Activator Like</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The authors declare that they have no competing interests.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors’ contributions</bold>
        </p>
        <p>ZP, FFW and SL designed the study and wrote the manuscript. ZP, YH, JX, NP, AA, FFW and SL contributed to data analyses. ZP and YH performed the experiments. JJ and ZL provided <italic>X. translucens</italic> strains collected from Canada and North Dakota, respectively. AA and ZL assisted in revising manuscript. All authors read and approved the final version of the manuscript.</p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgements</title>
      <p>We thank Haiyan Huang and Kim Park for technical assistance. We thank Dr. Yanni Lun for performing microarray experiments and Hanquan Liang for Illumina sequencing in the Integrated Genomic Facility at Kansas State University. We thank Interdisciplinary Center for Biotechnology Research (ICBR) at University of Florida for PacBio sequencing. We thank Dr. Sunghun Park for providing experimental support. We thank Dr. Bikram Gill for providing wheat seeds. This research is supported by National Science Foundation research award IOS-1238189.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>White</surname>
              <given-names>FF</given-names>
            </name>
            <name>
              <surname>Potnis</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Koebnik</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>The type III effectors of Xanthomonas</article-title>
          <source>Molecular Plant Pathology</source>
          <year>2009</year>
          <volume>10</volume>
          <issue>6</issue>
          <fpage>749</fpage>
          <lpage>766</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1364-3703.2009.00590.x</pub-id>
          <?supplied-pmid 19849782?>
          <pub-id pub-id-type="pmid">19849782</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Adhikari</surname>
              <given-names>TB</given-names>
            </name>
            <name>
              <surname>Gurung</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hansen</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Bonman</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Pathogenic and genetic diversity of Xanthomonas translucens pv. Undulosa in North Dakota</article-title>
          <source>Phytopathology</source>
          <year>2012</year>
          <volume>102</volume>
          <issue>4</issue>
          <fpage>390</fpage>
          <lpage>402</lpage>
          <pub-id pub-id-type="doi">10.1094/PHYTO-07-11-0201</pub-id>
          <?supplied-pmid 22204654?>
          <pub-id pub-id-type="pmid">22204654</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bragard</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Singer</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Alizadeh</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Vauterin</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Maraite</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Swings</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Xanthomonas translucens from small grains: diversity and phytopathological relevance</article-title>
          <source>Phytopathology</source>
          <year>1997</year>
          <volume>87</volume>
          <issue>11</issue>
          <fpage>1111</fpage>
          <lpage>1117</lpage>
          <pub-id pub-id-type="doi">10.1094/PHYTO.1997.87.11.1111</pub-id>
          <?supplied-pmid 18945007?>
          <pub-id pub-id-type="pmid">18945007</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bragard</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Verdier</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Maraite</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Genetic diversity among Xanthomonas campestris strains pathogenic for small grains</article-title>
          <source>Applied and environmental microbiology</source>
          <year>1995</year>
          <volume>61</volume>
          <issue>3</issue>
          <fpage>1020</fpage>
          <lpage>1026</lpage>
          <?supplied-pmid 16534952?>
          <pub-id pub-id-type="pmid">16534952</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rademaker</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Norman</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Forster</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Louws</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Schultz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>De Bruijn</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Classification and identification of Xanthomonas translucens isolates, including those pathogenic to ornamental asparagus</article-title>
          <source>Phytopathology</source>
          <year>2006</year>
          <volume>96</volume>
          <issue>8</issue>
          <fpage>876</fpage>
          <lpage>884</lpage>
          <pub-id pub-id-type="doi">10.1094/PHYTO-96-0876</pub-id>
          <?supplied-pmid 18943753?>
          <pub-id pub-id-type="pmid">18943753</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bentley</surname>
              <given-names>DR</given-names>
            </name>
          </person-group>
          <article-title>Whole-genome re-sequencing</article-title>
          <source>Current opinion in genetics &amp; development</source>
          <year>2006</year>
          <volume>16</volume>
          <issue>6</issue>
          <fpage>545</fpage>
          <lpage>552</lpage>
          <pub-id pub-id-type="doi">10.1016/j.gde.2006.10.009</pub-id>
          <pub-id pub-id-type="pmid">17055251</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Metzker</surname>
              <given-names>ML</given-names>
            </name>
          </person-group>
          <article-title>Sequencing technologies—the next generation</article-title>
          <source>Nature reviews genetics</source>
          <year>2010</year>
          <volume>11</volume>
          <issue>1</issue>
          <fpage>31</fpage>
          <lpage>46</lpage>
          <pub-id pub-id-type="doi">10.1038/nrg2626</pub-id>
          <?supplied-pmid 19997069?>
          <pub-id pub-id-type="pmid">19997069</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gardiner</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Upadhyaya</surname>
              <given-names>NM</given-names>
            </name>
            <name>
              <surname>Stiller</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ellis</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Dodds</surname>
              <given-names>PN</given-names>
            </name>
            <name>
              <surname>Kazan</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Genomic analysis of Xanthomonas translucens pathogenic on wheat and barley reveals cross-kingdom gene transfer events and diverse protein delivery systems</article-title>
          <source>PLoS One</source>
          <year>2014</year>
          <volume>9</volume>
          <fpage>1</fpage>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wichmann</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Vorhölter</surname>
              <given-names>FJ</given-names>
            </name>
            <name>
              <surname>Hersemann</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Widmer</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Blom</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Niehaus</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The noncanonical type III secretion system of Xanthomonas translucens pv. graminis is essential for forage grass infection</article-title>
          <source>Molecular plant pathology</source>
          <year>2013</year>
          <volume>14</volume>
          <issue>6</issue>
          <fpage>576</fpage>
          <lpage>588</lpage>
          <pub-id pub-id-type="doi">10.1111/mpp.12030</pub-id>
          <?supplied-pmid 23578314?>
          <pub-id pub-id-type="pmid">23578314</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pesce</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Bolot</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Cunnac</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Portier</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Fischer-Le Saux</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Jacques</surname>
              <given-names>M-A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>High-quality draft genome sequence of the Xanthomonas translucens pv. cerealis pathotype strain CFBP 2541</article-title>
          <source>Genome announcements</source>
          <year>2015</year>
          <volume>3</volume>
          <issue>1</issue>
          <fpage>e01574</fpage>
          <lpage>01514</lpage>
          <pub-id pub-id-type="doi">10.1128/genomeA.01574-14</pub-id>
          <?supplied-pmid 25676771?>
          <pub-id pub-id-type="pmid">25676771</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bashir</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Klammer</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Robins</surname>
              <given-names>WP</given-names>
            </name>
            <name>
              <surname>Chin</surname>
              <given-names>C-S</given-names>
            </name>
            <name>
              <surname>Webster</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Paxinos</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A hybrid approach for the automated finishing of bacterial genomes</article-title>
          <source>Nature biotechnology</source>
          <year>2012</year>
          <volume>30</volume>
          <issue>7</issue>
          <fpage>701</fpage>
          <lpage>707</lpage>
          <pub-id pub-id-type="doi">10.1038/nbt.2288</pub-id>
          <?supplied-pmid 22750883?>
          <pub-id pub-id-type="pmid">22750883</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chin</surname>
              <given-names>C-S</given-names>
            </name>
            <name>
              <surname>Alexander</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Marks</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Klammer</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Drake</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Heiner</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Nonhybrid, finished microbial genome assemblies from long-read SMRT sequencing data</article-title>
          <source>Nature methods</source>
          <year>2013</year>
          <volume>10</volume>
          <issue>6</issue>
          <fpage>563</fpage>
          <lpage>569</lpage>
          <pub-id pub-id-type="doi">10.1038/nmeth.2474</pub-id>
          <?supplied-pmid 23644548?>
          <pub-id pub-id-type="pmid">23644548</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koren</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Schatz</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Walenz</surname>
              <given-names>BP</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Howard</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Ganapathy</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Hybrid error correction and de novo assembly of single-molecule sequencing reads</article-title>
          <source>Nature biotechnology</source>
          <year>2012</year>
          <volume>30</volume>
          <issue>7</issue>
          <fpage>693</fpage>
          <lpage>700</lpage>
          <pub-id pub-id-type="doi">10.1038/nbt.2280</pub-id>
          <?supplied-pmid 22750884?>
          <pub-id pub-id-type="pmid">22750884</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kurtz</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Phillippy</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Delcher</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Smoot</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Shumway</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Antonescu</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Versatile and open software for comparing large genomes</article-title>
          <source>Genome biology</source>
          <year>2004</year>
          <volume>5</volume>
          <issue>2</issue>
          <fpage>R12</fpage>
          <pub-id pub-id-type="doi">10.1186/gb-2004-5-2-r12</pub-id>
          <?supplied-pmid 14759262?>
          <pub-id pub-id-type="pmid">14759262</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barrangou</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Fremaux</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Deveau</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Richards</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Boyaval</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Moineau</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>CRISPR provides acquired resistance against viruses in prokaryotes</article-title>
          <source>Science</source>
          <year>2007</year>
          <volume>315</volume>
          <issue>5819</issue>
          <fpage>1709</fpage>
          <lpage>1712</lpage>
          <pub-id pub-id-type="doi">10.1126/science.1138140</pub-id>
          <?supplied-pmid 17379808?>
          <pub-id pub-id-type="pmid">17379808</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Garneau</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Dupuis</surname>
              <given-names>M-È</given-names>
            </name>
            <name>
              <surname>Villion</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Romero</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Barrangou</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Boyaval</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA</article-title>
          <source>Nature</source>
          <year>2010</year>
          <volume>468</volume>
          <issue>7320</issue>
          <fpage>67</fpage>
          <lpage>71</lpage>
          <pub-id pub-id-type="doi">10.1038/nature09523</pub-id>
          <?supplied-pmid 21048762?>
          <pub-id pub-id-type="pmid">21048762</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Horvath</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Romero</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Coûté-Monvoisin</surname>
              <given-names>A-C</given-names>
            </name>
            <name>
              <surname>Richards</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Deveau</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Moineau</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Diversity, activity, and evolution of CRISPR loci in Streptococcus thermophilus</article-title>
          <source>Journal of bacteriology</source>
          <year>2008</year>
          <volume>190</volume>
          <issue>4</issue>
          <fpage>1401</fpage>
          <lpage>1412</lpage>
          <pub-id pub-id-type="doi">10.1128/JB.01415-07</pub-id>
          <?supplied-pmid 18065539?>
          <pub-id pub-id-type="pmid">18065539</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marraffini</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Sontheimer</surname>
              <given-names>EJ</given-names>
            </name>
          </person-group>
          <article-title>CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea</article-title>
          <source>Nature Reviews Genetics</source>
          <year>2010</year>
          <volume>11</volume>
          <issue>3</issue>
          <fpage>181</fpage>
          <lpage>190</lpage>
          <pub-id pub-id-type="doi">10.1038/nrg2749</pub-id>
          <?supplied-pmid 20125085?>
          <pub-id pub-id-type="pmid">20125085</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Makarova</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Haft</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Barrangou</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Brouns</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Charpentier</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Horvath</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Evolution and classification of the CRISPR–Cas systems</article-title>
          <source>Nature Reviews Microbiology</source>
          <year>2011</year>
          <volume>9</volume>
          <issue>6</issue>
          <fpage>467</fpage>
          <lpage>477</lpage>
          <pub-id pub-id-type="doi">10.1038/nrmicro2577</pub-id>
          <?supplied-pmid 21552286?>
          <pub-id pub-id-type="pmid">21552286</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pieretti</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Royer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Barbe</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Carrere</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Koebnik</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Cociancich</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The complete genome sequence of Xanthomonas albilineans provides new insights into the reductive genome evolution of the xylem-limited Xanthomonadaceae</article-title>
          <source>BMC genomics</source>
          <year>2009</year>
          <volume>10</volume>
          <issue>1</issue>
          <fpage>616</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-2164-10-616</pub-id>
          <?supplied-pmid 20017926?>
          <pub-id pub-id-type="pmid">20017926</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bart</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Cohn</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kassen</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>McCallum</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Shybut</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Petriello</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>High-throughput genomic sequencing of cassava bacterial blight strains identifies conserved effectors to target for durable resistance</article-title>
          <source>Proceedings of the National Academy of Sciences</source>
          <year>2012</year>
          <volume>109</volume>
          <issue>28</issue>
          <fpage>E1972</fpage>
          <lpage>E1979</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.1208003109</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Jia</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Sosso</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Frommer</surname>
              <given-names>WB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Lateral organ boundaries 1 is a disease susceptibility gene for citrus bacterial canker disease</article-title>
          <source>Proceedings of the National Academy of Sciences</source>
          <year>2014</year>
          <volume>111</volume>
          <issue>4</issue>
          <fpage>E521</fpage>
          <lpage>E529</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.1313271111</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Strauß</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>van Poecke</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Strauß</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Römer</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Minsavage</surname>
              <given-names>GV</given-names>
            </name>
            <name>
              <surname>Singh</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>RNA-seq pinpoints a Xanthomonas TAL-effector activated resistance gene in a large-crop genome</article-title>
          <source>Proceedings of the National Academy of Sciences</source>
          <year>2012</year>
          <volume>109</volume>
          <issue>47</issue>
          <fpage>19480</fpage>
          <lpage>19485</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.1212415109</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koren</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Phillippy</surname>
              <given-names>AM</given-names>
            </name>
          </person-group>
          <article-title>One chromosome, one contig: complete microbial genomes from long-read sequencing and assembly</article-title>
          <source>Curr Opin Microbiol</source>
          <year>2015</year>
          <volume>23</volume>
          <fpage>110</fpage>
          <lpage>120</lpage>
          <pub-id pub-id-type="doi">10.1016/j.mib.2014.11.014</pub-id>
          <?supplied-pmid 25461581?>
          <pub-id pub-id-type="pmid">25461581</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boch</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Scholze</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Schornack</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Landgraf</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hahn</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kay</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Breaking the code of DNA binding specificity of TAL-type III effectors</article-title>
          <source>Science</source>
          <year>2009</year>
          <volume>326</volume>
          <issue>5959</issue>
          <fpage>1509</fpage>
          <lpage>1512</lpage>
          <pub-id pub-id-type="doi">10.1126/science.1178811</pub-id>
          <?supplied-pmid 19933107?>
          <pub-id pub-id-type="pmid">19933107</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <mixed-citation publication-type="other">Moscou MJ, Bogdanove AJ. A simple cipher governs DNA recognition by TAL effectors. Science. 2009;326(5959):1501–1.</mixed-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ashton</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Nair</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Dallman</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Rubino</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Rabsch</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Mwaigwisya</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>MinION nanopore sequencing identifies the position and structure of a bacterial antibiotic resistance island</article-title>
          <source>Nat Biotechnol</source>
          <year>2015</year>
          <volume>33</volume>
          <issue>3</issue>
          <fpage>296</fpage>
          <lpage>300</lpage>
          <pub-id pub-id-type="doi">10.1038/nbt.3103</pub-id>
          <?supplied-pmid 25485618?>
          <pub-id pub-id-type="pmid">25485618</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Loman</surname>
              <given-names>NJ</given-names>
            </name>
            <name>
              <surname>Watson</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Successful test launch for nanopore sequencing</article-title>
          <source>Nat Methods</source>
          <year>2015</year>
          <volume>12</volume>
          <issue>4</issue>
          <fpage>303</fpage>
          <lpage>304</lpage>
          <pub-id pub-id-type="doi">10.1038/nmeth.3327</pub-id>
          <?supplied-pmid 25825834?>
          <pub-id pub-id-type="pmid">25825834</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fang</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Munera</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Friedman</surname>
              <given-names>DI</given-names>
            </name>
            <name>
              <surname>Mandlik</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Chao</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Banerjee</surname>
              <given-names>O</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Genome-wide mapping of methylated adenine residues in pathogenic Escherichia coli using single-molecule real-time sequencing</article-title>
          <source>Nature biotechnology</source>
          <year>2012</year>
          <volume>30</volume>
          <issue>12</issue>
          <fpage>1232</fpage>
          <lpage>1239</lpage>
          <pub-id pub-id-type="doi">10.1038/nbt.2432</pub-id>
          <?supplied-pmid 23138224?>
          <pub-id pub-id-type="pmid">23138224</pub-id>
        </element-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jones</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Dangl</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
          <article-title>The plant immune system</article-title>
          <source>Nature</source>
          <year>2006</year>
          <volume>444</volume>
          <issue>7117</issue>
          <fpage>323</fpage>
          <lpage>329</lpage>
          <pub-id pub-id-type="doi">10.1038/nature05286</pub-id>
          <?supplied-pmid 17108957?>
          <pub-id pub-id-type="pmid">17108957</pub-id>
        </element-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tai</surname>
              <given-names>TH</given-names>
            </name>
            <name>
              <surname>Dahlbeck</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Clark</surname>
              <given-names>ET</given-names>
            </name>
            <name>
              <surname>Gajiwala</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Pasion</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Whalen</surname>
              <given-names>MC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Expression of the Bs2 pepper gene confers resistance to bacterial spot disease in tomato</article-title>
          <source>Proceedings of the National Academy of Sciences</source>
          <year>1999</year>
          <volume>96</volume>
          <issue>24</issue>
          <fpage>14153</fpage>
          <lpage>14158</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.96.24.14153</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mellano</surname>
              <given-names>VJ</given-names>
            </name>
            <name>
              <surname>Cooksey</surname>
              <given-names>DA</given-names>
            </name>
          </person-group>
          <article-title>Development of host range mutants of Xanthomonas campestris pv. translucens</article-title>
          <source>Applied and environmental microbiology</source>
          <year>1988</year>
          <volume>54</volume>
          <issue>4</issue>
          <fpage>884</fpage>
          <lpage>889</lpage>
          <?supplied-pmid 16347609?>
          <pub-id pub-id-type="pmid">16347609</pub-id>
        </element-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Waney</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Kingsley</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gabriel</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Xanthomonas campestris pv. translucens genes determining host-specific virulence and general virulence on cereals identified by Tn5-gusA insertion mutagenesis</article-title>
          <source>Mol Plant-Microbe Interact</source>
          <year>1991</year>
          <volume>4</volume>
          <fpage>623</fpage>
          <lpage>627</lpage>
          <pub-id pub-id-type="doi">10.1094/MPMI-4-623</pub-id>
        </element-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boch</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bonas</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>Xanthomonas AvrBs3 family-type III effectors: discovery and function</article-title>
          <source>Annual review of phytopathology</source>
          <year>2010</year>
          <volume>48</volume>
          <fpage>419</fpage>
          <lpage>436</lpage>
          <pub-id pub-id-type="doi">10.1146/annurev-phyto-080508-081936</pub-id>
          <?supplied-pmid 19400638?>
          <pub-id pub-id-type="pmid">19400638</pub-id>
        </element-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>White</surname>
              <given-names>FF</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Host and pathogen factors controlling the rice-Xanthomonas oryzae interaction</article-title>
          <source>Plant Physiology</source>
          <year>2009</year>
          <volume>150</volume>
          <issue>4</issue>
          <fpage>1677</fpage>
          <lpage>1686</lpage>
          <pub-id pub-id-type="doi">10.1104/pp.109.139360</pub-id>
          <?supplied-pmid 19458115?>
          <pub-id pub-id-type="pmid">19458115</pub-id>
        </element-citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Antony</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>White</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Rice xa13 recessive resistance to bacterial blight is defeated by induction of the disease susceptibility gene Os-11 N3</article-title>
          <source>The Plant Cell</source>
          <year>2010</year>
          <volume>22</volume>
          <issue>11</issue>
          <fpage>3864</fpage>
          <lpage>3876</lpage>
          <pub-id pub-id-type="doi">10.1105/tpc.110.078964</pub-id>
          <?supplied-pmid 21098734?>
          <pub-id pub-id-type="pmid">21098734</pub-id>
        </element-citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cernadas</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Doyle</surname>
              <given-names>EL</given-names>
            </name>
            <name>
              <surname>Niño-Liu</surname>
              <given-names>DO</given-names>
            </name>
            <name>
              <surname>Wilkins</surname>
              <given-names>KE</given-names>
            </name>
            <name>
              <surname>Bancroft</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Code-assisted discovery of TAL effector targets in bacterial leaf streak of rice reveals contrast with bacterial blight and a novel susceptibility gene</article-title>
          <source>PLoS Pathog</source>
          <year>2014</year>
          <volume>10</volume>
          <issue>2</issue>
          <fpage>e1003972</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.ppat.1003972</pub-id>
          <?supplied-pmid 24586171?>
          <pub-id pub-id-type="pmid">24586171</pub-id>
        </element-citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kay</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hahn</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Marois</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Hause</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Bonas</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>A bacterial effector acts as a plant transcription factor and induces a cell size regulator</article-title>
          <source>Science</source>
          <year>2007</year>
          <volume>318</volume>
          <issue>5850</issue>
          <fpage>648</fpage>
          <lpage>651</lpage>
          <pub-id pub-id-type="doi">10.1126/science.1144956</pub-id>
          <?supplied-pmid 17962565?>
          <pub-id pub-id-type="pmid">17962565</pub-id>
        </element-citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Zou</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Ye</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Xiong</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Ji</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Zakria</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A Potential disease susceptibility gene CsLOB of citrus is targeted by a major virulence effector PthA of Xanthomonas citri subsp. citri</article-title>
          <source>Molecular plant</source>
          <year>2014</year>
          <volume>7</volume>
          <issue>5</issue>
          <fpage>912</fpage>
          <lpage>915</lpage>
          <pub-id pub-id-type="doi">10.1093/mp/sst176</pub-id>
          <?supplied-pmid 24398629?>
          <pub-id pub-id-type="pmid">24398629</pub-id>
        </element-citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wichmann</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Bergelson</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Effector genes of Xanthamonas axonopodis pv. vesicatoria promote transmission and enhance other fitness traits in the field</article-title>
          <source>Genetics</source>
          <year>2004</year>
          <volume>166</volume>
          <issue>2</issue>
          <fpage>693</fpage>
          <lpage>706</lpage>
          <pub-id pub-id-type="doi">10.1534/genetics.166.2.693</pub-id>
          <?supplied-pmid 15020460?>
          <pub-id pub-id-type="pmid">15020460</pub-id>
        </element-citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Sugio</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>White</surname>
              <given-names>FF</given-names>
            </name>
          </person-group>
          <article-title>Os8N3 is a host disease-susceptibility gene for bacterial blight of rice</article-title>
          <source>Proceedings of the National Academy of Sciences</source>
          <year>2006</year>
          <volume>103</volume>
          <issue>27</issue>
          <fpage>10503</fpage>
          <lpage>10508</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.0604088103</pub-id>
        </element-citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>De Feyter</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Gabriel</surname>
              <given-names>DW</given-names>
            </name>
          </person-group>
          <article-title>Host-specific symptoms and increased release of Xanthomonas citri and X. campestris pv. malvacearum from leaves are determined by the 102-bp tandem repeats of pthA and avrb6, respectively</article-title>
          <source>MPMI-Molecular Plant Microbe Interactions</source>
          <year>1994</year>
          <volume>7</volume>
          <issue>3</issue>
          <fpage>345</fpage>
          <lpage>355</lpage>
          <pub-id pub-id-type="doi">10.1094/MPMI-7-0345</pub-id>
        </element-citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhou</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Peng</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Long</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Sosso</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Eom</surname>
              <given-names>JS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Gene targeting by the TAL effector PthXo2 reveals cryptic resistance gene for bacterial blight of rice</article-title>
          <source>The Plant Journal</source>
          <year>2015</year>
          <volume>82</volume>
          <issue>4</issue>
          <fpage>632</fpage>
          <lpage>643</lpage>
          <pub-id pub-id-type="doi">10.1111/tpj.12838</pub-id>
          <?supplied-pmid 25824104?>
          <pub-id pub-id-type="pmid">25824104</pub-id>
        </element-citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cohn</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bart</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Shybut</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Dahlbeck</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Gomez</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Morbitzer</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Xanthomonas axonopodis virulence is promoted by a transcription activator-like effector-mediated induction of a SWEET sugar transporter in cassava</article-title>
          <source>Molecular Plant-Microbe Interactions</source>
          <year>2014</year>
          <volume>27</volume>
          <issue>11</issue>
          <fpage>1186</fpage>
          <lpage>1198</lpage>
          <pub-id pub-id-type="doi">10.1094/MPMI-06-14-0161-R</pub-id>
          <?supplied-pmid 25083909?>
          <pub-id pub-id-type="pmid">25083909</pub-id>
        </element-citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hummel</surname>
              <given-names>AW</given-names>
            </name>
            <name>
              <surname>Doyle</surname>
              <given-names>EL</given-names>
            </name>
            <name>
              <surname>Bogdanove</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
          <article-title>Addition of transcription activator‐like effector binding sites to a pathogen strain‐specific rice bacterial blight resistance gene makes it effective against additional strains and against bacterial leaf streak</article-title>
          <source>New Phytologist</source>
          <year>2012</year>
          <volume>195</volume>
          <issue>4</issue>
          <fpage>883</fpage>
          <lpage>893</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1469-8137.2012.04216.x</pub-id>
          <?supplied-pmid 22747776?>
          <pub-id pub-id-type="pmid">22747776</pub-id>
        </element-citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <mixed-citation publication-type="other">Zeng X, Tian D, Gu K, Zhou Z, Yang X, Luo Y, et al. Genetic engineering of the Xa10 promoter forbroad-spectrum and durable resistance to Xanthomonas oryzae pv. oryzae. Plant Biotechnol J. 2015;13(7):993-1001.</mixed-citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>White</surname>
              <given-names>FF</given-names>
            </name>
          </person-group>
          <article-title>Diverse members of the AvrBs3/PthA family of type III effectors are major virulence determinants in bacterial blight disease of rice</article-title>
          <source>Molecular plant-microbe interactions</source>
          <year>2004</year>
          <volume>17</volume>
          <issue>11</issue>
          <fpage>1192</fpage>
          <lpage>1200</lpage>
          <pub-id pub-id-type="doi">10.1094/MPMI.2004.17.11.1192</pub-id>
          <?supplied-pmid 15553245?>
          <pub-id pub-id-type="pmid">15553245</pub-id>
        </element-citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ruan</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Qian</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Fang</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Shi</surname>
              <given-names>Z</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>De novo assembly of human genomes with massively parallel short read sequencing</article-title>
          <source>Genome research</source>
          <year>2010</year>
          <volume>20</volume>
          <issue>2</issue>
          <fpage>265</fpage>
          <lpage>272</lpage>
          <pub-id pub-id-type="doi">10.1101/gr.097261.109</pub-id>
          <?supplied-pmid 20019144?>
          <pub-id pub-id-type="pmid">20019144</pub-id>
        </element-citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Durbin</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Fast and accurate long-read alignment with Burrows–Wheeler transform</article-title>
          <source>Bioinformatics</source>
          <year>2010</year>
          <volume>26</volume>
          <issue>5</issue>
          <fpage>589</fpage>
          <lpage>595</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/btp698</pub-id>
          <?supplied-pmid 20080505?>
          <pub-id pub-id-type="pmid">20080505</pub-id>
        </element-citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>DePristo</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Banks</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Poplin</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Garimella</surname>
              <given-names>KV</given-names>
            </name>
            <name>
              <surname>Maguire</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Hartl</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A framework for variation discovery and genotyping using next-generation DNA sequencing data</article-title>
          <source>Nature genetics</source>
          <year>2011</year>
          <volume>43</volume>
          <issue>5</issue>
          <fpage>491</fpage>
          <lpage>498</lpage>
          <pub-id pub-id-type="doi">10.1038/ng.806</pub-id>
          <?supplied-pmid 21478889?>
          <pub-id pub-id-type="pmid">21478889</pub-id>
        </element-citation>
      </ref>
      <ref id="CR51">
        <label>51.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McKenna</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hanna</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Banks</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Sivachenko</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Cibulskis</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kernytsky</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data</article-title>
          <source>Genome research</source>
          <year>2010</year>
          <volume>20</volume>
          <issue>9</issue>
          <fpage>1297</fpage>
          <lpage>1303</lpage>
          <pub-id pub-id-type="doi">10.1101/gr.107524.110</pub-id>
          <?supplied-pmid 20644199?>
          <pub-id pub-id-type="pmid">20644199</pub-id>
        </element-citation>
      </ref>
      <ref id="CR52">
        <label>52.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Overbeek</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Olson</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Pusch</surname>
              <given-names>GD</given-names>
            </name>
            <name>
              <surname>Olsen</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Davis</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Disz</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The SEED and the Rapid Annotation of microbial genomes using Subsystems Technology (RAST)</article-title>
          <source>Nucleic acids research</source>
          <year>2014</year>
          <volume>42</volume>
          <issue>D1</issue>
          <fpage>D206</fpage>
          <lpage>D214</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkt1226</pub-id>
          <?supplied-pmid 24293654?>
          <pub-id pub-id-type="pmid">24293654</pub-id>
        </element-citation>
      </ref>
      <ref id="CR53">
        <label>53.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Siguier</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Pérochon</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lestrade</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Mahillon</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Chandler</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>ISfinder: the reference centre for bacterial insertion sequences</article-title>
          <source>Nucleic acids research</source>
          <year>2006</year>
          <volume>34</volume>
          <issue>suppl 1</issue>
          <fpage>D32</fpage>
          <lpage>D36</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkj014</pub-id>
          <?supplied-pmid 16381877?>
          <pub-id pub-id-type="pmid">16381877</pub-id>
        </element-citation>
      </ref>
      <ref id="CR54">
        <label>54.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Young</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>D-C</given-names>
            </name>
            <name>
              <surname>Shearman</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Fargier</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>A multilocus sequence analysis of the genus Xanthomonas</article-title>
          <source>Systematic and Applied Microbiology</source>
          <year>2008</year>
          <volume>31</volume>
          <issue>5</issue>
          <fpage>366</fpage>
          <lpage>377</lpage>
          <pub-id pub-id-type="doi">10.1016/j.syapm.2008.06.004</pub-id>
          <?supplied-pmid 18783906?>
          <pub-id pub-id-type="pmid">18783906</pub-id>
        </element-citation>
      </ref>
      <ref id="CR55">
        <label>55.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Paradis</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Claude</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Strimmer</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>APE: analyses of phylogenetics and evolution in R language</article-title>
          <source>Bioinformatics</source>
          <year>2004</year>
          <volume>20</volume>
          <issue>2</issue>
          <fpage>289</fpage>
          <lpage>290</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/btg412</pub-id>
          <?supplied-pmid 14734327?>
          <pub-id pub-id-type="pmid">14734327</pub-id>
        </element-citation>
      </ref>
      <ref id="CR56">
        <label>56.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Potnis</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Krasileva</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Chow</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Almeida</surname>
              <given-names>NF</given-names>
            </name>
            <name>
              <surname>Patil</surname>
              <given-names>PB</given-names>
            </name>
            <name>
              <surname>Ryan</surname>
              <given-names>RP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Comparative genomics reveals diversity among xanthomonads infecting tomato and pepper</article-title>
          <source>BMC genomics</source>
          <year>2011</year>
          <volume>12</volume>
          <issue>1</issue>
          <fpage>146</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-2164-12-146</pub-id>
          <?supplied-pmid 21396108?>
          <pub-id pub-id-type="pmid">21396108</pub-id>
        </element-citation>
      </ref>
      <ref id="CR57">
        <label>57.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Ausubel</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Brent</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kingston</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Moore</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Seidman</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <source>Current Protocols in Molecular Biology John Wiley &amp; Sons New York NY</source>
          <year>1994</year>
        </element-citation>
      </ref>
      <ref id="CR58">
        <label>58.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alexeyev</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>The pKNOCK series of broad-host-range mobilizable suicide vectors for gene knockout and targeted DNA insertion into the chromosome of gram-negative bacteria</article-title>
          <source>Biotechniques</source>
          <year>1999</year>
          <volume>26</volume>
          <issue>5</issue>
          <fpage>824</fpage>
          <lpage>826</lpage>
          <?supplied-pmid 10337469?>
          <pub-id pub-id-type="pmid">10337469</pub-id>
        </element-citation>
      </ref>
      <ref id="CR59">
        <label>59.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hopkins</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>White</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Guo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Leach</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Identification of a family of avirulence genes from Xanthomonas oryzae pv. oryzae</article-title>
          <source>Mol Plant-Microbe Interact</source>
          <year>1992</year>
          <volume>5</volume>
          <issue>6</issue>
          <fpage>451</fpage>
          <lpage>459</lpage>
          <pub-id pub-id-type="doi">10.1094/MPMI-5-451</pub-id>
          <?supplied-pmid 1335800?>
          <pub-id pub-id-type="pmid">1335800</pub-id>
        </element-citation>
      </ref>
      <ref id="CR60">
        <label>60.</label>
        <mixed-citation publication-type="other">Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expressionanalyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;20;43(7):e47.</mixed-citation>
      </ref>
      <ref id="CR61">
        <label>61.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smyth</surname>
              <given-names>GK</given-names>
            </name>
          </person-group>
          <article-title>Linear models and empirical bayes methods for assessing differential expression in microarray experiments</article-title>
          <source>Statistical applications in genetics and molecular biology</source>
          <year>2004</year>
          <volume>3</volume>
          <fpage>Article3</fpage>
          <pub-id pub-id-type="doi">10.2202/1544-6115.1027</pub-id>
          <?supplied-pmid 16646809?>
          <pub-id pub-id-type="pmid">16646809</pub-id>
        </element-citation>
      </ref>
      <ref id="CR62">
        <label>62.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Benjamini</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Hochberg</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Controlling the false discovery rate - a practical and powerful approach to multiple testing</article-title>
          <source>J Roy Stat Soc B Met</source>
          <year>1995</year>
          <volume>57</volume>
          <issue>1</issue>
          <fpage>289</fpage>
          <lpage>300</lpage>
        </element-citation>
      </ref>
      <ref id="CR63">
        <label>63.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Livak</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Schmittgen</surname>
              <given-names>TD</given-names>
            </name>
          </person-group>
          <article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method</article-title>
          <source>Methods</source>
          <year>2001</year>
          <volume>25</volume>
          <issue>4</issue>
          <fpage>402</fpage>
          <lpage>408</lpage>
          <pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id>
          <?supplied-pmid 11846609?>
          <pub-id pub-id-type="pmid">11846609</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:4700565</identifier><datestamp>2016-01-06</datestamp><setSpec>behbrain</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="http://jats.nlm.nih.gov/ns/archiving/1.0/ http://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Behav Brain Funct</journal-id>
      <journal-id journal-id-type="iso-abbrev">Behav Brain Funct</journal-id>
      <journal-title-group>
        <journal-title>Behavioral and Brain Functions : BBF</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1744-9081</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC4700565</article-id>
      <article-id pub-id-type="pmcid">PMC4700565</article-id>
      <article-id pub-id-type="pmc-uid">4700565</article-id>
      <article-id pub-id-type="publisher-id">86</article-id>
      <article-id pub-id-type="doi">10.1186/s12993-015-0086-4</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Long-term influence of recurrent acute otitis media on neural involuntary attention switching in 2-year-old children</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Haapala</surname>
            <given-names>Sini</given-names>
          </name>
          <address>
            <phone>+358 41 468 4259</phone>
            <email>sini.haapala@utu.fi</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Niemitalo-Haapola</surname>
            <given-names>Elina</given-names>
          </name>
          <address>
            <email>elina.niemitalo-haapola@oulu.fi</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Raappana</surname>
            <given-names>Antti</given-names>
          </name>
          <address>
            <email>araappa@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff4"/>
          <xref ref-type="aff" rid="Aff5"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kujala</surname>
            <given-names>Tiia</given-names>
          </name>
          <address>
            <email>tiia.kujala@oulu.fi</email>
          </address>
          <xref ref-type="aff" rid="Aff5"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Suominen</surname>
            <given-names>Kalervo</given-names>
          </name>
          <address>
            <email>vlkalervo.suominen@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jansson-Verkasalo</surname>
            <given-names>Eira</given-names>
          </name>
          <address>
            <email>eira.jansson-verkasalo@utu.fi</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kujala</surname>
            <given-names>Teija</given-names>
          </name>
          <address>
            <email>teija.m.kujala@helsinki.fi</email>
          </address>
          <xref ref-type="aff" rid="Aff6"/>
          <xref ref-type="aff" rid="Aff7"/>
        </contrib>
        <aff id="Aff1"><label/>Department of Speech and Language Pathology, Faculty of Social Sciences, Publicum, University of Turku, 20014 Turku, Finland </aff>
        <aff id="Aff2"><label/>Clinical Neurophysiology, Oulu University Hospital, PO Box 21, 90029 Oulu, Finland </aff>
        <aff id="Aff3"><label/>Child Language Research Center and Logopedics, Faculty of Humanities, University of Oulu, PO Box 1000, 90014 Oulu, Finland </aff>
        <aff id="Aff4"><label/>Department of Otolaryngology–Head and Neck Surgery, Oulu University Hospital, PO Box 21, 90029 Oulu, Finland </aff>
        <aff id="Aff5"><label/>Department of Otolaryngology, University of Oulu, PO Box 5000, 90014 Oulu, Finland </aff>
        <aff id="Aff6"><label/>Cicero Learning, University of Helsinki, PO Box 9, 00014 Helsinki, Finland </aff>
        <aff id="Aff7"><label/>Cognitive Brain Research Unit, Institute of Behavioural Sciences, University of Helsinki, PO Box 9, 00014 Helsinki, Finland </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>4</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>4</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2015</year>
      </pub-date>
      <volume>12</volume>
      <elocation-id>1</elocation-id>
      <history>
        <date date-type="received">
          <day>30</day>
          <month>9</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>24</day>
          <month>12</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© Haapala et al. 2016</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>A large group of young children are exposed to repetitive middle ear infections but the effects of the fluctuating hearing sensations on immature central auditory system are not fully understood. The present study investigated the consequences of early childhood recurrent acute otitis media (RAOM) on involuntary auditory attention switching.</p>
        </sec>
        <sec>
          <title>Methods</title>
          <p>By utilizing auditory event-related potentials, neural mechanisms of involuntary attention were studied in 22–26 month-old children (N = 18) who had had an early childhood RAOM and healthy controls (N = 19). The earlier and later phase of the P3a (eP3a and lP3a) and the late negativity (LN) were measured for embedded novel sounds in the passive multi-feature paradigm with repeating standard and deviant syllable stimuli. The children with RAOM had tympanostomy tubes inserted and all the children in both study groups had to have clinically healthy ears at the time of the measurement assessed by an otolaryngologist.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>The results showed that lP3a amplitude diminished less from frontal to central and parietal areas in the children with RAOM than the controls. This might reflect an immature control of involuntary attention switch. Furthermore, the LN latency was longer in children with RAOM than in the controls, which suggests delayed reorientation of attention in RAOM.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>The lP3a and LN responses are affected in toddlers who have had a RAOM even when their ears are healthy. This suggests detrimental long-term effects of RAOM on the neural mechanisms of involuntary attention.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Otitis media</kwd>
        <kwd>Involuntary attention</kwd>
        <kwd>Orienting</kwd>
        <kwd>ERPs</kwd>
        <kwd>P3a</kwd>
        <kwd>Late negativity</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution>Langnet Doctoral Programme, Ministry of Education and Culture (FI)</institution>
          </funding-source>
        </award-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004756</institution-id>
              <institution>Emil Aaltosen Säätiö</institution>
            </institution-wrap>
          </funding-source>
        </award-group>
        <award-group>
          <funding-source>
            <institution>Alma and K.A. Snellman Foundation (FI)</institution>
          </funding-source>
        </award-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002341</institution-id>
              <institution>Suomen Akatemia</institution>
            </institution-wrap>
          </funding-source>
          <award-id>276414</award-id>
          <principal-award-recipient>
            <name>
              <surname>Kujala</surname>
              <given-names>Teija</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
      </funding-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>© The Author(s) 2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Background</title>
      <p>About 30 % of children have recurrent middle ear infections (recurrent acute otitis media, RAOM) in their early childhood [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Due to challenges in diagnosing and classifying middle ear status, otitis media (OM) is commonly used as a general term for various forms of middle ear fluid and inflammation. A general definition for RAOM has been three or more episodes of acute otitis media (AOM) per 6 months or four or more AOM episodes per year [<xref ref-type="bibr" rid="CR3">3</xref>]. After an episode of AOM, middle ear fluid is present for few days to over 2 months [<xref ref-type="bibr" rid="CR4">4</xref>]. Fluid in the middle ear causes about 20–30 dB conductive hearing loss [<xref ref-type="bibr" rid="CR5">5</xref>], and, especially when asymmetric, it affects interaural temporal and level difference cues compromising binaural sound localization [<xref ref-type="bibr" rid="CR6">6</xref>]. Fluctuating hearing sensations during the development of central auditory system has been connected to atypical auditory processing [<xref ref-type="bibr" rid="CR7">7</xref>–<xref ref-type="bibr" rid="CR11">11</xref>], which can lead to problems in language acquisition [<xref ref-type="bibr" rid="CR12">12</xref>]. Therefore, it is necessary to get a better understanding of the consequences of early childhood RAOM on immature central nervous system.</p>
      <p>Behavioral studies in children with OM have shown problems in regulation of auditory attention [<xref ref-type="bibr" rid="CR13">13</xref>–<xref ref-type="bibr" rid="CR18">18</xref>]. Involuntary orientation to environmental events as well as selective maintenance of attention is essential for speech processing and language learning. Involuntary attention accounts for the detection and selection of potentially biologically meaningful information of events unrelated to the ongoing task [<xref ref-type="bibr" rid="CR19">19</xref>]. For example, a screeching noise of a braking car causes an attention switch of a pedestrian who is talking on the phone, and leads to the distraction of the ongoing activity. After the evaluation of the irrelevant novel stimulus, the reorientation back to the recent activity takes place. Involuntary attention is a bottom-up (stimulus-driven) process [<xref ref-type="bibr" rid="CR19">19</xref>] but during maturation the developing top-down mechanisms start to inhibit distractors which are not meaningful, in other words, children learn to separate relevant from irrelevant stimuli [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>]. An excessive tendency to orient to the irrelevant stimuli requiring a lot of attentional resources makes goal-directed behavior harder [<xref ref-type="bibr" rid="CR22">22</xref>].</p>
      <p>School-aged children with OM history were shown to have deficits of selective auditory attention in dichotic listening tasks [<xref ref-type="bibr" rid="CR13">13</xref>–<xref ref-type="bibr" rid="CR15">15</xref>]. They also showed increased reorientation time of attention during behavioral tasks [<xref ref-type="bibr" rid="CR16">16</xref>]. Rated by their teachers, school-children with OM history were suggested to be less task-oriented [<xref ref-type="bibr" rid="CR17">17</xref>] but not in all studies [<xref ref-type="bibr" rid="CR23">23</xref>]. Studies in toddlers are scarce, probably due to the weak co-operation skills in children at this age. However, toddlers with chronic OM were shown to express reduced attention during book reading at the time of middle ear effusion and, according the questionnaire, their mothers rated them as easily distractible [<xref ref-type="bibr" rid="CR18">18</xref>]. The neural mechanisms beyond these findings are still unknown.</p>
      <p>Event-related potentials (ERPs) are a feasible approach for studying non-invasively neural mechanisms of involuntary auditory attention without tasks requiring co-operation skills [<xref ref-type="bibr" rid="CR24">24</xref>]. The auditory P3a is a large positive deflection elicited by unexpected, novel sounds which substantially differ from other sounds, for example slam of the door or human cough. The P3a reflects involuntary attention mechanisms and orientation of attention [<xref ref-type="bibr" rid="CR22">22</xref>]. It peaks fronto-centrally at 200–300 ms after the onset of a distracting stimulus [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>].</p>
      <p>P3a was often found to be biphasic [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. Two phases, early and late, have been identified in children [<xref ref-type="bibr" rid="CR28">28</xref>–<xref ref-type="bibr" rid="CR30">30</xref>] already at the age of 2 years [<xref ref-type="bibr" rid="CR31">31</xref>]. Early P3a (eP3a) was suggested to reflect the automatic detection of violation in the neural model of existing world and thus, to represent the orientation of attention [<xref ref-type="bibr" rid="CR32">32</xref>]. It is maximal at vertex and diminishes posteriorly and laterally [<xref ref-type="bibr" rid="CR33">33</xref>]. In contrast, late P3a (lP3a) was suggested to reflect actual attention switch and it is maximal frontally [<xref ref-type="bibr" rid="CR33">33</xref>]. Morphology of these responses is quite similar in children and adults but the scalp topography of children’s P3a is more anterior than that of adults [<xref ref-type="bibr" rid="CR30">30</xref>]. The eP3a may mature earlier than lP3a, which continues to enhance frontally during development [<xref ref-type="bibr" rid="CR34">34</xref>]. Hence, processing of acoustic novelty in the childhood resembles that in the adulthood although some underlying neural networks still continue to develop. Atypical P3a responses have been connected to abnormal involuntary attention, for example, parietally enhanced lP3a was found in children with attention deficit hyperactivity disorder (ADHD) [<xref ref-type="bibr" rid="CR29">29</xref>].</p>
      <p>The ERP waveform also reflects reorienting of attention back to the primary task after recognizing and evaluating a distracting stimulus [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>]. In adults, P3a is followed by reorienting negativity (RON) [<xref ref-type="bibr" rid="CR37">37</xref>]. A counterpart of RON in children was suggested to be the late negativity (LN, also called as negative component, Nc) [<xref ref-type="bibr" rid="CR28">28</xref>–<xref ref-type="bibr" rid="CR31">31</xref>]. The LN latency, peaking at around 400–700 ms after the onset of a novel stimulus, reflects reorienting time [<xref ref-type="bibr" rid="CR21">21</xref>]. The LN has the maximal amplitude at fronto-central scalp areas [<xref ref-type="bibr" rid="CR21">21</xref>]. Large LN reflects enhanced neural effort to reorienting [<xref ref-type="bibr" rid="CR37">37</xref>] or more attention paid to the surprising event [<xref ref-type="bibr" rid="CR30">30</xref>]. During maturation, the LN amplitude has been suggested to decrease [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR34">34</xref>].</p>
      <p>The aim of this study was to compare the involuntary attentional mechanisms in 2-year-old healthy children with RAOM history and their healthy age-matched controls by recording auditory ERPs. For that purpose, novel stimuli were embedded in the multi-feature paradigm with syllables to elicit eP3a, lP3a, and LN. It was hypothesized that children with RAOM would show atypically enhanced and/or short latency P3a reflecting enhanced distractibility for the intrusive novel sounds and to have larger amplitude and/or longer latency of LN indicating more neural effort to reorienting and/or longer re-orientation time of attention than their healthy peers. Studies of P3a and novelty-related LN in toddlers are scarce and to our knowledge, this is the first study measuring these responses in children with RAOM.</p>
    </sec>
    <sec id="Sec2" sec-type="materials|methods">
      <title>Methods</title>
      <sec id="Sec3">
        <title>Participants</title>
        <p>Twenty-four children with a middle ear infection history were recruited to the RAOM group (at least three AOM per 6 months or four AOM per 1 year) from the Ear, Nose and Throat clinic of Oulu University hospital. During 1 year in 2009–2010, all children aged 22–26 months fulfilling the criteria of this study with a tympanostomy tube insertion participated (for a more detailed AOM history see [<xref ref-type="bibr" rid="CR7">7</xref>]). The EEG recording was done on average 33 days (range 20–56 d) after the tympanostomy tube insertion. Twenty-two age matched control children with 0–2 AOM were recruited with public advertisements. All families participated voluntarily to the study and an informed written consent was obtained from the parents of children. Families were paid 15€ for travelling costs. The study was in accordance of Declaration of Helsinki and approved by the Ethics Committee of Northern Osthrobotnia Hospital District (reference number 6/2009).</p>
        <p>Participants were from monolingual Finnish-speaking families. They were born full-term with normal birth weight, and developing typically in their sensory, cognitive, and motor skills according to parental questionnaires and the examinations at the family and health care clinics during the first 2 years of life. No family history of speech, language, or other developmental impairments or severe neuropsychiatric diseases was allowed. The standardized Finnish version of Reynell Developmental Language Scales III, the Comprehension scale [<xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR39">39</xref>] was applied to exclude developmental language disorders. At the time of the EEG recording, transient evoked otoacoustic emissions (TEOAEs; nonlinear click sequence 1.5–4.5 kHz, 73 dB SPL, pass/refer result; MADSEN AccuScreen<sup>®</sup> pro, GN Otometrics, Taastrup, Denmark) were checked. Four children with RAOM and six control children did not co-operate in the TEOAE measurement, but all the children had passed a TEOAE screening at a postnatal period in Oulu University Hospital. Right before the EEG recording, all children were assessed with pneumatic otoscopy and if needed by tympanometry and/or otomicroscopy by an otolaryngologist to ensure that they had clinically healthy ears at the time of the measurement.</p>
        <p>In the RAOM group, one child was excluded because of a family history of dyslexia and one because the results of the Reynell III did not meet the criteria for normal speech comprehension, and an additional examination of speech-language pathologist showed signs of severe language disorder. Two children with RAOM had atypically enhanced P3a responses (24.07 and 23.20 µV), and the statistical analysis indicated them to be outliers, i.e., their responses being at abnormal distance from the other ones (2.51–17.63 µV). Because we hypothesized that the children with RAOM would have enhanced P3a responses, we decided to exclude these two children from the further analysis to avoid the bias of these extreme values on the results of the RAOM group. Furthermore, two children did not arrive to the measurement at the appointed time. In the control group, two children had to be excluded from the analysis because of a large amount of alpha activity in their EEG leading to low signal-to-noise ratio. One control children was excluded because of acute OM diagnosed at the time of measurement. The total number of children in this study was 18 in the RAOM group and 19 in the control group after these exclusions. There were no significant differences between the final groups in gender (RAOM: 10 boys; controls 11 boys), age (RAOM: mean 24 months, min–max 22–26; controls: mean 24 months, min–max 22–26), or mother’s education (RAOM: 4 low, 13 middle or high; controls 2 low, 17 middle or high). The educational information of one mother in the RAOM group was not available.</p>
      </sec>
      <sec id="Sec4">
        <title>Stimuli and experimental design</title>
        <p>ERPs were recorded in a passive condition with the multi-feature paradigm (“Optimum-1”), which was shown to be a fast and eligible method for obtaining several ERPs reflecting different stages of auditory processing in adults [<xref ref-type="bibr" rid="CR40">40</xref>–<xref ref-type="bibr" rid="CR42">42</xref>], school-aged children [<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR44">44</xref>], and toddlers [<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR46">46</xref>]. In the multi-feature paradigm, the standard and the deviant sounds are presented in the same sequence so that every other stimulus is the standard and every other stimulus is one of the several deviants. In the deviants, only one sound feature (e.g., vowel or frequency) of the standard stimulus is changed at a time while the other features remain the same and strengthen the memory representation of the standard stimulus. To study attentional mechanisms, distracting novel sounds may also be embedded in the same sound stream [<xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR46">46</xref>].</p>
        <p>The standards were Finnish semisynthetic consonant–vowel syllables/ke:/or/pi:/(duration 170 ms). Every other stimulus sequence included standard/ke:/and every other included standard/pi:/. The deviants (duration 170 ms) were five different deviations in these syllables (frequency F0 ± 8 Hz, intensity ± 7 dB, consonant from/ke:/to/pe:/and from/pi:/to/ki:/, vowel from/ke:/to/ki:/and from/pi:/to/pe:/, and vowel duration from syllable length of 170 ms to 120 ms) [<xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR47">47</xref>]. The obligatory and MMN responses elicited by standards and deviants were reported earlier [<xref ref-type="bibr" rid="CR7">7</xref>]. In addition, there were totally differing novel sounds (duration 200 ms, including a fall and a rise time of 10 ms), which were non-synthetic, environmental human (e.g. coughs and laughs) or non-human (e.g. door slamming and telephone ringing) sounds [<xref ref-type="bibr" rid="CR42">42</xref>]. In the stimulus sequence, every other stimulus was a standard (probability 50 %) and every other was one of the deviants (probability 8.3 % for each) or a novel sound (probability 8.3 %). The presentation of stimuli was pseudo-randomized so that all five deviants and one novel stimulus appeared once among 12 successive stimuli, and the same deviant or novel was never repeated after the standard stimulus following it. The stimulus onset asynchrony was 670 ms. The stimuli were in the sequences lasting for about 6 min., each starting with 10 standards, and including 540 stimuli from which 275 were standards and 44 were novels sounds, the rest being deviant syllables (44 of each deviant type). Three to four stimulus sequences were presented to each participant.</p>
        <p>Stimuli were presented in an electrically shielded and sound-attenuated room (reverberation time .3 s, background noise level 43 dB) with the sound pressure level of 75 dB via two loudspeakers (Genelec<sup>®</sup> 6010A, Genelec Ltd., Iisalmi, Finland). The loudspeakers were in front of the child at a distance of 1.3 m and in a 40-degree angle from the child’s head.</p>
      </sec>
      <sec id="Sec5">
        <title>EEG recording</title>
        <p>The EEG (.16–1000 Hz, sampling rate 5000 Hz) was recorded with 32 channel electro-cap with Ag–AgCl electrodes placed according to the international 10/20 system (ActiCAP 002 and Brain Vision BrainAmp system and software; Brain Products GmbH, Gilching, Germany). The FCz electrode served as online reference and impedances were kept below 20 kΩ. Additional electrodes placed above the outer canthus of the right eye and below the outer canthus of the left eye with bipolar montage were used for electro-oculogram.</p>
        <p>Toddlers sat in a chair or in their parent’s lap, watching voiceless cartoons or children’s books, or played with silent toys. The parents were instructed to be as quiet as possible. The recording was camera monitored from the next room and an experienced EEG technician monitored the quality of the EEG signal during recording. During the same recording session, the children participated in an EEG recording with three to four stimulus sequences with background noise [<xref ref-type="bibr" rid="CR48">48</xref>]. The total examination time for each participant was about two and half hours, from which the EEG registration took about 45 min. There were breaks with refreshments between the stimulus sequences.</p>
      </sec>
      <sec id="Sec6">
        <title>Analysis</title>
        <p>Brain Vision Analyzer 2.0 (BrainProducts, GmpH) was used for offline analysis. Data were down sampled to 250 Hz and re-referenced to the average of the mastoid electrodes. Band pass filtering of .5–45 Hz, 24 dB/oct was applied to avoid aliasing and signals not originated from the brain [<xref ref-type="bibr" rid="CR49">49</xref>]. After visual inspection, channels Fp1, Fp2, PO9, PO10, O1, Oz, and O2 were disabled from further analyzis because of artefacts. Ocular correction was done with an independent component analysis. Extracerebral artefacts with voltage exceeding ±150 μV at any electrode were removed and data were filtered with band pass of 1–20 Hz, 48 dB/oct. ERPs for standard and novel stimuli were averaged from baseline corrected EEG epochs of –100 ms prestimulus to 670 ms after stimulus onset. The first 10 standard stimuli in each recorded sequence and the standard stimuli right after the novel stimuli were excluded from the analysis. Two-tailed <italic>t</italic>-test indicated no significant group differences in the mean number of averaged epochs for standards or novels. The mean number of epochs for standard and novel stimuli in the RAOM group was 675 (min–max 373–856) and 133 (min–max 75–170), respectively, and in the control group 719 (min–max 517–856) and 143 (min–max 99–171), respectively.</p>
        <p>To identify the P3a and LN, ERPs for standards were subtracted from those for novels. The grand average difference waves showed the biphasic P3a elicited by novel stimuli. Hence, eP3a and lP3a were separately analyzed. The channel selection for the peak detection was done after visual inspection, which showed the most prominent eP3a at the Cz electrode and lP3a and LN at the Fz electrode. The peak detection was done individually for each child within time windows of 180–300 ms for eP3a, 300–440 ms for lP3a, and 420–600 ms for LN. The peak latencies were determined from the most positive (eP3a and lP3a) or the most negative (LN) peak within those windows, and the mean peak amplitudes were calculated from ±20 ms time window around the peak latencies.</p>
        <p>The statistical analyses were done for the F3, Fz, F4, C3, Cz, C4, P3, Pz, and P4 electrodes. The existence of each ERP was determined by comparing its amplitude to zero with a two-tailed <italic>t</italic>-test. The amplitude differences between the groups were examined with repeated measures analysis of variance (ANOVA) and the Fisher’s least significant difference (LSD) post hoc test. In ANOVA, between-subject factor was group (RAOM vs. control) and within-subject factors were anterior-posterior (AP; F3-Fz-F4 vs. C3-Cz-C4 vs. P3-Pz-P4) and right-left (RL; F3-C3-P3 vs. Fz-Cz-Pz vs. F4-C4-P4) electrode positions. The Huynh–Feldt correction was applied when appropriate. One-way ANOVA was used for studying latency differences between the groups. For the effect-size estimation, the partial eta squared (<italic>ƞ</italic><sub arrange="stack"><italic>p</italic></sub><sup arrange="stack"><italic>2</italic></sup>) was calculated.</p>
      </sec>
    </sec>
    <sec id="Sec7" sec-type="results">
      <title>Results</title>
      <p>The eP3a significantly differed from zero in the children with RAOM and in the controls (two tailed <italic>t</italic>-test; <italic>p</italic> ≤ .001; Table <xref rid="Tab1" ref-type="table">1</xref>, Fig. <xref rid="Fig1" ref-type="fig">1</xref>) with no group differences in the amplitude, amplitude scalp distribution, or latency. In both groups, the eP3a amplitude was stronger at the frontal and central electrodes than at the parietal electrodes (<italic>F</italic> [2, 57] = 42.09, <italic>p</italic> &lt; .001, <italic>ƞ</italic><sub arrange="stack"><italic>p</italic></sub><sup arrange="stack"><italic>2</italic></sup> = .53; LSD post hoc <italic>p</italic> &lt; .001).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Mean amplitude and latency of ERPs elicited by novel stimuli in children in both groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2"/><th align="left" rowspan="2">Electrode</th><th align="left" colspan="2">Amplitude µV</th><th align="left" colspan="2">Latency ms</th></tr><tr><th align="left">RAOM</th><th align="left">Control</th><th align="left">RAOM</th><th align="left">Control</th></tr></thead><tbody><tr><td align="left">eP3a</td><td align="left">Cz</td><td char="(" align="char">6.66 (4.30)</td><td char="(" align="char">6.97 (3.44)</td><td char="(" align="char">244 (26)</td><td char="(" align="char">248 (25)</td></tr><tr><td align="left">lP3a</td><td align="left">Fz</td><td char="(" align="char">9.30 (3.69)</td><td char="(" align="char">9.67 (3.74)</td><td char="(" align="char">348 (36)</td><td char="(" align="char">341 (22)</td></tr><tr><td align="left">LN</td><td align="left">Fz</td><td char="(" align="char">–2.82 (3.38)</td><td char="(" align="char">–2.34 (3.04)</td><td char="(" align="char">
<italic>599</italic> (40)</td><td char="(" align="char">
<italic>526</italic> (43)</td></tr></tbody></table><table-wrap-foot><p>Standard deviations are in parentheses</p><p>A significant group difference is italized</p><p>
<italic>RAOM</italic> recurrent acute otitis media</p></table-wrap-foot></table-wrap><fig id="Fig1"><label>Fig. 1</label><caption><p>ERPs (eP3a, lP3a, and LN) elicited by novel stimuli in children with recurrent acute otitis media (RAOM) and their controls; <bold>a</bold> grand average standard and novel ERP waves, <bold>b</bold> grand average difference (novel minus standard ERP) waves, and <bold>c</bold> scalp topographies</p></caption><graphic xlink:href="12993_2015_86_Fig1_HTML" id="MO1"/></fig></p>
      <p>There was a significant lP3a in both groups (two tailed <italic>t</italic>-test; <italic>p</italic> ≤ .001; Table <xref rid="Tab1" ref-type="table">1</xref>, Fig. <xref rid="Fig1" ref-type="fig">1</xref>). A repeated measures ANOVA for the lP3a amplitude indicated a significant AP x group interaction (<italic>F</italic> [2, 59] = 3.94, <italic>p</italic> = .03, <italic>ƞ</italic><sub arrange="stack"><italic>p</italic></sub><sup arrange="stack"><italic>2</italic></sup> = .10). According to the LSD post hoc test, the children with RAOM showed a more even AP distribution than the control children who had a clear frontally maximal and posteriorly diminishing amplitude scalp distribution (mean amplitudes frontally 8.99 vs. 9.67 µV, centrally 7.12 vs. 6.04 µV, and parietally 3.64 vs. 2.17 µV in the RAOM and control groups, respectively). Furthermore, a significant AP x RL interaction with no group difference was found (<italic>F</italic> [4, 140] = 4.98, <italic>p</italic> &lt; .001, <italic>ƞ</italic><sub arrange="stack"><italic>p</italic></sub><sup arrange="stack"><italic>2</italic></sup> = .13). LSD post hoc test indicated an even RL amplitude distribution at frontal electrodes, but stronger left hemispheric activation compared to the vertex and the right line at central electrodes (<italic>p</italic> &lt; .001) and also stronger left than right line responses at parietal electrodes (<italic>p</italic> = .03). There was no group difference for the lP3a latency.</p>
      <p>In both groups, a significant LN was found (two tailed <italic>t</italic>-test; RAOM: <italic>p</italic> = .001; control: <italic>p</italic> = .004; Table <xref rid="Tab1" ref-type="table">1</xref>, Fig. <xref rid="Fig1" ref-type="fig">1</xref>). A repeated measures ANOVA for the LN amplitude indicated a significant AP × RL interaction (<italic>F</italic> [4, 148] = 2.96, <italic>p</italic> = .02). This was due to the weakest amplitude at F3 (LSD post hoc; <italic>p</italic> = .001–.03) and the strongest amplitude at Cz (LSD post hoc; <italic>p</italic> = .001–.002). There were no group differences in the amplitude or amplitude scalp distribution of LN. However, one-way ANOVA indicated a significant group difference in the LN latency (<italic>F</italic> [1, 37] = 32.76, <italic>p</italic> &lt; .001, <italic>ƞ</italic><sub arrange="stack"><italic>p</italic></sub><sup arrange="stack"><italic>2</italic></sup> = .47), which peaked later in the children with RAOM than in the controls.</p>
    </sec>
    <sec id="Sec8" sec-type="discussion">
      <title>Discussion</title>
      <p>This study examined the effects of early childhood RAOM on neural mechanisms of involuntary attention at the age of 2 years. For that purpose, the P3a and LN elicited by distracting novel sounds were measured in the linguistic multi-feature paradigm at the time when all the participants had healthy ears and their sound encoding reflected by obligatory ERPs was found to be intact in an earlier study [<xref ref-type="bibr" rid="CR7">7</xref>]. Both the children with RAOM and the controls showed a clearly identifiable P3a with two phases (eP3a and lP3a) and a LN, the morphology of which was found to be consistent with earlier studies in children [<xref ref-type="bibr" rid="CR28">28</xref>–<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR46">46</xref>]. However, the topography and timing of these responses were distinct in the two groups. These findings suggest different maturational trajectories in the two groups of children and suggest that the consequences of OM are not limited to the middle ear effusion period but the effects are long-lasting.</p>
      <p>The amplitude, distribution, or latency of the eP3a did not differ between the groups. This suggests the similar automatic detection of a novel stimulus and the early stages of the orientation of attention [<xref ref-type="bibr" rid="CR32">32</xref>] in the groups. The eP3a was larger frontally and centrally than parietally in both groups being in line with earlier studies in typically developed school-aged children [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR34">34</xref>] and in adults [<xref ref-type="bibr" rid="CR33">33</xref>].</p>
      <p>In contrast, a significant group difference was found in the lP3a reflecting the actual attention switch [<xref ref-type="bibr" rid="CR33">33</xref>]. The lP3a amplitude diminished less in the children with RAOM than in the controls from frontal to central and parietal areas, which may indicate an immature control of attention switch in children with RAOM. A frontally prominent lP3a has been linked to the neural maturation of the frontal cortex and attention control [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR34">34</xref>]. Likewise, an enhanced lP3a at the posterior scalp areas has earlier been found in easily distractible children with ADHD [<xref ref-type="bibr" rid="CR29">29</xref>]. The current result supports the behavioural finding on the distractibility of toddlers with OM [<xref ref-type="bibr" rid="CR18">18</xref>]. Distractibility can lead to weak utilization of the auditory channel in learning [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR50">50</xref>], since it limits the ability to ignore irrelevant auditory stimuli. At 2 years of age, this may contribute to the emerging language by disrupting child’s engagement with social-communicative actions critical for language learning.</p>
      <p>The LN latency was longer in the children with RAOM than in the controls suggesting delayed reorienting back to the ongoing activity [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR34">34</xref>]. This corresponds with previous results suggesting delayed reorienting in school-children in a behavioral test [<xref ref-type="bibr" rid="CR16">16</xref>] and might indicate that children with RAOM have an abnormally low resistance to auditory distraction. This is supported by our previous results suggesting neural sensitivity to sound loudness changes in these same 2-year-old children with RAOM [<xref ref-type="bibr" rid="CR7">7</xref>]. The result is also consistent with the elevated auditory sensitivity to sounds described in adolescents with childhood OM [<xref ref-type="bibr" rid="CR51">51</xref>].</p>
      <p>Our results show that RAOM has long-term effects leading to abnormal attention control at the age of 2 years when rapid developmental neural changes are involved. Studies on attentional neural mechanisms in older children with early childhood RAOM would be pertinent since they would disclose whether the neural changes observed are transient or still persisting at the later stages of development.</p>
      <p>There were two children in the RAOM group who were excluded from the group analysis because of their abnormally enhanced P3a responses. The exclusion was done to avoid the bias of these statistically confirmed outliers on the results of the RAOM group. However, we should notice that these extreme P3a responses might reflect a genuine effect of RAOM and indicate enhanced distractibility of these children, but this should be studied further in the future.</p>
      <p>When interpreting the results, it should be taken into account that the accurate hearing thresholds were not available at the time of the measurement. Accurate hearing thresholds can be reliably measured from the age of three onwards [<xref ref-type="bibr" rid="CR52">52</xref>]. Because the participants in the current study were 22–26 months old we decided to use TEOAE screening to exclude congenital hearing losses. However, there were six children in the RAOM group and four children in the control group who could not tolerate the TEOAE measurement at the time of EEG. Because these children had passed the TEOAE screening at the postnatal period, we decided to include them in the study. However, there is a possibility that a child who has passed the TEOAE screening at birth may develop hearing deficit later. Hearing levels were assumed to be at normal levels in all participants while the children with RAOM had had tympanostomy tubes inserted and, according the parental reports, there were no concerns of hearing in the screenings at the family and health care clinics where Finnish children are followed up regularly. Furthermore, these same children showed age-typical cortical sound encoding with no group differences in our earlier study [<xref ref-type="bibr" rid="CR7">7</xref>]. This refers to hearing levels within the normal range at the time of the EEG.</p>
    </sec>
    <sec id="Sec9" sec-type="conclusion">
      <title>Conclusions</title>
      <p>To conclude, this study showed abnormal neural mechanisms of involuntary attention in 2-year-old children with RAOM. For the distracting novel sounds, the RAOM group showed atypical neural organization signified by a more even lP3a scalp distribution in anterior-posterior axis than in the controls, who had a more frontally oriented lP3a. This can be a sign of immature neural processing and enhanced distractibility. Furthermore, the children with RAOM showed delayed re-orienting back to the ongoing activity indicated by their prolonged LN latency. Since all the children had clinically healthy ears at the time of the study, the current results suggest that early childhood RAOM has long-term effects on the immature central nervous system. This further supports the suggestion that early childhood RAOM should be taken as a risk factor for the developing auditory central nervous system.</p>
    </sec>
  </body>
  <back>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>LN</term>
          <def>
            <p>late negativity</p>
          </def>
        </def-item>
        <def-item>
          <term>OM</term>
          <def>
            <p>otitis media</p>
          </def>
        </def-item>
        <def-item>
          <term>RAOM</term>
          <def>
            <p>recurrent acute otitis media</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <ack>
      <title>Authors’ contributions</title>
      <p>SH designed the study with the help of EJ-V and TeK, recruited the participants, collected and analysed the data, and drafted the manuscript. EN-H recruited the participants, collected the data, and edited the manuscript. AR recruited the participants with RAOM, collected the data from their medical records, examined their ears before the EEG measurement, and edited the manuscript. TiK examined the ears of the control children before the EEG measurement, collected the data of their OM history, and edited the manuscript. KS was responsible for the installation of the programs and the functioning of the EEG equipment. EJ-V and TeK supervised the study, contributed to the interpretation of the data, and helped with drafting the manuscript. All authors read and approved the manuscript.</p>
      <sec id="FPar1">
        <title>Acknowledgements</title>
        <p>This work was supported by the Langnet doctoral programme, Ministry of Education and Culture, Finland (SH), the Emil Aaltonen Foundation, Finland, and the Alma and K.A. Snellman Foundation, Oulu, Finland (EN-H), and Academy of Finland, grant number 276414 (TeK). We are grateful for EEG technician Raija Remes (Clinical Neurophysiology, Oulu University Hospital) for her invaluable help in data collection, and all the families participating in the study.</p>
      </sec>
      <sec id="FPar2">
        <title>Competing interests</title>
        <p>The authors declare that they have no competing interests.</p>
      </sec>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sipilä</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Pukander</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Karma</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Incidence of acute otitis media up to the age of 1 ½ years in urban infants</article-title>
          <source>Acta Otolaryngol</source>
          <year>1987</year>
          <volume>104</volume>
          <fpage>138</fpage>
          <lpage>145</lpage>
          <pub-id pub-id-type="doi">10.3109/00016488709109059</pub-id>
          <?supplied-pmid 3661155?>
          <pub-id pub-id-type="pmid">3661155</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Teele</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Klein</surname>
              <given-names>JO</given-names>
            </name>
            <name>
              <surname>Rosner</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study</article-title>
          <source>J Infect Dis</source>
          <year>1989</year>
          <volume>160</volume>
          <fpage>83</fpage>
          <lpage>94</lpage>
          <pub-id pub-id-type="doi">10.1093/infdis/160.1.83</pub-id>
          <?supplied-pmid 2732519?>
          <pub-id pub-id-type="pmid">2732519</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lieberthal</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Carrol</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Chonmaitree</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ganiats</surname>
              <given-names>TG</given-names>
            </name>
            <name>
              <surname>Hoberman</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Jackson</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Joffe</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>DT</given-names>
            </name>
            <name>
              <surname>Rosenfeld</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Sevilla</surname>
              <given-names>XD</given-names>
            </name>
            <name>
              <surname>Schwartz</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Tunkel</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>The diagnosis and management of acute otitis media</article-title>
          <source>Pediatrics</source>
          <year>2013</year>
          <volume>131</volume>
          <fpage>e964</fpage>
          <lpage>e999</lpage>
          <pub-id pub-id-type="doi">10.1542/peds.2012-3488</pub-id>
          <?supplied-pmid 23439909?>
          <pub-id pub-id-type="pmid">23439909</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tapiainen</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kujala</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Renko</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Koivunen</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Kontiokari</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kristo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pokka</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Alho</surname>
              <given-names>O-P</given-names>
            </name>
            <name>
              <surname>Uhari</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Effect of antimicrobial treatment of acute otitis media on the daily disappearance of middle ear effusion: a placebo-controlled trial</article-title>
          <source>JAMA Pediatr</source>
          <year>2014</year>
          <volume>168</volume>
          <fpage>635</fpage>
          <lpage>641</lpage>
          <pub-id pub-id-type="doi">10.1001/jamapediatrics.2013.5311</pub-id>
          <?supplied-pmid 24797294?>
          <pub-id pub-id-type="pmid">24797294</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ravicz</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Rosowski</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Merchant</surname>
              <given-names>SN</given-names>
            </name>
          </person-group>
          <article-title>Mechanisms of hearing loss resulting from middle-ear fluid</article-title>
          <source>Hear Res</source>
          <year>2004</year>
          <volume>195</volume>
          <fpage>103</fpage>
          <lpage>130</lpage>
          <pub-id pub-id-type="doi">10.1016/j.heares.2004.05.010</pub-id>
          <?supplied-pmid 15350284?>
          <pub-id pub-id-type="pmid">15350284</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thornton</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Chevallier</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Koka</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Lupo</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Tollin</surname>
              <given-names>DJ</given-names>
            </name>
          </person-group>
          <article-title>The conductive hearing loss due to an experimentally induced middle ear effusion alters the interaural level and time difference cues to sound location</article-title>
          <source>J Assoc Res Otolaryngol</source>
          <year>2012</year>
          <volume>13</volume>
          <fpage>641</fpage>
          <lpage>654</lpage>
          <pub-id pub-id-type="doi">10.1007/s10162-012-0335-2</pub-id>
          <?supplied-pmid 22648382?>
          <pub-id pub-id-type="pmid">22648382</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haapala</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Niemitalo-Haapola</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Raappana</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kujala</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Suominen</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kujala</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Jansson-Verkasalo</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Effects of recurrent acute otitis media on cortical speech-sound processing in 2-year old children</article-title>
          <source>Ear Hear</source>
          <year>2014</year>
          <volume>35</volume>
          <fpage>e75</fpage>
          <lpage>e83</lpage>
          <pub-id pub-id-type="doi">10.1097/AUD.0000000000000002</pub-id>
          <?supplied-pmid 24370565?>
          <pub-id pub-id-type="pmid">24370565</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mody</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schwartz</surname>
              <given-names>RG</given-names>
            </name>
            <name>
              <surname>Gravel</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Ruben</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
          <article-title>Speech perception and verbal memory in children with and without histories of otitis media</article-title>
          <source>J Speech Lang Hear Res</source>
          <year>1999</year>
          <volume>42</volume>
          <fpage>1069</fpage>
          <lpage>1079</lpage>
          <pub-id pub-id-type="doi">10.1044/jslhr.4205.1069</pub-id>
          <?supplied-pmid 10515506?>
          <pub-id pub-id-type="pmid">10515506</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maruthy</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mannarukrishnaiah</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Effect of early onset otitis media on brainstem and cortical auditory processing</article-title>
          <source>Behav Brain Funct</source>
          <year>2008</year>
          <volume>4</volume>
          <fpage>17</fpage>
          <pub-id pub-id-type="doi">10.1186/1744-9081-4-17</pub-id>
          <?supplied-pmid 18384677?>
          <pub-id pub-id-type="pmid">18384677</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moore</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Hartley</surname>
              <given-names>DEH</given-names>
            </name>
            <name>
              <surname>Hogan</surname>
              <given-names>SCM</given-names>
            </name>
          </person-group>
          <article-title>Effects of otitis media with effusion on central auditory function</article-title>
          <source>Int Congr Ser</source>
          <year>2003</year>
          <volume>1254</volume>
          <fpage>81</fpage>
          <lpage>88</lpage>
          <pub-id pub-id-type="doi">10.1016/S0531-5131(03)01089-6</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zumach</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Chenault</surname>
              <given-names>MN</given-names>
            </name>
            <name>
              <surname>Anteunis</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Gerrits</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Speech perception after early-life otitis media with fluctuating hearing loss</article-title>
          <source>Audiol Neurootol.</source>
          <year>2011</year>
          <volume>16</volume>
          <fpage>304</fpage>
          <lpage>314</lpage>
          <pub-id pub-id-type="doi">10.1159/000322501</pub-id>
          <?supplied-pmid 21160177?>
          <pub-id pub-id-type="pmid">21160177</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Whitton</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Polley</surname>
              <given-names>DB</given-names>
            </name>
          </person-group>
          <article-title>Evaluating the perceptual and pathophysiological consequences of auditory deprivation in early postnatal life: a comparison of basic and clinical studies</article-title>
          <source>J Assoc Res Otolaryngol</source>
          <year>2011</year>
          <volume>12</volume>
          <fpage>535</fpage>
          <lpage>547</lpage>
          <pub-id pub-id-type="doi">10.1007/s10162-011-0271-6</pub-id>
          <?supplied-pmid 21607783?>
          <pub-id pub-id-type="pmid">21607783</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Asbjørnsen</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Holmefjord</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Reisaeter</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Møller</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Klausen</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Prytz</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Boliek</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Obrzut</surname>
              <given-names>JE</given-names>
            </name>
          </person-group>
          <article-title>Lasting auditory attention impairment after persistent middle ear infections: a dichotic listening study</article-title>
          <source>Dev Med Child Neurol</source>
          <year>2000</year>
          <volume>42</volume>
          <fpage>481</fpage>
          <lpage>486</lpage>
          <pub-id pub-id-type="doi">10.1017/S001216220000089X</pub-id>
          <?supplied-pmid 10972421?>
          <pub-id pub-id-type="pmid">10972421</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Asbjørnsen</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Obrzut</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Boliek</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Myking</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Holmefjord</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Reisaeter</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Klausen</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Møller</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Impaired auditory attention skills following middle-ear infections</article-title>
          <source>Child Neuropsychol</source>
          <year>2005</year>
          <volume>11</volume>
          <fpage>121</fpage>
          <lpage>133</lpage>
          <pub-id pub-id-type="doi">10.1080/092970490911243</pub-id>
          <?supplied-pmid 16036440?>
          <pub-id pub-id-type="pmid">16036440</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Klausen</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Møller</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Holmefjord</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Reisaeter</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Asbjørnsen</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Lasting effects of otitis media with effusion on language skills and listening performance</article-title>
          <source>Acta Otolaryngol Suppl</source>
          <year>2000</year>
          <volume>543</volume>
          <fpage>73</fpage>
          <lpage>76</lpage>
          <pub-id pub-id-type="doi">10.1080/000164800454026</pub-id>
          <?supplied-pmid 10908983?>
          <pub-id pub-id-type="pmid">10908983</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dhamani</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Leung</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Carlile</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sharma</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Switch attention to listen</article-title>
          <source>Sci Rep</source>
          <year>2013</year>
          <volume>3</volume>
          <fpage>1297</fpage>
          <pub-id pub-id-type="doi">10.1038/srep01297</pub-id>
          <?supplied-pmid 23416613?>
          <pub-id pub-id-type="pmid">23416613</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roberts</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Burchinal</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Collier</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Ramey</surname>
              <given-names>CT</given-names>
            </name>
            <name>
              <surname>Koch</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Henderson</surname>
              <given-names>FW</given-names>
            </name>
          </person-group>
          <article-title>Otitis media in early childhood and cognitive, academic, and classroom performance of the school-aged child</article-title>
          <source>Pediatrics</source>
          <year>1989</year>
          <volume>83</volume>
          <fpage>477</fpage>
          <lpage>485</lpage>
          <?supplied-pmid 2927985?>
          <pub-id pub-id-type="pmid">2927985</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Feagans</surname>
              <given-names>LV</given-names>
            </name>
            <name>
              <surname>Kipp</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Blood</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>The effects of otitis media on the attention skills of day-care-attending toddlers</article-title>
          <source>Dev Psychol</source>
          <year>1994</year>
          <volume>30</volume>
          <fpage>701</fpage>
          <lpage>708</lpage>
          <pub-id pub-id-type="doi">10.1037/0012-1649.30.5.701</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Corbetta</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Shulman</surname>
              <given-names>GL</given-names>
            </name>
          </person-group>
          <article-title>Control of goal-directed and stimulus-driven attention in the brain</article-title>
          <source>Nat Rev Neurosci</source>
          <year>2002</year>
          <volume>3</volume>
          <fpage>201</fpage>
          <lpage>215</lpage>
          <pub-id pub-id-type="doi">10.1038/nrn755</pub-id>
          <?supplied-pmid 11994752?>
          <pub-id pub-id-type="pmid">11994752</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gomes</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Molholm</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Christodoulou</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ritter</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Cowan</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>The development of auditory attention in children</article-title>
          <source>Front Biosci</source>
          <year>2000</year>
          <volume>5</volume>
          <fpage>D108</fpage>
          <lpage>D120</lpage>
          <pub-id pub-id-type="doi">10.2741/Gomes</pub-id>
          <?supplied-pmid 10702373?>
          <pub-id pub-id-type="pmid">10702373</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wetzel</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Widmann</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Berti</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Schröger</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>The development of involuntary and voluntary attention from childhood to adulthood: a combined behavioral and event-related potential study</article-title>
          <source>Clin Neurophysiol</source>
          <year>2006</year>
          <volume>117</volume>
          <fpage>2191</fpage>
          <lpage>2203</lpage>
          <pub-id pub-id-type="doi">10.1016/j.clinph.2006.06.717</pub-id>
          <?supplied-pmid 16926109?>
          <pub-id pub-id-type="pmid">16926109</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Escera</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Alho</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Schröger</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Winkler</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Involuntary attention and distractibility as evaluated with event-related brain potentials</article-title>
          <source>Audiol Neurootol</source>
          <year>2000</year>
          <volume>5</volume>
          <fpage>151</fpage>
          <lpage>166</lpage>
          <pub-id pub-id-type="doi">10.1159/000013877</pub-id>
          <?supplied-pmid 10859410?>
          <pub-id pub-id-type="pmid">10859410</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Minter</surname>
              <given-names>KR</given-names>
            </name>
            <name>
              <surname>Roberts</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Hooper</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Burchinal</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Zeisel</surname>
              <given-names>SA</given-names>
            </name>
          </person-group>
          <article-title>Early childhood otitis media in relation to children’s attention-related behavior in the first six years of life</article-title>
          <source>Pediatrics</source>
          <year>2001</year>
          <volume>107</volume>
          <fpage>1037</fpage>
          <lpage>1042</lpage>
          <pub-id pub-id-type="doi">10.1542/peds.107.5.1037</pub-id>
          <?supplied-pmid 11331683?>
          <pub-id pub-id-type="pmid">11331683</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kujala</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Näätänen</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>The adaptive brain: a neurophysiological perspective</article-title>
          <source>Prog Neurobiol</source>
          <year>2010</year>
          <volume>91</volume>
          <fpage>55</fpage>
          <lpage>67</lpage>
          <pub-id pub-id-type="doi">10.1016/j.pneurobio.2010.01.006</pub-id>
          <?supplied-pmid 20117165?>
          <pub-id pub-id-type="pmid">20117165</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Courchesne</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Hillyard</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Galambos</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Stimulus novelty, task relevance and the visual evoked potential in man</article-title>
          <source>Electroencephalogr Clin Neurophysiol</source>
          <year>1975</year>
          <volume>39</volume>
          <fpage>131</fpage>
          <lpage>143</lpage>
          <pub-id pub-id-type="doi">10.1016/0013-4694(75)90003-6</pub-id>
          <?supplied-pmid 50210?>
          <pub-id pub-id-type="pmid">50210</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Squires</surname>
              <given-names>NK</given-names>
            </name>
            <name>
              <surname>Squires</surname>
              <given-names>KC</given-names>
            </name>
            <name>
              <surname>Hillyard</surname>
              <given-names>SA</given-names>
            </name>
          </person-group>
          <article-title>Two varieties of long-latency positive waves evoked by unpredictable auditory stimuli in man</article-title>
          <source>Electroenceph Clin Neurophysiol</source>
          <year>1975</year>
          <volume>38</volume>
          <fpage>387</fpage>
          <lpage>401</lpage>
          <pub-id pub-id-type="doi">10.1016/0013-4694(75)90263-1</pub-id>
          <?supplied-pmid 46819?>
          <pub-id pub-id-type="pmid">46819</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Friedman</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Cycowicz</surname>
              <given-names>YM</given-names>
            </name>
            <name>
              <surname>Gaeta</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>The novelty P3: an event-related brain potential (ERP) sign of the brain’s evaluation of novelty</article-title>
          <source>Neurosci Biobehav Rev</source>
          <year>2001</year>
          <volume>25</volume>
          <fpage>355</fpage>
          <lpage>373</lpage>
          <pub-id pub-id-type="doi">10.1016/S0149-7634(01)00019-7</pub-id>
          <?supplied-pmid 11445140?>
          <pub-id pub-id-type="pmid">11445140</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gumenyuk</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Korzyukov</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Alho</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Escera</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Schröger</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Ilmoniemi</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Näätänen</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Brain activity index of distractibility in normal school-age children</article-title>
          <source>Neurosci Lett</source>
          <year>2001</year>
          <volume>314</volume>
          <fpage>147</fpage>
          <lpage>150</lpage>
          <pub-id pub-id-type="doi">10.1016/S0304-3940(01)02308-4</pub-id>
          <?supplied-pmid 11704305?>
          <pub-id pub-id-type="pmid">11704305</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gumenyuk</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Korzyukov</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Escera</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Hämäläinen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Huotilainen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Häyrinen</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Oksanen</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Näätänen</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>von Wendt</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Alho</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Electrophysiological evidence of enhanced distractibility in ADHD children</article-title>
          <source>Neurosci Lett</source>
          <year>2005</year>
          <volume>374</volume>
          <fpage>212</fpage>
          <lpage>217</lpage>
          <pub-id pub-id-type="doi">10.1016/j.neulet.2004.10.081</pub-id>
          <?supplied-pmid 15663965?>
          <pub-id pub-id-type="pmid">15663965</pub-id>
        </element-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Määttä</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Saavalainen</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Könönen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Pääkkönen</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Muraja-Murro</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Partanen</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Processing of highly novel auditory events in children and adults: an event-related potential study</article-title>
          <source>Neuroreport</source>
          <year>2005</year>
          <volume>16</volume>
          <fpage>1443</fpage>
          <lpage>1446</lpage>
          <pub-id pub-id-type="doi">10.1097/01.wnr.0000177014.36979.3f</pub-id>
          <?supplied-pmid 16110268?>
          <pub-id pub-id-type="pmid">16110268</pub-id>
        </element-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kushnerenko</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Čeponienė</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Balan</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Fellman</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Näätänen</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Maturation of the auditory change detection response in infants: a longitudinal ERP study</article-title>
          <source>Neuroreport</source>
          <year>2002</year>
          <volume>13</volume>
          <fpage>1843</fpage>
          <lpage>1848</lpage>
          <pub-id pub-id-type="doi">10.1097/00001756-200210280-00002</pub-id>
          <?supplied-pmid 12395076?>
          <pub-id pub-id-type="pmid">12395076</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamaguchi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Knight</surname>
              <given-names>RT</given-names>
            </name>
          </person-group>
          <article-title>Effects of temporal-parietal lesions on the somatosensory P3 to lower limb stimulation</article-title>
          <source>Electroencephalogr Clin Neurophysiol</source>
          <year>1992</year>
          <volume>84</volume>
          <fpage>139</fpage>
          <lpage>148</lpage>
          <pub-id pub-id-type="doi">10.1016/0168-5597(92)90018-7</pub-id>
          <?supplied-pmid 1372228?>
          <pub-id pub-id-type="pmid">1372228</pub-id>
        </element-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Escera</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Alho</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Winkler</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Näätänen</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Neural mechanisms of involuntary attention to acoustic novelty and change</article-title>
          <source>J Cogn Neurosci</source>
          <year>1998</year>
          <volume>10</volume>
          <fpage>590</fpage>
          <lpage>604</lpage>
          <pub-id pub-id-type="doi">10.1162/089892998562997</pub-id>
          <?supplied-pmid 9802992?>
          <pub-id pub-id-type="pmid">9802992</pub-id>
        </element-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Čeponienė</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Lepistö</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Soininen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Aronen</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Alku</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Näätänen</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Event-related potentials associated with sound discrimination versus novelty detection in children</article-title>
          <source>Psychophysiology</source>
          <year>2004</year>
          <volume>41</volume>
          <fpage>130</fpage>
          <lpage>141</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1469-8986.2003.00138.x</pub-id>
          <?supplied-pmid 14693008?>
          <pub-id pub-id-type="pmid">14693008</pub-id>
        </element-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Escera</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Yago</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Alho</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Electrical responses reveal the temporal dynamics of brain events during involuntary attention switching</article-title>
          <source>Eur J Neurosci</source>
          <year>2001</year>
          <volume>14</volume>
          <fpage>877</fpage>
          <lpage>883</lpage>
          <pub-id pub-id-type="doi">10.1046/j.0953-816x.2001.01707.x</pub-id>
          <?supplied-pmid 11576192?>
          <pub-id pub-id-type="pmid">11576192</pub-id>
        </element-citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Näätänen</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <source>Attention and brain function</source>
          <year>1992</year>
          <publisher-loc>Hillsdale</publisher-loc>
          <publisher-name>Lawrence Erlbaum Associates</publisher-name>
        </element-citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schröger</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Wolff</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Attentional orienting and reorienting is indicated by human event-related brain potentials</article-title>
          <source>Neuroreport</source>
          <year>1998</year>
          <volume>15</volume>
          <fpage>3355</fpage>
          <lpage>3358</lpage>
          <pub-id pub-id-type="doi">10.1097/00001756-199810260-00003</pub-id>
          <pub-id pub-id-type="pmid">9855279</pub-id>
        </element-citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Edwards</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Fletcher</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Garman</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hughes</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Letts</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Sinka</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <source>Reynell Developmental Language Scales</source>
          <year>1997</year>
          <edition>3</edition>
          <publisher-loc>Berkshire</publisher-loc>
          <publisher-name>The NFER Nelson Publishing Ltd</publisher-name>
        </element-citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Kortesmaa</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Heimonen</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Merikoski</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Warma</surname>
              <given-names>M-L</given-names>
            </name>
            <name>
              <surname>Varpela</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <source>Reynellin kielellisen kehityksen testi [Reynell developmental language scales]</source>
          <year>2001</year>
          <publisher-loc>Helsinki</publisher-loc>
          <publisher-name>Psykologien kustannus Oy</publisher-name>
        </element-citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Näätänen</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Pakarinen</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Rinne</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Takegata</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>The mismatch negativity (MMN): towards the optimal paradigm</article-title>
          <source>Clin Neurophysiol</source>
          <year>2004</year>
          <volume>115</volume>
          <fpage>140</fpage>
          <lpage>144</lpage>
          <pub-id pub-id-type="doi">10.1016/j.clinph.2003.04.001</pub-id>
          <?supplied-pmid 14706481?>
          <pub-id pub-id-type="pmid">14706481</pub-id>
        </element-citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kujala</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Lovio</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Lepistö</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Laasonen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Näätänen</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Evaluation of multi-attribute auditory discrimination in dyslexia with the mismatch negativity</article-title>
          <source>Clin Neurophysiol</source>
          <year>2006</year>
          <volume>117</volume>
          <fpage>885</fpage>
          <lpage>893</lpage>
          <pub-id pub-id-type="doi">10.1016/j.clinph.2006.01.002</pub-id>
          <?supplied-pmid 16497552?>
          <pub-id pub-id-type="pmid">16497552</pub-id>
        </element-citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sorokin</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Alku</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Kujala</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Change and novelty detection in speech and non-speech sound streams</article-title>
          <source>Brain Res</source>
          <year>2010</year>
          <volume>1327</volume>
          <fpage>77</fpage>
          <lpage>90</lpage>
          <pub-id pub-id-type="doi">10.1016/j.brainres.2010.02.052</pub-id>
          <?supplied-pmid 20188710?>
          <pub-id pub-id-type="pmid">20188710</pub-id>
        </element-citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lovio</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Pakarinen</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Huotilainen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Alku</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Silvennoinen</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Näätänen</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kujala</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Auditory discrimination profiles of speech sound changes in 6-year-old children as determined with the multi-feature MMN paradigm</article-title>
          <source>Clin Neurophysiol</source>
          <year>2009</year>
          <volume>120</volume>
          <fpage>916</fpage>
          <lpage>921</lpage>
          <pub-id pub-id-type="doi">10.1016/j.clinph.2009.03.010</pub-id>
          <?supplied-pmid 19386542?>
          <pub-id pub-id-type="pmid">19386542</pub-id>
        </element-citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lovio</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Näätänen</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kujala</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Abnormal pattern of cortical speech feature discrimination in 6-year-old children at risk for dyslexia</article-title>
          <source>Brain Res</source>
          <year>2010</year>
          <volume>1335</volume>
          <fpage>53</fpage>
          <lpage>62</lpage>
          <pub-id pub-id-type="doi">10.1016/j.brainres.2010.03.097</pub-id>
          <?supplied-pmid 20381471?>
          <pub-id pub-id-type="pmid">20381471</pub-id>
        </element-citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Niemitalo-Haapola</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Lapinlampi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kujala</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Alku</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Kujala</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Suominen</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Jansson-Verkasalo</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Linguistic multi-feature paradigm as an eligible measure of central auditory processing and novelty detection in 2-year-old children</article-title>
          <source>Cogn Neurosci</source>
          <year>2013</year>
          <volume>4</volume>
          <fpage>99</fpage>
          <lpage>106</lpage>
          <pub-id pub-id-type="doi">10.1080/17588928.2013.781146</pub-id>
          <?supplied-pmid 24073735?>
          <pub-id pub-id-type="pmid">24073735</pub-id>
        </element-citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Putkinen</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Niinikuru</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Lipsanen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Tervaniemi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Huotilainen</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Fast measurement of auditory event-related potential profiles in 2–3-year-olds</article-title>
          <source>Dev Neuropsychol</source>
          <year>2012</year>
          <volume>37</volume>
          <fpage>51</fpage>
          <lpage>75</lpage>
          <pub-id pub-id-type="doi">10.1080/87565641.2011.615873</pub-id>
          <?supplied-pmid 22292831?>
          <pub-id pub-id-type="pmid">22292831</pub-id>
        </element-citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alku</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Tiitinen</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Näätänen</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>A method for generating natural-sounding speech stimuli for cognitive brain research</article-title>
          <source>Clin Neurophysiol</source>
          <year>1999</year>
          <volume>110</volume>
          <fpage>1329</fpage>
          <lpage>1333</lpage>
          <pub-id pub-id-type="doi">10.1016/S1388-2457(99)00088-7</pub-id>
          <?supplied-pmid 10454267?>
          <pub-id pub-id-type="pmid">10454267</pub-id>
        </element-citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Niemitalo-Haapola</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Haapala</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Jansson-Verkasalo</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Kujala</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Background noise degrades central auditory processing in toddlers</article-title>
          <source>Ear Hear</source>
          <year>2015</year>
          <volume>36</volume>
          <fpage>e342</fpage>
          <lpage>e351</lpage>
          <pub-id pub-id-type="doi">10.1097/AUD.0000000000000192</pub-id>
          <?supplied-pmid 26200926?>
          <pub-id pub-id-type="pmid">26200926</pub-id>
        </element-citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Luck</surname>
              <given-names>SJ</given-names>
            </name>
          </person-group>
          <source>An introduction to the event-related potential technique</source>
          <year>2005</year>
          <publisher-loc>Massachusetts</publisher-loc>
          <publisher-name>The MITT Press</publisher-name>
        </element-citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Escera</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Corral</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Role of mismatch negativity and novelty-P3 in involuntary auditory attention</article-title>
          <source>Int J Psychophysiol</source>
          <year>2007</year>
          <volume>21</volume>
          <fpage>251</fpage>
          <lpage>264</lpage>
          <pub-id pub-id-type="doi">10.1027/0269-8803.21.34.251</pub-id>
        </element-citation>
      </ref>
      <ref id="CR51">
        <label>51.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Widen</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Erlandsson</surname>
              <given-names>SI</given-names>
            </name>
          </person-group>
          <article-title>Erlandsson SI. Self-reported tinnitus and noise sensitivity among adolescents in Sweden</article-title>
          <source>Noise Health</source>
          <year>2004</year>
          <volume>7</volume>
          <fpage>29</fpage>
          <lpage>40</lpage>
          <?supplied-pmid 15703147?>
          <pub-id pub-id-type="pmid">15703147</pub-id>
        </element-citation>
      </ref>
      <ref id="CR52">
        <label>52.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>McCormick</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>McCormick</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Behavioral hearing tests for infants in the first years of life</article-title>
          <source>Paediatric audiology 0–5 years</source>
          <year>2004</year>
          <edition>3</edition>
          <publisher-loc>London</publisher-loc>
          <publisher-name>Whurr Publishers</publisher-name>
          <fpage>67</fpage>
          <lpage>107</lpage>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:4700566</identifier><datestamp>2016-01-06</datestamp><setSpec>bmcgeno</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="http://jats.nlm.nih.gov/ns/archiving/1.0/ http://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Genomics</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Genomics</journal-id>
      <journal-title-group>
        <journal-title>BMC Genomics</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1471-2164</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC4700566</article-id>
      <article-id pub-id-type="pmcid">PMC4700566</article-id>
      <article-id pub-id-type="pmc-uid">4700566</article-id>
      <article-id pub-id-type="publisher-id">2343</article-id>
      <article-id pub-id-type="doi">10.1186/s12864-015-2343-1</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Co-linearity and divergence of the A subgenome of <italic>Brassica juncea</italic> compared with other <italic>Brassica</italic> species carrying different A subgenomes</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Zou</surname>
            <given-names>Jun</given-names>
          </name>
          <address>
            <email>daist82@163.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hu</surname>
            <given-names>Dandan</given-names>
          </name>
          <address>
            <email>hudandan@webmail.hzau.edu.cn</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>Peifa</given-names>
          </name>
          <address>
            <email>394447475@qq.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Raman</surname>
            <given-names>Harsh</given-names>
          </name>
          <address>
            <email>harsh.raman@dpi.nsw.gov.au</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Liu</surname>
            <given-names>Zhongsong</given-names>
          </name>
          <address>
            <email>zsliu48@sohu.com</email>
          </address>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>Xianjun</given-names>
          </name>
          <address>
            <email>lxxjjz@sina.com</email>
          </address>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Parkin</surname>
            <given-names>Isobel A. P.</given-names>
          </name>
          <address>
            <email>isobel.parkin@agr.gc.ca</email>
          </address>
          <xref ref-type="aff" rid="Aff4"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chalhoub</surname>
            <given-names>Boulos</given-names>
          </name>
          <address>
            <email>chalhoub@evry.inra.fr</email>
          </address>
          <xref ref-type="aff" rid="Aff5"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Meng</surname>
            <given-names>Jinling</given-names>
          </name>
          <address>
            <email>jmeng@mail.hzau.edu.cn</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <aff id="Aff1"><label/>National Key Laboratory of Crop Genetic Improvement, Key Laboratory of Rapeseed Genetic Improvement, Ministry of Agriculture P. R. China, Huazhong Agricultural University, Wuhan, 430070 China </aff>
        <aff id="Aff2"><label/>Graham Centre for Agricultural Innovation (an alliance between the Charles Sturt University and NSW Department of Primary Industries), Wagga Wagga Agricultural Institute, Wagga Wagga, NSW 2650 Australia </aff>
        <aff id="Aff3"><label/>Oilseed Crops Institute, Hunan Agricultural University, Changsha, 410128 China </aff>
        <aff id="Aff4"><label/>Agriculture and Agri-Food Canada, 107 Science Place, Saskatoon, SK S7N 0X2 Canada </aff>
        <aff id="Aff5"><label/>Unité de Recherche en Génomique Végétale (Institut National de la Recherche Agronomique, Centre National de la Recherche Scientifique, Université d’Evry Val d’Essonnes), Organization and Evolution of Plant Genomes, 91057 Evry cedex, France </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>5</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>5</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <volume>17</volume>
      <elocation-id>18</elocation-id>
      <history>
        <date date-type="received">
          <day>11</day>
          <month>4</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>22</day>
          <month>12</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© Zou et al. 2015</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>There are three basic <italic>Brassica</italic> genomes (A, B, and C) and three parallel sets of subgenomes distinguished in the diploid <italic>Brassica</italic> (i.e.: <italic>B. rapa</italic>, A<sup>r</sup>A<sup>r</sup>; <italic>B. nigra</italic>, B<sup>ni</sup>B<sup>ni</sup>; <italic>B. oleracea</italic>, C<sup>o</sup>C<sup>o</sup>) and the derived allotetraploid species (i.e.: <italic>B. juncea</italic>, A<sup>j</sup>A<sup>j</sup>B<sup>j</sup>B<sup>j</sup>; <italic>B. napus</italic>, A<sup>n</sup>A<sup>n</sup>C<sup>n</sup>C<sup>n</sup>; <italic>B. carinata,</italic> B<sup>c</sup>B<sup>c</sup>C<sup>c</sup>C<sup>c</sup>). To understand subgenome differentiation in <italic>B. juncea</italic> in comparison to other A genome-carrying <italic>Brassica</italic> species (<italic>B. rapa</italic> and <italic>B. napus</italic>), we constructed a dense genetic linkage map of <italic>B. juncea</italic>, and conducted population genetic analysis on diverse lines of the three A-genome carrying <italic>Brassica</italic> species using a genotyping-by-sequencing approach (DArT-seq).</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>A dense genetic linkage map of <italic>B. juncea</italic> was constructed using an F<sub>2</sub> population derived from Sichuan Yellow/Purple Mustard. The map included 3329 DArT-seq markers on 18 linkage groups and covered 1579 cM with an average density of two markers per cM. Based on this map and the alignment of the marker sequences with the physical genome of <italic>Arabidopsis thaliana</italic>, we observed strong co-linearity of the ancestral blocks among the different A subgenomes but also considerable block variation. Comparative analyses at the level of genome sequences of <italic>B. rapa</italic> and <italic>B. napus</italic>, and marker sequence anchored on the genetic map of <italic>B. juncea</italic>, revealed a total of 30 potential inversion events across large segments and 20 potential translocation events among the three A subgenomes. Population genetic analysis on 26 accessions of the three A genome-carrying <italic>Brassica</italic> species showed that the highest genetic distance were estimated when comparing A<sup>j</sup>-A<sup>n</sup> than between A<sup>n</sup>-A<sup>r</sup> and A<sup>j</sup>-A<sup>r</sup> subgenome pairs.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>The development of the dense genetic linkage map of <italic>B. juncea</italic> with informative DArT-seq marker sequences and availability of the reference sequences of the A<sup>r</sup>, and A<sup>n</sup>C<sup>n</sup> genomes allowed us to compare the A subgenome structure of <italic>B. juncea</italic> (A<sup>j</sup>) . Our results suggest that strong co-linearity exists among the three A <italic>Brassica</italic> genomes (A<sup>r</sup>, A<sup>n</sup> and A<sup>j</sup>) but with apparent subgenomic variation. Population genetic analysis on three A-genome carrying <italic>Brassica</italic> species support the idea that <italic>B. juncea</italic> has distinct genomic diversity, and/or evolved from a different A genome progenitor of <italic>B. napus</italic>.</p>
        </sec>
        <sec>
          <title>Electronic supplementary material</title>
          <p>The online version of this article (doi:10.1186/s12864-015-2343-1) contains supplementary material, which is available to authorized users.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>
          <italic>Brassica juncea</italic>
        </kwd>
        <kwd>Dense genetic map</kwd>
        <kwd>Subgenome</kwd>
        <kwd>Genome organization</kwd>
        <kwd>Co-linearity</kwd>
        <kwd>Divergence</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution>the National Basic Research Program of China</institution>
          </funding-source>
          <award-id>2015CB150200</award-id>
          <principal-award-recipient>
            <name>
              <surname>Zou</surname>
              <given-names>Jun</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id>
              <institution>National Natural Science Foundation of China</institution>
            </institution-wrap>
          </funding-source>
          <award-id>31271762</award-id>
          <principal-award-recipient>
            <name>
              <surname>Liu</surname>
              <given-names>Zhongsong</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
        <award-group>
          <funding-source>
            <institution>the Open Research Fund by National Key Laboratory of Crop Genetic Improvement of Huazhong Agricultural University</institution>
          </funding-source>
          <award-id>ZK201212</award-id>
          <principal-award-recipient>
            <name>
              <surname>Zou</surname>
              <given-names>Jun</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
      </funding-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>© The Author(s) 2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Background</title>
      <p>High-throughput sequencing techniques have enabled researchers to construct dense genetic linkage maps for various agricultural crops [<xref ref-type="bibr" rid="CR1">1</xref>–<xref ref-type="bibr" rid="CR4">4</xref>]. These high-density maps not only give detailed resolution of genomes but also provide excellent platforms to identify molecular markers for qualitative and quantitative loci associated with trait(s) of interest. Genome-wide comparative analyses allow the elucidation of chromosomal rearrangements resulting from speciation, genome evolution, and adaptation as well as the identification of novel alleles for genetic improvement within and among crop species [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. A number of genetic linkage maps of species in the Brassicaceae family have been generated over the past 20 years, largely focusing on commercially important <italic>Brassica</italic> species. These genetic linkage maps were based on traditional DNA markers such as restriction fragment length polymorphism (RFLP), amplified fragment length polymorphism (AFLP) and simple sequence repeats (SSR) [<xref ref-type="bibr" rid="CR7">7</xref>–<xref ref-type="bibr" rid="CR13">13</xref>], and high-throughput RNA and DNA sequence markers detected by single nucleotide polymorphism (SNP) arrays, re-sequencing or genotyping-by-sequencing technologies [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR14">14</xref>–<xref ref-type="bibr" rid="CR17">17</xref>].</p>
      <p>Comparative mapping studies with the well-characterized relative <italic>Arabidopsis thaliana</italic> revealed a common hexaploid ancestor in the lineage of the Brassicas. These mapping studies also identified 21–24 conserved ancestral blocks of the Brassicaceae [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR18">18</xref>–<xref ref-type="bibr" rid="CR21">21</xref>]. These blocks have been used extensively in comparative genomic analyses among <italic>Brassica</italic> species. Genome-wide analyses between the allotetraploid <italic>B. napus</italic> and its diploid progenitors <italic>B. rapa</italic> and <italic>B. oleracea</italic> have shown significant genomic co-linearity [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>], and functional conservation of genetic loci governing important traits has also been revealed between different A subgenomes [<xref ref-type="bibr" rid="CR22">22</xref>]; however, changes in the subgenome resulting from events such as genome duplication, inversion and homoeologous exchange have been documented in <italic>B. napus</italic> [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>].</p>
      <p>In the U’s triangle of <italic>Brassica</italic> [<xref ref-type="bibr" rid="CR25">25</xref>], there are three basic genomes (A, B and C), i.e. A<sup>r</sup> in <italic>B. rapa</italic>, B<sup>ni</sup> in <italic>B. nigra</italic>, C<sup>o</sup> in <italic>B. olereaca</italic>, and three sets of corresponding subgenomes in the cultivated allotetraploid oilseed<italic>Brassica</italic> species, i.e. A<sup>j</sup>B<sup>j</sup> of <italic>B. juncea</italic> (Indian or Oriental mustard, 2n = 4 × = 36), A<sup>n</sup>C<sup>n</sup> of <italic>B. napus</italic> (rapeseed, 2n = 4 × = 38), and B<sup>c</sup>C<sup>c</sup> of <italic>B. carinata</italic> (Ethiopian mustard, 2n = 4 × = 34). Genome differentiation, due to translocation, inversion, deletion, duplication, and transposon activation would be expected to have occurred among the different subgenomes in these polyploid <italic>Brassica</italic> species as a result of genomic shock during interspecific hybridization, and long-term domestication and cultivation [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR26">26</xref>–<xref ref-type="bibr" rid="CR29">29</xref>]. The extensive genetic diversity occurring within these agriculturally important oilseed species has been exploited to create novel germplasm resources in pre-breeding programs [<xref ref-type="bibr" rid="CR30">30</xref>–<xref ref-type="bibr" rid="CR32">32</xref>]. Understanding the genetic basis of the subgenomic variation among the three sets of <italic>Brassica</italic> subgenomes may provide insights for genomics-based rapeseed breeding programs involving favorable allele introgression from allied species.</p>
      <p>In the present study, we focus on <italic>B. juncea</italic>, an ancient oilseed crop which is acknowledged for its suitability for cultivation under moisture-limited (drought) and hot conditions. <italic>B. juncea</italic> also harbors loci for resistance to blackleg disease, which is caused by the fungus <italic>Leptosphaeria maculans</italic> [<xref ref-type="bibr" rid="CR33">33</xref>]. <italic>B. juncea</italic> has been grown widely for oil and protein in Asia, especially India and China, and other parts of the world for approximately 6000 years [<xref ref-type="bibr" rid="CR34">34</xref>]. However, genetic and genomic resources for <italic>B. juncea</italic> are scarce compared with the resources for the major rapeseed crop, <italic>B. napus</italic>. The first genetic linkage map of <italic>B. juncea</italic> was constructed with 343 RFLP markers using a mapping population derived from two Canadian cultivars [<xref ref-type="bibr" rid="CR11">11</xref>]. Subsequently, several genetic linkage maps have been constructed using mapping populations originating from Canada, India and Europe by SSR and AFLP markers [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>]. Recently, a high-density genetic linkage map of <italic>B. juncea</italic> was developed using RNA-based SNP markers [<xref ref-type="bibr" rid="CR16">16</xref>].</p>
      <p>The availability of the linkage and comparative maps of bi-parental populations of <italic>B. juncea</italic> [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR35">35</xref>–<xref ref-type="bibr" rid="CR37">37</xref>], and the reference sequences of the A<sup>r</sup> genome of <italic>B. rapa</italic>, and the A<sup>n</sup> genome of <italic>B. napus</italic> [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR38">38</xref>], has made it possible to analyze the subgenomic variation among different A genomes of <italic>B. juncea</italic>, <italic>B. napus</italic> and<italic>B. rapa</italic>. Here, we report the construction of a dense genetic linkage map of <italic>B. juncea</italic> generated using an F<sub>2</sub> population, derived from Sichuan Yellow (SY) and Purple Mustard (PM) [<xref ref-type="bibr" rid="CR37">37</xref>] designated as SY-PM population, with high-throughput markers based on the genotyping-by-sequencing approach, DArT-seq [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR39">39</xref>]. We also investigated allelic diversity and population structure among 26 genotypes of three <italic>Brassica</italic> species carrying A genomes (i.e., <italic>B. juncea, B. rapa</italic> and <italic>B. napus</italic>) that represent different geographic origins. We compared the genome-wide arrangement of sequences and the constitution of the 24 ancestral genomic blocks (A–X) of Brassicaceae in <italic>B. juncea</italic>, <italic>B. rapa</italic> and <italic>B. napus</italic>. These results would provide valuable resources for <italic>Brassica</italic> genomic studies, especially for understanding and exploring subgenomic variation among different <italic>Brassica</italic> species.</p>
    </sec>
    <sec id="Sec2">
      <title>Results</title>
      <sec id="Sec3">
        <title>Construction of a dense genetic linkage map of <italic>B. juncea</italic></title>
        <p>We used a set of 4833 representative markers, selected from 6836 identified DArT-seq polymorphic markers with less than 10 % missing rate, to construct the genetic map for SY-PM population. A total of 3329 of the markers could be assigned into 18 large linkage groups, while the remaining 1504 markers which could not be linked to any of the large groups were discarded. The 3329 linked markers detected 1570 discrete genetic loci on 18 linkage groups and covered 1579 cM (centiMorgan) with an average density of two markers per cM. Seventy-two percent (1132) of the loci were detected by single markers, while 438 were defined by multiple markers and were therefore defined as genetic “bin loci” (Table <xref rid="Tab1" ref-type="table">1</xref>, Additional files <xref rid="MOESM1" ref-type="media">1</xref> and <xref rid="MOESM2" ref-type="media">2</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Characteristics of linkage groups of an intercross SY-PM population of <italic>B. juncea</italic>
</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Linkage group (LG)</th><th>No. of single-marker loci</th><th>No. of bin loci</th><th>Total number of loci</th><th>Total number of mapped markers</th><th>Coverage (cM)</th></tr></thead><tbody><tr><td>A01</td><td>62</td><td>32</td><td>94</td><td>274</td><td>91</td></tr><tr><td>A02</td><td>75</td><td>21</td><td>96</td><td>189</td><td>72.3</td></tr><tr><td>A03</td><td>72</td><td>26</td><td>98</td><td>163</td><td>94.9</td></tr><tr><td>A04</td><td>48</td><td>13</td><td>61</td><td>133</td><td>63.3</td></tr><tr><td>A05</td><td>71</td><td>24</td><td>95</td><td>150</td><td>94.4</td></tr><tr><td>A06</td><td>80</td><td>25</td><td>105</td><td>160</td><td>98.2</td></tr><tr><td>A07</td><td>40</td><td>31</td><td>71</td><td>163</td><td>71.5</td></tr><tr><td>A08</td><td>59</td><td>26</td><td>85</td><td>177</td><td>66.4</td></tr><tr><td>A09</td><td>62</td><td>38</td><td>100</td><td>311</td><td>108</td></tr><tr><td>A10</td><td>71</td><td>12</td><td>83</td><td>144</td><td>68.4</td></tr><tr><td>Subtotal for the A subgenome</td><td>640</td><td>248</td><td>888</td><td>1864</td><td>828.4</td></tr><tr><td>B01</td><td>41</td><td>26</td><td>67</td><td>171</td><td>62.8</td></tr><tr><td>B02</td><td>67</td><td>39</td><td>106</td><td>236</td><td>105.1</td></tr><tr><td>B03</td><td>69</td><td>17</td><td>86</td><td>230</td><td>59.8</td></tr><tr><td>B04</td><td>66</td><td>17</td><td>83</td><td>139</td><td>115.4</td></tr><tr><td>B05</td><td>51</td><td>19</td><td>70</td><td>125</td><td>102.2</td></tr><tr><td>B06</td><td>50</td><td>11</td><td>61</td><td>79</td><td>75.8</td></tr><tr><td>B07</td><td>60</td><td>39</td><td>99</td><td>246</td><td>102.2</td></tr><tr><td>B08</td><td>88</td><td>22</td><td>110</td><td>239</td><td>126.7</td></tr><tr><td>Subtotal for the B subgenome</td><td>492</td><td>190</td><td>682</td><td>1465</td><td>750</td></tr><tr><td>Total for the AB genome</td><td>1132</td><td>438</td><td>1570</td><td>3329</td><td>1578.5</td></tr><tr><td>Mean (per LG)</td><td>62.9</td><td>24.3</td><td>87.2</td><td>184.9</td><td>87.7</td></tr></tbody></table></table-wrap></p>
        <p>The 3329 mapped markers were used for comparative genomic analysis. In total, 1031 marker sequences representing 787 genetic loci could be aligned with the genome sequence of <italic>A. thaliana</italic> (Additional file <xref rid="MOESM2" ref-type="media">2</xref>), which were used to discriminate the constitution of the conserved ancestral Brassicaceae blocks in the genome of <italic>B. juncea</italic>. A total of 78 block-units were identified in the dense genetic map of the SY-PM population (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). Five blocks (i.e., A, F, J, R and U), each of which had an average of 6 copies, often covered large genetic regions spanning 20 cM or more (e.g., large F blocks on the A01, A03, A05, and B05 linkage groups) in the SY-PM map.<fig id="Fig1"><label>Fig. 1</label><caption><p>The genetic linkage map of the SY-PM population of <italic>B. junce</italic>a. Genetic loci are shown with purple bars (single marker loci) and longer black bars (bin loci) with code number. The genetic distance for a locus is indicated for the first and last bars on each linkage group, in addition to the red scale bars. The conserved ancestral blocks of Brassicaceae are labeled as A to X and are shown on the body of each linkage group except the small blocks (distance ≤2 cM) which are shown on the left side of each chromosome</p></caption><graphic xlink:href="12864_2015_2343_Fig1_HTML" id="MO1"/></fig></p>
      </sec>
      <sec id="Sec4">
        <title>Co-linearity analysis between the A-subgenomes of different <italic>Brassica</italic> species</title>
        <p>Conserved <italic>Brassica</italic> blocks that were identified in the A<sup>j</sup> subgenome of <italic>B. juncea</italic> through genetic mapping (see above) were used for co-linearity analysis with the two sequenced A genomes, i.e. A<sup>r</sup> and A<sup>n</sup> subgenome [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR38">38</xref>]. Blocks A, B and I (four copies) were the most prevalent blocks in the A<sup>j</sup> subgenome, while the blocks B (eight copies) and T (seven copies) were the two most abundant blocks in the A<sup>r</sup> and A<sup>n</sup> subgenomes (Additional file <xref rid="MOESM3" ref-type="media">3</xref>).</p>
        <p>Strong co-linearity was found among the three A subgenomes, while a few conserved ancestral blocks were apparently subjected to inversions, deletions, and shuffling (blocks exchange) (Fig. <xref rid="Fig2" ref-type="fig">2</xref>). Comparing the A<sup>r</sup> and A<sup>n</sup> genomes, for example, there was an inversion between blocks O and P in chromosome A09 companied by deletion of block M on chromosome A<sup>n</sup>09, but deletion of block V in A<sup>r</sup>09, and a duplication of block T and B was observed in A<sup>r</sup>08 compared to A<sup>n</sup>08. The restricted alignment of the marker sequences to the ancestral blocks and the limitations of genetic mapping make it difficult to confirm the absence of blocks in SY-PM genetic map. However, several small insertions in the ancestral blocks of <italic>B. juncea</italic> could be observed, e.g. a small segment from block C was inserted in block J on A<sup>j</sup>05.<fig id="Fig2"><label>Fig. 2</label><caption><p>Block arrangement and ancestral karyotypes in three A subgenomes of <italic>Brassica</italic> species. Comparison were made among the A<sup>r</sup> subgenome in <italic>B. rapa</italic>, A<sup>n</sup> in <italic>B. napus</italic>, and A<sup>j</sup> in <italic>B. juncea</italic>. The constitution of the ancestral blocks in each subgenome is arranged correspondingly. The blocks in the brackets indicate blocks or small insertion that varied among different genetic maps for the species</p></caption><graphic xlink:href="12864_2015_2343_Fig2_HTML" id="MO2"/></fig></p>
        <p>The three A subgenomes were compared pairwise by mapping the linkage groups A1 to A10 of <italic>B. juncea</italic> to the genome sequences of the A<sup>r</sup> and A<sup>n</sup> subgenomes. As expected, good co-linearity was observed across all the compared chromosomes (Fig. <xref rid="Fig3" ref-type="fig">3a</xref> and Additional file <xref rid="MOESM4" ref-type="media">4</xref>); however, potential genome-wide chromosomal rearrangement events, both inversions and translocations, were detected among the three subgenomes (Table <xref rid="Tab2" ref-type="table">2</xref> and Fig. <xref rid="Fig3" ref-type="fig">3a</xref>, <xref rid="Fig3" ref-type="fig">b</xref>). A total of 30 potential inversion events across large segments and 20 potential translocation events were observed for the three comparisons.<fig id="Fig3"><label>Fig. 3</label><caption><p>Chromosomal structural variations among the A<sup>j</sup>, A<sup>r</sup> and A<sup>n</sup> subgenomes in <italic>Brassica.</italic> The scales indicate the physical distance for the genome sequences (Mb) of A<sup>r</sup> and A<sup>n</sup> subgenomes and the genetic distance for A<sup>j</sup> subgenome. <bold>a</bold> Inversion events detected among the A<sup>j</sup>, A<sup>r</sup>, and A<sup>n</sup> subgenomes. The A10 chromosomes from the three subgenomes are shown. Inversion events that occurred in the other chromosomes are given in Additional file <xref rid="MOESM4" ref-type="media">4</xref>. The grey lines between the chromosomes indicate consistent alignment, and inversion events are indicated with blue lines. The letters in the body of the chromosomes indicate the large ancestral blocks. <bold>b</bold> Translocation events detected among the A<sup>j</sup>, A<sup>r</sup>, and A<sup>n</sup>. The translocation events involving the A<sup>j</sup> subgenome are shown with blue lines and the other translocation events are indicated with grey lines inside the circle</p></caption><graphic xlink:href="12864_2015_2343_Fig3_HTML" id="MO3"/></fig><table-wrap id="Tab2"><label>Table 2</label><caption><p>Chromosome rearrangement events detected among three A subgenomes of <italic>Brassica</italic> species</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Chromosome</th><th colspan="3">Inversion</th><th colspan="4">Translocation<sup>b</sup>
</th></tr><tr><th>A<sup>j</sup>-A<sup>r</sup>
</th><th>A<sup>j</sup>-A<sup>n</sup>
</th><th>A<sup>n</sup>-A<sup>r</sup>
</th><th>A<sup>j</sup>-A<sup>r</sup>
</th><th>A<sup>j</sup>-A<sup>n</sup>
</th><th>A<sup>r</sup>- &gt; A<sup>n</sup>
</th><th>A<sup>n</sup>- &gt; A<sup>r</sup>
</th></tr></thead><tbody><tr><td>A01</td><td>2(2)</td><td>2(2)</td><td>6(3)<sup>a</sup>
</td><td>0</td><td>0</td><td>0</td><td>3</td></tr><tr><td>A02</td><td>3(2)</td><td>2(1)</td><td>7(6)</td><td>0</td><td>0</td><td>0</td><td>4</td></tr><tr><td>A03</td><td>0(0)</td><td>2(0)</td><td>4(3)</td><td>0</td><td>0</td><td>2</td><td>1</td></tr><tr><td>A04</td><td>2(0)</td><td>1(0)</td><td>4(4)</td><td>1</td><td>1</td><td>0</td><td>0</td></tr><tr><td>A05</td><td>1(0)</td><td>0(0)</td><td>10(7)</td><td>0</td><td>1</td><td>4</td><td>3</td></tr><tr><td>A06</td><td>1(1)</td><td>1(1)</td><td>3(2)</td><td>0</td><td>0</td><td>1</td><td>0</td></tr><tr><td>A07</td><td>1(0)</td><td>1(0)</td><td>11(10)</td><td>0</td><td>0</td><td>3</td><td>0</td></tr><tr><td>A08</td><td>1(0)</td><td>1(0)</td><td>3(3)</td><td>0</td><td>1</td><td>4</td><td>2</td></tr><tr><td>A09</td><td>1(1)</td><td>2(1)</td><td>8(5)</td><td>0</td><td>0</td><td>1</td><td>0</td></tr><tr><td>A10</td><td>1(0)</td><td>3(2)</td><td>6(4)</td><td>1</td><td>0</td><td>0</td><td>2</td></tr><tr><td>Total</td><td>13(6)</td><td>15(7)</td><td>62(47)</td><td>2</td><td>3</td><td>15</td><td>15</td></tr></tbody></table><table-wrap-foot><p>
<sup>a</sup>The numbers indicate the total number of inversion events and the numbers in brackets indicate small inversion events where the segment was below the physical distance of 1 Mb between A<sup>n</sup> and A<sup>r</sup>, and from 0.6 to 1.2 cM between A<sup>j</sup> and A<sup>r</sup>/A<sup>n</sup>
</p><p>
<sup>b</sup>The symbol “&gt;” indicates the direction of translocation</p></table-wrap-foot></table-wrap></p>
      </sec>
      <sec id="Sec5">
        <title>Evolutionary analysis among <italic>Brassica</italic> species with an A subgenome</title>
        <p>To further investigate the phylogenetic relationship and population structure between <italic>B. juncea</italic> and the other <italic>Brassica</italic> species with an A subgenome, a set of 47,550 high quality DArT-seq markers was used to genotype 26 accessions selected from <italic>B. juncea</italic>, <italic>B. rapa</italic>, and <italic>B. napus</italic> (Table <xref rid="Tab3" ref-type="table">3</xref>). The level of detected marker polymorphism was 30.6 % and 28.9 %, in the two allotetraploid species <italic>B. napus</italic> and <italic>B. juncea</italic>, respectively, and 19.1 % in the diploid <italic>B. rapa</italic>. The markers were aligned to the published genome sequence of <italic>B. rapa</italic>, <italic>B. napus</italic>, and to the unpublished draft genome sequence of <italic>B. juncea</italic> (Isobel Parkin, personal communication). The 28,267 polymorphic markers were aligned with strict parameters (E-value ≤ 10<sup>−20</sup> and match length ≥ 60 bp) to the genome sequences, 43 % of the markers aligned to multiple regions, but more than half (16,077) were found to align uniquely to the A (3296), B (8278) and C (4573) genomes, respectively, and were referred to as the ABC-markers.<table-wrap id="Tab3"><label>Table 3</label><caption><p>The diverse lines of three <italic>Brassica</italic> species carrying A subgenomes analyzed in this study</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Code</th><th>Species</th><th>Accession name</th><th>Country of origin</th><th>Conservation</th><th>Breeding period</th><th>Seed quality</th><th>Other notes</th></tr></thead><tbody><tr><td>Bj-1</td><td>
<italic>B. juncea</italic>
</td><td>113'68</td><td>Germany</td><td>Self-pollinated</td><td>Before 1980</td><td>High EAC<sup>a</sup>, high GLU</td><td>Spring type, cultivar</td></tr><tr><td>Bj-2</td><td>
<italic>B. juncea</italic>
</td><td>Changyanghuangjie</td><td>China</td><td>DH line</td><td>Before 1980</td><td>High EAC, high GLU</td><td>Spring type, cultivar</td></tr><tr><td>Bj-3</td><td>
<italic>B. juncea</italic>
</td><td>Huayekucai</td><td>China</td><td>Self-pollinated</td><td>Before 1980</td><td>High EAC, high GLU</td><td>Spring type, cultivar, Aphid–resistant</td></tr><tr><td>Bj-4</td><td>
<italic>B. juncea</italic>
</td><td>K-100</td><td>Pakistan</td><td>Self-pollinated</td><td>Before 1980</td><td>High EAC, high GLU</td><td>Spring type, cultivar</td></tr><tr><td>Bj-5</td><td>
<italic>B. juncea</italic>
</td><td>SV9041341</td><td>Sweden</td><td>Self-pollinated</td><td>Before 1980</td><td>High EAC, high GLU</td><td>Spring type, cultivar</td></tr><tr><td>Bj-6</td><td>
<italic>B. juncea</italic>
</td><td>Silayangka</td><td>Russia</td><td>Self-pollinated</td><td>1980–2000</td><td>Low EAC, high GLU</td><td>Spring type, cultivar</td></tr><tr><td>Yellow-S</td><td>
<italic>B. juncea</italic>
</td><td>Sichuan Yellow</td><td>China (Southwest)</td><td>Self-pollinated</td><td>Before 1980</td><td>High EAC, high GLU</td><td>Spring type, landrace</td></tr><tr><td>Purple-M</td><td>
<italic>B. juncea</italic>
</td><td>Purple Mustard</td><td>China (Central)</td><td>Self-pollinated</td><td>Before 1980</td><td>High EAC, high GLU</td><td>Spring type, cultivar</td></tr><tr><td>Br-1</td><td>
<italic>B. rapa</italic>
</td><td>Chengduaiyoucai</td><td>China (West)</td><td>Self-pollinated</td><td>Before 1980</td><td>High EAC, high GLU</td><td>Spring type, cultivar</td></tr><tr><td>Br-2</td><td>
<italic>B. rapa</italic>
</td><td>Xishuiyoucai</td><td>China (Central)</td><td>Self-pollinated</td><td>Before 1980</td><td>High EAC, high GLU</td><td>Semi-winter type, landrace</td></tr><tr><td>Br-3</td><td>
<italic>B. rapa</italic>
</td><td>Yangyou2</td><td>China (Southeast)</td><td>Self-pollinated</td><td>Before 1980</td><td>High EAC, high GLU</td><td>Spring type, cultivar</td></tr><tr><td>Br-4</td><td>
<italic>B. rapa</italic>
</td><td>B3</td><td>China (Central)</td><td>DH line</td><td>Before 1980</td><td>High EAC, high GLU High EAC, high GLU</td><td>Winter type, landrace</td></tr><tr><td>Br-5</td><td>
<italic>B. rapa</italic>
</td><td>Tianmenyoucaibai</td><td>China (Central)</td><td>Self-pollinated</td><td>Before 1980</td><td>High EAC, high GLU</td><td>Semi-winter type, cultivar</td></tr><tr><td>Br-6</td><td>
<italic>B. rapa</italic>
</td><td>Chiifu</td><td>Korea</td><td>Self-pollinated</td><td>Before 1980</td><td>High EAC, high GLU</td><td>Spring type, sequenced cultivar</td></tr><tr><td>Br-7</td><td>
<italic>B. rapa</italic>
</td><td>Denglongzhong</td><td>China</td><td>Self-pollinated</td><td>Before 1980</td><td>High EAC, high GLU</td><td>Spring type, landrace</td></tr><tr><td>Br-8</td><td>
<italic>B. rapa</italic>
</td><td>Qixingjian</td><td>China (South)</td><td>Self-pollinated</td><td>Before 1980</td><td>High EAC, high GLU</td><td>Spring type, cultivar, low sensentitvie to <italic>Peronospora</italic>
</td></tr><tr><td>Br-9</td><td>
<italic>B. rapa</italic>
</td><td>Shangdangyoucai</td><td>China (Northeast)</td><td>Self-pollinated</td><td>Before 1980</td><td>High EAC, high GLU</td><td>Winter type, cultivar</td></tr><tr><td>Bn-1</td><td>
<italic>B. napus</italic>
</td><td>Brauner Schnittkohl</td><td>Siberian</td><td>Self-pollinated</td><td>Before 1980</td><td>Unkown</td><td>Wild napus, kale</td></tr><tr><td>Bn-2</td><td>
<italic>B. napus</italic>
</td><td>English Giant</td><td>England</td><td>Self-pollinated</td><td>Before 1980</td><td>Unkown</td><td>Wild napus, Winter forage rape</td></tr><tr><td>Bn-3</td><td>
<italic>B. napus</italic>
</td><td>Vige DH1</td><td>Sweden</td><td>Self-pollinated</td><td>Before 1980</td><td>Unkown</td><td>Wild napus, Winter forage rape</td></tr><tr><td>Bn-4</td><td>
<italic>B. napus</italic>
</td><td>Sure Regent</td><td>Europe</td><td>Self-pollinated</td><td>1977</td><td>High EAC, high GLU</td><td>Winter, cultivar</td></tr><tr><td>Bn-5</td><td>
<italic>B. napus</italic>
</td><td>Bronowski</td><td>Poland</td><td>Self-pollinated</td><td>Before 1970</td><td>High EAC, low GLU</td><td>Spring type, cultivar</td></tr><tr><td>Bn-6</td><td>
<italic>B. napus</italic>
</td><td>Bievenun</td><td>France</td><td>Self-pollinated</td><td>1982</td><td>Low EAC, high GLU</td><td>Winter type, cultivar</td></tr><tr><td>Bn-7</td><td>
<italic>B. napus</italic>
</td><td>Chuangyou2</td><td>China (Southwest)</td><td>Self-pollinated</td><td>1960–1970</td><td>High EAC, high GLU</td><td>Semi-winter type, cultivar</td></tr><tr><td>Bn-8</td><td>
<italic>B. napus</italic>
</td><td>Ningyou1</td><td>China (Southeast)</td><td>Self-pollinated</td><td>1968</td><td>Middle GLU, middle EAC</td><td>Semi-winter type, cultivar</td></tr><tr><td>Bn-9</td><td>
<italic>B. napus</italic>
</td><td>Huashang3</td><td>China (Central)</td><td>DH line</td><td>1999</td><td>Low EAC, Low GLU</td><td>Semi-winter type, cultivar</td></tr></tbody></table><table-wrap-foot><p>
<sup>a</sup>EAC and GLU represent the abbreviation of seed erucic acid and seed glucosinolate, respectively</p></table-wrap-foot></table-wrap></p>
        <p>Phylogenetic analysis of the three A-genome containing species was studied with the ABC-markers. It was shown that <italic>B. juncea</italic> species was clearly divergent from the other two species, <italic>B. rapa</italic> and <italic>B. napus</italic>, which shared a closer genetic relationship (Fig. <xref rid="Fig4" ref-type="fig">4a</xref>). When the subset of A genome specific markers (3296) was used to construct the phylogenetic tree, however, <italic>B. juncea</italic> showed a closer genetic relationship with the A genome species-<italic>B. rapa</italic>, and <italic>B. napus</italic> was separated from its two related A genome-carrying species (Fig. <xref rid="Fig4" ref-type="fig">4b</xref>, Additional file <xref rid="MOESM5" ref-type="media">5</xref>). Similar results were also found when the two sets of A genome markers (all of the markers with alignment to A genomes including those with multiple alignment to other genomes, and A genome-specific markers) were used to estimate genetic distance for the three species. The A genome in <italic>Brassica</italic> seems differentiated into two clades, A<sup>j</sup>-A<sup>r</sup> clade and A<sup>n</sup> clade (Additional file <xref rid="MOESM6" ref-type="media">6</xref>).<fig id="Fig4"><label>Fig. 4</label><caption><p>Phylogenetic tree of the three A genome contained species <italic>B. rapa</italic>, <italic>B. juncea</italic> and <italic>B. napus.</italic>
<bold>a</bold> Evaluated with a set of markers (16,077) which was aligned to unique positions of A, B and C genomes (ABC-markers), respectively; the figure shown <italic>B. juncea</italic> being separated from other two species. <bold>b</bold> Evaluated with a subset of markers (3296) which were uniquely aligned to A genome; the figure shown a close relationship between <italic>B. juncea</italic> and <italic>B. rapa</italic>, and together separated from <italic>B. napus</italic>. 26 accessions of the three <italic>Brassica</italic> species, i.e., <italic>B. rapa</italic>, <italic>B. juncea</italic> and <italic>B. napus</italic>, were used</p></caption><graphic xlink:href="12864_2015_2343_Fig4_HTML" id="MO4"/></fig></p>
        <p>Population structure analysis [<xref ref-type="bibr" rid="CR40">40</xref>] constructed with all the ABC-markers also revealed clear genetic differentiation among the 26 accessions of the three <italic>Brassica</italic> species (Fig. <xref rid="Fig5" ref-type="fig">5a</xref>, Additional file <xref rid="MOESM7" ref-type="media">7</xref>). At K = 2, <italic>B. rapa</italic> and <italic>B. napus</italic> shared close membership and obviously diverged from <italic>B. juncea</italic>, suggesting a unique gene pool for <italic>B. juncea</italic>, which would be mainly attributed to the B genome composition of <italic>B. juncea</italic>. At K = 3, the three species were separated, however, the <italic>B. juncea</italic> cultivar Silayangka (code No. Bj-6) from Russia and a breeding accession Vige DH1 (code No. Bn-3) of <italic>B. napu</italic>s from Sweden shared part membership with <italic>B. rapa</italic>, suggesting gene flow or introgression from subgenome A<sup>r</sup> to A<sup>j</sup> and A<sup>r</sup> to A<sup>n</sup> may have occurred. When we evaluated the genetic structure using the A genome specific markers, the highest ∆K value was observed at K = 2 (∆K &gt; 1000), and the two clades, A<sup>j</sup>-A<sup>r</sup> clade and A<sup>n</sup> clade, appeared again as in the phylogenetic analysis (Fig. <xref rid="Fig5" ref-type="fig">5b</xref>). However, gene flow between the A<sup>j</sup>-A<sup>r</sup> clade and the A<sup>n</sup> clade was also suggested, in particular from A<sup>n</sup> to A<sup>r</sup>. Gene flow among different A subgenomes was more obvious at K =3 (<sup>∆</sup>K ≈ =400) where a strong gene flow of A<sup>j</sup> &gt; A<sup>r</sup> was suggested, while the <italic>B. juncea</italic> cultivar Silayangka, contrarily, seems to have received introgressions from two subgenomes, A<sup>r</sup> and A<sup>n</sup> (Fig. <xref rid="Fig5" ref-type="fig">5b</xref>, Additional file <xref rid="MOESM7" ref-type="media">7</xref>).<fig id="Fig5"><label>Fig. 5</label><caption><p>Graphical representation of population genetic structure of the 26 <italic>Brassica</italic> accessions generated using the program STRUCTURE. <bold>a</bold> Population structures were evaluated with a set of markers (16,077) which was aligned to unique positions of A, B and C genomes (ABC-markers). The ∆K values were &gt;3500 and &gt;5000 at K = 2 (up) and K = 3 (lower), respectively (Additional file <xref rid="MOESM7" ref-type="media">7</xref>A). <bold>b</bold> Population structures were evaluated with A genome specific markers. The ∆K values were &gt;1000 and ≈ 400 at K = 2 (up) and K = 3 (lower), respectively (Additional file <xref rid="MOESM7" ref-type="media">7</xref>B)</p></caption><graphic xlink:href="12864_2015_2343_Fig5_HTML" id="MO5"/></fig></p>
      </sec>
    </sec>
    <sec id="Sec6">
      <title>Discussion</title>
      <p>High-density accurate genetic maps are essential for quantitative trait locus (QTL) analyses, ordering of sequences on physical maps (genome assembly), map-based cloning of genes, and comparative mapping across populations within and between species. Population size, missing data, and segregation distortion of markers can affect the accuracy of a genetic linkage map [<xref ref-type="bibr" rid="CR41">41</xref>]. Although the original set of polymorphic markers detected with relatively high quality was as high as 6836 (with missing rate ≤ 10 % and reproducibility scores &gt;90 %), only 70 % of the markers (4833) with high confidence (with missing data rate ≤ 5 % or could be classified in genetic bins represented by markers with less than 5 % missing rate) were selected to construct the linkage genetic map of <italic>B. juncea</italic>, to ensure the quality of the genetic map. To retain the sequence information associated with as many of the 1570 mapped loci as possible, the concept of “bin loci” was used [<xref ref-type="bibr" rid="CR42">42</xref>] allowing a total of 3329 markers to be anchored on the map (Additional file <xref rid="MOESM2" ref-type="media">2</xref>).</p>
      <p>Of the 24 ancient karyotype blocks, 23 were detected in the SY-PM genetic map. The G block was not found perhaps because of the limited genetic diversity on the G blocks between the parents of the SY-PM mapping population and/or the short physical length of the G blocks in the <italic>A. thaliana</italic>, <italic>B. rapa</italic>, and <italic>B. napus</italic> genomes. We calculated that, compared with the other ancestral blocks, the G block was small in the <italic>A. thaliana</italic> (1.6 Mb) and much smaller in <italic>B. napus</italic> (0.8 Mb) genomes. Only a very few markers identified among the 26 accessions of the three species could be aligned to the ancestral block G of Brassicaceae, and also only a few G blocks have been identified in <italic>Brassica</italic> genomes previously [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR6">6</xref>–<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR43">43</xref>] (Additional file <xref rid="MOESM3" ref-type="media">3</xref>). These findings suggested that the genetic diversity of the G blocks might be limited in <italic>Brassica</italic> species, or a feature of the G block is evolutionarily conserved, which leads to few informative markers available for comparative analysis.</p>
      <p>It is interesting and important to understand the evolutionary processes and genomic variation that occurred in the A, B, and C genome of <italic>Brassica</italic> species that were domesticated by our Neolithic ancestors. Since the sequence information of A<sup>j</sup>B<sup>j</sup>, B<sup>ni</sup> and B<sup>c</sup>C<sup>c</sup> genomes is currently not yet available in public domain, we concentrated on genetic comparisons among A genome containing <italic>Brassica</italic> species. In this study, the comparative analysis based on the macro-constitution of the 24 conserved ancestral blocks suggested that these ancestral blocks may have undergone different evolutionary processes which apparently lost or increased certain blocks in the three A genome-carrying <italic>Brassica</italic> species relative to the common ancestor (Table <xref rid="Tab2" ref-type="table">2</xref>, Additional file <xref rid="MOESM3" ref-type="media">3</xref>). From the three pair-wise comparisons between the three A genome-carrying species, assisted with a comparative genetic map and genome sequence analysis, we found considerable inversion and translocation events among the three A subgenomes (Table <xref rid="Tab2" ref-type="table">2</xref>, Additional file <xref rid="MOESM4" ref-type="media">4</xref>). Greater genomic differentiation and more inversion and translocation-like events were observed here in comparisons between A<sup>r</sup> and A<sup>n</sup> than that between A<sup>j</sup> and A<sup>r</sup>, or between A<sup>j</sup> and A<sup>n</sup>. It is to note that the resolution is greater when estimating divergence between A<sup>r</sup> and A<sup>n</sup> based on their genome sequence assemblies than with the A<sup>j</sup> genome based on the genetic map. However, we may have over-estimated or under-estimated some of the structural variation, since it could also result from mistakes during the genome sequence assembly. Despite this, the observed variation of ancestral blocks and chromosome structure among the three A genomes suggests that the three A subgenomes are differentiated by considerable genomic variation even though they share strong co-linearity. These data provide insights into the evolutionary processes that differentiate the diploid <italic>Brassica</italic> sub-genomes, which will be more comprehensively analyzed and understood when the genome sequence of <italic>B. juncea</italic>, <italic>B. nigra</italic>, <italic>B. carinata</italic> will be available.</p>
      <p>Increasing evidence has shown that the B genome diverged from the A/C genome about 6–7 million years ago (Mya), while the A genome of <italic>B. rapa</italic> and C genome of <italic>B. oleracea</italic> may have diverged about 3.7 Mya, as determined by co-linearity and <italic>Ks</italic> analyses across the genomes [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR44">44</xref>–<xref ref-type="bibr" rid="CR46">46</xref>]. The population genetic analysis of 26 accessions of the three A genome-carrying <italic>Brassica</italic> species with a common set of ABC-markers showed three clear sub-populations representing the three species, indicating <italic>B. juncea</italic> was divergent from <italic>B. rapa</italic> and <italic>B. napus</italic>, which is likely mainly attributed to the B genome composition in <italic>B. juncea</italic> and the C genome composition in <italic>B. napus</italic> (Fig. <xref rid="Fig4" ref-type="fig">4a</xref>, Additional file <xref rid="MOESM5" ref-type="media">5</xref>, Fig. <xref rid="Fig5" ref-type="fig">5a</xref>). These results also supported previous hypothesis that the B genome diverged earlier from the A/C genome into an independent lineage. Interestingly, when the accessions of the three species were evaluated with A-genome-specific markers, two major clades, A<sup>j</sup>-A<sup>r</sup> clade and A<sup>n</sup> clade, were observed, which was quite different from the result evaluated using the ABC-markers (Figs. <xref rid="Fig4" ref-type="fig">4b</xref> and  <xref rid="Fig5" ref-type="fig">5b</xref>, Additional file <xref rid="MOESM5" ref-type="media">5</xref>). These results were consistent with the hypothesis that both species of <italic>B. rapa</italic> and <italic>B. juncea</italic> originated from a close geographical region or the same center of origin, Asia, and have closer A subgenomes, whereas <italic>B. napus</italic> originated from Europe as a result of spontaneous hybridization between <italic>B. rapa</italic> and <italic>B. oleracea</italic> [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR34">34</xref>]. More accessions of <italic>B. rapa</italic> originating from Europe should be examined in the future. Herein, we used old cultivars and landraces of Asian origin (Table <xref rid="Tab3" ref-type="table">3</xref>), which might have been less frequently involved in gene introgression. Additionally, the gene flow observed between the A<sup>j</sup>-A<sup>r</sup> clade and the A<sup>n</sup> clade as shown in Fig. <xref rid="Fig5" ref-type="fig">5</xref> suggested the introgression of A<sup>r</sup> to A<sup>j</sup> or A<sup>n</sup> during the breeding process of the development of cultivars.</p>
      <p>Subgenomic differentiation in <italic>Brassica</italic> may be significant in creating novel types in <italic>Brassica</italic> species that could help broaden the genetic diversity or increase heterosis. Considerable effort has focused on exploring introgression from the A genome of <italic>B. rapa</italic> or <italic>B. napus</italic>, C genome of <italic>B. oleracea</italic> or <italic>B. carinata</italic> into <italic>B. napus</italic> or <italic>B. juncea</italic> [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR47">47</xref>–<xref ref-type="bibr" rid="CR52">52</xref>]. Our results support the idea that <italic>B. juncea</italic> has distinct genomic diversity, and/or evolved from a different A genome progenitor than <italic>B. napus</italic>. We suggest that variation in the A<sup>j</sup> subgenome of <italic>B. juncea</italic> could be applied to the genetic improvement of <italic>B. napus</italic>. Additionally, the possible divergence between the A genome progenitor of <italic>B. napus</italic> and Asian <italic>B. rapa</italic> accessions would suggest that these lines would be very useful to broaden the genomic diversity of <italic>B. napus</italic>.</p>
      <p>The dense genetic linkage map and the comparative analysis of three A subgenomes described here, will contribute to a better understanding of <italic>Brassica</italic> subgenomics. This will also help in a comprehensive understanding of variation in the A, B and C genomes and efforts towards genome sequencing of <italic>B. juncea</italic>, <italic>B. carinata</italic> and <italic>B. nigra</italic>.</p>
    </sec>
    <sec id="Sec7">
      <title>Conclusions</title>
      <p>Here, we described the construction of a dense genetic linkage map of <italic>B. juncea</italic> based on a DArT-seq approach and compared the genome constitution of the 24 ancestral blocks of Brassicaceae and the chromosome rearrangement events among three A-genome carrying <italic>Brassica</italic> species (<italic>B. rapa</italic>, <italic>B. juncea</italic>, and <italic>B. napus</italic>). The genetic map of <italic>B. juncea</italic> was constructed using an F<sub>2</sub> population derived from two Chinese cultivars SY and PM, and contained 3329 DArT-seq markers at 1570 genetic loci. We identified 18 linkage groups that covered a genetic distance of 1579 cM and detected 23 of the 24 conserved ancestral blocks of Brassicaceae in the SY-PM genetic map. The chromosome rearrangements among the three A subgenomes revealed by genetic mapping and genome sequence comparative analysis, and the population genetic analysis of diverse lines of the three A-genome carrying <italic>Brassica</italic> species, showed that the A<sup>j</sup> subgenome of <italic>B. juncea</italic> had a close relationship with A<sup>r</sup> subgenome, and was quite different from the A<sup>n</sup> subgenome. Our results support the idea that <italic>B. juncea</italic> has distinct genomic diversity, and/or evolved from a different A genome progenitor than <italic>B. napus</italic>, which could be exploited for genetic improvement of <italic>B. napus</italic>. The dense genetic map presented here will help in generating reference sequences of the different U’ triangle [<xref ref-type="bibr" rid="CR25">25</xref>] genomes and subgenomes and would further facilitate the (i) elucidation of genomic differentiation as a result of speciation, evolution, and adaptation of different <italic>Brassica</italic> species, and (ii) the transfer of favorable alleles between species to develop improved varieties to meet the global demand for vegetable oils.</p>
    </sec>
    <sec id="Sec8">
      <title>Methods</title>
      <sec id="Sec9">
        <title>Plant materials and development of the genetic mapping population</title>
        <p>Two Chinese landraces of the oilseed <italic>B. juncea</italic>, Sichuan Yellow (abbreviated as ‘SY’) and Purple Mustard (abbreviated as ‘PM’), were used to construct an F<sub>2</sub> genetic mapping population (abbreviated as ‘SY-PM’). Both parental lines were subjected to self-pollination for eight successive generations. The maternal parent, ‘SY’, is a local variety with yellow seed color from Sichuan Province, the southwest of China. The paternal parent, ‘PM’ is a local variety with black seed color from Hunan Province, in the central region of China [<xref ref-type="bibr" rid="CR37">37</xref>]. One individual ‘SY’ plant was pollinated by ‘PM’. A single F<sub>1</sub> plant from this cross was self-pollinated, and 168 F<sub>2</sub> plants were obtained. This F<sub>2</sub> population (SY-PM) was used for genetic linkage map construction.</p>
        <p>A total of 26 relatively old accessions representing the A genomes of the major cultivated oilseed <italic>Brassica</italic> species, mostly Asian <italic>B. juncea</italic> and <italic>B. rapa,</italic> and <italic>B. napus</italic> collected from different countries, were used in the comparative analysis (Table <xref rid="Tab3" ref-type="table">3</xref>).</p>
      </sec>
      <sec id="Sec10">
        <title>Genotyping</title>
        <p>Whole-genome profiling of the SY-PM population and 26 accessions of the three A-genome carrying <italic>Brassica</italic> species was performed using the DArT-seq at Diversity Arrays Technology Pty. Ltd. (DArT P/L, Canberra, Australia). DNA extraction and genotyping by DArT-seq technique were performed as described previously [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR39">39</xref>]. We used genomic DNA (50 ng/μl) isolated from fresh and young leaves. DArT-seq was performed using the HiSeq2000, next-generation sequencing platform (Illumina, USA). Both SNPs and presence-absence polymorphisms, collectively called ‘DArT-seq markers’, were identified by DArT P/L. The 69-bp long DArT-seq markers sequences were used for the comparative genome analysis. We identified a total of 10,174, and 81,372 sequence variants comprising both <italic>in silico</italic> DArTs (referred to as present/absent markers) and SNP markers in the SY-PM genetic mapping population, and the 26 accessions of the three species, respectively. We used markers that had overall call rates &gt;90 % for present/absent markers (percentage of valid scores of all possible scores for a marker), call rates &gt;90 % and Q values &gt;2.0 for SNP markers (the logarithm of the minimum false discovery rate at which the test may be called significant), and percentages of the missing data or errors in the diverse population of ≤5 % and mapping population of ≤10 %. Finally, a total of 6836 and 47,550 high quality DArT-seq markers were filtered out in the SY-PM population and 26 diverse lines, respectively.</p>
      </sec>
      <sec id="Sec11">
        <title>Genetic map construction and genomic comparative analysis</title>
        <p>To construct the genetic map, we first used 6836 polymorphic markers (with call rate (&gt;90 %) and missing rate ≤10 %) identified in the SY-PM mapping population to classify genetic bins. We discarded those genetic bins totally consisting of the markers with more than 5 % missing rate. Therefore, 4833 markers were remained for constructing genetic map. Secondly, we choose representative markers with the least missing data from each “bin locus” together with the single markers (1132) with less than 5 % missing rate to construct the genetic map. The genetic map of the SY-PM population of <italic>B. juncea</italic>, was constructed using JoinMap (version 4.0) [<xref ref-type="bibr" rid="CR53">53</xref>]. The genetic mapping process and the parameters were described previously [<xref ref-type="bibr" rid="CR15">15</xref>]. Distorted segregation of markers was analyzed using the <italic>χ</italic><sup>2</sup> (Chi-square) test according to the expected segregation ratio for presence/absence of markers and SNP variants in an F<sub>2</sub> population. To estimate the impact of distortion on the accuracy of the marker order on the genetic map, we compared the genetic position of each locus in the SY-PM genetic map with and without the inclusion of the distorted markers. Almost the same order of loci, but with genetic distances that changed by under 0.6 cM, was observed in the different versions of the genetic maps when the majority of distorted markers was added or deleted for map construction. Occasionally, inversions covering 0.1-1 cM of a genomic region were detected when distorted markers were added. These markers were deleted to construct an accurate genetic map. We used a pragmatic approach to include distorted markers that did not alter the order of markers within linkage groups. Unlikely “double recombinants” were also checked and discarded for genetic mapping. Linkage groups were assigned according to their alignment with the <italic>B. rapa</italic> and <italic>B. napus</italic> genome sequences [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR38">38</xref>] and the positions of the DArT-seq markers on the <italic>B. carinata</italic> genetic map [<xref ref-type="bibr" rid="CR15">15</xref>]. Since the recombination events were limited with the population, some of the markers could be mapped on the same genetic position at the linkage map because of no-recombination, and therefore, we defined such markers as “bin markers” and such genetic position as “a bin locus” [<xref ref-type="bibr" rid="CR42">42</xref>]. All of the high quality markers recorded in the SY-PM population and 26 diverse lines with known sequence were used in BLAST searches (with default parameters) against the <italic>A. thaliana</italic> (TAIR9 genome release, <ext-link ext-link-type="uri" xlink:href="ftp://ftp.arabidopsis.org/home/tair/Genes/TAIR9_genome_release/TAIR9_chr_all.fas">ftp://ftp.arabidopsis.org/home/tair/Genes/TAIR9_genome_release/TAIR9_chr_all.fas</ext-link>)<italic>, B. rapa</italic> [<xref ref-type="bibr" rid="CR38">38</xref>], and <italic>B. napus</italic> [<xref ref-type="bibr" rid="CR23">23</xref>] genome sequences, and the unpublished genome sequence of <italic>B. juncea</italic> provided by Isobel AP Parkin (Agriculture and Agri-Food Canada, Canada).</p>
        <p>We set the E-value ≤ 10<sup>−6</sup> and the match length to over 40 bp (DArT-seq marker sequence was 69 bp in length), to filter the matches to ancestral blocks for SY-PM genetic mapping population. A total of 659 marker sequences in the SY-PM genetic map could be aligned to the ancestral block. Meanwhile, by aligning the marker sequence to the “Darmor” genome of <italic>B. napus</italic> [<xref ref-type="bibr" rid="CR23">23</xref>], an additional 156 marker sequence could be assigned to certain ancestral blocks. The marker sequence were finally assigned to certain ancestral blocks according to the best match length, E value, good alignment consistency with adjacent loci, good alignment consistency among bin markers, good alignment consistency with other published genetic map of <italic>B. juncea</italic>. As a result, 815 marker sequences representing 767 loci on the SY-PM genetic map were aligned with the sequences of <italic>A. thaliana</italic> for further analysis. At least three consecutive homologous loci assigned to the same ancestral block were defined as a synteny block [<xref ref-type="bibr" rid="CR15">15</xref>], and only one or two closest loci assigned to the same ancestral block with nearly 100 % identity were considered as a small segment of insertion. Using homology searches against the <italic>Arabidopsis</italic> pseudo-chromosomes as described previously [<xref ref-type="bibr" rid="CR15">15</xref>], the 24 ancestral blocks (A to X) that are conserved in Brassicaceae family and be organized to generate the eight chromosomes of the ancestral crucifer karyotype [<xref ref-type="bibr" rid="CR19">19</xref>], were identified in the genetic map of the SY-PM population. The chromosomal constitution of the A subgenome of <italic>B. juncea</italic> was compared with the two A subgenomes of <italic>B. rapa</italic> and <italic>B. napus</italic> as described previously [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR29">29</xref>].</p>
        <p>The DArT-seq marker sequence were only 69 bp in length and therefore likely to generate a large number of alignments for the SY-PM genetic mapping population and the 26 accessions of the three species in which A, B and C genomes contained. To identify the most appropriate alignment to the <italic>Brassica</italic> genome sequence for each maker sequence, we set the E-value ≤ 10<sup>−20</sup> and the match length ≥ 60 bp to filter the match. We therefore used the match for further genome comparison analysis between three A subgenomes with the SY-PM genetic map. We also discerned those markers uniquely aligned to A, B and C genomes, and those markers with multiple alignments to different genomes, respectively, which were used for the population genetic analysis for the diverse lines of the three A genome-carrying species.</p>
        <p>Genomic changes such as inversion and translocation events among the three A genome pairs, A<sup>j</sup>-A<sup>n</sup>, A<sup>j</sup>-A<sup>r</sup>, and A<sup>r</sup>-A<sup>n</sup>, were identified by comparative genetic mapping using the loci with known sequence information in the linkage groups of the A genome of the SY-PM population and their corresponding alignment matches in the A<sup>r</sup> and A<sup>n</sup> genomes. Based on the <italic>B. juncea</italic> (SY-PM) population size in this study (168 lines), a genetic distance of 0.6 cM (100/168), would be the shortest permitted genetic distance within its resolving power according to the criterion of one ‘cM’. Considering the possibility of genetic mapping errors resulting from missing data and double crossing-overs, a valid inversion event was recognized if the order of the marker cluster was reversed over a genetic distance that was greater than the permitted distance for error (i.e., 0.6 cM in the SY-PM genetic map). At least two loci should be inverted in a valid inversion, and we did not discern the too complicated inverted loci without consistent inverted order. At the same time, the alignment information of the markers included in the same genetic bins was also used to judge the order of the loci. An inversion that occurred between the genetic distance (0.6 cM) and double genetic distance (1.2 cM), was identified as an inversion event in a small segment, and an inversion that covered more than 1.2 cM was identified as an inversion event in a large segment. A genetic distance of 0.6 cM in the linkage groups of the A genome would correspond to a physical distance of about 1 Mb, based on the size of the A genome (approximately 485 Mb) and the total map length of the A<sup>j</sup> linkage groups on the SY-PM genetic map. Therefore, the physical distance of 1 Mb was used as the critical distance to discern an inversion event happened within small segments or within large segments of the genome. For discerning translocation event between A<sup>r</sup> to A<sup>n</sup> by comparison with genome sequence, a valid translocation event was discerned if the segment with more than four successive adjacent genes was aligned to different chromosome of the other A subgenomes. If we observed markers located in one locus or adjacent loci of A<sup>j</sup>, but they were mapped in different chromosomes of A<sup>r</sup> or A<sup>n</sup> with 100 % unique identity alignment to these chromosomes, we counted a candidate translocation event between A<sup>j</sup> and A<sup>r</sup>/A<sup>n</sup>. To confirm the stability of marker order around the detected translocations, we randomly moved the neighbor markers to reconstruct genetic maps and compare the order of the common markers between the maps (before and after moving neighboring markers), the potential translocation events were then finally ‘declared’ if there was no change of the order of the common markers.</p>
      </sec>
      <sec id="Sec12">
        <title>Genetic diversity and population structure analysis</title>
        <p>A total of 47,550 high quality DArT-seq variants, were scored in 26 accessions of the three A genome-carrying species (<italic>B. rapa</italic>, <italic>B. juncea</italic> and <italic>B. napus</italic>) and used for further analysis. Genetic dissimilarities among diverse genotypes were estimated using Nei’s coefficient [<xref ref-type="bibr" rid="CR54">54</xref>] and used for the phylogeny reconstruction using the UPGMA (unweighted pair-group method with arithmetic means) method implemented in PowerMarker version 3.25 [<xref ref-type="bibr" rid="CR55">55</xref>]. The phylogenetic tree was viewed using MEGA 4.0 [<xref ref-type="bibr" rid="CR56">56</xref>]. Analysis of the population structure among the accessions was performed using STRUCTURE version 2.3.4 [<xref ref-type="bibr" rid="CR40">40</xref>]. The length of burn-in time and replication number were both set to 100,000 in each run. To identify and determine the most probable number of populations (K), we calculated the <sup>∆</sup>K values of K from 1 to 10 replicate runs for each K. Finally, we selected the K value that corresponded to the peak of the <sup>∆</sup>K graph after plotting [<xref ref-type="bibr" rid="CR57">57</xref>].</p>
      </sec>
      <sec id="Sec13">
        <title>Availability of supporting data</title>
        <p>All the supporting data are included as additional files. Phylogenetic data is available in the TreeBASE as accession number S18584 (<ext-link ext-link-type="uri" xlink:href="http://purl.org/phylo/treebase/phylows/study/TB2:S18584">http://purl.org/phylo/treebase/phylows/study/TB2:S18584</ext-link>), and more detailed information for the marker sequence alignment and phylogenetic analysis could be also available from the Dryad Digital Repository: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.5061/dryad.56986">http://dx.doi.org/10.5061/dryad.56986</ext-link>.</p>
      </sec>
    </sec>
  </body>
  <back>
    <app-group>
      <app id="App1">
        <sec id="Sec14">
          <title>Additional files</title>
          <p>
            <media position="anchor" xlink:href="12864_2015_2343_MOESM1_ESM.xlsx" id="MOESM1">
              <label>Additional file 1:</label>
              <caption>
                <p>
<bold>Information of DArT-seq markers and genotypes of the SY-PM genetic mapping population of </bold>
<bold><italic>B. juncea.</italic></bold> (XLSX 6076 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="12864_2015_2343_MOESM2_ESM.xlsx" id="MOESM2">
              <label>Additional file 2:</label>
              <caption>
                <p>
<bold>Information of the linkage map of the </bold>
<bold><italic>B. juncea</italic></bold>
<bold>constructed with SY-PM population.</bold> (XLSX 1052 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="12864_2015_2343_MOESM3_ESM.xlsx" id="MOESM3">
              <label>Additional file 3:</label>
              <caption>
                <p>
<bold>The copies of ancestral blocks of Brassicaceae discriminated in </bold>
<bold><italic>Brassica</italic></bold>
<bold>species and</bold>
<bold><italic>Brassica</italic></bold>
<bold>subgenomes.</bold> (XLSX 15 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="12864_2015_2343_MOESM4_ESM.xlsx" id="MOESM4">
              <label>Additional file 4:</label>
              <caption>
                <p>
<bold>Comparison between the three A subgenomes.</bold> Ten sheets present the comparison from A1 to A10 among the three A subgenomes. The lines with blue color in one segment show an inversion event. (XLSX 2894 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="12864_2015_2343_MOESM5_ESM.pdf" id="MOESM5">
              <label>Additional file 5:</label>
              <caption>
                <p>
<bold>Phylogenetic tree of the three A genome-contained species evaluated with different sets of markers.</bold> A, Evaluated with all of high-quality markers with genome alignments (28,267) (left), with a set of markers (16,077) which was aligned to unique positions of A, B and C genomes (ABC-markers, middle), and markers (12,781) which were uniquely aligned to B (8278) and C (4503) genomes(right), respectively. All of the three figures shown that <italic>B. juncea</italic> was separated from other two species. B, Evaluated with markers aligned to A genome uniquely (3296) (left), and 3296 A genome specific markers plus 11,321 markers with alignment on A genome along with positions on other genome(s). <italic>B. juncea</italic> and <italic>B. rapa</italic> shown close relationship and separated from <italic>B. napus</italic>. (PDF 552 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="12864_2015_2343_MOESM6_ESM.xlsx" id="MOESM6">
              <label>Additional file 6:</label>
              <caption>
                <p>
<bold>Calculation on the population genetic distance among the three species carrying A genome by resampling.</bold> (XLSX 30 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="12864_2015_2343_MOESM7_ESM.pdf" id="MOESM7">
              <label>Additional file 7:</label>
              <caption>
                <p>
<bold>The ∆K value of the population genetic structure of the 26</bold>
<bold><italic>Brassica</italic></bold>
<bold>accessions generated using the STRUCTURE program calculation with different data set of markers.</bold> A, Evaluated with a set of markers (16,077) which was aligned to unique positions of A, B and C genomes (ABC-markers). The highest ∆K value was observed at K = 3, where K is the most probable number of populations. An inflexion high ∆K value was also observed at K = 2, which also indicated the genetic relationship among the diverse lines. B, Evaluated with markers aligned to A genome uniquely (3296). The highest ∆K value was observed at K = 2, and an inflexion high ∆K value was also observed at K =3, which also indicated the genetic relationship among the diverse lines. (PDF 162 kb)</p>
              </caption>
            </media>
          </p>
        </sec>
      </app>
    </app-group>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>AFLP</term>
          <def>
            <p>amplified fragment length polymorphism</p>
          </def>
        </def-item>
        <def-item>
          <term>
            <italic>B. juncea</italic>
          </term>
          <def>
            <p>
              <italic>Brassica juncea</italic>
            </p>
          </def>
        </def-item>
        <def-item>
          <term>bp</term>
          <def>
            <p>basepair</p>
          </def>
        </def-item>
        <def-item>
          <term>cM</term>
          <def>
            <p>centiMorgan</p>
          </def>
        </def-item>
        <def-item>
          <term>DArT P/L</term>
          <def>
            <p>Diversity Arrays Technology Pty. Ltd.</p>
          </def>
        </def-item>
        <def-item>
          <term>EAC</term>
          <def>
            <p>seed erucic acid</p>
          </def>
        </def-item>
        <def-item>
          <term>GLU</term>
          <def>
            <p>glucosinolate</p>
          </def>
        </def-item>
        <def-item>
          <term>LG</term>
          <def>
            <p>linkage group</p>
          </def>
        </def-item>
        <def-item>
          <term>Mb</term>
          <def>
            <p>megabase</p>
          </def>
        </def-item>
        <def-item>
          <term>MYA</term>
          <def>
            <p>million years ago</p>
          </def>
        </def-item>
        <def-item>
          <term>PM</term>
          <def>
            <p>purple mustard</p>
          </def>
        </def-item>
        <def-item>
          <term>QTL</term>
          <def>
            <p>quantitative trait locus</p>
          </def>
        </def-item>
        <def-item>
          <term>RFLP</term>
          <def>
            <p>restriction fragment length polymorphism</p>
          </def>
        </def-item>
        <def-item>
          <term>SNP</term>
          <def>
            <p>single nucleotide polymorphism</p>
          </def>
        </def-item>
        <def-item>
          <term>SSR</term>
          <def>
            <p>simple sequence repeats</p>
          </def>
        </def-item>
        <def-item>
          <term>SY</term>
          <def>
            <p>sichuan yellow</p>
          </def>
        </def-item>
        <def-item>
          <term>UPGMA</term>
          <def>
            <p>unweighted pair-group method with arithmetic means</p>
          </def>
        </def-item>
        <def-item>
          <term>
            <italic>χ</italic>
            <sup>2</sup>
          </term>
          <def>
            <p>Chi-square</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The authors declare that they have no competing interests.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors’ contributions</bold>
        </p>
        <p>JZ performed the research, analyzed the data and wrote the manuscript; DDH and PFL analyzed the data, and revised the manuscript; XJL and ZSL constructed the genetic mapping population; HR, ZSL and JM designed the research, revised the manuscript, and supported the project. IP provided the alignment of all of the marker sequence to the draft genome sequence of <italic>B. juncea</italic> and revised the manuscript. BC provided the genome sequence of <italic>B. napus</italic> and revised the manuscript. All authors read, and approved the final manuscript.</p>
      </fn>
    </fn-group>
    <ack>
      <p>The authors gratefully acknowledge the financial support provided by the National Basic Research Program of China (Grant No. 2015CB150200), National Science Foundation of China (31271762), the Open Research Fund by National Key Laboratory of Crop Genetic Improvement of Huazhong Agricultural University (ZK201212), and NSW Agricultural Genomics Centre under BioFirst Initiative. The authors also acknowledge Dr. Andrzej Kilian, DArT P/L for genotyping the SY-PM population.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deokar</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Ramsay</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Sharpe</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Diapari</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sindhu</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bett</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Genome wide SNP identification in chickpea for use in development of a high density genetic map and improvement of chickpea reference genome assembly</article-title>
          <source>BMC Genomics</source>
          <year>2014</year>
          <volume>15</volume>
          <fpage>708</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-2164-15-708</pub-id>
          <?supplied-pmid 25150411?>
          <pub-id pub-id-type="pmid">25150411</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Delourme</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Falentin</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Fomeju</surname>
              <given-names>BF</given-names>
            </name>
            <name>
              <surname>Boillot</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lassalle</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Andre</surname>
              <given-names>I</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>High-density SNP-based genetic map development and linkage disequilibrium assessment in <italic>Brassica napus</italic> L</article-title>
          <source>BMC Genomics</source>
          <year>2013</year>
          <volume>14</volume>
          <fpage>120</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-2164-14-120</pub-id>
          <?supplied-pmid 23432809?>
          <pub-id pub-id-type="pmid">23432809</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Castillo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ramirez</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Kilian</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Atienza</surname>
              <given-names>SG</given-names>
            </name>
          </person-group>
          <article-title>High-throughput genotyping of wheat-barley amphiploids utilising diversity array technology (DArT)</article-title>
          <source>BMC Plant Biol</source>
          <year>2013</year>
          <volume>13</volume>
          <fpage>87</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-2229-13-87</pub-id>
          <?supplied-pmid 23725040?>
          <pub-id pub-id-type="pmid">23725040</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bus</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hecht</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Huettel</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Reinhardt</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Stich</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>High-throughput polymorphism detection and genotyping in <italic>Brassica napus</italic> using next-generation RAD sequencing</article-title>
          <source>BMC Genomics</source>
          <year>2012</year>
          <volume>13</volume>
          <fpage>281</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-2164-13-281</pub-id>
          <?supplied-pmid 22726880?>
          <pub-id pub-id-type="pmid">22726880</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sharma</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Lim</surname>
              <given-names>YP</given-names>
            </name>
          </person-group>
          <article-title>Comparative genomics of Brassicaceae crops</article-title>
          <source>Breed Sci</source>
          <year>2014</year>
          <volume>64</volume>
          <issue>1</issue>
          <fpage>3</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="doi">10.1270/jsbbs.64.3</pub-id>
          <?supplied-pmid 24987286?>
          <pub-id pub-id-type="pmid">24987286</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Parkin</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Bancroft</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Schmidt</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Chasing Ghosts: Comparative Mapping in the Brassicaceae</article-title>
          <source>Genetics and genomics of the Brassicaceae</source>
          <year>2011</year>
          <publisher-loc>New York</publisher-loc>
          <publisher-name>Springer</publisher-name>
          <fpage>153</fpage>
          <lpage>170</lpage>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lagercrantz</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Putterill</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Coupland</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Lydiate</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Comparative mapping in <italic>Arabidopsis</italic> and <italic>Brassica</italic>, fine scale genome collinearity and congruence of genes controlling flowering time</article-title>
          <source>Plant J</source>
          <year>1996</year>
          <volume>9</volume>
          <issue>1</issue>
          <fpage>13</fpage>
          <lpage>20</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1365-313X.1996.09010013.x</pub-id>
          <?supplied-pmid 8580970?>
          <pub-id pub-id-type="pmid">8580970</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Parkin</surname>
              <given-names>IAP</given-names>
            </name>
            <name>
              <surname>Gulden</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Sharpe</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Lukens</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Trick</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Osborn</surname>
              <given-names>TC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Segmental structure of the <italic>Brassica napus</italic> genome based on comparative analysis with <italic>Arabidopsis thaliana</italic></article-title>
          <source>Genetics</source>
          <year>2005</year>
          <volume>171</volume>
          <issue>2</issue>
          <fpage>765</fpage>
          <lpage>781</lpage>
          <pub-id pub-id-type="doi">10.1534/genetics.105.042093</pub-id>
          <?supplied-pmid 16020789?>
          <pub-id pub-id-type="pmid">16020789</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Panjabi</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Jagannath</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bisht</surname>
              <given-names>NC</given-names>
            </name>
            <name>
              <surname>Padmaja</surname>
              <given-names>KL</given-names>
            </name>
            <name>
              <surname>Sharma</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gupta</surname>
              <given-names>V</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Comparative mapping of <italic>Brassica juncea</italic> and <italic>Arabidopsis thaliana</italic> using Intron Polymorphism (IP) markers: homoeologous relationships, diversification and evolution of the A, B and C <italic>Brassica</italic> genomes</article-title>
          <source>BMC Genomics</source>
          <year>2008</year>
          <volume>9</volume>
          <fpage>113</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-2164-9-113</pub-id>
          <?supplied-pmid 18315867?>
          <pub-id pub-id-type="pmid">18315867</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guo</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Zou</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Long</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Meng</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>A genetic linkage map of <italic>Brassica carinata</italic> constructed with a doubled haploid population</article-title>
          <source>Theor Appl Genet</source>
          <year>2012</year>
          <volume>125</volume>
          <issue>6</issue>
          <fpage>1113</fpage>
          <lpage>1124</lpage>
          <pub-id pub-id-type="doi">10.1007/s00122-012-1898-3</pub-id>
          <?supplied-pmid 22669300?>
          <pub-id pub-id-type="pmid">22669300</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cheung</surname>
              <given-names>WY</given-names>
            </name>
            <name>
              <surname>Friesen</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Rakow</surname>
              <given-names>GFW</given-names>
            </name>
            <name>
              <surname>Séguin-Swartz</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Landry</surname>
              <given-names>BS</given-names>
            </name>
          </person-group>
          <article-title>A RFLP-based linkage map of mustard [<italic>Brassica juncea</italic> (L.) Czern. and Coss.]</article-title>
          <source>Theor Appl Genet</source>
          <year>1997</year>
          <volume>94</volume>
          <fpage>841</fpage>
          <lpage>851</lpage>
          <pub-id pub-id-type="doi">10.1007/s001220050485</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lionneton</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Ravera</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sanchez</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Aubert</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Delourme</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Ochatt</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Development of an AFLP-based linkage map and localization of QTLs for seed fatty acid content in condiment mustard (<italic>Brassica juncea</italic>)</article-title>
          <source>Genome</source>
          <year>2002</year>
          <volume>45</volume>
          <fpage>1203</fpage>
          <lpage>1215</lpage>
          <pub-id pub-id-type="doi">10.1139/g02-095</pub-id>
          <?supplied-pmid 12502267?>
          <pub-id pub-id-type="pmid">12502267</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pradhan</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Gupta</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Mukhopadhyay</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Arumugam</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Sodhi</surname>
              <given-names>YS</given-names>
            </name>
            <name>
              <surname>Pental</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>A high-density linkage map in <italic>Brassica juncea</italic> (Indian mustard) using AFLP and RFLP markers</article-title>
          <source>Theor Appl Genet</source>
          <year>2003</year>
          <volume>106</volume>
          <fpage>607</fpage>
          <lpage>614</lpage>
          <?supplied-pmid 12595988?>
          <pub-id pub-id-type="pmid">12595988</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Qu</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Wittkop</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Yi</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Xiao</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A High-Density SNP map for accurate mapping of seed fibre QTL in <italic>Brassica napus</italic> L</article-title>
          <source>PLoS One</source>
          <year>2013</year>
          <volume>8</volume>
          <issue>12</issue>
          <fpage>e83052</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0083052</pub-id>
          <?supplied-pmid 24386142?>
          <pub-id pub-id-type="pmid">24386142</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zou</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Raman</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Guo</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Wei</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Luo</surname>
              <given-names>Z</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Constructing a dense genetic linkage map and mapping QTL for the traits of flower development in <italic>Brassica carinata</italic></article-title>
          <source>Theor Appl Genet</source>
          <year>2014</year>
          <volume>127</volume>
          <issue>7</issue>
          <fpage>1593</fpage>
          <lpage>1605</lpage>
          <pub-id pub-id-type="doi">10.1007/s00122-014-2321-z</pub-id>
          <?supplied-pmid 24824567?>
          <pub-id pub-id-type="pmid">24824567</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Paritosh</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Gupta</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Yadava</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Singh</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Pradhan</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Pental</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>RNA-seq based SNPs for mapping in <italic>Brassica juncea</italic> (AABB): synteny analysis between the two constituent genomes A (from <italic>B. rapa</italic>) and B (from <italic>B. nigra</italic>) shows highly divergent gene block arrangement and unique block fragmentation patterns</article-title>
          <source>BMC Genomics</source>
          <year>2014</year>
          <volume>15</volume>
          <fpage>396</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-2164-15-396</pub-id>
          <?supplied-pmid 24886001?>
          <pub-id pub-id-type="pmid">24886001</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cai</surname>
              <given-names>GQ</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>QY</given-names>
            </name>
            <name>
              <surname>Yi</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Fan</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>CY</given-names>
            </name>
            <name>
              <surname>Edwards</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A bi-filtering method for processing single nucleotide polymorphism array data improves the quality of genetic map and accuracy of quantitative trait locus mapping in doubled haploid populations of polyploid <italic>Brassica napus</italic></article-title>
          <source>BMC Genomics</source>
          <year>2015</year>
          <volume>16</volume>
          <fpage>409</fpage>
          <pub-id pub-id-type="doi">10.1186/s12864-015-1559-4</pub-id>
          <?supplied-pmid 26018616?>
          <pub-id pub-id-type="pmid">26018616</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sharma</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Padmaja</surname>
              <given-names>KL</given-names>
            </name>
            <name>
              <surname>Gupta</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Paritosh</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Pradhan</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Pental</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Two plastid DNA lineages-Rapa/Oleracea and Nigra-within the Tribe Brassiceae can be best explained by reciprocal crosses at hexaploidy: Evidence from divergence times of the plastid genomes and R-Block eenes of the A and B Genomes of <italic>Brassica juncea</italic></article-title>
          <source>Plos One</source>
          <year>2014</year>
          <volume>9</volume>
          <issue>4</issue>
          <fpage>e93260</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0093260</pub-id>
          <?supplied-pmid 24691069?>
          <pub-id pub-id-type="pmid">24691069</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schranz</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Lysak</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Mitchell-Olds</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>The ABC’s of comparative genomics in the Brassicaceae: building blocks of crucifer genomes</article-title>
          <source>Trends Plant Sci</source>
          <year>2006</year>
          <volume>11</volume>
          <issue>11</issue>
          <fpage>535</fpage>
          <lpage>542</lpage>
          <pub-id pub-id-type="doi">10.1016/j.tplants.2006.09.002</pub-id>
          <?supplied-pmid 17029932?>
          <pub-id pub-id-type="pmid">17029932</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Town</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Cheung</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Maiti</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Crabtree</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Haas</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Wortman</surname>
              <given-names>JR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Comparative genomics of <italic>Brassica oleracea</italic> and <italic>Arabidopsis thaliana</italic> reveal gene loss, fragmentation, and dispersal after polyploidy</article-title>
          <source>Plant Cell</source>
          <year>2006</year>
          <volume>18</volume>
          <issue>6</issue>
          <fpage>1348</fpage>
          <lpage>1359</lpage>
          <pub-id pub-id-type="doi">10.1105/tpc.106.041665</pub-id>
          <?supplied-pmid 16632643?>
          <pub-id pub-id-type="pmid">16632643</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lysak</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Koch</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Pecinka</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Schubert</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Chromosome triplication found across the tribe Brassiceae</article-title>
          <source>Genome Res</source>
          <year>2005</year>
          <volume>15</volume>
          <issue>4</issue>
          <fpage>516</fpage>
          <lpage>525</lpage>
          <pub-id pub-id-type="doi">10.1101/gr.3531105</pub-id>
          <?supplied-pmid 15781573?>
          <pub-id pub-id-type="pmid">15781573</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Ramchiary</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Dhandapani</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Hur</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Nou</surname>
              <given-names>I-S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Quantitative trait loci mapping in <italic>Brassica rapa</italic> revealed the structural and functional conservation of genetic loci governing morphological and yield component traits in the A, B, and C subgenomes of <italic>Brassica</italic> species</article-title>
          <source>DNA Res</source>
          <year>2013</year>
          <volume>20</volume>
          <issue>1</issue>
          <fpage>1</fpage>
          <lpage>16</lpage>
          <pub-id pub-id-type="doi">10.1093/dnares/dss029</pub-id>
          <?supplied-pmid 23223793?>
          <pub-id pub-id-type="pmid">23223793</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chalhoub</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Denoeud</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Parkin</surname>
              <given-names>IAP</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>X</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Early allopolyploid evolution in the post-Neolithic <italic>Brassica napus</italic> oilseed genome</article-title>
          <source>Science</source>
          <year>2014</year>
          <volume>345</volume>
          <issue>6199</issue>
          <fpage>950</fpage>
          <lpage>953</lpage>
          <pub-id pub-id-type="doi">10.1126/science.1253435</pub-id>
          <?supplied-pmid 25146293?>
          <pub-id pub-id-type="pmid">25146293</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jiang</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Ramchiary</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>YB</given-names>
            </name>
            <name>
              <surname>Jin</surname>
              <given-names>MN</given-names>
            </name>
            <name>
              <surname>Feng</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>RY</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Structural and functional comparative mapping between the <italic>Brassica</italic> A genomes in allotetraploid <italic>Brassica napus</italic> and diploid <italic>Brassica rapa</italic></article-title>
          <source>Theor Appl Genet</source>
          <year>2011</year>
          <volume>123</volume>
          <issue>4</issue>
          <fpage>927</fpage>
          <lpage>941</lpage>
          <pub-id pub-id-type="doi">10.1007/s00122-011-1637-1</pub-id>
          <?supplied-pmid 21761162?>
          <pub-id pub-id-type="pmid">21761162</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nagaharu</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>Genome analysis in <italic>Brassica</italic> with special reference to the experimental formation of <italic>B. napus</italic> and peculiar mode of fertilization</article-title>
          <source>Jpn JBot</source>
          <year>1935</year>
          <volume>7</volume>
          <fpage>389</fpage>
          <lpage>452</lpage>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zou</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Tian</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Xiao</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Fu</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Broadening the avenue of intersubgenomic heterosis in oilseed <italic>Brassica</italic></article-title>
          <source>Theor Appl Genet</source>
          <year>2010</year>
          <volume>120</volume>
          <issue>2</issue>
          <fpage>283</fpage>
          <lpage>290</lpage>
          <pub-id pub-id-type="doi">10.1007/s00122-009-1201-4</pub-id>
          <?supplied-pmid 19911158?>
          <pub-id pub-id-type="pmid">19911158</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zou</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Fu</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Gong</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Qian</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Xia</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Pires</surname>
              <given-names>JC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title><italic>De novo</italic> genetic variation associated with retrotransposon activation, genomic rearrangements and trait variation in a recombinant inbred line population of <italic>Brassica napus</italic> derived from interspecific hybridization with <italic>Brassica rapa</italic></article-title>
          <source>Plant J</source>
          <year>2011</year>
          <volume>68</volume>
          <issue>2</issue>
          <fpage>212</fpage>
          <lpage>224</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-313X.2011.04679.x</pub-id>
          <?supplied-pmid 21689170?>
          <pub-id pub-id-type="pmid">21689170</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Pires</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Gaeta</surname>
              <given-names>RT</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Bancroft</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Schmidt</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Structural and Functional Evolution of Resynthesized Polyploids</article-title>
          <source>Genetics and genomics of the Brassicaceae</source>
          <year>2011</year>
          <publisher-loc>New York</publisher-loc>
          <publisher-name>Springer</publisher-name>
          <fpage>323</fpage>
          <lpage>345</lpage>
        </element-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cheng</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Mandakova</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Xie</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Lysak</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>X</given-names>
            </name>
          </person-group>
          <article-title>Deciphering the diploid ancestral genome of the mesohexaploid <italic>Brassica rapa</italic></article-title>
          <source>Plant Cell</source>
          <year>2013</year>
          <volume>25</volume>
          <issue>5</issue>
          <fpage>1541</fpage>
          <lpage>1554</lpage>
          <pub-id pub-id-type="doi">10.1105/tpc.113.110486</pub-id>
          <?supplied-pmid 23653472?>
          <pub-id pub-id-type="pmid">23653472</pub-id>
        </element-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mei</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Qian</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Fu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Frauen</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Genetic investigation of the origination of allopolyploid with virtually synthesized lines: Application to the C subgenome of <italic>Brassica napus</italic></article-title>
          <source>Heredity</source>
          <year>2011</year>
          <volume>106</volume>
          <issue>6</issue>
          <fpage>955</fpage>
          <lpage>961</lpage>
          <pub-id pub-id-type="doi">10.1038/hdy.2010.143</pub-id>
          <?supplied-pmid 21102622?>
          <pub-id pub-id-type="pmid">21102622</pub-id>
        </element-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Navabi</surname>
              <given-names>ZK</given-names>
            </name>
            <name>
              <surname>Parkin</surname>
              <given-names>IA</given-names>
            </name>
            <name>
              <surname>Pires</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Xiong</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Thiagarajah</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Good</surname>
              <given-names>AG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Introgression of B-genome chromosomes in a doubled haploid population of <italic>Brassica napus</italic> x <italic>B. carinata</italic></article-title>
          <source>Genome</source>
          <year>2010</year>
          <volume>53</volume>
          <issue>8</issue>
          <fpage>619</fpage>
          <lpage>629</lpage>
          <pub-id pub-id-type="doi">10.1139/G10-039</pub-id>
          <?supplied-pmid 20725149?>
          <pub-id pub-id-type="pmid">20725149</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nelson</surname>
              <given-names>MN</given-names>
            </name>
            <name>
              <surname>Chevre</surname>
              <given-names>A-M</given-names>
            </name>
            <name>
              <surname>Jenczewski</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Mason</surname>
              <given-names>AS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Trigenomic Bridges for Brassica Improvement</article-title>
          <source>Crit Rev Plant Sci</source>
          <year>2011</year>
          <volume>30</volume>
          <issue>6</issue>
          <fpage>524</fpage>
          <lpage>547</lpage>
          <pub-id pub-id-type="doi">10.1080/07352689.2011.615700</pub-id>
        </element-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chèvre</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Barret</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Eber</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Dupuy</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Brun</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Tanguy</surname>
              <given-names>X</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Selection of stable <italic>Brassica napus-B. juncea</italic> recombinant lines resistant to blackleg (<italic>Leptosphaeria maculans</italic>). 1. Identification of molecular markers, chromosomal and genomic origin of the introgression</article-title>
          <source>Theor Appl Genet</source>
          <year>1997</year>
          <volume>95</volume>
          <issue>7</issue>
          <fpage>1104</fpage>
          <lpage>1111</lpage>
          <pub-id pub-id-type="doi">10.1007/s001220050669</pub-id>
        </element-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wan</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Nelson</surname>
              <given-names>MN</given-names>
            </name>
            <name>
              <surname>Chauhan</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Redden</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Burton</surname>
              <given-names>WA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Evidence from genome-wide simple sequence repeat markers for a polyphyletic origin and secondary centers of genetic diversity of <italic>Brassica juncea</italic> in China and India</article-title>
          <source>J Hered</source>
          <year>2013</year>
          <volume>104</volume>
          <fpage>416</fpage>
          <lpage>427</lpage>
          <pub-id pub-id-type="doi">10.1093/jhered/est015</pub-id>
          <?supplied-pmid 23519868?>
          <pub-id pub-id-type="pmid">23519868</pub-id>
        </element-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sharma</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Aggarwal</surname>
              <given-names>RAK</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Mohapatra</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Sharma</surname>
              <given-names>RP</given-names>
            </name>
          </person-group>
          <article-title>Construction of an RAPD linkage map and localization of QTLs for oleic acid level using recombinant inbreds in mustard (<italic>Brassica juncea</italic>)</article-title>
          <source>Genome</source>
          <year>2002</year>
          <volume>45</volume>
          <fpage>467</fpage>
          <lpage>472</lpage>
          <pub-id pub-id-type="doi">10.1139/g02-001</pub-id>
          <?supplied-pmid 12033614?>
          <pub-id pub-id-type="pmid">12033614</pub-id>
        </element-citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Christianson</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Rimmer</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Good</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Lydiate</surname>
              <given-names>DJ</given-names>
            </name>
          </person-group>
          <article-title>Mapping genes for resistance to <italic>Leptosphaeria maculans</italic> in <italic>Brassica juncea</italic></article-title>
          <source>Genome</source>
          <year>2006</year>
          <volume>49</volume>
          <fpage>30</fpage>
          <lpage>41</lpage>
          <pub-id pub-id-type="doi">10.1139/g05-085</pub-id>
          <?supplied-pmid 16462899?>
          <pub-id pub-id-type="pmid">16462899</pub-id>
        </element-citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>XJ</given-names>
            </name>
            <name>
              <surname>Yuan</surname>
              <given-names>MZ</given-names>
            </name>
            <name>
              <surname>Guan</surname>
              <given-names>CY</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>SY</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>SY</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>ZS</given-names>
            </name>
          </person-group>
          <article-title>Inheritance, mapping, and origin of yellow-seeded trait in <italic>Brassica juncea</italic></article-title>
          <source>Acta Agron Sin</source>
          <year>2009</year>
          <volume>35</volume>
          <fpage>839</fpage>
          <lpage>847</lpage>
          <pub-id pub-id-type="doi">10.3724/SP.J.1006.2009.00839</pub-id>
        </element-citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The genome of the mesopolyploid crop species <italic>Brassica rapa</italic></article-title>
          <source>Nat Genet</source>
          <year>2011</year>
          <volume>43</volume>
          <issue>10</issue>
          <fpage>1035</fpage>
          <lpage>U1157</lpage>
          <pub-id pub-id-type="doi">10.1038/ng.919</pub-id>
          <?supplied-pmid 21873998?>
          <pub-id pub-id-type="pmid">21873998</pub-id>
        </element-citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Raman</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Raman</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kilian</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Detering</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Carling</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Coombes</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Genome-wide delineation of natural variation for pod shatter resistance in <italic>Brassica napus</italic></article-title>
          <source>Plos One</source>
          <year>2014</year>
          <volume>9</volume>
          <issue>7</issue>
          <fpage>13</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0101673</pub-id>
        </element-citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pritchard</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Stephens</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Donnelly</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Inference of population structure using multilocus genotype data</article-title>
          <source>Genetics</source>
          <year>2000</year>
          <volume>155</volume>
          <issue>2</issue>
          <fpage>945</fpage>
          <lpage>959</lpage>
          <?supplied-pmid 10835412?>
          <pub-id pub-id-type="pmid">10835412</pub-id>
        </element-citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jansen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>de Jong</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>van Ooijen</surname>
              <given-names>JW</given-names>
            </name>
          </person-group>
          <article-title>Constructing dense genetic linkage maps</article-title>
          <source>Theor Appl Genet</source>
          <year>2001</year>
          <volume>102</volume>
          <issue>6–7</issue>
          <fpage>1113</fpage>
          <lpage>1122</lpage>
          <pub-id pub-id-type="doi">10.1007/s001220000489</pub-id>
        </element-citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bancroft</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Morgan</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Fraser</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Higgins</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Wells</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Clissold</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Dissecting the genome of the polyploid crop oilseed rape by transcriptome sequencing</article-title>
          <source>Nat Biotechnol</source>
          <year>2011</year>
          <volume>29</volume>
          <issue>8</issue>
          <fpage>762</fpage>
          <lpage>U128</lpage>
          <pub-id pub-id-type="doi">10.1038/nbt.1926</pub-id>
          <?supplied-pmid 21804563?>
          <pub-id pub-id-type="pmid">21804563</pub-id>
        </element-citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lagercrantz</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>Comparative mapping between <italic>Arabidopsis thaliana</italic> and <italic>Brassica nigra</italic> indicates that <italic>Brassica</italic> genomes have evolved through extensive genome replication accompanied by chromosome fusions and frequent rearrangements</article-title>
          <source>Genetics</source>
          <year>1998</year>
          <volume>150</volume>
          <issue>3</issue>
          <fpage>1217</fpage>
          <lpage>1228</lpage>
          <?supplied-pmid 9799273?>
          <pub-id pub-id-type="pmid">9799273</pub-id>
        </element-citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beilstein</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Al-Shehbaz</surname>
              <given-names>IA</given-names>
            </name>
            <name>
              <surname>Kellogg</surname>
              <given-names>EA</given-names>
            </name>
          </person-group>
          <article-title>Brassicaceae phylogeny and trichome evolution</article-title>
          <source>Am J Bot</source>
          <year>2006</year>
          <volume>93</volume>
          <issue>4</issue>
          <fpage>607</fpage>
          <lpage>619</lpage>
          <pub-id pub-id-type="doi">10.3732/ajb.93.4.607</pub-id>
          <?supplied-pmid 21646222?>
          <pub-id pub-id-type="pmid">21646222</pub-id>
        </element-citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Warwick</surname>
              <given-names>SI</given-names>
            </name>
            <name>
              <surname>Sauder</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Mayer</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Al-Shenbaz</surname>
              <given-names>IA</given-names>
            </name>
          </person-group>
          <article-title>Phylogenetic relationships in the tribes Schizopetaleae and Thelypodieae (Brassicaceae) based on nuclear ribosomal ITS region and plastid ndhF DNA sequences</article-title>
          <source>Botany-Botanique</source>
          <year>2009</year>
          <volume>87</volume>
          <issue>10</issue>
          <fpage>961</fpage>
          <lpage>985</lpage>
          <pub-id pub-id-type="doi">10.1139/B09-051</pub-id>
        </element-citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Navabi</surname>
              <given-names>ZK</given-names>
            </name>
            <name>
              <surname>Huebert</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Sharpe</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>O’Neill</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Bancroft</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Parkin</surname>
              <given-names>IAP</given-names>
            </name>
          </person-group>
          <article-title>Conserved microstructure of the <italic>Brassica</italic> B Genome of <italic>Brassica nigra</italic> in relation to homologous regions of <italic>Arabidopsis thaliana</italic>, <italic>B. rapa</italic> and <italic>B. oleracea</italic></article-title>
          <source>BMC Genomics</source>
          <year>2013</year>
          <volume>14</volume>
          <fpage>250</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-2164-14-250</pub-id>
          <?supplied-pmid 23586706?>
          <pub-id pub-id-type="pmid">23586706</pub-id>
        </element-citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gupta</surname>
              <given-names>MGS</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Banga</surname>
              <given-names>SS</given-names>
            </name>
          </person-group>
          <article-title>Population structure and breeding value of a new type of <italic>Brassica juncea</italic> created by combining A and B genomes from related allotetraploids</article-title>
          <source>Theor Appl Genet</source>
          <year>2015</year>
          <volume>128</volume>
          <issue>2</issue>
          <fpage>221</fpage>
          <lpage>234</lpage>
          <pub-id pub-id-type="doi">10.1007/s00122-014-2423-7</pub-id>
          <?supplied-pmid 25399317?>
          <pub-id pub-id-type="pmid">25399317</pub-id>
        </element-citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tian</surname>
              <given-names>ET</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>YF</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>LL</given-names>
            </name>
            <name>
              <surname>Zou</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Meng</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
          <article-title>Synthesis of a <italic>Brassica</italic> trigenomic allohexaploid (<italic>B. carinata</italic> x <italic>B. rapa</italic>) <italic>de novo</italic> and its stability in subsequent generations</article-title>
          <source>Theor Appl Genet</source>
          <year>2010</year>
          <volume>121</volume>
          <issue>8</issue>
          <fpage>1431</fpage>
          <lpage>1440</lpage>
          <pub-id pub-id-type="doi">10.1007/s00122-010-1399-1</pub-id>
          <?supplied-pmid 20607208?>
          <pub-id pub-id-type="pmid">20607208</pub-id>
        </element-citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yu</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Lydiate</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Gugel</surname>
              <given-names>RK</given-names>
            </name>
            <name>
              <surname>Sharpe</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Rimmer</surname>
              <given-names>SR</given-names>
            </name>
          </person-group>
          <article-title>Introgression of <italic>Brassica rapa</italic> subsp. sylvestris blackleg resistance into <italic>B. napus</italic></article-title>
          <source>Mol Breeding</source>
          <year>2012</year>
          <volume>30</volume>
          <issue>3</issue>
          <fpage>1495</fpage>
          <lpage>1506</lpage>
          <pub-id pub-id-type="doi">10.1007/s11032-012-9735-6</pub-id>
        </element-citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Girke</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Schierholt</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Becker</surname>
              <given-names>HC</given-names>
            </name>
          </person-group>
          <article-title>Extending the rapeseed genepool with resynthesized <italic>Brassica napus</italic> L. I: Genetic diversity</article-title>
          <source>Genet Resour Crop Ev</source>
          <year>2012</year>
          <volume>59</volume>
          <issue>7</issue>
          <fpage>1441</fpage>
          <lpage>1447</lpage>
          <pub-id pub-id-type="doi">10.1007/s10722-011-9772-8</pub-id>
        </element-citation>
      </ref>
      <ref id="CR51">
        <label>51.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Girke</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Schierholt</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Becker</surname>
              <given-names>HC</given-names>
            </name>
          </person-group>
          <article-title>Extending the rapeseed gene pool with resynthesized <italic>Brassica napus</italic> II: Heterosis</article-title>
          <source>Theor Appl Genet</source>
          <year>2012</year>
          <volume>124</volume>
          <issue>6</issue>
          <fpage>1017</fpage>
          <lpage>1026</lpage>
          <pub-id pub-id-type="doi">10.1007/s00122-011-1765-7</pub-id>
          <?supplied-pmid 22159759?>
          <pub-id pub-id-type="pmid">22159759</pub-id>
        </element-citation>
      </ref>
      <ref id="CR52">
        <label>52.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bennett</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Seguin-Swartz</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Rahman</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Broadening genetic diversity in canola using the C-genome species <italic>Brassica oleracea</italic> L</article-title>
          <source>Crop Sci</source>
          <year>2012</year>
          <volume>52</volume>
          <issue>5</issue>
          <fpage>2030</fpage>
          <lpage>2039</lpage>
          <pub-id pub-id-type="doi">10.2135/cropsci2011.11.0580</pub-id>
        </element-citation>
      </ref>
      <ref id="CR53">
        <label>53.</label>
        <mixed-citation publication-type="other">Van Ooijen JW: JoinMap 4.0, Software for the calculation of genetic linkage maps in experimental populations. Kyazma B.V., Wageningen, Netherlands. 2006.</mixed-citation>
      </ref>
      <ref id="CR54">
        <label>54.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nei</surname>
              <given-names>MTF</given-names>
            </name>
            <name>
              <surname>Tateno</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Accuracy of estimated phylogenetic trees from molecular data. II. Gene frequency data</article-title>
          <source>J Mol Evol</source>
          <year>1983</year>
          <volume>19</volume>
          <issue>2</issue>
          <fpage>153</fpage>
          <lpage>170</lpage>
          <pub-id pub-id-type="doi">10.1007/BF02300753</pub-id>
          <?supplied-pmid 6571220?>
          <pub-id pub-id-type="pmid">6571220</pub-id>
        </element-citation>
      </ref>
      <ref id="CR55">
        <label>55.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Muse</surname>
              <given-names>SV</given-names>
            </name>
          </person-group>
          <article-title>PowerMarker: an integrated analysis environment for genetic marker analysis</article-title>
          <source>Bioinformatics</source>
          <year>2005</year>
          <volume>21</volume>
          <issue>9</issue>
          <fpage>2128</fpage>
          <lpage>2129</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/bti282</pub-id>
          <?supplied-pmid 15705655?>
          <pub-id pub-id-type="pmid">15705655</pub-id>
        </element-citation>
      </ref>
      <ref id="CR56">
        <label>56.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tamura</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Dudley</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Nei</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>MEGA4: Molecular evolutionary genetics analysis (MEGA) software version 4.0</article-title>
          <source>Mol Biol Evol</source>
          <year>2007</year>
          <volume>24</volume>
          <issue>8</issue>
          <fpage>1596</fpage>
          <lpage>1599</lpage>
          <pub-id pub-id-type="doi">10.1093/molbev/msm092</pub-id>
          <?supplied-pmid 17488738?>
          <pub-id pub-id-type="pmid">17488738</pub-id>
        </element-citation>
      </ref>
      <ref id="CR57">
        <label>57.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Evanno</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Regnaut</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Goudet</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Detecting the number of clusters of individuals using the software STRUCTURE: a simulation study</article-title>
          <source>Mol Ecol</source>
          <year>2005</year>
          <volume>14</volume>
          <issue>8</issue>
          <fpage>2611</fpage>
          <lpage>2620</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-294X.2005.02553.x</pub-id>
          <?supplied-pmid 15969739?>
          <pub-id pub-id-type="pmid">15969739</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:4700567</identifier><datestamp>2016-01-06</datestamp><setSpec>micrcellf</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="http://jats.nlm.nih.gov/ns/archiving/1.0/ http://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Microb Cell Fact</journal-id>
      <journal-id journal-id-type="iso-abbrev">Microb. Cell Fact</journal-id>
      <journal-title-group>
        <journal-title>Microbial Cell Factories</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1475-2859</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC4700567</article-id>
      <article-id pub-id-type="pmcid">PMC4700567</article-id>
      <article-id pub-id-type="pmc-uid">4700567</article-id>
      <article-id pub-id-type="publisher-id">402</article-id>
      <article-id pub-id-type="doi">10.1186/s12934-015-0402-6</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Assembly of a novel biosynthetic pathway for gentamicin B production in <italic>Micromonospora echinospora</italic></article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Ni</surname>
            <given-names>Xianpu</given-names>
          </name>
          <address>
            <email>nixianpu126@126.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sun</surname>
            <given-names>Zhenpeng</given-names>
          </name>
          <address>
            <email>1026625249@qq.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gu</surname>
            <given-names>Yawen</given-names>
          </name>
          <address>
            <email>gyw0636@163.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cui</surname>
            <given-names>Hao</given-names>
          </name>
          <address>
            <email>cuihao102@163.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Xia</surname>
            <given-names>Huanzhang</given-names>
          </name>
          <address>
            <email>xiahz612@sina.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <aff id="Aff1">School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, No.103 Wenhua Road, Shenyang, Liaoning China </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>5</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>5</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <volume>15</volume>
      <elocation-id>1</elocation-id>
      <history>
        <date date-type="received">
          <day>13</day>
          <month>10</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>22</day>
          <month>12</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© Ni et al. 2015</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Isepamicin is a weakly toxic but highly active aminoglycoside antibiotic derivative of gentamicin B. Gentamicin B is a naturally occurring minor component isolated from <italic>Micromonospora echinospora</italic>. 2ʹ-NH<sub>2</sub>-containing gentamicin C complex is a dominant compound produced by wild-type <italic>M</italic>. <italic>echinospora</italic>; by contrast, 2ʹ-OH-containing gentamicin B is produced as a minor component. However, the biosynthetic pathway of gentamicin B remains unclear. Considering that gentamicin B shares a unique C<sub>2ʹ</sub> hydroxyl group with kanamycin A, we aimed to design a new biosynthetic pathway of gentamicin B by combining twelve steps of gentamicin biosynthesis and two steps of kanamycin biosynthesis.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>We blocked the biosynthetic pathway of byproducts and generated a strain overproducing JI-20A, which was used as a precursor of gentamicin B biosynthesis, by disrupting <italic>gen</italic>K and <italic>gen</italic>P. The amount of JI-20A produced in <italic>M. echinospora</italic> ∆K∆P reached 911 μg/ml, which was 14-fold higher than that of <italic>M. echinospora</italic> ∆P. The enzymes KanJ and KanK necessary to convert 2ʹ-NH<sub>2</sub> into 2ʹ-OH from the kanamycin biosynthetic pathway were heterologously expressed in <italic>M. echinospora</italic> ΔKΔP to transform JI-20A into gentamicin B. The strain with <italic>kan</italic>JK under <italic>PermE*</italic> could produce 80 μg/ml of gentamicin B, which was tenfold higher than that of the wild-type strain. To enhance gentamicin B production, we employed different promoters and gene integration combinations. When a P<italic>hrd</italic>B promoter was used and <italic>kan</italic>J and <italic>kan</italic>K were integrated in the genome through gene replacement, gentamicin B was generated as the major product with a maximum yield of 880 μg/ml.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>We constructed a new biosynthetic pathway of high-level gentamicin B production; in this pathway, most byproducts were removed. This method also provided novel insights into the biosynthesis of secondary metabolites via the combinatorial biosynthesis.</p>
        </sec>
        <sec>
          <title>Electronic supplementary material</title>
          <p>The online version of this article (doi:10.1186/s12934-015-0402-6) contains supplementary material, which is available to authorized users.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>
          <italic>Micromonospora echinospora</italic>
        </kwd>
        <kwd>Gentamicin B</kwd>
        <kwd>Metabolic engineering</kwd>
        <kwd>Artificial biosynthetic pathway</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id>
              <institution>National Natural Science Foundation of China</institution>
            </institution-wrap>
          </funding-source>
          <award-id>8127341</award-id>
          <principal-award-recipient>
            <name>
              <surname>Xia</surname>
              <given-names>Huanzhang</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
        <award-group>
          <funding-source>
            <institution>General project of scientific research of the Education Department of Liaoning Province</institution>
          </funding-source>
          <award-id>L2014389</award-id>
          <principal-award-recipient>
            <name>
              <surname>Ni</surname>
              <given-names>Xianpu</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
        <award-group>
          <funding-source>
            <institution>Specialized Research Fund for the Doctoral Program of Higher Education</institution>
          </funding-source>
          <award-id>20122134130001</award-id>
          <principal-award-recipient>
            <name>
              <surname>Xia</surname>
              <given-names>Huanzhang</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
      </funding-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>© The Author(s) 2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Background</title>
      <p>Aminoglycoside antibiotics have been widely used to treat severe bacterial infections; for instance, streptomycin was administered as the first effective anti-tuberculosis agent. Other aminoglycoside antibiotics include 2-deoxystreptamine (2-DOS) containing gentamicin, kanamycin, neomycin, and butirosin. However, the critical resistance mechanism of aminoglycoside antibiotics in pathogens is enzymatic inactivation. As such, semi-synthetic aminoglycosides have been created to overcome pathogen enzymatic inactivation. For example, isepamicin is developed by introducing (S)-3-amino-2-hydroxypropionyl side chains to the 1-amino group of gentamicin B. This side chain can block the modification by various aminoglycoside-modifying enzymes. Thus, isepamicin is highly stable against aminoglycoside-inactivating enzymes [<xref ref-type="bibr" rid="CR1">1</xref>].</p>
      <p>Isepamicin is manufactured from gentamicin B, which is co-produced in <italic>Micromonospora echinospora</italic>. Gentamicin C complex is produced by <italic>M. echinospora</italic> as its major product. By contrast, gentamicin A, B, and X are yielded by <italic>M. echinospora</italic> as minor components [<xref ref-type="bibr" rid="CR2">2</xref>]. Gentamicin A and X are intermediates of gentamicin C biosynthesis. However, gentamicin B is not an intermediate of the gentamicin C biosynthetic pathway because gentamicin B cannot be biotransformed by <italic>M. echinospora</italic> into any gentamicin C component [<xref ref-type="bibr" rid="CR2">2</xref>]. Thus far, the biosynthetic pathway of gentamicin B remains unclear.</p>
      <p>The biosynthetic pathway of gentamicin has been elucidated (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). The gene cluster of gentamicin has also been cloned [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. The genes involved in the biosynthesis of pseudodisaccharide paromamine and pseudotrisaccharide gentamicin A2 have been identified [<xref ref-type="bibr" rid="CR5">5</xref>]. The production of gentamicin X2 from A2 involves four enzymes: oxidoreductase, transaminase, and two methyltransferases [<xref ref-type="bibr" rid="CR6">6</xref>]. X2 can also be transformed into JI-20A by C-6ʹ dehydrogenase and transaminase [<xref ref-type="bibr" rid="CR7">7</xref>–<xref ref-type="bibr" rid="CR9">9</xref>]. Moreover, GenK is the methyltransferase of C-6ʹ in gentamicin, and <italic>gen</italic>K disruption generates a gentamicin C1a-overproducing strain [<xref ref-type="bibr" rid="CR10">10</xref>–<xref ref-type="bibr" rid="CR12">12</xref>]. GenP is a phosphotransferase participating in 3ʹ,4ʹ-deoxygenation in the gentamicin biosynthetic pathway [<xref ref-type="bibr" rid="CR13">13</xref>]. If <italic>gen</italic>P is disrupted, JI-20A,JI-20B, and JI-20Ba accumulate in mutant strains [<xref ref-type="bibr" rid="CR9">9</xref>]. In this study, <italic>gen</italic>K and <italic>gen</italic>P were disrupted simultaneously to generate strains producing JI-20A, which was designed as a precursor of gentamicin B biosynthesis (Fig. <xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p>Biosynthetic pathway for gentamicin and the proposed strategy for gentamicin B biosynthetic pathway (inside the <italic>dashed line</italic>)</p></caption><graphic xlink:href="12934_2015_402_Fig1_HTML" id="MO1"/></fig></p>
      <p>The structure of gentamicin B resembles that of both gentamicin C and kanamycin A. Unlike most 2-DOS-containing aminoglycosides, kanamycin A contains a hydroxy group at C<sub>2ʹ</sub>; gentamicin B shares this unique structure with kanamycin A. The methylated pentose ring of gentamicin B is also similar to that of gentamicin C and is designated as garaosamine. Gentamicin B can be synthesized via a biosynthetic pathway similar to that of kanamycin A on the basis of molecular structure. In the kanamycin A biosynthetic pathway in <italic>Streptomyces kanamyceticus</italic>, 2ʹ-NH<sub>2</sub> is converted into 2ʹ-OH by using KanJ and KanK; in the process, 2-oxoglutarate, Fe<sup>2+</sup>, O<sub>2</sub>, and NADH are utilized [<xref ref-type="bibr" rid="CR14">14</xref>]. We hypothesized that gentamicin B could be biosynthesized from JI-20A, a compound structurally similar to gentamicin B, except NH<sub>2</sub> group at C<sub>2ʹ</sub> (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). Thus, JI-20A could be converted into gentamicin B in JI-20A-overproducing strain via two steps catalyzed by KanJ and KanK. Using the assembly and metabolically engineered biosynthesis pathway of gentamicin B, we can eliminate byproducts and improve gentamicin B production.</p>
    </sec>
    <sec id="Sec2">
      <title>Results and discussion</title>
      <sec id="Sec3">
        <title>Construction of JI-20A-overproducing strain by disrupting <italic>gen</italic>P and <italic>gen</italic>K genes</title>
        <p>The original strain can potentially generate gentamicin B; as such, we determined whether gentamicin B is synthesized from the 2ʹ-amino-containing precursor by the KanJ and KanK homologs. However, the genes homologous to <italic>kan</italic>J and <italic>kan</italic>K have yet to be detected in <italic>M. echinospora</italic>. Considering that the biosynthetic pathway of gentamicin B remains unclear, we aimed to construct an artificial pathway of gentamicin B biosynthesis. JI-20A and gentamicin B are similar in terms of chemical structure except at C2ʹ. JI-20A contains an amino group at C2ʹ, whereas gentamicin B comprises a hydroxyl group at the same position. The structural difference between JI-20A and gentamicin B is similar to the difference between kanamycin A and B. Considering that kanamycin B is converted into kanamycin A by KanJ and KanK, we determined whether KanJ and KanK can also transform JI-20A into gentamicin B.</p>
        <p>To generate a JI-20A-producing strain, we simultaneously disrupted the 6ʹ-methyltransferase gene <italic>gen</italic>K and the 3ʹ-phosphotransferase gene <italic>gen</italic>P in this study (Fig. <xref rid="Fig2" ref-type="fig">2</xref>). We separately generated <italic>gen</italic>P- and <italic>gen</italic>K-disrupting strains in our previous work [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. The <italic>gen</italic>P-disrupting strain does not produce gentamicin C complex, which are the main products of the wild-type strain but are the main byproducts in gentamicin B production. In this study, the <italic>gen</italic>K-disrupting plasmid was introduced to <italic>M. echinospora</italic> ∆P to obtain the double-gene-disrupting strain <italic>M. echinospora</italic> ∆K∆P (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S1A). The disrupting strain was fermented and its products were analyzed through high-performance liquid chromatography with evaporative light scattering detector (HPLC-ELSD). JI-20B and JI-20Ba were the main products of <italic>M. echinospora</italic> ∆P but were undetectable in <italic>M. echinospora</italic> ∆K∆P (Fig. <xref rid="Fig3" ref-type="fig">3</xref>). JI-20A was produced up to 911 μg/ml, which was 14-fold higher than that produced by <italic>M. echinospora</italic> ∆P. We blocked the biosynthesis of gentamicin C1, C1a, C2, C2a, JI-20B, and JI-20Ba and generated a JI-20A-overproducing strain by disrupting <italic>gen</italic>P and <italic>gen</italic>K.<fig id="Fig2"><label>Fig. 2</label><caption><p>Genotypes of <italic>M. echinospora</italic> and its recombinant strains</p></caption><graphic xlink:href="12934_2015_402_Fig2_HTML" id="MO2"/></fig><fig id="Fig3"><label>Fig. 3</label><caption><p>HPLC-ELSD analysis of gentamicin production in fermentations. <italic>gB</italic> gentamicin B, <italic>20Ba</italic> JI-20Ba</p></caption><graphic xlink:href="12934_2015_402_Fig3_HTML" id="MO3"/></fig></p>
      </sec>
      <sec id="Sec4">
        <title>Construction of a new gentamicin B biosynthetic pathway through the heterologous expression of <italic>kan</italic>J and <italic>kan</italic>K</title>
        <p>The <italic>kan</italic>J and <italic>kan</italic>K genes under the control of the strong promoter P<italic>erm</italic>E<italic>*</italic> were cloned into the site-specific integration plasmid pEAP1 to construct pSPUJK1. pSPUJK1 was introduced to <italic>M. echinospora</italic> ∆K∆P through conjugation and exconjugants were selected through erythromycin resistance; as a result, <italic>M. echinospora</italic> JK1 was generated (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S1B). <italic>M. echinospora</italic> JK1 was fermented under the same condition used to ferment the wild-type strain. The fermentation products of <italic>M. echinospora</italic> JK1 were also analyzed through HPLC-ELSD. Compared with the wild-type strain, <italic>M. echinospora</italic> JK1 produced a new product exhibiting a retention time similar to that of gentamicin B (Fig. <xref rid="Fig3" ref-type="fig">3</xref>).</p>
        <p>To determine the structure of the new product of <italic>M. echinospora</italic> JK1, we analyzed the purified product through mass spectrometry. The exact mass of the product was 482.26 (<italic>m</italic>/<italic>z</italic> 483.26), which corresponds to gentamicin B (Fig. <xref rid="Fig4" ref-type="fig">4</xref>). Furthermore, the protonated fragments were the same as those of the reported mass spectra of gentamicin B [<xref ref-type="bibr" rid="CR15">15</xref>], that is, the glycoside bond of gentamicin B cleavage formed the fragment b + c (<italic>m</italic>/<italic>z</italic> 324.17). The glycoside found at the C<sub>6</sub>–O of 2-DOS decomposed; thus, the fragments b + c + x (<italic>m</italic>/<italic>z</italic> 366.18) were produced. Nevertheless, gentamicin B yields the same molecular weight as that of gentamicin X2, which is another minor component of gentamicin. To verify the structure of the new product, we recorded the corresponding <sup>1</sup>H and <sup>13</sup>C NMR data. The <sup>1</sup>H spectrum of the new product was similar to that of gentamicin B [<xref ref-type="bibr" rid="CR16">16</xref>] (Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Figure S2). Moreover, the <sup>13</sup>C NMR data of the new product (Table <xref rid="Tab1" ref-type="table">1</xref>) were identical with the reported NMR data of gentamicin B [<xref ref-type="bibr" rid="CR17">17</xref>]. MS and NMR data demonstrated that the product from <italic>M. echinospora</italic> JK1 is gentamicin B.<fig id="Fig4"><label>Fig. 4</label><caption><p>Structural determination of gentamicin B by MS/MS. <bold>a</bold> Structure of gentamicin B. <bold>b</bold> Mass spectra of the new product from <italic>M. echinospora</italic>JK1</p></caption><graphic xlink:href="12934_2015_402_Fig4_HTML" id="MO4"/></fig><table-wrap id="Tab1"><label>Table 1</label><caption><p>
<sup>13</sup>C NMR spectral data for gentamicin B [<xref ref-type="bibr" rid="CR16">16</xref>] and the new compound from <italic>M. echinospora</italic> JK1 (for atom numbering see Fig. <xref rid="Fig1" ref-type="fig">1</xref>)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Atom</th><th align="left">Gentamicin B (δ)</th><th align="left">New compound (δ)</th></tr></thead><tbody><tr><td align="left">1</td><td char="." align="char">50.6</td><td char="." align="char">49.7</td></tr><tr><td align="left">2</td><td char="." align="char">28.3</td><td char="." align="char">27.5</td></tr><tr><td align="left">3</td><td char="." align="char">48.4</td><td char="." align="char">47.5</td></tr><tr><td align="left">4</td><td char="." align="char">79.0</td><td char="." align="char">78.3</td></tr><tr><td align="left">5</td><td char="." align="char">73.1</td><td char="." align="char">72.3</td></tr><tr><td align="left">6</td><td char="." align="char">84.6</td><td char="." align="char">83.8</td></tr><tr><td align="left">1′</td><td char="." align="char">96.6</td><td char="." align="char">95.9</td></tr><tr><td align="left">2′</td><td char="." align="char">71.7</td><td char="." align="char">70.6</td></tr><tr><td align="left">3′</td><td char="." align="char">73.0</td><td char="." align="char">72.0</td></tr><tr><td align="left">4′</td><td char="." align="char">71.6</td><td char="." align="char">69.8</td></tr><tr><td align="left">5′</td><td char="." align="char">69.5</td><td char="." align="char">68.6</td></tr><tr><td align="left">6′</td><td char="." align="char">41.1</td><td char="." align="char">40.1</td></tr><tr><td align="left">1′′</td><td char="." align="char">102.0</td><td char="." align="char">101.2</td></tr><tr><td align="left">2′′</td><td char="." align="char">67.2</td><td char="." align="char">67.6</td></tr><tr><td align="left">3′′</td><td char="." align="char">64.2</td><td char="." align="char">63.3</td></tr><tr><td align="left">4′′</td><td char="." align="char">70.8</td><td char="." align="char">70.6</td></tr><tr><td align="left">5′′</td><td char="." align="char">68.6</td><td char="." align="char">66.2</td></tr><tr><td align="left">3′′–N–CH<sub>3</sub>
</td><td char="." align="char">35.3</td><td char="." align="char">34.3</td></tr><tr><td align="left">4′′–CH<sub>3</sub>
</td><td char="." align="char">21.7</td><td char="." align="char">20.8</td></tr></tbody></table></table-wrap></p>
        <p>Although gentamicin B production is greatly improved in <italic>M. echinospora</italic> JK1 compared with that of the wild-type strain, the yield is only 85 μg/ml in <italic>M. echinospora</italic> JK1. A large quantity of JI-20A in <italic>M. echinospora</italic> JK1 was also found in the fermentation broth. Therefore, the expression levels of <italic>kan</italic>J and <italic>kan</italic>K were genetically manipulated to improve gentamicin B production.</p>
      </sec>
      <sec id="Sec5">
        <title>Enhancing gentamicin B production through the genetic manipulation of <italic>kan</italic>JK</title>
        <p>The genetic stability of the strains applied in industrial fermentation is very important. However, gentamicin B production in <italic>M. echinospora</italic> JK1 decreased from 162 μg/ml to 80 μg/ml in five generations of unselected passages (Fig. <xref rid="Fig5" ref-type="fig">5</xref>a). We proposed that the instability of <italic>M. echinospora</italic> JK1 is caused by the homologous recombination between the P<italic>erm</italic>E* upstream of <italic>kan</italic>JK and the native promoter of <italic>erm</italic>E, which was used as a selection marker gene in pSPUJK1. In addition, the instability may be caused by chromosomal rearrangements or plasmid elimination from the chromosome, which can occur when a φC31-derived plasmid is used in strains containing multiple pseudo <italic>att</italic>B sites [<xref ref-type="bibr" rid="CR18">18</xref>].<fig id="Fig5"><label>Fig. 5</label><caption><p>Production and stability analysis of gentamicin B-producing strains. <bold>a</bold> Stability of gentamicin B production in <italic>M. echinospora</italic>JK1 and JK2 strains. <bold>b</bold> Production analysis of gentamicin B in <italic>M. echinospora</italic> ΔKΔP and <italic>kan</italic>JK heterologous expression strains. Error bars represent standard deviations. Samples were analyzed through HPLC and quantified on the basis of the peak areas</p></caption><graphic xlink:href="12934_2015_402_Fig5_HTML" id="MO5"/></fig></p>
        <p>To avoid genetic instability, we integrated <italic>kan</italic>J and <italic>kan</italic>K into the chromosome through homologous recombination instead of site-specific insertion. Considering that <italic>gen</italic>P has been disrupted in <italic>M. echinospora</italic> ∆K∆P, we designed <italic>kan</italic>J and <italic>kan</italic>K to replace <italic>gen</italic>P (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S1C). To reduce JI-20A production and improve gentamicin B production, we placed <italic>kan</italic>J and <italic>kan</italic>K under the control of the strong promoter P<italic>erm</italic>E<italic>*</italic> (Fig. <xref rid="Fig2" ref-type="fig">2</xref>). Moreover, the fermentation broth of the gene replacement strain <italic>M. echinospora</italic> JK2 was analyzed through HPLC-ELSD. Figure <xref rid="Fig5" ref-type="fig">5</xref>a shows that the gentamicin B production by <italic>M. echinospora</italic> JK2 was more stable than that by <italic>M. echinospora</italic> JK1. Gentamicin B production increased to 342 μg/ml. However, <italic>M. echinospora</italic> JK2 produced a considerable quantity of JI-20A.</p>
        <p>The native promoter of <italic>gen</italic>P was used to improve gentamicin B production. To eliminate any possibility of polar effects on other genes, we designed <italic>kan</italic>JK as a replacement of the open reading frame of <italic>gen</italic>P, and no other elements were introduced (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S1D). As such, the native ribosome binding site (RBS) and promoter of <italic>gen</italic>P (or promoter of its operon) were employed by <italic>kan</italic>JK. Although the regulatory elements of <italic>gen</italic>P have yet to be determined, we proposed that all regulatory elements of <italic>gen</italic>P can be used. In the fermentation of <italic>M. echinospora</italic> JK3, <italic>kan</italic>JK was expressed as gentamicin B was produced in JK3. Gentamicin B production also reached 436 μg/ml. P<italic>erm</italic>E<italic>*</italic>, which exhibits a strong promoter activity, is widely used for the gene expression in <italic>Actinomyces</italic>. However, this work found that P<italic>erm</italic>E<italic>*</italic> is weaker than the native promoter of <italic>gen</italic>P.This phenomenon occurred possibly because P<italic>erm</italic>E* originates from <italic>Saccharopolyspora erythraea</italic>; as such, P<italic>erm</italic>E* cannot be as effective in <italic>M. echinospora</italic> as in <italic>S. erythraea</italic>. Another possible cause is the ineffectiveness of the RBS of the construction because the translation initiation of P<italic>erm</italic>E<italic>*</italic>-<italic>kan</italic>J-<italic>kan</italic>K is weak when analyzed with the RBS Calculator [<xref ref-type="bibr" rid="CR19">19</xref>].</p>
        <p>JI-20A accumulation in the fermentation broths of <italic>M. echinospora</italic> JK2 and JK3 indicated the inefficiency of KanJ and KanK. Thus, an increase in KanJK expression may enhance their total activity and gentamicin B production. The P<italic>hrd</italic>B promoter of <italic>Streptomyces coelicolor</italic>is stronger than P<italic>erm</italic>E<italic>*</italic> [<xref ref-type="bibr" rid="CR20">20</xref>]. Therefore, a <italic>kan</italic>JK under the control of P<italic>hrd</italic>B was constructed and introduced to <italic>M. echinospora</italic> ∆K∆P; as a result, a mutant strain <italic>M. echinospora</italic> JK4 was generated (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S1E).</p>
        <p>The HPLC analysis of the fermentation broth of <italic>M. echinospora</italic> JK4 revealed that gentamicin B production reached 880 μg/ml; by contrast, JI-20A production decreased to 143 μg/ml. Figure <xref rid="Fig5" ref-type="fig">5</xref>b shows that gentamicin B production increased by 2.5-fold when the P<italic>hrd</italic>B promoter was used compared with that when P<italic>erm</italic>E<italic>*</italic> was used. This result confirmed that the expression level of KanJK was enhanced by replacing the promoter P<italic>erm</italic>E<italic>*</italic> with P<italic>hrd</italic>B.</p>
        <p>The genome analysis of <italic>Actinomyces</italic> revealed the presence of numerous gene clusters encoding secondary metabolites [<xref ref-type="bibr" rid="CR21">21</xref>]. <italic>Actinomyces</italic> can be metabolically engineered to overproduce native metabolites or analogs. With the development of synthetic biological tools, improved bioinformatics tools of metabolic engineering, and enhanced sensitivity and sophistication of analytical methods, secondary metabolite production is feasible in various cellular factories [<xref ref-type="bibr" rid="CR22">22</xref>].</p>
      </sec>
    </sec>
    <sec id="Sec6">
      <title>Conclusions</title>
      <p>We successfully established an artificial biosynthetic pathway to achieve a high-level production of gentamicin B. The genes <italic>gen</italic>K and <italic>gen</italic>P were disrupted in <italic>M. echinospora</italic> to producethe JI-20A, which is the precursor of gentamicin B. JI-20Aproduction in the gene-disrupting strain <italic>M. echinospora</italic> ΔKΔP reached 911 μg/ml, which was 14-fold higher than that of <italic>M. echinospora</italic> ∆P. We disrupted the biosynthesis of gentamicin C1, C1a, C2, C2a, JI-20B, and JI-20Ba by disrupting <italic>gen</italic>P and <italic>gen</italic>K. The removal of byproducts in fermentation broth will be beneficial to purification because antibiotic purification is costly and time consuming.</p>
      <p>An artificial pathway for the conversion of JI-20A to gentamicin B was constructed through the heterologous overexpression of <italic>kan</italic>J and <italic>kan</italic>K in <italic>M. echinospora</italic> ΔKΔP. The <italic>kan</italic>JK-overexpressing strain under the control of <italic>PermE*</italic> can produce 80 μg/ml gentamicin B, which was tenfold higher than that of the wild-type strain. Different promoters and gene integration combinations were investigated to improve gentamicin B production. When the P<italic>hrd</italic>B promoter was used and <italic>kan</italic>J and <italic>kan</italic>K were integrated in the genome through gene replacement, gentamicin B was produced as a major product with a maximum yield of 880 μg/ml.These results confirmed that microbiological strains can be engineered through the metabolic engineering of an intrinsic biosynthetic pathway and the introduction of exogenous genes to produce high yields of target products.</p>
    </sec>
    <sec id="Sec7">
      <title>Methods</title>
      <sec id="Sec8">
        <title>Bacterial strains, plasmids, media, and culture conditions</title>
        <p>The strains and plasmids used in this work are listed in Table <xref rid="Tab2" ref-type="table">2</xref>. <italic>Escherichia coli</italic> Top10 was used as the cloning host grown on Luria–Bertani (LB) liquid or solid medium. Liquid ATCC172 was used for the vegetative growth of <italic>M. echinospora</italic>. The conjugal transfer was performed on MS agar. Solid slanting medium was used for <italic>M. echinospora</italic> sporulation. The previously described media and culture conditions were used for gentamicin production [<xref ref-type="bibr" rid="CR8">8</xref>].<table-wrap id="Tab2"><label>Table 2</label><caption><p>Strains and plasmids used in this study</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Strains or plasmids</th><th align="left">Relevant characteristic</th><th align="left">Reference or source</th></tr></thead><tbody><tr><td align="left">Strains</td><td align="left"/><td align="left"/></tr><tr><td align="left"> <italic>E. coli</italic> TOP10</td><td align="left">F-<italic>mcr</italic>AΔ(<italic>mrr</italic>-<italic>hsd</italic>RMS-<italic>mcr</italic>BC), φ80<italic>lac</italic>ZΔM15,Δ<italic>lac</italic>X74, <italic>deo</italic>R, <italic>rec</italic>A1, <italic>ara</italic>D139Δ(<italic>ara</italic>-<italic>leu</italic>)7697, <italic>gal</italic>U, <italic>gal</italic>K, <italic>rps</italic>L(Str<sup>R</sup>), <italic>end</italic>A1, <italic>nup</italic>G</td><td align="left">Invitrogen</td></tr><tr><td align="left"> <italic>E. coli</italic> ET12567/pUZ8002</td><td align="left">Methylation defective, strain used in <italic>E. coli</italic>-<italic>streptomyces</italic> intergeneric conjugation</td><td align="left">[<xref ref-type="bibr" rid="CR25">25</xref>]</td></tr><tr><td align="left"> <italic>S. kanamyceticus</italic>
</td><td align="left">Kanamycin producing strain</td><td align="left">CGMCC4.1441</td></tr><tr><td align="left"> <italic>M. echinospora</italic>
</td><td align="left">Wild-type strain, gentamicin C1a, C2, C2a, and C1 producer</td><td align="left">ATCC 15835</td></tr><tr><td align="left"> <italic>M. echinospora</italic>ΔP</td><td align="left">
<italic>M. echinospora</italic> with disrupted <italic>gen</italic>P</td><td align="left">[<xref ref-type="bibr" rid="CR7">7</xref>]</td></tr><tr><td align="left"> <italic>M. echinospora</italic>ΔKΔP</td><td align="left">
<italic>M. echinospora</italic> with disrupted <italic>gen</italic>K and <italic>gen</italic>P</td><td align="left">This study</td></tr><tr><td align="left"> <italic>M. echinospora</italic> JK1</td><td align="left">Heterologous, genome-based expression of <italic>kan</italic>J and <italic>kan</italic>K, with replacement of the native promoter by P<italic>erm</italic>E* in <italic>M. echinospora</italic>ΔKΔP.</td><td align="left">This study</td></tr><tr><td align="left"> <italic>M. echinospora</italic> JK2</td><td align="left">
<italic>M. echinospora</italic>ΔKΔP + heterologous expression of <italic>kan</italic>J and <italic>kan</italic>K under the promoter P<italic>erm</italic>E*, insertion at <italic>gen</italic>P locus in <italic>M. echinospora</italic> ΔKΔP</td><td align="left">This study</td></tr><tr><td align="left"> <italic>M. echinospora</italic> JK3</td><td align="left">Heterologous expression of <italic>kan</italic>J and <italic>kan</italic>K under promoter P<italic>gen</italic>P, insertion at <italic>gen</italic>P locus in <italic>M. echinospora</italic> ΔKΔP</td><td align="left">This study</td></tr><tr><td align="left"> <italic>M. echinospora</italic> JK4</td><td align="left">Heterologous expression of <italic>kan</italic>J and <italic>kan</italic>K under promoter P<italic>hrd</italic>B, insertion at <italic>gen</italic>P locus in <italic>M. echinospora</italic> ΔKΔP</td><td align="left">This study</td></tr><tr><td align="left">Plasmids</td><td align="left"/><td align="left"/></tr><tr><td align="left"> pKC1139</td><td align="left">
<italic>E. coli</italic>-<italic>streptomyces</italic> shuttle vector, Am<sup>R</sup>
</td><td align="left">[<xref ref-type="bibr" rid="CR26">26</xref>]</td></tr><tr><td align="left"> pSPU241</td><td align="left">pIJ2925 derivative carrying the <italic>Streptomyces</italic> constitutive promoter P<italic>erm</italic>E* and To terminator, Amp<sup>R</sup>
</td><td align="left">[<xref ref-type="bibr" rid="CR8">8</xref>]</td></tr><tr><td align="left"> pEAP1</td><td align="left">pSET152 carrying <italic>erm</italic>E, the apramycin resistance-conferring gene <italic>aac</italic>(3)IV was replaced by the ampicillin resistance-conferring gene <italic>bla</italic>, Amp<sup>R</sup>, Erm<sup>R</sup>
</td><td align="left">[<xref ref-type="bibr" rid="CR8">8</xref>]</td></tr><tr><td align="left"> pSPU503</td><td align="left">pKC1139 carrying homologous arms of genK (<italic>gac</italic>D), used in <italic>gen</italic>K disruption</td><td align="left">[<xref ref-type="bibr" rid="CR12">12</xref>]</td></tr><tr><td align="left"> pJK1</td><td align="left">pEAP1 carrying P<italic>erm</italic>E*-<italic>kan</italic>J-<italic>kan</italic>K, used in generating <italic>M. echinospora</italic> JK1</td><td align="left">This study</td></tr><tr><td align="left"> pJK2</td><td align="left">pKC1139 carrying homologous arms and <italic>kan</italic>JK, used in generating <italic>M. echinospora</italic> JK2</td><td align="left">This study</td></tr><tr><td align="left"> pJK3</td><td align="left">pKC1139 carrying homologous arms and P<italic>erm</italic>E*-<italic>kan</italic>J-<italic>kan</italic>K, used in generating <italic>M. echinospora</italic> JK3</td><td align="left">This study</td></tr><tr><td align="left"> pJK4</td><td align="left">pKC1139 carrying homologous arms andP<italic>hrd</italic>B-<italic>kan</italic>J-<italic>kan</italic>K, used in generating <italic>M. echinospora</italic> JK4</td><td align="left">This study</td></tr></tbody></table><table-wrap-foot><p>
<italic>Amp</italic>
<sup><italic>R</italic></sup> ampicillin resistance, <italic>Am</italic>
<sup><italic>R</italic></sup> ampramycin resistance, <italic>Erm</italic>
<sup><italic>R</italic></sup> erythromycin resistance</p></table-wrap-foot></table-wrap></p>
      </sec>
      <sec id="Sec9">
        <title>Construction of <italic>kan</italic>J and <italic>kan</italic>K expression plasmids</title>
        <p>DNA isolation and manipulation were performed as described by Sambrook [<xref ref-type="bibr" rid="CR23">23</xref>]. Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Table S1 lists the primers used in this work. The <italic>kan</italic>J and <italic>kan</italic>K genes were amplified from the genomic DNA of <italic>S. kanamyceticus</italic>. The primers were designed using the biosynthetic gene sequence of kanamycin (GenBank accession number: AJ628422.2) and gentamicin (GenBank accession number:AJ628149.4). The primers Pkanjk-up1 and Pkanjk-down1 were used to amplify a 1.95 kb fragment containing intact <italic>kan</italic>J and <italic>kan</italic>K. The PCR product was digested with <italic>Hin</italic>dIII and <italic>Bam</italic>HI and then ligated to pSPU241; thus, pJK241 was generated. The 2.6 kb insert containing P<italic>erm</italic>E<italic>*</italic>-<italic>kan</italic>JK-To was recovered as a <italic>Bgl</italic>II fragment and then inserted into the same site of pEAP1 to generate pSPUJK1.</p>
        <p>The primers Ph1 and Ph2 were used to amplify the downstream homologous arm and to generate a gene replacement vector with <italic>kan</italic>JK genes under P<italic>erm</italic>E<italic>*</italic>. The primers Ph3 and Ph4 were utilized to amplify the upstream homologous arm. Pkanjk-up2 and Pkanjk-down2 were also employed to amplify the intact <italic>kan</italic>JK fragment. Perm-up and Perm-down were used to amplify P<italic>erm</italic>E<italic>*.</italic> P<italic>erm</italic>E<italic>*</italic>, <italic>kan</italic>JK, and the upstream homologous arm fragment were fused through overlap extension PCR in accordance with a previously described procedure [<xref ref-type="bibr" rid="CR24">24</xref>]. The overlapping PCR product was ligated with pMD18-T (Takara) and digested with <italic>Xba</italic>I and <italic>Sma</italic>I; the downstream homologous arm was digested with <italic>Xba</italic>I and <italic>Sma</italic>I. Afterward, the digested fragments were ligated to pKC1139; thus, pSPUJK2 was generated.</p>
        <p>The primers Ph1 and Ph2 were used to amplify the downstream homologous arm and the primers Ph33 and Ph4 were utilized to amplify the upstream homologous arm to generate a vector for gene replacement. Pkanjk-up3 and Pkanjk-down2 were also used to amplify <italic>kan</italic>JK. The overlap extension PCR was employed using the primers Ph4 and Pkanjk-down2 to fuse the <italic>kan</italic>JK fragment and the upstream homologous arm. The overlap PCR product was ligated using pMD18-T(Takara) and then digested with <italic>Xba</italic>I and <italic>Sma</italic>I. The downstream homologous arm was digested with <italic>Xba</italic>I and <italic>Sma</italic>I. The digested fragments were then ligated to pKC1139; thus, pSPUJK3 was generated.</p>
        <p>The primers Ph34 and Ph4 were used to amplify the upstream homologous arm to generate a gene replacement vector with <italic>kan</italic>JK genes under the strong promoter P<italic>hrd</italic>B. Pkanjk-up4 and Pkanjk-down2 were utilized to amplify the intact <italic>kan</italic>JK fragment. Phrd-up and Phrd-down were also used to amplify P<italic>hrd</italic>B. The upstream homologous arm fragment, P<italic>hrd</italic>B, and <italic>kan</italic>JK were then fused through overlap extension PCR. The overlap PCR product was then ligated with pMD18-T and then digested with <italic>Xba</italic>I and <italic>Sma</italic>I. The downstream homologous arm was digested with <italic>Xba</italic>I and <italic>Sma</italic>I. The digested fragments were ligated to pKC1139. Thus, pSPUJK4 was generated.</p>
      </sec>
      <sec id="Sec10">
        <title>Construction of <italic>gen</italic>K-disrupting and <italic>kan</italic>JK-expressing strains</title>
        <p><italic>gen</italic>K-disrupting and <italic>kan</italic>JK-expressing plasmids were introduced to <italic>M. echinospora</italic> through conjugation on MS medium at 28 °C for 24 h. After the medium was spread with 50 mg of apramycin (erythromycin was used for pSPUJK1) and 100 mg of pipemidic acid per liter, incubation was performed at 28 °C for 7 days. Exconjugants were initially selected to determine the apramycin-resistance (the first crossover event) phenotype because pSPU503, pSPUJK2, pSPUJK3, and pSPUJK4 plasmids contain an apramycin-resistance gene; the apramycin-sensitive (the second crossover event) phenotype was then used to isolate the strains via the desired double-crossover homologous recombination event. Genomic DNA was extracted and used as a template DNA in PCR. The PCR products were subjected to DNA sequencing to demonstrate that <italic>kan</italic>J and <italic>kan</italic>K exist in the <italic>kan</italic>JK-expressing strains.</p>
      </sec>
      <sec id="Sec11">
        <title>Antibiotic isolation and analysis</title>
        <p>The pH of the culture broth was adjusted to 2.0 by using H<sub>2</sub>SO<sub>4</sub>. The acidified broth was agitated for 30 min and then centrifuged at 11,378×<italic>g</italic> 10 min. The pH of the supernatant was readjusted to 7.0 with NaOH. The pretreated supernatant was centrifuged again at 11,378×<italic>g</italic> for 10 min. The supernatant was then applied to strongly acidic resin 001 × 7 (Shandong Lukang Record Pharmaceutical Co., Ltd).The bound substances were eluted with 2 mol/L NH<sub>4</sub>OH. Second cation-exchange chromatography was performed on weakly acidic resin D152 (Shandong Lukang Record Pharmaceutical Co., Ltd). The bound substances were eluted with the gradient elution of NH<sub>4</sub>OH (from 0.1 to 1.0 mol/L).</p>
        <p>The elution from the acidic resin was used as the sample for the reversed-phase HPLC-ELSD analysis in a reverse C18 column at an evaporation temperature of 45 °C, nitrogen pressure of 3.5 bar, and a mobile phase of 0.2 mol/L trifluoroacetatic acid–methanol (97:3) at a flow rate of 0.6 ml/min. Authentic gentamicin B was used as standard. The purified products were analyzed using an LC/MS/MS instrument (Bruker micrOTOF-Q). The mass spectrometer was set in a positive mode. <sup>1</sup>H and <sup>13</sup>C NMR data were recorded on Bruker AV600 at 600 MHz frequency, and D<sub>2</sub>O was used as a solvent.</p>
      </sec>
    </sec>
  </body>
  <back>
    <app-group>
      <app id="App1">
        <sec id="Sec12">
          <title>Additional file</title>
          <p>
            <media position="anchor" xlink:href="12934_2015_402_MOESM1_ESM.pdf" id="MOESM1">
              <caption>
                <p>
10.1186/s12934-015-0402-6 Schematic representation and confirmation of recombination strains. (A) Gene disruption of <italic>gen</italic>K and <italic>gen</italic>P. (B) Expression of <italic>kan</italic>J and <italic>kan</italic>K by site specific intergration. (C) Expression of <italic>kan</italic>J and <italic>kan</italic>K with the promoter <italic>Perm</italic>E*. (D) Expression of <italic>kan</italic>J and <italic>kan</italic>K with the native promoter of genP. (E) Expression of <italic>kan</italic>J and <italic>kan</italic>K with promoter <italic>Phrd</italic>B.</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="12934_2015_402_MOESM2_ESM.pdf" id="MOESM2">
              <caption>
                <p>
10.1186/s12934-015-0402-6
<sup>1</sup>H NMR spectrum of the new compound from <italic>kan</italic>JK expression strains.</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="12934_2015_402_MOESM3_ESM.pdf" id="MOESM3">
              <caption>
                <p>
10.1186/s12934-015-0402-6 Sequence of primers used in this study.</p>
              </caption>
            </media>
          </p>
        </sec>
      </app>
    </app-group>
    <ack>
      <title>Authors’ contributions</title>
      <p>XN performed the experiments, analyzed the primary data, and prepared the manuscript. ZS constructed <italic>M. echinospora</italic> JK3 and JK4 strains and assisted in fermentation experiments. YG assisted in the MS and NMR data analysis and revised the manuscript. HC assisted in product purification. HX supervised the whole research and revised the manuscript. All authors read and approved the final manuscript.</p>
      <sec id="FPar1">
        <title>Acknowledgements</title>
        <p>This work was supported by the National Natural Science Foundation of China (8127341), Specialized Research Fund for the Doctoral Program of Higher Education (20122134130001), and the General Project of Scientific Research of the Education Department of Liaoning Province (L2014389).</p>
      </sec>
      <sec id="FPar2">
        <title>Competing interests</title>
        <p>The authors declare that they have no competing interests.</p>
      </sec>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Petrikkos</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Giamarellou</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Tsagaraki</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Pefanis</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Evaluation of the efficacy and safety of isepamicin in the treatment of various bacterial infections</article-title>
          <source>J Chemother</source>
          <year>1995</year>
          <volume>7</volume>
          <issue>Suppl 2</issue>
          <fpage>161</fpage>
          <lpage>164</lpage>
          <pub-id pub-id-type="pmid">8622106</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Testa</surname>
              <given-names>RT</given-names>
            </name>
            <name>
              <surname>Tilley</surname>
              <given-names>BC</given-names>
            </name>
          </person-group>
          <article-title>Biotransformation, a new approach to aminoglycoside biosynthesis. II. Gentamicin</article-title>
          <source>J Antibiot</source>
          <year>1976</year>
          <volume>29</volume>
          <issue>2</issue>
          <fpage>140</fpage>
          <lpage>146</lpage>
          <pub-id pub-id-type="doi">10.7164/antibiotics.29.140</pub-id>
          <pub-id pub-id-type="pmid">931800</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kharel</surname>
              <given-names>MK</given-names>
            </name>
            <name>
              <surname>Basnet</surname>
              <given-names>DB</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>HC</given-names>
            </name>
            <name>
              <surname>Liou</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Moon</surname>
              <given-names>YH</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Woo</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Sohng</surname>
              <given-names>JK</given-names>
            </name>
          </person-group>
          <article-title>Molecular cloning and characterization of a 2-deoxystreptamine biosynthetic gene cluster in gentamicin-producing <italic>Micromonospora echinospora</italic> ATCC15835</article-title>
          <source>Mol Cells</source>
          <year>2004</year>
          <volume>18</volume>
          <issue>1</issue>
          <fpage>71</fpage>
          <lpage>78</lpage>
          <pub-id pub-id-type="pmid">15359126</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Unwin</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Standage</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Alexander</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Hosted</surname>
              <given-names>T</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Horan</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Wellington</surname>
              <given-names>EM</given-names>
            </name>
          </person-group>
          <article-title>Gene cluster in <italic>Micromonospora echinospora</italic> ATCC15835 for the biosynthesis of the gentamicin C complex</article-title>
          <source>J Antibiot</source>
          <year>2004</year>
          <volume>57</volume>
          <issue>7</issue>
          <fpage>436</fpage>
          <lpage>445</lpage>
          <pub-id pub-id-type="doi">10.7164/antibiotics.57.436</pub-id>
          <pub-id pub-id-type="pmid">15376556</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Park</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Hong</surname>
              <given-names>JSJ</given-names>
            </name>
            <name>
              <surname>Parajuli</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Jung</surname>
              <given-names>WS</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Lim</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Sohng</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Yoon</surname>
              <given-names>YJ</given-names>
            </name>
          </person-group>
          <article-title>Genetic dissection of the biosynthetic route to gentamicin A2 by heterologous expression of its minimal gene set</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>2008</year>
          <volume>105</volume>
          <issue>24</issue>
          <fpage>8399</fpage>
          <lpage>8404</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.0803164105</pub-id>
          <pub-id pub-id-type="pmid">18550838</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huang</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Moison</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Guo</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Jian</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Duan</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Deng</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Leadlay</surname>
              <given-names>PF</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Delineating the biosynthesis of gentamicin X2, the common precursor of the gentamicin C antibiotic complex</article-title>
          <source>Chem Biol</source>
          <year>2015</year>
          <volume>22</volume>
          <issue>2</issue>
          <fpage>251</fpage>
          <lpage>261</lpage>
          <pub-id pub-id-type="doi">10.1016/j.chembiol.2014.12.012</pub-id>
          <pub-id pub-id-type="pmid">25641167</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guo</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Duan</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Jian</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Leeper</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Deng</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Leadlay</surname>
              <given-names>PF</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Specificity and promiscuity at the branch point in gentamicin biosynthesis</article-title>
          <source>Chem Biol</source>
          <year>2014</year>
          <volume>21</volume>
          <issue>5</issue>
          <fpage>608</fpage>
          <lpage>618</lpage>
          <pub-id pub-id-type="doi">10.1016/j.chembiol.2014.03.005</pub-id>
          <pub-id pub-id-type="pmid">24746560</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ni</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ji</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Xia</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Genetic engineering combined with random mutagenesis to enhance G418 production in <italic>Micromonospora echinospora</italic></article-title>
          <source>J Ind Microbiol Biotechnol</source>
          <year>2014</year>
          <volume>41</volume>
          <issue>9</issue>
          <fpage>1383</fpage>
          <lpage>1390</lpage>
          <pub-id pub-id-type="doi">10.1007/s10295-014-1479-3</pub-id>
          <pub-id pub-id-type="pmid">25031027</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ni</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Ren</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Xia</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Biosynthesis of epimers C2 and C2a in the gentamicin C complex</article-title>
          <source>ChemBioChem</source>
          <year>2015</year>
          <volume>16</volume>
          <issue>13</issue>
          <fpage>1933</fpage>
          <lpage>1942</lpage>
          <pub-id pub-id-type="doi">10.1002/cbic.201500258</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hong</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Yan</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Identification of gntK, a gene required for the methylation of purpurosamine C-6′ in gentamicin biosynthesis</article-title>
          <source>J Gen Appl Microbiol</source>
          <year>2012</year>
          <volume>58</volume>
          <issue>5</issue>
          <fpage>349</fpage>
          <lpage>356</lpage>
          <pub-id pub-id-type="doi">10.2323/jgam.58.349</pub-id>
          <pub-id pub-id-type="pmid">23149679</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Karki</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Kwon</surname>
              <given-names>HJ</given-names>
            </name>
          </person-group>
          <article-title>Gene inactivation study on <italic>gnt</italic>K, a putative C-methyltransferase gene in gentamicin biosynthesis from <italic>Micromonospora echinospora</italic></article-title>
          <source>J Korean Soc Appl Biol Chem</source>
          <year>2012</year>
          <volume>55</volume>
          <issue>3</issue>
          <fpage>1</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="doi">10.1007/s13765-012-2041-5</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ni</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Xia</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Construction of a gentamicin C1a-overproducing strain of <italic>Micromonospora purpurea</italic> by inactivation of the gacD gene</article-title>
          <source>Microbiol Res</source>
          <year>2013</year>
          <volume>168</volume>
          <issue>3</issue>
          <fpage>263</fpage>
          <lpage>267</lpage>
          <pub-id pub-id-type="doi">10.1016/j.micres.2012.12.006</pub-id>
          <pub-id pub-id-type="pmid">23305768</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shao</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Characterization of a key aminoglycoside phosphotransferase in gentamicin biosynthesis</article-title>
          <source>Bioorg Med Chem Lett</source>
          <year>2013</year>
          <volume>23</volume>
          <issue>5</issue>
          <fpage>1438</fpage>
          <lpage>1441</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bmcl.2012.12.064</pub-id>
          <pub-id pub-id-type="pmid">23339967</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sucipto</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kudo</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Eguchi</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>The last step of kanamycin biosynthesis: unique deamination reaction catalyzed by the alpha-ketoglutarate-dependent nonheme iron dioxygenase KanJ and the NADPH-dependent reductase KanK</article-title>
          <source>Angew Chem Int Ed Engl</source>
          <year>2012</year>
          <volume>51</volume>
          <issue>14</issue>
          <fpage>3428</fpage>
          <lpage>3431</lpage>
          <pub-id pub-id-type="doi">10.1002/anie.201108122</pub-id>
          <pub-id pub-id-type="pmid">22374809</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zupančič-Kralj</surname>
              <given-names>Lucija</given-names>
            </name>
          </person-group>
          <article-title>Identification of gentamicin impurities by liquid chromatography tandem mass spectrometry</article-title>
          <source>JPharm Biomed Anal</source>
          <year>2009</year>
          <volume>50</volume>
          <issue>5</issue>
          <fpage>1037</fpage>
          <lpage>1043</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jpba.2009.06.004</pub-id>
          <pub-id pub-id-type="pmid">19577403</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bérdy</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Pauncz</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Vajna</surname>
              <given-names>ZM</given-names>
            </name>
            <name>
              <surname>Horváth</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Gyimesi</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Koczka</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Metabolites of gentamicin-producing <italic>Micromonospora</italic> species. I. Isolation and identification of metabolites</article-title>
          <source>J Antibiot</source>
          <year>1977</year>
          <volume>30</volume>
          <issue>11</issue>
          <fpage>945</fpage>
          <lpage>954</lpage>
          <pub-id pub-id-type="doi">10.7164/antibiotics.30.945</pub-id>
          <pub-id pub-id-type="pmid">591461</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nagabhushan</surname>
              <given-names>TL</given-names>
            </name>
            <name>
              <surname>Cooper</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Tsai</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Daniels</surname>
              <given-names>PJL</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>GH</given-names>
            </name>
          </person-group>
          <article-title>The syntheses and biological properties of 1-N-(S-4-amino-2-hydroxybutyryl)-gentamicin B and 1-N-(S-3-amino-2-hydroxypropionyl)-gentamicin B</article-title>
          <source>J Antibiot</source>
          <year>1978</year>
          <volume>31</volume>
          <issue>7</issue>
          <fpage>681</fpage>
          <lpage>687</lpage>
          <pub-id pub-id-type="doi">10.7164/antibiotics.31.681</pub-id>
          <pub-id pub-id-type="pmid">690003</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Combes</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Till</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Bee</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>MC</given-names>
            </name>
          </person-group>
          <article-title>The <italic>streptomyces</italic> genome contains multiple pseudo-attB sites for the (phi)C31-encoded site-specific recombination system</article-title>
          <source>J Bacteriol</source>
          <year>2002</year>
          <volume>184</volume>
          <issue>20</issue>
          <fpage>5746</fpage>
          <lpage>5752</lpage>
          <pub-id pub-id-type="doi">10.1128/JB.184.20.5746-5752.2002</pub-id>
          <pub-id pub-id-type="pmid">12270833</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Salis</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Mirsky</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Voigt</surname>
              <given-names>CA</given-names>
            </name>
          </person-group>
          <article-title>Automated design of synthetic ribosome binding sites to control protein expression</article-title>
          <source>Nat Biotechnol</source>
          <year>2009</year>
          <volume>27</volume>
          <issue>10</issue>
          <fpage>946</fpage>
          <lpage>950</lpage>
          <pub-id pub-id-type="doi">10.1038/nbt.1568</pub-id>
          <pub-id pub-id-type="pmid">19801975</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Du</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Wei</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Tian</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Niu</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Tan</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Improvement of gougerotin and nikkomycin production by engineering their biosynthetic gene clusters</article-title>
          <source>Appl Microbiol Biotechnol</source>
          <year>2013</year>
          <volume>97</volume>
          <issue>14</issue>
          <fpage>6383</fpage>
          <lpage>6396</lpage>
          <pub-id pub-id-type="doi">10.1007/s00253-013-4836-7</pub-id>
          <pub-id pub-id-type="pmid">23515837</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ōmura</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ikeda</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ishikawa</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hanamoto</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Takahashi</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Shinose</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Takahashi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Horikawa</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Nakazawa</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Osonoe</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Genome sequence of an industrial microorganism <italic>Streptomyces avermitilis</italic>: deducing the ability of producing secondary metabolites</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>2001</year>
          <volume>98</volume>
          <issue>21</issue>
          <fpage>12215</fpage>
          <lpage>12220</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.211433198</pub-id>
          <pub-id pub-id-type="pmid">11572948</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Keasling</surname>
              <given-names>JD</given-names>
            </name>
          </person-group>
          <article-title>Synthetic biology and the development of tools for metabolic engineering</article-title>
          <source>Metab Eng</source>
          <year>2012</year>
          <volume>14</volume>
          <issue>3</issue>
          <fpage>189</fpage>
          <lpage>195</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ymben.2012.01.004</pub-id>
          <pub-id pub-id-type="pmid">22314049</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Sambrook</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Russell</surname>
              <given-names>DW</given-names>
            </name>
          </person-group>
          <source>Molecular cloning: a laboratory manual</source>
          <year>2001</year>
          <edition>3</edition>
          <publisher-loc>New York</publisher-loc>
          <publisher-name>Cold spring harbor laboratory press</publisher-name>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shevchuk</surname>
              <given-names>NA</given-names>
            </name>
            <name>
              <surname>Bryksin</surname>
              <given-names>AV</given-names>
            </name>
            <name>
              <surname>Nusinovich</surname>
              <given-names>YA</given-names>
            </name>
            <name>
              <surname>Cabello</surname>
              <given-names>FC</given-names>
            </name>
            <name>
              <surname>Sutherland</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ladisch</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Construction of long DNA molecules using long PCR-based fusion of several fragments simultaneously</article-title>
          <source>Nucleic Acids Res</source>
          <year>2004</year>
          <volume>32</volume>
          <issue>2</issue>
          <fpage>e19</fpage>
          <lpage>19</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gnh014</pub-id>
          <pub-id pub-id-type="pmid">14739232</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>MacNeil</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Gewain</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Ruby</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Dezeny</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Gibbons</surname>
              <given-names>PH</given-names>
            </name>
            <name>
              <surname>MacNeil</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Analysis of <italic>Streptomyces avermitilis</italic> genes required for avermectin biosynthesis utilizing a novel integration vector</article-title>
          <source>Gene</source>
          <year>1992</year>
          <volume>111</volume>
          <issue>1</issue>
          <fpage>61</fpage>
          <lpage>68</lpage>
          <pub-id pub-id-type="doi">10.1016/0378-1119(92)90603-M</pub-id>
          <pub-id pub-id-type="pmid">1547955</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bierman</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Logan</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>O’Brien</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Seno</surname>
              <given-names>ET</given-names>
            </name>
            <name>
              <surname>Rao</surname>
              <given-names>RN</given-names>
            </name>
            <name>
              <surname>Schoner</surname>
              <given-names>BE</given-names>
            </name>
          </person-group>
          <article-title>Plasmid cloning vectors for the conjugal transfer of DNA from <italic>Escherichia coli</italic> to <italic>Streptomyces</italic> spp</article-title>
          <source>Gene</source>
          <year>1992</year>
          <volume>116</volume>
          <issue>1</issue>
          <fpage>43</fpage>
          <lpage>49</lpage>
          <pub-id pub-id-type="doi">10.1016/0378-1119(92)90627-2</pub-id>
          <pub-id pub-id-type="pmid">1628843</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:4700568</identifier><datestamp>2016-01-06</datestamp><setSpec>bmcph</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="http://jats.nlm.nih.gov/ns/archiving/1.0/ http://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Public Health</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Public Health</journal-id>
      <journal-title-group>
        <journal-title>BMC Public Health</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1471-2458</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC4700568</article-id>
      <article-id pub-id-type="pmcid">PMC4700568</article-id>
      <article-id pub-id-type="pmc-uid">4700568</article-id>
      <article-id pub-id-type="publisher-id">2681</article-id>
      <article-id pub-id-type="doi">10.1186/s12889-015-2681-6</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>An ecological analysis of food outlet density and prevalence of type II diabetes in South Carolina counties</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>AlHasan</surname>
            <given-names>Dana M.</given-names>
          </name>
          <address>
            <email>dalhasan@email.sc.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Eberth</surname>
            <given-names>Jan Marie</given-names>
          </name>
          <address>
            <email>jmeberth@mailbox.sc.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <aff id="Aff1"><label/>Department of Epidemiology and Biostatistics, University of South Carolina, Columbia, SC USA </aff>
        <aff id="Aff2"><label/>Department of Epidemiology and Biostatistics, Statewide Cancer Prevention and Control Program, University of South Carolina, Columbia, SC USA </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>5</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>5</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2015</year>
      </pub-date>
      <volume>16</volume>
      <elocation-id>10</elocation-id>
      <history>
        <date date-type="received">
          <day>11</day>
          <month>7</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>22</day>
          <month>12</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© AlHasan and Eberth. 2015</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Studies suggest that the built environment with high numbers of fast food restaurants and convenience stores and low numbers of super stores and grocery stores are related to obesity, type II diabetes mellitus, and other chronic diseases. Since few studies assess these relationships at the county level, we aim to examine fast food restaurant density, convenience store density, super store density, and grocery store density and prevalence of type II diabetes among counties in South Carolina.</p>
        </sec>
        <sec>
          <title>Methods</title>
          <p>Pearson’s correlation between four types of food outlet densities- fast food restaurants, convenience stores, super stores, and grocery stores- and prevalence of type II diabetes were computed. The relationship between each of these food outlet densities were mapped with prevalence of type II diabetes, and OLS regression analysis was completed adjusting for county-level rates of obesity, physical inactivity, density of recreation facilities, unemployment, households with no car and limited access to stores, education, and race.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>We showed a significant, negative relationship between fast food restaurant density and prevalence of type II diabetes, and a significant, positive relationship between convenience store density and prevalence of type II diabetes. In adjusted analysis, the food outlet densities (of any type) was not associated with prevalence of type II diabetes.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>This ecological analysis showed no associations between fast food restaurants, convenience stores, super stores, or grocery stores densities and the prevalence of type II diabetes. Consideration of environmental, social, and cultural determinants, as well as individual behaviors is needed in future research.</p>
        </sec>
        <sec>
          <title>Electronic supplementary material</title>
          <p>The online version of this article (doi:10.1186/s12889-015-2681-6) contains supplementary material, which is available to authorized users.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>South Carolina</kwd>
        <kwd>Geographic information systems</kwd>
        <kwd>Diabetes</kwd>
        <kwd>Fast food restaurants</kwd>
        <kwd>Convenience stores</kwd>
        <kwd>Super stores</kwd>
        <kwd>Grocery stores</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>© The Author(s) 2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Background</title>
      <p>Type II diabetes mellitus (DM) is growing at an alarming rate worldwide and in the United States (U.S.). An estimated 221 million adults in the world [<xref ref-type="bibr" rid="CR1">1</xref>], and an estimated 25.8 million people in the U.S. have DM [<xref ref-type="bibr" rid="CR2">2</xref>]. In South Carolina, one of 15 states that compromises the diabetes belt [<xref ref-type="bibr" rid="CR3">3</xref>], an estimated 450,000 individuals are diagnosed with DM, which does not include those undiagnosed or with pre-diabetes [<xref ref-type="bibr" rid="CR4">4</xref>]. In fact, DM is the 7<sup>th</sup> leading cause of death in South Carolina [<xref ref-type="bibr" rid="CR5">5</xref>], and this state ranks as the 4<sup>th</sup> highest in the nation in terms of DM prevalence [<xref ref-type="bibr" rid="CR5">5</xref>].</p>
      <p>When DM is not managed, it leads to complications including but not limited to cardiovascular diseases, retinopathy, and kidney failure [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. These complications increase risk for disability, risk for mortality, hospitalization rates, and medical costs thus placing additional physical and financial burdens upon the individual [<xref ref-type="bibr" rid="CR8">8</xref>]. Likewise, healthcare institutions treating DM complications take on financial burdens [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. In 2012, the total estimated costs in the U.S. from DM were $245 billion [<xref ref-type="bibr" rid="CR10">10</xref>]. Similarly, in 2013, the total amount for hospital charges related to DM diagnosis in South Carolina was $321 million [<xref ref-type="bibr" rid="CR5">5</xref>]. Hence, it is essential to understand DM risk factors and to design effective interventions to reduce the risks and costs associated with DM treatment.</p>
      <p>Known risk factors of DM include genetic predisposition, age (≥45 years), obesity, physical inactivity, and diet- particularly foods rich in carbohydrates [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. Race or ethnic background is also a significant predictor of DM. DM disproportionately affects non-Hispanic Blacks compared with Whites [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. In 2011, an estimated 12.6 % of non-Hispanic Black adults (age ≥ 20) were diagnosed with DM [<xref ref-type="bibr" rid="CR2">2</xref>], and in 2011, 1 in 8 African Americans in South Carolina have DM [<xref ref-type="bibr" rid="CR5">5</xref>].</p>
      <p>Unfortunately, many weight loss interventions geared towards individuals have been unsuccessful in reducing DM prevalence [<xref ref-type="bibr" rid="CR13">13</xref>]. Therefore, it is essential for research to focus on the built environment in which individuals’ behavioral decisions are influenced [<xref ref-type="bibr" rid="CR14">14</xref>]. Studies show the food environment, especially those with a high number of fast food restaurants and convenience stores, to be associated with increased dietary intake [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>], and that exposure to poor food quality has important effects on overweight and obesity [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. Such food environments are defined as obesogenic environments because they have high levels of nutrient-deficient, highly-caloric, affordable food that promote food consumption and physical inactivity [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR19">19</xref>].</p>
      <p>Fast food restaurants particularly provide foods lacking in nutritional value (i.e. foods low in calcium, folate, vitamin A, vitamin C, and dietary fiber) and thus contribute to poor quality dietary patterns [<xref ref-type="bibr" rid="CR20">20</xref>]. Davis et al. demonstrated that students whose schools were proximal to fast food restaurants on average consumed more servings of soda and were more overweight compared to students whose schools were less proximal to fast food restaurants [<xref ref-type="bibr" rid="CR17">17</xref>]. Babey et al. showed that people in communities with increased fast food restaurants and less grocery stores are more likely to have DM [<xref ref-type="bibr" rid="CR21">21</xref>].</p>
      <p>Similar to fast food restaurants, convenience stores are stocked with low quality food options. Galvez et al. illustrated that the presence of convenience stores is associated with increased risk of obesity [<xref ref-type="bibr" rid="CR22">22</xref>]. Because obesity is a predictor of DM, it is hypothesized that the presence of convenience stores will also be associated with DM.</p>
      <p>It is also suggested that lack of supermarkets and grocery stores, which provide healthy options, contribute to the risk of obesity [<xref ref-type="bibr" rid="CR23">23</xref>]. Inagami’s et al. study revealed that abundance of and proximity to supermarkets within residential census tracts were associated with increased fruit and vegetable intake among pregnant women [<xref ref-type="bibr" rid="CR24">24</xref>]. More so, distance from the home to a super or grocery store may limit accessibility because some individuals may live farther away or lack the transportation to obtain high quality foods [<xref ref-type="bibr" rid="CR11">11</xref>].</p>
      <p>Few studies have assessed the association between food environment and DM at the macro level. Yet, it is important for county-level studies to research how attributes within the built environment contribute to DM prevalence and research how access to food influences eating behavior [<xref ref-type="bibr" rid="CR25">25</xref>]. Understanding the role food outlets play in contributing to DM is vital because it can greatly contribute to future public policy making. Thus, further efforts to understand how the built environment plays a role among the known DM risk factors are needed. In particular, how do types and amount of food outlets play a role in DM prevalence?</p>
      <p>This study aims to examine the relationship between the density of four types of food outlets- fast food restaurants, convenience stores, super stores, and grocery stores- and the prevalence of county-level DM in 2011 in South Carolina, while adjusting for the following county-level risk factors: obesity, physical inactivity, recreation facility density, unemployment, education, households with no cars and limited access to stores, and race.</p>
    </sec>
    <sec id="Sec2">
      <title>Methods</title>
      <sec id="Sec3">
        <title>Study design</title>
        <p>This study was an ecological analysis examining the relationship between four types of food outlet densities- fast food restaurants, convenience stores, super stores, and grocery stores- and DM prevalence in 2011 among the 46 counties of South Carolina. The analysis controlled for the following county-level covariates: obesity, physical inactivity, density of recreation facilities, unemployment, education, households with no car and limited access to stores, and race. Multiple secondary data sources were used: the US Census Topologically Integrated Geographic Encoding and Referencing (TIGER) Line Files [<xref ref-type="bibr" rid="CR26">26</xref>], the Centers for Disease Control and Prevention (CDC) which administers the Behavioral Risk Factor Surveillance System (BRFSS) [<xref ref-type="bibr" rid="CR27">27</xref>], the US Department of Agriculture Economic Research Service (USDA) [<xref ref-type="bibr" rid="CR28">28</xref>], and the US Decennial Census [<xref ref-type="bibr" rid="CR29">29</xref>]. All of the data used was publically available.</p>
      </sec>
      <sec id="Sec4">
        <title>Data collection</title>
        <p>The South Carolina county map was retrieved from the US Census TIGER Line Files for 2011 [<xref ref-type="bibr" rid="CR26">26</xref>]. County polygons were joined with county-level covariates using the “spatial join” tool in ArcGIS Desktop Version 10.2.2 for Windows (Environmental Systems Research Institute, Redlands, CA).</p>
        <sec id="Sec5">
          <title>Dependent variable: DM</title>
          <p>DM prevalence is the age-adjusted percentage of adults (age ≥ 20) in South Carolina with diabetes excluding those with gestational diabetes in 2011. DM prevalence was obtained from the CDC [<xref ref-type="bibr" rid="CR27">27</xref>].</p>
        </sec>
        <sec id="Sec6">
          <title>Independent variables</title>
          <p>Fast food restaurants, convenience stores, super stores, and grocery stores were downloaded from the USDA 2011 data [<xref ref-type="bibr" rid="CR28">28</xref>]. Because urban areas are correlated with neighborhood availability of food outlets and individual eating behavior [<xref ref-type="bibr" rid="CR30">30</xref>], population density is taken into account by dividing the number of food outlets per 1000 county residents.</p>
          <p>Fast food restaurant densities are the number of limited-service restaurants in each county in South Carolina per 1000 residents. The North American Industry Classification System (NAICS) code for fast food restaurants is 722211 and includes businesses mainly engaged in providing food services where customers pay before eating. Food may be consumed at the establishment, taken out, or delivered.</p>
          <p>Convenience store densities are the number of convenience stores in each county in South Carolina per 1000 residents. The NAICS codes for convenience stores are 445120 and 447110 and includes stores mainly engaged in providing limited goods such as bread, soda, and snacks.</p>
          <p>Super store densities are the number of supercenters and warehouse clubs in each county in South Carolina per 1000 residents. The NAICS code for super stores is 452910 and includes stores mainly engaged in providing groceries along with general lines of merchandise.</p>
          <p>Grocery store densities are the number of supermarkets and grocery stores in each county in South Carolina per 1000 residents. The NAICS code for grocery store is 445110 and includes stores mainly known as supermarkets and excludes convenience stores with or without gasoline sales as well as large, general-merchandise stores.</p>
        </sec>
        <sec id="Sec7">
          <title>Covariates</title>
          <p>The covariates considered for this study are obesity, physical inactivity, recreation, unemployment, education, households with no car and at least one mile away from a store, and race.</p>
          <p>Obesity prevalence is the age-adjusted percentage of adults (age ≥ 20) in South Carolina with a body mass index ≥ 30 in 2011. Body mass index is computed by dividing weight in kilograms by height in meters squared. Physical inactivity prevalence is the age-adjusted prevalence of adults (age ≥ 20) in South Carolina, who reported no leisure-time physical activity in the past 30 days in 2011. These data were obtained from the CDC collected from BRFSS [<xref ref-type="bibr" rid="CR27">27</xref>], which is based on self- report measures.</p>
          <p>Recreation is the number of recreational facilities in each county in South Carolina per 1000 residents in 2011 and obtained from the USDA [<xref ref-type="bibr" rid="CR28">28</xref>]. The NAICS code is 713940 and includes establishments mainly engaged in fitness and sport facilities.</p>
          <p>Unemployment is the unemployment rate in each county in South Carolina in 2011. This was downloaded from the US Census 2010 [<xref ref-type="bibr" rid="CR29">29</xref>] that is collected from the Bureau of Labor Statistics. Education is the percentage of adults with only a high school diploma in each county in South Carolina. These data were also downloaded from the US Census, specifically the 2009-2013 American Community Survey.</p>
          <p>Households with no cars and at least one mile from a store is the percentage of housing units in each county in South Carolina with no car and at least one mile away from a supermarket or large grocery store in 2010. These data were obtained from the USDA [<xref ref-type="bibr" rid="CR28">28</xref>].</p>
          <p>Race is the percentage of each county’s resident population in South Carolina that is non-Hispanic Black or African American in 2010 obtained from the USDA [<xref ref-type="bibr" rid="CR28">28</xref>]. Neither of these data were available for the year 2011. A description of the data sources used to extract these variables is found in Additional file <xref rid="MOESM1" ref-type="media">1</xref>.</p>
        </sec>
      </sec>
      <sec id="Sec8">
        <title>Data analysis</title>
        <p>Pearson’s correlation coefficients were computed to assess the crude relationship between each food outlet density and DM prevalence in SAS software, Version 9.3 for Windows (SAS Institute, Cary, NC). Bivariate maps were created in ESRI ArcGIS (Environmental Systems Research Institute, Redlands, CA) to represent the geographical distribution of food outlet densities and DM prevalence among the 46 counties in South Carolina. DM prevalence was split into three ranks based on the following measures: 7.6–10.5 %, 10.6–13.0 %, and 13.1–15.6 %. Likewise, food outlet densities were split into three ranks. Fast food restaurant densities were based on the following categories: 0.25–0.50, 0.51–0.70, and 0.71–1.13. Convenience store densities: 0.32–0.60, 0.61–0.80, and 0.81–1.12. Super store densities: 0–0.001, 0.002–0.02, and 0.03–0.04. Grocery store densities: 0–0.15, 0.16–0.20, and 0.21–0.31. Categories were created based on equal intervals or included at least ten counties in a category.</p>
        <p>To analyze the association between each food outlet density and DM prevalence, linear regression models using ordinary least squares (OLS) method were calculated in ArcGIS. OLS regression was completed with DM as the dependent variable and adjusting for obesity, physical inactivity, recreation, unemployment, education, households with no car and limited access to a store, and race. Diagnostics of the models were performed and did not show spatial autocorrelation and did not violate other model assumptions. Multicollinearity was assessed and all Variance Inflation Factors were less than 7.0. Diagnostics also showed that the variables explain 80 % of the variation observed.</p>
      </sec>
    </sec>
    <sec id="Sec9">
      <title>Results</title>
      <sec id="Sec10">
        <title>Descriptive statistics</title>
        <p>Table <xref rid="Tab1" ref-type="table">1</xref> summarizes mean values of DM prevalence, food outlet densities, and covariates for each county in South Carolina. The maximum value of DM prevalence was 15.6 % (Hampton County), the minimum was 7.6 % (Beaufort County), and the overall mean prevalence of DM was 12.1 %. The maximum value of fast food restaurant densities was 1.14 (Horry County), the minimum was 0.25 (Saluda County), and the overall state mean was 0.59. The maximum value of convenience store densities was 1.12 (Marlboro County), the minimum was 0.32 (Berkeley County), and the overall state mean was 0.69. The maximum value of super store densities was 0.04 (Barnwell County), the minimum was 0 (several counties), and the overall state mean was 0.01. The maximum value of grocery store densities was 0.31 (Bamberg County), the minimum was 0.07 (Calhoun County), and the overall state mean was 0.19. There was also variation among the covariates between counties (see Table <xref rid="Tab1" ref-type="table">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Descriptive characteristics of Counties in South Carolina</p></caption><table frame="hsides" rules="groups"><thead><tr><th>County</th><th>Density of fast food restaurants</th><th>Density of convenience stores</th><th>Density of super stores</th><th>Density of grocery stores</th><th>Diabetes prevalence (%)</th><th>Obesity prevalence (%)</th><th>Physical inactivity prevalence (%)</th><th>Density of recreation facilities</th><th>Densities of households with no car and greater than 1 mile from store</th><th>Unemployment rate</th><th>Education</th><th>Non-hispanic black or African American (%)</th></tr></thead><tbody><tr><td>Abbeville</td><td char="." align="char">0.397</td><td char="." align="char">0.477</td><td>0</td><td char="." align="char">0.199</td><td>11.4</td><td>34.8</td><td>28.9</td><td>0</td><td char="." align="char">6.05</td><td char="." align="char">12.4</td><td char="." align="char">33.41</td><td char="." align="char">28.17</td></tr><tr><td>Aiken</td><td char="." align="char">0.548</td><td char="." align="char">0.573</td><td>0.019</td><td char="." align="char">0.180</td><td>10.1</td><td>31.4</td><td>24.9</td><td>0.06</td><td char="." align="char">3.24</td><td char="." align="char">9.2</td><td char="." align="char">31.57</td><td char="." align="char">24.39</td></tr><tr><td>Allendale</td><td char="." align="char">0.393</td><td char="." align="char">0.786</td><td>0</td><td char="." align="char">0.196</td><td>15.4</td><td>39.4</td><td>33.7</td><td>0</td><td char="." align="char">4.08</td><td char="." align="char">18.4</td><td char="." align="char">34.12</td><td char="." align="char">73.38</td></tr><tr><td>Anderson</td><td char="." align="char">0.817</td><td char="." align="char">0.690</td><td>0.016</td><td char="." align="char">0.149</td><td>10.6</td><td>33.4</td><td>28.8</td><td>0.06</td><td char="." align="char">3.26</td><td char="." align="char">10.3</td><td char="." align="char">31.91</td><td char="." align="char">15.93</td></tr><tr><td>Bamberg</td><td char="." align="char">0.626</td><td char="." align="char">0.626</td><td>0</td><td char="." align="char">0.313</td><td>14.4</td><td>41.1</td><td>31.6</td><td>0.06</td><td char="." align="char">3.97</td><td char="." align="char">16.2</td><td char="." align="char">26.02</td><td char="." align="char">61.21</td></tr><tr><td>Barnwell</td><td char="." align="char">0.537</td><td char="." align="char">0.850</td><td>0.045</td><td char="." align="char">0.179</td><td>11.9</td><td>38.3</td><td>28.9</td><td>0.04</td><td char="." align="char">6.38</td><td char="." align="char">15.2</td><td char="." align="char">39.05</td><td char="." align="char">44.05</td></tr><tr><td>Beaufort</td><td char="." align="char">0.656</td><td char="." align="char">0.383</td><td>0.012</td><td char="." align="char">0.200</td><td>7.6</td><td>22.5</td><td>16</td><td>0.16</td><td char="." align="char">3.05</td><td char="." align="char">8.7</td><td char="." align="char">24.37</td><td char="." align="char">18.90</td></tr><tr><td>Berkeley</td><td char="." align="char">0.605</td><td char="." align="char">0.321</td><td>0.016</td><td char="." align="char">0.104</td><td>12.7</td><td>36.3</td><td>25.6</td><td>0.05</td><td char="." align="char">2.56</td><td char="." align="char">9.5</td><td char="." align="char">31.69</td><td char="." align="char">24.75</td></tr><tr><td>Calhoun</td><td char="." align="char">0.264</td><td char="." align="char">0.792</td><td>0</td><td char="." align="char">0.066</td><td>14.9</td><td>39.7</td><td>28.7</td><td>0</td><td char="." align="char">8.33</td><td char="." align="char">12.3</td><td char="." align="char">37.77</td><td char="." align="char">42.31</td></tr><tr><td>Charleston</td><td char="." align="char">0.987</td><td char="." align="char">0.461</td><td>0.020</td><td char="." align="char">0.274</td><td>10.4</td><td>25.9</td><td>21.1</td><td>0.11</td><td char="." align="char">2.26</td><td char="." align="char">8.3</td><td char="." align="char">21.30</td><td char="." align="char">29.55</td></tr><tr><td>Cherokee</td><td char="." align="char">0.702</td><td char="." align="char">0.774</td><td>0.018</td><td char="." align="char">0.180</td><td>11.5</td><td>32.8</td><td>32.2</td><td>0.07</td><td char="." align="char">3.49</td><td char="." align="char">14.7</td><td char="." align="char">35.15</td><td char="." align="char">20.26</td></tr><tr><td>Chester</td><td char="." align="char">0.456</td><td char="." align="char">0.790</td><td>0</td><td char="." align="char">0.304</td><td>12.3</td><td>37.2</td><td>27.2</td><td>0.06</td><td char="." align="char">5.18</td><td char="." align="char">17.3</td><td char="." align="char">38.83</td><td char="." align="char">37.26</td></tr><tr><td>Chesterfield</td><td char="." align="char">0.473</td><td char="." align="char">0.558</td><td>0.021</td><td char="." align="char">0.258</td><td>11.9</td><td>35.4</td><td>30.3</td><td>0.04</td><td char="." align="char">7.26</td><td char="." align="char">12.9</td><td char="." align="char">38.65</td><td char="." align="char">32.48</td></tr><tr><td>Clarendon</td><td char="." align="char">0.605</td><td char="." align="char">1.037</td><td>0.029</td><td char="." align="char">0.115</td><td>13.5</td><td>38.3</td><td>28</td><td>0.03</td><td char="." align="char">5.29</td><td char="." align="char">14.5</td><td char="." align="char">38.06</td><td char="." align="char">49.70</td></tr><tr><td>Colleton</td><td char="." align="char">0.647</td><td char="." align="char">0.932</td><td>0.026</td><td char="." align="char">0.285</td><td>14.2</td><td>38.2</td><td>30.5</td><td>0.05</td><td char="." align="char">7.63</td><td char="." align="char">14.1</td><td char="." align="char">35.39</td><td char="." align="char">38.85</td></tr><tr><td>Darlington</td><td char="." align="char">0.454</td><td char="." align="char">0.805</td><td>0.015</td><td char="." align="char">0.190</td><td>13.5</td><td>33.8</td><td>32</td><td>0.09</td><td char="." align="char">3.81</td><td char="." align="char">12.9</td><td char="." align="char">36.89</td><td char="." align="char">41.44</td></tr><tr><td>Dillon</td><td char="." align="char">0.567</td><td char="." align="char">0.850</td><td>0</td><td char="." align="char">0.252</td><td>13.2</td><td>39.8</td><td>35.9</td><td>0</td><td char="." align="char">7.26</td><td char="." align="char">15.8</td><td char="." align="char">39.60</td><td char="." align="char">45.94</td></tr><tr><td>Dorchester</td><td char="." align="char">0.539</td><td char="." align="char">0.341</td><td>0.007</td><td char="." align="char">0.121</td><td>9.7</td><td>30</td><td>22.9</td><td>0.05</td><td char="." align="char">2.36</td><td char="." align="char">8.9</td><td char="." align="char">29.31</td><td char="." align="char">25.53</td></tr><tr><td>Edgefield</td><td char="." align="char">0.300</td><td char="." align="char">0.450</td><td>0</td><td char="." align="char">0.112</td><td>11.6</td><td>33.5</td><td>26</td><td>0.04</td><td char="." align="char">4.12</td><td char="." align="char">9.9</td><td char="." align="char">37.95</td><td char="." align="char">36.88</td></tr><tr><td>Fairfield</td><td char="." align="char">0.297</td><td char="." align="char">0.764</td><td>0.042</td><td char="." align="char">0.085</td><td>15.3</td><td>40.6</td><td>29.7</td><td>0</td><td char="." align="char">6.26</td><td char="." align="char">14.5</td><td char="." align="char">39.57</td><td char="." align="char">58.91</td></tr><tr><td>Florence</td><td char="." align="char">0.791</td><td char="." align="char">0.696</td><td>0.015</td><td char="." align="char">0.297</td><td>12.6</td><td>36.8</td><td>27.3</td><td>0.06</td><td char="." align="char">5.01</td><td char="." align="char">11.2</td><td char="." align="char">33.28</td><td char="." align="char">41.06</td></tr><tr><td>Georgetown</td><td char="." align="char">0.750</td><td char="." align="char">0.617</td><td>0.017</td><td char="." align="char">0.283</td><td>10.9</td><td>35.5</td><td>26.5</td><td>0.08</td><td char="." align="char">5.39</td><td char="." align="char">13.5</td><td char="." align="char">32.31</td><td char="." align="char">33.46</td></tr><tr><td>Greenville</td><td char="." align="char">0.854</td><td char="." align="char">0.460</td><td>0.017</td><td char="." align="char">0.186</td><td>9.9</td><td>29.3</td><td>23.3</td><td>0.13</td><td char="." align="char">2.32</td><td char="." align="char">8.6</td><td char="." align="char">26.06</td><td char="." align="char">17.86</td></tr><tr><td>Greenwood</td><td char="." align="char">0.730</td><td char="." align="char">0.730</td><td>0.014</td><td char="." align="char">0.229</td><td>9.5</td><td>32.5</td><td>25.5</td><td>0.09</td><td char="." align="char">2.50</td><td char="." align="char">11.3</td><td char="." align="char">29.97</td><td char="." align="char">31.19</td></tr><tr><td>Hampton</td><td char="." align="char">0.768</td><td char="." align="char">1.105</td><td>0</td><td char="." align="char">0.288</td><td>15.6</td><td>43.5</td><td>32</td><td>0</td><td char="." align="char">7.35</td><td char="." align="char">12.9</td><td char="." align="char">38.65</td><td char="." align="char">53.41</td></tr><tr><td>Horry</td><td char="." align="char">1.140</td><td char="." align="char">0.612</td><td>0.033</td><td char="." align="char">0.199</td><td>9.8</td><td>27.6</td><td>22</td><td>0.10</td><td char="." align="char">2.48</td><td char="." align="char">11.9</td><td char="." align="char">32.08</td><td char="." align="char">13.28</td></tr><tr><td>Jasper</td><td char="." align="char">0.714</td><td char="." align="char">0.953</td><td>0.040</td><td char="." align="char">0.238</td><td>12.8</td><td>39.3</td><td>25.2</td><td>0.04</td><td char="." align="char">5.33</td><td char="." align="char">9.9</td><td char="." align="char">40.23</td><td char="." align="char">45.62</td></tr><tr><td>Kershaw</td><td char="." align="char">0.546</td><td char="." align="char">0.707</td><td>0.016</td><td char="." align="char">0.112</td><td>10.4</td><td>30.7</td><td>27.5</td><td>0.05</td><td char="." align="char">5.08</td><td char="." align="char">11.0</td><td char="." align="char">34.44</td><td char="." align="char">24.40</td></tr><tr><td>Lancaster</td><td char="." align="char">0.449</td><td char="." align="char">0.603</td><td>0.026</td><td char="." align="char">0.282</td><td>12</td><td>34.9</td><td>26.9</td><td>0.05</td><td char="." align="char">2.83</td><td char="." align="char">13.3</td><td char="." align="char">34.12</td><td char="." align="char">23.69</td></tr><tr><td>Laurens</td><td char="." align="char">0.421</td><td char="." align="char">0.737</td><td>0</td><td char="." align="char">0.180</td><td>13</td><td>38</td><td>32</td><td>0.05</td><td char="." align="char">6.49</td><td char="." align="char">11.6</td><td char="." align="char">36.02</td><td char="." align="char">25.26</td></tr><tr><td>Lee</td><td char="." align="char">0.422</td><td char="." align="char">0.474</td><td>0</td><td char="." align="char">0.263</td><td>13.4</td><td>41.5</td><td>31</td><td>0</td><td char="." align="char">8.57</td><td char="." align="char">16.2</td><td char="." align="char">38.31</td><td char="." align="char">64.07</td></tr><tr><td>Lexington</td><td char="." align="char">0.756</td><td char="." align="char">0.532</td><td>0.026</td><td char="." align="char">0.157</td><td>10.1</td><td>29.9</td><td>24</td><td>0.09</td><td char="." align="char">2.08</td><td char="." align="char">8.0</td><td char="." align="char">27.70</td><td char="." align="char">14.10</td></tr><tr><td>Mccormick</td><td char="." align="char">0.399</td><td char="." align="char">0.698</td><td>0</td><td char="." align="char">0.199</td><td>14.6</td><td>40.1</td><td>30.6</td><td>0</td><td char="." align="char">5.39</td><td char="." align="char">13.6</td><td char="." align="char">28.56</td><td char="." align="char">49.54</td></tr><tr><td>Marion</td><td char="." align="char">0.457</td><td char="." align="char">0.792</td><td>0.030</td><td char="." align="char">0.304</td><td>13.2</td><td>39.7</td><td>31.7</td><td>0.03</td><td char="." align="char">5.56</td><td char="." align="char">17.7</td><td char="." align="char">43.21</td><td char="." align="char">55.55</td></tr><tr><td>Marlboro</td><td char="." align="char">0.421</td><td char="." align="char">1.122</td><td>0</td><td char="." align="char">0.246</td><td>11.1</td><td>32.8</td><td>28.5</td><td>0</td><td char="." align="char">7.85</td><td char="." align="char">19.7</td><td char="." align="char">40.53</td><td char="." align="char">50.64</td></tr><tr><td>Newberry</td><td char="." align="char">0.477</td><td char="." align="char">0.901</td><td>0.027</td><td char="." align="char">0.159</td><td>12</td><td>34.7</td><td>26.5</td><td>0.05</td><td char="." align="char">4.24</td><td char="." align="char">10.3</td><td char="." align="char">32.04</td><td char="." align="char">30.75</td></tr><tr><td>Oconee</td><td char="." align="char">0.685</td><td char="." align="char">0.524</td><td>0.013</td><td char="." align="char">0.215</td><td>11</td><td>31.5</td><td>22.4</td><td>0.03</td><td char="." align="char">3.75</td><td char="." align="char">10.0</td><td char="." align="char">33.48</td><td char="." align="char">7.47</td></tr><tr><td>Orangeburg</td><td char="." align="char">0.751</td><td char="." align="char">0.947</td><td>0.011</td><td char="." align="char">0.239</td><td>14.3</td><td>41.4</td><td>27.8</td><td>0.07</td><td char="." align="char">5.90</td><td char="." align="char">15.8</td><td char="." align="char">35.43</td><td char="." align="char">61.93</td></tr><tr><td>Pickens</td><td char="." align="char">0.719</td><td char="." align="char">0.594</td><td>0.008</td><td char="." align="char">0.092</td><td>10.3</td><td>29.6</td><td>22</td><td>0.09</td><td char="." align="char">3.61</td><td char="." align="char">9.8</td><td char="." align="char">30.19</td><td char="." align="char">6.54</td></tr><tr><td>Richland</td><td char="." align="char">0.779</td><td char="." align="char">0.445</td><td>0.015</td><td char="." align="char">0.136</td><td>11.5</td><td>31.9</td><td>24.1</td><td>0.08</td><td char="." align="char">1.86</td><td char="." align="char">9.2</td><td char="." align="char">22.39</td><td char="." align="char">45.40</td></tr><tr><td>Saluda</td><td char="." align="char">0.251</td><td char="." align="char">0.704</td><td>0</td><td char="." align="char">0.151</td><td>11.8</td><td>33.2</td><td>27.6</td><td>0</td><td char="." align="char">5.94</td><td char="." align="char">9.7</td><td char="." align="char">40.59</td><td char="." align="char">26.14</td></tr><tr><td>Spartanburg</td><td char="." align="char">0.694</td><td char="." align="char">0.603</td><td>0.021</td><td char="." align="char">0.143</td><td>11.3</td><td>29.2</td><td>26.6</td><td>0.10</td><td char="." align="char">3.55</td><td char="." align="char">10.9</td><td char="." align="char">30.76</td><td char="." align="char">20.44</td></tr><tr><td>Sumter</td><td char="." align="char">0.521</td><td char="." align="char">0.661</td><td>0.009</td><td char="." align="char">0.186</td><td>13.8</td><td>34.6</td><td>29.8</td><td>0.06</td><td char="." align="char">4.09</td><td char="." align="char">12.0</td><td char="." align="char">30.60</td><td char="." align="char">46.63</td></tr><tr><td>Union</td><td char="." align="char">0.453</td><td char="." align="char">0.837</td><td>0</td><td char="." align="char">0.174</td><td>13.4</td><td>36</td><td>32.9</td><td>0.03</td><td char="." align="char">4.45</td><td char="." align="char">16.0</td><td char="." align="char">37.51</td><td char="." align="char">31.15</td></tr><tr><td>Williamsburg</td><td char="." align="char">0.381</td><td char="." align="char">0.763</td><td>0</td><td char="." align="char">0.235</td><td>15.3</td><td>43.1</td><td>31</td><td>0.03</td><td char="." align="char">11.57</td><td char="." align="char">16.7</td><td char="." align="char">40.02</td><td char="." align="char">65.44</td></tr><tr><td>York</td><td char="." align="char">0.711</td><td char="." align="char">0.486</td><td>0.022</td><td char="." align="char">0.174</td><td>9.1</td><td>27.9</td><td>21.6</td><td>0.09</td><td char="." align="char">2.31</td><td char="." align="char">11.0</td><td char="." align="char">28.18</td><td char="." align="char">18.85</td></tr><tr><td>South Carolina</td><td char="." align="char">0.59</td><td char="." align="char">0.69</td><td>0.014</td><td char="." align="char">0.19</td><td>12.14</td><td>34.95</td><td>27.59</td><td>0.05</td><td char="." align="char">4.81</td><td char="." align="char">12.56</td><td char="." align="char">33.85</td><td char="." align="char">35.95</td></tr></tbody></table></table-wrap></p>
      </sec>
      <sec id="Sec11">
        <title>Bivariate maps</title>
        <p>Figure <xref rid="Fig1" ref-type="fig">1</xref> displays the bivariate maps between the four food outlet densities and DM prevalence, each based on three ranks (i.e., low, medium, high). The highest rank combination formed between fast food restaurant densities and DM prevalence was observed in two PeeDee region counties: Hampton and Orangburg. The lowest rank combination was observed in Aiken, Beaufort, Dorchester, and Kershaw counties. The highest rank combination formed between convenience store densities and DM prevalence was observed primarily along the 1-95 corrdior (i.e., Clarendon, Colleton, Darlington, Dillion, Hampton, Orangeburg, and Union counties). The lowest rank combination was found in Aiken, Beaufort, Charleston, Dorchester, Greenville, Lexington, Pickens, and York counties. Rank combinations between super store density, grocery store density, and DM prevalence are also shown in Fig. <xref rid="Fig1" ref-type="fig">1</xref>.<fig id="Fig1"><label>Fig. 1</label><caption><p>Bivariate ranking between Diabetes Mellitus prevalence and density of food outlets in South Carolina counties, 2011</p></caption><graphic xlink:href="12889_2015_2681_Fig1_HTML" id="MO1"/></fig></p>
      </sec>
      <sec id="Sec12">
        <title>Correlations</title>
        <p>Pearson correlation coefficients between each food outlet density and DM prevalence are presented in Table <xref rid="Tab2" ref-type="table">2</xref>. Two food outlet densities reached statistical significance at the 0.05 level and were moderately correlated with DM prevalence: fast food restaurants (<italic>r</italic> = -0.45) and convenience stores (<italic>r</italic> = 0.54). Super stores (<italic>r</italic> = -0.21) and grocery stores (<italic>r</italic> = 0.16) had weak correlations with DM prevalence and did not reach statistical significance.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Pearson’s correlation coefficients between density of food outlets and County-level diabetes prevalence in South Carolina, 2011</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Food outlet</th><th>Correlation</th><th>
<italic>P</italic>-value</th></tr></thead><tbody><tr><td>Fast food restaurants</td><td char="." align="char">-0.45</td><td>0.007<sup>a</sup>
</td></tr><tr><td>Convenience stores</td><td char="." align="char">0.54</td><td>&lt;0.001<sup>a</sup>
</td></tr><tr><td>Super stores</td><td char="." align="char">-0.21</td><td>0.16</td></tr><tr><td>Grocery stores</td><td char="." align="char">0.16</td><td>0.29</td></tr></tbody></table><table-wrap-foot><p>
<sup>a</sup>Correlation is significant at the 0.05 level</p><p>
<italic>N</italic> = 46</p></table-wrap-foot></table-wrap></p>
      </sec>
      <sec id="Sec13">
        <title>OLS regression</title>
        <p>Table <xref rid="Tab3" ref-type="table">3</xref> presents results from OLS regression analyses. Model 1 is a simple linear regression with each food outlet density considered as the only explanatory variable. The models predicted that for every 1 % increase in DM prevalence in a county, the density of fast food restaurants decreases by 4.52 % (<italic>p</italic>-value = 0.002), and the density of convenience stores increases by 5.33 % (<italic>p</italic>-value &lt; 0.001). Model 2 is adjusted for the following county-level covariates: obesity, physical inactivity, recreation, unemployment, education, households with no car and limited access to a store, and race. The models show that 80 % of the variation in DM is explained by the variables (adjusted R-squared was consistent across all models). No food outlet density reached statistical significance in these adjusted models.<table-wrap id="Tab3"><label>Table 3</label><caption><p>Multiple-variable linear regression prediction County-level diabetes with density of food outlets in South Carolina, 2011</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th colspan="3">Model 1</th><th colspan="3">Model 2<sup>b</sup>
</th></tr><tr><th>Food outlet</th><th>Beta coefficient</th><th>Standard error</th><th>
<italic>P</italic>-value</th><th>Beta coefficient</th><th>Standard error</th><th>
<italic>P</italic>-value</th></tr></thead><tbody><tr><td>Fast Food Restaurants</td><td>-4.52</td><td>1.34</td><td>0.002<sup>a</sup>
</td><td>-0.55</td><td>0.90</td><td>0.54</td></tr><tr><td>Convenience Stores</td><td>5.33</td><td>1.24</td><td>&lt;0.001<sup>a</sup>
</td><td>0.89</td><td>0.86</td><td>0.31</td></tr><tr><td>Super Stores</td><td>-31.91</td><td>22.31</td><td>0.16</td><td>-0.40</td><td>11.66</td><td>0.97</td></tr><tr><td>Grocery Stores</td><td>4.61</td><td>4.30</td><td>0.29</td><td>-3.70</td><td>2.13</td><td>0.09</td></tr></tbody></table><table-wrap-foot><p>
<sup>a</sup>Beta coefficients are significant at the 0.05 level</p><p>
<sup>b</sup>Model 2 adjusted for obesity, physical inactivity, recreation facility density, unemployed, education, household with no cars and limited access to a store, and race</p><p>
<italic>N</italic> = 46</p></table-wrap-foot></table-wrap></p>
      </sec>
    </sec>
    <sec id="Sec14">
      <title>Discussion</title>
      <p>Type II Diabetes Mellitus, along with other chronic diseases, is growing rapidly in South Carolina and the United States. Since the built environment has been shown to influence DM [<xref ref-type="bibr" rid="CR13">13</xref>–<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR21">21</xref>], this study examined the relationship between four types of food outlets accounting for density of population and the prevalence of DM. Both convenience stores and fast food restaurants are associated with poor food quality and thus were expected to be positively correlated with prevalence of DM. Likewise, super and grocery stores are associated with healthy food options and thus were expected to be negatively correlated with prevalence of DM. Pearson correlations revealed that the density of convenience stores had a moderate, positive correlation with DM, but the density of fast food restaurants had a moderate, negative correlation with DM. Super stores and grocery stores were not significantly correlated with DM prevalence.</p>
      <p>The expectation that fast food restaurants and convenience stores are positively associated with DM and that super stores and grocery stores are negatively associated with DM was more evident in the bivariate maps. Aligned with our hypothesis, Hampton County for example, had the highest rank combination between fast food restaurant densities and DM prevalence as well as convenience store densities and DM prevalence. In fact, Hampton County has the highest prevalence of DM and obesity within South Carolina. This county also had the lowest rank of super store densities and the highest rank of grocery store densities. With Hampton County having one of the state’s smallest population densities, the lack of super stores is to be expected [<xref ref-type="bibr" rid="CR31">31</xref>]. Small grocery stores are more common in rural counties [<xref ref-type="bibr" rid="CR31">31</xref>].</p>
      <p>Our results are unexpected due to the lack of healthful foods provided by fast food restaurants and convenience stores [<xref ref-type="bibr" rid="CR20">20</xref>] as well as studies demonstrating the positive association between fast food restaurants and chronic diseases, such as obesity, at the macro level [<xref ref-type="bibr" rid="CR13">13</xref>]. Studies found that proximity to fast food outlets is associated with greater food intake and availability of convenience stores is associated with increased risk of obesity [<xref ref-type="bibr" rid="CR25">25</xref>]. Yet, studies have also been inconsistent with fast food restaurants resulting in negative or null associations between obesity and/or frequency of fast food consumption [<xref ref-type="bibr" rid="CR30">30</xref>]. Jeffrey’s et al. study found no association between fast food proximity and fast food consumption or BMI [<xref ref-type="bibr" rid="CR32">32</xref>]. The inconsistent findings in the literature may be caused by the lack of an established definition for fast food restaurants. This study used the definition based on NAICS code whereas other studies may provide their own definition. Additionally, the NAICS code is defined as food establishments where consumers pay before eating thus also including food establishments that provide healthy alternatives, such as Subway®. The inconsistent findings in the literature may also be due to differences in spatial scale. Ahern’s county-level study found obesity rates to be negatively associated with fast food restaurants and positively associated with grocery stores (in non-metro areas only), where as Maddock’s state-level analysis found obesity rates to be positively associated with fast food restaurants [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR25">25</xref>].</p>
      <p>The null findings regarding super store densities and grocery store densities to DM prevalence contradict the literature. Other studies found that larger food stores and super stores are associated with better access to high quality food, such as fresh fruits and vegetables [<xref ref-type="bibr" rid="CR32">32</xref>–<xref ref-type="bibr" rid="CR38">38</xref>], and the availability of supermarkets is associated with healthier diets, lower rates of obesity, and a longer life span [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR39">39</xref>–<xref ref-type="bibr" rid="CR43">43</xref>].</p>
      <p>The significant covariates in the regression models were obesity, physical inactivity, and race (except when considering the density of fast food restaurants as the exposure). This is expected because DM disproportionately affects non-Hispanic Blacks and African Americans. Previous studies have found that Blacks and disadvantaged groups are more likely to live in areas with inadequate access to healthy foods directly affecting their health [<xref ref-type="bibr" rid="CR24">24</xref>].</p>
      <sec id="Sec15">
        <title>Limitations</title>
        <p>This study has several limitations. DM, obesity, and physical inactivity were based on self-reported data collected by BRFSS. However, studies have shown self-report DM based on a physician’s diagnosis to be highly validated [<xref ref-type="bibr" rid="CR44">44</xref>], and self-reported weight and height to compute BMI to also be validated among adults [<xref ref-type="bibr" rid="CR45">45</xref>]. Additionally, BRFSS obtains county-level estimates by aggregating three years of data for a single estimate due to the limiting sample size preventing possible calculations for a single year. BRFSS also includes type I diabetes mellitus along with the DM data making it difficult to distinguish between the two types of diabetes; however, type II diabetes accounts for 90–95 % of all diabetes cases [<xref ref-type="bibr" rid="CR11">11</xref>]. Furthermore, the study analysis did not consider spatial spillover: the impact of food outlets in bordering counties in other states. It is likely for individuals living in a border county to purchase food from nearby state counties. Moreover, because our total sample only included 46 counties, the power to detect statistical differences was reduced. Finally, the ecological nature of the study subjugates it to the ecological fallacy, thus limiting its inference to the county level only.</p>
      </sec>
    </sec>
    <sec id="Sec16">
      <title>Conclusions</title>
      <p>Overall, findings from this ecological study do not show significant associations between any of the four types of food outlets and the prevalence of DM. This emphasizes the role of individual behavioral decisions on DM prevalence as well as the need for studies that examine the role of food outlet density on health outcomes at various spatial scales. DM and other chronic diseases are multi-faceted and relate to many factors including both individual and environmental as well as social and cultural. Therefore, to further understand the impact on DM, future research should include both the structure of the built environment- food outlets and recreational space- and individual factors in order to construct a thorough, comprehensive model of the contextual factors contributing to the increase of chronic diseases. Assessing the environmental, social, and cultural determinants of chronic diseases is key in establishing health-promoting environments. There is a strong need to advocate for such environmental change.</p>
    </sec>
  </body>
  <back>
    <app-group>
      <app id="App1">
        <sec id="Sec17">
          <title>Additional file</title>
          <p>
            <media position="anchor" xlink:href="12889_2015_2681_MOESM1_ESM.doc" id="MOESM1">
              <label>Additional file 1:</label>
              <caption>
                <p>
<bold>Study Variables’ Data Sources.</bold> (DOC 35 kb)</p>
              </caption>
            </media>
          </p>
        </sec>
      </app>
    </app-group>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The authors declare that they have no competing interests.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors’ contributions</bold>
        </p>
        <p>DMA performed the statistical analysis and drafted the manuscript. JME made substantial contributions to the design of the study and revised the manuscript critically. All authors read and approved the final manuscript.</p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgements</title>
      <p>We thank Charity Breneman who provided technical services in GIS and writing services.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chaput</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Despres</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Bouchard</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Astrup</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Tremblay</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Sleep duration as a risk factor for the development of type 2 diabetes or impaired glucose tolerance: analyses of the Quebec family study</article-title>
          <source>Sleep Med</source>
          <year>2009</year>
          <volume>10</volume>
          <fpage>919</fpage>
          <lpage>24</lpage>
          <pub-id pub-id-type="doi">10.1016/j.sleep.2008.09.016</pub-id>
          <?supplied-pmid 19332380?>
          <pub-id pub-id-type="pmid">19332380</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <mixed-citation publication-type="other">Center For Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2007.</mixed-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <mixed-citation publication-type="other">Barker LE, Kirtland KA, Gregg EW, Geiss LS, Thompson TJ. Geographic distribution of diagnosed diabetes in the U.S.: a diabetes belt. Am J Prev Med. 2011;40(4):434-439.</mixed-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <mixed-citation publication-type="other">South Carolina Department of Health and Environmental Control. Burden of Diabetes Report. 2012.</mixed-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <mixed-citation publication-type="other">Department of Health and Environmental Control. Diabetes in South Carolina fact sheet. 2014; Available at: <ext-link ext-link-type="uri" xlink:href="http://www.scdhec.gov/Library/ML-025328.pdf">http://www.scdhec.gov/Library/ML-025328.pdf</ext-link></mixed-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <collab>American Diabetes Association</collab>
          </person-group>
          <article-title>Diagnosis and classification of diabetes mellitus</article-title>
          <source>Diabetes Care</source>
          <year>2005</year>
          <volume>28</volume>
          <fpage>S37</fpage>
          <lpage>42</lpage>
          <pub-id pub-id-type="doi">10.2337/diacare.28.suppl_1.S37</pub-id>
          <pub-id pub-id-type="pmid">15618111</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Amos</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>McCarty</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Zimmet</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>The rising global burden of diabetes and its complications: estimates and projections to the year 2010</article-title>
          <source>Diabetes Med</source>
          <year>1997</year>
          <volume>14</volume>
          <fpage>S1</fpage>
          <lpage>85</lpage>
          <pub-id pub-id-type="doi">10.1002/(SICI)1096-9136(199712)14:5+&lt;S7::AID-DIA522&gt;3.3.CO;2-I</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jones</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Homer</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Murphy</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Essien</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Milstein</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Seville</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Understanding diabetes population dynamics through simulation modeling and experimentation</article-title>
          <source>Oppor Demands Public Health Syst</source>
          <year>2006</year>
          <volume>96</volume>
          <issue>3</issue>
          <fpage>488</fpage>
          <lpage>94</lpage>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <collab>American Diabetes Association</collab>
          </person-group>
          <article-title>Economic consequences of diabetes mellitus in the US in 1997</article-title>
          <source>Diabetes Care</source>
          <year>1998</year>
          <volume>21</volume>
          <fpage>296</fpage>
          <lpage>309</lpage>
          <pub-id pub-id-type="doi">10.2337/diacare.21.2.296</pub-id>
          <pub-id pub-id-type="pmid">9539999</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <collab>American Diabetes Association</collab>
          </person-group>
          <article-title>Economic costs of diabetes in the U.S. in 2012</article-title>
          <source>Diabetes Care</source>
          <year>2013</year>
          <volume>36</volume>
          <fpage>1033</fpage>
          <lpage>46</lpage>
          <pub-id pub-id-type="doi">10.2337/dc12-2625</pub-id>
          <pub-id pub-id-type="pmid">23468086</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <mixed-citation publication-type="other">Chatterji M. Association between food deserts and diabetes related morbidity and mortality among residents of Fulton County, Georgia. Thesis, Georgia State Univeristy. 2013.</mixed-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Duru</surname>
              <given-names>OK</given-names>
            </name>
            <name>
              <surname>Gerzoff</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Selby</surname>
              <given-names>JV</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Ackermann</surname>
              <given-names>RT</given-names>
            </name>
            <name>
              <surname>Karter</surname>
              <given-names>AJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Identifying risk factors for racial disparities in diabetes outcomes: the translating research into action for diabetes study</article-title>
          <source>Med Care</source>
          <year>2009</year>
          <volume>47</volume>
          <issue>6</issue>
          <fpage>700</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.1097/MLR.0b013e318192609d</pub-id>
          <?supplied-pmid 19480090?>
          <pub-id pub-id-type="pmid">19480090</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maddock</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>The relationship between obesity and the prevalence of fast food restaurants: state-level analysis</article-title>
          <source>Am J Health Promot</source>
          <year>2004</year>
          <volume>19</volume>
          <issue>2</issue>
          <fpage>137</fpage>
          <lpage>43</lpage>
          <pub-id pub-id-type="doi">10.4278/0890-1171-19.2.137</pub-id>
          <?supplied-pmid 15559714?>
          <pub-id pub-id-type="pmid">15559714</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cummins</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Macintyre</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Food environments and obesity- neighbourhood or nation?</article-title>
          <source>Int J Epidemiol</source>
          <year>2006</year>
          <volume>35</volume>
          <fpage>100</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="doi">10.1093/ije/dyi276</pub-id>
          <?supplied-pmid 16338945?>
          <pub-id pub-id-type="pmid">16338945</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barnes</surname>
              <given-names>TL</given-names>
            </name>
            <name>
              <surname>Bell</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Freedman</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Colabianchi</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Liese</surname>
              <given-names>AD</given-names>
            </name>
          </person-group>
          <article-title>Do people really know what food retailers exist in their neighborhood? Examining GIS-based and perceived presence of retail food outlets in an eight-county region of South Carolina</article-title>
          <source>Spat Spatio-temporal Epidemiol</source>
          <year>2010</year>
          <volume>13</volume>
          <fpage>31</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="doi">10.1016/j.sste.2015.04.004</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Block</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Scribner</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>DeSalvo</surname>
              <given-names>KB</given-names>
            </name>
          </person-group>
          <article-title>Fast food, race/ethnicity, and income: a geographic analysis</article-title>
          <source>Am J Prev Med</source>
          <year>2004</year>
          <volume>27</volume>
          <issue>3</issue>
          <fpage>211</fpage>
          <lpage>7</lpage>
          <?supplied-pmid 15450633?>
          <pub-id pub-id-type="pmid">15450633</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Davis</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Carpenter</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Proximity of fast-food restaurants to schools and adolescent obesity</article-title>
          <source>Am J Public Health</source>
          <year>2009</year>
          <volume>3</volume>
          <issue>99</issue>
          <fpage>505</fpage>
          <lpage>10</lpage>
          <pub-id pub-id-type="doi">10.2105/AJPH.2008.137638</pub-id>
          <pub-id pub-id-type="pmid">19106421</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fraser</surname>
              <given-names>LK</given-names>
            </name>
            <name>
              <surname>Clarke</surname>
              <given-names>GP</given-names>
            </name>
            <name>
              <surname>Cade</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Edwards</surname>
              <given-names>KL</given-names>
            </name>
          </person-group>
          <article-title>Fast food and obesity: a spatial analysis in a large United Kingdom population of children aged 13-15</article-title>
          <source>Am J Prev Med</source>
          <year>2012</year>
          <volume>42</volume>
          <issue>5</issue>
          <fpage>77</fpage>
          <lpage>85</lpage>
          <pub-id pub-id-type="doi">10.1016/j.amepre.2012.02.007</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reidpath</surname>
              <given-names>DD</given-names>
            </name>
            <name>
              <surname>Burns</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Garrard</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Mahoney</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Townsend</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>An ecological study of the relationship between social and environmental determinants of obesity</article-title>
          <source>Health Place</source>
          <year>2002</year>
          <volume>8</volume>
          <fpage>141</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="doi">10.1016/S1353-8292(01)00028-4</pub-id>
          <?supplied-pmid 11943585?>
          <pub-id pub-id-type="pmid">11943585</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Satia</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Galanko</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Seiga-Riz</surname>
              <given-names>AM</given-names>
            </name>
          </person-group>
          <article-title>Eating at fast-food restaurants is associated with dietart intake, demographic, psychosocial and behavioural factors among African Americans in North Carolina</article-title>
          <source>Public Health Nutr</source>
          <year>2004</year>
          <volume>7</volume>
          <issue>8</issue>
          <fpage>1089</fpage>
          <lpage>96</lpage>
          <pub-id pub-id-type="doi">10.1079/PHN2004662</pub-id>
          <?supplied-pmid 15548348?>
          <pub-id pub-id-type="pmid">15548348</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <mixed-citation publication-type="other">Babey SH, Diamant AL, Hastert TA, and Harvey S. Designed for disease: the link between local food environments and obesity and diabetes. UCLA Center for Health Policy Research. 2008.</mixed-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Galvez</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Hong</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Liao</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Godbold</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Brenner</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Childhood obesity and neighborhood food store availability in an inner city community</article-title>
          <source>Acaad Pediator</source>
          <year>2009</year>
          <volume>9</volume>
          <issue>5</issue>
          <fpage>339</fpage>
          <lpage>43</lpage>
          <pub-id pub-id-type="doi">10.1016/j.acap.2009.05.003</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Powell</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Slater</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mirtcheva</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Bao</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Chaloupka</surname>
              <given-names>FJ</given-names>
            </name>
          </person-group>
          <article-title>Food store availability and neighborhood characteristics in the United States</article-title>
          <source>Prev Med</source>
          <year>2007</year>
          <volume>44</volume>
          <fpage>189</fpage>
          <lpage>95</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ypmed.2006.08.008</pub-id>
          <?supplied-pmid 16997358?>
          <pub-id pub-id-type="pmid">16997358</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Inagami</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Finch</surname>
              <given-names>BK</given-names>
            </name>
            <name>
              <surname>Asch</surname>
              <given-names>SM</given-names>
            </name>
          </person-group>
          <article-title>You are where you shop: grocery store locations, weight and neigborhoods</article-title>
          <source>Am J Prev Med</source>
          <year>2006</year>
          <volume>31</volume>
          <issue>1</issue>
          <fpage>10</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.1016/j.amepre.2006.03.019</pub-id>
          <?supplied-pmid 16777537?>
          <pub-id pub-id-type="pmid">16777537</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ahern</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Dukas</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>A national study of the association between food environments and county-level health outcomes</article-title>
          <source>J Rural Health</source>
          <year>2011</year>
          <volume>27</volume>
          <fpage>367</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1748-0361.2011.00378.x</pub-id>
          <?supplied-pmid 21967380?>
          <pub-id pub-id-type="pmid">21967380</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <mixed-citation publication-type="other">2011 TIGER/Line Shapefiles [machine-readable data files] and Technical Documentation prepared by the U.S. Census Bureau, 2011. Available at: <ext-link ext-link-type="uri" xlink:href="http://www.census.gov/geo/maps-data/data/tiger-line.html">http://www.census.gov/geo/maps-data/data/tiger-line.html</ext-link>.</mixed-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <mixed-citation publication-type="other">Center for Disease Control and Prevention. County Data Indicators, 2011. Available at: <ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/diabetes/atlas/countydata/County_ListofIndicators.html">http://www.cdc.gov/diabetes/atlas/countydata/County_ListofIndicators.html</ext-link></mixed-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <mixed-citation publication-type="other">Economic Research Service, U.S. Department of Agriculture (USDA). Food Environment Atlas. Available at: <ext-link ext-link-type="uri" xlink:href="http://www.ers.usda.gov/data-products/food-environment-atlas.aspx">http://www.ers.usda.gov/data-products/food-environment-atlas.aspx</ext-link>.</mixed-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <mixed-citation publication-type="other">US Bureau of the Census American Fact Finder. 2010 Available at: <ext-link ext-link-type="uri" xlink:href="http://factfinder.census.gov">http://factfinder.census.gov</ext-link>.</mixed-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <mixed-citation publication-type="other">Richardson AS, Boone-Heinonen J, Popkin BM, Gordon-Larsen P. Neighborhood fast food restaurants and fast food consumption: a national study. BMC Public Health. 2011; 11(543).</mixed-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kaufaman</surname>
              <given-names>PR</given-names>
            </name>
          </person-group>
          <article-title>Rural poor have less access to supermarkets, larege grocery stores</article-title>
          <source>Rural Dev Perspect</source>
          <year>1998</year>
          <volume>13</volume>
          <fpage>19</fpage>
          <lpage>26</lpage>
        </element-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <mixed-citation publication-type="other">Jeffery RW, Baxter J, McGuire M, and Linde J. Are fast food restaurants an environmental risk factor for obesity? Int J Behav Nutr Phys Activ. 2006; 3(2).</mixed-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Glanz</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Sallis</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Saelens</surname>
              <given-names>BE</given-names>
            </name>
            <name>
              <surname>Frank</surname>
              <given-names>LD</given-names>
            </name>
          </person-group>
          <article-title>Nutrition environment measures survet in stores (NEMS-): development and evaluation</article-title>
          <source>Am J Prev Med</source>
          <year>2007</year>
          <volume>32</volume>
          <issue>4</issue>
          <fpage>282</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1016/j.amepre.2006.12.019</pub-id>
          <?supplied-pmid 17383559?>
          <pub-id pub-id-type="pmid">17383559</pub-id>
        </element-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Horowitz</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Colson</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Hebert</surname>
              <given-names>PL</given-names>
            </name>
            <name>
              <surname>Lancaster</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Barriers to buying healthy foods for people with diabetes: evidence of environmental disparities</article-title>
          <source>Am J Public Health</source>
          <year>2004</year>
          <volume>9</volume>
          <issue>94</issue>
          <fpage>1549</fpage>
          <lpage>54</lpage>
          <pub-id pub-id-type="doi">10.2105/AJPH.94.9.1549</pub-id>
          <pub-id pub-id-type="pmid">15333313</pub-id>
        </element-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jetter</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Cassady</surname>
              <given-names>DL</given-names>
            </name>
          </person-group>
          <article-title>The availability and cost of healthier food alternatives</article-title>
          <source>Am J Prev Med</source>
          <year>2006</year>
          <volume>30</volume>
          <issue>1</issue>
          <fpage>38</fpage>
          <lpage>44</lpage>
          <pub-id pub-id-type="doi">10.1016/j.amepre.2005.08.039</pub-id>
          <?supplied-pmid 16414422?>
          <pub-id pub-id-type="pmid">16414422</pub-id>
        </element-citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Larai</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Siega-Riz</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Kaufman</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>SJ</given-names>
            </name>
          </person-group>
          <article-title>Proximity of supermarkets is positively associated with diet quality index for pregnancy</article-title>
          <source>Prev Med</source>
          <year>2004</year>
          <volume>39</volume>
          <fpage>869</fpage>
          <lpage>75</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ypmed.2004.03.018</pub-id>
          <pub-id pub-id-type="pmid">15475018</pub-id>
        </element-citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liese</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Weis</surname>
              <given-names>KE</given-names>
            </name>
            <name>
              <surname>Pluto</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Lawson</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Food store types, availability, and cost of foods in a rural environment</article-title>
          <source>Am Diet Assoc</source>
          <year>2007</year>
          <volume>11</volume>
          <issue>107</issue>
          <fpage>1916</fpage>
          <lpage>23</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jada.2007.08.012</pub-id>
        </element-citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gonzales</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>MacLeod</surname>
              <given-names>KE</given-names>
            </name>
            <name>
              <surname>Winkleby</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Socioeconomic and food-related physical characteristics of the neighborhood environment are associated with body mass index</article-title>
          <source>J Epidemiol Commun Health</source>
          <year>2007</year>
          <volume>61</volume>
          <fpage>491</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1136/jech.2006.051680</pub-id>
        </element-citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Larson</surname>
              <given-names>NI</given-names>
            </name>
            <name>
              <surname>Story</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Nelson</surname>
              <given-names>MC</given-names>
            </name>
          </person-group>
          <article-title>Neighborhood environments: disparities in access to healthy foods in the U.S</article-title>
          <source>Am J Prev Med</source>
          <year>2009</year>
          <volume>36</volume>
          <issue>1</issue>
          <fpage>74</fpage>
          <lpage>81e10</lpage>
          <pub-id pub-id-type="doi">10.1016/j.amepre.2008.09.025</pub-id>
          <?supplied-pmid 18977112?>
          <pub-id pub-id-type="pmid">18977112</pub-id>
        </element-citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morland</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Diez Roux</surname>
              <given-names>AV</given-names>
            </name>
            <name>
              <surname>Wing</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Supermarkets, other food stores, and obesity: the atherosclerosis risk in communities study</article-title>
          <source>339</source>
          <year>2006</year>
          <volume>30</volume>
          <issue>4</issue>
          <fpage>333</fpage>
          <lpage>9</lpage>
        </element-citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morland</surname>
              <given-names>KB</given-names>
            </name>
            <name>
              <surname>Evenson</surname>
              <given-names>KR</given-names>
            </name>
          </person-group>
          <article-title>Obesity prevalence and the local food environment</article-title>
          <source>Health Place</source>
          <year>2009</year>
          <volume>15</volume>
          <issue>2</issue>
          <fpage>491</fpage>
          <lpage>495</lpage>
          <pub-id pub-id-type="doi">10.1016/j.healthplace.2008.09.004</pub-id>
          <?supplied-pmid 19022700?>
          <pub-id pub-id-type="pmid">19022700</pub-id>
        </element-citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Cubbin</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ahn</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Winkleby</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Changes in neighborhood food store environment, food behavior and body mass index, 1980-1990</article-title>
          <source>Public Health Nutr</source>
          <year>2008</year>
          <volume>11</volume>
          <issue>9</issue>
          <fpage>963</fpage>
          <lpage>70</lpage>
          <pub-id pub-id-type="doi">10.1017/S136898000700105X</pub-id>
          <?supplied-pmid 17894915?>
          <pub-id pub-id-type="pmid">17894915</pub-id>
        </element-citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zenk</surname>
              <given-names>SN</given-names>
            </name>
            <name>
              <surname>Schulz</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Hollis-Neely</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Campbell</surname>
              <given-names>RT</given-names>
            </name>
            <name>
              <surname>Holmes</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Watkins</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Fruit and vegetable intake in African Americans income store characteristics</article-title>
          <source>Am J Prev Med</source>
          <year>2005</year>
          <volume>29</volume>
          <fpage>1</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1016/j.amepre.2005.03.002</pub-id>
          <?supplied-pmid 15958245?>
          <pub-id pub-id-type="pmid">15958245</pub-id>
        </element-citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kehoe</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Leske</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Chylack</surname>
              <given-names>LT</given-names>
            </name>
          </person-group>
          <article-title>Comparing self-reported and physician-reported medical history</article-title>
          <source>Am J Epidemiol</source>
          <year>1994</year>
          <volume>139</volume>
          <fpage>813</fpage>
          <lpage>8</lpage>
          <?supplied-pmid 8178794?>
          <pub-id pub-id-type="pmid">8178794</pub-id>
        </element-citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <mixed-citation publication-type="other">Pierannunzi C, Hu S, Balluz L. A systematic review of publications assessing reliability and validity of the Behavioral Risk Factor Surveillance System (BRFSS), 2004–2011. BMC Med Res Methodol. 2013;13:49.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:4700569</identifier><datestamp>2016-01-06</datestamp><setSpec>bmcresnotes</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="http://jats.nlm.nih.gov/ns/archiving/1.0/ http://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Res Notes</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Res Notes</journal-id>
      <journal-title-group>
        <journal-title>BMC Research Notes</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1756-0500</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC4700569</article-id>
      <article-id pub-id-type="pmcid">PMC4700569</article-id>
      <article-id pub-id-type="pmc-uid">4700569</article-id>
      <article-id pub-id-type="publisher-id">1814</article-id>
      <article-id pub-id-type="doi">10.1186/s13104-015-1814-4</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Short Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Brief report on ecological momentary assessment: everyday states predict HIV prevention behaviors</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Cook</surname>
            <given-names>Paul F.</given-names>
          </name>
          <address>
            <email>paul.cook@ucdenver.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>McElwain</surname>
            <given-names>Catherine J.</given-names>
          </name>
          <address>
            <email>catherine.mcelwain@ucdenver.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bradley-Springer</surname>
            <given-names>Lucy A.</given-names>
          </name>
          <address>
            <email>lucy.bradley-springer@ucdenver.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <aff id="Aff1"><label/>University of Colorado College of Nursing, Campus Box C288-04, Aurora, CO 80045 USA </aff>
        <aff id="Aff2"><label/>University of Colorado School of Medicine, 12631 E. 17th Ave., Mail Stop 8204, Aurora, CO 80045 USA </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>4</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>4</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <volume>9</volume>
      <elocation-id>9</elocation-id>
      <history>
        <date date-type="received">
          <day>2</day>
          <month>7</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>17</day>
          <month>12</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© Cook et al. 2016</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Prevention behaviors help persons living with HIV (PLWH) to avoid transmitting HIV, and psychological variables have been found to predict HIV prevention behaviors. These variables have typically been measured using retrospective questionnaires about average psychological states over a period of time, which are likely to be biased by selective recall and interpretation. Measuring the same variables as momentary states, in the day-to-day context where they actually occur, may reveal different relationships to behavior.</p>
        </sec>
        <sec>
          <title>Findings</title>
          <p>21 PLWH completed daily surveys about momentary states and prevention behaviors. Brief, validated measures were used to assess control beliefs, mood, stress, coping, social support, stigma, knowledge, and motivation. We used multilevel models to predict prevention behaviors from momentary states the previous day, while controlling for the effect of multiple observations from the same person over time. Participants reported a moderate overall level of HIV prevention behaviors during the 6-month study. Although lapses in prevention were infrequent, there was room for improvement. Control beliefs, mood, and motivation had significant prospective effects on HIV prevention behaviors, <italic>r</italic>s = 0.07−0.21. Stress and coping had effects approaching significance.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>Some momentary states predicted prevention behaviors, providing partial support for the motivational model. This finding supports past research showing effects of momentary states on behavior, and advances the science by testing multiple predictors. High within-sample diversity strengthened generalizability, but the overall sample size was small and the findings require replication. Future research should continue to examine the everyday experiences of PLWH as influences on their behavior.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Ecological momentary assessment</kwd>
        <kwd>HIV</kwd>
        <kwd>Motivation</kwd>
        <kwd>Prevention</kwd>
        <kwd>Theory</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>© The Author(s) 2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Findings</title>
      <sec id="Sec2">
        <title>Background</title>
        <p>Preventing transmission of human immunodeficiency virus (HIV) is a major public health issue. Behaviors like abstinence, condom use, and/or using clean needles help persons living with HIV (PLWH) avoid transmitting HIV to others [<xref ref-type="bibr" rid="CR1">1</xref>]. Although many PLWH take precautions to avoid transmitting HIV, a significant number engage in behaviors that place others at risk: for instance, 26 % of anal sex occurrences for HIV-positive men who have sex with men (MSM) are unprotected even when their partner is HIV-seronegative or of unknown serostatus [<xref ref-type="bibr" rid="CR2">2</xref>]. In addition to reducing new infection rates, prevention using condoms benefits PLWH by reducing their chance of acquiring other sexually transmitted diseases or treatment-resistant strains of HIV.</p>
        <p>Although prevention programs for PLWH have been developed based on various theoretical models and many of these are efficacious [<xref ref-type="bibr" rid="CR3">3</xref>], the predictors of PLWH’s HIV prevention behaviors are still not well understood. One meta-analysis found that the strongest predictors of prevention behaviors among PLWH were belief in one’s control over situations and behaviors, positive mood, having information about HIV, being concerned about HIV, social support, ability to communicate about HIV, motivation to have safer sex, lack of perceived barriers to condom use, absence of avoidant coping strategies, and absence of psychotic symptoms or sexual compulsiveness [<xref ref-type="bibr" rid="CR4">4</xref>].</p>
        <sec id="Sec3">
          <title>Momentary states as predictors of HIV prevention behavior</title>
          <p>Many health phenomena including HIV prevention behaviors can be meaningfully understood as <italic>momentary states</italic> that have high levels of within-person variability and fluctuate during everyday life [<xref ref-type="bibr" rid="CR5">5</xref>–<xref ref-type="bibr" rid="CR7">7</xref>]. However, most research [<xref ref-type="bibr" rid="CR4">4</xref>] has measured variables retrospectively and in aggregate as <italic>traits</italic>, which are long-term and stable patterns of interpreting and responding to events. For example, researchers might ask PLWH about their typical mood or usual motivation over a period of days or weeks, then correlate these reports with similar aggregate measures of behavior. Studies have shown only moderate correlations between state and trait metrics of the same construct [<xref ref-type="bibr" rid="CR8">8</xref>], and state- versus trait-level measures of the same construct may predict behavior in different ways. This discrepancy results from cognitive biases in recall and interpretation, which link trait-level aggregate measures more closely to people’s ideas about themselves than to their actual experiences in the moment [<xref ref-type="bibr" rid="CR9">9</xref>].</p>
          <p>Ecological momentary assessment (EMA) methods evaluate momentary states and behaviors close to the time they actually occur [<xref ref-type="bibr" rid="CR10">10</xref>], and can reveal new insights about the predictors of HIV prevention behaviors. A few studies using EMA suggest that HIV prevention behaviors depend on momentary mood [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>] and contextual factors including alcohol use [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. Mustanski’s study [<xref ref-type="bibr" rid="CR12">12</xref>] included a specific comparison of the same variables measured as momentary states and as stable traits, and found that state-level emotion measures—in particular high anxiety and low positive affect—had stronger effects than trait-level emotion measures on HIV prevention behaviors.</p>
        </sec>
        <sec id="Sec4">
          <title>Theoretical model and goals of the current study</title>
          <p>This pilot study examined potential momentary state predictors of HIV prevention behaviors based on a motivational model in which five momentary state variables predict motivation for HIV prevention, which in turn predicts HIV prevention behaviors [<xref ref-type="bibr" rid="CR15">15</xref>]. The model was derived from leading theories and research on trait-level predictor variables: <italic>control beliefs</italic> and <italic>social support</italic> as in the Theory of Planned Behavior [TPB] [<xref ref-type="bibr" rid="CR16">16</xref>]; <italic>motivation</italic> as in the Information-Motivation-Behavioral Skills [IMB] Model [<xref ref-type="bibr" rid="CR17">17</xref>]; <italic>stress</italic>, <italic>coping</italic>, and <italic>mood</italic> as in Leventhal’s dual-process model of health behavior [<xref ref-type="bibr" rid="CR18">18</xref>]. We also tested <italic>HIV stigma</italic> as an additional variable inversely related to social support, and <italic>information</italic> as a variable that some authors have considered important (as in the IMB model) but that others have found to be unrelated to behavior at the trait level (as in the TPB). Crepaz and Marks’s meta-analysis [<xref ref-type="bibr" rid="CR4">4</xref>] also found trait-level effects for information, control beliefs, mood, social support, coping and motivation on prevention.</p>
          <p>Given that a single failure of HIV prevention behaviors can lead to transmission, and that these behaviors occur relatively infrequently in the context of everyday life, the future development of both theory and interventions depends on a better understanding of state-level predictors of behavior. Overall patterns tend to be easier to discern than the variables that predict specific incidents, but they are less useful when attempting to intervene [<xref ref-type="bibr" rid="CR19">19</xref>]. Although many of the predictor variables included in this pilot study are well supported by prior research, the element of <italic>time</italic> in state-level analyses introduces additional within-person variability and limits the applicability of trait-level theories in predicting state-level behaviors [<xref ref-type="bibr" rid="CR20">20</xref>]. Our goal in the current study was therefore to screen multiple predictors suggested by the motivational model of momentary state influences on behavior [<xref ref-type="bibr" rid="CR15">15</xref>], in order to guide further theory development and research.</p>
        </sec>
      </sec>
      <sec id="Sec5">
        <title>Methods</title>
        <p>Data were collected in a pilot study using daily electronic surveys with PLWH. The study’s methods are published elsewhere [<xref ref-type="bibr" rid="CR15">15</xref>], but summarized below.</p>
        <sec id="Sec6">
          <title>Participants</title>
          <p>This study was conducted in accordance with the Declaration of Helsinki and approved by the Colorado Multiple Institutional Review Board (protocol #06-0948). Participants were 21 PLWH recruited from an outpatient infectious disease practice in Denver, CO. Another 15 PLWH invited to the study declined to participate, primarily because of the time commitment required. Quota sampling was used to recruit a diverse sample in terms of race/ethnicity and gender, approximating the current demographics of the U. S. HIV epidemic [<xref ref-type="bibr" rid="CR15">15</xref>]. Participants’ demographic characteristics are summarized in Table <xref rid="Tab1" ref-type="table">1</xref>. Attrition was 33 % over 6 months, with some evidence that minority PLWH were more likely to refuse participation and also to leave the study early. Detailed recruitment, participation, and attrition data are published elsewhere [<xref ref-type="bibr" rid="CR15">15</xref>].<table-wrap id="Tab1"><label>Table 1</label><caption><p>Participant demographics (N = 21)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Characteristic</th><th align="left">M (SD) or frequency (%)</th></tr></thead><tbody><tr><td align="left">Age</td><td align="left">42.0 years (8.8 years)</td></tr><tr><td align="left">Gender</td><td align="left">15 men (71 %) 6 women (29 %)</td></tr><tr><td align="left">Race/ethnicity</td><td align="left">9 African–American (43 %) <break/>7 White non-Hispanic (33 %) <break/>5 White Hispanic (24 %)</td></tr><tr><td align="left">Sexual orientation</td><td align="left">14 MSM (67 %) <break/>1 heterosexual man (5 %) <break/>6 heterosexual women (28 %)</td></tr><tr><td align="left">Injection drug use</td><td align="left">3 injection drug users (14 %) <break/>18 non-IDU (86 %)</td></tr></tbody></table><table-wrap-foot><p>
<italic>MSM</italic> men who have sex with men, <italic>IDU</italic> injection drug user</p></table-wrap-foot></table-wrap></p>
        </sec>
        <sec id="Sec7">
          <title>Procedure</title>
          <p>Each participant was given a personal digital assistant (PDA) handheld computer and asked to complete a 5-minute questionnaire (26–46 questions, depending on skip logic) once daily at a time they had pre-selected. Participants completed the questionnaire once at the start of the study with a research assistant, to ensure that they understood the questions and the response choices. PDAs were password-protected. Daily responses were date- and time-stamped. Participants completed questionnaires on 72 % of study days (range 37–92 %) for an average of 4 months (range 1–8). A total of 2319 daily questionnaires were completed by 21 PLWH during the 6-month study. The original study was designed to identify the optimal duration of daily monitoring, so variability in the number of data points per individual was expected. PLWH returned to the clinic in person to download data from their PDA every 2 months. At these visits, PLWH also answered open-ended questions to identify any additional factors that they believed impacted their HIV prevention behaviors. Participants were paid $25 per visit, and were allowed to keep their PDAs if they participated for at least 2 months.</p>
        </sec>
        <sec id="Sec8">
          <title>Measures</title>
          <p>Daily PDA questionnaires were used to evaluate participants’ state-level control beliefs,<xref ref-type="fn" rid="Fn1">1</xref> mood, perceived social support, experience of stigma related to HIV, information received about HIV, stress experienced, coping strategies used, and motivation for HIV prevention. The <italic>stress</italic> scale had separate items for acute and chronic stressors. The <italic>coping</italic> scale included a multi-item scale on specific coping strategies used, plus a separate single item about whether the selected coping strategies successfully resolved the problem. The <italic>information</italic> scale was coded <italic>yes/no</italic> to correct for significant skew. <italic>Motivation</italic> was measured using a proxy variable, based on participants’ positive or negative evaluation of any new information received about HIV prevention. As a check on the comprehensiveness of the list of potential predictors, we asked participants at the end of the study to suggest any other important predictors of their HIV prevention behaviors that we did not consider.</p>
          <p>For the dependent variable in the analysis, participants answered questions about their HIV <italic>prevention behaviors</italic> (e.g., carrying condoms, avoiding risky situations). Items were taken from the Behavioral Risk Factor Screening Survey, a measure of prevention behaviors developed by the Centers for Disease Control and Prevention (CDC) and used for population-level epidemiological data collection [<xref ref-type="bibr" rid="CR21">21</xref>]. To improve reliability of the CDC’s original <italic>yes/no</italic> items, our 7-item measure substituted response choices from a well-validated tool for daily survey data collection, the Diary of Ambulatory Behavioral States [<xref ref-type="bibr" rid="CR22">22</xref>], that asked participants to rate their performance of each behavior on a 4-point scale (1 = <italic>NO!!</italic>, 2 = <italic>no??</italic>, 3 = <italic>yes??</italic>, 4 = <italic>YES!!</italic>). In a prior study, participants said that these response choices were easy to use and to understand, with the lower-case font and question marks indicating less certainty than the capital font and exclamation points, and items using this response scale showed good reliability [<xref ref-type="bibr" rid="CR15">15</xref>]. Because multiple prevention strategies may be used, any prevention is better than none, and using more strategies may be more effective, an average of the seven prevention items was used for analysis. Other items asked about HIV risk behaviors (e.g., unprotected sex, sharing needles), but these had too little variability for analysis because most PLWH reported no risk behaviors. The risk items also appeared to be more vulnerable to social desirability bias than the prevention items. Most measures were non-reactive with repeated use and all had adequate reliability. Additional measurement detail is provided in [<xref ref-type="bibr" rid="CR15">15</xref>].</p>
        </sec>
        <sec id="Sec9">
          <title>Data analysis</title>
          <p>Data were analyzed using a prospective prediction strategy in which each participant’s scores on each momentary state predictor variable were compared with their self-reported behavior at the subsequent data collection point, which was usually the next day. Multilevel models were used to correct for the intra-class correlation (<italic>ICC</italic>) of data points from the same participant, which in this study was high for most variables, <italic>ICC</italic>s = 0.64–0.93 [<xref ref-type="bibr" rid="CR15">15</xref>]. Nonparametric multilevel models were used to correct for skew in the dependent variable [<xref ref-type="bibr" rid="CR23">23</xref>]. In tests of within-person relationships, power for multilevel models is based on the number of observations adjusted for the <italic>ICC</italic>, rather than on the number of participants. With an average of 110 data points from each of 21 participants, power was .80 to detect moderate effects of <italic>r</italic> = 0.48 or larger at <italic>α</italic> = 0.05 [<xref ref-type="bibr" rid="CR24">24</xref>]. We first tested for the effect of time on prevention behaviors, then tested each potential predictor variable individually. Alpha was not corrected across models in this preliminary study.</p>
        </sec>
      </sec>
      <sec id="Sec10">
        <title>Results</title>
        <sec id="Sec11">
          <title>HIV prevention behaviors</title>
          <p>Participants reported an overall moderate level of HIV prevention behaviors during the study, <italic>M</italic> = 2.52 out of 4 possible points (<italic>SD</italic> = 0.45). The range of participant responses was slightly restricted, 1.22–3.11 on a 1–4 scale, meaning that no participant ever said they used <italic>no</italic> prevention strategies, and no participant ever endorsed <italic>all</italic> prevention items over a 6-month monitoring period. There was some negative skew in the prevention measure, skew/<italic>SE</italic><sub><italic>skew</italic></sub> = −2.63, meaning that participants gave higher scores on the prevention scale more often than they gave lower ones. We corrected for skew using nonparametric analyses. A multilevel model with time as a level-1 predictor and data clustered within individuals showed that individual participants’ prevention behaviors were relatively stable based on a flat linear trend, <italic>t</italic>(8) = −0.25, <italic>p</italic> = 0.81, <italic>β</italic> = −0.0001. Although relatively high ICCs for all momentary state variables mean that these states fluctuated only slightly over time, the ICC for prevention behavior was particularly stable at .93. This suggests that gaps in HIV prevention behaviors are relatively infrequent and therefore potentially hard to predict.</p>
          <p>In an interview question asked during the baseline assessment, 100 % of participants said they had adequate knowledge of how to prevent HIV transmission. Interestingly, 70 % (16/21) said they also had adequate knowledge of how to prevent HIV infection at the time they were originally infected with HIV. Neither current nor past self-reported knowledge of HIV prevention had any relationship to current HIV prevention behaviors as reported on the daily questionnaires, <italic>p</italic>s &gt; 0.58. Furthermore, there were no significant relationships between HIV prevention behaviors and any of PLWH’s momentary states measured on the <italic>same</italic> day, all <italic>p</italic>s &gt; 0.05.</p>
        </sec>
        <sec id="Sec12">
          <title>Prediction of HIV prevention behaviors from momentary states</title>
          <p>Table <xref rid="Tab2" ref-type="table">2</xref> shows the relationship of each momentary state variable to PLWH’s self-reported HIV prevention behaviors at the next daily data collection point. Scores on the prevention behaviors scale were significantly related to participants’ prior-day report of higher control beliefs, <italic>r</italic> = 0.10, <italic>p</italic> &lt; 0.001, better mood, <italic>r</italic> = 0.07, <italic>p</italic> = 0.004, and higher motivation based on a positive evaluation of new information received, <italic>r</italic> = 0.21, <italic>p</italic> = 0.05. Chronic stress, <italic>r</italic> = 0.07, <italic>p</italic> = 0.13, and successful coping, <italic>r</italic> = 0.06, <italic>p</italic> = 0.19, did not reach conventional levels for statistical significance as predictors of prevention behaviors, and their effect sizes were small. Furthermore, neither acute stress nor the number of coping strategies used predicted HIV prevention behaviors. Additionally, HIV-related stigma, social support, and information each failed to prospectively predict HIV prevention behaviors.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Predictors of PLWH’s self-reported HIV prevention behaviors</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Construct</th><th align="left">Effect on next-day prevention scale score</th></tr></thead><tbody><tr><td align="left">Control beliefs<sup>a</sup>
</td><td align="left">
<italic>T</italic> (1630) = 3.95, <italic>p</italic> &lt; 0.001, <italic>r</italic> = 0.10***</td></tr><tr><td align="left">Mood</td><td align="left">
<italic>T</italic> (1639) = 2.96, <italic>p</italic> = 0.004, <italic>r</italic> = 0.07**</td></tr><tr><td align="left">Stigma </td><td align="left">HIV stigma scale: <italic>T</italic> (1618) = −0.84, <italic>p</italic> = 0.40, <italic>r</italic> = 0.02</td></tr><tr><td align="left" rowspan="2">Stress</td><td align="left">Acute stress item: <italic>T</italic> (1622) = 0.08, <italic>p</italic> = 0.94, <italic>r</italic> &lt; 0.01 </td></tr><tr><td align="left">Chronic stress item: <italic>T</italic> (466) = −1.52, <italic>p</italic> = 0.13, <italic>r</italic> = 0.07</td></tr><tr><td align="left" rowspan="2">Coping</td><td align="left">Assessment of daily coping: <italic>T</italic> (231) = 0.86, <italic>p</italic> = 0.39, <italic>r</italic> = 0.06</td></tr><tr><td align="left">Successful resolution item: <italic>T</italic> (466) = −1.30, <italic>p</italic> = 0.19, <italic>r</italic> = 0.06</td></tr><tr><td align="left">Social support</td><td align="left">
<italic>T</italic> (1631) = −0.57, <italic>p</italic> = 0.57, <italic>r</italic> = 0.01</td></tr><tr><td align="left">HIV stigma</td><td align="left">
<italic>T</italic> (1631) = 0.06, <italic>p</italic> = 0.95, <italic>r</italic> &lt; 0.01</td></tr><tr><td align="left">Information source</td><td align="left">
<italic>T</italic> (85) = 0.80, <italic>p</italic> = 0.43, <italic>r</italic> = 0.09</td></tr><tr><td align="left">Motivation<sup>a</sup>
</td><td align="left">
<italic>T</italic> (85) = 1.97, <italic>p</italic> = 0.05, <italic>r</italic> = 0.21*</td></tr><tr><td align="left">Risk behaviors</td><td align="left">
<italic>T</italic> (1612) = 0.55, <italic>p</italic> = 0.58, <italic>r</italic> = 0.01</td></tr></tbody></table><table-wrap-foot><p>* <italic>p</italic> ≤ 0.05, ** <italic>p</italic> ≤ 0.01, *** <italic>p</italic> ≤ 0.001</p><p>
<sup>a</sup>Variable names clarified from Cook, et al., 2010: Control Beliefs were originally labeled “Negative Thoughts” which sounds misleadingly like Mood; and in the current study Motivation is a proxy variable as described in the text, labeled “Evaluation of Source” in the 2010 paper</p></table-wrap-foot></table-wrap></p>
        </sec>
        <sec id="Sec13">
          <title>Additional possible predictors identified by participants</title>
          <p>In addition to the momentary state variables included in daily surveys, participants said that health context variables were important for their HIV prevention behaviors. For instance, participants said they were more likely to take steps for prevention when they were feeling well, but that they also might be more likely to encounter risky situations. Participants suggested that the researchers should ask further questions about medication use, side effects, and stigma experiences with health care providers, especially new providers. Despite a lack of significant findings on the coping scale, participants’ feedback indicated that this set of items was interesting and relevant to their daily lives: some participants stated that the questionnaire made them more aware of how stress impacted their daily moods and reactions, while others said it made them more aware of their own coping strategies.</p>
        </sec>
      </sec>
      <sec id="Sec14">
        <title>Discussion</title>
        <p>PLWH reported relatively high and consistent prevention behaviors over the course of this study, and these did not correlate with momentary states measured on the same day. However, momentary states did prospectively predict HIV prevention behaviors the next day. Consistent with research on trait-level predictors of HIV prevention behaviors [<xref ref-type="bibr" rid="CR25">25</xref>], this included significant effects for control beliefs, mood, and motivation. Consistent with theory [<xref ref-type="bibr" rid="CR15">15</xref>] and prior research [<xref ref-type="bibr" rid="CR25">25</xref>], new information did not predict prevention behaviors. Contrary to theory [<xref ref-type="bibr" rid="CR15">15</xref>], neither social support nor stigma predicted prevention behaviors; this was contrary to past research at the trait level showing a significant effect of social support [<xref ref-type="bibr" rid="CR25">25</xref>]. Stress and coping were each measured with two subscales, which showed nonsignificant effects. These predictor variables have each been found significant at the trait level [<xref ref-type="bibr" rid="CR25">25</xref>], and their failure to predict behaviors in the current study may have been due to sample size or measurement limitations. Based on these considerations, the relevance of stress and coping at the momentary state level remains unclear.</p>
        <p>The current study confirms previous findings about the state-level effects of mood [<xref ref-type="bibr" rid="CR12">12</xref>], supports other state-level predictors that have previously been tested only as traits, and advances the science of momentary state influences on behavior by testing multiple predictors in an integrated theory of state-level influences on behavior. Prior studies have examined only one or a few state-level predictors and had limited theoretical grounding. Although not all variables in the theoretical model underlying this study were confirmed to predict HIV prevention behaviors, the model received partial support.</p>
        <p>The current study tested whether momentary states <italic>prospectively</italic> predicted HIV prevention behaviors on the next day, which is a slightly different strategy from many EMA studies that look at relationships between momentary states and behaviors measured concurrently—e.g., [<xref ref-type="bibr" rid="CR26">26</xref>]. Even though the next day’s prevention behaviors were more distant in time from the assessment of momentary states, our primary objective was to establish potential causation between predictor variables and prevention behaviors when both were measured as state-level constructs, a goal that was supported by the prospective daily data analysis strategy employed. Additionally, most prevention behaviors are actions taken prospectively (e.g., carrying condoms), so it may be most useful to focus on variables that predict next-day prevention behaviors as early warning signs that can be used to direct needed interventions before lapses in prevention occur.</p>
        <sec id="Sec15">
          <title>Limitations and directions for future research</title>
          <p>Because the current findings are based on a small sample, they may not generalize to all PLWH, and even predictors with weak effects might still be appropriate for further research. Although this study used quota sampling to recruit PLWH who were demographically similar to the U.S. HIV epidemic as a whole, results still may generalize primarily to White PLWH because of the higher attrition among minority PLWH. All data provided by minority participants were included in the analysis, but the total number of data points from this group was smaller. Statistical power was adequate to detect moderate effects based on over 2300 daily questionnaires completed by participants, but high between-participant variability in a small sample might have contributed to weaker than expected effects. The number of participants is comparable to the small <italic>N</italic> in some prior EMA studies of PLWH [<xref ref-type="bibr" rid="CR27">27</xref>], although at least two larger-scale studies have been conducted on individual risk factors: alcohol [<xref ref-type="bibr" rid="CR13">13</xref>] and mood [<xref ref-type="bibr" rid="CR12">12</xref>]. Statistical models with multiple simultaneous predictors were not used in the current analysis because of the high risk of sample-dependent results and a potential lack of generalizability when data-driven decision rules are used with a small sample. Future research should (a) include a larger number of participants; (b) collect many daily data points per participant to capture state-level variability; (c) include multiple predictors of prevention behaviors in a single multiple-variable statistical model to test their relative importance; and (d) test predictors such as alcohol and mood that are well supported by prior research as well as those identified as potentially meaningful in small-scale pilot work such as the current study.</p>
          <p>To partially address the limitations of significance testing with a small sample, we reported effect sizes (correlation coefficients) for all analyses to quantify the relative importance of each studied predictor variable. Additionally, we asked participants open-ended questions to identify other variables that might be important to study. These questions revealed that PLWH saw healthcare variables including adherence, side effects, and provider relationships as potentially important for future research of this type. In addition, PLWH emphasized the importance of coping as an important factor in HIV prevention behaviors; even though this study showed small and nonsignificant effects of stress and coping on prevention behaviors, based on the findings of other studies [<xref ref-type="bibr" rid="CR4">4</xref>] and participants’ suggestions in the current study these may still be potentially important variables for future research. Because the receipt of new information showed no relationship to prevention, but motivation for prevention after receiving new information was a better predictor, future studies should examine motivation separately from whether participants received any new information about HIV.</p>
        </sec>
      </sec>
      <sec id="Sec16">
        <title>Conclusions</title>
        <p>Momentary states are under-studied, proximal variables that appear to predict HIV prevention behaviors among PLWH, and that may have different effects from trait-level predictors because they are less affected by biases associated with recall and interpretation. Despite a small sample size, our study gathered a large amount of data from individual participants and examined a range of predictor variables in order to enhance the limited literature on momentary state predictors of PLWH’s prevention behaviors. Further, we used a prospective analysis strategy examining the effects of momentary states on behavior at the next daily data collection point, a novel method that strengthens causal interpretations. Additional research using EMA is needed to clarify the momentary states that are most conducive to HIV prevention behaviors.</p>
      </sec>
    </sec>
  </body>
  <back>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>EMA</term>
          <def>
            <p>ecological momentary assessment</p>
          </def>
        </def-item>
        <def-item>
          <term>HIV</term>
          <def>
            <p>human immunodeficiency virus</p>
          </def>
        </def-item>
        <def-item>
          <term>ICC</term>
          <def>
            <p>intra-class correlation coefficient</p>
          </def>
        </def-item>
        <def-item>
          <term>IDU</term>
          <def>
            <p>injection drug user</p>
          </def>
        </def-item>
        <def-item>
          <term>IMB</term>
          <def>
            <p>information-motivation-behavioral skills model</p>
          </def>
        </def-item>
        <def-item>
          <term>MSM</term>
          <def>
            <p>men who have sex with men</p>
          </def>
        </def-item>
        <def-item>
          <term>PDA</term>
          <def>
            <p>personal digital assistant device</p>
          </def>
        </def-item>
        <def-item>
          <term>PLWH</term>
          <def>
            <p>persons living with HIV</p>
          </def>
        </def-item>
        <def-item>
          <term>TPB</term>
          <def>
            <p>theory of planned behavior</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <fn-group>
      <fn id="Fn1">
        <label>1</label>
        <p>Although this variable was labeled “negative thoughts” in our initial methods paper, it is more accurately described as “control beliefs” based on item content. This label is also more useful for placing current findings in the context of prior research.</p>
      </fn>
    </fn-group>
    <ack>
      <title>Authors’ contributions</title>
      <p>PFC and LBA designed the study. PFC and CJM carried out the data collection and completed the statistical analyses. CJM and LBA contributed clinical interpretation during data analysis and writing. PFC drafted the manuscript, with editorial assistance from LBA. All authors read and approved the final manuscript.</p>
      <sec id="FPar1">
        <title>Acknowledgements</title>
        <p>This research was supported by a developmental award from the Colorado Center for AIDS Research, NIH Grant #P30 AI054907-02, with additional support from the UCDHSC General Clinical Research Center, NIH Grant #M01 RR00051. The authors also wish to thank Dr. Elizabeth Connick, Dr. Steven Johnson, and Abigail Lord for consultation on research and clinical topics, the staff and patients at the University of Colorado Infectious Disease Group Practice for their support of the study, and Dr. Samantha MaWhinney for statistical consultation during study design.</p>
      </sec>
      <sec id="FPar2">
        <title>Competing interests</title>
        <p>In the past 3 years, author PFC has received grant support from Merck &amp; Co. Inc. and from the Colorado Health Foundation, and has served as a consultant for Takeda Inc., the Optometric Glaucoma Society, Medical Simulation Corporation, Competency and Credentialing Institute Inc., and Academic Impressions Inc. In addition, authors PFC and LBS have each received grant support from several U.S. Federal agencies: HRSA, CDC, SAMHSA, and/or NIH.</p>
      </sec>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <collab>Centers for Disease Control and Prevention (CDC)</collab>
          </person-group>
          <article-title>Advancing HIV prevention: new strategies for a changing epidemic-United States, 2003</article-title>
          <source>Morbid Mortal Wkly Rep</source>
          <year>2003</year>
          <volume>52</volume>
          <issue>15</issue>
          <fpage>1</fpage>
          <lpage>4</lpage>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Crepaz</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Marks</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Liau</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mullins</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Aupont</surname>
              <given-names>LW</given-names>
            </name>
            <name>
              <surname>Marshall</surname>
              <given-names>KJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Prevalence of unprotected anal intercourse among HIV-diagnosed MSM in the United States: a meta-analysis</article-title>
          <source>AIDS</source>
          <year>2009</year>
          <volume>23</volume>
          <fpage>1617</fpage>
          <lpage>1629</lpage>
          <pub-id pub-id-type="doi">10.1097/QAD.0b013e32832effae</pub-id>
          <?supplied-pmid 19584704?>
          <pub-id pub-id-type="pmid">19584704</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Crepaz</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Lyles</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Wolitski</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Passin</surname>
              <given-names>WF</given-names>
            </name>
            <name>
              <surname>Rama</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Herbst</surname>
              <given-names>JH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Do prevention interventions reduce HIV risk behaviours among people living with HIV? A meta-analytic review of controlled trials</article-title>
          <source>AIDS</source>
          <year>2006</year>
          <volume>20</volume>
          <fpage>143</fpage>
          <lpage>157</lpage>
          <pub-id pub-id-type="doi">10.1097/01.aids.0000196166.48518.a0</pub-id>
          <?supplied-pmid 16511407?>
          <pub-id pub-id-type="pmid">16511407</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Crepaz</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Marks</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Towards an understanding of sexual risk behavior in people living with HIV: a review of social, psychological, and medical findings</article-title>
          <source>AIDS</source>
          <year>2002</year>
          <volume>25</volume>
          <fpage>135</fpage>
          <lpage>149</lpage>
          <pub-id pub-id-type="doi">10.1097/00002030-200201250-00002</pub-id>
          <pub-id pub-id-type="pmid">11807297</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barta</surname>
              <given-names>WD</given-names>
            </name>
            <name>
              <surname>Kiene</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Tennen</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Abu-Hasaballah</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Ferrer</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>The idiographic study of inconsistent condom use behavior of persons living with HIV</article-title>
          <source>AIDS Care</source>
          <year>2007</year>
          <volume>19</volume>
          <fpage>1058</fpage>
          <lpage>1064</lpage>
          <pub-id pub-id-type="doi">10.1080/09540120701294252</pub-id>
          <?supplied-pmid 17852005?>
          <pub-id pub-id-type="pmid">17852005</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Courvoisier</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Eid</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nussbeck</surname>
              <given-names>FW</given-names>
            </name>
          </person-group>
          <article-title>Mixture distribution latent state-trait analysis: basic ideas and applications</article-title>
          <source>Psychol Methods</source>
          <year>2007</year>
          <volume>12</volume>
          <fpage>80</fpage>
          <lpage>104</lpage>
          <pub-id pub-id-type="doi">10.1037/1082-989X.12.1.80</pub-id>
          <?supplied-pmid 17402813?>
          <pub-id pub-id-type="pmid">17402813</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fridhandler</surname>
              <given-names>BM</given-names>
            </name>
          </person-group>
          <article-title>Conceptual note on state, trait, and the state–trait distinction</article-title>
          <source>J Pers Social Psychol</source>
          <year>1986</year>
          <volume>50</volume>
          <fpage>169</fpage>
          <lpage>174</lpage>
          <pub-id pub-id-type="doi">10.1037/0022-3514.50.1.169</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ptacek</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Pierce</surname>
              <given-names>GR</given-names>
            </name>
            <name>
              <surname>Thompson</surname>
              <given-names>EL</given-names>
            </name>
          </person-group>
          <article-title>Finding evidence of dispositional coping</article-title>
          <source>J Res Personal</source>
          <year>2006</year>
          <volume>40</volume>
          <fpage>1137</fpage>
          <lpage>1151</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jrp.2005.12.001</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Schwarz</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Mehl</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Conner</surname>
              <given-names>TS</given-names>
            </name>
          </person-group>
          <article-title>Why researchers should think “real-time”: a cognitive rationale</article-title>
          <source>Handbook of research methods for studying daily life</source>
          <year>2012</year>
          <publisher-loc>New York</publisher-loc>
          <publisher-name>Guilford</publisher-name>
          <fpage>22</fpage>
          <lpage>42</lpage>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tennen</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Affleck</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Coyne</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Larsen</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>DeLongis</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Paper and plastic in daily diary research: comment on Green, Rafaeli, Bolger, Shrout, and Reis (2006)</article-title>
          <source>Psychol Methods</source>
          <year>2006</year>
          <volume>11</volume>
          <fpage>112</fpage>
          <lpage>118</lpage>
          <pub-id pub-id-type="doi">10.1037/1082-989X.11.1.112</pub-id>
          <?supplied-pmid 16594771?>
          <pub-id pub-id-type="pmid">16594771</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barta</surname>
              <given-names>WD</given-names>
            </name>
            <name>
              <surname>Tennen</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kiene</surname>
              <given-names>SM</given-names>
            </name>
          </person-group>
          <article-title>Alcohol-involved sexual risk behavior among heavy drinkers living with HIV/AIDS: negative affect, self-efficay, and sexual craving</article-title>
          <source>Psychol Addict Behav</source>
          <year>2010</year>
          <volume>24</volume>
          <fpage>563</fpage>
          <lpage>570</lpage>
          <pub-id pub-id-type="doi">10.1037/a0021414</pub-id>
          <?supplied-pmid 21198219?>
          <pub-id pub-id-type="pmid">21198219</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mustanski</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>The influence of state and trait affect on HIV risk behaviors: a daily diary study of MSM</article-title>
          <source>Health Psychol</source>
          <year>2007</year>
          <volume>26</volume>
          <fpage>618</fpage>
          <lpage>626</lpage>
          <pub-id pub-id-type="doi">10.1037/0278-6133.26.5.618</pub-id>
          <?supplied-pmid 17845113?>
          <pub-id pub-id-type="pmid">17845113</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barta</surname>
              <given-names>WD</given-names>
            </name>
            <name>
              <surname>Portnoy</surname>
              <given-names>DB</given-names>
            </name>
            <name>
              <surname>Kiene</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Tennen</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Abu-Hasaballah</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Ferrer</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>A daily process investigation of alcohol-involved sexual risk behavior among economically disadvantaged problem drinkers living with HIV/AIDS</article-title>
          <source>AIDS Behav</source>
          <year>2008</year>
          <volume>12</volume>
          <fpage>729</fpage>
          <lpage>740</lpage>
          <pub-id pub-id-type="doi">10.1007/s10461-007-9342-4</pub-id>
          <?supplied-pmid 18071894?>
          <pub-id pub-id-type="pmid">18071894</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mckirnan</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Ostrow</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Hope</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Sex, drugs and escape: a psychological model of HIV-risk sexual behaviors</article-title>
          <source>AIDS Care</source>
          <year>1996</year>
          <volume>8</volume>
          <fpage>655</fpage>
          <lpage>670</lpage>
          <pub-id pub-id-type="doi">10.1080/09540129650125371</pub-id>
          <?supplied-pmid 8993716?>
          <pub-id pub-id-type="pmid">8993716</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cook</surname>
              <given-names>PF</given-names>
            </name>
            <name>
              <surname>McElwain</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Bradley-Springer</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Feasibility of a PDA diary method to study daily experiences in persons living with HIV</article-title>
          <source>Res Nurs Health</source>
          <year>2010</year>
          <volume>33</volume>
          <fpage>221</fpage>
          <lpage>234</lpage>
          <pub-id pub-id-type="doi">10.1002/nur.20381</pub-id>
          <?supplied-pmid 20499392?>
          <pub-id pub-id-type="pmid">20499392</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ajzen</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Fishbein</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Questions raised by a reasoned action approach: comment on Ogden (2003)</article-title>
          <source>Health Psychol</source>
          <year>2004</year>
          <volume>23</volume>
          <fpage>431</fpage>
          <lpage>434</lpage>
          <pub-id pub-id-type="doi">10.1037/0278-6133.23.4.431</pub-id>
          <?supplied-pmid 15264981?>
          <pub-id pub-id-type="pmid">15264981</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fisher</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Fisher</surname>
              <given-names>WA</given-names>
            </name>
            <name>
              <surname>Amico</surname>
              <given-names>KR</given-names>
            </name>
            <name>
              <surname>Harman</surname>
              <given-names>JJ</given-names>
            </name>
          </person-group>
          <article-title>An information-motivation-behavioral skills model of adherence to antiretroviral therapy</article-title>
          <source>Health Psychol</source>
          <year>2006</year>
          <volume>25</volume>
          <fpage>462</fpage>
          <lpage>473</lpage>
          <pub-id pub-id-type="doi">10.1037/0278-6133.25.4.462</pub-id>
          <?supplied-pmid 16846321?>
          <pub-id pub-id-type="pmid">16846321</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Teel</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Meek</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>McNamara</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Watson</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Perspectives unifying symptom interpretation</article-title>
          <source>Image J Nurs Sch</source>
          <year>1997</year>
          <volume>29</volume>
          <issue>2</issue>
          <fpage>175</fpage>
          <lpage>181</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1547-5069.1997.tb01553.x</pub-id>
          <?supplied-pmid 9212516?>
          <pub-id pub-id-type="pmid">9212516</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <mixed-citation publication-type="other">Silver N. The signal and the noise. 2013.</mixed-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Riley</surname>
              <given-names>WT</given-names>
            </name>
            <name>
              <surname>Rivera</surname>
              <given-names>DE</given-names>
            </name>
            <name>
              <surname>Atienza</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Nilsen</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Allison</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Mermelstein</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Health behavior models in the age of mobile interventions: are our theories up to the task?</article-title>
          <source>Transl Behav Med</source>
          <year>2011</year>
          <volume>1</volume>
          <issue>1</issue>
          <fpage>53</fpage>
          <lpage>71</lpage>
          <pub-id pub-id-type="doi">10.1007/s13142-011-0021-7</pub-id>
          <?supplied-pmid 21796270?>
          <pub-id pub-id-type="pmid">21796270</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <mixed-citation publication-type="other">Centers for Disease Control and Prevention (CDC). Behavioral risk factor surveillance system. Retrieved 8 Aug 2006 from <ext-link ext-link-type="uri" xlink:href="http://www.cdcgov/brfss/2006">http://www.cdcgov/brfss/2006</ext-link>.</mixed-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Kamarck</surname>
              <given-names>TW</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Krantz</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Baum</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>The diary of ambulatory behavioral states: a new approach to the assessment of psychosocial influences on ambulatory cardiovascular activity</article-title>
          <source>Technology and methods in behavioral medicine</source>
          <year>1998</year>
          <publisher-loc>Mahwah</publisher-loc>
          <publisher-name>Erlbaum</publisher-name>
          <fpage>163</fpage>
          <lpage>185</lpage>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <mixed-citation publication-type="other">HLM 6: Hierarchical linear and nonlinear modeling [computer program]. Lincolnwood: Scientific Software International; 2006.</mixed-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maas</surname>
              <given-names>CJM</given-names>
            </name>
            <name>
              <surname>Hox</surname>
              <given-names>JJ</given-names>
            </name>
          </person-group>
          <article-title>Sufficient sample sizes for multilevel modeling</article-title>
          <source>Methodology</source>
          <year>2007</year>
          <volume>1</volume>
          <fpage>86</fpage>
          <lpage>92</lpage>
          <pub-id pub-id-type="doi">10.1027/1614-2241.1.3.86</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Crepaz</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Hart</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Marks</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Highly active antiretroviral therapy and sexual risk behavior: a meta-analytic review</article-title>
          <source>J Am Med Assoc</source>
          <year>2004</year>
          <volume>292</volume>
          <fpage>224</fpage>
          <lpage>236</lpage>
          <pub-id pub-id-type="doi">10.1001/jama.292.2.224</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Reis</surname>
              <given-names>HT</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Mehl</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Conner</surname>
              <given-names>TS</given-names>
            </name>
          </person-group>
          <article-title>Why researchers should think “real-world”: A conceptual rationale</article-title>
          <source>Handbook of research methods for studying daily life</source>
          <year>2012</year>
          <publisher-loc>New York</publisher-loc>
          <publisher-name>Guilford</publisher-name>
          <fpage>3</fpage>
          <lpage>21</lpage>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Janda</surname>
              <given-names>LH</given-names>
            </name>
            <name>
              <surname>Markowski</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Derlega</surname>
              <given-names>VJ</given-names>
            </name>
            <name>
              <surname>Nezlek</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>McCain</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Daily events and mood state among individuals living with HIV: examination of the within-persons approach to data collection using daily diary methodology</article-title>
          <source>J Nurs Meas</source>
          <year>2006</year>
          <volume>14</volume>
          <fpage>116</fpage>
          <lpage>128</lpage>
          <pub-id pub-id-type="doi">10.1891/jnm-v14i2a004</pub-id>
          <?supplied-pmid 17086784?>
          <pub-id pub-id-type="pmid">17086784</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:4700570</identifier><datestamp>2016-01-06</datestamp><setSpec>malarj</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="http://jats.nlm.nih.gov/ns/archiving/1.0/ http://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Malar J</journal-id>
      <journal-id journal-id-type="iso-abbrev">Malar. J</journal-id>
      <journal-title-group>
        <journal-title>Malaria Journal</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1475-2875</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC4700570</article-id>
      <article-id pub-id-type="pmcid">PMC4700570</article-id>
      <article-id pub-id-type="pmc-uid">4700570</article-id>
      <article-id pub-id-type="publisher-id">1044</article-id>
      <article-id pub-id-type="doi">10.1186/s12936-015-1044-1</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Spatially variable risk factors for malaria in a geographically heterogeneous landscape, western Kenya: an explorative study</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7144-7318</contrib-id>
          <name>
            <surname>Homan</surname>
            <given-names>Tobias</given-names>
          </name>
          <address>
            <email>tobiassolarmal@gmail.com</email>
            <email>tobias.homan@wur.nl</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Maire</surname>
            <given-names>Nicolas</given-names>
          </name>
          <address>
            <email>nicolas.maire@unibas.ch</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hiscox</surname>
            <given-names>Alexandra</given-names>
          </name>
          <address>
            <email>alexandra.hiscox@wur.nl</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Di Pasquale</surname>
            <given-names>Aurelio</given-names>
          </name>
          <address>
            <email>aurelio.dipasquale@unibas.ch</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kiche</surname>
            <given-names>Ibrahim</given-names>
          </name>
          <address>
            <email>ibrahimkiche@yahoo.com</email>
          </address>
          <xref ref-type="aff" rid="Aff4"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Onoka</surname>
            <given-names>Kelvin</given-names>
          </name>
          <address>
            <email>kaonoka@yahoo.com</email>
          </address>
          <xref ref-type="aff" rid="Aff4"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mweresa</surname>
            <given-names>Collins</given-names>
          </name>
          <address>
            <email>cmweresa@icipe.org</email>
          </address>
          <xref ref-type="aff" rid="Aff4"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mukabana</surname>
            <given-names>Wolfgang R.</given-names>
          </name>
          <address>
            <email>rmukabana@yahoo.co.uk</email>
          </address>
          <xref ref-type="aff" rid="Aff5"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ross</surname>
            <given-names>Amanda</given-names>
          </name>
          <address>
            <email>amanda.ross@unibas.ch</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Smith</surname>
            <given-names>Thomas A.</given-names>
          </name>
          <address>
            <email>thomas-a.smith@unibas.ch</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Takken</surname>
            <given-names>Willem</given-names>
          </name>
          <address>
            <email>willem.takken@wur.nl</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <aff id="Aff1"><label/>Laboratory of Entomology, Wageningen University and Research Centre, Wageningen, The Netherlands </aff>
        <aff id="Aff2"><label/>Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland </aff>
        <aff id="Aff3"><label/>University of Basel, Basel, Switzerland </aff>
        <aff id="Aff4"><label/>Department of Medical Entomology, International Centre of Insect Physiology and Ecology, Nairobi, Kenya </aff>
        <aff id="Aff5"><label/>School of Biological Sciences, University of Nairobi, Nairobi, Kenya </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>4</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>4</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <volume>15</volume>
      <elocation-id>1</elocation-id>
      <history>
        <date date-type="received">
          <day>17</day>
          <month>7</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>9</day>
          <month>12</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© Homan et al. 2015</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Large reductions in malaria transmission and mortality have been achieved over the last decade, and this has mainly been attributed to the scale-up of long-lasting insecticidal bed nets and indoor residual spraying with insecticides. Despite these gains considerable residual, spatially heterogeneous, transmission remains. To reduce transmission in these foci, researchers need to consider the local demographical, environmental and social context, and design an appropriate set of interventions. Exploring spatially variable risk factors for malaria can give insight into which human and environmental characteristics play important roles in sustaining malaria transmission.</p>
        </sec>
        <sec>
          <title>Methods</title>
          <p>On Rusinga Island, western Kenya, malaria infection was tested by rapid diagnostic tests during two cross-sectional surveys conducted 3 months apart in 3632 individuals from 790 households. For all households demographic data were collected by means of questionnaires. Environmental variables were derived using Quickbird satellite images. Analyses were performed on 81 project clusters constructed by a traveling salesman algorithm, each containing 50–51 households. A standard linear regression model was fitted containing multiple variables to determine how much of the spatial variation in malaria prevalence could be explained by the demographic and environmental data. Subsequently, a geographically-weighted regression (GWR) was performed assuming non-stationarity of risk factors. Special attention was taken to investigate the effect of residual spatial autocorrelation and local multicollinearity.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>Combining the data from both surveys, overall malaria prevalence was 24 %. Scan statistics revealed two clusters which had significantly elevated numbers of malaria cases compared to the background prevalence across the rest of the study area. A multivariable linear model including environmental and household factors revealed that higher socioeconomic status, outdoor occupation and population density were associated with increased malaria risk. The local GWR model improved the model fit considerably and the relationship of malaria with risk factors was found to vary spatially over the island; in different areas of the island socio-economic status, outdoor occupation and population density were found to be positively or negatively associated with malaria prevalence.</p>
        </sec>
        <sec>
          <title>Discussion</title>
          <p>Identification of risk factors for malaria that vary geographically can provide insight into the local epidemiology of malaria. Examining spatially variable relationships can be a helpful tool in exploring which set of targeted interventions could locally be implemented. Supplementary malaria control may be directed at areas, which are identified as at risk. For instance, areas with many people that work outdoors at night may need more focus in terms of vector control.</p>
          <p>Trial registration: Trialregister.nl NTR3496—SolarMal, registered on 20 June 2012</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Malaria</kwd>
        <kwd>Spatial heterogeneity</kwd>
        <kwd>Geographically weighted regression</kwd>
        <kwd>Spatially variable risk factors</kwd>
        <kwd>Kenya</kwd>
        <kwd>Socio-economic status</kwd>
        <kwd>Occupation</kwd>
        <kwd>Population density</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution>COmON Foundation</institution>
          </funding-source>
        </award-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100005688</institution-id>
              <institution>Gottfried und Julia Bangerter-Rhyner-Stiftung (CH)</institution>
            </institution-wrap>
          </funding-source>
        </award-group>
        <award-group>
          <funding-source>
            <institution>Novartis Foundation for Medical Biological Research project</institution>
          </funding-source>
        </award-group>
      </funding-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>© The Author(s) 2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Background</title>
      <p>Across sub-Saharan Africa, malaria remains one of the leading causes of morbidity and mortality with up to 200 million symptomatic cases every year [<xref ref-type="bibr" rid="CR1">1</xref>]. In Kenya, 75 % of the population is at risk of malaria infection, but due to intensified control efforts the number of malaria cases has decreased two fold in one decade to well under five million annually. Interventions which have contributed to the decline of malaria transmission and mortality are the use of insecticide-treated nets (ITNs), long-lasting insecticidal nets (LLINs), indoor residual spraying (IRS) and treatment of patients with artemisinin-based combination therapy (ACT) [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. The goal of WHO and Roll Back Malaria (RBM) is to continue the efforts to fight malaria until local elimination and eventually eradication is achieved [<xref ref-type="bibr" rid="CR4">4</xref>–<xref ref-type="bibr" rid="CR6">6</xref>].</p>
      <p>Since large successes have been realized and many areas have moved into a pre-elimination phase, the epidemiology of malaria is changing [<xref ref-type="bibr" rid="CR7">7</xref>]. Although malaria transmission has always been geographically heterogeneous, under pressure of current interventions the spatial heterogeneity of malaria becomes more pronounced, typically characterized by areas or clusters of households that persistently have higher proportions of infected individuals compared with the population average. In order to aid the malaria elimination phase, a better understanding of the epidemiology of malaria, considering geographical heterogeneity, is needed [<xref ref-type="bibr" rid="CR8">8</xref>]. Heterogeneity in malaria transmission is not a new phenomenon [<xref ref-type="bibr" rid="CR9">9</xref>], but because of improved research methods and the enhanced capacity of information technology, recent studies have more frequently shed light on the smaller-scale geographical heterogeneity of malaria [<xref ref-type="bibr" rid="CR10">10</xref>–<xref ref-type="bibr" rid="CR12">12</xref>]. Studies suggest that factors associated with the spatial clustering of malaria include: house structure, human behaviour, environmental, geographical and demographical variables [<xref ref-type="bibr" rid="CR13">13</xref>–<xref ref-type="bibr" rid="CR17">17</xref>].</p>
      <p>Many studies have investigated clustering and the spatial heterogeneity of malaria risk [<xref ref-type="bibr" rid="CR18">18</xref>–<xref ref-type="bibr" rid="CR21">21</xref>] but fewer studies have investigated ways in which relationships of factors influencing this heterogeneity vary over space. Lessons can be learnt from studies that investigated the geographically varying nature of factors on agricultural [<xref ref-type="bibr" rid="CR22">22</xref>] and environmental [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>] outcomes. Relatively few studies have addressed the questions of causes of spatial heterogeneity in health outcomes [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>] like malaria [<xref ref-type="bibr" rid="CR27">27</xref>–<xref ref-type="bibr" rid="CR30">30</xref>].</p>
      <p>In the present study, it is explored whether risk factors for malaria also vary over space. Household and environmental risk factors contributing to malaria prevalence were studied by means of a frequentist non-spatial risk model and clusters of elevated malaria risk were identified through scan statistics. The final aim of this study was to investigate the spatial heterogeneity in relationships between malaria prevalence and associated risk factors by Geographically Weighted Regression (GWR). The added value of using this geostatistical model is explored, and the advantage compared to a standard linear regression model is evaluated.</p>
      <p>The study is embedded as part of a baseline study in a large malaria vector control trial (SolarMal) on Rusinga Island, western Kenya [<xref ref-type="bibr" rid="CR31">31</xref>]. The SolarMal trial aims to reduce malaria transmission on Rusinga Island by mass trapping of malaria vectors with odour-baited traps (OBTs), which contain a blend of organic volatiles that mimic a human odour [<xref ref-type="bibr" rid="CR32">32</xref>]. Through daily removal trapping the project aims to reduce malaria vector populations and eventually decrease malaria transmission. The analysis of spatial heterogeneity of risk factors for malaria can give a better understanding of malaria epidemiology and can be of value for programme managers who want explore targeting interventions to specific geographical locations.</p>
    </sec>
    <sec id="Sec2">
      <title>Methods</title>
      <sec id="Sec3">
        <title>Study site and population</title>
        <p>Rusinga Island is located in Lake Victoria off the shore of western Kenya (between 0°20′51.53″–0°26′33.73″ South, and 34°13′43.19″–34°07′23.78″ East). The island is located in Mbita sub-county, under the administration of Homa Bay County in western Kenya (Fig. <xref rid="Fig1" ref-type="fig">1</xref>) and is connected to Mbita Point on the mainland by a causeway. Rusinga Island has a land surface of nearly 44 km<sup>2</sup> with most of the residential areas situated between 1100 and 1200 m above sea level around the lakeshore of the island. This region experiences a bimodal pattern of rainfall, with the longer rains usually starting in March and ending in June and a shorter rainy season from November to December. Average temperatures range from 20 to 29 °C in the rainy season and from 25 to 34 °C in the dry season.<fig id="Fig1"><label>Fig. 1</label><caption><p>Kenya with the Homa Bay County highlighted where the study site is located. Rusinga Island is mapped showing population density per 250 m<sup>2</sup> with the boundaries of 81 clusters with equal numbers of households. The <italic>blank space</italic> in the <italic>centre</italic> of the map is an uninhabited hill and the densely populated south-east is magnified—depicted in the <italic>bottom right of the figure</italic>
</p></caption><graphic xlink:href="12936_2015_1044_Fig1_HTML" id="MO1"/></fig></p>
        <p>On Rusinga Island, the population is traditionally part of the Luo tribe. The principal occupation is fishing and labour associated with fishing, otherwise many of the inhabitants are involved in rain-fed subsistence agriculture. Malaria transmission occurs throughout the year, with peaks in transmission late in the rainy seasons when parasite prevalence is approximately 30 % across the population [<xref ref-type="bibr" rid="CR28">28</xref>]. <italic>Plasmodium falciparum</italic> is the most prevalent species of malaria in western Kenya accounting for 98 % of the cases and the malaria transmitting vectors are <italic>Anopheles funestus</italic> and to a lesser extent <italic>Anopheles gambiae</italic> s.s. and <italic>Anopheles arabiensis</italic> [<xref ref-type="bibr" rid="CR33">33</xref>–<xref ref-type="bibr" rid="CR35">35</xref>].</p>
      </sec>
      <sec id="Sec4">
        <title>Field set up</title>
        <p>The SolarMal project is based at the Thomas Odhiambo Campus of the International Centre of Insect Physiology and Ecology (TOC-icipe) in the village of Mbita Point, one kilometre from the causeway which connects the island to the mainland. Meteorological data such as daily temperature and precipitation were obtained from the Suba meteorological field station at Rusinga Island (0°24′19.28″ South and 34°08′51.94″ East). A health and demographic surveillance system (HDSS) was set up to visit every individual living on Rusinga Island three times per year. A census enumeration survey, conducted from May to July 2012 recorded 23,337 individuals residing in 6954 residential structures (henceforth termed houses) divided into 4063 economically independent households. During the census HDSS round, the coordinates of all residential structures, as well as public buildings, were recorded. Fieldworkers were equipped with mobile tablet computer devices (Samsung Galaxy Tab 2, 10.1) with in inbuilt global positioning system (GPS) receiver for the data collection. All individuals were asked to provide their full name, sex, date of birth, main occupation and their relationship to the head of household. An individual was considered eligible for participation in the study when he or she intended to live for at least 6 months on the island. Data collection and handling was conducted using general structured questionnaires in the OpenHDS data collection and management platform. Data were transferred on a daily basis to a secured local server enabling researchers to work with a completely digital near real time database. Clean data were deposited in a MySQL database. During baseline studies one HDSS update survey was conducted from January to June 2013. For the rollout of the intervention the island was divided into 81 geographically contiguous clusters with 50–51 households per cluster. The households were allocated to clusters according to a travelling salesman algorithm by which the shortest imaginary route connecting every household on the island was identified. A new cluster was created after every 50–51 households [<xref ref-type="bibr" rid="CR36">36</xref>] (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). 81 clusters is a sufficient number of units to carry out regression while a sample from approximately 50 households provides enough statistical power to estimate the true value for a cluster.</p>
      </sec>
      <sec id="Sec5">
        <title>Malaria surveillance</title>
        <p>During the baseline period before the rollout of the intervention commenced, two parasitological prevalence surveys were conducted in a cross section of the study population. Households were randomly selected for inclusion in each prevalence survey to the point where 10 % of the population was included. All members of selected households were informed in advance of the date and time of the survey and were invited to assemble at a public place such as a church or a school near their home for malaria testing. In total, residents of 790 randomly selected households were sampled, covering 1223 houses. The first survey examined 1822 individuals (7.8 % of the total island population) and was carried out during the start of the short rainy season starting from September and finishing in November 2012. A second prevalence survey examined 1810 individuals (7.7 % of the total population) and was conducted from February to April 2013. Individual body temperature was measured by means of a Braun™ IRT 3020 ear thermometer. A drop of blood was obtained through a finger prick and directly tested for antigens of malaria parasites using an SD BIOLINE™ Malaria Ag P.f/Pan (HRP-II/pLDH) Rapid Diagnostic Test (RDT). The SD Bioline RDT kit results distinguish between infection with <italic>P. falciparum</italic> and other <italic>Plasmodium</italic> species. However, tests results with more than one positive reading or indicating multiple species of <italic>Plasmodium</italic> were pooled. If the individual tested positive for malaria antigens, an appropriate dose of Coartem<sup>®</sup> (Artemether/lumefantrine) was provided free of charge.</p>
      </sec>
      <sec id="Sec6">
        <title>Household information</title>
        <p>Besides the demographic information, Table <xref rid="Tab1" ref-type="table">1</xref> lists variables recorded concerning the house structure and existing malaria prevention behaviour and whether they were derived from the level of the individual or the household. An index of socioeconomic status (SES) was constructed by means of a principal component analysis producing tertiles of socioeconomic status on basis of six variables, [<xref ref-type="bibr" rid="CR37">37</xref>] as used in the Kenyan national malaria indicator survey. [<xref ref-type="bibr" rid="CR38">38</xref>] The variables used were: whether the dwelling was owned or rented, whether agricultural land was owned, highest education level of the head of household, location of the kitchen, the wall structure and the floor cover. Every individual was categorized into one of the three SES classes: high, intermediate and low. Data were transformed into continuous variables with means calculated per cluster based Means of variables per cluster were constructed either on basis of individual level data or household level data (Table <xref rid="Tab1" ref-type="table">1</xref>). Sex was expressed as the proportion of males per cluster; age was divided into three dummy variables, the proportion of children under 5 years old, between 5 and 15 years and above 15 years; occupation was categorized as the proportion of people in a cluster having an outdoor occupation; house ownership is the proportion of houses that are owner-occupied rather than rented; for SES the two lowest categories were pooled so a dummy variable remained for high SES and not a high SES, the percentage of people having the highest and the lowest socio-economic status; eaves as the percentage of houses with open eaves; and condition of nets is the proportion of people sleeping under an intact net.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Variables considered for the global regression model of malaria prevalence</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Variable</th><th align="left">Description for GWR per project cluster</th></tr></thead><tbody><tr><td align="left">Sex</td><td align="left">% males</td></tr><tr><td align="left">Age1</td><td align="left">% of children under 5 years old</td></tr><tr><td align="left">Age2</td><td align="left">% of children between 5 and 15 years old</td></tr><tr><td align="left">Age3</td><td align="left">% of people above the age of 15</td></tr><tr><td align="left">Occupation</td><td align="left">% outdoor occupation</td></tr><tr><td align="left">People per sleeping room</td><td align="left">Mean people per sleeping room</td></tr><tr><td align="left">People per house</td><td align="left">Mean people per house</td></tr><tr><td align="left">Screened eaves</td><td align="left">% houses with open eaves</td></tr><tr><td align="left">Condition of bed nets</td><td align="left">% bed nets without damages</td></tr><tr><td align="left">House sprayed last 12 months</td><td align="left">% sprayed houses in last 12 months</td></tr><tr><td align="left">Nets per person</td><td align="left">Mean number of nets per person</td></tr><tr><td align="left">Socio economic status1</td><td align="left">% of people with highest SES</td></tr><tr><td align="left">Socio economic status2</td><td align="left">% of people with lowest SES</td></tr><tr><td align="left">House ownership</td><td align="left">% of houses owned</td></tr><tr><td align="left">Population density</td><td align="left">Mean population density</td></tr><tr><td align="left">Mosquito exposure</td><td align="left">Mean malaria mosquito catches per house</td></tr><tr><td align="left">NDVI</td><td align="left">Mean NDVI</td></tr><tr><td align="left">TWI</td><td align="left">Mean TWI</td></tr><tr><td align="left">Distance to lake</td><td align="left">Mean distance to the lake</td></tr><tr><td align="left">Elevation from lake</td><td align="left">Mean elevation from lake</td></tr><tr><td align="left">Distance to clinic</td><td align="left">Mean distance to nearest health clinic</td></tr></tbody></table><table-wrap-foot><p>
<italic>SES</italic> socio economic status, <italic>NDVI</italic> normalized difference vegetation index, <italic>TWI</italic> topographic wetness index</p></table-wrap-foot></table-wrap></p>
      </sec>
      <sec id="Sec7">
        <title>Entomological monitoring</title>
        <p>Monitoring of mosquitoes took place across five consecutive rounds from September 2012 until June 2013, selecting 80 households per round, each time by means of a simple random sample, with replacement, of all households on the island. Mosquitoes were collected inside and outside selected households using odour-baited MM-X traps (American Biophysics Corporation, RI, USA) [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR39">39</xref>]. Data from the first, second, fourth and fifth rounds of surveillance (September to November 2012 and March to June 2013) were pooled as they corresponded temporally with the two baseline malaria prevalence surveys. In total entomological data from 353 households was included in this study. The total number of female anophelines caught inside and outside each household was pooled as a single observation for that particular household.</p>
      </sec>
      <sec id="Sec8">
        <title>Geographical variables</title>
        <p>A multispectral QuickBird image, taken on 17/03/2010 with a spatial resolution of 2.4 m, was obtained through DigitalGlobe<sup>®</sup>. Initially, the image was used for geo-referencing of residential and public structures and infrastructure. The image was geo-referenced, radio-metrically corrected, corrected for sensor and platform-induced distortions, and was ready for orthorectification. Orthorectification was performed using a Digital Elevation Model (DEM). The DEM used was an ASTER GDEM 2, the geographical coordinate system was referenced to the 1984 World Geodetic System (WGS84). Several geographic variables were derived for each household using the image and DEM: elevation relative to lake, distance to lake, distance to nearest clinic, population density, the Normalized Difference Vegetation Index (NDVI) and the Topographic Wetness Index (TWI). The NDVI is a commonly used indication of greenness and is calculated based on the values of the red and near infrared spectral bands within a radius of 250 m. The TWI defines the wetness of an area and combines the upstream area with the local slope expressed as the number of cells ‘upstream’ of cells measuring 30 × 30 m (900 m<sup>2</sup>). Population density measures were calculated within a radius of 250 metres. All the geographical variables per household were averaged per project cluster for data analysis and the analysis was at cluster-level. Geographic data and variables were pre-processed, compiled and displayed using ArcGIS (ArcGIS 10.2.1, ESRI Inc., Redlands, CA, USA).</p>
      </sec>
      <sec id="Sec9">
        <title>Statistical analysis</title>
        <p>For this analysis the measurements of both prevalence surveys were pooled and the mean malaria prevalence per project cluster on basis of individual RDT outcomes was analysed and mapped with smoothing using areal interpolation technique. Areal interpolation is a kriging-based interpolation method that considers involvement of polygons of different shapes [<xref ref-type="bibr" rid="CR40">40</xref>]. A Gaussian distribution for data averaged over polygons was used to produce semivariograms. Semivariograms were then used to investigate the degree of spatial variation; the model function was chosen which captured the most empirical data points within its confidence intervals.</p>
        <p>Unlike the regression analyses that are based on continuous household or individual data of project clusters (Table <xref rid="Tab1" ref-type="table">1</xref>), the detection of potential ‘hot spots’ of malaria cases were analysed with a binomial distribution on an individual level, with the outcome variable malaria positive or negative. Kuldorff spatial scan statistic analyses were performed (SaTScan, v9.1.1) [<xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR42">42</xref>] using a circular window that gradually scans the map of the island, quantifying the number of observed and expected observations within the window for every house. Within each circle, values in a radius around each household were compared to the expected values and a likelihood ratio test was subsequently performed. P values were obtained by 999 Monte Carlo replications and when p values were ≤0.05, houses in this circle were considered to be part of a significant hot spot of elevated malaria prevalence. The maximum scan window was set at 1.5 km and a maximum of 50 % of the population was allowed in one possible hot spot.</p>
        <p>Stationary epidemiological risk models assume that observations are geographically independent. These ‘global’ models assume that malaria and the coefficients of predictor variables apply to the whole island [<xref ref-type="bibr" rid="CR43">43</xref>]. Outcomes can be biased because the models do not account for spatial dependence considering that the relationship of risk factors for malaria can vary over space, such as demographical and environmental features [<xref ref-type="bibr" rid="CR44">44</xref>]. In order to gain an enhanced insight into variation in malaria outcomes, incorporating potential spatial dependence of predictor and dependent variables is vital where disease patterns are spatially heterogeneous. Moreover, to effectively capture spatially variable associations between risk factors and malaria outcomes, regression coefficients may vary locally as well. To include these considerations of spatial non-stationarity a geographically weighted regression (GWR) model was deployed [<xref ref-type="bibr" rid="CR45">45</xref>]. A log transformation was performed to normalize the slightly positively skewed malaria prevalence data on cluster level.</p>
        <p>To explore which predictor variables to include in the GWR model, a global multivariable regression (stationary model) was initially performed. In adopting the best model for explaining log transformed risk several other model features other than the best goodness-of-fit or statistical significance of predictors were looked at. Next, the assumption of normally distributed residuals of the estimated outcome (tested by the Jarque–Bera test) was tested as the model prediction function relies on normally distributed unexplained variance. The predictor variables that were included cannot have any multicollinearity in order to prevent duplication of capturing any predictive effect (indicated by a Variance Inflation Factor of &lt;7.5). Moreover, regression residuals need to be randomly distributed to make sure that observed relationships are not inflated because the observed minus the predicted values are not independent from each other [<xref ref-type="bibr" rid="CR46">46</xref>]. Regression residuals were examined for residual spatial autocorrelation (RSA). Furthermore, a test to detect heteroscedasticity was carried out to get an idea of heterogeneity in the relationship between the predictor and dependent variables (Breusch–Pagan statistic). The model that satisfied all these requirements and had the highest R<sup>2</sup> was selected for further analysis in a GWR model. The model did not control for possible correlated observations.</p>
        <p>In relationships between dependent and independent variables the GWR produces local linear regression models. The coefficients in a standard linear regression model are assumed to be the same at every location, whereas regression coefficients of a GWR model are attached to each individual location, in this case the location of a central point of a cluster [<xref ref-type="bibr" rid="CR47">47</xref>]. Coordinates of project clusters were determined by taking the centroids of the polygon features. The GWR regression model is thus:<disp-formula id="Equ1"><label>1</label><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$y_{i} = \beta_{0} + \mathop \sum \limits_{k = 1}^{p - 1} \beta_{k} x_{ki} + \varepsilon_{i}$$\end{document}</tex-math><mml:math id="M2" display="block"><mml:mrow><mml:msub><mml:mi>y</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi mathvariant="italic">β</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:munderover><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:munderover><mml:msub><mml:mi mathvariant="italic">β</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="italic">ε</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:math><graphic xlink:href="12936_2015_1044_Article_Equ1.gif" position="anchor"/></alternatives></disp-formula>where every observation <italic>i</italic> has its own set of coordinates, <inline-formula id="IEq1"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$y_{i}$$\end{document}</tex-math><mml:math id="M4"><mml:msub><mml:mi>y</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12936_2015_1044_Article_IEq1.gif"/></alternatives></inline-formula> is the cluster prevalence and <inline-formula id="IEq2"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$x_{ki}$$\end{document}</tex-math><mml:math id="M6"><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="12936_2015_1044_Article_IEq2.gif"/></alternatives></inline-formula> is the value for a covariate <italic>k</italic> for observation <italic>i</italic>, <inline-formula id="IEq3"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\beta_{0}$$\end{document}</tex-math><mml:math id="M8"><mml:msub><mml:mi mathvariant="italic">β</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12936_2015_1044_Article_IEq3.gif"/></alternatives></inline-formula> is the intercept, <inline-formula id="IEq4"><alternatives><tex-math id="M9">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\beta_{k}$$\end{document}</tex-math><mml:math id="M10"><mml:msub><mml:mi mathvariant="italic">β</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12936_2015_1044_Article_IEq4.gif"/></alternatives></inline-formula> is the coefficient estimate for a covariate <italic>k</italic>, and <inline-formula id="IEq5"><alternatives><tex-math id="M11">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\varepsilon_{i}$$\end{document}</tex-math><mml:math id="M12"><mml:msub><mml:mi mathvariant="italic">ε</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12936_2015_1044_Article_IEq5.gif"/></alternatives></inline-formula> is the random error for observation <italic>i</italic>, and <italic>p</italic> is the number of regression coefficients to be estimated. Estimations of predictor variables were obtained using subsets of data in a radius around observed geographical data points. Weights were applied to the subsets of observations, with a Gaussian decaying influence as distance increases. The radius determining the distance at which neighbouring data points influence the local models is known as the kernel bandwidth. For this analysis an adaptive kernel function (bi-square) was chosen instead of using a fixed radius; it considers a number of neighbouring data points leading to weights:<disp-formula id="Equ2"><label>2</label><alternatives><tex-math id="M13">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$W_{ij} = \left\{ {\begin{array}{*{20}c} {\left[ {1 - \left( {\frac{{d_{ij} }}{{d_{iN} }}} \right)^{2} } \right]^{2} } \\ 0 \\ \end{array} } \right.$$\end{document}</tex-math><mml:math id="M14" display="block"><mml:mrow><mml:msub><mml:mi>W</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfenced close="" open="{" separators=""><mml:mrow><mml:mtable columnspacing="0.5ex"><mml:mtr><mml:mtd><mml:msup><mml:mfenced close="]" open="[" separators=""><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msup><mml:mfenced close=")" open="(" separators=""><mml:mfrac><mml:msub><mml:mi>d</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>d</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>N</mml:mi></mml:mrow></mml:msub></mml:mfrac></mml:mfenced><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfenced><mml:mn>2</mml:mn></mml:msup></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mn>0</mml:mn></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced></mml:mrow></mml:math><graphic xlink:href="12936_2015_1044_Article_Equ2.gif" position="anchor"/></alternatives></disp-formula>where <inline-formula id="IEq6"><alternatives><tex-math id="M15">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$W_{ij}$$\end{document}</tex-math><mml:math id="M16"><mml:msub><mml:mi>W</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="12936_2015_1044_Article_IEq6.gif"/></alternatives></inline-formula> is the weight of data at location <italic>j</italic> estimated for location <italic>i,</italic><inline-formula id="IEq7"><alternatives><tex-math id="M17">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$d_{ij}$$\end{document}</tex-math><mml:math id="M18"><mml:msub><mml:mi>d</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="12936_2015_1044_Article_IEq7.gif"/></alternatives></inline-formula> is the distance between locations <italic>i</italic> and <italic>j,</italic><inline-formula id="IEq8"><alternatives><tex-math id="M19">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$d_{iN}$$\end{document}</tex-math><mml:math id="M20"><mml:msub><mml:mi>d</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>N</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="12936_2015_1044_Article_IEq8.gif"/></alternatives></inline-formula> is the distance to the spatial neighbours of location <italic>i</italic> and <italic>N</italic> is the number of neighbours considered <inline-formula id="IEq9"><alternatives><tex-math id="M21">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{W}}_{\text{ij}}$$\end{document}</tex-math><mml:math id="M22"><mml:msub><mml:mtext>W</mml:mtext><mml:mtext>ij</mml:mtext></mml:msub></mml:math><inline-graphic xlink:href="12936_2015_1044_Article_IEq9.gif"/></alternatives></inline-formula> takes zero for locations that are farther away from location i than the kernel bandwidth set. The optimal bandwidth and the associated weighting function were obtained by choosing the lowest score of the corrected Akaike information criterion (AIC<italic>c</italic>). It seeks parsimony, finding a balance between model fit and amount of parameters in the model. The AIC<italic>c</italic> was obtained by reducing the estimation error of our dependent outcome to a minimum and is:<disp-formula id="Equ3"><label>3</label><alternatives><tex-math id="M23">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{AIC}}c = 2n\log e \left( {\hat{\sigma }} \right) + n\log e(2\pi ) + \left\{ {\frac{n + tr(S)}{n - 2 - tr(S)}} \right\}$$\end{document}</tex-math><mml:math id="M24" display="block"><mml:mrow><mml:mtext>AIC</mml:mtext><mml:mi>c</mml:mi><mml:mo>=</mml:mo><mml:mn>2</mml:mn><mml:mi>n</mml:mi><mml:mo>log</mml:mo><mml:mi>e</mml:mi><mml:mfenced close=")" open="(" separators=""><mml:mover accent="true"><mml:mi mathvariant="italic">σ</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mfenced><mml:mo>+</mml:mo><mml:mi>n</mml:mi><mml:mo>log</mml:mo><mml:mi>e</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mn>2</mml:mn><mml:mi mathvariant="italic">π</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:mfenced close="}" open="{" separators=""><mml:mfrac><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>S</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mo>-</mml:mo><mml:mn>2</mml:mn><mml:mo>-</mml:mo><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>S</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mfrac></mml:mfenced></mml:mrow></mml:math><graphic xlink:href="12936_2015_1044_Article_Equ3.gif" position="anchor"/></alternatives></disp-formula>where <inline-formula id="IEq10"><alternatives><tex-math id="M25">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\hat{\sigma }$$\end{document}</tex-math><mml:math id="M26"><mml:mover accent="true"><mml:mi mathvariant="italic">σ</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:math><inline-graphic xlink:href="12936_2015_1044_Article_IEq10.gif"/></alternatives></inline-formula> is the estimated standard deviation of the error, and <italic>tr</italic>(<italic>S</italic>) is the trace of the matrix of covariates.</p>
        <p>A set of local goodness-of-fit statistics was derived by plotting the local R<sup>2</sup> per cluster. Furthermore, local coefficients and p-values belonging to predictor variables yielded were plotted to explore the geographically varying relationships with malaria prevalence. A semivariogram of regression residuals is constructed to explore the spatial structure of the model. To examine the final GWR model for possible spatial autocorrelation in the residuals (RSA), a Moran’s I test was performed on the residuals between observed and predicted values of malaria prevalence. Finally the model predictions were validated by means of exhaustive cross validation. Many different samples of training and a validation sets were considered to validate predictions in every cluster.</p>
        <p>Special attention is given to the issue of local multicollinearity because GWR outcomes can be heavily biased, and local coefficients can become inflated if different predictor variables have similar geographical patterns [<xref ref-type="bibr" rid="CR48">48</xref>]. Local multicollinearity is assessed by the condition number. This number increases if predictor variables show similar patterns, and when this number is above 30, the model is assumed to be unstable and unreliable.</p>
        <p>Statistical analysis and model building were performed using R software (RStudio, Inc.© version 0.98.1102 package <italic>spgwr</italic>), GWR4© (Newcastle University, UK) and ArcGIS (10.2.1, ESRI Inc., Redlands, USA).</p>
      </sec>
      <sec id="Sec10">
        <title>Ethical clearance</title>
        <p>Ethical approval was obtained from the Kenyan Medical Research Institute (KEMRI); non-SSC Protocol No. 350. All participants were provided with written and oral information regarding the project aims, the ongoing demographic and entomological surveillance activities, the implementation of the intervention, and the collection and use of blood samples. Adults, mature minors and caregivers of children provided written informed consent in the local language agreeing to participation in the SolarMal project activities.</p>
      </sec>
    </sec>
    <sec id="Sec11">
      <title>Results</title>
      <p>Possible hot spots of elevated malaria risk were identified by plotting the malaria prevalence per project cluster and smoothed with the areal interpolation technique (Fig. <xref rid="Fig2" ref-type="fig">2</xref>a). The island-wide malaria prevalence was 24 % and the prevalence per cluster varied between 9 and 75 %. Subsequently a SatScan analysis was conducted revealing two significant hot spots of malaria; one in the west and one in the central north of the island (see Fig. <xref rid="Fig2" ref-type="fig">2</xref>b). The primary hot spot of malaria is located in the central north of the island, the observed number of cases here was significantly higher than predicted from island-wide values (Table <xref rid="Tab2" ref-type="table">2</xref>). The risk of malaria in this hot spot is almost three times higher than for areas outside this hot spot (RR = 2.65, LLratio = 42.509, p value ≤0.0001). Furthermore, a secondary hot spot of malaria was identified in the west of the island with more than twice the risk for malaria infection (RR = 2.12, LLratio = 20.399, p value = 0.001).<fig id="Fig2"><label>Fig. 2</label><caption><p>
<bold>a</bold> Mean malaria prevalence per cluster on the basis of sampled individuals across Rusinga Island using Aerial interpolation. <bold>b</bold> Map of Rusinga Island showing two clusters of households (<italic>orange dots</italic>) with significantly elevated levels of malaria prevalence. The primary cluster is located at the central north of the island; a secondary cluster is covering an area to the west. Figure 2
<bold>a</bold> would suggest another cluster of malaria in the south-east, however prevalence in this area is not significantly greater than in neighbouring areas. The <italic>grey dots</italic>
<bold>b</bold> with black outlines are the sampled houses in the prevalence surveys; the paler <italic>grey dots</italic> indicate all houses on the island</p></caption><graphic xlink:href="12936_2015_1044_Fig2_HTML" id="MO5"/></fig><table-wrap id="Tab2"><label>Table 2</label><caption><p>Summary results of hot spots detected by SatScan</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Cluster</th><th align="left">Relative Risk</th><th align="left">LL ratio</th><th align="left">P value</th><th align="left">Number of individuals</th><th align="left">Expected infected individuals</th><th align="left">Infected individuals</th></tr></thead><tbody><tr><td align="left">1</td><td char="." align="char">2.65</td><td char="." align="char">42.51</td><td char="." align="char">&lt;0.0001</td><td char="." align="char">298</td><td char="." align="char">29</td><td char="." align="char">69</td></tr><tr><td align="left">2</td><td char="." align="char">2.12</td><td char="." align="char">20.40</td><td char="." align="char">0.001</td><td char="." align="char">212</td><td char="." align="char">23</td><td char="." align="char">46</td></tr></tbody></table></table-wrap></p>
      <sec id="Sec12">
        <title>Global linear regression model</title>
        <p>The multivariable global linear regression (GLR) model explains 26.8 % (R<sup>2</sup>) of the total variation between project clusters in malaria prevalence. The model and statistics on model assumptions are summarized in Table <xref rid="Tab3" ref-type="table">3</xref>. The null-hypothesis of no residual spatial autocorrelation (RSA) in the model is maintained with the Moran’s I statistic not being significant, showing that the regression residuals are randomly distributed and not missing key explanatory variable. The Breusch–Pagan statistic examines whether the relationship of predictor variables with malaria prevalence is similar around the island; heteroscedasticity is clearly present (with a p value of 0.03). Furthermore, the residuals of the outcome variable are approximately normally distributed indicating no deviation from the distributional assumptions of the model.<table-wrap id="Tab3"><label>Table 3</label><caption><p>Summary results for best non-spatial linear regression model for malaria prevalence</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Variable</th><th align="left">Coefficient</th><th align="left">Std error</th><th align="left">P value</th><th align="left">Robust Std error</th><th align="left">Robust P value</th><th align="left">VIF</th></tr></thead><tbody><tr><td align="left">Intercept</td><td align="left">−0.827</td><td char="." align="char">0.059</td><td char="." align="char">&lt;0.0001</td><td char="." align="char">0.061</td><td char="." align="char">&lt;0.0001</td><td align="left">–</td></tr><tr><td align="left">Outdoor occupation</td><td align="left">0.566</td><td char="." align="char">0.195</td><td char="." align="char">0.005</td><td char="." align="char">0.200</td><td char="." align="char">0.006</td><td align="left">1.16</td></tr><tr><td align="left">Highest SES</td><td align="left">0.240</td><td char="." align="char">0.098</td><td char="." align="char">0.017</td><td char="." align="char">0.101</td><td char="." align="char">0.020</td><td align="left">1.55</td></tr><tr><td align="left">Population density</td><td align="left">−0.004</td><td char="." align="char">0.001</td><td char="." align="char">&lt;0.0001</td><td char="." align="char">0.001</td><td char="." align="char">0.001</td><td align="left">1.38</td></tr></tbody></table><table frame="hsides" rules="groups"><thead><tr><th align="left">Statistic</th><th align="left" colspan="6">Value</th></tr></thead><tbody><tr><td align="left">Joint Wald Statistic</td><td align="left" colspan="6">18.75; p = 0.001</td></tr><tr><td align="left">Moran’s I</td><td align="left" colspan="6">0.45; p = 0.21</td></tr><tr><td align="left">Breusch–Pagan statistic</td><td align="left" colspan="6">8.86; p = 0.03</td></tr><tr><td align="left">Jarque–Bera statistic</td><td align="left" colspan="6">4.05; p = 0.13</td></tr></tbody></table><table-wrap-foot><p>
<italic>SES</italic> socio economic status, <italic>VIF</italic> variance inflation factor</p></table-wrap-foot></table-wrap></p>
        <p>Because heteroscedasticity is significantly present in the GLR model, the robust p value and standard errors were used to assess the relationships of the predictor variables with malaria prevalence. Outdoor occupation is the strongest significant predictor in the model with a coefficient of 0.57 (and a p value of &lt;0.0001). Furthermore, belonging to a household with a high SES is positively associated with malaria prevalence with a significant coefficient of 0.24 (and a p value of 0.02). A third significant predictor variable is population density, although the coefficient was only −0.004 (p value of 0.001). All predictor variables in the final global model were tested for multicollinearity, and all are well below the threshold of 7.5 (Table <xref rid="Tab3" ref-type="table">3</xref>).</p>
      </sec>
      <sec id="Sec13">
        <title>Geographically weighted regression model</title>
        <p>The predictor variables of the GLR model (outdoor occupation, SES and population density) were incorporated into a geographically weighted regression model. To determine the number of neighbouring clusters for local regression the bandwidth with the lowest AICc was chosen. The bi-square adaptive kernel function looks at an adaptive number neighbours and the influence of these neighbours decays following a Gaussian distribution so that closer observations have most weight. So local regression for clusters that have few data points adjacent, will include clusters farther away. Comparing the global and the local model shows that the GWR model performs better than the GLR model with an AIC (a measure to compare model quality) value of −43.8 versus −40.2 (Table <xref rid="Tab4" ref-type="table">4</xref>). Moreover, the GWR model fits considerably better taking into account non-stationarity. The capability of the GWR model to predict malaria prevalence on basis of the selected predictors is best expressed by looking at the R<sup>2</sup>, improving the model fit from 27 to 69 %. Other indications that show a better fitting and predicting model are the residual sum of squares and the −2 Log Likelihood, both statistics are less than half compared to the local model.<table-wrap id="Tab4"><label>Table 4</label><caption><p>Comparison between global regression and GWR model</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Variable</th><th align="left">GLR</th><th align="left">GWR</th></tr></thead><tbody><tr><td align="left">AIC</td><td align="left">−40.86</td><td align="left">−43.18</td></tr><tr><td align="left">Moran’s I</td><td align="left">0.45; p = 0.21</td><td align="left">0.23; p = 0.25</td></tr><tr><td align="left">R<sup>2</sup>
</td><td align="left">0.268</td><td align="left">0.694</td></tr><tr><td align="left">Residual sum of squares</td><td align="left">2.53</td><td align="left">0.985</td></tr><tr><td align="left">−2 Log likelihood</td><td align="left">−50.86</td><td align="left">−127.26</td></tr></tbody></table><table-wrap-foot><p>Model fit is compared with AIC, explanatory power of the models is compared by R<sup>2</sup> and the Moran’s I of residuals indicates the degree of spatial autocorrelation</p></table-wrap-foot></table-wrap></p>
        <p>Exploring the spatial structure of the model residuals with an anisotropic averaged semivariogram shows that the distance up to which RSA occurs (the range) is 2.7 km (Fig. <xref rid="Fig3" ref-type="fig">3</xref>). The sill has a value of 0.825, indicating that the variance of residuals between households beyond the value of the RSA range is fairly high. Within the range the variance starts from 0.61 (the nugget), demonstrating that the degree of RSA is not pronounced. Spatial autocorrelation in the residuals of the final GWR model was then assessed by a Moran’s I test and this actually directed to some RSA. Nevertheless this yielded a p-value of 0.25, thus the null hypothesis of no significant RSA was maintained. R<sup>2</sup> values per cluster vary between 32 and 87 % with a mean of 63 % (Fig. <xref rid="Fig4" ref-type="fig">4</xref>a). Local multicollinearity assessed by the condition number yields values of between 6.7 and 19.2 with a mean of 12.9, indicating that the model is marginally affected by multicollinearity (Fig. <xref rid="Fig4" ref-type="fig">4</xref>b). Cross validation of the predicted malaria values with the measured values yielded predictions for 74 of 81 project clusters that were statistically significant.<fig id="Fig3"><label>Fig. 3</label><caption><p>Semivariogram of the residuals of the final GWR model, with the <italic>dotted line</italic> showing the fitted value. The semivariance is shown on the y-axis. The semivariance of the residuals between households starts at 0.61 (nugget) demonstrating some spatial autocorrelation on distances up to 2.7 km (range). Beyond this threshold the semivariance is high and stabilizes at 0.825 (sill) indicating minimal RSA</p></caption><graphic xlink:href="12936_2015_1044_Fig3_HTML" id="MO6"/></fig><fig id="Fig4"><label>Fig. 4</label><caption><p>
<bold>a</bold> Goodness-of-fit statistics indicate how well the GWR model fits per cluster, expressed by R<sup>2</sup> and <bold>b</bold> Multicollinearity per cluster, expressed by the condition number. A higher condition number indicates an increased degree of multicollinearity</p></caption><graphic xlink:href="12936_2015_1044_Fig4_HTML" id="MO7"/></fig></p>
        <p>Geographically varying effects of outdoor occupation, SES and population density in the GWR model are illustrated in Fig. <xref rid="Fig5" ref-type="fig">5</xref>. Regression coefficients were back-transformed after the initial log transformation of malaria prevalence in the model, and presented as exponentiated coefficients. This is interpreted for the highest SES category as the relative malaria risk compared to being in a lower SES category or having another occupation. The same interpretation applies to the outdoor occupation variable. For average population density the interpretation of the coefficient is best expressed as the increase in malaria risk for every one person increase in the average number of individuals per 250 m<sup>2</sup>.<fig id="Fig5"><label>Fig. 5</label><caption><p>Geographically varying coefficients expressed as the relative risk per cluster for predictor variables of malaria prevalence in the final GWR model. <bold>a</bold> Outdoor occupation, <bold>b</bold> highest SES, <bold>c</bold> population density</p></caption><graphic xlink:href="12936_2015_1044_Fig5_HTML" id="MO8"/></fig></p>
        <p>Population density, outdoor occupation and highest SES differ in having a positive or negative association with malaria prevalence. Coefficients of each variable can have a positive or negative association and the direction of the association varies depending on the local values of those explanatory variables. Coefficients that are equal to one indicate a similar malaria risk compared to the surrounding comparator clusters, whereas coefficients risks above one demonstrate an increased risk for malaria. The coefficients of malaria for population density varied between 0.268 and 2.569 indicating that the association between malaria and population density could be positive or negative depending on the area of the island. The variation in coefficients of malaria for those in the highest SES group ranged between 0.841 and 1.334, also indicative of a negative association in some areas of the island but a positive association in other areas. Outdoor occupation also had a spatially variable association with malaria, with exponentiated coefficients ranging between 0.807 and 1.320. P values of regression coefficients of all three explanatory variables also vary over space (Fig. <xref rid="Fig6" ref-type="fig">6</xref>), indicating that the statistically significant relationships were not equally strong everywhere on the island.<fig id="Fig6"><label>Fig. 6</label><caption><p>Geographically varying values of significance per cluster for predictor variables of malaria prevalence in the final GWR model. <bold>a</bold> Outdoor occupation, <bold>b</bold> highest SES, <bold>c</bold> population density</p></caption><graphic xlink:href="12936_2015_1044_Fig6_HTML" id="MO9"/></fig></p>
      </sec>
    </sec>
    <sec id="Sec14">
      <title>Discussion</title>
      <p>Over the past decade large reductions in malaria have been achieved, yet the current distribution of malaria is still spatially heterogeneous [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR49">49</xref>]. Considerable research is currently being conducted to find tools for malaria control that are able to target residual malaria transmission, in order to reach the goals set by the RBM initiative to eliminate malaria where possible, or reduce it to a minimum [<xref ref-type="bibr" rid="CR50">50</xref>, <xref ref-type="bibr" rid="CR51">51</xref>]. Established interventions such as LLINs, IRS and case management have proven to be effective but this one size fits all strategy is not appropriate when moving into the elimination phase [<xref ref-type="bibr" rid="CR8">8</xref>]. These existing methods will need to be complemented by novel tools, which may entail interventions targeting local geography, demography and societal context [<xref ref-type="bibr" rid="CR6">6</xref>]. Exploring locally varying relationships of risk factors for malaria may aid in exploring and eventually targeting appropriate interventions. Traditional descriptions and models report on the progressively heterogeneous nature of malaria transmission, but analyses reporting on risk factors for malaria and disease usually ignore spatial heterogeneity of the underlying risk factors of disease [<xref ref-type="bibr" rid="CR52">52</xref>].</p>
      <p>In exploring spatially varying relationships of risk factors for malaria, factors that are directly related to malaria risk as well as proxy factors were used. Socioeconomic status, screened eaves and condition of bed nets are examples of factors directly influencing malaria risk, whereas distance to nearest clinic and environmental variables as TWI and NDVI can have an indirect effect because of access to anti-malarials or proximity to possible breeding sites for malaria vectors. The GLR model explained 27 % of the spatial variance in malaria prevalence, however GWR analysis greatly improved model fit to 69 %. A better fit by the GWR model is confirmed by a reduction in the residual sum of squares as well as an increased likelihood when comparing the global and the local model (Table <xref rid="Tab4" ref-type="table">4</xref>). Local estimations of model fit did vary somewhat over the island (Fig. <xref rid="Fig4" ref-type="fig">4</xref>a), and whilst there are several areas where the model does not fit more than 50 %, in all study clusters an improved fit using the GWR was observed compared with the global model.</p>
      <p>Outdoor occupation and activity at night have previously been associated with higher risk for malaria [<xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR54">54</xref>]. In the case of Rusinga Island, many people are involved in fishing and labour related to fishing, and these activities are generally performed in shifts during the night. It is known that in between shifts, fishermen spend their time around fishing beaches close to their home with little or no protection against biting malaria mosquitoes. It is during the night that <italic>Anopheles gambiae</italic> s.l. and <italic>An. funestus</italic> mosquitoes exhibit their peak host-seeking behaviour, biting mostly indoors but also outdoors [<xref ref-type="bibr" rid="CR55">55</xref>], thus people who are active at night are expected to be at increased risk for receiving infective mosquito bites. Spatial heterogeneity of outdoor occupation in the south-east of the island is characterized by a large area where having an outdoor occupation leads to increased risk of malaria. This is the area of Rusinga with the highest proportion of fishermen. Malaria infections could be acquired there, subsequently fuelling the malaria reservoir and infection risk for others in these areas, a concept that has been proposed previously [<xref ref-type="bibr" rid="CR56">56</xref>]. Study clusters that include fishing beaches almost all appear to have higher risk because of outdoor occupations. For example the small cluster in the north and the smaller clusters west of the island, which fall within a malaria hot spot (Fig. <xref rid="Fig2" ref-type="fig">2</xref>b). In the northern part of the island there are also clusters with a reduced risk of malaria for outdoor occupation; these clusters lie in one of the malaria hot spots. The effect is not as large and is also less significant, but possibly an explanation here can be that in this area farming, also an outdoor occupation, is the dominant occupation, usually performed during the day when mosquitoes are less active. Nevertheless working outside at dawn and dusk becomes increasingly more important as a predictor of malaria risk as the mosquito vectors are recurrently reported to bite after sunrise and before sunset [<xref ref-type="bibr" rid="CR33">33</xref>].</p>
      <p>Socioeconomic status has often been linked with risk of malaria. Better schooling, improved housing and a higher income are commonly associated with reduced malaria risk [<xref ref-type="bibr" rid="CR57">57</xref>]. On Rusinga, areas with a higher risk as well as areas with a lower risk for malaria when residing in the highest SES category are identified. The local patterns of SES show that a positive association with malaria mostly affects the central western part of the island and the tip in the north-east (orange clusters), with an increased risk of malaria. The south-eastern part (green clusters) of the island, by contrast, yield clusters that show a reduced risk of malaria among those with the highest SES.</p>
      <p>Socioeconomic status itself does not affect malaria directly; hence the components of SES were further explored. It was found that in most of the clusters where high SES is associated with increased malaria risk, most farmland and dwellings are owned by the occupants while house structure is predominantly poor. This could suggest that variables as owning land and a house, indicators for being in a high SES class, do not necessarily directly relate to reduced malaria risk. Thus even though people are in the highest SES class, the house structure could allow for considerable malaria risk because there is poor protection against mosquitoes entering the house. A higher education level of the head of household could indicate that there is more financial freedom within the family. This can possibly result in a higher expenditure on health care and malaria prevention, which would presumably lead to reduced malaria risk. The components of location of kitchen and wall structure in this SES PCA are proxies of exposure to mosquitoes. When people cook outside during sunset and at night-time they may be exposed to outdoor-biting mosquitoes. Finally and interestingly SES did not have a strong (Fig. <xref rid="Fig5" ref-type="fig">5</xref>b) or significant relationship (Fig. <xref rid="Fig6" ref-type="fig">6</xref>b) with malaria in the hot spots (Fig. <xref rid="Fig2" ref-type="fig">2</xref>b). Thus, residing in a malaria hot spot was independent of house ownership, educational level or other SES factors.</p>
      <p>A higher population density was associated with a slightly reduced risk of malaria in the GLR model, in keeping with previous findings from various studies in both urban and rural settings in Africa [<xref ref-type="bibr" rid="CR58">58</xref>]. Higher population density has a large protective effect in some clusters farther from the lake and further from potential breeding sites, whereas the association between population density and malaria risk was positive in some clusters closer to the lake. It appears that the effect of a higher population density depended on proximity to possible breeding sites of malaria vectors near the lake shore. In a large simulation study [<xref ref-type="bibr" rid="CR19">19</xref>] the dynamics of a spatially heterogeneous human and mosquito population was modelled and it was suggested that where there are few mosquitoes or breeding sites, the chance of receiving an infective bite is reduced in densely populated areas whereas the chance or receiving an infective bite is not reduced in sparsely populated areas. On the other hand, if there are many breeding sites and many mosquitoes close to a densely populated area, the chance of malaria transmission increases considerably compared to areas that are less densely populated where the chance or malaria transmission does not increase further with increasing mosquito numbers.</p>
      <p>Other risk factors considered in the GLR model have all been suggested in previous literature as predictive for malaria risk. Remarkably, human age and mosquito counts as a proxy for exposure did not enter the final model. Young children (0–5 years) and adolescents typically have a higher risk of malaria because of different behaviour regarding malaria prevention and less well developed immune systems [<xref ref-type="bibr" rid="CR59">59</xref>]. However, on Rusinga age was not significantly related to malaria, and there was no spatial heterogeneity in the effect of age on malaria. Furthermore, increased numbers of mosquitoes caught in some clusters were not accompanied by higher local prevalence. Screened eaves was not a significant predictor, but this can be explained by the fact that more than 90 % of the households did not have screened eaves and therefore there was insufficient information relating to the impact of this variable. There was a fairly homogenous coverage of bed nets and IRS activities across the island in the year prior to the present study. Bed nets continued to be used, but no further IRS treatments took place. This lack of variability could explain why number of bed nets and IRS coverage were not significantly associated with malaria. NDVI and TWI were also rather homogeneous over the island and therefore not important predictors for malaria. Finally, the average distance to a clinic did not play a role in this model. On this relatively small island, there are five health clinics or dispensaries, and even the households furthest away from a health clinic are at a walking distance of only 3 km.</p>
      <p>An advantage of this study is firstly the assumption that non-stationarity of underlying risk factors for malaria can improve model fit considerably and can subsequently be used to explore geographically varying factors responsible for spatial patterns of malaria. Local outcomes and relationships can shed light on why malaria persists in certain areas. Secondly, as the data collected for this analysis serves as the baseline survey for a large vector control study, this analysis can assist in exploring further research and explain why the interventions may ultimately perform better in some areas than in others. One could consider increasing the intensity of available malaria interventions near fishing beaches at night, account for poor housing structures and reduce the number of traps in a densely populated area where high population density is associated with lower risk of malaria.</p>
      <p>It is essential to understand the degree by which the results could be influenced by the unit of analysis. The use of discrete zones to perform spatial analysis is very common [<xref ref-type="bibr" rid="CR60">60</xref>], but rather contradictory because geographical variation is a continuous process. Project clusters were defined and used to perform the intervention study, with the baseline malaria data described here. The number of clusters and population size per cluster were optimized and adopted for the rollout of the vector control intervention with optimal statistical power as well as community acceptance [<xref ref-type="bibr" rid="CR61">61</xref>]. Creation of 81 clusters with an even number of households per cluster was calculated to provide sufficient generalizability and randomness to detect a possible difference in malaria incidence (T Smith, personal communication). As the intervention trial is analysed on basis of geographical divisions it was logical to use the same clusters for analysis of baseline data, which gave rise to this work. Spatial analyses are often performed on a similar scale at which this data was collected, for instance on village or county level [<xref ref-type="bibr" rid="CR62">62</xref>]. Published work stresses that a societal or biological rationale is important when constructing discrete geographical zones. The rationale behind using the project clusters in this study is because it will be valuable to know what factors will have influenced the outcome of the vector intervention study which was conducted on this cluster scale. However, using different discrete clusters or cluster sizes or individual level data may yield slightly different outcomes. More detailed variation in coefficients is yielded when using smaller units and vice versa [<xref ref-type="bibr" rid="CR47">47</xref>]. Additionally, when using an adaptive kernel function the radius of data included of local regression is variable. Also here it applies that smaller scale local regression usually leads to more variation in coefficients [<xref ref-type="bibr" rid="CR63">63</xref>], and this mostly leads to weaker or stronger local relationships rather than reversed relationships. Nonetheless, when first performing a global linear regression, one can be confident that the risk factors obtained are important predictors of malaria and that subsequently the local coefficients of GWR are justified, despite of varying strengths of the relationships being influenced by the scale chosen [<xref ref-type="bibr" rid="CR60">60</xref>].</p>
      <p>Further limitations of this analysis are linked with the statistical methods used by GWR [<xref ref-type="bibr" rid="CR64">64</xref>]. GWR has been criticized for lacking an integrated statistical framework because it represents a collective of local spatial regressions and a precise inference becomes imperfect. In understanding the varying coefficients one has to bear in mind that the coefficients that were estimated can be interpreted as an exploration and not as exact inference [<xref ref-type="bibr" rid="CR62">62</xref>]. Since this issue was raised, significance tests have been developed to reduce uncertainty about the relationships identified using this approach. These local tests were incorporated in our analysis, showing areas where relationships were more significant than in other areas. Another concern raised regarding GWR is that the technique yields local effects that can be inflated because of residual spatial autocorrelation and multicollinearity. Residual spatial autocorrelation occurs when regression residuals cluster spatially, violating the assumption of independence in a linear regression model. Even though GWR accounts for this by adding a random error term for observations, coefficients can become inflated due to clustering of residuals. In this analysis much care was invested in examining and testing for RSA, minimizing possible uncertainty in coefficients resulting from RSA. Finally, in recent years another limitation of GWR was put forward; inflation of local coefficients because of local multicollinearity [<xref ref-type="bibr" rid="CR65">65</xref>]. If predictor variables locally indicate the same patterns, their effect on the outcome variable can be overestimated. Since this problem was raised several tools have been developed to assess the extent of local multicollinearity [<xref ref-type="bibr" rid="CR48">48</xref>]. In this analysis a measure of local multicollinearity by means of the condition number was incorporated, but it is concluded that this issue caused a negligible distorting effect on the local coefficients.</p>
    </sec>
    <sec id="Sec15">
      <title>Conclusion</title>
      <p>In this study, geographically-varying risk factors for malaria were modelled. The spatial heterogeneity of malaria risk factors is explored rather than concluding upon perfect inferences. The study reveals that predictor variables for malaria vary geographically even over small distances of several kilometres. The exploration demonstrates that assuming stationarity of risk factors by means of a global statistical model ignores spatial components that can yield useful information and improve model fit. Being part of the highest SES, working outdoors (during night time) and population density were most predictive for malaria patterns on Rusinga Island. When considering SES as a risk factor for malaria one has to bear in mind that this depends on the local setting and the components included, hence results need to be interpreted with caution. All relationships with risk factors were spatially heterogeneous and these varying effects can be used to explore for what reasons vector intervention at the island possibly may have dissimilar effects in different areas.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Authors’ contributions</title>
      <p>TS, NM, WT, AH, CM, WRM and TH designed the study, TH, NM, AdP, IK and KO designed and implemented the questionnaires and managed the database of the Health and Demographic Surveillance System, AH and WT designed the entomological monitoring study, TS and AR assisted with the spatial analysis and TH performed the statistical analyses. TH, AH and WT wrote the manuscript. All authors read and approved the final manuscript.</p>
      <sec id="FPar1">
        <title>Acknowledgements</title>
        <p>We want to thank the population of Rusinga Island for cooperating with us and for embracing the project. We are also very thankful to our fieldworkers and staff at the International Centre of Insect Physiology and Ecology, enabling us to implement and manage all our scientific activities from the field station in Mbita. This study was funded by a grant from the COmON Foundation through the campaign Food for Thought of the Wageningen University Fund. AR gratefully acknowledges support from the Julia Bangerter-Rhyne Stiftung and the Novartis Foundation for Medical Biological Research project 13A13.</p>
      </sec>
      <sec id="FPar2">
        <title>Competing interests</title>
        <p>The authors declare that they have no competing interests.</p>
      </sec>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>WHO</collab>
          </person-group>
          <source>World Malaria Report</source>
          <year>2014</year>
          <publisher-loc>Geneva</publisher-loc>
          <publisher-name>World Health Organization</publisher-name>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Murray</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Rosenfeld</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Lim</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Andrews</surname>
              <given-names>KG</given-names>
            </name>
            <name>
              <surname>Foreman</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Haring</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Global malaria mortality between 1980 and 2010: a systematic analysis</article-title>
          <source>Lancet</source>
          <year>2012</year>
          <volume>379</volume>
          <fpage>413</fpage>
          <lpage>431</lpage>
          <pub-id pub-id-type="doi">10.1016/S0140-6736(12)60034-8</pub-id>
          <?supplied-pmid 22305225?>
          <pub-id pub-id-type="pmid">22305225</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Okiro</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Alegana</surname>
              <given-names>VA</given-names>
            </name>
            <name>
              <surname>Noor</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Snow</surname>
              <given-names>RW</given-names>
            </name>
          </person-group>
          <article-title>Changing malaria intervention coverage, transmission and hospitalization in Kenya</article-title>
          <source>Malar J</source>
          <year>2010</year>
          <volume>9</volume>
          <fpage>285</fpage>
          <pub-id pub-id-type="doi">10.1186/1475-2875-9-285</pub-id>
          <?supplied-pmid 20946689?>
          <pub-id pub-id-type="pmid">20946689</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <mixed-citation publication-type="other">RBM: Annual report 2013. Roll Back Malaria Partnership, Geneva, Switzerland; 2013.</mixed-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tanner</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>de Savigny</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Malaria eradication back on the table</article-title>
          <source>Bull World Health Organ</source>
          <year>2008</year>
          <volume>86</volume>
          <fpage>82</fpage>
          <pub-id pub-id-type="doi">10.2471/BLT.07.050633</pub-id>
          <?supplied-pmid 18297155?>
          <pub-id pub-id-type="pmid">18297155</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alonso</surname>
              <given-names>PL</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Arevalo-Herrera</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Binka</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Chitnis</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Collins</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A research agenda to underpin malaria eradication</article-title>
          <source>PLoS Med</source>
          <year>2011</year>
          <volume>8</volume>
          <fpage>e1000406</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pmed.1000406</pub-id>
          <?supplied-pmid 21311579?>
          <pub-id pub-id-type="pmid">21311579</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cotter</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Sturrock</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Hsiang</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Phillips</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Hwang</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The changing epidemiology of malaria elimination: new strategies for new challenges</article-title>
          <source>Lancet</source>
          <year>2013</year>
          <volume>382</volume>
          <fpage>900</fpage>
          <lpage>911</lpage>
          <pub-id pub-id-type="doi">10.1016/S0140-6736(13)60310-4</pub-id>
          <?supplied-pmid 23594387?>
          <pub-id pub-id-type="pmid">23594387</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Snow</surname>
              <given-names>RW</given-names>
            </name>
          </person-group>
          <article-title>Global malaria eradication and the importance of <italic>Plasmodium falciparum</italic> epidemiology in Africa</article-title>
          <source>BMC Med</source>
          <year>2015</year>
          <volume>13</volume>
          <fpage>23</fpage>
          <pub-id pub-id-type="doi">10.1186/s12916-014-0254-7</pub-id>
          <?supplied-pmid 25644195?>
          <pub-id pub-id-type="pmid">25644195</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Greenwood</surname>
              <given-names>BM</given-names>
            </name>
          </person-group>
          <article-title>The microepidemiology of malaria and its importance to malaria control</article-title>
          <source>Trans R Soc Trop Med Hyg</source>
          <year>1989</year>
          <volume>83</volume>
          <issue>Suppl</issue>
          <fpage>25</fpage>
          <lpage>29</lpage>
          <pub-id pub-id-type="doi">10.1016/0035-9203(89)90599-3</pub-id>
          <?supplied-pmid 2576161?>
          <pub-id pub-id-type="pmid">2576161</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Clark</surname>
              <given-names>TD</given-names>
            </name>
            <name>
              <surname>Greenhouse</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Njama-Meya</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Nzarubara</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Maiteki-Sebuguzi</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Staedke</surname>
              <given-names>SG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Factors determining the heterogeneity of malaria incidence in children in Kampala, Uganda</article-title>
          <source>J Infect Dis</source>
          <year>2008</year>
          <volume>198</volume>
          <fpage>393</fpage>
          <lpage>400</lpage>
          <pub-id pub-id-type="doi">10.1086/589778</pub-id>
          <?supplied-pmid 18522503?>
          <pub-id pub-id-type="pmid">18522503</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ernst</surname>
              <given-names>KC</given-names>
            </name>
            <name>
              <surname>Adoka</surname>
              <given-names>SO</given-names>
            </name>
            <name>
              <surname>Kowuor</surname>
              <given-names>DO</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>John</surname>
              <given-names>CC</given-names>
            </name>
          </person-group>
          <article-title>Malaria hotspot areas in a highland Kenya site are consistent in epidemic and non-epidemic years and are associated with ecological factors</article-title>
          <source>Malar J</source>
          <year>2006</year>
          <volume>5</volume>
          <fpage>78</fpage>
          <pub-id pub-id-type="doi">10.1186/1475-2875-5-78</pub-id>
          <?supplied-pmid 16970824?>
          <pub-id pub-id-type="pmid">16970824</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wanjala</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Waitumbi</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Githeko</surname>
              <given-names>AK</given-names>
            </name>
          </person-group>
          <article-title>Identification of malaria transmission and epidemic hotspots in the western Kenya highlands: its application to malaria epidemic prediction</article-title>
          <source>Parasit Vectors</source>
          <year>2011</year>
          <volume>4</volume>
          <fpage>81</fpage>
          <pub-id pub-id-type="doi">10.1186/1756-3305-4-81</pub-id>
          <?supplied-pmid 21595898?>
          <pub-id pub-id-type="pmid">21595898</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bousema</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kreuels</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Gosling</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Adjusting for heterogeneity of malaria transmission in longitudinal studies</article-title>
          <source>J Infect Dis</source>
          <year>2011</year>
          <volume>204</volume>
          <fpage>1</fpage>
          <lpage>3</lpage>
          <pub-id pub-id-type="doi">10.1093/infdis/jir225</pub-id>
          <?supplied-pmid 21628650?>
          <pub-id pub-id-type="pmid">21628650</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mosha</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Sturrock</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Greenwood</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Sutherland</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Gadalla</surname>
              <given-names>NB</given-names>
            </name>
            <name>
              <surname>Atwal</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Hot spot or not: a comparison of spatial statistical methods to predict prospective malaria infections</article-title>
          <source>Malar J</source>
          <year>2014</year>
          <volume>13</volume>
          <fpage>53</fpage>
          <pub-id pub-id-type="doi">10.1186/1475-2875-13-53</pub-id>
          <?supplied-pmid 24517452?>
          <pub-id pub-id-type="pmid">24517452</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Srivastava</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nagpal</surname>
              <given-names>BN</given-names>
            </name>
            <name>
              <surname>Joshi</surname>
              <given-names>PL</given-names>
            </name>
            <name>
              <surname>Paliwal</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Dash</surname>
              <given-names>AP</given-names>
            </name>
          </person-group>
          <article-title>Identification of malaria hot spots for focused intervention in tribal state of India: a GIS based approach</article-title>
          <source>Int J Health Geogr</source>
          <year>2009</year>
          <volume>8</volume>
          <fpage>30</fpage>
          <pub-id pub-id-type="doi">10.1186/1476-072X-8-30</pub-id>
          <?supplied-pmid 19457227?>
          <pub-id pub-id-type="pmid">19457227</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Toty</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Barre</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Le Goff</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Larget-Thiery</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Rahola</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Couret</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Fontenille</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Malaria risk in Corsica, former hot spot of malaria in France</article-title>
          <source>Malar J</source>
          <year>2010</year>
          <volume>9</volume>
          <fpage>231</fpage>
          <pub-id pub-id-type="doi">10.1186/1475-2875-9-231</pub-id>
          <?supplied-pmid 20704707?>
          <pub-id pub-id-type="pmid">20704707</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>XN</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Guo</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Spatial patterns of malaria reported deaths in Yunnan Province, China</article-title>
          <source>Am J Trop Med Hyg</source>
          <year>2013</year>
          <volume>88</volume>
          <fpage>526</fpage>
          <lpage>535</lpage>
          <pub-id pub-id-type="doi">10.4269/ajtmh.2012.12-0217</pub-id>
          <?supplied-pmid 23269660?>
          <pub-id pub-id-type="pmid">23269660</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kreuels</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Kobbe</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Adjei</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kreuzberg</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>von Reden</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Bater</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Spatial variation of malaria incidence in young children from a geographically homogeneous area with high endemicity</article-title>
          <source>J Infect Dis</source>
          <year>2008</year>
          <volume>197</volume>
          <fpage>85</fpage>
          <lpage>93</lpage>
          <pub-id pub-id-type="doi">10.1086/524066</pub-id>
          <?supplied-pmid 18171290?>
          <pub-id pub-id-type="pmid">18171290</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smith</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Dushoff</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>McKenzie</surname>
              <given-names>FE</given-names>
            </name>
          </person-group>
          <article-title>The risk of a mosquito-borne infection in a heterogeneous environment</article-title>
          <source>PLoS Biol</source>
          <year>2004</year>
          <volume>2</volume>
          <fpage>e368</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pbio.0020368</pub-id>
          <?supplied-pmid 15510228?>
          <pub-id pub-id-type="pmid">15510228</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bejon</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>TN</given-names>
            </name>
            <name>
              <surname>Nyundo</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Hay</surname>
              <given-names>SI</given-names>
            </name>
            <name>
              <surname>Benz</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Gething</surname>
              <given-names>PW</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A micro-epidemiological analysis of febrile malaria in Coastal Kenya showing hotspots within hotspots</article-title>
          <source>Elife</source>
          <year>2014</year>
          <volume>3</volume>
          <fpage>e02130</fpage>
          <pub-id pub-id-type="doi">10.7554/eLife.02130</pub-id>
          <?supplied-pmid 24843017?>
          <pub-id pub-id-type="pmid">24843017</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brooker</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Clarke</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Njagi</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Polack</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mugo</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Estambale</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Spatial clustering of malaria and associated risk factors during an epidemic in a highland area of western Kenya</article-title>
          <source>Trop Med Int Health</source>
          <year>2004</year>
          <volume>9</volume>
          <fpage>757</fpage>
          <lpage>766</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-3156.2004.01272.x</pub-id>
          <?supplied-pmid 15228485?>
          <pub-id pub-id-type="pmid">15228485</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Feuillet</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Coquin</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Mercier</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Cossart</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Decaulne</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Jonsson</surname>
              <given-names>HP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Focusing on the spatial non-stationarity of landslide predisposing factors in northern Iceland: do paraglacial factors vary over space?</article-title>
          <source>Prog Phys Geogr</source>
          <year>2014</year>
          <volume>38</volume>
          <fpage>354</fpage>
          <lpage>377</lpage>
          <pub-id pub-id-type="doi">10.1177/0309133314528944</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rodrigues</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>de la Riva</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Fotheringham</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Modeling the spatial variation of the explanatory factors of human-caused wildfires in Spain using geographically weighted logistic regression</article-title>
          <source>Appl Geogr</source>
          <year>2014</year>
          <volume>48</volume>
          <fpage>52</fpage>
          <lpage>63</lpage>
          <pub-id pub-id-type="doi">10.1016/j.apgeog.2014.01.011</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Luo</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Wei</surname>
              <given-names>YHD</given-names>
            </name>
          </person-group>
          <article-title>Modeling spatial variations of urban growth patterns in Chinese cities: the case of Nanjing</article-title>
          <source>Landsc Urban Plan</source>
          <year>2009</year>
          <volume>91</volume>
          <fpage>51</fpage>
          <lpage>64</lpage>
          <pub-id pub-id-type="doi">10.1016/j.landurbplan.2008.11.010</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gilbert</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Chakraborty</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Using geographically weighted regression for environmental justice analysis: cumulative cancer risks from air toxics in Florida</article-title>
          <source>Soc Sci Res</source>
          <year>2011</year>
          <volume>40</volume>
          <fpage>273</fpage>
          <lpage>286</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ssresearch.2010.08.006</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Comber</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Brunsdon</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Radburn</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>A spatial analysis of variations in health access: linking geography, socio-economic status and access perceptions</article-title>
          <source>Int J Health Geogr</source>
          <year>2011</year>
          <volume>10</volume>
          <fpage>44</fpage>
          <pub-id pub-id-type="doi">10.1186/1476-072X-10-44</pub-id>
          <?supplied-pmid 21787394?>
          <pub-id pub-id-type="pmid">21787394</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ehlkes</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Krefis</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Kreuels</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Krumkamp</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Adjei</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Ayim-Akonor</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Geographically weighted regression of land cover determinants of <italic>Plasmodium falciparum</italic> transmission in the Ashanti Region of Ghana</article-title>
          <source>Int J Health Geogr</source>
          <year>2014</year>
          <volume>13</volume>
          <fpage>35</fpage>
          <pub-id pub-id-type="doi">10.1186/1476-072X-13-35</pub-id>
          <?supplied-pmid 25270342?>
          <pub-id pub-id-type="pmid">25270342</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haque</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Scott</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Hashizume</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fisher</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Haque</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Yamamoto</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Glass</surname>
              <given-names>GE</given-names>
            </name>
          </person-group>
          <article-title>Modelling malaria treatment practices in Bangladesh using spatial statistics</article-title>
          <source>Malar J</source>
          <year>2012</year>
          <volume>11</volume>
          <fpage>63</fpage>
          <pub-id pub-id-type="doi">10.1186/1475-2875-11-63</pub-id>
          <?supplied-pmid 22390636?>
          <pub-id pub-id-type="pmid">22390636</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grillet</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Barrera</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Martinez</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Berti</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Fortin</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Disentangling the effect of local and global spatial variation on a mosquito-borne infection in a neotropical heterogeneous environment</article-title>
          <source>Am J Trop Med Hyg</source>
          <year>2010</year>
          <volume>82</volume>
          <fpage>194</fpage>
          <lpage>201</lpage>
          <pub-id pub-id-type="doi">10.4269/ajtmh.2010.09-0040</pub-id>
          <?supplied-pmid 20133991?>
          <pub-id pub-id-type="pmid">20133991</pub-id>
        </element-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Giardina</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Kasasa</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sie</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Utzinger</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Tanner</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Vounatsou</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Effects of vector-control interventions on changes in risk of malaria parasitaemia in sub-Saharan Africa: a spatial and temporal analysis</article-title>
          <source>Lancet Global Health</source>
          <year>2014</year>
          <volume>2</volume>
          <fpage>e601</fpage>
          <lpage>e615</lpage>
          <pub-id pub-id-type="doi">10.1016/S2214-109X(14)70300-6</pub-id>
          <?supplied-pmid 25304636?>
          <pub-id pub-id-type="pmid">25304636</pub-id>
        </element-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hiscox</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Maire</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kiche</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Silkey</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Homan</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Oria</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Mweresa</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Otieno</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Ayugi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bousema</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Sawa</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Alaii</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Leeuwis</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Mukabana</surname>
              <given-names>WR</given-names>
            </name>
            <name>
              <surname>Takken</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>The SolarMal Project: innovative mosquito trapping technology for malaria control</article-title>
          <source>Malar J</source>
          <year>2012</year>
          <volume>11</volume>
          <issue>Suppl 1</issue>
          <fpage>O45</fpage>
          <pub-id pub-id-type="doi">10.1186/1475-2875-11-S1-O45</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Menger</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Van Loon</surname>
              <given-names>JJA</given-names>
            </name>
            <name>
              <surname>Takken</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Assessing the efficacy of candidate mosquito repellents against the background of an attractive source that mimics a human host</article-title>
          <source>Med Vet Entomol</source>
          <year>2014</year>
          <volume>28</volume>
          <issue>4</issue>
          <fpage>407</fpage>
          <lpage>413</lpage>
          <pub-id pub-id-type="doi">10.1111/mve.12061</pub-id>
          <?supplied-pmid 24797537?>
          <pub-id pub-id-type="pmid">24797537</pub-id>
        </element-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bayoh</surname>
              <given-names>MN</given-names>
            </name>
            <name>
              <surname>Mathias</surname>
              <given-names>DK</given-names>
            </name>
            <name>
              <surname>Odiere</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Mutuku</surname>
              <given-names>FM</given-names>
            </name>
            <name>
              <surname>Kamau</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Gimnig</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Vulule</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Hawley</surname>
              <given-names>WA</given-names>
            </name>
            <name>
              <surname>Hamel</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>ED</given-names>
            </name>
          </person-group>
          <article-title><italic>Anopheles gambiae</italic>: historical population decline associated with regional distribution of insecticide-treated bed nets in western Nyanza Province, Kenya</article-title>
          <source>Malar J</source>
          <year>2010</year>
          <volume>9</volume>
          <fpage>62</fpage>
          <pub-id pub-id-type="doi">10.1186/1475-2875-9-62</pub-id>
          <?supplied-pmid 20187956?>
          <pub-id pub-id-type="pmid">20187956</pub-id>
        </element-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhou</surname>
              <given-names>GF</given-names>
            </name>
            <name>
              <surname>Afrane</surname>
              <given-names>YA</given-names>
            </name>
            <name>
              <surname>Vardo-Zalik</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Atieli</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Zhong</surname>
              <given-names>DB</given-names>
            </name>
            <name>
              <surname>Wamae</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Changing patterns of malaria epidemiology between 2002 and 2010 in Western Kenya: the fall and rise of malaria</article-title>
          <source>PLoS One</source>
          <year>2011</year>
          <volume>6</volume>
          <fpage>e20318</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0020318</pub-id>
          <?supplied-pmid 21629783?>
          <pub-id pub-id-type="pmid">21629783</pub-id>
        </element-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Olanga</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Okombo</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Irungu</surname>
              <given-names>LW</given-names>
            </name>
            <name>
              <surname>Mukabana</surname>
              <given-names>WR</given-names>
            </name>
          </person-group>
          <article-title>Parasites and vectors of malaria on Rusinga Island</article-title>
          <source>Western Kenya. Parasit Vectors</source>
          <year>2015</year>
          <volume>8</volume>
          <fpage>250</fpage>
          <pub-id pub-id-type="doi">10.1186/s13071-015-0860-z</pub-id>
          <?supplied-pmid 25928743?>
          <pub-id pub-id-type="pmid">25928743</pub-id>
        </element-citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <mixed-citation publication-type="other">Garfinkel R. Motivation and modeling. In: Lawler EL, Lenstra JK, Kan AR, Shmoys DB, editors. The traveling salesman problem. A guided tour of combinatorial optimization. Wiley; 1985.</mixed-citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vyas</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kumaranayake</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Constructing socio-economic status indices: how to use principal components analysis</article-title>
          <source>Health Policy Plann</source>
          <year>2006</year>
          <volume>21</volume>
          <fpage>459</fpage>
          <lpage>468</lpage>
          <pub-id pub-id-type="doi">10.1093/heapol/czl029</pub-id>
        </element-citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <mixed-citation publication-type="other">KNBS: Kenya Malaria Indicator Survey. Nairobi, Kenya: Division of Malaria Control, Ministry of Public Health and Sanitation, Kenya National Bureau of Statistics, and ICF Macro; 2012.</mixed-citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mweresa</surname>
              <given-names>CK</given-names>
            </name>
            <name>
              <surname>Omusula</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Otieno</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>van Loon</surname>
              <given-names>JJA</given-names>
            </name>
            <name>
              <surname>Takken</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Mukabana</surname>
              <given-names>WR</given-names>
            </name>
          </person-group>
          <article-title>Molasses as a source of carbon dioxide for attracting the malaria mosquitoes <italic>Anopheles gambiae</italic> and <italic>Anopheles funestus</italic></article-title>
          <source>Malar J</source>
          <year>2014</year>
          <volume>13</volume>
          <fpage>160</fpage>
          <pub-id pub-id-type="doi">10.1186/1475-2875-13-160</pub-id>
          <?supplied-pmid 24767543?>
          <pub-id pub-id-type="pmid">24767543</pub-id>
        </element-citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hawley</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Mollering</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>A comparative analysis of areal interpolation methods</article-title>
          <source>Cartogr Geogr Inform Sci</source>
          <year>2005</year>
          <volume>32</volume>
          <fpage>411</fpage>
          <lpage>423</lpage>
          <pub-id pub-id-type="doi">10.1559/152304005775194818</pub-id>
        </element-citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jung</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Kulldorff</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Klassen</surname>
              <given-names>AC</given-names>
            </name>
          </person-group>
          <article-title>A spatial scan statistic for ordinal data</article-title>
          <source>Stat Med</source>
          <year>2007</year>
          <volume>26</volume>
          <fpage>1594</fpage>
          <lpage>1607</lpage>
          <pub-id pub-id-type="doi">10.1002/sim.2607</pub-id>
          <?supplied-pmid 16795130?>
          <pub-id pub-id-type="pmid">16795130</pub-id>
        </element-citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kulldorff</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nagarwalla</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Spatial disease clusters: detection and inference</article-title>
          <source>Stat Med</source>
          <year>1995</year>
          <volume>14</volume>
          <fpage>799</fpage>
          <lpage>810</lpage>
          <pub-id pub-id-type="doi">10.1002/sim.4780140809</pub-id>
          <?supplied-pmid 7644860?>
          <pub-id pub-id-type="pmid">7644860</pub-id>
        </element-citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lopez</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Mathers</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Ezzati</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Jamison</surname>
              <given-names>DT</given-names>
            </name>
            <name>
              <surname>Murray</surname>
              <given-names>CJL</given-names>
            </name>
          </person-group>
          <article-title>Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data</article-title>
          <source>Lancet</source>
          <year>2006</year>
          <volume>367</volume>
          <fpage>1747</fpage>
          <lpage>1757</lpage>
          <pub-id pub-id-type="doi">10.1016/S0140-6736(06)68770-9</pub-id>
          <?supplied-pmid 16731270?>
          <pub-id pub-id-type="pmid">16731270</pub-id>
        </element-citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Anselin</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Local Indicators of Spatial Association—Lisa</article-title>
          <source>Geogr Anal</source>
          <year>1995</year>
          <volume>27</volume>
          <fpage>93</fpage>
          <lpage>115</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1538-4632.1995.tb00338.x</pub-id>
        </element-citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brunsdon</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Fotheringham</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Charlton</surname>
              <given-names>ME</given-names>
            </name>
          </person-group>
          <article-title>Geographically weighted regression: a method for exploring spatial nonstationarity</article-title>
          <source>Geogr Anal</source>
          <year>1996</year>
          <volume>28</volume>
          <fpage>281</fpage>
          <lpage>298</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1538-4632.1996.tb00936.x</pub-id>
        </element-citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Anselin</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Under the hood—issues in the specification and interpretation of spatial regression models</article-title>
          <source>Agr Econ</source>
          <year>2002</year>
          <volume>27</volume>
          <fpage>247</fpage>
          <lpage>267</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1574-0862.2002.tb00120.x</pub-id>
        </element-citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fotheringham</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Charlton</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Brunsdon</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Geographically weighted regression: a natural evolution of the expansion method for spatial data analysis</article-title>
          <source>Environ Plann A</source>
          <year>1998</year>
          <volume>30</volume>
          <fpage>1905</fpage>
          <lpage>1927</lpage>
          <pub-id pub-id-type="doi">10.1068/a301905</pub-id>
        </element-citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wheeler</surname>
              <given-names>DC</given-names>
            </name>
          </person-group>
          <article-title>Diagnostic tools and a remedial method for collinearity in geographically weighted regression</article-title>
          <source>Environ Plann A</source>
          <year>2007</year>
          <volume>39</volume>
          <fpage>2464</fpage>
          <lpage>2481</lpage>
          <pub-id pub-id-type="doi">10.1068/a38325</pub-id>
        </element-citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Noor</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Kinyoki</surname>
              <given-names>DK</given-names>
            </name>
            <name>
              <surname>Mundia</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Kabaria</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Mutua</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Alegana</surname>
              <given-names>VA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The changing risk of <italic>Plasmodium falciparum</italic> malaria infection in Africa: 2000-10: a spatial and temporal analysis of transmission intensity</article-title>
          <source>Lancet</source>
          <year>2014</year>
          <volume>383</volume>
          <fpage>1739</fpage>
          <lpage>1747</lpage>
          <pub-id pub-id-type="doi">10.1016/S0140-6736(13)62566-0</pub-id>
          <?supplied-pmid 24559537?>
          <pub-id pub-id-type="pmid">24559537</pub-id>
        </element-citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Owens</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Malaria and the millennium development goals</article-title>
          <source>Arch Dis Child</source>
          <year>2015</year>
          <volume>100</volume>
          <issue>Suppl 1</issue>
          <fpage>S53</fpage>
          <lpage>S56</lpage>
          <pub-id pub-id-type="doi">10.1136/archdischild-2013-305441</pub-id>
          <?supplied-pmid 25613970?>
          <pub-id pub-id-type="pmid">25613970</pub-id>
        </element-citation>
      </ref>
      <ref id="CR51">
        <label>51.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Killeen</surname>
              <given-names>GF</given-names>
            </name>
          </person-group>
          <article-title>Characterizing, controlling and eliminating residual malaria transmission</article-title>
          <source>Malar J</source>
          <year>2014</year>
          <volume>13</volume>
          <fpage>330</fpage>
          <pub-id pub-id-type="doi">10.1186/1475-2875-13-330</pub-id>
          <?supplied-pmid 25149656?>
          <pub-id pub-id-type="pmid">25149656</pub-id>
        </element-citation>
      </ref>
      <ref id="CR52">
        <label>52.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pullan</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Sturrock</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Soares Magalhaes</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Clements</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Brooker</surname>
              <given-names>SJ</given-names>
            </name>
          </person-group>
          <article-title>Spatial parasite ecology and epidemiology: a review of methods and applications</article-title>
          <source>Parasitology</source>
          <year>2012</year>
          <volume>139</volume>
          <fpage>1870</fpage>
          <lpage>1887</lpage>
          <pub-id pub-id-type="doi">10.1017/S0031182012000698</pub-id>
          <?supplied-pmid 23036435?>
          <pub-id pub-id-type="pmid">23036435</pub-id>
        </element-citation>
      </ref>
      <ref id="CR53">
        <label>53.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Monroe</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Asamoah</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Lam</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Koenker</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Psychas</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Lynch</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Outdoor-sleeping and other night-time activities in northern Ghana: implications for residual transmission and malaria prevention</article-title>
          <source>Malar J</source>
          <year>2015</year>
          <volume>14</volume>
          <fpage>35</fpage>
          <pub-id pub-id-type="doi">10.1186/s12936-015-0543-4</pub-id>
          <?supplied-pmid 25627277?>
          <pub-id pub-id-type="pmid">25627277</pub-id>
        </element-citation>
      </ref>
      <ref id="CR54">
        <label>54.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dunn</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Le Mare</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Makungu</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Malaria risk behaviours, socio-cultural practices and rural livelihoods in southern Tanzania: implications for bednet usage</article-title>
          <source>Soc Sci Med</source>
          <year>2011</year>
          <volume>72</volume>
          <fpage>408</fpage>
          <lpage>417</lpage>
          <pub-id pub-id-type="doi">10.1016/j.socscimed.2010.11.009</pub-id>
          <?supplied-pmid 21211875?>
          <pub-id pub-id-type="pmid">21211875</pub-id>
        </element-citation>
      </ref>
      <ref id="CR55">
        <label>55.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Govella</surname>
              <given-names>NJ</given-names>
            </name>
            <name>
              <surname>Ferguson</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Why use of interventions targeting outdoor biting mosquitoes will be necessary to achieve malaria elimination</article-title>
          <source>Front Physiol</source>
          <year>2012</year>
          <volume>3</volume>
          <fpage>199</fpage>
          <pub-id pub-id-type="doi">10.3389/fphys.2012.00199</pub-id>
          <?supplied-pmid 22701435?>
          <pub-id pub-id-type="pmid">22701435</pub-id>
        </element-citation>
      </ref>
      <ref id="CR56">
        <label>56.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Prosper</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Ruktanonchai</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Martcheva</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Assessing the role of spatial heterogeneity and human movement in malaria dynamics and control</article-title>
          <source>J Theor Biol</source>
          <year>2012</year>
          <volume>303</volume>
          <fpage>1</fpage>
          <lpage>14</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jtbi.2012.02.010</pub-id>
          <?supplied-pmid 22525434?>
          <pub-id pub-id-type="pmid">22525434</pub-id>
        </element-citation>
      </ref>
      <ref id="CR57">
        <label>57.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tusting</surname>
              <given-names>LS</given-names>
            </name>
            <name>
              <surname>Willey</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Lucas</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Thompson</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kafy</surname>
              <given-names>HT</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Socioeconomic development as an intervention against malaria: a systematic review and meta-analysis</article-title>
          <source>Lancet</source>
          <year>2013</year>
          <volume>382</volume>
          <fpage>963</fpage>
          <lpage>972</lpage>
          <pub-id pub-id-type="doi">10.1016/S0140-6736(13)60851-X</pub-id>
          <?supplied-pmid 23790353?>
          <pub-id pub-id-type="pmid">23790353</pub-id>
        </element-citation>
      </ref>
      <ref id="CR58">
        <label>58.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hay</surname>
              <given-names>SI</given-names>
            </name>
            <name>
              <surname>Guerra</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Tatem</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Atkinson</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Snow</surname>
              <given-names>RW</given-names>
            </name>
          </person-group>
          <article-title>Urbanization, malaria transmission and disease burden in Africa</article-title>
          <source>Nat Rev Microbiol</source>
          <year>2005</year>
          <volume>3</volume>
          <fpage>81</fpage>
          <lpage>90</lpage>
          <pub-id pub-id-type="doi">10.1038/nrmicro1069</pub-id>
          <?supplied-pmid 15608702?>
          <pub-id pub-id-type="pmid">15608702</pub-id>
        </element-citation>
      </ref>
      <ref id="CR59">
        <label>59.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carneiro</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Roca-Feltrer</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Griffin</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Tanner</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schellenberg</surname>
              <given-names>JA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Age-patterns of malaria vary with severity, transmission intensity and seasonality in sub-Saharan Africa: a systematic review and pooled analysis</article-title>
          <source>PLoS One</source>
          <year>2010</year>
          <volume>5</volume>
          <fpage>e8988</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0008988</pub-id>
          <?supplied-pmid 20126547?>
          <pub-id pub-id-type="pmid">20126547</pub-id>
        </element-citation>
      </ref>
      <ref id="CR60">
        <label>60.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Fotheringham</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Brunsdon</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Charlton</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Tate</surname>
              <given-names>NJ</given-names>
            </name>
            <name>
              <surname>Atkinson</surname>
              <given-names>PM</given-names>
            </name>
          </person-group>
          <article-title>Scale issues and geographically weighted regression</article-title>
          <source>Modelling scale in geographical information science</source>
          <year>2001</year>
          <publisher-loc>New York</publisher-loc>
          <publisher-name>Wiley</publisher-name>
          <fpage>124</fpage>
          <lpage>140</lpage>
        </element-citation>
      </ref>
      <ref id="CR61">
        <label>61.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oria</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Hiscox</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Alaii</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ayugi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mukabana</surname>
              <given-names>WR</given-names>
            </name>
            <name>
              <surname>Takken</surname>
              <given-names>W</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Tracking the mutual shaping of the technical and social dimensions of solar-powered mosquito trapping systems (SMoTS) for malaria control on Rusinga Island, western Kenya</article-title>
          <source>Parasit Vectors</source>
          <year>2014</year>
          <volume>7</volume>
          <fpage>523</fpage>
          <pub-id pub-id-type="doi">10.1186/s13071-014-0523-5</pub-id>
          <?supplied-pmid 25404420?>
          <pub-id pub-id-type="pmid">25404420</pub-id>
        </element-citation>
      </ref>
      <ref id="CR62">
        <label>62.</label>
        <mixed-citation publication-type="other">Wheeler D. Geographically weighted regression. In: Handbook of regional science. Heidelberg: Springer-Verlag; 2014.</mixed-citation>
      </ref>
      <ref id="CR63">
        <label>63.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guo</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>ZH</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>LJ</given-names>
            </name>
          </person-group>
          <article-title>Comparison of bandwidth selection in application of geographically weighted regression: a case study</article-title>
          <source>Can J Forest Res</source>
          <year>2008</year>
          <volume>38</volume>
          <fpage>2526</fpage>
          <lpage>2534</lpage>
          <pub-id pub-id-type="doi">10.1139/X08-091</pub-id>
        </element-citation>
      </ref>
      <ref id="CR64">
        <label>64.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Paez</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Farber</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wheeler</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>A simulation-based study of geographically weighted regression as a method for investigating spatially varying relationships</article-title>
          <source>Environ Plann A</source>
          <year>2011</year>
          <volume>43</volume>
          <fpage>2992</fpage>
          <lpage>3010</lpage>
          <pub-id pub-id-type="doi">10.1068/a44111</pub-id>
        </element-citation>
      </ref>
      <ref id="CR65">
        <label>65.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wheeler</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Tiefelsdorf</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Multicollinearity and correlation among local regression coefficients in geographically weighted regression</article-title>
          <source>J Geogr Systems</source>
          <year>2005</year>
          <volume>7</volume>
          <fpage>161</fpage>
          <lpage>187</lpage>
          <pub-id pub-id-type="doi">10.1007/s10109-005-0155-6</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:4700571</identifier><datestamp>2016-01-06</datestamp><setSpec>parasitvect</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="http://jats.nlm.nih.gov/ns/archiving/1.0/ http://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Parasit Vectors</journal-id>
      <journal-id journal-id-type="iso-abbrev">Parasit Vectors</journal-id>
      <journal-title-group>
        <journal-title>Parasites &amp; Vectors</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1756-3305</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC4700571</article-id>
      <article-id pub-id-type="pmcid">PMC4700571</article-id>
      <article-id pub-id-type="pmc-uid">4700571</article-id>
      <article-id pub-id-type="publisher-id">1284</article-id>
      <article-id pub-id-type="doi">10.1186/s13071-015-1284-5</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>LmABCB3, an atypical mitochondrial ABC transporter essential for <italic>Leishmania major</italic> virulence, acts in heme and cytosolic iron/sulfur clusters biogenesis</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Martínez-García</surname>
            <given-names>Marta</given-names>
          </name>
          <address>
            <email>martamg@ipb.csic.es</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Campos-Salinas</surname>
            <given-names>Jenny</given-names>
          </name>
          <address>
            <email>jennycampos@ipb.csic.es</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cabello-Donayre</surname>
            <given-names>María</given-names>
          </name>
          <address>
            <email>mariacabello@ipb.csic.es</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pineda-Molina</surname>
            <given-names>Estela</given-names>
          </name>
          <address>
            <email>estelap.pineda@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gálvez</surname>
            <given-names>Francisco J.</given-names>
          </name>
          <address>
            <email>frangalv@hotmail.es</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Orrego</surname>
            <given-names>Lina M.</given-names>
          </name>
          <address>
            <email>linaorrego256@ipb.csic.es</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sánchez-Cañete</surname>
            <given-names>María P.</given-names>
          </name>
          <address>
            <email>sophie.malagarie@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Malagarie-Cazenave</surname>
            <given-names>Sophie</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Koeller</surname>
            <given-names>David M.</given-names>
          </name>
          <address>
            <email>koellerd@ohsu.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Pérez-Victoria</surname>
            <given-names>José M.</given-names>
          </name>
          <address>
            <email>josepv@ipb.csic.es</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <aff id="Aff1"><label/>Instituto de Parasitología y Biomedicina “López-Neyra” (IPBLN), CSIC, PTS Granada, Granada, Spain </aff>
        <aff id="Aff2"><label/>Department of Molecular &amp; Medical Genetics, Oregon Health &amp; Science University, Portland, OR USA </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>5</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>5</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <volume>9</volume>
      <elocation-id>7</elocation-id>
      <history>
        <date date-type="received">
          <day>14</day>
          <month>9</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>23</day>
          <month>12</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© Martínez-García et al. 2016</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Mitochondria play essential biological functions including the synthesis and trafficking of porphyrins and iron/sulfur clusters (ISC), processes that in mammals involve the mitochondrial ATP-Binding Cassette (ABC) transporters ABCB6 and ABCB7, respectively. The mitochondrion of pathogenic protozoan parasites such as <italic>Leishmania</italic> is a promising goal for new therapeutic approaches. <italic>Leishmania </italic>infects human macrophages producing the neglected tropical disease known as leishmaniasis. Like most trypanosomatid parasites, <italic>Leishmania </italic>is auxotrophous for heme and must acquire porphyrins from the host.</p>
        </sec>
        <sec>
          <title>Methods</title>
          <p>LmABCB3, a new <italic>Leishmania major</italic> protein with significant sequence similarity to human ABCB6/ABCB7, was identified and characterized using bioinformatic tools. Fluorescent microscopy was used to determine its cellular localization, and its level of expression was modulated by molecular genetic techniques. Intracellular in vitro assays were used to demonstrate its role in amastigotes replication, and an in vivo mouse model was used to analyze its role in virulence. Functional characterization of LmABCB3 was carried out in <italic>Leishmania</italic> promastigotes and <italic>Saccharomyces cerevisiae</italic>. Structural analysis of LmABCB3 was performed using molecular modeling software.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>LmABCB3 is an atypical ABC half-transporter that has a unique N-terminal extension not found in any other known ABC protein. This extension is required to target LmABCB3 to the mitochondrion and includes a potential metal-binding domain. We have shown that LmABCB3 interacts with porphyrins and is required for the mitochondrial synthesis of heme from a host precursor. We also present data supporting a role for LmABCB3 in the biogenesis of cytosolic ISC, essential cofactors for cell viability in all three kingdoms of life. LmABCB3 fully complemented the severe growth defect shown in yeast lacking ATM1, an orthologue of human ABCB7 involved in exporting from the mitochondria a gluthatione-containing compound required for the generation of cytosolic ISC. Indeed, docking analyzes performed with a LmABCB3 structural model using trypanothione, the main thiol in this parasite, as a ligand showed how both, LmABCB3 and yeast ATM1, contain a similar thiol-binding pocket. Additionally, we show solid evidence suggesting that <italic>LmABCB3</italic> is an essential gene as dominant negative inhibition of LmABCB3 is lethal for the parasite. Moreover, the abrogation of only one allele of the gene did not impede promastigote growth in axenic culture but prevented the replication of intracellular amastigotes and the virulence of the parasites in a mouse model of cutaneous leishmaniasis.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>Altogether our results present the previously undescribed LmABCB3 as an unusual mitochondrial ABC transporter essential for <italic>Leishmania</italic> survival through its role in the generation of heme and cytosolic ISC. Hence, LmABCB3 could represent a novel target to combat leishmaniasis.</p>
        </sec>
        <sec>
          <title>Electronic supplementary material</title>
          <p>The online version of this article (doi:10.1186/s13071-015-1284-5) contains supplementary material, which is available to authorized users.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Heme trafficking and metabolism</kwd>
        <kwd>Iron/sulfur clusters</kwd>
        <kwd>Trypanosomatid parasites</kwd>
        <kwd>Mitochondrial ABC transporter</kwd>
        <kwd>
          <italic>Leishmania</italic>
        </kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003329</institution-id>
              <institution>Ministerio de Economía y Competitividad (ES)</institution>
            </institution-wrap>
          </funding-source>
          <award-id>SAF2011-28215</award-id>
          <principal-award-recipient>
            <name>
              <surname>Pérez-Victoria</surname>
              <given-names>José M.</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002878</institution-id>
              <institution>Consejería de Economía, Innovación, Ciencia y Empleo, Junta de Andalucía (ES)</institution>
            </institution-wrap>
          </funding-source>
          <award-id>BIO1786</award-id>
          <principal-award-recipient>
            <name>
              <surname>Pérez-Victoria</surname>
              <given-names>José M.</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003329</institution-id>
              <institution>Ministerio de Economía y Competitividad (ES)</institution>
            </institution-wrap>
          </funding-source>
          <award-id>FPI Fellowship</award-id>
          <principal-award-recipient>
            <name>
              <surname>Martínez-García</surname>
              <given-names>Marta</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003176</institution-id>
              <institution>Ministerio de Educación, Cultura y Deporte (ES)</institution>
            </institution-wrap>
          </funding-source>
          <award-id>FPU Fellowship</award-id>
          <principal-award-recipient>
            <name>
              <surname>Cabello-Donayre</surname>
              <given-names>María</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003339</institution-id>
              <institution>Consejo Superior de Investigaciones Científicas (ES)</institution>
            </institution-wrap>
          </funding-source>
          <award-id>JAE-DOC</award-id>
          <principal-award-recipient>
            <name>
              <surname>Malagarie-Cazenave</surname>
              <given-names>Sophie</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
      </funding-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>© The Author(s) 2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Background</title>
      <p>Leishmaniasis is a complex neglected tropical disease produced by different species of the protozoan parasite <italic>Leishmania</italic> [<xref ref-type="bibr" rid="CR1">1</xref>]. This pathogen belongs to the Trypanosomatidae family, which also includes <italic>Trypamosoma brucei</italic>, the agent of sleeping sickness, and <italic>Trypanosoma cruzi</italic>, which is responsible for Chagas’ disease [<xref ref-type="bibr" rid="CR2">2</xref>]. <italic>Leishmania</italic> has a digenetic life cycle that includes an extracellular flagellated promastigote form, which resides in the insect vector, and an intracellular amastigote form, which replicates inside the macrophages of the infected host and causes different forms of disease depending on the species [<xref ref-type="bibr" rid="CR1">1</xref>]. According to the WHO and DNDi [<xref ref-type="bibr" rid="CR3">3</xref>], leishmaniasis occurs in 98 countries with 350 million people living at risk. Each year, there are an estimated 1.3 million new cases, 30–40,000 deaths and 1,974,000 DALYs (the sum of years of potential life lost due to premature mortality and the years of productive life lost due to disability). Due to the lack of surveillance systems and the frequent occurrence of the disease in remote areas and marginalized populations [<xref ref-type="bibr" rid="CR3">3</xref>]these are likely underestimates of its global impact. In the absence of vaccines, chemotherapy remains the main weapon to fight this disease. However, the limited efficacy and high toxicity of the drugs available, together with the emergence of numerous drug-resistant strains, have severely compromised their utility. Thus, there is an urgent need to find new treatments for this neglected disease.</p>
      <p>Like most trypanosomatid parasites, <italic>Leishmania</italic> is auxotrophous for heme and must acquire this essential porphyrin from the host [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. Therefore, proteins involved in porphyrin uptake and intra-cellular trafficking could represent attractive targets for drug development. <italic>In vitro</italic>, <italic>Leishmania</italic> promastigotes can obtain heme through two independent routes [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. Hemoglobin-bound heme is taken up via receptor-mediated endocytosis [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>] and routed to the lysosome via early LRab5- and late LRab7-containing endosomes, followed by digestion of the globin protein [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. The trafficking of the released heme to the mitochondria requires the intracellular ATP Binding Cassette (ABC) transporter LABCG5 [<xref ref-type="bibr" rid="CR7">7</xref>]. <italic>Leishmania</italic> promastigotes can also obtain heme from an exogenous supplement of free hemin [<xref ref-type="bibr" rid="CR6">6</xref>] by an active transport process [<xref ref-type="bibr" rid="CR7">7</xref>] which depends on a specific heme transporter called LHR1, recently identified in <italic>L. amazonensis</italic> [<xref ref-type="bibr" rid="CR12">12</xref>]. LHR1 is essential for viability of the parasite [<xref ref-type="bibr" rid="CR12">12</xref>] and the deletion of even one <italic>lhr1</italic> allele severely reduce virulence in an <italic>in vivo</italic> model of cutaneous leishmaniasis [<xref ref-type="bibr" rid="CR13">13</xref>], validating LHR1 as a promising drug target. Regardless of the mechanism of import, heme must get to the mitochondria, where it is required for the synthesis of the heme-containing cytochromes of the respiratory chain. To date the mechanism via which the parasite imports heme into mitochondria is unknown. In the case of intracellular amastigotes, it has been suggested that they could use coproporphyrinogen, a heme precursor from the macrophage, which could then be converted to heme in the mitochondrion of the parasite [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. Subsequently, the just synthesized heme would need to be exported to the parasite cytosol, where it would exert an essential role, through a not yet known mechanism.</p>
      <p>In mammals, the mitochondrial ABC half-transporter ABCB6 has been proposed to be responsible for mitochondrial porphyrin uptake required for <italic>de novo</italic> heme biosynthesis [<xref ref-type="bibr" rid="CR16">16</xref>]. This transporter has also been found at the plasma membrane [<xref ref-type="bibr" rid="CR17">17</xref>], the Golgi apparatus [<xref ref-type="bibr" rid="CR18">18</xref>], and endo-lysosomal vesicles [<xref ref-type="bibr" rid="CR19">19</xref>]. ABC half-transporters are composed of both a transmembrane domain (TMD) and a nucleotide binding domain (NBD), and function as dimers [<xref ref-type="bibr" rid="CR20">20</xref>]. In the case of mammalian ABCB6, an additional N-terminal TMD (TMD0) with no sequence homology to any known protein is involved in its endo-lysosomal targeting [<xref ref-type="bibr" rid="CR21">21</xref>]. Close homologues of mammalian ABCB6 include the mitochondrial ABC half transporters ABCB7 (also from mammals) and ATM1 from <italic>Saccharomyces cerevisiae</italic>, which all have significant sequence homology [<xref ref-type="bibr" rid="CR20">20</xref>]. These last transporters, located in the inner mitochondrial membrane, are involved in the biogenesis of cytosolic iron/sulfur clusters (ISC) [<xref ref-type="bibr" rid="CR22">22</xref>–<xref ref-type="bibr" rid="CR24">24</xref>]. ISC are ancient cofactors found in many enzymes involved in electron transport, enzyme catalysis and regulation of gene expression, and are therefore essential for cell viability in all three kingdoms of life [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>], including trypanosomatid parasites [<xref ref-type="bibr" rid="CR27">27</xref>]. These vital cofactors are formed in the mitochondria by the ISC machinery [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. It has been suggested that ISC assembled in mitochondria are coordinated with glutathione (GSH) to form a GSH-ISC complex that is exported from mitochondria by ABCB7/ATM1 [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>] although the nature of the sulfur- and GSH- containing compound transported by ABCB7/ATM1 is still not known with certainty [<xref ref-type="bibr" rid="CR24">24</xref>]. Then, the cytosolic ISC assembly (CIA) machinery uses this mitochondrial export product for the assembly of cytosolic and nuclear iron-sulfur proteins [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR28">28</xref>]. Both mitochondrial ISC and cytosolic CIA machineries are quite conserved in trypanosomatid parasites [<xref ref-type="bibr" rid="CR27">27</xref>]. ABCB7 is essential in mice [<xref ref-type="bibr" rid="CR30">30</xref>], and in humans, ABCB7 mutations cause X-linked sideroblastic anemia and ataxia (XLSA/A), a rare disorder characterized by an early-onset of non- or slowly progressive spinocerebellar ataxia and mild to moderate anemia [<xref ref-type="bibr" rid="CR31">31</xref>]. In yeast, deletion of <italic>ATM1</italic> causes a drastic reduction of growth on rich medium, and complete growth failure on minimal medium [<xref ref-type="bibr" rid="CR32">32</xref>].</p>
      <p>The genome of <italic>Leishmania major</italic> contains a gene (<italic>LmABCB3</italic>) with sequence similarity to human <italic>ABCB6/7</italic> [<xref ref-type="bibr" rid="CR33">33</xref>], and in this work we describe its functional characterization. We have found that this protein contains a unique N-terminal extension, not found in any other ABC transporter outside the genus <italic>Leishmania</italic>, which includes a potential metal binding site and is required for the proper mitochondrial localization of the protein. Functional assays in <italic>Leishmania</italic> and yeast showed that LmABCB3 is involved in the biogenesis of mitochondrial heme and cytosolic ISC. Finally, we demonstrate that LmABCB3 is an essential protein required at minimal levels to allow parasite virulence in a mouse model of leishmaniasis.</p>
    </sec>
    <sec id="Sec2">
      <title>Methods</title>
      <sec id="Sec3">
        <title>Chemical compounds</title>
        <p>DAPI dihydrochloride, MES hydrate, Yeast synthetic drop-out medium supplements without uracil, Yeast synthetic drop-out medium supplements without tryptophan, lithium acetate dihydrate, phorbol 12-myristate 13-acetate (PMA), dibasic potassium phosphate, monopotassium phosphate, sodium chloride, DL-dithiothreitol (threo-1,4-dimercapto-2,3-butanediol), Triton X-100 (4-(1,1,3,3-tetramethylbutyl) phenyl-polyethylene glycol), Laemmli sample buffer, sodium hydrosulfite, PMSF (phenylmethylsulfonyl fluoride), D-(+)-glucose, D-galactose, glycerol, lactate acid, ethanol and hemin were obtained from Sigma. 5′-fluoroorotic acid (FOA) was from Zymo Research. PPIX-Na was from Frontier Scientific. MitoTracker Red and anti-GFP were from Molecular Probes (Invitrogen).</p>
      </sec>
      <sec id="Sec4">
        <title>Strains, culture conditions and cell transfection</title>
        <p>Promastigote forms of wild-type <italic>L. major</italic> (MHOM/IL/80/Friedlin) were maintained <italic>in vitro</italic> at 28 °C in modified RPMI-1640 medium (Invitrogen, Carlsbad, CA) supplemented with 10 % heat-inactivated fetal bovine serum (hiFBS, Invitrogen), as described previously [<xref ref-type="bibr" rid="CR34">34</xref>]. Promastigotes were transfected with the different constructs and selected for the corresponding resistance as described previously [<xref ref-type="bibr" rid="CR35">35</xref>]. The yeast background W303 ΔATM1 (MATa,<italic>ade</italic>2,<italic>can</italic>1-100 <italic>leu</italic>2-3,112,<italic>trp</italic>1-1,<italic>ura</italic>3-1 <italic>his</italic>3-11,15 <italic>atm</italic>1:HIS3::ade4), W303 ΔATM1 + ATM1 (MATa,<italic>ade</italic>2,<italic>can</italic>1-100,<italic>his</italic>3-11,15,<italic>leu</italic>2-3,112,<italic>trp</italic>1-1,<italic>ura</italic>3-,<italic>atm</italic>1:HIS3::<italic>ade</italic>4 [pMW114(URA3)]) has been previously described [<xref ref-type="bibr" rid="CR36">36</xref>]. Plasmids were transformed into the strain W303ΔATM1 + ATM1, using the lithium acetate method [<xref ref-type="bibr" rid="CR37">37</xref>]. Transformants were selected on 2 % w/v glucose SC (−Trp) plates.</p>
      </sec>
      <sec id="Sec5">
        <title>DNA manipulation</title>
        <p><italic>LmABCB3</italic> (GeneDB- <italic>L. major</italic>, Accession Code LmjF32.3080) was isolated from genomic DNA of <italic>L. major</italic> by PCR using primers pairs (see all primers used in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S2) mg1-mg2 and mg1-mg3. PCR products were cloned respectively into the <italic>Leishmania</italic> expression vector pXG (Strain B1288) and pXG-/GFP+ (strain B2863) [<xref ref-type="bibr" rid="CR38">38</xref>], kindly provided by Dr. Stephen M. Beverley (Washington University School of Medicine, USA) and sequenced. In the case of <italic>LmABCB3_∆UNE</italic>, DNA was amplified using primers pairs mg4-mg5. Site-directed mutagenesis to replace lysine 675 for methionine (K675/M) to give <italic>LABCB3</italic><sup><italic>K/M</italic></sup> was carried out with QuikChange XL Site-Directed Mutagenesis (Stratagene, La Jolla, CA) using primers pairs mg6-mg7. To express <italic>LmABCB3</italic> in yeast, first, <italic>LmABCB3</italic> was amplified (mg8-mg9), cloned in pENTR<sup>TM</sup>/SD/D-TOPO<sup>R</sup> (Invitrogen) and sequenced. Then, <italic>LmABCB3</italic> was cloned by recombination into the yeast expression vector PDR299 (kindly provided by Dr. Olivier Cagnac (EEZ-CSIC, Spain)).</p>
      </sec>
      <sec id="Sec6">
        <title>Gene deletion constructs containing <italic>hygromycin</italic> B <italic>phosphotransferase</italic> (HYG)</title>
        <p>Targeted gene replacement of the <italic>L. major LmABCB3</italic> gene was performed as described by FJ Perez-Victoria <italic>et al</italic>. [<xref ref-type="bibr" rid="CR39">39</xref>] for the case of the <italic>L. donovani LdMT</italic> gene. Briefly, a targeting DNA fragment was constructed in which the <italic>hyg</italic> gene (conferring resistance to hygromycin B), preceded by 400 bp of the 5′-untranslated region of the <italic>L. major dhfr-ts</italic> gene, was flanked by <italic>LmABCB3</italic> upstream (primers pairs mg10-mg11) and downstream (mg12-mg13) regions (Fig. <xref rid="Fig3" ref-type="fig">3a</xref>). The different fragments were amplified by PCR from genomic DNA using the indicated primers, subcloned into pGEM-T vector (Promega), and assembled in this vector. Log phase <italic>L. major</italic> promastigotes were transfected with 5 μg of the linearized DNA targeting constructions, generated by <italic>SphI</italic> and <italic>Not I</italic> digestion, by using the Amaxa Nucleofector System (Lonza). Transfected parasites were selected with 50 μg/ml hygromicin B in semi-solid culture medium as described in [<xref ref-type="bibr" rid="CR39">39</xref>].</p>
      </sec>
      <sec id="Sec7">
        <title>Fluorescence microscopy</title>
        <p>For mitochondrial labelling, promastigotes were incubated with 50 nM of MitoTracker Red (Molecular Probes) for 30 min a 28 °C, as previously described [<xref ref-type="bibr" rid="CR7">7</xref>]. Cells were washed in cold PBS and processed by microscopic observation. Images were acquired with confocal Leica SP5 microscopy and deconvolved using Huygens Professional from Scientific Volume Imaging (<ext-link ext-link-type="uri" xlink:href="http://www.svi.nl/">http://www.svi.nl</ext-link>).</p>
      </sec>
      <sec id="Sec8">
        <title>Gene expression analysis</title>
        <p>Total RNA was prepared from control and <italic>LmABCB3</italic><sup><italic>+/−</italic></sup>cells by using a total RNA isolation kit (Roche Biochemicals). cDNA was synthesized from 1 μg of total RNA using qSCRIPT<sup>TM</sup>cDNA Synthesis kit (Quanta Biosciences, Inc.) according to the manufacturer’s instructions). The cDNA obtained was amplified with primers mg14 and mg15 for <italic>LmABCB3</italic> and with primers mg16 and mg17 for <italic>GADPH</italic> (as internal control). Quantitative PCR was performed with iTaq Universal SYBR Green Supermix (BIORAD).</p>
      </sec>
      <sec id="Sec9">
        <title>In vitro infection of THP-1 macrophages</title>
        <p>THP-1 macrophages (Sigma) infections with <italic>L. major</italic> were performed as described [<xref ref-type="bibr" rid="CR40">40</xref>]. Briefly, THP-1 macrophages were infected at 35 °C with stationary-phase promastigotes forms of control and <italic>LmABCB3</italic><sup><italic>+/−</italic></sup><italic>L. major</italic> parasites at a ratio of 1:10 (macrophages:parasites). Excess parasites were removed after 24 h by washing and the macrophages were further incubated for the indicated times at 37 °C in a 5 % CO<sub>2</sub> atmosphere. Cells were then fixed, stained with DAPI and observed in a wide-field Olympus IX81 fluorescence microscopy. Parasites were quantified using an analyze counter of the Image J software (<ext-link ext-link-type="uri" xlink:href="http://rsb.info.nih.gov/ij/">http://rsb.info.nih.gov/ij/</ext-link>) as described [<xref ref-type="bibr" rid="CR41">41</xref>].</p>
      </sec>
      <sec id="Sec10">
        <title>Analysis of in vivo infection</title>
        <p>The analysis of the in vivo infection was performed as described in [<xref ref-type="bibr" rid="CR34">34</xref>] with some modifications. Briefly, six-week-old male C57BL/6 J mice (Charles River Breeding Laboratories) were maintained in the Animal Facility Service of our Institute under pathogen-free conditions. Animals (seven mice/group) were injected subcutaneously (s.c.) in their left hind footpads with 10<sup>6</sup> 
<italic>L. major</italic> stationary promastigotes resuspended in PBS (1.2 mM KH<sub>2</sub>PO<sub>4</sub>, 8.1 mM Na<sub>2</sub>HPO<sub>4</sub>, 130 mMNaCl and 2.6 mMKCl adjusted to pH 7), as described above. Disease progression was monitored by determining the inflammation thickness and the area of the lesion of the infected footpad using a Digimatic Caliper (Mitutoyo, Japan) and comparing these values with the uninfected contralateral control footpad.</p>
      </sec>
      <sec id="Sec11">
        <title>Analysis of <italic>de novo</italic> synthesized heme</title>
        <p>Synthesis of heme from its precursor PPIX was performed as previously described [<xref ref-type="bibr" rid="CR7">7</xref>] with some modifications. Briefly, parasites were incubated in culture medium supplemented with 10 % heme free FBS for 16 h with or without 0.5 uM PPIX at 28 °C. Then parasites were washed, lysed with freeze/thawing cycles with liquid nitrogen and intracellular heme was measured with the Hemin Assay Kit (Sigma) and normalized for the amount of protein. <italic>De novo</italic> synthesized heme was the difference between heme levels measured in parasites incubated in the presence and the absence of PPIX.</p>
      </sec>
      <sec id="Sec12">
        <title>Hemin-agarose pull-down assays</title>
        <p>Hemin-agarose pull-down experiments were performed as described previously [<xref ref-type="bibr" rid="CR7">7</xref>] but solubilizing the membrane proteins before the pulldown assay. Briefly, 2 μg of membrane proteins of parasites expressing LmABCB3-GFP, obtained as described [<xref ref-type="bibr" rid="CR42">42</xref>], were solubilized with 1 % Triton X-100 during 3 h at 4 °C. After ultracentrifugation, solubilized proteins were diluted 10-fold with dilution buffer (100 mMKPi pH 7.4, 150 mMNaCl, 1 mM sodium hidrosulfite and 1 mM PMSF) to decrease the final detergent concentration to 0.1 %. Washed hemin-agarose aliquots were equilibrated with cold dilution buffer containing 0.1 % Triton X-100 and incubated with 30 μg solubilized protein during 30 min at 4 °C. Then, samples were washed four times with cold washing buffer (50 mMKPi pH 7.4, 150 mMNaCl, 0.1 % Triton X-100 and 1 mM DTT) and eluted with 20 μl of Laemmly sample buffer. LmABCB3-GFP was detected by western blotting using a polyclonal antibody against GFP. When indicated, different concentrations of free hemin or PPIX-Na were included during incubation of the solubilized proteins with the hemin-agarose.</p>
      </sec>
      <sec id="Sec13">
        <title>Effects of the heterologous expression of LmABCB3 on the growth of yeast lacking ScATM1</title>
        <p>W303 ΔATM1 + ATM1 and W303 ΔATM1 + ATM1 + LmABCB3 cells were plated on 2 % (w/v) glucose minimal (SD) media (6.7 g/L yeast nitrogen base without amino acids, 1.87 g/L yeast synthetic drop-out supplements without tryptophan) containing or not 1 mg/ml FOA and incubated at 30 °C for three days. W303 ΔATM1, W303 ΔATM1 + ATM1 and W303 ΔATM1 + ABCB3 were diluted into rich (YP) media (20 g/L peptone, 10 g/L yeast extract, 3.8 g/L MES) supplemented with the indicated carbon sources: (2 % (w/v) glucose, 3 % (w/v) galactose, 2 % (w/v) lactate, 2 % (w/v) glycerol or 2 % (v/v) ethanol) to an <italic>A</italic><sub>600</sub> = 0.05. After one and two days of growth at 30 °C, the <italic>A</italic><sub>600</sub> was measured.</p>
      </sec>
      <sec id="Sec14">
        <title>Model building and docking analysis</title>
        <p>A model for the 3D-structure of <italic>L. major</italic> ABCB3 (aa 283–875) was built using Phyre2 molecular modeling server (<ext-link ext-link-type="uri" xlink:href="http://www.sbg.bio.ic.ac.uk/phyre2/html/page.cgi?id">http://www.sbg.bio.ic.ac.uk/phyre2/html/page.cgi?id</ext-link>= index) based on <italic>L. major</italic> ABCB3 complete protein sequence. DALI server (<ext-link ext-link-type="uri" xlink:href="http://ekhidna.biocenter.helsinki.fi/dali_server/">http://ekhidna.biocenter.helsinki.fi/dali_server/</ext-link>) calculated the 3D-structural superimposition of yeast ATM1 structure (pdb code: 1 MHY, aa) and <italic>L. major</italic> ABCB3 model. Docking calculations were run into the Autodock 4.0 program. The predicted model for LmABCB3 (aa 283–875) was prepared for docking through the AutodockTools interface (<ext-link ext-link-type="uri" xlink:href="http://autodock.scripps.edu/">http://autodock.scripps.edu/</ext-link>). The trypanothione coordinates were uploaded from the PDB structure 4ADW and used as a potential ligand. None of the residues in the protein were used as constrains in the docking simulation. The number of ligand orientations to the protein that are samples was set as default.</p>
      </sec>
      <sec id="Sec15">
        <title>Bioinformatic tools used</title>
        <p>Sequences retrieval using Uniprot (<ext-link ext-link-type="uri" xlink:href="http://www.uniprot.org/">http://www.uniprot.org/</ext-link>) allowed a search for homology patterns through the BLAST (<ext-link ext-link-type="uri" xlink:href="http://blast.ncbi.nlm.nih.gov/Blast.cgi?PROGRAM=blastp&amp;PAGE_TYPE=BlastSearch&amp;LINK_LOC=blasthome">http://blast.ncbi.nlm.nih.gov/Blast.cgi?PROGRAM=blastp&amp;PAGE_TYPE=BlastSearch&amp;LINK_LOC=blasthome</ext-link>) and CLUSTALW (<ext-link ext-link-type="uri" xlink:href="https://npsa-prabi.ibcp.fr/cgi-bin/npsa_automat.pl?page=npsa_clustalw.html">https://npsa-prabi.ibcp.fr/cgi-bin/npsa_automat.pl?page=npsa_clustalw.html</ext-link>) software packages.</p>
        <p>The identification of undescribed and potential new regions in the UNE sequence of LmABCB3 was achieved by the SMART domain recognition resource. The membrane bound topology recognition software MEMSAT3 (<ext-link ext-link-type="uri" xlink:href="http://bioinf.cs.ucl.ac.uk/?id=756">http://bioinf.cs.ucl.ac.uk/?id=756</ext-link>) was used through the interactive platform for secondary structure prediction analysis PSIPRED (<ext-link ext-link-type="uri" xlink:href="http://bioinf.cs.ucl.ac.uk/psipred/">http://bioinf.cs.ucl.ac.uk/psipred/</ext-link>). The identification of a mitochondrial targeting sequence was performed using Mitoprot software (<ext-link ext-link-type="uri" xlink:href="http://ihg.gsf.de/ihg/mitoprot.html">http://ihg.gsf.de/ihg/mitoprot.html</ext-link>).</p>
        <p>To assess the phylogenetic analysis of mitochondrial ABCB transporter sequences, protein sequences were first aligned using MAFFT (<ext-link ext-link-type="uri" xlink:href="http://mafft.cbrc.jp/alignment/server/">http://mafft.cbrc.jp/alignment/server/</ext-link>). The resulting multiple alignments were subjected to phylogenetic analysis using the Maximum Likelihood method of the MEGA 6 software [<xref ref-type="bibr" rid="CR43">43</xref>]. Initial tree(s) for the heuristic search were obtained automatically by applying Neighbor-Join and BioNJ algorithms to a matrix of pairwise distances estimated using a JTT model, and then selecting the topology with superior log likelihood value.</p>
      </sec>
      <sec id="Sec16">
        <title>Statistical analysis</title>
        <p>Experiments were performed three times in duplicate. All data are presented as mean and error represents S.E.M. Statistical significance was determined by Student’s <italic>t</italic>-test. Significance was considered as <italic>p</italic> &lt; 0.05.</p>
      </sec>
      <sec id="Sec17">
        <title>Ethics statement</title>
        <p>All experiments were performed according to the National/EU Guidelines for the Care and Use of Laboratory Animals in Research and the approval of the Ethics Committee of the Spanish National Research Council (CSIC, file JMPV.1.14/CEEA).</p>
      </sec>
    </sec>
    <sec id="Sec18">
      <title>Results</title>
      <sec id="Sec19">
        <title>LmABCB3 is an atypical ABC half-transporter with a unique N-terminal extension (UNE)</title>
        <p>Initially, we used human ABCB6, a known mitochondrial porphyrin transporter, as a template to identify putative homologs in the <italic>L. major</italic> genome database. This preliminary Blast analysis identified a potential <italic>L. major</italic> candidate, named ABCB3 (GeneDB-<italic>Leishmania major</italic>, Accession Code LmjF.32.3080) by Leprohon et al. [<xref ref-type="bibr" rid="CR33">33</xref>]. This gene was annotated as a 2112 nucleotide gene coding for a 704 amino acids protein of 77.39 kDa. However, the <italic>L. major</italic> ABCB3 gene also contains two additional in phase ATG codons (ATG<sub>−597</sub> and ATG<sub>−582</sub> in Fig. <xref rid="Fig1" ref-type="fig">1a</xref>) [<xref ref-type="bibr" rid="CR44">44</xref>] upstream of the annotated initial ATG (ATG<sub>0</sub> in Fig. <xref rid="Fig1" ref-type="fig">1a</xref>). ATG<sub>−582</sub>is conserved in all <italic>Leishmania</italic> genomes analyzed whereas ATG<sub>−597</sub> is found exclusively in <italic>L. major</italic>. Interestingly, none of these upstream ATG codons are present in the syntenic genes in the <italic>T. cruzi</italic> and <italic>T. brucei</italic> genomes (Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Figure S1). Use of ATG<sub>−597</sub> predicts a coding region of 2709 nt, and a protein of 903 amino acids with a molecular weight of 97.7 kDa, including a unique N-terminal extension (UNE) of 20 kDa (Fig. <xref rid="Fig1" ref-type="fig">1b</xref>). This UNE includes 199 amino acids with a predicted isoelectric point (Ip) of 9.5, in contrast to the rest of the protein, which is more acidic (Ip of 5.9). A blast analysis using the UNE region showed that it was found exclusively in <italic>Leishmania</italic> ABCB3, and that it was not present in any other sequenced genome, including those of the related organisms <italic>T. brucei</italic> and <italic>T. cruzi</italic> (Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Figure S1). Similarly, there was no significant sequence similarity between the UNE region and the unique TMD0 domain from HsABCB6. Moreover, although secondary structure prediction analysis proposed a mainly helical configuration together with non-structured regions (possibly involved in protein-protein interactions) we have not been able to find a structural homologue for this extra sequence through different structural homology model based search programs [<xref ref-type="bibr" rid="CR45">45</xref>]. However using both a domain identification resource (SMART, [<xref ref-type="bibr" rid="CR46">46</xref>]) and a secondary structure prediction algorithm (Psipred, [<xref ref-type="bibr" rid="CR47">47</xref>]) new potential sub-regions that may provide a lead to the function of this extension have been identified (Fig. <xref rid="Fig1" ref-type="fig">1b</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p>LmABCB3 contains a unique N-terminal extension (UNE). <bold>a</bold> Schematic representation of <italic>LmABCB3</italic> containing mRNA. In phase ATG codons found in 5‘ UTR and TGA Stop codon are indicated. <bold>b</bold> Schematic representation of LmABCB3 (<italic>up</italic>) showing the unique N-terminal extension (UNE), the Transmembrane Domain (TMD) and the Nucleotide Binding domain (NBD), indicating the K<sup>675</sup>M mutation (K/M) in the conserved Walker A motif that inactivates the protein. The schematic representation of the UNE region (<italic>down</italic>) highlights several motifs and sequences: i) a putative Mitochondrial Localization Signal (MLS) with conserved MLRR motif (<italic>underlined in red</italic>) and Arg (<italic>red</italic>) and hydrophobic Ala, Val and Leu residues (<italic>green</italic>); ii) a putative transmembrane segment (TM); iii) a TRASH domain with conserved Cys probably involved in metal co-ordination (<italic>red</italic>) and other residues (<italic>green</italic>) conserved in 70 % of TRASH domains [<xref ref-type="bibr" rid="CR50">50</xref>]; iv) a Glycine/Serine repeat and iv) a putative signal peptide (<italic>red line</italic>). <bold>c</bold> Phylogenetic analysis of mitochondrial ABCB transporter sequences from <italic>Leishmania</italic>, mammals and yeast. Aligned protein sequences were subjected to phylogenetic analysis as described in Methods. The human representative of each mammalian subfamily was incorporated in the analysis to define each subfamily. Lm: <italic>L. major</italic>; Tb: <italic>T. brucei</italic>; Tc: <italic>T. cruzi</italic>; Hs: <italic>H. sapiens</italic>; Sc: <italic>S. cereviciae</italic>
</p></caption><graphic xlink:href="13071_2015_1284_Fig1_HTML" id="MO1"/></fig></p>
        <p>There are several motifs and sequence elements present in the UNE region, including a signal peptide sequence spanning from the N-terminal methionine to position 40 (Signal-BLAST, [<xref ref-type="bibr" rid="CR48">48</xref>]). The sequence from amino acids 45 to 65 encodes a potential transmembrane segment as proposed by MEMSAT3 [<xref ref-type="bibr" rid="CR49">49</xref>], although this result has not been confirmed by other available membrane topology prediction programs. A putative metal binding domain (aa 78–117) belonging to the TRASH super family was identified using the SMART algorithm. TRASH domains contain a well-conserved cysteine containing motif involved in metal coordination, represented in LmABCB3 by cysteines 78, 105, and 109 (Fig. <xref rid="Fig1" ref-type="fig">1b</xref>), and play roles in metal sensing, regulation and trafficking and in heavy-metal resistance [<xref ref-type="bibr" rid="CR50">50</xref>]. Finally, a Glycine/Serine repeat (aa 166–180) was located next to the described metal-binding site. Similar amino acid repeats with diverse functions as structural components of proteoglycans [<xref ref-type="bibr" rid="CR51">51</xref>] or as hinge sequences in inmunoglobulins [<xref ref-type="bibr" rid="CR52">52</xref>] have been reported.</p>
        <p>Finally, a comparative analysis between LmABCB3 and representative mitochondrial ABCB transporters using the CLUSTALW software [<xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR54">54</xref>] (Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Table S1) showed the highest degree of similarity with HsABCB6 (31.0 % identity), HsABCB7 (29.3 % identity) and ScATM1 (27.8 % identity) and the lowest (23.6–18.1 % identity) with HsABCB8, HsABCB10, ScMDL1 and ScMDL2. The sequence identity of LmABCB3 with the proteins encoded by the syntenic genes in <italic>T. brucei</italic> and <italic>T. cruzi</italic> was 45.7 % and 49.0 %, respectively. A phylogenetic analysis of this family of proteins indeed confirmed that LmABCB3 belonged to the HsABCB6/7-ScATM1 cluster (Fig. <xref rid="Fig1" ref-type="fig">1c</xref>).</p>
      </sec>
      <sec id="Sec20">
        <title>LmABCB3 is localized to the mitochondrion</title>
        <p>A theoretical analysis performed with MitoProtII software [<xref ref-type="bibr" rid="CR55">55</xref>] indicated a higher probability for a mitochondrial localization of LmABCB3 when the UNE region was included (94.9 % vs 56.4 %). In order to confirm this prediction we used confocal microscopy to evaluate the localization of C-terminal GFP tagged full-length LmABC3, and a truncated version lacking the UNE (LmABCB3_∆UNE). Western blot analysis using antibodies against GFP confirmed the expression of both proteins (Additional file <xref rid="MOESM4" ref-type="media">4</xref>: Figure S2). Next, we compared the cellular distribution of these GFP-tagged proteins with the mitochondrial marker MitoTracker Red, and calculated the co-localization coefficients (Pearson’s and Mander’s) after image deconvolution. LmABCB3 co-localized completely with the mitochondrial marker (Fig. <xref rid="Fig2" ref-type="fig">2a</xref>) with a Pearson’s co-localization index of 0.80 ± 0.03 (Fig. <xref rid="Fig2" ref-type="fig">2b</xref>). In contrast, LmABCB3_∆UNE was not localized to the mitochondrion (Fig. <xref rid="Fig2" ref-type="fig">2a and b</xref>, Pearson’s index of 0.23 ± 0.01). The exclusion of LmABCB3_∆UNE from mitochondria was evidenced by Mander’s index of 0.07 ± 0.02 compared with the Mander’s index for full LmABCB3 (0.81 ± 0.06) (Fig. <xref rid="Fig2" ref-type="fig">2c</xref>). All together these results indicate that the UNE region was required for the proper trafficking of LmABCB3 to the mitochondrion. Analysis of the sequence of the UNE predicts the presence of an MLRR sequence at its amino terminus that is rich in arginines and hydrophobic amino acids (alanine, valine and leucine) (Fig. <xref rid="Fig1" ref-type="fig">1b</xref>), which is characteristic of mitochondrial localization signals found in trypanosomatid protozoa [<xref ref-type="bibr" rid="CR56">56</xref>, <xref ref-type="bibr" rid="CR57">57</xref>].<fig id="Fig2"><label>Fig. 2</label><caption><p>The UNE region is required for the mitochondrial localization of LmABCB3. <bold>a</bold> Subcellular localization of LmABCB3. Representative picture <italic>of L. major</italic> promastigotes expressing LmABCB3-GFP or LmABCB3_∆UNE-GFP (GFP) were incubated at 28 °C with 50 nM of Mitotracker Red (Mit-Red) for 30 min at 4 °C. Nomarsky images are shown in the inset. Scale bar: 1 μm. The figure shows a representative parasite of a total population of parasites with a similar fluorescence pattern. <bold>b</bold>-<bold>c</bold> Quantitative colocalization analysis. Pearson’s coefficient (<bold>b</bold>) was calculated for each individual deconvolved image. Mander’s coefficients (<bold>c</bold>) were calculated to define the M1 and M2 as the proportion of pixels in one channel (M1 = green, GFP) that overlap with some signal in other channel (M2 = red, Mit-Red). Both coefficients were assessed using “JACoP”, a colocalization plugin available in Fiji software. Full: LmABCB3-GFP; ∆UNE: LmABCB3_∆UNE-GFP. ** <italic>p</italic> &lt; 0.001</p></caption><graphic xlink:href="13071_2015_1284_Fig2_HTML" id="MO2"/></fig></p>
      </sec>
      <sec id="Sec21">
        <title>LmABCB3 is an essential protein for <italic>Leishmania</italic></title>
        <p>LmABCB3 is constitutively expressed in <italic>L. major</italic> promastigotes [<xref ref-type="bibr" rid="CR44">44</xref>]. This fact, together with the dimerization requirement of ABC half-transporters to become functional, allowed us to attempt the down-regulation of LmABCB3 activity through a dominant-negative approach, as we have described previously for LmABCG5 [<xref ref-type="bibr" rid="CR7">7</xref>] and LmABCG2 [<xref ref-type="bibr" rid="CR34">34</xref>]. To do so, we introduced a mutation at position 675 (K<sup>675</sup>M, K/M) which eliminates a conserved lysine inside the Walker A motif (Fig. <xref rid="Fig1" ref-type="fig">1b</xref>), known to be critical for ATP hydrolysis in ABC transporters [<xref ref-type="bibr" rid="CR58">58</xref>]. Similar mutations, even if present only in one catalytic domain, inactivated all known ABC proteins [<xref ref-type="bibr" rid="CR58">58</xref>]. Indeed, the overexpression of different ABC half-transporters with an equivalent K/M substitution produced dominant-negative inhibition in many wild-type half-transporters [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR59">59</xref>]. Subsequently, we transfected into <italic>L. major</italic> constructs containing either wild-type <italic>LmABCB3</italic> or mutated <italic>LmABCB3</italic><sup><italic>K/M</italic></sup>. Transgenic parasites were easily recovered after hygromycin selection using the wild-type construct, as expected. In contrast, it was impossible to obtain parasites expressing mutant LmABCB3<sup>K/M</sup> in spite of more than eight independent transfection assays performed. This result suggested not only that LmABCB3 function was essential for <italic>L. major</italic> promastigotes, but also that the low levels of functional wild-type (Wt) dimer expected from the dominant negative approach used were not sufficient to cover the requirements of the parasite.</p>
      </sec>
      <sec id="Sec22">
        <title>Heterozygous deletion of <italic>LmABCB3</italic> allele severely reduces <italic>L. major</italic> virulence</title>
        <p>The dominant negative strategy produced important insights about an essential role of LmABCB3 but it did not allow us to perform further functional assays. We therefore deleted one allele of <italic>LmABCB3</italic> by homologous recombination following the strategy described in Fig. <xref rid="Fig3" ref-type="fig">3a</xref>, to obtain a heterozygous knock out line (<italic>LmABCB3</italic><sup><italic>+/−</italic></sup>). Thus, parasites were transfected with a linearized hygromycin resistant cassette flanked by 5′ and 3′ <italic>LmABCB3</italic> UTR sequences. After hygromycin selection, a clone was recovered and its DNA isolated. The insertion of the hygromycin cassette in the right <italic>locus</italic> was confirmed by PCR (Fig. <xref rid="Fig3" ref-type="fig">3b</xref>): using a forward primer from the 5′ UTR region of the <italic>LmABCB3</italic> gene and a reverse primer from the hygromycin resistance gene, an amplification of the expected size was obtained only in <italic>LmABCB3</italic><sup><italic>+/−</italic></sup>parasites. Analysis by real-time quantitative PCR (RT-qPCR) showed an approximate 60 % reduction in <italic>LmABCB3 </italic>mRNA level in <italic>LmABCB3</italic><sup><italic>+/−</italic></sup>cells (Fig. <xref rid="Fig3" ref-type="fig">3c</xref>). Although gene expression in trypanosomatids is post-transcriptionally regulated, this result suggests a reduction in LmABCB3 protein level in <italic>LmABCB3</italic><sup><italic>+/−</italic></sup>parasites, a point that could not be definitively confirmed due to the absence of specific antibodies. We could not obtain any double knock out line using a similar strategy with a second resistance cassette, in spite of many assays, consistent with the essential role of LmABCB3 as described above.<fig id="Fig3"><label>Fig. 3</label><caption><p>Generation and characterization of <italic>L. major</italic> promastigotes with one <italic>LmABCB3</italic> allele deleted. <bold>a</bold> Schematic representation of the <italic>LmABCB3</italic> locus and the hygromycin-resistance gene targeting construct used for gene replacement. The primers used (arrows 1–3) to verify the specific gene targeting and the expected sizes of the PCR-amplified products with the different pairs of primers are indicated. <bold>b</bold> PCR analysis of the <italic>LmABCB3</italic> locus in control and single knock out (<italic>LmABCB3</italic>
<sup><italic>+/−</italic></sup>) mutant promastigotes. The specific gene-targeting PCR product (primers 1 and 3, 3.6 kb) confirmed that replacement with the hygromycin-resistance gene in one LmABCB3 allele in <italic>LmABCB3</italic>
<sup><italic>+/−</italic></sup>parasites (+/−, lanes 2). Primers 1 and 2 amplified the expected 1.6 kb product in Wt (+/+, lanes 1) and in <italic>LmABCB3</italic>
<sup><italic>+/−</italic></sup>parasites. Lanes 3 shows the DNA marker used. <bold>c</bold>
<italic>LmABCB3</italic>
<sup><italic>+/−</italic></sup>promastigotes have reduced <italic>LmABCB3</italic> expression. The expression level of <italic>LmABCB3</italic> from control and <italic>LmABCB3</italic>
<sup><italic>+/−</italic></sup>
<italic>L. major</italic> promastigotes was analyzed by qRT-PCR using mRNA isolated from each cell line as described in Methods. **<italic>p</italic> &lt;0.001. <bold>d</bold>
<italic>LmABCB3</italic>
<sup><italic>+/−</italic></sup> parasites grow as axenic promastigotes. Growth curve obtained after cultivation of control (<italic>white circles</italic>) and <italic>LmABCB3</italic>
<sup><italic>+/−</italic></sup>(<italic>black circles</italic>) promastigotes during the indicated time. The results represent the mean ± SEM of three independent experiments. *<italic>p</italic> &lt; 0.05; **<italic>p</italic> &lt; 0.001</p></caption><graphic xlink:href="13071_2015_1284_Fig3_HTML" id="MO3"/></fig></p>
        <p>The reduced expression of LmABCB3in <italic>LmABCB3</italic><sup><italic>+/−</italic></sup>cells resulted in a 30 % (<italic>p</italic> &lt; 0.001) reduction in growth of promastigote parasites (Fig. <xref rid="Fig3" ref-type="fig">3d</xref>). This result contrasts with the dominant negative lethal effect above described, probably indicating that the level of functional LmABCB3 is higher in <italic>LmABCB3</italic><sup><italic>+/−</italic></sup> parasites than in dominant negative parasites. To compare the ability of control and <italic>LmABCB3</italic><sup><italic>+/−</italic></sup> parasites to infect host macrophages and replicate as intracellular amastigotes, THP-1 macrophages were infected with stationary-phase promastigotes from control and <italic>LmABCB3</italic><sup><italic>+/−</italic></sup> parasites. The percentage of infected macrophages and the number of intracellular amastigotes were quantified at 24 and 120 h post infection. Although <italic>LmABCB3</italic><sup><italic>+/−</italic></sup> parasites were capable of infecting macrophages (Fig. <xref rid="Fig4" ref-type="fig">4a</xref>), they did it at a significantly lower rate than control parasites (15 vs 42 %, <italic>p</italic> &lt; 0.0002) (Fig. <xref rid="Fig4" ref-type="fig">4b</xref>). Significantly, during the 5 days post infection, the number of control amastigotes increased almost 3-fold (2.78-fold increase, <italic>p</italic> &lt; 0.0009), whereas the <italic>LmABCB3</italic><sup><italic>+/−</italic></sup> parasites failed to complete a single replication cycle inside the macrophages (1.31-fold increase, <italic>p</italic> &gt; 0.44) (Fig. <xref rid="Fig4" ref-type="fig">4c</xref>).<fig id="Fig4"><label>Fig. 4</label><caption><p>LmABCB3 is required for the intracellular replication of amastigotes. <bold>a</bold>. Infection of macrophages by control and <italic>LmABCB3</italic>
<sup><italic>±/−</italic></sup> parasites. Representative picture of the infection of THP-1 macrophages with control and <italic>LmABCB3</italic>
<sup><italic>+/−</italic></sup> stationary-phase <italic>L. major</italic> promastigotes, performed as described in Methods. At the indicated points, cells were fixed and DAPI (blue) stained. The macrophages nuclei (mn) and the kinetoplast and nuclei of intracellular amastigotes (arrowhead) are indicated. Scale bar: 5 um. <bold>b</bold>
<italic>LmABCB3</italic>
<sup><italic>+/−</italic></sup> parasites have reduced ability to infect macrophages. THP-1 macrophages were infected with control and <italic>LmABCB3</italic>
<sup><italic>+/−</italic></sup>promastigotes as above described and the percentage of infected macrophages (<italic>n</italic> = 300 macrophages/group) was calculated. The results shown are the means ± SEM of three independent experiments performed in duplicated. **<italic>p</italic> &lt;0.0002. <bold>c</bold>
<italic>LmABCB3</italic>
<sup><italic>+/−</italic></sup>parasites are unable to replicate as intracellular amastigotes. THP-1 macrophages were infected with control and <italic>LmABCB3</italic>
<sup><italic>+/−</italic></sup> promastigotes as above described and the average number of intracellular amastigotes per infected macrophage was calculated at the indicated time points. The results shown are the means ± SEM. **<italic>p</italic> &lt;0.0009</p></caption><graphic xlink:href="13071_2015_1284_Fig4_HTML" id="MO4"/></fig></p>
        <p>As <italic>LmABCB3</italic><sup><italic>+/−</italic></sup> parasites did not replicate properly as intracellular amastigotes in the in vitro assay, we decided to analyze their ability to produce disease in an in vivo murine model of cutaneous leishmaniasis. C57BL/6 mice were infected with 10<sup>6</sup> control or <italic>LmABCB3</italic><sup><italic>+/−</italic></sup> stationary-phase promastigotes by s.c. footpad inoculation, and inflammation in the footpad was monitored weekly for 15 weeks (Fig. <xref rid="Fig5" ref-type="fig">5</xref>). Mice infected with control parasites started developing progressive inflammation and edema around the injected site by the second week, reaching a maximum level at three weeks, after which the footpad began to recover slowly as expected for this model. In contrast, mice infected with <italic>LmABCB3</italic><sup><italic>+/−</italic></sup> parasites showed very little footpad inflammation, with minimal differences between infected and uninfected footpads.<fig id="Fig5"><label>Fig. 5</label><caption><p>LmABCB3 is essential for <italic>L. major</italic> virulence. C57BL/6 male mice were infected with 1 × 10<sup>6</sup> stationary-phase <italic>L. major</italic> promastigotes of control or <italic>LmABCB3</italic>
<sup><italic>+/−</italic></sup>
<italic>L. major</italic> in the left hind footpad. <bold>a</bold> Inflammation progression (difference between inoculated footpad and contralateral uninfected footpad) was recorded weekly. The values represent the means ± SEM of 7 mice. <bold>b</bold> Images show representative pictures of the footpad inflammation at 3 week post infection</p></caption><graphic xlink:href="13071_2015_1284_Fig5_HTML" id="MO5"/></fig></p>
      </sec>
      <sec id="Sec23">
        <title>LmABCB3 is required for mitochondrial heme biosynthesis</title>
        <p>We next analyzed whether the essential role of LmABCB3 in <italic>L. major</italic> was related to mitochondrial porphyrin trafficking, as shown for mammalian HsABCB6 [<xref ref-type="bibr" rid="CR16">16</xref>]. Although <italic>Leishmania</italic> is auxotrophous for heme, it possesses a ferrochelatase gene (not present in <italic>Trypanosoma</italic>) [<xref ref-type="bibr" rid="CR14">14</xref>] that adds iron to the precursor PPIX in the mitochondrial matrix to generate heme. This allows for an indirect quantification of the rate of mitochondrial porphyrin uptake via measurement of <italic>de novo</italic> heme synthesis from exogenous PPIX [<xref ref-type="bibr" rid="CR7">7</xref>]. As shown in Fig. <xref rid="Fig6" ref-type="fig">6a</xref>, LmABCB3 overexpression increased the amount of heme synthetized from PPIX up to 60 %. In contrast, the deletion of one allele of <italic>LmABCB3</italic> diminished the amount of <italic>de novo</italic> heme formation by around 75 % with respect to control parasites.<fig id="Fig6"><label>Fig. 6</label><caption><p>LmABCB3 is required for mitochondrial heme biosynthesis. <bold>a</bold> LmABCB3 cell levels correlate with the amount of heme synthesized from exogenous PPIX. The mitochondrial synthesis of heme from its precursor PPIX was measured as described in Experimental procedures after incubation of control, <italic>LmABCB3</italic>
<sup><italic>+/−</italic></sup> and LmABCB3 overexpressing <italic>L. major</italic> promastigotes with 0.5 μM PPIX. The results represent the mean ± SEM of three independent experiments. * <italic>p</italic>&lt;0.05, ** <italic>p</italic>&lt;0.02, *** <italic>p</italic>&lt;0.001. <bold>b</bold> LmABCB3 interacts with heme. Solubilized membrane proteins of <italic>L. major</italic> parasites overexpressing LmABCB3-GFP were subjected to a pull-down assay with hemin-agarose in the absence (0) or the presence of the indicated increasing concentration of free hemin (upper panel) or free PPIX (lower panel). LmABCB3-GFP was detected by inmmunoblotting with Anti-GFP antibody (1:5000)</p></caption><graphic xlink:href="13071_2015_1284_Fig6_HTML" id="MO6"/></fig></p>
        <p>We also explored the ability of LmABCB3 to bind heme using a pull-down assay, which demonstrated that detergent solubilized LmABCB3-GFP bound to hemin-agarose (Fig. <xref rid="Fig6" ref-type="fig">6b</xref>). This interaction was efficiently inhibited by 10 μM free hemin, whereas around 50-fold higher concentration of free PPIX was required to achieve similar inhibition of the LmABCB3-hemin agarose interaction (Fig. <xref rid="Fig6" ref-type="fig">6b</xref>). Altogether, these results provide clear evidence that LmABCB3 is involved in mitochondrial heme biosynthesis.</p>
      </sec>
      <sec id="Sec24">
        <title>LmABCB3 is required for the maturation of cytosolic iron/sulfur clusters</title>
        <p>In addition to HsABCB6, LmABCB3 also showed similarity to HsABCB7. This protein and its orthologue in <italic>S. cerevisiae</italic>, ATM1, form part of the mitochondrial ISC export machinery and are essential in the generation of cytosolic ISC [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. Deletion of <italic>ATM1</italic> gene causes a drastic growth defect in yeast cells, including failure to grow on minimal medium and inability to use non-fermentable carbon sources [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR60">60</xref>].</p>
        <p>To analyze the ability of LmABCB3 to complement ScATM1 function in yeast we transfected Δ<italic>ATM1</italic> yeast containing a plasmid-encoded copy of <italic>ScATM1</italic>with a <italic>URA3</italic> marker (ΔATM1/ATM1) [<xref ref-type="bibr" rid="CR36">36</xref>] with the yeast expression plasmid PDR299 containing either <italic>LmABCB3</italic> or no insert. Then, both yeast strains were plated in minimal medium with glucose containing or not 1 mg/ml 5′-fluoroorotic acid (FOA). This compound is converted to a toxic derivate in strains expressing the URA3 gene coding protein, allowing curing yeast strains of plasmid-encoded <italic>ATM1</italic> with <italic>URA3</italic> marker [<xref ref-type="bibr" rid="CR36">36</xref>]. Figure <xref rid="Fig7" ref-type="fig">7a</xref> shows that ΔATM1 yeast cells transfected with PDR229 lacking LmABCB3 were unable to grow in FOA containing plates, whereas <italic>ΔATM1</italic> cells expressing LmABCB3 grew normally, indicating that LmABCB3 was able to functionally complement ScATM1. We also assessed the effect of LmABCB3 on the growth of <italic>ΔATM1</italic>cells in rich medium in the presence of different carbon sources. As expected [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR36">36</xref>], <italic>ΔATM1</italic> yeast grew in fermentable (glucose and galactose) but not in non-fermentable (glycerol, lactate and ethanol) carbon sources, whereas <italic>ΔATM1/ATM1</italic> cells grew in all 5 (Fig. <xref rid="Fig7" ref-type="fig">7b</xref>). Interestingly, the expression of LmABCB3 was as effective as ScATM1 in restoring the growth of ΔATM1 yeast in both fermentable and non-fermentable carbon sources (Fig. <xref rid="Fig7" ref-type="fig">7b</xref>). These results strongly suggest that similar to ScATM1 and HsABCB7, LmABCB3 functions as a homodimer that localizes to the inner mitochondrial membrane with its NBD on the matrix side, and exports a substrate required for cytosolic ISC biogenesis.<fig id="Fig7"><label>Fig. 7</label><caption><p>LmABCB3 completely rescue the severe growth defect phenotype of yeast lacking ScATM1. <bold>a</bold> LmABCB3 allows the normal growth of ΔATM1 yeast in minimal medium. ΔATM1/ATM1 (control) and (ΔATM1/ATM1 + LmABCB3 (LmABCB3) cells were plated on minimal (SD) glucose media containing (+FOA) or not (−FOA) 1 mg/ml 5′-fluoroorotic acid (FOA) and incubated at 30 °C for three days. <bold>b</bold> LmABCB3 allows ΔATM1 yeast to use of non-fermentable carbon sources. ΔATM1, ΔATM1/ATM1 and ΔATM1/LmABCB3 cells were diluted into rich (YP) media containing 2 % (w/v) glucose, 3 % (w/v) galactose, 2 % (v/v) glycerol, 2 % (w/v) lactate, or 2 % (v/v) ethanol to an A<sub>600</sub> 0.05. After 24 (left) or 48 (right) hours of growth at 30 8C, the A<sub>600</sub> was measured. Growth is expressed relative to ΔATM1/ATM1 growth in HC glucose</p></caption><graphic xlink:href="13071_2015_1284_Fig7_HTML" id="MO7"/></fig></p>
        <p>Recently, the structure of ScATM1 [<xref ref-type="bibr" rid="CR61">61</xref>] and a related bacterial transporter [<xref ref-type="bibr" rid="CR62">62</xref>] have been solved. These proteins were crystalized in complex with GSH, in agreement with the proposed role of ScATM1 in the export of a GSH-ISC complex [<xref ref-type="bibr" rid="CR29">29</xref>] or any other sulfur- and GSH- containing molecule to the cytosol [<xref ref-type="bibr" rid="CR24">24</xref>]. GSH mainly interacts with ScATM1 by forming hydrogenen bonds with residues R<sup>280</sup>, R<sup>284</sup> and D<sup>398</sup> [<xref ref-type="bibr" rid="CR61">61</xref>]. Interestingly, these residues are conserved in HsABCB7 (R<sup>315</sup>, R<sup>319</sup> and E<sup>433</sup>) and LmABCB3 (R<sup>479</sup>, R<sup>483</sup> and E<sup>597</sup>) (Additional file <xref rid="MOESM5" ref-type="media">5</xref>: Figure S3). Other ScATM1 residues surrounding bound GSH [<xref ref-type="bibr" rid="CR61">61</xref>] were also generally conserved in the three transporters (Additional file <xref rid="MOESM5" ref-type="media">5</xref>: Figure S3). To further investigate this point, we have analyzed the predicted 3D structure of LmABCB3 by modeling methods.</p>
        <p>Briefly, a model of LmABCB3_∆UNE (comprising aa 283–875, and lacking the UNE region) was built using Phyre2 molecular modeling server [<xref ref-type="bibr" rid="CR45">45</xref>] based on protein structures present in the PDB (Protein Data Bank) database. The yeast ScATM1 was chosen by the server as having the structure closest to the LmABCB3_∆UNE model, with a 40 % sequence similarity. Next, we performed a 3D-structural superimposition of the yeast ScATM1 structure (PDB code: 1 MHY) and LmABCB3_∆UNE model using the DALI server [<xref ref-type="bibr" rid="CR63">63</xref>] with good pairwise alignment parameters (Z score: 26.5; RMSD:3.5 Å) (Fig. <xref rid="Fig8" ref-type="fig">8a</xref>). In this configuration the GSH binding site in ScATM1 is located in a mainly positively charged pocket, which corresponds to a similar cavity in LmABCB3 with well-conserved residues disposed in equivalent positions (Fig. <xref rid="Fig8" ref-type="fig">8b</xref>). Since trypanosomatid parasites possess a unique redox metabolism which is mainly based on trypanothione (T(SH)<sub>2</sub>) [<xref ref-type="bibr" rid="CR64">64</xref>], a molecule which contains two GSH, we hypothesized that LmABCB3 might be capable of binding T(SH)<sub>2</sub>. To evaluate this idea, docking calculations were carried out through Autodock 4.0 [<xref ref-type="bibr" rid="CR65">65</xref>] using the LmABCB3_∆UNE 3D-model and reduced trypanothione as a potential ligand (Fig. <xref rid="Fig8" ref-type="fig">8c and d</xref>). Subsequent data analysis predicted that the T(SH)<sub>2</sub> molecule could bind to the LmABCB3_∆UNE model with a favorable free energy change. Interestingly, the T(SH)<sub>2</sub> binding region in LmABCB3 is located in close proximity to the equivalent charged pocket that binds GSH in yeast ATM1 (Fig. <xref rid="Fig8" ref-type="fig">8c</xref>), with the previously described conserved residues surrounding the T(SH)<sub>2</sub> molecule (Fig. <xref rid="Fig8" ref-type="fig">8d</xref>). Significantly, a similar docking model built using the ScATM1 structural coordinates and GSH as a ligand predicted an interaction very similar to that found in the ScATM1 structure bound to GSH [<xref ref-type="bibr" rid="CR61">61</xref>].<fig id="Fig8"><label>Fig. 8</label><caption><p>LmABCB3 homology model shares a thiol binding region with ScATM1 (<bold>a</bold>). Structural homology among LmABCB3 and ScATM1. A model for the 3D-structure of <italic>L. major</italic> ABCB3_∆UNE (aa 283–875) was built using Phyre2 molecular modelling server based on LmABCB3_∆UNE complete protein sequence, its predicted secondary structure and protein structures present in the PDB (Protein Data Bank) database. The structure of yeast ATM1 (pdb code: 1 MHY) was chosen by the server as the less divergent to the constructed LmABCB3 model with a 40 % sequence similarity. 3D-structural superimposition of yeast ATM1 structure (represented as yellow ribbons) and <italic>L. major</italic> ABCB3_∆UNE model (showed in red ribbons) was done using the DALI server (Z score: 26.5; RMSD:3.5 Å). <bold>b</bold> LmABCB3 conserves a positively charged pocket similar to the glutathione binding cavity present in ScATM1. Molecular surface representation colored by electrostatic charges (blue, positive; red, negative) distribution of yeast ATM1 and <italic>L. major</italic> ABCB3_∆UNEmodel. A positively charged pocket which binds a GSH molecule in ScATM1 is highlighted. An equivalent positive region is also observed in the proposed LmABCB3 model. <bold>c</bold> Trypanothione binding region in LmABCB3 dimer. Left. A model of LmABCB3_∆UNE dimer was built with chains A and B colored in red and green respectively. The residues conforming the T(SH)<sub>2</sub> binding site of both monomers are highlighted in blue dots representation. Right. Molecular docking of reduced trypanothione (two molecules colored yelow) into the molecular surface of <italic>L. major</italic> ABCB3 dimer model (chains A and B colored red and green respectively) using Autodock4.0 program. <bold>d</bold> Close view of potential trypanothione binding site. The T(SH)<sub>2</sub> molecule (colored green) appears surrounded by LmABCB3 conserved residues (yellow) in the conserved cavity of LmABCB3 model (monomer represented in red sticks)</p></caption><graphic xlink:href="13071_2015_1284_Fig8_HTML" id="MO8"/></fig></p>
      </sec>
    </sec>
    <sec id="Sec25">
      <title>Discussion</title>
      <p>There is an urgent need to find new treatments against neglected tropical diseases. Over the past few years, the mitochondrion of protozoan parasites has emerged as a potent and promising goal for new therapeutic approaches (reviewed in [<xref ref-type="bibr" rid="CR66">66</xref>, <xref ref-type="bibr" rid="CR67">67</xref>]). In addition to cellular respiration, this organelle plays essential roles related to regulation of cellular iron homeostasis, including the synthesis and trafficking of porphyrins and the generation of iron-sulfur clusters (ISC) [<xref ref-type="bibr" rid="CR68">68</xref>, <xref ref-type="bibr" rid="CR69">69</xref>]. As iron is essential for trypanosomatids such as <italic>Leishmania</italic>, the route that controls its use is a potential target for drug development [<xref ref-type="bibr" rid="CR70">70</xref>]. In mammals, two mitochondrial ABC half-transporters, ABCB6 and ABCB7, have been proposed to function in porphyrin transport and ISC assembly, respectively [<xref ref-type="bibr" rid="CR20">20</xref>]. In this work we describe the functional characterization of a new <italic>L. major</italic> protein (LmABCB3), which shows significant sequence similarity with human ABCB6 and ABCB7.</p>
      <p>Our results suggest that LmABCB3 likely functions in the maturation of cytosolic ISC, similar to human ABCB7, with which it shares 29.3 % sequence identity. Accordingly, LmABCB3 was able to completely rescue the severe growth defect of yeast lacking the HsABCB7 orthologue ATM1, including the growth in minimal medium and the ability to use non-fermentable carbon sources. These results also suggest that LmABCB3 works as a homodimer located in the inner mitochondrial membrane, with the NBD facing to the matrix, similar to ScATM1 and HsABCB7 [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]. In mammals and yeast, it has been proposed that ABCB7/ATM1-like proteins transport a GSH-ISC complex [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>] or any other sulfur- and GSH- containing molecule [<xref ref-type="bibr" rid="CR24">24</xref>] across the mitochondrial inner membrane that is then transferred to the cytosolic ICA machinery [<xref ref-type="bibr" rid="CR28">28</xref>]. Indeed, structural studies with ScATM1 have shown that GSH binds to ScATM1 in a positively charged pocket [<xref ref-type="bibr" rid="CR61">61</xref>], which corresponds to a similar cavity in the LmABCB3 model in which most of the residues involved in GSH binding are completely conserved. One of them, D<sup>398</sup>, which corresponds to E<sup>597</sup> in LmABCB3, forms hydrogen bonds with GSH in ScATM1. Interestingly, mutation of the corresponding residue in HsABCB7 (E<sup>433</sup>) to lysine results in X-linked sideroblastic anemia and ataxia (XLSA/A) [<xref ref-type="bibr" rid="CR23">23</xref>], highlighting the functional importance of the thiol interaction. Moreover, trypanosomatid parasites possess a unique redox mechanism based on the molecule trypanothione (T(SH)<sub>2</sub>) as a GSH substitute [<xref ref-type="bibr" rid="CR64">64</xref>]. This parasite-specific dithiol is synthesized by the addition of two GSH molecules to spermidine and replaces the ubiquitous GSH system in the maintenance of redox homeostasis and xenobiotic detoxification [<xref ref-type="bibr" rid="CR64">64</xref>]. Interestingly, T(SH)<sub>2</sub> forms stable protein-free ISC species in vitro, suggesting a novel role of T(SH)<sub>2</sub> as an intracellular ISC carrier [<xref ref-type="bibr" rid="CR71">71</xref>]. In addition, docking analyzes indicate that T(SH)<sub>2</sub> could interact with LmABCB3 similar to the way GSH does with ScATM1. This suggests that LmABCB3 could transport a T(SH)<sub>2</sub>-ISC complex or any other T(SH)<sub>2</sub>- containing molecule out of the mitochondrion for the maturation of cytosolic and nuclear iron-sulfur proteins, which further supports the proposed link between thiol-redox and iron metabolism in these organisms [<xref ref-type="bibr" rid="CR71">71</xref>]. Determining whether this model is accurate or not will require elucidation of the structure of LmABCB3, but meanwhile it opens a new perspective in the understanding of LmABCB3 function.</p>
      <p>In addition to its role in cytosolic ISC assembly, our data clearly describe an activity of LmABCB3 related to heme metabolism. We found that LmABCB3 can bind to heme, and that LmABCB3 protein levels correlated with the rate of mitochondrial heme production from cytosolic PPIX. This role is not shared by ScATM1 as both, synthesis and transport of heme, are functional in ΔATM1 yeast [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR60">60</xref>]. LmABCB3 could therefore play a role in heme metabolism similar to human ABCB6, which is required for mitochondrial porphyrin import [<xref ref-type="bibr" rid="CR16">16</xref>], and shares the highest level of sequence similarity (31 %) with LmABCB3 of any of the known mitochondrial ABC transporters. However, the ability of LmABCB3 to functionally complement a yeast <italic>ATM1</italic> deletion, indicating that it is likely oriented with its NBD on the matrix side of the mitochondrial inner membrane, argue against this possibility. This orientation predicts a probable export function, whereas ABCB6 is a porphyrin importer [<xref ref-type="bibr" rid="CR16">16</xref>]. Alternatively, the effect of LmABCB3 on heme biosynthesis could reflect an essential interaction with ferrochelatase, as has been shown for the human ABCB7 [<xref ref-type="bibr" rid="CR72">72</xref>]. Both in vitro and in vivo pull-down assays have demonstrated that ABCB7 interacts with the carboxy-terminus of ferrochelatase, and the transient expression of ABCB7 results in an increase in the enzymatic activity and the expression level of ferrochelatase, contributing to the production of heme during the differentiation of erythroid cells [<xref ref-type="bibr" rid="CR72">72</xref>]. Finally, the results could be also explained if LmABCB3 exports <italic>de novo</italic> formed heme from the mitochondria, with less ability to transport PPIX, and increased levels of mitochondrial heme in LmABCB3<sup>+/−</sup> cells inhibit ferrochelatase activity. Supporting this is the finding that around 50-fold more PPIX than hemin is required to compete with the interaction of LmABCB3 with hemin-agarose. In addition, at concentrations that may be physiologically relevant, heme has been shown to inhibit mammalian ferrochelatase in a non-competitive manner with respect to iron [<xref ref-type="bibr" rid="CR73">73</xref>, <xref ref-type="bibr" rid="CR74">74</xref>]. Direct porphyrin transport assays with LmABCB3 reconstituted vesicles will be required to test this hypothesis. Other transporter such as RLIP76 mediates ATP-dependent transport of GSH conjugates as well as the hydrophobic compound doxorubicin [<xref ref-type="bibr" rid="CR75">75</xref>], and even ABCG2, a mammalian ABC protein that export porphyrins [<xref ref-type="bibr" rid="CR76">76</xref>], has been suggested to be also a GSH transporter [<xref ref-type="bibr" rid="CR77">77</xref>].</p>
      <p>Heme and ISC are co-factors required by a wide variety of essential enzymes involved in electron transport, enzyme catalysis and regulation of gene expression, and the ability to either synthesize or obtain them from the host is absolutely essential for the growth of trypanosomatid parasites [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR78">78</xref>]. LmABCB3 has a role in both heme and ISC metabolism, and we provide several lines of evidence demonstrating these functions are essential for survival of trypanosomatid parasites. First, the inhibition of LmABCB3 via overexpression of a dominant negative allele is lethal for the parasite. Others and we have employed this strategy to study the function of an ABC half transporter taken advantage of its requirement of dimerization to become functional [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR79">79</xref>]. However, to our knowledge, this is the first case of such a dramatic phenotype due to the dominant negative effect, indicating that the low level of functional Wt/Wt LmABCB3 dimers expected using this strategy is not sufficient to allow parasite growth. Second, although heterozygous deletion of one <italic>lmABCB3</italic> allele slightly alters promastigotes growth, it prevents <italic>L. major</italic> replication within macrophages. A double KO line could not be obtained, presumably due to its lethal effect. Consistent with an essential role of LmABCB3 in intracellular amastigotes, the elimination of one <italic>LmABCB3</italic> allele severely reduce parasite virulence in a mousemodel of cutaneous leishmaniasis. Thus, even though low LmABCB3 levels support the growth of axenic <italic>LmABCB3</italic><sup><italic>+/−</italic></sup> promastigotes, they are not sufficient for intracellular amastigotes to cause disease in mice. Although the involvement of <italic>Leishmania</italic> ISC- and/or heme-containing proteins in parasite virulence is not explored, this differential effect on both parasite stages could be explained by a more relevant role of the machinery involved in cytosolic ISC and/or heme metabolism in the amastigote stage. In fact, axenic promastigotes do not require to produce heme as it is taken from the culture medium [<xref ref-type="bibr" rid="CR6">6</xref>], whereas heme synthesis from macrophage coproporphyrinogen has been proposed to be functional in intracellular amastigotes [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. In contrast, results from high-throughput RNAi target sequencing in <italic>T. brucei</italic> [<xref ref-type="bibr" rid="CR80">80</xref>] suggest that down regulation of TbABCB3 does not affect cell proliferation of neither bloodstream nor procyclic trypomastigote stages. These results need to be confirmed by a specific RNAi assay, but they must been seen as quite unexpected in the case LmABCB3 and TbABCB3 were functional orthologues. Although <italic>Trypanosoma</italic> does not synthetize heme from precursors, it requires cytosolic ISC to survive [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR81">81</xref>]. </p>
      <p>Finally, a detailed analysis of the sequence of the transcribed LmABCB3 mRNA [<xref ref-type="bibr" rid="CR44">44</xref>] predicts an unusual topology that includes a UNE region not found in any other protein outside the genus <italic>Leishmania</italic>. This unique extension includes a consensus MLRR motif followed by a hydrophobic region rich in Ala, Leu, and Val, which has been proposed to allow for recognition and import via the mitochondrial import apparatus of trypanosomatid parasites [<xref ref-type="bibr" rid="CR56">56</xref>]. Our results have confirmed that the UNE region is required for the proper localization of LmABCB3 to mitochondria. Interestingly, the UNE is also predicted to contain a conserved metal-binding domain (TRASH), with a well-conserved cysteine motif probably involved in metal coordination [<xref ref-type="bibr" rid="CR50">50</xref>]. TRASH domains are known to function in metal sensing, trafficking, and heavy-metal resistance [<xref ref-type="bibr" rid="CR50">50</xref>]. The precise role of this domain in LmABCB3 remains to be elucidated, but based on its association with proteins involved in metal homeostasis, it is likely to be important for the function of LmABCB3 in heme/ISC metabolism.</p>
    </sec>
    <sec id="Sec26">
      <title>Conclusion</title>
      <p>We have shown that the novel <italic>Leishmania</italic> mitochondrial transporter LmABCB3 is the first ABC transporter described to be essential in any trypanosomatid parasite. We have provided solid evidences suggesting strongly that LmABCB3 plays critical roles in both mitochondrial heme and cytosolic ISC biogenesis that explain its essentiality. Based on the demonstration that diminution in functional LmABCB3 levels is deleterious for the parasite, agents that specifically inactivate LmABCB3 would likely be lethal for these pathogens, even in the absence of complete inhibition. The unique nature of the 20 kDa N-terminal peptide, including its requirement for mitochondrial import and the presence of a TRASH domain, makes it an outstanding candidate for the use of rational design methods for the development of specific LmABCB3 inhibitors to be used against <italic>Leishmania,</italic> responsible of a neglected disease that affects some of the poorest people on the planet.</p>
      <sec id="Sec28">
        <title>Note added in proof</title>
        <p>While our manuscript was under revision, Horáková and coworkers reported the characterization of TbAtm, the putative <italic>T. brucei</italic> ortholog of LmABCB3 [<xref ref-type="bibr" rid="CR82">82</xref>]. The authors showed that TbAtm is involved in cytosolic Fe-S cluster assembly but not in mitochondrial heme metabolism in procyclic forms of <italic>T. brucei</italic>. Contrary to our observations following the depletion of LmABCB3 in <italic>Leishmania</italic>, depletion of TbAtm led to limited growth defects in procyclic parasites.</p>
      </sec>
    </sec>
  </body>
  <back>
    <app-group>
      <app id="App1">
        <sec id="Sec27">
          <title>Additional files</title>
          <p>
            <media position="anchor" xlink:href="13071_2015_1284_MOESM1_ESM.tif" id="MOESM1">
              <label>Additional file 1: Table S2.</label>
              <caption>
                <p>Primer used in this study. Restriction enzyme sites are in bold and underlined. (TIF 657 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="13071_2015_1284_MOESM2_ESM.tif" id="MOESM2">
              <label>Additional file 2: Figure S1.</label>
              <caption>
                <p>The UNE domain is exclusive of <italic>Leishmania</italic> ABCB3. Schematic representation of putative mitochondrial ABCB transporters showing the unique N-terminal extension (UNE), the Transmembrane Domain (TMD), the Nucleotide Binding Domain (NBD) and the theoretical molecular weight. Lm: <italic>L. major</italic>; Li: <italic>L. infantum</italic>; Lmx: <italic>L. mexicana</italic>; Lb: <italic>L. braziliensis</italic>; Tb: <italic>T. brucei</italic>; Tc: <italic>T. cruzi</italic>; Hs: <italic>H. sapiens</italic>; Sc: <italic>S. cereviciae</italic>. (TIF 1523 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="13071_2015_1284_MOESM3_ESM.tif" id="MOESM3">
              <label>Additional file 3: Table S1.</label>
              <caption>
                <p>Homology between different putative mitochondrial ABCB half-trransporters. Analysis was performed with Clustal W (http://www.ncbi.nlm.nih.gov/protein/). Analyzed proteins (GenPept accession number in brackets) were from <italic>Leishmania major</italic>: LmABCB3 (XP_001685635,1), LmABCB1 (XP_001683806.1); <italic>Trypanosoma brucei</italic>: TbABCB3 (XP_829749.1), TbABCB1 (XP_828146,1); <italic>Trypanosoma cruzi</italic>: TcABCB3 (XP_811319.1), TcABCB1(XP_820554.1); <italic>Homo sapiens</italic>: HsABCB6 (NP_005680), HsABCB7 (NP_001258628.1), HsABCB8 (NP_001269222.1), HsABCB10 (NP_036221) and <italic>Saccharomyces cerevisiae</italic>: ScATM1 (NP_014030.1), ScMDL1 (NP_013289.1) and ScMDL2 (NP_015053.2). Data indicate the percentage of identity (grey) and similarity (white) between protein sequences. (TIF 1290 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="13071_2015_1284_MOESM4_ESM.tif" id="MOESM4">
              <label>Additional file 4: Figure S2.</label>
              <caption>
                <p>Expression of LmABCB3-GFP and LmABCB3_∆UNE-GFP. Western blot analysis of total protein from LmABCB3-GFP (lane 1) or LmABCB3_∆UNE-GFP (lane 2) and GFP (lane 3) expressing <italic>L. major</italic> parasites. Immunodetection were performed with antibody anti-GFP incubation at a 1:5000 dilution. The molecular mass standards (kDa) from Bio-Rad are indicated on the left. (TIF 2482 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="13071_2015_1284_MOESM5_ESM.tif" id="MOESM5">
              <label>Additional file 5: Figure S3.</label>
              <caption>
                <p>The ScATM1 residues that interact with glutathione are conserved in LmABCB3. The alignment of the indicated amino acids of <italic>S. cerevisiae</italic> ScATM1, <italic>H. sapiens</italic> HsABCB7 and <italic>L. major</italic> LmABCB3 (ClustalW software) shows that LmABCB3 share the ScATM1 residues forming hydrogenen bonds with GSH (highlighted in yellow). The E433 residue of HsABCB7 mutated to lysine in XLSA/A patients is indicated by a red arrow. Other ScATM1 residues surrounding bound GSH are highlighted in green. Identical (*), strongly similar (:) and weakly similar (.) amino acids are coloured in red, green and blue, respectively. (TIF 379 kb)</p>
              </caption>
            </media>
          </p>
        </sec>
      </app>
    </app-group>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The authors declare that they have no competing interests.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors’ contributions</bold>
        </p>
        <p>Conceived and designed the experiments: JMPV. Performed the experiments: MMG JCS MCD EPM FJG LMO MPSC SMC. Analyzed the data: MMG JCS MCD EPM DMK JMPV. Contributed reagents/materials/analysis tools: DMK JMPV. Wrote the paper: MMG JCS EPM DMK JMPV. All authors read and approved the final version of the manuscript.</p>
      </fn>
    </fn-group>
    <ack>
      <p>This work was supported by grants from the Spanish <italic>Ministerio de Economía y Competitividad</italic> SAF2011-28215 (JMPV) and <italic>Junta de Andalucia</italic> BIO1786 (JMPV) and by FEDER funds from the EU to JMPV. MMG was recipient of a FPI fellowship from the Spanish <italic>Ministerio de Economía y Competitividad</italic>; MCD was recipient of a FPU fellowship from the Spanish <italic>Ministerio de Educación, Cultura y Deporte</italic>; SMC was recipient of a JAE-DOC from the Spanish <italic>CSIC</italic> (<italic>Ministerio de Economía y Competitividad</italic>), cofounded by the Fondo Social Europeo.</p>
      <p>We thank Stephen M. Beverley (Washington University School of Medicine, USA) and Olivier Cagnac (EEZ-CSIC, Spain) for providing, respectively, the <italic>Leishmania</italic> and yeast vectors used throughout this research work. We also thank Clara Sánchez for her assistance with the experimental animal models and Eduardo Andrés León for his assistance in Bioinformatics tools. We are grateful to Francisco Gamarro and Santiago Castanys (IPBLN-CSIC, Spain) for their valuable comments on the manuscript.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pace</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Leishmaniasis</article-title>
          <source>J Infect</source>
          <year>2014</year>
          <volume>69</volume>
          <fpage>S10</fpage>
          <lpage>18</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jinf.2014.07.016</pub-id>
          <?supplied-pmid 25238669?>
          <pub-id pub-id-type="pmid">25238669</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McCall</surname>
              <given-names>LI</given-names>
            </name>
            <name>
              <surname>McKerrow</surname>
              <given-names>JH</given-names>
            </name>
          </person-group>
          <article-title>Determinants of disease phenotype in trypanosomatid parasites</article-title>
          <source>Trends Parasitol</source>
          <year>2014</year>
          <volume>30</volume>
          <issue>7</issue>
          <fpage>342</fpage>
          <lpage>349</lpage>
          <pub-id pub-id-type="doi">10.1016/j.pt.2014.05.001</pub-id>
          <?supplied-pmid 24946952?>
          <pub-id pub-id-type="pmid">24946952</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <mixed-citation publication-type="other">DNDi: <ext-link ext-link-type="uri" xlink:href="http://www.dndi.org/diseases-projects/leishmaniasis/">http://www.dndi.org/diseases-projects/leishmaniasis/</ext-link>.</mixed-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Trager</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <collab>CIBAFoundationSymposium</collab>
          </person-group>
          <article-title>Nutrition and biosynthetic capabilities of flagellates. Problems of in vitro cultivation and differentiation</article-title>
          <source>Trypanosomiasis and Leishmaniasis with special reference to Chagas’ disease</source>
          <year>1974</year>
          <publisher-loc>North Holland, Amsterdam</publisher-loc>
          <publisher-name>Elsevier-Excerpta</publisher-name>
          <fpage>225</fpage>
          <lpage>245</lpage>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Opperdoes</surname>
              <given-names>FR</given-names>
            </name>
            <name>
              <surname>Coombs</surname>
              <given-names>GH</given-names>
            </name>
          </person-group>
          <article-title>Metabolism of Leishmania: proven and predicted</article-title>
          <source>Trends Parasitol</source>
          <year>2007</year>
          <volume>23</volume>
          <issue>4</issue>
          <fpage>149</fpage>
          <lpage>158</lpage>
          <pub-id pub-id-type="doi">10.1016/j.pt.2007.02.004</pub-id>
          <?supplied-pmid 17320480?>
          <pub-id pub-id-type="pmid">17320480</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chang</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>KP</given-names>
            </name>
          </person-group>
          <article-title>Heme requirement and acquisition by extracellular and intracellular stages of Leishmania mexicana amazonensis</article-title>
          <source>Mol Biochem Parasitol</source>
          <year>1985</year>
          <volume>16</volume>
          <issue>3</issue>
          <fpage>267</fpage>
          <lpage>276</lpage>
          <pub-id pub-id-type="doi">10.1016/0166-6851(85)90069-6</pub-id>
          <?supplied-pmid 4058483?>
          <pub-id pub-id-type="pmid">4058483</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Campos-Salinas</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Cabello-Donayre</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Garcia-Hernandez</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Perez-Victoria</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Castanys</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gamarro</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A new ATP-binding cassette protein is involved in intracellular haem trafficking in Leishmania</article-title>
          <source>Mol Microbiol</source>
          <year>2011</year>
          <volume>79</volume>
          <issue>6</issue>
          <fpage>1430</fpage>
          <lpage>1444</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-2958.2010.07531.x</pub-id>
          <?supplied-pmid 21255121?>
          <pub-id pub-id-type="pmid">21255121</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sengupta</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Tripathi</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Tandon</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Raje</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Roy</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Basu</surname>
              <given-names>SK</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Hemoglobin endocytosis in Leishmania is mediated through a 46-kDa protein located in the flagellar pocket</article-title>
          <source>J Biol Chem</source>
          <year>1999</year>
          <volume>274</volume>
          <issue>5</issue>
          <fpage>2758</fpage>
          <lpage>2765</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.274.5.2758</pub-id>
          <?supplied-pmid 9915807?>
          <pub-id pub-id-type="pmid">9915807</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krishnamurthy</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Vikram</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Singh</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Agarwal</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mukhopadhyay</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Hemoglobin receptor in Leishmania is a hexokinase located in the flagellar pocket</article-title>
          <source>J Biol Chem</source>
          <year>2005</year>
          <volume>280</volume>
          <issue>7</issue>
          <fpage>5884</fpage>
          <lpage>5891</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M411845200</pub-id>
          <?supplied-pmid 15579464?>
          <pub-id pub-id-type="pmid">15579464</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Singh</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Tandon</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Krishnamurthy</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Vikram</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sharma</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Basu</surname>
              <given-names>SK</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Rab5-mediated endosome-endosome fusion regulates hemoglobin endocytosis in Leishmania donovani</article-title>
          <source>Embo J</source>
          <year>2003</year>
          <volume>22</volume>
          <issue>21</issue>
          <fpage>5712</fpage>
          <lpage>5722</lpage>
          <pub-id pub-id-type="doi">10.1093/emboj/cdg557</pub-id>
          <?supplied-pmid 14592970?>
          <pub-id pub-id-type="pmid">14592970</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Patel</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Singh</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Basu</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Mukhopadhyay</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Leishmania requires Rab7-mediated degradation of endocytosed hemoglobin for their growth</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2008</year>
          <volume>105</volume>
          <issue>10</issue>
          <fpage>3980</fpage>
          <lpage>3985</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.0800404105</pub-id>
          <?supplied-pmid 18319337?>
          <pub-id pub-id-type="pmid">18319337</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <mixed-citation publication-type="other">Huynh C, Yuan X, Miguel DC, Hamza I, Andrews NW: Heme uptake in Leishmania amazonensis is mediated by the transmembrane protein LHR1. PLoS Pathogens. 2012;8(7):e1002795.</mixed-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Miguel</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Flannery</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Mittra</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Andrews</surname>
              <given-names>NW</given-names>
            </name>
          </person-group>
          <article-title>Heme uptake mediated by LHR1 is essential for Leishmania amazonensis virulence</article-title>
          <source>Infect Immun</source>
          <year>2013</year>
          <volume>81</volume>
          <issue>10</issue>
          <fpage>3620</fpage>
          <lpage>3626</lpage>
          <pub-id pub-id-type="doi">10.1128/IAI.00687-13</pub-id>
          <?supplied-pmid 23876801?>
          <pub-id pub-id-type="pmid">23876801</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koreny</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Lukes</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Obornik</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Evolution of the haem synthetic pathway in kinetoplastid flagellates: an essential pathway that is not essential after all?</article-title>
          <source>Int J Parasitol</source>
          <year>2010</year>
          <volume>40</volume>
          <issue>2</issue>
          <fpage>149</fpage>
          <lpage>156</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ijpara.2009.11.007</pub-id>
          <?supplied-pmid 19968994?>
          <pub-id pub-id-type="pmid">19968994</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Akilov</surname>
              <given-names>OE</given-names>
            </name>
            <name>
              <surname>Kosaka</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>O’Riordan</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hasan</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Parasiticidal effect of delta-aminolevulinic acid-based photodynamic therapy for cutaneous leishmaniasis is indirect and mediated through the killing of the host cells</article-title>
          <source>Exp Dermatol</source>
          <year>2007</year>
          <volume>16</volume>
          <issue>8</issue>
          <fpage>651</fpage>
          <lpage>660</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1600-0625.2007.00578.x</pub-id>
          <?supplied-pmid 17620092?>
          <pub-id pub-id-type="pmid">17620092</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krishnamurthy</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Du</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Fukuda</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Sampath</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Mercer</surname>
              <given-names>KE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Identification of a mammalian mitochondrial porphyrin transporter</article-title>
          <source>Nature</source>
          <year>2006</year>
          <volume>443</volume>
          <issue>7111</issue>
          <fpage>586</fpage>
          <lpage>589</lpage>
          <?supplied-pmid 17006453?>
          <pub-id pub-id-type="pmid">17006453</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Paterson</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Shukla</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Black</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Tachiwada</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Garfield</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wincovitch</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Human ABCB6 localizes to both the outer mitochondrial membrane and the plasma membrane</article-title>
          <source>Biochemistry</source>
          <year>2007</year>
          <volume>46</volume>
          <issue>33</issue>
          <fpage>9443</fpage>
          <lpage>9452</lpage>
          <pub-id pub-id-type="doi">10.1021/bi700015m</pub-id>
          <?supplied-pmid 17661442?>
          <pub-id pub-id-type="pmid">17661442</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tsuchida</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Emi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kida</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Sakaguchi</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Human ABC transporter isoform B6 (ABCB6) localizes primarily in the Golgi apparatus</article-title>
          <source>Biochem Biophys Res Commun</source>
          <year>2008</year>
          <volume>369</volume>
          <issue>2</issue>
          <fpage>369</fpage>
          <lpage>375</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bbrc.2008.02.027</pub-id>
          <?supplied-pmid 18279659?>
          <pub-id pub-id-type="pmid">18279659</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kiss</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Brozik</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kucsma</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Toth</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gera</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Berry</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Shifting the paradigm: the putative mitochondrial protein ABCB6 resides in the lysosomes of cells and in the plasma membrane of erythrocytes</article-title>
          <source>PLoS One</source>
          <year>2012</year>
          <volume>7</volume>
          <issue>5</issue>
          <fpage>e37378</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0037378</pub-id>
          <?supplied-pmid 22655043?>
          <pub-id pub-id-type="pmid">22655043</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zutz</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gompf</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Schagger</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Tampe</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Mitochondrial ABC proteins in health and disease</article-title>
          <source>Biochim Biophys Acta</source>
          <year>2009</year>
          <volume>1787</volume>
          <issue>6</issue>
          <fpage>681</fpage>
          <lpage>690</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bbabio.2009.02.009</pub-id>
          <?supplied-pmid 19248758?>
          <pub-id pub-id-type="pmid">19248758</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kiss</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kucsma</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Brozik</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Tusnady</surname>
              <given-names>GE</given-names>
            </name>
            <name>
              <surname>Bergam</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>van Niel</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Role of the N-terminal transmembrane domain in the endo-lysosomal targeting and function of the human ABCB6 protein</article-title>
          <source>Biochem J</source>
          <year>2015</year>
          <volume>467</volume>
          <issue>1</issue>
          <fpage>127</fpage>
          <lpage>39</lpage>
          <pub-id pub-id-type="doi">10.1042/BJ20141085</pub-id>
          <?supplied-pmid 25627919?>
          <pub-id pub-id-type="pmid">25627919</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kispal</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Csere</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Prohl</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Lill</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>The mitochondrial proteins Atm1p and Nfs1p are essential for biogenesis of cytosolic Fe/S proteins</article-title>
          <source>EMBO J</source>
          <year>1999</year>
          <volume>18</volume>
          <issue>14</issue>
          <fpage>3981</fpage>
          <lpage>3989</lpage>
          <pub-id pub-id-type="doi">10.1093/emboj/18.14.3981</pub-id>
          <?supplied-pmid 10406803?>
          <pub-id pub-id-type="pmid">10406803</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bekri</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kispal</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Lange</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Fitzsimons</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Tolmie</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lill</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Human ABC7 transporter: gene structure and mutation causing X-linked sideroblastic anemia with ataxia with disruption of cytosolic iron-sulfur protein maturation</article-title>
          <source>Blood</source>
          <year>2000</year>
          <volume>96</volume>
          <issue>9</issue>
          <fpage>3256</fpage>
          <lpage>3264</lpage>
          <?supplied-pmid 11050011?>
          <pub-id pub-id-type="pmid">11050011</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lill</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Dutkiewicz</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Freibert</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Heidenreich</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Mascarenhas</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Netz</surname>
              <given-names>DJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The role of mitochondria and the CIA machinery in the maturation of cytosolic and nuclear iron-sulfur proteins</article-title>
          <source>Eur J Cell Biol</source>
          <year>2015</year>
          <volume>94</volume>
          <issue>7–9</issue>
          <fpage>280</fpage>
          <lpage>91</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejcb.2015.05.002</pub-id>
          <?supplied-pmid 26099175?>
          <pub-id pub-id-type="pmid">26099175</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lill</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Muhlenhoff</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>Maturation of iron-sulfur proteins in eukaryotes: mechanisms, connected processes, and diseases</article-title>
          <source>Annu Rev Biochem</source>
          <year>2008</year>
          <volume>77</volume>
          <fpage>669</fpage>
          <lpage>700</lpage>
          <pub-id pub-id-type="doi">10.1146/annurev.biochem.76.052705.162653</pub-id>
          <?supplied-pmid 18366324?>
          <pub-id pub-id-type="pmid">18366324</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Netz</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Mascarenhas</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Stehling</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Pierik</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Lill</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Maturation of cytosolic and nuclear iron-sulfur proteins</article-title>
          <source>Trends Cell Biol</source>
          <year>2014</year>
          <volume>24</volume>
          <issue>5</issue>
          <fpage>303</fpage>
          <lpage>312</lpage>
          <pub-id pub-id-type="doi">10.1016/j.tcb.2013.11.005</pub-id>
          <?supplied-pmid 24314740?>
          <pub-id pub-id-type="pmid">24314740</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lukes</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Basu</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Fe/S protein biogenesis in trypanosomes - a review</article-title>
          <source>Biochim Biophys Acta</source>
          <year>2015</year>
          <volume>1853</volume>
          <issue>6</issue>
          <fpage>1481</fpage>
          <lpage>1492</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bbamcr.2014.08.015</pub-id>
          <?supplied-pmid 25196712?>
          <pub-id pub-id-type="pmid">25196712</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Qi</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Cowan</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>A structural model for glutathione-complexed iron-sulfur cluster as a substrate for ABCB7-type transporters</article-title>
          <source>Chem Commun</source>
          <year>2014</year>
          <volume>50</volume>
          <issue>29</issue>
          <fpage>3795</fpage>
          <lpage>3798</lpage>
          <pub-id pub-id-type="doi">10.1039/c3cc48239a</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Cowan</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Glutathione-coordinated [2Fe-2S] cluster: a viable physiological substrate for mitochondrial ABCB7 transport</article-title>
          <source>Chem Commun</source>
          <year>2015</year>
          <volume>51</volume>
          <issue>12</issue>
          <fpage>2253</fpage>
          <lpage>2255</lpage>
          <pub-id pub-id-type="doi">10.1039/C4CC09175B</pub-id>
        </element-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pondarre</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Antiochos</surname>
              <given-names>BB</given-names>
            </name>
            <name>
              <surname>Campagna</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Clarke</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Greer</surname>
              <given-names>EL</given-names>
            </name>
            <name>
              <surname>Deck</surname>
              <given-names>KM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The mitochondrial ATP-binding cassette transporter Abcb7 is essential in mice and participates in cytosolic iron-sulfur cluster biogenesis</article-title>
          <source>Hum Mol Genet</source>
          <year>2006</year>
          <volume>15</volume>
          <issue>6</issue>
          <fpage>953</fpage>
          <lpage>964</lpage>
          <pub-id pub-id-type="doi">10.1093/hmg/ddl012</pub-id>
          <?supplied-pmid 16467350?>
          <pub-id pub-id-type="pmid">16467350</pub-id>
        </element-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Allikmets</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Raskind</surname>
              <given-names>WH</given-names>
            </name>
            <name>
              <surname>Hutchinson</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Schueck</surname>
              <given-names>ND</given-names>
            </name>
            <name>
              <surname>Dean</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Koeller</surname>
              <given-names>DM</given-names>
            </name>
          </person-group>
          <article-title>Mutation of a putative mitochondrial iron transporter gene (ABC7) in X-linked sideroblastic anemia and ataxia (XLSA/A)</article-title>
          <source>Hum Mol Genet</source>
          <year>1999</year>
          <volume>8</volume>
          <issue>5</issue>
          <fpage>743</fpage>
          <lpage>749</lpage>
          <pub-id pub-id-type="doi">10.1093/hmg/8.5.743</pub-id>
          <?supplied-pmid 10196363?>
          <pub-id pub-id-type="pmid">10196363</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leighton</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Schatz</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>An ABC transporter in the mitochondrial inner membrane is required for normal growth of yeast</article-title>
          <source>EMBO J</source>
          <year>1995</year>
          <volume>14</volume>
          <issue>1</issue>
          <fpage>188</fpage>
          <lpage>195</lpage>
          <?supplied-pmid 7828591?>
          <pub-id pub-id-type="pmid">7828591</pub-id>
        </element-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leprohon</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Legare</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Girard</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Papadopoulou</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Ouellette</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Modulation of Leishmania ABC protein gene expression through life stages and among drug-resistant parasites</article-title>
          <source>Eukaryot Cell</source>
          <year>2006</year>
          <volume>5</volume>
          <issue>10</issue>
          <fpage>1713</fpage>
          <lpage>1725</lpage>
          <pub-id pub-id-type="doi">10.1128/EC.00152-06</pub-id>
          <?supplied-pmid 17030997?>
          <pub-id pub-id-type="pmid">17030997</pub-id>
        </element-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Campos-Salinas</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Leon-Guerrero</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Gonzalez-Rey</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Delgado</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Castanys</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Perez-Victoria</surname>
              <given-names>JM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>LABCG2, a new ABC transporter implicated in phosphatidylserine exposure, is involved in the infectivity and pathogenicity of Leishmania</article-title>
          <source>PLoS Negl Trop Dis</source>
          <year>2013</year>
          <volume>7</volume>
          <issue>4</issue>
          <fpage>e2179</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pntd.0002179</pub-id>
          <?supplied-pmid 23638200?>
          <pub-id pub-id-type="pmid">23638200</pub-id>
        </element-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Parodi-Talice</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Araujo</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Torres</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Perez-Victoria</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Gamarro</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Castanys</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>The overexpression of a new ABC transporter in Leishmania is related to phospholipid trafficking and reduced infectivity</article-title>
          <source>Biochim Biophys Acta</source>
          <year>2003</year>
          <volume>1612</volume>
          <issue>2</issue>
          <fpage>195</fpage>
          <lpage>207</lpage>
          <pub-id pub-id-type="doi">10.1016/S0005-2736(03)00131-7</pub-id>
          <?supplied-pmid 12787938?>
          <pub-id pub-id-type="pmid">12787938</pub-id>
        </element-citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chloupkova</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>LeBard</surname>
              <given-names>LS</given-names>
            </name>
            <name>
              <surname>Koeller</surname>
              <given-names>DM</given-names>
            </name>
          </person-group>
          <article-title>MDL1 is a high copy suppressor of ATM1: evidence for a role in resistance to oxidative stress</article-title>
          <source>J Mol Biol</source>
          <year>2003</year>
          <volume>331</volume>
          <issue>1</issue>
          <fpage>155</fpage>
          <lpage>165</lpage>
          <pub-id pub-id-type="doi">10.1016/S0022-2836(03)00666-1</pub-id>
          <?supplied-pmid 12875842?>
          <pub-id pub-id-type="pmid">12875842</pub-id>
        </element-citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ito</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Fukuda</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Murata</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kimura</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Transformation of intact yeast cells treated with alkali cations</article-title>
          <source>J Bacteriol</source>
          <year>1983</year>
          <volume>153</volume>
          <issue>1</issue>
          <fpage>163</fpage>
          <lpage>168</lpage>
          <?supplied-pmid 6336730?>
          <pub-id pub-id-type="pmid">6336730</pub-id>
        </element-citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ha</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Schwarz</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Turco</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Beverley</surname>
              <given-names>SM</given-names>
            </name>
          </person-group>
          <article-title>Use of the green fluorescent protein as a marker in transfected Leishmania</article-title>
          <source>Mol Biochem Parasitol</source>
          <year>1996</year>
          <volume>77</volume>
          <issue>1</issue>
          <fpage>57</fpage>
          <lpage>64</lpage>
          <pub-id pub-id-type="doi">10.1016/0166-6851(96)02580-7</pub-id>
          <?supplied-pmid 8784772?>
          <pub-id pub-id-type="pmid">8784772</pub-id>
        </element-citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Perez-Victoria</surname>
              <given-names>FJ</given-names>
            </name>
            <name>
              <surname>Sanchez-Canete</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Castanys</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gamarro</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Phospholipid translocation and miltefosine potency require both L. donovani miltefosine transporter and the new protein LdRos3 in Leishmania parasites</article-title>
          <source>J Biol Chem</source>
          <year>2006</year>
          <volume>281</volume>
          <issue>33</issue>
          <fpage>23766</fpage>
          <lpage>23775</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M605214200</pub-id>
          <?supplied-pmid 16785229?>
          <pub-id pub-id-type="pmid">16785229</pub-id>
        </element-citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Park</surname>
              <given-names>EK</given-names>
            </name>
            <name>
              <surname>Jung</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>HI</given-names>
            </name>
            <name>
              <surname>Yoo</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>KS</given-names>
            </name>
          </person-group>
          <article-title>Optimized THP-1 differentiation is required for the detection of responses to weak stimuli</article-title>
          <source>Inflamm Res</source>
          <year>2007</year>
          <volume>56</volume>
          <issue>1</issue>
          <fpage>45</fpage>
          <lpage>50</lpage>
          <pub-id pub-id-type="doi">10.1007/s00011-007-6115-5</pub-id>
          <?supplied-pmid 17334670?>
          <pub-id pub-id-type="pmid">17334670</pub-id>
        </element-citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cavazzuti</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Paglietti</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Hunter</surname>
              <given-names>WN</given-names>
            </name>
            <name>
              <surname>Gamarro</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Piras</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Loriga</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Discovery of potent pteridine reductase inhibitors to guide antiparasite drug development</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2008</year>
          <volume>105</volume>
          <issue>5</issue>
          <fpage>1448</fpage>
          <lpage>1453</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.0704384105</pub-id>
          <?supplied-pmid 18245389?>
          <pub-id pub-id-type="pmid">18245389</pub-id>
        </element-citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Perez-Victoria</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Perez-Victoria</surname>
              <given-names>FJ</given-names>
            </name>
            <name>
              <surname>Roldan-Vargas</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Garcia-Hernandez</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Carvalho</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Castanys</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Non-reducing trisaccharide fatty acid monoesters: novel detergents in membrane biochemistry</article-title>
          <source>Biochim Biophys Acta</source>
          <year>2011</year>
          <volume>1808</volume>
          <issue>3</issue>
          <fpage>717</fpage>
          <lpage>726</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bbamem.2010.11.031</pub-id>
          <?supplied-pmid 21130727?>
          <pub-id pub-id-type="pmid">21130727</pub-id>
        </element-citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tamura</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Stecher</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Peterson</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Filipski</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>MEGA6: Molecular Evolutionary Genetics Analysis version 6.0</article-title>
          <source>Mol Biol Evol</source>
          <year>2013</year>
          <volume>30</volume>
          <issue>12</issue>
          <fpage>2725</fpage>
          <lpage>2729</lpage>
          <pub-id pub-id-type="doi">10.1093/molbev/mst197</pub-id>
          <?supplied-pmid 24132122?>
          <pub-id pub-id-type="pmid">24132122</pub-id>
        </element-citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rastrojo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Carrasco-Ramiro</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Crespillo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Reguera</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Aguado</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The transcriptome of Leishmania major in the axenic promastigote stage: transcript annotation and relative expression levels by RNA-seq</article-title>
          <source>BMC Genomics</source>
          <year>2013</year>
          <volume>14</volume>
          <fpage>223</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-2164-14-223</pub-id>
          <?supplied-pmid 23557257?>
          <pub-id pub-id-type="pmid">23557257</pub-id>
        </element-citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kelley</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Sternberg</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Protein structure prediction on the Web: a case study using the Phyre server</article-title>
          <source>Nat Protoc</source>
          <year>2009</year>
          <volume>4</volume>
          <issue>3</issue>
          <fpage>363</fpage>
          <lpage>371</lpage>
          <pub-id pub-id-type="doi">10.1038/nprot.2009.2</pub-id>
          <?supplied-pmid 19247286?>
          <pub-id pub-id-type="pmid">19247286</pub-id>
        </element-citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schultz</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Milpetz</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Bork</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Ponting</surname>
              <given-names>CP</given-names>
            </name>
          </person-group>
          <article-title>SMART, a simple modular architecture research tool: identification of signaling domains</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>1998</year>
          <volume>95</volume>
          <issue>11</issue>
          <fpage>5857</fpage>
          <lpage>5864</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.95.11.5857</pub-id>
          <?supplied-pmid 9600884?>
          <pub-id pub-id-type="pmid">9600884</pub-id>
        </element-citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McGuffin</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Bryson</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>DT</given-names>
            </name>
          </person-group>
          <article-title>The PSIPRED protein structure prediction server</article-title>
          <source>Bioinformatics</source>
          <year>2000</year>
          <volume>16</volume>
          <issue>4</issue>
          <fpage>404</fpage>
          <lpage>405</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/16.4.404</pub-id>
          <?supplied-pmid 10869041?>
          <pub-id pub-id-type="pmid">10869041</pub-id>
        </element-citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Frank</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Sippl</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>High-performance signal peptide prediction based on sequence alignment techniques</article-title>
          <source>Bioinformatics</source>
          <year>2008</year>
          <volume>24</volume>
          <issue>19</issue>
          <fpage>2172</fpage>
          <lpage>2176</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/btn422</pub-id>
          <?supplied-pmid 18697773?>
          <pub-id pub-id-type="pmid">18697773</pub-id>
        </element-citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jones</surname>
              <given-names>DT</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>WR</given-names>
            </name>
            <name>
              <surname>Thornton</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>A model recognition approach to the prediction of all-helical membrane protein structure and topology</article-title>
          <source>Biochemistry</source>
          <year>1994</year>
          <volume>33</volume>
          <issue>10</issue>
          <fpage>3038</fpage>
          <lpage>3049</lpage>
          <pub-id pub-id-type="doi">10.1021/bi00176a037</pub-id>
          <?supplied-pmid 8130217?>
          <pub-id pub-id-type="pmid">8130217</pub-id>
        </element-citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ettema</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Huynen</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>de Vos</surname>
              <given-names>WM</given-names>
            </name>
            <name>
              <surname>van der Oost</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>TRASH: a novel metal-binding domain predicted to be involved in heavy-metal sensing, trafficking and resistance</article-title>
          <source>Trends Biochem Sci</source>
          <year>2003</year>
          <volume>28</volume>
          <issue>4</issue>
          <fpage>170</fpage>
          <lpage>173</lpage>
          <pub-id pub-id-type="doi">10.1016/S0968-0004(03)00037-9</pub-id>
          <?supplied-pmid 12713899?>
          <pub-id pub-id-type="pmid">12713899</pub-id>
        </element-citation>
      </ref>
      <ref id="CR51">
        <label>51.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bourdon</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Krusius</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Campbell</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Schwartz</surname>
              <given-names>NB</given-names>
            </name>
            <name>
              <surname>Ruoslahti</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Identification and synthesis of a recognition signal for the attachment of glycosaminoglycans to proteins</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>1987</year>
          <volume>84</volume>
          <issue>10</issue>
          <fpage>3194</fpage>
          <lpage>3198</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.84.10.3194</pub-id>
          <?supplied-pmid 3472204?>
          <pub-id pub-id-type="pmid">3472204</pub-id>
        </element-citation>
      </ref>
      <ref id="CR52">
        <label>52.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Klein</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Galimidi</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Keeffe</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Bjorkman</surname>
              <given-names>PJ</given-names>
            </name>
          </person-group>
          <article-title>Design and characterization of structured protein linkers with differing flexibilities</article-title>
          <source>Protein Eng Des Sel</source>
          <year>2014</year>
          <volume>27</volume>
          <issue>10</issue>
          <fpage>325</fpage>
          <lpage>330</lpage>
          <pub-id pub-id-type="doi">10.1093/protein/gzu043</pub-id>
          <?supplied-pmid 25301959?>
          <pub-id pub-id-type="pmid">25301959</pub-id>
        </element-citation>
      </ref>
      <ref id="CR53">
        <label>53.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thompson</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Higgins</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Gibson</surname>
              <given-names>TJ</given-names>
            </name>
          </person-group>
          <article-title>CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice</article-title>
          <source>Nucleic Acids Res</source>
          <year>1994</year>
          <volume>22</volume>
          <issue>22</issue>
          <fpage>4673</fpage>
          <lpage>4680</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/22.22.4673</pub-id>
          <?supplied-pmid 7984417?>
          <pub-id pub-id-type="pmid">7984417</pub-id>
        </element-citation>
      </ref>
      <ref id="CR54">
        <label>54.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Combet</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Blanchet</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Geourjon</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Deleage</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>NPS@: network protein sequence analysis</article-title>
          <source>Trends Biochem Sci</source>
          <year>2000</year>
          <volume>25</volume>
          <issue>3</issue>
          <fpage>147</fpage>
          <lpage>150</lpage>
          <pub-id pub-id-type="doi">10.1016/S0968-0004(99)01540-6</pub-id>
          <?supplied-pmid 10694887?>
          <pub-id pub-id-type="pmid">10694887</pub-id>
        </element-citation>
      </ref>
      <ref id="CR55">
        <label>55.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Claros</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Vincens</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Computational method to predict mitochondrially imported proteins and their targeting sequences</article-title>
          <source>Eur J Biochem</source>
          <year>1996</year>
          <volume>241</volume>
          <issue>3</issue>
          <fpage>779</fpage>
          <lpage>786</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1432-1033.1996.00779.x</pub-id>
          <?supplied-pmid 8944766?>
          <pub-id pub-id-type="pmid">8944766</pub-id>
        </element-citation>
      </ref>
      <ref id="CR56">
        <label>56.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krnacova</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Vesteg</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hampl</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Vlcek</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Horvath</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Euglena gracilis and Trypanosomatids possess common patterns in predicted mitochondrial targeting presequences</article-title>
          <source>J Mol Evol</source>
          <year>2012</year>
          <volume>75</volume>
          <issue>3–4</issue>
          <fpage>119</fpage>
          <lpage>129</lpage>
          <pub-id pub-id-type="doi">10.1007/s00239-012-9523-2</pub-id>
          <?supplied-pmid 23064754?>
          <pub-id pub-id-type="pmid">23064754</pub-id>
        </element-citation>
      </ref>
      <ref id="CR57">
        <label>57.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Uboldi</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Lueder</surname>
              <given-names>FB</given-names>
            </name>
            <name>
              <surname>Walsh</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Spurck</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>McFadden</surname>
              <given-names>GI</given-names>
            </name>
            <name>
              <surname>Curtis</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A mitochondrial protein affects cell morphology, mitochondrial segregation and virulence in Leishmania</article-title>
          <source>Int J Parasitol</source>
          <year>2006</year>
          <volume>36</volume>
          <issue>14</issue>
          <fpage>1499</fpage>
          <lpage>1514</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ijpara.2006.08.006</pub-id>
          <?supplied-pmid 17011565?>
          <pub-id pub-id-type="pmid">17011565</pub-id>
        </element-citation>
      </ref>
      <ref id="CR58">
        <label>58.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ozvegy</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Varadi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sarkadi</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Characterization of drug transport, ATP hydrolysis, and nucleotide trapping by the human ABCG2 multidrug transporter. Modulation of substrate specificity by a point mutation</article-title>
          <source>J Biol Chem</source>
          <year>2002</year>
          <volume>277</volume>
          <issue>50</issue>
          <fpage>47980</fpage>
          <lpage>47990</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M207857200</pub-id>
          <?supplied-pmid 12374800?>
          <pub-id pub-id-type="pmid">12374800</pub-id>
        </element-citation>
      </ref>
      <ref id="CR59">
        <label>59.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Henriksen</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Gether</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Litman</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Effect of Walker A mutation (K86M) on oligomerization and surface targeting of the multidrug resistance transporter ABCG2</article-title>
          <source>J Cell Sci</source>
          <year>2005</year>
          <volume>118</volume>
          <issue>Pt 7</issue>
          <fpage>1417</fpage>
          <lpage>1426</lpage>
          <pub-id pub-id-type="doi">10.1242/jcs.01729</pub-id>
          <?supplied-pmid 15769853?>
          <pub-id pub-id-type="pmid">15769853</pub-id>
        </element-citation>
      </ref>
      <ref id="CR60">
        <label>60.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kispal</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Csere</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Guiard</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Lill</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>The ABC transporter Atm1p is required for mitochondrial iron homeostasis</article-title>
          <source>FEBS Lett</source>
          <year>1997</year>
          <volume>418</volume>
          <issue>3</issue>
          <fpage>346</fpage>
          <lpage>350</lpage>
          <pub-id pub-id-type="doi">10.1016/S0014-5793(97)01414-2</pub-id>
          <?supplied-pmid 9428742?>
          <pub-id pub-id-type="pmid">9428742</pub-id>
        </element-citation>
      </ref>
      <ref id="CR61">
        <label>61.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Srinivasan</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Pierik</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Lill</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Crystal structures of nucleotide-free and glutathione-bound mitochondrial ABC transporter Atm1</article-title>
          <source>Science</source>
          <year>2014</year>
          <volume>343</volume>
          <issue>6175</issue>
          <fpage>1137</fpage>
          <lpage>1140</lpage>
          <pub-id pub-id-type="doi">10.1126/science.1246729</pub-id>
          <?supplied-pmid 24604199?>
          <pub-id pub-id-type="pmid">24604199</pub-id>
        </element-citation>
      </ref>
      <ref id="CR62">
        <label>62.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Zhitnitsky</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Lewinson</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Rees</surname>
              <given-names>DC</given-names>
            </name>
          </person-group>
          <article-title>Structural basis for heavy metal detoxification by an Atm1-type ABC exporter</article-title>
          <source>Science</source>
          <year>2014</year>
          <volume>343</volume>
          <issue>6175</issue>
          <fpage>1133</fpage>
          <lpage>1136</lpage>
          <pub-id pub-id-type="doi">10.1126/science.1246489</pub-id>
          <?supplied-pmid 24604198?>
          <pub-id pub-id-type="pmid">24604198</pub-id>
        </element-citation>
      </ref>
      <ref id="CR63">
        <label>63.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Holm</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Rosenstrom</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Dali server: conservation mapping in 3D</article-title>
          <source>Nucleic Acids Res</source>
          <year>2010</year>
          <volume>38</volume>
          <issue>Web Server issue</issue>
          <fpage>W545</fpage>
          <lpage>549</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkq366</pub-id>
          <?supplied-pmid 20457744?>
          <pub-id pub-id-type="pmid">20457744</pub-id>
        </element-citation>
      </ref>
      <ref id="CR64">
        <label>64.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krauth-Siegel</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Comini</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Redox control in trypanosomatids, parasitic protozoa with trypanothione-based thiol metabolism</article-title>
          <source>Biochim Biophys Acta</source>
          <year>2008</year>
          <volume>1780</volume>
          <issue>11</issue>
          <fpage>1236</fpage>
          <lpage>1248</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bbagen.2008.03.006</pub-id>
          <?supplied-pmid 18395526?>
          <pub-id pub-id-type="pmid">18395526</pub-id>
        </element-citation>
      </ref>
      <ref id="CR65">
        <label>65.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goodsell</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Olson</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
          <article-title>Automated docking of substrates to proteins by simulated annealing</article-title>
          <source>Proteins</source>
          <year>1990</year>
          <volume>8</volume>
          <issue>3</issue>
          <fpage>195</fpage>
          <lpage>202</lpage>
          <pub-id pub-id-type="doi">10.1002/prot.340080302</pub-id>
          <?supplied-pmid 2281083?>
          <pub-id pub-id-type="pmid">2281083</pub-id>
        </element-citation>
      </ref>
      <ref id="CR66">
        <label>66.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Monzote</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Gille</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Mitochondria as a promising antiparasitic target</article-title>
          <source>Curr Clin Pharmacol</source>
          <year>2010</year>
          <volume>5</volume>
          <issue>1</issue>
          <fpage>55</fpage>
          <lpage>60</lpage>
          <pub-id pub-id-type="doi">10.2174/157488410790410605</pub-id>
          <?supplied-pmid 20236083?>
          <pub-id pub-id-type="pmid">20236083</pub-id>
        </element-citation>
      </ref>
      <ref id="CR67">
        <label>67.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sen</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Majumder</surname>
              <given-names>HK</given-names>
            </name>
          </person-group>
          <article-title>Mitochondrion of protozoan parasite emerges as potent therapeutic target: exciting drugs are on the horizon</article-title>
          <source>Curr Pharm Des</source>
          <year>2008</year>
          <volume>14</volume>
          <issue>9</issue>
          <fpage>839</fpage>
          <lpage>846</lpage>
          <pub-id pub-id-type="doi">10.2174/138161208784041024</pub-id>
          <?supplied-pmid 18473833?>
          <pub-id pub-id-type="pmid">18473833</pub-id>
        </element-citation>
      </ref>
      <ref id="CR68">
        <label>68.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Paul</surname>
              <given-names>VD</given-names>
            </name>
            <name>
              <surname>Lill</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Biogenesis of cytosolic and nuclear iron-sulfur proteins and their role in genome stability</article-title>
          <source>Biochim Biophys Acta</source>
          <year>2015</year>
          <volume>1853</volume>
          <issue>6</issue>
          <fpage>1528</fpage>
          <lpage>39</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bbamcr.2014.12.018</pub-id>
          <?supplied-pmid 25583461?>
          <pub-id pub-id-type="pmid">25583461</pub-id>
        </element-citation>
      </ref>
      <ref id="CR69">
        <label>69.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lill</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Fekete</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Sipos</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Rotte</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Is there an answer? Why are mitochondria essential for life?</article-title>
          <source>IUBMB life</source>
          <year>2005</year>
          <volume>57</volume>
          <issue>10</issue>
          <fpage>701</fpage>
          <lpage>703</lpage>
          <pub-id pub-id-type="doi">10.1080/15216540500305860</pub-id>
          <?supplied-pmid 16223711?>
          <pub-id pub-id-type="pmid">16223711</pub-id>
        </element-citation>
      </ref>
      <ref id="CR70">
        <label>70.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Taylor</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Kelly</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Iron metabolism in trypanosomatids, and its crucial role in infection</article-title>
          <source>Parasitology</source>
          <year>2010</year>
          <volume>137</volume>
          <issue>6</issue>
          <fpage>899</fpage>
          <lpage>917</lpage>
          <pub-id pub-id-type="doi">10.1017/S0031182009991880</pub-id>
          <?supplied-pmid 20152063?>
          <pub-id pub-id-type="pmid">20152063</pub-id>
        </element-citation>
      </ref>
      <ref id="CR71">
        <label>71.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Manta</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Pavan</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Sturlese</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Medeiros</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Crispo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Berndt</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Iron-sulfur cluster binding by mitochondrial monothiol glutaredoxin-1 of Trypanosoma brucei: molecular basis of iron-sulfur cluster coordination and relevance for parasite infectivity</article-title>
          <source>Antioxid Redox Signal</source>
          <year>2013</year>
          <volume>19</volume>
          <issue>7</issue>
          <fpage>665</fpage>
          <lpage>682</lpage>
          <pub-id pub-id-type="doi">10.1089/ars.2012.4859</pub-id>
          <?supplied-pmid 23259530?>
          <pub-id pub-id-type="pmid">23259530</pub-id>
        </element-citation>
      </ref>
      <ref id="CR72">
        <label>72.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Taketani</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kakimoto</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ueta</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Masaki</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Furukawa</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Involvement of ABC7 in the biosynthesis of heme in erythroid cells: interaction of ABC7 with ferrochelatase</article-title>
          <source>Blood</source>
          <year>2003</year>
          <volume>101</volume>
          <issue>8</issue>
          <fpage>3274</fpage>
          <lpage>3280</lpage>
          <pub-id pub-id-type="doi">10.1182/blood-2002-04-1212</pub-id>
          <?supplied-pmid 12480705?>
          <pub-id pub-id-type="pmid">12480705</pub-id>
        </element-citation>
      </ref>
      <ref id="CR73">
        <label>73.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dailey</surname>
              <given-names>HA</given-names>
            </name>
            <name>
              <surname>Fleming</surname>
              <given-names>JE</given-names>
            </name>
          </person-group>
          <article-title>Bovine ferrochelatase. Kinetic analysis of inhibition by N-methylprotoporphyrin, manganese, and heme</article-title>
          <source>J Biol Chem</source>
          <year>1983</year>
          <volume>258</volume>
          <issue>19</issue>
          <fpage>11453</fpage>
          <lpage>11459</lpage>
          <?supplied-pmid 6688622?>
          <pub-id pub-id-type="pmid">6688622</pub-id>
        </element-citation>
      </ref>
      <ref id="CR74">
        <label>74.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rossi</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Attwood</surname>
              <given-names>PV</given-names>
            </name>
            <name>
              <surname>Garcia-Webb</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Costin</surname>
              <given-names>KA</given-names>
            </name>
          </person-group>
          <article-title>Inhibition of human lymphocyte ferrochelatase activity by hemin</article-title>
          <source>Biochim Biophys Acta</source>
          <year>1990</year>
          <volume>1038</volume>
          <issue>3</issue>
          <fpage>375</fpage>
          <lpage>381</lpage>
          <pub-id pub-id-type="doi">10.1016/0167-4838(90)90251-A</pub-id>
          <?supplied-pmid 2340297?>
          <pub-id pub-id-type="pmid">2340297</pub-id>
        </element-citation>
      </ref>
      <ref id="CR75">
        <label>75.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Awasthi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Singhal</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Saini</surname>
              <given-names>MK</given-names>
            </name>
            <name>
              <surname>Pandya</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Pikula</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Novel function of human RLIP76: ATP-dependent transport of glutathione conjugates and doxorubicin</article-title>
          <source>Biochemistry</source>
          <year>2000</year>
          <volume>39</volume>
          <issue>31</issue>
          <fpage>9327</fpage>
          <lpage>9334</lpage>
          <pub-id pub-id-type="doi">10.1021/bi992964c</pub-id>
          <?supplied-pmid 10924126?>
          <pub-id pub-id-type="pmid">10924126</pub-id>
        </element-citation>
      </ref>
      <ref id="CR76">
        <label>76.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jonker</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Buitelaar</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wagenaar</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Van Der Valk</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Scheffer</surname>
              <given-names>GL</given-names>
            </name>
            <name>
              <surname>Scheper</surname>
              <given-names>RJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2002</year>
          <volume>99</volume>
          <issue>24</issue>
          <fpage>15649</fpage>
          <lpage>15654</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.202607599</pub-id>
          <?supplied-pmid 12429862?>
          <pub-id pub-id-type="pmid">12429862</pub-id>
        </element-citation>
      </ref>
      <ref id="CR77">
        <label>77.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brechbuhl</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Gould</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kachadourian</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Riekhof</surname>
              <given-names>WR</given-names>
            </name>
            <name>
              <surname>Voelker</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Day</surname>
              <given-names>BJ</given-names>
            </name>
          </person-group>
          <article-title>Glutathione transport is a unique function of the ATP-binding cassette protein ABCG2</article-title>
          <source>J Biol Chem</source>
          <year>2010</year>
          <volume>285</volume>
          <issue>22</issue>
          <fpage>16582</fpage>
          <lpage>16587</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M109.090506</pub-id>
          <?supplied-pmid 20332504?>
          <pub-id pub-id-type="pmid">20332504</pub-id>
        </element-citation>
      </ref>
      <ref id="CR78">
        <label>78.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Basu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Netz</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Haindrich</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Herlerth</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Lagny</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Pierik</surname>
              <given-names>AJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cytosolic iron-sulphur protein assembly is functionally conserved and essential in procyclic and bloodstream Trypanosoma brucei</article-title>
          <source>Mol Microbiol</source>
          <year>2014</year>
          <volume>93</volume>
          <issue>5</issue>
          <fpage>897</fpage>
          <lpage>910</lpage>
          <pub-id pub-id-type="doi">10.1111/mmi.12706</pub-id>
          <?supplied-pmid 25040552?>
          <pub-id pub-id-type="pmid">25040552</pub-id>
        </element-citation>
      </ref>
      <ref id="CR79">
        <label>79.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kage</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Tsukahara</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sugiyama</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Asada</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ishikawa</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Tsuruo</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Dominant-negative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of S-S dependent homodimerization</article-title>
          <source>Int J Cancer</source>
          <year>2002</year>
          <volume>97</volume>
          <issue>5</issue>
          <fpage>626</fpage>
          <lpage>630</lpage>
          <pub-id pub-id-type="doi">10.1002/ijc.10100</pub-id>
          <?supplied-pmid 11807788?>
          <pub-id pub-id-type="pmid">11807788</pub-id>
        </element-citation>
      </ref>
      <ref id="CR80">
        <label>80.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alsford</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Turner</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Obado</surname>
              <given-names>SO</given-names>
            </name>
            <name>
              <surname>Sanchez-Flores</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Glover</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Berriman</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome</article-title>
          <source>Genome Res</source>
          <year>2011</year>
          <volume>21</volume>
          <issue>6</issue>
          <fpage>915</fpage>
          <lpage>924</lpage>
          <pub-id pub-id-type="doi">10.1101/gr.115089.110</pub-id>
          <?supplied-pmid 21363968?>
          <pub-id pub-id-type="pmid">21363968</pub-id>
        </element-citation>
      </ref>
      <ref id="CR81">
        <label>81.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Estevez</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Haile</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Steinbuchel</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Quijada</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Clayton</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Effects of depletion and overexpression of the Trypanosoma brucei ribonuclease L inhibitor homologue</article-title>
          <source>Mol Biochem Parasitol</source>
          <year>2004</year>
          <volume>133</volume>
          <issue>1</issue>
          <fpage>137</fpage>
          <lpage>141</lpage>
          <pub-id pub-id-type="doi">10.1016/j.molbiopara.2003.09.009</pub-id>
          <?supplied-pmid 14668021?>
          <pub-id pub-id-type="pmid">14668021</pub-id>
        </element-citation>
      </ref>
      <ref id="CR82">
        <label>82.</label>
        <mixed-citation publication-type="other">Horáková E, Changmai P, Paris Z, Salmon D, Lukeš. Simultaneous depletion of Atm and Mdl rebalances cytosolic Fe-S cluster assembly but not heme import into the mitochondrion of Trypanosoma brucei J FEBS J. 2015;282(21):4157-75.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:4700572</identifier><datestamp>2016-01-06</datestamp><setSpec>malarj</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="http://jats.nlm.nih.gov/ns/archiving/1.0/ http://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Malar J</journal-id>
      <journal-id journal-id-type="iso-abbrev">Malar. J</journal-id>
      <journal-title-group>
        <journal-title>Malaria Journal</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1475-2875</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC4700572</article-id>
      <article-id pub-id-type="pmcid">PMC4700572</article-id>
      <article-id pub-id-type="pmc-uid">4700572</article-id>
      <article-id pub-id-type="publisher-id">1080</article-id>
      <article-id pub-id-type="doi">10.1186/s12936-015-1080-x</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Therapeutic efficacy of artesunate-amodiaquine and artemether-lumefantrine combinations in the treatment of uncomplicated malaria in two ecological zones in Ghana</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Abuaku</surname>
            <given-names>Benjamin</given-names>
          </name>
          <address>
            <email>babuaku@noguchi.ug.edu.gh</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Duah</surname>
            <given-names>Nancy</given-names>
          </name>
          <address>
            <email>nduah@noguchi.ug.edu.gh</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Quaye</surname>
            <given-names>Lydia</given-names>
          </name>
          <address>
            <email>lquaye@noguchi.ug.edu.gh</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Quashie</surname>
            <given-names>Neils</given-names>
          </name>
          <address>
            <email>nquashie@hotmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Malm</surname>
            <given-names>Keziah</given-names>
          </name>
          <address>
            <email>kezmalm@yahoo.com</email>
          </address>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bart-Plange</surname>
            <given-names>Constance</given-names>
          </name>
          <address>
            <email>constance.bartplange@ghsmail.org</email>
          </address>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Koram</surname>
            <given-names>Kwadwo</given-names>
          </name>
          <address>
            <email>kkoram@noguchi.ug.edu.gh</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <aff id="Aff1"><label/>Epidemiology Department, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, P. O. Box LG581, Legon, Ghana </aff>
        <aff id="Aff2"><label/>Centre for Tropical Clinical Pharmacology and Therapeutics, University of Ghana Medical School, P. O. Box GP4236, Accra, Ghana </aff>
        <aff id="Aff3"><label/>National Malaria Control Programme, Public Health Division, Ghana Health Service, Accra, Ghana </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>5</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>5</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <volume>15</volume>
      <elocation-id>6</elocation-id>
      <history>
        <date date-type="received">
          <day>6</day>
          <month>8</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>29</day>
          <month>12</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© Abuaku et al. 2016</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Case management based on prompt diagnosis and adequate treatment using artemisinin-based combination therapy (ACT) remains the main focus of malaria control in Ghana. As part of routine surveillance on the therapeutic efficacy of ACT in Ghana, the efficacy of amodiaquine-artesunate (AS-AQ) and artemether-lumefantrine (AL) were studied in six sentinel sites representing the forest and savannah zones of the country.</p>
        </sec>
        <sec>
          <title>Methods</title>
          <p>Three sites representing the two ecological zones studied AS-AQ whilst the other three sites studied AL. In each site, the study was a one-arm prospective evaluation of the clinical, parasitological, and haematological responses to directly observed therapy for uncomplicated malaria with either AS-AQ or AL among children aged 6 months and 9 years. The WHO 2009 protocol for monitoring anti-malarial drug efficacy was used for the study between July 2013 and March 2014.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>Per-protocol analyses on day 28 showed an overall PCR-corrected cure rate of 100 % for AS-AQ and 97.6 % (95 % CI 93.1, 99.5) for AL: 97.2 % (95 % CI 92.0, 99.4) in the forest zone and 100 % in the savannah zone. Kaplan–Meier survival analysis showed similar outcomes. Prevalence of fever decreased by about 75 % after the first day of treatment with each ACT in the two ecological zones. No child studied was parasitaemic on day 3, and gametocytaemia was generally maintained at low levels (&lt;5 %). Post-treatment mean haemoglobin concentrations significantly increased in the two ecological zones.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>Therapeutic efficacy of AS-AQ and AL remains over 90 % in the forest and savannah zones of Ghana. Additionally, post-treatment parasitaemia on day 3 is rare suggesting that artemisinin is still efficacious in Ghana.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Therapeutic efficacy</kwd>
        <kwd>Artesunate-amodiaquine</kwd>
        <kwd>Artemether-lumefantrine</kwd>
        <kwd>Uncomplicated malaria</kwd>
        <kwd>Ecological zones</kwd>
        <kwd>Ghana</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004417</institution-id>
              <institution>Global Fund to Fight AIDS, Tuberculosis and Malaria (CH)</institution>
            </institution-wrap>
          </funding-source>
        </award-group>
      </funding-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>© The Author(s) 2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Background</title>
      <p>Malaria remains a major public health problem in the world after decades of deployment of different interventions. Globally, an estimated 3.3 billion people are at risk of malaria infection and disease. It is estimated that in 2013 there were approximately 198 million cases of malaria worldwide, representing a decline of 30 % since year 2000. In the same year, malaria accounted for approximately 584,000 deaths worldwide, representing a decline of 47 % since year 2000. Africa remains the continent with the heaviest burden of malaria, accounting for about 90 % of all malaria deaths in the world. It is also estimated that about 78 % of all malaria deaths occur among children aged under 5 years [<xref ref-type="bibr" rid="CR1">1</xref>]. In 2013, malaria was estimated to account for 44 % of all outpatient clinic visits and 22.3 % of all under-five deaths in Ghana [<xref ref-type="bibr" rid="CR2">2</xref>].</p>
      <p>Case management based on prompt diagnosis and adequate treatment remains a major focus of malaria control in Ghana. Other interventions include intermittent preventive treatment among pregnant women (IPTp), long-lasting insecticide-treated nets (LLINs), indoor residual spraying (IRS), and recently seasonal malaria chemoprevention (SMC) [<xref ref-type="bibr" rid="CR3">3</xref>]. Evidence of the declining efficacy of chloroquine from 1998 to 2003, and the superiority of artemisnin-based combination therapy (ACT) resulted in the replacement of chloroquine with artesunate-amodiaquine (AS-AQ) combination in 2005 as first-line treatment for uncomplicated malaria in Ghana [<xref ref-type="bibr" rid="CR4">4</xref>–<xref ref-type="bibr" rid="CR6">6</xref>]. In 2008, artemether-lumefantrine (AL) and dihydroartemisinin-piperaquine (DHAP) were added as alternative first-line drugs for patients unable to tolerate AS-AQ [<xref ref-type="bibr" rid="CR7">7</xref>].</p>
      <p>Since 2005 the Noguchi Memorial Institute for Medical Research (NMIMR), in collaboration with the National Malaria Control Programme (NMCP), has been monitoring the therapeutic efficacy of first-line anti-malarial drugs from sentinel sites across Ghana with the view of providing continuous data to inform malaria treatment policy in the country. This paper covers the therapeutic efficacy of AS-AQ and AL across two ecological zones in Ghana during the period July 2013 to March 2014 using the 2009 WHO protocol for surveillance of anti-malarial drug efficacy [<xref ref-type="bibr" rid="CR8">8</xref>].</p>
    </sec>
    <sec id="Sec2">
      <title>Methods</title>
      <sec id="Sec3">
        <title>Study design</title>
        <p>The study was a one-arm prospective evaluation of the clinical, parasitological, and haematological responses to directly observed therapy for uncomplicated malaria with either AS-AQ or AL among children aged 6 months to 9 years in sentinel sites representing the savannah and forest zones of Ghana. The primary objective of the study was to assess cure rates in the two ecological zones whilst secondary objectives were to assess patterns of fever and parasite clearance as well as changes in haemoglobin levels and gametocyte carriage rates after treatment with AS-AQ and AL.</p>
      </sec>
      <sec id="Sec4">
        <title>Study sites</title>
        <p>Therapeutic efficacy of AS-AQ was studied in the Yendi Municipal and Wa Regional Hospitals (representing the savannah zone) and Hohoe Municipal Hospital (representing the forest zone). Therapeutic efficacy of AL was studied in Navrongo War Memorial Hospital (representing the savannah zone) and Bekwai Municipal and Begoro District Hospitals (representing the forest zone).</p>
        <p>The Yendi Municipal is located in the Northern region of Ghana with an estimated municipal population of 117,780 and an annual average rainfall of 1125 mm. Wa regional hospital is located within Wa municipal in the Upper West region of Ghana with an estimated municipal population of 107,214 and an annual average rainfall of between 840 mm and 1400 mm. The Navrongo War Memorial Hospital is located in the Kassena Nakana East district in the Upper East region of Ghana with an estimated district population of 109,944 and an annual average rainfall of 950 mm. Malaria transmission in the savannah zone of Ghana is generally perennial with marked seasonal variation and an annual entomological rate of about 418 infective bites per person per year [<xref ref-type="bibr" rid="CR9">9</xref>–<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR13">13</xref>–<xref ref-type="bibr" rid="CR15">15</xref>].</p>
        <p>Hohoe is located in the Volta region of Ghana with an estimated municipal population of 262,046 and an annual average rainfall of 1300 mm. The rainfall pattern is bimodal with two distinct rainy seasons: April to July as major and September to November as minor. Malaria transmission in the municipality is intense and peaks with the two rainy seasons. Bekwai municipal is located in the Ashanti region of Ghana with an estimated municipal population of 118,024. Annual rainfall in the municipality is 1600–1800 mm with double maxima rainfall in May and October each year. Malaria transmission in the municipality is intense and perennial. Begoro is located in the Fanteakwa district in the Eastern region of Ghana. The Fanteakwa district has an estimated population of 108,614. Annual rainfall in the district is 1500–2000 mm with double maxima rainfall in June and October each year. Malaria transmission in the district is intense and perennial. Annual entomological inoculation rate in the forest zone can be as high as 866 infective bites per person per year [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR16">16</xref>–<xref ref-type="bibr" rid="CR18">18</xref>].</p>
      </sec>
      <sec id="Sec5">
        <title>Study population</title>
        <p>Children aged between 6 months and 9 years with a history of fever suggestive of malaria were screened for the study. Blood samples from a finger prick were used to prepare thick and thin smears for malaria microscopy and haemoglobin level determination. Children who met the inclusion criteria were recruited into the study after parental consent had been obtained. Inclusion criteria included axillary temperature ≥37.5 °C or history of fever during the past 24 h; mono-infection with <italic>Plasmodium falciparum</italic>; parasite count ranging between 1000 and 250,000 per µl; haemoglobin level &gt;5 g/dl; and absence of signs/symptoms of severe malaria.</p>
      </sec>
      <sec id="Sec6">
        <title>Treatment</title>
        <p>All anti-malarials used in the study were fixed-dose combinations, and were supplied by the WHO, Geneva. For sites studying AS-AQ, children enrolled received single daily weight-based products from Sanofi Aventis. The products were 25/67.5 mg (batch number 1084, expiring 01/2015) for children weighing 4.5 to &lt;9 kg; 50/135 mg (batch number 3109, expiring 02/2015) for children weighing 9 to &lt;18 kg; and 100/270 mg (batch number 5433, expiring 01/2015) for children weighing 18 to &lt;36 kg. For sites studying AL, children enrolled received weight-based 20/120 mg of Coartem<sup>®</sup> (batch number F0785, expiring 05/2014) at 0, 8, 24, 36, 48, and 60 h. Children weighing 5 to &lt;15 kg were given one tablet per hour of treatment; those weighing 15 to &lt;25 kg were given two tablets per hour of treatment; and those weighing 25 to &lt;35 kg were given three tablets per hour of treatment. All tablets were dissolved in water and given under direct observation by a study nurse and children were observed for 30 min to ascertain retention of anti-malarial. Children who vomited during the observation period were re-treated with the same dose of anti-malarial and observed for an additional 30 min. Children with repeated vomiting were given parenteral therapy with quinine as per national standard treatment guidelines and excluded from the study. All children were allowed use of antipyretics. Children who showed signs/symptoms of severe malaria were withdrawn from the study.</p>
      </sec>
      <sec id="Sec7">
        <title>Patient follow-up</title>
        <p>Children enrolled into the study were followed-up for 28 days. Children were seen at the outpatient department on days 1, 2, 3, 7, 14, 21, and 28 (day of commencement of treatment was counted as day 0). At each follow-up visit, the children were clinically examined by a study Physician, who recorded findings on a Case Record Form (CRF). Parasitaemia levels (asexual and sexual) were assessed on days 2, 3, 7, 14, 21, 28, and any day within the 28-day follow-up period that a child is brought to the clinic with fever. Thick and thin smears were stained with 3 % Giemsa for 30–45 min for quantification of asexual parasites against 200 white blood cells using a hand tally counter. Sexual parasite counts were done per 1000 white blood cells. Parasitaemia levels were expressed per µl blood assuming white blood cell count of 8000 per µl blood. A smear was declared negative when examination of 100 thick-film fields did not show presence of asexual parasites. For quality control purposes, all blood slides were read by two qualified independent microscopists, and discordant readings were re-examined by a third qualified independent microscopist. Discordance was defined as differences between the first and second microscopists regarding presence/absence of asexual or sexual parasites; species diagnosis; and day 0 counts meeting the inclusion criterion of 1000–250,000 per µl blood. The first or second reading was taken as final depending on whichever agrees with the third reading. Filter paper blots were obtained on day 0 and at recurrence of parasitaemia for PCR genotyping. Merozoite surface proteins 1 and 2 (<italic>msp1</italic>, <italic>msp2</italic>), and glutamate-rich protein (<italic>glurp</italic>) were used to distinguish between re-infection and recrudescence [<xref ref-type="bibr" rid="CR19">19</xref>]. Haemoglobin levels were assessed for all study children on days 0, 14, and 28 using an automated haematology analyzer (Sysmex KX-21N™).</p>
      </sec>
      <sec id="Sec8">
        <title>Data analysis</title>
        <p>Per protocol analysis was used to assess treatment outcomes on day 28 for the two ecological zones based on the WHO 2009 criteria: Early treatment failure (ETF), Late Parasitological Failure (LPF), Late Clinical Failure (LCF), and Adequate Clinical and Parasitological Response (ACPR) [<xref ref-type="bibr" rid="CR8">8</xref>]. Kaplan–Meier survival analysis was used to assess the cumulative incidence of treatment success over the 28-day follow-up period. Secondary outcomes were patterns of fever and parasite clearance assessed for the two ecological zones using proportions (with 95 % CI) of children febrile/with temperature ≥37.5 °C or parasitaemic within the first week of follow-up. Haematological responses were also assessed using pre- and post-treatment mean haemoglobin levels on days 0, 14 and 28. Proportions were compared using Chi square and Fisher’s exact tests. Normally distributed variables were compared using Student’s <italic>t</italic> test while skewed distributions such as parasite counts were log transformed before using the normal approximation. Differences were considered significant at <italic>p</italic> &lt; 0.05.</p>
      </sec>
      <sec id="Sec9">
        <title>Ethics</title>
        <p>The Institutional Review Board of the Noguchi Memorial Institute for Medical Research, University of Ghana, reviewed and approved the study. Written informed consent was obtained from each parent/guardian at the start of the study. Each parent/guardian was informed of the objectives, methods, anticipated benefits and potential hazards of the study. They were also informed that they were at liberty to withdraw their children from the study at any time without penalty.</p>
      </sec>
    </sec>
    <sec id="Sec10">
      <title>Results</title>
      <sec id="Sec11">
        <title>Baseline characteristics</title>
        <p>A cumulative total of 310 children participated in the study in the two ecological zones: 140 received AS-AQ and 170 received AL. Of the children who received AS-AQ, 81 (57.9 %) were within the savannah zone. Of the children who received AL, 124 (72.9 %) were in the forest zone. For both anti-malarials, there were no significant differences between the two ecological zones, in terms of male/female ratio as well as baseline mean haemoglobin levels (Tables <xref rid="Tab1" ref-type="table">1</xref>, <xref rid="Tab2" ref-type="table">2</xref>). The majority of children who received AS-AQ were aged 5–9 years in the forest zone (55.9 %; 95 % CI 42.5, 68.6) and less than 5 years in the savannah zone (69.1 %; 95 % CI 57.8, 78.7). For the same group of children, mean axillary temperature was significantly higher in the savannah zone compared with the forest zone whilst geometric mean parasite count was significantly higher in the forest zone (Table <xref rid="Tab1" ref-type="table">1</xref>). Among children who received AL, there were no significant differences in baseline characteristics between the two ecological zones. No child receiving AL was reported to have taken any anti-malarial within the 14-day period preceding visit to the clinic (Table <xref rid="Tab2" ref-type="table">2</xref>). However, twelve children who received AS-AQ in the savannah zone were reported to have taken an anti-malarial within the same period preceding their visit to the clinic (14.8 %; 95 % CI 8.2, 24.8) (Table <xref rid="Tab1" ref-type="table">1</xref>). Intake of anti-malarial drugs among the twelve children was reported to have been stopped between 1 and 11 days prior to their visit to the clinic; mean number of days being 6.0 (±3.6). None of the children who received AS-AQ in the two ecological zones was gametocytaemic at baseline. Among children who received AL, none in the savannah zone and 4 (3.3 %) in the forest zone were gametocytaemic at baseline.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Demographic, clinical, parasitological, and haematological characteristics of patients treated with AS-AQ at baseline</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Characteristic</th><th align="left" rowspan="2">Total (n = 140)</th><th align="left" colspan="2">Ecological zone</th><th align="left" rowspan="2">p value</th></tr><tr><th align="left">Forest (n = 59)</th><th align="left">Savannah (n = 81)</th></tr></thead><tbody><tr><td align="left">Male/female</td><td align="left">74/66</td><td align="left">29/30</td><td align="left">45/36</td><td char="." align="char">0.563</td></tr><tr><td align="left" colspan="5">Age group</td></tr><tr><td align="left"> &lt;5 years</td><td align="left">82 (58.6 %)</td><td align="left">26 (44.1 %)</td><td align="left">56 (69.1 %)</td><td char="." align="char" rowspan="2">0.005</td></tr><tr><td align="left"> 5–9 years</td><td align="left">58 (41.4 %)</td><td align="left">33 (55.9 %)</td><td align="left">25 (30.9 %)</td></tr><tr><td align="left" colspan="5">Axillary temperature in °C</td></tr><tr><td align="left"> Mean temperature (sd)<sup>a</sup>
</td><td align="left">37.8 (0.9)</td><td align="left">37.5 (0.1)</td><td align="left">38.1 (1.1)</td><td char="." align="char" rowspan="2">0.000</td></tr><tr><td align="left"> Range (min, max)</td><td align="left">35.2, 40.0</td><td align="left">36.9, 37.5</td><td align="left">35.2, 40.0</td></tr><tr><td align="left" colspan="5">Parasitaemia/µl</td></tr><tr><td align="left"> Geometric mean</td><td align="left">32,479</td><td align="left">44,669</td><td align="left">25,750</td><td char="." align="char" rowspan="2">0.001</td></tr><tr><td align="left"> Range (min, max)</td><td align="left">(1000, 228,040)</td><td align="left">(1000, 228,040)</td><td align="left">(1029, 170,840)</td></tr><tr><td align="left" colspan="5">Haemoglobin level in g/dl</td></tr><tr><td align="left"> Mean (sd)<sup>a</sup>
</td><td align="left">8.7 (1.6)</td><td align="left">8.7 (1.0)</td><td align="left">8.7 (1.9)</td><td char="." align="char" rowspan="2">1.000</td></tr><tr><td align="left"> Range (min, max)</td><td align="left">(5.4, 13.9)</td><td align="left">(6.0, 13.9)</td><td align="left">(5.4, 13.9)</td></tr><tr><td align="left">Previous anti-malarial intake</td><td align="left">12 (8.6 %)</td><td align="left">0</td><td align="left">12 (14.8 %)<sup>b</sup>
</td><td char="." align="char">0.005</td></tr></tbody></table><table-wrap-foot><p>
<sup>a</sup>Standard deviation</p><p>
<sup>b</sup>Six children had taken AS-AQ and the other six had taken AL within the 14-day period preceding their visit to the clinic</p></table-wrap-foot></table-wrap><table-wrap id="Tab2"><label>Table 2</label><caption><p>Demographic, clinical, parasitological, and haematological characteristics of patients treated with AL at baseline</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Characteristic</th><th align="left" rowspan="2">Total (n = 170)</th><th align="left" colspan="2">Ecological zone</th><th align="left" rowspan="2">p value</th></tr><tr><th align="left">Forest (n = 124)</th><th align="left">Savannah (n = 46)</th></tr></thead><tbody><tr><td align="left">Male/female</td><td align="left">77/93</td><td align="left">56/68</td><td align="left">21/25</td><td char="." align="char">0.907</td></tr><tr><td align="left" colspan="5">Age group</td></tr><tr><td align="left"> &lt;5 years</td><td align="left">110 (64.7 %)</td><td align="left">81 (65.3 %)</td><td align="left">29 (63.0 %)</td><td char="." align="char" rowspan="2">0.924</td></tr><tr><td align="left"> 5–9 years</td><td align="left">60 (35.3 %)</td><td align="left">43 (34.7 %)</td><td align="left">17 (37.0 %)</td></tr><tr><td align="left" colspan="5">Axillary temperature in °C</td></tr><tr><td align="left"> Mean temperature (sd)<sup>a</sup>
</td><td align="left">38.1 (1.0)</td><td align="left">38.2 (1.0)</td><td align="left">37.9 (1.1)</td><td char="." align="char" rowspan="2">0.093</td></tr><tr><td align="left"> Range (min, max)</td><td align="left">35.6, 40.2</td><td align="left">35.6, 40.2</td><td align="left">35.9, 40.1</td></tr><tr><td align="left" colspan="5">Parasitaemia/µl</td></tr><tr><td align="left"> Geometric mean</td><td align="left">39,983</td><td align="left">38,665</td><td align="left">43,766</td><td char="." align="char" rowspan="2">0.415</td></tr><tr><td align="left"> Range (min, max)</td><td align="left">(1080, 240,840)</td><td align="left">(1080, 239,890)</td><td align="left">(1280, 240,840)</td></tr><tr><td align="left" colspan="5">Haemoglobin level in g/dl</td></tr><tr><td align="left"> Mean (sd)<sup>a</sup>
</td><td align="left">10.2 (1.5)</td><td align="left">10.2 (1.6)</td><td align="left">10.3 (1.2)</td><td char="." align="char" rowspan="2">0.695</td></tr><tr><td align="left"> Range (min, max)</td><td align="left">(5.6, 14.4)</td><td align="left">(5.6, 13.1)</td><td align="left">(6.4, 14.4)</td></tr></tbody></table><table-wrap-foot><p>
<sup>a</sup>Standard deviation</p></table-wrap-foot></table-wrap></p>
      </sec>
      <sec id="Sec12">
        <title>Primary outcomes</title>
        <p>Per protocol treatment outcomes on day 28 were assessed for a total of 278 evaluable children. Out of this, 125 received AS-AQ, and 153 received AL (Table <xref rid="Tab3" ref-type="table">3</xref>). PCR-uncorrected analyses showed an overall day 28 cure rate of 97.6 % (95 % CI 93.1, 99.5) for AS-AQ: 98 % (95 % CI 89.4, 99.9) in the forest zone and 97.3 % (95 % CI 90.7, 99.7) in the savannah zone. The overall PCR-uncorrected cure rate for AL was 79.1 % (95 % CI 71.8, 85.1): 85 % (95 % CI 77.5, 90.9) in the forest zone and 56.3 % (95 % CI 37.7, 73.6) in the savannah zone. PCR-corrected analyses showed an overall cure rate of 100 % (95 % CI 96.2, 99.9) for AS-AQ and 97.6 % (95 % CI 93.1, 99.5) for AL. Within the forest zone, PCR-corrected cure rate was 100 % (95 % CI 90.9, 99.8) for AS-AQ and 97.2 % (95 % CI 92.0, 99.4) for AL. Within the savannah zone, PCR-corrected cure rates for AS-AQ and AL were both 100 % (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). No early treatment failure (ETF) was observed following treatment with AS-AQ or AL.<table-wrap id="Tab3"><label>Table 3</label><caption><p>Per protocol day-28 treatment outcomes (PCR-uncorrected) for AS-AQ and AL by two ecological zones in Ghana</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Anti-malarial drug</th><th align="left" rowspan="2">Treatment outcome</th><th align="left" rowspan="2">Total</th><th align="left" colspan="2">Ecological zone</th></tr><tr><th align="left">Forest</th><th align="left">Savannah</th></tr></thead><tbody><tr><td align="left" rowspan="6">AS-AQ</td><td align="left"/><td align="left">n = 140</td><td align="left">n = 59</td><td align="left">n = 81</td></tr><tr><td align="left">ETF</td><td align="left">0</td><td align="left">0</td><td align="left">0</td></tr><tr><td align="left">LCF</td><td align="left">1</td><td align="left">1</td><td align="left">0</td></tr><tr><td align="left">LPF</td><td align="left">2</td><td align="left">0</td><td align="left">2</td></tr><tr><td align="left">ACPR</td><td align="left">122</td><td align="left">49</td><td align="left">73</td></tr><tr><td align="left">NA<sup>a</sup>
</td><td align="left">15</td><td align="left">9<sup>b</sup>
</td><td align="left">6<sup>c</sup>
</td></tr><tr><td align="left" rowspan="6">AL</td><td align="left"/><td align="left">n = 170</td><td align="left">n = 124</td><td align="left">n = 46</td></tr><tr><td align="left">ETF</td><td align="left">0</td><td align="left">0</td><td align="left">0</td></tr><tr><td align="left">LCF</td><td align="left">8</td><td align="left">8</td><td align="left">0</td></tr><tr><td align="left">LPF</td><td align="left">24</td><td align="left">10</td><td align="left">14</td></tr><tr><td align="left">ACPR</td><td align="left">121</td><td align="left">103</td><td align="left">18</td></tr><tr><td align="left">NA<sup>a</sup>
</td><td align="left">17</td><td align="left">3<sup>d</sup>
</td><td align="left">14<sup>e</sup>
</td></tr></tbody></table><table-wrap-foot><p>
<sup>a</sup>Not assessed</p><p>
<sup>b</sup>One was withdrawn on day 2 because she was generally weak. Eight were lost to follow-up: four on day 7; two on day 14; and two on day 21</p><p>
<sup>c</sup>All lost to follow-up: three on day 3; two on day 7; and one on day 14</p><p>
<sup>d</sup>One was withdrawn on day 0 because of excessive vomiting after intake of medicine. One each was lost to follow-up on days 1 and 2</p><p>
<sup>e</sup>All lost to follow-up: four on day 7; seven on day 14; and three on day 21</p></table-wrap-foot></table-wrap><fig id="Fig1"><label>Fig. 1</label><caption><p>Per protocol PCR-uncorrected and PCR-corrected cure rates for AS-AQ and AL in two ecological zones in Ghana. <italic>Colour blue</italic> is PCR-uncorrected data whilst <italic>dark red</italic> is PCR-corrected data</p></caption><graphic xlink:href="12936_2015_1080_Fig1_HTML" id="MO1"/></fig></p>
        <p>PCR-uncorrected Kaplan–Meier survival analysis for AS-AQ showed cumulative treatment success incidence of 1.000 for the two ecological zones until day 7, when the incidence of success declined to 0.987 (95 % CI 0.917, 0.999) in the savannah zone and remained 1.000 in the forest zone (p = 0.895). Incidence of treatment success with AS-AQ remained 1.000 and 0.987 in the forest and savannah zones, respectively until day 21, when both zones experienced a decline to 0.981 (95 % CI 0.884, 0.999) and 0.974 (95 % CI 0.902, 0.996), respectively (p = 0.721), and remained same between day 21 and day 28. For AL, PCR-uncorrected treatment success remained 1.000 in the two ecological zones until day 14 when cumulative incidence of treatment success declined to 0.984 (95 % CI 0.936, 0.997) in the forest zone and 0.929 (95 % CI 0.795, 0.981) in the savannah zone (p = 0.208). Cumulative incidence of treatment success further declined on day 21 to 0.942 (95 % CI 0.880, 0.974) in the forest zone and 0.667 (95 % CI 0.481, 0.815) in the savannah zone (p &lt; 0.001). Cumulative incidence of treatment success remained 0.942 in the forest zone until day 26, when it declined to 0.934 (95 % CI 0.870, 0.969), and further declined to 0.851 (95 % CI 0.772, 0.907) on day 28 compared with 0.601 (95 % CI 0.422, 0.766) on the same day in the savannah zone (p = 0.004) (Fig. <xref rid="Fig2" ref-type="fig">2</xref>). PCR-corrected Kaplan–Meier survival analyses showed a cumulative treatment success incidence of 0.979 (95 % CI 0.935, 0.993) for AL, translating into a cumulative treatment failure incidence of 0.021 (95 % CI 0.007, 0.065), and no treatment failure for AS-AQ.<fig id="Fig2"><label>Fig. 2</label><caption><p>PCR-uncorrected Kaplan–Meier survival curve for AS-AQ and AL in two ecological zones in Ghana. <italic>Dark blue line</italic> with diamond spots represents AS-AQ in the forest zone; <italic>dark red line</italic>
<italic>with square spots</italic> represents AS-AQ in the savannah zone; <italic>green line with delta spots</italic> represents combined or overall AS-AQ data (for both savannah and forest zones); <italic>purple line with (X) spots</italic> represents AL in the forest zone; <italic>light blue line</italic>
<italic>with (*) spots</italic> represent AL in the savannah zone; and <italic>orange line with circular spots</italic> represents combined or overall AL data (for both savannah and forest zones)</p></caption><graphic xlink:href="12936_2015_1080_Fig2_HTML" id="MO2"/></fig></p>
      </sec>
      <sec id="Sec13">
        <title>Secondary outcomes</title>
        <p>Generally, prevalence of fever decreased by about 75 % after first day of treatment with each ACT (26.4 %; 95 % CI 19.5, 34.7 for AS-AQ and 21.4 %; 95 % CI 15.6, 28.6 for AL; p = 0.372) (Fig. <xref rid="Fig3" ref-type="fig">3</xref>). For AS-AQ, only one child in the savannah zone was reported to have had fever on day 7 (1.2 %; 95 % CI 0.1, 8.0). This child was, however, aparasitaemic and remained same throughout the rest of the follow-up period. No child was febrile in the forest zone on day 7. For AL, no child was febrile on day 7 in the two ecological zones.<fig id="Fig3"><label>Fig. 3</label><caption><p>Proportion of children with fever during first week of follow-up by ecological zone. <italic>Dark blue line with diamond spots</italic> represents AS-AQ in the forest zone; <italic>dark red line with square spots</italic> represents AS-AQ in the savannah zone; <italic>green line with delta spots</italic> represents combined or overall AS-AQ data (for both savannah and forest zones); <italic>purple line with (X) spots</italic> represents AL in the forest zone; <italic>light blue line with (*) spots</italic> represent AL in the savannah zone; and <italic>orange line with circular spots</italic> represents combined or overall AL data (for both savannah and forest zones)</p></caption><graphic xlink:href="12936_2015_1080_Fig3_HTML" id="MO3"/></fig></p>
        <p>No child in the two ecological zones was parasitaemic on day 3 (Fig. <xref rid="Fig4" ref-type="fig">4</xref>). For AS-AQ, only one child in the savannah zone was parasitaemic on day 7 (1.3 %; 95 % CI 0.1, 7.9) as against none in the forest zone. The child who had malaria parasites on day 7 was confirmed by PCR to be a case of re-infection. For AL, no child was parasitaemic on day 7.<fig id="Fig4"><label>Fig. 4</label><caption><p>Proportion of children with parasites during first week of follow-up by ecological zone. <italic>Dark blue line with diamond spots</italic> represents AS-AQ in the forest zone; <italic>dark red line with square spots</italic> represents AS-AQ in the savannah zone; <italic>green line with delta spots</italic> represents combined or overall AS-AQ data (for both savannah and forest zones); <italic>purple line with (X) spots</italic> represents AL in the forest zone; <italic>light blue line with (*) spots</italic> represent AL in the savannah zone; and <italic>orange line with circular spots</italic> represents combined or overall AL data (for both savannah and forest zones)</p></caption><graphic xlink:href="12936_2015_1080_Fig4_HTML" id="MO4"/></fig></p>
        <p>Prevalence of gametocytaemia remained less than 5 % during the 28-day follow-up period after treatment with AS-AQ and AL in the two ecological zones. For AS-AQ, gametocytaemia was absent in the forest zone during the entire follow-up period. Gametocytaemia in the savannah zone was 1.3 % (95 % CI 0.1, 7.7) on days 2 and 3 after treatment with AS-AQ, and remained absent from day 7 to day 28. For AL, gametocytaemia in the forest zone declined from 3.3 % (95 % CI 1.1, 8.6) on day zero to 0.9 % (0.1, 5.5) on day 28 (p = 0.413), and was present only on day 7 (2.4 %; 95 % CI 0.1, 4.4) in the savannah zone.</p>
        <p>Mean haemoglobin concentration in the forest zone significantly increased from 8.7 (±1.0) at baseline to 9.2 (±0.8) on day 28 after treatment with AS-AQ (p = 0.006). Similarly, mean haemoglobin concentration in the same zone significantly increased from 10.2 (±1.6) at baseline to 10.7 (±1.3) on day 28 after treatment with AL (p = 0.011). Within the savannah zone, mean haemoglobin concentration significantly increased from 8.7 (±1.9) at baseline to 10.3 (±2.1) after treatment with AS-AQ (p &lt; 0.001) (Table <xref rid="Tab4" ref-type="table">4</xref>).<table-wrap id="Tab4"><label>Table 4</label><caption><p>Changes in mean haemoglobin levels after treatment with AS-AQ and AL in two ecological zones in Ghana</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="2">Anti-malarial</th><th align="left" colspan="4">Ecological zone</th></tr><tr><th align="left">Forest</th><th align="left">p value</th><th align="left">Savannah</th><th align="left">p value</th></tr></thead><tbody><tr><td align="left" rowspan="3">AS-AQ</td><td align="left">Day 0 mean Hb (sd)</td><td char="(" align="char">8.7 (1.0)</td><td char="." align="char">0.295</td><td align="left">8.7 (1.9)</td><td align="left"/></tr><tr><td align="left">Day 14 mean Hb (sd)</td><td char="(" align="char">8.9 (1.0)</td><td char="." align="char">0.006</td><td align="left">9.6 (1.8)</td><td char="." align="char">0.002</td></tr><tr><td align="left">Day 28 mean Hb (sd)</td><td char="(" align="char">9.2 (0.8)</td><td align="left"/><td align="left">10.3 (2.1)</td><td char="." align="char">&lt;0.001</td></tr><tr><td align="left" rowspan="3">AL</td><td align="left">Day 0 mean Hb (sd)</td><td char="(" align="char">10.2 (1.6)</td><td align="left"/><td align="left">10.3 (1.2)</td><td align="left"/></tr><tr><td align="left">Day 14 mean Hb (sd)</td><td char="(" align="char">10.4 (1.3)</td><td char="." align="char">0.299</td><td align="left">**</td><td align="left"/></tr><tr><td align="left">Day 28 mean Hb (sd)</td><td char="(" align="char">10.7 (1.3)</td><td char="." align="char">0.011</td><td align="left">**</td><td align="left"/></tr></tbody></table><table-wrap-foot><p>** Not available</p></table-wrap-foot></table-wrap></p>
      </sec>
    </sec>
    <sec id="Sec14">
      <title>Discussion</title>
      <p>The therapeutic efficacy of two of Ghana’s first-line anti-malarial drugs for the treatment of uncomplicated malaria (AS-AQ and AL) were studied in six sentinel sites representing the forest and savannah zones during the 2013/2014 surveillance period, with the view of providing information to guide malaria treatment policy in the country.</p>
      <p>The study showed that PCR-uncorrected cure rates for AS-AQ were 98 % (95 % CI 89.4, 99.9) in the forest zone and 97.3 % (95 % CI 90.7, 99.7) in the savannah zone whilst AL showed PCR-uncorrected cure rates of 85 % (95 % CI 77.5, 90.9) in the forest zone and 56.3 % (95 % CI 37.7, 73.6) in the savannah zone. Although the study was not a comparative study, the findings compare well with the observation of higher PCR-uncorrected cure rate for AS-AQ, compared with AL, in Mozambique [<xref ref-type="bibr" rid="CR20">20</xref>]. This observation may be explained by the longer terminal half-life of amodiaquine (approximately 10 days) over lumefantrine (approximately 4 days) resulting in a higher post-treatment prophylactic effect of AS-AQ [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR22">22</xref>]. This notwithstanding, PCR-corrected cure rates for AS-AQ and AL were comparable in the forest and savannah zones of Ghana (100 % for AS-AQ and 97.2–100 % for AL) as in other studies [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR22">22</xref>–<xref ref-type="bibr" rid="CR26">26</xref>].</p>
      <p>Both AS-AQ and AL achieved effective fever and parasite clearance in the two ecological zones. Prevalence of fever in both zones declined by 75 % after first day of treatment with each ACT; no child was parasitaemic on day 3; and prevalence of gametocytaemia generally declined from 3.3 to 0.9 % within the 28-day follow-up period. These findings suggest that ACT still has a rapid effect on fever and parasite clearance as well as gametocyte carriage in Ghana [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR28">28</xref>]. Absence of parasitaemia on day 3 is an indication that Ghana is currently free of artemisinin resistance based on WHO’s indicator of day 3 parasitaemia of ≥10 % [<xref ref-type="bibr" rid="CR29">29</xref>].</p>
      <p>Post-treatment mean haemoglobin concentrations assessed on day 28, compared with pre-treatment concentrations, showed significant increase with both AS-AQ and AL treatment in the forest zone, and AS-AQ in the savannah zone (there was no available post-treatment data for AL treatment in the savannah zone). These findings suggest that ACT treatment for uncomplicated malaria has a positive effect on post-treatment haemoglobin levels. Though some studies have not shown significantly improved post-treatment haemoglobin levels after ACT treatment [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR30">30</xref>], others have [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR31">31</xref>].</p>
    </sec>
    <sec id="Sec15">
      <title>Conclusions</title>
      <p>Therapeutic efficacy of AS-AQ and AL remains over 90 % in the forest and savannah zones of Ghana. The two drugs were effective in clearing fever and parasites as well as maintaining gametocytaemia at low rates (less than 5 %), and improving post-treatment mean haemoglobin levels. Artemisinin is still efficacious in Ghana by virtue of the absence of parasitaemia on day 3 post-treatment.
</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Authors’ contributions</title>
      <p>BA, KLM, CBP and KK conceived and designed the study. ND and NQ carried out molecular genetic studies to distinguish between re-infection and recrudescence. BA, KM, CBP and LQ coordinated the study. BA and KK participated in the data analysis. BA drafted the manuscript. All authors read and approved the final manuscript.</p>
      <sec id="FPar1">
        <title>Acknowledgements</title>
        <p>The authors wish to acknowledge the contributions of Dr. Felicia Owusu-Antwi (WHO, Ghana), Dr. Jackson Sillah (WHO-AFRO), Dr. Marian Warsame (WHO, Geneva), Dr. Pascal Ringwald (WHO, Geneva) and study teams in the six sentinel sites. We also wish to thank Messrs. Abdul Haruna, Joseph Otchere and Charles Attiogbe of the Noguchi Memorial Institute for Medical Research for their technical assistance. The study received financial support from the Global Fund to fight AIDS, Tuberculosis and Malaria (GFATM), through the National Malaria Control Programme.</p>
      </sec>
      <sec id="FPar2">
        <title>Competing interests</title>
        <p>The authors declare that they have no competing interests.</p>
      </sec>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <mixed-citation publication-type="other">WHO. World malaria report 2014. Geneva: World Health Organization. 2014.</mixed-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <mixed-citation publication-type="other">Ministry of Health. National malaria control programme 2013 annual report. 2013.</mixed-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <mixed-citation publication-type="other">Ministry of Health. Strategic plan for malaria control in Ghana 2014–2020. MOH. 2014.</mixed-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <mixed-citation publication-type="other">Koram KA. Mapping response of Plasmodium falciparum to chloroquine and other antimalarial drugs in Ghana, Project ID 980034. Final report submitted to MIM/TDR. 2003.</mixed-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koram</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Abuaku</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Duah</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Quashie</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Comparative efficacy of antimalarial drugs including ACTs in the treatment of uncomplicated malaria among children under 5 years in Ghana</article-title>
          <source>Acta Trop</source>
          <year>2005</year>
          <volume>95</volume>
          <fpage>194</fpage>
          <lpage>203</lpage>
          <pub-id pub-id-type="doi">10.1016/j.actatropica.2005.06.018</pub-id>
          <?supplied-pmid 16054584?>
          <pub-id pub-id-type="pmid">16054584</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <mixed-citation publication-type="other">Ghana Health Service. Final draft. Antimalarial drug policy for Ghana. GHS. 2004.</mixed-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <mixed-citation publication-type="other">Ministry of Health. Guidelines for case management of malaria in Ghana. MOH. 2009.</mixed-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <mixed-citation publication-type="other">WHO. Methods for surveillance of antimalarial drug efficacy. Geneva: World Health Organization. 2009.</mixed-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <mixed-citation publication-type="other">Ghana Statistical Service. 2010 population and housing census. Summary report of final results. GSS. 2012.</mixed-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <mixed-citation publication-type="other">Ghana. Duration of the malaria transmission season. [<ext-link ext-link-type="uri" xlink:href="http://www.mara.org.za/pdfmaps/GhaSeasonality.PDF">http://www.mara.org.za/pdfmaps/GhaSeasonality.PDF</ext-link>].</mixed-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oduro</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Koram</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Rogers</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Atuguba</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ansah</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Anyorigiya</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Severe <italic>falciparum</italic> malaria in young children of the Kassena-Nankana district of northern Ghana</article-title>
          <source>Malar J</source>
          <year>2007</year>
          <volume>6</volume>
          <fpage>96</fpage>
          <pub-id pub-id-type="doi">10.1186/1475-2875-6-96</pub-id>
          <?supplied-pmid 17662142?>
          <pub-id pub-id-type="pmid">17662142</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abonuusum</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Owusu-Daako</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Tannich</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>May</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Garms</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kruppa</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Malaria transmission in two rural communities in the forest zone of Ghana</article-title>
          <source>Parasitol Res</source>
          <year>2011</year>
          <volume>108</volume>
          <fpage>1465</fpage>
          <lpage>1471</lpage>
          <pub-id pub-id-type="doi">10.1007/s00436-010-2195-1</pub-id>
          <?supplied-pmid 21153839?>
          <pub-id pub-id-type="pmid">21153839</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <mixed-citation publication-type="other">Ghana Statistical Service. 2010 population and housing census. District Analytical Report, Yendi Municipality. GSS. 2014.</mixed-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <mixed-citation publication-type="other">Wa Municipal. [<ext-link ext-link-type="uri" xlink:href="http://www.mofa.gov.gh/site/%3fpage_id%3d1685">http://www.mofa.gov.gh/site/?page_id=1685</ext-link>].</mixed-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Appawu</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Owusu-Agyei</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Dadzie</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Asoala</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Anto</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Koram</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Malaria transmission dynamics at a site in northern Ghana proposed for testing malaria vaccines</article-title>
          <source>Trop Med Int Health</source>
          <year>2004</year>
          <volume>9</volume>
          <fpage>164</fpage>
          <lpage>170</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1365-3156.2003.01162.x</pub-id>
          <?supplied-pmid 14728621?>
          <pub-id pub-id-type="pmid">14728621</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <mixed-citation publication-type="other">Hohoe Municipal. [<ext-link ext-link-type="uri" xlink:href="http://www.mofa.gov.gh/site/%3fpage_id%3d1707">http://www.mofa.gov.gh/site/?page_id=1707</ext-link>].</mixed-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kweku</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Adjuik</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Binka</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Seidu</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Greenwood</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Chandramohan</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Seasonal intermittent preventive treatment for the prevention of anaemia and malaria in Ghanaian children: a randomized, placebo controlled trial</article-title>
          <source>PLoS One</source>
          <year>2008</year>
          <volume>3</volume>
          <fpage>e4000</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0004000</pub-id>
          <?supplied-pmid 19098989?>
          <pub-id pub-id-type="pmid">19098989</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <mixed-citation publication-type="other">Fanteakwa. [<ext-link ext-link-type="uri" xlink:href="http://www.mofa.gov.gh/site/%3fpage_id%3d1512">http://www.mofa.gov.gh/site/?page_id=1512</ext-link>].</mixed-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <mixed-citation publication-type="other">WHO. Methods and techniques for clinical trials on antimalarial drug efficacy: genotyping to identify parasite populations. Geneva: World Health Organization. 2008.</mixed-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nhama</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bassat</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Enosse</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nhacolo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mutemba</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Carvalho</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>In-vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated falciparum malaria in children: a multisite, open-label, two-cohort, clinical trial in Mozambique</article-title>
          <source>Malar J</source>
          <year>2014</year>
          <volume>13</volume>
          <fpage>309</fpage>
          <pub-id pub-id-type="doi">10.1186/1475-2875-13-309</pub-id>
          <?supplied-pmid 25108397?>
          <pub-id pub-id-type="pmid">25108397</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>White</surname>
              <given-names>NJ</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Farrar</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hotez</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Junghanss</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kang</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Lalloo</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>White</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Malaria</article-title>
          <source>Manson’s tropical diseases</source>
          <year>2014</year>
          <edition>23</edition>
          <publisher-loc>Philadelphia</publisher-loc>
          <publisher-name>Elsevier Saunders</publisher-name>
          <fpage>532</fpage>
          <lpage>697</lpage>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yeka</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lameyre</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Afizi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Fredrick</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lukwago</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kamya</surname>
              <given-names>MR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Efficacy and safety of fixed-dose artesunate-amodiaquine vs. artemether-lumefantrine for repeated treatment of uncomplicated malaria in Ugandan children</article-title>
          <source>PLoS One</source>
          <year>2014</year>
          <volume>9</volume>
          <fpage>e113311</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0113311</pub-id>
          <?supplied-pmid 25436614?>
          <pub-id pub-id-type="pmid">25436614</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Adjei</surname>
              <given-names>GO</given-names>
            </name>
            <name>
              <surname>Kurtzhals</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Rodrigues</surname>
              <given-names>OP</given-names>
            </name>
            <name>
              <surname>Alifrangis</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hoegberg</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Kitcher</surname>
              <given-names>ED</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up</article-title>
          <source>Malar J</source>
          <year>2008</year>
          <volume>7</volume>
          <fpage>127</fpage>
          <pub-id pub-id-type="doi">10.1186/1475-2875-7-127</pub-id>
          <?supplied-pmid 18620577?>
          <pub-id pub-id-type="pmid">18620577</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Falade</surname>
              <given-names>CO</given-names>
            </name>
            <name>
              <surname>Dada-Adegbola</surname>
              <given-names>HO</given-names>
            </name>
            <name>
              <surname>Ogunkunle</surname>
              <given-names>OO</given-names>
            </name>
            <name>
              <surname>Oguike</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Nash</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Ademowo</surname>
              <given-names>OG</given-names>
            </name>
          </person-group>
          <article-title>Evaluation of the comparative efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine and artesunate-amodiaquine-chlorpheniramine (Artemoclo™) for the treatment of acute uncomplicated malaria in Nigerian children</article-title>
          <source>Med Princ Pract</source>
          <year>2014</year>
          <volume>23</volume>
          <fpage>204</fpage>
          <lpage>211</lpage>
          <pub-id pub-id-type="doi">10.1159/000360578</pub-id>
          <?supplied-pmid 24732940?>
          <pub-id pub-id-type="pmid">24732940</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Espié</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Lima</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Atua</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Dhorda</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Flévaud</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Sompwe</surname>
              <given-names>EM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Efficacy of fixed-dose combination artesunate-amodiaquine versus artemether-lumefantrine for uncomplicated childhood <italic>Plasmodium falciparum</italic> malaria in Democratic Republic of Congo: a randomized non-inferiority trial</article-title>
          <source>Malar J</source>
          <year>2012</year>
          <volume>11</volume>
          <fpage>174</fpage>
          <pub-id pub-id-type="doi">10.1186/1475-2875-11-174</pub-id>
          <?supplied-pmid 22631564?>
          <pub-id pub-id-type="pmid">22631564</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Faye</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Offianan</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Ndiaye</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Tine</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Touré</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Djoman</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Efficacy and tolerability of artesunate-amodaiquine (Camoquin plus<sup>®</sup>) versus artemether-lumefantrine (Coartem<sup>®</sup>) against uncomplicated <italic>Plasmodium falciparum</italic> malaria: multisite trial in Senegal and Ivory Coast</article-title>
          <source>Trop Med Int Health</source>
          <year>2010</year>
          <volume>15</volume>
          <fpage>608</fpage>
          <lpage>613</lpage>
          <?supplied-pmid 20214761?>
          <pub-id pub-id-type="pmid">20214761</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koram</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Quaye</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Abuaku</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Efficacy of amodiaquine-artesunate combination for uncomplicated malaria in children under five years in Ghana</article-title>
          <source>Ghana Med J</source>
          <year>2008</year>
          <volume>42</volume>
          <fpage>55</fpage>
          <lpage>60</lpage>
          <?supplied-pmid 19180204?>
          <pub-id pub-id-type="pmid">19180204</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abuaku</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Duah</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Quaye</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Quashie</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Koram</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Therapeutic Efficacy of artemether-lumefantrine combination in the treatment of uncomplicated malaria among children under five years of age in three ecological zones in Ghana</article-title>
          <source>Malar J</source>
          <year>2012</year>
          <volume>11</volume>
          <fpage>388</fpage>
          <pub-id pub-id-type="doi">10.1186/1475-2875-11-388</pub-id>
          <?supplied-pmid 23173737?>
          <pub-id pub-id-type="pmid">23173737</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <mixed-citation publication-type="other">WHO. Global plan for artemisinin resistance containment. Geneva: World Health Organization. 2011.</mixed-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mulenga</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Van geertruyden</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Mwananyanda</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Chalwe</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Moerman</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Chilengi</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Safety and efficacy of lumefantrine-artemether (Coartem<sup>®</sup>) for the treatment of uncomplicated <italic>Plasmodium falciparum</italic> malaria in Zambian adults</article-title>
          <source>Malar J.</source>
          <year>2006</year>
          <volume>5</volume>
          <fpage>73</fpage>
          <pub-id pub-id-type="doi">10.1186/1475-2875-5-73</pub-id>
          <?supplied-pmid 16923176?>
          <pub-id pub-id-type="pmid">16923176</pub-id>
        </element-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mårtensson</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Strömberg</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Sisowath</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Msellem</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Gil</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Montgomery</surname>
              <given-names>SM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood <italic>Plasmodium falciparum</italic> malaria in Zanzibar, Tanzania</article-title>
          <source>Clin Infect Dis</source>
          <year>2005</year>
          <volume>41</volume>
          <fpage>1079</fpage>
          <lpage>1086</lpage>
          <pub-id pub-id-type="doi">10.1086/444460</pub-id>
          <?supplied-pmid 16163624?>
          <pub-id pub-id-type="pmid">16163624</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:4700573</identifier><datestamp>2016-01-06</datestamp><setSpec>malarj</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="http://jats.nlm.nih.gov/ns/archiving/1.0/ http://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Malar J</journal-id>
      <journal-id journal-id-type="iso-abbrev">Malar. J</journal-id>
      <journal-title-group>
        <journal-title>Malaria Journal</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1475-2875</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC4700573</article-id>
      <article-id pub-id-type="pmcid">PMC4700573</article-id>
      <article-id pub-id-type="pmc-uid">4700573</article-id>
      <article-id pub-id-type="publisher-id">1064</article-id>
      <article-id pub-id-type="doi">10.1186/s12936-015-1064-x</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Status of the use and compliance with malaria rapid diagnostic tests in formal private health facilities in Nigeria</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8273-5876</contrib-id>
          <name>
            <surname>Mokuolu</surname>
            <given-names>Olugbenga A.</given-names>
          </name>
          <address>
            <email>mokuolu@unilorin.edu.ng</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ntadom</surname>
            <given-names>Godwin N.</given-names>
          </name>
          <address>
            <email>ntadomg@yahoo.com</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ajumobi</surname>
            <given-names>Olufemi O.</given-names>
          </name>
          <address>
            <email>femiajumobi@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alero</surname>
            <given-names>Roberts A.</given-names>
          </name>
          <address>
            <email>aaroberts@cmul.edu.ng</email>
          </address>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wammanda</surname>
            <given-names>Robinson D.</given-names>
          </name>
          <address>
            <email>wammanda@yahoo.com</email>
          </address>
          <xref ref-type="aff" rid="Aff4"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Adedoyin</surname>
            <given-names>Olanrewaju T.</given-names>
          </name>
          <address>
            <email>ooadedoyin@yahoo.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Okafor</surname>
            <given-names>Henrietta U.</given-names>
          </name>
          <address>
            <email>huche57@yahoo.com</email>
          </address>
          <xref ref-type="aff" rid="Aff5"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alabi</surname>
            <given-names>Adekunle D.</given-names>
          </name>
          <address>
            <email>drkalabi@yahoo.com</email>
          </address>
          <xref ref-type="aff" rid="Aff6"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Odey</surname>
            <given-names>Friday A.</given-names>
          </name>
          <address>
            <email>faodey@unical.edu.ng</email>
          </address>
          <xref ref-type="aff" rid="Aff7"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Agomo</surname>
            <given-names>Chimere O.</given-names>
          </name>
          <address>
            <email>agomoco@hotmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff8"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Edozieh</surname>
            <given-names>Kate U.</given-names>
          </name>
          <address>
            <email>tarus740@yahoo.co.uk</email>
          </address>
          <xref ref-type="aff" rid="Aff9"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fagbemi</surname>
            <given-names>Tolulope O.</given-names>
          </name>
          <address>
            <email>teejones1605@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Njidda</surname>
            <given-names>Ahmad M.</given-names>
          </name>
          <address>
            <email>ahmadmnrufai@yahoo.com</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Babatunde</surname>
            <given-names>Seye</given-names>
          </name>
          <address>
            <email>babatundeo@who.int</email>
          </address>
          <xref ref-type="aff" rid="Aff10"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Agbo</surname>
            <given-names>Emmanuel C.</given-names>
          </name>
          <address>
            <email>slimshevy02@yahoo.com</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nwaneri</surname>
            <given-names>Nnamdi B.</given-names>
          </name>
          <address>
            <email>ndyblaise@yahoo.com</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Shekarau</surname>
            <given-names>Emmanuel D.</given-names>
          </name>
          <address>
            <email>saintsheka@yahoo.co.uk</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Obasa</surname>
            <given-names>Temitope O.</given-names>
          </name>
          <address>
            <email>drtopeobasa@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ezeigwe</surname>
            <given-names>Nnenna M.</given-names>
          </name>
          <address>
            <email>drninaezeigwe@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <aff id="Aff1"><label/>Department of Paediatrics and Child Health, College of Health Sciences, University of Ilorin, Ilorin, Kwara Nigeria </aff>
        <aff id="Aff2"><label/>National Malaria Elimination Programme, Federal Ministry of Health, Abuja, Nigeria </aff>
        <aff id="Aff3"><label/>University of Lagos, Lagos, Nigeria </aff>
        <aff id="Aff4"><label/>Ahmadu Bello University, Zaria, Nigeria </aff>
        <aff id="Aff5"><label/>University of Nigeria, Enugu, Nigeria </aff>
        <aff id="Aff6"><label/>Olabisi Onabanjo University, Sagamu, Nigeria </aff>
        <aff id="Aff7"><label/>University of Calabar, Calabar, Nigeria </aff>
        <aff id="Aff8"><label/>Nigeria Institute of Medical Research, Lagos, Nigeria </aff>
        <aff id="Aff9"><label/>Foundation for Charity and Community Health Nigeria, Abuja, Nigeria </aff>
        <aff id="Aff10"><label/>World Health Organization, Abuja, Nigeria </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>4</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>4</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <volume>15</volume>
      <elocation-id>4</elocation-id>
      <history>
        <date date-type="received">
          <day>7</day>
          <month>10</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>22</day>
          <month>12</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© Mokuolu et al. 2015</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>
Nigeria has the largest number of malaria-related deaths, accounting for a third of global malaria deaths. It is important that the country attains universal coverage of key malaria interventions, one of which is the policy of universal testing before treatment, which the country has recently adopted. However, there is a dearth of data on its implementation in formal private health facilities, where close to a third of the population seek health care. This study identified the level of use of malaria rapid diagnostic testing (RDT), compliance with test results and associated challenges in the formal private health facilities in Nigeria.</p>
        </sec>
        <sec>
          <title>Methods</title>
          <p>
A cross-sectional study that involved a multi-stage, random sampling of 240 formal private health facilities from the country’s six geo-political zones was conducted from July to August 2014. Data were collected using health facility records, healthcare workers’ interviews and an exit survey of febrile patients seen at the facilities, in order to determine fever prevalence, level of testing of febrile patience, compliance with test results, and health workers’ perceptions to RDT use.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>Data from the 201 health facilities analysed indicated a fever prevalence of 38.5 % (112,521/292,430). Of the 2077 exit interviews for febrile patients, malaria testing was ordered in 73.8 % (95 % CI 71.7–75.7 %). Among the 1270 tested, 61.8 % (719/1270) were tested with microscopy and 38.2 % (445/1270) with RDT. Compliance to malaria test result [administering arteminisin-based combination therapy (ACT) to positive patients and withholding ACT from negative patients] was 80.9 % (95 % CI 78.7–83 %). Compliance was not influenced by the age of patients or type of malaria test. The health facilities have various cadres of the health workers knowledgeable on RDT with 70 % knowing the meaning, while 84.5 % knew what it assesses. However, there was clearly a preference for microscopy as only 20 % reported performing only RDT.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>In formal private health facilities in Nigeria there is a high rate of malaria testing for febrile patients, high level of compliance with test results but relatively low level of RDT utilization. This calls for improved engagement of the formal private health sector with a view to achieving universal coverage targets on malaria testing.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Malaria rapid diagnostic tests</kwd>
        <kwd>Formal private health facility</kwd>
        <kwd>Compliance</kwd>
        <kwd>Nigeria</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004417</institution-id>
              <institution>Global Fund to Fight AIDS, Tuberculosis and Malaria</institution>
            </institution-wrap>
          </funding-source>
        </award-group>
      </funding-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>© The Author(s) 2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Background</title>
      <p>Malaria remains a major public health problem with over 3.2 billion of the world’s population at risk, of which 1.2 billion people are at high risk [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Over the last 15 years there has been concerted effort through global partnerships to mobilize resources for the deployment of cost-effective tools towards a significant reduction in malaria morbidity and mortality, with a decrease in malaria incidence by 30 % globally, and by 34 % in Africa [<xref ref-type="bibr" rid="CR2">2</xref>–<xref ref-type="bibr" rid="CR5">5</xref>]. Furthermore, the prevalence of malaria parasite infection (including both symptomatic and asymptomatic infections) fell from 173 million in 2000 to 128 million in 2013, a reduction of 26 % in Africa [<xref ref-type="bibr" rid="CR2">2</xref>]. These reductions are largely due to increased deployment of long-lasting, insecticide-treated nets (LLINs), increased availability of highly effective artemisinin-based combination treatment (ACT) and improved diagnosis of malaria. While deployment of LLINs and ACT have been significantly scaled up towards universal coverage levels in most countries, scale up of malaria diagnosis has been much slower, due to its greater dependence on a number of systemic issues influencing availability and usage in guiding anti-malarial prescriptions.</p>
      <p>In 2010 the WHO recommended universal testing before treatment in suspected cases of malaria [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. Implementing this requires expanded access to malaria diagnosis at all levels and sectors of health care delivery. The options for expanding access are scaling up microscopy and the use of malaria rapid diagnostic tests (RDTs). Malaria microscopy has inherent challenges as a primary tool for scaling up diagnosis. These challenges include quality control issues, supportive infrastructure, cost and manpower capacity needs [<xref ref-type="bibr" rid="CR8">8</xref>–<xref ref-type="bibr" rid="CR13">13</xref>]. The RDTs on the other hand, while not a substitute for microscopy, possess qualities that address many of the limitations of microscopy. This makes the use of RDT a more feasible strategy for expanding access to diagnosis [<xref ref-type="bibr" rid="CR14">14</xref>–<xref ref-type="bibr" rid="CR18">18</xref>]. Although, use of RDT has its own challenges e.g. use of excess buffer/inappropriate sample well, storage-related challenges but they are easily overcome with training and routine supervision. Several recent studies have continued to validate the usefulness and reliability of RDTs for malaria diagnosis in both children and adults [<xref ref-type="bibr" rid="CR19">19</xref>–<xref ref-type="bibr" rid="CR24">24</xref>]. The acceptability of RDT among care-seekers attending public healthcare facilities, patent medicine vendors and private health retailers has also been documented by research [<xref ref-type="bibr" rid="CR25">25</xref>–<xref ref-type="bibr" rid="CR32">32</xref>]. In addition, use of RDTs for malaria diagnosis have been reported to be cost-effective in the treatment of malaria, especially in relation to the cost of ACT and in the face of declining prevalence of malaria [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR33">33</xref>–<xref ref-type="bibr" rid="CR37">37</xref>].</p>
      <p>Consistent with WHO recommendation, Nigeria, in 2011, updated the National Malaria Treatment Guidelines to reflect universal testing before treatment for suspected cases of malaria [<xref ref-type="bibr" rid="CR29">29</xref>]. Prior to this, the policy in Nigeria recommended testing before treatment in children older than 5 years and in adults, with a more liberal bent for presumptive or syndromic treatment in children under 5 years. One of the objectives of the National Malaria Strategic Plan 2014–2020 is to test all care-seeking persons with suspected malaria using RDT or microscopy by 2020 [<xref ref-type="bibr" rid="CR30">30</xref>]. Attaining this objective makes it imperative for all levels and segments of the Nigerian health system to have access to, and appropriately utilize, malaria diagnostic tools. To this end the national malaria elimination programme (NMEP) commissioned implementation research to guide RDT scale-up and deployment to primary healthcare facilities in the public sector [<xref ref-type="bibr" rid="CR38">38</xref>].</p>
      <p>The private health sector in Nigeria is very large, consisting of formal tertiary, secondary and primary health facilities, pharmacies and informal drug retailers. The National Health Directory listed 34,173 health facilities in Nigeria at December 2011 [<xref ref-type="bibr" rid="CR39">39</xref>]. This has been updated recently to 34,423 health facilities in the country [<xref ref-type="bibr" rid="CR40">40</xref>]. Forty per cent of these registered health facilities belong to the private sector, especially at primary and secondary health care level [<xref ref-type="bibr" rid="CR39">39</xref>]. Regarding health-seeking behaviour, about 60 % of people seek treatment for fever from private health facilities while 40 % go to the public sector [<xref ref-type="bibr" rid="CR41">41</xref>]. Key implementing partners involved with malaria case management (including training on microscopy and RDT use) in the private health sector in Nigeria include the society for family health (SFH), DfID funded support for national malaria programme (SuNMaP) and PMI-funded malaria action programme for states (MAPS). The UNITAID is currently working on RDT roll-out to the private sector.</p>
      <p>Studies have indicated the inherent differences in healthcare practices across the different health sectors (private vs public) and even within the same sector [<xref ref-type="bibr" rid="CR42">42</xref>–<xref ref-type="bibr" rid="CR45">45</xref>]. Considering that the formal private health facilities are a major contributor to healthcare delivery in Nigeria, their compliance with national policies and treatment guidelines is critical to attainment of the overall goal of the NMEP. The independence by clients in dictating their service needs and overall mode of engagement of the formal private health sector, that is profit driven, precludes any extrapolation of data from the public sector to the formal private health sector.</p>
      <p>In light of the dearth of knowledge on the status of RDT use in the formal private health sector in Nigeria, this study was undertaken to identify practices related to the use of RDT in private health facilities. With lessons learnt from the surveys in the public health sector and informal private sector, it was expected that the findings from this study on formal private health facilities would complete the loop of understanding needed to guide continued deployment and use of RDTs in the country. Improved diagnosis will contribute to better treatment of malaria, thereby contributing further to reduction in malaria mortality and better tracking of progress made.</p>
    </sec>
    <sec id="Sec2" sec-type="materials|methods">
      <title>Methods</title>
      <p>This was a cross-sectional study to assess RDT use and its associated challenges in formal private health facilities in Nigeria. Formal private health facilities were defined as hospitals, clinics or maternity homes registered by the state ministry of health (SMOH) as a private health facility offering orthodox medical care. This excludes health facilities registered primarily as pharmacy/patent and proprietary medicine vendors and/or for laboratory services. State Hospital Management Boards register, regulate and license private health facilities. For the purpose of this study, only private hospitals were enrolled.</p>
      <sec id="Sec3">
        <title>Study sites</title>
        <p>Nigeria is a West African country with 36 states and 774 Local Government Areas (LGAs) and Federal Capital Territory (FCT). For administrative convenience and representation, the country uses geo-political zoning, comprising northcentral (six states and the FCT); northeast (six states); northwest (six states); southeast (five states); southsouth (six states and southwest (six states). Malaria transmission has been intense, stable and holo-endemic in most parts of the country. Recent reports suggest some changes over time, such that as at 2010, 85 % of Nigerians lived in areas supporting meso-endemic transmission, 15 % lived under conditions of hyper-holo-endemicity, with some areas within FCT and northeastern states supporting hypo-endemicity [<xref ref-type="bibr" rid="CR46">46</xref>]. Seasonality, intensity and duration of malaria transmission in Nigeria varies according to five ecological strata. These include mangrove swamps, rain forest, guinea-savannah, sudan-savannah and sahel-savannah. The duration of the season decreases from the south to the north, being perennial in duration in most of the south but lasting 3 months or less in the northeastern region bordering Chad [<xref ref-type="bibr" rid="CR47">47</xref>]. In the north, high transmission season is between July and November and in the south is between April and October with bimodal peaks in July and September.</p>
      </sec>
      <sec id="Sec4">
        <title>Study setting</title>
        <p>The study was designed to determine the prevalence of fever, the practices related to RDT use, and to understand the perception of a sample of health workers to RDT. It was anticipated that there could be significant variations in the quality of health facility records, thereby limiting their aggregation to answer the research questions. Three sets of tools were designed to address the study objectives:</p>
        <p>Health facility records: this was to focus on the record of illness episodes as documented in order to establish the proportion of complaints that were fever. The facility interview focused on attendance rate and proportion of fever cases over the preceding 6 months of the study. Information on the facility stock level, utilization of malaria commodities, supply chain management system, state of infrastructure and challenges encountered was also captured in the questionnaires. The records were extracted from National Health Management Information registers provided with support from the Global Fund through SFH or any other hospital register where these were not available.</p>
        <p>Healthcare workers’ interviews conducted to appraise the practices of the health facilities as reported by the health workers. Data were collected from the officers-in-charge or health personnel that dispense diagnostics.</p>
        <p>Exit interview of febrile patients: aimed at systematically and prospectively collating perceptions of patients regarding RDT at the private health facilities. In addition, it was expected to provide a reliable denominator to facilitate the estimates related to level of diagnosis and compliance with test results.</p>
      </sec>
      <sec id="Sec5">
        <title>Sampling technique</title>
        <p>The health facilities were selected using a multi-staged, random sampling technique. In the first stage, six states were randomly selected using geo-political zones as sampling frames viz; Cross-River in mangrove ecological zone, Enugu and Lagos in rain forest, Kaduna in sudan-savannah), Kwara and Ogun in guinea-savannah. States in the northeast geo-political zone were excluded on account of security reasons, and Lagos State was selected because of its coastal location and status as emerging mega city. In each selected state, two LGAs (one urban and one rural) were randomly selected. From each of the selected LGAs, the health facilities were selected by simple random sampling from a sampling frame of the list of registered private health facilities obtained from the SMOH. Twenty private health facilities were selected from each LGA. In cases where there were less than 20 private health facilities available in a selected LGA, data were collected from health facilities in a contiguous LGA to complete the sample size. Thus, data were collected from a total of 240 private health facilities across the country (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). One health facility survey questionnaire, one health worker interview questionnaire and ten exit interviews per facility was administered across health facilities surveyed.<fig id="Fig1"><label>Fig. 1</label><caption><p>Flow chart on sampling procedure</p></caption><graphic xlink:href="12936_2015_1064_Fig1_HTML" id="MO1"/></fig></p>
      </sec>
      <sec id="Sec6">
        <title>Study procedure</title>
        <p>Preliminary activities consisted of meetings between the Principal Investigator (PI), State team leaders and other key members of the study team to fine-tune the data capture tools and data analysis methods. Data collection tools comprised questionnaires to capture previous medical records, to ascertain hospital attendance and proportion of febrile patients tested and treated appropriately, and exit interview questionnaires to validate reported practice and community perception of RDT. The questionnaires were pre-tested in health facilities in the Federal capital city where the study would not be carried out and observations made during the pilot informed revision of the final data capture tools.</p>
        <p>At each study site, the study team comprised the team leader, six interviewers, the state epidemiologist, state malaria programme officer and malaria focal persons at the two LGAs. Field statisticians were assigned, one each, by NMEP to various study sites. A two-day training workshop was organized at each site prior to commencement of field work. During the workshops, the state team members were familiarized with the objectives of the study and introduced to the data capture tools. Ethical clearance for the study was obtained from the National Health Research and Ethics Committee (NHREC).</p>
      </sec>
      <sec id="Sec7">
        <title>Data collection</title>
        <p>Data were collected using study instruments over 22 days in each state from July to August 2014. Data collected were reviewed and cleaned each day by the state team leaders and field statisticians, who subsequently entered data in computer. At the end of data collection in each state, the field statisticians sent their data set to the central study statistician for pooled entry.</p>
      </sec>
      <sec id="Sec8">
        <title>Data management</title>
        <p>Data entry was done using EPI info version 3.5.4. There was onsite data entry by each of the team data management officers. Thereafter, data from the states were merged to create a common database. Simple frequencies were generated to facilitate the process of data cleaning. Queries were generated and clarifications sought from the respective teams as applicable. The cleaned dataset was subsequently exported to SPSS version 22 for analysis.</p>
        <p>
Frequency tables and charts were used to present simple proportions with 95 % confidence intervals (CI) using the online Vassarstat<sup>®</sup> application. Comparison of categorical variables and specific outcome was carried out using the Chi square test, while the comparison between continuous variables and specific discrete outcomes was done by Student <italic>t</italic> test. For all the statistical analysis, the level of significance was set at p &lt; 0.05, 95 % CI.</p>
      </sec>
      <sec id="Sec9">
        <title>Limitation</title>
        <p>This study did not address quality assurance of malaria diagnostics in the private sector. Record keeping was generally poor precluding a comparison of the data extracted from the registers among the study sites. The decision to use mainly the exit survey in defining denominators for the various measurements was informed by the anticipation of this possibility.</p>
      </sec>
    </sec>
    <sec id="Sec10" sec-type="results">
      <title>Results</title>
      <p>The study was conducted using three instruments: summary of medical records, exit interviews and key health staff interviews. The flow of data collection is summarized in Fig. <xref rid="Fig2" ref-type="fig">2</xref>. Of the 232 facilities with health workers’ responses to malaria testing practices, microscopy was done in 98 (42.2 %) health facilities, RDT in 46 (19.8 %), both RDT and microscopy in 74 (31.8 %), while 16 (6.8 %) reported that they do not carry out any malaria test in the facility. Of the 240 health facilities, 107 (44.6 %) currently had RDT in stock though 110 (45.8 %) use RDT routinely.<fig id="Fig2"><label>Fig. 2</label><caption><p>Description of algorithm for data collection and enrolment of subjects</p></caption><graphic xlink:href="12936_2015_1064_Fig2_HTML" id="MO2"/></fig></p>
      <sec id="Sec11">
        <title>Prevalence of fever from health facilities</title>
        <p>
Data of hospital registers from 240 healthcare facilities were assessed to determine prevalence of fever among hospital consultations; 39 incomplete records (Kwara: 27, Kaduna: 7, Cross-River: 3 and Ogun: 2) were excluded; data were analysed for 201 health facilities (Fig. <xref rid="Fig2" ref-type="fig">2</xref>). The prevalence of fever in relation to total attendance at the health facilities was 38.5 % (112,521/292,430) within the period of 6 months (January–June 2014) (Table <xref rid="Tab1" ref-type="table">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Record of attendance in sampled formal private health facilities in Nigeria</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">State (no of HF)<sup>a</sup>
</th><th align="left">Total attendance</th><th align="left">Total fever</th><th align="left">Percentage with fever</th></tr></thead><tbody><tr><td align="left">Cross River state (n = 37)</td><td char="." align="char">17,745</td><td char="." align="char">8374</td><td char="." align="char">47</td></tr><tr><td align="left">Enugu (n = 40)</td><td char="." align="char">73,670</td><td char="." align="char">29,924</td><td char="." align="char">41</td></tr><tr><td align="left">Kaduna (n = 33)</td><td char="." align="char">65,879</td><td char="." align="char">29,317</td><td char="." align="char">45</td></tr><tr><td align="left">Kwara (n = 13)</td><td char="." align="char">39,292</td><td char="." align="char">11,078</td><td char="." align="char">28</td></tr><tr><td align="left">Lagos (n = 39)</td><td char="." align="char">47,506</td><td char="." align="char">16,904</td><td char="." align="char">36</td></tr><tr><td align="left">Ogun (n = 38)</td><td char="." align="char">48,338</td><td char="." align="char">16,924</td><td char="." align="char">35</td></tr><tr><td align="left">Total (n = 200)</td><td char="." align="char">
<italic>292,430</italic>
</td><td char="." align="char">
<italic>112,521</italic>
</td><td char="." align="char">
<italic>38.5</italic>
</td></tr></tbody></table><table-wrap-foot><p>
<sup>a</sup>Data was incomplete in some states</p></table-wrap-foot></table-wrap></p>
      </sec>
      <sec id="Sec12">
        <title>Health facility practices from exit interviews</title>
        <p>
Concomitant symptoms: A total of 2077 exit interviews were conducted for febrile patients across the study sites (Fig. <xref rid="Fig2" ref-type="fig">2</xref>). In addition to fever, generalized weakness (60.9 %), cough/catarrh (44.5 %), vomiting/diarrhoea (39.9 %), pallor (8.1 %) and convulsion (1.3 %) were reported as presenting symptoms (Table <xref rid="Tab2" ref-type="table">2</xref>). The distribution of these symptoms was similar across the sites (Table <xref rid="Tab2" ref-type="table">2</xref>).<table-wrap id="Tab2"><label>Table 2</label><caption><p>Frequency of complaints among 2077 respondents with fever by study sites</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">State</th><th align="left" rowspan="2">Fever</th><th align="left" colspan="5">Concomitant symptoms</th></tr><tr><th align="left">General weakness</th><th align="left">Cough catarrh</th><th align="left">Diarrhoea vomiting</th><th align="left">Convulsions</th><th align="left">Pallor</th></tr></thead><tbody><tr><td align="left">C/River</td><td align="left">344</td><td align="left">258</td><td align="left">210</td><td align="left">120</td><td align="left">10</td><td align="left">3</td></tr><tr><td align="left">Enugu</td><td align="left">385</td><td align="left">181</td><td align="left">223</td><td align="left">154</td><td align="left">7</td><td align="left">19</td></tr><tr><td align="left">Kaduna</td><td align="left">398</td><td align="left">211</td><td align="left">140</td><td align="left">170</td><td align="left">0</td><td align="left">19</td></tr><tr><td align="left">Kwara</td><td align="left">375</td><td align="left">245</td><td align="left">152</td><td align="left">170</td><td align="left">6</td><td align="left">18</td></tr><tr><td align="left">Lagos</td><td align="left">327</td><td align="left">268</td><td align="left">149</td><td align="left">134</td><td align="left">1</td><td align="left">49</td></tr><tr><td align="left">Ogun</td><td align="left">248</td><td align="left">101</td><td align="left">109</td><td align="left">132</td><td align="left">4</td><td align="left">71</td></tr><tr><td align="left">Total</td><td align="left">
<italic>2077</italic>
</td><td align="left">
<italic>1264 (60.9)</italic>
</td><td align="left">
<italic>983 (44.5)</italic>
</td><td align="left">
<italic>880 (39.9)</italic>
</td><td align="left">
<italic>28 (1.3)</italic>
</td><td align="left">
<italic>179 (8.1)</italic>
</td></tr></tbody></table><table-wrap-foot><p>Multiple symptoms</p></table-wrap-foot></table-wrap></p>
        <p>Use of malaria diagnostics: Out of the 2077 febrile patients, 1533 had their blood tested during the hospital visit (Fig. <xref rid="Fig2" ref-type="fig">2</xref>), giving a testing rate of 73.8 % (95 % CI 71.7–75.7 %) for febrile patients visiting the formal private health facilities. Out of the 1533 patients who had their blood tested, 1259 (82.1 %) were told the outcome of the test carried out. Among those tested 1164 (75.9 %) knew the type of test carried out (microscopy or RDT). Of those that knew the test type, 719/1164 (61.8 %) were tested with microscopy, while 445 (38.2 %) were tested with RDT. Of the patients who knew the outcome of their tests, 1079 (85.7 %) were positive for malaria while 180 (14.3 %) were negative. Among respondents who provided information on payment for these laboratory services, 90.1 % of them reported that they paid for their blood test out of which 53.7 % knew the amount paid.</p>
        <p>
Reported compliance with test results: Compliance was computed from the total of those positive for malaria that had ACT and those negative for malaria that did not receive ACT/anti-malarial expressed as a proportion of the total tested. Findings in this regard showed that of 1078 patients whose malaria test results were reported positive, 892 (82.7 %) received ACT while out of 181 patients whose malaria tests were reported as negative, 126 (69.6 %) did not receive ACT. Thus, ‘compliance’ to malaria test result in administering ACT was 80.9 % (95 % CI 78.7–83.0 %). The compliance was 75 % in Enugu and consistently above 80 % in all the other states with Kwara having the highest at 87 % (Table <xref rid="Tab3" ref-type="table">3</xref>). Stratifying the reported compliance practices by the type of test performed and by age (&lt;5 vs 5 years and above) indicated that there were no apparent differences in the compliance patterns on the basis of these parameters (Table <xref rid="Tab4" ref-type="table">4</xref>).<table-wrap id="Tab3"><label>Table 3</label><caption><p>Compliance with use of ACTs</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">States</th><th align="left">Test Result Known</th><th align="left">Positive + ACT</th><th align="left">Negative–ACT</th><th align="left">Compliance (%)</th></tr></thead><tbody><tr><td align="left">C/River</td><td char="." align="char">262</td><td char="." align="char">191</td><td char="." align="char">19</td><td char="." align="char">80.2</td></tr><tr><td align="left">Enugu</td><td char="." align="char">203</td><td char="." align="char">134</td><td char="." align="char">18</td><td char="." align="char">74.9</td></tr><tr><td align="left">Kaduna</td><td char="." align="char">293</td><td char="." align="char">214</td><td char="." align="char">34</td><td char="." align="char">84.6</td></tr><tr><td align="left">Kwara</td><td char="." align="char">177</td><td char="." align="char">143</td><td char="." align="char">11</td><td char="." align="char">87.0</td></tr><tr><td align="left">Lagos</td><td char="." align="char">187</td><td char="." align="char">118</td><td char="." align="char">27</td><td char="." align="char">77.5</td></tr><tr><td align="left">Ogun</td><td char="." align="char">138</td><td char="." align="char">92</td><td char="." align="char">17</td><td char="." align="char">79.0</td></tr><tr><td align="left">Total</td><td char="." align="char">
<italic>1259</italic>
</td><td char="." align="char">
<italic>892</italic>
</td><td char="." align="char">
<italic>126</italic>
</td><td char="." align="char">
<italic>80.9</italic>
</td></tr></tbody></table></table-wrap><table-wrap id="Tab4"><label>Table 4</label><caption><p>Malaria Test result and ACT use</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Selection</th><th align="left" rowspan="2">n</th><th align="left" colspan="2">ACT given</th><th align="left" rowspan="2">Chi square P-value</th><th align="left" rowspan="2">Compliance (95 % CI)</th></tr><tr><th align="left">Yes (%)</th><th align="left">No (%)</th></tr></thead><tbody><tr><td align="left">All tests</td><td align="left">1259</td><td align="left"/><td align="left"/><td char="." align="char">&lt;0.0001</td><td char="(" align="char">80.9 (78.7–83.0)</td></tr><tr><td align="left"> Positive</td><td align="left"/><td char="(" align="char">892 (82.7)</td><td char="(" align="char">186 (17.3)</td><td align="left"/><td align="left"/></tr><tr><td align="left"> Negative</td><td align="left"/><td char="(" align="char">55 (30.4)</td><td char="(" align="char">126 (69.6)</td><td align="left"/><td align="left"/></tr><tr><td align="left">Microscopy only</td><td align="left">633</td><td align="left"/><td align="left"/><td char="." align="char">&lt;0.0001</td><td char="(" align="char">83.1 (80.0–85.8)</td></tr><tr><td align="left"> Positive</td><td align="left"/><td char="(" align="char">484 (85.7)</td><td char="(" align="char">81 (14.3)</td><td align="left"/><td align="left"/></tr><tr><td align="left"> Negative</td><td align="left"/><td char="(" align="char">26 (38.2 %)</td><td char="(" align="char">42 (61.8 %)</td><td align="left"/><td align="left"/></tr><tr><td align="left">mRDT only</td><td align="left">412</td><td align="left"/><td align="left"/><td char="." align="char">&lt;0.0001</td><td char="(" align="char">85.7 (82.0–88.7)</td></tr><tr><td align="left"> Positive</td><td align="left"/><td char="(" align="char">291 (88.7)</td><td char="(" align="char">37 (11.3)</td><td align="left"/><td align="left"/></tr><tr><td align="left"> Negative</td><td align="left"/><td char="(" align="char">22 (26.2)</td><td char="(" align="char">62 (73.8)</td><td align="left"/><td align="left"/></tr><tr><td align="left">Under 5</td><td align="left">117</td><td align="left"/><td align="left"/><td char="." align="char">&lt;0.0001</td><td char="(" align="char">79.5 (71.3–85.8)</td></tr><tr><td align="left"> Positive</td><td align="left"/><td char="(" align="char">84 (79.2)</td><td char="(" align="char">22 (20.8)</td><td align="left"/><td align="left"/></tr><tr><td align="left"> Negative</td><td align="left"/><td char="(" align="char">2 (18.2)</td><td char="(" align="char">9 (81.8)</td><td align="left"/><td align="left"/></tr><tr><td align="left">5-years &amp; above</td><td align="left">1081</td><td align="left"/><td align="left"/><td char="." align="char">&lt;0.0001</td><td char="(" align="char">80.9 (78.4–83.1)</td></tr><tr><td align="left"> Positive</td><td align="left"/><td char="(" align="char">760 (82.8)</td><td char="(" align="char">158 (17.2)</td><td align="left"/><td align="left"/></tr><tr><td align="left"> Negative</td><td align="left"/><td char="(" align="char">49 (30.1)</td><td char="(" align="char">114 (89.9)</td><td align="left"/><td align="left"/></tr></tbody></table></table-wrap></p>
      </sec>
      <sec id="Sec13">
        <title>Health facility practices from health workers’ in-depth interviews</title>
        <p>Two-hundred and forty health workers were interviewed in order to triangulate their information with what was obtained in the exit interviews so as to understand practices within the health facilities in relation to malaria diagnosis and treatment. The distribution of respondents shows that the majority were doctors 69 (29.1 %), followed by nurses 51 (21.5 %), medical laboratory scientists 50 (21.1 %), auxiliary nurses 31 (13.1 %), community health extension workers 26 (11.0 %), community health workers 7 (3.0 %) while pharmacists, 3 (1.3 %), were least represented.</p>
        <p>Health facilities with knowledgeable health workers: Among the 240 health workers, 70.0 % knew the meaning of RDT, while 84.5 % knew what RDT assesses. Of the 229 that responded to the question on specimen used for RDT, 210 (91.7 %) knew that blood was used for the test, one (0.4 %) said urine was used for the test while 18 (7.9 %) did not know the specimen used for the test. Of the 223 respondents to the question on how to carry out RDTs, 160 (71.7 %) knew how to carry out RDT while 63 (28.3 %) did not know. Practices of health workers were equally assessed. In 87.8 % (95 % CI 82–92 %) of health workers, results of RDT were available at the time of treating patient. The result of RDT was used in 73.7 % (95 % CI 67–79 %) to determine treatment. Reported mean time for performing RDT was 11.9 [standard deviation (SD) 7.7] minutes. The mean amount paid for the test was N375 (SD 175), an equivalent of $2.5 as at the time of the study. Perception-wise: 75 % (95 % CI 73–85 %) of health workers were of the opinion that RDT was useful in their facilities. In addition, the majority reported it took a short time, was easy to conduct, and that it did not interfere with clinic activities (Table <xref rid="Tab5" ref-type="table">5</xref>).<table-wrap id="Tab5"><label>Table 5</label><caption><p>Perceptions and practices from the key health workers’ interviews on malaria rapid diagnostic use in the health facilities</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Item assessed</th><th align="left">n</th><th align="left">Responses</th><th align="left">Percent (95 % CI)</th></tr></thead><tbody><tr><td align="left">Health facilities with knowledgeable health workers</td><td align="left"/><td align="left">
<italic>Correct knowledge</italic>
</td><td align="left"/></tr><tr><td align="left"> Meaning of RDT</td><td align="left">231</td><td align="left">168</td><td char="(" align="char">72.7 (67–78)</td></tr><tr><td align="left"> What RDT assesses</td><td align="left">232</td><td align="left">196</td><td char="(" align="char">81.7 (79–89)</td></tr><tr><td align="left"> Specimen required</td><td align="left">229</td><td align="left">210</td><td char="(" align="char">91.7 (87–95)</td></tr><tr><td align="left"> Report ability to do test</td><td align="left">223</td><td align="left">160</td><td char="(" align="char">71.7 (66–77)</td></tr><tr><td align="left">Health facility mRDT practices by health workers</td><td align="left"/><td align="left">
<italic>Practice is yes</italic>
</td><td align="left"/></tr><tr><td align="left"> Dedicated health worker for mRDT</td><td align="left">184</td><td align="left">125</td><td char="(" align="char">67.9 (61–74)</td></tr><tr><td align="left"> Use mRDT to determine treatment</td><td align="left">186</td><td align="left">137</td><td char="(" align="char">73.7 (67–79)</td></tr><tr><td align="left"> Use mRDT routinely</td><td align="left">185</td><td align="left">107</td><td char="(" align="char">107 (52–66)</td></tr><tr><td align="left"> Result available when treating patient</td><td align="left">156</td><td align="left">137</td><td char="(" align="char">87.8 (82–92)</td></tr><tr><td align="left">Perception in the health facilities on the use of mRDT Variable</td><td align="left"/><td align="left">
<italic>Favorable perception</italic>
</td><td align="left"/></tr><tr><td align="left"> Useful for malaria diagnosis</td><td align="left">166</td><td align="left">132</td><td char="(" align="char">79.5 (73–85)</td></tr><tr><td align="left"> Takes short time</td><td align="left">172</td><td align="left">155</td><td char="(" align="char">90.1 (85–94)</td></tr><tr><td align="left"> Easy to conduct</td><td align="left">131</td><td align="left">126</td><td char="(" align="char">96.2 (91–98)</td></tr><tr><td align="left"> Does not interfere with clinic activities</td><td align="left">129</td><td align="left">122</td><td char="(" align="char">94.6 (89–97)</td></tr></tbody></table></table-wrap></p>
      </sec>
    </sec>
    <sec id="Sec14" sec-type="discussion">
      <title>Discussion</title>
      <p>Fever prevalence from the health facilities’ records was 38.5 %. The prevalence varied from 28 to 47 % across the various geo-political zones of the country. The fever prevalence in this study is lower than previously reported rate of 60 % among outpatients [<xref ref-type="bibr" rid="CR29">29</xref>]. It is also slightly lower than the weighted average of 43 and 45 % reported among children taken to formal hospitals in northeastern and southern parts of the country, respectively [<xref ref-type="bibr" rid="CR48">48</xref>]. The reasons for this lowering in fever prevalence may be connected to overall reductions and gains made in the control of malaria and acute respiratory tract infections [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR46">46</xref>]. However, an additional possibility is that there is a wider range of non-febrile conditions that may be seen at the formal private health facilities since most users of such facilities tend to subscribe as families and they report there as their primary point of call for a variety of non-febrile conditions.</p>
      <p>Among the 2077 patients with fever, there were a number of concomitant symptoms. The most frequent being generalized weakness, cough, vomiting, and diarrhoea. The predictive importance of the individual symptoms in relation to malaria was not undertaken in this study. However, the combination of these features continues to underscore the challenge of developing a reliable clinical algorithm for the diagnosis of malaria. Most efforts in this regard have resulted in relatively poor sensitivity and specificity, making the diagnosis of malaria solely reliant on parasitological testing [<xref ref-type="bibr" rid="CR49">49</xref>–<xref ref-type="bibr" rid="CR51">51</xref>]. This was the basis of Nigeria’s recent policy change, in alignment with the global recommendation on testing before treatment, that until proven by test, a case of fever regardless of the clinical symptomatology, is ‘suspected’ malaria [<xref ref-type="bibr" rid="CR52">52</xref>]. This study’s finding on the status of the implementation of the ‘test before treatment’ strategy in a national survey of private health facilities is therefore instructive.</p>
      <p>This study showed that about three-quarters, 73.8 % (95 % CI 71.9–75.7 %) of fever cases were tested for malaria in private health facilities in Nigeria. This is much higher than testing rates reported in public health facilities in the country [<xref ref-type="bibr" rid="CR38">38</xref>]. The 2013 Nigeria Demographic and Health Survey (NDHS) reported that only 11.1 % of children under 5 years with fever had blood taken for testing [<xref ref-type="bibr" rid="CR41">41</xref>]. The finding could be considered counter-intuitive when it is considered that unlike public facilities, private facilities, which are classified under ‘alternative healthcare system’ in Nigeria’s three-tier structure (National Health Policy), are less supervised for quality of care and adherence to guidelines. Conversely, this finding is comforting, given the fact that more Nigerians seek care for fever in private health facilities despite the relatively larger size of the public health sector [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR41">41</xref>]. It perhaps lends some support to the underrated successes of the country’s decade-old Roll Back Malaria campaign aimed at achieving universal coverage of malaria interventions. It also probably reflects the support from RBM partners and the Global Fund to malaria case management in the private sector.</p>
      <p>A further possible reason for the high testing rate in private health facilities could be motivation for income generation, fear of litigation or simply an adherence to policy/practice regulation. Anecdotal evidence in informal medical discourse in Nigeria favours the notion that, because of economic gain, private practitioners are ‘quick on the draw’ to order tests for care-seekers. That said, the outcome of this study regarding the status of testing for malaria before treatment in private health facilities is commendable.</p>
      <p>Testing with RDTs was not observed to be as common as testing by microscopy, which, although considered the gold standard, requires more stringent conditions [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR54">54</xref>]. This appears consistent with some other studies where it has been observed that availability of RDTs was limited in a sample of private facilities that were studied [<xref ref-type="bibr" rid="CR55">55</xref>]. This is probably because formal private facilities are expected to be less resource-constrained than public facilities, even in low- and middle-income countries such as Nigeria, owing to their ‘for-profit’ orientation. There may also be concerns that the quality of RDTs could limit their preference in the private health facilities [<xref ref-type="bibr" rid="CR55">55</xref>]. Concerns about quality may have been why the double test of RDT and microscopy, was performed. The recent scale-up of RDT deployment in the NMEP has been largely directed at the public sector. Among the febrile patients, there was a very high prevalence of malaria positivity. This would appear somewhat discordant with the overall reduction in fever prevalence as observed in hospitals. Considering that microscopy was the dominant means of diagnosis, this finding raises concern about its quality assurance. This observation may need further exploration in studies that will focus significantly on quality assurance issues for malaria diagnosis in private health facilities. In the meanwhile, there might be the need for NMEP and RBM partners to strengthen quality assurance in malaria diagnosis in private sector by ensuring compliance with the provision of implementation guide for parasite-based diagnosis of malaria in Nigeria. Current findings will however suggest the need for more concerted outreach to formal private health facilities in order to improve their uptake of RDTs, especially given the challenges on quality assurance with malaria microscopy.</p>
      <p>The high rate of test-before-treatment practice in the private facilities was also complimented by a high level of compliance to the result of the malaria test. This study’s composite measure of ‘compliance’ to appropriate treatment with ACT following malaria test result was a high 80.9 % (95 % CI 78.7–83.0 %), inclusive of those whose tests were negative and were not given ACT. The level of compliance was not affected by type of test or age of patients. There is virtually no parallel national study to compare this important finding with, except the NDHS household-based surveys reporting that 6.0 % of children under five with fever were appropriately given ACT, irrespective of test-result status or the health provider type [<xref ref-type="bibr" rid="CR41">41</xref>]. ‘Compliance’ may also have been incentivised by the prospect of additional economic gain by prescribing a treatment, for a private establishment. However, as noted, the weighting of ‘compliance’ in this study also included not treating with ACT when the malaria test was negative. This balanced rational drug use is one of the cardinal indicators or measures of quality care. Several studies have already reported the cost-effectiveness of the test-before-treatment policy in case management of malaria [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR35">35</xref>–<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR56">56</xref>]. In this study, the cost of test was about $2.5 and this did not appear to be a disincentive to the testing rate. Overall, 9.3 % of the clients had any form of medical insurance. It is, therefore, unlikely that insurance coverage will be an important explanation for the testing rate in spite of the cost of testing. A peculiarity within the Nigerian system is the general belief that laboratory testing is part of the evidence of the quality of care and may serve as a facilitator of willingness to pay. The authors postulate that this may the underlying factor behind the sustained high testing rate despite the cost of testing.</p>
      <p>The spread of cadre of health workers reported in the present study is similar to that reported by Uzochukwu et al. [<xref ref-type="bibr" rid="CR42">42</xref>]. Their study showed that awareness and knowledge by health workers was higher among the public (72.2 %) than the private (50.0 %) health workers. The correct knowledge by over 70 % (range 71.7–91.7) of private health workers reported in the present study was higher than the 61.1 % reported by Uzochukwu et al. [<xref ref-type="bibr" rid="CR42">42</xref>]. The reason for this could be attributed to training on RDT conducted by several non-governmental organizations working in collaboration with the NMEP. These workers in the private health facilities reported a higher level of 79.5 % in the usefulness of RDT for malaria diagnosis than the 65.6 % health workers reported by the previous study [<xref ref-type="bibr" rid="CR38">38</xref>].</p>
      <p>The perception of the usefulness of RDT for malaria diagnosis and treatment among health workers in the private facilities was favourable. The perceived usefulness of the RDT test for diagnosis by the health workers in this study was 79.5 % (95 % CI 73–85 %) against 65.6 % previously reported [<xref ref-type="bibr" rid="CR42">42</xref>]. Health workers’ opinion that RDT took a “short time” was consistently high with that reported by same authors [<xref ref-type="bibr" rid="CR38">38</xref>]. These positive attitudes provide important opportunity for the scale up of RDT use in formal private health facilities with information targeted on addressing other areas of concerns that might limit their absolute confidence in the use of RDTs.</p>
      <p>Regardless of the point of care, when health providers adhere to or comply with malaria test results, it is expected that there will be a lot of benefit to the health systems, the patients and the health facilities.</p>
    </sec>
    <sec id="Sec15" sec-type="conclusion">
      <title>Conclusions</title>
      <p>This study revealed an unprecedented report of the status of malaria testing rate, and compliance with malaria test results in private health facilities in Nigeria. In formal private health facilities in Nigeria, there is a high rate of malaria testing for febrile patients, high level of compliance with test results but relatively low level of RDT utilization. This calls for improved engagement of the formal private health sector with a view to achieving universal coverage targets on malaria testing.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Authors’ contributions</title>
      <p>OAM and GNN conceived the study and participated in the design, implementation and development of the manuscript. COA and KUE performed the statistical analysis. OOA and RAA took the lead in the development of the study tools. All others participated equally in the development of the study protocol, implementation, review of data output and drafting of the manuscript. All the authors read and approved the final manuscript.</p>
      <sec id="FPar1">
        <title>Acknowledgements</title>
        <p>The authors are grateful to The Global Fund to Fight against AIDS, Tuberculosis and Malaria for the funding of the study as part of the support for the implementation researches on malaria rapid diagnostic tests in Nigeria.</p>
      </sec>
      <sec id="FPar2">
        <title>Competing interests</title>
        <p>The authors declare that they have no competing interests.</p>
      </sec>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>White</surname>
              <given-names>NJ</given-names>
            </name>
            <name>
              <surname>Pukrittayakamee</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hien</surname>
              <given-names>TT</given-names>
            </name>
            <name>
              <surname>Faiz</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Mokuolu</surname>
              <given-names>OA</given-names>
            </name>
            <name>
              <surname>Dondorp</surname>
              <given-names>AM</given-names>
            </name>
          </person-group>
          <article-title>Malaria</article-title>
          <source>Lancet</source>
          <year>2014</year>
          <volume>383</volume>
          <fpage>723</fpage>
          <lpage>735</lpage>
          <pub-id pub-id-type="doi">10.1016/S0140-6736(13)60024-0</pub-id>
          <?supplied-pmid 23953767?>
          <pub-id pub-id-type="pmid">23953767</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <mixed-citation publication-type="other">WHO: World Malaria Report 2014. Geneva, World Health Organization, 2014.</mixed-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Korenromp</surname>
              <given-names>EL</given-names>
            </name>
            <name>
              <surname>Hosseini</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Newman</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Cibulskis</surname>
              <given-names>RE</given-names>
            </name>
          </person-group>
          <article-title>Progress towards malaria control targets in relation to national malaria programme funding</article-title>
          <source>Malar J</source>
          <year>2013</year>
          <volume>12</volume>
          <fpage>18</fpage>
          <pub-id pub-id-type="doi">10.1186/1475-2875-12-18</pub-id>
          <?supplied-pmid 23317000?>
          <pub-id pub-id-type="pmid">23317000</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>de Jongh</surname>
              <given-names>TE</given-names>
            </name>
            <name>
              <surname>Harnmeijer</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Atun</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Korenromp</surname>
              <given-names>EL</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Puvimanasinghe</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Health impact of external funding for HIV, tuberculosis and malaria: systematic review</article-title>
          <source>Health Policy Plan</source>
          <year>2014</year>
          <volume>29</volume>
          <fpage>650</fpage>
          <lpage>662</lpage>
          <pub-id pub-id-type="doi">10.1093/heapol/czt051</pub-id>
          <?supplied-pmid 23921987?>
          <pub-id pub-id-type="pmid">23921987</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pigott</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Atun</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Moyes</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Hay</surname>
              <given-names>SI</given-names>
            </name>
            <name>
              <surname>Gething</surname>
              <given-names>PW</given-names>
            </name>
          </person-group>
          <article-title>Funding for malaria control 2006-2010: a comprehensive global assessment</article-title>
          <source>Malar J</source>
          <year>2012</year>
          <volume>11</volume>
          <fpage>246</fpage>
          <pub-id pub-id-type="doi">10.1186/1475-2875-11-246</pub-id>
          <?supplied-pmid 22839432?>
          <pub-id pub-id-type="pmid">22839432</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>WHO</collab>
          </person-group>
          <source>Guidelines for the treatment of malaria</source>
          <year>2010</year>
          <publisher-loc>Geneva</publisher-loc>
          <publisher-name>World Health Organization</publisher-name>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reyburn</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>New WHO guidelines for the treatment of malaria</article-title>
          <source>BMJ</source>
          <year>2010</year>
          <volume>340</volume>
          <fpage>c2637</fpage>
          <pub-id pub-id-type="doi">10.1136/bmj.c2637</pub-id>
          <?supplied-pmid 20511305?>
          <pub-id pub-id-type="pmid">20511305</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ayalew</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Tilahun</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Taye</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Performance evaluation of laboratory professionals on malaria microscopy in Hawassa Town Southern Ethiopia</article-title>
          <source>BMC Res Notes</source>
          <year>2014</year>
          <volume>7</volume>
          <fpage>839</fpage>
          <pub-id pub-id-type="doi">10.1186/1756-0500-7-839</pub-id>
          <?supplied-pmid 25422030?>
          <pub-id pub-id-type="pmid">25422030</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nateghpour</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Edrissian</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Raeisi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Motevalli-Haghi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Farivar</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Mohseni</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The Role of malaria microscopy training and refresher training courses in malaria control program in Iran during 2001–2011</article-title>
          <source>Iran J Parasitol</source>
          <year>2012</year>
          <volume>7</volume>
          <fpage>104</fpage>
          <lpage>109</lpage>
          <?supplied-pmid 23323099?>
          <pub-id pub-id-type="pmid">23323099</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ghouth</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Nasseb</surname>
              <given-names>FM</given-names>
            </name>
            <name>
              <surname>Al-Kaldy</surname>
              <given-names>KH</given-names>
            </name>
          </person-group>
          <article-title>The accuracy of the first response histidine-rich protein2 rapid diagnostic test compared with malaria microscopy for guiding field treatment in an outbreak of falciparum malaria</article-title>
          <source>Trop Parasitol</source>
          <year>2012</year>
          <volume>2</volume>
          <fpage>35</fpage>
          <lpage>37</lpage>
          <pub-id pub-id-type="doi">10.4103/2229-5070.97237</pub-id>
          <?supplied-pmid 23508787?>
          <pub-id pub-id-type="pmid">23508787</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Batwala</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Magnussen</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Hansen</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Nuwaha</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Cost-effectiveness of malaria microscopy and rapid diagnostic tests versus presumptive diagnosis: implications for malaria control in Uganda</article-title>
          <source>Malar J</source>
          <year>2011</year>
          <volume>10</volume>
          <fpage>372</fpage>
          <pub-id pub-id-type="doi">10.1186/1475-2875-10-372</pub-id>
          <?supplied-pmid 22182735?>
          <pub-id pub-id-type="pmid">22182735</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kilian</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Metzger</surname>
              <given-names>WG</given-names>
            </name>
            <name>
              <surname>Mutschelknauss</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Kabagambe</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Langi</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Korte</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>von Sonnenburg</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Reliability of malaria microscopy in epidemiological studies: results of quality control</article-title>
          <source>Trop Med Int Health</source>
          <year>2000</year>
          <volume>5</volume>
          <fpage>3</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1365-3156.2000.00509.x</pub-id>
          <?supplied-pmid 10672199?>
          <pub-id pub-id-type="pmid">10672199</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kahama-Maro</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>D’Acremont</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Mtasiwa</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Genton</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Lengeler</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Low quality of routine microscopy for malaria at different levels of the health system in Dar es Salaam</article-title>
          <source>Malar J</source>
          <year>2011</year>
          <volume>10</volume>
          <fpage>332</fpage>
          <pub-id pub-id-type="doi">10.1186/1475-2875-10-332</pub-id>
          <?supplied-pmid 22047131?>
          <pub-id pub-id-type="pmid">22047131</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Batwala</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Magnussen</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Nuwaha</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Are rapid diagnostic tests more accurate in diagnosis of plasmodium falciparum malaria compared to microscopy at rural health centres?</article-title>
          <source>Malar J</source>
          <year>2010</year>
          <volume>9</volume>
          <fpage>349</fpage>
          <pub-id pub-id-type="doi">10.1186/1475-2875-9-349</pub-id>
          <?supplied-pmid 21126328?>
          <pub-id pub-id-type="pmid">21126328</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Neumann</surname>
              <given-names>CG</given-names>
            </name>
            <name>
              <surname>Bwibo</surname>
              <given-names>NO</given-names>
            </name>
            <name>
              <surname>Siekmann</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>McLean</surname>
              <given-names>ED</given-names>
            </name>
            <name>
              <surname>Browdy</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Drorbaugh</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Comparison of blood smear microscopy to a rapid diagnostic test for in vitro testing for <italic>P. falciparum</italic> malaria in Kenyan school children</article-title>
          <source>East Afr Med J</source>
          <year>2008</year>
          <volume>85</volume>
          <fpage>544</fpage>
          <lpage>549</lpage>
          <?supplied-pmid 19413207?>
          <pub-id pub-id-type="pmid">19413207</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Endeshaw</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Gebre</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ngondi</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Graves</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Shargie</surname>
              <given-names>EB</given-names>
            </name>
            <name>
              <surname>Ejigsemahu</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Evaluation of light microscopy and rapid diagnostic test for the detection of malaria under operational field conditions: a household survey in Ethiopia</article-title>
          <source>Malar J</source>
          <year>2008</year>
          <volume>7</volume>
          <fpage>118</fpage>
          <pub-id pub-id-type="doi">10.1186/1475-2875-7-118</pub-id>
          <?supplied-pmid 18598344?>
          <pub-id pub-id-type="pmid">18598344</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wongsrichanalai</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Barcus</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Muth</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sutamihardja</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wernsdorfer</surname>
              <given-names>WH</given-names>
            </name>
          </person-group>
          <article-title>A review of malaria diagnostic tools: microscopy and rapid diagnostic test (RDT)</article-title>
          <source>Am J Trop Med Hyg</source>
          <year>2007</year>
          <volume>77</volume>
          <fpage>119</fpage>
          <lpage>127</lpage>
          <?supplied-pmid 18165483?>
          <pub-id pub-id-type="pmid">18165483</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gatti</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gramegna</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bisoffi</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Raglio</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gulletta</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Klersy</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A comparison of three diagnostic techniques for malaria: a rapid diagnostic test (NOW Malaria), PCR and microscopy</article-title>
          <source>Ann Trop Med Parasitol</source>
          <year>2007</year>
          <volume>101</volume>
          <fpage>195</fpage>
          <lpage>204</lpage>
          <pub-id pub-id-type="doi">10.1179/136485907X156997</pub-id>
          <?supplied-pmid 17362594?>
          <pub-id pub-id-type="pmid">17362594</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vyas</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Puwar</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Bhatt</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Kulkarni</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Fancy</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Study on validity of a rapid diagnostic test kit versus light microscopy for malaria diagnosis in Ahmedabad city</article-title>
          <source>India. East Mediterr Health J</source>
          <year>2014</year>
          <volume>20</volume>
          <fpage>236</fpage>
          <lpage>241</lpage>
          <?supplied-pmid 24952120?>
          <pub-id pub-id-type="pmid">24952120</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Odaga</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Sinclair</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Lokong</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Donegan</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hopkins</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Garner</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Rapid diagnostic tests versus clinical diagnosis for managing people with fever in malaria endemic settings</article-title>
          <source>Cochrane Database Syst Rev</source>
          <year>2014</year>
          <volume>4</volume>
          <fpage>Cd008998</fpage>
          <?supplied-pmid 24740584?>
          <pub-id pub-id-type="pmid">24740584</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Manyando</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Njunju</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Chileshe</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Siziya</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Shiff</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Rapid diagnostic tests for malaria and health workers’ adherence to test results at health facilities in Zambia</article-title>
          <source>Malar J</source>
          <year>2014</year>
          <volume>13</volume>
          <fpage>166</fpage>
          <pub-id pub-id-type="doi">10.1186/1475-2875-13-166</pub-id>
          <?supplied-pmid 24885996?>
          <pub-id pub-id-type="pmid">24885996</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rabiu</surname>
              <given-names>OR</given-names>
            </name>
            <name>
              <surname>Kosoko</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Falade</surname>
              <given-names>CO</given-names>
            </name>
            <name>
              <surname>Ademowo</surname>
              <given-names>OG</given-names>
            </name>
          </person-group>
          <article-title>Evaluation of the performances of two rapid diagnostic tests (Cyscope(R)mini and Paracheck-Pf(R)) in the diagnosis of malaria among febrile children in southwest Nigeria</article-title>
          <source>Med Princ Pract</source>
          <year>2013</year>
          <volume>22</volume>
          <fpage>255</fpage>
          <lpage>259</lpage>
          <pub-id pub-id-type="doi">10.1159/000345642</pub-id>
          <?supplied-pmid 23258268?>
          <pub-id pub-id-type="pmid">23258268</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Runsewe-Abiodun</surname>
              <given-names>IT</given-names>
            </name>
            <name>
              <surname>Efunsile</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ghebremedhin</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Sotimehin</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Ajewole</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Akinleye</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Malaria diagnostics: a comparative study of blood microscopy, a rapid diagnostic test and polymerase chain reaction in the diagnosis of malaria</article-title>
          <source>J Trop Pediatr</source>
          <year>2012</year>
          <volume>58</volume>
          <fpage>163</fpage>
          <lpage>164</lpage>
          <pub-id pub-id-type="doi">10.1093/tropej/fmr058</pub-id>
          <?supplied-pmid 21700669?>
          <pub-id pub-id-type="pmid">21700669</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ajumobi</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Sabitu</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Nguku</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Kwaga</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ntadom</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Gitta</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Performance of an HRP-2 rapid diagnostic test in Nigerian children less than 5 years of age</article-title>
          <source>Am J Trop Med Hyg</source>
          <year>2015</year>
          <volume>92</volume>
          <fpage>828</fpage>
          <lpage>833</lpage>
          <pub-id pub-id-type="doi">10.4269/ajtmh.13-0558</pub-id>
          <?supplied-pmid 25711608?>
          <pub-id pub-id-type="pmid">25711608</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baiden</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Owusu-Agyei</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Okyere</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Tivura</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Adjei</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Chandramohan</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Webster</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Acceptability of rapid diagnostic test-based management of Malaria among caregivers of under-five children in rural Ghana</article-title>
          <source>PLoS One</source>
          <year>2012</year>
          <volume>7</volume>
          <fpage>e45556</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0045556</pub-id>
          <?supplied-pmid 23029094?>
          <pub-id pub-id-type="pmid">23029094</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bharti</surname>
              <given-names>PK</given-names>
            </name>
            <name>
              <surname>Silawat</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Singh</surname>
              <given-names>PP</given-names>
            </name>
            <name>
              <surname>Singh</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Shukla</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Chand</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The usefulness of a new rapid diagnostic test, the First Response Malaria Combo (pLDH/HRP2) card test, for malaria diagnosis in the forested belt of central India</article-title>
          <source>Malar J</source>
          <year>2008</year>
          <volume>7</volume>
          <fpage>126</fpage>
          <pub-id pub-id-type="doi">10.1186/1475-2875-7-126</pub-id>
          <?supplied-pmid 18620560?>
          <pub-id pub-id-type="pmid">18620560</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Comoe</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Ouattara</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Raso</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Tanner</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Utzinger</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Koudou</surname>
              <given-names>BG</given-names>
            </name>
          </person-group>
          <article-title>Willingness to use a rapid diagnostic test for malaria in a rural area of central Cote d’Ivoire</article-title>
          <source>BMC Public Health</source>
          <year>1089</year>
          <volume>2012</volume>
          <fpage>12</fpage>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Elmardi</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Malik</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Abdelgadir</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ali</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Elsyed</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Mudather</surname>
              <given-names>MA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Feasibility and acceptability of home-based management of malaria strategy adapted to Sudan’s conditions using artemisinin-based combination therapy and rapid diagnostic test</article-title>
          <source>Malar J</source>
          <year>2009</year>
          <volume>8</volume>
          <fpage>39</fpage>
          <pub-id pub-id-type="doi">10.1186/1475-2875-8-39</pub-id>
          <?supplied-pmid 19272157?>
          <pub-id pub-id-type="pmid">19272157</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>FMOH</collab>
          </person-group>
          <source>National guidelines for diagnosis and treatment of malaria 2011</source>
          <year>2011</year>
          <publisher-loc>Abuja, Nigeria</publisher-loc>
          <publisher-name>Federal Ministry of Health</publisher-name>
        </element-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>FMOH</collab>
          </person-group>
          <source>National malaria strategic plan 2014–2020</source>
          <year>2014</year>
          <publisher-loc>Abuja, Nigeria</publisher-loc>
          <publisher-name>Federal Ministry of Health</publisher-name>
        </element-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Masanja</surname>
              <given-names>IM</given-names>
            </name>
            <name>
              <surname>Selemani</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Amuri</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Kajungu</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Khatib</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kachur</surname>
              <given-names>SP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Increased use of malaria rapid diagnostic tests improves targeting of anti-malarial treatment in rural Tanzania: implications for nationwide rollout of malaria rapid diagnostic tests</article-title>
          <source>Malar J</source>
          <year>2012</year>
          <volume>11</volume>
          <fpage>221</fpage>
          <pub-id pub-id-type="doi">10.1186/1475-2875-11-221</pub-id>
          <?supplied-pmid 22747655?>
          <pub-id pub-id-type="pmid">22747655</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Singh</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Mishra</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Shukla</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Chand</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Bharti</surname>
              <given-names>PK</given-names>
            </name>
          </person-group>
          <article-title>Diagnostic and prognostic utility of an inexpensive rapid on site malaria diagnostic test (ParaHIT f) among ethnic tribal population in areas of high, low and no transmission in central India</article-title>
          <source>BMC Infect Dis</source>
          <year>2005</year>
          <volume>5</volume>
          <fpage>50</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-2334-5-50</pub-id>
          <?supplied-pmid 15969747?>
          <pub-id pub-id-type="pmid">15969747</pub-id>
        </element-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Uzochukwu</surname>
              <given-names>BS</given-names>
            </name>
            <name>
              <surname>Obikeze</surname>
              <given-names>EN</given-names>
            </name>
            <name>
              <surname>Onwujekwe</surname>
              <given-names>OE</given-names>
            </name>
            <name>
              <surname>Onoka</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Griffiths</surname>
              <given-names>UK</given-names>
            </name>
          </person-group>
          <article-title>Cost-effectiveness analysis of rapid diagnostic test, microscopy and syndromic approach in the diagnosis of malaria in Nigeria: implications for scaling-up deployment of ACT</article-title>
          <source>Malar J</source>
          <year>2009</year>
          <volume>8</volume>
          <fpage>265</fpage>
          <pub-id pub-id-type="doi">10.1186/1475-2875-8-265</pub-id>
          <?supplied-pmid 19930666?>
          <pub-id pub-id-type="pmid">19930666</pub-id>
        </element-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rosas Aguirre</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Zavalaga</surname>
              <given-names>LF</given-names>
            </name>
            <name>
              <surname>Trelles de Belaunde</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Cost-effectiveness ratio of using rapid tests for malaria diagnosis in the Peruvian Amazon</article-title>
          <source>Rev Panam Salud Publica</source>
          <year>2009</year>
          <volume>25</volume>
          <fpage>377</fpage>
          <lpage>388</lpage>
          <pub-id pub-id-type="doi">10.1590/S1020-49892009000500001</pub-id>
          <?supplied-pmid 19695126?>
          <pub-id pub-id-type="pmid">19695126</pub-id>
        </element-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lubell</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Reyburn</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Mbakilwa</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Mwangi</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Chonya</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Whitty</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Mills</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>The cost-effectiveness of parasitologic diagnosis for malaria-suspected patients in an era of combination therapy</article-title>
          <source>Am J Trop Med Hyg</source>
          <year>2007</year>
          <volume>77</volume>
          <fpage>128</fpage>
          <lpage>132</lpage>
          <?supplied-pmid 18165484?>
          <pub-id pub-id-type="pmid">18165484</pub-id>
        </element-citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harchut</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Standley</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Dobson</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Klaassen</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Rambaud-Althaus</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Althaus</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Nowak</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Over-diagnosis of malaria by microscopy in the Kilombero Valley, Southern Tanzania: an evaluation of the utility and cost-effectiveness of rapid diagnostic tests</article-title>
          <source>Malar J</source>
          <year>2013</year>
          <volume>12</volume>
          <fpage>159</fpage>
          <pub-id pub-id-type="doi">10.1186/1475-2875-12-159</pub-id>
          <?supplied-pmid 23663437?>
          <pub-id pub-id-type="pmid">23663437</pub-id>
        </element-citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ansah</surname>
              <given-names>EK</given-names>
            </name>
            <name>
              <surname>Epokor</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Whitty</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Yeung</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hansen</surname>
              <given-names>KS</given-names>
            </name>
          </person-group>
          <article-title>Cost-effectiveness analysis of introducing RDTs for malaria diagnosis as compared to microscopy and presumptive diagnosis in central and peripheral public health facilities in Ghana</article-title>
          <source>Am J Trop Med Hyg</source>
          <year>2013</year>
          <volume>89</volume>
          <fpage>724</fpage>
          <lpage>736</lpage>
          <pub-id pub-id-type="doi">10.4269/ajtmh.13-0033</pub-id>
          <?supplied-pmid 23980131?>
          <pub-id pub-id-type="pmid">23980131</pub-id>
        </element-citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <mixed-citation publication-type="other">Mokuolu OA, Ntadom GN, Ajumobi OO, Adedoyin OT, Roberts AA, Agomo CA, et al. Experiences with implementation of malaria diagnostic testing at primary health care in Nigeria: implementation for scale-up. Abuja (FMOH Technical Report), 2013.</mixed-citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <mixed-citation publication-type="other">FMOH: A directory of health facilities in Nigeria. Abuja: 2012. p. 846.</mixed-citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Makinde</surname>
              <given-names>OA</given-names>
            </name>
            <name>
              <surname>Azeez</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bamidele</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Oyemakinde</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Oyediran</surname>
              <given-names>KA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Development of a master health facility list in Nigeria</article-title>
          <source>Online J Public Health Inform</source>
          <year>2014</year>
          <volume>6</volume>
          <fpage>e184</fpage>
          <pub-id pub-id-type="doi">10.5210/ojphi.v6i2.5287</pub-id>
          <?supplied-pmid 25422720?>
          <pub-id pub-id-type="pmid">25422720</pub-id>
        </element-citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <mixed-citation publication-type="other">National Population Commission, ICF-International. Nigeria Demographic and Health Survey 2013. Abuja, Nigeria: National Population Commission, Rockville: ICF-International; 2014</mixed-citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Uzochukwu</surname>
              <given-names>BS</given-names>
            </name>
            <name>
              <surname>Chiegboka</surname>
              <given-names>LO</given-names>
            </name>
            <name>
              <surname>Enwereuzo</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Nwosu</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Okorafor</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Onwujekwe</surname>
              <given-names>OE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Examining appropriate diagnosis and treatment of malaria: availability and use of rapid diagnostic tests and artemisinin-based combination therapy in public and private health facilities in south east Nigeria</article-title>
          <source>BMC Public Health</source>
          <year>2010</year>
          <volume>10</volume>
          <fpage>486</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-2458-10-486</pub-id>
          <?supplied-pmid 20712876?>
          <pub-id pub-id-type="pmid">20712876</pub-id>
        </element-citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Udoh</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Oyo-Ita</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Odey</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Effa</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Esu</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Oduwole</surname>
              <given-names>O</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Management of uncomplicated malaria in underfives in private and public health facilities in South-eastern Nigeria: a clinical audit of current practices</article-title>
          <source>Malar Res Treat</source>
          <year>2013</year>
          <volume>2013</volume>
          <fpage>575080</fpage>
          <?supplied-pmid 23401847?>
          <pub-id pub-id-type="pmid">23401847</pub-id>
        </element-citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mohlala</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Peltzer</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Phaswana-Mafuya</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Ramlagan</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Drug prescription habits in public and private health facilities in two provinces in South Africa</article-title>
          <source>East Mediterr Health J</source>
          <year>2010</year>
          <volume>16</volume>
          <fpage>324</fpage>
          <lpage>328</lpage>
          <?supplied-pmid 20795449?>
          <pub-id pub-id-type="pmid">20795449</pub-id>
        </element-citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hutchinson</surname>
              <given-names>PL</given-names>
            </name>
            <name>
              <surname>Do</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Agha</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Measuring client satisfaction and the quality of family planning services: a comparative analysis of public and private health facilities in Tanzania, Kenya and Ghana</article-title>
          <source>BMC Health Serv Res</source>
          <year>2011</year>
          <volume>11</volume>
          <fpage>203</fpage>
          <pub-id pub-id-type="doi">10.1186/1472-6963-11-203</pub-id>
          <?supplied-pmid 21864335?>
          <pub-id pub-id-type="pmid">21864335</pub-id>
        </element-citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <mixed-citation publication-type="other">Snow RW, Mundia CW, Kinyoki D, Linard C, Baba ES, Adegbe E, et al. A description of the epidemiology of malaria to guide the planning of control in Nigeria. Report prepared by SunMAP, WHO-Country Office Nigeria and the KEMRI-Wellcome Trust-University of Oxford Programme, Kenya for the Federal National Malaria Control Programme, Abuja. 2013.</mixed-citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <mixed-citation publication-type="other">NPC-Nigeria, NMCP-Nigeria, ICF-International. Nigeria malaria indicator survey 2010. Abuja. 2012.</mixed-citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Odu</surname>
              <given-names>BP</given-names>
            </name>
            <name>
              <surname>Mitchell</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Isa</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ugot</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Yusuf</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Cockcroft</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Andersson</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Equity and seeking treatment for young children with fever in Nigeria: a cross-sectional study in Cross River and Bauchi States</article-title>
          <source>Infect Dis Poverty</source>
          <year>2015</year>
          <volume>4</volume>
          <fpage>1</fpage>
          <pub-id pub-id-type="doi">10.1186/2049-9957-4-1</pub-id>
          <?supplied-pmid 25671126?>
          <pub-id pub-id-type="pmid">25671126</pub-id>
        </element-citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Otokpa</surname>
              <given-names>AO</given-names>
            </name>
            <name>
              <surname>Asuzu</surname>
              <given-names>MC</given-names>
            </name>
          </person-group>
          <article-title>A cross-sectional study for algorithm in diagnosing simple uncomplicated malaria in children in health facilities without laboratory backup in Nigeria</article-title>
          <source>Niger Postgrad Med J</source>
          <year>2014</year>
          <volume>21</volume>
          <fpage>115</fpage>
          <lpage>121</lpage>
          <?supplied-pmid 25126864?>
          <pub-id pub-id-type="pmid">25126864</pub-id>
        </element-citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bojang</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Obaro</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Morison</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Greenwood</surname>
              <given-names>BM</given-names>
            </name>
          </person-group>
          <article-title>A prospective evaluation of a clinical algorithm for the diagnosis of malaria in Gambian children</article-title>
          <source>Trop Med Int Health</source>
          <year>2000</year>
          <volume>5</volume>
          <fpage>231</fpage>
          <lpage>236</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1365-3156.2000.00538.x</pub-id>
          <?supplied-pmid 10810013?>
          <pub-id pub-id-type="pmid">10810013</pub-id>
        </element-citation>
      </ref>
      <ref id="CR51">
        <label>51.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chandramohan</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Carneiro</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Kavishwar</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Brugha</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Desai</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Greenwood</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>A clinical algorithm for the diagnosis of malaria: results of an evaluation in an area of low endemicity</article-title>
          <source>Trop Med Int Health</source>
          <year>2001</year>
          <volume>6</volume>
          <fpage>505</fpage>
          <lpage>510</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1365-3156.2001.00739.x</pub-id>
          <?supplied-pmid 11469942?>
          <pub-id pub-id-type="pmid">11469942</pub-id>
        </element-citation>
      </ref>
      <ref id="CR52">
        <label>52.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>WHO</collab>
          </person-group>
          <source>Guidelines for the treatment of malaria</source>
          <year>2015</year>
          <publisher-loc>Geneva</publisher-loc>
          <publisher-name>World Health Organization</publisher-name>
        </element-citation>
      </ref>
      <ref id="CR53">
        <label>53.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Azikiwe</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Ifezulike</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Siminialayi</surname>
              <given-names>IM</given-names>
            </name>
            <name>
              <surname>Amazu</surname>
              <given-names>LU</given-names>
            </name>
            <name>
              <surname>Enye</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Nwakwunite</surname>
              <given-names>OE</given-names>
            </name>
          </person-group>
          <article-title>A comparative laboratory diagnosis of malaria: microscopy versus rapid diagnostic test kits</article-title>
          <source>Asian Pac J Trop Biomed</source>
          <year>2012</year>
          <volume>2</volume>
          <fpage>307</fpage>
          <lpage>310</lpage>
          <pub-id pub-id-type="doi">10.1016/S2221-1691(12)60029-X</pub-id>
          <?supplied-pmid 23569920?>
          <pub-id pub-id-type="pmid">23569920</pub-id>
        </element-citation>
      </ref>
      <ref id="CR54">
        <label>54.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Batwala</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Magnussen</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Nuwaha</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Comparative feasibility of implementing rapid diagnostic test and microscopy for parasitological diagnosis of malaria in Uganda</article-title>
          <source>Malar J</source>
          <year>2011</year>
          <volume>10</volume>
          <fpage>373</fpage>
          <pub-id pub-id-type="doi">10.1186/1475-2875-10-373</pub-id>
          <?supplied-pmid 22182758?>
          <pub-id pub-id-type="pmid">22182758</pub-id>
        </element-citation>
      </ref>
      <ref id="CR55">
        <label>55.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Albertini</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Djalle</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Faye</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Gamboa</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Luchavez</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Mationg</surname>
              <given-names>ML</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Preliminary enquiry into the availability, price and quality of malaria rapid diagnostic tests in the private health sector of six malaria-endemic countries</article-title>
          <source>Trop Med Int Health</source>
          <year>2012</year>
          <volume>17</volume>
          <fpage>147</fpage>
          <lpage>152</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-3156.2011.02904.x</pub-id>
          <?supplied-pmid 22032415?>
          <pub-id pub-id-type="pmid">22032415</pub-id>
        </element-citation>
      </ref>
      <ref id="CR56">
        <label>56.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Parikh</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Amole</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Tarpley</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gbadero</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Davidson</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Vermund</surname>
              <given-names>SH</given-names>
            </name>
          </person-group>
          <article-title>Cost comparison of microscopy vs. empiric treatment for malaria in Southwestern Nigeria: a prospective study</article-title>
          <source>Malar J</source>
          <year>2010</year>
          <volume>9</volume>
          <fpage>371</fpage>
          <pub-id pub-id-type="doi">10.1186/1475-2875-9-371</pub-id>
          <?supplied-pmid 21176228?>
          <pub-id pub-id-type="pmid">21176228</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:4700574</identifier><datestamp>2016-01-06</datestamp><setSpec>malarj</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="http://jats.nlm.nih.gov/ns/archiving/1.0/ http://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Malar J</journal-id>
      <journal-id journal-id-type="iso-abbrev">Malar. J</journal-id>
      <journal-title-group>
        <journal-title>Malaria Journal</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1475-2875</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC4700574</article-id>
      <article-id pub-id-type="pmcid">PMC4700574</article-id>
      <article-id pub-id-type="pmc-uid">4700574</article-id>
      <article-id pub-id-type="publisher-id">1027</article-id>
      <article-id pub-id-type="doi">10.1186/s12936-015-1027-2</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Methodology</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title><italic>Plasmodium berghei</italic> bio-burden correlates with parasite lactate dehydrogenase: application to murine <italic>Plasmodium</italic> diagnostics</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>De</surname>
            <given-names>Sai Lata</given-names>
          </name>
          <address>
            <email>s.de@griffith.edu.au</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Stanisic</surname>
            <given-names>Danielle I.</given-names>
          </name>
          <address>
            <email>d.stanisic@griffith.edu.au</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rivera</surname>
            <given-names>Fabian</given-names>
          </name>
          <address>
            <email>fabian.rivera@qimrberghofer.edu.au</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Batzloff</surname>
            <given-names>Michael R.</given-names>
          </name>
          <address>
            <email>m.batzloff@griffith.edu.au</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Engwerda</surname>
            <given-names>Christian</given-names>
          </name>
          <address>
            <email>Christian.Engwerda@qimrberghofer.edu.au</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Good</surname>
            <given-names>Michael F.</given-names>
          </name>
          <address>
            <email>michael.good@griffith.edu.au</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <aff id="Aff1"><label/>Institute for Glycomics, Griffith University, Gold Coast, QLD Australia </aff>
        <aff id="Aff2"><label/>QIMR Berghofer Medical Research Institute, Brisbane, QLD Australia </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>4</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>4</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <volume>15</volume>
      <elocation-id>3</elocation-id>
      <history>
        <date date-type="received">
          <day>4</day>
          <month>9</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>2</day>
          <month>12</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© De et al. 2015</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>The spectrum of techniques to detect malaria parasites in whole blood is limited to measuring parasites in circulation. One approach that is currently used to enumerate total parasite bio-burden involves the use of bio-luminescent parasites. As an alternative approach, this study describes the use of a commercial ELISA human parasite lactate dehydrogenase (pLDH) detection kit to estimate total parasite bio-burden in murine malaria models.</p>
        </sec>
        <sec>
          <title>Methods</title>
          <p>The cross reactivity of pLDH in a commercial human malaria pLDH diagnostic kit was established in different components of blood for different murine malaria models. The use of pLDH as a measure of parasite bio-burden was evaluated by examining pLDH in relation to peripheral blood parasitaemia as determined by microscopy and calculating total parasite bio-burden using a bio-luminescent <italic>Plasmodium berghei</italic> ANKA luciferase parasite.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>The pLDH antigen was detected in all four murine <italic>Plasmodium</italic> species and in all components of <italic>Plasmodium</italic>-infected blood. A significant correlation (<italic>r</italic> = 0.6922, <italic>P</italic> value &lt;0.0001) was observed between total parasite bio-burden, measured as log average radiance, and concentration of pLDH units.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>This high throughput assay is a suitable measure of total parasite bio-burden in murine malaria infections. Unlike existing methods, it permits the estimation of both circulating and sequestered parasites, allowing a more accurate assessment of parasite bio-burden.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Malaria</kwd>
        <kwd>pLDH</kwd>
        <kwd>Murine <italic>Plasmodium</italic></kwd>
        <kwd>Parasite bio-burden</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000925</institution-id>
              <institution>National Health and Medical Research Council (AU)</institution>
            </institution-wrap>
          </funding-source>
          <award-id>1037304</award-id>
          <principal-award-recipient>
            <name>
              <surname>Good</surname>
              <given-names>Michael F.</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
      </funding-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>© The Author(s) 2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Background</title>
      <p>Malaria continues to be a leading cause of mortality in endemic countries, despite control and eradication initiatives, such as the use of insecticide-treated bed nets and anti-malaria drug treatment [<xref ref-type="bibr" rid="CR1">1</xref>]. Clinical disease typically presents as fever, chills, severe headache, and vomiting, and requires a prompt diagnosis followed by effective treatment to ensure resolution of the infection. Importantly, disease outcomes are directly correlated with total parasite burden [<xref ref-type="bibr" rid="CR2">2</xref>]. In rodent malaria models, Giemsa-stained blood films (the gold-standard microscopy technique) [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>], PCR [<xref ref-type="bibr" rid="CR5">5</xref>], flow cytometry [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>], fluorescent [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>] or DNA/RNA [<xref ref-type="bibr" rid="CR10">10</xref>–<xref ref-type="bibr" rid="CR12">12</xref>] markers and radioisotope labelling [<xref ref-type="bibr" rid="CR11">11</xref>] have been used to measure parasitaemia in in vivo preclinical efficacy studies for anti-malaria drugs and vaccine candidates. However, these approaches are limited to detecting circulating parasites and do not account for sequestered parasites, which is important for determining total parasite bio-burden. Bio-luminescence imaging, using transgenic parasite that express the firefly luciferase reporter protein, has been used not only to measure parasite growth in vivo and in vitro [<xref ref-type="bibr" rid="CR10">10</xref>], but also to visualize in vivo the parasite sequestration in deep tissues [<xref ref-type="bibr" rid="CR13">13</xref>–<xref ref-type="bibr" rid="CR16">16</xref>].</p>
      <p>Various assays using specific antibodies to parasite antigens have been employed [<xref ref-type="bibr" rid="CR17">17</xref>–<xref ref-type="bibr" rid="CR24">24</xref>]. Immunochromatographic assays, which utilize monoclonal antibodies against specific <italic>Plasmodium</italic> enzymes, are under development. The most promising antigens explored so far include: histidine rich protein-2 (HRP-2) [<xref ref-type="bibr" rid="CR25">25</xref>], parasite-specific lactate dehydrogenase (pLDH) [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR26">26</xref>–<xref ref-type="bibr" rid="CR28">28</xref>], and aldolase [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>]. These enzymes are involved in metabolic pathways essential for the growth and survival of <italic>Plasmodium</italic> parasites [<xref ref-type="bibr" rid="CR29">29</xref>].</p>
      <p>The enzyme pLDH is a soluble, energy-producing enzyme that is involved in the last step of the glycolytic pathway [<xref ref-type="bibr" rid="CR29">29</xref>]. As the red blood cells do not have functional mitochondria and the parasites have minimum oxygen uptake for the citric acid cycle [<xref ref-type="bibr" rid="CR31">31</xref>], it is highly dependent on anaerobic glucose metabolism [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. pLDH is produced by both asexual blood-stage parasites as well as the sexual stages, with a larger quantity of pLDH being produced during the asexual stage [<xref ref-type="bibr" rid="CR29">29</xref>]. pLDH antigen is preferable as a diagnostic marker over other antigens such as HRP-2, which is limited to <italic>Plasmodium falciparum</italic> only [<xref ref-type="bibr" rid="CR34">34</xref>]. Moreover, some <italic>P. falciparum</italic> strains have a deletion in the HRP-2 gene, resulting in false negative tests [<xref ref-type="bibr" rid="CR35">35</xref>]. Unlike HRP-2, pLDH does not persist in the blood [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>] and is cleared immediately post-active infection [<xref ref-type="bibr" rid="CR18">18</xref>–<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR39">39</xref>], thus making pLDH an ideal marker to estimate parasite bio-burden at the time of the assay.</p>
      <p>Previously, monoclonal antibodies specific for pLDH have been used to determine the sensitivity of <italic>Plasmodium berghei</italic> to anti-malarial drugs in vitro [<xref ref-type="bibr" rid="CR40">40</xref>]. A chromogenic pLDH assay has also been employed to enumerate the parasites in the blood of mice challenged with <italic>Plasmodium</italic><italic>yoelii</italic> 17XNL post vaccination with MSP1-19 [<xref ref-type="bibr" rid="CR41">41</xref>]. However, none of these approaches was compared to an established assay to quantify and validate total parasite bio-burden.</p>
      <p>The pLDH amino acid sequence has a 90 % sequence identity amongst all human <italic>Plasmodium</italic> species [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR42">42</xref>]. For human parasites, monoclonal antibodies against the shared common epitopes can be used to detect all species [<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR44">44</xref>]. Genetic conservation and variation of pLDH across different human and rodent species and strains of <italic>Plasmodium</italic> was reported by Talman et al. [<xref ref-type="bibr" rid="CR45">45</xref>]. Nucleotide BLAST analysis using 951 nucleotides of the <italic>P. falciparum</italic> 3D7 (<italic>Pf</italic> LDH) gene coding sequence [Accession ID XM_001349953.1] as the reference revealed the following per cent identity in different species of murine <italic>Plasmodium:</italic> 86 % identity with <italic>P. yoelii</italic> 17XNL [Accession ID XM_719008.1]; 85 % with <italic>Plasmodium chabaudi chabaudi</italic> [Accession ID XM_740087.1]; 85 % with <italic>P. berghei</italic> ANKA [Accession ID XM_674309.1]; and 83 % with <italic>Plasmodium vinckei</italic> [Accession ID XM_008624100.1]. The high degree of sequence similarity could potentially be exploited for use in diagnostics for rodent malaria parasites (Table <xref rid="Tab1" ref-type="table">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>pLDH protein sequence alignment analysis of different species of murine <italic>Plasmodium</italic>
</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="3">pLDH sequence alignment using Clustal Omega</th></tr></thead><tbody><tr><td align="left"/><td align="left">
1
</td><td align="left">
60
</td></tr><tr><td align="left">
<italic>P. falciparum</italic>
3D7
</td><td align="left" colspan="2">
MAPKAKIVLVGSGMIGGVMATLIVQKNLGDVVLFDIVKNMPHGKALDTSHTNVMAYSNCK
</td></tr><tr><td align="left">
<italic>P. vinckei</italic>
</td><td align="left" colspan="2">
M
<bold>PQRP</bold>
KIVLVGSGMIGGVMATLIVQKNLGDVV
<bold>M</bold>
FDIVK
<bold>D</bold>
MPHGKALDTSHTNVMAYSNCK
</td></tr><tr><td align="left">
<italic>P. chabaudi chabaudi</italic>
</td><td align="left" colspan="2">
MAPKAKIVLVGSGMIGGVMATLIVQKNLGDVV
<bold>M</bold>
FDIVK
<bold>D</bold>
MPHGKALDTSHTNVMAYSNC
<bold>Q</bold>
</td></tr><tr><td align="left">
<italic>P. yoelii</italic>
17XNL
</td><td align="left" colspan="2">
MAPKAKIVLVGSGMIGGVMATLIVQKNLGDVVLFDIVKNMPHGKALDTSHTNVMAYSNCK
</td></tr><tr><td align="left">
<italic>P. berghei</italic>
ANKA
</td><td align="left" colspan="2">
MAPKAKIVLVGSGMIGGVMATLIVQKNLGDVV
<bold>M</bold>
FDIVKNMPHGKALDTSHTNVMAYSNCK
</td></tr><tr><td align="left"/><td align="left">
61
</td><td align="left">
120
</td></tr><tr><td align="left">
<italic>P. falciparum</italic>
3D7
</td><td align="left" colspan="2">
VSGSNTYDDLAGADVVIVTAGFTKAPGKSDKEWNRDDLLPLNNKIMIEIGGHIKKNCPNA
</td></tr><tr><td align="left">
<italic>P. vinckei</italic>
</td><td align="left" colspan="2">
V
<bold>T</bold>
GSN
<bold>S</bold>
YDDL
<bold>K</bold>
GADVVIVTAGFTK
<bold>V</bold>
PGKS
<bold>E</bold>
KEWNRDDLLPLNNKIMIEIGGHIKK
<bold>Q</bold>
CPNA
</td></tr><tr><td align="left">
<italic>P. chabaudi chabaudi</italic>
</td><td align="left" colspan="2">
VSGSNTYDDL
<bold>K</bold>
GADVVIVTAGFTKAPGKSDKEWNRDDLLPLNNKIMIEIGGHIKK
<bold>H</bold>
CP
<bold>H</bold>
A
</td></tr><tr><td align="left">
<italic>P. yoelii</italic>
17XNL
</td><td align="left" colspan="2">
VSGSNTYDDL
<bold>KD</bold>
ADVVIVTAGFTKAPGKSDKEWNRDDLLPLNNKIMIEIGGHIK
<bold>N</bold>
NCPNA
</td></tr><tr><td align="left">
<italic>P. berghei</italic>
ANKA
</td><td align="left" colspan="2">
VSGSNTYDDL
<bold>KD</bold>
ADVVIVTAGFTKAPGKSDKEWNRDDLLPLNNKIMIEIGGHIK
<bold>N</bold>
NCPNA
</td></tr><tr><td align="left"/><td align="left">
121
</td><td align="left">
180
</td></tr><tr><td align="left">
<italic>P. falciparum</italic>
3D7
</td><td align="left" colspan="2">
FIIVVTNPVDVMVQLLHQHSGVPKNKIIGLGGVLDTSRLKYYISQKLNVCPRDVNAHIVG
</td></tr><tr><td align="left">
<italic>P. vinckei</italic>
</td><td align="left" colspan="2">
FIIVVTNPVDVMVQLLHQHSGVPKNKI
<bold>V</bold>
GLGGVLD
<bold>S</bold>
SR
<bold>F</bold>
KYYI
<bold>AE</bold>
KLNVCPRDVNAHIVG
</td></tr><tr><td align="left">
<italic>P. chabaudi chabaudi</italic>
</td><td align="left" colspan="2">
FIIVVTNPVDVMVQLLHQHSGVPKNKI
<bold>V</bold>
GLGGVLDTSRLKYYISQKLNVCPRDVNAHIVG
</td></tr><tr><td align="left">
<italic>P. yoelii</italic>
17XNL
</td><td align="left" colspan="2">
FIIVVTNPVDVMVQLLHQHSGVPKNKI
<bold>V</bold>
GLGGVLDTSRLKYYISQKLNVCPRDVNAHIVG
</td></tr><tr><td align="left">
<italic>P. berghei</italic>
ANKA
</td><td align="left" colspan="2">
FIIVVTNPVDVMVQLLHQHSGVPKNKI
<bold>V</bold>
GLGGVLDTSRLKYYISQKLNVCPRDVNAHIVG
</td></tr><tr><td align="left"/><td align="left">
181
</td><td align="left">
240
</td></tr><tr><td align="left">
<italic>P. falciparum</italic>
3D7
</td><td align="left" colspan="2">
AHGNKMVLLKRYITVGGIPLQEFINNKLISDAELEAIFDRTVNTALEIVNLHASPYVAPA
</td></tr><tr><td align="left">
<italic>P. vinckei</italic>
</td><td align="left" colspan="2">
AHGNKMVLLKRYITVGGIPLQEFINN
<bold>NK</bold>
I
<bold>TED</bold>
EL
<bold>K</bold>
A
<bold>MA</bold>
DRT
<bold>I</bold>
NTALEIVNLHASPYVAPA
</td></tr><tr><td align="left">
<italic>P. chabaudi chabaudi</italic>
</td><td align="left" colspan="2">
AHGNKMVLLKRYITVGGIP
<bold>I</bold>
QEFINNK
<bold>K</bold>
ISD
<bold>QD</bold>
LEAIFDRT
<bold>I</bold>
NTALEIVNLHASPYVAPA
</td></tr><tr><td align="left">
<italic>P. yoelii</italic>
17XNL
</td><td align="left" colspan="2">
AHGNKMVLLKRYITVGGIPLQEFINNK
<bold>K</bold>
I
<bold>T</bold>
D
<bold>Q</bold>
EL
<bold>D</bold>
AIFDRTVNTALEIVNLHASPYVAPA
</td></tr><tr><td align="left">
<italic>P. berghei</italic>
ANKA
</td><td align="left" colspan="2">
AHGNKMVLLKRYITVGGIPLQEFINNK
<bold>K</bold>
I
<bold>T</bold>
D
<bold>Q</bold>
EL
<bold>D</bold>
AIFDRT
<bold>I</bold>
NTALEIVNLHASPYVAPA
</td></tr><tr><td align="left"/><td align="left">
241
</td><td align="left">
300
</td></tr><tr><td align="left">
<italic>P. falciparum</italic>
3D7
</td><td align="left" colspan="2">
AAIIEMAESYLKDLKKVLICSTLLEGQYGHSDIFGGTPVVLGANGVEQVIELQLNSEEKA
</td></tr><tr><td align="left">
<italic>P. vinckei</italic>
</td><td align="left" colspan="2">
AAIIEMAESYLKDL
<bold>R</bold>
KVLICSTLLEG
<bold>E</bold>
YGH
<bold>K</bold>
DIF
<bold>A</bold>
GTP
<bold>L</bold>
V
<bold>I</bold>
G
<bold>G</bold>
NGVEQVIELQLN
<bold>ET</bold>
EK
<bold>M</bold>
</td></tr><tr><td align="left">
<italic>P. chabaudi chabaudi</italic>
</td><td align="left" colspan="2">
AAIIEMAESY
<bold>IR</bold>
DL
<bold>R</bold>
KVLICSTLLEGQYGH
<bold>K</bold>
DIF
<bold>A</bold>
GTP
<bold>L</bold>
V
<bold>I</bold>
G
<bold>G</bold>
NGVEQVIELQLN
<bold>AD</bold>
EK
<bold>K</bold>
</td></tr><tr><td align="left">
<italic>P. yoelii</italic>
17XNL
</td><td align="left" colspan="2">
AAIIEMAESY
<bold>IR</bold>
DL
<bold>R</bold>
KVLICSTLLEGQYGH
<bold>K</bold>
DIF
<bold>A</bold>
GTP
<bold>L</bold>
V
<bold>I</bold>
G
<bold>G</bold>
NGVEQVIELQLN
<bold>AD</bold>
EK
<bold>K</bold>
</td></tr><tr><td align="left">
<italic>P. berghei</italic>
ANKA
</td><td align="left" colspan="2">
AAIIEMAESY
<bold>IR</bold>
DL
<bold>R</bold>
KVLICSTLLEGQYGH
<bold>K</bold>
DIF
<bold>A</bold>
GTP
<bold>L</bold>
V
<bold>I</bold>
G
<bold>G</bold>
NGVEQVIELQLN
<bold>AD</bold>
EK
<bold>K</bold>
</td></tr><tr><td align="left"/><td align="left">
301
</td><td align="left">316</td></tr><tr><td align="left">
<italic>P. falciparum</italic>
3D7
</td><td align="left">
KFDEAIAETKRMKALA
</td><td align="left"/></tr><tr><td align="left">
<italic>P. vinckei</italic>
</td><td align="left">
<bold>H</bold>
FD
<bold>N</bold>
A
<bold>V</bold>
AET
<bold>A</bold>
RMKAL
<bold>I</bold>
</td><td align="left"/></tr><tr><td align="left">
<italic>P. chabaudi chabaudi</italic>
</td><td align="left">
KFDEA
<bold>V</bold>
AET
<bold>S</bold>
RMKAL
<bold>V</bold>
</td><td align="left"/></tr><tr><td align="left">
<italic>P. yoelii</italic>
17XNL
</td><td align="left">
KFDEA
<bold>V</bold>
AET
<bold>S</bold>
RMKAL
<bold>I</bold>
</td><td align="left"/></tr><tr><td align="left">
<italic>P. berghei</italic>
ANKA
</td><td align="left">
KFDEA
<bold>V</bold>
AET
<bold>S</bold>
RMKAL
<bold>I</bold>
</td><td align="left"/></tr></tbody></table><table-wrap-foot><p>
<italic>P. falciparum</italic> 3D7 (<italic>Pf</italic> LDH) [Accession ID XM_001349953.1] is the reference sequence. The bold letters indicate the dissimilarities in the amino acid sequences as compared to the pLDH amino acid sequence of <italic>P. falciparum</italic>. <italic>Plasmodium vinckei</italic> LDH [Accession ID XM_008624100.1]; <italic>P. chabaudi chabaudi</italic> LDH [Accession ID XM_740087.1]; <italic>P. yoelii</italic> 17XNL [Accession ID XM_719008.1]; <italic>P. berghei</italic> ANKA LDH [Accession ID XM_674309.1]</p></table-wrap-foot></table-wrap></p>
      <p>This study investigated the use of a commercial human <italic>Plasmodium</italic> pLDH ELISA diagnostic kit for detecting pLDH antigen as a measure of parasite bio-burden during murine malaria infections. This assay could be established as an alternative approach to measure parasite bio-burden in efficacy studies.</p>
    </sec>
    <sec id="Sec2" sec-type="materials|methods">
      <title>Methods</title>
      <sec id="Sec3">
        <title>Mice and ethics statement</title>
        <p>Female BALB/c mice aged 4–6 weeks were purchased from the Animal Resource Centre (ARC) (Canning Vale, Perth, Australia) and maintained under appropriate ARC and Griffith University conditions. This study was carried out in strict accordance with the National Health and Medical Research Council of Australia guidelines, as detailed in the document, <italic>Australian Code of Practice for the Care and Use of Animals for Scientific Purposes</italic>, <italic>8th ed</italic> [<xref ref-type="bibr" rid="CR46">46</xref>]. The Griffith University Animal Ethics Committee (GLY/05/12/AEC) and the QIMR Berghofer Medical Research Institute Ethics Committee (A02633M) approved the relevant animal procedures and protocols.</p>
      </sec>
      <sec id="Sec4">
        <title>Parasites and infections</title>
        <p>Cloned lines of <italic>P. chabaudi AS</italic>, <italic>P. yoelii 17XNL</italic>, <italic>P. yoelii YM</italic>, <italic>P. berghei</italic> and <italic>P. vinckei</italic> were used (provided by Richard Carter, University of Edinburgh, UK). Stabilates were maintained by intra-venous (IV) and intra-peritoneal (IP) passaging of 10<sup>6</sup> parasitized red blood cells (pRBC) into naïve BALB/c mice. <italic>Plasmodium berghei</italic> ANKA luc lines (provided by Chris Janse, Leiden University Medical Centre, The Netherlands) were used in the bio-luminescent experiments for in vivo imaging after one in vivo passage in mice.</p>
      </sec>
      <sec id="Sec5">
        <title>Evaluation of parasitaemia by microscopy</title>
        <p>Thin blood smears were prepared, air dried, fixed in methanol and stained with Giemsa. Slides were examined using bright field microscopy and counts were performed with 100× magnification. For negative or low parasitaemia films (&lt;1 %), at least 20 fields on the slide were counted. For high parasitaemia, at least 500 RBCs were counted. Percent parasitaemia was calculated as the number of pRBCs multiplied by 100 divided by the number of total RBCs.</p>
      </sec>
      <sec id="Sec6">
        <title>Assessment of pLDH antigen production in murine malaria models</title>
        <p>Qualitative and quantitative levels of pLDH antigens in BALB/c mice infected with <italic>P. chabaudi</italic> AS, <italic>P. yoelii</italic> 17XNL, <italic>P. yoelii</italic> YM, <italic>P. berghei</italic> ANKA, and <italic>P. vinckei</italic> were determined using the pLDH SD Malaria Antigen ELISA kit (Standard Diagnostics), a sandwich ELISA for the qualitative detection of human <italic>Plasmodium</italic> pLDH. For quantitative assessment, blood was collected on the following days for each of the rodent malaria parasites: <italic>P. chabaudi</italic> AS: Day 7 (29 %), <italic>P. berghei</italic> ANKA: Day 4 (34 %), <italic>P. vinckei</italic>: Day 4 (32 %), and <italic>P. yoelii</italic> YM: Day 5 (24 %). Recombinant pLDH supplied as the positive control in the kit was used to generate a standard curve dilution series with a starting concentration of 1320 ng/mL in PBS or naïve mouse blood. Fifty microlitres of the samples (negative and positive control, standard curve and test samples) were tested in triplicate and the manufacturer’s instructions were followed. Plates were read on an xMark microplate spectrophotometer (Biorad) at 450 nm, with a reference wavelength of 620 nm. The reading was completed within 30 min of the stop solution being added. The linear range was then logarithmically plotted to generate a linear equation to quantify levels of pLDH units in test samples. Positive wells were used to measure the concentration of pLDH unit, with the cut-off for positivity calculated as the mean + three standard deviations of the wells containing naïve mouse blood or PBS alone. The mean optical densities (ODs) were calculated for standards and used to plot a standard curve OD vs ng/mL recombinant pLDH antigen. The concentration of pLDH units in the samples was calculated from the optical density reading from the linear range of the standard curve (as in Fig. <xref rid="Fig2" ref-type="fig">2</xref>) such that 1 unit/mL in the test sample was equivalent to 1 ng/mL.</p>
      </sec>
      <sec id="Sec7">
        <title>Visualization and quantification of luciferase activity in mice infected with <italic>Plasmodium berghei</italic> ANKA luciferase</title>
        <p>Luciferase activity in <italic>P. berghei</italic> ANKA luc infected mice was visualized using an intensified-charge-coupled device (I-CCD) video camera of the in vivo Imaging System (IVIS 100, Xenogen) [<xref ref-type="bibr" rid="CR8">8</xref>]. Mice were anaesthetized using the isofluorane anaesthesia system (XGI-8, Xenogen). Following this, mice were injected IP with <sc>d</sc>-luciferin dissolved in PBS (100 mg/kg of body weight; Synchem, Kassel, Germany) and measurements were performed within 5 min of injection. Bio-luminescence imaging was acquired with an exposure time of 60 s. Imaging data were analysed using the living image (Xenogen) program. In asynchronous infections, measurements were performed on different days at the same time.</p>
      </sec>
      <sec id="Sec8">
        <title>Statistical analysis</title>
        <p>Graphical and statistical analysis was performed using GraphPad Prism 6. All the datasets are presented as mean ± SE, unless stated otherwise. Non-linear standard curves were generated and the linear part of the curve was used for re-plotting three or more points in logarithmic scale. Logarithmic and arithmetic curves were both used for fitting a trend-line and obtaining an equation, which was used to calculate the concentration of pLDH units from the mean absorbance, for each test sample as described above. The limit of detection (LOD) was calculated as the lowest value in the dilution series that was significantly different from the negative control values. An ANOVA was performed to estimate the LOD. One-way ANOVA was used for the analyses presented in Figs. <xref rid="Fig1" ref-type="fig">1</xref>a and <xref rid="Fig2" ref-type="fig">2</xref>a, b. Correlation analyses between concentration of pLDH units, parasitaemia and log average radiance were determined using Pearson’s correlation analysis. A Pearson <italic>r</italic> value greater than 0.6 was considered as a strong correlation and shown in the appropriate figures. <italic>P</italic> values less than 0.05 were deemed significant for all statistical analyses.<fig id="Fig1"><label>Fig. 1</label><caption><p>
<bold>a</bold> Qualitative detection of pLDH units in different blood components (undiluted) from a mouse infected with <italic>Plasmodium chabaudi AS. Individual bars</italic> represent negative and positive control from the kit, whole blood obtained from a naïve or <italic>P. chabaudi</italic> AS-infected BALB/c mouse, serum obtained from a naïve or <italic>P. chabaudi</italic> AS-infected BALB/c mouse or whole blood obtained from a <italic>P. chabaudi</italic> AS-infected mouse which had been drug treated. <bold>b</bold> Representation of a non-linear standard curve to quantify pLDH units (ng/mL). Recombinant pLDH from the kit was serially diluted in both PBS and blood and plotted as log 10 concentration of recombinant pLDH vs the OD. The <italic>dotted line</italic> shows the linear range of the curve. Each sample was tested in triplicate. <italic>Error bars</italic> represent the mean ± SE of experimental replicates. ****P value &lt;0.0001, ns not significant. One-way ANOVA was used to determine the statistical significance between groups</p></caption><graphic xlink:href="12936_2015_1027_Fig1_HTML" id="MO1"/></fig><fig id="Fig2"><label>Fig. 2</label><caption><p>
<bold>a</bold> Quantitative detection of pLDH units in whole blood of BALB/c mice infected with different murine <italic>Plasmodium</italic> species and <bold>b</bold> the mean concentration of pLDH units in different components of blood from BALB/c mice infected with <italic>Plasmodium</italic>
<italic>chabaudi</italic> AS (29.7 %) and <italic>Plasmodium</italic>
<italic>yoelii</italic> 17XNL (25 %). <italic>Percentages</italic> indicate the parasitaemia of the mice as determined by microscopy. Each sample was tested in triplicate. <italic>Error bars</italic> represent mean ± SE of experimental replicates. ****P value &lt;0.0001, **P value &lt;0.01, *P value &lt;0.1, ns not significant. One-way ANOVA was used to determine the statistically significant difference between groups</p></caption><graphic xlink:href="12936_2015_1027_Fig2_HTML" id="MO2"/></fig></p>
      </sec>
    </sec>
    <sec id="Sec9" sec-type="results">
      <title>Results</title>
      <sec id="Sec10">
        <title>Qualitative detection of pLDH in different blood components in mice infected with <italic>Plasmodium chabaudi</italic> AS</title>
        <p>Due to the sequence similarity between the mouse and human <italic>Plasmodium</italic> LDH genes [<xref ref-type="bibr" rid="CR45">45</xref>], this study utilized the human <italic>Plasmodium</italic> pLDH ELISA kit to assess its ability to detect murine <italic>Plasmodium</italic> pLDH. In a pilot study, pLDH was detected in both whole blood and serum obtained from a <italic>P</italic>. <italic>chabaudi</italic> AS infected mouse on day 7 post infection at 31 % parasitaemia (<italic>P</italic> value &lt;0.0001) (Fig. <xref rid="Fig1" ref-type="fig">1</xref>a). Whole blood and serum from both the naïve mouse and a mouse infected with <italic>P. chabaudi</italic> AS and drug cured (100 µL of malarone orally for 5 days), did not have significant detectable pLDH units (Fig. <xref rid="Fig1" ref-type="fig">1</xref>a).</p>
      </sec>
      <sec id="Sec11">
        <title>Generation of standard curves using recombinant pLDH</title>
        <p>Standard curves were generated for quantitative assessment of pLDH units in infected mice. Using the positive control (rec pLDH) from the commercial ELISA kit, serial dilutions were performed in both PBS and naïve mouse blood to establish standard curves. A representative standard curve from which the linear range was derived is shown in Fig. <xref rid="Fig1" ref-type="fig">1</xref>b. The linear range was approximately between 1.18 and 52.8 ng/mL.</p>
      </sec>
      <sec id="Sec12">
        <title>Quantification of pLDH units in different species of murine <italic>Plasmodium</italic></title>
        <p>It was next established if this assay could be used to quantify pLDH units in the whole blood from mice infected with each of the four species of murine malaria. pLDH was detectable in whole blood obtained from mice infected with each of the rodent <italic>Plasmodium</italic> species (Fig. <xref rid="Fig2" ref-type="fig">2</xref>a). Despite a similar parasitaemia (24–34 %), pLDH units were significantly lower in mice infected with <italic>P. vinckei</italic> compared to the mice infected with <italic>P. chabaudi</italic> AS, <italic>P. berghei</italic> ANKA and <italic>P. yoelii</italic> YM.</p>
      </sec>
      <sec id="Sec13">
        <title>Quantification of pLDH units in different parasitized blood components</title>
        <p>It was then asked whether pLDH was limited to the red blood cell compartment or present both in the serum and pRBC. Blood samples obtained from mice infected with <italic>P</italic>. <italic>chabaudi</italic> AS and <italic>P</italic>. <italic>yoelii</italic> YM were separated into their components and the levels of pLDH units were determined in whole blood, serum and washed RBCs. Washed RBCs were prepared by washing whole blood thrice with PBS by centrifugation at 1500 rpm for 10 min. pLDH was detected in all three sample types, with whole blood showing higher levels of pLDH units compared to the serum and washed red blood cells (Fig. <xref rid="Fig2" ref-type="fig">2</xref>b).</p>
      </sec>
      <sec id="Sec14">
        <title>Sensitivity of the pLDH assay in mice infected with <italic>Plasmodium</italic><italic>chabaudi</italic> AS and <italic>Plasmodium berghei</italic> ANKA</title>
        <p><italic>Plasmodium chabaudi</italic> AS and <italic>P. berghei</italic> ANKA were selected for further studies. The limit of detection (LODs) were established by serially diluting whole parasitized blood in naïve mouse blood. The LOD was approximately 0.7 % parasitaemia for <italic>P. chabaudi</italic> AS and 0.05 % for <italic>P. berghei</italic> ANKA (Fig. <xref rid="Fig3" ref-type="fig">3</xref>).<fig id="Fig3"><label>Fig. 3</label><caption><p>Limit of detection (LOD) of pLDH in BALB/c mice infected with <bold>a</bold>
<italic>Plasmodium</italic>
<italic>chabaudi</italic> AS (24 % parasitaemia) and <bold>b</bold>
<italic>Plasmodium</italic>
<italic>berghei</italic> ANKA (34 % parasitaemia). For this assay, infected whole blood was serially diluted in naïve mouse blood. ANOVA was used to estimate LOD. Each sample was tested in triplicate. <italic>Error bars</italic> represent mean ± SE of experimental replicates. The <italic>dotted line</italic> shows the limit of detection</p></caption><graphic xlink:href="12936_2015_1027_Fig3_HTML" id="MO3"/></fig></p>
      </sec>
      <sec id="Sec15">
        <title>Relationship between pLDH antigen levels and parasitaemia</title>
        <p>The correlation between levels of pLDH units and peripheral blood parasitaemias during the course of infection was then assessed. Blood was obtained from mice every day post onset of patent parasitaemia. To ensure that the <italic>P. chabaudi</italic>-infected mice were not anaemic and to allow collection of a suitable volume of blood, a large group of mice (n = 20) were infected and divided into two cohorts. Blood from each cohort was collected on alternate days. A strong correlation (<italic>r</italic> = 0.9889) was observed (Fig. <xref rid="Fig4" ref-type="fig">4</xref>).<fig id="Fig4"><label>Fig. 4</label><caption><p>Correlation between the concentration of pLDH units and peripheral blood parasitaemia of BALB/c mice (n = 20) infected with <italic>Plasmodium</italic>
<italic>chabaudi</italic> AS. <bold>a</bold> Mean parasitaemia in <italic>P. chabaudi</italic> AS infected mice. <bold>b</bold> Mean concentration of pLDH units in whole blood obtained from <italic>P. chabaudi</italic> AS infected mice. <bold>c</bold> Correlation between the mean concentration of pLDH and peripheral blood parasitaemia (<italic>r</italic> = 0.9889). <italic>Plus</italic>
<italic>symbol</italic> indicates that the mice were culled. <italic>Error bars</italic> represent mean ± SE of biological replicates</p></caption><graphic xlink:href="12936_2015_1027_Fig4_HTML" id="MO4"/></fig></p>
      </sec>
      <sec id="Sec16">
        <title>Relationship between pLDH units and total parasite bio-burden in mice infected with <italic>Plasmodium berghei</italic> ANKA luciferase</title>
        <p>To evaluate the assay as a measure of total parasite bio-burden, BALB/c mice (n = 16) were infected with <italic>P</italic>. <italic>berghei</italic> ANKA luciferase and parasitized whole blood was collected every alternate day from eight mice post visualization under the bio-illuminator (see “<xref rid="Sec2" ref-type="sec">Methods</xref>”) (Fig. <xref rid="Fig5" ref-type="fig">5</xref>). Total radiance (Fig. <xref rid="Fig6" ref-type="fig">6</xref>a) was determined for each mouse throughout the infection. The concentration of pLDH units and parasitaemia were also determined (Fig. <xref rid="Fig6" ref-type="fig">6</xref>b, c). No correlation (<italic>r</italic> = 0.2445) was observed between parasitaemia and pLDH units (Fig. <xref rid="Fig6" ref-type="fig">6</xref>d). However, a strong correlation (<italic>r</italic> = 0.6922) was observed between the levels of pLDH units and log average radiance (Fig. <xref rid="Fig6" ref-type="fig">6</xref>e).<fig id="Fig5"><label>Fig. 5</label><caption><p>Visualization of luciferase-expressing <italic>Plasmodium</italic>
<italic>berghei</italic> ANKA parasites in representative BALB/c mice. The distribution of parasites was visualized by measuring luciferase activity in animals by using an I-CCD video camera. <italic>Rainbow images</italic> show the relative level of luciferase activity ranging from low (<italic>blue</italic>), to medium (<italic>green</italic>), to high (<italic>yellow</italic>, <italic>red</italic>). The scale of total photon counts can be different between separate illustrations. The <italic>white arrows</italic> indicate a naïve mouse</p></caption><graphic xlink:href="12936_2015_1027_Fig5_HTML" id="MO5"/></fig><fig id="Fig6"><label>Fig. 6</label><caption><p>Relationship between pLDH units and total parasite bio-burden in mice (n = 16) infected with <italic>Plasmodium</italic>
<italic>berghei</italic> ANKA luciferase. <bold>a</bold> Bio-luminescence measured as average radiance [p/s/cmA2/sr] plotted on a logarithmic scale <italic>vs</italic> days post infection. <bold>b</bold> Mean concentration of pLDH units in whole blood obtained from infected mice days post infection. <bold>c</bold> Mean peripheral blood parasitaemia curves in infected mice as determined by microscopy. <bold>d</bold> Correlation between the pLDH units and mean parasitaemia, showing the coefficient correlation (<italic>r</italic> = 0.2445). <bold>e</bold> Correlation between the pLDH units and log average radiance, showing the coefficient correlation (<italic>r</italic> = 0.6992). <italic>Error bars</italic> represent mean ± SE of biological replicates. At day 1, the OD values for the infected mice were less than the control (naïve mouse blood)</p></caption><graphic xlink:href="12936_2015_1027_Fig6_HTML" id="MO6"/></fig></p>
      </sec>
    </sec>
    <sec id="Sec17" sec-type="discussion">
      <title>Discussion</title>
      <p>Current methods for the quantification of parasite levels in blood include microscopy, qPCR and flow cytometry, which are limited to detecting circulating parasites. These assays can be expensive and are unable to quantify total parasite bio-burden. Sequestration of parasites in the cerebral regions, placenta and bone marrow leads to an underestimation of total parasite bio-burden when using these assays [<xref ref-type="bibr" rid="CR47">47</xref>–<xref ref-type="bibr" rid="CR49">49</xref>]. This study demonstrated that pLDH units correlate with total parasite bio-burden in murine malaria models. A human <italic>Plasmodium</italic> antibody-based assay was used to quantify levels of pLDH in mice infected with different murine <italic>Plasmodium</italic>, including species that sequester in peripheral tissues or spleen, and established this assay as a measure of total parasite bio-burden.</p>
      <p>This study investigated the use of a commercial human malaria ELISA kit to detect levels of pLDH units in the blood and serum of infected mice. Some differences are observed between <italic>P.</italic><italic>falciparum</italic> and rodent malaria LDH sequences (see above); therefore, pLDH ‘units’ rather than amount of pLDH per se has been referred to when assessing rodent parasites, with one unit being defined as the OD equivalent of 1 ng of <italic>Pf</italic> LDH. pLDH units were detected at lower levels in <italic>P. vinckei</italic>-infected blood compared to mice infected with other parasites. The assay was more sensitive for <italic>P. berghei</italic> ANKA, which could be due to less sequence variation in the region of the antibody-binding site compared to other parasites. However, as the binding site of the antibody is currently unknown, this could not be confirmed.</p>
      <p>This study compared the levels of pLDH units to an established bio-burden assay with luciferase transgenic parasites [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR13">13</xref>] to establish an economical, high throughput in vivo parasite bio-burden assay that is not reliant on the use of luminescent parasites or expensive equipment. A strong correlation was observed between the bio-luminescence and pLDH assays. It was of interest that a strong correlation between <italic>P. berghei</italic> peripheral parasitaemia and pLDH levels was not detected, which may be due to the presence of sequestered parasites as shown in the bio-luminescent images (Fig. <xref rid="Fig5" ref-type="fig">5</xref>). The strong correlation that was observed between <italic>P. chabaudi</italic> peripheral parasitaemia and pLDH levels (Fig. <xref rid="Fig4" ref-type="fig">4</xref>c) likely reflects the fact that this parasite is highly synchronous and blood samples were taken in the morning when the parasites are at the ring stage and in the periphery.</p>
    </sec>
    <sec id="Sec18" sec-type="conclusion">
      <title>Conclusions</title>
      <p>This study demonstrates the use of an established human malaria pLDH kit for detecting murine malaria parasite bio-burden. pLDH was detected in four strains of murine <italic>Plasmodium</italic>. This assay permitted the estimation of pLDH in different components of infected blood, thus, accounting for both circulating and sequestered parasites. This is confirmed by the strong correlation between the bio-luminescence and pLDH units during the initial parasite growth. Therefore, this assay provides an accurate assessment of parasite bio-burden in rodent malaria species. Furthermore, these results suggest that the pLDH assay can provide a valid estimate of total parasite bio-burden in malaria-infected patients.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Authors’ contributions</title>
      <p>All authors contributed to the design of this study and/or participated in experimental work, collection and analysis of data and/or the interpretation of the results, and to the writing of the manuscript. All authors edited the final version of the manuscript. All authors read and approved the final manuscript.</p>
      <sec id="FPar1">
        <title>Acknowledgements</title>
        <p>This work was supported and funded by Griffith University and National Health and Medical Research Council (NHMRC, Australia). We thank Dr. Stephanie Yanow for reviewing the manuscript.</p>
      </sec>
      <sec id="FPar2">
        <title>Competing interests</title>
        <p>The authors declare that they have no competing interests.</p>
      </sec>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <mixed-citation publication-type="other">WHO. World malaria report 2014. Geneva: World Health Organization; 2014, p. 242.</mixed-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <mixed-citation publication-type="other">Baird JK, Owusu Agyei S, Utz GC, Koram K, Barcus MJ, Jones TR, et al. Seasonal malaria attack rates in infants and young children in northern Ghana. Am J Trop Med Hyg. 2002;66:280–6.</mixed-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Giemsa</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Werner</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Erfahrungen mit weiteren dem Chinin nahestehenden Alkaloiden und einigen ihrer Derivate bei Malaria (Chinidin, Hydrochinidin, Cinchonin, Hydrocinchonin, Cuprein, ChinSthylin und Chinpropylin)</article-title>
          <source>Archiv für Schiffs- und Tropenhygiene</source>
          <year>1914</year>
          <volume>18</volume>
          <fpage>12</fpage>
          <lpage>15</lpage>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fleischer</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Editorial: 100 years ago: Giemsa’s solution for staining of <italic>Plasmodia</italic></article-title>
          <source>Trop Med Int Health</source>
          <year>2004</year>
          <volume>9</volume>
          <fpage>755</fpage>
          <lpage>756</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-3156.2004.01278.x</pub-id>
          <?supplied-pmid 15228484?>
          <pub-id pub-id-type="pmid">15228484</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jarra</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Snounou</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Only viable parasites are detected by PCR following clearance of rodent malarial infections by drug treatment or immune responses</article-title>
          <source>Infect Immun</source>
          <year>1998</year>
          <volume>68</volume>
          <fpage>3783</fpage>
          <lpage>3787</lpage>
          <pub-id pub-id-type="pmid">9673262</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grimberg</surname>
              <given-names>BT</given-names>
            </name>
          </person-group>
          <article-title>Methodology and application of flow cytometry for investigation of human malaria parasites</article-title>
          <source>J Immunol Meth</source>
          <year>2011</year>
          <volume>361</volume>
          <fpage>1</fpage>
          <lpage>16</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jim.2011.01.015</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shapiro</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Apte</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Chojnowski</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Hanscheid</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Rebelo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Grimberg</surname>
              <given-names>BT</given-names>
            </name>
          </person-group>
          <article-title>Cytometry in malaria—a practical replacement for microscopy?</article-title>
          <source>Curr Protoc in Cytom</source>
          <year>2013</year>
          <volume>65</volume>
          <fpage>11.20.11</fpage>
          <lpage>11.20.23</lpage>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Franke-Fayard</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Trueman</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ramesar</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Mendoza</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>van der Keur</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>van der Linden</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A <italic>Plasmodium berghei</italic> reference line that constitutively expresses GFP at a high level throughout the complete life cycle</article-title>
          <source>Mol Biochem Parasitol</source>
          <year>2004</year>
          <volume>137</volume>
          <fpage>23</fpage>
          <lpage>33</lpage>
          <pub-id pub-id-type="doi">10.1016/j.molbiopara.2004.04.007</pub-id>
          <?supplied-pmid 15279948?>
          <pub-id pub-id-type="pmid">15279948</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Janse</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Franke-Fayard</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Mair</surname>
              <given-names>GR</given-names>
            </name>
            <name>
              <surname>Ramesar</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Thiel</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Engelmann</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>High efficiency transfection of <italic>Plasmodium berghei</italic> facilitates novel selection procedures</article-title>
          <source>Mol Biochem Parasitol</source>
          <year>2006</year>
          <volume>145</volume>
          <fpage>60</fpage>
          <lpage>70</lpage>
          <pub-id pub-id-type="doi">10.1016/j.molbiopara.2005.09.007</pub-id>
          <?supplied-pmid 16242190?>
          <pub-id pub-id-type="pmid">16242190</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Franke-Fayard</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Djokovic</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Dooren</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ramesar</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Waters</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Falade</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Simple and sensitive antimalarial drug screening in vitro and in vivo using transgenic luciferase expressing <italic>Plasmodium berghei</italic> parasites</article-title>
          <source>Int J Parasitol</source>
          <year>2008</year>
          <volume>38</volume>
          <fpage>1651</fpage>
          <lpage>1662</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ijpara.2008.05.012</pub-id>
          <?supplied-pmid 18590736?>
          <pub-id pub-id-type="pmid">18590736</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <mixed-citation publication-type="other">Pappas M. Chromium labelling of erythrocytes and their application in clearance and sequestration during malaria. In: Hayunga E, Stek MJ, editors. Nuclear and related techniques in parasitology. Vienna: International Atomic Energy Agency (IAEA); 1986, p. 89.</mixed-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Malleret</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Claser</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ong</surname>
              <given-names>ASM</given-names>
            </name>
            <name>
              <surname>Suwanarusk</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sriprawat</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Howland</surname>
              <given-names>SW</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A rapid and robust tri-color flow cytometry assay for monitoring malaria parasite development</article-title>
          <source>Sci Rep</source>
          <year>2011</year>
          <volume>1</volume>
          <fpage>118</fpage>
          <pub-id pub-id-type="doi">10.1038/srep00118</pub-id>
          <?supplied-pmid 22355635?>
          <pub-id pub-id-type="pmid">22355635</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Franke-Fayard</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Janse</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Cunha-Rodrigues</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ramesar</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Büscher</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Que</surname>
              <given-names>I</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Murine malaria parasite sequestration: CD36 is the major receptor, but cerebral pathology is unlinked to sequestration</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>2005</year>
          <volume>102</volume>
          <fpage>11468</fpage>
          <lpage>11473</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.0503386102</pub-id>
          <?supplied-pmid 16051702?>
          <pub-id pub-id-type="pmid">16051702</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Franke-Fayard</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Waters</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Janse</surname>
              <given-names>CJ</given-names>
            </name>
          </person-group>
          <article-title>Real-time in vivo imaging of transgenic bioluminescent blood stages of rodent malaria parasites in mice</article-title>
          <source>Nat Protoc</source>
          <year>2006</year>
          <volume>1</volume>
          <fpage>476</fpage>
          <lpage>485</lpage>
          <pub-id pub-id-type="doi">10.1038/nprot.2006.69</pub-id>
          <?supplied-pmid 17406270?>
          <pub-id pub-id-type="pmid">17406270</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fonager</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Pasini</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Braks</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Klop</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Ramesar</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Remarque</surname>
              <given-names>EJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Reduced CD36-dependent tissue sequestration of Plasmodium-infected erythrocytes is detrimental to malaria parasite growth in vivo</article-title>
          <source>J Exp Med</source>
          <year>2012</year>
          <volume>209</volume>
          <fpage>93</fpage>
          <lpage>107</lpage>
          <pub-id pub-id-type="doi">10.1084/jem.20110762</pub-id>
          <?supplied-pmid 22184632?>
          <pub-id pub-id-type="pmid">22184632</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Claser</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Malleret</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Gun</surname>
              <given-names>SY</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>AY</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>ZW</given-names>
            </name>
            <name>
              <surname>Teo</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>CD8+ T cells and IFN-gamma mediate the time-dependent accumulation of infected red blood cells in deep organs during experimental cerebral malaria</article-title>
          <source>PLoS One</source>
          <year>2011</year>
          <volume>6</volume>
          <fpage>e18720</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0018720</pub-id>
          <?supplied-pmid 21494565?>
          <pub-id pub-id-type="pmid">21494565</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Piper</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Vanderjagt</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Holbrook</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Makler</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Malaria lactate dehydrogenase: target for diagnosis and drug development</article-title>
          <source>Ann Trop Med Parasitol</source>
          <year>1996</year>
          <volume>90</volume>
          <fpage>433</fpage>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oduola</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Omitowoju</surname>
              <given-names>GO</given-names>
            </name>
            <name>
              <surname>Sowunmi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Makler</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Falade</surname>
              <given-names>CO</given-names>
            </name>
            <name>
              <surname>Kyle</surname>
              <given-names>DE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title><italic>Plasmodium falciparum</italic>: evaluation of lactate dehydrogenase in monitoring therapeutic responses to standard antimalarial drugs in Nigeria</article-title>
          <source>Exp Parasitol</source>
          <year>1997</year>
          <volume>87</volume>
          <fpage>283</fpage>
          <lpage>289</lpage>
          <pub-id pub-id-type="doi">10.1006/expr.1997.4251</pub-id>
          <?supplied-pmid 9371095?>
          <pub-id pub-id-type="pmid">9371095</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Palmer</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Lindo</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Klaskala</surname>
              <given-names>WI</given-names>
            </name>
            <name>
              <surname>Quesada</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Kaminsky</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Baum</surname>
              <given-names>MK</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Evaluation of the OptiMAL test for rapid diagnosis of <italic>Plasmodium vivax</italic> and <italic>Plasmodium falciparum</italic> malaria</article-title>
          <source>J Clin Microbiol</source>
          <year>1998</year>
          <volume>36</volume>
          <fpage>203</fpage>
          <lpage>206</lpage>
          <?supplied-pmid 9431947?>
          <pub-id pub-id-type="pmid">9431947</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Makler</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Piper</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Milhous</surname>
              <given-names>WK</given-names>
            </name>
          </person-group>
          <article-title>Lactate dehydrogenase and the diagnosis of malaria</article-title>
          <source>Parasitol Today</source>
          <year>1998</year>
          <volume>14</volume>
          <fpage>376</fpage>
          <lpage>377</lpage>
          <pub-id pub-id-type="doi">10.1016/S0169-4758(98)01284-8</pub-id>
          <?supplied-pmid 17040820?>
          <pub-id pub-id-type="pmid">17040820</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cooke</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Chiodini</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Doherty</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Moody</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ries</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Pinder</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Comparison of a parasite lactate dehydrogenase-based immunochromatographic antigen detection assay (OptiMAL) with microscopy for the detection of malaria parasites in human blood samples</article-title>
          <source>Am J Trop Med Hyg</source>
          <year>1999</year>
          <volume>60</volume>
          <fpage>173</fpage>
          <lpage>176</lpage>
          <?supplied-pmid 10072131?>
          <pub-id pub-id-type="pmid">10072131</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moody</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Chiodini</surname>
              <given-names>PL</given-names>
            </name>
          </person-group>
          <article-title>Non-microscopic method for malaria diagnosis using OptiMAL IT, a second-generation dipstick for malaria pLDH antigen detection</article-title>
          <source>Br J Biomed Sci</source>
          <year>2002</year>
          <volume>59</volume>
          <fpage>228</fpage>
          <lpage>231</lpage>
          <?supplied-pmid 12572958?>
          <pub-id pub-id-type="pmid">12572958</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <mixed-citation publication-type="other">WHO, FIND, CDC, TDR: Malaria rapid diagnostic test performance: results of WHO product testing
malaria RDTs: round 2 (2009). NLM Classification: WC 750. 2010. pp. 1–22. ISBN 9789241599467</mixed-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hendriksen</surname>
              <given-names>IC</given-names>
            </name>
            <name>
              <surname>Mtove</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Pedro</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Gomes</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Silamut</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Mwambuli</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Evaluation of a PfHRP2 and a pLDH-based rapid diagnostic test for the diagnosis of severe malaria in 2 populations of African children</article-title>
          <source>Clin Infect Dis</source>
          <year>2011</year>
          <volume>52</volume>
          <fpage>1100</fpage>
          <lpage>1107</lpage>
          <pub-id pub-id-type="doi">10.1093/cid/cir143</pub-id>
          <?supplied-pmid 21467015?>
          <pub-id pub-id-type="pmid">21467015</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beadle</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Long</surname>
              <given-names>GW</given-names>
            </name>
            <name>
              <surname>McElroy</surname>
              <given-names>PD</given-names>
            </name>
            <name>
              <surname>Hoffman</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Long</surname>
              <given-names>GW</given-names>
            </name>
            <name>
              <surname>Weiss</surname>
              <given-names>WR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Diagnosis of malaria by detection of <italic>Plasmodium falciparum</italic> HRP-2 antigen with a rapid dipstick antigen-capture assay</article-title>
          <source>Lancet</source>
          <year>1994</year>
          <volume>343</volume>
          <fpage>564</fpage>
          <lpage>568</lpage>
          <pub-id pub-id-type="doi">10.1016/S0140-6736(94)91520-2</pub-id>
          <?supplied-pmid 7906328?>
          <pub-id pub-id-type="pmid">7906328</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Makler</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Hinrichs</surname>
              <given-names>DJ</given-names>
            </name>
          </person-group>
          <article-title>Measurement of the lactate dehydrogenase activity of <italic>Plasmodium falciparum</italic> as an assessment of parasitemia</article-title>
          <source>Am J Trop Med Hyg</source>
          <year>1993</year>
          <volume>48</volume>
          <fpage>205</fpage>
          <lpage>210</lpage>
          <?supplied-pmid 8447524?>
          <pub-id pub-id-type="pmid">8447524</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jelinek</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kilian</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Henk</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mughusu</surname>
              <given-names>EB</given-names>
            </name>
            <name>
              <surname>Nothdurft</surname>
              <given-names>HD</given-names>
            </name>
            <name>
              <surname>Loscher</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Parasite-specific lactate dehydrogenase for the diagnosis of <italic>Plasmodium falciparum</italic> infection in an endemic area in west Uganda</article-title>
          <source>Trop Med Int Health</source>
          <year>1996</year>
          <volume>1</volume>
          <fpage>227</fpage>
          <lpage>230</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-3156.1996.tb00031.x</pub-id>
          <?supplied-pmid 8665389?>
          <pub-id pub-id-type="pmid">8665389</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Piper</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Lebras</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Wentworth</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Hunt-Cooke</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Houze</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Chiodini</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Immunocapture diagnostic assays for malaria using <italic>Plasmodium lactate</italic> dehydrogenase (pLDH)</article-title>
          <source>Am J Trop Med Hyg</source>
          <year>1999</year>
          <volume>60</volume>
          <fpage>109</fpage>
          <lpage>118</lpage>
          <?supplied-pmid 9988333?>
          <pub-id pub-id-type="pmid">9988333</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moody</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Rapid diagnostic tests for malaria parasites</article-title>
          <source>Clin Microbiol Rev</source>
          <year>2002</year>
          <volume>15</volume>
          <fpage>66</fpage>
          <lpage>78</lpage>
          <pub-id pub-id-type="doi">10.1128/CMR.15.1.66-78.2002</pub-id>
          <?supplied-pmid 11781267?>
          <pub-id pub-id-type="pmid">11781267</pub-id>
        </element-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mariette</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Barnadas</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Bouchier</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Tichit</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Menard</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Country-wide assessment of the genetic polymorphism in <italic>Plasmodium falciparum</italic> and <italic>Plasmodium vivax</italic> antigens detected with rapid diagnostic tests for malaria</article-title>
          <source>Malar J</source>
          <year>2008</year>
          <volume>7</volume>
          <fpage>219</fpage>
          <pub-id pub-id-type="doi">10.1186/1475-2875-7-219</pub-id>
          <?supplied-pmid 18957099?>
          <pub-id pub-id-type="pmid">18957099</pub-id>
        </element-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>MacRae</surname>
              <given-names>JI</given-names>
            </name>
            <name>
              <surname>Dixon</surname>
              <given-names>MWA</given-names>
            </name>
            <name>
              <surname>Dearnley</surname>
              <given-names>MK</given-names>
            </name>
            <name>
              <surname>Chua</surname>
              <given-names>HH</given-names>
            </name>
            <name>
              <surname>Chambers</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Kenny</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Mitochondrial metabolism of sexual and asexual blood stages of the malaria parasite <italic>Plasmodium falciparum</italic></article-title>
          <source>BMC Biol</source>
          <year>2013</year>
          <volume>11</volume>
          <fpage>67</fpage>
          <pub-id pub-id-type="doi">10.1186/1741-7007-11-67</pub-id>
          <?supplied-pmid 23763941?>
          <pub-id pub-id-type="pmid">23763941</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lang-Unnasch</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Murphy</surname>
              <given-names>AD</given-names>
            </name>
          </person-group>
          <article-title>Metabolic changes of the malaria parasite during the transition from the human to the mosquito host</article-title>
          <source>Annu Rev Microbiol</source>
          <year>1998</year>
          <volume>52</volume>
          <fpage>561</fpage>
          <lpage>590</lpage>
          <pub-id pub-id-type="doi">10.1146/annurev.micro.52.1.561</pub-id>
          <?supplied-pmid 9891808?>
          <pub-id pub-id-type="pmid">9891808</pub-id>
        </element-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brown</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Yowell</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Hoard</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Vander Jagt</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Hunsaker</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Deck</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Comparative structural analysis and kinetic properties of lactate dehydrogenases from the four species of human malarial parasites</article-title>
          <source>Biochemistry</source>
          <year>2004</year>
          <volume>43</volume>
          <fpage>6219</fpage>
          <lpage>6229</lpage>
          <pub-id pub-id-type="doi">10.1021/bi049892w</pub-id>
          <?supplied-pmid 15147206?>
          <pub-id pub-id-type="pmid">15147206</pub-id>
        </element-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Howard</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Uni</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Aikawa</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Aley</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Leech</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Lew</surname>
              <given-names>AM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Secretion of a malarial histidine-rich protein (Pf HRP II) from <italic>Plasmodium falciparum</italic>-infected erythrocytes</article-title>
          <source>J Cell Biol</source>
          <year>1986</year>
          <volume>103</volume>
          <fpage>1269</fpage>
          <lpage>1277</lpage>
          <pub-id pub-id-type="doi">10.1083/jcb.103.4.1269</pub-id>
          <?supplied-pmid 3533951?>
          <pub-id pub-id-type="pmid">3533951</pub-id>
        </element-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koita</surname>
              <given-names>OA</given-names>
            </name>
            <name>
              <surname>Doumbo</surname>
              <given-names>OK</given-names>
            </name>
            <name>
              <surname>Ouattara</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Tall</surname>
              <given-names>LK</given-names>
            </name>
            <name>
              <surname>Konaré</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Diakité</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>False-negative rapid diagnostic tests for malaria and deletion of the histidine-rich repeat region of the hrp2 gene</article-title>
          <source>Am J Trop Med Hyg</source>
          <year>2012</year>
          <volume>86</volume>
          <fpage>194</fpage>
          <lpage>198</lpage>
          <pub-id pub-id-type="doi">10.4269/ajtmh.2012.10-0665</pub-id>
          <?supplied-pmid 22302847?>
          <pub-id pub-id-type="pmid">22302847</pub-id>
        </element-citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fogg</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Twesigye</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Batwala</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Piola</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Nabasumba</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kiguli</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Assessment of three new parasite lactate dehydrogenase (pan-pLDH) tests for diagnosis of uncomplicated malaria</article-title>
          <source>Trans R Soc Trop Med Hyg</source>
          <year>2008</year>
          <volume>102</volume>
          <fpage>25</fpage>
          <lpage>31</lpage>
          <pub-id pub-id-type="doi">10.1016/j.trstmh.2007.09.014</pub-id>
          <?supplied-pmid 18031779?>
          <pub-id pub-id-type="pmid">18031779</pub-id>
        </element-citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gerstl</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Dunkley</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mukhtar</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>De Smet</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Baker</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Maikere</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Assessment of two malaria rapid diagnostic tests in children under five years of age, with follow-up of false-positive pLDH test results, in a hyperendemic falciparum malaria area, Sierra Leone</article-title>
          <source>Malar J</source>
          <year>2010</year>
          <volume>9</volume>
          <fpage>28</fpage>
          <pub-id pub-id-type="doi">10.1186/1475-2875-9-28</pub-id>
          <?supplied-pmid 20092620?>
          <pub-id pub-id-type="pmid">20092620</pub-id>
        </element-citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dieng</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Bah</surname>
              <given-names>IB</given-names>
            </name>
            <name>
              <surname>Ndiaye</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Diallo</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Diop</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Brasseur</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>In vitro evaluation of the sensitivity of <italic>Plasmodium falciparum</italic> to chloroquine using the deli-microtest in region of Dakar, Senegal</article-title>
          <source>Med Trop (Mars)</source>
          <year>2005</year>
          <volume>65</volume>
          <fpage>580</fpage>
          <lpage>583</lpage>
          <pub-id pub-id-type="pmid">16555520</pub-id>
        </element-citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Atchade</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Doderer-Lang</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Chabi</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Perrotey</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Abdelrahman</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Is a Plasmodium lactate dehydrogenase (pLDH) enzyme-linked immunosorbent (ELISA)-based assay a valid tool for detecting risky malaria blood donations in Africa?</article-title>
          <source>Malar J</source>
          <year>2013</year>
          <volume>12</volume>
          <fpage>279</fpage>
          <pub-id pub-id-type="doi">10.1186/1475-2875-12-279</pub-id>
          <?supplied-pmid 23927596?>
          <pub-id pub-id-type="pmid">23927596</pub-id>
        </element-citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Orjuela-Sanchez</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Duggan</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Nolan</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Frangos</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Carvalho</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>A lactate dehydrogenase ELISA-based assay for the in vitro determination of <italic>Plasmodium berghei</italic> sensitivity to anti-malarial drugs</article-title>
          <source>Malar J</source>
          <year>2012</year>
          <volume>11</volume>
          <fpage>366</fpage>
          <pub-id pub-id-type="doi">10.1186/1475-2875-11-366</pub-id>
          <?supplied-pmid 23126583?>
          <pub-id pub-id-type="pmid">23126583</pub-id>
        </element-citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Otsuki</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Yokouchi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Iyoku</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Tachibana</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tsuboi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Torii</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>The rodent malaria lactate dehydrogenase assay provides a high throughput solution for in vivo vaccine studies</article-title>
          <source>Parasitol Int</source>
          <year>2015</year>
          <volume>64</volume>
          <fpage>60</fpage>
          <lpage>63</lpage>
          <pub-id pub-id-type="doi">10.1016/j.parint.2015.02.001</pub-id>
          <?supplied-pmid 25701649?>
          <pub-id pub-id-type="pmid">25701649</pub-id>
        </element-citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Turgut-Balik</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Akbulut</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Shoemark</surname>
              <given-names>DK</given-names>
            </name>
            <name>
              <surname>Celik</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Moreton</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Sessions</surname>
              <given-names>RB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cloning, sequence and expression of the lactate dehydrogenase gene from the human malaria parasite, <italic>Plasmodium vivax</italic></article-title>
          <source>Biotechnol Lett</source>
          <year>2004</year>
          <volume>26</volume>
          <fpage>1051</fpage>
          <lpage>1055</lpage>
          <pub-id pub-id-type="doi">10.1023/B:BILE.0000032958.78158.10</pub-id>
          <?supplied-pmid 15218378?>
          <pub-id pub-id-type="pmid">15218378</pub-id>
        </element-citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mayxay</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Pukrittayakamee</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Newton</surname>
              <given-names>PN</given-names>
            </name>
            <name>
              <surname>White</surname>
              <given-names>NJ</given-names>
            </name>
          </person-group>
          <article-title>Mixed-species malaria infections in humans</article-title>
          <source>Trends Parasitol</source>
          <year>2004</year>
          <volume>20</volume>
          <fpage>233</fpage>
          <lpage>240</lpage>
          <pub-id pub-id-type="doi">10.1016/j.pt.2004.03.006</pub-id>
          <?supplied-pmid 15105024?>
          <pub-id pub-id-type="pmid">15105024</pub-id>
        </element-citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hurdayal</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Achilonu</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Choveaux</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Coetzer</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Dean Goldring</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Anti-peptide antibodies differentiate between plasmodial lactate dehydrogenases</article-title>
          <source>Peptides</source>
          <year>2010</year>
          <volume>31</volume>
          <fpage>525</fpage>
          <lpage>532</lpage>
          <pub-id pub-id-type="doi">10.1016/j.peptides.2010.01.002</pub-id>
          <?supplied-pmid 20093160?>
          <pub-id pub-id-type="pmid">20093160</pub-id>
        </element-citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Talman</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Duval</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Legrand</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Hubert</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Yen</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bell</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Evaluation of the intra- and inter-specific genetic variability of <italic>Plasmodium lactate</italic> dehydrogenase</article-title>
          <source>Malar J</source>
          <year>2007</year>
          <volume>6</volume>
          <fpage>140</fpage>
          <pub-id pub-id-type="doi">10.1186/1475-2875-6-140</pub-id>
          <?supplied-pmid 17961215?>
          <pub-id pub-id-type="pmid">17961215</pub-id>
        </element-citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <mixed-citation publication-type="other">National Health and Medical Research. Australian code for the care and use of animals for scientific purposes. 8th edn. Canberra: National Health and Medical Research Council; 2013.</mixed-citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hearn</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Rayment</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Landon</surname>
              <given-names>DN</given-names>
            </name>
            <name>
              <surname>Katz</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>de Souza</surname>
              <given-names>JB</given-names>
            </name>
          </person-group>
          <article-title>Immunopathology of cerebral malaria: morphological evidence of parasite sequestration in murine brain microvasculature</article-title>
          <source>Infect Immun</source>
          <year>2000</year>
          <volume>68</volume>
          <fpage>5364</fpage>
          <lpage>5376</lpage>
          <pub-id pub-id-type="doi">10.1128/IAI.68.9.5364-5376.2000</pub-id>
          <?supplied-pmid 10948166?>
          <pub-id pub-id-type="pmid">10948166</pub-id>
        </element-citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gonçalves</surname>
              <given-names>BP</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>C-Y</given-names>
            </name>
            <name>
              <surname>Morrison</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Holte</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kabyemela</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Prevots</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Parasite burden and severity of malaria in Tanzanian Children</article-title>
          <source>N Engl J Med</source>
          <year>2014</year>
          <volume>370</volume>
          <fpage>1799</fpage>
          <lpage>1808</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJMoa1303944</pub-id>
          <?supplied-pmid 24806160?>
          <pub-id pub-id-type="pmid">24806160</pub-id>
        </element-citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <mixed-citation publication-type="other">Joice R, Nilsson SK, Montgomery J, Dankwa S, Egan E, Morahan B, et al. <italic>Plasmodium falciparum</italic> transmission stages accumulate in the human bone marrow. Sci Transl Med. 2014;6:244re245.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:4700575</identifier><datestamp>2016-01-06</datestamp><setSpec>sigs</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="http://jats.nlm.nih.gov/ns/archiving/1.0/ http://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="case-report">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Stand Genomic Sci</journal-id>
      <journal-id journal-id-type="iso-abbrev">Stand Genomic Sci</journal-id>
      <journal-title-group>
        <journal-title>Standards in Genomic Sciences</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1944-3277</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC4700575</article-id>
      <article-id pub-id-type="pmcid">PMC4700575</article-id>
      <article-id pub-id-type="pmc-uid">4700575</article-id>
      <article-id pub-id-type="publisher-id">121</article-id>
      <article-id pub-id-type="doi">10.1186/s40793-015-0121-y</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Short Genome Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>The complete genome sequence and analysis of a plasmid-bearing myxobacterial strain <italic>Myxococcus fulvus</italic> 124B02 (M 206081)</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>Xiao-jing</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Han</surname>
            <given-names>Kui</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Feng</surname>
            <given-names>Jing</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zhuo</surname>
            <given-names>Li</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Li</surname>
            <given-names>Ya-jie</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Li</surname>
            <given-names>Yue-zhong</given-names>
          </name>
          <address>
            <email>lilab@sdu.edu.cn</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <aff id="Aff1">State Key Laboratory of Microbial Technology, School of Life Science, Shandong University, Jinan, 250100 China </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>4</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>4</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <volume>11</volume>
      <elocation-id>1</elocation-id>
      <history>
        <date date-type="received">
          <day>7</day>
          <month>5</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>11</day>
          <month>9</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© Chen et al. 2015</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <p>Myxobacteria, phylogenetically located in the delta division of the <italic>Proteobacteria</italic>, are well known for characterized social behaviors and large genomes of more than 9 Mb in size. <italic>Myxococcus fulvus</italic> is a typical species of the genus <italic>Myxococcus</italic> in the family <italic>Myxococcaceae. M. fulvus</italic> 124B02, originally isolated from a soil sample collected in Northeast China, is the one and only presently known myxobacterial strain that harbors an endogenous autonomously replicating plasmid, named pMF1. The endogenous plasmid is of importance for understanding the genome evolution of myxobacteria, as well as for the development of genetic engineering tools in myxobacteria. Here we describe the complete genome sequence of this organism. <italic>M. fulvus</italic> 124B02 consists of a circular chromosome with a total length of 11,048,835 bp and a circular plasmid of 18,634 bp. Comparative genomic analyses suggest that pMF1 has a longstanding sustention within myxobacteria, and probably contributes to the genome expansion of myxobacteria.</p>
        <sec>
          <title>Electronic supplementary material</title>
          <p>The online version of this article (doi:10.1186/s40793-015-0121-y) contains supplementary material, which is available to authorized users.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd><italic>Myxococcus fulvus</italic> 124B02</kwd>
        <kwd>Complete genome sequence</kwd>
        <kwd>Endogenous plasmid</kwd>
        <kwd>Autonomously replicate</kwd>
        <kwd>Genome expansion</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id>
              <institution>National Natural Science Foundation of China</institution>
            </institution-wrap>
          </funding-source>
          <award-id>31471183</award-id>
          <award-id>31130004</award-id>
          <principal-award-recipient>
            <name>
              <surname>Li</surname>
              <given-names>Yue-zhong</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
      </funding-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>© The Author(s) 2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Introduction</title>
      <p>The gliding Gram-negative myxobacteria are characterized by complex social behaviors, <italic>e.g.</italic> cells moving on solid surfaces in swarms, preying on other microorganisms in a ‘wolf-like’ pattern, and, when nutrients are depleted, developing into myxospores embodied in fruiting bodies [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. In addition, myxobacteria are able to produce various secondary metabolites and macromolecule degradation enzymes, not only having potential in applications but also probably working as ecological weapons against other living microorganisms [<xref ref-type="bibr" rid="CR3">3</xref>–<xref ref-type="bibr" rid="CR5">5</xref>]. Myxobacteria possess large genomes. For instance, the genomes of <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3727"><italic>Myxococcus xanthus</italic></ext-link> DK1622 and the halotolerant <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3720"><italic>M. fulvus</italic></ext-link> HW-1 are 9.14 Mb [<xref ref-type="bibr" rid="CR6">6</xref>] and 9.03 Mb [<xref ref-type="bibr" rid="CR7">7</xref>] in size, while the genomes of <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3762"><italic>Sorangium cellulosum</italic></ext-link> even reach to 13.03 Mb in strain So ce56 [<xref ref-type="bibr" rid="CR8">8</xref>] and 14.78 Mb in strain So0157-2 [<xref ref-type="bibr" rid="CR9">9</xref>], respectively. The So0157-2 genome is still the largest one reported in prokaryotes.</p>
      <p>Extrachromosomal autonomously replicating genetic materials are normally absent from myxobacterial cells. Up to now, pMF1, originally discovered from <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3720"><italic>M. fulvus</italic></ext-link> 124B02 [<xref ref-type="bibr" rid="CR10">10</xref>], is still the one and only endogenous plasmid that is able to replicate autonomously in myxobacterial cells. Genome sequencing of <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3720"><italic>M. fulvus</italic></ext-link> 124B02 is thus meaningful for understanding the evolution of myxobacterial genomes, and providing clues for the presence of pMF1 in strain 124B02. Here we report the complete genome sequence and analyses of <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3720"><italic>M. fulvus</italic></ext-link> 124B02.</p>
    </sec>
    <sec id="Sec2">
      <title>Organism information</title>
      <sec id="Sec3">
        <title>Classification and features</title>
        <p>Strain 124B02 was isolated from a soil sample collected in Northeast China [<xref ref-type="bibr" rid="CR11">11</xref>]. Vegetative cells of the strain are slender rods with tapering ends, 0.6-0.8 × 4–8 μm. The fruiting bodies are spherical or slightly pear-shaped with a diameter of 50–250 μm and a yellow red color. The strain did not grow expansively, but into membranaceous clumps on CYE solid plates. When grown in liquid CYE medium, the cells grew into spherical clumps. Figure <xref rid="Fig1" ref-type="fig">1</xref> shows morphological characteristics of <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3720"><italic>M. fulvus</italic></ext-link> 124B02. The optimal growth pH for strain 124B02 is in the range of 6.8–7.6, and the optimal growth temperature ranges between 26 °C and 32 °C. The predominant fatty acids of <italic>M.fulvus</italic> 124B02 cells were determined as <italic>iso</italic>-C<sub>15:0</sub> (33.18 %), C<sub>16:1</sub> ω5c (20.19 %), <italic>iso</italic>-C<sub>14:0</sub> 3-OH (6.27 %), C<sub>16:0</sub> (5.79 %) and C<sub>14:0</sub> (5.65 %). 2-hydroxy and 3-hydroxy fatty acids are the major hydroxyl fatty acid components of strain 124B02.<fig id="Fig1"><label>Fig. 1</label><caption><p>Morphological characteristics of <italic>M. fulvus</italic> 124B02. <bold>a</bold> Spherical clumps of strain 124B02 cells cultivated in liquid CYE medium. <bold>b</bold> Fruiting bodies formed on the TPM development medium. The pictures were taken after six days of incubation under a stereoscopic microscope, Bar = 50 μm. <bold>c</bold> Vegetative cells, Bar=5 μm</p></caption><graphic xlink:href="40793_2015_121_Fig1_HTML" id="MO1"/></fig></p>
        <p>Figure <xref rid="Fig2" ref-type="fig">2</xref> is a phylogenetic tree of the 16S rRNA gene sequences showing the location of <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3720"><italic>M. fulvus</italic></ext-link> 124B02 in the <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3691"><italic>Cystobacterineae</italic></ext-link> suborder of myxobacteria (the GenBank accession number of the 16S rRNA gene sequence of strain 124B02 is <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/EU137665">EU137665</ext-link>). All three 16S rRNA gene copies in the genome of strain 124B02 are identical, but differ by two nucleotides from the previously published 16S rRNA sequence generated from <italic>M.fulvus</italic> 124B02 (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/EU137665">EU137665</ext-link>). According to the morphological and phylogenetic characteristics, <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3720"><italic>M. fulvus</italic></ext-link> 124B02 was determined as a typical strain of <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3720"><italic>Myxococcus fulvus</italic></ext-link> (Table <xref rid="Tab1" ref-type="table">1</xref> shows the classification and general features of the strain).<fig id="Fig2"><label>Fig. 2</label><caption><p>Phylogenetic tree showing the position of <italic>M. fulvus</italic> 124B02 within the <italic>Cystobacterineae</italic>. The tree was inferred from 1,445 aligned bases [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>] of the 16S rRNA gene sequence under the maximum likelihood criterion [<xref ref-type="bibr" rid="CR37">37</xref>] and rooted with <italic>Nannocystis excedens</italic>. The branches are scaled in terms of the expected number of substitutions per site. Numbers above branches are the supporting values from 1,000 bootstrap replicates. Lineages with type strain genome sequencing projects registered in GOLD [<xref ref-type="bibr" rid="CR38">38</xref>] are shown in blue and published genomes in bold</p></caption><graphic xlink:href="40793_2015_121_Fig2_HTML" id="MO2"/></fig><table-wrap id="Tab1"><label>Table 1</label><caption><p>Classification and general features of <italic>M. fulvus</italic> 124B02 according to the MIGS recommendations [<xref ref-type="bibr" rid="CR39">39</xref>]</p></caption><table frame="hsides" rules="groups"><thead><tr><th>MIGS ID</th><th>Property</th><th>Term</th><th>Evidence code<sup>a</sup>
</th></tr></thead><tbody><tr><td/><td>Classification</td><td>Domain <italic>Bacteria</italic>
</td><td>TAS[<xref ref-type="bibr" rid="CR40">40</xref>]</td></tr><tr><td/><td/><td>Phylum <italic>Proteobacteria</italic>
</td><td>TAS[<xref ref-type="bibr" rid="CR41">41</xref>]</td></tr><tr><td/><td/><td>Class <italic>Deltaproteobacteria</italic>
</td><td>TAS[<xref ref-type="bibr" rid="CR42">42</xref>]</td></tr><tr><td/><td/><td>Order <italic>Myxococcales</italic>
</td><td>TAS[<xref ref-type="bibr" rid="CR43">43</xref>]</td></tr><tr><td/><td/><td>Suborder <italic>Cystobacterineae</italic>
</td><td>TAS[<xref ref-type="bibr" rid="CR44">44</xref>]</td></tr><tr><td/><td/><td>Family <italic>Myxococcaceae</italic>
</td><td>TAS[<xref ref-type="bibr" rid="CR45">45</xref>]</td></tr><tr><td/><td/><td>Genus <italic>Myxococcus</italic>
</td><td>TAS[<xref ref-type="bibr" rid="CR46">46</xref>]</td></tr><tr><td/><td/><td>Species <italic>Myxococcus fulvus</italic>
</td><td>TAS[<xref ref-type="bibr" rid="CR47">47</xref>, <xref ref-type="bibr" rid="CR48">48</xref>]</td></tr><tr><td/><td/><td>Strain 124B02</td><td>TAS[<xref ref-type="bibr" rid="CR10">10</xref>]</td></tr><tr><td/><td>Gram strain</td><td>Negative</td><td>TAS[<xref ref-type="bibr" rid="CR44">44</xref>]</td></tr><tr><td/><td>Cell shape</td><td>Rod</td><td>TAS[<xref ref-type="bibr" rid="CR1">1</xref>]</td></tr><tr><td/><td>Motility</td><td>Motile</td><td>TAS[<xref ref-type="bibr" rid="CR1">1</xref>]</td></tr><tr><td/><td>Sporulation</td><td>Myxospore</td><td>TAS[<xref ref-type="bibr" rid="CR1">1</xref>]</td></tr><tr><td/><td>Temperature range</td><td>Mesophile, 25–35 °C</td><td>TAS[<xref ref-type="bibr" rid="CR44">44</xref>]</td></tr><tr><td/><td>Optimum temperature</td><td>26–32 °C</td><td>TAS[<xref ref-type="bibr" rid="CR44">44</xref>]</td></tr><tr><td/><td>pH range; Optimum</td><td>6.4–8.8; 6.8–7.6</td><td>TAS[<xref ref-type="bibr" rid="CR47">47</xref>]</td></tr><tr><td/><td>Carbon source</td><td>Macromolecules such as proteins</td><td>TAS[<xref ref-type="bibr" rid="CR44">44</xref>]</td></tr><tr><td>MIGS-6</td><td>Habitat</td><td>Soil</td><td>IDA</td></tr><tr><td>MIGS-6.3</td><td>Salinity</td><td>Non-halophile</td><td>NAS</td></tr><tr><td>MIGS-22</td><td>Oxygen requirement</td><td>Aerobic</td><td>TAS[<xref ref-type="bibr" rid="CR1">1</xref>]</td></tr><tr><td>MIGS-15</td><td>Biotic relation</td><td>Free-living</td><td>NAS</td></tr><tr><td>MIGS-14</td><td>Pathogenicity</td><td>Non-pathogen</td><td>NAS</td></tr><tr><td/><td>Biosafety level</td><td>1</td><td>TAS[<xref ref-type="bibr" rid="CR49">49</xref>]</td></tr><tr><td/><td>Isolation</td><td>Soil</td><td>IDA</td></tr><tr><td>MIGS-4</td><td>Geographic location</td><td>Changchun, China</td><td>IDA</td></tr><tr><td>MIGS-5</td><td>Sample Collection</td><td>1999</td><td>IDA</td></tr><tr><td>MIGS-4.1</td><td>Latitude</td><td>not reported</td><td/></tr><tr><td>MIGS-4.2</td><td>Longitude</td><td>not reported</td><td/></tr><tr><td>MIGS-4.3</td><td>Depth</td><td>not reported</td><td/></tr><tr><td>MIGS-4.4</td><td>Altitude</td><td>not reported</td><td/></tr></tbody></table><table-wrap-foot><p>
<sup>a</sup>Evidence codes – <italic>TAS</italic> traceable author statement, <italic>i.e.</italic> the direct report in the literature, <italic>NAS</italic> non-traceable author statement, <italic>i.e.</italic> not directly observed for the living, isolated sample, but based on a generally accepted property for the species, or anecdotal evidence. These evidence codes are from the Gene Ontology project [<xref ref-type="bibr" rid="CR19">19</xref>]</p></table-wrap-foot></table-wrap></p>
      </sec>
    </sec>
    <sec id="Sec4">
      <title>Genome sequencing information</title>
      <sec id="Sec5">
        <title>Genome project history</title>
        <p>This organism was selected for sequencing because of its evolutionary significance as the only presently known myxobacterial strain bearing an endogenous plasmid. The genome project of <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3720"><italic>M. fulvus</italic></ext-link> 124B02 was deposited in the Genome Online Database and the complete genome sequence of strain 124B02 was deposited in GenBank under the accession number of <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/CP006003">CP006003</ext-link>. A summary of the project information is shown in Table <xref rid="Tab2" ref-type="table">2</xref>.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Genome sequencing project information</p></caption><table frame="hsides" rules="groups"><thead><tr><th>MIGS ID</th><th>Property</th><th>Term</th></tr></thead><tbody><tr><td>MIGS-31</td><td>Finishing quality</td><td>Finished</td></tr><tr><td>MIGS-28</td><td>Libraries used</td><td>Three genomic libraries: one 454 single read library,one 454 pair end library (3 kb), one Illumina pair end library (350)</td></tr><tr><td>MIGS-29</td><td>Sequencing platforms</td><td>Roche 454 GS FLX, Illumina GAII</td></tr><tr><td>MIGS-31.2</td><td>Fold coverage</td><td>25.8 × pyrosequence; 86.7 × Illumina</td></tr><tr><td>MIGS-30</td><td>Assemblers</td><td>Newbler assembler V2.3, Phrap, Velvet</td></tr><tr><td>MIGS-32</td><td>Gene calling method</td><td>GeneBank</td></tr><tr><td/><td>Locus Tag</td><td>MFUL124B02</td></tr><tr><td/><td>GenBank ID</td><td>CP006003</td></tr><tr><td/><td>GenBank Date of Release</td><td>May 6, 2015</td></tr><tr><td/><td>GOLD ID</td><td>Gp0043396</td></tr><tr><td/><td>BIOPROJECT</td><td>PRJNA203240</td></tr><tr><td>MIGS-13</td><td>Source material identifier</td><td>M 206081</td></tr><tr><td/><td>Project relevance</td><td>The host of plasmid pMF1</td></tr></tbody></table></table-wrap></p>
      </sec>
      <sec id="Sec6">
        <title>Growth conditions and genomic DNA preparation</title>
        <p><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3720"><italic>M. fulvus</italic></ext-link> 124B02 was cultivated in the CTT growth medium containing 1 % casitone, 10 mM Tris–HCl, 1 mM KH<sub>2</sub>PO<sub>4</sub>-K<sub>2</sub>HPO<sub>4</sub>, 8 mM MgSO<sub>4</sub>, pH 7.6. The cells were harvested by centrifugation after five days of incubation at 30 °C. DNA was extracted from the cell mass using the methods described previously [<xref ref-type="bibr" rid="CR12">12</xref>] with slight modifications. Briefly, approximately 50–100 mg cell pellets were suspended in 500 μl TE buffer, containing 25 mM Tris–HCl (pH 8.0), 25 mM EDTA, and 2 mg/ml lysozyme. The mixture was incubated at 37 °C for 1 h with periodic gentle inversion for cell lysis. Then, 2.5 μl proteinase K was added to a final concentration of 100 μg/ml, and the mixture was incubated at 37 °C for additional 1 h. The total protein was removed with Tris-saturated phenol-chloroform-isoamyl alcohol (25:24:1, pH 8.0). To precipitate DNA, 0.1 volume of 3 M sodium acetate (pH 5.3) and the same volume of isopropyl alcohol were added to the final supernatant. The DNA pellet was washed with 70 % ethanol twice, air-dried, and dissolved in 50 μl ddH<sub>2</sub>O.</p>
      </sec>
      <sec id="Sec7">
        <title>Genome sequencing and assembly</title>
        <p>Genome sequencing and assembly were performed in Shanghai Majorbio Bio-Pharm Technology Co., Ltd. The genome was sequenced with a combination of the Roche 454 GS FLX and Illumina GAII sequencing platforms. The 454 pyrosequencing reads, containing 285.8 Mb draft data, were firstly assembled using the Newbler assembler V2.3, producing 51 contigs in 23 scaffolds. This initial assembly was converted into a phrap assembly by making fake reads from the consensus, to collect the read pairs in the 454 paired end library. The clean data from Illumina GAII sequencing were assembled with Velvet assembler and the consensus sequences were shredded into 800-bp overlapped fake reads, which were assembled with the 454 draft data. In total, the combination of the Illumina and 454 sequencing platforms produced 112.5× coverage of the genome. The final assembly contained 738,315 pyro sequences and 12,776,900 Illumina reads. After the shotgun stage, reads were assembled with parallel phrap (High Performance Software, LLC). Then the Phred/Phrap/Consed software package [<xref ref-type="bibr" rid="CR13">13</xref>–<xref ref-type="bibr" rid="CR15">15</xref>] was used for quality assessment. Possible misassembles were corrected by sequencing the cloned bridging PCR fragments. We designed primers for the amplification of 76 gap regions to close gaps and to improve the quality of the finished genome. Gaps between contigs were closed by editing in Consed, PCR amplification and 3730 sequencing. The wrong bases were corrected by comparing with Illumina GAII data after the genome cyclization, using BWA (0.7.3a) [<xref ref-type="bibr" rid="CR16">16</xref>] and samtools (0.1.19) [<xref ref-type="bibr" rid="CR17">17</xref>]. The error rate of the completed genome sequence is less than 1 bp in 100,000 bp.</p>
      </sec>
      <sec id="Sec8">
        <title>Genome annotation</title>
        <p>The genome was annotated automatically in GenBank. In addition, we predicted Cluster Regularly Interspaced Short Palindromic Repeats (CRISPRS) with PILER-CR [<xref ref-type="bibr" rid="CR18">18</xref>]. We analyzed the predicted protein sequences against the National Center for Biotechnology Information (NCBI) non-redundant database, Gene Ontology [<xref ref-type="bibr" rid="CR19">19</xref>], KEGG [<xref ref-type="bibr" rid="CR20">20</xref>], and COG [<xref ref-type="bibr" rid="CR21">21</xref>] databases for functional annotation. The results were summarized with the InterProScan [<xref ref-type="bibr" rid="CR22">22</xref>] software. To analyze the COG annotation, hits with an E-value &lt; = 1e-5 were first retained. Then, only the best hit was selected for each protein. Signal peptides and transmembrane helices of all annotated proteins were predicted using SignalP 4.1 Sever [<xref ref-type="bibr" rid="CR23">23</xref>] and TMHMM Sever v. 2.0 respectively.</p>
      </sec>
    </sec>
    <sec id="Sec9">
      <title>Genome properties</title>
      <p>The genome statistics are provided in Table <xref rid="Tab3" ref-type="table">3</xref>, Table <xref rid="Tab4" ref-type="table">4</xref> and Fig. <xref rid="Fig3" ref-type="fig">3</xref><italic>.</italic><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3720"><italic>M. fulvus</italic></ext-link> 124B02 consists of a circular chromosome with a total length of 11,048,835 bp and a circular plasmid of 18,634 bp. The G+C contents of the chromosome and the plasmid are 69.96 % and 68.7 %, respectively. There were 8,515 predicted coding sequences (CDSs) in the genome, including 9 rRNAs and 80 tRNAs. The protein coding sequences occupied 86.13 % of the whole genome sequence. The majority of the protein-coding genes (5,042, 58.24 % of the total) were assigned putative functions in categories of orthologous group (COG), while the remaining ones were annotated as hypothetical proteins. The distribution of genes in COGs functional categories is presented in Table <xref rid="Tab5" ref-type="table">5</xref>.<table-wrap id="Tab3"><label>Table 3</label><caption><p>Information of <italic>M. fulvus</italic> 124B02 genome and the endogenous plasmid</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Label</th><th>Size (bp)</th><th>Topology</th><th>INSDC identifier</th><th>RefSeq ID</th></tr></thead><tbody><tr><td>Chromosome</td><td>11,048,835</td><td>Circular</td><td>CP006003</td><td>NZ_CP006003.1</td></tr><tr><td>Plasmid pMF1</td><td>18,634</td><td>Circular</td><td>EU137666.1</td><td>NC_010372.1</td></tr></tbody></table></table-wrap><table-wrap id="Tab4"><label>Table 4</label><caption><p>Statistics of <italic>M. fulvus</italic> 124B02 genome</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Attribute</th><th>Value</th><th>% of total<sup>a</sup>
</th></tr></thead><tbody><tr><td>Genome size (bp)</td><td>11,048,835</td><td>100.00</td></tr><tr><td>DNA coding (bp)</td><td>9,516,537</td><td>86.13</td></tr><tr><td>DNA G + C content (bp)</td><td>7,730,063</td><td>69.96</td></tr><tr><td>DNA scaffolds</td><td>0</td><td/></tr><tr><td>Total genes</td><td>8,658</td><td>100.00</td></tr><tr><td>Protein-coding genes</td><td>8,515</td><td>98.58</td></tr><tr><td>RNA genes</td><td>89</td><td>1.03</td></tr><tr><td>Pseudogenes</td><td>54</td><td>0.62</td></tr><tr><td>Genes in internal clusters</td><td>505</td><td>5.83</td></tr><tr><td>Genes with function prediction</td><td>4,749</td><td>54.85</td></tr><tr><td>Genes assigned to COGs</td><td>5,042</td><td>58.24</td></tr><tr><td>Genes with Pfam domain</td><td>5,929</td><td>68.48</td></tr><tr><td>Genes with signal peptides</td><td>984</td><td>11.37</td></tr><tr><td>Genes with transmembrances</td><td>1,605</td><td/></tr><tr><td>CRISPR repeats</td><td>1</td><td/></tr></tbody></table><table-wrap-foot><p>
<sup>a</sup>The total is based on either the size of the genome in base pairs or the total number of protein coding genes in the annotated genome</p></table-wrap-foot></table-wrap><fig id="Fig3"><label>Fig. 3</label><caption><p>Schematic map of the genome. From outside: Circle 1, genome positions in kb (started from <italic>dnaA</italic>); Circles 2 and 4, predicted protein coding sequences (CDSs) on the forward (<italic>outer wheel</italic>) and the reverse (<italic>inner wheel</italic>) strands, colored according to COG classification; Circle 3, GC skew plot; The positive GC skew value (<italic>blue</italic>) corresponds to leading strand and negative GC value (<italic>orange</italic>) correspond to lagging strand. Circles 5 and 6, expanded genes in <italic>M. fulvus</italic> 124B02, compared with <italic>M. stipitatus</italic> DSM 14675; Circles 7, putative virus and prophage-derived CDSs; Circle 8, GC content showing deviations from the average (69.96 %); Circle 9 and 10, putative plasmid-derived CDSs (leading strand, 1,879 CDSs; lagging strand, 2,046 CDSs); Core circle, paralogous CDSs</p></caption><graphic xlink:href="40793_2015_121_Fig3_HTML" id="MO3"/></fig><table-wrap id="Tab5"><label>Table 5</label><caption><p>The genes of <italic>M. fulvus</italic> 124B02 genome in COG functional categories</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Code</th><th>Value</th><th>%<sup>a</sup>
</th><th>Description</th></tr></thead><tbody><tr><td>J</td><td>203</td><td>2.38</td><td>Translation, ribosomal structure and biogenesis</td></tr><tr><td>A</td><td>5</td><td>0.06</td><td>RNA processing and modification</td></tr><tr><td>K</td><td>416</td><td>4.89</td><td>Transcription</td></tr><tr><td>L</td><td>205</td><td>2.41</td><td>Replication, recombination and repair</td></tr><tr><td>B</td><td>3</td><td>0.04</td><td>Chromatin structure and dynamics</td></tr><tr><td>D</td><td>44</td><td>0.52</td><td>Cell cycle control, cell division, chromosome partitioning</td></tr><tr><td>Y</td><td>-</td><td>-</td><td>Nuclear structure</td></tr><tr><td>V</td><td>129</td><td>1.51</td><td>Defense mechanisms</td></tr><tr><td>T</td><td>415</td><td>4.87</td><td>Signal transduction mechanisms</td></tr><tr><td>M</td><td>329</td><td>3.86</td><td>Cell wall/membrane/envelope biogenesis</td></tr><tr><td>N</td><td>117</td><td>1.37</td><td>Cell motility</td></tr><tr><td>Z</td><td>-</td><td>-</td><td>Cytoskeleton</td></tr><tr><td>W</td><td>-</td><td>-</td><td>Extracellular structures</td></tr><tr><td>U</td><td>65</td><td>0.76</td><td>Intracellular trafficking, secretion, and vesicular transport</td></tr><tr><td>O</td><td>235</td><td>2.76</td><td>Posttranslational modification, protein turnover, chaperones</td></tr><tr><td>C</td><td>227</td><td>2.67</td><td>Energy production and conversion</td></tr><tr><td>G</td><td>205</td><td>2.41</td><td>Carbohydrate transport and metabolism</td></tr><tr><td>E</td><td>342</td><td>4.02</td><td>Amino acid transport and metabolism</td></tr><tr><td>F</td><td>94</td><td>1.10</td><td>Nucleotide transport and metabolism</td></tr><tr><td>H</td><td>148</td><td>1.74</td><td>Coenzyme transport and metabolism</td></tr><tr><td>I</td><td>283</td><td>3.32</td><td>Lipid transport and metabolism</td></tr><tr><td>P</td><td>191</td><td>2.24</td><td>Inorganic ion transport and metabolism</td></tr><tr><td>Q</td><td>177</td><td>2.08</td><td>Secondary metabolites biosynthesis, transport and catabolism</td></tr><tr><td>R</td><td>767</td><td>9.01</td><td>General function prediction only</td></tr><tr><td>S</td><td>442</td><td>5.19</td><td>Function unknown</td></tr><tr><td>-</td><td>3,473</td><td>40.79</td><td>Not in COGs</td></tr></tbody></table><table-wrap-foot><p>
<sup>a</sup>The percentage is based on the total number of protein coding genes in <italic>M. fulvus</italic> 124B02 genome</p></table-wrap-foot></table-wrap></p>
    </sec>
    <sec id="Sec10">
      <title>Insights from the genome sequence</title>
      <p>Until now, 22 myxobacterial genomes have been released in NCBI database. Except for the anaerobic myxobacteria, whose genomes are approximately 5 Mb, all the aerobic myxobacteria have rather large genomes, ranging from 9.03 Mb of <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3720"><italic>M. fulvus</italic></ext-link> HW-1 to 14.78 Mb of <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3762"><italic>S. cellulosum</italic></ext-link> So0157-2. Compared with the other sequenced <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3719"><italic>Myxococcus</italic></ext-link> genomes, <italic>i.e.</italic> 9.14 Mb of <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3727"><italic>M. xanthus</italic></ext-link> DK1622 [<xref ref-type="bibr" rid="CR6">6</xref>], 9.03 Mb of <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3720"><italic>M. fulvus</italic></ext-link> HW-1 [<xref ref-type="bibr" rid="CR7">7</xref>], and 10.35 Mb of <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3725"><italic>M. stipitatus</italic></ext-link><ext-link ext-link-type="uri" xlink:href="http://doi.org/10.1601/strainfinder?urlappend=%3Fid%3DDSM+14675">DSM 14675</ext-link> [<xref ref-type="bibr" rid="CR24">24</xref>], the genome of <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3720"><italic>M. fulvus</italic></ext-link> 124B02 is rather large. It is known that horizontal gene transfer (HGT) [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>] and intra-chromosomal gene duplication (IGD) [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR28">28</xref>] are two major contributors for the expansion of most prokaryotic genomes. BLASTP searching against the other three sequenced <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3719"><italic>Myxococcus</italic></ext-link> genomes revealed 576 strain-specific duplications in the strain 124B02 genome (the core circle in Fig. <xref rid="Fig3" ref-type="fig">3</xref>), accounting for 6.7 % of the total CDSs. The exogenous genetic materials may be introduced into bacterial genomes via plasmids, prophages, virus, integrative conjugative elements, insertion sequence elements or other unclassified elements [<xref ref-type="bibr" rid="CR29">29</xref>]. Of the total 8,492 CDSs in <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3720"><italic>M. fulvus</italic></ext-link> 124B02 genome, 3926 (46.2 %) were probably derived from plasmids (circles 9 &amp; 10 in Fig. <xref rid="Fig3" ref-type="fig">3</xref>), which is similar to that in other myxobacteria [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. We conducted an all-blast-all analysis using BLASTP program with an E-value cutoff of 1e-5, and the results were transferred into OrthoMCL package to extract the paralogous and orthologous proteins. Interestingly, the phylogenomic analysis indicated that <italic>M.fulvus</italic> 124B02 is closer to <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3725"><italic>M. stipitatus</italic></ext-link><ext-link ext-link-type="uri" xlink:href="http://doi.org/10.1601/strainfinder?urlappend=%3Fid%3DDSM+14675">DSM 14675</ext-link>, rather than <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3727"><italic>M. xanthus</italic></ext-link> DK1622 or <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3720"><italic>M. fulvus</italic></ext-link> HW-1 (Fig. <xref rid="Fig4" ref-type="fig">4a</xref>), which was also supported by the genome synteny analysis (Fig. <xref rid="Fig4" ref-type="fig">4b</xref>). We found that the major differences between <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3720"><italic>M. fulvus</italic></ext-link> 124B02 and the other three <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3719"><italic>Myxococcus</italic></ext-link> strains were those protein sequences for the metabolism and environment adaption processes [Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1, Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S2, Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Table S3] and of those strain-specific genes. For example, according to the COG catalog, the major differences between <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3720"><italic>M. fulvus</italic></ext-link> 124B02 and <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3725"><italic>M. stipitatus</italic></ext-link><ext-link ext-link-type="uri" xlink:href="http://doi.org/10.1601/strainfinder?urlappend=%3Fid%3DDSM+14675">DSM 14675</ext-link> were in the families of lipid transport and metabolism (<italic>p</italic>-value is 0.0076, Fisher’s exact test, two-tailed test), transcription (<italic>p</italic>-value is 0.0097, Fisher’s exact test, two-tailed test), secondary metabolites biosynthesis, transport and catabolism (<italic>p</italic>-value is 0.0015, Fisher’s exact test, two-tailed test) and replication, recombination and repair (<italic>p</italic>-value is 0.0251, Fisher’s exact test, two-tailed test). <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3720"><italic>M. fulvus</italic></ext-link> 124B02 had approximately 1,230 kb strain-specific fragments, which scattered throughout the whole genome (circles 5 &amp; 6 in Fig. <xref rid="Fig3" ref-type="fig">3</xref>). Additional file <xref rid="MOESM4" ref-type="media">4</xref>: Table S4 lists the strain specific genes of replication, recombination and repair family, of which the number of <italic>M.fulvus</italic> 124B02 is less than <italic>M.stipitatus</italic><ext-link ext-link-type="uri" xlink:href="http://doi.org/10.1601/strainfinder?urlappend=%3Fid%3DDSM+14675">DSM 14675</ext-link>.<fig id="Fig4"><label>Fig. 4</label><caption><p>Phylogenomic analyses of <italic>M. fulvus</italic> 124B02. <bold>a</bold> A whole-genome phylogenomic tree of <italic>M. fulvus</italic> 124B02 and other sequenced myxobacterial strains using <italic>Co-phylog</italic> [<xref ref-type="bibr" rid="CR50">50</xref>]. <bold>b</bold> The schematic maps of whole-genome synteny using blastn in NCBI between <italic>M. fulvus</italic> 124B02 and the other three sequenced <italic>Myxococcus</italic> strains, <italic>i.e. M. xanthus</italic> DK1622, <italic>M. fulvus</italic> HW-1 and <italic>M. stipitatus</italic> DSM 14675. Genomic inversions were observed in <italic>M. fulvus</italic> 124B02 <italic>vs. M. xanthus</italic> DK1622 and <italic>M. fulvus</italic> 124B02 <italic>vs. M. fulvus</italic> HW-1</p></caption><graphic xlink:href="40793_2015_121_Fig4_HTML" id="MO4"/></fig></p>
      <p>pMF1 is a low copy number plasmid, containing 23 predicted ORFs [<xref ref-type="bibr" rid="CR10">10</xref>]. The plasmid has no obvious beneficial genes for persistence in host, such as the genes encoding for antibiotic resistance, virulence, or growth phenotypes. All the predicted genes in pMF1 are of unknown functions, except the replication system (<italic>pMF1.13-pMF1.16</italic>) and the partitioning system (<italic>pMF1.21-pMF1.23</italic>), both of which were determined by narrowing-down of sequence fragments [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>]. While the <italic>pMF1.19</italic> and <italic>pMF1.20</italic> genes were on the lagging strand, the others were located on the leading strand (Fig. <xref rid="Fig5" ref-type="fig">5</xref>). Interestingly, BLASTP searching against the GenBank database showed that pMF1.19 and pMF1.20 had multiple homologues, mostly in pairs, in different myxobacterial genomes, except that of <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3704"><italic>Anaeromyxobacter</italic></ext-link>. For example, there were at least ten homologues of pMF1.19 and nine of pMF1.20 in <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3727"><italic>M. xanthus</italic></ext-link> DK1622. The predicted protein products of these two genes contained the conserved Pfam09535 and Pfam09533 domains, but lack significant sequence similarities to any known protein families. These function-unknown homologues exist in myxobacteria only. The identities of these homologues ranged from 31 % (WP_011550397, <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3727"><italic>M. xanthus</italic></ext-link> DK1622) to 74 % (MFUL124B02_18095 of <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3720"><italic>M. fulvus</italic></ext-link> 124B02) for pMF1.19 and from 30 % (WP_011550387, <italic>M.xanthus</italic> DK1622) to 88.0 % (MFUL124B02_18100 of <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3720"><italic>M. fulvus</italic></ext-link> 124B02) for pMF1.20 (Fig. <xref rid="Fig6" ref-type="fig">6a</xref> and <xref rid="Fig6" ref-type="fig">b</xref> are phylogenetic trees of the pMF1.19 and pMF1.20 homologues, respectively). The homologues with highest similarities to pMF1.19 and pMF1.20 are both in <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3720"><italic>M. fulvus</italic></ext-link> 124B02 host genome, which suggested that pMF1 was more closely related with this strain than other myxobacteria. The homologues of pMF1.19 and pMF1.20 in the genome of <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3720"><italic>M. fulvus</italic></ext-link> 124B02 are summarized in an additional file [Additional file <xref rid="MOESM5" ref-type="media">5</xref>: Table S5]. In addition to pMF1.19 and pMF1.20, the pMF1.1- pMF1.5 proteins each had a unique homologue in <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3725"><italic>M. stipitatus</italic></ext-link><ext-link ext-link-type="uri" xlink:href="http://doi.org/10.1601/strainfinder?urlappend=%3Fid%3DDSM+14675">DSM 14675</ext-link>, from MYSTI_04154 to MYSTI_04158 (YP 007361138.1-YP 007361142.1) (Fig. <xref rid="Fig6" ref-type="fig">6c</xref>). It is also noted that, although there is no gene coding for mobility systems [<xref ref-type="bibr" rid="CR32">32</xref>], and we have not yet observed conjugative transfer of the plasmid between <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3719"><italic>Myxococcus</italic></ext-link> strains, the pMF1.2 and its homologue MYSTI_04155 had an AAA_10 and TraC-F-type motifs, both were reported to relate to conjugative transfer [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR34">34</xref>].<fig id="Fig5"><label>Fig. 5</label><caption><p>The organization of genes in pMF1. Except for <italic>pMF1.19</italic> and <italic>pMF1.20</italic> on the lagging strand, the other genes were located on the leading strand. A blue arrow means an operon</p></caption><graphic xlink:href="40793_2015_121_Fig5_HTML" id="MO5"/></fig><fig id="Fig6"><label>Fig. 6</label><caption><p>Homologues of pMF1 ORFs in myxobacterial genomes. <bold>a &amp; b</bold> are the unrooted phylogenetic trees of the pMF1.19 and pMF1.20 proteins and their homologues, respectively. <bold>c</bold> is the summary of the homologues of pMF1.1-1.5 in <italic>M. stipitatus</italic> DSM 14675. The homologous proteins that have identity &gt;= 40 %, E. value &lt; 1×10<sup>−5</sup> for pMF1.19, and identity &gt;= 40 %, E. value &lt; 1×10<sup>−5</sup> for pMF1.20. The phylogenetic trees were constructed using maximum likelihood program with the Poisson correction distance model of MEGA5 [<xref ref-type="bibr" rid="CR51">51</xref>]. The bootstrapping supports for the interior branch length of the trees were from 1,000 replicates</p></caption><graphic xlink:href="40793_2015_121_Fig6_HTML" id="MO6"/></fig></p>
    </sec>
    <sec id="Sec11">
      <title>Conclusions</title>
      <p><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3720"><italic>M. fulvus</italic></ext-link> 124B02 is a typical strain of <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3720"><italic>Myxococcus fulvus</italic></ext-link><italic>.</italic> The complete genome sequence of <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3720"><italic>M. fulvus</italic></ext-link> 124B02 is much larger than the other sequenced genomes of <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3719"><italic>Myxococcus</italic></ext-link> strains. The phylogenomic analysis of total genome sequence indicates that <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3720"><italic>M. fulvus</italic></ext-link> 124B02 is closer to <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3725"><italic>M. stipitatus</italic></ext-link><ext-link ext-link-type="uri" xlink:href="http://doi.org/10.1601/strainfinder?urlappend=%3Fid%3DDSM+14675">DSM 14675</ext-link>, rather than <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3727"><italic>M. xanthus</italic></ext-link> DK1622 or <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1601/nm.3720"><italic>M. fulvus</italic></ext-link> HW-1. Multiple copies of the pMF1.19 and pMF1.20 homologues in different myxobacterial strains suggest that myxobacterial genomes are open, not only to being subject to integrate foreign DNA sequences but also to being duplicated by self, in which the pMF1 plasmid played important roles. The bioinformatics analyses, together with the similar G+C contents of pMF1 and myxobacterial genomes, suggested that pMF1 had a longstanding co-adaption with myxobacteria, probably involving in the expansion of myxobacterial genomes.</p>
    </sec>
  </body>
  <back>
    <app-group>
      <app id="App1">
        <sec id="Sec12">
          <title>Additional files</title>
          <p>
            <media position="anchor" xlink:href="40793_2015_121_MOESM1_ESM.xlsx" id="MOESM1">
              <label>Additional file 1: Table S1.</label>
              <caption>
                <p>Comparison of COG assignments of the genes between <italic>M. fulvus</italic> 124B02 and <italic>M. stipitatus</italic> DSM 14675. (XLSX 11 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="40793_2015_121_MOESM2_ESM.xlsx" id="MOESM2">
              <label>Additional file 2: Table S2.</label>
              <caption>
                <p>Comparison of COG assignments of the genes between <italic>M. fulvus 124B02</italic> and <italic>M. fulvus</italic> HW-1. (XLSX 11 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="40793_2015_121_MOESM3_ESM.xlsx" id="MOESM3">
              <label>Additional file 3: Table S3.</label>
              <caption>
                <p>Comparison of COG assignments of the genes between <italic>M. fulvus</italic> 124B02 and <italic>M. xanthus</italic> DK1622. (XLSX 11 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="40793_2015_121_MOESM4_ESM.xlsx" id="MOESM4">
              <label>Additional file 4: Table S4.</label>
              <caption>
                <p>Strain-specific genes in the family of DNA replication, recombination and repair in <italic>M. fulvus</italic> 124B02, compared with DSM 14675. (XLSX 10 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="40793_2015_121_MOESM5_ESM.xlsx" id="MOESM5">
              <label>Additional file 5: Table S5.</label>
              <caption>
                <p>Homologues of pMF1.19 and pMF1.20 in <italic>M. fulvus</italic> 124B02. (XLSX 9 kb)</p>
              </caption>
            </media>
          </p>
        </sec>
      </app>
    </app-group>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>IGD</term>
          <def>
            <p>intra-chromosomal gene duplication</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The authors declare that they have no competing interests.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors’ contributions</bold>
        </p>
        <p>XJC, KH, LZ and YJL participated in genome sequencing analysis, bioinformatics analysis, drafted the original manuscript, and participated in the revision process. JF and XJC extracted the total genome for sequencing. XJC and YZL wrote the paper. YZL conceived the study, provided funding for the project. All the authors read and approved the final manuscript.</p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgements</title>
      <p>This work was financially supported by grants from the National Natural Science Foundation of China (grants 31471183 and 31130004).</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shimkets</surname>
              <given-names>LJ</given-names>
            </name>
          </person-group>
          <article-title>Social and developmental biology of the myxobacteria</article-title>
          <source>Microbiol Rev</source>
          <year>1990</year>
          <volume>54</volume>
          <fpage>473</fpage>
          <lpage>501</lpage>
          <?supplied-pmid 1708086?>
          <pub-id pub-id-type="pmid">1708086</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reichenbach</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>The ecology of the myxobacteria</article-title>
          <source>Environ Microbiol</source>
          <year>1999</year>
          <volume>1</volume>
          <fpage>15</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1462-2920.1999.00016.x</pub-id>
          <?supplied-pmid 11207714?>
          <pub-id pub-id-type="pmid">11207714</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weissman</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Müller</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Myxobacterial secondary metabolites: bioactivities and modes-of-action</article-title>
          <source>Nat Prod Rep</source>
          <year>2010</year>
          <volume>27</volume>
          <fpage>1276</fpage>
          <lpage>95</lpage>
          <pub-id pub-id-type="doi">10.1039/c001260m</pub-id>
          <?supplied-pmid 20520915?>
          <pub-id pub-id-type="pmid">20520915</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xiao</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Wei</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Ebright</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Wall</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Antibiotic production by myxobacteria plays a role in predation</article-title>
          <source>J Bacteriol</source>
          <year>2011</year>
          <volume>193</volume>
          <fpage>4626</fpage>
          <lpage>33</lpage>
          <pub-id pub-id-type="doi">10.1128/JB.05052-11</pub-id>
          <?supplied-pmid 21764930?>
          <pub-id pub-id-type="pmid">21764930</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>WY</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>XW</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>YZ</given-names>
            </name>
          </person-group>
          <article-title>The <italic>groEL2</italic> gene, but not <italic>groEL1</italic>, is required for biosynthesis of the secondary metabolite myxovirescin in <italic>Myxococcus xanthus</italic> DK1622</article-title>
          <source>Microbiology</source>
          <year>2014</year>
          <volume>160</volume>
          <fpage>488</fpage>
          <lpage>95</lpage>
          <pub-id pub-id-type="doi">10.1099/mic.0.065862-0</pub-id>
          <?supplied-pmid 24425771?>
          <pub-id pub-id-type="pmid">24425771</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goldman</surname>
              <given-names>BS</given-names>
            </name>
            <name>
              <surname>Nierman</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>Kaiser</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Slater</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Durkin</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Eisen</surname>
              <given-names>JA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Evolution of sensory complexity recorded in a myxobacterial genome</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2006</year>
          <volume>103</volume>
          <fpage>15200</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.0607335103</pub-id>
          <?supplied-pmid 17015832?>
          <pub-id pub-id-type="pmid">17015832</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>ZF</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>ZH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Genome sequence of the halotolerant marine bacterium <italic>Myxococcus fulvus</italic> HW-1</article-title>
          <source>J Bacteriol</source>
          <year>2011</year>
          <volume>193</volume>
          <fpage>5015</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.1128/JB.05516-11</pub-id>
          <?supplied-pmid 21868801?>
          <pub-id pub-id-type="pmid">21868801</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schneiker</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Perlova</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Kaiser</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Gerth</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Alici</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Altmeyer</surname>
              <given-names>MO</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Complete genome sequence of the myxobacterium <italic>Sorangium cellulosum</italic></article-title>
          <source>Nat Biotechnol</source>
          <year>2007</year>
          <volume>25</volume>
          <fpage>1281</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1038/nbt1354</pub-id>
          <?supplied-pmid 17965706?>
          <pub-id pub-id-type="pmid">17965706</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Han</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>ZF</given-names>
            </name>
            <name>
              <surname>Peng</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>LP</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>LG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Extraordinary expansion of a <italic>Sorangium cellulosum</italic> genome from an alkaline milieu</article-title>
          <source>Sci Rep</source>
          <year>2013</year>
          <volume>3</volume>
          <fpage>2101</fpage>
          <?supplied-pmid 23812535?>
          <pub-id pub-id-type="pmid">23812535</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhao</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Zhong</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Shen</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Xia</surname>
              <given-names>ZJ</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>QX</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>X</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Discovery of the autonomously replicating plasmid pMF1 from Myxococcus fulvus and development of a gene cloning system in <italic>Myxococcus xanthus</italic></article-title>
          <source>Appl Environ Microbiol</source>
          <year>2008</year>
          <volume>74</volume>
          <fpage>1980</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.1128/AEM.02143-07</pub-id>
          <?supplied-pmid 18245244?>
          <pub-id pub-id-type="pmid">18245244</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>YZ</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>Q</given-names>
            </name>
          </person-group>
          <article-title>Isolation and identification of myxobacterial sources in China</article-title>
          <source>Acta Microbiol Sinica</source>
          <year>2000</year>
          <volume>40</volume>
          <fpage>652</fpage>
          <lpage>6</lpage>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kieser</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Factors affecting the isolation of CCC DNA from <italic>Streptomyces lividans</italic> and <italic>Escherichia coli</italic></article-title>
          <source>Plasmid</source>
          <year>1984</year>
          <volume>12</volume>
          <fpage>19</fpage>
          <lpage>36</lpage>
          <pub-id pub-id-type="doi">10.1016/0147-619X(84)90063-5</pub-id>
          <?supplied-pmid 6387733?>
          <pub-id pub-id-type="pmid">6387733</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ewing</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Hillier</surname>
              <given-names>LD</given-names>
            </name>
            <name>
              <surname>Wendl</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Green</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Base-calling of automated sequencer traces usingPhred. I. Accuracy assessment</article-title>
          <source>Genome Res</source>
          <year>1998</year>
          <volume>8</volume>
          <fpage>175</fpage>
          <lpage>85</lpage>
          <pub-id pub-id-type="doi">10.1101/gr.8.3.175</pub-id>
          <?supplied-pmid 9521921?>
          <pub-id pub-id-type="pmid">9521921</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ewing</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Green</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Base-calling of automated sequencer traces using phred. II. Error probabilities</article-title>
          <source>Genome Res</source>
          <year>1998</year>
          <volume>8</volume>
          <fpage>186</fpage>
          <lpage>94</lpage>
          <pub-id pub-id-type="doi">10.1101/gr.8.3.186</pub-id>
          <?supplied-pmid 9521922?>
          <pub-id pub-id-type="pmid">9521922</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gordon</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Viewing and editing assembled sequences using Consed</article-title>
          <source>Curr Protoc Bioinformatics</source>
          <year>2003</year>
          <volume>12</volume>
          <fpage>11</fpage>
          <lpage>43</lpage>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Durbin</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Fast and accurate short read alignment with Burrows–Wheeler transform</article-title>
          <source>Bioinformatics</source>
          <year>2009</year>
          <volume>25</volume>
          <fpage>1754</fpage>
          <lpage>60</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/btp324</pub-id>
          <?supplied-pmid 19451168?>
          <pub-id pub-id-type="pmid">19451168</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Handsaker</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Wysoker</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Fennell</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ruan</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Homer</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The sequence alignment/map format and SAMtools</article-title>
          <source>Bioinformatics</source>
          <year>2009</year>
          <volume>25</volume>
          <fpage>2078</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/btp352</pub-id>
          <?supplied-pmid 19505943?>
          <pub-id pub-id-type="pmid">19505943</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Edgar</surname>
              <given-names>RC</given-names>
            </name>
          </person-group>
          <article-title>PILER-CR: fast and accurate identification of CRISPR repeats</article-title>
          <source>BMC Bioinformatics</source>
          <year>2007</year>
          <volume>8</volume>
          <fpage>18</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-2105-8-18</pub-id>
          <?supplied-pmid 17239253?>
          <pub-id pub-id-type="pmid">17239253</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ashburner</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ball</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Blake</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Botstein</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Butler</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Cherry</surname>
              <given-names>JM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Gene Ontology: tool for the unification of biology</article-title>
          <source>Nat Genet</source>
          <year>2000</year>
          <volume>25</volume>
          <fpage>25</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1038/75556</pub-id>
          <?supplied-pmid 10802651?>
          <pub-id pub-id-type="pmid">10802651</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ogata</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Goto</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sato</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Fujibuchi</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Bono</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kanehisa</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>KEGG: Kyoto encyclopedia of genes and genomes</article-title>
          <source>Nucleic Acids Res</source>
          <year>1999</year>
          <volume>27</volume>
          <fpage>29</fpage>
          <lpage>34</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/27.1.29</pub-id>
          <?supplied-pmid 9847135?>
          <pub-id pub-id-type="pmid">9847135</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tatusov</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Galperin</surname>
              <given-names>MY</given-names>
            </name>
            <name>
              <surname>Natale</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Koonin</surname>
              <given-names>EV</given-names>
            </name>
          </person-group>
          <article-title>The COG database: a tool for genome-scale analysis of protein functions and evolution</article-title>
          <source>Nucleic Acids Res</source>
          <year>2000</year>
          <volume>28</volume>
          <fpage>33</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/28.1.33</pub-id>
          <?supplied-pmid 10592175?>
          <pub-id pub-id-type="pmid">10592175</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zdobnov</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Apweiler</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>InterProScan–an integration platform for the signature-recognition methods in InterPro</article-title>
          <source>Bioinformatics</source>
          <year>2001</year>
          <volume>17</volume>
          <fpage>847</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/17.9.847</pub-id>
          <?supplied-pmid 11590104?>
          <pub-id pub-id-type="pmid">11590104</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Petersen</surname>
              <given-names>TN</given-names>
            </name>
            <name>
              <surname>Brunak</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>von Heijne</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Nielsen</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>SignalP 4.0: discriminating signal peptides from transmembrane regions</article-title>
          <source>Nat Methods</source>
          <year>2011</year>
          <volume>8</volume>
          <fpage>785</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.1038/nmeth.1701</pub-id>
          <?supplied-pmid 21959131?>
          <pub-id pub-id-type="pmid">21959131</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huntley</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kneip</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Treuner-Lange</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Søgaard-Andersen</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Complete genome sequence of Myxococcus stipitatus strain DSM 14675, a fruiting myxobacterium</article-title>
          <source>Genome Announc</source>
          <year>2013</year>
          <volume>1</volume>
          <fpage>e00100</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="doi">10.1128/genomeA.00100-13</pub-id>
          <pub-id pub-id-type="pmid">23405340</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gogarten</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Townsend</surname>
              <given-names>JP</given-names>
            </name>
          </person-group>
          <article-title>Horizontal gene transfer, genome innovation and evolution</article-title>
          <source>Nat Rev Microbiol</source>
          <year>2005</year>
          <volume>3</volume>
          <fpage>679</fpage>
          <lpage>87</lpage>
          <pub-id pub-id-type="doi">10.1038/nrmicro1204</pub-id>
          <?supplied-pmid 16138096?>
          <pub-id pub-id-type="pmid">16138096</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Takeuchi</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kaneko</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Koonin</surname>
              <given-names>EV</given-names>
            </name>
          </person-group>
          <article-title>Horizontal gene transfer can rescue prokaryotes from Muller’s ratchet: benefit of DNA from dead cells and population subdivision</article-title>
          <source>G3 (Bethesda)</source>
          <year>2014</year>
          <volume>4</volume>
          <fpage>325</fpage>
          <lpage>39</lpage>
          <pub-id pub-id-type="doi">10.1534/g3.113.009845</pub-id>
          <pub-id pub-id-type="pmid">24347631</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Andersson</surname>
              <given-names>DI</given-names>
            </name>
            <name>
              <surname>Hughes</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Gene amplification and adaptive evolution in bacteria</article-title>
          <source>Annu Rev Genet</source>
          <year>2009</year>
          <volume>43</volume>
          <fpage>167</fpage>
          <lpage>95</lpage>
          <pub-id pub-id-type="doi">10.1146/annurev-genet-102108-134805</pub-id>
          <?supplied-pmid 19686082?>
          <pub-id pub-id-type="pmid">19686082</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Serres</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Kerr</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>McCormack</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Riley</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Evolution by leaps: gene duplication in bacteria</article-title>
          <source>Biol Direct</source>
          <year>2009</year>
          <volume>4</volume>
          <fpage>46</fpage>
          <pub-id pub-id-type="doi">10.1186/1745-6150-4-46</pub-id>
          <?supplied-pmid 19930658?>
          <pub-id pub-id-type="pmid">19930658</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wozniak</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Waldor</surname>
              <given-names>MK</given-names>
            </name>
          </person-group>
          <article-title>Integrative and conjugative elements: mosaic mobile genetic elements enabling dynamic lateral gene flow</article-title>
          <source>Nat Rev Microbiol</source>
          <year>2010</year>
          <volume>8</volume>
          <fpage>552</fpage>
          <lpage>63</lpage>
          <pub-id pub-id-type="doi">10.1038/nrmicro2382</pub-id>
          <?supplied-pmid 20601965?>
          <pub-id pub-id-type="pmid">20601965</pub-id>
        </element-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sun</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>XJ</given-names>
            </name>
            <name>
              <surname>Feng</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>YZ</given-names>
            </name>
          </person-group>
          <article-title>Characterization of the partitioning system of Myxococcus plasmid pMF1</article-title>
          <source>PLoS One</source>
          <year>2011</year>
          <volume>6</volume>
          <fpage>e28122</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0028122</pub-id>
          <?supplied-pmid 22174771?>
          <pub-id pub-id-type="pmid">22174771</pub-id>
        </element-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Feng</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>XJ</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>YZ</given-names>
            </name>
          </person-group>
          <article-title>Characterization of the replication origin of the myxobacterial self-replicative plasmid pMF1</article-title>
          <source>Plasmid</source>
          <year>2012</year>
          <volume>68</volume>
          <fpage>105</fpage>
          <lpage>12</lpage>
          <pub-id pub-id-type="doi">10.1016/j.plasmid.2012.04.001</pub-id>
          <?supplied-pmid 22537554?>
          <pub-id pub-id-type="pmid">22537554</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smillie</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Garcillán-Barcia</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Francia</surname>
              <given-names>MV</given-names>
            </name>
            <name>
              <surname>Rocha</surname>
              <given-names>EP</given-names>
            </name>
            <name>
              <surname>de la Cruz</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Mobility of plasmids</article-title>
          <source>Microbiol Mol Biol R</source>
          <year>2010</year>
          <volume>74</volume>
          <fpage>434</fpage>
          <lpage>52</lpage>
          <pub-id pub-id-type="doi">10.1128/MMBR.00020-10</pub-id>
        </element-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marchler Bauer</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Marchler-Bauer</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Derbyshire</surname>
              <given-names>MK</given-names>
            </name>
            <name>
              <surname>Gonzales</surname>
              <given-names>NR</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Chitsaz</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>CDD: NCBI conserved domain database</article-title>
          <source>Nucleic Acids Res</source>
          <year>2015</year>
          <volume>43</volume>
          <issue>D</issue>
          <fpage>222</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gku1221</pub-id>
        </element-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Christie</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Vogel</surname>
              <given-names>JP</given-names>
            </name>
          </person-group>
          <article-title>Bacterial type IV secretion: conjugation systems adapted to deliver effector molecules to host cells</article-title>
          <source>Trends Microbiol</source>
          <year>2000</year>
          <volume>8</volume>
          <fpage>354</fpage>
          <lpage>60</lpage>
          <pub-id pub-id-type="doi">10.1016/S0966-842X(00)01792-3</pub-id>
          <?supplied-pmid 10920394?>
          <pub-id pub-id-type="pmid">10920394</pub-id>
        </element-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Grasso</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Sharlow</surname>
              <given-names>MF</given-names>
            </name>
          </person-group>
          <article-title>Multiple sequence alignment using partial order graphs</article-title>
          <source>Bioinformatics</source>
          <year>2002</year>
          <volume>18</volume>
          <fpage>452</fpage>
          <lpage>64</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/18.3.452</pub-id>
          <?supplied-pmid 11934745?>
          <pub-id pub-id-type="pmid">11934745</pub-id>
        </element-citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Castresana</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Selection of conserved blocks from multiple alignments for their use in phylogenetic analysis</article-title>
          <source>Mol Biol Evol</source>
          <year>2000</year>
          <volume>17</volume>
          <fpage>540</fpage>
          <lpage>52</lpage>
          <pub-id pub-id-type="doi">10.1093/oxfordjournals.molbev.a026334</pub-id>
          <?supplied-pmid 10742046?>
          <pub-id pub-id-type="pmid">10742046</pub-id>
        </element-citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stamatakis</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hoover</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Rougemont</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>A Rapid Bootstrap Algorithm for the RAxML Web Servers</article-title>
          <source>Syst Biol</source>
          <year>2008</year>
          <volume>57</volume>
          <fpage>758</fpage>
          <lpage>71</lpage>
          <pub-id pub-id-type="doi">10.1080/10635150802429642</pub-id>
          <?supplied-pmid 18853362?>
          <pub-id pub-id-type="pmid">18853362</pub-id>
        </element-citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reddy</surname>
              <given-names>TBK</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Stamatis</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Bertsch</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Isbandi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Jansson</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The Genomes OnLine Database (GOLD) v.5: a metadata management system based on a four level (meta) genome project classification</article-title>
          <source>Nucleic Acids Res</source>
          <year>2014</year>
          <volume>43</volume>
          <issue>Database issue</issue>
          <fpage>D1099</fpage>
          <lpage>106</lpage>
          <?supplied-pmid 25348402?>
          <pub-id pub-id-type="pmid">25348402</pub-id>
        </element-citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Field</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Garrity</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Gray</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Morrison</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Selengut</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Sterk</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The minimum information about agenome sequence (MIGS) specification</article-title>
          <source>Nat Biotechnol</source>
          <year>2008</year>
          <volume>26</volume>
          <fpage>541</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.1038/nbt1360</pub-id>
          <?supplied-pmid 18464787?>
          <pub-id pub-id-type="pmid">18464787</pub-id>
        </element-citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Woese</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Kandler</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Wheelis</surname>
              <given-names>ML</given-names>
            </name>
          </person-group>
          <article-title>Towards a natural system of organisms: proposal for the domains Archaea, Bacteria, and Eucarya</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>1990</year>
          <volume>87</volume>
          <fpage>4576</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.87.12.4576</pub-id>
          <?supplied-pmid 2112744?>
          <pub-id pub-id-type="pmid">2112744</pub-id>
        </element-citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Garrity</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Bell</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Lilburn</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <source>The revised road map to the manual</source>
          <year>2005</year>
          <publisher-loc>In</publisher-loc>
          <publisher-name>Bergey’s Manual of Systematic Bacteriology. Springer US</publisher-name>
          <fpage>159</fpage>
          <lpage>187</lpage>
        </element-citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Kuever</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Rainey</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>Widdel</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Garrity</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Brenner</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Krieg</surname>
              <given-names>NR</given-names>
            </name>
            <name>
              <surname>Staley</surname>
              <given-names>JT</given-names>
            </name>
          </person-group>
          <article-title>Class IV. Deltaproteobacteria class nov</article-title>
          <source>Bergey’s Manual of Systematic Bacteriology</source>
          <year>2005</year>
          <edition>2</edition>
          <publisher-loc>NY</publisher-loc>
          <publisher-name>Springer</publisher-name>
          <fpage>922</fpage>
        </element-citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tchan</surname>
              <given-names>YT</given-names>
            </name>
            <name>
              <surname>Pochon</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Prévot</surname>
              <given-names>AR</given-names>
            </name>
          </person-group>
          <article-title>Etude de systématique bactérienne. VIII. Essai de classification des <italic>Cytophaga</italic></article-title>
          <source>Ann Inst Pasteur (Paris)</source>
          <year>1948</year>
          <volume>74</volume>
          <fpage>394</fpage>
          <lpage>400</lpage>
        </element-citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <mixed-citation publication-type="other">Reichenbach H, Garrity GM, Brenner DJ, Krieg NR, Staley JT. Order VIII. Myxococcales. Tchan, Pochon and Prévot 1948, 398AL. Bergey’s manual of systematic bacteriology. Springer, New York, 2005;2(Part C):1059–1072.</mixed-citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Jahn</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <source>Beiträge zur botanischen Protistologie I: Die Polyangiden</source>
          <year>1924</year>
          <publisher-loc>Leipzig</publisher-loc>
          <publisher-name>Verlag Gebruder Borntraeger</publisher-name>
          <fpage>1</fpage>
          <lpage>107</lpage>
        </element-citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lang</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Stackebrandt</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Emended descriptions of the genera <italic>Myxococcus</italic> and <italic>Corallococcus</italic>, typification of the species <italic>Myxococcus stipitatus</italic> and <italic>Myxococcus macrosporus</italic> and a proposal that they be represented by neotype strains. Request for an opinion</article-title>
          <source>Int J Syst Evol Microbiol</source>
          <year>2009</year>
          <volume>59</volume>
          <fpage>2122</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1099/ijs.0.003566-0</pub-id>
          <?supplied-pmid 19567579?>
          <pub-id pub-id-type="pmid">19567579</pub-id>
        </element-citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jahn</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Myxobacteriales</article-title>
          <source>Kryptogamenflora der Mark Brandenburg</source>
          <year>1911</year>
          <volume>5</volume>
          <fpage>187</fpage>
          <lpage>206</lpage>
        </element-citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Skerman</surname>
              <given-names>VBD</given-names>
            </name>
            <name>
              <surname>McGowan</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Sneath</surname>
              <given-names>PHA</given-names>
            </name>
          </person-group>
          <article-title>Approved lists of bacterial names</article-title>
          <source>Int J Syst Bacteriol</source>
          <year>1980</year>
          <volume>30</volume>
          <fpage>225</fpage>
          <lpage>30</lpage>
          <pub-id pub-id-type="doi">10.1099/00207713-30-1-225</pub-id>
        </element-citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <mixed-citation publication-type="other">Agents B. Technical rules for biological agents. www.baua.de TRBA 466.</mixed-citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Jin</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Co-phylog: an assembly-free phylogenomic approach for closely related organisms</article-title>
          <source>Nucleic Acids Res</source>
          <year>2013</year>
          <volume>41</volume>
          <issue>7</issue>
          <fpage>e75</fpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkt003</pub-id>
          <?supplied-pmid 23335788?>
          <pub-id pub-id-type="pmid">23335788</pub-id>
        </element-citation>
      </ref>
      <ref id="CR51">
        <label>51.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tamura</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Peterson</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Peterson</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Stecher</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Nei</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods</article-title>
          <source>Mol Biol Evol</source>
          <year>2011</year>
          <volume>28</volume>
          <fpage>2731</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1093/molbev/msr121</pub-id>
          <?supplied-pmid 21546353?>
          <pub-id pub-id-type="pmid">21546353</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:4700576</identifier><datestamp>2016-01-06</datestamp><setSpec>jneurorehab</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="http://jats.nlm.nih.gov/ns/archiving/1.0/ http://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Neuroeng Rehabil</journal-id>
      <journal-id journal-id-type="iso-abbrev">J Neuroeng Rehabil</journal-id>
      <journal-title-group>
        <journal-title>Journal of NeuroEngineering and Rehabilitation</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1743-0003</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC4700576</article-id>
      <article-id pub-id-type="pmcid">PMC4700576</article-id>
      <article-id pub-id-type="pmc-uid">4700576</article-id>
      <article-id pub-id-type="publisher-id">109</article-id>
      <article-id pub-id-type="doi">10.1186/s12984-015-0109-2</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Real-time computer-based visual feedback improves visual acuity in downbeat nystagmus – a pilot study</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Teufel</surname>
            <given-names>Julian</given-names>
          </name>
          <address>
            <email>julian.teufel@med.uni-muenchen.de</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bardins</surname>
            <given-names>S.</given-names>
          </name>
          <address>
            <email>sbardins@nefo.med.uni-muenchen.de</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Spiegel</surname>
            <given-names>Rainer</given-names>
          </name>
          <address>
            <email>rainer.spiegel@usb.ch</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kremmyda</surname>
            <given-names>O.</given-names>
          </name>
          <address>
            <email>olympia.kremmyda@med.uni-muenchen.de</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Schneider</surname>
            <given-names>E.</given-names>
          </name>
          <address>
            <email>eschneid@hs-lausitz.de</email>
          </address>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Strupp</surname>
            <given-names>M.</given-names>
          </name>
          <address>
            <email>michael.strupp@med.uni-muenchen.de</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kalla</surname>
            <given-names>R.</given-names>
          </name>
          <address>
            <email>roger.kalla@insel.ch</email>
          </address>
          <xref ref-type="aff" rid="Aff4"/>
        </contrib>
        <aff id="Aff1"><label/>Department of Neurology and German Center for Vertigo and Balance Disorders, Ludwig-Maximilans-University Munich, Marchioninistr. 15, 81377 Munich, Germany </aff>
        <aff id="Aff2"><label/>Division of Internal Medicine, Basel University Hospital, Am Petersgraben 4, 4031 Basel, Switzerland </aff>
        <aff id="Aff3"><label/>Institute of Medical Technology, Brandenburg University of Technology Cottbus-Senftenberg, Großenhainer Str. 57, 01968 Senftenberg, Germany </aff>
        <aff id="Aff4"><label/>Department of Neurology Inselspital, Bern University Hospital, Freiburgstrasse 4, 3010 Bern, Switzerland </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>4</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>4</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <volume>13</volume>
      <elocation-id>1</elocation-id>
      <history>
        <date date-type="received">
          <day>5</day>
          <month>8</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>19</day>
          <month>12</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© Teufel et al. 2015</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Patients with downbeat nystagmus syndrome suffer from oscillopsia, which leads to an unstable visual perception and therefore impaired visual acuity. The aim of this study was to use real-time computer-based visual feedback to compensate for the destabilizing slow phase eye movements.</p>
        </sec>
        <sec>
          <title>Methods</title>
          <p>The patients were sitting in front of a computer screen with the head fixed on a chin rest. The eye movements were recorded by an eye tracking system (EyeSeeCam®). We tested the visual acuity with a fixed Landolt C (static) and during real-time feedback driven condition (dynamic) in gaze straight ahead and (20°) sideward gaze. In the dynamic condition, the Landolt C moved according to the slow phase eye velocity of the downbeat nystagmus. The Shapiro-Wilk test was used to test for normal distribution and one-way ANOVA for comparison.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>Ten patients with downbeat nystagmus were included in the study. Median age was 76 years and the median duration of symptoms was 6.3 years (SD +/- 3.1y). The mean slow phase velocity was moderate during gaze straight ahead (1.44°/s, SD +/- 1.18°/s) and increased significantly in sideward gaze (mean left 3.36°/s; right 3.58°/s). In gaze straight ahead, we found no difference between the static and feedback driven condition. In sideward gaze, visual acuity improved in five out of ten subjects during the feedback-driven condition (<italic>p</italic> = 0.043).</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>This study provides proof of concept that non-invasive real-time computer-based visual feedback compensates for the SPV in DBN. Therefore, real-time visual feedback may be a promising aid for patients suffering from oscillopsia and impaired text reading on screen. Recent technological advances in the area of virtual reality displays might soon render this approach feasible in fully mobile settings.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Downbeat nystagmus</kwd>
        <kwd>Visual acuity</kwd>
        <kwd>Eye tracking</kwd>
        <kwd>Video oculography</kwd>
        <kwd>Computer-based visual feedback</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002347</institution-id>
              <institution>Bundesministerium für Bildung und Forschung (DE)</institution>
            </institution-wrap>
          </funding-source>
          <award-id>01EO0901</award-id>
        </award-group>
      </funding-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>© The Author(s) 2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Background</title>
      <p>Many patients with nystagmus (involuntary eye movements) suffer from blurred vision, unstable visual perception and decreased visual acuity (VA), which leads to a decreased quality of life. Amongst different forms of nystagmus, the downbeat nystagmus syndrome (DBN) is a frequent central type fixation nystagmus [<xref ref-type="bibr" rid="CR1">1</xref>]. Patients predominantly suffer from balance disorders and oscillopsia. The latter results in a decrease of VA, in particular when looking downward during reading or to the right or left [<xref ref-type="bibr" rid="CR2">2</xref>]. One cycle of a nystagmus consists of a slow phase and a saccade (fast phase), whereby the slow phase velocity (SPV = deg/s) generally is a measurement for the intensity of the nystagmus. While the slow phase of DBN induces oscillopsia, the fast phase of DBN does not induce oscillopsia, as visual perception is suppressed during the corrective downward saccade [<xref ref-type="bibr" rid="CR3">3</xref>].</p>
      <p>DBN intensity can be reduced in slightly over 50 % of patients [<xref ref-type="bibr" rid="CR4">4</xref>–<xref ref-type="bibr" rid="CR7">7</xref>] by aminopyridines, but many patients do not respond to drug therapy. Furthermore, patients may not tolerate the medical treatment or they still suffer from an impaired VA including text reading. Hence, there is reason to search for other treatment principles and assistive technology may be one of the principles helping to improve VA.</p>
      <p>In this study, we investigated the effects of real-time visual feedback on the improvement of text reading measured by an increase in VA. Using a computer-assisted device (gaze-contingent-display) and an infrared video oculography system (EyeSeeCam®) [<xref ref-type="bibr" rid="CR8">8</xref>], we created on a computer screen a real-time feedback image of the visual field, which was controlled by the slow phase velocity of DBN. A similar approach has been conducted before by using a magnetic search coil or an optical device [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>].</p>
      <p>For the first time however, our aim was to stabilize the retinal image without the use of a magnetic search coil or an optical device. Therefore, we adopted a thoroughly different approach, without the need of any invasive procedures (coils or contact lenses) using a basically mobile set-up, though limited to a computer screen.</p>
    </sec>
    <sec id="Sec2">
      <title>Methods</title>
      <p>Patients with DBN were included in this prospective study regardless of the etiology or the duration of visual symptoms (for clinical detail see Table <xref rid="Tab1" ref-type="table">1</xref>). All patients gave their informed consent for participation in the study. The examination was performed in accordance with the Helsinki II Declaration and approved by the ethics committee of the Ludwig-Maximilians University Medical Faculty (No. 082/03).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Etiology of the DBN syndrome (idiopathic cerebellar syndrome; cerebellar atrophy; CANVAS), duration of visual symptoms and visual acuity as measured by orthoptic exam (Snellen chart, CC “cum correctione”) as well as SPV in gaze straight ahead (Landolt C, SC “sin correctione”)</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Age/sex</th><th>Etiology</th><th>Duration of symptoms (years)</th><th>Visual acuity Snellen chart</th><th>SPV in center gaze in °/s</th></tr></thead><tbody><tr><td>72/m</td><td>idiopathic</td><td>10</td><td>0.6</td><td>2.5</td></tr><tr><td>65/f</td><td>idiopathic</td><td>3</td><td>1</td><td>1.47</td></tr><tr><td>82/f</td><td>CANVAS</td><td>4</td><td>0.75</td><td>0.1</td></tr><tr><td>79/m</td><td>idiopathic</td><td>13</td><td>0.6</td><td>1.0</td></tr><tr><td>75/f</td><td>CANVAS</td><td>7</td><td>0.25</td><td>3.0</td></tr><tr><td>80/m</td><td>idiopathic</td><td>7</td><td>0.75</td><td>3.5</td></tr><tr><td>55/m</td><td>CANVAS</td><td>3</td><td>0.8</td><td>0.06</td></tr><tr><td>59/f</td><td>idiopathic</td><td>6</td><td>0.8</td><td>1.0</td></tr><tr><td>78/f</td><td>atrophy</td><td>7</td><td>1</td><td>0.8</td></tr><tr><td>77/f</td><td>idiopathic</td><td>3</td><td>0.58</td><td>1.0</td></tr><tr><td>
<italic>Mean</italic>
</td><td>-</td><td>6.3</td><td>0.71</td><td>1.44</td></tr><tr><td>
<italic>SD</italic>
</td><td>-</td><td>+/-3.13</td><td>+/-0.21</td><td>+/-1.18</td></tr></tbody></table></table-wrap></p>
      <p>VA was measured by a standard orthoptic exam (Snellen chart, CC “cum correctione”) and using the EyeSeeCam® system during a static condition and dynamic feedback condition (Fig. <xref rid="Fig1" ref-type="fig">1</xref>; Landolt C, SC “sin correctione”). Each patient was sitting upright at a distance of 55 cm in front of a monitor with the head fixed on a chin rest. The patient’s eyes were detected by an eye tracking system consisting of one infrared camera (EyeSeeCam®) [<xref ref-type="bibr" rid="CR8">8</xref>]. The eye was illuminated by an infrared light source integrated into the camera. A translucent hot mirror in front of each eye reflected only the infrared light in the direction of the camera. The camera was running at a sampling rate of 220 Hz. The eye position was measured with an accuracy of 0.5°. Visual stimulation was performed on an LCD monitor (BenQ, latency 2 ms, horizontal sync 120 Hz). The calibration was done presenting a center dot and four dots at 8.5° each left, right, up and down. We calculated clusters of the eye positions at each out of 5 fixation points (center, left, right, up, down). One cluster consisted of several slow and quick phases. Therefore, the center of the cluster was found approximately in the middle of the slow phase traces.<fig id="Fig1"><label>Fig. 1</label><caption><p>Vertical eye position (black line indicates vertical eye movements, gray line showing position of the Landolt C) in the static (left) and feedback-driven condition (right)</p></caption><graphic xlink:href="12984_2015_109_Fig1_HTML" id="MO1"/></fig></p>
      <p>VA was measured in multiple trials based on the correct identification of the Landolt C optotype orientation. The Landolt C was designed according to standard guidelines (NAS-NRC, 1980) [<xref ref-type="bibr" rid="CR11">11</xref>]. In each trial, one Landolt C was shown 6 times in different orientations. The size of the symbol on the initial trial was equivalent to a VA of 0.1. Each following trial the size of the Landolt C was decreased. The subjects’ results were entered manually by the experimenter. Each sequence was terminated after the participant erred on 2 consecutive judgements. The size of the Landolt C from the previous correct trial was used for determination of VA. The Landolt Cs were presented in two different conditions: static and feedback-driven. In each condition VA was tested in three positions relative to the head position: center, 20° to the left and 20° to the right. During the feedback-driven condition, the Landolt C was displayed in real-time movement with the same velocity as the upward drift of the eyes (=slow phase velocity; SPV). There was a latency of 20 ms between the onset of the upward slow phase and the onset of the movement of the Landolt C. In order to limit the ocular offset caused by a retinal error and small head movements, the Landolt C was shown in a predefined area (diameter 7.5°). The Landolt C position was automatically reset to the center point, in case it left the predefined area.</p>
      <p>The eye movement velocity was calculated using a numerical three-point differentiation of the eye position and a Gaussian low-pass filtering with a corner frequency of 30Hz. The high-frequency velocity peaks of the nystagmus’ quick phases, saccades and blink artifacts were removed from the eye velocity using an absolute acceleration threshold of 700°/s^2 and a subsequent floating median filter with a time window of 0.5 s. Finally, SPV was calculated as the median during the presentation of the stimulus on a predefined position.</p>
      <p>Statistical analysis was performed using SPSS (V 22, IBM Corp.). We applied the Shapiro-Wilk test to determine, whether the slow phase nystagmus velocity data were normally distributed. One-way ANOVA was used for comparison.</p>
    </sec>
    <sec id="Sec3">
      <title>Results</title>
      <p>Ten Patients with DBN (4 male) with different etiologies were included in the study (cerebellar atrophy (<italic>n</italic> = 1), CANVAS (CANVAS = cerebellar ataxia, neuropathy, vestibular areflexia syndrome; <italic>n</italic> = 3), idiopathic (<italic>n</italic> = 6)). Median age was 76 years (SD +/- 8.9 y) and the mean duration of symptoms was 6.3 years (SD +/- 3.1 y; range 3-13 y). The results of the VA measurement by orthoptic exam (Snellen chart) and the static/feedback conditions (Landolt C) are listed in Table <xref rid="Tab1" ref-type="table">1</xref>. As two patients had a visual acuity of 1, all patients were measured without eyeglasses (SC) to detect differences in both conditions.</p>
      <p>The mean slow phase velocity (SPV) was moderate during gaze straight ahead (1.44°/s, SD +/- 1.18°/s). As one would expect, SPV increased significantly in sideward gaze (Fig. <xref rid="Fig2" ref-type="fig">2</xref>; mean left 3.36°/s, SD +/- 2.23°/s; mean right 3.58°/s, SD +/- 1.8°/s; one-way ANOVA center-left <italic>p</italic> = 0.027, center-right <italic>p</italic> = 0.005). VA in center gaze during static and feedback-driven conditions remained stable throughout both measurements, i.e. revealing no significant change in either condition as the absolute values remained equal. In sideward gaze during the static condition, VA decreased compared to the VA in center gaze in seven out of ten subjects (mean VA, SD: center gaze 0.35 +/- 0.09; left 0.31 +/- 0.09; right 0.28 +/- 0.08; descriptive differences). VA remained equal in center gaze and improved in five out of ten subjects in sideward gaze during the feedback-driven condition compared to the static condition (mean VA, SD: center gaze 0.35 +/- 0.09; left 0.32 +/- 0.09; right 0.33 +/- 0.1; descriptive differences).<fig id="Fig2"><label>Fig. 2</label><caption><p>Slow phase velocity (SPV) of the DBN during gaze straight ahead as well as sideways (both left and right 20° off center) for all ten subjects. In gaze straight ahead, the mean SPV is 1.4°/s and increases noticeably in left and right position (mean left 3.36°/s; mean right 3.58°/s)</p></caption><graphic xlink:href="12984_2015_109_Fig2_HTML" id="MO2"/></fig></p>
      <p>Comparison of gaze induced changes in DBN correlated strongly with improvements in VA during the feedback-driven condition (r = 0.73, <italic>p</italic> = 0.016), classifing two distinct patient groups. Those patients with DBN whose VA improved during the feedback-driven condition showed the most prominent increase of SPV during sideward gaze (Fig. <xref rid="Fig3" ref-type="fig">3</xref>; group 1) compared to those patients (group 2) who did not. The mean improvement of VA was 0.01 in leftward and 0.1 in rightward gaze. In order to compare both groups with inferential statistics, we first tested whether the assumption of normal distribution was fulfilled. According to Shapiro-Wilk test, the data were normally distributed using the VA as dependent variable (group 1: <italic>p</italic> = 0.343; group 2: <italic>p</italic> = 0.251). The subsequent one-way ANOVA showed a significant difference (Fig. <xref rid="Fig4" ref-type="fig">4</xref>; <italic>p</italic> = 0.043; dependent variable SPV increase, independent variable feedback condition).<fig id="Fig3"><label>Fig. 3</label><caption><p>Difference in SPV (grey column) and visual acuity (VA, black column) after allocation in either group 1 (improvement of VA) or group 2 (no improvement in VA)</p></caption><graphic xlink:href="12984_2015_109_Fig3_HTML" id="MO3"/></fig><fig id="Fig4"><label>Fig. 4</label><caption><p>Statistical analysis (ANOVA, <italic>p</italic> = 0.043) shows a significant increase in SPV in the VA improvement group (mean SPV 2.9°/s; each dot indicates one subject) compared to the subjects without VA improvement (mean SPV 1.2°/s)</p></caption><graphic xlink:href="12984_2015_109_Fig4_HTML" id="MO4"/></fig></p>
    </sec>
    <sec id="Sec4">
      <title>Discussion</title>
      <p>This study investigated the effect of real-time visual feedback using a computer-assisted device on VA in ten patients with DBN syndrome. The major findings of this study were as follows: first, there was no effect on VA during gaze straight ahead, probably due to a low baseline SPV. This applied to patients with high or low SPV in gaze straight ahead. There were four patients with a SPV &gt;1°/s, however there was also no improvement after giving visual feedback in gaze straight ahead. Second, in sideward gaze however, VA improved significantly. If there was a decrease in VA in the static condition in sideward gaze compared to gaze straight ahead, the loss of VA could be compensated by the dynamic visual feedback. If there was no decrease in VA during sideward gaze, there was no improvement in VA accordingly.</p>
      <p>Looking at the difference in SPV between gaze straight ahead and in sideward gaze, there is no striking difference in VA during the static condition.</p>
      <p>The reason might be a central compensation mechanism for an unstable visual perception due to oscillopsia, which prevents a strong decline in VA. The central compensation mechanism could be further addressed by long-term analysis of acute lesions leading to visual impairment due to nystagmus because of a stroke or in multiple sclerosis. A sudden decrease in VA due to an acute lesion leading to an unstable visual field could reveal the effectiveness of our setup. However, visual impairment and difficulties in reading texts reduce the quality of life and even the capability to work, especially in an increasingly computerized working environment.</p>
      <p>A further problem may consist of technical reasons. A stable visual field is inherently necessary for an adequate VA. As there is a slight offset when the eye jumps back on target after the downward saccade, another corrective saccade is needed to refixate the target, if the latter does not match the previous retinal image. As mentioned above, the Landolt C was shown in a predefined area of 7.5° to limit the ocular offset. However, it cannot be ruled out that there occurred a retinal error fostering an unstable perception and therefore limiting the effectiveness of the feedback compensation.</p>
      <p>Effects of the positive influence of retinal image stabilization on VA have been previously reported [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. Yet, our setup presents a different technical approach, as there is no need for a magnetic search coil or the application of an optical device including contact lenses. The results of the previous studies cannot be compared directly to our computer-driven visual feedback due to the different technical approach. However, we can confirm the finding that retinal image stabilization in patients with acquired nystagmus leads to an improved VA. The focus of our study was on expanding the usage of an already existing eye tracking device as an easy-to-use and non-invasive application for an improved VA for reading on a computer screen.</p>
      <p>Looking at the results of a study investigating the effect of the drug 4-aminopyridine on VA in DBN syndrome, we can find an improvement of mean VA of 0.07 (from 0.59 to 0.66) in gaze straight ahead with a responder rate of 57 %, i.e. 57 % of patients responded successfully to treatment with 4-aminopyridine by reducing the nystagmus [<xref ref-type="bibr" rid="CR4">4</xref>]. Therefore, we can conclude that a reduction of SPV actually improves the VA. In our study, we found an improvement of mean VA of 0.1 in rightward gaze and 0.01 in leftward gaze for patients with a significant increase of SPV in sideward gaze. Since SPV in sideward gaze was not analyzed in the study with 4-aminopyridinne<sup>3</sup> those results cannot be transferred to our study. In the 4-aminopyridine study, the DBN patients showed a higher SPV at baseline than our cohort. Hence, we hypothesize that we did not find an improvement in VA during center gaze due to the small SPV at baseline.</p>
      <p>The question arises why there is only a subtle effect in gaze straight ahead using our visual feedback device. As already mentioned above, the reason could be that a central compensation mechanism already compensated for the oscillopsia, which persisted for years (mean duration of symptoms 6.3 years). Furthermore, the reason could be technical. It is possible that the lack of stability of the visual field could explain the poor VA in our experimental setup as well as the minor improvements. However, an even more unstable perception should even further decrease the VA.</p>
      <p>Given our findings and other studies using 4-aminopyridine, we can assume that there actually is an improvement in VA after reduction of SPV, as the VA correlated with the improvement of SPV.</p>
      <p>For investigating our experimental setup and proof of concept, our cohort can be considered sufficient. Further studies are needed to investigate these findings in a larger patient group.</p>
    </sec>
    <sec id="Sec5">
      <title>Conclusions</title>
      <p>This study provides proof of concept that real-time computer-based visual feedback compensates for the SPV in DBN and therefore improves VA. So far, our findings are limited to the mere testing of VA using the Landolt C in patients with chronic DBN. Further studies will have to investigate our results in acute lesions and larger patient cohorts. The novelty of our research was the different technical approach by application of a non-invasive setup using the EyeSeeCam<bold>®</bold> eye tracking system. Recent technological advances in the area of virtual reality displays might soon render this approach feasible in fully mobile settings.</p>
    </sec>
  </body>
  <back>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>ANOVA</term>
          <def>
            <p>analysis of variance</p>
          </def>
        </def-item>
        <def-item>
          <term>CANVAS</term>
          <def>
            <p>cerebellar ataxia, neuropathy, vestibular areflexia syndrome</p>
          </def>
        </def-item>
        <def-item>
          <term>CC</term>
          <def>
            <p>cum correctione</p>
          </def>
        </def-item>
        <def-item>
          <term>DBN</term>
          <def>
            <p>downbeat nystagmus</p>
          </def>
        </def-item>
        <def-item>
          <term>SC</term>
          <def>
            <p>sin correctione</p>
          </def>
        </def-item>
        <def-item>
          <term>SD</term>
          <def>
            <p>standard deviation</p>
          </def>
        </def-item>
        <def-item>
          <term>SPV</term>
          <def>
            <p>slow phase velocity</p>
          </def>
        </def-item>
        <def-item>
          <term>VA</term>
          <def>
            <p>visual acuity</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>Erich Schneider acts as an unpaid consultant and has received funding for travel from Interacoustics AS, a distributor of EyeSeeCam. He is the general manager and shareholder of EyeSeeTec GmbH, the manufacturer of EyeSeeCam. Stanislavs Bardins is a shareholder of EyeSeeTec GmbH.</p>
        <p>The authors JT, RS, OK, MS, RK declare that they have no competing interests.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors’ contributions</bold>
        </p>
        <p>JT has made substantial contributions to conception and design, acquisition of data, analysis and interpretation of data, drafting and revising the manuscript for important intellectual content. SB carried out the MATLAB programming, has made substantial contributions to conception and design, acquisition of data, analysis and interpretation of data, drafting and revising the manuscript for important intellectual content. RS has made substantial contributions to analysis and interpretation of data, drafting and revising the manuscript for important intellectual content. OK has made substantial contributions to analysis and interpretation of data, drafting and revising the manuscript for important intellectual content. ES has made substantial contributions to analysis and interpretation of data, drafting and revising the manuscript for important intellectual content. MS has made substantial contributions to analysis and interpretation of data, drafting and revising the manuscript for important intellectual content. RK has made substantial contributions to conception and design, acquisition of data, analysis and interpretation of data, drafting and revising the manuscript for important intellectual content. All authors read and approved the final manuscript.</p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgements</title>
      <p>We thank Dr. Corrado Bernasconi, PhD for critical revision of the statistical analysis.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Strupp</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Thurtell</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Shaikh</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Brandt</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Zee</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Leigh</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
          <article-title>Pharmacotherapy of vestibular and ocular motor disorders, including nystagmus</article-title>
          <source>J Neurol</source>
          <year>2011</year>
          <volume>258</volume>
          <issue>7</issue>
          <fpage>1207</fpage>
          <lpage>22</lpage>
          <pub-id pub-id-type="doi">10.1007/s00415-011-5999-8</pub-id>
          <?supplied-pmid 21461686?>
          <pub-id pub-id-type="pmid">21461686</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tilikete</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Vighetto</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Oscillopsia: causes and management</article-title>
          <source>Curr Opin Neurol</source>
          <year>2011</year>
          <volume>24</volume>
          <issue>1</issue>
          <fpage>38</fpage>
          <lpage>43</lpage>
          <pub-id pub-id-type="doi">10.1097/WCO.0b013e328341e3b5</pub-id>
          <?supplied-pmid 21102332?>
          <pub-id pub-id-type="pmid">21102332</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bremmer</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Kubischik</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hoffmann</surname>
              <given-names>KP</given-names>
            </name>
            <name>
              <surname>Krekelberg</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Neural dynamics of saccadic suppression</article-title>
          <source>J Neurosci</source>
          <year>2009</year>
          <volume>29</volume>
          <issue>40</issue>
          <fpage>12374</fpage>
          <lpage>83</lpage>
          <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2908-09.2009</pub-id>
          <?supplied-pmid 19812313?>
          <pub-id pub-id-type="pmid">19812313</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Claassen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Spiegel</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kalla</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Faldon</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kennard</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Danchaivijitr</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A randomised double-blind, cross-over trial of 4-aminopyridine for downbeat nystagmus--effects on slowphase eye velocity, postural stability, locomotion and symptoms</article-title>
          <source>J Neurol Neurosurg Psychiatry</source>
          <year>2013</year>
          <volume>84</volume>
          <issue>12</issue>
          <fpage>1392</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1136/jnnp-2012-304736</pub-id>
          <?supplied-pmid 23813743?>
          <pub-id pub-id-type="pmid">23813743</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kalla</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Glasauer</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Buttner</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Brandt</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Strupp</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>4-aminopyridine restores vertical and horizontal neural integrator function in downbeat nystagmus</article-title>
          <source>Brain</source>
          <year>2007</year>
          <volume>130</volume>
          <issue>Pt 9</issue>
          <fpage>2441</fpage>
          <lpage>51</lpage>
          <pub-id pub-id-type="doi">10.1093/brain/awm172</pub-id>
          <?supplied-pmid 17664175?>
          <pub-id pub-id-type="pmid">17664175</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kalla</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Glasauer</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Schautzer</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Lehnen</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Buttner</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Strupp</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>4-aminopyridine improves downbeat nystagmus, smooth pursuit, and VOR gain</article-title>
          <source>Neurology</source>
          <year>2004</year>
          <volume>62</volume>
          <issue>7</issue>
          <fpage>1228</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1212/01.WNL.0000118287.68294.E5</pub-id>
          <?supplied-pmid 15079036?>
          <pub-id pub-id-type="pmid">15079036</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Strupp</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schuler</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Krafczyk</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Jahn</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Schautzer</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Buttner</surname>
              <given-names>U</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study</article-title>
          <source>Neurology</source>
          <year>2003</year>
          <volume>61</volume>
          <issue>2</issue>
          <fpage>165</fpage>
          <lpage>70</lpage>
          <pub-id pub-id-type="doi">10.1212/01.WNL.0000078893.41040.56</pub-id>
          <?supplied-pmid 12874393?>
          <pub-id pub-id-type="pmid">12874393</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schneider</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Villgrattner</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Vockeroth</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bartl</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kohlbecher</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bardins</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>EyeSeeCam: an eye movement-driven head camera for the examination of natural visual exploration</article-title>
          <source>Ann N Y Acad Sci</source>
          <year>2009</year>
          <volume>1164</volume>
          <fpage>461</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1749-6632.2009.03858.x</pub-id>
          <?supplied-pmid 19645949?>
          <pub-id pub-id-type="pmid">19645949</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leigh</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Rushton</surname>
              <given-names>DN</given-names>
            </name>
            <name>
              <surname>Thurston</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Hertle</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Yaniglos</surname>
              <given-names>SS</given-names>
            </name>
          </person-group>
          <article-title>Effects of retinal image stabilization in acquired nystagmus due to neurologic disease</article-title>
          <source>Neurology</source>
          <year>1988</year>
          <volume>38</volume>
          <issue>1</issue>
          <fpage>122</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.1212/WNL.38.1.122</pub-id>
          <?supplied-pmid 3336443?>
          <pub-id pub-id-type="pmid">3336443</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yaniglos</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Leigh</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
          <article-title>Refinement of an optical device that stabilizes vision in patients with nystagmus</article-title>
          <source>Optom Vis Sci</source>
          <year>1992</year>
          <volume>69</volume>
          <issue>6</issue>
          <fpage>447</fpage>
          <lpage>50</lpage>
          <pub-id pub-id-type="doi">10.1097/00006324-199206000-00006</pub-id>
          <?supplied-pmid 1641226?>
          <pub-id pub-id-type="pmid">1641226</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ricci</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Cedrone</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Cerulli</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Standardized measurement of visual acuity</article-title>
          <source>Ophthalmic Epidemiol</source>
          <year>1998</year>
          <volume>5</volume>
          <issue>1</issue>
          <fpage>41</fpage>
          <lpage>53</lpage>
          <pub-id pub-id-type="doi">10.1076/opep.5.1.41.1499</pub-id>
          <?supplied-pmid 9575537?>
          <pub-id pub-id-type="pmid">9575537</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:4700577</identifier><datestamp>2016-01-06</datestamp><setSpec>bmcresnotes</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="http://jats.nlm.nih.gov/ns/archiving/1.0/ http://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="case-report">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Res Notes</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Res Notes</journal-id>
      <journal-title-group>
        <journal-title>BMC Research Notes</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1756-0500</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC4700577</article-id>
      <article-id pub-id-type="pmcid">PMC4700577</article-id>
      <article-id pub-id-type="pmc-uid">4700577</article-id>
      <article-id pub-id-type="publisher-id">1768</article-id>
      <article-id pub-id-type="doi">10.1186/s13104-015-1768-6</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Leprosy in Denmark 1980–2010: a review of 15 cases</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Aftab</surname>
            <given-names>Huma</given-names>
          </name>
          <address>
            <phone>+45 26202462</phone>
            <email>humaftab@dadlnet.dk</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nielsen</surname>
            <given-names>Susanne D.</given-names>
          </name>
          <address>
            <email>sdn@dadlnet.dk</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bygbjerg</surname>
            <given-names>Ib C.</given-names>
          </name>
          <address>
            <email>iby@sund.ku.dk</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <aff id="Aff1"><label/>Department of Infectious Diseases and Rheumatology, Rigshospitalet, Copenhagen, Denmark </aff>
        <aff id="Aff2"><label/>Global Health Section, Department of Public Health, University of Copenhagen, Copenhagen, Denmark </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>5</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>5</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <volume>9</volume>
      <elocation-id>10</elocation-id>
      <history>
        <date date-type="received">
          <day>1</day>
          <month>9</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>30</day>
          <month>11</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© Aftab et al. 2016</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Leprosy, caused by <italic>Mycobacterium leprae</italic>, is a chronic and progressive granulomatous disease affecting mainly the skin and the peripheral nervous system. If left unrecognized, the infection can lead to permanent nerve damage and disability. The clinical presentation depends on the immune response of the patient and can result in a wide spectrum of symptoms. Leprosy is a rare encounter in Scandinavia but remains endemic in some parts of the world, with some areas reporting an
increasing incidence. We performed a retrospective record review of leprosy cases in Denmark from 1980 to 2010 with the purpose of presenting the most common geographical, demographic and clinical findings and to discuss the diagnostic and therapeutic challenges of patients with leprosy.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>In total 15 cases were reviewed. The majority (87 %) of leprosy patients in Denmark were born in South- and Southeast Asia, and were presumed to have contracted the infection in their countries of origin. Patients were predominately young males (mean age: 28.6 years). Anaesthetic skin lesion with or without nerve enlargement were the most common clinical presentations (73 %). Immunological leprosy reactions were seen in 40 % of the cases. Diagnoses were based on clinical findings and skin biopsies. Treatment length varied but all patients received multidrug regimens.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>Leprosy should be kept in mind when encountering patients with suspicious skin lesions originating from leprosy endemic areas or with history of travel or work in the tropics. Due to the long incubation period with symptoms presenting long after immigration or return, clinicians often do not have the diagnosis in mind. The wide spectrum of symptoms and immunological reactions further complicates the diagnostic process. Treatment of leprosy and the complicated immunological reactions, which frequently accompanies the infection, should be performed in collaboration with a specialist.</p>
        </sec>
        <sec>
          <title>Electronic supplementary material</title>
          <p>The online version of this article (doi:10.1186/s13104-015-1768-6) contains supplementary material, which is available to authorized users.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Leprosy cases</kwd>
        <kwd>Clinical findings</kwd>
        <kwd>Immunology</kwd>
        <kwd>Treatment</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>© The Author(s) 2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Background</title>
      <p>Comparative genomics indicates that leprosy originated in Eastern Africa or the Near East, and was spread by human migration to rest of the world. Leprosy was well-recognized in ancient India and China since 4000 BC with the first known written reference to the disease 600 BC. Leprosy is believed to have arrived in Ireland through trade and commerce with the Far East and travelled to Scandinavia through the Vikings; however, some believe that the crusaders brought the disease to Europe from where it spread to the Americas [<xref ref-type="bibr" rid="CR1">1</xref>]. Others believe that Alexander the Great’s Greek soldiers introduced it to Europe [<xref ref-type="bibr" rid="CR2">2</xref>]. By the 12th century leprosy had become a widespread disease in Denmark giving rise to numerous leprosy hospitals/centres, demanding a large number of victims and inflicting a great deal of socioeconomic damage [<xref ref-type="bibr" rid="CR3">3</xref>]. In Norway the disease raged well into the 19th century giving rise to the world’s first national patient registry. In 1873, driven by epidemiological studies, the causative agent of leprosy was discovered by the Norwegian physician Gerard Armauer Hansen [<xref ref-type="bibr" rid="CR4">4</xref>], but not until a century later, in 1982, an efficient multidrug therapy (MDT) was recommended by the World Health Organisation (WHO) [<xref ref-type="bibr" rid="CR5">5</xref>]. The global prevalence rate has declined markedly following implementation of MDT. The WHO ‘elimination of leprosy’ goal is less than 1 per 10,000 persons in a given population receiving MDT. Elimination of leprosy at global level was achieved by the year 2000. At present, leprosy is endemic in countries such as India, Indonesia and Brazil, and these countries account for the bulk of newly detected cases. Thus, in 2013, a total of 180,618 cases were registered, and the prevalence rate was 0.32 in 10,000 worldwide [<xref ref-type="bibr" rid="CR6">6</xref>]. However, no decline was recorded and a rising incidence in some countries indicate continuous transmission. Some attribute this to the intensified leprosy control and new case finding strategies in endemic regions and not an increasing incidence <italic>per se</italic> [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>].</p>
      <p>The vast majority of infected individuals never develop clinically detectable symptoms and signs. Age and sex are important risk factors for developing leprosy: adolescents aged 10–19 and persons aged 30 or above are the most susceptible. Adult men are twice as likely to develop the infection as adult women [<xref ref-type="bibr" rid="CR9">9</xref>]. Although, household contacts of multibacillary (MB) cases have an increased risk of developing leprosy compared to the general population, infection acquired outside the household and subclinical infection is being recognized as an potential route of transmission, sustaining the high new detection rate of leprosy [<xref ref-type="bibr" rid="CR10">10</xref>–<xref ref-type="bibr" rid="CR13">13</xref>]; 90–95 % of spouses to infective leprosy patients did not acquire the infection in the pre-antibiotic era. Children of leprosy patients have an increased risk of acquiring the infection compared to the spouse, indicating that genetic similarity to the infected parent makes one more susceptible to the infection [<xref ref-type="bibr" rid="CR14">14</xref>]. Even though some studies have shown an association between susceptibility to leprosy and certain genes/chromosomal regions, more studies are needed to fully understand the genetics of susceptibility to leprosy [<xref ref-type="bibr" rid="CR15">15</xref>–<xref ref-type="bibr" rid="CR17">17</xref>].</p>
      <p>Today, in Scandinavia, as in most of Europe, leprosy remains non- autochthonous, brought to the region by immigrants from endemic areas, thus explaining its rarity: In Denmark less than one case per year has been reported during the last 30 years, and the leprosy situation in Denmark was last reviewed more than 20-years-ago [<xref ref-type="bibr" rid="CR18">18</xref>].</p>
      <p>The aim of our study was to give a brief overview of the history and of the current general knowledge on leprosy and conduct a retrospective review of leprosy cases from 1980 to 2010 in Denmark with emphasis on clinical characteristics and therapeutic challenges.</p>
      <sec id="Sec2">
        <title>The causative agent</title>
        <p>Leprosy is a chronic granulomatous infection caused by the intracellular acid fast bacilli <italic>Mycobacterium leprae</italic> (<italic>M. leprae</italic>) and is most likely transmitted through droplets from the upper respiratory tract of bacilliferous patients. Although transmission through skin under controlled laboratory conditions has been reported, infection through intact skin is not considered possible. The mycobacterium is difficult to study and has not successfully been cultured in vitro but only in armadillos and footpads of nude mice.
The infection has low virulence and a mean incubation period of 4–5 years, but the incubation period may be much longer [<xref ref-type="bibr" rid="CR19">19</xref>]. Incubation time for paucibacillary (PB) infections is assumed to be shorter than MB.</p>
        <p>The bacilli exhibit tropism for histiocytes and Schwann cells, causing anaesthetic skin lesions, and sensorimotor function loss [<xref ref-type="bibr" rid="CR20">20</xref>], and also for cooler parts of the body, such as eyebrows, earlobes and the nose.</p>
        <p>Even though <italic>M. leprae</italic> has been isolated from several environmental and animal reservoirs including armadillos (10), most authors agree on humans being the main reservoir of infection [<xref ref-type="bibr" rid="CR21">21</xref>].</p>
      </sec>
      <sec id="Sec3">
        <title>The clinico-pathological spectrum</title>
        <p>The wide spectrum of clinical presentations reflects the complexity of the immune response towards the causative agent and is graded according to the widely used Ridley–Jopling scheme, which is primarily based on the immunological characteristics. Clinical and histo-pathological characteristics are also considered, and delineated as two stable polar forms ranging from polar tuberculoid (TT) to polar lepromatous leprosy (LL), and in between the unstable borderline forms: borderline tuberculoid (BT), borderline leprosy (BB) and borderline lepromatous leprosy (BL). Thus, tuberculoid leprosy (T) refers to TT and BT while lepromatous leprosy forms (L) to BB, BL and LL. Borderline types are more likely to down- or upgrade through immunological reactions; type 1 reactions [<xref ref-type="bibr" rid="CR22">22</xref>]. Indeterminate leprosy, the earliest clinically detectable form of the disease is immunologically unstable. Most cases can be cured spontaneously, but some cases may go on to develop one of the determinate forms later. Leprosy may even present with nerve affection as the only symptom: pure neural leprosy.</p>
        <p>The clinico-pathological features in leprosy are the result of a varying immune response. Thus, T by mounting a strong cell mediated immune response restricts the infection to a single or few well demarcated, dry (anhydrosis) and scaly anaesthetic skin lesions (macules, plaques) with an elevated margin and central healing. The skin changes are often hypopigmented in dark skin and red/coppery coloured in lighter skin. Although early and significant nerve enlargement is common in T, and the most commonly affected nerves (most common one or few asymmetric nerve affections) are posterior tibial, ulnar, median, lateral popliteal, facial, and radial nerves (may also be affected in L), thickening of the cutaneous nerves close to the skin lesion is an important diagnostic clue.</p>
        <p>T lesions are dominated by CD4+ cells, histologically characterized by well-defined granulomas consisting of lymphocytes, epitheloid and giant cells and virtually no bacilli [<xref ref-type="bibr" rid="CR23">23</xref>], i.e. paucibacillary. The cellular infiltration may extend up to the epidermal layer of the skin. The strong immune reaction in T is probably a result of switching towards a Th1 response. The Th1 type response in patients at the tuberculoid pole (TT and BT) results in abundance of interferon -γ (INF-γ), Tumor Necrosis Factor (TNF-α), interleukins (IL)-2 and IL-15 and a positive skin test (Lepromin test). At the opposite pole (L), the clinical picture reflects a weak cell mediated immune response leading to disseminated infection with multiple skin lesions often distributed symmetrically on the body. In contrast to T, L patients have multiple erythematous or slightly hypopigmented skin lesions (macules, papules and nodules), with poorly defined borders and smooth shiny surfaces which are not necessarily anaesthetic in early stages of the disease. Nerve enlargement and palsy also develop later as compared to T: most common as multiple symmetric nerve affection. Progressive L cases can develop a disseminated infiltration of the skin causing a waxy appearance and thickening of the skin, most prominent in the face, <italic>facies leonidae</italic>. L cases may display systemic symptoms affecting the eyes, testes, bones and liver.</p>
        <p>L lesions are characterized by few T lymphocytes with a predominance of CD8+ cells, no granulomas, diffuse infiltration of undifferentiated ‘foamy’ macrophages and loads of bacilli, i.e. multibacillary. The epidermis stays intact until late stages of the disease. In contrast to the immune response seen in T, L lesions formed during the Th2 type response contain transcripts for IL-4, IL-5 and IL-10, are non-reactive to the Lepromin test and show high anti-M. leprae antibody titres which do not seem to convey any protection [<xref ref-type="bibr" rid="CR24">24</xref>–<xref ref-type="bibr" rid="CR26">26</xref>].</p>
        <p>The unresponsiveness to <italic>M. leprae</italic> extracts in the Lepromin test in L may be explained by immune deviation (the above described Th1 and Th2 immune responses), deletion (varying Th0 cell responsiveness to <italic>M. leprae)</italic> and/or inhibition of T cell responses by regulatory T cells (Tregs) [<xref ref-type="bibr" rid="CR27">27</xref>]. Some lepromatous patients are capable of mounting a Th1 response upon stimulation with cytokines such as IL-12 secreted by activated dendritic cells and stimulate naïve T cells which are present in T but not L lesions. This observation has led some to conclude that the Th2 immune status in L is reversible [<xref ref-type="bibr" rid="CR28">28</xref>]. Findings from some studies though do not support the notion of immune deviation in leprosy [<xref ref-type="bibr" rid="CR29">29</xref>] wherefore increasing interest in clarifying the role of Tregs in leprosy has evolved. However, studies of Tregs in leprosy have found conflicting results as both increased and decreased frequency of Tregs in L patients have been found [<xref ref-type="bibr" rid="CR30">30</xref>–<xref ref-type="bibr" rid="CR32">32</xref>]. Thus, more investigations into the role of Tregs in leprosy are needed [<xref ref-type="bibr" rid="CR33">33</xref>].</p>
      </sec>
      <sec id="Sec4">
        <title>Diagnosing leprosy</title>
        <p>According to WHO diagnostic criteria, a person with one of the two cardinal signs: (1) positive skin smear <italic>or</italic> (2) characteristic anaesthetic leprosy skin lesions with <italic>or</italic> without nerve thickening/enlargement with sensory or motor loss, is regarded as having leprosy. WHO recommends a simpler classification scheme based on number of skin lesions and bacillary load in skin smears. This is often used to classify leprosy based on number of skin lesions alone, where Paucibacillary (PB) leprosy corresponds with 1-5 skin lesions (indeterminate leprosy, TT and BT) and MB leprosy with &gt;6 skin lesions (BB, BL and LL) [<xref ref-type="bibr" rid="CR34">34</xref>].</p>
        <p>However, a considerable amount of patients will be misclassified with risk of both over- and undertreatment. Therefore, if not used in the field for operational purposes, experts recommend classifying patients according to the Ridley–Jopling scheme. Thus, whenever possible, a patient suspected of leprosy should undergo examination for the three cardinal signs of leprosy: (1) thorough inspection of the skin for leprosy lesions (morphology described above) and anaesthesia (light touch, pin prick and temperature) of such, (2) enlargement with <italic>or</italic> without sensory or motor loss of most commonly affected peripheral nerves (predilection sites mentioned above), and (3) positive skin smear. A total of 3–6 skin smears should be performed from skin lesions and in L cases from cooler sites with a high probability of finding AFB (earlobes, the forehead, extensor surfaces of the forearms and knees). Skin smears are used to assess the bacillary load: the bacteriological index (BI) and the viability of the mycobacteria; the morphological index (MI). The BI indicating the bacterial load is expressed on a logarithmic scale from 1 + (at least 1 bacillus in every 100 fields) to 6 + (at least 1000 bacilli in every field). Leprosy patients with a BI &lt; 2 are designated as PB while a BI &gt; 2 as MB. Before WHO recommended the current operational method of counting skin lesions to classify a patient as PB or MB, a positive skin slit smear from any site designated the patient as MB. Skin slit smears show poor sensitivity (particularly in PB cases), but their high specificity is very useful for identifying MB, which is the most infectious.</p>
        <p>Skin biopsies are usually performed when there is doubt about the diagnosis and remain the golden standard. Biopsies should be taken from an ‘active’ site i.e. red, enlarged and infiltrated. A modified Ziehl-Neelsen stain, such as the Wade Fite stain is preferable for the histological diagnosis. The histopathological characteristics of T and L are described above. According to WHO, only leprosy bacilli which appear as solid acid fast rods are viable while dead leprosy bacilli stain irregularly; this can aid in assessing the treatment effect.</p>
        <p>The Lepromin test is analogous to the tuberculin test used in tuberculosis. It relies on the host’s ability to mount a delayed hypersensitivity reaction after an intradermal injection of <italic>M. leprae</italic> antigens. The Lepromin test has low sensitivity and specificity, and a long waiting period of 3 weeks before a reaction can be observed after injection; therefore the test is rarely used. It has no diagnostic value, and was previously used to classify leprosy patients in tuberculoid when positive, and in lepromatous when negative.</p>
        <p>Serological tests are under development but are not used routinely due to their low sensitivity in patients at the tuberculoid pole, and have shown false positive reactions in non-leprosy patients [<xref ref-type="bibr" rid="CR35">35</xref>]. Some studies indicate that antibodies specific <italic>M. leprae</italic> antigens may be useful for detection of early disease in house hold contacts and for monitoring treatment efficacy [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>].</p>
        <p>PCR for <italic>M. leprae</italic> is sensitive and specific but not widely applied due to cost. Its use until now has been for epidemiological research purposes. In endemic areas it has a promising role for detection of early leprosy, PB cases with a low bacillary load and relapse [<xref ref-type="bibr" rid="CR38">38</xref>–<xref ref-type="bibr" rid="CR40">40</xref>].</p>
      </sec>
      <sec id="Sec5">
        <title>Treatment</title>
        <p>The WHO MDT for leprosy has proven to be highly effective and should be the first choice for all patients. Patients with up to five skin lesions and/or no bacilli (PB) are treated for 6 months with daily dapsone and monthly rifampicin, while multibacillary (MB) cases with more than six skin lesions and abundant bacilli should undergo a 12 months course of daily dapsone and clofazimine supplemented by monthly rifampicin and clofazimine [<xref ref-type="bibr" rid="CR41">41</xref>]. Skin lesions in MB patients with a high BI may clear more slowly and have a high BI at the end of treatment compared to MB patients with a lower BI; if such patients do not show improvement after completion of 12 months of MDT, WHO recommends an additional 12 months of MDT.</p>
        <p>Severe haemolysis can follow dapsone treatment in patients with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency. Dapsone should therefore be avoided in these patients. An adverse effect of clofazimine which doctors should be aware of, since it can lead to poor compliance, is reddish discoloration of the skin, conjunctivae and body excretions such as sputum and urine.</p>
        <p>Second line agents, ofloxacin and minocycline can be used in a single dose regimen for PB cases; Rifampicin-Ofloxacin-Minocycline, ‘ROM,’ for patients with a single leprosy skin lesion. This regimen was introduced by WHO in 1998 and should only be administered after careful examination of the skin making sure the patient only has one lesion and no nerve involvement. Since ROM has proven to be less effective than MDT for treatment of PB cases with more than one skin lesion, it is currently not recommended for PB cases presenting with 2–5 skin lesions [<xref ref-type="bibr" rid="CR42">42</xref>].</p>
      </sec>
      <sec id="Sec6">
        <title>Leprosy reactions</title>
        <p>Around 30 % of borderline cases experience type 1 [<xref ref-type="bibr" rid="CR43">43</xref>] reactions resulting in an upgrading of the cellular immune response, shifting the patients towards the tuberculoid pole and a Th1 response. Leprosy type 1 reactions are type IV delayed hypersensitivity immune reactions. The reactions are most commonly observed at initiation of therapy or during the puerperium. However, when the immune system fails to contain the infection a downgrading towards the lepromatous pole is taking place. Distinction between up- and downgrading may be difficult, and may require histo-pathological examination, although downgrading is usually observed prior to initiation of leprosy treatment, whereas upgrading, often occurs as a response to treatment. Type 1 up- and downgrading reactions cause acute inflammation of existing skin (oedema and ulceration) and nerve (motor-sensory loss) disease, new lesions and nerve involvement can also appear. Prompt diagnosis and treatment is of utmost importance due to the risk of permanent nerve damage. Patients should undergo thorough examination of nerves most commonly affected (as described earlier) and followed closely. Prednisolone starting at 30–40 mg tapered to 5 mg over 5–6 months under close observation of nerve function is generally recommended for type 1 reactions; there is however, currently no consensus on dosage and treatment duration [<xref ref-type="bibr" rid="CR43">43</xref>]. Results are awaited from controlled trials looking into different treatment regimens with prednisolone for leprosy patients with nerve impairment, and the effect of prednisolone prophylaxis for subclinical nerve function impairment [<xref ref-type="bibr" rid="CR44">44</xref>].</p>
        <p>Type 2 reactions, erythema nodosum leprosum (ENL) are mainly seen in BL and LL patients of whom 50 % (the 50 % refers to the subpolar LL group which is immunologically unstable compared to the LL polar form) are at risk of experiencing this complication. ENL is a type III immune response brought about by the inflammatory reaction towards immune-complexes. The immune-complexes deposited in various organ systems cause fever, erythematous painful nodules, uveitis, neuritis, arthritis and orchitis [<xref ref-type="bibr" rid="CR45">45</xref>]. ENL lesions are characterized by heavy neutrophil infiltration and high levels of TNF-α. The immunological mechanisms underlying the leprosy reactions are not fully understood [<xref ref-type="bibr" rid="CR46">46</xref>].</p>
        <p>Severe ENL can be life threatening and require prolonged immunosuppressive treatment. WHO recommend corticosteroids 1 mg/Kg body weight for 12 weeks. In case of severe ENL not responding to corticosteroid, clofazimine a corticosteroid sparing agents can be used; according to WHO guidelines clofazimine should be started at 100 mg, three times a day for maximum 12 weeks, where after it should be tapered to 100 mg twice a day for 12 weeks and then 100 mg once a day for 12–24 weeks. Clofazimine is more effective than thalidomide for prevention of ENL recurrences. Thalidomide in doses of 100–400 mg/day have shown to be effective in controlling the reaction, but more and larger trials are needed to prove its efficacy [<xref ref-type="bibr" rid="CR47">47</xref>], and due to its teratogenic side effects, WHO does not recommend its use for the treatment of ENL in women of childbearing age [<xref ref-type="bibr" rid="CR48">48</xref>]. Despite this: thalidomide is by many practitioners considered to be the most effective drug against ENL. Pentoxifylline is less effective than thalidomide, but has shown to be effective in alleviating ENL symptoms, and could be used as an alternative to thalidomide against ENL when thalidomide is contraindicated [<xref ref-type="bibr" rid="CR49">49</xref>].</p>
        <p>The time frame is important when distinguishing between relapse and leprosy reactions: New elements or nerve affection appearing less than 3 years after a successful course of MDT is more likely to be a reaction. However, the final diagnosis will depend on presence or not of bacilli. According to WHO a relapse in a MB case is defined as “<italic>multiplication of M. leprae, suspected by the marked increase (at least 2</italic>+ <italic>over the previous value) in the BI at any single site, usually with evidence of clinical deterioration”</italic>. To distinguish between relapse and reversal reactions in PB cases a trial of prednisolone is recommended; improvement within 4 weeks favours the diagnosis of a reversal reaction.</p>
        <p>Although co-infection with HIV does not seem to shift the patients towards the L pole, some studies indicate an increased incidence of type 1 reactions in patients receiving anti-retroviral treatment, probably as part of an immune reconstitution syndrome [<xref ref-type="bibr" rid="CR50">50</xref>, <xref ref-type="bibr" rid="CR51">51</xref>].</p>
      </sec>
    </sec>
    <sec id="Sec7">
      <title>Methods</title>
      <p>Leprosy is a mandatory notifiable disease in Denmark. Based on social security numbers, and retrieved from the national surveillance service database at Statens Serum Institut (SSI) leprosy cases reported in the period January, 1980 to December, 2010 were reviewed. Additionally, we searched the patient register at University Hospital of Copenhagen, Rigshospitalet which is the main referral hospital for tropical diseases in Denmark. For elaboration on medical history, clinical presentation, diagnostic procedures and treatment, medical records, photographs and letters from these and other notifying hospitals were collected.</p>
      <p>Permission to obtain information about leprosy cases was granted by the Danish National Board of Health (Additional file <xref rid="MOESM1" ref-type="media">1</xref>).</p>
    </sec>
    <sec id="Sec8">
      <title>Case presentation</title>
      <p>From 1980 to 2010, 17 cases of leprosy were reported to SSI and five additional cases were identified in the Rigshospitalet patient register. Only 14 of 22 journals were available. One of the cases had been suspected for leprosy, but this was never confirmed. This left us with 13 available medical records of confirmed cases. For two patients, information was collected from letters, photographs and personal correspondence with the attending physician. Thus, in total, information on 15 leprosy patients was reviewed.</p>
      <p>The available data were reviewed with focus on demographic data, clinical findings, diagnostic procedures and treatment. The results of these findings are summarized in Table <xref rid="Tab1" ref-type="table">1</xref>.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Summary of demographic and clinical features of leprosy patients in Denmark recorded from 1980 to 2010</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Variable</th><th align="left">Leprosy patients (N = 15), n (%)</th></tr></thead><tbody><tr><td align="left" colspan="2">Age (years)</td></tr><tr><td align="left"> Range</td><td align="left">5–74</td></tr><tr><td align="left"> Median</td><td align="left">23</td></tr><tr><td align="left" colspan="2">Gender</td></tr><tr><td align="left"> Male</td><td align="left">9 (60)</td></tr><tr><td align="left"> Female</td><td align="left">6 (40)</td></tr><tr><td align="left" colspan="2">Country of origin</td></tr><tr><td align="left"> Philippines</td><td align="left">3 (20)</td></tr><tr><td align="left"> Cambodia</td><td align="left">3 (20)</td></tr><tr><td align="left"> India</td><td align="left">3 (20)</td></tr><tr><td align="left"> Pakistan</td><td align="left">1 (7)</td></tr><tr><td align="left"> Cameroon</td><td align="left">1 (7)</td></tr><tr><td align="left"> Tanzania</td><td align="left">1 (7)</td></tr><tr><td align="left"> Thailand</td><td align="left">1 (7)</td></tr><tr><td align="left"> Sri Lanka</td><td align="left">2 (13)</td></tr><tr><td align="left" colspan="2">Duration of stay in Denmark (years)</td></tr><tr><td align="left"> Range</td><td align="left">0–20</td></tr><tr><td align="left"> Median</td><td align="left">0</td></tr><tr><td align="left">  0–5</td><td align="left">11 (73)</td></tr><tr><td align="left">  ≤6–10</td><td align="left">0</td></tr><tr><td align="left">  ≤11–15</td><td align="left">0</td></tr><tr><td align="left">  ≤16–20</td><td align="left">1 (7)</td></tr><tr><td align="left">  Unknown</td><td align="left">3 (20)</td></tr><tr><td align="left" colspan="2">Duration of clinical presentation (weeks)</td></tr><tr><td align="left"> Range</td><td align="left">3–384</td></tr><tr><td align="left"> Median</td><td align="left">36</td></tr><tr><td align="left" colspan="2">Classification</td></tr><tr><td align="left"> Tuberculoid leprosy (TT)</td><td align="left">5 (33)</td></tr><tr><td align="left"> Borderline tuberculoid leprosy (BT)/Borderline leprosy (BB)/Borderline lepromatous leprosy (BL)</td><td align="left">8 (53)</td></tr><tr><td align="left"> Lepromatous leprosy (LL)</td><td align="left">1 (7)</td></tr><tr><td align="left"> Indeterminate leprosy</td><td align="left">1 (7)</td></tr><tr><td align="left" colspan="2">Reactions</td></tr><tr><td align="left"> Type 1</td><td align="left">4 (27)</td></tr><tr><td align="left"> Type 2</td><td align="left">2 (13)</td></tr><tr><td align="left" colspan="2">Histopathological findings</td></tr><tr><td align="left"> Skin smears positive for bacilli (7 patients had skin smears performed)</td><td align="left">3 (43)</td></tr><tr><td align="left"> Granulomas in biopsies</td><td align="left">9 (60)</td></tr></tbody></table></table-wrap></p>
      <p>Leprosy was predominately imported to Denmark from South- and Southeast Asia (87 %), in particular India, The Philippines and Cambodia, all areas where leprosy is endemic; only two cases originated from African countries. Age of patients ranged from 5 to 74 years, and 11 of 15 patients (73 %) debuted in their second or third decade of life. The youngest patient (5-years-old) was a girl who had most probably contracted the infection from her father, who had been treated for leprosy in Nepal.</p>
      <p>Three patients (20 %) recalled exposure to leprosy. Five patients (33 %) were diagnosed and had also undergone treatment for leprosy before migrating to Denmark, while one patient (7 %) was defined as a relapse after consulting a leprologist in London.</p>
      <p>Diagnosis was based on travel history, clinical and pathological findings. Most patients were classified according to the Ripley and Jopling scheme. Among the 15 patients 53 % were classified as borderline leprosy types evenly distributed along the spectrum, whilst 33 and 7 % were classified as TT and LL respectively. Duration of symptoms varied from 3 weeks to 8 years, but it was only possible to deduce the length of delay in diagnosis from a few medical records since the date of the first contact with a medical professional was rarely mentioned. For the few for whom the dates were available, the time period from contact with a doctor to suspicion of leprosy was only a few weeks.</p>
      <p>Common clinical features were hypopigmentation, slightly dark reddish/brown skin lesions (macules, nodules and plaques), hyposensitivity/anaesthesia of skin lesions, nerve enlargement and palsy, in particular the ulnar and peroneal nerves. Approximately 73 % of cases presented with the two cardinal signs: anaesthetic skin lesions and peripheral nerve thickening. The most common symptom bringing the patient in contact with health authorities was skin changes mimicking conditions such as sarcoidosis and pityriasis versicolor. Initially, two leprosy cases (13 %) were, based on the histo-pathological finding of granulomatous skin changes, mistaken for sarcoidosis.</p>
      <p>According to the records available, slit skin smears were performed in seven of the 15 patients (47 %), and the results recorded in six (40 %). The patients from whom skin smears were not obtained were all classified as TT/BT cases. Skin biopsies were obtained from all patients, often on the suspicion of other dermatological disease (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). Bacilli were visualized in six of the 15 (40 %) skin biopsies, of which five were borderline leprosy types (BT, BB and BL) while one was a LL patient. Non-necrotizing granulomatous changes were found in nine biopsies (60 %). The Wade Fite stain was used on all biopsies but one. Histopathological description of biopsies from patients with TT was only available for the one patient who experienced a relapse. This showed hyperplasia of the epidermis, perivascular inflammation consisting of lymphohistiocytes, granulocytes and plasma cells and no granulomas. Biopsies from patients in the BT/BB spectrum showed epitheloid cells granulomas, giant cells and an unaffected epidermal zone, while BB/BL was characterized by a more diffuse infiltration with or without lymphocytes, no giant cells and in some cases, ‘foamy’ macrophages and AFB. Confluent infiltrates of histiocytes with neutrophile granulocytes and loads of AFB was the main finding in the LL relapse patient. PCR for detection of <italic>M. leprae</italic> was not performed in any of the 15 cases.<fig id="Fig1"><label>Fig. 1</label><caption><p>
<bold>a</bold> 22-year-old Filipino woman with leprosy initially suspected for sarcoidosis. The patient was designated as a case of BT/BB with a type 1 reaction (<bold>a</bold>). WADE FITE special stain of skin biopsy showing the acid fast <italic>M. leprae</italic> bacilli. <bold>b</bold>
<italic>Slightly elevated</italic>, <italic>scaly</italic> and <italic>light coppery coloured plaques</italic> on the <italic>right</italic> leg. Similar lesions were present universally</p></caption><graphic xlink:href="13104_2015_1768_Fig1_HTML" id="MO1"/></fig></p>
      <p>Four of the 15 patients (27 %) experienced a type 1 reaction of which two were classified as borderline lepromatous and diagnosed as downgrading reactions before initiation of leprosy treatment while the remaining presented with type 1 reaction symptoms shortly after initiation of leprosy treatment. The patients with downgrading type 1 reactions displayed the following symptoms: appearance of new anaesthetic skin elements and signs of increased inflammation of the existing ones. Both patients were feverish, one of them with increased C- reactive protein and neutrocytosis. Arthralgia and dactylitis were also present in both cases, while only one of them developed nerve palsy (drop foot). One patient experienced a type 1 reaction shortly after treatment initiation in Cameroun, before arriving in Denmark; the only symptom mentioned in the medical records regarding this was nerve palsy (peroneus paralysis). Half of the patients experiencing a type 1 reaction were treated with corticosteroids.</p>
      <p>The patients reacting with ENL (13 %) were BL/LL patients experiencing fever, universal lymphadenitis, flaring of skin elements in the form of inflamed noduli on the upper extremities. One had enlargement of the ulnar and auriuclaris magnus nerves, which was treated with a 1 week thalidomide course while the other received prednisolone due to systemic symptoms with haematuria.</p>
      <p>Most common complication/sequelae were decreased sensibility, particularly on the peripheral extremities, ulcers and secondary infections due to neuropathy, as well as keratosis and atrophy of fingers and toes. These patients were referred to an orthopaedist and/or orthopaedic surgeon for evaluation and treatment. Two patients had undergone amputation of fingers/toes, in total grade 2 disability (G2D) was recorded for three patients (20 %). One of three patients with G2D had the amputations done in Cameroun, while another had received several years of leprosy treatment in Thailand, and had been living with G2D for some time when a new reaction (ENL) brought him to a physician in Denmark; bringing G2D to 6 % in our patient sample.</p>
      <p>Some patients experienced improvement of their sensory disturbances during treatment but none had complete remission.</p>
      <p>Skin lesion with findings of granulomatous changes in skin biopsies often led to the suspicion of sarcoidosis. Other differential diagnoses mentioned were mostly dermatological: acne, pityriasis versicolor, erythema multiforme and Sweets syndrome.</p>
      <p>All patients, diagnosed with leprosy after 1982, when WHO launched the use of MDT, received this regimen. Duration of treatment varied and was not for all cases in accordance with WHO recommendations. Some received prolonged MDT (up to 12 years) due to continued presence of bacilli in skin samples, despite clinical improvement.</p>
    </sec>
    <sec id="Sec9">
      <title>Conclusion</title>
      <p>Leprosy remains a sporadic disease imported to Denmark. With less than one case detected per year it remains difficult for doctors in non-endemic countries to recognize or even to think of leprosy, which may lead to delay of diagnosis and treatment [<xref ref-type="bibr" rid="CR52">52</xref>]. Delayed diagnosis may lead to blindness, permanent nerve-damage and other disabilities. Even though anaesthesia of skin lesions is an important distinguishing feature it is often not recognized by the patient.</p>
      <p>According to some leprologists there is a predominance of male leprosy patients after puberty, this was also the case in our patient sample. Skin smears were not performed in 53 % of the patients and although these were classified as TT/BT cases not expected to be skin smear positive, skin smears should be performed in all patients suspected for leprosy. Only one patient could recall close contact to an infectious leprosy patient in the household.</p>
      <p>Skin biopsies, perhaps because of diagnostic uncertainty, were performed in all patients. Demonstration of acid fast bacilli was not possible in seven of the 15 (60 %) skin biopsies; therefore exposure, travel history and clinical presentation were essential to supplement histology. The more sensitive PCR for <italic>M. leprae</italic> could have proven helpful in these cases [<xref ref-type="bibr" rid="CR53">53</xref>].</p>
      <p>Classification of the disease is important for several reasons: borderline patients are unstable and at risk of experiencing type 1 reaction that can lead to serious nerve damage, while lepromatous and borderline lepromatous leprosy is associated with type 2 reactions which often are complicated by systemic effects. Both these conditions require corticosteroids and close monitoring of the clinical course due to the tendency to recur causing further damage [<xref ref-type="bibr" rid="CR54">54</xref>, <xref ref-type="bibr" rid="CR55">55</xref>]. Another aspect making classification important is when choosing treatment regimen: cf. WHO’s recommendations which are only 6 months for paucibacillary against 12 months for multibacillary leprosy. Skin samples can be positive for non-viable-bacilli years after completion of MDT, and this is not an indication for prolongation of treatment. Unfortunately, viability may be difficult to determine, unless the bacilli are looking disintegrated/discoloured at microscopy. There are no standard international guidelines for how often and how long after completion of MDT a patient should be examined with skin smears. It is also unclear how long a patient should be followed after ending treatment. WHO recommends skin smears at the start of treatment and if relapse/deterioration is suspected. Leading leprologists prefer to discharge patients if they display no complications and are smear negative, except MB patients, who are followed for 2 years after completion of MDT, whilst patients with permanent eye and/or nerve damage are followed lifelong.</p>
      <p>Due to the long incubation period, the diagnosis should be kept in mind when encountering patients from endemic areas displaying dermatological or neurological symptoms even years after immigration. Special attention and care should be given to detection and treatment of complications, in particular to those with neuropathy, which can be lasting. Anaesthetic skin lesions, which were the most common clinical finding in our review, should lead to a high suspicion of leprosy.</p>
    </sec>
    <sec id="Sec10">
      <title>Consent</title>
      <p>The Danish National Board of Health granted permission to publish this case report. Written informed consent was obtained from the patient for publication of case reports and any accompanying images.</p>
    </sec>
  </body>
  <back>
    <app-group>
      <app id="App1">
        <sec id="Sec20">
          <title>Additional file</title>
          <p>
            <media position="anchor" xlink:href="13104_2015_1768_MOESM1_ESM.docx" id="MOESM1">
              <caption>
                <p>
10.1186/s13104-015-1768-6 CARE checklist was followed and used as a guideline for the development of the case report for this manuscript.</p>
              </caption>
            </media>
          </p>
        </sec>
      </app>
    </app-group>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>AFB</term>
          <def>
            <p>acid fast bacilli</p>
          </def>
        </def-item>
        <def-item>
          <term>BB</term>
          <def>
            <p>borderline leprosy</p>
          </def>
        </def-item>
        <def-item>
          <term>BL</term>
          <def>
            <p>borderline lepromatous leprosy</p>
          </def>
        </def-item>
        <def-item>
          <term>BT</term>
          <def>
            <p>borderline tuberculoid leprosy</p>
          </def>
        </def-item>
        <def-item>
          <term>ENL</term>
          <def>
            <p>erythema nodosum leprosum</p>
          </def>
        </def-item>
        <def-item>
          <term>G2D</term>
          <def>
            <p>grade 2 disability</p>
          </def>
        </def-item>
        <def-item>
          <term>IL</term>
          <def>
            <p>interleukin</p>
          </def>
        </def-item>
        <def-item>
          <term>INF-γ</term>
          <def>
            <p>interferon -γ</p>
          </def>
        </def-item>
        <def-item>
          <term>LL</term>
          <def>
            <p>lepromatous leprosy</p>
          </def>
        </def-item>
        <def-item>
          <term>MB</term>
          <def>
            <p>multibacillary</p>
          </def>
        </def-item>
        <def-item>
          <term>MDT</term>
          <def>
            <p>multidrug therapy</p>
          </def>
        </def-item>
        <def-item>
          <term>PB</term>
          <def>
            <p>paucibacillary</p>
          </def>
        </def-item>
        <def-item>
          <term>SSI</term>
          <def>
            <p>Statens Serum Institut</p>
          </def>
        </def-item>
        <def-item>
          <term>TT</term>
          <def>
            <p>tuberculoid leprosy</p>
          </def>
        </def-item>
        <def-item>
          <term>TNF-α</term>
          <def>
            <p>Tumor Necrosis Factor</p>
          </def>
        </def-item>
        <def-item>
          <term>WHO</term>
          <def>
            <p>World Health Organization</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <ack>
      <title>Authors’ contributions</title>
      <p>HA conducted the literature search, interpreted the data and drafted the manuscript. SDN and ICB conceived of the study and revised the manuscript. All authors read and approved the final manuscript.</p>
      <sec id="FPar1">
        <title>Acknowledgements</title>
        <p>The authors are very grateful to Professor Diana Lockwood for her insightful comments and recommendations on leprosy treatment and monitoring, and to Professor Sebastian Lucas for improving the histopathological diagnoses.</p>
      </sec>
      <sec id="FPar2">
        <title>Competing interests</title>
        <p>The authors declare that they have no competing interests.</p>
      </sec>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Richards</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Leprosy in Scandinavia: a discussion of its origins, its survival, and its effect on Scandinavian life over the course of nine centuries</article-title>
          <source>Centaurus</source>
          <year>1960</year>
          <volume>7</volume>
          <fpage>101</fpage>
          <lpage>133</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1600-0498.1960.tb00260.x</pub-id>
          <?supplied-pmid 13741269?>
          <pub-id pub-id-type="pmid">13741269</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Monot</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>On the origin of leprosy</article-title>
          <source>Science</source>
          <year>2005</year>
          <volume>308</volume>
          <issue>5724</issue>
          <fpage>1040</fpage>
          <lpage>1042</lpage>
          <pub-id pub-id-type="doi">10.1126/science/1109759</pub-id>
          <?supplied-pmid 15894530?>
          <pub-id pub-id-type="pmid">15894530</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Christensen</surname>
              <given-names>VB</given-names>
            </name>
            <name>
              <surname>Boldsen</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
          <article-title>Medieval leprosy</article-title>
          <source>Ugeskr Laeger</source>
          <year>2001</year>
          <volume>163</volume>
          <issue>51</issue>
          <fpage>7248</fpage>
          <lpage>7250</lpage>
          <?supplied-pmid 11797556?>
          <pub-id pub-id-type="pmid">11797556</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vogelsang</surname>
              <given-names>TM</given-names>
            </name>
          </person-group>
          <article-title>Leprosy in Norway</article-title>
          <source>Med Hist</source>
          <year>1965</year>
          <volume>9</volume>
          <fpage>29</fpage>
          <lpage>35</lpage>
          <pub-id pub-id-type="doi">10.1017/S0025727300030118</pub-id>
          <?supplied-pmid 14252325?>
          <pub-id pub-id-type="pmid">14252325</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Waters</surname>
              <given-names>MF</given-names>
            </name>
          </person-group>
          <article-title>Chemotherapy of leprosy–current status and future prospects</article-title>
          <source>Trans R Soc Trop Med Hyg</source>
          <year>1993</year>
          <volume>87</volume>
          <issue>5</issue>
          <fpage>500</fpage>
          <lpage>503</lpage>
          <pub-id pub-id-type="doi">10.1016/0035-9203(93)90063-V</pub-id>
          <?supplied-pmid 8266396?>
          <pub-id pub-id-type="pmid">8266396</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <collab>Global leprosy update</collab>
          </person-group>
          <article-title>2013; reducing disease burden</article-title>
          <source>Wkly Epidemiol Rec</source>
          <year>2014</year>
          <volume>89</volume>
          <issue>36</issue>
          <fpage>389</fpage>
          <lpage>400</lpage>
          <pub-id pub-id-type="pmid">25202781</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Britton</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Lockwood</surname>
              <given-names>DN</given-names>
            </name>
          </person-group>
          <article-title>Leprosy</article-title>
          <source>Lancet</source>
          <year>2004</year>
          <volume>363</volume>
          <issue>9416</issue>
          <fpage>1209</fpage>
          <lpage>1219</lpage>
          <pub-id pub-id-type="doi">10.1016/S0140-6736(04)15952-7</pub-id>
          <?supplied-pmid 15081655?>
          <pub-id pub-id-type="pmid">15081655</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Talhari</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Hansen’s disease: a vanishing disease?</article-title>
          <source>Mem Inst Oswaldo Cruz</source>
          <year>2012</year>
          <volume>107</volume>
          <issue>Suppl 1</issue>
          <fpage>13</fpage>
          <lpage>16</lpage>
          <pub-id pub-id-type="doi">10.1590/S0074-02762012000900003</pub-id>
          <?supplied-pmid 23283447?>
          <pub-id pub-id-type="pmid">23283447</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bakker</surname>
              <given-names>MI</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Risk factors for developing leprosy–a population-based cohort study in Indonesia</article-title>
          <source>Lepr Rev</source>
          <year>2006</year>
          <volume>77</volume>
          <issue>1</issue>
          <fpage>48</fpage>
          <lpage>61</lpage>
          <?supplied-pmid 16715690?>
          <pub-id pub-id-type="pmid">16715690</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Matsuoka</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Genotyping of Mycobacterium leprae on the basis of the polymorphism of TTC repeats for analysis of leprosy transmission</article-title>
          <source>J Clin Microbiol</source>
          <year>2004</year>
          <volume>42</volume>
          <issue>2</issue>
          <fpage>741</fpage>
          <lpage>745</lpage>
          <pub-id pub-id-type="doi">10.1128/JCM.42.2.741-745.2004</pub-id>
          <?supplied-pmid 14766846?>
          <pub-id pub-id-type="pmid">14766846</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beyene</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Nasal carriage of Mycobacterium leprae DNA in healthy individuals in Lega Robi village, Ethiopia</article-title>
          <source>Epidemiol Infect</source>
          <year>2003</year>
          <volume>131</volume>
          <issue>2</issue>
          <fpage>841</fpage>
          <lpage>848</lpage>
          <pub-id pub-id-type="doi">10.1017/S0950268803001079</pub-id>
          <?supplied-pmid 14596524?>
          <pub-id pub-id-type="pmid">14596524</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Salipante</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Hall</surname>
              <given-names>BG</given-names>
            </name>
          </person-group>
          <article-title>Towards the molecular epidemiology of Mycobacterium leprae: strategies, successes, and shortcomings</article-title>
          <source>Infect Genet Evol</source>
          <year>2011</year>
          <volume>11</volume>
          <issue>7</issue>
          <fpage>1505</fpage>
          <lpage>1513</lpage>
          <pub-id pub-id-type="doi">10.1016/j.meegid.2011.06.003</pub-id>
          <?supplied-pmid 21708290?>
          <pub-id pub-id-type="pmid">21708290</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fine</surname>
              <given-names>PE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Household and dwelling contact as risk factors for leprosy in northern Malawi</article-title>
          <source>Am J Epidemiol</source>
          <year>1997</year>
          <volume>146</volume>
          <issue>1</issue>
          <fpage>91</fpage>
          <lpage>102</lpage>
          <pub-id pub-id-type="doi">10.1093/oxfordjournals.aje.a009195</pub-id>
          <?supplied-pmid 9215227?>
          <pub-id pub-id-type="pmid">9215227</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Joyce</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
          <article-title>Historic aspects of human susceptibility to leprosy and the risk of conjugal transmission</article-title>
          <source>Mem Inst Oswaldo Cruz</source>
          <year>2012</year>
          <volume>107</volume>
          <issue>Suppl 1</issue>
          <fpage>17</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="doi">10.1590/S0074-02762012000900004</pub-id>
          <?supplied-pmid 23283448?>
          <pub-id pub-id-type="pmid">23283448</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mira</surname>
              <given-names>MT</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Chromosome 6q25 is linked to susceptibility to leprosy in a Vietnamese population</article-title>
          <source>Nat Genet</source>
          <year>2003</year>
          <volume>33</volume>
          <issue>3</issue>
          <fpage>412</fpage>
          <lpage>415</lpage>
          <pub-id pub-id-type="doi">10.1038/ng1096</pub-id>
          <?supplied-pmid 12577057?>
          <pub-id pub-id-type="pmid">12577057</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mira</surname>
              <given-names>MT</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Susceptibility to leprosy is associated with PARK2 and PACRG</article-title>
          <source>Nature</source>
          <year>2004</year>
          <volume>427</volume>
          <issue>6975</issue>
          <fpage>636</fpage>
          <lpage>640</lpage>
          <pub-id pub-id-type="doi">10.1038/nature02326</pub-id>
          <?supplied-pmid 14737177?>
          <pub-id pub-id-type="pmid">14737177</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Blackwell</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Genetics of host resistance and susceptibility to intramacrophage pathogens: a study of multicase families of tuberculosis, leprosy and leishmaniasis in north-eastern Brazil</article-title>
          <source>Int J Parasitol</source>
          <year>1998</year>
          <volume>28</volume>
          <issue>1</issue>
          <fpage>21</fpage>
          <lpage>28</lpage>
          <pub-id pub-id-type="doi">10.1016/S0020-7519(97)00175-6</pub-id>
          <?supplied-pmid 9504332?>
          <pub-id pub-id-type="pmid">9504332</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jensen</surname>
              <given-names>AG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Leprosy–still a possibility in Denmark</article-title>
          <source>Ugeskr Laeger</source>
          <year>1992</year>
          <volume>154</volume>
          <issue>24</issue>
          <fpage>1712</fpage>
          <lpage>1713</lpage>
          <?supplied-pmid 1632008?>
          <pub-id pub-id-type="pmid">1632008</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Suzuki</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Infection during infancy and long incubation period of leprosy suggested in a case of a chimpanzee used for medical research</article-title>
          <source>J Clin Microbiol</source>
          <year>2010</year>
          <volume>48</volume>
          <issue>9</issue>
          <fpage>3432</fpage>
          <lpage>3434</lpage>
          <pub-id pub-id-type="doi">10.1128/JCM.00017-10</pub-id>
          <?supplied-pmid 20631101?>
          <pub-id pub-id-type="pmid">20631101</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spierings</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Novel mechanisms in the immunopathogenesis of leprosy nerve damage: the role of Schwann cells, T cells and Mycobacterium leprae</article-title>
          <source>Immunol Cell Biol</source>
          <year>2000</year>
          <volume>78</volume>
          <issue>4</issue>
          <fpage>349</fpage>
          <lpage>355</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1440-1711.2000.00939.x</pub-id>
          <?supplied-pmid 10947859?>
          <pub-id pub-id-type="pmid">10947859</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rodrigues</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Lockwood</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Leprosy now: epidemiology, progress, challenges, and research gaps</article-title>
          <source>Lancet Infect Dis</source>
          <year>2011</year>
          <volume>11</volume>
          <issue>6</issue>
          <fpage>464</fpage>
          <lpage>470</lpage>
          <pub-id pub-id-type="doi">10.1016/S1473-3099(11)70006-8</pub-id>
          <?supplied-pmid 21616456?>
          <pub-id pub-id-type="pmid">21616456</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ridley</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Jopling</surname>
              <given-names>WH</given-names>
            </name>
          </person-group>
          <article-title>Classification of leprosy according to immunity. A five-group system</article-title>
          <source>Int J Lepr Mycobact Dis Off Organ Int Lepr Assoc</source>
          <year>1966</year>
          <volume>34</volume>
          <issue>3</issue>
          <fpage>255</fpage>
          <lpage>273</lpage>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Walker</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Lockwood</surname>
              <given-names>DN</given-names>
            </name>
          </person-group>
          <article-title>The clinical and immunological features of leprosy</article-title>
          <source>Br Med Bull</source>
          <year>2006</year>
          <volume>77–78</volume>
          <fpage>103</fpage>
          <lpage>121</lpage>
          <pub-id pub-id-type="doi">10.1093/bmb/ldl010</pub-id>
          <?supplied-pmid 17090777?>
          <pub-id pub-id-type="pmid">17090777</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sieling</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Modlin</surname>
              <given-names>RL</given-names>
            </name>
          </person-group>
          <article-title>Cytokine patterns at the site of mycobacterial infection</article-title>
          <source>Immunobiology</source>
          <year>1994</year>
          <volume>191</volume>
          <issue>4–5</issue>
          <fpage>378</fpage>
          <lpage>387</lpage>
          <pub-id pub-id-type="doi">10.1016/S0171-2985(11)80443-2</pub-id>
          <?supplied-pmid 7713551?>
          <pub-id pub-id-type="pmid">7713551</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moraes</surname>
              <given-names>MO</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cytokine mRNA expression in leprosy: a possible role for interferon-gamma and interleukin-12 in reactions (RR and ENL)</article-title>
          <source>Scand J Immunol</source>
          <year>1999</year>
          <volume>50</volume>
          <issue>5</issue>
          <fpage>541</fpage>
          <lpage>549</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1365-3083.1999.00622.x</pub-id>
          <?supplied-pmid 10564558?>
          <pub-id pub-id-type="pmid">10564558</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Madan</surname>
              <given-names>NK</given-names>
            </name>
            <name>
              <surname>Agarwal</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Chander</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Serum cytokine profile in leprosy and its correlation with clinico-histopathological profile</article-title>
          <source>Lepr Rev</source>
          <year>2011</year>
          <volume>82</volume>
          <issue>4</issue>
          <fpage>371</fpage>
          <lpage>382</lpage>
          <?supplied-pmid 22439277?>
          <pub-id pub-id-type="pmid">22439277</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Britton</surname>
              <given-names>WJ</given-names>
            </name>
          </person-group>
          <article-title>Immunology of leprosy</article-title>
          <source>Trans R Soc Trop Med Hyg</source>
          <year>1993</year>
          <volume>87</volume>
          <issue>5</issue>
          <fpage>508</fpage>
          <lpage>514</lpage>
          <pub-id pub-id-type="doi">10.1016/0035-9203(93)90066-Y</pub-id>
          <?supplied-pmid 8266398?>
          <pub-id pub-id-type="pmid">8266398</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>de Jong</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>IL-2 and IL-12 act in synergy to overcome antigen-specific T cell unresponsiveness in mycobacterial disease</article-title>
          <source>J Immunol</source>
          <year>1997</year>
          <volume>159</volume>
          <issue>2</issue>
          <fpage>786</fpage>
          <lpage>793</lpage>
          <?supplied-pmid 9218596?>
          <pub-id pub-id-type="pmid">9218596</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kaplan</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>An analysis of in vitro T cell responsiveness in lepromatous leprosy</article-title>
          <source>J Exp Med</source>
          <year>1985</year>
          <volume>162</volume>
          <issue>3</issue>
          <fpage>917</fpage>
          <lpage>929</lpage>
          <pub-id pub-id-type="doi">10.1084/jem.162.3.917</pub-id>
          <?supplied-pmid 3928804?>
          <pub-id pub-id-type="pmid">3928804</pub-id>
        </element-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Attia</surname>
              <given-names>EA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Circulating CD4 + CD25 high FoxP3 + T cells vary in different clinical forms of leprosy</article-title>
          <source>Int J Dermatol</source>
          <year>2010</year>
          <volume>49</volume>
          <issue>10</issue>
          <fpage>1152</fpage>
          <lpage>1158</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-4632.2010.04535.x</pub-id>
          <?supplied-pmid 20883403?>
          <pub-id pub-id-type="pmid">20883403</pub-id>
        </element-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Palermo</surname>
              <given-names>ML</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Increased expression of regulatory T cells and down-regulatory molecules in lepromatous leprosy</article-title>
          <source>Am J Trop Med Hyg</source>
          <year>2012</year>
          <volume>86</volume>
          <issue>5</issue>
          <fpage>878</fpage>
          <lpage>883</lpage>
          <pub-id pub-id-type="doi">10.4269/ajtmh.2012.12-0088</pub-id>
          <?supplied-pmid 22556091?>
          <pub-id pub-id-type="pmid">22556091</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kumar</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Th3 immune responses in the progression of leprosy via molecular cross-talks of TGF-beta, CTLA-4 and Cbl-b</article-title>
          <source>Clin Immunol</source>
          <year>2011</year>
          <volume>141</volume>
          <issue>2</issue>
          <fpage>133</fpage>
          <lpage>142</lpage>
          <pub-id pub-id-type="doi">10.1016/j.clim.2011.06.007</pub-id>
          <?supplied-pmid 21807564?>
          <pub-id pub-id-type="pmid">21807564</pub-id>
        </element-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Polycarpou</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Lockwood</surname>
              <given-names>DN</given-names>
            </name>
          </person-group>
          <article-title>New findings in the pathogenesis of leprosy and implications for the management of leprosy</article-title>
          <source>Curr Opin Infect Dis</source>
          <year>2013</year>
          <volume>26</volume>
          <issue>5</issue>
          <fpage>413</fpage>
          <lpage>419</lpage>
          <?supplied-pmid 23982232?>
          <pub-id pub-id-type="pmid">23982232</pub-id>
        </element-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <collab>WHO Expert Committee on Leprosy</collab>
          </person-group>
          <source>World Health Organ Tech Rep Ser</source>
          <year>1998</year>
          <volume>874</volume>
          <fpage>1</fpage>
          <lpage>43</lpage>
          <pub-id pub-id-type="pmid">9627517</pub-id>
        </element-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kumar</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Sinha</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sehgal</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>High incidence of IgG antibodies to phenolic glycolipid in non-leprosy patients in India</article-title>
          <source>J Dermatol</source>
          <year>1998</year>
          <volume>25</volume>
          <issue>4</issue>
          <fpage>238</fpage>
          <lpage>241</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1346-8138.1998.tb02388.x</pub-id>
          <?supplied-pmid 9609981?>
          <pub-id pub-id-type="pmid">9609981</pub-id>
        </element-citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baeza</surname>
              <given-names>I</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Lepromatous leprosy patients produce antibodies that recognise non-bilayer lipid arrangements containing mycolic acids</article-title>
          <source>Mem Inst Oswaldo Cruz</source>
          <year>2012</year>
          <volume>107</volume>
          <issue>Suppl 1</issue>
          <fpage>95</fpage>
          <lpage>103</lpage>
          <pub-id pub-id-type="doi">10.1590/S0074-02762012000900016</pub-id>
          <?supplied-pmid 23283460?>
          <pub-id pub-id-type="pmid">23283460</pub-id>
        </element-citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spencer</surname>
              <given-names>JS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Identification of serological biomarkers of infection, disease progression and treatment efficacy for leprosy</article-title>
          <source>Mem Inst Oswaldo Cruz</source>
          <year>2012</year>
          <volume>107</volume>
          <issue>Suppl 1</issue>
          <fpage>79</fpage>
          <lpage>89</lpage>
          <pub-id pub-id-type="doi">10.1590/S0074-02762012000900014</pub-id>
          <?supplied-pmid 23283458?>
          <pub-id pub-id-type="pmid">23283458</pub-id>
        </element-citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bang</surname>
              <given-names>PD</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Evaluation of polymerase chain reaction-based detection of Mycobacterium leprae for the diagnosis of leprosy</article-title>
          <source>J Dermatol</source>
          <year>2009</year>
          <volume>36</volume>
          <issue>5</issue>
          <fpage>269</fpage>
          <lpage>276</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1346-8138.2009.00637.x</pub-id>
          <?supplied-pmid 19382997?>
          <pub-id pub-id-type="pmid">19382997</pub-id>
        </element-citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Banerjee</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Diagnosing leprosy: revisiting the role of the slit-skin smear with critical analysis of the applicability of polymerase chain reaction in diagnosis</article-title>
          <source>Int J Dermatol</source>
          <year>2011</year>
          <volume>50</volume>
          <issue>12</issue>
          <fpage>1522</fpage>
          <lpage>1527</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-4632.2011.04994.x</pub-id>
          <?supplied-pmid 22097999?>
          <pub-id pub-id-type="pmid">22097999</pub-id>
        </element-citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Natrajan</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Histological diagnosis of early and suspicious leprosy by in situ PCR</article-title>
          <source>Indian J Lepr</source>
          <year>2012</year>
          <volume>84</volume>
          <issue>3</issue>
          <fpage>185</fpage>
          <lpage>194</lpage>
          <?supplied-pmid 23484333?>
          <pub-id pub-id-type="pmid">23484333</pub-id>
        </element-citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <mixed-citation publication-type="other">World Health Organization expert commitee on Leprosy. Summary of Current Recommendations for Management of Leprosy in the Field, 1998. WHO Technical Report Series.</mixed-citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Setia</surname>
              <given-names>MS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Is there a role for rifampicin, ofloxacin and minocycline (ROM) therapy in the treatment of leprosy? Systematic review and meta-analysis</article-title>
          <source>Trop Med Int Health</source>
          <year>2011</year>
          <volume>16</volume>
          <issue>12</issue>
          <fpage>1541</fpage>
          <lpage>1551</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-3156.2011.02873.x</pub-id>
          <?supplied-pmid 21914093?>
          <pub-id pub-id-type="pmid">21914093</pub-id>
        </element-citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Walker</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Lockwood</surname>
              <given-names>DN</given-names>
            </name>
          </person-group>
          <article-title>Leprosy type 1 (reversal) reactions and their management</article-title>
          <source>Lepr Rev</source>
          <year>2008</year>
          <volume>79</volume>
          <issue>4</issue>
          <fpage>372</fpage>
          <lpage>386</lpage>
          <?supplied-pmid 19274984?>
          <pub-id pub-id-type="pmid">19274984</pub-id>
        </element-citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wagenaar</surname>
              <given-names>I</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Two randomized controlled clinical trials to study the effectiveness of prednisolone treatment in preventing and restoring clinical nerve function loss in leprosy: the TENLEP study protocols</article-title>
          <source>BMC Neurol</source>
          <year>2012</year>
          <volume>12</volume>
          <fpage>159</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-2377-12-159</pub-id>
          <?supplied-pmid 23249098?>
          <pub-id pub-id-type="pmid">23249098</pub-id>
        </element-citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cuevas</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Erythema nodosum leprosum: reactional leprosy</article-title>
          <source>Semin Cutan Med Surg</source>
          <year>2007</year>
          <volume>26</volume>
          <issue>2</issue>
          <fpage>126</fpage>
          <lpage>130</lpage>
          <pub-id pub-id-type="doi">10.1016/j.sder.2007.02.010</pub-id>
          <?supplied-pmid 17544965?>
          <pub-id pub-id-type="pmid">17544965</pub-id>
        </element-citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kahawita</surname>
              <given-names>IP</given-names>
            </name>
            <name>
              <surname>Lockwood</surname>
              <given-names>DN</given-names>
            </name>
          </person-group>
          <article-title>Towards understanding the pathology of erythema nodosum leprosum</article-title>
          <source>Trans R Soc Trop Med Hyg</source>
          <year>2008</year>
          <volume>102</volume>
          <issue>4</issue>
          <fpage>329</fpage>
          <lpage>337</lpage>
          <pub-id pub-id-type="doi">10.1016/j.trstmh.2008.01.004</pub-id>
          <?supplied-pmid 18313706?>
          <pub-id pub-id-type="pmid">18313706</pub-id>
        </element-citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Van Veen</surname>
              <given-names>NH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Interventions for erythema nodosum leprosum. A Cochrane review</article-title>
          <source>Lepr Rev</source>
          <year>2009</year>
          <volume>80</volume>
          <issue>4</issue>
          <fpage>355</fpage>
          <lpage>372</lpage>
          <?supplied-pmid 20306635?>
          <pub-id pub-id-type="pmid">20306635</pub-id>
        </element-citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <mixed-citation publication-type="other">WHO guide to the management of ENL reactions. <ext-link ext-link-type="uri" xlink:href="http://www.who.int/lep/research/WHOenlguide.pdf?ua=1">http://www.who.int/lep/research/WHOenlguide.pdf?ua=1</ext-link>. Retrieved from the WHO topic page “Leprosy elimination” (<ext-link ext-link-type="uri" xlink:href="http://www.who.int/lep/mdt/clofazimine/en/">http://www.who.int/lep/mdt/clofazimine/en/</ext-link>).</mixed-citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sales</surname>
              <given-names>AM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Double-blind trial of the efficacy of pentoxifylline vs thalidomide for the treatment of type II reaction in leprosy</article-title>
          <source>Braz J Med Biol Res</source>
          <year>2007</year>
          <volume>40</volume>
          <issue>2</issue>
          <fpage>243</fpage>
          <lpage>248</lpage>
          <pub-id pub-id-type="doi">10.1590/S0100-879X2007000200011</pub-id>
          <?supplied-pmid 17273661?>
          <pub-id pub-id-type="pmid">17273661</pub-id>
        </element-citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ustianowski</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Lawn</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>Lockwood</surname>
              <given-names>DN</given-names>
            </name>
          </person-group>
          <article-title>Interactions between HIV infection and leprosy: a paradox</article-title>
          <source>Lancet Infect Dis</source>
          <year>2006</year>
          <volume>6</volume>
          <issue>6</issue>
          <fpage>350</fpage>
          <lpage>360</lpage>
          <pub-id pub-id-type="doi">10.1016/S1473-3099(06)70493-5</pub-id>
          <?supplied-pmid 16728321?>
          <pub-id pub-id-type="pmid">16728321</pub-id>
        </element-citation>
      </ref>
      <ref id="CR51">
        <label>51.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Menezes</surname>
              <given-names>VM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Epidemiological and clinical patterns of 92 patients co-infected with HIV and Mycobacterium leprae from Rio de Janeiro State, Brazil</article-title>
          <source>Trans R Soc Trop Med Hyg</source>
          <year>2014</year>
          <volume>108</volume>
          <issue>2</issue>
          <fpage>63</fpage>
          <lpage>70</lpage>
          <pub-id pub-id-type="doi">10.1093/trstmh/trt113</pub-id>
          <?supplied-pmid 24361943?>
          <pub-id pub-id-type="pmid">24361943</pub-id>
        </element-citation>
      </ref>
      <ref id="CR52">
        <label>52.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Forno</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The difficulty in diagnosis and treatment of leprosy</article-title>
          <source>J Travel Med</source>
          <year>2010</year>
          <volume>17</volume>
          <issue>4</issue>
          <fpage>281</fpage>
          <lpage>283</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1708-8305.2010.00419.x</pub-id>
          <?supplied-pmid 20636605?>
          <pub-id pub-id-type="pmid">20636605</pub-id>
        </element-citation>
      </ref>
      <ref id="CR53">
        <label>53.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Martinez</surname>
              <given-names>AN</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>PCR-based techniques for leprosy diagnosis: from the laboratory to the clinic</article-title>
          <source>PLoS Negl Trop Dis</source>
          <year>2014</year>
          <volume>8</volume>
          <issue>4</issue>
          <fpage>e2655</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pntd.0002655</pub-id>
          <?supplied-pmid 24722358?>
          <pub-id pub-id-type="pmid">24722358</pub-id>
        </element-citation>
      </ref>
      <ref id="CR54">
        <label>54.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lockwood</surname>
              <given-names>DN</given-names>
            </name>
          </person-group>
          <article-title>Steroids in leprosy type 1 (reversal) reactions: mechanisms of action and effectiveness</article-title>
          <source>Lepr Rev</source>
          <year>2000</year>
          <volume>71</volume>
          <issue>Suppl</issue>
          <fpage>S111</fpage>
          <lpage>S114</lpage>
          <?supplied-pmid 11201865?>
          <pub-id pub-id-type="pmid">11201865</pub-id>
        </element-citation>
      </ref>
      <ref id="CR55">
        <label>55.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pocaterra</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India</article-title>
          <source>Am J Trop Med Hyg</source>
          <year>2006</year>
          <volume>74</volume>
          <issue>5</issue>
          <fpage>868</fpage>
          <lpage>879</lpage>
          <?supplied-pmid 16687695?>
          <pub-id pub-id-type="pmid">16687695</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:4700578</identifier><datestamp>2016-01-06</datestamp><setSpec>bmcph</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="http://jats.nlm.nih.gov/ns/archiving/1.0/ http://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Public Health</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Public Health</journal-id>
      <journal-title-group>
        <journal-title>BMC Public Health</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1471-2458</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC4700578</article-id>
      <article-id pub-id-type="pmcid">PMC4700578</article-id>
      <article-id pub-id-type="pmc-uid">4700578</article-id>
      <article-id pub-id-type="publisher-id">2665</article-id>
      <article-id pub-id-type="doi">10.1186/s12889-015-2665-6</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Hungry for an intervention? Adolescents’ ratings of acceptability of eating-related intervention strategies</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Stok</surname>
            <given-names>F. Marijn</given-names>
          </name>
          <address>
            <email>marijn.stok@uni-konstanz.de</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Ridder</surname>
            <given-names>Denise T. D.</given-names>
          </name>
          <address>
            <email>d.t.d.deridder@uu.nl</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Vet</surname>
            <given-names>Emely</given-names>
          </name>
          <address>
            <email>emely.devet@wur.nl</email>
          </address>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nureeva</surname>
            <given-names>Liliya</given-names>
          </name>
          <address>
            <email>liliyan@asb.dk</email>
          </address>
          <xref ref-type="aff" rid="Aff4"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Luszczynska</surname>
            <given-names>Aleksandra</given-names>
          </name>
          <address>
            <email>aluszczy@uccs.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff5"/>
          <xref ref-type="aff" rid="Aff6"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wardle</surname>
            <given-names>Jane</given-names>
          </name>
          <xref ref-type="aff" rid="Aff7"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gaspar</surname>
            <given-names>Tania</given-names>
          </name>
          <address>
            <email>tania.gaspar.barra@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff8"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Wit</surname>
            <given-names>John B. F.</given-names>
          </name>
          <address>
            <email>j.dewit@unsw.edu.au</email>
          </address>
          <xref ref-type="aff" rid="Aff9"/>
        </contrib>
        <aff id="Aff1"><label/>Psychological Assessment and Health Psychology, University of Konstanz, PO Box 47, 78457 Konstanz, Germany </aff>
        <aff id="Aff2"><label/>Department of Clinical and Health Psychology, Utrecht University, Utrecht, The Netherlands </aff>
        <aff id="Aff3"><label/>Wageningen University and Research Centre, Communication, Philosophy and Technology, Centre for Integrative Development, Wageningen, The Netherlands </aff>
        <aff id="Aff4"><label/>Department of Business Administration, University of Aarhus, Aarhus, Denmark </aff>
        <aff id="Aff5"><label/>Psychology Department in Wroclaw, University of Social Sciences and Humanities, Warsaw, Poland </aff>
        <aff id="Aff6"><label/>Trauma, Health, &amp; Hazards Center, University of Colorado, Boulder, CO USA </aff>
        <aff id="Aff7"><label/>Department of Epidemiology &amp; Public Health, University College London, Health Behaviour Research Centre, London, UK </aff>
        <aff id="Aff8"><label/>Faculty of Human Kinetics, Technical University of Lisbon, Lisbon, Portugal </aff>
        <aff id="Aff9"><label/>National Centre in HIV Social Research, University of New South Wales, Sydney, Australia </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>5</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>5</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2015</year>
      </pub-date>
      <volume>16</volume>
      <elocation-id>5</elocation-id>
      <history>
        <date date-type="received">
          <day>12</day>
          <month>8</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>21</day>
          <month>12</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© Stok et al. 2016</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Effective interventions promoting healthier eating behavior among adolescents are urgently needed. One factor that has been shown to impact effectiveness is whether the target population accepts the intervention. While previous research has assessed adults’ acceptance of eating-related interventions, research on the opinion of adolescents is lacking. The current study addressed this gap in the literature.</p>
        </sec>
        <sec>
          <title>Methods</title>
          <p>Two thousand seven hundred sixty four adolescents (aged 10–17 years) from four European countries answered questions about individual characteristics (socio-demographics, anthropometrics, and average daily intake of healthy and unhealthy foods) and the acceptability of ten eating-related intervention strategies. These strategies varied in type (either promoting healthy eating or discouraging unhealthy eating), level of intrusiveness, setting (home, school, broader out-of-home environment), and change agent (parents, teacher, policy makers).</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>Based on adolescents’ acceptability ratings, strategies could be clustered into two categories, those promoting healthy eating and those discouraging unhealthy eating, with acceptability rated significantly higher for the former. Acceptability of intervention strategies was rated moderate on average, but higher among girls, younger, overweight and immigrant adolescents, and those reporting healthier eating. Polish and Portuguese adolescents were overall more accepting of strategies than UK and Dutch adolescents.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>Adolescents preferred intervention strategies that promote healthy eating over strategies that discourage unhealthy eating. Level of intrusiveness affected acceptability ratings for the latter type of strategies only. Various individual and behavioral characteristics were associated with acceptability. These findings provide practical guidance for the selection of acceptable intervention strategies to improve adolescents’ eating behavior.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Overweight</kwd>
        <kwd>Eating behavior</kwd>
        <kwd>Adolescents</kwd>
        <kwd>Prevention</kwd>
        <kwd>Interventions</kwd>
        <kwd>Public policy</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004963</institution-id>
              <institution>Seventh Framework Programme (BE)</institution>
            </institution-wrap>
          </funding-source>
          <award-id>Health-F2-2008-223488</award-id>
          <principal-award-recipient>
            <name>
              <surname>de Ridder</surname>
              <given-names>Denise T. D.</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
      </funding-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>© The Author(s) 2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Background</title>
      <p>The high prevalence of overweight and obesity in adolescence is a pressing public health issue, with rates of overweight ranging between 10 and 40 percent among European adolescents [<xref ref-type="bibr" rid="CR1">1</xref>]. Childhood obesity has been identified by the World Health Organization [<xref ref-type="bibr" rid="CR2">2</xref>] as one of the most serious public health challenges of the 21st century. Obesity is associated with the development of non-communicable diseases, including cardiovascular diseases and diabetes. The risk of developing these diseases increases with earlier age of onset and longer duration of obesity, increasing the vulnerability of those who develop excess weight before adulthood [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. Preventing and treating obesity in youngsters is a public health priority, and policy makers have designed and implemented many policies and interventions aimed at preventing and decreasing overweight and obesity in children and adolescents [<xref ref-type="bibr" rid="CR5">5</xref>]. So far, however, these strategies have not been able to successfully reduce obesity rates [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>].</p>
      <sec id="Sec2">
        <title>Public support for diet-related interventions strategies</title>
        <p>An important prerequisite for the successful implementation of interventions is that the target population accepts them [<xref ref-type="bibr" rid="CR8">8</xref>–<xref ref-type="bibr" rid="CR11">11</xref>]. This is important both on a political level, because politicians are unlikely to favor policies that may lose them votes, and in terms of potential effectiveness, because behavior change is unlikely to occur following implementation of strategies that the target population does not consider acceptable [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. Research into popular opinion regarding health promotion policies in general, and diet-related policies in particular, has soared in the past decade. This research has consistently found that public support tends to be highest for the least intrusive policies, such as education programs and the promotion of healthy eating, and lowest for intrusive, restrictive policies, such as bans on advertising or selling unhealthy products, or taxation of unhealthy products [<xref ref-type="bibr" rid="CR8">8</xref>–<xref ref-type="bibr" rid="CR11">11</xref>].</p>
        <p>A further consistent finding is that public support is generally higher for policies to improve the diet of children and adolescents [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR12">12</xref>], and remains high, albeit at a somewhat lower level [<xref ref-type="bibr" rid="CR12">12</xref>], if these policies are restrictive or intrusive. However, these findings are exclusively based on research among adults, and may reflect a general tendency to be supportive of restrictive policies as long as they do not affect oneself [<xref ref-type="bibr" rid="CR8">8</xref>].</p>
      </sec>
      <sec id="Sec3">
        <title>The adolescent perspective</title>
        <p>An important open question is thus how youngsters themselves feel about potential intervention strategies aimed at improving their dietary behavior. While the political argument for the importance of policy acceptability is less applicable to adolescents, as they are not yet voters, the policy effectiveness argument may be especially relevant for adolescents. Adolescents are developing their own identity, opinions and ideas [<xref ref-type="bibr" rid="CR13">13</xref>], and typically portray a stronger than average negative response to the sense of being pushed in a certain direction [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. Intervention strategies that give adolescents the feeling that their behavior is being steered or their freedom of choice is being restricted may induce feelings of resistance to the behavior proposed in the intervention [<xref ref-type="bibr" rid="CR16">16</xref>]. This in turn may cause psychological reactance [<xref ref-type="bibr" rid="CR17">17</xref>], which adolescents may attempt to resolve by acting out against the suggested behavior (i.e., doing exactly that what is being warned against), or by derogating the source of the message.</p>
        <p>It is therefore critical to understand how adolescents themselves feel about various possible intervention strategies to improve healthy diets, which types of strategies they find acceptable and which not. In the current study, we investigate the extent to which adolescents accept ten possible strategies aimed at improving their eating behavior. Three research questions will be addressed: (1) To what extent do adolescents accept various intervention strategies; (2) can single strategies be clustered into meaningful categories; and (3) which individual and behavioral characteristics are associated with acceptance for these clusters of intervention strategies.</p>
      </sec>
    </sec>
    <sec id="Sec4">
      <title>Methods</title>
      <sec id="Sec5">
        <title>Respondents and procedure</title>
        <p>This study was conducted as part of the “Temptations to Eat Moderated by Personal and Environmental Self-regulatory Tools” (TEMPEST) project undertaken in nine European countries. The presented data were collected through a larger self-report survey in four of these countries, investigating environmental influences on the self-regulation of children’s and adolescents’ eating behavior. Previous publications have reported on other instruments included in this survey, which are not discussed in the current paper [<xref ref-type="bibr" rid="CR18">18</xref>–<xref ref-type="bibr" rid="CR21">21</xref>]. The four countries in which data were collected are Poland, Portugal, the Netherlands and the United Kingdom (UK). These four countries were selected because they differ predictably with respect to socio-economic and socio-cultural characteristics, as well as regarding childhood overweight prevalence [<xref ref-type="bibr" rid="CR1">1</xref>]. Respondents were recruited via primary schools and high schools (<italic>N</italic> = 24). Our aim was to recruit 600 participants per country, distributed across our targeted age range of 10 to 17 years. Schools were selected based on availability and willingness to participate in the study. However, to ensure a diverse sample, care was taken to select schools from both rural and urban areas (50.9 % versus 49.1 %, respectively), and from areas of both low and high socio-economic status (31.4 % versus 68.6 %, respectively). A total of 2764 adolescents between the ages of 10 and 17 years participated in the study.</p>
        <p>In each country, an authorized review board granted ethical approval for the study or granted exemption from the requirement to seek approval. Specifically, in the UK, ethics approval was granted by the University College London Research Ethics Committee. In Poland, the International Review Board – KEBE of the University of Social Sciences and Humanities in Warsaw granted approval, and in Portugal approval was granted by the ethics committee of the São João Hospital Centre. In The Netherlands the Central Committee on Research Involving Human Subjects indicated that ethics approval did not have to be sought for this study. Consent (active or passive, depending on country regulations) for participation was sought from parents or caregivers. Specifically, active parental or caregiver consent was sought in Poland, while passive consent was sought in the UK and The Netherlands. In Portugal, internal school regulations differed on whether active or passive consent should be obtained, and both approaches were used in this country following each school’s guidelines. In all countries, assent was obtained from the respondents on the day of the study by informing the pupils that they were free to decide if they wanted to participate in the study or not. Respondents could discontinue participation at any time. Respondents filled out the questionnaire during class hours and in their regular class setting. Their teacher and a research assistant were present in the classroom during data collection.</p>
      </sec>
      <sec id="Sec6">
        <title>Measures</title>
        <p>The questionnaire was prepared in English, translated into each country’s (main) language, and back-translated into English. Where required, translations were revised. In the current study, only the measures described below were included. The full questionnaire is available from the authors upon request. All items were self-reported.</p>
        <p>Various individual and behavioral characteristics were assessed. Respondents reported their <italic>age</italic> and <italic>gender</italic>. They also self-reported their height and weight, from which <italic>Body Mass Index (BMI)</italic> was calculated and categorized as underweight, normal weight, overweight or obese based on cut-off points for age and gender described by the International Obesity Task Force [<xref ref-type="bibr" rid="CR22">22</xref>]. For ease of analysis, a dichotomous <italic>weight class</italic> variable was calculated (normal weight or underweight vs. overweight or obese). <italic>Immigrant status</italic> (native vs. immigrant) was determined based on the language respondents reported speaking with their parents [<xref ref-type="bibr" rid="CR23">23</xref>]. <italic>Family affluence</italic> was assessed with the child-appropriate Family Affluence Scale (FAS [<xref ref-type="bibr" rid="CR24">24</xref>]). Using the procedure outlined by the authors of the scale, three affluence categories (low vs. medium vs. high) were created. Average daily intake of four types of food (pieces of fruit, servings of vegetables, number of unhealthy snacks and number of soft drinks) was assessed using a 5-point scale (ranging from 0 = zero per day to 4 = four or more per day). Two composite scores were created reflecting <italic>healthy eating</italic> (fruit and vegetables) and <italic>unhealthy eating</italic> (unhealthy snacks and soft drinks).</p>
        <p><italic>Acceptability of intervention strategies to improve eating behavior:</italic> a list of ten possible intervention strategies, aimed specifically at adolescent populations, was generated by the research team, inspired by previous research and inventories of available strategies [<xref ref-type="bibr" rid="CR5">5</xref>–<xref ref-type="bibr" rid="CR8">8</xref>]. Care was taken to vary the intervention strategies on four dimensions: type, intrusiveness, setting, and change agent. With regard to type of strategy, we selected an equal number of strategies aimed at promoting healthy eating behavior and at discouraging unhealthy eating behavior. With regard to intrusiveness, following the example of Diepeveen and colleagues [<xref ref-type="bibr" rid="CR8">8</xref>], we used the Nuffield intervention ladder [<xref ref-type="bibr" rid="CR25">25</xref>] to select strategies that varied in level of intrusiveness and limitation of freedom of choice. With regard to setting, we selected strategies occurring in various environmental contexts (e.g. home, school, broader out-of-home environment). Finally, regarding change agent, we varied the person delivering the intervention strategy (e.g. parents, teachers, policy makers). Acceptability of each strategy was assessed by asking respondents to indicate extent of agreement with use of the strategy (e.g. “Schools should not sell unhealthy snacks and soft drinks”; “Healthy foods and drinks should be cheaper than unhealthy products”; for all statements, see Table <xref rid="Tab2" ref-type="table">2</xref>); responses were given on a 5-point Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree).</p>
      </sec>
      <sec id="Sec7">
        <title>Data analysis</title>
        <p>First, acceptability of each of the strategies and overall acceptability across all ten strategies were calculated. Second, a principal component analysis was conducted to determine whether the ten strategies could be grouped into higher-order categories, and to determine which dimension(s) (type, level of intrusiveness, setting, or change agent) this grouping would be based on. Third, a paired samples <italic>t</italic>-test was used to assess whether acceptability differed significantly between these higher-order categories. Third, regression analyses were conducted to determine whether individual and behavioral characteristics (i.e., socio-demographic and anthropometric characteristics, and average daily healthy and unhealthy food intake) were associated with acceptance for specific categories of interventions.</p>
      </sec>
    </sec>
    <sec id="Sec8">
      <title>Results</title>
      <p>Descriptive statistics of the sample are depicted in Table <xref rid="Tab1" ref-type="table">1</xref>. Respondents’ mean age was 13.2 years (<italic>SD</italic> = 1.9, range 10–17); 50.9 % were boys and 49.1 % were girls. Most respondents (94.2 %) spoke the country’s native language at home. Most indicated high family affluence (52.5 %), with fewer respondents from families of medium (35.8 %) and low (11.7 %) affluence. Using self-reported height and weight data, it was estimated that most respondents (71.5 %) had a BMI in the normal range. Of the remaining respondents, 11.9 % were underweight, 13.4 % were overweight and 3.2 % were obese. On average, respondents consumed 4.0 portions of fruit and vegetables per day (<italic>SD</italic> = 2.3), and 3.9 unhealthy snacks and soft drinks (<italic>SD</italic> = 2.4).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Means and standard deviations or percentages for the main variables under study</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Variable</th><th>Mean (or percentages)</th><th>Standard Deviation</th></tr></thead><tbody><tr><td>Age</td><td>13.2 years (range 10–17)</td><td>1.9</td></tr><tr><td rowspan="2">Gender</td><td>50.9 % boys</td><td rowspan="2">n.a.</td></tr><tr><td>49.1 % girls</td></tr><tr><td rowspan="4">Weight status</td><td>11.9 % underweight</td><td rowspan="4">n.a.</td></tr><tr><td>71.5 % normal weight</td></tr><tr><td>13.4 % overweight</td></tr><tr><td>3.2 % obese</td></tr><tr><td rowspan="3">Family affluence status</td><td>11.7 % low FAS</td><td rowspan="3">n.a.</td></tr><tr><td>35.8 % medium FAS</td></tr><tr><td>52.5 % high FAS</td></tr><tr><td rowspan="2">Immigrant status</td><td>94.2 % native</td><td rowspan="2">n.a.</td></tr><tr><td>5.8 % immigrant</td></tr><tr><td>Overall acceptance of intervention strategies</td><td>3.20 (range 1–5)</td><td>0.83</td></tr><tr><td>Healthy food intake (average daily intake)</td><td>4.0 (range 0–10)</td><td>2.3</td></tr><tr><td>Unhealthy food intake (average daily intake)</td><td>3.9 (range 0–10)</td><td>2.4</td></tr></tbody></table></table-wrap></p>
      <sec id="Sec9">
        <title>Support for interventions strategies</title>
        <p>Across all ten strategies, mean endorsement was slightly above the mid-point of a five-point scale ranging from 1 to 5 (<italic>M</italic> = 3.20, <italic>SD</italic> = 0.83, see Table <xref rid="Tab1" ref-type="table">1</xref>), corresponding to the response ‘neither agree nor disagree’. Table <xref rid="Tab2" ref-type="table">2</xref> provides the acceptability ratings of all ten strategies, ordered from lowest to highest. There was considerable variation in the extent to which respondents deemed the various strategies to be acceptable (see Table <xref rid="Tab2" ref-type="table">2</xref>), with mean responses per strategy ranging from 2.28 (indicating mild unacceptability) to 3.82 (indicating mild acceptability) on a five-point scale. Adolescents were most accepting of the strategy of parents discussing the importance of healthy eating with their children (<italic>M</italic> = 3.82, <italic>SD</italic> = 1.07), and least accepting of the strategy of banning the sale of unhealthy foods and drinks to young people (<italic>M</italic> = 2.28, <italic>SD</italic> = 1.29).<table-wrap id="Tab2"><label>Table 2</label><caption><p>Intervention strategies, ranging from lowest to highest endorsement, with mean endorsement (<italic>SD</italic>), component loadings (loadings &gt; .40 indicated in bold) from the Principal Component Analysis, and item-total correlations with the relevant subscale</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Intervention strategy</th><th>Mean acceptability (SD)</th><th>PCA factor loadings component 1</th><th>PCA factor loadings component 2</th><th>Item-total correlations subscale “promoting healthy eating”<sup>b</sup>
</th><th>Item-total correlations subscale “discouraging unhealthy eating”<sup>b</sup>
</th></tr></thead><tbody><tr><td>1. Unhealthy foods and drinks should be banned for sale to young people</td><td>2.28 (1.29)</td><td>.10</td><td>
<bold>.87</bold>
</td><td/><td>.82</td></tr><tr><td>2. Advertising of snacks and soft drinks to young people should be prohibited</td><td>2.54 (1.25)</td><td>.16</td><td>
<bold>.82</bold>
</td><td/><td>.81</td></tr><tr><td>3. The price of snacks and soft drinks should be increased so that young people consume less</td><td>2.78 (1.33)</td><td>.27</td><td>
<bold>.76</bold>
</td><td/><td>.81</td></tr><tr><td>4. Schools should not sell unhealthy snacks and soft drinks</td><td>2.92 (1.27)</td><td>.36</td><td>
<bold>.69</bold>
</td><td/><td>.78</td></tr><tr><td>5. Snacks and soft drinks should have health warning labels<sup>a</sup>
</td><td>3.30 (1.25)</td><td>
<bold>.49</bold>
</td><td>
<bold>.49</bold>
</td><td/><td>.69</td></tr><tr><td>6. It is a good idea to have rules at home about eating fruits and vegetables</td><td>3.55 (1.10)</td><td>
<bold>.80</bold>
</td><td>.21</td><td>.82</td><td/></tr><tr><td>7. Teachers should encourage young people to eat healthily</td><td>3.55 (1.10)</td><td>
<bold>.70</bold>
</td><td>.35</td><td>.78</td><td/></tr><tr><td>8. Young people should learn more about healthy eating in school</td><td>3.62 (1.10)</td><td>
<bold>.80</bold>
</td><td>.23</td><td>.83</td><td/></tr><tr><td>9. Healthy foods and drinks should be cheaper than unhealthy products</td><td>3.64 (1.18)</td><td>
<bold>.61</bold>
</td><td>.26</td><td>.70</td><td/></tr><tr><td>10. It is important that parents talk with their children about the importance of healthy eating</td><td>3.82 (1.07)</td><td>
<bold>.84</bold>
</td><td>.04</td><td>.79</td><td/></tr><tr><td rowspan="2">
<italic>Principal Component Analysis</italic>
</td><td>
<italic>Eigenvalue</italic>
</td><td>4.86</td><td>1.47</td><td/><td/></tr><tr><td>
<italic>Explained variance</italic>
</td><td>48.6 %</td><td>14.7 %</td><td/><td/></tr><tr><td/><td>
<italic>Cronbach’s alpha</italic>
</td><td/><td/><td>.84</td><td>.84</td></tr></tbody></table><table-wrap-foot><p>
<sup>a</sup>Item 5 loaded equally on both factors. It is included in component 2 based on theoretical reasoning. Therefore, the subscale “strategies promoting healthy eating” was composed of items 6 to 10, while the subscale “strategies discouraging unhealthy eating” was composed of items 1 to 5. <sup>b</sup>All correlations significant at <italic>p</italic> &lt; .01</p></table-wrap-foot></table-wrap></p>
      </sec>
      <sec id="Sec10">
        <title>Factorial structure of acceptability of intervention strategies</title>
        <p>To determine whether the strategies could be clustered into meaningful categories based on the acceptability ratings, a principal component analysis with orthogonal (varimax) rotation was performed. Bartlett’s test of sphericity (<italic>Χ</italic> [<xref ref-type="bibr" rid="CR2">2</xref>] (45) = 11144.05, <italic>p</italic> &lt; .001) indicated satisfactory correlations between items. Two components had eigenvalues &gt;1 (Kaiser’s criterion). Inspection of the scree plot confirmed the adequacy of a two-factor solution, with the point of inflexion occurring at the third factor. Together these two factors explained 63.3 % of the variance. Table <xref rid="Tab2" ref-type="table">2</xref> shows the factor loadings after rotation. Inspection of the items clustering on each component indicated that component 1 (five items) pertained exclusively to strategies aimed at promoting healthy eating, and component 2 (five items) to strategies aimed at discouraging unhealthy eating. While item five loaded equally on both factors, it was included component 2 based on conceptual grounds, as it reflects a strategy aimed at discouraging unhealthy eating. A paired samples <italic>t</italic>-test showed that adolescents gave higher acceptability ratings for strategies promoting healthy eating (<italic>M</italic> = 3.63, <italic>SD</italic> = 0.87) than strategies discouraging unhealthy eating (<italic>M</italic> = 2.77, <italic>SD</italic> = 1.00), <italic>t</italic> (2620) = 50.31, <italic>p</italic> &lt; .001, <italic>d</italic> = 0.92. The two subscales correlated moderately strongly (<italic>r</italic> = .57, <italic>p</italic> &lt; .001).</p>
      </sec>
      <sec id="Sec11">
        <title>Factors associated with acceptability of the two categories of intervention strategies</title>
        <p>Having established two clear categories of intervention strategies, we proceeded to investigate which individual and behavioral characteristics (age, gender, country, overweight status, family affluence, immigrant status, and healthy and unhealthy food intake) were associated with acceptability of the two categories of strategies. The results (see Table <xref rid="Tab3" ref-type="table">3</xref>) showed that reported acceptability of strategies promoting healthy eating was higher among younger adolescents, girls, Polish and Portuguese adolescents, immigrant adolescents, adolescents eating more healthy food items, and adolescents eating fewer unhealthy food items. Acceptability of strategies promoting healthy eating was also marginally higher among overweight and obese adolescents. There was no association with family affluence. Acceptability of strategies discouraging unhealthy eating was higher among younger adolescents, overweight and obese adolescents, Polish and Portuguese adolescents, adolescents eating more healthy food items and adolescents eating fewer unhealthy food items. Acceptability of strategies discouraging unhealthy eating was also marginally higher among girls and immigrants. There was no association with family affluence. Additional analyses (data not shown) using each country as reference category in turn indicated that, across both categories of intervention strategies, Portuguese adolescents gave higher acceptance scores than Polish adolescents (although the difference for strategies promoting healthy eating was only marginally significant), and that Polish adolescents gave higher acceptance scores than Dutch and UK adolescents.<table-wrap id="Tab3"><label>Table 3</label><caption><p>Multiple regression analyses of acceptability of intervention strategy categories on individual and behavioral characteristics</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th colspan="3">Acceptability of strategies promoting healthy eating<sup>a</sup>
</th><th colspan="3">Acceptability of strategies discouraging unhealthy eating<sup>b</sup>
</th></tr><tr><th>Individual and behavioral characteristics</th><th>
<italic>B</italic> (<italic>SE</italic>)</th><th>
<italic>β</italic>
</th><th>
<italic>p</italic>
</th><th>
<italic>B</italic> (<italic>SE</italic>)</th><th>
<italic>β</italic>
</th><th>
<italic>p</italic>
</th></tr></thead><tbody><tr><td>Age</td><td>-.05 (.01)</td><td>-.12</td><td>&lt;.001</td><td>-.09 (.01)</td><td>-.19</td><td>&lt;.001</td></tr><tr><td>Gender (0 = boy, 1 = girl)</td><td>.17 (.04)</td><td>.10</td><td>&lt;.001</td><td>.08 (.04)</td><td>.04</td><td>.055</td></tr><tr><td>Country: Netherlands vs. UK</td><td>.04 (.06)</td><td>.02</td><td>.524</td><td>-.01 (.07)</td><td>-.00</td><td>.919</td></tr><tr><td>Country: Poland vs. UK</td><td>.19 (.05)</td><td>.11</td><td>.001</td><td>.24 (.06)</td><td>.11</td><td>&lt;.001</td></tr><tr><td>Country: Portugal vs. UK</td><td>.28 (.06)</td><td>.13</td><td>&lt;.001</td><td>.40 (.07)</td><td>.16</td><td>&lt;.001</td></tr><tr><td>Overweight status (0 = not overweight, 1 = overweight)</td><td>.10 (.05)</td><td>.04</td><td>.054</td><td>.25 (.06)</td><td>.09</td><td>&lt;.001</td></tr><tr><td>Family affluence: high vs. low</td><td>.03 (.06)</td><td>.02</td><td>.604</td><td>.09 (.07)</td><td>.04</td><td>.192</td></tr><tr><td>Family affluence: medium vs. low</td><td>.03 (.06)</td><td>.02</td><td>.580</td><td>.10 (.07)</td><td>.05</td><td>.140</td></tr><tr><td>Immigrant status (0 = native, 1 = immigrant)</td><td>.22 (.08)</td><td>.06</td><td>.008</td><td>.16 (.10)</td><td>.04</td><td>.096</td></tr><tr><td>Healthy food intake index</td><td>.06 (.01)</td><td>.16</td><td>&lt;.001</td><td>.05 (.01)</td><td>.11</td><td>&lt;.001</td></tr><tr><td>Unhealthy food intake index</td><td>-.06 (.01)</td><td>-.17</td><td>&lt;.001</td><td>-.07 (.01)</td><td>-.17</td><td>&lt;.001</td></tr></tbody></table><table-wrap-foot><p>
<sup>a</sup>R<sup>2</sup> = .11, <italic>F</italic> (11,2029) = 23.70, <italic>p</italic> &lt; .001; <sup>b</sup>R<sup>2</sup> = .14, <italic>F</italic> (11,2026) = 29.26, <italic>p</italic> &lt; .001</p></table-wrap-foot></table-wrap></p>
      </sec>
    </sec>
    <sec id="Sec12">
      <title>Discussion</title>
      <p>This study investigated adolescents’ acceptance of intervention strategies aimed at improving their eating behavior. While previous studies have investigated the extent to which adults accept interventions targeted at adolescents, research into the extent to which adolescents themselves find such interventions acceptable is scarce. Overall, adolescents rated the strategies as neither acceptable nor unacceptable, but acceptability was higher among younger adolescents, girls, overweight or obese adolescents, immigrant adolescents and those with healthier average daily food intake (as evidenced by higher intake of healthy, and lower intake of unhealthy, foods). Portuguese adolescents were most accepting of the strategies, followed by Polish adolescents, while Dutch and UK adolescents reported the lowest acceptability. These findings partially align with previous findings from studies investigating acceptability of interventions among adult populations. For example, previous studies have also found that women tend to be more accepting of interventions [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>] and that those reporting unhealthier behaviors are less accepting of interventions [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR26">26</xref>].</p>
      <p>Novel findings are that younger adolescents, overweight and obese adolescents, Portuguese and Polish adolescents, and immigrant adolescents are more accepting of intervention strategies. Younger adolescents’ higher acceptance as compared to older adolescents may be due to the fact that the need for autonomy and personal agency increase during adolescence [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR28">28</xref>], which may inversely relate to acceptance of intervention strategies imposing rules and regulations. There are at least two possible explanations for the finding that overweight and obese adolescents reported higher acceptability than normal weight adolescents. On the one hand, it could be that these adolescents experience a genuine need for outside help, reflected in higher acceptability. On the other hand, their higher acceptability ratings may also be an expression of social desirability. The finding that Portuguese and Polish adolescents reported higher acceptability than Dutch and UK adolescents may be due to the differences between these countries in individualism [<xref ref-type="bibr" rid="CR29">29</xref>]. Corresponding to our finding that Portuguese adolescents are most accepting of the interventions strategies, Hofstede [<xref ref-type="bibr" rid="CR29">29</xref>] reports that Portuguese culture is highly collectivist, more so than Polish culture and much more so than Dutch and UK culture (correspondingly, we found that Polish adolescents, while reporting lower acceptability of intervention strategies than their Portuguese peers, reported higher acceptability than Dutch and UK adolescents). A more individualistic culture may translate into less support for rules and regulations imposed by others, as in such a culture, people typically experience a higher need for personal agency and self-determination [<xref ref-type="bibr" rid="CR29">29</xref>]. The same argument could apply to our finding regarding higher acceptability ratings by immigrant adolescents, as their native culture may be more collectivist than that of the host country.</p>
      <sec id="Sec13">
        <title>Factorial structure of the strategies</title>
        <p>The strategies were found to be separable into two meaningful categories, based on the type of strategy: the first category reflected policies aimed at promoting healthy eating, while the second reflected policies aimed at discouraging unhealthy eating. The dimension of “type of strategy” was thus more influential for acceptability than the other dimensions (level of intrusiveness, setting and change agent). This is very clear, for example, with regard to the two items reflecting price manipulations, which only differ in type of strategy and share the same level of intrusiveness, the same setting and the same change agent. Crucially, the item reflecting an increase in the price of unhealthy foods (i.e., a strategy discouraging unhealthy eating) was rated as the second-lowest acceptable strategy, while the item reflecting a decrease in the price of healthy foods (i.e., a strategy promoting healthy eating) was rated as the second-highest acceptable strategy.</p>
        <p>While type of strategy was thus clearly the most important dimension in terms of acceptability, the results suggest that the other dimensions also affected acceptability ratings, at least for strategies discouraging unhealthy eating. Regarding the level of intrusiveness, strategies discouraging unhealthy eating with lower levels of intrusiveness (according to the Nuffield intervention ladder [<xref ref-type="bibr" rid="CR25">25</xref>]) were rated as more acceptable. Similar to adults [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR10">10</xref>], adolescents thus show a preference for less intrusive strategies, at least where strategies aimed at discouraging unhealthy eating are concerned. Importantly, however, for strategies aimed at promoting healthy eating, adolescents did not show a preference for less intrusive interventions. This may point to an important implication, namely that adolescents actually accept intervention strategies, even when these are intrusive, as long as they are aimed at improving healthy eating behavior. Other studies have shown a similar preference of adolescents for promotion of the ‘right’ behavior over discouragement of the ‘wrong’ behavior [<xref ref-type="bibr" rid="CR20">20</xref>].</p>
        <p>In a similar vein, strategies discouraging unhealthy eating in a broader out-of-home setting and strategies delivered by policy makers as change agents were rated as less acceptable than strategies in a home or school setting and strategies delivered by parents or teachers. Again, for strategies aimed at promoting healthy eating, setting and change agent do not appear to have a systematic influence on acceptability, with scores varying across the different types of settings and change agents. It is important to note that the dimensions of setting and change agent are not completely separate dimensions but are intertwined to a certain extent (parents are more likely to be change agent for strategies in a home setting, for example). However, the distinction between the two is not redundant. For example, the strategy of prohibiting soft drinks and unhealthy schools refers to a school setting, but is delivered not by teachers but by policy makers.</p>
      </sec>
      <sec id="Sec14">
        <title>Limitations</title>
        <p>The current study is not without limitations. An important limitation is that we assessed acceptability of only ten intervention strategies, which were determined by the authors. Many more strategies exist [<xref ref-type="bibr" rid="CR30">30</xref>] which have not been included in the current analysis. Similar investigations should therefore be carried out for more systemically organized and exhaustive lists of intervention strategies, for example in order to determine whether the finding that adolescents indicate higher acceptability for less intrusive strategies aimed at discouraging unhealthy also holds across a larger array of strategies. Furthermore, it should be noted that one of our strategies (“Healthy foods and drinks should be cheaper than unhealthy products”) is not strictly a strategy, but rather the result of one or more strategies that could encompass either increasing the price of unhealthy food or decreasing the price of healthy food, or both. While our factor analysis indicates that our respondents primarily associated this item with the promotion of healthy eating, we have not directly tested this assumption.</p>
        <p>Another limitation lies in the fact that we have currently only assessed associations of a limited number of individual characteristics (socio-demographics, BMI and average healthy and unhealthy food intake) with acceptability. While these characteristics have been found to be associated with policy support in earlier studies among adults [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR10">10</xref>], several additional factors have been shown to be substantially associated with acceptance of interventions, such as attributions of the causes of obesity [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>], regulatory focus (promotion versus prevention [<xref ref-type="bibr" rid="CR27">27</xref>]), and health risk concerns [<xref ref-type="bibr" rid="CR26">26</xref>] or problem identification [<xref ref-type="bibr" rid="CR10">10</xref>]. It would be important for future research on adolescents’ acceptance of eating-related interventions to take these additional factors into account.</p>
      </sec>
    </sec>
    <sec id="Sec15">
      <title>Conclusions</title>
      <p>Adult support for intervention strategies aimed at improving youngsters’ eating behavior is typically high. However, less research has investigated the views of adolescents themselves with regard to such strategies. The present study aimed to contribute to filling this gap in the literature. The results demonstrated that adolescents are, overall, moderately accepting of such strategies. Importantly, level of acceptability was moderated by type of intervention strategy: adolescents reported higher acceptability for strategies aimed at increasing healthy eating behavior than for strategies aimed at decreasing unhealthy eating behavior. Furthermore, adolescents showed a preference for non-intrusive strategies over more intrusive ones, particularly with regard to strategies aimed at decreasing unhealthy eating. As it has been shown that intervention strategies are more likely to actually instigate behavior change when they are considered acceptable by the people they are targeted at [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR11">11</xref>], these findings may hold important practical implications for policy makers and intervention planners.</p>
    </sec>
    <sec id="Sec16">
      <title>Availability of data and materials</title>
      <p>Not applicable.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn>
        <p>Jane Wardle deceased.</p>
      </fn>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The authors declare that they have no competing interests.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors’ contributions</bold>
        </p>
        <p>All authors contributed to the conception of the TEMPEST survey. MS and JdW designed the study and developed the measure assessing acceptability of intervention strategies. All authors were involved in participant recruitment and data collection. Statistical analyses were conducted by MS, JdW and LN. MS and JdW prepared the manuscript. DdR, EdV, LN, AL, JW and TG provided critical revisions. JW saw and approved an earlier version the manuscript, but sadly passed away before the manuscript was finalized. All other authors saw and approved the final version of the paper for submission.</p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgements</title>
      <p>We were devastated to learn of the passing of our esteemed and dear colleague Professor Jane Wardle. This research was supported by the European Community FP7 Research Program (Health-F2-2008-223488). The authors acknowledge all members of the TEMPEST team.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lien</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Henriksen</surname>
              <given-names>HB</given-names>
            </name>
            <name>
              <surname>Nynoem</surname>
              <given-names>LL</given-names>
            </name>
            <name>
              <surname>Wind</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Klepp</surname>
              <given-names>KI</given-names>
            </name>
          </person-group>
          <article-title>Availability of data assessing the prevalence and trends of overweight and obesity among European adolescents</article-title>
          <source>Pub Health Nut</source>
          <year>2010</year>
          <volume>13</volume>
          <fpage>1680</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.1017/S1368980010002223</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <mixed-citation publication-type="other">World Health Organization. Childhood overweight and obesity, 2014: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/dietphysicalactivity/childhood/en/">http://www.who.int/dietphysicalactivity/childhood/en/</ext-link> Accessed 2 April 2015.</mixed-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dietz</surname>
              <given-names>WH</given-names>
            </name>
          </person-group>
          <article-title>Health consequences of obesity in youth: Childhood predictors of adult disease</article-title>
          <source>Pediatrics</source>
          <year>1998</year>
          <volume>101</volume>
          <fpage>518</fpage>
          <lpage>25</lpage>
          <?supplied-pmid 12224658?>
          <pub-id pub-id-type="pmid">12224658</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Freedman</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Mei</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Srinivasan</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Berenson</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Dietz</surname>
              <given-names>WH</given-names>
            </name>
          </person-group>
          <article-title>Cardiovascular risk factors and excess adiposity among overweight children and adolescents: The Bogalusa heart study</article-title>
          <source>J Pediatr</source>
          <year>2007</year>
          <volume>150</volume>
          <fpage>12</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jpeds.2006.08.042</pub-id>
          <?supplied-pmid 17188605?>
          <pub-id pub-id-type="pmid">17188605</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brescoll</surname>
              <given-names>VL</given-names>
            </name>
            <name>
              <surname>Kersh</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Brownell</surname>
              <given-names>KD</given-names>
            </name>
          </person-group>
          <article-title>Assessing the feasibility and impact of federal childhood obesity policies</article-title>
          <source>Annals Am A Polit Soc Sci</source>
          <year>2008</year>
          <volume>615</volume>
          <fpage>178</fpage>
          <lpage>94</lpage>
          <pub-id pub-id-type="doi">10.1177/0002716207309189</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Capacci</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mazzocchi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Shankar</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Macias</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Verbeke</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Pérez-Cueto</surname>
              <given-names>FJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Policies to promote healthy eating in Europe: A structured review of policies and their effectiveness</article-title>
          <source>Nutr Rev</source>
          <year>2012</year>
          <volume>70</volume>
          <fpage>188</fpage>
          <lpage>200</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1753-4887.2011.00442.x</pub-id>
          <?supplied-pmid 22364161?>
          <pub-id pub-id-type="pmid">22364161</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Traill</surname>
              <given-names>WB</given-names>
            </name>
            <name>
              <surname>Shankar</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Bramila Macias</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bech-Larsen</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Aschemann-Witzel</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Strand</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Interventions to promote healthy eating habits: Evaluation and recommendations</article-title>
          <source>Obes Rev</source>
          <year>2010</year>
          <volume>11</volume>
          <fpage>895</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1467-789X.2010.00717.x</pub-id>
          <?supplied-pmid 20202134?>
          <pub-id pub-id-type="pmid">20202134</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Diepeveen</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ling</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Suhrcke</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Roland</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Marteau</surname>
              <given-names>TM</given-names>
            </name>
          </person-group>
          <article-title>Public acceptability of government intervention to change health-related behaviours: A systematic review and narrative synthesis</article-title>
          <source>BMC Publ Health</source>
          <year>2013</year>
          <volume>13</volume>
          <fpage>756</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-2458-13-756</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hardus</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Van Vuuren</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Crawford</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Worsley</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Public perceptions of the causes and prevention of obesity among primary school children</article-title>
          <source>Int J Obes</source>
          <year>2003</year>
          <volume>27</volume>
          <fpage>1465</fpage>
          <lpage>71</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.ijo.0802463</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hilbert</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Rief</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Braehler</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>What determines public support of obesity prevention?</article-title>
          <source>J Epidemiol Commun Health</source>
          <year>2007</year>
          <volume>61</volume>
          <fpage>585</fpage>
          <lpage>90</lpage>
          <pub-id pub-id-type="doi">10.1136/jech.2006.050906</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oliver</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Public opinion and the politics of obesity in America</article-title>
          <source>J Health Polit Policy Law</source>
          <year>2007</year>
          <volume>30</volume>
          <fpage>923</fpage>
          <lpage>54</lpage>
          <pub-id pub-id-type="doi">10.1215/03616878-30-5-923</pub-id>
          <pub-id pub-id-type="pmid">16477792</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Evans</surname>
              <given-names>WD</given-names>
            </name>
            <name>
              <surname>Finkelstein</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Kamerow</surname>
              <given-names>DB</given-names>
            </name>
            <name>
              <surname>Renaud</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Public perceptions of childhood obesity</article-title>
          <source>Am Prev Med</source>
          <year>2005</year>
          <volume>28</volume>
          <fpage>26</fpage>
          <lpage>32</lpage>
          <pub-id pub-id-type="doi">10.1016/j.amepre.2004.09.008</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Erikson</surname>
              <given-names>EH</given-names>
            </name>
          </person-group>
          <source>Identity, youth, and crisis</source>
          <year>1968</year>
          <publisher-loc>New York</publisher-loc>
          <publisher-name>Norton</publisher-name>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Burgoon</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Alvaro</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Grandpre</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Voulodakis</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Price Dillard</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Pfau</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Revisiting the theory of psychological reactance: Communicating threats to attitudinal freedom</article-title>
          <source>The persuasion handbook: Developments in theory and practice</source>
          <year>2002</year>
          <publisher-loc>Thousand Oakes</publisher-loc>
          <publisher-name>Sage</publisher-name>
          <fpage>213</fpage>
          <lpage>32</lpage>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Miller</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Lane</surname>
              <given-names>LT</given-names>
            </name>
            <name>
              <surname>Deatrick</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Potts</surname>
              <given-names>KA</given-names>
            </name>
          </person-group>
          <article-title>Psychological reactance and promotional health messages: The effects of controlling language, lexical concreteness, and the restoration of freedom</article-title>
          <source>Hum Commun Res</source>
          <year>2007</year>
          <volume>33</volume>
          <fpage>219</fpage>
          <lpage>40</lpage>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Silvia</surname>
              <given-names>PJ</given-names>
            </name>
          </person-group>
          <article-title>Reactance and the dynamics of disagreement: Multiple paths from threatened freedom to resistance to persuasion</article-title>
          <source>Eur J Soc Psychol</source>
          <year>2006</year>
          <volume>36</volume>
          <fpage>673</fpage>
          <lpage>85</lpage>
          <pub-id pub-id-type="doi">10.1002/ejsp.309</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Brehm</surname>
              <given-names>JW</given-names>
            </name>
          </person-group>
          <source>A theory of psychological reactance</source>
          <year>1966</year>
          <publisher-loc>New York</publisher-loc>
          <publisher-name>Academic</publisher-name>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>De Vet</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>De Wit</surname>
              <given-names>JBF</given-names>
            </name>
            <name>
              <surname>Luszczynska</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Stok</surname>
              <given-names>FM</given-names>
            </name>
            <name>
              <surname>Gaspar</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Pratt</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Access to excess: how do adolescents deal with unhealthy foods in their environment?</article-title>
          <source>Eur J Pub Health</source>
          <year>2013</year>
          <volume>5</volume>
          <fpage>752</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.1093/eurpub/cks185</pub-id>
          <pub-id pub-id-type="pmid">23329704</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Luszczynska</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>De Wit</surname>
              <given-names>JBF</given-names>
            </name>
            <name>
              <surname>De Vet</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Januszewicz</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Liszewska</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>How the role of at-home and out-of-home environment on snacks and sweetened beverages intake changes from preadolescence to mid-adolescence: The interplay between environment and self-regulation</article-title>
          <source>J Youth Adol</source>
          <year>2013</year>
          <volume>42</volume>
          <fpage>1873</fpage>
          <lpage>83</lpage>
          <pub-id pub-id-type="doi">10.1007/s10964-013-9908-6</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stok</surname>
              <given-names>FM</given-names>
            </name>
            <name>
              <surname>De Vet</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>De Wit</surname>
              <given-names>JBF</given-names>
            </name>
            <name>
              <surname>Luszczynska</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Safron</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>De Ridder</surname>
              <given-names>DTD</given-names>
            </name>
          </person-group>
          <article-title>The proof is in the eating: Peer social norms are associated with adolescents’ intended and actual eating behavior</article-title>
          <source>Pub Health Nutr</source>
          <year>2015</year>
          <volume>18</volume>
          <fpage>1044</fpage>
          <lpage>51</lpage>
          <pub-id pub-id-type="doi">10.1017/S1368980014001268</pub-id>
          <pub-id pub-id-type="pmid">24940622</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>De Wit</surname>
              <given-names>JBF</given-names>
            </name>
            <name>
              <surname>Stok</surname>
              <given-names>FM</given-names>
            </name>
            <name>
              <surname>Smolenski</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>de Ridder</surname>
              <given-names>DD</given-names>
            </name>
            <name>
              <surname>de Vet</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Gaspar</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Food culture in the home environment: Family meal practices and values can support healthy eating and self-regulation in young people in four European countries</article-title>
          <source>Appl Psychol Health Well Being</source>
          <year>2015</year>
          <volume>7</volume>
          <fpage>22</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="doi">10.1111/aphw.12034</pub-id>
          <?supplied-pmid 25346476?>
          <pub-id pub-id-type="pmid">25346476</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cole</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Bellizzi</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Flegal</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Dietz</surname>
              <given-names>WH</given-names>
            </name>
          </person-group>
          <article-title>Establishing a standard definition for child overweight and obesity worldwide: International survey</article-title>
          <source>Br Med J</source>
          <year>2000</year>
          <volume>320</volume>
          <fpage>1240</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="doi">10.1136/bmj.320.7244.1240</pub-id>
          <pub-id pub-id-type="pmid">10797032</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Berry</surname>
              <given-names>JW</given-names>
            </name>
          </person-group>
          <article-title>A psychology of immigration</article-title>
          <source>J Soc Issues</source>
          <year>2001</year>
          <volume>57</volume>
          <fpage>615</fpage>
          <lpage>31</lpage>
          <pub-id pub-id-type="doi">10.1111/0022-4537.00231</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Currie</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Molcho</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Boyce</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Holstein</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Torsheim</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Richter</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Researching health inequalities in adolescents: The development of the Health Behaviour in School-aged Children (HBSC) family affluence scale</article-title>
          <source>Soc Sci Med</source>
          <year>2008</year>
          <volume>66</volume>
          <fpage>1429</fpage>
          <lpage>36</lpage>
          <pub-id pub-id-type="doi">10.1016/j.socscimed.2007.11.024</pub-id>
          <?supplied-pmid 18179852?>
          <pub-id pub-id-type="pmid">18179852</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <mixed-citation publication-type="other">Nuffield Council on Bioethics. Public Health: ethical issues. London: Nuffield Council on Bioethics; 2007.</mixed-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mazzocchi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Cagnone</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bech-Larsen</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Niedźwiedzka</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Saba</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Shankar</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>What is the public appetite for healthy eating policies? Evidence from a cross-European survey</article-title>
          <source>Health Econ Policy Law</source>
          <year>2015</year>
          <volume>10</volume>
          <fpage>267</fpage>
          <lpage>92</lpage>
          <pub-id pub-id-type="doi">10.1017/S1744133114000346</pub-id>
          <?supplied-pmid 25170630?>
          <pub-id pub-id-type="pmid">25170630</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Arnett</surname>
              <given-names>JJ</given-names>
            </name>
          </person-group>
          <source>Adolescence and emerging adulthood: A cultural approach</source>
          <year>2010</year>
          <edition>4</edition>
          <publisher-loc>Boston</publisher-loc>
          <publisher-name>Prentice Hall</publisher-name>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stok</surname>
              <given-names>FM</given-names>
            </name>
            <name>
              <surname>De Ridder</surname>
              <given-names>DTD</given-names>
            </name>
            <name>
              <surname>Adriaanse</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>De Wit</surname>
              <given-names>JBF</given-names>
            </name>
          </person-group>
          <article-title>Looking cool or attaining self-rule. Different motives for autonomy and their effects on unhealthy snack purchase</article-title>
          <source>Appetite</source>
          <year>2010</year>
          <volume>54</volume>
          <fpage>607</fpage>
          <lpage>10</lpage>
          <pub-id pub-id-type="doi">10.1016/j.appet.2010.02.017</pub-id>
          <?supplied-pmid 20211669?>
          <pub-id pub-id-type="pmid">20211669</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Hofstede</surname>
              <given-names>GH</given-names>
            </name>
          </person-group>
          <source>Culture’s consequences: Comparing values, behaviors, institutions and organizations across nations</source>
          <year>2001</year>
          <publisher-loc>Thousand Oakes</publisher-loc>
          <publisher-name>Sage</publisher-name>
        </element-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barry</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Brescoll</surname>
              <given-names>VL</given-names>
            </name>
            <name>
              <surname>Gollust</surname>
              <given-names>SE</given-names>
            </name>
          </person-group>
          <article-title>Framing childhood obesity: How individualizing the problem affects public support for prevention</article-title>
          <source>Polit Psychol</source>
          <year>2013</year>
          <volume>34</volume>
          <fpage>327</fpage>
          <lpage>49</lpage>
          <pub-id pub-id-type="doi">10.1111/pops.12018</pub-id>
        </element-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beeken</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Wardle</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Public beliefs about the causes of obesity and attitudes toward policy initiatives in Great Britain</article-title>
          <source>Pub Health Nutr</source>
          <year>2013</year>
          <volume>16</volume>
          <fpage>2132</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.1017/S1368980013001821</pub-id>
          <pub-id pub-id-type="pmid">23866723</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:4700579</identifier><datestamp>2016-01-06</datestamp><setSpec>bmcgeno</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="http://jats.nlm.nih.gov/ns/archiving/1.0/ http://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Genomics</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Genomics</journal-id>
      <journal-title-group>
        <journal-title>BMC Genomics</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1471-2164</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC4700579</article-id>
      <article-id pub-id-type="pmcid">PMC4700579</article-id>
      <article-id pub-id-type="pmc-uid">4700579</article-id>
      <article-id pub-id-type="publisher-id">2354</article-id>
      <article-id pub-id-type="doi">10.1186/s12864-015-2354-y</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Improved transcription and translation with L-leucine stimulation of mTORC1 in Roberts syndrome</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Xu</surname>
            <given-names>Baoshan</given-names>
          </name>
          <address>
            <email>bax@stowers.org</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gogol</surname>
            <given-names>Madelaine</given-names>
          </name>
          <address>
            <email>mcm@stowers.org</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gaudenz</surname>
            <given-names>Karin</given-names>
          </name>
          <address>
            <email>kzg@stowers.org</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Gerton</surname>
            <given-names>Jennifer L.</given-names>
          </name>
          <address>
            <email>jeg@stowers.org</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <aff id="Aff1"><label/>Stowers Institute for Medical Research, 1000 E 50th St, Kansas City, MO 64110 USA </aff>
        <aff id="Aff2"><label/>Department of Biochemistry and Molecular Biology, University of Kansas School of Medicine, 3901 Rainbow Blvd, Kansas City, KS 66160 USA </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>5</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>5</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <volume>17</volume>
      <elocation-id>25</elocation-id>
      <history>
        <date date-type="received">
          <day>9</day>
          <month>7</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>21</day>
          <month>12</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© Xu et al. 2015</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Roberts syndrome (RBS) is a human developmental disorder caused by mutations in the cohesin acetyltransferase ESCO2. We previously reported that mTORC1 signaling was depressed and overall translation was reduced in RBS cells and zebrafish models for RBS. Treatment of RBS cells and zebrafish RBS models with L-leucine partially rescued mTOR function and protein synthesis, correlating with increased cell division and improved development.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>In this study, we use RBS cells to model mTORC1 repression and analyze transcription and translation with ribosome profiling to determine gene-level effects of L-leucine. L-leucine treatment partially rescued translational efficiency of ribosomal subunits, translation initiation factors, snoRNA production, and mitochondrial function in RBS cells, consistent with these processes being mTORC1 controlled. In contrast, other genes are differentially expressed independent of L-leucine treatment, including imprinted genes such as <italic>H19</italic> and <italic>GTL2</italic>, miRNAs regulated by GTL2, <italic>HOX</italic> genes, and genes in nucleolar associated domains.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>Our study distinguishes between gene expression changes in RBS cells that are TOR dependent and those that are independent. Some of the TOR independent gene expression changes likely reflect the architectural role of cohesin in chromatin looping and gene expression. This study reveals the dramatic rescue effects of L-leucine stimulation of mTORC1 in RBS cells and supports that normal gene expression and translation requires <italic>ESCO2</italic> function.</p>
        </sec>
        <sec>
          <title>Electronic supplementary material</title>
          <p>The online version of this article (doi:10.1186/s12864-015-2354-y) contains supplementary material, which is available to authorized users.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keyword</title>
        <kwd>Ribosome profiling</kwd>
        <kwd>Gene expression</kwd>
        <kwd>Roberts syndrome (RBS)</kwd>
        <kwd>mTORC1 pathway</kwd>
        <kwd>Translation</kwd>
        <kwd>Cohesin</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000912</institution-id>
              <institution>March of Dimes Foundation</institution>
            </institution-wrap>
          </funding-source>
          <award-id>#6-FY14-434</award-id>
          <principal-award-recipient>
            <name>
              <surname>Gerton</surname>
              <given-names>Jennifer L.</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
      </funding-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>© The Author(s) 2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Background</title>
      <p>Cohesinopathies are a group of developmental disorders, including Roberts syndrome (RBS) and Cornelia de Lange syndrome (CdLS), caused by loss of function mutations in the cohesin complex or its regulators. The cohesin complex is a structural component of chromosomes and helps to facilitate many different chromosomal processes such as genome organization, chromosome segregation, double-strand break repair, and gene expression. The developmental defects associated with the cohesinopathies include slow growth and small size, hirsutism, mental retardation, craniofacial anomalies, limb malformations, and heart, gastrointestinal, and auditory problems. While the molecular etiology of these developmental disorders is unclear, one working model is that the loss of cohesin function results in changes in gene expression during embryogenesis [<xref ref-type="bibr" rid="CR1">1</xref>–<xref ref-type="bibr" rid="CR5">5</xref>]. These changes in gene expression could occur via several mechanisms including altered gene looping or genome architecture [<xref ref-type="bibr" rid="CR6">6</xref>–<xref ref-type="bibr" rid="CR10">10</xref>].</p>
      <p>RBS is an autosomal recessive, multi-system developmental syndrome caused by loss of function mutation in a gene that encodes a cohesin acetyltransferase, <italic>ESCO2</italic> [<xref ref-type="bibr" rid="CR11">11</xref>]. A hallmark of chromosomes from RBS cells is heterochromatic repulsion, observed in metaphase spreads, possibly indicating a lack of cohesion at these regions [<xref ref-type="bibr" rid="CR12">12</xref>]. Two genes, <italic>ESCO1</italic> and <italic>ESCO2</italic>, both encode acetyltransferases that acetylate the SMC3 subunit of cohesin during DNA replication to lock the cohesin ring onto DNA. A mutation in yeast <italic>ECO1</italic>, which is a yeast homolog of human <italic>ESCO1/2</italic>, was recently shown to disrupt cohesion, replication, transcription, and looping at the ribosomal DNA (rDNA) repeats [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. Mutations that disrupt the acetyltransferase activity of Eco1/ESCO2 also disrupt nucleolar architecture, impair ribosomal RNA (rRNA) production and ribosome biogenesis, and reduce protein biosynthesis in budding yeast and human RBS cells [<xref ref-type="bibr" rid="CR14">14</xref>–<xref ref-type="bibr" rid="CR16">16</xref>]. Cohesin binds to the rDNA in every organism studied [<xref ref-type="bibr" rid="CR17">17</xref>], giving cohesin the potential to affect the structure and function of the nucleolus which is essential for both ribosome biogenesis and organization of the genome.</p>
      <p>We recently reported that mTOR (mammalian target of rapamycin) signaling was strongly downregulated in human RBS patient cells, accompanied by p53 activation [<xref ref-type="bibr" rid="CR16">16</xref>]. Amino acids, and in particular L-leucine (L-Leu), have been shown to stimulate mTORC1. In zebrafish models for RBS and CdLS, L-Leu boosted cell proliferation, protein synthesis, and development [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. The dramatic rescue effect of L-Leu at the cellular and organismal level suggests that cohesinopathies are caused in part by translational defects [<xref ref-type="bibr" rid="CR19">19</xref>]. Since the mTOR pathway is a critical regulator of protein translation and ribosome function, and p53 is an indicator of nucleolar stress, translational impairment may contribute to differential gene expression in RBS. Therefore, we have used RBS as a disease model to address mTOR-associated transcription and translation dysfunction. A number of reports have shown that mTOR kinase signaling controls mRNA translation by two branches. The first is through phosphorylation of 4EBP1 (Eukaryotic translation initiation factor 4E-binding protein 1) [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>]. The unphosphorylated form of 4EBP1 is a translational repressor that directly binds to eIF4E (eukaryotic translation initiation factor 4E), a limiting component for translation initiation for 40S. Phosphorylation of 4EBP1 releases eIF4E for translation initiation. mTOR also controls translation via phosphorylation of RPS6 by RPS6 kinase (S6K1) which activates ribosomal protein S6 to promote its 40S ribosome function. The depression of mTOR observed in RBS cells affects both branches of the pathway which converge on 40S function.</p>
      <p>In addition to its role in promoting nucleolar function, cohesin plays a role throughout the genome in forming chromatin loops that can affect gene expression. For instance, cohesin promotes the formation of loops at the imprinted loci <italic>IGF2-H19</italic> [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>], Myc [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>], and pluripotency factors [<xref ref-type="bibr" rid="CR6">6</xref>]. The misregulation of any of these master regulators can have grave consequences for cell-type specification and cellular function. The cohesin-dependent control of chromosome organization is another mechanism, in addition to changes in mTOR signaling, that is predicted to underpin the gene expression changes associated with the cohesinopathies.</p>
      <p>The rescue provided by L-Leu in animal and tissue culture models for the cohesinopathies strongly suggested that many of the critical transcriptional changes were ameliorated by boosting translation. To address L-Leu dependent transcription and translation at a gene-by-gene level, we examined translation initiation complexes and performed ribosome profiling in RBS cells. We found that L-Leu partially rescued translation initiation, translational efficiency of ribosomal subunits and translation factors, and mitochondrial function in RBS cells. However, other differentially expressed genes do not respond to L-Leu, suggesting they are misexpressed independent of the TOR pathway. These include the imprinted genes and <italic>HOX</italic> genes which are known to be regulated by cohesin-dependent looping events. This is consistent with our previous observation that L-Leu stimulates mTORC1 without rescuing the architectural defects in the nucleolus observed in RBS cells. Our results suggest targeting mTORC1 with L-Leu rescues a significant fraction of the differential gene expression associated with RBS. L-Leu could be a promising therapeutic strategy for human diseases associated with poor translation.</p>
    </sec>
    <sec id="Sec2" sec-type="results">
      <title>Results</title>
      <sec id="Sec3">
        <title>40S and 60S ribosome subunits are present at lower levels in RBS cells</title>
        <p>Our previous studies demonstrated ribosome biogenesis and protein synthesis were defective in RBS cells. For our analysis, we used normal human fibroblasts, RBS fibroblasts (homozygous mutation 877_878 delAG in exon 4 of <italic>ESCO2</italic>), and RBS fibroblasts in which a wild-type copy of the <italic>ESCO2</italic> gene has been added back (corrected cells) [<xref ref-type="bibr" rid="CR12">12</xref>]. We also used two other RBS cell lines (GM21873 and GM21872), which were (1) untransformed amniotic fluid-derived, and (2) a fetal skin fibroblast cell line. For untransformed primary fibroblasts, the donor subject was homozygous for a 5 bp deletion at nucleotide 307 in exon 3 of the <italic>ESCO2</italic> gene (c.307_311delAGAAA) resulting in a frameshift that leads to a truncated protein (p.I102fsX1). For untransformed amniocytes, the donor subject was a compound heterozygote. One allele has a 1 bp deletion at nucleotide 752 in exon 3 of the <italic>ESCO2</italic> gene (c.752delA), and the second allele has an A &gt; G substitution in intron 6 [c.IVS6-7A &gt; G (c.1132-7A &gt; G)]. Both the immortalized RBS fibroblasts and the two untransformed RBS cell lines had similar depression of the mTORC1 signaling pathway, an aberrant cell cycle pattern, and reduced protein translation. Moreover, L-Leu treatment partially rescued cell proliferation and survival, ribosome biogenesis, and protein biosynthesis similarly in all three RBS lines [<xref ref-type="bibr" rid="CR16">16</xref>]. We selected the transformed RBS fibroblasts for use in our current study because the corrected version provides an excellent control.</p>
        <p>We decided to examine expression of individual ribosomal proteins in the WT, RBS mutant, and corrected cell lines. Western blotting analysis revealed lower levels of both 40S small subunit and 60S large subunit ribosome proteins including RPS7, RPS19, RPL5, RPL23, and RPL24 in the mutant relative to WT and corrected cells (Fig. <xref rid="Fig1" ref-type="fig">1a</xref>, Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S1a). Since L-Leu is able to improve protein biosynthesis in RBS cells, we examined the effect of L-Leu on ribosomal proteins. Since D-leucine (D-Leu) is not used as an amino acid, we used D-Leu treatment as a negative control. The levels of both RPS7 and RPL24 were partially rescued by L-Leu supplement but not the bioinactive D-Leu (Fig. <xref rid="Fig1" ref-type="fig">1b</xref>, Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S1b). In addition, eIF2α phosphorylation was elevated in RBS cells, suggesting a state of translational repression similar to nutrition starvation. Interestingly, we found the phospho-eIF2α level in RBS cells declined with L-Leu supplementation. The data suggested that defective ribosome biogenesis in RBS includes lower levels of ribosomal proteins that can be rescued with L-Leu. Furthermore, the eIF2α phosphorylation suggests the possibility of an integrated stress response [<xref ref-type="bibr" rid="CR26">26</xref>] that includes defective translation initiation that can be relieved with L-Leu.<fig id="Fig1"><label>Fig. 1</label><caption><p>Ribosomal components and translation initiation complexes were present at low levels in RBS cells. <bold>a</bold> Western blotting showed that 40S small ribosome proteins RPS7 and RPS19, and 60S large ribosome proteins RPL5, RPL23, and RPL24 were decreased in <italic>ESCO2</italic> mutant (M) compared to WT fibroblasts (WT) or corrected fibroblasts (C). <bold>b</bold> L-Leu supplement, but not D-Leu, partially rescued RPS7 and RPL24 protein levels, and reversed the elevation of eIF2α phosphorylation in RBS cells. α-Tubulin and eiF2α serve as loading controls. <bold>c</bold> m7-GTP coupled beads were used to pull down translation initiation complexes from whole cell lysates. 4EBP1 protein was strongly enriched in RBS cells, accompanied by less binding of eIF4G1, but this trend was partially reversed in RBS cells treated with L-Leu. eIF4E levels were not affected. <bold>d</bold> Antibodies to eIF4E were used to pull down translation initiation complexes. 4EBP1 was present at high levels in RBS cells, correlating with less eIF4G1 and the inhibition of translation initiation. L-Leu supplement promoted the assembly of the translation competent eIF4E complex. <bold>e</bold> Antibodies to eIF3B were used to pull down translation initiation complexes. eIF4E and eIF4G1 were present at lower levels in RBS cells, but this trend was partially reversed by L-Leu supplement</p></caption><graphic xlink:href="12864_2015_2354_Fig1_HTML" id="MO1"/></fig></p>
      </sec>
      <sec id="Sec4">
        <title>Low levels of translation initiation complexes in RBS cells are partially rescued by L-Leu</title>
        <p>To further investigate translation initiation, we used pull downs to examine the formation of translation initiation complexes. 4EBP1 is a protein that prevents translation initiation when its unphosphorylated form interacts with eIF4E. Since L-Leu improved 4EBP1 phosphorylation in RBS cells (Fig. <xref rid="Fig1" ref-type="fig">1c, d</xref>), we further examined the 5’cap mRNA translation initiation complex using an m7GTP binding assay. m7GTP beads pull down more 4EBP1 protein in RBS cells compared to corrected cells (Fig. <xref rid="Fig1" ref-type="fig">1c</xref>). 4EBP1 binding to eIF4E inhibits the eIF4E-eIF4G interaction, blocking translation initiation. Consistently, eIF4G protein displayed less binding to m7GTP in RBS cells. The addition of L-Leu partially reduced 4EBP1 levels in m7GTP fraction, and restored eIF4G binding for RBS cells.</p>
        <p>To further evaluate translation initiation complexes, we immunoprecipitated eIF4E and examined interacting proteins (Fig. <xref rid="Fig1" ref-type="fig">1d</xref>). We observed an enrichment of 4EBP1 in the eIF4E pull down in RBS cell lysates, and a marked reduction in eIF4G1. L-Leu treatment rescued eIF4G1- eIF4E association, and released the 4EBP1 inhibitory interaction. Finally, we pulled down eIF3B to assess eIF3B-eIF4E-eIF4G assembly of the 43S pre-initiation complex. The eIF4G1 and eIF4E proteins were present at lower levels in immunoprecipitations from RBS cells (Fig. <xref rid="Fig1" ref-type="fig">1e</xref>), but their levels were efficiently rescued by the addition of L-Leu. We also found that L-Leu partly rescued low levels of phospho-S6K1 in RBS fibroblasts (Fig. <xref rid="Fig1" ref-type="fig">1e</xref>). Collectively, the results clearly indicated that RBS fibroblasts have fewer translation initiation competent complexes. Their formation could be partially rescued by L-Leu supplement.</p>
      </sec>
      <sec id="Sec5">
        <title>L-Leu relieved translational efficiency for several gene classes in RBS</title>
        <p>To systematically determine the translational efficiency of each mRNA in RBS fibroblasts, we used ribosome profiling and RNA deep sequencing. Wild-type, mutant, and corrected fibroblasts were treated with D-Leu (bioinactive form) or L-Leu. Ribosome profiling monitors translational efficiency by measuring ribosome-protected mRNA fragments (ribosome footprints) relative to the number of mRNAs [<xref ref-type="bibr" rid="CR27">27</xref>]. We collected cells treated for 3 h to assess mRNAs with immediate translational changes in response to L-Leu. We also collected cells treated for 24 h to examine the long term effects of L-Leu on RBS cells. We detected exon-mapped ribosome footprints that corresponded to actively translated RefSeq mRNAs. Numbers of total reads per sample ranged from 5.0e + 06 to 3.0e + 07. The number of ribosome footprints that map to each mRNA divided by the number of total mRNA reads (gene-specific reads per million total exon-mapped reads, or RPKM) reflects the proportion of ribosomes engaged in the translation of that transcript. In our ribosome profiling and RNA seq analysis, the patterns between wild-type and <italic>ESCO2</italic>-corrected cells were similar, although not identical, at the transcriptional and translational levels (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S2). The differences between the WT cells and the corrected cells could be due to the differences in genetic background as well as slight overexpression of ESCO2 in the corrected cells [<xref ref-type="bibr" rid="CR12">12</xref>]. Given that the <italic>ESCO2</italic>-corrected cells mostly resembled WT cells, we decided to focus our analysis on the comparison of the mutant and corrected cells since they have the identical genetic backgrounds.</p>
        <p>Two recent studies have examined translational efficiency in the presence of mTOR chemical inhibitors [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>]. The translation of genes with 5' terminal oligopyrimidine (5′ TOP) motifs, which includes many ribosomal protein genes and a number of translation initiation and elongation factors, is particularly inefficient in the presence of these compounds [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>]. Strikingly, almost all 5’ TOP genes showed poor translational efficiency in RBS cells (Fig. <xref rid="Fig2" ref-type="fig">2a</xref>). This efficiency was partially rescued with L-Leu at both 3 and 24 h treatment, consistent with our Western blotting results for individual ribosomal protein subunits. Furthermore, the 5’ TOP genes were likely <italic>de novo</italic> translational targets of mTORC1 stimulation because they responded strongly at 3 h L-Leu treatment.<fig id="Fig2"><label>Fig. 2</label><caption><p>L-Leu increased translation of genes with poor translational efficiency in RBS cells. The corrected (cor) and RBS mutant (mut) cells were treated with either D-Leu or L-Leu for 3 h or 24 h. Cells were collected for ribosome profiling. <bold>a</bold> The boxplot shows the translational efficiency for genes with a 5’ TOP sequence. These mRNAs showed poor translational efficiency in RBS cells, which was partly rescued by L-Leu treatment. Corrected cells with D-Leu 24 h versus Mutant cells with D-Leu 24 h, <italic>P</italic> = 6.9e-22; Mutant cells with L-Leu 24 h versus Mutant cells with D-Leu 24 h, <italic>P</italic> = 4.4e-14; Corrected cells with D-Leu 3 h versus Mutant cells with D-Leu 3 h, <italic>P</italic> = 8.8e-16; Mutant cells with L-Leu 3 h versus Mutant cells with D-Leu 3 h, <italic>P</italic> = 1.9e-16. <bold>b</bold> The boxplot shows the translational efficiency for genes with a PRTE sequence. These mRNAs showed poor translational efficiency in RBS cells that was partially improved by L-Leu. Corrected cells with D-Leu 24 h versus Mutant cells with D-Leu 24 h, <italic>P</italic> = 7.1e-14; Mutant cells with L-Leu 24 h versus Mutant cells with D-Leu 24 h, <italic>P</italic> = 8.5e-9; Corrected cells with D-Leu 3 h versus Mutant cells with D-Leu 3 h, <italic>P</italic> = 2.8e-14; Mutant cells with L-Leu 3 h versus Mutant cells with D-Leu 3 h, <italic>P</italic> = 5.3e-15. <bold>c</bold> The boxplot shows the translational efficiency for genes previously defined to be hypersensitive to mTOR inhibition via Babel analysis [<xref ref-type="bibr" rid="CR28">28</xref>]. These mRNAs showed poor translational efficiency in RBS cells that was partially improved by L-Leu. Corrected cells with D-Leu 24 h versus Mutant cells with D-Leu 24 h, <italic>P</italic> = 0.0002; Mutant cells with L-Leu 24 h versus Mutant cells with D-Leu 24 h, <italic>P</italic> = 0.14; Corrected cells with D-Leu 3 h versus Mutant cells with D-Leu 3 h, <italic>P</italic> = 3.5e-8; Mutant cells with L-Leu 3 h versus Mutant cells with D-Leu 3 h, <italic>P</italic> = 2.1e-6</p></caption><graphic xlink:href="12864_2015_2354_Fig2_HTML" id="MO2"/></fig></p>
        <p>Hsieh et al. reported a second group of genes with a pyrimidine-rich translational element (PRTE) that were hyperdependent on mTOR-controlled translation [<xref ref-type="bibr" rid="CR20">20</xref>]. Similar to the 5'terminal oligopyrimidine (5’TOP) genes, almost 90 % of these genes were poorly translated in RBS cells, but their translational efficiency improved dramatically with both 3 and 24 h of L-Leu supplementation (Fig. <xref rid="Fig2" ref-type="fig">2b</xref>). These genes function in various cellular processes such as glycogen storage (PGM1), cytokinesis (MYH14), mRNA metabolism (PABPC1), nuclear import (IPO7), protein transport (AP2A1), osteogenesis (CRTAP), nucleosome assembly (NAP1L1), and heat shock (HSPA8). Moreover, the PRTE genes, like the 5’TOP genes, were likely <italic>de novo</italic> translational targets of mTORC1 signaling because they responded strongly to 3 h treatment.</p>
        <p>Previous analysis by another group using a bioinformatics approach known as Babel analysis identified genes with significantly reduced translation associated with impeded mTOR activity [<xref ref-type="bibr" rid="CR28">28</xref>]. In addition to the PRTE and 5’TOP genes, this group of genes includes subunits of the eIF3 complex, and multiple Rab family Ras-related GTPases involved in endocytic trafficking. More than 60 % of these genes showed poor translational efficiency in RBS cells that was partially rescued with both 3 and 24 h L-Leu treatment (Fig. <xref rid="Fig2" ref-type="fig">2c</xref>; Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S1). The mRNA levels of the 5’TOP, PRTE, and Babel gene groups were not significantly affected in mutant versus corrected cells, nor were they affected by L-leucine treatment (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S3), strongly arguing for a translation-based rescue.</p>
        <p>These results demonstrate that the gene groups that show exceptionally poor translation in response to pharmacological inhibition of mTORC1 also show poor translational activity in RBS cells. Furthermore, the translation of these same gene groups was partly improved by L-Leu treatment. For these gene groups, the effects of 3 and 24 h treatments were similar, suggesting that these gene groups contain many direct targets of the mTORC1 pathway. Taken together, these results are consistent with the conclusion that L-Leu activates mTORC1 function in RBS fibroblasts.</p>
        <p>In addition to using predefined gene lists, we identified all genes whose translational efficiency was increased with L-Leu treatment in RBS cells. We used different methods to identify genes with improved translation efficiency: 1) Babel analysis, 2) fold change in translational efficiency greater than two and a minimum of 20 reads. For both methods, the gene ontology (GO) term analysis was very similar and included enrichment for ribosome components, translation initiation and elongation factors, protein targeting/sorting genes (co-translational process, and post-translational translocation), and RNA metabolism genes (Tables S2, S3, S4). We found that L-Leu improved the translational efficiency of more genes at the long timepoint (561 genes at 24 h <italic>vs</italic> 299 genes at 3 h). These results suggest that improved translational efficiency of direct mTORC1 targets at the short timepoint improved the translational efficiency of more genes following longer term treatment.</p>
        <p>We used MEME to discover new motifs associated with genes with 2 fold or greater improved translational efficiency at 3 h [<xref ref-type="bibr" rid="CR29">29</xref>]. Motif analysis identified 5’TOP and PRTE sequences, as expected, but also identified a new motif “CCAGGCTGGTCT” (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S4). This motif does not correspond to any known transcription factor binding site. GO term analysis for genes with the new motif included translational elongation and translational termination, but also more surprisingly, protein localization to the endoplasmic reticulum, and mRNA catabolic processes (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S4; Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S5). mRNAs with the motif may represent newly discovered targets of mTORC1 dependent translation (Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S6).</p>
        <p>Loss of mTORC2 function has been shown to inhibit translation of many cell cycle proteins, including cohesin and condensin subunits such as SMC3, STAG1, NIPBL, SMC2 and SMC4 [<xref ref-type="bibr" rid="CR30">30</xref>]. We wondered whether L-Leu stimulation would affect transcription or translation of these mTORC2 targets. While the transcription and translation of many of these genes is altered in the mutant as compared to corrected cells, they did not show a coherent response to L-Leu (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S5; Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S7), helping to confirm that L-Leu specifically boosted mTORC1-dependent translation.</p>
      </sec>
      <sec id="Sec6">
        <title>Poor mitochondrial function in RBS is partially improved by L-Leu</title>
        <p>It has been reported that mTORC1 inhibition reduces mitochondrial biogenesis and activity via a 4EBP1 dependent mechanism [<xref ref-type="bibr" rid="CR31">31</xref>]. We examined the behavior of 868 human genes annotated with cellular component “mitochondrial part.” We found that most of these genes are differentially expressed in the RBS cells compared to corrected cells (heatmap, Fig. <xref rid="Fig3" ref-type="fig">3a</xref>; Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S8), and remain differentially expressed upon L-Leu treatment. However, about ~30 % of these genes are leucine responsive at both timepoints (green bar). The GO terms associated with the leucine responsive cluster are ATP synthesis (biological process), cytochrome C oxidase activity and NADH dehydrogenase activity (molecular function), and respiratory chain complex I (cellular compartment) (Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S9).<fig id="Fig3"><label>Fig. 3</label><caption><p>L-Leu treatment partially rescued mitochondrial function in RBS cells. <bold>a</bold> The heatmap shows that genes with mitochondrial function are differentially expressed in RBS cells. The yellow and purple bars indicate gene groups that are downregulated or upregulated, respectively, in the mutant cells, and are unresponsive to leucine. The subgroup that is affected by L-leucine treatment in the RBS cells is indicated by the green bar. See Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S9 for GO terms for the leucine responsive cluster. <bold>b</bold> Intracellular ATP concentration was low in RBS cells but significantly improved by L-Leu treatment for 24 h. <bold>c</bold> Cytochrome c oxidase activity was impaired in RBS cells but significantly improved by L-Leu supplement for 24 h. For <bold>b</bold> and <bold>c</bold> error bars represent standard deviation of three biological replicates and the <italic>p</italic> value was calculated from a <italic>t</italic>-test</p></caption><graphic xlink:href="12864_2015_2354_Fig3_HTML" id="MO3"/></fig></p>
        <p>We also examined the translational efficiency of the same 868 genes. We found that the translational efficiency of 32 genes showed improvement at 3 h and 96 genes at 24 h with L-Leu (Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S8). GO terms associated with the genes that respond at 3 h were mitochondrial ribosome and respiratory chain, followed with mitochondrial membrane and metabolic processes related to the production of ATP, NADH, and cytochrome C at 24 h (Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S10). Overall it appears that for a subset of genes with mitochondrial function, L-Leu treatment improved gene expression, and this occurred in conjunction with an effect on translational efficiency for a smaller group of genes in the RBS cells. The expression and translation of a subset of genes with mitochondrial function may be responsive to mTORC1 signaling. The genes with increased translational efficiency at 24 h in L-Leu are less likely to be direct targets of mTORC1 signaling, in contrast to the 5’TOP, PRTE, and Babel genes.</p>
        <p>To further study whether the improved transcription and translation of mitochondrial genes with L-Leu manifested in improved mitochondrial function, we measured cellular ATP levels (Fig. <xref rid="Fig3" ref-type="fig">3b</xref>) and cytochrome c oxidase activity (Fig. <xref rid="Fig3" ref-type="fig">3c</xref>). These measures of mitochondrial activity in RBS cells were low compared to controls. Low ATP levels are associated with upregulation of the AMP-activated protein kinase (AMPK) signaling [<xref ref-type="bibr" rid="CR32">32</xref>], and, consistently, we previously reported an increase in AMPK signaling in RBS [<xref ref-type="bibr" rid="CR16">16</xref>]. Additionally, the dysfunction of cytochrome C oxidase activity elevates intracellular reactive oxygen species production [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR34">34</xref>], a finding that correlates well with the previously reported increased ROS in RBS cells [<xref ref-type="bibr" rid="CR16">16</xref>]. Both ATP levels and cytochrome C oxidase activity were partly rescued by stimulation of mTORC1 function with L-Leu. Collectively, our results indicate impaired mitochondrial gene expression, translation, and function are associated with RBS, and these defects can be partially restored by L-Leu supplementation, suggesting the defects may be due in part to low mTORC1 signaling.</p>
      </sec>
      <sec id="Sec7">
        <title>snoRNAs are differentially expressed in RBS cells</title>
        <p>snoRNAs guide chemical modification of ribosomal RNAs, transfer RNAs, small nuclear RNAs, and mRNAs [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>]. C/D box snoRNAs guide methylation and H/ACA box snoRNAs guide pseudouridylation. These modifications can affect the stability of RNAs and their ability to interact with other RNAs and proteins. We examined the expression of snoRNAs in RBS cells. Many snoRNAs of both types were elevated in the RBS patient cells (Fig. <xref rid="Fig4" ref-type="fig">4a</xref>; Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S11). L-Leu supplement significantly affected snoRNA levels in both the RBS and corrected cells, but had a bigger effect and partially reversed the increased levels of snoRNAs in RBS cells, suggesting that this gene group may be responsive to mTORC1 signaling.<fig id="Fig4"><label>Fig. 4</label><caption><p>High levels of snoRNAs in RBS cells were partially reduced by L-Leu treatment. We selected a group of 379 snoRNA genes based on the biotype “snoRNA” and having the words “C/D box” or “H/ACA box” in the description field from ensembl. <bold>a</bold> The boxplot shows the expression of these genes is increased in RBS cells, but partly reduced with L-Leu treatment (gene data in Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S11). Corrected cells with D-Leu 24 h versus Mutant cells with D-Leu 24 h, <italic>P</italic> = 1.4e-275; Mutant cells with L-Leu 24 h versus Mutant cells with D-Leu 24 h, <italic>P</italic> = 3e-53; Corrected cells with D-Leu 3 h versus Mutant cells with D-Leu 3 h, <italic>P</italic> = 7.6e-243; Mutant cells with L-Leu 3 h versus Mutant cells with D-Leu 3 h, <italic>P</italic> = 7.1e-98. <italic>P</italic> values in <bold>a</bold> and <bold>c</bold> were generated using a <italic>t</italic> test. <bold>b</bold> The scatter plot depicts the log2 fold change for snoRNAs in RBS mutant vs corrected at 3 h D-Leu (x axis) versus the same for host genes (y axis). The correlation is 0.76. <bold>c</bold> The boxplot shows the snoRNA host gene expression was not significantly different between corrected cells and mutant cells, and the host gene expression is not affected by L-Leu treatment. Corrected cells with D-Leu 24 h versus Mutant cells with D-Leu 24 h, <italic>P</italic> = 0.3; Mutant cells with L-Leu 24 h versus Mutant cells with D-Leu 24 h, <italic>P</italic> = 0.96; Corrected cells with D-Leu 3 h versus Mutant cells with D-Leu 3 h, <italic>P</italic> = 0.1; Mutant cells with L-Leu 3 h versus Mutant cells with D-Leu 3 h, <italic>P</italic> = 0.62. <bold>d</bold> The scatter plot depicts the log2 fold change for snoRNAs in RBS mutant L-Leu vs D-Leu at 3 h (x axis) versus the same for host genes (y axis). The correlation is 0.07</p></caption><graphic xlink:href="12864_2015_2354_Fig4_HTML" id="MO4"/></fig></p>
        <p>Many snoRNA genes are hosted by ribosomal protein genes. We found a positive correlation (0.76) between snoRNA levels and the expression of their host gene for the <italic>ESCO2</italic>-mutant cells (Fig. <xref rid="Fig4" ref-type="fig">4b</xref>). However, host genes were relatively unaffected with L-Leu (Fig. <xref rid="Fig4" ref-type="fig">4c</xref>); the correlation between host genes and snoRNAs with L-Leu treatment was 0.07 (Fig. <xref rid="Fig4" ref-type="fig">4d</xref>). Taken together, these results suggest that the production of snoRNAs may be controlled by an unknown mTORC1-dependent mechanism that does not rely on the expression of the host genes. Nevertheless, the increase in snoRNAs in RBS cells has the potential to affect the modification and behavior of many RNAs.</p>
      </sec>
      <sec id="Sec8">
        <title>The imprinted <italic>H19</italic> and <italic>GTL2</italic> loci are differentially expressed in RBS cells</title>
        <p>The cohesin complex has been shown to physically regulate expression via looping at the <italic>IGF2-H19</italic> imprinted region [<xref ref-type="bibr" rid="CR22">22</xref>]. <italic>IGF2-H19</italic> shows a parent of origin specific monoallelic expression pattern that is important for embryogenesis and its disruption contributes to the etiology of several fetal disorders [<xref ref-type="bibr" rid="CR23">23</xref>]. The long noncoding RNA H19 negatively regulates IGF2 (insulin growth factor 2), and <italic>H19</italic> deletion increases IGF2 signaling. In addition, H19 serves as a precursor of miRNA-675, which prevents <italic>IGF-1R</italic> (insulin-like growth factor 1 receptor) expression. <italic>IGF-1R</italic> activity promotes downstream PI3K/Akt/mTOR signaling [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR38">38</xref>].</p>
        <p>We wondered whether the expression of imprinted loci was affected in RBS cells. In fact, several imprinted genes were differentially expressed in RBS cells (Fig. <xref rid="Fig5" ref-type="fig">5a</xref>). For example, RNAs involved in growth suppression and stem cell maintenance, including <italic>MEG3/GTL2,</italic> were present at higher levels. Another group of RNAs from imprinted genes were present at lower levels, including <italic>MEST</italic>, and the p53 repressor (<italic>MKRN1</italic>). <italic>H19</italic> was significantly elevated in RBS cells (Fig. <xref rid="Fig5" ref-type="fig">5b</xref>). Moreover, miRNA-675 was also elevated (Fig. <xref rid="Fig5" ref-type="fig">5c</xref>), as would be expected based on the elevation in <italic>H19</italic>. Since miRNA-675 may negatively regulate the PI3K-Akt- mTORC1 pathway, this H19/miRNA-675 elevation might contribute to mTORC1 depression in RBS. The differential expression of imprinted genes was not significantly affected by L-Leu, suggesting the differential expression of these genes is not due to low mTORC1 signaling, but may instead be related to defects in gene looping/chromosome architecture and/or altered DNA methylation patterns [<xref ref-type="bibr" rid="CR39">39</xref>].<fig id="Fig5"><label>Fig. 5</label><caption><p>Imprinted genes are differentially expressed in RBS cells. <bold>a</bold> A heatmap displays the expression pattern of various imprinted genes in RBS and corrected cells with or without L-Leu. <bold>b</bold> The histograms show the average from three biological samples and the error bar indicates the standard deviation. The results are shown from 24 h treatment with L-Leu. The data from the 3 h treatment showed a similar pattern. H19 was upregulated ~ 4 fold in the mutant cells relative to the corrected cells. <bold>c</bold> The micro-RNA 675 was elevated ~ 3 fold in the mutant cells. <bold>d</bold> The imprinted <italic>MEG3/GTL2</italic> and <italic>MEG8/Rian</italic> genes were markedly increased in expression in RBS cells</p></caption><graphic xlink:href="12864_2015_2354_Fig5_HTML" id="MO5"/></fig></p>
        <p><italic>MEG3/GTL2-DLK1</italic> is another imprinted locus regulated by differentially methylated regions (DMRs). Cohesin has been reported to colocalize with CTCF at this locus where it binds to the <italic>GTL2</italic> DMR on the unmethylated maternal allele [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR41">41</xref>], potentially playing a repressive function for <italic>MEG3/GTL2</italic> expression [<xref ref-type="bibr" rid="CR40">40</xref>]. Cohesin binds to the <italic>GTL2</italic> DMR on the unmethylated maternal allele. <italic>GTL2</italic> is a growth suppressor that strongly activates p53 expression. <italic>GTL2</italic> regulates maternal expression of an miRNA cluster [<xref ref-type="bibr" rid="CR42">42</xref>–<xref ref-type="bibr" rid="CR47">47</xref>], where it promotes the expression of miRNAs that could reduce mTORC1 signaling by inhibiting translation of their target mRNAs [<xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR49">49</xref>]. Both <italic>GTL2</italic> mRNA and <italic>GTL2</italic>-regulated miRNAs showed an elevation in RBS cells by RNA seq analysis which was verified by qPCR (Fig. <xref rid="Fig5" ref-type="fig">5d</xref>; Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S6). We also found a significant increase in <italic>MEG8/Rian</italic> in RBS cells. <italic>MEG8</italic> is a maternally expressed, imprinted long non-coding RNA transcribed from the same DNA as <italic>GTL2</italic>. Our results suggest that loss of cohesin acetyltransferase function alters expression from the <italic>IGF2-H19</italic> and <italic>MEG3/GTL2-DLK1</italic> imprinted loci, providing one possible speculative mechanism by which cohesin could influence mTORC1 signaling and translation.</p>
      </sec>
      <sec id="Sec9">
        <title>L-Leu independent differential gene expression in RBS cells</title>
        <p>Homeobox (<italic>HOX</italic>) genes are a group of transcription factors that determine the anterior-posterior axis of an embryo. Recent work indicates that cohesin influences <italic>HOX</italic> gene expression through chromatin architecture organization [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR50">50</xref>–<xref ref-type="bibr" rid="CR52">52</xref>]. We examined <italic>HOX</italic> gene expression in RBS cells and found that the expression of many <italic>HOX</italic> A, B, C, and D subunits is reduced [<xref ref-type="bibr" rid="CR3">3</xref>], independent of L-Leu treatment, while translation is unaffected (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S7). Although taken all together the differential expression for this gene group is not statistically significant between mutant and corrected cells, the reduced expression of many individual genes is significant, and this reduced expression is apparent in the stretch of the boxes into the negative log2 values. The data suggest that <italic>ESCO2</italic> dependent <italic>HOX</italic> gene expression and architecture is independent of <italic>ESCO2</italic>-induced mTORC1 defects.</p>
        <p>There are over 6000 differentially expressed genes in RBS cells, but ~1000 fewer with L-Leu treatment, suggesting a significant fraction of the differential expression could be translation-driven. The most notable and top GO term for the upregulated genes in the RBS mutant cells treated with L-Leu vs D-Leu at 3 h is “respiratory chain complex I” (Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S12). However, the differential expression of particular gene groups in RBS cells, such as <italic>HOX</italic> genes and imprinted genes, was independent of L-Leu. We previously reported that the nucleolar architecture in RBS cells is only rescued by <italic>ESCO2</italic> replacement, not by L-Leu addition [<xref ref-type="bibr" rid="CR16">16</xref>]. Similar to the rDNA, these loci may be examples where basic chromatin architecture is dependent on cohesin acetylation and cannot be rescued with leucine.</p>
        <p>Previous work has shown that regions from almost all human chromosomes associate with nucleoli [<xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR54">54</xref>]. These regions have been termed NADs for nucleolar associated domains. Given the disruption of nucleolar morphology in the RBS cells, we wondered whether the expression of genes within NADs was affected. We found that genes in many of the domains were differentially expressed in RBS cells (Fig. <xref rid="Fig6" ref-type="fig">6</xref>, Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S13). In some cases genes that were not expressed in RBS cells became expressed in the corrected cells, and in other cases the reverse occurred. Whichever trend was observed was true for most of the genes within that NAD, arguing that the domains are behaving as a unit. The differential expression was mostly independent of L-Leu, consistent with the lack of rescue of the nucleolar morphology with L-Leu. We conclude that disruption of nucleolar morphology has the potential to affect the expression of genes normally associated with nucleoli.<fig id="Fig6"><label>Fig. 6</label><caption><p>Nucleolar associated genes are differentially expressed in RBS cells. Expression levels of genes located in nucleolar associated domains (NADs, indicated on the left) is shown in a heatmap for corrected cells (C) and RBS cells (M) treated with either D-Leu (D) or L-Leu (L) for 3 or 24 h. Within each domain, genes tend to show a similar pattern, although some domains show increased expression in the corrected cells while others show reduced expression. In general these patterns are unaffected by the addition of L-leucine. Data can be found in Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S13</p></caption><graphic xlink:href="12864_2015_2354_Fig6_HTML" id="MO6"/></fig></p>
      </sec>
    </sec>
    <sec id="Sec10" sec-type="discussion">
      <title>Discussion</title>
      <p>We provide compelling molecular evidence that L-Leu can partially rescue translation initiation and mitochondrial function via its stimulation of mTORC1 in RBS cells. Ribosome profiling combined with RNA seq allowed us to evaluate the contribution of differential expression and translation in RBS. We speculate that L-Leu provides partial rescue of translation and translation-dependent gene expression without rescuing cohesin dependent chromatin organization. Our data, combined with the existing literature, argues that at least two different mechanisms generate differential gene expression in RBS cells: 1) defects in looping or other aspects of chromosome architecture and 2) loss of translation function. This second mechanism can be targeted by L-Leu stimulation of mTORC1 signaling. Our work suggests the possibility that a few critical loci that contribute to translation, such as imprinted genes and rDNA, play a key role in the RBS disorder. L-Leu treatment allows us to begin to distinguish between differential gene expression that is dependent on mTORC1 signaling versus independent in the <italic>ESCO2</italic> mutant. Our studies suggest targeting translation with the non-toxic amino acid L-Leu may be a productive strategy in human diseases with poor translation, such as the cohesinopathies.</p>
      <p>Additional human diseases with defects in translation include the ribosomopathies, diseases caused by defects in ribosome biogenesis [<xref ref-type="bibr" rid="CR55">55</xref>]. Stimulation of the TOR pathway with L-Leu in the ribosomopathy Diamond Blackfan anemia has shown promise as a therapeutic [<xref ref-type="bibr" rid="CR56">56</xref>, <xref ref-type="bibr" rid="CR57">57</xref>] and is currently being tested in a Phase I clinical trial. Translational control is emerging as an important regulatory mechanism for many different cell types, such as germline stem cells, hematopoietic stem cells, and neurons [<xref ref-type="bibr" rid="CR58">58</xref>]. Another process affected in over 40 different human diseases is mitochondrial function. We provide the first evidence that mitochondrial function is affected in RBS fibroblasts, and we further report that L-Leu stimulation of mTORC1 could promote both translation initiation and mitochondrial function. Together these findings suggest that it will be important to study the role of mTORC1 in embryo development, cell identity, and mitochondrial function in order to discover strategies to target this pathway to treat human disease associated with translation impairment.</p>
      <p>How L-Leu stimulates mTORC1 has been the topic of debate. Two groups have argued that the charged form of the leucine tRNA synthetase is a key factor in the activation of the Ragulator complex that activates TOR [<xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR60">60</xref>]. Others have argued that the mechanism may involve direct sensing of amino acids in the lysosome, where mTORC1 is located during activation [<xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR62">62</xref>]. While the exact molecular mechanism is still unclear, our work provides a detailed molecular picture of how transcription and translation respond to L-Leu activation of mTORC1. We found evidence that the 5’TOP and PRTE-containing mRNAs respond more quickly to L-Leu than other targets, such as mRNAs with mitochondrial function, suggesting that mTORC1 stimulation affects immediate targets followed by secondary targets. Our study also suggests that pharmacological inhibition of mTORC1 with small molecules has similar effects on translational efficiency as genetically-induced depression by <italic>ESCO2</italic> mutation.</p>
      <p>Cohesin and CTCF (CCCTC-binding factor) co-localize at a significant fraction of cohesin binding sites where these proteins likely directly regulate genome architecture and gene expression. Some of these sites include the imprinted genes and the <italic>HOX</italic> genes. Recently, the Hi-C method has identified that loss of cohesin or CTCF function not only causes the loss of some chromatin interactions, but also leads to the gain of other interactions [<xref ref-type="bibr" rid="CR63">63</xref>]. Cohesin appears to positively regulate some loci and negatively regulate others, making the effects of loss of function difficult to predict. However, we have previously provided evidence that acetylated cohesin promotes expression of the ribosomal DNA repeats and the formation of nucleoli. CTCF is also important for the formation of nucleoli [<xref ref-type="bibr" rid="CR64">64</xref>]. Nucleoli likely provide a keystone for genome architecture [<xref ref-type="bibr" rid="CR64">64</xref>–<xref ref-type="bibr" rid="CR67">67</xref>], suggesting that disruption in the organization of rDNA could have extensive effects on the organization and expression of most chromosomes such as that observed at NADs. In the future it will be interesting to analyze chromosome organization in the absence of <italic>ESCO2</italic> function and how this impacts gene expression.</p>
      <p>Partial loss of function in many different cohesin related genes (<italic>ESCO2, SMC1, SMC3, NIPBL, RAD21</italic>) causes translation defects in yeast, zebrafish, and human cells [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. Collectively, these observations suggest that one evolutionarily conserved function of cohesin is to couple chromosome structure with the translational output of the cell. The mechanisms that link these processes may include the role of cohesin in bringing two DNA sequences together such as (1) looping of promoter and terminator within the rDNA for effective polymerase recycling and rRNA production, (2) gathering of the rDNA repeats into a functional nucleolus which may provide an anchor point for genome architecture, and (3) regulation of looping of promoter and regulatory sequences and therefore expression at imprinted loci and <italic>HOX</italic> genes. Additional mechanisms for coupling chromosome structure to translation may exist. This study provides a gene by gene understanding of how L-Leu stimulation of mTORC1 affects gene expression and translation.</p>
    </sec>
    <sec id="Sec11" sec-type="conclusion">
      <title>Conclusions</title>
      <p><italic>ESCO2</italic>, a gene encoding an acetyltransferase for cohesin, is required for normal gene expression and translation. We characterized the effect of L-Leu on translation initiation complexes, mitochondrial function, gene expression and translational efficiency in <italic>ESCO2</italic> mutant RBS cells in which mTORC1 signaling is depressed. We find L-Leu provides a significant rescue effect for all of these measures. L-Leu activation of mTORC1 function may be a useful approach for human diseases with disruption of these functions.</p>
    </sec>
    <sec id="Sec12" sec-type="materials|methods">
      <title>Methods</title>
      <sec id="Sec13">
        <title>Reagents</title>
        <p>Reagents were obtained from the following sources: antibodies to S6K1, 4EBP1, eIF4E, phospho-S51 eIF2α, eIF2α, eIF4G1 from Cell Signaling; antibodies to eIF3b (N20), α-tubulin, S6K, RPS7, RPS19, RPL5 and horseradish-peroxidase-labelled anti-mouse, anti-goat and anti-rabbit secondary antibodies from Santa Cruz Biotechnology; Anti-p70S6K1 (phospho T389) antibody from Abcam company; antibodies to RPL23 from Sigma company; antibodies to RPL24 from Genetex company. Complete Protease Mixture from Roche Applied Science; cycloheximide from Sigma; immobilized 2’/3’-EDA-7-methyl-GTP- agarose beads from Jena Bioscience GmbH, Germany; DMEM from Life Technologies Inc.; inactivated fetal calf serum from Invitrogen; Dynabeads® magnetic separation system from Life Technologies Inc.</p>
      </sec>
      <sec id="Sec14">
        <title>Preparation of cell lysates and affinity purifications</title>
        <p>Cells were rinsed once with ice-cold PBS and lysed in ice-cold lysis buffer (buffer A: 50 mM HEPES-KOH (pH 7.4), 2 mM EDTA, 10 mM pyrophosphate, 10 mM β-glycerophosphate, 40 mM NaCl, 1 % Trition X-100 and one tablet of EDTA-free protease inhibitors (Roche) per 25 mL. The soluble fraction of the cell lysate was isolated by centrifugation at 12,000 g for 10 min. For immunoprecipitations, primary antibodies were added to lysates and incubated with rotation for overnight at 4 °C. 20 μl of a 50 % slurry of protein G-dynabeads were then added and the incubation continued for an additional 3 h. Immunoprecipitates were washed three times with lysis buffer. Immunoprecipitated proteins were denatured by the addition of 20 μl of sample buffer and boiled for 5 min, resolved by 8–16 % SDS–PAGE, and analyzed by Western blot. For m7GTP affinity purifications, 2’/3’-EDA-7-methyl-GTP- agarose beads were washed with lysis buffer. 20 μl of beads from a 50 % slurry was added to cell lysates and incubated with rotation overnight at 4 °C. Beads were washed three times with lysis buffer, denatured by the addition of 50 μl sample buffer, and analyzed by Western blot.</p>
      </sec>
      <sec id="Sec15">
        <title>Preparation of ribosome profiling samples</title>
        <p>Ribosome profiling samples were essentially collected and processed as described in the Mammalian ARTseq™ Ribosome Profiling Kit (Epicentre, cat. no. RPHMR12126, protocol version 2012). In brief, human wild-type fibroblasts, <italic>ESCO2</italic>-mutant RBS fibroblasts, and <italic>ESCO2</italic>-corrected RBS fibroblasts were grown on 15-cm plates in DMEM medium supplemented with 10 % Fetal Bovine Serum (FBS). At 80 % confluence, the cells were washed two times with PBS, and grown for another 24 h in DMEM/10 % FBS. Subsequently, the cells were supplemented with 10 mM D-leucine (D-Leu) or L-Leu and incubated for either 3 or 24 h. Prior to lysis, the cells were incubated for 1 min in DMEM containing 0.1 mg/ml cycloheximide (US Biological, cat. no. C8500-10). After a rinse with ice cold PBS containing 0.1 mg/ml cycloheximide, the cells from up to three plates (~20–60, 000,000 cells) were collected by scraping into 800 μl chilled Mammalian Lysis Buffer (ART-Seq 1X Mammalian Polysome Buffer, 1 % Triton X-100, 0.1 % NP-40, 1 mM DTT, 10 U/ml DNase I, 0.1 mg/ml cycloheximide). The cell lysate was triturated 10 times through a 26G needle to insure complete lysis, incubated for 10 min on ice with periodic agitation, and clarified by a 10 min centrifugation at 20,000 x g at 4 °C. The RNA concentration of the supernatant was determined using the Quant-iT RiboGreen RNA Assay Kit (Invitrogen) and a SpectraMax M2 reader (Molecular Devices) according to manufacturer’s instructions. Aliquots were flash-frozen in liquid nitrogen and stored at −80 °C. Ribosome-protected mRNA fragments (RPFs) and fragmented total RNA depleted for ribosomal RNA were sequenced for each sample. Footprinting was performed at room temperature for 45 min using ART-Seq Nuclease (Epicentre), then stopped with SUPERase•In™ RNase Inhibitor (Life Technologies). For the 24 h timepoint samples, 400 μl of clarified lysate was used and 2.8 units of nuclease was added per μg of RNA. For the 3 h timepoint samples, 300 μl of lysate was used and the amount of nuclease was reduced to 0.5 units/μg of RNA. RPFs were isolated from 200 to 400 μl of the nuclease/SUPERase•In™ treated lysate using 2–4 Sephacryl S400 columns (GE Healthcare: MicroSpin S-400 HR, cat. no. 27-5140-01), followed by acid phenol:chloroform extraction and isopropanol precipitation. Total RNA was isolated from untreated lysate by acid phenol:chloroform extraction and isopropanol precipitation. Ribosomal RNA was removed from 1–5 μg of RPFs and total RNA using either the Ribo-Zero™ Magnetic or the Ribo-Zero™ Magnetic Gold Kit (Human/Mouse/Rat) (Epicentre). To purify the Ribo-Zero treated samples, the RNA Clean &amp; Concentrator™-5 Kit (Zymo Research) was used as described in the ART-Seq protocol. RPFs in the range of 26–34 nt were size selected by PAGE purification and the total RNA was heat fragmented. Libraries were constructed as described in the ART-Seq protocol. The desired 140–160 bp PCR-amplified libraries were purified from excess adapter-only product (~113 bp) by PAGE purification. Library pools were sequenced on a HiSeq 2500 System (Illumina) with the 50 bp Single-End read protocol.</p>
      </sec>
      <sec id="Sec16">
        <title>RNA sequencing analyses</title>
        <p>Before alignment, ribosome footprint and total mRNA libraries were processed to remove cloning artifacts. Processed reads were then aligned to a database of human rRNA sequences using the bowtie2 short-read alignment program (version 2.1.0 with parameters -k 1 -N 1 --local) to remove reads from ribosomal RNA. A very small percentage of reads aligned to rRNA sequences in most cases, ranging from 0.2 to 12 %. The remaining reads were then aligned to the hg19 human genome using tophat (version 2.0.8 with parameters --segment-mismatches 1 -x1 -g1 --no-coverage-search). Translational efficiency was calculated as footprint RPKM/mRNA RPKM. Values from biological replicates were averaged together.</p>
      </sec>
      <sec id="Sec17">
        <title>Gene ontology analysis</title>
        <p>To determine enrichment for gene ontology categories, differentially expressed or translated genes were analyzed using the GeneAnswers package in R (version 3.0.2). Representative gene ontology categories from each contrast with a <italic>P</italic> value &lt; 0.05 were selected.</p>
      </sec>
      <sec id="Sec18">
        <title>Cellular ATP assay in RBS cells</title>
        <p>Cells were cultured as for ribosome profiling. Samples were prepared according to the instructions provided by the ATP Colorimetric/Fluorometric Assay Kit of the BioVision company. Cells (1 × 10<sup>6</sup>) were lysed in 100 μl of ATP Assay Buffer and centrifuged at 4 °C at 15,000 g for 2 min to pellet insoluble material. 2–50 μl supernatant was added to a well in a 96-well plate, and the final volume was adjusted to 50 μl/well with ATP Assay Buffer. Samples were tested at several doses to make sure the readings were within the standard curve range.</p>
      </sec>
      <sec id="Sec19">
        <title>Mitochondria isolation for cultured cells and cytochrome c oxidase assay</title>
        <p>Cells were cultured as for ribosome profiling. Mitochondria were isolated according to the instructions provided by the Mitochondria isolation kit from the Thermo Scientific company. For the cytochrome c oxidase assay, we used the Cytochrome c Oxidase Assay Kit from Sigma-Aldrich. The reaction was started by the addition of 50 ml of Ferrocytochrome c Substrate Solution and mixed by inversion. Absorbance was read at A<sub>550</sub>/min immediately due to the rapid reaction rate of this enzyme. Background values were between 0.001 and 0.005 A<sub>550</sub>/min.</p>
      </sec>
      <sec id="Sec20">
        <title>Real-Time quantitative PCR of microRNAs in RBS cells</title>
        <p>Total RNA (50–200 ng/μl) was extracted from <italic>ESCO2</italic>-mutant RBS cells or corrected RBS cells with L-Leu or D-Leu treatment. The RNA concentration was measured by Bioanalyzer RNA Nano chip, and normalized for reverse transcription (RT). For each 15 μl RT reaction, total RNA (10 ng of total RNA per 15 μl reaction) was combined with the RT master mix (TaqMan® MicroRNA Reverse Transcription Kit, PN4366596, Applied Biosystems). 3 μl of the RT primers was transferred to the appropriate tubes, and reactions were subjected to thermal cycling. TaqMan gene expression assays (Applied Biosystems) were performed on triplicate samples with a 7500 Real-Time cycler (Applied Biosystems). U6 snRNA serves as a reference control. The TaqMan gene expression assays were performed according to the manufacturer’s instructions. All qRT-PCR was performed using TaqMan probes.</p>
      </sec>
      <sec id="Sec21">
        <title>Statistical analysis</title>
        <p>The results are reported as mean values ± standard error (mean ± s.e.). Statistical analysis was performed by Student's <italic>t</italic>-test with SigmaPlot-Systat Software (Sigmaplot Software Inc). An ANOVA two-way model was used to compare continuous variables. A <italic>P</italic> value &lt;0.05 was considered statistically significant.</p>
      </sec>
      <sec id="Sec22">
        <title>Description of additional data</title>
        <p>Additional data include seven figures and thirteen tables.</p>
      </sec>
      <sec id="Sec23">
        <title>Accession numbers</title>
        <p>The data set supporting the results of this article is available in the Gene Expression Omnibus repository, [#GSE64962].</p>
      </sec>
      <sec id="Sec24">
        <title>Data availability</title>
        <p>Original data underlying this manuscript can be accessed from the Stowers Original Data Repository at <ext-link ext-link-type="uri" xlink:href="http://www.stowers.org/research/publications/libpb-1023">http://www.stowers.org/research/publications/libpb-1023</ext-link>.</p>
      </sec>
    </sec>
  </body>
  <back>
    <app-group>
      <app id="App1">
        <sec id="Sec25">
          <title>Additional files</title>
          <p>
            <media position="anchor" xlink:href="12864_2015_2354_MOESM1_ESM.zip" id="MOESM1">
              <label>Additional file 1: Figure S1.</label>
              <caption>
                <p>Quantitation of Western blotting in Fig. <xref rid="Fig1" ref-type="fig">1a</xref> and <xref rid="Fig1" ref-type="fig">b</xref>. <bold>Figure S2.</bold> Gene transcription and translation pattern of WT cells and ESCO2-Corrected cells. <bold>Figure S3.</bold> The boxplots display the show expression of mRNAs with 5’TOP sequences (a), PRTE sequences (b), and Babel genes (c). <bold>Figure S4.</bold> Motif and GO terms associated with genes with increased translational efficiency upon L-leucine treatment in RBS cells. <bold>Figure S5.</bold> mTORC2 show regulated genes do not show a coherent response to L-leucine. <bold>Figure S6.</bold> GTL2-regulated miRNAs are increased in RBS cells independent of L-Leu. <bold>Figure S7.</bold> Homeobox (HOX) gene expression is reduced in RBS cells. (ZIP 4.64 MB)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="12864_2015_2354_MOESM2_ESM.zip" id="MOESM2">
              <label>Additional file 2: Table S1.</label>
              <caption>
                <p>Summary table of Babel analysis. <bold>Table S2.</bold> GO term analysis of genes that show improved translational efficiency in RBS cells with L-leucine. <bold>Table S3.</bold> List for genes with fold change in translational efficiency greater than two and a total number of reads over 20 counts at 3 h. <bold>Table S4.</bold> List for genes with fold change in translational efficiency greater than two and a total number of reads over 20 counts at 24 h. <bold>Table S5.</bold> GO term analysis for genes with the new motif. <bold>Table S6.</bold> List of genes that have the new motif. <bold>Table S7.</bold> Summary table of data in boxplot of mTORC2-regulated gene show transcription and translation in Figure S5. <bold>Table S8.</bold> Summary table of data in heatmap for 868 mitochondrial genes—expression (Fig. <xref rid="Fig3" ref-type="fig">3</xref>) and translation. <bold>Table S9.</bold> GO term analysis for mitochondrial genes that show improve transcription with L-leucine. <bold>Table S10.</bold> GO term analysis for mitochondrial genes that improve translation with L-leucine. <bold>Table S11.</bold> Summary table of data in boxplot of snoRNAs expression in Fig. <xref rid="Fig4" ref-type="fig">4</xref>. <bold>Table S12.</bold> GO term analysis of differentially expressed genes in RBS cells. <bold>Table S13.</bold> List of genes in NADs and their expression, from Fig. <xref rid="Fig6" ref-type="fig">6</xref>. (ZIP 1.78 MB)</p>
              </caption>
            </media>
          </p>
        </sec>
      </app>
    </app-group>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>4EBP1</term>
          <def>
            <p>Eukaryotic translation initiation factor 4E-binding protein 1</p>
          </def>
        </def-item>
        <def-item>
          <term>5’TOP</term>
          <def>
            <p>5'terminal oligopyrimidine</p>
          </def>
        </def-item>
        <def-item>
          <term>AMPK</term>
          <def>
            <p>AMP-activated protein kinase</p>
          </def>
        </def-item>
        <def-item>
          <term>CdLS</term>
          <def>
            <p>Cornelia de Lange syndrome</p>
          </def>
        </def-item>
        <def-item>
          <term>D-Leu</term>
          <def>
            <p>D-leucine</p>
          </def>
        </def-item>
        <def-item>
          <term>DMR</term>
          <def>
            <p>Differentially methylated regions</p>
          </def>
        </def-item>
        <def-item>
          <term>eIF4E</term>
          <def>
            <p>eukaryotic translation initiation factor 4E</p>
          </def>
        </def-item>
        <def-item>
          <term>GO</term>
          <def>
            <p>Gene ontology</p>
          </def>
        </def-item>
        <def-item>
          <term>
            <italic>HOX</italic>
          </term>
          <def>
            <p>Homeobox</p>
          </def>
        </def-item>
        <def-item>
          <term>IGF-1R</term>
          <def>
            <p>Insulin-like growth factor 1 receptor</p>
          </def>
        </def-item>
        <def-item>
          <term>IGF2</term>
          <def>
            <p>Insulin growth factor 2</p>
          </def>
        </def-item>
        <def-item>
          <term>L-Leu</term>
          <def>
            <p>L-leucine</p>
          </def>
        </def-item>
        <def-item>
          <term>NAD</term>
          <def>
            <p>Nucleolar associated domains</p>
          </def>
        </def-item>
        <def-item>
          <term>PRTE</term>
          <def>
            <p>Pyrimidine-rich translational element</p>
          </def>
        </def-item>
        <def-item>
          <term>RBS</term>
          <def>
            <p>Roberts syndrome</p>
          </def>
        </def-item>
        <def-item>
          <term>rDNA</term>
          <def>
            <p>ribosomal DNA</p>
          </def>
        </def-item>
        <def-item>
          <term>rRNA</term>
          <def>
            <p>ribosomal RNA</p>
          </def>
        </def-item>
        <def-item>
          <term>ribosome footprint</term>
          <def>
            <p>ribosome-protected mRNA fragments</p>
          </def>
        </def-item>
        <def-item>
          <term>RPKM</term>
          <def>
            <p>Gene-specific reads per million total exon-mapped reads.</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The authors declare that they have no competing interests.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors’ contributions</bold>
        </p>
        <p>BX performed all of the experiments and helped draft the manuscript. KG assisted with the ribosome profiling experiments. MG performed the data analysis. JG helped draft the manuscript. All authors have read and approved the manuscript.</p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgements</title>
      <p>This work was supported by SIMR and MOD (#6-FY14-434). We thank the de Winter lab for the RBS cell lines. The human cells used in this study were originally obtained by the de Winter lab, which had approval from the Institutional Review board of the VU Medical Center. Approval for our research is covered by a material transfer agreement with the VU University Medical Center and is further outlined and approved by the Stowers Internal Review Board. We gratefully acknowledge Dr. Linheng Li and Dr. Pengxu Qian (Stowers Institute for Medical Research) for sharing unpublished data and helpful discussions. We thank Richard Shrock for help with manuscript preparation.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Monnich</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kuriger</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Print</surname>
              <given-names>CG</given-names>
            </name>
            <name>
              <surname>Horsfield</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>A zebrafish model of Roberts syndrome reveals that Esco2 depletion interferes with development by disrupting the cell cycle</article-title>
          <source>PloS one</source>
          <year>2011</year>
          <volume>6</volume>
          <issue>5</issue>
          <fpage>e20051</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0020051</pub-id>
          <?supplied-pmid 21637801?>
          <pub-id pub-id-type="pmid">21637801</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Muto</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Calof</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Lander</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Schilling</surname>
              <given-names>TF</given-names>
            </name>
          </person-group>
          <article-title>Multifactorial origins of heart and gut defects in nipbl-deficient zebrafish, a model of Cornelia de Lange Syndrome</article-title>
          <source>PLoS biology</source>
          <year>2011</year>
          <volume>9</volume>
          <issue>10</issue>
          <fpage>e1001181</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pbio.1001181</pub-id>
          <?supplied-pmid 22039349?>
          <pub-id pub-id-type="pmid">22039349</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Muto</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ikeda</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lopez-Burks</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Kikuchi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Calof</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Lander</surname>
              <given-names>AD</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Nipbl and mediator cooperatively regulate gene expression to control limb development</article-title>
          <source>PLoS genetics</source>
          <year>2014</year>
          <volume>10</volume>
          <issue>9</issue>
          <fpage>e1004671</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pgen.1004671</pub-id>
          <?supplied-pmid 25255084?>
          <pub-id pub-id-type="pmid">25255084</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kawauchi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Calof</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Santos</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Lopez-Burks</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Hoang</surname>
              <given-names>MP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Multiple organ system defects and transcriptional dysregulation in the Nipbl(+/−) mouse, a model of Cornelia de Lange Syndrome</article-title>
          <source>PLoS genetics</source>
          <year>2009</year>
          <volume>5</volume>
          <issue>9</issue>
          <fpage>e1000650</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pgen.1000650</pub-id>
          <?supplied-pmid 19763162?>
          <pub-id pub-id-type="pmid">19763162</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Remeseiro</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Cuadrado</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gomez-Lopez</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Pisano</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Losada</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>A unique role of cohesin-SA1 in gene regulation and development</article-title>
          <source>The EMBO journal</source>
          <year>2012</year>
          <volume>31</volume>
          <issue>9</issue>
          <fpage>2090</fpage>
          <lpage>2102</lpage>
          <pub-id pub-id-type="doi">10.1038/emboj.2012.60</pub-id>
          <?supplied-pmid 22415368?>
          <pub-id pub-id-type="pmid">22415368</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kagey</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Newman</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Bilodeau</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Zhan</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Orlando</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>van Berkum</surname>
              <given-names>NL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mediator and cohesin connect gene expression and chromatin architecture</article-title>
          <source>Nature</source>
          <year>2010</year>
          <volume>467</volume>
          <issue>7314</issue>
          <fpage>430</fpage>
          <lpage>435</lpage>
          <pub-id pub-id-type="doi">10.1038/nature09380</pub-id>
          <?supplied-pmid 20720539?>
          <pub-id pub-id-type="pmid">20720539</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Degner</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Verma-Gaur</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>TP</given-names>
            </name>
            <name>
              <surname>Bossen</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Iverson</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Torkamani</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>CCCTC-binding factor (CTCF) and cohesin influence the genomic architecture of the Igh locus and antisense transcription in pro-B cells</article-title>
          <source>Proceedings of the National Academy of Sciences of the United States of America</source>
          <year>2011</year>
          <volume>108</volume>
          <issue>23</issue>
          <fpage>9566</fpage>
          <lpage>9571</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.1019391108</pub-id>
          <?supplied-pmid 21606361?>
          <pub-id pub-id-type="pmid">21606361</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tedeschi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wutz</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Huet</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Jaritz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wuensche</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Schirghuber</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Wapl is an essential regulator of chromatin structure and chromosome segregation</article-title>
          <source>Nature</source>
          <year>2013</year>
          <volume>501</volume>
          <issue>7468</issue>
          <fpage>564</fpage>
          <lpage>568</lpage>
          <pub-id pub-id-type="doi">10.1038/nature12471</pub-id>
          <?supplied-pmid 23975099?>
          <pub-id pub-id-type="pmid">23975099</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>DeMare</surname>
              <given-names>LE</given-names>
            </name>
            <name>
              <surname>Leng</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Cotney</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Reilly</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Yin</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Sarro</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The genomic landscape of cohesin-associated chromatin interactions</article-title>
          <source>Genome research</source>
          <year>2013</year>
          <volume>23</volume>
          <issue>8</issue>
          <fpage>1224</fpage>
          <lpage>1234</lpage>
          <pub-id pub-id-type="doi">10.1101/gr.156570.113</pub-id>
          <?supplied-pmid 23704192?>
          <pub-id pub-id-type="pmid">23704192</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <mixed-citation publication-type="other">Cuadrado A, Remeseiro S, Grana O, Pisano DG, Losada A. The contribution of cohesin-SA1 to gene expression and chromatin architecture in two murine tissues. Nucleic acids research. 2015;3.</mixed-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vega</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Waisfisz</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Gordillo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sakai</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Yanagihara</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Yamada</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Roberts syndrome is caused by mutations in ESCO2, a human homolog of yeast ECO1 that is essential for the establishment of sister chromatid cohesion</article-title>
          <source>Nature genetics.</source>
          <year>2005</year>
          <volume>37</volume>
          <issue>5</issue>
          <fpage>468</fpage>
          <lpage>470</lpage>
          <pub-id pub-id-type="doi">10.1038/ng1548</pub-id>
          <?supplied-pmid 15821733?>
          <pub-id pub-id-type="pmid">15821733</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van der Lelij</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Godthelp</surname>
              <given-names>BC</given-names>
            </name>
            <name>
              <surname>van Zon</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>van Gosliga</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Oostra</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Steltenpool</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The cellular phenotype of Roberts syndrome fibroblasts as revealed by ectopic expression of ESCO2</article-title>
          <source>PloS one</source>
          <year>2009</year>
          <volume>4</volume>
          <issue>9</issue>
          <fpage>e6936</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0006936</pub-id>
          <?supplied-pmid 19738907?>
          <pub-id pub-id-type="pmid">19738907</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harris</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Bose</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>KK</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ross</surname>
              <given-names>RT</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cohesion promotes nucleolar structure and function</article-title>
          <source>Molecular biology of the cell</source>
          <year>2014</year>
          <volume>25</volume>
          <issue>3</issue>
          <fpage>337</fpage>
          <lpage>346</lpage>
          <pub-id pub-id-type="doi">10.1091/mbc.E13-07-0377</pub-id>
          <?supplied-pmid 24307683?>
          <pub-id pub-id-type="pmid">24307683</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bose</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>KK</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Slaughter</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cohesin Proteins Promote Ribosomal RNA Production and Protein Translation in Yeast and Human Cells</article-title>
          <source>PLoS genetics</source>
          <year>2012</year>
          <volume>8</volume>
          <issue>6</issue>
          <fpage>e1002749</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pgen.1002749</pub-id>
          <?supplied-pmid 22719263?>
          <pub-id pub-id-type="pmid">22719263</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gard</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Light</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Xiong</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Bose</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>McNairn</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cohesinopathy mutations disrupt the subnuclear organization of chromatin</article-title>
          <source>The Journal of cell biology</source>
          <year>2009</year>
          <volume>187</volume>
          <issue>4</issue>
          <fpage>455</fpage>
          <lpage>462</lpage>
          <pub-id pub-id-type="doi">10.1083/jcb.200906075</pub-id>
          <?supplied-pmid 19948494?>
          <pub-id pub-id-type="pmid">19948494</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xu</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>KK</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Gerton</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
          <article-title>Stimulation of mTORC1 with L-leucine rescues defects associated with Roberts syndrome</article-title>
          <source>PLoS genetics</source>
          <year>2013</year>
          <volume>9</volume>
          <issue>10</issue>
          <fpage>e1003857</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pgen.1003857</pub-id>
          <?supplied-pmid 24098154?>
          <pub-id pub-id-type="pmid">24098154</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xu</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gerton</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
          <article-title>Roberts syndrome: A deficit in acetylated cohesin leads to nucleolar dysfunction</article-title>
          <source>Rare diseases.</source>
          <year>2014</year>
          <volume>2</volume>
          <fpage>e27743</fpage>
          <pub-id pub-id-type="doi">10.4161/rdis.27743</pub-id>
          <?supplied-pmid 25054091?>
          <pub-id pub-id-type="pmid">25054091</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <mixed-citation publication-type="other">Xu B, Sowa N, Cardenas ME, Gerton JL. L-leucine partially rescues translational and developmental defects associated with zebrafish models of Cornelia de Lange syndrome. Hum Mol Genet. 2015;24(6):1540–55</mixed-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <mixed-citation publication-type="other">Zakari M, Yuen K, Gerton JL. Etiology and pathogenesis of the cohesinopathies. Wiley interdisciplinary reviews Developmental biology. 2015;4(5):489–504</mixed-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hsieh</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Edlind</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Ingolia</surname>
              <given-names>NT</given-names>
            </name>
            <name>
              <surname>Janes</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Sher</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The translational landscape of mTOR signalling steers cancer initiation and metastasis</article-title>
          <source>Nature</source>
          <year>2012</year>
          <volume>485</volume>
          <issue>7396</issue>
          <fpage>55</fpage>
          <lpage>61</lpage>
          <pub-id pub-id-type="doi">10.1038/nature10912</pub-id>
          <?supplied-pmid 22367541?>
          <pub-id pub-id-type="pmid">22367541</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thoreen</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Chantranupong</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Keys</surname>
              <given-names>HR</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Gray</surname>
              <given-names>NS</given-names>
            </name>
            <name>
              <surname>Sabatini</surname>
              <given-names>DM</given-names>
            </name>
          </person-group>
          <article-title>A unifying model for mTORC1-mediated regulation of mRNA translation</article-title>
          <source>Nature</source>
          <year>2012</year>
          <volume>485</volume>
          <issue>7396</issue>
          <fpage>109</fpage>
          <lpage>113</lpage>
          <pub-id pub-id-type="doi">10.1038/nature11083</pub-id>
          <?supplied-pmid 22552098?>
          <pub-id pub-id-type="pmid">22552098</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nativio</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Wendt</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Ito</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Huddleston</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Uribe-Lewis</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Woodfine</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cohesin is required for higher-order chromatin conformation at the imprinted IGF2-H19 locus</article-title>
          <source>PLoS genetics</source>
          <year>2009</year>
          <volume>5</volume>
          <issue>11</issue>
          <fpage>e1000739</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pgen.1000739</pub-id>
          <?supplied-pmid 19956766?>
          <pub-id pub-id-type="pmid">19956766</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nativio</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sparago</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ito</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Weksberg</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Riccio</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Murrell</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Disruption of genomic neighbourhood at the imprinted IGF2-H19 locus in Beckwith-Wiedemann syndrome and Silver-Russell syndrome</article-title>
          <source>Human molecular genetics</source>
          <year>2011</year>
          <volume>20</volume>
          <issue>7</issue>
          <fpage>1363</fpage>
          <lpage>1374</lpage>
          <pub-id pub-id-type="doi">10.1093/hmg/ddr018</pub-id>
          <?supplied-pmid 21282187?>
          <pub-id pub-id-type="pmid">21282187</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rhodes</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Bentley</surname>
              <given-names>FK</given-names>
            </name>
            <name>
              <surname>Print</surname>
              <given-names>CG</given-names>
            </name>
            <name>
              <surname>Dorsett</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Misulovin</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Dickinson</surname>
              <given-names>EJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Positive regulation of c-Myc by cohesin is direct, and evolutionarily conserved</article-title>
          <source>Dev Biol</source>
          <year>2010</year>
          <volume>344</volume>
          <issue>2</issue>
          <fpage>637</fpage>
          <lpage>649</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ydbio.2010.05.493</pub-id>
          <?supplied-pmid 20553708?>
          <pub-id pub-id-type="pmid">20553708</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Antony</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Dasgupta</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Rhodes</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>McEwan</surname>
              <given-names>MV</given-names>
            </name>
            <name>
              <surname>Print</surname>
              <given-names>CG</given-names>
            </name>
            <name>
              <surname>O’Sullivan</surname>
              <given-names>JM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cohesin modulates transcription of estrogen-responsive genes</article-title>
          <source>Biochimica et biophysica acta</source>
          <year>2015</year>
          <volume>1849</volume>
          <issue>3</issue>
          <fpage>257</fpage>
          <lpage>269</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bbagrm.2014.12.011</pub-id>
          <?supplied-pmid 25542856?>
          <pub-id pub-id-type="pmid">25542856</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sidrauski</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Acosta-Alvear</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Khoutorsky</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Vedantham</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Hearn</surname>
              <given-names>BR</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Pharmacological brake-release of mRNA translation enhances cognitive memory</article-title>
          <source>Elife.</source>
          <year>2013</year>
          <volume>2</volume>
          <fpage>e00498</fpage>
          <pub-id pub-id-type="doi">10.7554/eLife.00498</pub-id>
          <?supplied-pmid 23741617?>
          <pub-id pub-id-type="pmid">23741617</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ingolia</surname>
              <given-names>NT</given-names>
            </name>
            <name>
              <surname>Ghaemmaghami</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Newman</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Weissman</surname>
              <given-names>JS</given-names>
            </name>
          </person-group>
          <article-title>Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling</article-title>
          <source>Science</source>
          <year>2009</year>
          <volume>324</volume>
          <issue>5924</issue>
          <fpage>218</fpage>
          <lpage>223</lpage>
          <pub-id pub-id-type="doi">10.1126/science.1168978</pub-id>
          <?supplied-pmid 19213877?>
          <pub-id pub-id-type="pmid">19213877</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Olshen</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Hsieh</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Stumpf</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Olshen</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Ruggero</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>BS</given-names>
            </name>
          </person-group>
          <article-title>Assessing gene-level translational control from ribosome profiling</article-title>
          <source>Bioinformatics</source>
          <year>2013</year>
          <volume>29</volume>
          <issue>23</issue>
          <fpage>2995</fpage>
          <lpage>3002</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/btt533</pub-id>
          <?supplied-pmid 24048356?>
          <pub-id pub-id-type="pmid">24048356</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bailey</surname>
              <given-names>TL</given-names>
            </name>
            <name>
              <surname>Boden</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Buske</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>Frith</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Grant</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Clementi</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>MEME SUITE: tools for motif discovery and searching</article-title>
          <source>Nucleic acids research</source>
          <year>2009</year>
          <volume>37</volume>
          <issue>Web Server issue</issue>
          <fpage>W202</fpage>
          <lpage>W208</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkp335</pub-id>
          <?supplied-pmid 19458158?>
          <pub-id pub-id-type="pmid">19458158</pub-id>
        </element-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stumpf</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Moreno</surname>
              <given-names>MV</given-names>
            </name>
            <name>
              <surname>Olshen</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>BS</given-names>
            </name>
            <name>
              <surname>Ruggero</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>The translational landscape of the mammalian cell cycle</article-title>
          <source>Molecular cell</source>
          <year>2013</year>
          <volume>52</volume>
          <issue>4</issue>
          <fpage>574</fpage>
          <lpage>582</lpage>
          <pub-id pub-id-type="doi">10.1016/j.molcel.2013.09.018</pub-id>
          <?supplied-pmid 24120665?>
          <pub-id pub-id-type="pmid">24120665</pub-id>
        </element-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morita</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gravel</surname>
              <given-names>SP</given-names>
            </name>
            <name>
              <surname>Chenard</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Sikstrom</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Zheng</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Alain</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>mTORC1 controls mitochondrial activity and biogenesis through 4E-BP-dependent translational regulation</article-title>
          <source>Cell metabolism</source>
          <year>2013</year>
          <volume>18</volume>
          <issue>5</issue>
          <fpage>698</fpage>
          <lpage>711</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cmet.2013.10.001</pub-id>
          <?supplied-pmid 24206664?>
          <pub-id pub-id-type="pmid">24206664</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mihaylova</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Shaw</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
          <article-title>The AMPK signalling pathway coordinates cell growth, autophagy and metabolism</article-title>
          <source>Nat Cell Biol</source>
          <year>2011</year>
          <volume>13</volume>
          <issue>9</issue>
          <fpage>1016</fpage>
          <lpage>1023</lpage>
          <pub-id pub-id-type="doi">10.1038/ncb2329</pub-id>
          <?supplied-pmid 21892142?>
          <pub-id pub-id-type="pmid">21892142</pub-id>
        </element-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leadsham</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Sanders</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Giannaki</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bastow</surname>
              <given-names>EL</given-names>
            </name>
            <name>
              <surname>Hutton</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Naeimi</surname>
              <given-names>WR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Loss of cytochrome c oxidase promotes RAS-dependent ROS production from the ER resident NADPH oxidase, Yno1p, in yeast</article-title>
          <source>Cell metabolism</source>
          <year>2013</year>
          <volume>18</volume>
          <issue>2</issue>
          <fpage>279</fpage>
          <lpage>286</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cmet.2013.07.005</pub-id>
          <?supplied-pmid 23931758?>
          <pub-id pub-id-type="pmid">23931758</pub-id>
        </element-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Vazquez</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Moghaddas</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hoppel</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Lesnefsky</surname>
              <given-names>EJ</given-names>
            </name>
          </person-group>
          <article-title>Production of reactive oxygen species by mitochondria: central role of complex III</article-title>
          <source>The Journal of biological chemistry</source>
          <year>2003</year>
          <volume>278</volume>
          <issue>38</issue>
          <fpage>36027</fpage>
          <lpage>36031</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M304854200</pub-id>
          <?supplied-pmid 12840017?>
          <pub-id pub-id-type="pmid">12840017</pub-id>
        </element-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schwartz</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bernstein</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Mumbach</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Jovanovic</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Herbst</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Leon-Ricardo</surname>
              <given-names>BX</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Transcriptome-wide Mapping Reveals Widespread Dynamic-Regulated Pseudouridylation of ncRNA and mRNA</article-title>
          <source>Cell</source>
          <year>2014</year>
          <volume>159</volume>
          <issue>1</issue>
          <fpage>148</fpage>
          <lpage>162</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2014.08.028</pub-id>
          <?supplied-pmid 25219674?>
          <pub-id pub-id-type="pmid">25219674</pub-id>
        </element-citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carlile</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Rojas-Duran</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Zinshteyn</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Shin</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Bartoli</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Gilbert</surname>
              <given-names>WV</given-names>
            </name>
          </person-group>
          <article-title>Pseudouridine profiling reveals regulated mRNA pseudouridylation in yeast and human cells</article-title>
          <source>Nature</source>
          <year>2014</year>
          <volume>515</volume>
          <issue>7525</issue>
          <fpage>143</fpage>
          <lpage>146</lpage>
          <pub-id pub-id-type="doi">10.1038/nature13802</pub-id>
          <?supplied-pmid 25192136?>
          <pub-id pub-id-type="pmid">25192136</pub-id>
        </element-citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Martins</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Olmos</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Missiaglia</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Shipley</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Targeting the insulin-like growth factor pathway in rhabdomyosarcomas: rationale and future perspectives</article-title>
          <source>Sarcoma.</source>
          <year>2011</year>
          <volume>2011</volume>
          <fpage>209736</fpage>
          <pub-id pub-id-type="doi">10.1155/2011/209736</pub-id>
          <?supplied-pmid 21437217?>
          <pub-id pub-id-type="pmid">21437217</pub-id>
        </element-citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Keniry</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Oxley</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Monnier</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Kyba</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Dandolo</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Smits</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and Igf1r</article-title>
          <source>Nat Cell Biol</source>
          <year>2012</year>
          <volume>14</volume>
          <issue>7</issue>
          <fpage>659</fpage>
          <lpage>665</lpage>
          <pub-id pub-id-type="doi">10.1038/ncb2521</pub-id>
          <?supplied-pmid 22684254?>
          <pub-id pub-id-type="pmid">22684254</pub-id>
        </element-citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bell</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Felsenfeld</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene</article-title>
          <source>Nature</source>
          <year>2000</year>
          <volume>405</volume>
          <issue>6785</issue>
          <fpage>482</fpage>
          <lpage>485</lpage>
          <pub-id pub-id-type="doi">10.1038/35013100</pub-id>
          <?supplied-pmid 10839546?>
          <pub-id pub-id-type="pmid">10839546</pub-id>
        </element-citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lin</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ferguson-Smith</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Schultz</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Bartolomei</surname>
              <given-names>MS</given-names>
            </name>
          </person-group>
          <article-title>Nonallelic transcriptional roles of CTCF and cohesins at imprinted loci</article-title>
          <source>Molecular and cellular biology</source>
          <year>2011</year>
          <volume>31</volume>
          <issue>15</issue>
          <fpage>3094</fpage>
          <lpage>3104</lpage>
          <pub-id pub-id-type="doi">10.1128/MCB.01449-10</pub-id>
          <?supplied-pmid 21628529?>
          <pub-id pub-id-type="pmid">21628529</pub-id>
        </element-citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kernohan</surname>
              <given-names>KD</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Tremblay</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Bonvissuto</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Eubanks</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Mann</surname>
              <given-names>MR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>ATRX partners with cohesin and MeCP2 and contributes to developmental silencing of imprinted genes in the brain</article-title>
          <source>Dev Cell</source>
          <year>2010</year>
          <volume>18</volume>
          <issue>2</issue>
          <fpage>191</fpage>
          <lpage>202</lpage>
          <pub-id pub-id-type="doi">10.1016/j.devcel.2009.12.017</pub-id>
          <?supplied-pmid 20159591?>
          <pub-id pub-id-type="pmid">20159591</pub-id>
        </element-citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seitz</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Royo</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Bortolin</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>SP</given-names>
            </name>
            <name>
              <surname>Ferguson-Smith</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Cavaille</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>A large imprinted microRNA gene cluster at the mouse Dlk1-Gtl2 domain</article-title>
          <source>Genome research</source>
          <year>2004</year>
          <volume>14</volume>
          <issue>9</issue>
          <fpage>1741</fpage>
          <lpage>1748</lpage>
          <pub-id pub-id-type="doi">10.1101/gr.2743304</pub-id>
          <?supplied-pmid 15310658?>
          <pub-id pub-id-type="pmid">15310658</pub-id>
        </element-citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kircher</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bock</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Paulsen</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Structural conservation versus functional divergence of maternally expressed microRNAs in the Dlk1/Gtl2 imprinting region</article-title>
          <source>BMC Genomics.</source>
          <year>2008</year>
          <volume>9</volume>
          <fpage>346</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-2164-9-346</pub-id>
          <?supplied-pmid 18651963?>
          <pub-id pub-id-type="pmid">18651963</pub-id>
        </element-citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Byrne</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Colgrave</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Vuocolo</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Pearson</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Bidwell</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Cockett</surname>
              <given-names>NE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The imprinted retrotransposon-like gene PEG11 (RTL1) is expressed as a full-length protein in skeletal muscle from Callipyge sheep</article-title>
          <source>PLoS One</source>
          <year>2010</year>
          <volume>5</volume>
          <issue>1</issue>
          <fpage>e8638</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0008638</pub-id>
          <?supplied-pmid 20072617?>
          <pub-id pub-id-type="pmid">20072617</pub-id>
        </element-citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Caiment</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Charlier</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Hadfield</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Cockett</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Georges</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Baurain</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Assessing the effect of the CLPG mutation on the microRNA catalog of skeletal muscle using high-throughput sequencing</article-title>
          <source>Genome research</source>
          <year>2010</year>
          <volume>20</volume>
          <issue>12</issue>
          <fpage>1651</fpage>
          <lpage>1662</lpage>
          <pub-id pub-id-type="doi">10.1101/gr.108787.110</pub-id>
          <?supplied-pmid 20944086?>
          <pub-id pub-id-type="pmid">20944086</pub-id>
        </element-citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Luk</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Burchard</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>KF</given-names>
            </name>
            <name>
              <surname>Shek</surname>
              <given-names>FH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>DLK1-DIO3 genomic imprinted microRNA cluster at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survival</article-title>
          <source>The Journal of biological chemistry</source>
          <year>2011</year>
          <volume>286</volume>
          <issue>35</issue>
          <fpage>30706</fpage>
          <lpage>30713</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M111.229831</pub-id>
          <?supplied-pmid 21737452?>
          <pub-id pub-id-type="pmid">21737452</pub-id>
        </element-citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Snyder</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Rice</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Estrella</surname>
              <given-names>NL</given-names>
            </name>
            <name>
              <surname>Held</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kandarian</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Naya</surname>
              <given-names>FJ</given-names>
            </name>
          </person-group>
          <article-title>MEF2A regulates the Gtl2-Dio3 microRNA mega-cluster to modulate WNT signaling in skeletal muscle regeneration</article-title>
          <source>Development</source>
          <year>2013</year>
          <volume>140</volume>
          <issue>1</issue>
          <fpage>31</fpage>
          <lpage>42</lpage>
          <pub-id pub-id-type="doi">10.1242/dev.081851</pub-id>
          <?supplied-pmid 23154418?>
          <pub-id pub-id-type="pmid">23154418</pub-id>
        </element-citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Qian</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Paulson</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Haug</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>The Imprinted Dlk1-Gtl2 Locus Epigenetically Regulates Primitive Hematopoietic Stem Cell Mitochondrial Function and Energy Metabolism Via Repression of PI3K/Akt/mTOR Pathway</article-title>
          <source>Blood.</source>
          <year>2014</year>
          <volume>124</volume>
          <issue>21</issue>
          <fpage>1</fpage>
          <pub-id pub-id-type="pmid">24993873</pub-id>
        </element-citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <mixed-citation publication-type="other">Qian P, He XC, Paulson A, Li Z, Tao F, Perry JM, et al. The Dlk1-Gtl2 Locus Preserves LT-HSC Function by Inhibiting the PI3K-mTOR Pathway to Restrict Mitochondrial Metabolism. Cell Stem Cell. 2015;23.</mixed-citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zuin</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Dixon</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>van der Reijden</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Ye</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Kolovos</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Brouwer</surname>
              <given-names>RW</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cohesin and CTCF differentially affect chromatin architecture and gene expression in human cells</article-title>
          <source>Proceedings of the National Academy of Sciences of the United States of America</source>
          <year>2014</year>
          <volume>111</volume>
          <issue>3</issue>
          <fpage>996</fpage>
          <lpage>1001</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.1317788111</pub-id>
          <?supplied-pmid 24335803?>
          <pub-id pub-id-type="pmid">24335803</pub-id>
        </element-citation>
      </ref>
      <ref id="CR51">
        <label>51.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Holwerda</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>de Laat</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Chromatin loops, gene positioning, and gene expression</article-title>
          <source>Front Genet.</source>
          <year>2012</year>
          <volume>3</volume>
          <fpage>217</fpage>
          <pub-id pub-id-type="doi">10.3389/fgene.2012.00217</pub-id>
          <?supplied-pmid 23087710?>
          <pub-id pub-id-type="pmid">23087710</pub-id>
        </element-citation>
      </ref>
      <ref id="CR52">
        <label>52.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Misulovin</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Schwartz</surname>
              <given-names>YB</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>XY</given-names>
            </name>
            <name>
              <surname>Kahn</surname>
              <given-names>TG</given-names>
            </name>
            <name>
              <surname>Gause</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>MacArthur</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Association of cohesin and Nipped-B with transcriptionally active regions of the Drosophila melanogaster genome</article-title>
          <source>Chromosoma</source>
          <year>2008</year>
          <volume>117</volume>
          <issue>1</issue>
          <fpage>89</fpage>
          <lpage>102</lpage>
          <pub-id pub-id-type="doi">10.1007/s00412-007-0129-1</pub-id>
          <?supplied-pmid 17965872?>
          <pub-id pub-id-type="pmid">17965872</pub-id>
        </element-citation>
      </ref>
      <ref id="CR53">
        <label>53.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nemeth</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Conesa</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Santoyo-Lopez</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Medina</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Montaner</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Peterfia</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Initial genomics of the human nucleolus</article-title>
          <source>PLoS genetics</source>
          <year>2010</year>
          <volume>6</volume>
          <issue>3</issue>
          <fpage>e1000889</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pgen.1000889</pub-id>
          <?supplied-pmid 20361057?>
          <pub-id pub-id-type="pmid">20361057</pub-id>
        </element-citation>
      </ref>
      <ref id="CR54">
        <label>54.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van Koningsbruggen</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gierlinski</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schofield</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Barton</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Ariyurek</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>High-resolution whole-genome sequencing reveals that specific chromatin domains from most human chromosomes associate with nucleoli</article-title>
          <source>Molecular biology of the cell</source>
          <year>2010</year>
          <volume>21</volume>
          <issue>21</issue>
          <fpage>3735</fpage>
          <lpage>3748</lpage>
          <pub-id pub-id-type="doi">10.1091/mbc.E10-06-0508</pub-id>
          <?supplied-pmid 20826608?>
          <pub-id pub-id-type="pmid">20826608</pub-id>
        </element-citation>
      </ref>
      <ref id="CR55">
        <label>55.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Narla</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ebert</surname>
              <given-names>BL</given-names>
            </name>
          </person-group>
          <article-title>Ribosomopathies: human disorders of ribosome dysfunction</article-title>
          <source>Blood</source>
          <year>2010</year>
          <volume>115</volume>
          <issue>16</issue>
          <fpage>3196</fpage>
          <lpage>3205</lpage>
          <pub-id pub-id-type="doi">10.1182/blood-2009-10-178129</pub-id>
          <?supplied-pmid 20194897?>
          <pub-id pub-id-type="pmid">20194897</pub-id>
        </element-citation>
      </ref>
      <ref id="CR56">
        <label>56.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jaako</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Debnath</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Olsson</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Bryder</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Flygare</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Karlsson</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Dietary L-leucine improves the anemia in a mouse model for Diamond-Blackfan anemia</article-title>
          <source>Blood</source>
          <year>2012</year>
          <volume>120</volume>
          <issue>11</issue>
          <fpage>2225</fpage>
          <lpage>2228</lpage>
          <pub-id pub-id-type="doi">10.1182/blood-2012-05-431437</pub-id>
          <?supplied-pmid 22791294?>
          <pub-id pub-id-type="pmid">22791294</pub-id>
        </element-citation>
      </ref>
      <ref id="CR57">
        <label>57.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Payne</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Virgilio</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Narla</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Levine</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Paw</surname>
              <given-names>BH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>L-Leucine improves the anemia and developmental defects associated with Diamond-Blackfan anemia and del(5q) MDS by activating the mTOR pathway</article-title>
          <source>Blood</source>
          <year>2012</year>
          <volume>120</volume>
          <issue>11</issue>
          <fpage>2214</fpage>
          <lpage>2224</lpage>
          <pub-id pub-id-type="doi">10.1182/blood-2011-10-382986</pub-id>
          <?supplied-pmid 22734070?>
          <pub-id pub-id-type="pmid">22734070</pub-id>
        </element-citation>
      </ref>
      <ref id="CR58">
        <label>58.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xue</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Barna</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Specialized ribosomes: a new frontier in gene regulation and organismal biology</article-title>
          <source>Nature reviews Molecular cell biology</source>
          <year>2012</year>
          <volume>13</volume>
          <issue>6</issue>
          <fpage>355</fpage>
          <lpage>369</lpage>
          <pub-id pub-id-type="doi">10.1038/nrm3359</pub-id>
          <?supplied-pmid 22617470?>
          <pub-id pub-id-type="pmid">22617470</pub-id>
        </element-citation>
      </ref>
      <ref id="CR59">
        <label>59.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Han</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Jeong</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Kwon</surname>
              <given-names>NH</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>HK</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Leucyl-tRNA synthetase is an intracellular leucine sensor for the mTORC1-signaling pathway</article-title>
          <source>Cell</source>
          <year>2012</year>
          <volume>149</volume>
          <issue>2</issue>
          <fpage>410</fpage>
          <lpage>424</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2012.02.044</pub-id>
          <?supplied-pmid 22424946?>
          <pub-id pub-id-type="pmid">22424946</pub-id>
        </element-citation>
      </ref>
      <ref id="CR60">
        <label>60.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bonfils</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Jaquenoud</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bontron</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ostrowicz</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ungermann</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>De Virgilio</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Leucyl-tRNA synthetase controls TORC1 via the EGO complex</article-title>
          <source>Molecular cell</source>
          <year>2012</year>
          <volume>46</volume>
          <issue>1</issue>
          <fpage>105</fpage>
          <lpage>110</lpage>
          <pub-id pub-id-type="doi">10.1016/j.molcel.2012.02.009</pub-id>
          <?supplied-pmid 22424774?>
          <pub-id pub-id-type="pmid">22424774</pub-id>
        </element-citation>
      </ref>
      <ref id="CR61">
        <label>61.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zoncu</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Bar-Peled</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Efeyan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sancak</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Sabatini</surname>
              <given-names>DM</given-names>
            </name>
          </person-group>
          <article-title>mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the vacuolar H(+)-ATPase</article-title>
          <source>Science</source>
          <year>2011</year>
          <volume>334</volume>
          <issue>6056</issue>
          <fpage>678</fpage>
          <lpage>683</lpage>
          <pub-id pub-id-type="doi">10.1126/science.1207056</pub-id>
          <?supplied-pmid 22053050?>
          <pub-id pub-id-type="pmid">22053050</pub-id>
        </element-citation>
      </ref>
      <ref id="CR62">
        <label>62.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bar-Peled</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Schweitzer</surname>
              <given-names>LD</given-names>
            </name>
            <name>
              <surname>Zoncu</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sabatini</surname>
              <given-names>DM</given-names>
            </name>
          </person-group>
          <article-title>Ragulator is a GEF for the rag GTPases that signal amino acid levels to mTORC1</article-title>
          <source>Cell</source>
          <year>2012</year>
          <volume>150</volume>
          <issue>6</issue>
          <fpage>1196</fpage>
          <lpage>1208</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2012.07.032</pub-id>
          <?supplied-pmid 22980980?>
          <pub-id pub-id-type="pmid">22980980</pub-id>
        </element-citation>
      </ref>
      <ref id="CR63">
        <label>63.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dixon</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Selvaraj</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yue</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Shen</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Topological domains in mammalian genomes identified by analysis of chromatin interactions</article-title>
          <source>Nature</source>
          <year>2012</year>
          <volume>485</volume>
          <issue>7398</issue>
          <fpage>376</fpage>
          <lpage>380</lpage>
          <pub-id pub-id-type="doi">10.1038/nature11082</pub-id>
          <?supplied-pmid 22495300?>
          <pub-id pub-id-type="pmid">22495300</pub-id>
        </element-citation>
      </ref>
      <ref id="CR64">
        <label>64.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hernandez-Hernandez</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Soto-Reyes</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Ortiz</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Arriaga-Canon</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Echeverria-Martinez</surname>
              <given-names>OM</given-names>
            </name>
            <name>
              <surname>Vazquez-Nin</surname>
              <given-names>GH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Changes of the nucleolus architecture in absence of the nuclear factor CTCF</article-title>
          <source>Cytogenetic and genome research</source>
          <year>2012</year>
          <volume>136</volume>
          <issue>2</issue>
          <fpage>89</fpage>
          <lpage>96</lpage>
          <pub-id pub-id-type="doi">10.1159/000335752</pub-id>
          <?supplied-pmid 22286186?>
          <pub-id pub-id-type="pmid">22286186</pub-id>
        </element-citation>
      </ref>
      <ref id="CR65">
        <label>65.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Padeken</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Mendiburo</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Chlamydas</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Schwarz</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Kremmer</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Heun</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>The nucleoplasmin homolog NLP mediates centromere clustering and anchoring to the nucleolus</article-title>
          <source>Molecular cell</source>
          <year>2013</year>
          <volume>50</volume>
          <issue>2</issue>
          <fpage>236</fpage>
          <lpage>249</lpage>
          <pub-id pub-id-type="doi">10.1016/j.molcel.2013.03.002</pub-id>
          <?supplied-pmid 23562326?>
          <pub-id pub-id-type="pmid">23562326</pub-id>
        </element-citation>
      </ref>
      <ref id="CR66">
        <label>66.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yusufzai</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Tagami</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Nakatani</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Felsenfeld</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>CTCF tethers an insulator to subnuclear sites, suggesting shared insulator mechanisms across species</article-title>
          <source>Molecular cell</source>
          <year>2004</year>
          <volume>13</volume>
          <issue>2</issue>
          <fpage>291</fpage>
          <lpage>298</lpage>
          <pub-id pub-id-type="doi">10.1016/S1097-2765(04)00029-2</pub-id>
          <?supplied-pmid 14759373?>
          <pub-id pub-id-type="pmid">14759373</pub-id>
        </element-citation>
      </ref>
      <ref id="CR67">
        <label>67.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Torrano</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Navascues</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Docquier</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Burke</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Chernukhin</surname>
              <given-names>I</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Targeting of CTCF to the nucleolus inhibits nucleolar transcription through a poly(ADP-ribosyl)ation-dependent mechanism</article-title>
          <source>Journal of cell science</source>
          <year>2006</year>
          <volume>119</volume>
          <issue>Pt 9</issue>
          <fpage>1746</fpage>
          <lpage>1759</lpage>
          <pub-id pub-id-type="doi">10.1242/jcs.02890</pub-id>
          <?supplied-pmid 16595548?>
          <pub-id pub-id-type="pmid">16595548</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:4700580</identifier><datestamp>2016-01-06</datestamp><setSpec>bmcmedicine</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="http://jats.nlm.nih.gov/ns/archiving/1.0/ http://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="brief-report">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Med</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Med</journal-id>
      <journal-title-group>
        <journal-title>BMC Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1741-7015</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC4700580</article-id>
      <article-id pub-id-type="pmcid">PMC4700580</article-id>
      <article-id pub-id-type="pmc-uid">4700580</article-id>
      <article-id pub-id-type="publisher-id">545</article-id>
      <article-id pub-id-type="doi">10.1186/s12916-015-0545-7</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Correspondence</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Cancer and fertility preservation: international recommendations from an expert meeting</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1797-5296</contrib-id>
          <name>
            <surname>Lambertini</surname>
            <given-names>Matteo</given-names>
          </name>
          <address>
            <phone>+39 010 5600666</phone>
            <email>matteo.lambertini85@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Del Mastro</surname>
            <given-names>Lucia</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pescio</surname>
            <given-names>Maria C.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Andersen</surname>
            <given-names>Claus Y.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff4"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Azim</surname>
            <given-names>Hatem A.</given-names>
            <suffix>Jr.</suffix>
          </name>
          <xref ref-type="aff" rid="Aff5"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Peccatori</surname>
            <given-names>Fedro A.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff6"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Costa</surname>
            <given-names>Mauro</given-names>
          </name>
          <xref ref-type="aff" rid="Aff7"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Revelli</surname>
            <given-names>Alberto</given-names>
          </name>
          <xref ref-type="aff" rid="Aff8"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Salvagno</surname>
            <given-names>Francesca</given-names>
          </name>
          <xref ref-type="aff" rid="Aff8"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gennari</surname>
            <given-names>Alessandra</given-names>
          </name>
          <xref ref-type="aff" rid="Aff9"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ubaldi</surname>
            <given-names>Filippo M.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff10"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>La Sala</surname>
            <given-names>Giovanni B.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff11"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>De Stefano</surname>
            <given-names>Cristofaro</given-names>
          </name>
          <xref ref-type="aff" rid="Aff12"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wallace</surname>
            <given-names>W. Hamish</given-names>
          </name>
          <xref ref-type="aff" rid="Aff13"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Partridge</surname>
            <given-names>Ann H.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff14"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Anserini</surname>
            <given-names>Paola</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <aff id="Aff1"><label/>Department of Medical Oncology, U.O. Oncologia Medica 2, IRCCS AOU San Martino – IST, Genoa, Italy </aff>
        <aff id="Aff2"><label/>Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, IRCCS AOU San Martino – IST, Genoa, Italy </aff>
        <aff id="Aff3"><label/>Physiopathology of Human Reproduction, IRCCS AOU San Martino – IST, Genoa, Italy </aff>
        <aff id="Aff4"><label/>Laboratory of Reproductive Biology, Section 5712, Juliane Marie Centre for Women, Children and Reproduction, University Hospital of Copenhagen, Copenhagen, Denmark </aff>
        <aff id="Aff5"><label/>BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium </aff>
        <aff id="Aff6"><label/>Fertility and Procreation Unit, Gynecologic Oncology Department, European Institute of Oncology, Milan, Italy </aff>
        <aff id="Aff7"><label/>Reproductive Medicine Department, International Evangelic Hospital, Genoa, Italy </aff>
        <aff id="Aff8"><label/>Physiopathology of Reproduction and In Vitro Fertilization Unit, S. Anna Hospital, University of Turin, Turin, Italy </aff>
        <aff id="Aff9"><label/>Department of Medical Oncology, E.O. Galliera, Genoa, Italy </aff>
        <aff id="Aff10"><label/>GENERA Centre for Reproductive Medicine, Clinica Valle Giulia, Rome, Italy </aff>
        <aff id="Aff11"><label/>Obstetric and Gynecology Department, Azienda Ospedaliera Arcispedale S. Maria Nuova-IRCCS, University of Modena and Reggio Emilia, Reggio Emilia, Italy </aff>
        <aff id="Aff12"><label/>Children and Women Health Department, Physiopathology of Human Reproduction Unit, “San Giuseppe Moscati” Hospital, Avellino, Italy </aff>
        <aff id="Aff13"><label/>Department of Haematology/Oncology, Royal Hospital for Sick Children, and Department of Child Life and Health, University of Edinburgh, Edinburgh, UK </aff>
        <aff id="Aff14"><label/>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>4</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>4</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <volume>14</volume>
      <elocation-id>1</elocation-id>
      <history>
        <date date-type="received">
          <day>15</day>
          <month>9</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>16</day>
          <month>12</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© Lambertini et al. 2016</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <p>In the last years, thanks to the improvement in the prognosis of cancer patients, a growing attention has been given to the fertility issues. International guidelines on fertility preservation in cancer patients recommend that physicians discuss, as early as possible, with all patients of reproductive age their risk of infertility from the disease and/or treatment and their interest in having children after cancer, and help with informed fertility preservation decisions. As recommended by the American Society of Clinical Oncology and the European Society for Medical Oncology, sperm cryopreservation and embryo/oocyte cryopreservation are standard strategies for fertility preservations in male and female patients, respectively; other strategies (e.g. pharmacological protection of the gonads and gonadal tissue cryopreservation) are considered experimental techniques. However, since then, new data have become available, and several issues in this field are still controversial and should be addressed by both patients and their treating physicians.</p>
        <p>In April 2015, physicians with expertise in the field of fertility preservation in cancer patients from several European countries were invited in Genova (Italy) to participate in a workshop on the topic of “cancer and fertility preservation”. A total of ten controversial issues were discussed at the conference. Experts were asked to present an up-to-date review of the literature published on these topics and the presentation of own unpublished data was encouraged. On the basis of the data presented, as well as the expertise of the invited speakers, a total of ten recommendations were discussed and prepared with the aim to help physicians in counseling their young patients interested in fertility preservation.</p>
        <p>Although there is a great interest in this field, due to the lack of large prospective cohort studies and randomized trials on these topics, the level of evidence is not higher than 3 for most of the recommendations highlighting the need of further research efforts in many areas of this field. The participation to the ongoing registries and prospective studies is crucial to acquire more robust information in order to provide evidence-based recommendations.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Fertility preservation</kwd>
        <kwd>cancer patients</kwd>
        <kwd>survivorship issues</kwd>
        <kwd>sperm cryopreservation</kwd>
        <kwd>embryo cryopreservation</kwd>
        <kwd>oocyte cryopreservation</kwd>
        <kwd>ovarian tissue cryopreservation</kwd>
        <kwd>luteinizing hormone-releasing hormone analogs</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef"/>
              <institution>Associazione Italiana per la Ricerca sul Cancro (AIRC)</institution>
            </institution-wrap>
          </funding-source>
          <award-id>2013-14272</award-id>
        </award-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef"/>
              <institution>Italian Ministry of Health</institution>
            </institution-wrap>
          </funding-source>
          <award-id>CCM project, approved by D.M. 05/03/2012</award-id>
        </award-group>
      </funding-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>© The Author(s) 2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Background</title>
      <p>Although cancer incidence increases with age and peaks after the age of 50, thousands of young women and men are diagnosed with cancer every year [<xref ref-type="bibr" rid="CR1">1</xref>]. Modern anticancer treatments have led to significant reduction in mortality, but also to an increase in unwanted side effects such as reduced fertility. Combined with an increased age for childbearing [<xref ref-type="bibr" rid="CR2">2</xref>], a higher number of cancer survivors require fertility preservation to complete their families.</p>
      <p>The threat or experience of treatment-related infertility can lead to psychological distress [<xref ref-type="bibr" rid="CR3">3</xref>], and many patients are interested in maintaining fertility and future reproductive function at the time of cancer diagnosis [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. Moreover, fertility concerns may also substantially affect their treatment decisions [<xref ref-type="bibr" rid="CR6">6</xref>–<xref ref-type="bibr" rid="CR8">8</xref>]. Thus, great attention to fertility issues is warranted at the time of cancer diagnosis.</p>
      <p>International guidelines recommend that physicians discuss, as early as possible, with all patients of reproductive age their risk of infertility from the disease and/or treatment and their interest in having children after cancer, and help with informed fertility preservation decisions [<xref ref-type="bibr" rid="CR9">9</xref>–<xref ref-type="bibr" rid="CR11">11</xref>]. As recommended by the American Society of Clinical Oncology (ASCO) and the European Society for Medical Oncology (ESMO), sperm cryopreservation and embryo/oocyte cryopreservation are standard strategies for fertility preservation in male and female patients, respectively [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. Other strategies (e.g. pharmacological protection of the gonads and gonadal tissue cryopreservation) are still generally considered experimental techniques [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. However, new data in this field have become available over the past few years for consideration. Furthermore, several issues remain controversial with regard to the safety and efficacy of fertility preservation strategies in cancer survivors. In the present manuscript, we summarize and discuss the up-to-date knowledge on ten controversial topics in the field of fertility preservation in young patients with cancer.</p>
    </sec>
    <sec id="Sec2" sec-type="materials|methods">
      <title>Methods</title>
      <p>In April 2015, physicians with expertise in the field of fertility preservation in cancer patients from several European countries were invited in Genova (Italy) to participate in a workshop on the topic of “cancer and fertility preservation”. The invited experts represented different disciplines related to the topic including oncologists, hematologists, gynecologists, fertility specialists.</p>
      <p>A total of ten controversial issues were focused on at the conference. Experts were asked to present an up-to-date review of the literature on these topics. In addition, the presentation of own unpublished data when available was encouraged.</p>
      <p>On the basis of the data presented, as well as the expertise of the invited speakers, recommendations surrounding each topic were discussed and prepared with the aim to help physicians in counseling their young cancer patients interested in fertility preservation. To gain a United States (US) perspective, the recommendations were discussed and reviewed by Dr. Ann H. Partridge, from the Dana-Farber Cancer Institute, Boston (MA).</p>
      <p>To evaluate the levels of evidence and grades of recommendation, the grading system commonly used in oncology was chosen (Table <xref rid="Tab1" ref-type="table">1</xref>) [<xref ref-type="bibr" rid="CR11">11</xref>].<table-wrap id="Tab1"><label>Table 1</label><caption><p>Levels of evidence and grades of recommendation (according to the ESMO Clinical Practice Guidelines for fertility preservation in cancer patients [<xref ref-type="bibr" rid="CR11">11</xref>])</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="2">Levels of evidence</th></tr></thead><tbody><tr><td>I</td><td>Evidence from at least one large randomized, controlled trial of good methodological quality (low potential for bias) or meta-analyses of well-conducted randomized trials without heterogeneity</td></tr><tr><td>II</td><td>Small randomized trials or large randomized trials with a suspicion of bias (lower methodological quality) or meta-analyses of such trials or of trials with demonstrated heterogeneity</td></tr><tr><td>III</td><td>Prospective cohort studies</td></tr><tr><td>IV</td><td>Retrospective cohort studies or case–control studies</td></tr><tr><td>V</td><td>Studies without control group, case reports, experts opinions</td></tr><tr><td colspan="2">Grade of recommendation</td></tr><tr><td>A</td><td>Strong evidence for efficacy with a substantial clinical benefit, strongly recommended</td></tr><tr><td>B</td><td>Strong or moderate evidence for efficacy but with a limited clinical benefit, generally recommended</td></tr><tr><td>C</td><td>Insufficient evidence for efficacy or benefit does not outweigh the risk or the disadvantages (adverse events, costs, etc.), optional</td></tr><tr><td>D</td><td>Moderate evidence against efficacy or for adverse outcome, generally not recommended</td></tr><tr><td>E</td><td>Strong evidence against efficacy or for adverse outcome, never recommended</td></tr></tbody></table></table-wrap></p>
      <sec id="Sec3">
        <title>Controversial issues in fertility preservation in cancer patients</title>
        <sec id="Sec4">
          <title>Is there an increased risk of developing breast cancer in women treated with ovarian stimulating drugs for infertility?</title>
          <p>Elevated blood level of endogenous estrogen are known to be associated with an increased risk of breast cancer [<xref ref-type="bibr" rid="CR12">12</xref>–<xref ref-type="bibr" rid="CR14">14</xref>]. A large meta-analysis including more than 50 observational studies for a total of 160,000 women, demonstrated a higher risk of having breast cancer (relative risk [RR] = 1.35; 95 % confidence intervals [CI] 1.21-1.49) for users of hormone-replacement therapy (HRT) for 5 years or longer [<xref ref-type="bibr" rid="CR15">15</xref>].</p>
          <p>For these reasons, some concerns exist on the safety of using ovarian stimulating drugs. However, unlike HRT, characterized by a long lasting exposure to low estrogen levels and more robust data on the subsequent risk of breast cancer with this approach [<xref ref-type="bibr" rid="CR15">15</xref>], the use of ovarian stimulating drugs in subfertile patients is associated with significantly higher circulating estrogen levels for transient and shorter periods but with conflicting results on the risk of breast neoplasms [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>].</p>
          <p>Recently, a systematic review and meta-analysis of cohort studies evaluated the association between hormonal infertility treatments and risk of developing breast cancer [<xref ref-type="bibr" rid="CR18">18</xref>]. A total of 20 studies with 207,914 women exposed to hormonal treatments for infertility and 2,347 incident cases of breast cancer were included. Overall, no increased risk was detected with the use of hormonal treatments for infertility (summary RR [SRR] = 1.05; 95 % CI 0.96-1.14) but a significant heterogeneity among studies was detected (I<sup>2</sup> = 59 %; <italic>P</italic> = 0.001) [<xref ref-type="bibr" rid="CR18">18</xref>]. In subgroup analyses, when considering only the seven studies with the in vitro fertilization (IVF) procedure, no increase in breast cancer risk was detected (SRR = 0.96; 95 % CI 0.81-1.14). On the contrary, a moderately increased breast cancer risk was observed in the three studies where women were treated outside IVF protocols (SRR = 1.26; 95 % CI 1.06-1.50): however, to note, in these studies patients were enrolled before 1980. Overall, the meta-analysis did not support the hypothesis that hormonal treatments for infertility are associated with an increased breast cancer risk [<xref ref-type="bibr" rid="CR18">18</xref>].</p>
          <p>Recently, a large US cohort study reported reassuring results about the long-term effects of ovarian stimulating drugs with clomiphene or gonadotropins [<xref ref-type="bibr" rid="CR19">19</xref>]. After a median follow up of 30 years, out of 9,892 women evaluated for infertility, 749 developed breast cancer. Ever use of clomiphene citrate was not associated with risk (hazard ratio [HR] = 1.05; 95 % CI 0.90-1.22). However, a significantly elevated risk was observed for patients who received both a high cumulative dose (i.e. ≥ 2251 mg) and multiple cycles (i.e. ≥ 6 cycles), with an HR of 1.27 (95 % CI 1.02-1.59). Ever use of gonadotropins was not significantly associated with the risk of developing breast cancer (HR = 1.14; 95 % CI 0.89-1.44), with no trends according to dosage, number of cycles, or age at first use [<xref ref-type="bibr" rid="CR19">19</xref>].</p>
          <p>Despite these encouraging findings for infertile women who wish to undergo IVF procedures, caution is needed because it is difficult to assess the risk of breast cancer in this setting. In fact, several factors (e.g. pregnancy, infertility itself and the use of different therapeutic protocols) might impact study results due to their direct or indirect effect on the risk of developing breast cancer [<xref ref-type="bibr" rid="CR18">18</xref>]. Moreover, the evidence derived from observational studies have possible biases, including selection bias and ascertainment bias [<xref ref-type="bibr" rid="CR18">18</xref>].</p>
          <sec id="FPar1">
            <title>Recommendation 1</title>
            <p>Ovarian stimulating drugs with standard treatment protocols may be administered in subfertile/infertile women without increasing the risk of developing breast cancer (III, B). The long-term use of clomiphene outside the current limited indications (i.e. first-line therapy of WHO Group II anovulatory infertility) should be discouraged because of a possible increase in breast cancer risk (III, B).</p>
          </sec>
        </sec>
        <sec id="Sec5">
          <title>Should pregnancy after cancer be considered safe?</title>
          <p>A considerable proportion of cancer patients of childbearing age (approximately 50 %) desire pregnancy at the time of cancer diagnosis [<xref ref-type="bibr" rid="CR20">20</xref>]. However, cancer survivors have lower fecundity rates than the general population. A large population-based matched cohort study showed that despite an overall lower pregnancy rate in cancer survivors (23 % of men and 13 % of female) than in controls from the general population (32 % of men and 22 % of female), male survivors initiated pregnancies in a higher proportion (HR = 0.74; 95 % CI 0.71-0.78) than female survivors (HR = 0.61; 95 % CI 0.58-0.64) [<xref ref-type="bibr" rid="CR21">21</xref>]. Patients with malignant melanoma or thyroid cancer showed a similar pregnancy rate as compared to the controls: a possible reason is that the treatments required for these diseases when caught at early stages have no major negative impact on patients’ fertility [<xref ref-type="bibr" rid="CR21">21</xref>]. Survivors of ovarian cancer, testicular cancer, and Hodgkin lymphoma diagnosed in men, showed increasing pregnancy rates over time [<xref ref-type="bibr" rid="CR21">21</xref>]. On the other hand, survivors of leukemia, cervical cancer or breast tumors showed the lowest rates for subsequent pregnancies [<xref ref-type="bibr" rid="CR21">21</xref>].</p>
          <p>Breast cancer patients have the lowest pregnancy rate among cancer survivors, with an overall 67 % reduction in the chance of having babies after cancer treatment as compared to the general population [<xref ref-type="bibr" rid="CR21">21</xref>]. This observation reflects not only the damage to ovarian reserve due to the gonadotoxic treatments required, but also patient and provider concerns related to a possible negative impact of pregnancy on the evolution of breast cancer, being a hormonally driven disease. However, available data suggest that pregnancy after breast cancer does not negatively impact patients’ prognosis, irrespectively of the hormone receptor status of the tumor. A meta-analysis of 14 retrospective control-matched studies showed that breast cancer patients who became pregnant following diagnosis and treatment had a 41 % reduced risk of death compared to women who did not get pregnant (pooled RR [PRR] = 0.59; 95 % CI 0.50-0.70) [<xref ref-type="bibr" rid="CR22">22</xref>]. While these results could be partially confounded by selection bias or the healthy mother effect, and lack of information in hormone receptor positive patients, a more recent multicenter retrospective cohort study adjusting for this effect confirmed safety of pregnancy after breast cancer even in patients with endocrine-sensitive disease [<xref ref-type="bibr" rid="CR23">23</xref>]. This study showed no difference in disease-free survival (DFS) between pregnant and non-pregnant patients in the estrogen-receptor positive group (HR = 0.91; 95 % CI 0.67-1.24), nor in the estrogen-receptor negative cohort (HR = 0.75; 95 % CI 0.51-1.08) [<xref ref-type="bibr" rid="CR23">23</xref>]. Importantly, no impact of abortion on patient outcome was observed either [<xref ref-type="bibr" rid="CR23">23</xref>].</p>
          <p>In addition, the possible occurrence of congenital abnormalities and the potential obstetric and birth complications are two main concerns for young cancer survivors who want to reproduce after anticancer treatment. In general, reseach has revealed that the neonatal outcomes in both male and female survivors are not different from those of the general population [<xref ref-type="bibr" rid="CR24">24</xref>–<xref ref-type="bibr" rid="CR29">29</xref>]. However, high induced abortion rates have been observed in patients who became pregnant after breast cancer diagnosis reaching as high as 30 % [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>]. Moreover, in breast cancer survivors, a higher incidence of birth complications (i.e. caesarean section, preterm birth, babies with low birth weight) was observed in patients as compared to controls [<xref ref-type="bibr" rid="CR25">25</xref>]. Women undergoing pelvic irradiation might experience uterine damage with a possible increased risk of miscarriage, preterm birth, and low birth weight [<xref ref-type="bibr" rid="CR32">32</xref>]. For all these reasons, a close monitoring of pregnancy in such patients is recommended [<xref ref-type="bibr" rid="CR33">33</xref>].</p>
          <p>To date, pregnancy after cancer should be considered safe and not be discouraged in general [<xref ref-type="bibr" rid="CR11">11</xref>]. However, it is not clear yet the ideal interval to wait between the end of anticancer treatments and conception. Two main interval issues should be considered: to wait until the patient is at lower risk of relapse, and to wait until the anticancer therapy is out of a patient’s system (i.e. up to 3–6 months following the last administered dose) [<xref ref-type="bibr" rid="CR11">11</xref>]. According to expert opinion, the timing should be “personalized” taking into account age and ovarian reserve of the patient, previous treatments and time of their completion, and individual risk of relapse [<xref ref-type="bibr" rid="CR11">11</xref>]. In breast cancer patients with hormone receptor-positive disease, the need for adjuvant endocrine therapy is another important issue to be considered: its use for up to 5–10 years can lead to a natural decline in ovarian reserve due to age, thus hindering the chances of future pregnancies. An international prospective study with the aim to evaluate the feasibility and safety of a temporary interruption of endocrine therapy to allow pregnancy is ongoing (the POSITIVE study) [<xref ref-type="bibr" rid="CR34">34</xref>].</p>
          <sec id="FPar2">
            <title>Recommendation 2</title>
            <p>Pregnancy in cancer survivors, after adequate treatment and follow up, should not be discouraged, including among patients with endocrine-sensitive breast cancer (III, A).</p>
          </sec>
        </sec>
        <sec id="Sec6">
          <title>Should all patients be referred to a fertility unit before initiating anticancer treatments?</title>
          <p>Anticancer treatments (surgery, radiotherapy, cytotoxic chemotherapy and endocrine therapy) may affect male and female fertility transiently or permanently [<xref ref-type="bibr" rid="CR9">9</xref>]. Surgery can have a direct impact on patients’ fertility causing anatomic or vascular problems (e.g. retrograde ejaculation or impaired ejaculation, changes to the uterus, cervix or vagina) [<xref ref-type="bibr" rid="CR9">9</xref>]. Chemotherapy and radiotherapy have a direct gonadotoxic effect by destroying ovarian follicles that constitute woman’s ovarian reserve [<xref ref-type="bibr" rid="CR35">35</xref>–<xref ref-type="bibr" rid="CR37">37</xref>] and by compromising sperm number, motility, morphology, and DNA integrity in male patients [<xref ref-type="bibr" rid="CR9">9</xref>]. Finally, endocrine treatments used in breast cancer patients have both a direct and indirect effect on fertility and ovarian function: the direct effect, occurring during treatment only, is due to an impairment in ovulatory and endometrial functions, while the indirect effect is associated with the delay to conception that allows ovarian aging.</p>
          <p>As recommended by major international guidelines on fertility preservation in cancer patients, clinicians should discuss with their patients the potential impact of anticancer treatment on fertility as early as possible and help with fertility preservation decisions among at-risk survivors interested in having children after cancer [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR38">38</xref>].</p>
          <p>However, the rate of treatment-related infertility is variable and depends on several factors: type of cancer, age of the patient, history of previous treatment for infertility and comorbidities, type and dose of the chemotherapy regimen used, method of administration (oral versus intravenous), size and location of the radiation field and its dose, need of adjuvant endocrine therapy (Table <xref rid="Tab2" ref-type="table">2</xref>) [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR39">39</xref>]. Specifically, type of treatment and patients’ age are the most important factors to be taken into account when counseling the patients [<xref ref-type="bibr" rid="CR40">40</xref>].<table-wrap id="Tab2"><label>Table 2</label><caption><p>Risk of treatment-related infertility with the main anticancer therapies (modified from the original [<xref ref-type="bibr" rid="CR9">9</xref>])</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Degree of risk</th><th colspan="2">Type of anticancer treatment</th></tr><tr><th>Women</th><th>Men</th></tr></thead><tbody><tr><td>High risk<break/> (&gt;80 % risk of permanent amenorrhea in women; prolonged azoospermia in men)</td><td>-HSC transplantation with cyclophosphamide/TBI or cyclophosphamide/busulfan<break/>-External beam radiation to a field that includes the ovaries<break/>-CMF, CEF, CAF, TAC x 6 cycles in women ≥ 40 years</td><td>-Radiation &gt; 2.5 Gy to testis<break/>-Chlorambucil (1.4 g/m2)<break/>-Cyclophosphamide (19 g/m2)<break/>-Procarbazine (4 g/m2)<break/>-Melphalan (140 mg/m2)<break/>-Cisplatin (500 mg/m2)<break/>-BCNU (1 g/m2) and CCNU (500 mg/m2)</td></tr><tr><td>Intermediate risk<break/> (40 % - 60 % risk of permanent amenorrhea in women; likelihood of azoospermia in men especially when given with other sterilizing agents)</td><td>-BEACOPP<break/>-CMF, CEF, CAF, TAC x 6 cycles in women age 30–39<break/>-AC x 4 cycles in women ≥ 40 years<break/>-AC or EC x 4 → Taxanes</td><td>-Busulfan (600 mg/kg)<break/>-Ifosfamide (42 g/m2)<break/>-BCNU (300 mg/m2)<break/>-Nitrogen mustard<break/>-Actinomycin D</td></tr><tr><td>Low risk<break/> (&lt;20 % risk of permanent amenorrhea in women; only temporary reductions in sperm counts in men especially when not given with other sterilizing agents)</td><td>-ABVD in women ≥ 32 years<break/>-CHOP x 4–6 cycles<break/>-CVP<break/>-AML therapy (anthracycline/cytarabine)<break/>-ALL therapy (multi-agent)<break/>-CMF, CEF, CAF, TAC x 6 cycles in women ≤ 30 years<break/>-AC x 4 cycles in women ≤ 40 years</td><td>-Carboplatin (2 g/m2)<break/>-Doxorubicin (770 mg/m2)<break/>-Thiotepa (400 mg/m2)<break/>-Cytosine arabinoside (1 g/m2)<break/>-Vinblastine (50 g/m2)<break/>-Vincristine (8 g/m2)</td></tr><tr><td>Very low or no risk<break/> (risk of permanent amenorrhea in women; temporary reductions in sperm count in men but additive effects are possible)</td><td>-ABVD in women &lt; 32 years<break/>-Methotrexate<break/>-Fluorouracil<break/>-Vincristine<break/>-Tamoxifen</td><td>-Amsacrine<break/>-Bleomycin<break/>-Dacarbazine<break/>-Daunorubicin<break/>-Epirubicin<break/>-Etoposide<break/>-Fludarabine<break/>-Fluorouracil<break/>−6-mercaptopurine<break/>-Methotrexate<break/>-Mitoxantrone,<break/>-Thioguanine<break/>-Prednisone<break/>-Interferon-α</td></tr><tr><td>Unknown risk<break/> (risk of permanent amenorrhea in women; effect on sperm production in men)</td><td>-Monoclonal antibodies (trastuzumab, bevacizumab, cetuximab)<break/>-Tyrosine kinase inhibitors (erlotinib, imatinib)</td><td>-Oxaliplatin<break/>-Irinotecan<break/>-Monoclonal antibodies (trastuzumab, bevacizumab, cetuximab)<break/>-Tyrosine kinase inhibitors (erlotinib, imatinib)<break/>-Taxanes</td></tr></tbody></table><table-wrap-foot><p>
<italic>HSC</italic> hematopoietic stem cell, <italic>TBI</italic> total body irradiation, <italic>CMF</italic> cyclophosphamide, methotrexate, fluorouracil, <italic>CEF</italic> cyclophosphamide, epirubicin, fluorouracil, <italic>CAF</italic> cyclophosphamide, doxorubicin, fluorouracil, <italic>TAC</italic> docetaxel, doxorubicin, cyclophosphamide,<italic> BEACOPP</italic> doxorubicin, belomycin, vincristine, etoposide, cyclophosphamide, procarbazine, <italic>BCNU</italic> carmustine, <italic>CCNU</italic> lomustine, <italic>AC</italic> doxorubicin, cyclophosphamide, <italic>EC</italic> epirubicin, cyclophosphamide, <italic>ABVD</italic> doxorubicin, bleomycin, vinblastin, dacarbazine, <italic>CHOP</italic> cyclophosphamide, doxorubicin, vincristine, prednisone, <italic>CVP</italic> cyclophosphamide, vincristine, prednisone, <italic>AML</italic> acute myeloid leukemia, <italic>ALL</italic> acute lymphocitic leukemia</p></table-wrap-foot></table-wrap></p>
          <p>Onco-fertility counseling should be individualized, discussing both the absolute benefits of the proposed anticancer treatment (e.g. adjuvant chemotherapy or long duration of endocrine therapy in young breast cancer patients at low risk of recurrence) and the risk of infertility for each individual (based on patient-related factors [age, comorbidities, ovarian reserve in women [<xref ref-type="bibr" rid="CR41">41</xref>]] and the sterilizing potential of the treatment proposed). In some situations the risk of treatment-related infertility can be difficult to estimate due to limited available data; however, providers should not overestimate the risk of treatment-related infertility for cancer patients and some of them (e.g. very young patients undergoing treatment at low risk of infertility) can be reassured that they will not likely require the help of a fertility clinic after cancer treatment [<xref ref-type="bibr" rid="CR42">42</xref>]. On the other hand, the perception of a high risk for infertility is individual and the patients’ own wishes should also be taken into account. Further, to note that even with regimens associated with low risk of gonadotoxicity (e.g. doxorubicin,bleomycin,vinblastine,dacarbazine [ABVD] in Hodgkin lymphoma patients), nonetheless ovarian reserve is reduced and fertility may be impaired, particularly when pregnancy is delayed [<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR44">44</xref>]. Moreover, some patients may relapse and subsequently become candidates for different types of chemotherapy and at higher doses with a consequent negative impact on their gonadal function.</p>
          <sec id="FPar3">
            <title>Recommendation 3</title>
            <p>All patients with potential interest in keeping their fertility should be referred to fertility unit for adequate determination of risk of infertility, chances of future conception and how to proactively preserve it (V, A). However, some cancer patients will not require the help of a fertility clinic after cancer treatment (V, B). Since several patient- and treatment-related factors are associated with the risk of developing infertility, the oncofertility counseling should be tailored to the individual patient (V, A).</p>
          </sec>
        </sec>
        <sec id="Sec7">
          <title>Are gamete and embryo cryopreservation strategies accepted by young cancer patients, when available and accessible?</title>
          <p>Despite a growing amount of evidence suggesting that fertility issues are of great importance for young cancer patients, how many are counseled and offered these procedures is not well documented. In men, sperm cryopreservation is an effective strategy for fertility preservation: it does not require major delays in treatment initiation and can be easily performed in many centers [<xref ref-type="bibr" rid="CR45">45</xref>]. In women, access to standard strategies (oocytes/embryos cryopreservation) may be more difficult because of urgent need for treatment, and lack of a well-organized interaction between oncology and fertility units.</p>
          <p>The percentage of women who choose to undergo the available fertility preservation options after fertility counseling varies from 2 % to over 50 % [<xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR47">47</xref>]. In a recent large study conducted in breast cancer patients, only 10 % of women took active steps to reduce their chance of infertility (7 % underwent embryo cryopreservation, 1 % oocyte cryopreservation and 3 % accepted the administration of luteinizing hormone-releasing hormone analogs [LHRHa]); however, an increasing trend over time in the proportion of patients who pursued fertility preservation strategies was observed (from 5 % in 2006 to 15 % in 2012) [<xref ref-type="bibr" rid="CR7">7</xref>].</p>
          <p>In a recent prospective study conducted in 7 large Italian Institutions, the rate of application of cryopreservation techniques was evaluated in male and female cancer patients who underwent onco-fertility counseling over a period of 2 years (unpublished observations). Out of 510 men, 507 (99.4 %) cryopreserved at least one semen sample, and 88 (17.4 %) patients underwent two or more sperm collections. Out of 491 women, 132 (26.8 %) were considered not eligible for cryopreservation strategies (i.e. due to need to start chemotherapy immediately, inadequate ovarian reserve, high risk of complication or use of treatments with a low risk of gonadotoxicity). Among eligible patients, 66.6 % underwent cryopreservation techniques to preserve fertility (Table <xref rid="Tab3" ref-type="table">3</xref>). The lack of discussion of fertility issues between patients and physicians [<xref ref-type="bibr" rid="CR47">47</xref>–<xref ref-type="bibr" rid="CR49">49</xref>], and inadequate access to the strategies, are possible explanations of these findings [<xref ref-type="bibr" rid="CR50">50</xref>, <xref ref-type="bibr" rid="CR51">51</xref>].<table-wrap id="Tab3"><label>Table 3</label><caption><p>The choices regarding fertility preservation of female cancer patients enrolled in the Italian study</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Type of cancer<break/>
<italic>n</italic> (%)</th><th>Eligible for cryopreservation strategies<break/>
<italic>n</italic> (%)</th><th>Declined cryopreservation strategies<break/>
<italic>n</italic> (%)</th><th>Accepted oocyte cryopreservation<break/>
<italic>n</italic> (%)</th><th>Accepted ovarian tissue cryopreservation<break/>
<italic>n</italic> (%)</th></tr></thead><tbody><tr><td>Breast<break/> 281 (57.2)</td><td>186 (66.2)</td><td>76 (40.9)</td><td>103 (55.4)</td><td>7 (3.8)</td></tr><tr><td>Hematologic disease<break/> 123 (25.1)</td><td>98 (79.7)</td><td>27 (27.6)</td><td>50 (51.0)</td><td>21 (21.4)</td></tr><tr><td>Others<break/> 87 (17.7)</td><td>75 (86.2)</td><td>17 (22.7)</td><td>38 (50.7)</td><td>20 (26.7)</td></tr><tr><td>Total<break/> 491 (100)</td><td>359 (73.1)</td><td>120 (33.4)</td><td>191 (53.2)</td><td>48 (13.4)</td></tr></tbody></table></table-wrap></p>
          <p>Greater effort is needed to improve both the communication between patients and physicians about fertility risks and preservation options, and the collaboration among oncologists and fertility specialists to give patients the opportunity to undergo well-timed and complete reproductive counseling. Further research is needed to better understand the preferences of patients among the available strategies for fertility preservation: this information would have great importance from a public health perspective and for resource allocation standpoint. Moreover, a better understanding of the factors that influence patients’ choice would help physicians to improve the quality of their fertility counseling.</p>
          <sec id="FPar4">
            <title>Recommendation 4</title>
            <p>In men, sperm cryopreservation is an easily accessible and widely available option in more than 95 % of patients and should be encouraged for those who want to preserve fertility (III, A). On the contrary, from 2 % to 65 % of women undergo one of the available cryopreservation options: oncologists should discuss with them the fertility issues and secure proper counseling in appropriate centers prior to cancer treatment (IV, A).</p>
          </sec>
        </sec>
        <sec id="Sec8">
          <title>Which are the results and the safety of assisted reproduction technologies (ART) in male patients previously treated with chemotherapy?</title>
          <p>Anticancer treatments (i.e. chemotherapy and radiotherapy) can damage the germinal epithelium in men resulting in oligozoospermia or azoospermia: in fact, a large proportion of patients treated for cancer have lower sperm concentrations than matched controls [<xref ref-type="bibr" rid="CR9">9</xref>]. Currently, no strategies for medical protection of the germinal epithelium are available. Further, prepubertal age cannot be considered a protective factor from gonadotoxic insults. Data suggest that cancer itself can influence spermatogenesis [<xref ref-type="bibr" rid="CR52">52</xref>]. However, no correlation between semen alterations and cancer stage or associated symptoms has been detected [<xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR54">54</xref>].</p>
          <p>Sperm cryopreservation before gonadotoxic therapies is the standard strategy for fertility preservation in adult men [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. A large proportion of treated patients maintains or regains a level of spermatogenesis adequate to obtain spontaneous conception [<xref ref-type="bibr" rid="CR55">55</xref>]. However, male cancer survivors who don’t recover spermatogenesis nor had their semen cryopreserved before cytotoxic therapy may need ART, and specifically intracytoplasmatic sperm injection (ICSI), in order to reproduce. Therefore, when considering the safety of conception after radiotherapy and/or chemotherapy, there are three different scenarios: a) spontaneous conception in patients with continued post radiotherapy/chemotherapy spermatogenesis; b) ART conception with normal or abnormal cryopreserved sperm; c) ART conception with post radiotherapy/chemotherapy residual spermatogenesis (ICSI particularly).</p>
          <p>The limited available data on fatherhood after cancer are related to offspring from spontaneous conceptions or from IVF/ICSI with spermatozoa cryopreserved before the initiation of anticancer treatments. Until recently, none of the research reported an increased rate of congenital abnormalities or malignancies in children born from treated patients with subsequent spontaneous conceptions [<xref ref-type="bibr" rid="CR52">52</xref>]. In a large retrospective cohort analysis of validated cases of congenital anomalies among 4,699 children of 1,128 male and 1,627 female cancer survivors an anomaly prevalence of 2.7 % has been found in the offspring of cancer survivors, similar to the prevalence in the general population of the US [<xref ref-type="bibr" rid="CR56">56</xref>]. Conceptions from ART treatments were excluded from the study as the use of donor could not be determined [<xref ref-type="bibr" rid="CR56">56</xref>]. For children whose fathers were exposed to radiation or alkylating agents versus neither, the prevalence of anomalies was 1.9 % versus 1.7 % (<italic>p</italic> = 0.79). Testicular radiation dose (mean 0.48 Gray) was not related to the risk of congenital anomalies (odds ratio [OR] = 1.01; 95 % 0.36-2.83 for 0.50+ Gray). Treatment with alkylating agents was not significantly associated with anomalies in the children of male survivors [<xref ref-type="bibr" rid="CR56">56</xref>].</p>
          <p>Conflicting results were demonstrated in a cohort study from Danish and Swedish registries, regarding 8,670 babies with a paternal history of cancer: a total of 8,162 children were conceived naturally and 508 were conceived using ART (i.e. IVF or ICSI) [<xref ref-type="bibr" rid="CR57">57</xref>]. Overall, the offspring of male cancer survivors were more likely to have major congenital abnormalities than those of fathers without cancer (RR = 1.17; 95 % CI 1.05-1.31), with some differences between the different types of cancer. Although not significant, a link between paternal history of cancer and risk of major congenital abnormalities was suggested in children born within 2 years of their father’s cancer diagnosis (RR = 1.27; 95 % CI 0.89-1.80) [<xref ref-type="bibr" rid="CR57">57</xref>]. The association between paternal history of cancer and risk of congenital abnormalities was not modified by the mode of conception, natural conception (RR = 1.17; 95 % CI 1.04-1.31) or ART (RR = 1.22; 95 % CI 0.80-1.87). Out of the 205 children conceived through ART with available information, 137 (55 %) were conceived using fresh post-treatment semen and 68 (27 %) using sperm cryopreserved before treatment initiation. The same prevalence of major congenital abnormalities were observed in children conceived using fresh post-treatment semen (4.4 %) or those born using cryopreserved pre-treatment spermatozoa (4.4 %) [<xref ref-type="bibr" rid="CR57">57</xref>]. Although limited by small numbers, this finding suggests the possibility that the increase in abnormalities could be due to some factors unrelated to anticancer therapies.</p>
          <p>The efficacy of ART in patients treated for cancer seems to be good. In a comparative study of male cancer survivors treated with ICSI using cryopreserved sperm, which were compared to non-cancer infertile males that had previously frozen sperm, the live birth rate using ART was similar in the two groups [<xref ref-type="bibr" rid="CR58">58</xref>].</p>
          <p>To our knowledge, only two studies have been published describing the offspring of patients undergoing ART conceptions with the use of fresh ejaculated or testicular semen after treatment [<xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR60">60</xref>]. Ping and colleagues described the fertility outcome in 117 testicular cancer survivors [<xref ref-type="bibr" rid="CR59">59</xref>]. Out of 21 patients who banked their semen before starting chemotherapy, 19 achieved conception by ART (11 patients used fresh semen and 8 used cryopreserved semen) [<xref ref-type="bibr" rid="CR59">59</xref>]. A total of 37 healthy babies were conceived with no congenital malformations or childhood malignancies [<xref ref-type="bibr" rid="CR59">59</xref>]. Recently, a large US experience reported the successful treatment of post-chemotherapy azoospermia with the use of microsurgical testicular sperm extraction: a total of 73 post-chemotherapy azoospermic patients who underwent ART were included [<xref ref-type="bibr" rid="CR60">60</xref>]. Sperm was retrieved in 37 % of patients; fertilization rate by ICSI (per injected oocyte) was 57.1 %, with a reported clinical pregnancy rate of 50 % and an overall live birth rate of 42 %. A total of 15 deliveries were described, with 5 twin births. The 20 children were healthy with no apparent abnormalities; no details on obstetric outcome were reported [<xref ref-type="bibr" rid="CR60">60</xref>].</p>
          <p>In a recent large population-based study on the outcomes of progeny born after ART in the general population, there was no increase in the overall risk of cancer among British children born after assisted conception during the 17-year study period [<xref ref-type="bibr" rid="CR61">61</xref>]. Increased risks of hepatoblastoma and rhabdomyosarcoma were detected, but the absolute risks were small [<xref ref-type="bibr" rid="CR61">61</xref>].</p>
          <sec id="FPar5">
            <title>Recommendation 5</title>
            <p>Paucity of data is available on fatherhood after cancer. Although most of the published data are reassuring, some recent conflicting results suggest a potential increased risk of birth defects particularly among the children born closer to a paternal cancer diagnosis, and caution should be taken in counseling these patients (V, B for discussion with patients); data on children conceived after ART are too scarce to draw any conclusion although in the general population, available evidence for the outcomes of progeny after ART suggests safety of the techniques themselves (V, B for discussion with patients).</p>
          </sec>
        </sec>
        <sec id="Sec9">
          <title>Is it safe to perform a controlled ovarian stimulation (COS) in female cancer patients?</title>
          <p>Different protocols with different preparations and dosages, are available in standard ART for oocyte or embryo cryopreservation [<xref ref-type="bibr" rid="CR62">62</xref>]. Two safety issues should be considered for COS in cancer patients: a possible delay in cancer treatment initiation (the 2-week duration of standard protocols), and a possible negative impact of ovarian stimulation on the prognosis of patients with hormone-responsive tumors in particular.</p>
          <p>For many diseases, delays of 2 weeks prior to anti-neoplastic therapy are not possible (e.g. acute leukemia). However, even in the setting of adjuvant therapy, concerns arise regarding timing of therapy. In early stage breast cancer, evidence suggests that the earlier adjuvant chemotherapy is administered, in general, the better patients’ outcome is obtained [<xref ref-type="bibr" rid="CR63">63</xref>]. Thus, efforts have been made to limit delays to preserve fertility in such settings. In recent years, random stimulation protocols inducing luteolysis have been adopted to allow to start COS practically anytime during the menstrual cycle without having to wait until the follicular phase [<xref ref-type="bibr" rid="CR64">64</xref>], but even these protocols require at least 2 weeks of treatment, during which time cancer therapy must be delayed. Preliminary experiences with these “random-start protocols” showed promising results in terms of oocyte recovery and maturity rate (Table <xref rid="Tab4" ref-type="table">4</xref>) [<xref ref-type="bibr" rid="CR65">65</xref>–<xref ref-type="bibr" rid="CR73">73</xref>].<table-wrap id="Tab4"><label>Table 4</label><caption><p>Published experiences with “random-start protocols”</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Author</th><th>No. patients</th><th>No. of retrieved oocytes</th><th>No. of cryopreserved oocytes/embryos</th><th>Maturation rate (%)</th><th>Fertilization rate (%)</th></tr></thead><tbody><tr><td>Von Wolff et al. [<xref ref-type="bibr" rid="CR65">65</xref>]</td><td>12</td><td>10.0 ± 5.7</td><td>NR</td><td>80.4</td><td>75.6</td></tr><tr><td>Michaan et al. [<xref ref-type="bibr" rid="CR66">66</xref>]</td><td>22</td><td>8.8 ± 6.0</td><td>5.4 ± 4.5</td><td>NR</td><td>NR</td></tr><tr><td>Bedoschi et al. [<xref ref-type="bibr" rid="CR67">67</xref>]</td><td>2</td><td>12</td><td>7</td><td>70.0</td><td>83.3</td></tr><tr><td>Sonmezer et al. [<xref ref-type="bibr" rid="CR68">68</xref>]</td><td>3</td><td>9 - 17</td><td>7 - 10</td><td>58.8 – 77.7</td><td>69.2 – 87.5</td></tr><tr><td>Maman et al. [<xref ref-type="bibr" rid="CR69">69</xref>]</td><td>5</td><td>12.8 ± 8.4</td><td>6.4 ± 6.6</td><td>48.6 ± 18.3</td><td>69.2 ± 47.4</td></tr><tr><td>Nayak et al. [<xref ref-type="bibr" rid="CR70">70</xref>]</td><td>4</td><td>6 - 30</td><td>5 - 20</td><td>NR</td><td>93.3 – 100</td></tr><tr><td>Cakmak H et al. [<xref ref-type="bibr" rid="CR71">71</xref>]</td><td>35</td><td>9.9 (7.7 – 12.7)</td><td>NR</td><td>67 (59 – 76)</td><td>87 (72–100)</td></tr><tr><td>Buendgen NK et al. [<xref ref-type="bibr" rid="CR72">72</xref>]</td><td>10</td><td>8.8 (SD: 5.1)</td><td>NR</td><td>NR</td><td>63.6 (SD: 32.9)</td></tr><tr><td>Keskin U et al. [<xref ref-type="bibr" rid="CR73">73</xref>]</td><td>3</td><td>4 - 16</td><td>3 - 9</td><td>NR</td><td>75</td></tr></tbody></table><table-wrap-foot><p>
<italic>NR</italic> not reported, <italic>SD</italic> standard deviation</p></table-wrap-foot></table-wrap></p>
          <p>The risk of ovarian hyperstimulation syndrome (OHSS), a severe complication of COS, should be taken into account, particularly in young patients with high ovarian reserve. In these cases, triggering ovulation with LHRHa instead of human chorionic gonadotropin (HCG) has been proven to significantly reduce the occurrence of OHSS, a complication that may also further delay the start of anticancer treatments [<xref ref-type="bibr" rid="CR74">74</xref>].</p>
          <p>The short-term exposure to high estrogen levels due to the COS is an important safety concern in patients with breast cancer. For this reason alternative protocols for ovarian stimulation with the use of tamoxifen [<xref ref-type="bibr" rid="CR75">75</xref>] or letrozole [<xref ref-type="bibr" rid="CR76">76</xref>] have been developed. In these relatively small studies, no negative consequence on the quality of the oocytes and embryos collected has been observed [<xref ref-type="bibr" rid="CR75">75</xref>, <xref ref-type="bibr" rid="CR77">77</xref>] and pregnancy rates have been similar to those expected in a noncancer population undergoing IVF [<xref ref-type="bibr" rid="CR78">78</xref>]. The largest prospective analysis with the use of cryopreservation strategies in breast cancer patients reported the safety of a COS with the use of letrozole in 79 women who were compared with 136 patients not undergoing any fertility-preserving procedures serving as controls [<xref ref-type="bibr" rid="CR79">79</xref>]. After a median follow up of 23.4 months post-chemotherapy, no difference in relapse-free survival was observed among the two groups (HR = 0.56; 95 % CI 0.17-1.9; <italic>P</italic> = 0.36) [<xref ref-type="bibr" rid="CR79">79</xref>]. Recently, updated results of the study, including a larger sample size (338 patients, 120 women undergoing COS and 218 controls) with a longer median follow up (4.9 years), confirmed the safety of the procedure [<xref ref-type="bibr" rid="CR80">80</xref>]. Safety and feasibility of performing two consecutive COS with the use of letrozole to increase the oocyte/embryo yield for fertility preservation has also been reported [<xref ref-type="bibr" rid="CR81">81</xref>]. However, further research in this filed is needed on larger series to confirm these results.</p>
          <p>To avoid the need for COS, cryopreservation of immature oocyte or of oocytes matured in vitro are under clinical development [<xref ref-type="bibr" rid="CR82">82</xref>, <xref ref-type="bibr" rid="CR83">83</xref>]. With these techniques, oocytes are collected without hormonal stimulation or with a short stimulation lasting 3–5 days; the immature oocytes collected can be then cryopreserved after maturation in vitro or cryopreserved at the immature stage and then matured in vitro after thaw before insemination. So far, only one child was born in a cancer patient in whom the immature oocytes were collected prior to gonadotoxic treatment [<xref ref-type="bibr" rid="CR84">84</xref>]. These strategies should be considered still experimental.</p>
          <p>To date, only one study has reported the safety of performing ART following anticancer treatments for breast cancer treatment [<xref ref-type="bibr" rid="CR85">85</xref>]. The authors evaluated the survival outcomes of a cohort of 198 patients who became pregnant after breast cancer diagnosis and treatment of whom 25 women underwent ART resulting in 36 pregnancies [<xref ref-type="bibr" rid="CR85">85</xref>]. A total of 37 ART cycles were performed: 13 oocyte donation, 13 ovarian stimulation for IVF, and 11 ovulation induction. Patients who underwent ART tended to have more favorable characteristics (e.g. higher percentage of estrogen receptor positive disease, low grade tumor and node negative status) [<xref ref-type="bibr" rid="CR85">85</xref>]. At a median follow up of 50 months, no difference in DFS and overall survival has been observed between patients with spontaneous pregnancies and those who underwent ART procedures [<xref ref-type="bibr" rid="CR85">85</xref>]. However, more data are needed to confirm the safety of performing a COS in patients with prior diagnosis and treatment of breast cancer.</p>
          <sec id="FPar6">
            <title>Recommendation 6</title>
            <p>The current limited data suggest the safety of a COS in cancer patients (III, B). “Random-start protocols” can be employed to avoid delays in anticancer treatment initiation (III, B). LHRHa ovulation triggering should be adopted in patients at moderate-high risk for OHSS (I, A). Letrozole (or tamoxifen) should be incorporated in the protocol for COS in cancer patients with hormone-responsive tumors (III, B).</p>
          </sec>
        </sec>
        <sec id="Sec10">
          <title>Which method for cryopreservation of embryos or oocytes should be used and what should we expect from the use of this strategy in female cancer patients?</title>
          <p>Embryo cryopreservation and oocyte cryopreservation are standard strategies for fertility preservation in female cancer patients [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. In countries where embryo freezing is prohibited by law (e.g. Italy), oocyte cryostorage is the only applicable non-experimental technology.</p>
          <p>Two different methods for embryo or oocyte cryopreservation are currently available: slow freezing and vitrification [<xref ref-type="bibr" rid="CR86">86</xref>]. Slow freezing procedure has been the first procedure to be developed: with this method, eggs are gradually frozen with low concentration of cryoprotectant agents, thus minimizing both structural damages and intracellular formation of ice [<xref ref-type="bibr" rid="CR87">87</xref>]. Vitrification uses higher concentrations of cryoprotectants and an ultra-quick cooling is performed to avoid toxicity and to reduce the transitional stage; egg survival and fertilization rates with vitrification are expected to be higher, since the structural damage due to the formation of ice crystals is avoided [<xref ref-type="bibr" rid="CR88">88</xref>]. In a recent Cochrane meta-analysis of two studies, vitrification showed a higher clinical pregnancy rate than slow freezing (RR = 3.86, 95 % CI 1.63-9.11) and better results in terms of oocyte survival rate, fertilization rate and embryo quality [<xref ref-type="bibr" rid="CR89">89</xref>]. However, no information on live birth rates was reported. In experienced laboratories, results with vitrification may be similar to those obtained with fresh eggs but success rates are still highly operator-dependent [<xref ref-type="bibr" rid="CR90">90</xref>]. Irrespective of which method is used, the success rates are best in women under 36 years, although success has been reported up to age 44 with vitrification [<xref ref-type="bibr" rid="CR91">91</xref>].</p>
          <p>In Italy, due to the legal restrictions limiting the use of embryo cryopreservation, an increasing trend toward the use of oocyte freezing has been shown since 2004. Using data from the Italian Registry of ART in the period 2007–2011, Levi Setti and colleagues showed an increasing use of vitrification in infertile couples and by 2010 vitrification became the most applied technique [<xref ref-type="bibr" rid="CR92">92</xref>]. The success of oocyte cryopreservation with slow freezing and vitrification were then retrospectively compared, confirming a statistically significant higher performance of vitrification than slow freezing, although not as high as with fresh cycles [<xref ref-type="bibr" rid="CR92">92</xref>].</p>
          <p>Most of the available data on pregnancies obtained with thawing of embryos or oocytes derive from the infertile non-oncologic population. Pregnancy rate after embryo thawing is strongly dependent on age, ranging from over 40 % in women younger than 35 years to less than 20 % in women over 40 years [<xref ref-type="bibr" rid="CR93">93</xref>]. Similar results in experienced hands have been shown after oocyte cryopreservation [<xref ref-type="bibr" rid="CR94">94</xref>, <xref ref-type="bibr" rid="CR95">95</xref>]. The number of oocytes or embryos stored is another factor that strongly impacts on the outcomes.</p>
          <p>Cancer patients might have a weaker response to COS [<xref ref-type="bibr" rid="CR96">96</xref>]: a retrospective observational study reported a lower number of retrieved oocytes in cancer patients as compared to a historical control group of age-matched women who underwent ART [<xref ref-type="bibr" rid="CR97">97</xref>].</p>
          <p>As a matter of fact, many issues should be considered when analyzing ovarian response to COS in cancer patients, such as the particular protocols used (i.e. “random-start protocols” to avoid the delay in treatment initiation, or the use of tamoxifen or letrozole in patients with hormone sensitive diseases to reduce the risk of the exposure to the high estradiol levels during COS) and/or the presence of a possible underlying reduced ovarian reserve (e.g. patients with BRCA 1–2 mutations or due to concurrent illness) [<xref ref-type="bibr" rid="CR98">98</xref>, <xref ref-type="bibr" rid="CR99">99</xref>].</p>
          <p>To increase the oocyte yield for fertility preservation, it has been proposed to perform two consecutive ovarian stimulation cycles [<xref ref-type="bibr" rid="CR81">81</xref>]. However, this approach is not feasible in many cancer settings due to the delay it would necessitate in starting treatment.</p>
          <p>Very limited data are available on pregnancy rates with thawed oocytes or embryos in cancer patients. To date, a total of 8 deliveries have been reported after oocyte warming in the oncologic population [<xref ref-type="bibr" rid="CR100">100</xref>]. Recently, out of 357 patients who had their oocytes cryopreserved after cancer diagnosis, 11 cancer survivors (8 with breast cancer, 1 with Hodgkin lymphoma, 1 with endometrial adenocarcinoma, and 1 with thyroid cancer) returned for ART [<xref ref-type="bibr" rid="CR101">101</xref>]. In this cohort, a total of 4 pregnancies were achieved and delivered at term after warming vitrified oocytes with no major or minor malformations; the delivery rate per cycle was calculated to be 36.6 % [<xref ref-type="bibr" rid="CR101">101</xref>]. Even more recently, Oktay and colleagues provided the pregnancy and fertility preservation outcomes in a cohort of 131 breast cancer patients who had previously undergone COH with letrozole for embryo cryopreservation [<xref ref-type="bibr" rid="CR78">78</xref>]. A total of 33 women underwent 40 attempts to transfer embryos obtaining 18 pregnancies and 25 live births [<xref ref-type="bibr" rid="CR78">78</xref>]. Pregnancy rates were comparable to those expected in the general noncancer population undergoing IVF [<xref ref-type="bibr" rid="CR78">78</xref>].</p>
          <sec id="FPar7">
            <title>Recommendation 7</title>
            <p>Embryo and oocyte cryopreservation are standard options for fertility preservation (III, B). Vitrification showed a better performance than slow freezing (II, B). During oncofertility counseling, patients should be aware that data on the success of these strategies derive from infertile women in general and that a different ovarian response to stimulation might be expected in cancer patients (IV, B).</p>
          </sec>
        </sec>
        <sec id="Sec11">
          <title>Is there any best candidate for ovarian tissue cryopreservation?</title>
          <p>Ovarian tissue cryopreservation has been proven to be an effective, yet still experimental, technique to preserve fertility in patients undergoing gonadotoxic therapies [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. Following re-implantation of ovarian tissue, a successful recovery of ovarian function is expected in almost all cases within 3 to 6 months, with possible sustained longevity of function of the transplanted tissue [<xref ref-type="bibr" rid="CR102">102</xref>, <xref ref-type="bibr" rid="CR103">103</xref>]. To date, a total of 40 live births have been reported in cancer patients after transplantation of frozen/thawed ovarian tissue [<xref ref-type="bibr" rid="CR104">104</xref>]. It is basically impossible to calculate a precise pregnancy rate for transplantation of cryopreserved ovarian tissue until a large cohort of patients have had all their tissue transplanted [<xref ref-type="bibr" rid="CR105">105</xref>]. Combining 80 cases from 4 fertility centers, the pregnancy rate (i.e. ratio between the number of women who conceived and the number of transplanted women) with the use of this technique was 25 % [<xref ref-type="bibr" rid="CR106">106</xref>–<xref ref-type="bibr" rid="CR109">109</xref>]. Overall, the pregnancy rate with the use of cryopreservation of ovarian tissue seems to be increasing [<xref ref-type="bibr" rid="CR105">105</xref>].</p>
          <p>Although ovarian tissue cryopreservation is still an experimental strategy, it might be proposed to selected patients. In particular, this method is the only available option to preserve fertility in prepubertal girls who are candidates to gonadotoxic therapies [<xref ref-type="bibr" rid="CR40">40</xref>].</p>
          <p>A major advantage of this technique over oocyte or embryo cryopreservation is that only few days are required for its application: tissue retrieval can be performed by laparoscopy, which can be planned shortly after cancer diagnosis, or during a laparotomy if needed for oncologic therapies. This technique can be performed at any time of the menstrual cycle and does not require hormonal stimulation. For these reasons, cryopreservation of ovarian tissue can be proposed to selected patients who cannot delay the initiation of anticancer treatments [<xref ref-type="bibr" rid="CR110">110</xref>].</p>
          <p>Another promising indication of ovarian cortex cryopreservation is the situation in which patients have already received chemotherapy. Mature or immature egg collection is not recommended in patients who have received recent chemotherapy, owing to possible decreased or no response to ovarian stimulation, genetically abnormal oocytes, and deleterious effects on reproductive outcome (i.e. high abortion and malformation rates), as suggested by animal studies [<xref ref-type="bibr" rid="CR111">111</xref>, <xref ref-type="bibr" rid="CR112">112</xref>]. On the contrary, the collection of ovarian tissue may be successfully performed after a few cycles of chemotherapy due to the fact that a substantial number of primordial follicles will still survive and be present in cortical tissue [<xref ref-type="bibr" rid="CR113">113</xref>].</p>
          <p>The success of ovarian tissue cryopreservation is strongly dependent upon the patient’s ovarian reserve. For this reason, patients over 40 years or with reduced ovarian reserve are not good candidates [<xref ref-type="bibr" rid="CR114">114</xref>]. Furthermore, a potential risk of reintroducing malignant cells when the tissue is re-implanted should be considered [<xref ref-type="bibr" rid="CR115">115</xref>–<xref ref-type="bibr" rid="CR117">117</xref>]. Therefore, patients diagnosed with cancer with a high risk of malignant contamination to the ovaries (e.g. aggressive hematologic malignancies) and with no reliable molecular markers for a pre-transplantation examination may be not eligible for ovarian tissue auto-transplantation [<xref ref-type="bibr" rid="CR118">118</xref>]. Finally, it should be specified that the possibility to reduce ovarian reserve with ovarian cortex biopsy has not been well studied to date.</p>
          <sec id="FPar8">
            <title>Recommendation 8</title>
            <p>The best candidates for ovarian tissue cryopreservation are prepubertal girls (III, A). The technique may also be proposed to patients scheduled for treatments with a high risk of premature ovarian insufficiency who cannot delay anticancer treatments or who have already received chemotherapy, or with contraindications to COS (III, B). Patients with cancer with a high risk of malignant contamination to the ovaries (e.g. aggressive hematologic malignancies) should not be considered eligible for ovarian tissue auto-transplantation (V, B).</p>
          </sec>
        </sec>
        <sec id="Sec12">
          <title>Should ovarian cortex tissue banking be performed locally or should it be centralized?</title>
          <p>Embryo and oocyte cryostorage is commonly applied in several fertility units as part of infertility treatments, whereas ovarian cortex cryopreservation is applied only as a technique for fertility preservation in patients at risk of gonadic exhaustion. Moreover, the effective assessment of a program of ovarian tissue cryopreservation requires time: in fact, many years may pass before a sample is thawed and transplanted. Due to the relatively low number of procedures requested and the difficulty in evaluating survival of primordial follicles, the technique of ovarian cortex cryopreservation should be concentrated to few centers with the appropriate expertise [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>].</p>
          <p>Animal experiments showed that the conservation of ovarian tissue at 4 °C for up to 18 hours causes no morphological damage to preantral follicles; on the contrary, the storage of ovarian tissue at 20 °C for 18 hours significantly reduces the percentage of morphologically normal follicles [<xref ref-type="bibr" rid="CR119">119</xref>]. Several reports have demonstrated the feasibility of harvesting the ovarian cortex in one site and then transporting it to another site to be frozen. In specific cooling devices, primordial follicles can survive to transportation for up to 4–6 hours prior to cryopreservation [<xref ref-type="bibr" rid="CR120">120</xref>, <xref ref-type="bibr" rid="CR121">121</xref>]. Pregnancies after ovarian tissue cryostorage following a transportation for more than 20 hours have also been reported [<xref ref-type="bibr" rid="CR122">122</xref>].</p>
          <p>Centers that perform cryopreservation, storage and transplantations of ovarian tissue require a connection with highly specialized laboratories for detecting traces of malignant cells in the sample at both pathologic and molecular levels before the grafting. Optimization of freezing methods and cancer cell detection techniques are other two valid reasons to concentrate the application of an “experimental technique” in a few referral centers. On the other hand it would be preferable to organize the harvesting of the tissue locally to ensure the access to this technique to all the eligible patients. Even though some skills are required to perform an ovarian cortex biopsy suitable for cryopreservation, any gynecological or fertility unit may easily acquire them.</p>
          <sec id="FPar9">
            <title>Recommendation 9</title>
            <p>In order to optimize the procedure in terms of both patient management and cost-effectiveness, the harvesting of the tissue can be performed locally but subsequent sample freezing and storage centralized (III, B). A well-organized network between fertility units is required (III, B).</p>
          </sec>
        </sec>
        <sec id="Sec13">
          <title>Should ovarian suppression with LHRHa be proposed as a reliable strategy to preserve ovarian function and fertility during chemotherapy?</title>
          <p>Ovarian suppression with the use of LHRHa during chemotherapy is an attractive option to preserve gonadal function and fertility given the wide availability of such agents and the advantage of causing no delay in the initiation of anticancer therapies [<xref ref-type="bibr" rid="CR123">123</xref>]. A total of 10 randomized studies in patients with breast cancer [<xref ref-type="bibr" rid="CR124">124</xref>–<xref ref-type="bibr" rid="CR133">133</xref>], 2 in women with lymphoma [<xref ref-type="bibr" rid="CR134">134</xref>, <xref ref-type="bibr" rid="CR135">135</xref>] and 1 in ovarian cancer patients [<xref ref-type="bibr" rid="CR136">136</xref>] have been conducted to evaluate the efficacy of this strategy: overall, these trials reported conflicting results. Heterogeneous target population and differences in the patient populations, chemotherapy regimens used, duration of follow up and study end-points are the major limitations in comparing these studies [<xref ref-type="bibr" rid="CR137">137</xref>]. A total of 12 meta-analyses have attempted to summarize the data from all these trials [<xref ref-type="bibr" rid="CR138">138</xref>–<xref ref-type="bibr" rid="CR149">149</xref>]: the majority of them showed a potential efficacy of the technique in reducing the risk of premature ovarian failure, especially in breast cancer patients.</p>
          <p>However, despite this research effort, ovarian suppression with LHRHa during chemotherapy is still considered an experimental strategy to preserve fertility by some international guidelines due to both the uncertainty regarding the efficacy of this strategy and the absence of data on pregnancies and long-term ovarian function [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>].</p>
          <p>Recently, two large randomized trials evaluating the efficacy of ovarian suppression with LHRHa during chemotherapy in breast cancer patients have reported long-term outcome results [<xref ref-type="bibr" rid="CR133">133</xref>, <xref ref-type="bibr" rid="CR150">150</xref>]. Of note is that in the POEMS-SWOG S0230 trial only patients with endocrine-insensitive disease were enrolled, while the majority of women in the PROMISE-GIM6 study had hormone receptor-positive breast cancer. Both trials reported a statistically significant reduction in the incidence of chemotherapy-induced POF in patients receiving LHRHa, one year after the end of chemotherapy in the PROMISE-GIM6 study (OR = 0.28; <italic>P</italic> &lt; 0.001) [<xref ref-type="bibr" rid="CR127">127</xref>] and two years after the end of chemotherapy in the POEMS-SWOG S0230 trial (OR = 0.30; <italic>P</italic> = 0.04) [<xref ref-type="bibr" rid="CR133">133</xref>]. An increased pregnancy rate was reported by both the POEMS-SWOG S0230 (OR = 2.45; <italic>P</italic> = 0.03) [<xref ref-type="bibr" rid="CR133">133</xref>] and the PROMISE-GIM6 (age-adjusted HR = 2.40; <italic>P</italic> = 0.20) studies [<xref ref-type="bibr" rid="CR150">150</xref>]. Furthermore, an increased probability for menstrual resumption at longer follow-up (age-adjusted HR = 1.48; <italic>P</italic> = 0.006) was shown in the PROMISE-GIM6 study for patients in the LHRHa arm [<xref ref-type="bibr" rid="CR150">150</xref>]. A recent meta-analysis including all the randomized trials conducted in breast cancer patients confirmed the efficacy of temporary ovarian suppression with LHRHa during chemotherapy in reducing the risk of treatment-related premature ovarian failure (OR = 0.36; <italic>P</italic> &lt; 0.001) and increasing the pregnancy rate (OR = 1.83; <italic>P</italic> = 0.041) [<xref ref-type="bibr" rid="CR149">149</xref>].</p>
          <p>Recently, the 2015 St. Gallen International Expert Consensus panel and the National Comprehensive Cancer Network (NCCN) guidelines have been updated to acknowledge the use of LHRHa in preventing chemotherapy-induced ovarian failure of hormone receptor negative breast cancer patients [<xref ref-type="bibr" rid="CR151">151</xref>, <xref ref-type="bibr" rid="CR152">152</xref>]. An individual patient data meta-analysis of randomized studies conducted in breast cancer patients is ongoing with the aim to better elucidate the efficacy of ovarian suppression with LHRHa as a strategy to protect both ovarian function and fertility (PROSPERO registration number: CRD42014015638) [<xref ref-type="bibr" rid="CR153">153</xref>].</p>
          <p>Ovarian suppression with LHRHa during chemotherapy can be used in combination with other preservation techniques including cryopreservation strategies, thus increasing the chance of both fertility and gonadal function preservation after anti-cancer systemic therapies.</p>
          <sec id="FPar10">
            <title>Recommendation 10</title>
            <p>Ovarian suppression with the use of LHRHa during chemotherapy should be considered a reliable strategy to preserve ovarian function and fertility, at least in breast cancer patients, given the availability of new data suggesting both the safety and the efficacy of the procedure have become available (I, A)*.</p>
            <p>(*CYA, HAA, GBLS and WHW disagree with this statement, considering the strategy still experimental).</p>
          </sec>
        </sec>
      </sec>
    </sec>
    <sec id="Sec14" sec-type="conclusion">
      <title>Conclusions</title>
      <p>Over the last several years, thanks to improvements in the prognoses of cancer patients, increasing attention has been given to survivors’ fertility issues. International guidelines on this topic have been recently updated and published [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. However, since then, new data have become available, and several issues in this field remain controversial. On the basis of the discussion during the meeting, the expert panel has drafted a total of 10 recommendations (Table <xref rid="Tab5" ref-type="table">5</xref>).<table-wrap id="Tab5"><label>Table 5</label><caption><p>The 10 recommendations drafted by the expert panel</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Recommendations</th></tr></thead><tbody><tr><td>1) Ovarian stimulating drugs with standard treatment protocols may be administered in subfertile/infertile women without increasing the risk of developing breast cancer (III, B). The long-term use of clomiphene outside the current limited indications (i.e. first-line therapy of WHO Group II anovulatory infertility) should be discouraged because of a possible increase in breast cancer risk (III, B).</td></tr><tr><td>2) Pregnancy in cancer survivors, after adequate treatment and follow up, should not be discouraged, including among patients with endocrine-sensitive breast cancer (III, A).</td></tr><tr><td>3) All patients with potential interest in keeping their fertility should be referred to fertility unit for adequate determination of risk of infertility, chances of future conception and how to proactively preserve it (V, A). However, some cancer patients will not require the help of a fertility clinic after cancer treatment (V, B). Since several patient- and treatment-related factors are associated with the risk of developing infertility, the oncofertility counseling should be tailored to the individual patient (V, A).</td></tr><tr><td>4) In men, sperm cryopreservation is an easily accessible and widely available option in more than 95 % of patients and should be encouraged for those who want to preserve fertility (III, A). On the contrary, from 2 % to 65 % of women undergo one of the available cryopreservation options: oncologists should discuss with them the fertility issues and secure proper counseling in appropriate centers prior to cancer treatment (IV, A).</td></tr><tr><td>5) Paucity of data is available on fatherhood after cancer. Although most of the published data are reassuring, some recent conflicting results suggest a potential increased risk of birth defects particularly among the children born closer to a paternal cancer diagnosis, and caution should be taken in counseling these patients (V, B for discussion with patients); data on children conceived after ART are too scarce to draw any conclusion although in the general population, available evidence for the outcomes of progeny after ART suggests safety of the techniques themselves (V, B for discussion with patients).</td></tr><tr><td>6) The current limited data suggest the safety of a COS in cancer patients (III, B). “Random-start protocols” can be employed to avoid delays in anticancer treatment initiation (III, B). LHRHa ovulation triggering should be adopted in patients at moderate-high risk for OHSS (I, A). Letrozole (or tamoxifen) should be incorporated in the protocol for COS in cancer patients with hormone-responsive tumors (III, B).</td></tr><tr><td>7) Embryo and oocyte cryopreservation are standard options for fertility preservation (III, B). Vitrification showed a better performance than slow freezing (II, B). During oncofertility counseling, patients should be aware that data on the success of these strategies derive from infertile women in general and that a different ovarian response to stimulation might be expected in cancer patients (IV, B).</td></tr><tr><td>8) The best candidates for ovarian tissue cryopreservation are prepubertal girls (III, A). The technique may also be proposed to patients scheduled for treatments with a high risk of premature ovarian insufficiency who cannot delay anticancer treatments or who have already received chemotherapy, or with contraindications to COS (III, B). Patients with cancer with a high risk of malignant contamination to the ovaries (e.g. aggressive hematologic malignancies) should not be considered eligible for ovarian tissue auto-transplantation (V, B).</td></tr><tr><td>9) In order to optimize the procedure in terms of both patient management and cost-effectiveness, the harvesting of the tissue can be performed locally but subsequent sample freezing and storage centralized (III, B). A well-organized network between fertility units is required (III, B).</td></tr><tr><td>10) Ovarian suppression with the use of LHRHa during chemotherapy should be considered a reliable strategy to preserve ovarian function and fertility, at least in breast cancer patients, given the availability of new data suggesting both the safety and the efficacy of the procedure have become available (I, A)*.<break/>(*CYA, HAA, GBLS and WHW disagree with this statement, considering the strategy still experimental).</td></tr></tbody></table></table-wrap></p>
      <p>Although there is a great interest in this field, due to the lack of large prospective cohort studies and randomized studies on these topics, the level of evidence is not higher than 3 for most of the recommendations highlighting the need of further research efforts. Several registries and prospective studies are ongoing to evaluate feasibility, safety and efficacy of fertility preserving strategies in cancer patients and encouraging patient participation in these studies is crucial to acquire more robust conclusions.</p>
    </sec>
  </body>
  <back>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>ASCO</term>
          <def>
            <p>American Society of Clinical Oncology</p>
          </def>
        </def-item>
        <def-item>
          <term>ESMO</term>
          <def>
            <p>European Society for Medical Oncology</p>
          </def>
        </def-item>
        <def-item>
          <term>US</term>
          <def>
            <p>United States</p>
          </def>
        </def-item>
        <def-item>
          <term>RR</term>
          <def>
            <p>relative risk</p>
          </def>
        </def-item>
        <def-item>
          <term>CI</term>
          <def>
            <p>confidence intervals</p>
          </def>
        </def-item>
        <def-item>
          <term>HRT</term>
          <def>
            <p>hormone-replacement therapy</p>
          </def>
        </def-item>
        <def-item>
          <term>SRR</term>
          <def>
            <p>summary relative risk</p>
          </def>
        </def-item>
        <def-item>
          <term>IVF</term>
          <def>
            <p>in vitro fertilization</p>
          </def>
        </def-item>
        <def-item>
          <term>HR</term>
          <def>
            <p>hazard ratio</p>
          </def>
        </def-item>
        <def-item>
          <term>PRR</term>
          <def>
            <p>pooled relative risk</p>
          </def>
        </def-item>
        <def-item>
          <term>DFS</term>
          <def>
            <p>disease-free survival</p>
          </def>
        </def-item>
        <def-item>
          <term>ABVD</term>
          <def>
            <p>doxorubicin/bleomycin/vinblastine/dacarbazine</p>
          </def>
        </def-item>
        <def-item>
          <term>LHRHa</term>
          <def>
            <p>luteinizing hormone-releasing hormone analogs</p>
          </def>
        </def-item>
        <def-item>
          <term>ART</term>
          <def>
            <p>assisted reproduction technologies</p>
          </def>
        </def-item>
        <def-item>
          <term>ICSI</term>
          <def>
            <p>intracytoplasmatic sperm injection</p>
          </def>
        </def-item>
        <def-item>
          <term>OR</term>
          <def>
            <p>odds ratio</p>
          </def>
        </def-item>
        <def-item>
          <term>COS</term>
          <def>
            <p>controlled ovarian stimulation</p>
          </def>
        </def-item>
        <def-item>
          <term>OHSS</term>
          <def>
            <p>ovarian hyperstimulation syndrome</p>
          </def>
        </def-item>
        <def-item>
          <term>HCG</term>
          <def>
            <p>human chorionic gonadotropin</p>
          </def>
        </def-item>
        <def-item>
          <term>NCCN</term>
          <def>
            <p>National Comprehensive Cancer Network</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The authors have declared that they have no competing interests.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors’ contributions</bold>
        </p>
        <p>ML, LDM, MCP and PA were involved in the organization of the workshop on “cancer and fertility preservation” and conceived of the idea to draft the manuscript. ML, LDM and PA drafted and led on the writing of the manuscript. All the other authors revised the manuscript critically for important intellectual content and re-drafted some of its section. The recommendations were discussed and revised by all the authors before their final version. All the authors have read and approved the final version of the manuscript, and agreed to be accountable for all aspects of the work to ensure its accuracy and integrity.</p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgements</title>
      <p>This work was partially supported by a grant from the Associazione Italiana per la Ricerca sul Cancro (AIRC; investigator grant number: 2013–14272) and by a grant from the Italian Ministry of Health (Centro Nazionale per la Prevenzione e il Controllo delle Malattie, CCM project, approved by D.M. 05/03/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>American Cancer Society</collab>
          </person-group>
          <source>Cancer Facts &amp; Figures 2015</source>
          <year>2015</year>
          <publisher-loc>Atlanta</publisher-loc>
          <publisher-name>American Cancer Society</publisher-name>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Johnson</surname>
              <given-names>J-A</given-names>
            </name>
            <name>
              <surname>Tough</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Society of Obstetricians and Gynaecologists of Canada, Delayed child-bearing</article-title>
          <source>J Obstet Gynaecol Can</source>
          <year>2012</year>
          <volume>34</volume>
          <issue>1</issue>
          <fpage>80</fpage>
          <lpage>93</lpage>
          <?supplied-pmid 22260768?>
          <pub-id pub-id-type="pmid">22260768</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rosen</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Rodriguez-Wallberg</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Rosenzweig</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Psychosocial distress in young cancer survivors</article-title>
          <source>Semin Oncol Nurs</source>
          <year>2009</year>
          <volume>25</volume>
          <issue>4</issue>
          <fpage>268</fpage>
          <lpage>277</lpage>
          <?supplied-pmid 19879433?>
          <pub-id pub-id-type="pmid">19879433</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Canada</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Schover</surname>
              <given-names>LR</given-names>
            </name>
          </person-group>
          <article-title>The psychosocial impact of interrupted childbearing in long-term female cancer survivors</article-title>
          <source>Psychooncology</source>
          <year>2012</year>
          <volume>21</volume>
          <issue>2</issue>
          <fpage>134</fpage>
          <lpage>143</lpage>
          <?supplied-pmid 22271533?>
          <pub-id pub-id-type="pmid">22271533</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gorman</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Bailey</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Pierce</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Su</surname>
              <given-names>HI</given-names>
            </name>
          </person-group>
          <article-title>How do you feel about fertility and parenthood? The voices of young female cancer survivors</article-title>
          <source>J Cancer Surviv Res Pract</source>
          <year>2012</year>
          <volume>6</volume>
          <issue>2</issue>
          <fpage>200</fpage>
          <lpage>209</lpage>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Partridge</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Gelber</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Peppercorn</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Sampson</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Knudsen</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Laufer</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Web-based survey of fertility issues in young women with breast cancer</article-title>
          <source>J Clin Oncol</source>
          <year>2004</year>
          <volume>22</volume>
          <issue>20</issue>
          <fpage>4174</fpage>
          <lpage>4183</lpage>
          <?supplied-pmid 15483028?>
          <pub-id pub-id-type="pmid">15483028</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ruddy</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Gelber</surname>
              <given-names>SI</given-names>
            </name>
            <name>
              <surname>Tamimi</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Ginsburg</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Schapira</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Come</surname>
              <given-names>SE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Prospective study of fertility concerns and preservation strategies in young women with breast cancer</article-title>
          <source>J Clin Oncol</source>
          <year>2014</year>
          <volume>32</volume>
          <issue>11</issue>
          <fpage>1151</fpage>
          <lpage>1156</lpage>
          <?supplied-pmid 24567428?>
          <pub-id pub-id-type="pmid">24567428</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Senkus</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Gomez</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Dirix</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Jerusalem</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Murray</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Van Tienhoven</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Attitudes of young patients with breast cancer toward fertility loss related to adjuvant systemic therapies. EORTC study 10002 BIG 3–98</article-title>
          <source>Psychooncology</source>
          <year>2014</year>
          <volume>23</volume>
          <issue>2</issue>
          <fpage>173</fpage>
          <lpage>182</lpage>
          <?supplied-pmid 24038775?>
          <pub-id pub-id-type="pmid">24038775</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Schover</surname>
              <given-names>LR</given-names>
            </name>
            <name>
              <surname>Partridge</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Patrizio</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Wallace</surname>
              <given-names>WH</given-names>
            </name>
            <name>
              <surname>Hagerty</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>American Society of Clinical Oncology recommendations on fertility preservation in cancer patients</article-title>
          <source>J Clin Oncol</source>
          <year>2006</year>
          <volume>24</volume>
          <issue>18</issue>
          <fpage>2917</fpage>
          <lpage>2931</lpage>
          <?supplied-pmid 16651642?>
          <pub-id pub-id-type="pmid">16651642</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Loren</surname>
              <given-names>AW</given-names>
            </name>
            <name>
              <surname>Mangu</surname>
              <given-names>PB</given-names>
            </name>
            <name>
              <surname>Beck</surname>
              <given-names>LN</given-names>
            </name>
            <name>
              <surname>Brennan</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Magdalinski</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Partridge</surname>
              <given-names>AH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Fertility Preservation for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update</article-title>
          <source>J Clin Oncol</source>
          <year>2013</year>
          <volume>31</volume>
          <issue>19</issue>
          <fpage>2500</fpage>
          <lpage>2510</lpage>
          <?supplied-pmid 23715580?>
          <pub-id pub-id-type="pmid">23715580</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Peccatori</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>Azim</surname>
              <given-names>HA</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Orecchia</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Hoekstra</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Pavlidis</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kesic</surname>
              <given-names>V</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up</article-title>
          <source>Ann Oncol</source>
          <year>2013</year>
          <volume>24</volume>
          <issue>Suppl 6</issue>
          <fpage>vi160</fpage>
          <lpage>vi170</lpage>
          <?supplied-pmid 23813932?>
          <pub-id pub-id-type="pmid">23813932</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Key</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Appleby</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Barnes</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Reeves</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Endogenous Hormones and Breast Cancer Collaborative Group. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies</article-title>
          <source>J Natl Cancer Inst</source>
          <year>2002</year>
          <volume>94</volume>
          <issue>8</issue>
          <fpage>606</fpage>
          <lpage>616</lpage>
          <?supplied-pmid 11959894?>
          <pub-id pub-id-type="pmid">11959894</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eliassen</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Missmer</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Tworoger</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Spiegelman</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Barbieri</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Dowsett</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women</article-title>
          <source>J Natl Cancer Inst</source>
          <year>2006</year>
          <volume>98</volume>
          <issue>19</issue>
          <fpage>1406</fpage>
          <lpage>1415</lpage>
          <?supplied-pmid 17018787?>
          <pub-id pub-id-type="pmid">17018787</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fortner</surname>
              <given-names>RT</given-names>
            </name>
            <name>
              <surname>Eliassen</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Spiegelman</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Willett</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>Barbieri</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Hankinson</surname>
              <given-names>SE</given-names>
            </name>
          </person-group>
          <article-title>Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses’ Health Study II</article-title>
          <source>Breast Cancer Res</source>
          <year>2013</year>
          <volume>15</volume>
          <issue>2</issue>
          <fpage>R19</fpage>
          <?supplied-pmid 23497468?>
          <pub-id pub-id-type="pmid">23497468</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <mixed-citation publication-type="other">Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet. 1997;350(9084):1047–59.</mixed-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Calderon-Margalit</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Friedlander</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Yanetz</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kleinhaus</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Perrin</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Manor</surname>
              <given-names>O</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cancer risk after exposure to treatments for ovulation induction</article-title>
          <source>Am J Epidemiol</source>
          <year>2009</year>
          <volume>169</volume>
          <issue>3</issue>
          <fpage>365</fpage>
          <lpage>375</lpage>
          <?supplied-pmid 19037008?>
          <pub-id pub-id-type="pmid">19037008</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Källén</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Finnström</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Lindam</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nilsson</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Nygren</surname>
              <given-names>K-G</given-names>
            </name>
            <name>
              <surname>Olausson</surname>
              <given-names>PO</given-names>
            </name>
          </person-group>
          <article-title>Malignancies among women who gave birth after in vitro fertilization</article-title>
          <source>Hum Reprod</source>
          <year>2011</year>
          <volume>26</volume>
          <issue>1</issue>
          <fpage>253</fpage>
          <lpage>258</lpage>
          <?supplied-pmid 21088017?>
          <pub-id pub-id-type="pmid">21088017</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gennari</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Costa</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Puntoni</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Paleari</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>De Censi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sormani</surname>
              <given-names>MP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Breast cancer incidence after hormonal treatments for infertility: systematic review and meta-analysis of population-based studies</article-title>
          <source>Breast Cancer Res Treat</source>
          <year>2015</year>
          <volume>150</volume>
          <issue>2</issue>
          <fpage>405</fpage>
          <lpage>413</lpage>
          <?supplied-pmid 25744295?>
          <pub-id pub-id-type="pmid">25744295</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brinton</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Scoccia</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Moghissi</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Westhoff</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Niwa</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ruggieri</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Long-term relationship of ovulation-stimulating drugs to breast cancer risk</article-title>
          <source>Cancer Epidemiol Biomark Prev</source>
          <year>2014</year>
          <volume>23</volume>
          <issue>4</issue>
          <fpage>584</fpage>
          <lpage>593</lpage>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Letourneau</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Ebbel</surname>
              <given-names>EE</given-names>
            </name>
            <name>
              <surname>Katz</surname>
              <given-names>PP</given-names>
            </name>
            <name>
              <surname>Katz</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ai</surname>
              <given-names>WZ</given-names>
            </name>
            <name>
              <surname>Chien</surname>
              <given-names>AJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer</article-title>
          <source>Cancer</source>
          <year>2012</year>
          <volume>118</volume>
          <issue>6</issue>
          <fpage>1710</fpage>
          <lpage>1717</lpage>
          <?supplied-pmid 21887678?>
          <pub-id pub-id-type="pmid">21887678</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stensheim</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Cvancarova</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Møller</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Fosså</surname>
              <given-names>SD</given-names>
            </name>
          </person-group>
          <article-title>Pregnancy after adolescent and adult cancer: a population-based matched cohort study</article-title>
          <source>Int J Cancer J Int Cancer</source>
          <year>2011</year>
          <volume>129</volume>
          <issue>5</issue>
          <fpage>1225</fpage>
          <lpage>1236</lpage>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Azim</surname>
              <given-names>HA</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Santoro</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Pavlidis</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Gelber</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kroman</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Azim</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Safety of pregnancy following breast cancer diagnosis: a meta-analysis of 14 studies</article-title>
          <source>Eur J Cancer</source>
          <year>2011</year>
          <volume>47</volume>
          <issue>1</issue>
          <fpage>74</fpage>
          <lpage>83</lpage>
          <?supplied-pmid 20943370?>
          <pub-id pub-id-type="pmid">20943370</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Azim</surname>
              <given-names>HA</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Kroman</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Paesmans</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gelber</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Rotmensz</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Ameye</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Prognostic impact of pregnancy after breast cancer according to estrogen receptor status: a multicenter retrospective study</article-title>
          <source>J Clin Oncol</source>
          <year>2013</year>
          <volume>31</volume>
          <issue>1</issue>
          <fpage>73</fpage>
          <lpage>79</lpage>
          <?supplied-pmid 23169515?>
          <pub-id pub-id-type="pmid">23169515</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sutton</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Buzdar</surname>
              <given-names>AU</given-names>
            </name>
            <name>
              <surname>Hortobagyi</surname>
              <given-names>GN</given-names>
            </name>
          </person-group>
          <article-title>Pregnancy and offspring after adjuvant chemotherapy in breast cancer patients</article-title>
          <source>Cancer</source>
          <year>1990</year>
          <volume>65</volume>
          <issue>4</issue>
          <fpage>847</fpage>
          <lpage>850</lpage>
          <?supplied-pmid 2297653?>
          <pub-id pub-id-type="pmid">2297653</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dalberg</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Eriksson</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Holmberg</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Birth outcome in women with previously treated breast cancer--a population-based cohort study from Sweden</article-title>
          <source>PLoS Med</source>
          <year>2006</year>
          <volume>3</volume>
          <issue>9</issue>
          <fpage>e336</fpage>
          <?supplied-pmid 16968117?>
          <pub-id pub-id-type="pmid">16968117</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Langagergaard</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Gislum</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Skriver</surname>
              <given-names>MV</given-names>
            </name>
            <name>
              <surname>Nørgård</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Lash</surname>
              <given-names>TL</given-names>
            </name>
            <name>
              <surname>Rothman</surname>
              <given-names>KJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Birth outcome in women with breast cancer</article-title>
          <source>Br J Cancer</source>
          <year>2006</year>
          <volume>94</volume>
          <issue>1</issue>
          <fpage>142</fpage>
          <lpage>146</lpage>
          <?supplied-pmid 16306874?>
          <pub-id pub-id-type="pmid">16306874</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Azim</surname>
              <given-names>HA</given-names>
            </name>
            <name>
              <surname>Metzger-Filho</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>de Azambuja</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Loibl</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Focant</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Gresko</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Pregnancy occurring during or following adjuvant trastuzumab in patients enrolled in the HERA trial (BIG 01–01)</article-title>
          <source>Breast Cancer Res Treat</source>
          <year>2012</year>
          <volume>133</volume>
          <issue>1</issue>
          <fpage>387</fpage>
          <lpage>391</lpage>
          <?supplied-pmid 22367645?>
          <pub-id pub-id-type="pmid">22367645</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>De Sanctis</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Filippone</surname>
              <given-names>FR</given-names>
            </name>
            <name>
              <surname>Alfò</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Muni</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Cavalieri</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Pulsoni</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Impact of different treatment approaches on pregnancy outcomes in 99 women treated for Hodgkin lymphoma</article-title>
          <source>Int J Radiat Oncol Biol Phys</source>
          <year>2012</year>
          <volume>84</volume>
          <issue>3</issue>
          <fpage>755</fpage>
          <lpage>761</lpage>
          <?supplied-pmid 22414282?>
          <pub-id pub-id-type="pmid">22414282</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Winther</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Olsen</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Shyr</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Mulvihill</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Stovall</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Genetic disease in the children of Danish survivors of childhood and adolescent cancer</article-title>
          <source>J Clin Oncol</source>
          <year>2012</year>
          <volume>30</volume>
          <issue>1</issue>
          <fpage>27</fpage>
          <lpage>33</lpage>
          <?supplied-pmid 22124106?>
          <pub-id pub-id-type="pmid">22124106</pub-id>
        </element-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ives</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Saunders</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Bulsara</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Semmens</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Pregnancy after breast cancer: population based study</article-title>
          <source>BMJ</source>
          <year>2007</year>
          <volume>334</volume>
          <issue>7586</issue>
          <fpage>194</fpage>
          <?supplied-pmid 17158581?>
          <pub-id pub-id-type="pmid">17158581</pub-id>
        </element-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lawrenz</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Henes</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Neunhoeffer</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Fehm</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Huebner</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kanz</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Pregnancy after successful cancer treatment: what needs to be considered?</article-title>
          <source>Onkologie</source>
          <year>2012</year>
          <volume>35</volume>
          <issue>3</issue>
          <fpage>128</fpage>
          <lpage>132</lpage>
          <?supplied-pmid 22414979?>
          <pub-id pub-id-type="pmid">22414979</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Critchley</surname>
              <given-names>HOD</given-names>
            </name>
            <name>
              <surname>Wallace</surname>
              <given-names>WHB</given-names>
            </name>
          </person-group>
          <article-title>Impact of cancer treatment on uterine function</article-title>
          <source>J Natl Cancer Inst Monogr</source>
          <year>2005</year>
          <volume>34</volume>
          <fpage>64</fpage>
          <lpage>68</lpage>
          <?supplied-pmid 15784827?>
          <pub-id pub-id-type="pmid">15784827</pub-id>
        </element-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wallace</surname>
              <given-names>WHB</given-names>
            </name>
            <name>
              <surname>Thompson</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Guideline Development Group, Long term follow-up of survivors of childhood cancer: summary of updated SIGN guidance</article-title>
          <source>BMJ</source>
          <year>2013</year>
          <volume>346</volume>
          <fpage>f1190</fpage>
          <?supplied-pmid 23535255?>
          <pub-id pub-id-type="pmid">23535255</pub-id>
        </element-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pagani</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Ruggeri</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Manunta</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Saunders</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Peccatori</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Cardoso</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Pregnancy after breast cancer: Are young patients willing to participate in clinical studies?</article-title>
          <source>Breast</source>
          <year>2015</year>
          <volume>24</volume>
          <issue>3</issue>
          <fpage>201</fpage>
          <lpage>207</lpage>
          <?supplied-pmid 25662412?>
          <pub-id pub-id-type="pmid">25662412</pub-id>
        </element-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wallace</surname>
              <given-names>WHB</given-names>
            </name>
            <name>
              <surname>Thomson</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Kelsey</surname>
              <given-names>TW</given-names>
            </name>
          </person-group>
          <article-title>The radiosensitivity of the human oocyte</article-title>
          <source>Hum Reprod</source>
          <year>2003</year>
          <volume>18</volume>
          <issue>1</issue>
          <fpage>117</fpage>
          <lpage>121</lpage>
          <?supplied-pmid 12525451?>
          <pub-id pub-id-type="pmid">12525451</pub-id>
        </element-citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wallace</surname>
              <given-names>WHB</given-names>
            </name>
            <name>
              <surname>Thomson</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Saran</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Kelsey</surname>
              <given-names>TW</given-names>
            </name>
          </person-group>
          <article-title>Predicting age of ovarian failure after radiation to a field that includes the ovaries</article-title>
          <source>Int J Radiat Oncol Biol Phys</source>
          <year>2005</year>
          <volume>62</volume>
          <issue>3</issue>
          <fpage>738</fpage>
          <lpage>744</lpage>
          <?supplied-pmid 15936554?>
          <pub-id pub-id-type="pmid">15936554</pub-id>
        </element-citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kalich-Philosoph</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Roness</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Carmely</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Fishel-Bartal</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ligumsky</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Paglin</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cyclophosphamide triggers follicle activation and “burnout”; AS101 prevents follicle loss and preserves fertility</article-title>
          <source>Sci Transl Med</source>
          <year>2013</year>
          <volume>5</volume>
          <issue>185</issue>
          <fpage>185ra62</fpage>
          <?supplied-pmid 23677591?>
          <pub-id pub-id-type="pmid">23677591</pub-id>
        </element-citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Anderson</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Mitchell</surname>
              <given-names>RT</given-names>
            </name>
            <name>
              <surname>Kelsey</surname>
              <given-names>TW</given-names>
            </name>
            <name>
              <surname>Spears</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Telfer</surname>
              <given-names>EE</given-names>
            </name>
            <name>
              <surname>Wallace</surname>
              <given-names>WHB</given-names>
            </name>
          </person-group>
          <article-title>Cancer treatment and gonadal function: experimental and established strategies for fertility preservation in children and young adults</article-title>
          <source>Lancet Diabetes Endocrinol</source>
          <year>2015</year>
          <volume>3</volume>
          <issue>7</issue>
          <fpage>556</fpage>
          <lpage>567</lpage>
          <?supplied-pmid 25873571?>
          <pub-id pub-id-type="pmid">25873571</pub-id>
        </element-citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wallace</surname>
              <given-names>WHB</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Irvine</surname>
              <given-names>DS</given-names>
            </name>
          </person-group>
          <article-title>Fertility preservation for young patients with cancer: who is at risk and what can be offered?</article-title>
          <source>Lancet Oncol</source>
          <year>2005</year>
          <volume>6</volume>
          <issue>4</issue>
          <fpage>209</fpage>
          <lpage>218</lpage>
          <?supplied-pmid 15811616?>
          <pub-id pub-id-type="pmid">15811616</pub-id>
        </element-citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wallace</surname>
              <given-names>WHB</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Kelsey</surname>
              <given-names>TW</given-names>
            </name>
            <name>
              <surname>Edgar</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Fertility preservation for girls and young women with cancer: population-based validation of criteria for ovarian tissue cryopreservation</article-title>
          <source>Lancet Oncol</source>
          <year>2014</year>
          <volume>15</volume>
          <issue>10</issue>
          <fpage>1129</fpage>
          <lpage>1136</lpage>
          <?supplied-pmid 25130994?>
          <pub-id pub-id-type="pmid">25130994</pub-id>
        </element-citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abusief</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Missmer</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Ginsburg</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Weeks</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Partridge</surname>
              <given-names>AH</given-names>
            </name>
          </person-group>
          <article-title>Relationship between reproductive history, anthropometrics, lifestyle factors, and the likelihood of persistent chemotherapy-related amenorrhea in women with premenopausal breast cancer</article-title>
          <source>Fertil Steril</source>
          <year>2012</year>
          <volume>97</volume>
          <issue>1</issue>
          <fpage>154</fpage>
          <lpage>159</lpage>
          <?supplied-pmid 22192139?>
          <pub-id pub-id-type="pmid">22192139</pub-id>
        </element-citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lavery</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Tsiligiannis</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Carby</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Reproductive options for female cancer patients: balancing hope and realistic expectation</article-title>
          <source>Curr Opin Oncol</source>
          <year>2014</year>
          <volume>26</volume>
          <issue>5</issue>
          <fpage>501</fpage>
          <lpage>507</lpage>
          <?supplied-pmid 25046204?>
          <pub-id pub-id-type="pmid">25046204</pub-id>
        </element-citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Van der Kaaij</surname>
              <given-names>MAE</given-names>
            </name>
            <name>
              <surname>Heutte</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Meijnders</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Abeilard-Lemoisson</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Spina</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Moser</surname>
              <given-names>EC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Premature ovarian failure and fertility in long-term survivors of Hodgkin’s lymphoma: a European Organisation for Research and Treatment of Cancer Lymphoma Group and Groupe d’Etude des Lymphomes de l’Adulte Cohort Study</article-title>
          <source>J Clin Oncol</source>
          <year>2012</year>
          <volume>30</volume>
          <issue>3</issue>
          <fpage>291</fpage>
          <lpage>299</lpage>
          <?supplied-pmid 22184372?>
          <pub-id pub-id-type="pmid">22184372</pub-id>
        </element-citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Behringer</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Mueller</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Goergen</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Thielen</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Eibl</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Stumpf</surname>
              <given-names>V</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Gonadal function and fertility in survivors after Hodgkin lymphoma treatment within the German Hodgkin Study Group HD13 to HD15 trials</article-title>
          <source>J Clin Oncol</source>
          <year>2013</year>
          <volume>31</volume>
          <issue>2</issue>
          <fpage>231</fpage>
          <lpage>239</lpage>
          <?supplied-pmid 23150709?>
          <pub-id pub-id-type="pmid">23150709</pub-id>
        </element-citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Williams</surname>
              <given-names>DH</given-names>
            </name>
          </person-group>
          <article-title>Sperm banking and the cancer patient</article-title>
          <source>Ther Adv Urol</source>
          <year>2010</year>
          <volume>2</volume>
          <issue>1</issue>
          <fpage>19</fpage>
          <lpage>34</lpage>
          <?supplied-pmid 21789080?>
          <pub-id pub-id-type="pmid">21789080</pub-id>
        </element-citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lawrenz</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Jauckus</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kupka</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Strowitzki</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>von Wolff</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Fertility preservation in &gt;1,000 patients: patient’s characteristics, spectrum, efficacy and risks of applied preservation techniques</article-title>
          <source>Arch Gynecol Obstet</source>
          <year>2011</year>
          <volume>283</volume>
          <issue>3</issue>
          <fpage>651</fpage>
          <lpage>656</lpage>
          <?supplied-pmid 21120512?>
          <pub-id pub-id-type="pmid">21120512</pub-id>
        </element-citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Armuand</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Rodriguez-Wallberg</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Wettergren</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Ahlgren</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Enblad</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Höglund</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Sex differences in fertility-related information received by young adult cancer survivors</article-title>
          <source>J Clin Oncol</source>
          <year>2012</year>
          <volume>30</volume>
          <issue>17</issue>
          <fpage>2147</fpage>
          <lpage>2153</lpage>
          <?supplied-pmid 22585695?>
          <pub-id pub-id-type="pmid">22585695</pub-id>
        </element-citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Duffy</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Allen</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Clark</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Discussions regarding reproductive health for young women with breast cancer undergoing chemotherapy</article-title>
          <source>J Clin Oncol</source>
          <year>2005</year>
          <volume>23</volume>
          <issue>4</issue>
          <fpage>766</fpage>
          <lpage>773</lpage>
          <?supplied-pmid 15681520?>
          <pub-id pub-id-type="pmid">15681520</pub-id>
        </element-citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hohmann</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Borgmann-Staudt</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Rendtorff</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Reinmuth</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Holzhausen</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Willich</surname>
              <given-names>SN</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Patient counselling on the risk of infertility and its impact on childhood cancer survivors: results from a national survey</article-title>
          <source>J Psychosoc Oncol</source>
          <year>2011</year>
          <volume>29</volume>
          <issue>3</issue>
          <fpage>274</fpage>
          <lpage>285</lpage>
          <?supplied-pmid 21590573?>
          <pub-id pub-id-type="pmid">21590573</pub-id>
        </element-citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Quinn</surname>
              <given-names>GP</given-names>
            </name>
            <name>
              <surname>Vadaparampil</surname>
              <given-names>ST</given-names>
            </name>
            <name>
              <surname>Gwede</surname>
              <given-names>CK</given-names>
            </name>
            <name>
              <surname>Miree</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>King</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Clayton</surname>
              <given-names>HB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Discussion of fertility preservation with newly diagnosed patients: oncologists’ views</article-title>
          <source>J Cancer Surviv Res Pract</source>
          <year>2007</year>
          <volume>1</volume>
          <issue>2</issue>
          <fpage>146</fpage>
          <lpage>155</lpage>
        </element-citation>
      </ref>
      <ref id="CR51">
        <label>51.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Köhler</surname>
              <given-names>TS</given-names>
            </name>
            <name>
              <surname>Kondapalli</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Woodruff</surname>
              <given-names>TK</given-names>
            </name>
            <name>
              <surname>Brannigan</surname>
              <given-names>RE</given-names>
            </name>
          </person-group>
          <article-title>Results from the survey for preservation of adolescent reproduction (SPARE) study: gender disparity in delivery of fertility preservation message to adolescents with cancer</article-title>
          <source>J Assist Reprod Genet</source>
          <year>2011</year>
          <volume>28</volume>
          <issue>3</issue>
          <fpage>269</fpage>
          <lpage>277</lpage>
          <?supplied-pmid 21110080?>
          <pub-id pub-id-type="pmid">21110080</pub-id>
        </element-citation>
      </ref>
      <ref id="CR52">
        <label>52.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dohle</surname>
              <given-names>GR</given-names>
            </name>
          </person-group>
          <article-title>Male infertility in cancer patients: Review of the literature</article-title>
          <source>Int J Urol</source>
          <year>2010</year>
          <volume>17</volume>
          <issue>4</issue>
          <fpage>327</fpage>
          <lpage>331</lpage>
          <?supplied-pmid 20202000?>
          <pub-id pub-id-type="pmid">20202000</pub-id>
        </element-citation>
      </ref>
      <ref id="CR53">
        <label>53.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chung</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Irani</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Knee</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Efymow</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Blasco</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Patrizio</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Sperm cryopreservation for male patients with cancer: an epidemiological analysis at the University of Pennsylvania</article-title>
          <source>Eur J Obstet Gynecol Reprod Biol</source>
          <year>2004</year>
          <volume>113</volume>
          <issue>Suppl 1</issue>
          <fpage>S7</fpage>
          <lpage>S11</lpage>
          <?supplied-pmid 15041122?>
          <pub-id pub-id-type="pmid">15041122</pub-id>
        </element-citation>
      </ref>
      <ref id="CR54">
        <label>54.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Agarwal</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Allamaneni</surname>
              <given-names>SSR</given-names>
            </name>
          </person-group>
          <article-title>Disruption of spermatogenesis by the cancer disease process</article-title>
          <source>J Natl Cancer Inst Monogr</source>
          <year>2005</year>
          <volume>34</volume>
          <fpage>9</fpage>
          <lpage>12</lpage>
          <?supplied-pmid 15784813?>
          <pub-id pub-id-type="pmid">15784813</pub-id>
        </element-citation>
      </ref>
      <ref id="CR55">
        <label>55.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brydøy</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fosså</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>Klepp</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Bremnes</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Wist</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Wentzel-Larsen</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Paternity following treatment for testicular cancer</article-title>
          <source>J Natl Cancer Inst</source>
          <year>2005</year>
          <volume>97</volume>
          <issue>21</issue>
          <fpage>1580</fpage>
          <lpage>1588</lpage>
          <?supplied-pmid 16264178?>
          <pub-id pub-id-type="pmid">16264178</pub-id>
        </element-citation>
      </ref>
      <ref id="CR56">
        <label>56.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Signorello</surname>
              <given-names>LB</given-names>
            </name>
            <name>
              <surname>Mulvihill</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Green</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Munro</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Stovall</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Weathers</surname>
              <given-names>RE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Congenital anomalies in the children of cancer survivors: a report from the childhood cancer survivor study</article-title>
          <source>J Clin Oncol</source>
          <year>2012</year>
          <volume>30</volume>
          <issue>3</issue>
          <fpage>239</fpage>
          <lpage>245</lpage>
          <?supplied-pmid 22162566?>
          <pub-id pub-id-type="pmid">22162566</pub-id>
        </element-citation>
      </ref>
      <ref id="CR57">
        <label>57.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ståhl</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Boyd</surname>
              <given-names>HA</given-names>
            </name>
            <name>
              <surname>Giwercman</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lindholm</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Jensen</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kjær</surname>
              <given-names>SK</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Risk of birth abnormalities in the offspring of men with a history of cancer: a cohort study using Danish and Swedish national registries</article-title>
          <source>J Natl Cancer Inst</source>
          <year>2011</year>
          <volume>103</volume>
          <issue>5</issue>
          <fpage>398</fpage>
          <lpage>406</lpage>
          <?supplied-pmid 21303994?>
          <pub-id pub-id-type="pmid">21303994</pub-id>
        </element-citation>
      </ref>
      <ref id="CR58">
        <label>58.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>García</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Herrero</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Holzer</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Tulandi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Assisted reproductive outcomes of male cancer survivors</article-title>
          <source>J Cancer Surviv Res Pract</source>
          <year>2015</year>
          <volume>9</volume>
          <issue>2</issue>
          <fpage>208</fpage>
          <lpage>214</lpage>
        </element-citation>
      </ref>
      <ref id="CR59">
        <label>59.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ping</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Gu</surname>
              <given-names>B-H</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>Y-R</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Z</given-names>
            </name>
          </person-group>
          <article-title>Fertility outcome of patients with testicular tumor: before and after treatment</article-title>
          <source>Asian J Androl</source>
          <year>2014</year>
          <volume>16</volume>
          <issue>1</issue>
          <fpage>107</fpage>
          <lpage>111</lpage>
          <?supplied-pmid 24369141?>
          <pub-id pub-id-type="pmid">24369141</pub-id>
        </element-citation>
      </ref>
      <ref id="CR60">
        <label>60.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hsiao</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Stahl</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Osterberg</surname>
              <given-names>EC</given-names>
            </name>
            <name>
              <surname>Nejat</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Palermo</surname>
              <given-names>GD</given-names>
            </name>
            <name>
              <surname>Rosenwaks</surname>
              <given-names>Z</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Successful treatment of postchemotherapy azoospermia with microsurgical testicular sperm extraction: the Weill Cornell experience</article-title>
          <source>J Clin Oncol</source>
          <year>2011</year>
          <volume>29</volume>
          <issue>12</issue>
          <fpage>1607</fpage>
          <lpage>1611</lpage>
          <?supplied-pmid 21402606?>
          <pub-id pub-id-type="pmid">21402606</pub-id>
        </element-citation>
      </ref>
      <ref id="CR61">
        <label>61.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Williams</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Bunch</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Stiller</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Murphy</surname>
              <given-names>MFG</given-names>
            </name>
            <name>
              <surname>Botting</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Wallace</surname>
              <given-names>WH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cancer risk among children born after assisted conception</article-title>
          <source>N Engl J Med</source>
          <year>2013</year>
          <volume>369</volume>
          <issue>19</issue>
          <fpage>1819</fpage>
          <lpage>1827</lpage>
          <?supplied-pmid 24195549?>
          <pub-id pub-id-type="pmid">24195549</pub-id>
        </element-citation>
      </ref>
      <ref id="CR62">
        <label>62.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Polat</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bozdag</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Yarali</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Best protocol for controlled ovarian hyperstimulation in assisted reproductive technologies: fact or opinion?</article-title>
          <source>Semin Reprod Med</source>
          <year>2014</year>
          <volume>32</volume>
          <issue>4</issue>
          <fpage>262</fpage>
          <lpage>271</lpage>
          <?supplied-pmid 24919025?>
          <pub-id pub-id-type="pmid">24919025</pub-id>
        </element-citation>
      </ref>
      <ref id="CR63">
        <label>63.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Balduzzi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Leonardi</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Cardillo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Orecchia</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Dellapasqua</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Iorfida</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Timing of adjuvant systemic therapy and radiotherapy after breast-conserving surgery and mastectomy</article-title>
          <source>Cancer Treat Rev</source>
          <year>2010</year>
          <volume>36</volume>
          <issue>6</issue>
          <fpage>443</fpage>
          <lpage>450</lpage>
          <?supplied-pmid 20304562?>
          <pub-id pub-id-type="pmid">20304562</pub-id>
        </element-citation>
      </ref>
      <ref id="CR64">
        <label>64.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cakmak</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Rosen</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
          <article-title>Ovarian stimulation in cancer patients</article-title>
          <source>Fertil Steril</source>
          <year>2013</year>
          <volume>99</volume>
          <issue>6</issue>
          <fpage>1476</fpage>
          <lpage>1484</lpage>
          <?supplied-pmid 23635348?>
          <pub-id pub-id-type="pmid">23635348</pub-id>
        </element-citation>
      </ref>
      <ref id="CR65">
        <label>65.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Von Wolff</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Thaler</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Frambach</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Zeeb</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Lawrenz</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Popovici</surname>
              <given-names>RM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase</article-title>
          <source>Fertil Steril</source>
          <year>2009</year>
          <volume>92</volume>
          <issue>4</issue>
          <fpage>1360</fpage>
          <lpage>1365</lpage>
          <pub-id pub-id-type="pmid">18930226</pub-id>
        </element-citation>
      </ref>
      <ref id="CR66">
        <label>66.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Michaan</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Ben-David</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Ben-Yosef</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Almog</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Many</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pauzner</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Ovarian stimulation and emergency in vitro fertilization for fertility preservation in cancer patients</article-title>
          <source>Eur J Obstet Gynecol Reprod Biol</source>
          <year>2010</year>
          <volume>149</volume>
          <issue>2</issue>
          <fpage>175</fpage>
          <lpage>177</lpage>
          <?supplied-pmid 20074845?>
          <pub-id pub-id-type="pmid">20074845</pub-id>
        </element-citation>
      </ref>
      <ref id="CR67">
        <label>67.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bedoschi</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>de Albuquerque</surname>
              <given-names>FO</given-names>
            </name>
            <name>
              <surname>Ferriani</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Navarro</surname>
              <given-names>PA</given-names>
            </name>
          </person-group>
          <article-title>Ovarian stimulation during the luteal phase for fertility preservation of cancer patients: case reports and review of the literature</article-title>
          <source>J Assist Reprod Genet</source>
          <year>2010</year>
          <volume>27</volume>
          <issue>8</issue>
          <fpage>491</fpage>
          <lpage>494</lpage>
          <?supplied-pmid 20455017?>
          <pub-id pub-id-type="pmid">20455017</pub-id>
        </element-citation>
      </ref>
      <ref id="CR68">
        <label>68.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sönmezer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Türkçüoğlu</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Coşkun</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Oktay</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Random-start controlled ovarian hyperstimulation for emergency fertility preservation in letrozole cycles</article-title>
          <source>Fertil Steril</source>
          <year>2011</year>
          <volume>95</volume>
          <issue>6</issue>
          <fpage>2125.e9</fpage>
          <lpage>11</lpage>
          <pub-id pub-id-type="pmid">21292255</pub-id>
        </element-citation>
      </ref>
      <ref id="CR69">
        <label>69.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maman</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Meirow</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Brengauz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Raanani</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Dor</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hourvitz</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Luteal phase oocyte retrieval and in vitro maturation is an optional procedure for urgent fertility preservation</article-title>
          <source>Fertil Steril</source>
          <year>2011</year>
          <volume>95</volume>
          <issue>1</issue>
          <fpage>64</fpage>
          <lpage>67</lpage>
          <?supplied-pmid 20688325?>
          <pub-id pub-id-type="pmid">20688325</pub-id>
        </element-citation>
      </ref>
      <ref id="CR70">
        <label>70.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nayak</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Wakim</surname>
              <given-names>AN</given-names>
            </name>
          </person-group>
          <article-title>Random-start gonadotropin-releasing hormone (GnRH) antagonist-treated cycles with GnRH agonist trigger for fertility preservation</article-title>
          <source>Fertil Steril</source>
          <year>2011</year>
          <volume>96</volume>
          <issue>1</issue>
          <fpage>e51</fpage>
          <lpage>e54</lpage>
          <?supplied-pmid 21601193?>
          <pub-id pub-id-type="pmid">21601193</pub-id>
        </element-citation>
      </ref>
      <ref id="CR71">
        <label>71.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cakmak</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Katz</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Cedars</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Rosen</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
          <article-title>Effective method for emergency fertility preservation: random-start controlled ovarian stimulation</article-title>
          <source>Fertil Steril</source>
          <year>2013</year>
          <volume>100</volume>
          <issue>6</issue>
          <fpage>1673</fpage>
          <lpage>1680</lpage>
          <?supplied-pmid 23987516?>
          <pub-id pub-id-type="pmid">23987516</pub-id>
        </element-citation>
      </ref>
      <ref id="CR72">
        <label>72.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Buendgen</surname>
              <given-names>NK</given-names>
            </name>
            <name>
              <surname>Schultze-Mosgau</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Cordes</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Diedrich</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Griesinger</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Initiation of ovarian stimulation independent of the menstrual cycle: a case–control study</article-title>
          <source>Arch Gynecol Obstet</source>
          <year>2013</year>
          <volume>288</volume>
          <issue>4</issue>
          <fpage>901</fpage>
          <lpage>904</lpage>
          <?supplied-pmid 23545834?>
          <pub-id pub-id-type="pmid">23545834</pub-id>
        </element-citation>
      </ref>
      <ref id="CR73">
        <label>73.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Keskin</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Ercan</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Yilmaz</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Babacan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Korkmaz</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Duru</surname>
              <given-names>NK</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Random-start controlled ovarian hyperstimulation with letrozole for fertility preservation in cancer patients: case series and review of literature</article-title>
          <source>J Pak Med Assoc</source>
          <year>2014</year>
          <volume>64</volume>
          <issue>7</issue>
          <fpage>830</fpage>
          <lpage>832</lpage>
          <?supplied-pmid 25255597?>
          <pub-id pub-id-type="pmid">25255597</pub-id>
        </element-citation>
      </ref>
      <ref id="CR74">
        <label>74.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Youssef</surname>
              <given-names>MAFM</given-names>
            </name>
            <name>
              <surname>Van der Veen</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Al-Inany</surname>
              <given-names>HG</given-names>
            </name>
            <name>
              <surname>Mochtar</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Griesinger</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Nagi Mohesen</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology</article-title>
          <source>Cochrane Database Syst Rev</source>
          <year>2014</year>
          <volume>10</volume>
          <fpage>CD008046</fpage>
          <?supplied-pmid 25358904?>
          <pub-id pub-id-type="pmid">25358904</pub-id>
        </element-citation>
      </ref>
      <ref id="CR75">
        <label>75.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meirow</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Raanani</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Maman</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Paluch-Shimon</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Shapira</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies</article-title>
          <source>Fertil Steril</source>
          <year>2014</year>
          <volume>102</volume>
          <issue>2</issue>
          <fpage>488</fpage>
          <lpage>495</lpage>
          <?supplied-pmid 24934489?>
          <pub-id pub-id-type="pmid">24934489</pub-id>
        </element-citation>
      </ref>
      <ref id="CR76">
        <label>76.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Revelli</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Porcu</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Levi Setti</surname>
              <given-names>PE</given-names>
            </name>
            <name>
              <surname>Delle Piane</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Merlo</surname>
              <given-names>DF</given-names>
            </name>
            <name>
              <surname>Anserini</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Is letrozole needed for controlled ovarian stimulation in patients with estrogen receptor-positive breast cancer?</article-title>
          <source>Gynecol Endocrinol</source>
          <year>2013</year>
          <volume>29</volume>
          <issue>11</issue>
          <fpage>993</fpage>
          <lpage>996</lpage>
          <?supplied-pmid 24000936?>
          <pub-id pub-id-type="pmid">24000936</pub-id>
        </element-citation>
      </ref>
      <ref id="CR77">
        <label>77.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oktay</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hourvitz</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sahin</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Oktem</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Safro</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Cil</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>2006</year>
          <volume>91</volume>
          <issue>10</issue>
          <fpage>3885</fpage>
          <lpage>3890</lpage>
          <?supplied-pmid 16882752?>
          <pub-id pub-id-type="pmid">16882752</pub-id>
        </element-citation>
      </ref>
      <ref id="CR78">
        <label>78.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oktay</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Turan</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Bedoschi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Pacheco</surname>
              <given-names>FS</given-names>
            </name>
            <name>
              <surname>Moy</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Fertility Preservation Success Subsequent to Concurrent Aromatase Inhibitor Treatment and Ovarian Stimulation in Women With Breast Cancer</article-title>
          <source>J Clin Oncol</source>
          <year>2015</year>
          <volume>33</volume>
          <issue>22</issue>
          <fpage>2424</fpage>
          <lpage>2429</lpage>
          <?supplied-pmid 26101247?>
          <pub-id pub-id-type="pmid">26101247</pub-id>
        </element-citation>
      </ref>
      <ref id="CR79">
        <label>79.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Azim</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Costantini-Ferrando</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Oktay</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study</article-title>
          <source>J Clin Oncol</source>
          <year>2008</year>
          <volume>26</volume>
          <issue>16</issue>
          <fpage>2630</fpage>
          <lpage>2635</lpage>
          <?supplied-pmid 18509175?>
          <pub-id pub-id-type="pmid">18509175</pub-id>
        </element-citation>
      </ref>
      <ref id="CR80">
        <label>80.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oktay</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bedoschi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Turan</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Safety of letrozole-gonadotropin controlled ovarian stimulation protocol in women with breast cancer undergoing fertility preservation before or after tumor resection via embryo or oocyte cryopreservation: A prospective cohort study</article-title>
          <source>Cancer Res</source>
          <year>2015</year>
          <volume>75</volume>
          <fpage>abstract P5-15-02</fpage>
        </element-citation>
      </ref>
      <ref id="CR81">
        <label>81.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Turan</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Bedoschi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Moy</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Oktay</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation in breast cancer patients</article-title>
          <source>Fertil Steril</source>
          <year>2013</year>
          <volume>100</volume>
          <issue>6</issue>
          <fpage>1681</fpage>
          <lpage>5.e1</lpage>
          <?supplied-pmid 24055050?>
          <pub-id pub-id-type="pmid">24055050</pub-id>
        </element-citation>
      </ref>
      <ref id="CR82">
        <label>82.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oktay</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Demirtas</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Son</surname>
              <given-names>W-Y</given-names>
            </name>
            <name>
              <surname>Lostritto</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Chian</surname>
              <given-names>R-C</given-names>
            </name>
            <name>
              <surname>Tan</surname>
              <given-names>SL</given-names>
            </name>
          </person-group>
          <article-title>In vitro maturation of germinal vesicle oocytes recovered after premature luteinizing hormone surge: description of a novel approach to fertility preservation</article-title>
          <source>Fertil Steril</source>
          <year>2008</year>
          <volume>89</volume>
          <issue>1</issue>
          <fpage>228.e19</fpage>
          <lpage>22</lpage>
          <pub-id pub-id-type="pmid">17517403</pub-id>
        </element-citation>
      </ref>
      <ref id="CR83">
        <label>83.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cao</surname>
              <given-names>Y-X</given-names>
            </name>
            <name>
              <surname>Chian</surname>
              <given-names>R-C</given-names>
            </name>
          </person-group>
          <article-title>Fertility preservation with immature and in vitro matured oocytes</article-title>
          <source>Semin Reprod Med</source>
          <year>2009</year>
          <volume>27</volume>
          <issue>6</issue>
          <fpage>456</fpage>
          <lpage>464</lpage>
          <?supplied-pmid 19806514?>
          <pub-id pub-id-type="pmid">19806514</pub-id>
        </element-citation>
      </ref>
      <ref id="CR84">
        <label>84.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Prasath</surname>
              <given-names>EB</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>MLH</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>WHW</given-names>
            </name>
            <name>
              <surname>Lim</surname>
              <given-names>CJW</given-names>
            </name>
            <name>
              <surname>Tharmalingam</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Hendricks</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>First pregnancy and live birth resulting from cryopreserved embryos obtained from in vitro matured oocytes after oophorectomy in an ovarian cancer patient</article-title>
          <source>Hum Reprod</source>
          <year>2014</year>
          <volume>29</volume>
          <issue>2</issue>
          <fpage>276</fpage>
          <lpage>278</lpage>
          <?supplied-pmid 24327539?>
          <pub-id pub-id-type="pmid">24327539</pub-id>
        </element-citation>
      </ref>
      <ref id="CR85">
        <label>85.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goldrat</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Kroman</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Peccatori</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>Cordoba</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Pistilli</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Lidegaard</surname>
              <given-names>O</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Pregnancy following breast cancer using assisted reproduction and its effect on long-term outcome</article-title>
          <source>Eur J Cancer</source>
          <year>2015</year>
          <volume>51</volume>
          <issue>12</issue>
          <fpage>1490</fpage>
          <lpage>1496</lpage>
          <?supplied-pmid 26070684?>
          <pub-id pub-id-type="pmid">26070684</pub-id>
        </element-citation>
      </ref>
      <ref id="CR86">
        <label>86.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gook</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Edgar</surname>
              <given-names>DH</given-names>
            </name>
          </person-group>
          <article-title>Human oocyte cryopreservation</article-title>
          <source>Hum Reprod Update</source>
          <year>2007</year>
          <volume>13</volume>
          <issue>6</issue>
          <fpage>591</fpage>
          <lpage>605</lpage>
          <?supplied-pmid 17846105?>
          <pub-id pub-id-type="pmid">17846105</pub-id>
        </element-citation>
      </ref>
      <ref id="CR87">
        <label>87.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Borini</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Levi Setti</surname>
              <given-names>PE</given-names>
            </name>
            <name>
              <surname>Anserini</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>De Luca</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>De Santis</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Porcu</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Multicenter observational study on slow-cooling oocyte cryopreservation: clinical outcome</article-title>
          <source>Fertil Steril</source>
          <year>2010</year>
          <volume>94</volume>
          <issue>5</issue>
          <fpage>1662</fpage>
          <lpage>1668</lpage>
          <?supplied-pmid 20047739?>
          <pub-id pub-id-type="pmid">20047739</pub-id>
        </element-citation>
      </ref>
      <ref id="CR88">
        <label>88.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smith</surname>
              <given-names>GD</given-names>
            </name>
            <name>
              <surname>Serafini</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Fioravanti</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Yadid</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Coslovsky</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hassun</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Prospective randomized comparison of human oocyte cryopreservation with slow-rate freezing or vitrification</article-title>
          <source>Fertil Steril</source>
          <year>2010</year>
          <volume>94</volume>
          <issue>6</issue>
          <fpage>2088</fpage>
          <lpage>2095</lpage>
          <?supplied-pmid 20171613?>
          <pub-id pub-id-type="pmid">20171613</pub-id>
        </element-citation>
      </ref>
      <ref id="CR89">
        <label>89.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Glujovsky</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Riestra</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Sueldo</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Fiszbajn</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Repping</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nodar</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Vitrification versus slow freezing for women undergoing oocyte cryopreservation</article-title>
          <source>Cochrane Database Syst Rev</source>
          <year>2014</year>
          <volume>9</volume>
          <fpage>CD010047</fpage>
          <?supplied-pmid 25192224?>
          <pub-id pub-id-type="pmid">25192224</pub-id>
        </element-citation>
      </ref>
      <ref id="CR90">
        <label>90.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Solé</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Santaló</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Boada</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Clua</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Rodríguez</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Martínez</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>How does vitrification affect oocyte viability in oocyte donation cycles? A prospective study to compare outcomes achieved with fresh versus vitrified sibling oocytes</article-title>
          <source>Hum Reprod</source>
          <year>2013</year>
          <volume>28</volume>
          <issue>8</issue>
          <fpage>2087</fpage>
          <lpage>2092</lpage>
          <?supplied-pmid 23744895?>
          <pub-id pub-id-type="pmid">23744895</pub-id>
        </element-citation>
      </ref>
      <ref id="CR91">
        <label>91.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cil</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Bang</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Oktay</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Age-specific probability of live birth with oocyte cryopreservation: an individual patient data meta-analysis</article-title>
          <source>Fertil Steril</source>
          <year>2013</year>
          <volume>100</volume>
          <issue>2</issue>
          <fpage>492</fpage>
          <lpage>9.e3</lpage>
          <?supplied-pmid 23706339?>
          <pub-id pub-id-type="pmid">23706339</pub-id>
        </element-citation>
      </ref>
      <ref id="CR92">
        <label>92.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Levi Setti</surname>
              <given-names>PE</given-names>
            </name>
            <name>
              <surname>Porcu</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Patrizio</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Vigiliano</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>De Luca</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>D’ Aloja</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Human oocyte cryopreservation with slow freezing versus vitrification. Results from the National Italian Registry data, 2007–2011</article-title>
          <source>Fertil Steril</source>
          <year>2014</year>
          <volume>102</volume>
          <issue>1</issue>
          <fpage>90</fpage>
          <lpage>5.e2</lpage>
          <?supplied-pmid 24794316?>
          <pub-id pub-id-type="pmid">24794316</pub-id>
        </element-citation>
      </ref>
      <ref id="CR93">
        <label>93.</label>
        <mixed-citation publication-type="other">Clinic Summary Report. <ext-link ext-link-type="uri" xlink:href="https://www.sartcorsonline.com/rptCSR_PublicMultYear.aspx?ClinicPKID=0">https://www.sartcorsonline.com/rptCSR_PublicMultYear.aspx?ClinicPKID=0</ext-link>. Accessed 22 Dec 2015.</mixed-citation>
      </ref>
      <ref id="CR94">
        <label>94.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bianchi</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Lappi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bonu</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Borini</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Oocyte slow freezing using a 0.2-0.3 M sucrose concentration protocol: is it really the time to trash the cryopreservation machine?</article-title>
          <source>Fertil Steril</source>
          <year>2012</year>
          <volume>97</volume>
          <issue>5</issue>
          <fpage>1101</fpage>
          <lpage>1107</lpage>
          <?supplied-pmid 22365380?>
          <pub-id pub-id-type="pmid">22365380</pub-id>
        </element-citation>
      </ref>
      <ref id="CR95">
        <label>95.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rienzi</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Cobo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Paffoni</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Scarduelli</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Capalbo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Vajta</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Consistent and predictable delivery rates after oocyte vitrification: an observational longitudinal cohort multicentric study</article-title>
          <source>Hum Reprod</source>
          <year>2012</year>
          <volume>27</volume>
          <issue>6</issue>
          <fpage>1606</fpage>
          <lpage>1612</lpage>
          <?supplied-pmid 22442248?>
          <pub-id pub-id-type="pmid">22442248</pub-id>
        </element-citation>
      </ref>
      <ref id="CR96">
        <label>96.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Quintero</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Helmer</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>JQ</given-names>
            </name>
            <name>
              <surname>Westphal</surname>
              <given-names>LM</given-names>
            </name>
          </person-group>
          <article-title>Ovarian stimulation for fertility preservation in patients with cancer</article-title>
          <source>Fertil Steril</source>
          <year>2010</year>
          <volume>93</volume>
          <issue>3</issue>
          <fpage>865</fpage>
          <lpage>868</lpage>
          <?supplied-pmid 19013563?>
          <pub-id pub-id-type="pmid">19013563</pub-id>
        </element-citation>
      </ref>
      <ref id="CR97">
        <label>97.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Domingo</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Guillén</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Ayllón</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Martínez</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Muñoz</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Pellicer</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment</article-title>
          <source>Fertil Steril</source>
          <year>2012</year>
          <volume>97</volume>
          <issue>4</issue>
          <fpage>930</fpage>
          <lpage>934</lpage>
          <?supplied-pmid 22283969?>
          <pub-id pub-id-type="pmid">22283969</pub-id>
        </element-citation>
      </ref>
      <ref id="CR98">
        <label>98.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oktay</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Barad</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Babayev</surname>
              <given-names>SN</given-names>
            </name>
          </person-group>
          <article-title>Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks</article-title>
          <source>J Clin Oncol</source>
          <year>2010</year>
          <volume>28</volume>
          <issue>2</issue>
          <fpage>240</fpage>
          <lpage>244</lpage>
          <?supplied-pmid 19996028?>
          <pub-id pub-id-type="pmid">19996028</pub-id>
        </element-citation>
      </ref>
      <ref id="CR99">
        <label>99.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pal</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Keefe</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Narod</surname>
              <given-names>SA</given-names>
            </name>
          </person-group>
          <article-title>Hereditary Breast Cancer Clinical Study Group. Fertility in women with BRCA mutations: a case–control study</article-title>
          <source>Fertil Steril</source>
          <year>2010</year>
          <volume>93</volume>
          <issue>6</issue>
          <fpage>1805</fpage>
          <lpage>1808</lpage>
          <?supplied-pmid 19200971?>
          <pub-id pub-id-type="pmid">19200971</pub-id>
        </element-citation>
      </ref>
      <ref id="CR100">
        <label>100.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alvarez</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Solé</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Devesa</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fábregas</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Boada</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tur</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Live birth using vitrified--warmed oocytes in invasive ovarian cancer: case report and literature review</article-title>
          <source>Reprod Biomed Online</source>
          <year>2014</year>
          <volume>28</volume>
          <issue>6</issue>
          <fpage>663</fpage>
          <lpage>668</lpage>
          <?supplied-pmid 24745835?>
          <pub-id pub-id-type="pmid">24745835</pub-id>
        </element-citation>
      </ref>
      <ref id="CR101">
        <label>101.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Martinez</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rabadan</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Domingo</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Cobo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pellicer</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Garcia-Velasco</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Obstetric outcome after oocyte vitrification and warming for fertility preservation in women with cancer</article-title>
          <source>Reprod Biomed Online</source>
          <year>2014</year>
          <volume>29</volume>
          <issue>6</issue>
          <fpage>722</fpage>
          <lpage>728</lpage>
          <?supplied-pmid 25444506?>
          <pub-id pub-id-type="pmid">25444506</pub-id>
        </element-citation>
      </ref>
      <ref id="CR102">
        <label>102.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>WS</given-names>
            </name>
            <name>
              <surname>Chung</surname>
              <given-names>MK</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>HC</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>HH</given-names>
            </name>
            <name>
              <surname>Hill</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Long-term ovarian function and fertility after heterotopic autotransplantation of cryobanked human ovarian tissue: 8-year experience in cancer patients</article-title>
          <source>Fertil Steril</source>
          <year>2009</year>
          <volume>91</volume>
          <issue>6</issue>
          <fpage>2349</fpage>
          <lpage>2354</lpage>
          <?supplied-pmid 18675964?>
          <pub-id pub-id-type="pmid">18675964</pub-id>
        </element-citation>
      </ref>
      <ref id="CR103">
        <label>103.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Andersen</surname>
              <given-names>CY</given-names>
            </name>
            <name>
              <surname>Silber</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Bergholdt</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Berghold</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Jorgensen</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Ernst</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Long-term duration of function of ovarian tissue transplants: case reports</article-title>
          <source>Reprod Biomed Online</source>
          <year>2012</year>
          <volume>25</volume>
          <issue>2</issue>
          <fpage>128</fpage>
          <lpage>132</lpage>
          <?supplied-pmid 22687323?>
          <pub-id pub-id-type="pmid">22687323</pub-id>
        </element-citation>
      </ref>
      <ref id="CR104">
        <label>104.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Donnez</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Dolmans</surname>
              <given-names>M-M</given-names>
            </name>
            <name>
              <surname>Pellicer</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Diaz-Garcia</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ernst</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Macklon</surname>
              <given-names>KT</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Fertility preservation for age-related fertility decline</article-title>
          <source>Lancet</source>
          <year>2015</year>
          <volume>385</volume>
          <issue>9967</issue>
          <fpage>506</fpage>
          <lpage>507</lpage>
          <?supplied-pmid 25705839?>
          <pub-id pub-id-type="pmid">25705839</pub-id>
        </element-citation>
      </ref>
      <ref id="CR105">
        <label>105.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Andersen</surname>
              <given-names>CY</given-names>
            </name>
          </person-group>
          <article-title>Success and challenges in fertility preservation after ovarian tissue grafting</article-title>
          <source>Lancet</source>
          <year>2015</year>
          <volume>385</volume>
          <issue>9981</issue>
          <fpage>1947</fpage>
          <lpage>1948</lpage>
          <?supplied-pmid 26090642?>
          <pub-id pub-id-type="pmid">26090642</pub-id>
        </element-citation>
      </ref>
      <ref id="CR106">
        <label>106.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Donnez</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Dolmans</surname>
              <given-names>M-M</given-names>
            </name>
            <name>
              <surname>Pellicer</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Diaz-Garcia</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Sanchez Serrano</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schmidt</surname>
              <given-names>KT</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation</article-title>
          <source>Fertil Steril</source>
          <year>2013</year>
          <volume>99</volume>
          <issue>6</issue>
          <fpage>1503</fpage>
          <lpage>1513</lpage>
          <?supplied-pmid 23635349?>
          <pub-id pub-id-type="pmid">23635349</pub-id>
        </element-citation>
      </ref>
      <ref id="CR107">
        <label>107.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Donnez</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Dolmans</surname>
              <given-names>M-M</given-names>
            </name>
          </person-group>
          <article-title>Transplantation of ovarian tissue</article-title>
          <source>Best Pract Res Clin Obstet Gynaecol</source>
          <year>2014</year>
          <volume>28</volume>
          <issue>8</issue>
          <fpage>1188</fpage>
          <lpage>1197</lpage>
          <?supplied-pmid 25450187?>
          <pub-id pub-id-type="pmid">25450187</pub-id>
        </element-citation>
      </ref>
      <ref id="CR108">
        <label>108.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Macklon</surname>
              <given-names>KT</given-names>
            </name>
            <name>
              <surname>Jensen</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Loft</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ernst</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Andersen</surname>
              <given-names>CY</given-names>
            </name>
          </person-group>
          <article-title>Treatment history and outcome of 24 deliveries worldwide after autotransplantation of cryopreserved ovarian tissue, including two new Danish deliveries years after autotransplantation</article-title>
          <source>J Assist Reprod Genet</source>
          <year>2014</year>
          <volume>31</volume>
          <issue>11</issue>
          <fpage>1557</fpage>
          <lpage>1564</lpage>
          <?supplied-pmid 25212530?>
          <pub-id pub-id-type="pmid">25212530</pub-id>
        </element-citation>
      </ref>
      <ref id="CR109">
        <label>109.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dittrich</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Hackl</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lotz</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Hoffmann</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Beckmann</surname>
              <given-names>MW</given-names>
            </name>
          </person-group>
          <article-title>Pregnancies and live births after 20 transplantations of cryopreserved ovarian tissue in a single center</article-title>
          <source>Fertil Steril</source>
          <year>2015</year>
          <volume>103</volume>
          <issue>2</issue>
          <fpage>462</fpage>
          <lpage>468</lpage>
          <?supplied-pmid 25487750?>
          <pub-id pub-id-type="pmid">25487750</pub-id>
        </element-citation>
      </ref>
      <ref id="CR110">
        <label>110.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meirow</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Ra’anani</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Biderman</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Ovarian tissue cryopreservation and transplantation: a realistic, effective technology for fertility preservation</article-title>
          <source>Methods Mol Biol</source>
          <year>2014</year>
          <volume>1154</volume>
          <fpage>455</fpage>
          <lpage>473</lpage>
          <?supplied-pmid 24782023?>
          <pub-id pub-id-type="pmid">24782023</pub-id>
        </element-citation>
      </ref>
      <ref id="CR111">
        <label>111.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bar-Joseph</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ben-Aharon</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Rizel</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Stemmer</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Tzabari</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Shalgi</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Doxorubicin-induced apoptosis in germinal vesicle (GV) oocytes</article-title>
          <source>Reprod Toxicol</source>
          <year>2010</year>
          <volume>30</volume>
          <issue>4</issue>
          <fpage>566</fpage>
          <lpage>572</lpage>
          <?supplied-pmid 20656019?>
          <pub-id pub-id-type="pmid">20656019</pub-id>
        </element-citation>
      </ref>
      <ref id="CR112">
        <label>112.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kujjo</surname>
              <given-names>LL</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Pereira</surname>
              <given-names>RJG</given-names>
            </name>
            <name>
              <surname>Dhar</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Marrero-Rosado</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Sengupta</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Chemotherapy-induced late transgenerational effects in mice</article-title>
          <source>PLoS One</source>
          <year>2011</year>
          <volume>6</volume>
          <issue>3</issue>
          <fpage>e17877</fpage>
          <?supplied-pmid 21437292?>
          <pub-id pub-id-type="pmid">21437292</pub-id>
        </element-citation>
      </ref>
      <ref id="CR113">
        <label>113.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Greve</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Clasen-Linde</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Andersen</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Andersen</surname>
              <given-names>MK</given-names>
            </name>
            <name>
              <surname>Sørensen</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>Rosendahl</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cryopreserved ovarian cortex from patients with leukemia in complete remission contains no apparent viable malignant cells</article-title>
          <source>Blood</source>
          <year>2012</year>
          <volume>120</volume>
          <issue>22</issue>
          <fpage>4311</fpage>
          <lpage>4316</lpage>
          <?supplied-pmid 22709693?>
          <pub-id pub-id-type="pmid">22709693</pub-id>
        </element-citation>
      </ref>
      <ref id="CR114">
        <label>114.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oktay</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Evidence for limiting ovarian tissue harvesting for the purpose of transplantation to women younger than 40 years of age</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>2002</year>
          <volume>87</volume>
          <issue>4</issue>
          <fpage>1907</fpage>
          <lpage>1908</lpage>
          <?supplied-pmid 11932340?>
          <pub-id pub-id-type="pmid">11932340</pub-id>
        </element-citation>
      </ref>
      <ref id="CR115">
        <label>115.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rosendahl</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Andersen</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Ralfkiær</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Kjeldsen</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Andersen</surname>
              <given-names>MK</given-names>
            </name>
            <name>
              <surname>Andersen</surname>
              <given-names>CY</given-names>
            </name>
          </person-group>
          <article-title>Evidence of residual disease in cryopreserved ovarian cortex from female patients with leukemia</article-title>
          <source>Fertil Steril</source>
          <year>2010</year>
          <volume>94</volume>
          <issue>6</issue>
          <fpage>2186</fpage>
          <lpage>2190</lpage>
          <?supplied-pmid 20100619?>
          <pub-id pub-id-type="pmid">20100619</pub-id>
        </element-citation>
      </ref>
      <ref id="CR116">
        <label>116.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rosendahl</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Greve</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Andersen</surname>
              <given-names>CY</given-names>
            </name>
          </person-group>
          <article-title>The safety of transplanting cryopreserved ovarian tissue in cancer patients: a review of the literature</article-title>
          <source>J Assist Reprod Genet</source>
          <year>2013</year>
          <volume>30</volume>
          <issue>1</issue>
          <fpage>11</fpage>
          <lpage>24</lpage>
          <?supplied-pmid 23263841?>
          <pub-id pub-id-type="pmid">23263841</pub-id>
        </element-citation>
      </ref>
      <ref id="CR117">
        <label>117.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sørensen</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>Greve</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Wielenga</surname>
              <given-names>VT</given-names>
            </name>
            <name>
              <surname>Wallace</surname>
              <given-names>WHB</given-names>
            </name>
            <name>
              <surname>Andersen</surname>
              <given-names>CY</given-names>
            </name>
          </person-group>
          <article-title>Safety considerations for transplanting cryopreserved ovarian tissue to restore fertility in female patients who have recovered from Ewing’s sarcoma</article-title>
          <source>Future Oncol</source>
          <year>2014</year>
          <volume>10</volume>
          <issue>2</issue>
          <fpage>277</fpage>
          <lpage>283</lpage>
          <?supplied-pmid 24490613?>
          <pub-id pub-id-type="pmid">24490613</pub-id>
        </element-citation>
      </ref>
      <ref id="CR118">
        <label>118.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bastings</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Beerendonk</surname>
              <given-names>CCM</given-names>
            </name>
            <name>
              <surname>Westphal</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Massuger</surname>
              <given-names>LF</given-names>
            </name>
          </person-group>
          <article-title>a. G, Kaal SEJ, van Leeuwen FE, et al. Autotransplantation of cryopreserved ovarian tissue in cancer survivors and the risk of reintroducing malignancy: a systematic review</article-title>
          <source>Hum Reprod Update</source>
          <year>2013</year>
          <volume>19</volume>
          <issue>5</issue>
          <fpage>483</fpage>
          <lpage>506</lpage>
          <?supplied-pmid 23817363?>
          <pub-id pub-id-type="pmid">23817363</pub-id>
        </element-citation>
      </ref>
      <ref id="CR119">
        <label>119.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lucci</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Kacinskis</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Rumpf</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Báo</surname>
              <given-names>SN</given-names>
            </name>
          </person-group>
          <article-title>Effects of lowered temperatures and media on short-term preservation of zebu (Bos indicus) preantral ovarian follicles</article-title>
          <source>Theriogenology</source>
          <year>2004</year>
          <volume>61</volume>
          <issue>2–3</issue>
          <fpage>461</fpage>
          <lpage>472</lpage>
          <?supplied-pmid 14662144?>
          <pub-id pub-id-type="pmid">14662144</pub-id>
        </element-citation>
      </ref>
      <ref id="CR120">
        <label>120.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schmidt</surname>
              <given-names>KLT</given-names>
            </name>
            <name>
              <surname>Ernst</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Byskov</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Nyboe Andersen</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Yding</surname>
              <given-names>AC</given-names>
            </name>
          </person-group>
          <article-title>Survival of primordial follicles following prolonged transportation of ovarian tissue prior to cryopreservation</article-title>
          <source>Hum Reprod</source>
          <year>2003</year>
          <volume>18</volume>
          <issue>12</issue>
          <fpage>2654</fpage>
          <lpage>2659</lpage>
          <?supplied-pmid 14645187?>
          <pub-id pub-id-type="pmid">14645187</pub-id>
        </element-citation>
      </ref>
      <ref id="CR121">
        <label>121.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rosendahl</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schmidt</surname>
              <given-names>KT</given-names>
            </name>
            <name>
              <surname>Ernst</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Rasmussen</surname>
              <given-names>PE</given-names>
            </name>
            <name>
              <surname>Loft</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Byskov</surname>
              <given-names>AG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cryopreservation of ovarian tissue for a decade in Denmark: a view of the technique</article-title>
          <source>Reprod Biomed Online</source>
          <year>2011</year>
          <volume>22</volume>
          <issue>2</issue>
          <fpage>162</fpage>
          <lpage>171</lpage>
          <?supplied-pmid 21239230?>
          <pub-id pub-id-type="pmid">21239230</pub-id>
        </element-citation>
      </ref>
      <ref id="CR122">
        <label>122.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dittrich</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Lotz</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Keck</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Hoffmann</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Mueller</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Beckmann</surname>
              <given-names>MW</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Live birth after ovarian tissue autotransplantation following overnight transportation before cryopreservation</article-title>
          <source>Fertil Steril</source>
          <year>2012</year>
          <volume>97</volume>
          <issue>2</issue>
          <fpage>387</fpage>
          <lpage>390</lpage>
          <?supplied-pmid 22177311?>
          <pub-id pub-id-type="pmid">22177311</pub-id>
        </element-citation>
      </ref>
      <ref id="CR123">
        <label>123.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lambertini</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ginsburg</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Partridge</surname>
              <given-names>AH</given-names>
            </name>
          </person-group>
          <article-title>Update on fertility preservation in young women undergoing breast cancer and ovarian cancer therapy</article-title>
          <source>Curr Opin Obstet Gynecol</source>
          <year>2015</year>
          <volume>27</volume>
          <issue>1</issue>
          <fpage>98</fpage>
          <lpage>107</lpage>
          <?supplied-pmid 25490381?>
          <pub-id pub-id-type="pmid">25490381</pub-id>
        </element-citation>
      </ref>
      <ref id="CR124">
        <label>124.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Badawy</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Elnashar</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>El-Ashry</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Shahat</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study</article-title>
          <source>Fertil Steril</source>
          <year>2009</year>
          <volume>91</volume>
          <issue>3</issue>
          <fpage>694</fpage>
          <lpage>697</lpage>
          <?supplied-pmid 18675959?>
          <pub-id pub-id-type="pmid">18675959</pub-id>
        </element-citation>
      </ref>
      <ref id="CR125">
        <label>125.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sverrisdottir</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nystedt</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Johansson</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Fornander</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial</article-title>
          <source>Breast Cancer Res Treat</source>
          <year>2009</year>
          <volume>117</volume>
          <issue>3</issue>
          <fpage>561</fpage>
          <lpage>567</lpage>
          <?supplied-pmid 19153828?>
          <pub-id pub-id-type="pmid">19153828</pub-id>
        </element-citation>
      </ref>
      <ref id="CR126">
        <label>126.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leonard</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Adamson</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Ballinger</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Bertelli</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Coleman</surname>
              <given-names>RE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The OPTION trial of adjuvant ovarian protection by goserelin in adjuvant chemotherapy for early breast cancer</article-title>
          <source>J Clin Oncol</source>
          <year>2010</year>
          <volume>28</volume>
          <issue>15</issue>
          <fpage>abstract 590</fpage>
        </element-citation>
      </ref>
      <ref id="CR127">
        <label>127.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Del Mastro</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Boni</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Michelotti</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gamucci</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Olmeo</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Gori</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial</article-title>
          <source>JAMA</source>
          <year>2011</year>
          <volume>306</volume>
          <issue>3</issue>
          <fpage>269</fpage>
          <lpage>276</lpage>
          <?supplied-pmid 21771987?>
          <pub-id pub-id-type="pmid">21771987</pub-id>
        </element-citation>
      </ref>
      <ref id="CR128">
        <label>128.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gerber</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>von Minckwitz</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Stehle</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Reimer</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Felberbaum</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Maass</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study</article-title>
          <source>J Clin Oncol</source>
          <year>2011</year>
          <volume>29</volume>
          <issue>17</issue>
          <fpage>2334</fpage>
          <lpage>2341</lpage>
          <?supplied-pmid 21537042?>
          <pub-id pub-id-type="pmid">21537042</pub-id>
        </element-citation>
      </ref>
      <ref id="CR129">
        <label>129.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Munster</surname>
              <given-names>PN</given-names>
            </name>
            <name>
              <surname>Moore</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Ismail-Khan</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Cox</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Lacevic</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gross-King</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer</article-title>
          <source>J Clin Oncol</source>
          <year>2012</year>
          <volume>30</volume>
          <issue>5</issue>
          <fpage>533</fpage>
          <lpage>538</lpage>
          <?supplied-pmid 22231041?>
          <pub-id pub-id-type="pmid">22231041</pub-id>
        </element-citation>
      </ref>
      <ref id="CR130">
        <label>130.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Elgindy</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>El-Haieg</surname>
              <given-names>DO</given-names>
            </name>
            <name>
              <surname>Khorshid</surname>
              <given-names>OM</given-names>
            </name>
            <name>
              <surname>Ismail</surname>
              <given-names>EI</given-names>
            </name>
            <name>
              <surname>Abdelgawad</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sallam</surname>
              <given-names>HN</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Gonadatrophin suppression to prevent chemotherapy-induced ovarian damage: a randomized controlled trial</article-title>
          <source>Obstet Gynecol</source>
          <year>2013</year>
          <volume>121</volume>
          <issue>1</issue>
          <fpage>78</fpage>
          <lpage>86</lpage>
          <?supplied-pmid 23262931?>
          <pub-id pub-id-type="pmid">23262931</pub-id>
        </element-citation>
      </ref>
      <ref id="CR131">
        <label>131.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Song</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Yuan</surname>
              <given-names>Z</given-names>
            </name>
          </person-group>
          <article-title>Effect of leuprolide acetate on ovarian function after cyclophosphamide-doxorubicin-based chemotherapy in premenopausal patients with breast cancer: results from a phase II randomized trial</article-title>
          <source>Med Oncol</source>
          <year>2013</year>
          <volume>30</volume>
          <issue>3</issue>
          <fpage>667</fpage>
          <?supplied-pmid 23904400?>
          <pub-id pub-id-type="pmid">23904400</pub-id>
        </element-citation>
      </ref>
      <ref id="CR132">
        <label>132.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Karimi-Zarchi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Forat-Yazdi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Vafaeenasab</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Nakhaie-Moghadam</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Miratashi-Yazdi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Teimoori</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Evaluation of the effect of GnRH agonist on menstrual reverse in breast cancer cases treated with cyclophosphamide</article-title>
          <source>Eur J Gynaecol Oncol</source>
          <year>2014</year>
          <volume>35</volume>
          <issue>1</issue>
          <fpage>59</fpage>
          <lpage>61</lpage>
          <?supplied-pmid 24654464?>
          <pub-id pub-id-type="pmid">24654464</pub-id>
        </element-citation>
      </ref>
      <ref id="CR133">
        <label>133.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moore</surname>
              <given-names>HCF</given-names>
            </name>
            <name>
              <surname>Unger</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Phillips</surname>
              <given-names>K-A</given-names>
            </name>
            <name>
              <surname>Boyle</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Hitre</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Porter</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy</article-title>
          <source>N Engl J Med</source>
          <year>2015</year>
          <volume>372</volume>
          <issue>10</issue>
          <fpage>923</fpage>
          <lpage>932</lpage>
          <?supplied-pmid 25738668?>
          <pub-id pub-id-type="pmid">25738668</pub-id>
        </element-citation>
      </ref>
      <ref id="CR134">
        <label>134.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Behringer</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Wildt</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Mueller</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Mattle</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Ganitis</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>van den Hoonaard</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma. Final results of a phase II trial from the German Hodgkin Study Group</article-title>
          <source>Ann Oncol</source>
          <year>2010</year>
          <volume>21</volume>
          <issue>10</issue>
          <fpage>2052</fpage>
          <lpage>2060</lpage>
          <?supplied-pmid 20305034?>
          <pub-id pub-id-type="pmid">20305034</pub-id>
        </element-citation>
      </ref>
      <ref id="CR135">
        <label>135.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Demeestere</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Brice</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Peccatori</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>Kentos</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gaillard</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Zachee</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Gonadotropin-releasing hormone agonist for the prevention of chemotherapy-induced ovarian failure in patients with lymphoma: 1-year follow-up of a prospective randomized trial</article-title>
          <source>J Clin Oncol</source>
          <year>2013</year>
          <volume>31</volume>
          <issue>7</issue>
          <fpage>903</fpage>
          <lpage>909</lpage>
          <?supplied-pmid 23129737?>
          <pub-id pub-id-type="pmid">23129737</pub-id>
        </element-citation>
      </ref>
      <ref id="CR136">
        <label>136.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gilani</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Hasanzadeh</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ghaemmaghami</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ramazanzadeh</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Ovarian preservation with gonadotropin-releasing hormone analog during chemotherapy</article-title>
          <source>Asia Pac J Clin Oncol</source>
          <year>2007</year>
          <volume>3</volume>
          <issue>2</issue>
          <fpage>79</fpage>
          <lpage>83</lpage>
        </element-citation>
      </ref>
      <ref id="CR137">
        <label>137.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tomasi-Cont</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Lambertini</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hulsbosch</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Peccatori</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Amant</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Strategies for fertility preservation in young early breast cancer patients</article-title>
          <source>Breast</source>
          <year>2014</year>
          <volume>23</volume>
          <issue>5</issue>
          <fpage>503</fpage>
          <lpage>510</lpage>
          <?supplied-pmid 24934638?>
          <pub-id pub-id-type="pmid">24934638</pub-id>
        </element-citation>
      </ref>
      <ref id="CR138">
        <label>138.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Clowse</surname>
              <given-names>MEB</given-names>
            </name>
            <name>
              <surname>Behera</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Anders</surname>
              <given-names>CK</given-names>
            </name>
            <name>
              <surname>Copland</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Coffman</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Leppert</surname>
              <given-names>PC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis</article-title>
          <source>J Womens Health 2002</source>
          <year>2009</year>
          <volume>18</volume>
          <issue>3</issue>
          <fpage>311</fpage>
          <lpage>319</lpage>
        </element-citation>
      </ref>
      <ref id="CR139">
        <label>139.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ben-Aharon</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Gafter-Gvili</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Leibovici</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Stemmer</surname>
              <given-names>SM</given-names>
            </name>
          </person-group>
          <article-title>Pharmacological interventions for fertility preservation during chemotherapy: a systematic review and meta-analysis</article-title>
          <source>Breast Cancer Res Treat</source>
          <year>2010</year>
          <volume>122</volume>
          <issue>3</issue>
          <fpage>803</fpage>
          <lpage>811</lpage>
          <?supplied-pmid 20571868?>
          <pub-id pub-id-type="pmid">20571868</pub-id>
        </element-citation>
      </ref>
      <ref id="CR140">
        <label>140.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Jee</surname>
              <given-names>BC</given-names>
            </name>
            <name>
              <surname>Suh</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Ting</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Use of hormonal protection for chemotherapy-induced gonadotoxicity</article-title>
          <source>Clin Obstet Gynecol</source>
          <year>2010</year>
          <volume>53</volume>
          <issue>4</issue>
          <fpage>740</fpage>
          <lpage>752</lpage>
          <?supplied-pmid 21048441?>
          <pub-id pub-id-type="pmid">21048441</pub-id>
        </element-citation>
      </ref>
      <ref id="CR141">
        <label>141.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bedaiwy</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Abou-Setta</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Desai</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Hurd</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Starks</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>El-Nashar</surname>
              <given-names>SA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: a systematic review and meta-analysis</article-title>
          <source>Fertil Steril</source>
          <year>2011</year>
          <volume>95</volume>
          <issue>3</issue>
          <fpage>e1–4</fpage>
          <lpage>14</lpage>
          <pub-id pub-id-type="pmid">21145541</pub-id>
        </element-citation>
      </ref>
      <ref id="CR142">
        <label>142.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Cui</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy induced premature ovarian failure in premenopausal women</article-title>
          <source>Cochrane Database Syst Rev</source>
          <year>2011</year>
          <volume>11</volume>
          <fpage>CD008018</fpage>
          <?supplied-pmid 22071842?>
          <pub-id pub-id-type="pmid">22071842</pub-id>
        </element-citation>
      </ref>
      <ref id="CR143">
        <label>143.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Shi</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>X</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Concurrent treatment with gonadotropin-releasing hormone agonists for chemotherapy-induced ovarian damage in premenopausal women with breast cancer: a meta-analysis of randomized controlled trials</article-title>
          <source>Breast</source>
          <year>2013</year>
          <volume>22</volume>
          <issue>2</issue>
          <fpage>150</fpage>
          <lpage>157</lpage>
          <?supplied-pmid 23298851?>
          <pub-id pub-id-type="pmid">23298851</pub-id>
        </element-citation>
      </ref>
      <ref id="CR144">
        <label>144.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fu</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Gonadotropin-Releasing Hormone Analog Cotreatment for the Preservation of Ovarian Function during Gonadotoxic Chemotherapy for Breast Cancer: A Meta-Analysis</article-title>
          <source>PLoS One</source>
          <year>2013</year>
          <volume>8</volume>
          <issue>6</issue>
          <fpage>e66360</fpage>
          <?supplied-pmid 23805216?>
          <pub-id pub-id-type="pmid">23805216</pub-id>
        </element-citation>
      </ref>
      <ref id="CR145">
        <label>145.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Del Mastro</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Ceppi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Poggio</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Bighin</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Peccatori</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Demeestere</surname>
              <given-names>I</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trials</article-title>
          <source>Cancer Treat Rev</source>
          <year>2014</year>
          <volume>40</volume>
          <issue>5</issue>
          <fpage>675</fpage>
          <lpage>683</lpage>
          <?supplied-pmid 24360817?>
          <pub-id pub-id-type="pmid">24360817</pub-id>
        </element-citation>
      </ref>
      <ref id="CR146">
        <label>146.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vitek</surname>
              <given-names>WS</given-names>
            </name>
            <name>
              <surname>Shayne</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hoeger</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Messing</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Fung</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Gonadotropin-releasing hormone agonists for the preservation of ovarian function among women with breast cancer who did not use tamoxifen after chemotherapy: a systematic review and meta-analysis</article-title>
          <source>Fertil Steril</source>
          <year>2014</year>
          <volume>102</volume>
          <issue>3</issue>
          <fpage>808</fpage>
          <lpage>815</lpage>
          <?supplied-pmid 25044080?>
          <pub-id pub-id-type="pmid">25044080</pub-id>
        </element-citation>
      </ref>
      <ref id="CR147">
        <label>147.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sun</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Dongol</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kong</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Protection of ovarian function by GnRH agonists during chemotherapy: a meta-analysis</article-title>
          <source>Int J Oncol</source>
          <year>2014</year>
          <volume>44</volume>
          <issue>4</issue>
          <fpage>1335</fpage>
          <lpage>1340</lpage>
          <?supplied-pmid 24535045?>
          <pub-id pub-id-type="pmid">24535045</pub-id>
        </element-citation>
      </ref>
      <ref id="CR148">
        <label>148.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Elgindy</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Sibai</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Abdelghani</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mostafa</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Protecting Ovaries During Chemotherapy Through Gonad Suppression: A Systematic Review and Meta-analysis</article-title>
          <source>Obstet Gynecol</source>
          <year>2015</year>
          <volume>126</volume>
          <issue>1</issue>
          <fpage>187</fpage>
          <lpage>195</lpage>
          <?supplied-pmid 26241272?>
          <pub-id pub-id-type="pmid">26241272</pub-id>
        </element-citation>
      </ref>
      <ref id="CR149">
        <label>149.</label>
        <mixed-citation publication-type="other">Lambertini M, Ceppi M, Poggio F, Peccatori FA, Azim HA Jr, Ugolini D, et al. Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies. Ann Oncol 2015; 26(12):2408-19.</mixed-citation>
      </ref>
      <ref id="CR150">
        <label>150.</label>
        <mixed-citation publication-type="other">Lambertini M, Boni L, Michelotti A, Gamucci T, Scotto T, Gori S, et al. Ovarian suppression with triptorelin during adjuvant breast cancer chemotherapy and long-term ovarian function, pregnancies, and disease-free survival. A randomized clinical trial. JAMA. 2015;314(24):2632-40.</mixed-citation>
      </ref>
      <ref id="CR151">
        <label>151.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Coates</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Winer</surname>
              <given-names>EP</given-names>
            </name>
            <name>
              <surname>Goldhirsch</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gelber</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Gnant</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Piccart-Gebhart</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Tailoring therapies - improving the management of early breast cancer: St GallenInternational Expert Consensus on the Primary Therapy of Early Breast Cancer 2015</article-title>
          <source>Ann Oncol</source>
          <year>2015</year>
          <volume>26</volume>
          <issue>8</issue>
          <fpage>1533</fpage>
          <lpage>1546</lpage>
          <?supplied-pmid 25939896?>
          <pub-id pub-id-type="pmid">25939896</pub-id>
        </element-citation>
      </ref>
      <ref id="CR152">
        <label>152.</label>
        <mixed-citation publication-type="other">National Comprehensive Cancer Network (NCCN) Guidelines. <ext-link ext-link-type="uri" xlink:href="http://www.nccn.org/professionals/physician_gls/pdf/breast.pdf">http://www.nccn.org/professionals/physician_gls/pdf/breast.pdf</ext-link>. Accessed 22 Dec 2015.</mixed-citation>
      </ref>
      <ref id="CR153">
        <label>153.</label>
        <mixed-citation publication-type="other">University of York. Centre for Reviews and Dissemination. Luteinizing hormone-releasing hormone (LHRH) analogs as a strategy to protect ovarian function and fertility in premenopausal breast cancer patients undergoing chemotherapy: an individual patient data meta-analysis of randomized trials (The MOMMY study). <ext-link ext-link-type="uri" xlink:href="http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42014015638#.VLglxydetKp">http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42014015638#.VLglxydetKp</ext-link>. Accessed 22 Dec 2015.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:4700582</identifier><datestamp>2016-01-06</datestamp><setSpec>bmceb</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="http://jats.nlm.nih.gov/ns/archiving/1.0/ http://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Evol Biol</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Evol. Biol</journal-id>
      <journal-title-group>
        <journal-title>BMC Evolutionary Biology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1471-2148</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC4700582</article-id>
      <article-id pub-id-type="pmcid">PMC4700582</article-id>
      <article-id pub-id-type="pmc-uid">4700582</article-id>
      <article-id pub-id-type="publisher-id">578</article-id>
      <article-id pub-id-type="doi">10.1186/s12862-015-0578-8</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Age related decline in female lar gibbon great call performance suggests that call features correlate with physical condition</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1559-4975</contrib-id>
          <name>
            <surname>Terleph</surname>
            <given-names>Thomas A.</given-names>
          </name>
          <address>
            <phone>(203) 371-7784</phone>
            <email>terlepht@sacredheart.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Malaivijitnond</surname>
            <given-names>S.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2"/>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Reichard</surname>
            <given-names>U. H.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff4"/>
        </contrib>
        <aff id="Aff1"><label/>Department of Biology, Sacred Heart University, 5151 Park Ave, Fairfield, CT 06825 USA </aff>
        <aff id="Aff2"><label/>National Primate Research Center of Thailand, Saraburi, Thailand </aff>
        <aff id="Aff3"><label/>Department of Biology, Faculty of Science, Chulalongkorn University, Bangkok, Thailand </aff>
        <aff id="Aff4"><label/>Department of Anthropology and Center for Ecology, Southern Illinois University Carbondale, Carbondale, Il USA </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>5</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>5</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <volume>16</volume>
      <elocation-id>4</elocation-id>
      <history>
        <date date-type="received">
          <day>18</day>
          <month>8</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>21</day>
          <month>12</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© Terleph et al. 2015</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>White-handed gibbons (<italic>Hylobates lar</italic>) are small Asian apes known for living in stable territories and producing loud, elaborate vocalizations (songs), often in well-coordinated male/female duets. The female great call, the most conspicuous phrase of the repertoire, has been hypothesized to function in intra-sexual territorial defense. We therefore predicted that characteristics of the great call would correlate with a caller’s physical condition, and thus might honestly reflect resource holding potential (RHP). Because measurement of RHP is virtually impossible for wild animals, we used age as a proxy, hypothesizing that great call climaxes are difficult to produce and maintain over time, and that older adults will therefore perform lower quality great calls than young adults. To test this we analyzed the great call climaxes of 15 wild lar gibbon females at Khao Yai National Park, Thailand and 2 captive females at Leo Conservation Center, Greenwich, CT.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>Findings show that call climaxes correlate with female age, as young animals (<italic>n</italic> = 8, mean age: 12.9 years) produced climaxes with a higher frequency range (delta F0), maximum F0 frequency and duty cycle than old animals (<italic>n</italic> = 9, mean age: 29.6 years). A permuted discriminant function analysis also correctly classified calls by age group. During long song bouts the maximum F0 frequency of great call climaxes’ also decreased. Additional data support the hypothesis that short <italic>high notes</italic>, associated with rapid inhalation as an individual catches its breath, reflect increased caller effort. Older females produced more <italic>high notes</italic> than younger females, but the difference only approached statistical significance, suggesting that calling effort may be similar across different ages. Finally, for the first time in this species, we measured peak intensity of calls in captive females. They were capable of producing climaxes in excess of 100 dB at close range (2.7 m).</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>Age and within-bout differences in the lar gibbon great call climax suggest that call features correlate with physical condition and thus the call may have evolved as an honest signal in the context of intra-sexual territorial defense and possibly also in male mate choice via sexual selection, although further testing of these hypotheses is necessary.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Primate vocalizations</kwd>
        <kwd>Hylobatidae</kwd>
        <kwd>Ape communication</kwd>
        <kwd>Great call</kwd>
        <kwd>Honest signaling</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution>Goldberg Research Grant</institution>
          </funding-source>
        </award-group>
        <award-group>
          <funding-source>
            <institution>Sacred Heart University</institution>
          </funding-source>
        </award-group>
      </funding-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>© The Author(s) 2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Background</title>
      <p>Territorial vocalizations may honestly indicate an individual’s resource holding potential (RHP) if call qualities are determined by physiological constraints [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Characteristics of vocalizations, including both spectral and temporal parameters, can vary with body size, age, rank, hormonal state or fatigue level [<xref ref-type="bibr" rid="CR3">3</xref>–<xref ref-type="bibr" rid="CR13">13</xref>], all of which are measures of physical condition and can thus be assumed to also be correlates of RHP. Associations between physical condition and vocal qualities have been studied most often in male animals (exceptions: [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]), a sampling bias that may be due to the fact that males show greater variation in RHP, because they are usually thought to be under greater sexual selection pressure than females. More direct physiological measures of RHP, such as energetic output during contests, including ventilation rate or overall O<sub>2</sub> consumption (review: [<xref ref-type="bibr" rid="CR16">16</xref>]) would be extremely useful, as they could be directly related to field-based data, such as long term territory tenure or reproductive success.</p>
      <p>Because direct measures of RHP are difficult to obtain from wild animals under natural conditions [<xref ref-type="bibr" rid="CR17">17</xref>], field researchers may have to rely on indirect measures, like body size, to assess physical condition. Unfortunately, body size can likewise be difficult to measure directly in wild animals, and because of this impediment, in primate studies age has been used as a proxy for body condition [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. In fact, age may be just as reliable an indicator of RHP as size, because regardless of one’s size, physical decline that influences RHP comes with advanced age. Primate respiratory function, for example, is associated with overall health [<xref ref-type="bibr" rid="CR19">19</xref>] and progressively decreases with age [<xref ref-type="bibr" rid="CR20">20</xref>–<xref ref-type="bibr" rid="CR22">22</xref>]. An individual’s age should affect not only RHP but also the individual’s ability to produce physiologically demanding vocal signals, because changes in respiratory functioning associated with age include a reduction in the lungs’ vital capacity due to loss of elasticity and distensibility, and a reduction in abdominal muscle mass [<xref ref-type="bibr" rid="CR23">23</xref>].</p>
      <p>Measurable characteristics of song quality that are potentially influenced by lung capacity include call intensity, call rate, and note lengths [<xref ref-type="bibr" rid="CR24">24</xref>]. These vocal qualities are predicted to change with age and can therefore serve as indirect measures of RHP. While measuring call intensity from wild animals is difficult, measuring its spectral correlates is not. Two vocal parameters associated with loud calls that may signal RHP are the maximum fundamental frequency (F0) and the degree of change in F0 within a call note (delta F0). This is because F0 is dependent on subglottal pressure [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>]; so frequency and intensity are not controlled independently in the loud vocalizations of mammals [<xref ref-type="bibr" rid="CR26">26</xref>], and receivers from a variety of taxa have been shown to respond to high intensity sounds as a fitness cue [<xref ref-type="bibr" rid="CR27">27</xref>–<xref ref-type="bibr" rid="CR30">30</xref>]. Furthermore, in the red deer (<italic>Cervus elaphus</italic>), for example, females prefer male calls with a higher F0 [<xref ref-type="bibr" rid="CR31">31</xref>], and in some primates high-ranking individuals produce loud calls with a higher F0 than lower ranking animals [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]. High F0 can also signal hormonal condition: male lar gibbons (<italic>Hylobates lar</italic>) show a positive association between androgen levels and F0 [<xref ref-type="bibr" rid="CR33">33</xref>], and in other primates, e.g. male chacma baboons (<italic>Papio ursinus</italic>), androgen levels strongly correlate with social rank, and decline following a lowering in rank [<xref ref-type="bibr" rid="CR34">34</xref>].</p>
      <p>In addition to loud, high F0 signals potentially indicating that an animal has large or powerful lungs, in animals with large larynxes, like most primates, reaching a high F0 also requires extreme muscular strength to stiffen the vocal folds. Thus receivers may additionally interpret loud, high pitched calls as a fitness signal associated with larynx strength, which may correspond with overall body strength [<xref ref-type="bibr" rid="CR25">25</xref>], although to our knowledge this hypothesis has so far not been tested in primates.</p>
      <p>Temporal aspects of loud calls can also be associated with caller condition or state. Examples include young adults producing longer calls than more senior individuals [<xref ref-type="bibr" rid="CR33">33</xref>], and high-ranking males generating not only longer notes [<xref ref-type="bibr" rid="CR10">10</xref>], but also higher call rates, longer bouts and greater participation in competitive calling bouts [<xref ref-type="bibr" rid="CR35">35</xref>]. Note duration or rate may also correlate with a signaler’s immediate energy levels, potentially providing a more useful cue to an animal’s current physical condition than static body size cues [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR36">36</xref>].</p>
      <p>Gibbons (family Hylobatidae) are small Asian apes that produce loud, complex vocalizations in song bouts, and females produce the great call, often in the context of well-coordinated duets with a mate [<xref ref-type="bibr" rid="CR37">37</xref>–<xref ref-type="bibr" rid="CR39">39</xref>]. Great calls likely evolved for distance communication, as they are audible up to 1 km or further through the forest [<xref ref-type="bibr" rid="CR40">40</xref>–<xref ref-type="bibr" rid="CR42">42</xref>], although the intensity of these calls has previously been measured in only one gibbon species, the siamang (<italic>Symphalangus syndactylus</italic>) [<xref ref-type="bibr" rid="CR43">43</xref>]. The great call is thought to serve primarily as a spacing mechanism between females in inter-group communication, excluding females from each other’s territories [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR44">44</xref>–<xref ref-type="bibr" rid="CR47">47</xref>], and as such has had the potential to evolve into an honest signal of RHP.</p>
      <p>The great calls of all gibbon species have a conspicuous climax near the end, characterized by notes produced at the highest speed and/or pitch, and a peak in amplitude [<xref ref-type="bibr" rid="CR48">48</xref>]. For lar gibbons (<italic>Hylobates lar</italic>) the notes of the call climax contribute substantially to inter-individual variability and span a wide frequency range [<xref ref-type="bibr" rid="CR49">49</xref>]. The closely spaced notes of the call climax are also the loudest notes produced by females, suggesting that the climax may be difficult to produce. If this is the case, then the great call climax potentially serves as an honest signal of a caller’s physical condition and thus may have evolved in the context of resource competition between females, the social context in which great calls are often given [<xref ref-type="bibr" rid="CR41">41</xref>], or in the context of mate choice by males.</p>
      <p>Although age has not been verified experimentally to correlate with RHP in white-handed gibbons, in order to provide support for the hypothesis that the lar gibbon’s great call climax is an honest index of caller condition, we used age as the most appropriate and available proxy for RHP, given that physical strength generally declines with age, including a reduction in respiratory function [<xref ref-type="bibr" rid="CR20">20</xref>–<xref ref-type="bibr" rid="CR23">23</xref>]. We predicted that, because F0 correlates with call intensity, older animals would show (i) a lower maximum F0 frequency, (ii) a lower F0 frequency range in the highest pitched climax note (delta F0), and (iii) a smaller ratio of note to inter-note interval durations (duty cycle). If these climax parameters are constrained by a caller’s condition and thus RHP, it should become increasingly more difficult for an aging individual to maximize them, relative to a younger individual. We also predict that, if older animals have more difficulty maintaining robust call climaxes, (iv) this will be revealed by an increase in brief, high-pitched inspirations, hereafter referred to (in italics) as ‘<italic>high notes’</italic>. Our previous research has shown that <italic>high notes</italic> occur between the longer, regular expiration notes of lar gibbon great calls, in particular following the climax notes that rise in frequency or that are maintained at high frequency and intensity [<xref ref-type="bibr" rid="CR49">49</xref>]. They result from brief inhalations as the animal “catches its breath” between longer notes, with an average of two <italic>high notes</italic> occurring per great call (range: 0–5) [<xref ref-type="bibr" rid="CR49">49</xref>]. We tested the hypothesis that <italic>high notes</italic> correspond with an increased vocal effort by analyzing the length and F0 frequency of great call notes that immediately precede <italic>high notes</italic>, versus great call notes that do not, predicting that (v) <italic>high notes</italic> will follow longer, higher pitched great call climax notes that span a wider frequency range.</p>
      <p>To further test the hypothesis that our measures of the great call climax are potential indices of RHP, we analyzed how vocal parameters change within individual singing bouts, predicting that (vi) as a bout of great calls progresses, the maximum F0, delta F0, and climax duty cycle will decrease, and the number of <italic>high notes</italic> will increase, possibly because an individual’s vocal ability becomes taxed over the course of singing.</p>
      <p>Finally, we also report, for the first time in this species, the peak intensity of great call climaxes, using measurements from captive animals. By quantifying the high intensity of great call climaxes, we lend support to the hypothesis that production of great call climaxes pushes females to their physical limits.</p>
    </sec>
    <sec id="Sec2" sec-type="materials|methods">
      <title>Methods</title>
      <sec id="Sec3">
        <title>Subjects and recordings</title>
        <p>We made recordings from a large group of adult female lar gibbons, spanning a wide age range (9–45.2 years). 15 of the subjects were wild animals, recorded at the Mo Singto—Klong E-Tau long-term research site at Khao Yai National Park, Thailand (101°22’E, 14°26’N), 130 km NE of Bangkok in June-July 2013 and July-August 2014, under a research permit issued by the National Research Council of Thailand (NRCT) and the Department of National Parks, Wildlife and Plant Conservation (DNP) of Thailand. All wild lar gibbons have been habituated to the presence of researchers for decades, in some cases for their entire lifetime. We also obtained recordings from two captive female lar gibbons at the LEO Zoological Conservation Center in Greenwich, Connecticut, USA. Each captive animal was housed with an adult male in one of two large outdoor enclosures. We made all recordings with a digital solid-state recorder (Marantz PMD661, Kanagawa, Japan) and a Sennheiser microphone: K6 power module and ME67 recording head and windscreen (Sennheiser Electronic, Wedemark, Germany). All recordings were 24 bit, with a 48 kHz sample rate.</p>
        <p>All research was approved by the Institutional Animal Care Committee of Sacred Heart University, and adhered to the American Society of Primatologists Principles for the Ethical Treatment of Non-Human Primates. We avoided direct interaction with animals in all cases, but to minimize recording distances we usually approached wild gibbons close enough to record from directly underneath the tree in which an individual was vocalizing (&lt;50 m), and in direct line of sight. We recorded all calls between 6:00 and 11:00 AM, as the females engaged in morning duets with males, often in response to the calls of nearby animals. We identified individual wild animals by territory location and individual pelage color and markings based on long-term photo-records and long-term knowledge of individuals [<xref ref-type="bibr" rid="CR50">50</xref>].</p>
      </sec>
      <sec id="Sec4">
        <title>Age estimates</title>
        <p>We determined the ages of the two captive animals from birth records. The wild gibbon population has been studied for decades and all females included in our analyses have been monitored continuously since they were first recorded in the study population [<xref ref-type="bibr" rid="CR50">50</xref>–<xref ref-type="bibr" rid="CR53">53</xref>]. Precise birth records were available for six females within a window of accuracy of ±53.8 days (range 2–120 days; Table <xref rid="Tab1" ref-type="table">1</xref>). For the other wild females (<italic>N</italic> = 9) we estimated a minimum age, based on reproductive history. One female (R) was first seen as a subadult in her natal group and her birth was back-dated based on her estimated age. For the remaining 8 females, minimum age was calculated based on long-term records of reproductive history. We used age at first reproduction as the most objective measure to calculate a female’s minimum age because, compared to other developmental landmarks, age at first reproduction has shown low inter-individual variation in our population [<xref ref-type="bibr" rid="CR53">53</xref>]. Four females with unknown birth dates (A, H, NOS, S) were residents when long-term monitoring of the population began. For these females, we used date of first observation and reproductive history to calculate minimum female age. We assumed that each female was the mother of all non-adults in each group at the time of first observation and that the oldest non-adult was always the female’s first offspring. We then subtracted the age of the oldest non-adult in the group from the date the female was first recorded. For example, adult female NOS was first observed in September 1999 when she was carrying a 1-year old infant, which was the only non-adult in the group. Subtracting 1 year from September 1999 resulted in back-dating the offspring’s birth to September 1998. To estimate the female’s minimum age, we further assumed that females in our population do not give birth before the age of 10.5 years, which is the average age at first reproduction, based on long-term demographic records [<xref ref-type="bibr" rid="CR53">53</xref>]. Subtracting 10.5 years from the female’s assumed date of first reproduction then gave a minimum birth estimate for the female herself. In the case of adult female NOS, subtracting 10.5 years from September 1998 indicated that the female was born not later than March 1988. Thus, when we recorded her song in June 2013 she was at least 25 years 3 months old (Table <xref rid="Tab1" ref-type="table">1</xref>). For a second group of young females (<italic>N</italic> = 4), for whom we could not know birth dates (BD, C, D, E) because they immigrated into the study population as adults, we likewise based age estimates on first reproduction by subtracting 10.5 years from the time of these females’ recorded first parturition (Table <xref rid="Tab1" ref-type="table">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Ages of all females studied</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Female</th><th>Age at first vocal recording (years/months)</th><th>Window of accuracy (days)</th></tr></thead><tbody><tr><td colspan="3">
<bold>Females with known birth date (</bold>
<bold><italic>N</italic></bold> 
<bold>= 8)</bold>
</td></tr><tr><td> 
<bold>T</bold>
</td><td>
<bold>27/6</bold>
</td><td>
<bold>±120</bold>
</td></tr><tr><td> 
<bold>So</bold>
<sup><bold>a</bold></sup>
</td><td>
<bold>25/9</bold>
</td><td>-</td></tr><tr><td> 
<bold>G</bold>
</td><td>
<bold>23/7</bold>
</td><td>
<bold>±90</bold>
</td></tr><tr><td> 
<bold>N</bold>
</td><td>
<bold>17/7</bold>
</td><td>
<bold>±60</bold>
</td></tr><tr><td> 
<italic>M</italic>
</td><td>
<italic>16/8</italic>
</td><td>
<italic>±2</italic>
</td></tr><tr><td> 
<italic>J</italic>
</td><td>
<italic>15/0</italic>
</td><td>
<italic>±30</italic>
</td></tr><tr><td> 
<italic>W</italic>
</td><td>
<italic>11/5</italic>
</td><td>
<italic>±21</italic>
</td></tr><tr><td> 
<italic>Te</italic>
<sup><italic>a</italic></sup>
</td><td>
<italic>9/0</italic>
</td><td>
<italic>-</italic>
</td></tr><tr><td colspan="3">
<bold>Females with estimated birth date (</bold>
<bold><italic>N</italic></bold> 
<bold>= 9)</bold>
</td></tr><tr><td> 
<bold>A</bold>
</td><td>
<bold>45/2</bold>
</td><td>-</td></tr><tr><td> 
<bold>S</bold>
</td><td>
<bold>38/2</bold>
</td><td>-</td></tr><tr><td> 
<bold>H</bold>
</td><td>
<bold>34/3</bold>
</td><td>-</td></tr><tr><td> 
<bold>R</bold>
</td><td>
<bold>29/5</bold>
</td><td>-</td></tr><tr><td> 
<bold>NOS</bold>
</td><td>
<bold>25/3</bold>
</td><td>-</td></tr><tr><td> 
<italic>D</italic>
</td><td>
<italic>16/3</italic>
</td><td>
<italic>-</italic>
</td></tr><tr><td> 
<italic>E</italic>
</td><td>
<italic>13/5</italic>
</td><td>
<italic>-</italic>
</td></tr><tr><td> 
<italic>C</italic>
</td><td>
<italic>11/7</italic>
</td><td>
<italic>-</italic>
</td></tr><tr><td> 
<italic>BD</italic>
</td><td>
<italic>10/2</italic>
</td><td>
<italic>-</italic>
</td></tr></tbody></table><table-wrap-foot><p>
<sup>a</sup>denotes a captive female. The names and ages of young females (&lt; the median Age of 17 years and 7 months) are indicated by italics. The names and ages of old females are in bold</p></table-wrap-foot></table-wrap></p>
        <p>Our method of calculating female age based on first parturition potentially underestimates the age of these 4 animals, if individuals had a birth prior to their natal dispersal and/or before their emigration into the study population. However, secondary female dispersal has not yet been observed in the Khao Yai white-handed gibbon population and our approach to calculate female ages was conservative as it resulted in minimum ages. Moreover, a margin of error of only a few years is unlikely to be consequential, particularly for the purpose of grouping animals into the broad categories of young and old, given the long lifespan of the species and the broad range of ages sampled. The maximum lifespan of captive Hylobates has been reported to be 35.6 years [<xref ref-type="bibr" rid="CR54">54</xref>], but this is an underestimate, as two of the wild subjects in our study exceeded that age, at 38.2 and 45.2 years, and a captive gibbon (<italic>H. muelleri</italic>) has been reported to have lived 60 years [<xref ref-type="bibr" rid="CR55">55</xref>].</p>
      </sec>
      <sec id="Sec5">
        <title>Measurement parameters</title>
        <p>We converted all recordings of great call climaxes into spectrograms (Window type: Hann, FFT size: 512 hz, frame overlap: 50 %), using Raven Pro 1.5 Sound Analysis Software (Cornell Lab of Ornithology Bioacoustics Research Program, Ithaca, New York), and made measurements from the spectrograms. The amplitude and frequency of the lar gibbon’s great call climax rises and falls over multiple notes [<xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR49">49</xref>]; we defined it as consisting of three notes: the expiration note that reaches the highest frequency of the great call, and the notes that immediately precede and follow it (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). We measured frequency and temporal parameters from 230 great calls (mean: 13.5 calls per animal; range: 2–27). The frequency measures were maximum and range (delta) of F0 frequency for the highest note of each climax, as well as the lowest F0 frequency of the great call climax. The temporal measure was the duty cycle of each climax, and was calculated as the total duration of the three notes in a climax (signal) divided by the signal plus the sum of the inter-note intervals that followed each climax note. A larger duty cycle thus represents longer climax note output relative to the breaks between notes. We also compared the total number of <italic>high notes</italic> (rapid inspirations) per call, across all animals.<fig id="Fig1"><label>Fig. 1</label><caption><p>Waveform (top) and spectrogram (bottom) of the lar great call, from a 24 year old female. Three <italic>high notes</italic> are indicated, and represent the sounds associated with inhalations between great call notes. The three notes of the climax are also labeled. Window type: Hann, FFT size: 1124 Hz, frame overlap: 50 %. Harmonics and background noise have been removed from this image</p></caption><graphic xlink:href="12862_2015_578_Fig1_HTML" id="MO1"/></fig></p>
        <p>In addition, we combined the measures described above to create an index of call quality for each animal, to obtain a single measure that could be compared across all ages. We created the index by ranking animals, from 1 to 17 (<italic>n</italic> = 17 animals), in each of the first three measurement parameters (delta F0, maximum F0 and duty cycle). The lowest rank for a given measure, a rank of 1, was thus assigned to the animal that had the smallest value of that measure, and a rank of 17 (or the highest rank) to the animal with the highest value. Consistent with our predictions, <italic>high note</italic> production was ranked in the reverse order, so that the lowest ranked animal produced the greatest average number of <italic>high notes</italic> per call. All four ranking positions were then averaged for each animal, to produce its individual ranking index.</p>
        <p>Two age groups were compared, using separate between-subject t-tests (two tails), to test the hypothesis that broadly differing age classes are distinguishable, even if more precise ages cannot always be predicted based on call characteristics. Too few subjects were available to divide the sample further. Thus, all animals below the median age of 17.6 years were categorized as young adults (<italic>n</italic> = 8, mean age: 12.9 years, range: 9–16.7 years), and all others as old adults (<italic>n</italic> = 9, mean age: 29.6 years, range: 17.6–45.2 years) (Table <xref rid="Tab1" ref-type="table">1</xref>). For each of the measures we first calculated within-animal means, and then compared these means across all 17 animals. We corrected for multiple t-tests using the method described by Benjamini and Hochberg [<xref ref-type="bibr" rid="CR56">56</xref>], which adjusted the P level of significance from 0.05 to 0.0375. In order to explore the overall relationships between age and the call parameters across the entire population, we also made separate regressions for each measurement parameter, as a function of caller age.</p>
        <p>In order to determine how often great calls can be accurately assigned to either the young adult or old adult age groups, we also used the call parameters in a nested, permuted discriminant function analysis (pDFA) [<xref ref-type="bibr" rid="CR57">57</xref>]. We conducted the pDFA using a function written in R [<xref ref-type="bibr" rid="CR58">58</xref>] by R. Mundry, and based on the function Ida of the R package MASS [<xref ref-type="bibr" rid="CR59">59</xref>]. Delta F0 was omitted as a classification parameter for this analysis, as it was highly correlated with the maximum F0 frequency measure. Three animals (D, E and G) were also excluded from the analysis because their call sample sizes were too small (2–3 calls). The remaining 14 animals had a mean of 15.9 ± 1.8 great calls per animal (range: 6–27).</p>
        <p>In order to test the hypothesis that <italic>high notes</italic> correspond with an increase in vocal effort, we used separate paired T-tests to compare the delta F0, maximum F0, and the note duration of climax notes, depending on whether or not they were followed by a <italic>high note</italic>. We predicted that when a female exaggerates a climax note by increasing these parameters, it will require her to produce a rapid inspiration (<italic>high note</italic>), and thus <italic>high notes</italic> will follow longer notes that span a wider frequency range and reach a higher pitch.</p>
        <p>The results of our comparison of song parameters by age allowed us to predict that these parameters would change over the course of song bouts, within individuals. We were able to record bouts containing ≥ 8 great calls from seven females, all from the wild population (mean: 9.9 calls per bout; range: 8–12, mean bout length 32.8 min, range 12–54 min). Two animals produced two bouts each; for each of these animals, we averaged the note parameters from each of their bouts and used those averages to represent that animal in subsequent comparisons. We calculated the mean delta F0, maximum F0, climax duty cycle and number of <italic>high notes</italic> per great call from each animal’s bout. Since bouts differed in the number of great calls produced, in order to generate regressions that compared measurement parameters over the course of bouts, we plotted each parameter over the last 7 great calls of a given bout, as a percentage of the average value obtained from the calls that preceded these 7 calls, at the start of the bout (<italic>n</italic> = 1–5 great calls, depending on the number of calls in a given bout). We also compared parameters obtained from the first four and last four great calls of bouts, predicting that delta F0, maximum F0, and duty cycle would be decreased, and <italic>high note</italic> production increased from early to late in bouts. We used matched-sample, two-tailed t-tests to compare the early versus late bout parameters.</p>
      </sec>
      <sec id="Sec6">
        <title>Intensity measures</title>
        <p>We recorded the peak intensity (dB SPL, A scale, 125 ms ‘fast’ time weighting) of great call climaxes from the two captive animals (ages 9.0 and 25.9 years) in their outdoor enclosures, each housed with an adult male. We obtained dB measures with an SPL meter (Checkmate CM-150, Galaxy Audio, Wichita, KS) with a built in ½ inch electret condenser microphone and a windscreen (frequency range 31.5Hz-8KHz, measuring level range 30-130 dB, accuracy ±1.5 dB), and only collected data when the animals were oriented towards the microphone. Animals were separated from the microphone by wire mesh, all calls were produced and recorded from heights of over 2 m, and no major sound reflective structures were in the vicinity of the recording site, so the data are essentially free-field. As subjects were free to move within their enclosures, we had to measure from a range of distances, between 2.7 and 6.1 m. In order to control for amplitude differences due to the effect of spherical spreading, the dB of all calls obtained from distances greater than the nearest (2.7 m) call were adjusted to that distance standard by applying the inverse distance law. In order to calculate the mean dB of all peak call notes for a given individual, each dB measure was converted to intensity, these intensity measures were then averaged, and that average was then converted back into an average dB measure. Peak call amplitudes were compared between the two animals with a two-tailed between-subjects <italic>t</italic>-test.</p>
      </sec>
    </sec>
    <sec id="Sec7" sec-type="results">
      <title>Results</title>
      <sec id="Sec8">
        <title>Age and great call climaxes</title>
        <p>The differences in call parameters between the two age groups, which we describe in this section, are summarized in Fig. <xref rid="Fig2" ref-type="fig">2</xref>. Young adult females had a larger delta F0 (mean 802 ± 84 Hz, range 569 – 1206) than old females (mean 586 ± 31 Hz, range 416 – 692, T (15) = 2.70, <italic>p</italic> = 0.031). Similarly, a significant inverse relationship (<italic>r</italic> = −0.484) existed between delta F0 of the peak climax note and caller age (F (1, 15) = 4.58; <italic>p</italic> = 0.049). Young adults also produced significantly higher maximum F0 frequencies (mean 1599 ± 57 Hz, range 1387 – 1788) than old adults (mean 1441 ± 23 Hz, range 1329 – 1546, T (15) = 2.88, <italic>p</italic> = 0.02), but an inverse relationship (<italic>r</italic> = −0.474) between the maximum F0 of great call climaxes and caller age barely failed to reach statistical significance (F (1, 15) = 3.99; <italic>p</italic> = 0.06).<fig id="Fig2"><label>Fig. 2</label><caption><p>Comparisons of great call parameters between young adults (white bars) and old adults (gray bars). The overall call quality index (<bold>f</bold>) summarizes rankings derived from four parameters: delta F0 (<bold>a</bold>), maximum F0 (<bold>b</bold>), duty cycle (<bold>c</bold>) and number of <italic>high notes</italic> (<bold>d</bold>). Error bars represent ± 1 SEM. *<italic>P</italic> &lt; 0.05, ***<italic>P</italic> &lt; 0.001, NS: not significant</p></caption><graphic xlink:href="12862_2015_578_Fig2_HTML" id="MO2"/></fig></p>
        <p>The maximum F0 effects described above may be due to a general lowering of voice in older females, rather than solely due to a failure to reach higher pitch in the peak notes. Lowering of voice has been identified in other female primates, as a correlate of increased body size [<xref ref-type="bibr" rid="CR60">60</xref>], but it is not known if gibbons increase in size throughout adulthood. In order to investigate the possibility that overall F0 decreased with age, we also measured the lowest F0 frequency of the climax, but found no difference between the age groups. The lowest F0 frequency was 528 ± 7 Hz for the young adult group and 531 ± 10 Hz for the older females (T (15) = 0.20, <italic>p</italic> = 0.84). Similarly, there was no correlation between this measure and caller age, across the entire population (<italic>r</italic> = 0.006) (F (1, 15) = 0.001; <italic>p</italic> = 0.98). Based on this result, it is unlikely that the lower maximum F0 of old females was related to a general lowering of voice with increasing age, but rather to a failure to produce high climaxes.</p>
        <p>Great call climaxes from young adult females had a higher duty cycle (mean 0.76 ± 0.01, range 0.73 – 0.81) than those of old females (mean 0.71 ± 0.01, range 0.66 – 0.79) (T (15) = 2.98, <italic>p</italic> = 0.01), meaning that young females had a longer duration of notes relative to the intervals between them. The overall negative correlation (<italic>r</italic> = − 0.425) across the entire population, however, barely failed to reach significance (F (1, 15) = 3.32; <italic>p</italic> = 0.09).</p>
        <p>In contrast to the F0 and duty cycle measures, where young females were expected to show higher performance, old females were predicted to produce more <italic>high notes</italic>. Since <italic>high note</italic> averages were derived from count data, we confirmed that our <italic>high note</italic> data were normally distributed before we analyzed them, by performing a Shapiro-Wilk W Test (W = 0.95, <italic>p</italic> = 0.47). Although a trend for young females to produce fewer <italic>high notes</italic> than old females existed, it was not significant. The mean rate of <italic>high note</italic> production by young adult females was 2.17 ± 0.28 and that of the old females was 2.72 ± 0.31 (T (15) = 1.38, <italic>p</italic> = 0.18). We also did not find a significant correlation between age and the number of <italic>high notes</italic> produced per great call (r = 0.36) (F (1, 15) = 2.19; <italic>p</italic> = 0.16).</p>
        <p>The overall call quality index, a summary of the call features described above, differed between the young (mean 11.6 ± 0.63, range 8.5 – 13.75) and old females (mean 6.6 ± 1.03, range 2 – 11): T (15) = 4.25, <italic>p</italic> &lt; 0.001. The call quality index rankings also showed a negative correlation (r = − 0.68) with caller age (F (1, 15) = 13.3; <italic>p</italic> = 0.002), Fig. <xref rid="Fig3" ref-type="fig">3</xref>. The permuted discriminant function analysis, used to discriminate great calls by age group, correctly classified the calls into their respective age group at a rate significantly greater than chance (62.4 %, <italic>p</italic> = 0.022).<fig id="Fig3"><label>Fig. 3</label><caption><p>Call quality index by caller age. The call quality index is based on rankings within the population in regards to four characteristics of the female great call: The maximum F0 frequency of the climax, the delta F0 frequency of the climax, the duty cycle of the climax, and the number of <italic>high notes</italic> produced</p></caption><graphic xlink:href="12862_2015_578_Fig3_HTML" id="MO3"/></fig></p>
      </sec>
      <sec id="Sec9">
        <title><italic>High note</italic> inspirations follow longer climax notes that span a wider frequency</title>
        <p>Within individuals, climax notes that were followed by <italic>high notes</italic> were longer (mean: 1833 ± 108, range: 1520 – 2923 ms) than those not followed by <italic>high notes</italic> (mean: 1506 ± 67, range 1050 – 1819 ms) (T (16) = 3.5, <italic>p</italic> = 0.003) (Fig. <xref rid="Fig4" ref-type="fig">4a</xref>). In addition, when followed by <italic>high notes</italic>, climax notes had a higher maximum F0 frequency: (mean: 1388 ± 43, range: 1128 – 1757 Hz, versus: 957 ± 36, range: 749 – 1207 Hz) (T (16) = 9.7, p &lt; 0.0001) (Fig. <xref rid="Fig4" ref-type="fig">4b</xref>), as well as a higher delta F0 (mean: 593 ± 47, range: 323 – 1206 Hz, versus: 247 ± 19, range: 146 – 386 Hz) (T (16) = 7.68, <italic>p</italic> &lt; 0.0001) (Fig. <xref rid="Fig4" ref-type="fig">4c</xref>).<fig id="Fig4"><label>Fig. 4</label><caption><p>Analysis of climax notes that are followed by <italic>high note</italic> inhalations versus those that are not, within animals. Climax notes that are followed by <italic>high notes</italic> are longer (<bold>a</bold>), have a higher maximum F0 frequency (<bold>b</bold>) and a higher delta F0 frequency (<bold>c</bold>) than notes that are not followed by <italic>high notes</italic>. White bars: climax notes not followed by a <italic>high note</italic>, Black bars: climax notes followed by a <italic>high note</italic>. Error bars represent ± 1 SEM. **: <italic>P</italic> &lt; 0.01, ****: <italic>P</italic> &lt; 0.0001</p></caption><graphic xlink:href="12862_2015_578_Fig4_HTML" id="MO4"/></fig></p>
        <p>Because <italic>high notes</italic> are produced by inspiration and more often follow longer expiration climax notes of higher maximum F0 and delta F0, <italic>high notes</italic> may reflect a greater effort invested in producing the note that precedes them. <italic>High notes</italic> may be produced involuntarily, as a female rapidly inhales to refill lungs that were depleted by the preceding note. Thus, the production of <italic>high notes</italic> potentially indicates that a female is having difficulty producing a high quality climax, and that females with waning stamina may be forced to produce more <italic>high notes</italic> during a song bout.</p>
      </sec>
      <sec id="Sec10">
        <title>Climaxes change within song bouts</title>
        <p>Maximum F0 decreased over the course of song bouts (<italic>r</italic> = − 0.78) (F (1, 6) = 9.3; <italic>p</italic> = 0.023). Mean maximum F0 at the beginning of bouts was 1488 ± 66 Hz, and at the end 1430 ± 67 Hz. (T (6) = 2.79, <italic>p</italic> = 0.032). This frequency decrease across bouts is consistent with the notion that the production of high frequency call climaxes may be difficult to sustain. A trend of decreasing delta F0 over the course of song bouts barely failed to reach significance, (r = −0.69) (F (1, 6) = 5.5; <italic>p</italic> = 0.057), and mean delta F0 did not significantly differ between the beginning (640 ± 118 Hz) and the end (566 ± 74 Hz) of bouts: (T (6) = 1.13, <italic>p</italic> = 0.30). A trend of increasing <italic>high note</italic> production from the beginning (1.63 ± 0.32) to the end of bouts barely failed to reach statistical significance (1.84 ± 0.3) (T (6) =2.12, <italic>p</italic> = 0.078), and the overall trend over the course of the entire bouts (r = 0.66) was also not significant (F (1, 6) = 4.7; <italic>p</italic> = 0.074). We did not find a significant trend in duty cycle change over the course of bouts (<italic>r</italic> = 0.13) (F (1, 6) = 0.11; <italic>p</italic> = 0.11). Duty cycle was 0.679 ± 0.04 at the beginning of bouts, and 0.683 ± 0.04 at the end (T (6) = 0.39, <italic>p</italic> = 0.70). Extended great call bouts thus result in a decrease in maximum F0, but not in robust changes to the other call parameters.</p>
      </sec>
      <sec id="Sec11">
        <title>Climaxes can exceed 100 dB</title>
        <p>We also measured the intensity of great call climaxes. Each of the two captive animals from whom call intensity was measured was capable of producing climax notes in excess of 100 dB SPL at 2.7 m. The younger animal’s peak call intensity (mean = 105.3 dB, range 101.4-106.9 dB, <italic>n</italic> = 3) was higher than that of the older female (mean = 98.5 dB, range 80.3-103.5 dB, <italic>n</italic> = 11): t (12) = 2.2, <italic>p</italic> = 0.047), demonstrating that maximum call amplitude can differ between individuals. Whether or not such differences are associated with age will require analysis of a significantly larger sample. This finding reveals that the amplitude of lar gibbons’ great calls is comparable to vocalizations that are known for their high intensity from other species, such as the Mantled howling monkey (<italic>Alouatta palliata</italic>) calls: &gt;90 dB at 5 m [<xref ref-type="bibr" rid="CR61">61</xref>], or the roars of lions (<italic>Panthera leo</italic>): approximately 114 dB at 1 m [<xref ref-type="bibr" rid="CR62">62</xref>].</p>
      </sec>
    </sec>
    <sec id="Sec12" sec-type="discussion">
      <title>Discussion</title>
      <p>Our study is the first to demonstrate the effect of age on the production of gibbon great calls. The great call is arguably the most significant vocalization in the female gibbon’s vocal repertoire, in part due to its long-range propagation. If the differences in the call parameters that we measured correlate with physical condition, then young females may be capable of signaling high RHP to potential rivals. These hypotheses have not yet been fully tested, but our interpretation is compatible with field observations of female-female replacement, because among the females of known ages that have been observed to date, only young females have replaced old females, and not <italic>vice versa</italic> (<italic>N</italic> = 3; [<xref ref-type="bibr" rid="CR53">53</xref>]). Here we have analyzed cross-sectional data of vocalizations from multiple individuals, but in order to provide a more reliable estimation of long-term within-individual variation, a longitudinal study involving data collected at different ages from the same individuals would be needed. Cross-sectional studies run the risk of being biased by differential mortality [<xref ref-type="bibr" rid="CR63">63</xref>], but that is not likely to be the case for the species we studied, which is very long-lived, with low adult mortality.</p>
      <p>Within-bout changes to the climax of the territorial great call and measures of the high intensity of climaxes support the hypothesis that these vocalizations are produced at the limit of callers’ vocal abilities, and thus may indicate a caller’s condition or stamina. We do not yet know if this is the case, and further testing of this hypothesis would be technically challenging. Appropriate tests would require experiments that directly measure individual physical condition and relate it to our great call measures, in addition to field data showing that great calls predict, for example, territory size, quality, length of tenure on a territory, or lifetime reproductive success. Nevertheless, additional characteristics of the great call climax, and the contexts in which it occurs, are in line with the hypothesis. Climaxes have been described as “penetrating and unmusical” [<xref ref-type="bibr" rid="CR40">40</xref>], and, unlike the other notes of the species’ repertoire, often contain multiple harmonics and rapid jumps in pitch, unstable and noisy qualities that correspond with the chaotic vocal-fold vibration that typically occurs when a mammal’s vocal folds are taxed by reaching their amplitude and/or frequency limit [<xref ref-type="bibr" rid="CR64">64</xref>, <xref ref-type="bibr" rid="CR65">65</xref>]. Great calls also often fail to reach full pitch on the climax [<xref ref-type="bibr" rid="CR40">40</xref>], climax notes are sometimes ‘left out’ while the preceding rising and following falling notes are still produced (pers. observ.), and when calls are occasionally stalled or entirely aborted, it is typically just before the climax [<xref ref-type="bibr" rid="CR38">38</xref>], further suggesting that the climax is the most difficult part of the call to produce. It is also noteworthy that, during development, young adolescent and subadult lar females may practice great calls in temporal synchrony with their mother’s calling, yet usually do not produce the climax portion of the call until they are fully mature or, more often, until they sing independently of their mother [<xref ref-type="bibr" rid="CR66">66</xref>, <xref ref-type="bibr" rid="CR67">67</xref>].</p>
      <p>The great call differences by age that we have documented could reflect differences in caller motivation rather than physical ability, what game theoretical models describe as ‘aggressiveness signaling’ [<xref ref-type="bibr" rid="CR68">68</xref>]. For example, older adult females may produce softer, lower-pitched climaxes to avoid conflicts with neighbors, and not because they are incapable of producing more robust calls. Alternatively, younger adults may be more motivated to call because they have more recently acquired a territory and thus may have more to lose than an older individual who has been a long-time resident. Territory ownership is critical for female reproduction, because over the approximately three decades that the population analyzed here has been monitored, no female has successfully reproduced who was not a resident on a territory. Our findings, however, suggest that it may not be the case that the age differences in call climaxes that we have found are related to motivation. <italic>High note</italic> inhalations likely correlate with caller effort because they follow climax notes, the loudest notes that female lar gibbons produce [<xref ref-type="bibr" rid="CR49">49</xref>], and as we have shown here, when an individual produces a <italic>high note</italic>, it follows a climax note of higher average frequency, higher delta F0 and longer duration. Thus, since both young and old animals produced a similar number of <italic>high notes</italic> in their great call climaxes, they likely exert a similar effort to produce them. If the effort exerted in call production remains high throughout life, then the differences we have measured in other call parameters are more likely to be attributable to age-related physiological decline than to motivation. Similarly, <italic>high notes</italic> could potentially maintain a signal’s honesty throughout life and even within bouts, if attempts to exaggerate a climax result in the production of more of these notes, thus revealing to listeners the difficulties an individual of comparatively lower quality may have producing a climax. Playback studies would be an effective method of testing the functional significance of <italic>high notes</italic>.</p>
      <p>If the great call climax contains cues that make it an honest index of a caller’s physical condition, this does not guarantee that other animals attend to such cues, or that they are even capable of detecting the differences that we describe. It is theoretically possible that evolutionary constraints have acted to enforce honest call climaxes, but in the absence of selection specifically for honesty [<xref ref-type="bibr" rid="CR24">24</xref>]. However, as loud territorial calls that correlate with RHP have been shown to influence conspecific behavior in multiple taxa [<xref ref-type="bibr" rid="CR8">8</xref>–<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR28">28</xref>–<xref ref-type="bibr" rid="CR30">30</xref>], and because there is strong competition between gibbon females for possession of a territory [<xref ref-type="bibr" rid="CR41">41</xref>], which was likely the ultimate reason for hylobatids living in pairs [<xref ref-type="bibr" rid="CR69">69</xref>, <xref ref-type="bibr" rid="CR70">70</xref>], it is reasonable to expect that an evolutionary pressure existed for female calls to signal RHP. The current study did not test whether listeners can detect and differentially respond to the great call features that we have quantified, for which the most appropriate test would be to measure responses to great calls in playback experiments. Field observations do, however, suggest that other animals attend to the climax. The female’s mate usually ceases calling until just after the great call climax [<xref ref-type="bibr" rid="CR71">71</xref>], and neighboring animals also often pause their own duet singing until after the conclusion of another female’s great call climax (pers. observ.). The fact that males stop their calling to listen to neighboring females’ call climaxes further suggests that one possible function of the great call may be to advertise a female’s condition to prospective mates outside of her current pair bond. This is in line with mounting evidence that lar gibbons employ a mixed reproductive strategy that includes females mating polyandrously, both within multi-male groups, with neighboring males from outside the group, and with floaters arriving from more distant locations [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR53">53</xref>].</p>
      <p>Psychophysical data on primate auditory perception suggest that the maximum F0 and delta F0 differences that we quantified here (the smallest being the change in maximum F0 frequency within bouts, at approximately 4 %) are large enough to be detectable by conspecific listeners. In general, auditory thresholds are similar across many primates [<xref ref-type="bibr" rid="CR72">72</xref>], but still await measurement for gibbons. Macaques (<italic>Macaca fuscata</italic> and <italic>M. mulatta</italic>) can detect frequency changes of approximately 2–3 % for pure-tone stimuli below 2 kHz [<xref ref-type="bibr" rid="CR73">73</xref>, <xref ref-type="bibr" rid="CR74">74</xref>]. Frequency discrimination is similar for baboons [<xref ref-type="bibr" rid="CR75">75</xref>], and even greater for humans [<xref ref-type="bibr" rid="CR73">73</xref>]. Hence, if lar gibbons show frequency sensitivity like that of other primates, the variation in maximum F0 and delta F0 that we report here between age groups and over the course of bouts should be detectable. Similarly, detecting the production of <italic>high notes</italic> is likely to be trivial for immediate neighbors, as human observers easily hear <italic>high notes</italic> from distances that are typical of encounters between neighboring animals [<xref ref-type="bibr" rid="CR49">49</xref>]. But <italic>high notes</italic> should not be discriminable at greater distances, as they are of high frequency and low amplitude and therefore attenuate rapidly in a forest environment. If <italic>high note</italic> detection is only possible between immediate neighbors, then those neighbors may be able to discriminate calls more accurately than distant animals, who generally pose more of a threat to one’s territory than an immediate neighbor [<xref ref-type="bibr" rid="CR76">76</xref>]. However, if <italic>high notes</italic> are involuntarily produced from rapid inhalation when a female “catches her breath” after producing a robust climax note, then natural selection would likely act to minimize this potential cue of low RHP. More tests are needed to explore the significance of great call <italic>high notes</italic>, especially because we did not find age differences in their production.</p>
      <p>Our measurements of peak call intensity were all obtained from the highest pitched expirations of the call climax, demonstrating that intensity and frequency are correlated in the great call, and likely interdependent. Similarly, a positive correlation between amplitude and F0 occurs in loud vocalizations from multiple taxa [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR77">77</xref>, <xref ref-type="bibr" rid="CR78">78</xref>], and high F0 has been positively associated with social rank as well [<xref ref-type="bibr" rid="CR10">10</xref>]. As amplitude and F0 are often correlated, receivers could theoretically attend to either one, or both parameters. For lar gibbon great calls, however, maximum F0 is likely to be more reliably transmitted to receivers than intensity. This is because call intensity should vary much more than frequency, both between and within calls, as the caller is often changing her directional orientation. These changes are in fact typical during climaxes, when a female may perform acrobatic locomotor displays that include leaping between tree branches [<xref ref-type="bibr" rid="CR79">79</xref>]. Additional studies are needed to analyze the relationship between intensity and the spectral and temporal features of great calls. Of the up to 19 currently recognized gibbon species [<xref ref-type="bibr" rid="CR80">80</xref>], call intensity has only been measured in one other species, the siamang (<italic>Symphalangus syndactylus</italic>) [<xref ref-type="bibr" rid="CR43">43</xref>]. The maximum intensity reported for siamang calls was between 95 to 113 dB SPL, but measurements were taken at varying distances that were not reported for each call, so a direct comparison to the lar female’s peak call intensity, which we report here, is not possible.</p>
      <p>Although many studies that analyze the temporal features of calls have measured note duration [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR81">81</xref>] or note rates [<xref ref-type="bibr" rid="CR82">82</xref>, <xref ref-type="bibr" rid="CR83">83</xref>], we chose a more complex parameter, the duty cycle of call climaxes. We chose this as a potential correlate of caller age because selection does not seem to have favored either long note durations or enough notes to emphasize a rapid delivery rate in the lar gibbon call climax. In regard to note durations, in all gibbon species whose great calls have been analyzed, the climaxes are characterized by multiple notes of short duration, and this appears to be the ancestral condition for hylobatids [<xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR79">79</xref>]. Furthermore, lar gibbon climax notes are high-pitched and loud, features associated with a rapid emptying of the lungs and therefore not expected to correlate with a maximization of note duration, especially because the climax is spread over multiple notes. We also did not expect note rate to differ by age or across bouts because, relative to other gibbon species [<xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR79">79</xref>], the lar gibbon’s call climax has only a few notes that are produced at a relatively low rate. In contrast, even if selection has not specifically favored long notes or a rapid delivery rate in lar great call climaxes, a high ratio of note to inter-note interval duration (duty cycle) is potentially an index of caller condition because it provides a single metric that summarizes the duration in which multiple loud, high pitched call notes can be sustained, relative to the time needed to refill the lungs between them. It is reasonable to assume that potential indices of caller condition like this, and others [<xref ref-type="bibr" rid="CR24">24</xref>], can include integrals of multiple features, especially in the context of a complex, multi-component vocalization such as the great call. Furthermore, if gibbons attend to multiple features of their neighbor’s calls, they may be able to assess age and thus potentially RHP with greater accuracy, as the overall call quality indices that we report here suggest.</p>
      <p>Our within-bout results revealed a decrease in maximum F0, similar to the negative age-effect. But unlike the effect of age, no change in duty cycle was observed over the course of bouts. Overall, the within-bout changes that we observed support the notion that the production of great call climaxes with a high F0 cannot be sustained over prolonged bouts. Unfortunately, our within-bout sample contained too few callers to allow for age comparisons across extended bouts.</p>
      <p>It is not known what specific proximate mechanisms are responsible for the age-related changes to vocal output that we report. Reproductive hormonal condition is one likely candidate. Although there is an association between androgen level and call qualities in male lar gibbons [<xref ref-type="bibr" rid="CR33">33</xref>], the effect of hormones on female great calls has not yet been studied, and is technically challenging as hormone levels fluctuate considerably across the menstrual cycle [<xref ref-type="bibr" rid="CR80">80</xref>]. Changes in female vocal quality are known to occur throughout life in humans, including during menstruation, pregnancy and menopause [<xref ref-type="bibr" rid="CR85">85</xref>, <xref ref-type="bibr" rid="CR86">86</xref>], and estrogen deprivation associated with menopause changes the mucous membrane lining of the vocal tract which can lead to voice changes [<xref ref-type="bibr" rid="CR23">23</xref>]. Hormonal state is also correlated with changes to the voice in yellow baboons (<italic>Papio cynocephalus cynocephalus</italic>) [<xref ref-type="bibr" rid="CR87">87</xref>], and Barbary macaques (<italic>M. sylvanus</italic>) [<xref ref-type="bibr" rid="CR14">14</xref>].</p>
      <p>Changes to the female voice, especially those mediated by sex steroid hormones, may influence mate choice by males. Barbary macaque males, for example, respond more strongly to female calls that signal an increased probability of conception [<xref ref-type="bibr" rid="CR14">14</xref>], and in humans the female voice is rated as more attractive by men as the probability of conception increases [<xref ref-type="bibr" rid="CR88">88</xref>]. Similar hormonally-influenced vocal cues may be of particular importance in gibbon signaling, as they have the potential to provide information to neighboring males when visual cues, such as sexual swellings, are difficult to assess. Lar gibbons produce only moderate sexual swellings [<xref ref-type="bibr" rid="CR84">84</xref>], and inhabit dense forest environments that limit the effectiveness of visual signals. In contrast to visual signals, the great call climax is an effective long-range signal. Although white-handed gibbons are primarily pair-living, long-term demographic data from Khao Yai show that females change a social partner several times over the reproductive life-span [<xref ref-type="bibr" rid="CR53">53</xref>]. Thus, selection may have promoted a long-range signal in lar gibbon females that could not only signal her RHP, but also might increase her attractiveness to males in the area, thereby increasing her own reproductive success.</p>
    </sec>
    <sec id="Sec13" sec-type="conclusion">
      <title>Conclusion</title>
      <p>Here we have shown that a vocal signal, the great call climax of female lar gibbons, often exceeds 100 dB SPL at close range and shows declines in frequency with age and within bouts, as well as age-related declines in temporal characteristics. If the measures that we used are predictive of an animal’s RHP, which is not yet known, then these findings suggest that the great call might serve as an index of caller condition in the context of female-female competition in territorial defense, and potentially also for attracting a mate(s). Further studies are needed to explore these possibilities.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The authors report no competing interests.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors’ contributions</bold>
        </p>
        <p>TT conceived and designed the study, collected data and drafted the manuscript. SM participated in study design and execution, and helped draft the manuscript. UR also conceived and designed the study, collected data and helped draft the manuscript. All authors read and approved the final manuscript.</p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgements</title>
      <p>Thanks to the National Research Council of Thailand for research permits, and the Department of the National Parks, Wildlife, and Plant Conservation for park permits. We also thank K. Homsud and K. Srinoppawan, Superintendents of Khao Yai National Park, Marcella Leone, Director of the LEO Zoological Conservation Center, and R. Mundry, for his assistance with the pDFA test.</p>
      <sec id="FPar1">
        <title>Funding</title>
        <p>Goldberg Research Grant, Nacey Maggioncalda Foundation and a URCG grant, Sacred Heart University to T. Terleph.</p>
      </sec>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Vehrencamp</surname>
              <given-names>SL</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Espmark</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Amundsen</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Rosenqvist</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Handicap, index, and conventional signal elements of bird song</article-title>
          <source>Animal Signals: Signaling and Signal Design in Animal Communication</source>
          <year>2000</year>
          <publisher-loc>Trondheim</publisher-loc>
          <publisher-name>Tapir Publishers</publisher-name>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Maynard Smith</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Harper</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <source>Animal Signals</source>
          <year>2003</year>
          <publisher-loc>Oxford</publisher-loc>
          <publisher-name>Oxford U Press</publisher-name>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Davies</surname>
              <given-names>NB</given-names>
            </name>
            <name>
              <surname>Halliday</surname>
              <given-names>TR</given-names>
            </name>
          </person-group>
          <article-title>Deep croaks and fighting assessment in toads <italic>Bufo bufo</italic></article-title>
          <source>Nature</source>
          <year>1978</year>
          <volume>274</volume>
          <fpage>683</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="doi">10.1038/274683a0</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Clutton-Brock</surname>
              <given-names>TH</given-names>
            </name>
            <name>
              <surname>Albon</surname>
              <given-names>SD</given-names>
            </name>
          </person-group>
          <article-title>The roaring of red deer and the evolution of honest advertising</article-title>
          <source>Behaviour</source>
          <year>1979</year>
          <volume>69</volume>
          <fpage>145</fpage>
          <lpage>70</lpage>
          <pub-id pub-id-type="doi">10.1163/156853979X00449</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ryan</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Brenowitz</surname>
              <given-names>EA</given-names>
            </name>
          </person-group>
          <article-title>The role of body size, phylogeny, and ambient noise in the evolution of bird song</article-title>
          <source>Am Nat.</source>
          <year>1985</year>
          <volume>126</volume>
          <fpage>87</fpage>
          <lpage>100</lpage>
          <pub-id pub-id-type="doi">10.1086/284398</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Inoue</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Age gradations in vocalization and body weight in Japanese monkeys (<italic>Macaca fuscata</italic>)</article-title>
          <source>Folia Primatol.</source>
          <year>1988</year>
          <volume>51</volume>
          <fpage>76</fpage>
          <lpage>86</lpage>
          <pub-id pub-id-type="doi">10.1159/000156359</pub-id>
          <?supplied-pmid 3254854?>
          <pub-id pub-id-type="pmid">3254854</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bee</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Perrill</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Owen</surname>
              <given-names>PC</given-names>
            </name>
          </person-group>
          <article-title>Size assessment in simulated territorial encounters between male green frogs (<italic>Rana clamitans</italic>)</article-title>
          <source>Behav Ecol Sociobiol.</source>
          <year>1999</year>
          <volume>45</volume>
          <fpage>177</fpage>
          <lpage>84</lpage>
          <pub-id pub-id-type="doi">10.1007/s002650050551</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <mixed-citation publication-type="other">Sanvito S, Galimberti F, Miller EH. Vocal signalling of male southern elephant seals is honest but imprecise Anim Behav. 2007;73:287–299. </mixed-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reby</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>McComb</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Anatomical constraints generate honesty: acoustic cues to age and weight in the roars of red deer stags</article-title>
          <source>Anim Behav.</source>
          <year>2003</year>
          <volume>65</volume>
          <fpage>519</fpage>
          <lpage>30</lpage>
          <pub-id pub-id-type="doi">10.1006/anbe.2003.2078</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fischer</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kitchen</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Seyfarth</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Cheney</surname>
              <given-names>DL</given-names>
            </name>
          </person-group>
          <article-title>Baboon loud calls advertise male quality: acoustic features and their relation to rank, age, and exhaustion</article-title>
          <source>Behav Ecol Sociobiol.</source>
          <year>2004</year>
          <volume>56</volume>
          <fpage>140</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1007/s00265-003-0739-4</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ey</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Hammerschmidt</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Seyfarth</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Fischer</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Age-and sex-related variations in clear calls of <italic>Papio ursinus</italic></article-title>
          <source>Int J Primatol.</source>
          <year>2007</year>
          <volume>28</volume>
          <fpage>947</fpage>
          <lpage>60</lpage>
          <pub-id pub-id-type="doi">10.1007/s10764-007-9139-3</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vannoni</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>McElligott</surname>
              <given-names>AG</given-names>
            </name>
          </person-group>
          <article-title>Low frequency groans indicate larger and more dominant fallow deer (<italic>Dama dama</italic>) males</article-title>
          <source>PLoS One</source>
          <year>2008</year>
          <volume>3</volume>
          <fpage>e3113</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0003113</pub-id>
          <?supplied-pmid 18769619?>
          <pub-id pub-id-type="pmid">18769619</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Erb</surname>
              <given-names>WM</given-names>
            </name>
            <name>
              <surname>Hodges</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Hammerschmidt</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Individual, contextual, and age-related acoustic variation in simakobu (<italic>Simias concolor</italic>) loud calls</article-title>
          <source>PLoS One</source>
          <year>2013</year>
          <volume>8</volume>
          <issue>12</issue>
          <fpage>e83131</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0083131</pub-id>
          <?supplied-pmid 24376651?>
          <pub-id pub-id-type="pmid">24376651</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Semple</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>McComb</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Perception of female reproductive state from vocal cues in a mammal species</article-title>
          <source>P Roy Soc Lond B Bio.</source>
          <year>2000</year>
          <volume>267</volume>
          <fpage>707</fpage>
          <lpage>12</lpage>
          <pub-id pub-id-type="doi">10.1098/rspb.2000.1060</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Langmore</surname>
              <given-names>NE</given-names>
            </name>
            <name>
              <surname>Davies</surname>
              <given-names>NB</given-names>
            </name>
            <name>
              <surname>Hatchwell</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Hartley</surname>
              <given-names>IR</given-names>
            </name>
          </person-group>
          <article-title>Female song attracts males in the alpine accentor <italic>Prunella collaris</italic></article-title>
          <source>P Roy Soc Lond B Bio.</source>
          <year>1996</year>
          <volume>263</volume>
          <fpage>141</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.1098/rspb.1996.0022</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Briffa</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sneddon</surname>
              <given-names>LU</given-names>
            </name>
          </person-group>
          <article-title>Physiological constraints on contest behavior</article-title>
          <source>Funct Ecol.</source>
          <year>2007</year>
          <volume>21</volume>
          <fpage>627</fpage>
          <lpage>37</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-2435.2006.01188.x</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ulijaszek</surname>
              <given-names>SJ</given-names>
            </name>
          </person-group>
          <article-title>Human energetic methods in biological anthropology</article-title>
          <source>Yearb Phys Anthropol</source>
          <year>1992</year>
          <volume>35</volume>
          <fpage>215</fpage>
          <lpage>42</lpage>
          <pub-id pub-id-type="doi">10.1002/ajpa.1330350609</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hammerschmidt</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Freundstein</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Jurgens</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>Vocal development in squirrel monkeys</article-title>
          <source>Behaviour</source>
          <year>2001</year>
          <volume>138</volume>
          <fpage>1179</fpage>
          <lpage>204</lpage>
          <pub-id pub-id-type="doi">10.1163/156853901753287190</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wahba</surname>
              <given-names>WM</given-names>
            </name>
          </person-group>
          <article-title>Influence of aging on lung function - clinical significance of changes from age twenty</article-title>
          <source>Anesth Analg.</source>
          <year>1983</year>
          <volume>62</volume>
          <fpage>764</fpage>
          <lpage>76</lpage>
          <pub-id pub-id-type="doi">10.1213/00000539-198308000-00011</pub-id>
          <?supplied-pmid 6346955?>
          <pub-id pub-id-type="pmid">6346955</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Awan</surname>
              <given-names>SN</given-names>
            </name>
          </person-group>
          <article-title>The aging female voice: acoustic and respiratory data</article-title>
          <source>Clin Linguist Phonet</source>
          <year>2006</year>
          <volume>20</volume>
          <fpage>171</fpage>
          <lpage>80</lpage>
          <pub-id pub-id-type="doi">10.1080/02699200400026918</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Quanjer</surname>
              <given-names>PH</given-names>
            </name>
            <name>
              <surname>Stanojevic</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Cole</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Baur</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Hall</surname>
              <given-names>GL</given-names>
            </name>
            <name>
              <surname>Culver</surname>
              <given-names>BH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations</article-title>
          <source>Eur Respir J.</source>
          <year>2012</year>
          <volume>40</volume>
          <fpage>1324</fpage>
          <lpage>43</lpage>
          <pub-id pub-id-type="doi">10.1183/09031936.00080312</pub-id>
          <?supplied-pmid 22743675?>
          <pub-id pub-id-type="pmid">22743675</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Herring</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Avdalovic</surname>
              <given-names>MV</given-names>
            </name>
            <name>
              <surname>Quesenberry</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Putney</surname>
              <given-names>LF</given-names>
            </name>
            <name>
              <surname>Tyler</surname>
              <given-names>NK</given-names>
            </name>
            <name>
              <surname>Ventimiglia</surname>
              <given-names>FF</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Accelerated structural decrements in the aging female rhesus macaque lung compared with males</article-title>
          <source>Am J Physiol Lung Cell Mol Physiol.</source>
          <year>2013</year>
          <volume>304</volume>
          <fpage>125</fpage>
          <lpage>34</lpage>
          <pub-id pub-id-type="doi">10.1152/ajplung.00226.2012</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sataloff</surname>
              <given-names>RT</given-names>
            </name>
            <name>
              <surname>Rosen</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Hawkshaw</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Spiegel</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>The three ages of voice, the aging adult voice</article-title>
          <source>J Voice.</source>
          <year>1997</year>
          <volume>2</volume>
          <fpage>156</fpage>
          <lpage>60</lpage>
          <pub-id pub-id-type="doi">10.1016/S0892-1997(97)80072-0</pub-id>
          <pub-id pub-id-type="pmid">9181537</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Fitch</surname>
              <given-names>WT</given-names>
            </name>
            <name>
              <surname>Hauser</surname>
              <given-names>MD</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Simmons</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Fay</surname>
              <given-names>RR</given-names>
            </name>
            <name>
              <surname>Popper</surname>
              <given-names>AN</given-names>
            </name>
          </person-group>
          <article-title>Unpacking “honesty”: vertebrate vocal production and the evolution of acoustic signals</article-title>
          <source>Acoustic Communications</source>
          <year>2002</year>
          <publisher-loc>New York</publisher-loc>
          <publisher-name>Springer</publisher-name>
          <fpage>65</fpage>
          <lpage>137</lpage>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Titze</surname>
              <given-names>IR</given-names>
            </name>
            <name>
              <surname>Riede</surname>
              <given-names>TA</given-names>
            </name>
          </person-group>
          <article-title>cervid vocal fold model suggests greater glottal efficiency in calling at high frequencies</article-title>
          <source>PLoS Comput Biol</source>
          <year>2010</year>
          <volume>6</volume>
          <fpage>e1000897</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pcbi.1000897</pub-id>
          <?supplied-pmid 20808882?>
          <pub-id pub-id-type="pmid">20808882</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Titze</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>On the relation between subglottal pressure and fundamental frequency in phonation</article-title>
          <source>J Acoust Soc Am.</source>
          <year>1989</year>
          <volume>85</volume>
          <fpage>901</fpage>
          <lpage>906</lpage>
          <pub-id pub-id-type="doi">10.1121/1.397562</pub-id>
          <?supplied-pmid 2926005?>
          <pub-id pub-id-type="pmid">2926005</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ritschard</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Riebel</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Brumm</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Female zebra finches prefer high amplitude song</article-title>
          <source>Anim Behav.</source>
          <year>2010</year>
          <volume>79</volume>
          <fpage>877</fpage>
          <lpage>83</lpage>
          <pub-id pub-id-type="doi">10.1016/j.anbehav.2009.12.038</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Latimer</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Sippel</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Acoustic cues for female choice and male competition in <italic>Tettigonia cantans</italic></article-title>
          <source>Anim Behav.</source>
          <year>1987</year>
          <volume>35</volume>
          <fpage>887</fpage>
          <lpage>900</lpage>
          <pub-id pub-id-type="doi">10.1016/S0003-3472(87)80124-0</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Arak</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Female mate selection in the natterjack toad: active choice or passive attraction?</article-title>
          <source>Behav Ecol Sociobiol.</source>
          <year>1988</year>
          <volume>22</volume>
          <fpage>317</fpage>
          <lpage>27</lpage>
        </element-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Castellano</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Rosso</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Laoretti</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Doglio</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Giacoma</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Call intensity and female preferences in the European green toad</article-title>
          <source>Ethology</source>
          <year>2000</year>
          <volume>106</volume>
          <fpage>1129</fpage>
          <lpage>41</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1439-0310.2000.00639.x</pub-id>
        </element-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reby</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Charlton</surname>
              <given-names>BD</given-names>
            </name>
            <name>
              <surname>Locatelli</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>McComb</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Oestrous red deer hinds prefer male roars with higher fundamental frequencies</article-title>
          <source>P Roy Soc Lond B Bio.</source>
          <year>2010</year>
          <volume>277</volume>
          <fpage>2747</fpage>
          <lpage>53</lpage>
          <pub-id pub-id-type="doi">10.1098/rspb.2010.0467</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Riede</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Arcadi</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Owren</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Nonlinear acoustics in the pant hoots of common chimpanzees (<italic>Pan troglodytes</italic>): vocalizing at the edge</article-title>
          <source>J Acoust Soc Am.</source>
          <year>2007</year>
          <volume>121</volume>
          <fpage>1758</fpage>
          <lpage>67</lpage>
          <pub-id pub-id-type="doi">10.1121/1.2427115</pub-id>
          <?supplied-pmid 17407912?>
          <pub-id pub-id-type="pmid">17407912</pub-id>
        </element-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barelli</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Mundry</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Heistermann</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hammerschmidt</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Cues to androgens and quality in male gibbon songs</article-title>
          <source>PLoS One</source>
          <year>2013</year>
          <volume>8</volume>
          <fpage>e82748</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0082748</pub-id>
          <?supplied-pmid 24367551?>
          <pub-id pub-id-type="pmid">24367551</pub-id>
        </element-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gesquiere</surname>
              <given-names>LR</given-names>
            </name>
            <name>
              <surname>Learn</surname>
              <given-names>NH</given-names>
            </name>
            <name>
              <surname>Simao</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Onyango</surname>
              <given-names>PO</given-names>
            </name>
            <name>
              <surname>Alberts</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Altmann</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Life at the top: rank and stress in wild male baboons</article-title>
          <source>Science.</source>
          <year>2011</year>
          <volume>333</volume>
          <fpage>357</fpage>
          <lpage>60</lpage>
          <pub-id pub-id-type="doi">10.1126/science.1207120</pub-id>
          <?supplied-pmid 21764751?>
          <pub-id pub-id-type="pmid">21764751</pub-id>
        </element-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kitchen</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Seyfarth</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Fischer</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Cheney</surname>
              <given-names>DL</given-names>
            </name>
          </person-group>
          <article-title>Loud calls as indicators of dominance in male baboons (<italic>Papio cynocephalus ursinus</italic>)</article-title>
          <source>Behav Ecol Sociobiol.</source>
          <year>2003</year>
          <volume>53</volume>
          <fpage>374</fpage>
          <lpage>84</lpage>
        </element-citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fitch</surname>
              <given-names>WT</given-names>
            </name>
            <name>
              <surname>Hauser</surname>
              <given-names>MD</given-names>
            </name>
          </person-group>
          <article-title>Vocal production in nonhuman primates: Acoustics, physiology, and functional constraints on "honest" advertisement</article-title>
          <source>Am J Primatol.</source>
          <year>1995</year>
          <volume>37</volume>
          <fpage>191</fpage>
          <lpage>219</lpage>
          <pub-id pub-id-type="doi">10.1002/ajp.1350370303</pub-id>
        </element-citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marshall</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Marshall</surname>
              <given-names>ER</given-names>
            </name>
          </person-group>
          <article-title>Gibbons and their territorial songs</article-title>
          <source>Science</source>
          <year>1976</year>
          <volume>193</volume>
          <fpage>235</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.1126/science.193.4249.235</pub-id>
          <?supplied-pmid 17796155?>
          <pub-id pub-id-type="pmid">17796155</pub-id>
        </element-citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Haimoff</surname>
              <given-names>EH</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Preuschoft</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Chivers</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Brockelman</surname>
              <given-names>WY</given-names>
            </name>
            <name>
              <surname>Creel</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Acoustic and organizational features of gibbon songs</article-title>
          <source>The lesser apes: evolutionary and behavioural biology</source>
          <year>1984</year>
          <publisher-loc>Edinburgh</publisher-loc>
          <publisher-name>Edinburgh University Press</publisher-name>
        </element-citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="editor">
            <name>
              <surname>Preuschoft</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Chivers</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Brockelman</surname>
              <given-names>WY</given-names>
            </name>
            <name>
              <surname>Creel</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <source>The lesser apes: evolutionary and behavioural biology</source>
          <year>1984</year>
          <publisher-loc>Edinburgh</publisher-loc>
          <publisher-name>Edinburgh University Press</publisher-name>
        </element-citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Raemaekers</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Raemaekers</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Haimoff</surname>
              <given-names>EH</given-names>
            </name>
          </person-group>
          <article-title>Loud calls of the gibbon (<italic>Hylobates lar</italic>) - repertoire, organization and context</article-title>
          <source>Behaviour</source>
          <year>1984</year>
          <volume>91</volume>
          <fpage>146</fpage>
          <lpage>89</lpage>
          <pub-id pub-id-type="doi">10.1163/156853984X00263</pub-id>
        </element-citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reichard</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Sommer</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Group encounters in wild gibbons (<italic>Hylobates lar</italic>): agonism, affiliation, and the concept of infanticide</article-title>
          <source>Behaviour</source>
          <year>1997</year>
          <volume>134</volume>
          <fpage>1135</fpage>
          <lpage>74</lpage>
          <pub-id pub-id-type="doi">10.1163/156853997X00106</pub-id>
        </element-citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Asensio</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Brockelman</surname>
              <given-names>WY</given-names>
            </name>
            <name>
              <surname>Malaivijitnond</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Reichard</surname>
              <given-names>UH</given-names>
            </name>
          </person-group>
          <article-title>White-handed gibbon (<italic>Hylobates lar</italic>) core area use over a short-time scale</article-title>
          <source>Biotropica</source>
          <year>2014</year>
          <volume>46</volume>
          <fpage>461</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1111/btp.12121</pub-id>
        </element-citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Todd</surname>
              <given-names>NPM</given-names>
            </name>
            <name>
              <surname>Merker</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Siamang gibbons exceed the saccular threshold: intensity of the song of <italic>Hylobates syndactylus</italic></article-title>
          <source>J Acoust Soc Am.</source>
          <year>2004</year>
          <volume>115</volume>
          <fpage>3077</fpage>
          <lpage>80</lpage>
          <pub-id pub-id-type="doi">10.1121/1.1736273</pub-id>
          <?supplied-pmid 15237832?>
          <pub-id pub-id-type="pmid">15237832</pub-id>
        </element-citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mitani</surname>
              <given-names>JC</given-names>
            </name>
          </person-group>
          <article-title>Gibbon song duets and intergroup spacing</article-title>
          <source>Behaviour</source>
          <year>1985</year>
          <volume>92</volume>
          <fpage>59</fpage>
          <lpage>96</lpage>
          <pub-id pub-id-type="doi">10.1163/156853985X00389</pub-id>
        </element-citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Raemaekers</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Raemaekers</surname>
              <given-names>PM</given-names>
            </name>
          </person-group>
          <article-title>Field playback of loud calls to gibbons (<italic>Hylobates lar</italic>): territorial, sex-specific and species-specific responses</article-title>
          <source>Anim Behav.</source>
          <year>1985</year>
          <volume>33</volume>
          <fpage>481</fpage>
          <lpage>93</lpage>
          <pub-id pub-id-type="doi">10.1016/S0003-3472(85)80071-3</pub-id>
        </element-citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cowlishaw</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Song function in gibbons</article-title>
          <source>Behaviour</source>
          <year>1992</year>
          <volume>121</volume>
          <fpage>131</fpage>
          <lpage>53</lpage>
          <pub-id pub-id-type="doi">10.1163/156853992X00471</pub-id>
        </element-citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cheyne</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Chivers</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Sugardjito</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Covariation in the great calls of rehabilitant and wild gibbons <italic>Hylobates agilis albibarbis</italic></article-title>
          <source>Raffles Bull Zool</source>
          <year>2007</year>
          <volume>55</volume>
          <fpage>201</fpage>
          <lpage>7</lpage>
        </element-citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Geissmann</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <source>Evolution of communication in gibbons (Hylobatidae)</source>
          <year>1993</year>
          <publisher-loc>Faculty II</publisher-loc>
          <publisher-name>Ph.D: Zürich University Anthropological Institute, Philosoph</publisher-name>
        </element-citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Terleph</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Malaivijitnond</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Reichard</surname>
              <given-names>UH</given-names>
            </name>
          </person-group>
          <article-title>Lar gibbon (<italic>Hylobates lar</italic>) great call reveals individual caller identity</article-title>
          <source>Am J Primatol.</source>
          <year>2015</year>
          <volume>77</volume>
          <fpage>811</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="doi">10.1002/ajp.22406</pub-id>
          <?supplied-pmid 25800578?>
          <pub-id pub-id-type="pmid">25800578</pub-id>
        </element-citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Reichard</surname>
              <given-names>UH</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Lappan</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Whittacker</surname>
              <given-names>DJ</given-names>
            </name>
          </person-group>
          <article-title>Social organization and mating system of Khao Yai white-handed gibbons, 1992–2006</article-title>
          <source>The gibbons: new perspectives on small ape socioecology and population biology</source>
          <year>2009</year>
          <publisher-loc>NY</publisher-loc>
          <publisher-name>Springer</publisher-name>
        </element-citation>
      </ref>
      <ref id="CR51">
        <label>51.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brockelman</surname>
              <given-names>WY</given-names>
            </name>
            <name>
              <surname>Reichard</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Treesucon</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Raemaekers</surname>
              <given-names>JJ</given-names>
            </name>
          </person-group>
          <article-title>Dispersal, pair formation and social structure in gibbons (<italic>Hylobates lar</italic>)</article-title>
          <source>Behav Ecol Sociobiol.</source>
          <year>1998</year>
          <volume>42</volume>
          <fpage>329</fpage>
          <lpage>39</lpage>
          <pub-id pub-id-type="doi">10.1007/s002650050445</pub-id>
        </element-citation>
      </ref>
      <ref id="CR52">
        <label>52.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barelli</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Boesch</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Heistermann</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Reichard</surname>
              <given-names>UH</given-names>
            </name>
          </person-group>
          <article-title>Female white-handed gibbons (<italic>Hylobates lar</italic>) lead group movements and have priority of access to food resources</article-title>
          <source>Behaviour</source>
          <year>2008</year>
          <volume>145</volume>
          <fpage>965</fpage>
          <lpage>81</lpage>
          <pub-id pub-id-type="doi">10.1163/156853908784089243</pub-id>
        </element-citation>
      </ref>
      <ref id="CR53">
        <label>53.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Reichard</surname>
              <given-names>UH</given-names>
            </name>
            <name>
              <surname>Ganpanakngan</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Barelli</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Kappeler</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Watts</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>White handed gibbons of Khao Yai: social flexibility, reproductive strategies, and a slow life history</article-title>
          <source>Long-term field studies of primates</source>
          <year>2012</year>
          <publisher-loc>Berlin</publisher-loc>
          <publisher-name>Springer</publisher-name>
        </element-citation>
      </ref>
      <ref id="CR54">
        <label>54.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Judge</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Carey</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Postreproductive life predicted by primate patterns</article-title>
          <source>J Gerontol Biol Sci.</source>
          <year>2000</year>
          <volume>55</volume>
          <fpage>201</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1093/gerona/55.4.B201</pub-id>
        </element-citation>
      </ref>
      <ref id="CR55">
        <label>55.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Geissmann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Geschke</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Blanchard</surname>
              <given-names>BJ</given-names>
            </name>
          </person-group>
          <article-title>Longevity in gibbons (Hylobatidae)</article-title>
          <source>Gibbon J.</source>
          <year>2009</year>
          <volume>5</volume>
          <fpage>81</fpage>
          <lpage>92</lpage>
        </element-citation>
      </ref>
      <ref id="CR56">
        <label>56.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Benjamini</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Hochberg</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Controlling the false discovery rate: a practical and powerful approach to multiple testing</article-title>
          <source>J R Stat Soc Series B Stat Methodol.</source>
          <year>1995</year>
          <volume>57</volume>
          <fpage>289</fpage>
          <lpage>300</lpage>
        </element-citation>
      </ref>
      <ref id="CR57">
        <label>57.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mundry</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sommer</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Discriminant function analysis with nonindependent data: consequences and an alternative</article-title>
          <source>Anim Behav.</source>
          <year>2007</year>
          <volume>74</volume>
          <fpage>965</fpage>
          <lpage>976</lpage>
          <pub-id pub-id-type="doi">10.1016/j.anbehav.2006.12.028</pub-id>
        </element-citation>
      </ref>
      <ref id="CR58">
        <label>58.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>R Core Team</collab>
          </person-group>
          <source>R: A language and environment for statistical computing</source>
          <year>2015</year>
          <publisher-loc>Vienna, Austria</publisher-loc>
          <publisher-name>R Foundation for Statistical Computing</publisher-name>
        </element-citation>
      </ref>
      <ref id="CR59">
        <label>59.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Venables</surname>
              <given-names>WN</given-names>
            </name>
            <name>
              <surname>Ripley</surname>
              <given-names>BD</given-names>
            </name>
          </person-group>
          <source>Modern Applied Statistics with S</source>
          <year>2002</year>
          <edition>4</edition>
          <publisher-loc>New York</publisher-loc>
          <publisher-name>Springer</publisher-name>
        </element-citation>
      </ref>
      <ref id="CR60">
        <label>60.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pfefferle</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Fischer</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Sounds and size: identification of acoustic variables that reflect body size in hamadryas baboons</article-title>
          <source>Papio hamadryas. Anim Behav.</source>
          <year>2006</year>
          <volume>72</volume>
          <fpage>43</fpage>
          <lpage>51</lpage>
          <pub-id pub-id-type="doi">10.1016/j.anbehav.2005.08.021</pub-id>
        </element-citation>
      </ref>
      <ref id="CR61">
        <label>61.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Whitehead</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <source>Long-distance Vocalizations and Spacing in Mantled Howling Monkeys, <italic>Alouatta palliata</italic></source>
          <year>1985</year>
          <publisher-loc>Chapel Hill</publisher-loc>
          <publisher-name>PH D: University of North Carolina</publisher-name>
        </element-citation>
      </ref>
      <ref id="CR62">
        <label>62.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Larom</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Garstang</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Payne</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Raspet</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Lindeque</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>The influence of surface atmospheric conditions on the range and area reached by animal vocalizations</article-title>
          <source>J Exp Biol.</source>
          <year>1997</year>
          <volume>200</volume>
          <fpage>421</fpage>
          <lpage>31</lpage>
          <?supplied-pmid 9057305?>
          <pub-id pub-id-type="pmid">9057305</pub-id>
        </element-citation>
      </ref>
      <ref id="CR63">
        <label>63.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nussey</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Coulson</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Festa-Bianchet</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gaillard</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>The evolutionary ecology of senescence: measuring senescence in wild animal populations, towards a longitudinal approach</article-title>
          <source>Funct Ecol.</source>
          <year>2008</year>
          <volume>22</volume>
          <fpage>393</fpage>
          <lpage>406</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-2435.2008.01408.x</pub-id>
        </element-citation>
      </ref>
      <ref id="CR64">
        <label>64.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wilden</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Herzel</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Peters</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Tembrock</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Subharmonics, biphonation, and deterministic chaos in mammal vocalization</article-title>
          <source>Bioacoustics</source>
          <year>1998</year>
          <volume>9</volume>
          <fpage>171</fpage>
          <lpage>96</lpage>
          <pub-id pub-id-type="doi">10.1080/09524622.1998.9753394</pub-id>
        </element-citation>
      </ref>
      <ref id="CR65">
        <label>65.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fitch</surname>
              <given-names>WT</given-names>
            </name>
            <name>
              <surname>Neubauer</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Herzel</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Calls out of chaos: The adaptive significance of nonlinear phenomena in mammalian vocal production</article-title>
          <source>Anim Behav.</source>
          <year>2002</year>
          <volume>63</volume>
          <fpage>407</fpage>
          <lpage>18</lpage>
          <pub-id pub-id-type="doi">10.1006/anbe.2001.1912</pub-id>
        </element-citation>
      </ref>
      <ref id="CR66">
        <label>66.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brockelman</surname>
              <given-names>WY</given-names>
            </name>
            <name>
              <surname>Schilling</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Inheritance of stereotyped gibbon calls</article-title>
          <source>Nature</source>
          <year>1984</year>
          <volume>312</volume>
          <fpage>634</fpage>
          <lpage>636</lpage>
          <pub-id pub-id-type="doi">10.1038/312634a0</pub-id>
          <?supplied-pmid 6542175?>
          <pub-id pub-id-type="pmid">6542175</pub-id>
        </element-citation>
      </ref>
      <ref id="CR67">
        <label>67.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koda</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Lemasson</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Oyakawa</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Rizaldi</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Pamungkas</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Masataka</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Possible role of mother-daughter vocal interactions on the development of species-specific song in gibbons</article-title>
          <source>PLoS One</source>
          <year>2013</year>
          <volume>8</volume>
          <fpage>e71432</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0071432</pub-id>
          <?supplied-pmid 23951160?>
          <pub-id pub-id-type="pmid">23951160</pub-id>
        </element-citation>
      </ref>
      <ref id="CR68">
        <label>68.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hurd</surname>
              <given-names>PL</given-names>
            </name>
          </person-group>
          <article-title>Resource holding potential, subjective resource value, and game theoretical models of aggressiveness signaling</article-title>
          <source>J Theoret Biol.</source>
          <year>2006</year>
          <volume>241</volume>
          <fpage>639</fpage>
          <lpage>48</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jtbi.2006.01.001</pub-id>
          <pub-id pub-id-type="pmid">16469335</pub-id>
        </element-citation>
      </ref>
      <ref id="CR69">
        <label>69.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Reichard</surname>
              <given-names>UH</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Reichard</surname>
              <given-names>UH</given-names>
            </name>
            <name>
              <surname>Boesch</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Social monogamy in gibbons: the male perspective</article-title>
          <source>Monogamy mating strategies and partnerships in birds, humans and other mammals</source>
          <year>2003</year>
          <publisher-loc>Cambridge</publisher-loc>
          <publisher-name>Cambridge U Press</publisher-name>
          <fpage>190</fpage>
          <lpage>213</lpage>
        </element-citation>
      </ref>
      <ref id="CR70">
        <label>70.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lukas</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Clutton-Brock</surname>
              <given-names>TH</given-names>
            </name>
          </person-group>
          <article-title>The evolution of social monogamy in mammals</article-title>
          <source>Science</source>
          <year>2013</year>
          <volume>341</volume>
          <fpage>526</fpage>
          <lpage>30</lpage>
          <pub-id pub-id-type="doi">10.1126/science.1238677</pub-id>
          <?supplied-pmid 23896459?>
          <pub-id pub-id-type="pmid">23896459</pub-id>
        </element-citation>
      </ref>
      <ref id="CR71">
        <label>71.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Geissmann</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Duet-splitting and the evolution of gibbon songs</article-title>
          <source>Biol. Rev.</source>
          <year>2002</year>
          <volume>77</volume>
          <fpage>57</fpage>
          <lpage>76</lpage>
          <pub-id pub-id-type="doi">10.1017/S1464793101005826</pub-id>
          <?supplied-pmid 11911374?>
          <pub-id pub-id-type="pmid">11911374</pub-id>
        </element-citation>
      </ref>
      <ref id="CR72">
        <label>72.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fay</surname>
              <given-names>RR</given-names>
            </name>
          </person-group>
          <article-title>Comparative psychoacoustics</article-title>
          <source>Hearing Res.</source>
          <year>1988</year>
          <volume>34</volume>
          <fpage>295</fpage>
          <lpage>306</lpage>
          <pub-id pub-id-type="doi">10.1016/0378-5955(88)90009-3</pub-id>
        </element-citation>
      </ref>
      <ref id="CR73">
        <label>73.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sinnott</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Owren</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Petersen</surname>
              <given-names>MR</given-names>
            </name>
          </person-group>
          <article-title>Auditory frequency discrimination in primates: species differences (Cercopithecus, Macaca, Homo)</article-title>
          <source>J Comp Psychol.</source>
          <year>1987</year>
          <volume>101</volume>
          <fpage>126</fpage>
          <lpage>31</lpage>
          <pub-id pub-id-type="doi">10.1037/0735-7036.101.2.126</pub-id>
        </element-citation>
      </ref>
      <ref id="CR74">
        <label>74.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pfingst</surname>
              <given-names>BE</given-names>
            </name>
          </person-group>
          <article-title>Comparison of spectral and nonspectral frequency difference limens for human and nonhuman primates</article-title>
          <source>J Acoust Soc Am.</source>
          <year>1993</year>
          <volume>93</volume>
          <fpage>2124</fpage>
          <lpage>29</lpage>
          <pub-id pub-id-type="doi">10.1121/1.406673</pub-id>
          <?supplied-pmid 8473625?>
          <pub-id pub-id-type="pmid">8473625</pub-id>
        </element-citation>
      </ref>
      <ref id="CR75">
        <label>75.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hienz</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Weerts</surname>
              <given-names>EM</given-names>
            </name>
          </person-group>
          <article-title>The discrimination of baboon grunt calls and human vowel sounds by baboons</article-title>
          <source>J Acoust Soc Am.</source>
          <year>2004</year>
          <volume>116</volume>
          <fpage>1692</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.1121/1.1778902</pub-id>
          <?supplied-pmid 15478436?>
          <pub-id pub-id-type="pmid">15478436</pub-id>
        </element-citation>
      </ref>
      <ref id="CR76">
        <label>76.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Temeles</surname>
              <given-names>EJ</given-names>
            </name>
          </person-group>
          <article-title>The role of neighbors in territorial systems – when are they dear enemies</article-title>
          <source>Anim Behav.</source>
          <year>1994</year>
          <volume>47</volume>
          <fpage>339</fpage>
          <lpage>50</lpage>
          <pub-id pub-id-type="doi">10.1006/anbe.1994.1047</pub-id>
        </element-citation>
      </ref>
      <ref id="CR77">
        <label>77.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beckers</surname>
              <given-names>GJL</given-names>
            </name>
            <name>
              <surname>Suthers</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>ten Cate</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Mechanisms of frequency and amplitude modulation in ring dove song</article-title>
          <source>J Exp Biol.</source>
          <year>2003</year>
          <volume>206</volume>
          <fpage>1833</fpage>
          <lpage>43</lpage>
          <pub-id pub-id-type="doi">10.1242/jeb.00364</pub-id>
          <?supplied-pmid 12728005?>
          <pub-id pub-id-type="pmid">12728005</pub-id>
        </element-citation>
      </ref>
      <ref id="CR78">
        <label>78.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lopez</surname>
              <given-names>PT</given-names>
            </name>
            <name>
              <surname>Narins</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Lewis</surname>
              <given-names>ER</given-names>
            </name>
            <name>
              <surname>Moore</surname>
              <given-names>SW</given-names>
            </name>
          </person-group>
          <article-title>Acoustically induced call modification in the white-lipped frog</article-title>
          <source>Leptodactylus albilabris. Anim Behav.</source>
          <year>1988</year>
          <volume>36</volume>
          <fpage>1295</fpage>
          <lpage>308</lpage>
          <pub-id pub-id-type="doi">10.1016/S0003-3472(88)80198-2</pub-id>
        </element-citation>
      </ref>
      <ref id="CR79">
        <label>79.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Geissmann</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Wallin</surname>
              <given-names>NL</given-names>
            </name>
            <name>
              <surname>Merker</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Gibbon Songs and Human Music from an Evolutionary Perspective</article-title>
          <source>The Origins of Music</source>
          <year>2000</year>
          <publisher-loc>Cambridge</publisher-loc>
          <publisher-name>MIT Press</publisher-name>
          <fpage>103</fpage>
          <lpage>23</lpage>
        </element-citation>
      </ref>
      <ref id="CR80">
        <label>80.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Anandam</surname>
              <given-names>MV</given-names>
            </name>
            <name>
              <surname>Groves</surname>
              <given-names>CP</given-names>
            </name>
            <name>
              <surname>Molur</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Rawson</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Richardson</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Roos</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Mittermeier</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Rylands</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>DE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Species accounts of Hylobatidae</article-title>
          <source>Handbook of the mammals of the world, 3. Primates</source>
          <year>2013</year>
          <publisher-loc>Barcelona</publisher-loc>
          <publisher-name>Lynx Edicions</publisher-name>
          <fpage>778</fpage>
          <lpage>91</lpage>
        </element-citation>
      </ref>
      <ref id="CR81">
        <label>81.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wich</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>van der Post</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Heistermann</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mohle</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>van Hooff</surname>
              <given-names>JARAM</given-names>
            </name>
            <name>
              <surname>Sterck</surname>
              <given-names>EHM</given-names>
            </name>
          </person-group>
          <article-title>Life-phase related changes in male loud call characteristics and testosterone levels in wild Thomas langurs</article-title>
          <source>Int J Primatol.</source>
          <year>2003</year>
          <volume>24</volume>
          <fpage>1251</fpage>
          <lpage>65</lpage>
          <pub-id pub-id-type="doi">10.1023/B:IJOP.0000005991.97232.2a</pub-id>
        </element-citation>
      </ref>
      <ref id="CR82">
        <label>82.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boinski</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Campbell</surname>
              <given-names>AF</given-names>
            </name>
          </person-group>
          <article-title>Use of trill vocalizations to coordinate troop movement among white-faced capuchins—a 2nd field test</article-title>
          <source>Behaviour</source>
          <year>1995</year>
          <volume>11–12</volume>
          <fpage>875</fpage>
          <lpage>901</lpage>
          <pub-id pub-id-type="doi">10.1163/156853995X00054</pub-id>
        </element-citation>
      </ref>
      <ref id="CR83">
        <label>83.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koda</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Shimooka</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Sugiura</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Effects of caller activity and habitat visibility on contact call rate of wild Japanese macaques (<italic>Macaca fuscata</italic>)</article-title>
          <source>Am J Primatol.</source>
          <year>2008</year>
          <volume>70</volume>
          <fpage>1055</fpage>
          <lpage>63</lpage>
          <pub-id pub-id-type="doi">10.1002/ajp.20597</pub-id>
          <?supplied-pmid 18646194?>
          <pub-id pub-id-type="pmid">18646194</pub-id>
        </element-citation>
      </ref>
      <ref id="CR84">
        <label>84.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barelli</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Heistermann</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Boesch</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Reichard</surname>
              <given-names>UH</given-names>
            </name>
          </person-group>
          <article-title>Sexual swellings in wild white-handed gibbon females (<italic>Hylobates lar</italic>) indicate the probability of ovulation</article-title>
          <source>Horm Behav.</source>
          <year>2008</year>
          <volume>51</volume>
          <fpage>221</fpage>
          <lpage>30</lpage>
          <pub-id pub-id-type="doi">10.1016/j.yhbeh.2006.10.008</pub-id>
          <pub-id pub-id-type="pmid">17137580</pub-id>
        </element-citation>
      </ref>
      <ref id="CR85">
        <label>85.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bryant</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Haselton</surname>
              <given-names>MG</given-names>
            </name>
          </person-group>
          <article-title>Vocal cues of ovulation in human females</article-title>
          <source>Biol Letters</source>
          <year>2009</year>
          <volume>5</volume>
          <fpage>12</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="doi">10.1098/rsbl.2008.0507</pub-id>
        </element-citation>
      </ref>
      <ref id="CR86">
        <label>86.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Caruso</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Roccasalva</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Sapienza</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Zappala</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nuciforo</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Biondi</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Laryngeal cytological aspects in women with surgically induced menopause who were treated with transdermal estrogen replacement therapy</article-title>
          <source>Fertil Steril.</source>
          <year>2000</year>
          <volume>74</volume>
          <fpage>1073</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1016/S0015-0282(00)01582-X</pub-id>
          <?supplied-pmid 11119730?>
          <pub-id pub-id-type="pmid">11119730</pub-id>
        </element-citation>
      </ref>
      <ref id="CR87">
        <label>87.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Semple</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>McComb</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Alberts</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Altmann</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Information content of female copulation calls in yellow baboons</article-title>
          <source>Am. J. Primatol.</source>
          <year>2002</year>
          <volume>56</volume>
          <fpage>43</fpage>
          <lpage>56</lpage>
          <pub-id pub-id-type="doi">10.1002/ajp.1062</pub-id>
          <?supplied-pmid 11793412?>
          <pub-id pub-id-type="pmid">11793412</pub-id>
        </element-citation>
      </ref>
      <ref id="CR88">
        <label>88.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pipitone</surname>
              <given-names>RN</given-names>
            </name>
            <name>
              <surname>Gallup</surname>
              <given-names>GG</given-names>
            </name>
          </person-group>
          <article-title>Women's voice attractiveness varies across the menstrual cycle</article-title>
          <source>Evol Hum Behav</source>
          <year>2008</year>
          <volume>29</volume>
          <issue>4</issue>
          <fpage>268</fpage>
          <lpage>74</lpage>
          <pub-id pub-id-type="doi">10.1016/j.evolhumbehav.2008.02.001</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:4700583</identifier><datestamp>2016-01-06</datestamp><setSpec>implemsci</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="http://jats.nlm.nih.gov/ns/archiving/1.0/ http://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Implement Sci</journal-id>
      <journal-id journal-id-type="iso-abbrev">Implement Sci</journal-id>
      <journal-title-group>
        <journal-title>Implementation Science : IS</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1748-5908</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC4700583</article-id>
      <article-id pub-id-type="pmcid">PMC4700583</article-id>
      <article-id pub-id-type="pmc-uid">4700583</article-id>
      <article-id pub-id-type="publisher-id">362</article-id>
      <article-id pub-id-type="doi">10.1186/s13012-015-0362-6</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Short Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Elaborating on theory with middle managers’ experience implementing healthcare innovations in practice</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Birken</surname>
            <given-names>Sarah A.</given-names>
          </name>
          <address>
            <phone>(919) 445-0774</phone>
            <email>birken@unc.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>DiMartino</surname>
            <given-names>Lisa D.</given-names>
          </name>
          <address>
            <email>Lisa.DiMartino@unc.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kirk</surname>
            <given-names>Meredith A.</given-names>
          </name>
          <address>
            <email>kqmeredi@live.unc.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Shoou-Yih D.</given-names>
          </name>
          <address>
            <email>sylee@email.unc.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>McClelland</surname>
            <given-names>Mark</given-names>
          </name>
          <address>
            <email>mcclelm@ccf.org</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Albert</surname>
            <given-names>Nancy M.</given-names>
          </name>
          <address>
            <email>albertn@ccf.org</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <aff id="Aff1"><label/>Department of Health Policy and Management, Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, 1103E McGavran-Greenberg, 135 Dauer Drive, Campus Box 7411, Chapel Hill, NC 27599-7411 USA </aff>
        <aff id="Aff2"><label/>Office of Nursing Research and Innovation, Cleveland Clinic, 9500 Euclid Ave., Cleveland, OH 44195 USA </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>4</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>4</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2015</year>
      </pub-date>
      <volume>11</volume>
      <elocation-id>2</elocation-id>
      <history>
        <date date-type="received">
          <day>31</day>
          <month>8</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>21</day>
          <month>12</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© Birken et al. 2015</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>The theory of middle managers’ role in implementing healthcare innovations hypothesized that middle managers influence implementation effectiveness by fulfilling the following four roles: diffusing information, synthesizing information, mediating between strategy and day-to-day activities, and selling innovation implementation. The theory also suggested several activities in which middle managers might engage to fulfill the four roles. The extent to which the theory aligns with middle managers’ experience in practice is unclear. We surveyed middle managers (<italic>n</italic> = 63) who attended a nursing innovation summit to (1) assess alignment between the theory and middle managers’ experience in practice and (2) elaborate on the theory with examples from middle managers’ experience overseeing innovation implementation in practice.</p>
        </sec>
        <sec>
          <title>Findings</title>
          <p>Middle managers rated all of the theory’s hypothesized four roles as “extremely important” but ranked diffusing and synthesizing information as the most important and selling innovation implementation as the least important. They reported engaging in several activities that were consistent with the theory’s hypothesized roles and activities such as diffusing information via meetings and training. They also reported engaging in activities not described in the theory such as appraising employee performance.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>Middle managers’ experience aligned well with the theory and expanded definitions of the roles and activities that it hypothesized. Future studies should assess the relationship between hypothesized roles and the effectiveness with which innovations are implemented in practice. If evidence supports the theory, the theory should be leveraged to promote the fulfillment of hypothesized roles among middle managers, doing so may promote innovation implementation.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Middle managers</kwd>
        <kwd>Nurse managers</kwd>
        <kwd>Job roles</kwd>
        <kwd>Healthcare</kwd>
        <kwd>Innovation implementation</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>© The Author(s) 2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Background</title>
      <p>Middle managers—employees who are supervised by an organization’s top managers and who supervise frontline employees [<xref ref-type="bibr" rid="CR1">1</xref>]—have received increased attention in recent healthcare innovation implementation research [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. This emerging literature suggests that middle managers influence innovation implementation by bridging informational gaps between top managers and frontline employees that might otherwise impede innovation implementation [<xref ref-type="bibr" rid="CR1">1</xref>–<xref ref-type="bibr" rid="CR3">3</xref>]. To leverage middle managers’ influence, it is important to understand how they influence innovation implementation.</p>
      <p>The theory of middle managers’ role in implementing innovations in healthcare organizations (“the middle manager role theory”) hypothesized that middle managers promote innovation implementation by fulfilling four roles: diffusing information, synthesizing information, mediating between strategy and day-to-day activities, and selling innovation implementation [<xref ref-type="bibr" rid="CR1">1</xref>]. It also suggested several activities middle managers might engage in to fulfill the four roles. For example, to diffuse information, middle managers might provide frontline employees with information necessary to implement innovations. Table <xref rid="Tab1" ref-type="table">1</xref> lists the four roles and examples of activities middle managers might engage in to fulfill the roles.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Roles and activities hypothesized in the middle manager role theory [<xref ref-type="bibr" rid="CR1">1</xref>]</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Hypothesized activities<sup>a</sup>
</th><th>Examples of activities identified in this study</th></tr></thead><tbody><tr><td colspan="2">Hypothesized role 1: diffusing information</td></tr><tr><td>• Relay information regarding innovation implementation to employees (p 6)<break/>• Stay attuned to top managers’ and frontline employees’ moods and needs (p 6)<break/>• Provide frontline employees with the information necessary to implement innovations (p 6)<break/>• Provide top managers with feedback regarding innovation implementation status (p 6)<break/>• Field employees’ questions regarding innovation implementation (p 6)<break/>• Inform employees of an innovation that is expected to be implemented (p 6)<break/>• Disseminate information regarding material support for innovation implementation (p 6)<break/>• Disseminate information regarding emotional support for innovation implementation (p 6)<break/>• Disseminate rewards for innovation implementation (p 6)</td><td>• Websites<break/>• Print/electronic materials<break/>• Training<break/>• Communicating information (e.g., in-person, meetings, email)<break/>• Education</td></tr><tr><td colspan="2">Hypothesized role 2: synthesizing information</td></tr><tr><td>• Make general information about innovation implementation relevant to unique organizations and employees (p 6)<break/>• Monitor employees’ responses to the information and reinterpret the information in a way that the employee may find more relevant (p 6)<break/>• Use daily conversations to help frontline employees understand key information regarding innovation implementation (p 7)<break/>• Interpret facts about innovation implementation may convey to employees the relevance of the innovation to the specific roles that they are expected to fulfill (p 7)<break/>• Explain to employees the specific ways in which someone in their role would be supported and rewarded for innovation implementation (p 7)</td><td>• Workflow integration<break/>• Providing examples</td></tr><tr><td colspan="2">Hypothesized role 3: mediating between strategy and day-to-day activities</td></tr><tr><td>• Give employees the tools necessary to implement innovations (p 7)<break/>• Translate information into concrete tasks that must be carried out to effectively implement innovations (p 7)<break/>• Provide employees with practical feedback on their innovation implementation-related performance (p 7)<break/>• Form “strategic communities” that promote the implementation of new technologies (p 7)<break/>• Identify specific activities in which employees are expected to engage to promote an organization’s strategy of innovation implementation (p 7)</td><td>• Provide data<break/>• Funding<break/>• Resources<break/>• Assuring right equipment/tools<break/>• Support<break/>• Workflow integration<break/>• Reminders/follow-up</td></tr><tr><td colspan="2">Hypothesized role 4: selling innovation implementation</td></tr><tr><td>• Justify innovation implementation (p 7)<break/>• Encourage employees to consistently and effectively use innovations (p 7)<break/>• Convince employees that innovation implementation is worthy of their attention (p 7)<break/>• Set innovation implementation-related norms (p 8)<break/>• Maintain a positive attitude regarding innovation implementation (p 8)<break/>• Help employees to appreciate the rationale underlying organizational changes (p 8)</td><td>• Describing benefits<break/>• Generating “buy-in” from employees<break/>• Providing rewards<break/>• Reinforcement<break/>• Communicating information</td></tr></tbody></table><table-wrap-foot><p>
<sup>a</sup>Activities intended to fulfill hypothesized roles are described on indicated page numbers in the theory to which we compare middle managers’ experience in practice in this study [<xref ref-type="bibr" rid="CR1">1</xref>]</p></table-wrap-foot></table-wrap></p>
      <p>Although the theory has received some empirical support [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>], the extent to which it aligns with middle managers’ experience in practice is unclear. The objectives of this study were to (1) assess alignment between middle managers’ experience and the theory’s hypothesized roles and activities and (2) elaborate on the theory with examples from middle managers’ experience. Resulting evidence may inform initiatives to promote middle managers’ commitment to innovation implementation [<xref ref-type="bibr" rid="CR3">3</xref>].</p>
    </sec>
    <sec id="Sec2">
      <title>Method</title>
      <p>The study capitalized on a live conference of 154 nurse managers who participated in the Cleveland Clinic’s 2014 Nursing Innovation Summit. The Summit defined, described, and promoted clinical practice innovations (e.g., role redesign on a hospital nursing unit) and described strategies for navigating innovation implementation. During the Summit, SB distributed a self-administered questionnaire that contained closed and open-ended questions. Closed-ended items assessed the extent to which participants’ experience aligned with hypothesized roles and activities (Table <xref rid="Tab1" ref-type="table">1</xref>) [<xref ref-type="bibr" rid="CR1">1</xref>]. Specifically, we asked participants to:<list list-type="order"><list-item><p>Rate the importance of each of the four hypothesized roles when overseeing innovation implementation in a healthcare organization, using a 7-point Likert scale from 1 (not at all important) to 7 (extremely important) and</p></list-item><list-item><p>Rank the relative importance of the four hypothesized roles when tasked with innovation implementation</p></list-item></list></p>
      <p>We used descriptive statistics to summarize perceptions of the importance and relative importance (ranking) of the four hypothesized roles.</p>
      <p>Open-ended (qualitative text entry) items allowed participants to elaborate on activities they engaged in to fulfill their roles. Specifically, we asked participants to provide:<list list-type="order"><list-item><p>Examples of activities they engaged in to fulfill each of the four hypothesized roles and</p></list-item><list-item><p>Descriptions of activities they engaged in to promote innovation implementation that they perceived to be unrelated to the four hypothesized roles</p></list-item></list></p>
      <p>We employed template analysis, combining content analysis with grounded theory, to analyze participants’ examples of activities engaged in to promote innovation implementation. Content analysis involved using a priori definitions of activities hypothesized in the middle manager role theory; grounded theory allowed activities not hypothesized in the theory to emerge from the analysis [<xref ref-type="bibr" rid="CR4">4</xref>]. Text units that were aligned with one of the theory’s four roles were coded as such. For instance, “providing in-services” was coded as an activity intended to fulfill the role of diffusing information. Text units that were not aligned with one of the theory’s four roles were coded as emergent and therefore potential elaborations on the middle manager role theory.</p>
      <p>The questionnaire was distributed to all 154 Summit participants; of these, 63 were eligible to complete the questionnaire because they identified as ever having been a middle manager and had overseen innovation implementation in a healthcare organization. All eligible participants completed the questionnaire (<italic>n</italic> = 63; response rate = 100 %). The institutional review board at the University of North Carolina at Chapel Hill approved the study and waived written consent due to minimal risks to study participants.</p>
    </sec>
    <sec id="Sec3">
      <title>Findings</title>
      <sec id="Sec4">
        <title>Importance and relative importance of hypothesized roles</title>
        <p>Participants generally reported that all roles were “extremely important.” However, one third ranked diffusing and synthesizing information as the most important roles. The majority (60 %) ranked selling innovation implementation as the least important role (Table <xref rid="Tab2" ref-type="table">2</xref>).<table-wrap id="Tab2"><label>Table 2</label><caption><p>Overall and relative importance of hypothesized roles of middle managers in implementing healthcare innovations (<italic>n</italic> = 63)</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="2">Importance of middle manager’s role in implementing innovation (mean score; 1 = not important, 7 = very important)</th></tr></thead><tbody><tr><td>• Diffusing information</td><td>6.83 (SD = .46)</td></tr><tr><td>• Synthesizing information</td><td>6.71 (SD = .66)</td></tr><tr><td>• Mediating between strategy and day-to-day activities</td><td>6.71 (SD = .55)</td></tr><tr><td>• Selling innovation implementation</td><td>6.63 (SD = .68)</td></tr><tr><td colspan="2">Relative importance of middle manager’s role in implementing innovation (%)</td></tr><tr><td rowspan="2">• Diffusing information</td><td>Most important: 31</td></tr><tr><td>Least important: 13</td></tr><tr><td rowspan="2">• Synthesizing information</td><td>Most important: 34</td></tr><tr><td>Least important: 13</td></tr><tr><td rowspan="2">• Mediating between strategy and day-to-day activities</td><td>Most important: 24</td></tr><tr><td>Least important: 13</td></tr><tr><td rowspan="2">• Selling innovation implementation</td><td>Most important: 10</td></tr><tr><td>Least important: 38 </td></tr></tbody></table></table-wrap></p>
      </sec>
      <sec id="Sec5">
        <title>Activities to fulfill roles</title>
        <p>Table <xref rid="Tab1" ref-type="table">1</xref> contains examples of activities participants engaged in to fulfill roles. For example, one participant noted that “remaining positive and encouraging feedback” was important to sell innovation implementation (ID: 31).</p>
        <p>Table <xref rid="Tab3" ref-type="table">3</xref> lists five activities that participants perceived to be unrelated to the four hypothesized roles and suggests how they might elaborate on one of the hypothesized roles. For example, one participant continuously assessed employees’ understanding of the innovation and strategies being used to implement it (i.e., measuring employees’ innovation implementation-related performance) to ensure effective implementation; we posit that measuring employees’ innovation implementation-related performance mediated between strategy and day-to-day activities by giving employees feedback that they could use to improve innovation implementation.<table-wrap id="Tab3"><label>Table 3</label><caption><p>Emergent activities in which middle managers engage to implement healthcare innovations</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Activity</th><th>Examples of activity (participant ID)</th></tr></thead><tbody><tr><td colspan="2">Hypothesized role 1: diffusing information</td></tr><tr><td>• Obtaining information</td><td>• “Research[ing] information [about the innovation]” (10)<break/>• “[Conducting a] literature search [about the innovation]” (11)</td></tr><tr><td>• Communicating information to external stakeholders</td><td>• “Communicat[ing] results [of innovation implementation] to community network” (8)</td></tr><tr><td colspan="2">Hypothesized role 2: synthesizing information</td></tr><tr><td>• Adapting innovation to local context</td><td>• “Trouble-shooting” (7)<break/>• “Frustrations are expected; time-table change” (11)<break/>• “Fine-tuning processes” (52)</td></tr><tr><td colspan="2">Hypothesized role 3: mediating between strategy and day-to-day activities</td></tr><tr><td>• Measuring employees’ innovation implementation-related performance</td><td>•“Evaluating work-arounds” (7)<break/>• “Establish[ing] benchmarks” (11)<break/>• “[Creating an] evaluation tool” (29)<break/>• “Evaluat[ing] the process” (43)<break/>• “Running…daily data for staff to see” (43)<break/>• “Auditing” (44)<break/>• “Monitoring compliance” (52)</td></tr><tr><td>• Engaging in innovation implementation-related activities</td><td>• “Refer[ring] patients to complete treatment” (8)<break/>• “[Doing] what the [frontline] staff [do]” (53)</td></tr><tr><td colspan="2">Hypothesized role 4: selling innovation implementation</td></tr><tr><td colspan="2">None</td></tr></tbody></table></table-wrap></p>
      </sec>
    </sec>
    <sec id="Sec6">
      <title>Conclusions</title>
      <p>In this study, we sought to elaborate on the middle manager role theory and assess its alignment with middle managers’ experience. Our ability to draw conclusions is limited by our convenience sample and space restrictions for qualitative data entry on the questionnaire; however, study participants shared compelling experiences that are likely to be somewhat consistent with our population of interest: middle managers who oversee innovation implementation in healthcare organizations.</p>
      <p>The middle manager role theory generally aligned well with the practical experience of study participants. Of note, participants reported that, in practice, selling innovation implementation is the least important of the four roles. This finding helps to distinguish middle managers from champions. Champions are often top managers or physicians who attempt to persuade employees to engage in innovation implementation (e.g., [<xref ref-type="bibr" rid="CR5">5</xref>]). Whereas champions may give frontline employees the motivation to implement an innovation, middle managers may give frontline employees the means to do so with practical information, tools, and assistance.</p>
      <p>Quantitative and qualitative results differed with respect to participants’ perceptions of the importance of synthesizing information and selling innovation implementation. A third of participants ranked synthesizing information as their most important role, but participants offered the fewest examples of synthesizing information. The opposite is true with selling innovation implementation. It is possible that participants interpreted synthesizing information as a means of selling innovation implementation (e.g., interpreting facts about innovation implementation to convey relevance). On the other hand, middle managers may view selling innovation implementation as champions’ role and, therefore, less central to their own. Despite this, middle managers may engage in selling innovation implementation because they feel better equipped to do so than engaging in roles that they deem more important, such as synthesizing information. Future research should assess whether this is the case; if so, implementation efforts may benefit from training middle managers to engage in the roles that they deem important but are ill-equipped to perform and to delegate roles that they view as less central (e.g., asking champions to sell innovation implementation).</p>
      <p>Activities participants engaged in that they perceived to be unrelated to the four hypothesized roles expand definitions in the middle manager role theory. Based on our findings, we revised the names and definitions of the four hypothesized roles (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). Researchers should assess the relationship between hypothesized roles and implementation effectiveness. If engaging in hypothesized roles promotes implementation effectiveness, then the middle manager role theory should be leveraged to develop an intervention to enable middle managers to fulfill hypothesized roles with the support of top managers [<xref ref-type="bibr" rid="CR2">2</xref>]; doing so may promote the implementation of innovations intended to reduce the gap between evidence and practice [<xref ref-type="bibr" rid="CR3">3</xref>].<fig id="Fig1"><label>Fig. 1</label><caption><p>Refined theory of middle managers’ role in implementing innovations in healthcare organizations. <italic>Asterisk</italic> obtaining and diffusing information includes diffusing information internally and externally. <italic>Dagger</italic> mediating between strategy and day-to-day activities involves measuring performance and engaging in frontline activities</p></caption><graphic xlink:href="13012_2015_362_Fig1_HTML" id="MO1"/></fig></p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The authors declare that they have no competing interests.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors’ contributions</bold>
        </p>
        <p>All authors made significant contributions to manuscript. SB, MM, and NA collected data. SB, LD, and AK analyzed the data. SB, LD, and DL drafted and all authors critically revised the manuscript for important intellectual content. All authors have read and gave final approval of the version of the manuscript submitted for publication.</p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgements</title>
      <p>We are grateful for the time and contribution of middle managers who participated in the study.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Birken</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>SY</given-names>
            </name>
            <name>
              <surname>Weiner</surname>
              <given-names>BJ</given-names>
            </name>
          </person-group>
          <article-title>Uncovering middle managers’ role in healthcare innovation implementation</article-title>
          <source>Implement Sci</source>
          <year>2012</year>
          <volume>7</volume>
          <fpage>28</fpage>
          <pub-id pub-id-type="doi">10.1186/1748-5908-7-28</pub-id>
          <?supplied-pmid 22472001?>
          <pub-id pub-id-type="pmid">22472001</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Birken</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>SY</given-names>
            </name>
            <name>
              <surname>Weiner</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Chin</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Chiu</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schaefer</surname>
              <given-names>CT</given-names>
            </name>
          </person-group>
          <article-title>From strategy to action: how top managers’ support increases middle managers’ commitment to innovation implementation in health care organizations</article-title>
          <source>Health Care Manage Rev</source>
          <year>2014</year>
          <volume>40</volume>
          <fpage>159</fpage>
          <lpage>68</lpage>
          <pub-id pub-id-type="doi">10.1097/HMR.0000000000000018</pub-id>
          <pub-id pub-id-type="pmid">24566252</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Birken</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>SY</given-names>
            </name>
            <name>
              <surname>Weiner</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Chin</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Schaefer</surname>
              <given-names>CT</given-names>
            </name>
          </person-group>
          <article-title>Improving the effectiveness of health care innovation implementation: middle managers as change agents</article-title>
          <source>Med Care Res Rev</source>
          <year>2013</year>
          <volume>70</volume>
          <fpage>29</fpage>
          <lpage>45</lpage>
          <pub-id pub-id-type="doi">10.1177/1077558712457427</pub-id>
          <?supplied-pmid 22930312?>
          <pub-id pub-id-type="pmid">22930312</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>King</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <source>Qualitative methods and analysis in organizational research</source>
          <year>1998</year>
          <publisher-loc>London, England</publisher-loc>
          <publisher-name>Sage</publisher-name>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <mixed-citation publication-type="other">Hawk M, Ricci E, Huber G, Myers M. Opportunities for social workers in the patient centered medical home. Soc Work Public Health. 2015;30(2):175–84. doi: 10.1080/19371918.2014.969862. Epub 2014 Dec 12.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:4700584</identifier><datestamp>2016-01-06</datestamp><setSpec>actaneurocomm</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="http://jats.nlm.nih.gov/ns/archiving/1.0/ http://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Acta Neuropathol Commun</journal-id>
      <journal-id journal-id-type="iso-abbrev">Acta Neuropathol Commun</journal-id>
      <journal-title-group>
        <journal-title>Acta Neuropathologica Communications</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2051-5960</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC4700584</article-id>
      <article-id pub-id-type="pmcid">PMC4700584</article-id>
      <article-id pub-id-type="pmc-uid">4700584</article-id>
      <article-id pub-id-type="publisher-id">269</article-id>
      <article-id pub-id-type="doi">10.1186/s40478-015-0269-0</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Spatial genomic heterogeneity in diffuse intrinsic pontine and midline high-grade glioma: implications for diagnostic biopsy and targeted therapeutics</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Hoffman</surname>
            <given-names>Lindsey M.</given-names>
          </name>
          <address>
            <email>Lindsey.hoffman@cchmc.org</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>DeWire</surname>
            <given-names>Mariko</given-names>
          </name>
          <address>
            <email>mariko.dewire@cchmc.org</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Ryall</surname>
            <given-names>Scott</given-names>
          </name>
          <address>
            <email>Scott.ryall@sickkids.ca</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Buczkowicz</surname>
            <given-names>Pawel</given-names>
          </name>
          <address>
            <email>Pawel.buczkowicz@sickkids.ca</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Leach</surname>
            <given-names>James</given-names>
          </name>
          <address>
            <email>james.leach@cchmc.org</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Miles</surname>
            <given-names>Lili</given-names>
          </name>
          <address>
            <email>lili.miles@nemours.org</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ramani</surname>
            <given-names>Arun</given-names>
          </name>
          <address>
            <email>arun.ramani@sickkids.ca</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Brudno</surname>
            <given-names>Michael</given-names>
          </name>
          <address>
            <email>Michael.brudno@sickkids.ca</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kumar</surname>
            <given-names>Shiva Senthil</given-names>
          </name>
          <address>
            <email>shiva.kumar@cchmc.org</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Drissi</surname>
            <given-names>Rachid</given-names>
          </name>
          <address>
            <email>rachid.drissi@cchmc.org</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Dexheimer</surname>
            <given-names>Phillip</given-names>
          </name>
          <address>
            <email>phillip.dexheimer@cchmc.org</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Salloum</surname>
            <given-names>Ralph</given-names>
          </name>
          <address>
            <email>ralph.salloum@cchmc.org</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chow</surname>
            <given-names>Lionel</given-names>
          </name>
          <address>
            <email>lionel.chow@cchmc.org</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hummel</surname>
            <given-names>Trent</given-names>
          </name>
          <address>
            <email>trent.hummel@cchmc.org</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Stevenson</surname>
            <given-names>Charles</given-names>
          </name>
          <address>
            <email>Charles.stevenson@cchmc.org</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lu</surname>
            <given-names>Q. Richard</given-names>
          </name>
          <address>
            <email>Richard.lu@cchmc.org</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jones</surname>
            <given-names>Blaise</given-names>
          </name>
          <address>
            <email>blaise.jones@cchmc.org</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Witte</surname>
            <given-names>David</given-names>
          </name>
          <address>
            <email>david.witte@cchmc.org</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Aronow</surname>
            <given-names>Bruce</given-names>
          </name>
          <address>
            <email>bruce.aronow@cchmc.org</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Hawkins</surname>
            <given-names>Cynthia E.</given-names>
          </name>
          <address>
            <email>Cynthia.hawkins@sickkids.ca</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes" equal-contrib="yes">
          <name>
            <surname>Fouladi</surname>
            <given-names>Maryam</given-names>
          </name>
          <address>
            <phone>513-803-0721</phone>
            <email>Maryam.fouladi@cchmc.org</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <aff id="Aff1"><label/>Cincinnati Children’s Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229 USA </aff>
        <aff id="Aff2"><label/>The Hospital for Sick Children, Toronto, Canada </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>4</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>4</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <volume>4</volume>
      <elocation-id>1</elocation-id>
      <history>
        <date date-type="received">
          <day>18</day>
          <month>12</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>20</day>
          <month>12</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© Hoffman et al. 2015</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Introduction</title>
          <p>Diffuse intrinsic pontine glioma (DIPG) and midline high-grade glioma (mHGG) are lethal childhood brain tumors. Spatial genomic heterogeneity has been well-described in adult HGG but has not been comprehensively characterized in pediatric HGG. We performed whole exome sequencing on 38-matched primary, contiguous, and metastatic tumor sites from eight children with DIPG (<italic>n</italic> = 7) or mHGG (<italic>n</italic> = 1) collected using a unique MRI-guided autopsy protocol. Validation was performed using Sanger sequencing, Droplet Digital polymerase-chain reaction, immunohistochemistry, and fluorescent in-situ hybridization.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>Median age at diagnosis was 6.1 years (range: 2.9–23.3 years). Median overall survival was 13.2 months (range: 11.2–32.2 months). Contiguous tumor infiltration and distant metastases were observed in seven and six patients, respectively, including leptomeningeal dissemination in three DIPGs. Histopathological heterogeneity was evident in seven patients, including intra-pontine heterogeneity in two DIPGs, ranging from World Health Organization grade II to IV astrocytoma. We found conservation of heterozygous K27M mutations in H3F3A (<italic>n</italic> = 4) or HIST1H3B (<italic>n</italic> = 3) across all primary, contiguous, and metastatic tumor sites in all DIPGs. ACVR1 (<italic>n</italic> = 2), PIK3CA (<italic>n</italic> = 2), FGFR1 (<italic>n</italic> = 2), and MET (<italic>n</italic> = 1) were also intra-tumorally conserved. ACVR1 was co-mutated with HIST1H3B (<italic>n</italic> = 2). In contrast, PDGFRA amplification and mutation were spatially heterogeneous, as were mutations in BCOR (<italic>n</italic> = 1), ATRX (<italic>n</italic> = 2), and MYC (<italic>n</italic> = 1). TP53 aberrations (<italic>n</italic> = 3 patients) varied by type and location between primary and metastatic tumors sites but were intra-tumorally conserved. </p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>Spatial conservation of prognostically-relevant and therapeutically-targetable somatic mutations in DIPG and mHGG contrasts the significant heterogeneity of driver mutations seen in adult HGG and supports uniform implementation of diagnostic biopsy in DIPG and mHGG to classify molecular risk groups and guide therapeutic strategy.</p>
        </sec>
        <sec>
          <title>Electronic supplementary material</title>
          <p>The online version of this article (doi:10.1186/s40478-015-0269-0) contains supplementary material, which is available to authorized users.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Genomic heterogeneity</kwd>
        <kwd>Pediatric</kwd>
        <kwd>Glioma</kwd>
        <kwd>Targeted therapeutics</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution>Sophie's Angel Run</institution>
          </funding-source>
        </award-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000015</institution-id>
              <institution>Canadian Cancer Society Research Institute</institution>
            </institution-wrap>
          </funding-source>
        </award-group>
      </funding-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>© The Author(s) 2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Introduction</title>
      <p>Diffuse intrinsic pontine glioma (DIPG) is an aggressive pediatric brain tumor with a median survival of less than 1 year, despite current multimodal therapies [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Midline, non-brainstem high-grade gliomas (mHGGs) in children share clinical and biological features with DIPG and have a similarly dismal prognosis [<xref ref-type="bibr" rid="CR3">3</xref>–<xref ref-type="bibr" rid="CR5">5</xref>]. Historically, reluctance to biopsy these precariously located tumors to obtain tissue has impeded the understanding of their biology. Recently, greater acceptance of the safety of biopsy [<xref ref-type="bibr" rid="CR6">6</xref>–<xref ref-type="bibr" rid="CR9">9</xref>], development of autopsy-based protocols [<xref ref-type="bibr" rid="CR10">10</xref>–<xref ref-type="bibr" rid="CR12">12</xref>], and advancement of high-throughput sequencing technology have enabled unprecedented insight into the molecular underpinnings of DIPG and mHGG. Genomic studies have detailed recurrent aberrations in many canonical cancer pathways and mutations in novel oncogenes, such as highly recurrent histone mutations (<italic>H3F3A</italic> or <italic>HIST1H3B/C/I</italic>) and <italic>ACVR1</italic> [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>].</p>
      <p>Despite remarkable genomic discoveries, therapeutic progress for DIPG and mHGG has remained static. The standard treatment, focal radiotherapy, provides only transient local control and fails to address the recently reported metastatic potential of these highly infiltrative tumors [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. Clinical trials of adjuvant chemotherapy and targeted therapy, including those targeting critical pathways, such as platelet-derived growth factor receptor alpha (PDGFRA) [<xref ref-type="bibr" rid="CR7">7</xref>–<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR17">17</xref>], have not improved outcome over many decades [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. Intra-tumoral genomic heterogeneity and clonal evolution are well-recognized in the pathogenesis and therapeutic resistance of adult HGG [<xref ref-type="bibr" rid="CR19">19</xref>–<xref ref-type="bibr" rid="CR21">21</xref>]. We previously reported intra-tumoral histopathological variation in DIPGs from autopsy [<xref ref-type="bibr" rid="CR1">1</xref>]. However, evaluation of spatial genomic heterogeneity, which carries important implications for determining the generalizability of molecular profiles derived from small diagnostic biopsies and scientifically-sound integration of molecularly-targeted therapies, has not been reported in DIPG or mHGG. We used whole exome sequencing (WES) to comprehensively evaluate spatial intra-tumoral genomic heterogeneity in eight children with DIPG or mHGG.</p>
    </sec>
    <sec id="Sec2">
      <title>Materials and methods</title>
      <sec id="Sec3">
        <title>Patient cohort</title>
        <p>Tissue samples (<italic>n</italic> = 38) and clinical data were obtained from eight patients with DIPG (<italic>n</italic> = 7) or mHGG (<italic>n</italic> = 1) consented to the IRB-approved Pediatric Brain Tumor Repository (PBTR) autopsy protocol (Study: 2013–1245) at Cincinnati Children’s Hospital Medical Center from 2013–2014. Diagnosis of DIPG was based on rapidly progressive clinical symptoms and imaging characteristics on pre-treatment magnetic resonance imaging (MRI) (infiltrative tumor involving at least two-thirds of the pons). One patient with a bi-thalamic tumor underwent biopsy (not sequenced); no DIPGs were biopsied. Diagnostic and post-mortem imaging for all patients was centrally reviewed by one neuro-radiologist (J.L.).</p>
        <sec id="Sec4">
          <title>Autopsy protocol</title>
          <p>Median time from death to autopsy was 11.8 h (range: 4.8–20 h). Time to autopsy did not affect the quality or quantity of DNA. Normal brain and tumor visible on gross examination, including at least two locations in the pons (usually left anterior and right posterior), were sampled when the brain was harvested from the calvarium. After harvest, the whole brain was fixed in formalin. <italic>Ex-vivo</italic> MRI was performed on the fixed whole brain of seven patients (Patient 5 not imaged due to poor anatomical configuration after harvest) using a 1.5-Tesla MR system employing high-resolution volumetric T1- and T2-weighted images. 3D renderings were performed to optimize orientation of gradient-echo T1. Coronal and axial oblique images were obtained on the cerebrum and cerebellum, respectively. Volumetric data sets were reconstructed into standard anatomic orientations, and all attempts were made to duplicate standard in vivo slice orientation for planar data sets. The pathologist (L.M.) and neuro-radiologist jointly reviewed hematoxylin &amp; eosin (H&amp;E) sections and MRI images to determine contiguous and metastatic tumor locations. Tumor was classified as “primary” if located within the pons (or thalamus in Patient 8), “contiguous” if involving a CNS structure adjoining the primary tumor, or “metastatic” if involving a non-contiguous CNS structure. Routine sections of the frontal lobe, cerebellar cortex, all deep gray nuclei of cerebrum/cerebellum, and all brainstem structures were taken regardless of gross and/or MRI abnormalities. Two neuropathologists (L.M., C.H.) independently reviewed each tumor sample to assign histology, grade, and tumor percentage. To ensure adequate tumor content (Fig. <xref rid="Fig1" ref-type="fig">1</xref>), H&amp;E slides were reviewed from each frozen specimen, the initial cut of each formalin-fixed paraffin-embedded (FFPE) block, and an additional cut of FFPE block after scrolls were obtained for DNA extraction.<fig id="Fig1"><label>Fig. 1</label><caption><p>Spatial histopathological and genomic landscape of DIPG and mHGG in children. Histology and WHO grade were frequently heterogeneous within the pons or between the pons and contiguous or metastatic sites. Somatic mutations (indicated by a black box or stripped overlay of a colored box if co-existing with a copy number change) in <italic>H3F3A</italic> (H3.3), <italic>HIST1H3B</italic> (H3.1), <italic>ACVR1</italic>, <italic>PIK3CA</italic>, <italic>FGFR1</italic>, and <italic>MET</italic> were conserved across all disease sites. Somatic mutations in <italic>ATRX, BCOR</italic>, <italic>MYC</italic>, and <italic>PDGFRA</italic> and <italic>PDGFRA</italic> amplification were spatially heterogeneous. WHO = World Health Organization, FFPE = formalin-fixed paraffin-embedded</p></caption><graphic xlink:href="40478_2015_269_Fig1_HTML" id="MO1"/></fig></p>
        </sec>
      </sec>
      <sec id="Sec5">
        <title>Whole exome sequencing alignment and structural variants</title>
        <p>DNA extraction was performed on frozen tissue as previously described [<xref ref-type="bibr" rid="CR22">22</xref>] and on FFPE tissue using Biochain’s FFPE Tissue DNA Extraction Kit (#K5019100). Library preparation and WES were performed at BGI Americas using the Agilent SureSelect Human All Exon V5 Kit and Illumina HiSeq 2500 using V3 chemistry, respectively. All samples were sequenced at an average depth of 100× (4 samples per lane generating 12 Gb of raw data per sample). The Burrows-Wheeler Aligner [<xref ref-type="bibr" rid="CR23">23</xref>] tool was used to map all reads to the human genome build GRCh37/hg19. The GATK variant calling pipeline was followed to identify single nucleotide polymorphisms. MuTect 1.1.4 was used to detect somatic single nucleotide variants (SNVs) in 46 candidate genes with clinical significance (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1). Variants with sufficient coverage were further annotated using Annovar and SNPeff, giving RefSeq gene annotations, amino acid changes, ExAC SIFT, PolyPhen, LTR and MutationTaster scores.</p>
      </sec>
      <sec id="Sec6">
        <title>Histology and immunohistochemistry</title>
        <p>H&amp;E staining and p53 immunohistochemistry (IHC) [p53 (DO-7) primary mouse antibody 790–2912] were performed on 4 μm paraffin sections mounted on positively charged slides. Immuno-detection was performed as previously described [<xref ref-type="bibr" rid="CR1">1</xref>].</p>
      </sec>
      <sec id="Sec7">
        <title>Sanger sequencing and droplet digital polymerase-chain reaction</title>
        <p><italic>H3F3A</italic> and <italic>HIST1H3B</italic> were partially sequenced as described by Wu et al. [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR24">24</xref>] (Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S2). Somatic SNVs identified by WES were validated using Droplet Digital PCR System according to manufacturer instructions (BioRad, Mississauga, Canada) (Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Table S3). Samples were read in duplicate, and data were considered if at least 100 droplets contained fluorescent signal from either VIC or FAM channels in both duplicates. Samples were considered positive for mutation if at least 10 positive droplets were detected in the mutant channel (FAM). Mutational allele frequencies were estimated using a ratio between the mutant channel signal and total positive droplet counts.</p>
      </sec>
      <sec id="Sec8">
        <title>Florescence in-situ hybridization</title>
        <p>Florescence in-situ hybridization (FISH) for PDGFRA (Empire Genomics dual-color break apart probe) and c-MYC (Abbott Molecular dual-color break apart probe) was performed on 4 μm paraffin sections mounted on positively charged slides with DAPI II counterstain.</p>
      </sec>
      <sec id="Sec9">
        <title>Statistics</title>
        <p>Bioinformatic methods are described above. Descriptive statistics were used to report the frequency of genetic changes across disease locations.</p>
      </sec>
    </sec>
    <sec id="Sec10">
      <title>Results</title>
      <sec id="Sec11">
        <title>Clinical and histopathological characteristics</title>
        <p>Patient characteristics and treatment data are listed in Table <xref rid="Tab1" ref-type="table">1</xref>. Median age at diagnosis was 6.1 years (range: 2.9-23.3 years); median overall survival (OS) was 13.2 months (range: 11.2–32.2 months). Median time between the last pre- and post-mortem imaging was 46 days (range: 28–448 days). Only Patient 1 had evidence of distant metastases on pre-mortem imaging (5 months after diagnosis). Primary tumors were glioblastoma (GBM, <italic>n</italic> = 7) or anaplastic astrocytoma (AA, <italic>n</italic> = 1) (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). Intra-tumoral histopathological heterogeneity was observed in the primary tumor of seven of eight patients, including the primary tumor in Patient 1 that demonstrated regions with WHO grade II, III, and IV astrocytoma. The histological grade of primary and metastatic sites varied in four of five DIPG patients with metastatic disease. Intracranial leptomeningeal dissemination was observed in three of seven DIPGs (leptomeningeal disease for Patient 1 was not sequenced) (Fig. <xref rid="Fig1" ref-type="fig">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Clinical characteristics of patients with DIPG and mHGG</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Patient</th><th>Age at Diagnosis (years)</th><th>Sex</th><th>Primary Tumor</th><th>Treatment at Diagnosis</th><th>OS (months)</th><th>Time to Autopsy (hours)</th></tr></thead><tbody><tr><td>1</td><td char="." align="char">7.7</td><td>Male</td><td>DIPG</td><td>XRT + bevacizumab, irinotecan</td><td char="." align="char">24.4</td><td>19</td></tr><tr><td>2</td><td char="." align="char">2.9</td><td>Male</td><td>DIPG</td><td>XRT</td><td char="." align="char">32.2</td><td>17.5</td></tr><tr><td>3</td><td char="." align="char">4.3</td><td>Male</td><td>DIPG</td><td>XRT + HDAC inhibitor</td><td char="." align="char">11.2</td><td>15.5</td></tr><tr><td>4</td><td char="." align="char">4.4</td><td>Male</td><td>DIPG</td><td>XRT + HDAC inhibitor</td><td char="." align="char">11.5</td><td>4.8</td></tr><tr><td>5</td><td char="." align="char">3.5</td><td>Male</td><td>DIPG</td><td>XRT + EGFR inhibitor</td><td char="." align="char">16.8</td><td>5.5</td></tr><tr><td>6</td><td char="." align="char">23.3</td><td>Male</td><td>DIPG</td><td>XRT + HDAC inhibitor</td><td char="." align="char">13.4</td><td>8</td></tr><tr><td>7</td><td char="." align="char">12.3</td><td>Female</td><td>DIPG</td><td>XRT + PARP inhibitor, TMZ</td><td char="." align="char">11.8</td><td>20</td></tr><tr><td>8</td><td char="." align="char">15.1</td><td>Female</td><td>Bi-thalamic HGG</td><td>XRT + bevacizumab, TMZ, irinotecan</td><td char="." align="char">13.2</td><td>8</td></tr></tbody></table><table-wrap-foot><p>
<italic>DIPG</italic> diffuse intrinsic pontine glioma, <italic>HGG</italic> high-grade glioma, <italic>TMZ</italic> temozolomide, <italic>HDAC</italic> histone deacetylase, <italic>PARP</italic> poly ADP ribose polymerase, <italic>EGFR</italic> epidermal growth factor receptor, <italic>OS</italic> overall survival, <italic>XRT</italic> radiotherapy</p></table-wrap-foot></table-wrap></p>
      </sec>
      <sec id="Sec12">
        <title>Lack of heterogeneity in core gene set supports their role as driver mutations and potential therapeutic targets</title>
        <p>Relevant genomic findings are summarized in Fig. <xref rid="Fig1" ref-type="fig">1</xref>. Heterozygous H3K27M mutations were detected by WES across all primary, contiguous, and metastatic disease sites in all seven DIPG patients and were validated by ddPCR (Additional file <xref rid="MOESM4" ref-type="media">4</xref>: Table S4) and Sanger sequencing (Additional file <xref rid="MOESM5" ref-type="media">5</xref>: Figure S1). H3.3-K27M was found in four DIPGs and co-occurred with <italic>PDGFRA</italic> amplification and <italic>TP53</italic> aberrations in two cases, an association we previously described [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR22">22</xref>]. <italic>ACVR1</italic> mutation (G328V/W) was found in two patients, both with H3.1-K27M. Mutations in <italic>ACVR1</italic> (2 patients), <italic>FGFR1</italic> (K697E or N98S) (two patients), <italic>MET</italic> (S572N) (1 patient), and <italic>PIK3CA</italic> (E545K or I291M) (2 patients) were conserved across all disease locations, as confirmed by ddPCR (Additional file <xref rid="MOESM4" ref-type="media">4</xref>: Table S4). <italic>TP53</italic> aberrations were observed in three patients, including deletion and/or mutation, across all disease sites in Patient 8 (Additional file <xref rid="MOESM6" ref-type="media">6</xref>: Figure S2), who did not harbor a histone mutation, suggesting <italic>TP53</italic> as a potential driver. Varied <italic>TP53</italic> aberrations were also found across all disease locations in two DIPGs with H3.3-K27M mutations, perhaps representing a secondary but important genetic event.</p>
      </sec>
      <sec id="Sec13">
        <title>Gene mutations demonstrating spatial heterogeneity suggest secondary hits and poor potential for monotherapy</title>
        <p><italic>PDGFRA</italic> point mutations occurred in two of eight patients. All disease sites in Patient 1 harbored two <italic>PDGFRA</italic> mutations (S247L, Y555C), but only 1 of 6 disease sites in Patient 3, which also exhibited high-level <italic>PDGFRA</italic> amplification, harbored a <italic>PDGFRA</italic> mutation (E229K) (Fig. <xref rid="Fig2" ref-type="fig">2</xref>). <italic>PDGFRA</italic> gain/amplification was observed in five patients and showed notable intra-tumoral heterogeneity (Additional file <xref rid="MOESM7" ref-type="media">7</xref>: Figure S3), suggesting clonality of this recurrent genetic event. Other intra-tumorally heterogeneous mutations included <italic>ATRX</italic>, <italic>BCOR</italic>, and <italic>MYC</italic>. Heterozygous <italic>ATRX</italic> mutations were found in Patients 6 (H2254R) and 8 (R2197L); while conserved across all disease sites in Patient 8, the <italic>ATRX</italic> mutation in Patient 6 was absent in the metastatic compartment. A heterozygous <italic>BCOR</italic> mutation (A535V) was found in a single pontine site in Patient 2, and a heterozygous <italic>MYC</italic> mutation (Q51L) was found in both pontine sites in Patient 5 but was absent in the metastatic lesion. FISH confirmed no <italic>MYC</italic> copy number gain in any tumor samples from Patient 5.<fig id="Fig2"><label>Fig. 2</label><caption><p>Intra-tumoral heterogeneity in a 4-year old male with DIPG (Patient 3). Each row represents a distinct disease location, including four different areas in the primary tumor, one contiguous lesion in the right basal ganglia, and one metastatic leptomeningeal lesion. <bold>a</bold> H&amp;Es of each tumor location demonstrate WHO grade IV histology in all except the right basal ganglia lesion (WHO grade III), <bold>b</bold> P53 IHC demonstrates variable positivity, <bold>c</bold>
<italic>PDGFRA</italic> FISH demonstrates gain or amplification in 3 of 4 sites within the pontine tumor, gain in the contiguous right basal ganglia lesion, and amplification in the metastatic leptomeningeal lesion, <bold>d</bold>
<italic>PDGFRA</italic> ddPCR demonstrating PDGFRA mutation observed in the right posterior pons, <bold>e</bold>
<italic>H3F3A</italic> was mutated in all samples as demonstrated by Sanger sequencing, <bold>f</bold> sample location taken from fresh (“Primary Pons”, <italic>Row 1</italic>) or fixed tissue (<italic>remaining rows</italic>) at autopsy corresponding to tumor location identified on post-mortem MRI imaging (<bold>g</bold>). Because post-mortem imaging was only performed on fixed tissue, MRI imaging for the fresh tissue sample (“Primary Pons”, <italic>Row 1</italic>) was a pre-mortem MRI performed approximately 6 weeks prior to death</p></caption><graphic xlink:href="40478_2015_269_Fig2_HTML" id="MO2"/></fig></p>
        <p>Except for <italic>TP53</italic>, we did not detect somatic mutations in genes involved in cell-cycle regulation, such as <italic>CDK4/6</italic>, <italic>CCND1/2/3</italic>, <italic>CDKN2A/B</italic> or <italic>RB1</italic>. Amplification of <italic>CDK4/6</italic> or <italic>CCND1/2/3</italic>, more common in DIPG [<xref ref-type="bibr" rid="CR14">14</xref>], was not assessed. As expected, H3G34R/V mutations, predominantly reported in hemispheric pediatric HGGs [<xref ref-type="bibr" rid="CR25">25</xref>], were also not found.</p>
      </sec>
    </sec>
    <sec id="Sec14">
      <title>Discussion</title>
      <p>Recent large-scale genomic studies have established the inter-patient molecular complexity of pediatric HGGs [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]; however, limited understanding of spatial subclonal architecture has impeded development of effective therapies. To our knowledge, we are the first to report multi-regional genetic analyses of matched primary, contiguous, and metastatic sites from DIPG and mHGG. Disease-defining somatic mutations in <italic>H3F3A</italic>, <italic>HIST1H3B</italic>, and <italic>ACVR1</italic> were conserved across all tumor locations, as were mutations affecting the (RTK)-PI3K-MAPK pathway. However, other targetable molecular aberrations, such as <italic>PDGFRA</italic>, were spatially heterogeneous. Findings from this study reiterate the distinct biology between pediatric and adult HGG and are critical for establishing the role of diagnostic biopsy and informing therapeutic strategy for these lethal pediatric tumors.</p>
      <p>Our findings confirm the propensity of DIPG and mHGG for aggressive local and distant metastatic spread (Fig. <xref rid="Fig1" ref-type="fig">1</xref>) and are consistent with our prior study in which extra-brainstem and leptomeningeal disease was found in 25 and 39 % of DIPGs from autopsy, respectively [<xref ref-type="bibr" rid="CR1">1</xref>]. Caretti et al. similarly reported leptomeningeal involvement in a quarter of DIPGs from autopsy [<xref ref-type="bibr" rid="CR26">26</xref>]. Importantly, we found histological evidence of metastatic disease by post-mortem MRI in five cases in which tumor was not seen on pre-mortem imaging or grossly at autopsy. Hence, disease dissemination is prevalent, but in most cases appears late in the disease course.</p>
      <p>Spatial histological heterogeneity, frequently reported in adult GBM [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR28">28</xref>], was observed in all but one patient in our cohort (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). Tissue from two DIPGs demonstrated intra-pontine histologic variation, including one with evidence of WHO grade II, III, and IV astrocytoma. We previously reported substantial histologic heterogeneity at various levels of the brainstem in DIPGs from autopsy [<xref ref-type="bibr" rid="CR1">1</xref>]; other autopsy studies have reported limited histologic evaluation of one pontine site, most of which were high-grade [<xref ref-type="bibr" rid="CR12">12</xref>]. Metastatic lesions in our cohort tended to be of lower histologic grade, a finding consistent with our prior report [<xref ref-type="bibr" rid="CR1">1</xref>]. While variation in metastatic regions may represent sampling bias in areas of lower tumor content, our finding of histologic heterogeneity within the densely tumor-packed pons in DIPG reiterates the poor reliability of histopathological grading for clinical stratification [<xref ref-type="bibr" rid="CR1">1</xref>].</p>
      <p>Significant temporal and spatial genetic and epigenetic heterogeneity has been reported in adult HGG, including regional variation of known driver mutations <italic>EGFR</italic>, <italic>MET</italic>, <italic>PTEN</italic>, and <italic>CDK6</italic> [<xref ref-type="bibr" rid="CR19">19</xref>], as well as heterogeneity of <italic>MGMT</italic> promoter methylation [<xref ref-type="bibr" rid="CR29">29</xref>]. We are the first to undertake comprehensive evaluation of the spatial genomic landscape of DIPG and mHGG in children. The most significant genomic discovery in DIPG and mHGG, to date, has been that of recurrent mutations in evolutionarily highly-conserved histone genes <italic>H3F3A</italic> and <italic>HIST1H3B</italic>, resulting in replacement of lysine 27 by methionine (K27M); these mutually exclusive somatic alterations occur in approximately 80 % of DIPGs [<xref ref-type="bibr" rid="CR14">14</xref>] and 50 % of pediatric thalamic GBMs [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. Unlike the remarkable intra-tumoral heterogeneity of driver mutations in adult HGG, we confirmed the presence of heterozygous K27M mutations in <italic>H3F3A</italic> or <italic>HIST1H3B</italic> in 100 % of tumor cells across all disease compartments in four and three DIPGs, respectively. This finding builds on prior reports demonstrating consistently high allelic frequency of histone mutations in all primary DIPG tumor cells using deep sequencing [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR30">30</xref>] and Kambhampati et al. finding of conservation of H3.3-K27M by IHC between the pons and ventricular tumor extension in one DIPG patient from autopsy [<xref ref-type="bibr" rid="CR11">11</xref>]. Activating point mutations of <italic>ACVR1</italic>, present in 20–30 % of DIPGs [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR14">14</xref>] and potentially targetable, were also conserved across all tumor compartments. <italic>ACVR1</italic> mutations were strongly associated with H3.1-K27M, as previously described [<xref ref-type="bibr" rid="CR14">14</xref>]. Furthermore, spatial conservation of activating mutations of <italic>FGFR1</italic>, <italic>PIK3CA,</italic> and <italic>MET</italic> supports the therapeutic relevance of targeting the (RTK)-PI3K-MAPK pathway in DIPG. Spatial homogeneity of <italic>PIK3CA</italic> mutations, in particular, supports their role as “founder mutations” in pediatric HGG, as suggested by Wu et al. who discovered a common <italic>PIK3CA</italic> mutation (Q546K) in multiple tumor subclones derived from matched mHGG samples from diagnosis and recurrence, suggesting not only spatial but also longitudinal conservation [<xref ref-type="bibr" rid="CR14">14</xref>]. Although <italic>TP53</italic> aberrations were present across all tumor compartments, the type and location of aberration varied suggesting that they are critical, but likely secondary hits.</p>
      <p>Similar to adult HGG, we observed subclonal variation of <italic>PDGFRA</italic> aberrations in our cohort. Spatial heterogeneity was particularly evident for Patient 3 in whom amplification was observed in three of six tumor locations (Fig. <xref rid="Fig2" ref-type="fig">2</xref>). Fontebasso et al. similarly reported amplification in one of five primary tumor sites in a treatment-naive mHGG [<xref ref-type="bibr" rid="CR5">5</xref>]. Interestingly, in Patient 3, one pontine site bearing high-level <italic>PDGFRA</italic> amplification also harbored a missense <italic>PDGFRA</italic> mutation (E229K); other sites with <italic>PDGFRA</italic> gain/amplification were wild-type with sufficient read coverage, suggesting later acquisition of this activating mutation in <italic>PDGFRA</italic>-amplified clones. Our findings are similar to Puget et al. who reported co-occurrence of <italic>PDGFRA</italic> mutation and amplification in three treatment-naïve DIPGs [<xref ref-type="bibr" rid="CR31">31</xref>] but differ from a report by Paugh et al. who found mutual exclusivity of amplification and mutation in 26 and 5 % of 43 DIPGs, respectively [<xref ref-type="bibr" rid="CR32">32</xref>]. While it is apparent that <italic>PDGFRA</italic> mutations and copy number changes arise in subclonal populations, further studies are needed to determine their temporal order and functional consequence.</p>
      <p>Our description of the spatial genomic landscape of DIPG and mHGG provides critical insight into the utility of diagnostic biopsy and the biologic rationale behind selection of therapeutic targets. Since the 1980s, imaging, rather than tissue, diagnosis has been the standard for DIPG and most mHGGs. More recently, pre-treatment biopsy has gained wider acceptance given the procedure’s low morbidity [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>] and discovery of potentially actionable genetic alterations that may inform therapy [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. Despite a notable shift in perspective in the pediatric neuro-oncology community, ongoing concerns about intrinsic heterogeneity, poor ability to decipher driver from bystander mutations, and sampling bias from the small tissue yield of stereotactic biopsy have impeded uniform implementation of pre-treatment biopsy to guide therapy. Our study offers several important insights in favor of diagnostic biopsy for DIPG and mHGG, including definitive demonstration that disease-driving histone mutations are intra-tumorally conserved. Several large clinico-genomic studies have demonstrated the prognostic relevance of H3 mutations [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR34">34</xref>]. Ongoing acquisition of pre-treatment tissue will allow refinement of histone mutation-based risk groups and molecular signatures, which have potential to elucidate oncogenic mechanisms and resistance pathways. Our findings also demonstrate that stereotactic biopsy of the safest intracranial disease location offers <italic>bona fide</italic> representation of certain molecular aberrations, abrogating the need for multiple biopsies at different sites of primary or metastatic tumor to elucidate the molecular signature from which therapy may be informed. Furthermore, the finding from this and other reports [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR32">32</xref>] that primary and metastatic tumor sites may demonstrate variable histopathological grades of astrocytoma (grades II-IV) without affecting prognosis or defining risk groups also supports the recommendation to limit the number of biopsy locations. Stereotactic biopsy of DIPG and mHGG should only be performed at specialized medical centers with skilled pediatric neurosurgeons trained in such techniques to minimize risk.</p>
      <p>Development of adjuvant therapies should be focused on targeting highly conserved genetic aberrations, which likely represent true disease drivers. Promising preclinical data demonstrating potent ability of demethylase inhibitors (e.g. GSKJ4) to reverse the broad epigenetic dysregulation and transcriptional signature induced by H3 mutations in DIPG support ongoing efforts for clinical translation of such agents [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. Grasso et al. also reported compelling in vivo data demonstrating the therapeutic efficacy of multi-histone deacetylase inhibitor panobinostat in H3-mutant DIPG xenografts, including synergistic effect with GSKJ4 [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. Ongoing work with ALK2 inhibitors for <italic>ACVR1</italic>-mutant DIPG is also encouraging [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR34">34</xref>]. Therapies directed against subclonal variants in DIPG and mHGG, such as <italic>PDGFRA</italic>, should not be abandoned but rather pursued in combination instead of monotherapy. Therapeutic implications of our findings should be formally tested in clinical trials implementing biopsy-directed targeted therapies. Indeed, target-based stratification based on biopsy results is already underway in several ongoing clinical trials in newly-diagnosed DIPGs (NCT01182350, NCT02233049).</p>
    </sec>
    <sec id="Sec15">
      <title>Conclusion</title>
      <p>Though conclusions from our study must be validated in a larger cohort, preferably including diagnostic and autopsy tissue for longitudinal comparison, our findings have immediate clinical relevance for children with DIPG and mHGG by supporting broader implementation of diagnostic biopsy to facilitate ongoing biologic discovery, further define molecular risk groups, and inform therapeutic strategy.</p>
    </sec>
  </body>
  <back>
    <app-group>
      <app id="App1">
        <sec id="Sec16">
          <title>Additional files</title>
          <p>
            <media position="anchor" xlink:href="40478_2015_269_MOESM1_ESM.xls" id="MOESM1">
              <label>Additional file 1: Table S1.</label>
              <caption>
                <p>Whole exome sequencing results on 46 candidate genes with previous clinical significance. (XLS 89 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="40478_2015_269_MOESM2_ESM.xls" id="MOESM2">
              <label>Additional file 2: Table S2.</label>
              <caption>
                <p>H3F3A and HIST1H3B Sanger Sequencing Primers. (XLS 8 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="40478_2015_269_MOESM3_ESM.xls" id="MOESM3">
              <label>Additional file 3: Table S3.</label>
              <caption>
                <p>ddPCR primer and probe design. (XLS 14 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="40478_2015_269_MOESM4_ESM.xls" id="MOESM4">
              <label>Additional file 4: Table S4.</label>
              <caption>
                <p>Digital droplet raw droplet counts and mutant allele frequency. (XLS 22 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="40478_2015_269_MOESM5_ESM.pdf" id="MOESM5">
              <label>Additional file 5: Figure S1.</label>
              <caption>
                <p>Chromats of sanger sequencing results for a) HIST1H3B and b) H3F3A K27M. (PDF 245 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="40478_2015_269_MOESM6_ESM.pdf" id="MOESM6">
              <label>Additional file 6: Figure S2.</label>
              <caption>
                <p>Immunohistochemistry validation of TP53 mutants. (PDF 216 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="40478_2015_269_MOESM7_ESM.pdf" id="MOESM7">
              <label>Additional file 7: Figure S3.</label>
              <caption>
                <p>FISH validation for PDGFRA copy number alterations. (PDF 354 kb)</p>
              </caption>
            </media>
          </p>
        </sec>
      </app>
    </app-group>
    <fn-group>
      <fn>
        <p>Lindsey M. Hoffman, Mariko DeWire, Scott Ryall, Cynthia E. Hawkins and Maryam Fouladi contributed equally to this work.</p>
      </fn>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The authors have no disclaimers or conflicts of interest.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors’ contributions</bold>
        </p>
        <p>LMH, MD, SR, PB, JL, RD, CEH, and MF contributed to writing the manuscript. LMH, MD, SR, PB, PD, CEH, and MF designed the study. All authors contributed to data collection. LMH, MD, SR, PB, JL, LM, AR, MB, SSK, RD, QRL, BJ, DW, BA, CEH, and MF contributed to data analysis and interpretation. All authors critically reviewed the manuscript and agreed to submit for publication.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors’ informations</bold>
        </p>
        <p>Lindsey M. Hoffman, Mariko DeWire, Scott Ryall are co-first authors.</p>
        <p>Cynthia E. Hawkins, Maryam Fouladi are co-senior authors.</p>
      </fn>
    </fn-group>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Buczkowicz</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Bartels</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Bouffet</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Becher</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Hawkins</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications</article-title>
          <source>Acta Neuropathol</source>
          <year>2014</year>
          <volume>128</volume>
          <fpage>573</fpage>
          <lpage>581</lpage>
          <pub-id pub-id-type="doi">10.1007/s00401-014-1319-6</pub-id>
          <?supplied-pmid 25047029?>
          <pub-id pub-id-type="pmid">25047029</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Robison</surname>
              <given-names>NJ</given-names>
            </name>
            <name>
              <surname>Kieran</surname>
              <given-names>MW</given-names>
            </name>
          </person-group>
          <article-title>Diffuse intrinsic pontine glioma: a reassessment</article-title>
          <source>J Neurooncol</source>
          <year>2014</year>
          <volume>119</volume>
          <fpage>7</fpage>
          <lpage>15</lpage>
          <pub-id pub-id-type="doi">10.1007/s11060-014-1448-8</pub-id>
          <?supplied-pmid 24792486?>
          <pub-id pub-id-type="pmid">24792486</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hashizume</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Andor</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Ihara</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Lerner</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Gan</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>X</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma</article-title>
          <source>Nat Med</source>
          <year>2014</year>
          <volume>20</volume>
          <fpage>1394</fpage>
          <lpage>1396</lpage>
          <pub-id pub-id-type="doi">10.1038/nm.3716</pub-id>
          <?supplied-pmid 25401693?>
          <pub-id pub-id-type="pmid">25401693</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aihara</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Mukasa</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gotoh</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Saito</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Nagae</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Tsuji</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>H3F3A K27M mutations in thalamic gliomas from young adult patients</article-title>
          <source>Neuro Oncol</source>
          <year>2014</year>
          <volume>16</volume>
          <fpage>140</fpage>
          <lpage>146</lpage>
          <pub-id pub-id-type="doi">10.1093/neuonc/not144</pub-id>
          <?supplied-pmid 24285547?>
          <pub-id pub-id-type="pmid">24285547</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fontebasso</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Papillon-Cavanagh</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Schwartzentruber</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Nikbakht</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Gerges</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Fiset</surname>
              <given-names>P-O</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma</article-title>
          <source>Nat Genet</source>
          <year>2014</year>
          <volume>46</volume>
          <fpage>462</fpage>
          <lpage>466</lpage>
          <pub-id pub-id-type="doi">10.1038/ng.2950</pub-id>
          <?supplied-pmid 24705250?>
          <pub-id pub-id-type="pmid">24705250</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grasso</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Truffaux</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Berlow</surname>
              <given-names>NE</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Debily</surname>
              <given-names>M-A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Functionally defined therapeutic targets in diffuse intrinsic pontine glioma</article-title>
          <source>Nat Med</source>
          <year>2015</year>
          <volume>21</volume>
          <fpage>555</fpage>
          <lpage>559</lpage>
          <pub-id pub-id-type="doi">10.1038/nm.3855</pub-id>
          <?supplied-pmid 25939062?>
          <pub-id pub-id-type="pmid">25939062</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kieran</surname>
              <given-names>MW</given-names>
            </name>
          </person-group>
          <article-title>Time to rethink the unthinkable: upfront biopsy of children with newly diagnosed diffuse intrinsic pontine glioma (DIPG)</article-title>
          <source>Pediatr Blood Cancer</source>
          <year>2015</year>
          <volume>62</volume>
          <fpage>3</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="doi">10.1002/pbc.25266</pub-id>
          <?supplied-pmid 25284709?>
          <pub-id pub-id-type="pmid">25284709</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Puget</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Beccaria</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Blauwblomme</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Roujeau</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>James</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Grill</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Biopsy in a series of 130 pediatric diffuse intrinsic Pontine gliomas</article-title>
          <source>Childs Nerv Syst</source>
          <year>2015</year>
          <volume>31</volume>
          <fpage>1773</fpage>
          <lpage>1780</lpage>
          <pub-id pub-id-type="doi">10.1007/s00381-015-2832-1</pub-id>
          <?supplied-pmid 26351229?>
          <pub-id pub-id-type="pmid">26351229</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>ZJ</given-names>
            </name>
            <name>
              <surname>Rao</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Bhambhani</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Poulik</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Altinok</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Diffuse intrinsic pontine glioma biopsy: a single institution experience</article-title>
          <source>Pediatr Blood Cancer</source>
          <year>2015</year>
          <volume>62</volume>
          <fpage>163</fpage>
          <lpage>165</lpage>
          <pub-id pub-id-type="doi">10.1002/pbc.25224</pub-id>
          <?supplied-pmid 25263768?>
          <pub-id pub-id-type="pmid">25263768</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Taylor</surname>
              <given-names>KR</given-names>
            </name>
            <name>
              <surname>Mackay</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Truffaux</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Butterfield</surname>
              <given-names>YS</given-names>
            </name>
            <name>
              <surname>Morozova</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Philippe</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma</article-title>
          <source>Nat Genet</source>
          <year>2014</year>
          <volume>46</volume>
          <fpage>457</fpage>
          <lpage>461</lpage>
          <pub-id pub-id-type="doi">10.1038/ng.2925</pub-id>
          <?supplied-pmid 24705252?>
          <pub-id pub-id-type="pmid">24705252</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kambhampati</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Perez</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Yadavilli</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Saratsis</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Hill</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Ho</surname>
              <given-names>C-Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A standardized autopsy procurement allows for the comprehensive study of DIPG biology</article-title>
          <source>Oncotarget</source>
          <year>2015</year>
          <volume>6</volume>
          <fpage>12740</fpage>
          <lpage>12747</lpage>
          <pub-id pub-id-type="doi">10.18632/oncotarget.3374</pub-id>
          <?supplied-pmid 25749048?>
          <pub-id pub-id-type="pmid">25749048</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Broniscer</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Baker</surname>
              <given-names>JN</given-names>
            </name>
            <name>
              <surname>Baker</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Chi</surname>
              <given-names>SN</given-names>
            </name>
            <name>
              <surname>Geyer</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Morris</surname>
              <given-names>EB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Prospective collection of tissue samples at autopsy in children with diffuse intrinsic pontine glioma</article-title>
          <source>Cancer</source>
          <year>2010</year>
          <volume>116</volume>
          <fpage>4632</fpage>
          <lpage>4637</lpage>
          <pub-id pub-id-type="doi">10.1002/cncr.25405</pub-id>
          <?supplied-pmid 20589749?>
          <pub-id pub-id-type="pmid">20589749</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Buczkowicz</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Hoeman</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Rakopoulos</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Pajovic</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Letourneau</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Dzamba</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations</article-title>
          <source>Nat Genet</source>
          <year>2014</year>
          <volume>46</volume>
          <fpage>451</fpage>
          <lpage>456</lpage>
          <pub-id pub-id-type="doi">10.1038/ng.2936</pub-id>
          <?supplied-pmid 24705254?>
          <pub-id pub-id-type="pmid">24705254</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wu</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Diaz</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Paugh</surname>
              <given-names>BS</given-names>
            </name>
            <name>
              <surname>Rankin</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Ju</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma</article-title>
          <source>Nat Genet</source>
          <year>2014</year>
          <volume>46</volume>
          <fpage>444</fpage>
          <lpage>450</lpage>
          <pub-id pub-id-type="doi">10.1038/ng.2938</pub-id>
          <?supplied-pmid 24705251?>
          <pub-id pub-id-type="pmid">24705251</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sethi</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Allen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Donahue</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Karajannis</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gardner</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wisoff</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Prospective neuraxis MRI surveillance reveals a high risk of leptomeningeal dissemination in diffuse intrinsic pontine glioma</article-title>
          <source>J Neurooncol</source>
          <year>2011</year>
          <volume>102</volume>
          <fpage>121</fpage>
          <lpage>127</lpage>
          <pub-id pub-id-type="doi">10.1007/s11060-010-0301-y</pub-id>
          <?supplied-pmid 20623246?>
          <pub-id pub-id-type="pmid">20623246</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gururangan</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>McLaughlin</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Brashears</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Watral</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Provenzale</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Coleman</surname>
              <given-names>RE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Incidence and patterns of neuraxis metastases in children with diffuse pontine glioma</article-title>
          <source>J Neurooncol</source>
          <year>2006</year>
          <volume>77</volume>
          <fpage>207</fpage>
          <lpage>212</lpage>
          <pub-id pub-id-type="doi">10.1007/s11060-005-9029-5</pub-id>
          <?supplied-pmid 16568209?>
          <pub-id pub-id-type="pmid">16568209</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Broniscer</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Baker</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>Wetmore</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Pai Panandiker</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Davidoff</surname>
              <given-names>AM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Phase I trial, pharmacokinetics, and pharmacodynamics of vandetanib and dasatinib in children with newly diagnosed diffuse intrinsic pontine glioma</article-title>
          <source>Clin Cancer Res</source>
          <year>2013</year>
          <volume>19</volume>
          <fpage>3050</fpage>
          <lpage>3058</lpage>
          <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-13-0306</pub-id>
          <?supplied-pmid 23536435?>
          <pub-id pub-id-type="pmid">23536435</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jansen</surname>
              <given-names>MHA</given-names>
            </name>
            <name>
              <surname>van Vuurden</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Vandertop</surname>
              <given-names>WP</given-names>
            </name>
            <name>
              <surname>Kaspers</surname>
              <given-names>GJL</given-names>
            </name>
          </person-group>
          <article-title>Diffuse intrinsic pontine gliomas: a systematic update on clinical trials and biology</article-title>
          <source>Cancer Treat Rev</source>
          <year>2012</year>
          <volume>38</volume>
          <fpage>27</fpage>
          <lpage>35</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ctrv.2011.06.007</pub-id>
          <?supplied-pmid 21764221?>
          <pub-id pub-id-type="pmid">21764221</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sottoriva</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Spiteri</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Piccirillo</surname>
              <given-names>SGM</given-names>
            </name>
            <name>
              <surname>Touloumis</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Collins</surname>
              <given-names>VP</given-names>
            </name>
            <name>
              <surname>Marioni</surname>
              <given-names>JC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2013</year>
          <volume>110</volume>
          <fpage>4009</fpage>
          <lpage>4014</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.1219747110</pub-id>
          <?supplied-pmid 23412337?>
          <pub-id pub-id-type="pmid">23412337</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Patel</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Tirosh</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Trombetta</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Shalek</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Gillespie</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Wakimoto</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma</article-title>
          <source>Science</source>
          <year>2014</year>
          <volume>344</volume>
          <fpage>1396</fpage>
          <lpage>1401</lpage>
          <pub-id pub-id-type="doi">10.1126/science.1254257</pub-id>
          <?supplied-pmid 24925914?>
          <pub-id pub-id-type="pmid">24925914</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Suzuki</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Aoki</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Chiba</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Sato</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Shiozawa</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Shiraishi</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mutational landscape and clonal architecture in grade II and III gliomas</article-title>
          <source>Nat Genet</source>
          <year>2015</year>
          <volume>47</volume>
          <fpage>458</fpage>
          <lpage>468</lpage>
          <pub-id pub-id-type="doi">10.1038/ng.3273</pub-id>
          <?supplied-pmid 25848751?>
          <pub-id pub-id-type="pmid">25848751</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dorris</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Sobo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Onar-Thomas</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Panditharatna</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Stevenson</surname>
              <given-names>CB</given-names>
            </name>
            <name>
              <surname>Gardner</surname>
              <given-names>SL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Prognostic significance of telomere maintenance mechanisms in pediatric high-grade gliomas</article-title>
          <source>J Neurooncol</source>
          <year>2014</year>
          <volume>117</volume>
          <fpage>67</fpage>
          <lpage>76</lpage>
          <pub-id pub-id-type="doi">10.1007/s11060-014-1374-9</pub-id>
          <?supplied-pmid 24477622?>
          <pub-id pub-id-type="pmid">24477622</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Durbin</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Fast and accurate long-read alignment with Burrows-Wheeler transform</article-title>
          <source>Bioinformatics</source>
          <year>2010</year>
          <volume>26</volume>
          <fpage>589</fpage>
          <lpage>595</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/btp698</pub-id>
          <?supplied-pmid 20080505?>
          <pub-id pub-id-type="pmid">20080505</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wu</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Broniscer</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>McEachron</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Paugh</surname>
              <given-names>BS</given-names>
            </name>
            <name>
              <surname>Becksfort</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas</article-title>
          <source>Nat Genet</source>
          <year>2012</year>
          <volume>44</volume>
          <fpage>251</fpage>
          <lpage>253</lpage>
          <pub-id pub-id-type="doi">10.1038/ng.1102</pub-id>
          <?supplied-pmid 22286216?>
          <pub-id pub-id-type="pmid">22286216</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schwartzentruber</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Korshunov</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>X-Y</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>DTW</given-names>
            </name>
            <name>
              <surname>Pfaff</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Jacob</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma</article-title>
          <source>Nature</source>
          <year>2012</year>
          <volume>482</volume>
          <fpage>226</fpage>
          <lpage>231</lpage>
          <pub-id pub-id-type="doi">10.1038/nature10833</pub-id>
          <?supplied-pmid 22286061?>
          <pub-id pub-id-type="pmid">22286061</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Caretti</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Bugiani</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Freret</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schellen</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Jansen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>van Vuurden</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Subventricular spread of diffuse intrinsic pontine glioma</article-title>
          <source>Acta Neuropathol</source>
          <year>2014</year>
          <volume>128</volume>
          <fpage>605</fpage>
          <lpage>607</lpage>
          <pub-id pub-id-type="doi">10.1007/s00401-014-1307-x</pub-id>
          <?supplied-pmid 24929912?>
          <pub-id pub-id-type="pmid">24929912</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aubry</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>de Tayrac</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Etcheverry</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Clavreul</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Saikali</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Menei</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>From the core to beyond the margin: a genomic picture of glioblastoma intratumor heterogeneity</article-title>
          <source>Oncotarget</source>
          <year>2015</year>
          <volume>6</volume>
          <fpage>12094</fpage>
          <lpage>12109</lpage>
          <pub-id pub-id-type="doi">10.18632/oncotarget.3297</pub-id>
          <?supplied-pmid 25940437?>
          <pub-id pub-id-type="pmid">25940437</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Parker</surname>
              <given-names>NR</given-names>
            </name>
            <name>
              <surname>Khong</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Parkinson</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Howell</surname>
              <given-names>VM</given-names>
            </name>
            <name>
              <surname>Wheeler</surname>
              <given-names>HR</given-names>
            </name>
          </person-group>
          <article-title>Molecular heterogeneity in glioblastoma: potential clinical implications</article-title>
          <source>Front Oncol</source>
          <year>2015</year>
          <volume>5</volume>
          <fpage>55</fpage>
          <?supplied-pmid 25785247?>
          <pub-id pub-id-type="pmid">25785247</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Parkinson</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Wheeler</surname>
              <given-names>HR</given-names>
            </name>
            <name>
              <surname>Clarkson</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>McKenzie</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Biggs</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Little</surname>
              <given-names>NS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Variation of O(6)-methylguanine-DNA methyltransferase (MGMT) promoter methylation in serial samples in glioblastoma</article-title>
          <source>J Neurooncol</source>
          <year>2008</year>
          <volume>87</volume>
          <fpage>71</fpage>
          <lpage>78</lpage>
          <pub-id pub-id-type="doi">10.1007/s11060-007-9486-0</pub-id>
          <?supplied-pmid 18004504?>
          <pub-id pub-id-type="pmid">18004504</pub-id>
        </element-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <mixed-citation publication-type="other">Mackay A, Vinci M, Anna B, Bjerke L, Taylor K, Nandhabalan M, et al. Integrative molecular meta-analysis of 700 pediatric high grade glioma and DIPG defines widespread inter- and intra-tumoral heterogeneity. Neuro-Oncol. 2015;17:iii12. (abstr HG–11).</mixed-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Puget</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Philippe</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Bax</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Job</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Varlet</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Junier</surname>
              <given-names>M-P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mesenchymal transition and PDGFRA amplification/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomas</article-title>
          <source>PLoS One</source>
          <year>2012</year>
          <volume>7</volume>
          <fpage>e30313</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0030313</pub-id>
          <?supplied-pmid 22389665?>
          <pub-id pub-id-type="pmid">22389665</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Paugh</surname>
              <given-names>BS</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Qu</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Endersby</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Diaz</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Novel oncogenic PDGFRA mutations in pediatric high-grade gliomas</article-title>
          <source>Cancer Res</source>
          <year>2013</year>
          <volume>73</volume>
          <fpage>6219</fpage>
          <lpage>6229</lpage>
          <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-13-1491</pub-id>
          <?supplied-pmid 23970477?>
          <pub-id pub-id-type="pmid">23970477</pub-id>
        </element-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Khuong-Quang</surname>
              <given-names>D-A</given-names>
            </name>
            <name>
              <surname>Buczkowicz</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Rakopoulos</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>X-Y</given-names>
            </name>
            <name>
              <surname>Fontebasso</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Bouffet</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas</article-title>
          <source>Acta Neuropathol</source>
          <year>2012</year>
          <volume>124</volume>
          <fpage>439</fpage>
          <lpage>447</lpage>
          <pub-id pub-id-type="doi">10.1007/s00401-012-0998-0</pub-id>
          <?supplied-pmid 22661320?>
          <pub-id pub-id-type="pmid">22661320</pub-id>
        </element-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Castel</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Philippe</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Calmon</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Le Dret</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Truffaux</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Boddaert</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes</article-title>
          <source>Acta Neuropathol</source>
          <year>2015</year>
          <volume>130</volume>
          <issue>6</issue>
          <fpage>815</fpage>
          <lpage>27</lpage>
          <pub-id pub-id-type="doi">10.1007/s00401-015-1478-0</pub-id>
          <?supplied-pmid 26399631?>
          <pub-id pub-id-type="pmid">26399631</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:4700586</identifier><datestamp>2016-01-06</datestamp><setSpec>liphdis</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="http://jats.nlm.nih.gov/ns/archiving/1.0/ http://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Lipids Health Dis</journal-id>
      <journal-id journal-id-type="iso-abbrev">Lipids Health Dis</journal-id>
      <journal-title-group>
        <journal-title>Lipids in Health and Disease</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1476-511X</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC4700586</article-id>
      <article-id pub-id-type="pmcid">PMC4700586</article-id>
      <article-id pub-id-type="pmc-uid">4700586</article-id>
      <article-id pub-id-type="publisher-id">174</article-id>
      <article-id pub-id-type="doi">10.1186/s12944-015-0174-3</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>TGF-β1/FGF-2 signaling mediates the 15-HETE-induced differentiation of adventitial fibroblasts into myofibroblasts</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>Li</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>Yan</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Li</surname>
            <given-names>Guixia</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>Minggang</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Huang</surname>
            <given-names>Wei</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>Yanrui</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Li</surname>
            <given-names>Yumei</given-names>
          </name>
          <address>
            <phone>+86-459-8153069</phone>
            <email>liym013021@163.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <aff id="Aff1"><label/>Department of Pharmacology, Harbin Medical University-Daqing, Xinyang Road 39, Daqing, Heilongjiang Province 163319 China </aff>
        <aff id="Aff2"><label/>Daqing Qil Fields General Hospital, Heilongjiang, Daqing, Heilongjiang Province 163319 China </aff>
        <aff id="Aff3"><label/>Biopharmaceutical Institute of the Heilongjiang Academy of Medical Sciences, Harbin, Heilongjiang Province 150081 China </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>5</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>5</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <volume>15</volume>
      <elocation-id>2</elocation-id>
      <history>
        <date date-type="received">
          <day>28</day>
          <month>9</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>29</day>
          <month>12</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© Zhang et al. 2015</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p> Pulmonary adventitial fibroblasts (PAFs) are activated under stress stimuli leading to their differentiation into myofibroblasts, which is involved in vessel remodeling. 15-HETE is known as an important factor in vessel remodeling under hypoxia; however, the role of 15-HETE in PAF phenotypic alteration is not clear.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>The effect of 15-HETE on PAF phenotypic alterations was investigated in the present study. PAFs were treated with 15-HETE (0.5 μM) for 24 h, and the myofibroblast marker α-smooth muscle actin (α-SMA) was analyzed. The 15-HETE induced α-SMA expression and cell morphology. 15-HETE upregulated FGF-2 levels in PAFs, and knockdown FGF-2 by siRNAs blocked the enhanced α-SMA expression induced by 15-HETE. p38 kinase was activated, and blocked depressed 15-HETE-induced FGF-2 expression. The downstream of p38 pathway, Egr-1 activation, was also raised by 15-HETE treatment, and silenced Egr-1 suppressed the 15-HETE-induced upregulation of FGF-2. TGF-β1 was upregulated with FGF-2 treatment, and α-SMA expression induced by FGF-2 was inhibited after the cell was transferred with TGF-β1 siRNA. Meanwhile, FGF-2 increased α-SMA expression and improved proliferation, which was associated with p27<sup>kip1</sup> and cyclin E variation.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>The above results suggest that p38/Egr-1 pathway-mediated FGF-2 is involved in 15-HETE-induced differentiation of PAFs into myofibroblasts and cell proliferation.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Pulmonary adventitial fibroblasts</kwd>
        <kwd>15-HETE</kwd>
        <kwd>FGF-2</kwd>
        <kwd>Myofibroblasts</kwd>
        <kwd>p38/Egr-1</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution>the Project of educational bureau of Heilongjiang Province</institution>
          </funding-source>
          <award-id>12531297</award-id>
          <principal-award-recipient>
            <name>
              <surname>Zhang</surname>
              <given-names>Li</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
      </funding-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>© The Author(s) 2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Background</title>
      <p>Pulmonary vasculature remodeling is the main characteristic of pulmonary artery hypertension (PAH), secondary to chronic obstructive pulmonary disease (COPD) or interstitial lung diseases. Vessel remodeling includes the alterations in the intima, media, and adventitia of the pulmonary artery [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Hypoxia is the pathological basis of pulmonary vascular remodeling, especially in the adventitia. It is recognized as the earliest and most prominent structural change during the PAH process [<xref ref-type="bibr" rid="CR3">3</xref>]. Previous reports indicate that 15-hydroxyeicosatetraenoic acid (15-HETE), one of the most important metabolic products of arachidonic acid (AA) catalyzed by 15-lipoxygenase, is a novel molecule involved in many cellular processes, including cell proliferation, fibrosis, migration, and inflammation [<xref ref-type="bibr" rid="CR4">4</xref>]. In response to hypoxia, adventitial fibroblast (PAF) is activated and undergoes phenotypic changes, which is followed with proliferation, differentiation, upregulation of contractile and extracellular matrix proteins, and a release of factors that directly affect medial smooth muscle cell tone and growth. PAF transformation is thought to be the key step of hypoxia-induced pulmonary vascular remodeling [<xref ref-type="bibr" rid="CR5">5</xref>]. 15-HETE induced vascular PAF migration through the activation of STAT3 and stimulated vascular adventitial fibrosis via p38 MAPK-dependent TGF-β1 pathway were clarified by our previous studies [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. We also identified 15-HETE-induced differentiation of PAF into myofibroblast; however, how and why this happened remains unclear. Thus, we aim to explore the mechanism for 15-HETE-induced PAF phenotypic alteration in this study.</p>
      <p>In hypoxia-induced pulmonary hypertension, the early and dramatic increase in the appearance of α-SMA in the adventitia is observed [<xref ref-type="bibr" rid="CR8">8</xref>]. α-SMA is the most frequently used marker for myofibroblast identification, and the expression of α-SMA in the adventitial vessel wall is a significant signal of fibroblast differentiations into myofibroblast [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. Myofibroblasts accumulation contributes to the changes in vascular tone and structure under pathophysiological situations. Myofibroblasts are also the most important producers of collagen, fibronectin, tenascin, and elastin in the fibrotic tissues in response to change in the local environment. Thus, myofibroblasts are implicated as key participants in pulmonary vascular remodeling [<xref ref-type="bibr" rid="CR11">11</xref>].</p>
      <p>The stiffening of the pulmonary adventitial layer is recognized as the most sensing response when pulmonary arteries undergo hypoxia. Activation of some growth factors, with subsequent stimulation of protein kinase C and mitogen activated protein (MAP) kinase family members as well as phosphatidylinositol 3-kinase (PI3K), are important regulators of hypoxia-induced PAF proliferation [<xref ref-type="bibr" rid="CR12">12</xref>]. Some potent mediators in response to earlier hypoxia have been established by a variety of hypotheses. FGF-2 is one of the most interesting growth factors among those regulators such as ET-1, TGF-β, and PDGF. FGF-2 belongs to the fibroblast growth factor family. It is a key player in the process of cell proliferation and differentiation under various stimuli. FGF-2 mediated cell phenotypic changes and increased nuclear p27<sup>kip1</sup> and FoxO3a through PI3K-Akt and ERK pathways during hypoxia-induced vascular remodeling [<xref ref-type="bibr" rid="CR13">13</xref>].</p>
      <p>Excessive proliferation and migration of PAFs greatly contributed to the pathobiology of PAH [<xref ref-type="bibr" rid="CR14">14</xref>]. The myofibroblasts could migrate from the adventitia to the media or even the intima, leading to vessel thickening. Myofibroblast accumulation in the intima of arteries has been well documented and is consistently observed accompanying hypoxia in PAH patients [<xref ref-type="bibr" rid="CR15">15</xref>]. However, where these proliferative cells originate from and who mediates the process is unclear. Here we intend to study the role of 15-HETE in PAF proliferation and cell phenotypic changes, further exploring the underlying mechanisms of 15-HETE in this process.</p>
    </sec>
    <sec id="Sec2" sec-type="materials|methods">
      <title>Methods</title>
      <sec id="Sec3">
        <title>Reagents</title>
        <p>15-HETE was purchased from Cayman Chemicals (Ann Arbor, MI), Anti-phospho-p38, anti-p38, cyclin E, FGF-2, α-SMA, TGF-β1 and GAPDH were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). FGF-2 and Egr-1 siRNAs, FGF-2 and SP600125 were obtained from Sigma, USA. siRNA oligo was synthesized by GenePharma Co., Ltd (Shanghai, China).</p>
      </sec>
      <sec id="Sec4">
        <title>Cell culture</title>
        <p>Adventitia from the main pulmonary artery was harvested from fresh rat lung. The pulmonary artery tissue was carefully dissected free of blood vessels and fat under a dissecting microscope, as previous described [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. Muscular tissue and endothelial cell layers were removed by gentle abrasion of the vessel. The remaining tissue (adventitia) was then dissected into 1 mm<sup>2</sup> portions. The portions of tissue were evenly distributed over the base of a 25 cm<sup>2</sup> culture flasks containing 2 ml of Dulbecco’s modified eagle medium (DMEM) with 20 % fetal bovine serum (FBS). The explants were incubated in a humidified atmosphere with 5 % CO<sub>2</sub> at 37 °C. Fibroblast cells grew from the plants in about 5 days. They were passaged and cultured in 15 % FBS. The 2 to 5 passages were used for the following experiments.</p>
      </sec>
      <sec id="Sec5">
        <title>MTT</title>
        <p>PAFs were cultured in a 96-well culture plate (about 1 × 10<sup>4</sup>), and then the cells were transferred with siR15-LO, siRp27<sup>kipl</sup> or siRNC in DMEM with 5 % FBS. Then the samples were exposed to hypoxia (3 % O<sub>2</sub>). Cinnamyl-3,4-dihydroxy-a’-cyanocinnamate (CDC) or SP600125 at the indicated concentrations were added under hypoxic condition. At the end of the incubation in 37 °C, the cells were incubated for 4 h in a medium containing 0.5 % 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide (MTT), the yellow mitochondrial dye. The amount of blue formazan dye formed from MTT is proportional to the number of surviving cells. The reaction was terminated by adding DMSO to the medium followed by incubation for 10 min. The spectrophotometer absorbance at 540 nm was measured.</p>
      </sec>
      <sec id="Sec6">
        <title>Cell transient transfection</title>
        <p>To instigate the knockdown of p27<sup>kip1</sup>, the PAFs were transfected with small interfering RNA, which was designed and synthesized by GenePharma using X-treme Gene siRNA Transfection Reagent (Roche Applied Science, Mannheim, Germany). FAM-tagged non-targeted control siRNA (siRNC) was used to examine and optimize the efficiency of transfection and acted as a negative control. The sense sequences of siRNA and α FAM-tagged non-targeted control sequence were listed below:</p>
        <p>TGF-β1: (NM:012775) 5′-CUGACAGCUUUGCGAAUUATT-3′</p>
        <p>p27<sup>kipl</sup>: (NM_199501.1) 5′-CCAGGACCUCAAGAAGUUUTT-3′,</p>
        <p>NC control: 5′-UUCUCCGAACGUGUCACGUTT-3′.</p>
        <p>PAFs were starved with DMEM without serum for 24 h before treatment. 10 μl X-tremeGene siRNA Transfection Reagent were diluted in 90 μl serum-free Opti-MEM-1 medium for 5 min, and 7.5 μl siRNA was diluted with 92.5 μl serum-free Opti-MEM-1 medium, respectively. Then the two above mixtures were mixed for another 20 min at RT. Changed the cell medium for DMEM and added the siRNA and Transfection Reagent mixtures to the cells for 6 h. Cells incubated with siRNC in the same process served as controls. The transfected medium was discarded and cells were cultured in DMEM containing 5 % FBS under normal or 15-HETE stimulation for 24 h. Protein contents were checked with Western blot.</p>
      </sec>
      <sec id="Sec7">
        <title>Immunofluorescence study and microscopic observation</title>
        <p>PAFs were cultured on a poly-L-lysine-coated cover glass (15 mm diameter) and washed three times with PBS, followed by fixation with 4 % paraformaldehyde at room temperature (RT) for 15 min. After permeabilization with 0.1 % Triton X-100 for 15 min, the cells were blocked with 3 % normal goat serum at RT for 30 min, followed by incubation with anti-α-SMA primary antibodies (1:100) in PBS at 4 °C overnight. After being washed three times with PBS, the cells were incubated with FITC-conjugated secondary antibody (1:100) diluted by PBS at RT for 2 h and DAPI away from light. Then the cover glass was mounted and examined with the Live cell station (DMI6000B, Leica, Germany).</p>
      </sec>
      <sec id="Sec8">
        <title>Western blot</title>
        <p>For Western blot analysis, total proteins were extracted with 400 μl lysis buffer (Tris 50 mM, pH 7.4, NaCl 150 mM, Triton X-100 1 %, EDTA 1 mM, and PMSF 2 mM) and cleaved for 30 min on ice. Then the lysates were centrifuged at 13,500 rpm for 10 min at 4 °C, and the supernatant was collected. The protein concentration in the supernatant was determined by the bicinchoninic acid protein assay (Pierce, Rockford, IL) with bovine serum albumin (BSA) as a standard. 50 μg proteins of each sample were fractionated on a 10 % SDS-polyacrylamide gel. After being electrophoretically transferred to a Pure Nitrocellulose Blotting membrane (Pall Life Science), the membranes were incubated in a blocking buffer (Tris 20 mM, pH 7.6, NaCl 150 mM, and Tween 20 0.1 %) containing 5 % nonfat dry milk powder, and then the blots were probed with primary antibodies overnight at 4 °C, with GAPDH as an internal control. The immunoreactivity was detected using an enhanced chemiluminescence (ECL) and then exposed to X-ray film in a darkroom. Immunoblots were scanned using a V330 densitometer and protein bands were quantified with Quantity One software (EPSON, Bio-Rad Laboratories, Hercules, CA).</p>
      </sec>
      <sec id="Sec9">
        <title>Statistical analysis</title>
        <p>All data is presented as mean ± SEM. There are more than two groups of continuous variables in this study, so an one-way analysis of variance ANOVA followed by Bonferroni or Dunnett’s post-hoc test was used for multiple comparisons. A two-tailed value of <italic>p</italic> &lt; 0.05 is considered a statistically significant difference. Data is analyzed using the GraphPad Prism 5.0 and SPSS 14.0.</p>
      </sec>
    </sec>
    <sec id="Sec10">
      <title>Results</title>
      <sec id="Sec11">
        <title>15-HETE induces PAF phenotypic changes</title>
        <p>Adventitial fibroblasts differentiate into myofibroblast phenotype under 15-HETE stimulation as our previous studies reported. α-SMA, the most frequently used marker for myofibroblast identification was studied. PAFs were treated with 15-HETE (0.5 μM) for 24 h. As shown in Fig. <xref rid="Fig1" ref-type="fig">1a</xref>, cells in the presence of 15-HETE, α-SMA protein levels were significantly increased. Meanwhile, immunofluorescent staining also showed 15-HETE increased α-SMA levels in PAFs (Fig. <xref rid="Fig1" ref-type="fig">1b</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p>15-HETE induced PAF phenotypic changes. PAFs were incubated with 15-HETE (0.5 μM) for 24 h. Subsequently myofibroblast markers, α-SMA protein expression, was determined as a percentage of the untreated controls using Western blot (<bold>a</bold>) and (<bold>b</bold>). The characteristics of myofibroblasts was assayed by immunocytochemistry staining; the nuclei was stained with 4′,6-diamidino-2-phenylindole (DAPI). Magnification: 200X. Data consists of the means of three independent experiments ± SEM (<italic>n</italic> = 3). * <italic>p</italic> &lt; 0.05 vs. controls</p></caption><graphic xlink:href="12944_2015_174_Fig1_HTML" id="MO1"/></fig></p>
      </sec>
      <sec id="Sec12">
        <title>FGF-2 was involved in 15-HETE-induced cell phenotypic alterations</title>
        <p>The differentiation of fibroblasts into myofibroblasts is regulated by a complex microenvironment consisting of growth factors, cytokines, adhesion molecules, and ECM molecules. To examine whether FGF-2 is involved in 15-HETE-induced PAF phenotypic changes, we determined the FGF-2 expression after 15-HETE exposure through immunoblotting. The results showed 15-HETE exposure significantly increased FGF-2 levels (Fig. <xref rid="Fig2" ref-type="fig">2a</xref>). Furthermore, silencing FGF-2 with RNAi technique, α-SMA expression was low in cells transfected with siRFGF (Fig. <xref rid="Fig2" ref-type="fig">2b</xref>). The efficiency of FGF-2 silence was validated, and silenced FGF-2 also decreased the α-SMA expression without 15-HETE exposure (Fig. <xref rid="Fig2" ref-type="fig">2c</xref>). These results suggest that 15-HETE-induced phenotypic conversion of fibroblasts into myofibroblasts was mediated by FGF-2 through detecting α-SMA expression levels.<fig id="Fig2"><label>Fig. 2</label><caption><p>FGF-2 was involved in 15-HETE-induced cell phenotypic alterations. Cells were treated with 15-HETE (0.5 μM) for 24 h. <bold>a</bold> Western blot for FGF-2 expression. <bold>b</bold> Cells were transferred with FGF-2 siRNAs, α-SMA was analyzed by Western blot. <bold>c</bold> The efficiency of FGF-2 silence and its effects on α-SMA without 15-HETE treatments were validated. Data consists of the means of three independent experiments ± SEM (<italic>n</italic> = 3). * <italic>p</italic> &lt; 0.05 vs. controls; +<italic>p</italic> &lt;0 .05 vs. 15-HETE</p></caption><graphic xlink:href="12944_2015_174_Fig2_HTML" id="MO2"/></fig></p>
      </sec>
      <sec id="Sec13">
        <title>15-HETE-induced FGF-2 upregulation requires p38 MAPK</title>
        <p>PAFs were treated with 15-HETE, p38 MAPK and its downstream target Egr-1 activity was analyzed. As shown in Fig. <xref rid="Fig3" ref-type="fig">3a</xref> &amp; <xref rid="Fig3" ref-type="fig">b</xref>, both p38 and Egr-1 phosphorylation levels were raised by 15-HETE stimulation. To determine the effect of p38 on 15-HETE increased FGF-2 expression in PAFs, a pharmacological inhibitor was used. SB203580, an inhibitor of p38 kinase, blocked 15-HETE induced FGF-2 upregulation (Fig. <xref rid="Fig3" ref-type="fig">3c</xref>). Egr-1 was able to improve the promoter activity of FGF-2 as reported [<xref ref-type="bibr" rid="CR16">16</xref>]. So we performed a knockdown of Egr-1, then cells were treated with 15-HETE, and we found that FGF-2 expression was resumed to the control levels (Fig. <xref rid="Fig3" ref-type="fig">3d</xref>).<fig id="Fig3"><label>Fig. 3</label><caption><p>15-HETE-induced FGF-2 upregulation requires p38 MAPK. Cells were treated with 15-HETE (0.5 μM) for 24 h. <bold>a</bold> Western blot for p38 phosphylation and total p38 levels, and p-Egr-1 expression (<bold>b</bold>). <bold>c</bold> Cells treated with p38 specific inhibitor, SB203580 (10 μM), or transfection with Egr-1 siRNA (<bold>d</bold>), FGF-2 was analyzed using Western blot. Data consists of the means of three independent experiments ± SEM (<italic>n</italic> = 3). * <italic>p</italic> &lt; 0.05 vs. controls; +<italic>p</italic> &lt; 0.05 vs. 15-HETE</p></caption><graphic xlink:href="12944_2015_174_Fig3_HTML" id="MO3"/></fig></p>
      </sec>
      <sec id="Sec14">
        <title>FGF-2-induced α-SMA expression is mediated by TGF-β1</title>
        <p>TGF-β1 is a well-known cytokine capable of inducing the transition of a fibroblast into a myofibroblast phenotype by stimulating α-SMA expression and collagen production [28]. We performed immunoblotting directly for TGF-β1 expression after the cells were treated with FGF-2. Figure <xref rid="Fig4" ref-type="fig">4a</xref> showed that FGF-2 exposure (4 h) significantly upregulates the level of TGF-β1 protein in PAFs. To evaluate whether the increase in α-SMA expression induced by FGF-2 is dependent on TGF-β1, PAFs were transiently transfected with TGF-β1 siRNA, and then stimulated with FGF-2. We found TGF-β1 knockdown inhibited FGF-2-induced α-SMA increments in PAFs (Fig. <xref rid="Fig4" ref-type="fig">4b</xref>).<fig id="Fig4"><label>Fig. 4</label><caption><p>FGF-2-induced α-SMA expression is mediated by TGF-β1. Cells were treated with FGF-2 (15 ng/ml) for 4 h. <bold>a</bold> Western blot for TGF-β1 expression. <bold>b</bold> Cells transferred with TGF-β1 siRNAs, α-SMA changes were analyzed. Data consist of the means of three independent experiments ± SEM (<italic>n</italic> = 3). * <italic>p</italic> &lt; 0.05 vs. controls; +<italic>p</italic> &lt; 0.05 vs. 15-HETE</p></caption><graphic xlink:href="12944_2015_174_Fig4_HTML" id="MO4"/></fig></p>
      </sec>
      <sec id="Sec15">
        <title>FGF-2 induces α-SMA expression and cell proliferation</title>
        <p>FGF-2-induced α-SMA expressions were assessed by immunoblotting and immunofluorescent staining, the results revealing that FGF-2 upregulated α-SMA levels (Fig. <xref rid="Fig5" ref-type="fig">5a</xref> &amp; <xref rid="Fig5" ref-type="fig">b</xref>). As the transformation of fibroblasts into myofibroblasts always occurs concomitantly with proliferation, we detected the cell viability and cyclin E changes after FGF-2 stimulation. We found that FGF-2 exposure significantly increased cell viability and cyclin E expression in PAFs (Fig. <xref rid="Fig5" ref-type="fig">5c</xref> &amp; <xref rid="Fig5" ref-type="fig">d</xref>).<fig id="Fig5"><label>Fig. 5</label><caption><p>FGF-2 induces α-SMA expression and cell proliferation. Cells were treated with FGF-2 (15 ng/ml) for 4 h. α-SMA protein expressions were determined by Western Blot (<bold>a</bold>) and Immunocytochemistry Staining. The nuclei were stained with DAPI. Magnification: 200X (<bold>b</bold>). <bold>c</bold> Cell viability was measured with MTT, and cell cyclin protein cyclin E (<bold>d</bold>) and p27<sup>kip1</sup> (<bold>e</bold>) were assayed by Western blot. Cells were transferred with p27<sup>kip1</sup> siRNAs, cell viability was measured with MTT (<bold>f</bold>), and cylin E was analyzed with Western blot (<bold>g</bold>). Data consists of the means of three independent experiments ± SEM (<italic>n</italic> = 3). *<italic>p</italic> &lt; 0.05 vs. controls; +<italic>p</italic> &lt; 0.05 vs. 15-HETE</p></caption><graphic xlink:href="12944_2015_174_Fig5_HTML" id="MO5"/></fig></p>
        <p>p27<sup>kip1</sup> is known inhibitor for cell cycle G1/S transition, and is related to cell proliferation. Therefore, we measured p27<sup>kip1</sup> levels in FGF-2 treated cells in order to infer the role it plays in cell viability and cyclin E expression. Western blot analysis revealed that, compared with the controls, there is a significant reduction in p27<sup>kip1</sup> levels after the PAFs’ exposure to FGF-2 stimulation (Fig. <xref rid="Fig5" ref-type="fig">5e</xref>). Moreover, transfection with p27<sup>kip1</sup> siRNA, cell viability and cyclin E were further enhanced in PAFs (Fig. <xref rid="Fig5" ref-type="fig">5f</xref> &amp; <xref rid="Fig5" ref-type="fig">g</xref>). This data suggests that FGF-2 initiates both growth and differentiation signals simultaneously in PAFs.</p>
      </sec>
    </sec>
    <sec id="Sec16">
      <title>Discussion</title>
      <p>15-HETE is a metabolic product of AA catalyzed by 15-LO, and it plays a noteworthy role in the pathogenesis of vessel wall diseases [<xref ref-type="bibr" rid="CR17">17</xref>]. 15-HETE was reported to stimulate VSMC and PAEC proliferation and apoptosis, thus contributing to hypoxia induced pulmonary artery remodeling. Our previous studies also indicated that 15-HETE induced PAF migration and mediated the adventitial fibrosis in the early stage of PAH <italic>in vivo</italic> [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. Recently, more and more evidence shows that fibroblasts could differentiate into myofibroblasts under hypoxia, which could be critical to hypoxia-induced pulmonary vascular remodeling [<xref ref-type="bibr" rid="CR18">18</xref>]. However, whether 15-HETE was involved in this pathological process is not clear. In the present study, we investigated the effect of 15-HETE on the PAF phenotypic alteration and explored the underlying mechanisms. We found that 15-HETE upregulated the myofibroblast marker α-SMA, and the FGF-2 expression. The blockage of FGF-2 by siRNA or the inhibition of p38 MAPK relieved the upregulation of α-SMA. Meanwhile, TGF-β1 was required for 15-HETE-induced α-SMA accumulation. Our study indicates that 15-HETE was involved in the cell phenotypic alteration of PAFs, and the TGF-β1 mediated FGF-2 signal pathways could be a novel target for pulmonary vascular adventitial remodeling.</p>
      <p>Arterial walls are heterogeneous three-layered structures composed of the intima, media and adventitia [<xref ref-type="bibr" rid="CR19">19</xref>]. Most studies focus on the endothelial cells and smooth muscle cells (SMC), the principal cellular constituents of the intima and media. Recently, the concept that the vascular adventitia acts as a biological processing center for the regulation of vessel wall function is rapidly emerging, and much more attention is paid to the adventitia and PAFs [<xref ref-type="bibr" rid="CR20">20</xref>]. In the early stage of PAH, the adventitia is much more sensitive to the environmental stresses such as hypoxia, rapidly expressing and recruiting proteins/factors which perpetuate the inflammatory response. They increase the expression of contractile and extracellular matrix (ECM) protein, differentiating into SM-like cells, which can migrate to the inner layer with greater propensity of proliferation. Meanwhile, the phenotypic alteration and proliferative PAFs synthesize and release inflammatory chemokines and neovascular growth factors, further promoting the vascular angiogenesis and remodeling [<xref ref-type="bibr" rid="CR21">21</xref>]. In brief, the contribution of adventitial fibroblast phenotype changes to the PAH vascular remodeling cannot be overlooked.</p>
      <p>TGF-β1 and FGF-2 are responsible for the phenotypic changes in the activated PAFs. They are the well-known cytokines capable of inducing fibroblast transition into the myofibroblast phenotype by stimulating α-SMA expression and collagen production [<xref ref-type="bibr" rid="CR22">22</xref>]. It is believed that in hypoxia induced pulmonary vascular remodeling, TGF-β1 and FGF-2 mediate the differentiation of fibroblasts from proliferative phenotype into collagen-production and then into myofibroblastic phenotypes [<xref ref-type="bibr" rid="CR23">23</xref>]. TGF-β1 induced the isoform switching of fibroblast growth factor (FGF) receptors, causing the cells to become sensitive to FGF-2. FGF-2 is a type of heparin-binding growth factor affecting the proliferation of cells, driving the differentiation of PAFs into myofibroblast through the MAPK and extracellular ERK1 and ERK2 pathways [<xref ref-type="bibr" rid="CR24">24</xref>]. In the present study, 15-HETE increased the expression of FGF-2 and α-SMA expression. Meanwhile FGF-2 induced upregulation of α-SMA can be blocked by the inhibition of TGF-β1. This data correlated well with our previous studies, indicating that 15-HETE promoted the proliferation of PAFs by the activation of TGF-β1.</p>
      <p>The proliferation of PAFs originating in “smooth muscle-like cells” plays a key role in the early stage of cell migration and vessel remodeling. The role of 15-HETE in proliferation of myofibroblast remains unclear. p27<sup>kip1</sup> is a kind of CDK inhibitor different from the p53 or p16. p27<sup>kip1</sup> negatively regulates the cell cycle through the inhibition of cyclin enzyme activity, preventing the cells’ G1/S phase transition, and contributes to depressing the cell proliferation [<xref ref-type="bibr" rid="CR25">25</xref>]. Cyclin E, a regulation actor of CDK2 subunits, mediates the cell cycle G1/S transition. We found that 15-HETE induced the abnormal expression of p27<sup>kip1</sup>, which may lead to G1/S conversion disorder [<xref ref-type="bibr" rid="CR26">26</xref>]. However, no reports showed the relationship between p27<sup>kip1</sup> and cell phenotypic alterations in PAFs. This is the first observation in our present study that 15-HETE increased cyclin E expression through inhibiting p27<sup>kip1</sup> in PAFs. This indicates that 15-HETE induced PAF differentiation via the FGF-2/ TGF-β1 pathway.</p>
    </sec>
    <sec id="Sec17">
      <title>Conclusions</title>
      <p>In conclusion, our study suggests that 15-HETE converted adventitial fibroblasts into myofibroblasts through the TGF-β1-mediated FGF-2 signal pathway and stimulated “smooth muscle-like” PAF proliferation based on upregulation of cyclin E induced by p27<sup>kip1</sup>. Our study showed the importance of 15-HETE in PAF cell phenotypic alteration and proliferation under hypoxic stimulation, and it potentiated the therapy target of adventitial remodeling in PAH.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The authors declare that they have no competing interests.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors’ contributions</bold>
        </p>
        <p>LZ carried out the molecular mechanism studies, participated in the sequence alignment and drafted the manuscript. YC and MC carried out the Immunofluorescence study and microscopic observation. HW and GL participated in animal care, fresh cell isolation, and cell culture. YR-L participated in the design of the study and performed the statistical analysis. YM-L and LZ conceived of the study, participated in its design and coordination, and helped to draft the manuscript. All authors read and approved the final manuscript.</p>
      </fn>
    </fn-group>
    <ack>
      <p>This work was supported by the Project of Educational Bureau of Heilongjiang Province, China (No. 12531297).</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tuder</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Stacher</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Robinson</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Graham</surname>
              <given-names>BB</given-names>
            </name>
          </person-group>
          <article-title>Pathology of pulmonary hypertension</article-title>
          <source>Clin Chest Med</source>
          <year>2013</year>
          <volume>34</volume>
          <issue>4</issue>
          <fpage>639</fpage>
          <lpage>50</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ccm.2013.08.009</pub-id>
          <?supplied-pmid 24267295?>
          <pub-id pub-id-type="pmid">24267295</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jeffery</surname>
              <given-names>TK</given-names>
            </name>
            <name>
              <surname>Morrell</surname>
              <given-names>NW</given-names>
            </name>
          </person-group>
          <article-title>Molecular and cellular basis of pulmonary vascular remodeling in pulmonary hypertension</article-title>
          <source>Prog Cardiovasc Dis</source>
          <year>2002</year>
          <volume>45</volume>
          <issue>3</issue>
          <fpage>173</fpage>
          <lpage>202</lpage>
          <pub-id pub-id-type="doi">10.1053/pcad.2002.130041</pub-id>
          <?supplied-pmid 12525995?>
          <pub-id pub-id-type="pmid">12525995</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stenmark</surname>
              <given-names>KR</given-names>
            </name>
            <name>
              <surname>Davie</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Frid</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gerasimovskaya</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Das</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Role of the adventitia in pulmonary vascular remodeling</article-title>
          <source>Physiology</source>
          <year>2006</year>
          <volume>21</volume>
          <fpage>134</fpage>
          <lpage>45</lpage>
          <pub-id pub-id-type="doi">10.1152/physiol.00053.2005</pub-id>
          <?supplied-pmid 16565479?>
          <pub-id pub-id-type="pmid">16565479</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ma</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Niu</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Key role of 15-lipoxygenase/15-hydroxyeicosatetraenoic acid in pulmonary vascular remodeling and vascular angiogenesis associated with hypoxic pulmonary hypertension</article-title>
          <source>Hypertension</source>
          <year>2011</year>
          <volume>58</volume>
          <issue>4</issue>
          <fpage>679</fpage>
          <lpage>88</lpage>
          <pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.111.171561</pub-id>
          <?supplied-pmid 21859965?>
          <pub-id pub-id-type="pmid">21859965</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schermuly</surname>
              <given-names>RT</given-names>
            </name>
            <name>
              <surname>Ghofrani</surname>
              <given-names>HA</given-names>
            </name>
            <name>
              <surname>Wilkins</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Grimminger</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Mechanisms of disease: pulmonary arterial hypertension</article-title>
          <source>Nat Rev Cardiol</source>
          <year>2011</year>
          <volume>8</volume>
          <issue>8</issue>
          <fpage>443</fpage>
          <lpage>55</lpage>
          <pub-id pub-id-type="doi">10.1038/nrcardio.2011.87</pub-id>
          <?supplied-pmid 21691314?>
          <pub-id pub-id-type="pmid">21691314</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Su</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Yi</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>15-LO/15-HETE mediated vascular adventitia fibrosis via p38 MAPK-dependent TGF-β</article-title>
          <source>J Cell Physiol</source>
          <year>2014</year>
          <volume>229</volume>
          <issue>2</issue>
          <fpage>245</fpage>
          <lpage>57</lpage>
          <pub-id pub-id-type="doi">10.1002/jcp.24443</pub-id>
          <?supplied-pmid 23982954?>
          <pub-id pub-id-type="pmid">23982954</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Xing</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>STAT3-mediated MMP-2 expression is required for 15-HETE-induced vascular adventitial fibroblast migration</article-title>
          <source>J Steroid Biochem Mol Biol</source>
          <year>2015</year>
          <volume>149</volume>
          <fpage>106</fpage>
          <lpage>17</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jsbmb.2015.01.015</pub-id>
          <?supplied-pmid 25623089?>
          <pub-id pub-id-type="pmid">25623089</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stenmark</surname>
              <given-names>KR</given-names>
            </name>
            <name>
              <surname>Bouchey</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Nemenoff</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Dempsey</surname>
              <given-names>EC</given-names>
            </name>
            <name>
              <surname>Das</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Hypoxia-induced pulmonary vascular remodeling: contribution of the adventitial fibroblasts</article-title>
          <source>Physiol Res</source>
          <year>2000</year>
          <volume>49</volume>
          <issue>5</issue>
          <fpage>503</fpage>
          <lpage>17</lpage>
          <?supplied-pmid 11191356?>
          <pub-id pub-id-type="pmid">11191356</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Short</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nemenoff</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Zawada</surname>
              <given-names>WM</given-names>
            </name>
            <name>
              <surname>Stenmark</surname>
              <given-names>KR</given-names>
            </name>
            <name>
              <surname>Das</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Hypoxia induces differentiation of pulmonary artery adventitial fibroblasts into myofibroblasts</article-title>
          <source>Am J Physiol Cell Physiol</source>
          <year>2004</year>
          <volume>286</volume>
          <issue>2</issue>
          <fpage>C416</fpage>
          <lpage>25</lpage>
          <pub-id pub-id-type="doi">10.1152/ajpcell.00169.2003</pub-id>
          <?supplied-pmid 14561589?>
          <pub-id pub-id-type="pmid">14561589</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Amara</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Goven</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Prost</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Muloway</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Crestani</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Boczkowski</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFbeta1-induced fibroblast differentiation into myofibroblasts</article-title>
          <source>Thorax</source>
          <year>2010</year>
          <volume>65</volume>
          <issue>8</issue>
          <fpage>733</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1136/thx.2009.113456</pub-id>
          <?supplied-pmid 20685750?>
          <pub-id pub-id-type="pmid">20685750</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stenmark</surname>
              <given-names>KR</given-names>
            </name>
            <name>
              <surname>Gerasimovskaya</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Nemenoff</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Das</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Hypoxic activation of adventitial fibroblasts: role in vascular remodeling</article-title>
          <source>Chest</source>
          <year>2002</year>
          <volume>122</volume>
          <issue>6 Suppl</issue>
          <fpage>326S</fpage>
          <lpage>34</lpage>
          <pub-id pub-id-type="doi">10.1378/chest.122.6_suppl.326S</pub-id>
          <?supplied-pmid 12475810?>
          <pub-id pub-id-type="pmid">12475810</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Das</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Dempsey</surname>
              <given-names>EC</given-names>
            </name>
            <name>
              <surname>Bouchey</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Reyland</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Stenmark</surname>
              <given-names>KR</given-names>
            </name>
          </person-group>
          <article-title>Chronic hypoxia induces exaggerated growth responses in pulmonary artery adventitial fibroblasts: potential contribution of specific protein kinase C isozymes</article-title>
          <source>Am J Respir Cell Mol Biol</source>
          <year>2000</year>
          <volume>22</volume>
          <issue>1</issue>
          <fpage>15</fpage>
          <lpage>25</lpage>
          <pub-id pub-id-type="doi">10.1165/ajrcmb.22.1.3536</pub-id>
          <?supplied-pmid 10615061?>
          <pub-id pub-id-type="pmid">10615061</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Khalil</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>YD</given-names>
            </name>
            <name>
              <surname>O’Connor</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Duronio</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Proliferation of pulmonary interstitial fibroblasts is mediated by transforming growth factor-beta1-induced release of extracellular fibroblast growth factor-2 and phosphorylation of p38 MAPK and JNK</article-title>
          <source>J Biol Chem</source>
          <year>2005</year>
          <volume>280</volume>
          <issue>52</issue>
          <fpage>43000</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M510441200</pub-id>
          <?supplied-pmid 16246848?>
          <pub-id pub-id-type="pmid">16246848</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Coen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gabbiani</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Bochaton-Piallat</surname>
              <given-names>ML</given-names>
            </name>
          </person-group>
          <article-title>Myofibroblast-mediated adventitial remodeling: an underestimated player in arterial pathology</article-title>
          <source>Arterioscler Thromb Vasc Biol</source>
          <year>2011</year>
          <volume>31</volume>
          <issue>11</issue>
          <fpage>2391</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.1161/ATVBAHA.111.231548</pub-id>
          <?supplied-pmid 21868702?>
          <pub-id pub-id-type="pmid">21868702</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Loomis-King</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Flaherty</surname>
              <given-names>KR</given-names>
            </name>
            <name>
              <surname>Moore</surname>
              <given-names>BB</given-names>
            </name>
          </person-group>
          <article-title>Pathogenesis, current treatments and future directions for idiopathic pulmonary fibrosis</article-title>
          <source>Curr Opin Pharmacol</source>
          <year>2013</year>
          <volume>13</volume>
          <issue>3</issue>
          <fpage>377</fpage>
          <lpage>85</lpage>
          <pub-id pub-id-type="doi">10.1016/j.coph.2013.03.015</pub-id>
          <?supplied-pmid 23602652?>
          <pub-id pub-id-type="pmid">23602652</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jin</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Sheikh</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Detillieux</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Cattini</surname>
              <given-names>PA</given-names>
            </name>
          </person-group>
          <article-title>Role for early growth response-1 protein in alpha(1)-adrenergic stimulation of fibroblast growth factor-2 promoter activity in cardiac myocytes</article-title>
          <source>Mol Pharmacol</source>
          <year>2000</year>
          <volume>57</volume>
          <issue>5</issue>
          <fpage>984</fpage>
          <lpage>90</lpage>
          <?supplied-pmid 10779383?>
          <pub-id pub-id-type="pmid">10779383</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhu</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Medhora</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Campbell</surname>
              <given-names>WB</given-names>
            </name>
            <name>
              <surname>Spitzbarth</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Baker</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Jacobs</surname>
              <given-names>ER</given-names>
            </name>
          </person-group>
          <article-title>Chronic hypoxia activates lung 15-lipoxygenase, which catalyzes production of 15-HETE and enhances constriction in neonatal rabbit pulmonary arteries</article-title>
          <source>Circ Res</source>
          <year>2003</year>
          <volume>92</volume>
          <issue>9</issue>
          <fpage>992</fpage>
          <lpage>1000</lpage>
          <pub-id pub-id-type="doi">10.1161/01.RES.0000070881.65194.8F</pub-id>
          <?supplied-pmid 12690037?>
          <pub-id pub-id-type="pmid">12690037</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maruoka</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sakao</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kantake</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tanabe</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kasahara</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kurosu</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Characterization of myofibroblasts in chronic thromboembolic pulmonary hypertension</article-title>
          <source>Int J Cardiol</source>
          <year>2012</year>
          <volume>159</volume>
          <issue>2</issue>
          <fpage>119</fpage>
          <lpage>27</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ijcard.2011.02.037</pub-id>
          <?supplied-pmid 21406312?>
          <pub-id pub-id-type="pmid">21406312</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Martinez-Lemus</surname>
              <given-names>LA</given-names>
            </name>
          </person-group>
          <article-title>The dynamic structure of arterioles</article-title>
          <source>Basic Clin Pharmacol Toxicol</source>
          <year>2012</year>
          <volume>110</volume>
          <issue>1</issue>
          <fpage>5</fpage>
          <lpage>11</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1742-7843.2011.00813.x</pub-id>
          <?supplied-pmid 21989114?>
          <pub-id pub-id-type="pmid">21989114</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stenmark</surname>
              <given-names>KR</given-names>
            </name>
            <name>
              <surname>Yeager</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>EI Kasmi</surname>
              <given-names>KC</given-names>
            </name>
            <name>
              <surname>Nozik-Grayck</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Gerasimovskaya</surname>
              <given-names>EV</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The adventitia: essential regulator of vascular wall structure and function</article-title>
          <source>Annu Rev Physiol</source>
          <year>2013</year>
          <volume>75</volume>
          <fpage>23</fpage>
          <lpage>47</lpage>
          <pub-id pub-id-type="doi">10.1146/annurev-physiol-030212-183802</pub-id>
          <?supplied-pmid 23216413?>
          <pub-id pub-id-type="pmid">23216413</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barnes</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Gorin</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases</article-title>
          <source>Kidney Int</source>
          <year>2011</year>
          <volume>79</volume>
          <issue>9</issue>
          <fpage>944</fpage>
          <lpage>56</lpage>
          <pub-id pub-id-type="doi">10.1038/ki.2010.516</pub-id>
          <?supplied-pmid 21307839?>
          <pub-id pub-id-type="pmid">21307839</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cushing</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Mariner</surname>
              <given-names>PD</given-names>
            </name>
            <name>
              <surname>Liao</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Sims</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Anseth</surname>
              <given-names>KS</given-names>
            </name>
          </person-group>
          <article-title>Fibroblast growth factor represses Smad-mediated myofibroblast activation in aortic valvular interstitial cells</article-title>
          <source>FASEB J</source>
          <year>2008</year>
          <volume>22</volume>
          <issue>6</issue>
          <fpage>1769</fpage>
          <lpage>77</lpage>
          <pub-id pub-id-type="doi">10.1096/fj.07-087627</pub-id>
          <?supplied-pmid 18218921?>
          <pub-id pub-id-type="pmid">18218921</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Peng</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Carretero</surname>
              <given-names>OA</given-names>
            </name>
            <name>
              <surname>Peterson</surname>
              <given-names>EL</given-names>
            </name>
            <name>
              <surname>Rhaleb</surname>
              <given-names>NE</given-names>
            </name>
          </person-group>
          <article-title>Ac-SDKP inhibits transforming growth factor-beta1-induced differentiation of human cardiac fibroblasts into myofibroblasts</article-title>
          <source>Am J Physiol Heart Circ Physiol</source>
          <year>2010</year>
          <volume>298</volume>
          <issue>5</issue>
          <fpage>H1357</fpage>
          <lpage>64</lpage>
          <pub-id pub-id-type="doi">10.1152/ajpheart.00464.2009</pub-id>
          <?supplied-pmid 20154264?>
          <pub-id pub-id-type="pmid">20154264</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Makino</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Jinnin</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Muchemwa</surname>
              <given-names>FC</given-names>
            </name>
            <name>
              <surname>Fukushima</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kogushi-Nishi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Moriya</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Basic fibroblast growth factor stimulates the proliferation of human dermal fibroblasts via the ERK1/2 and JNK pathways</article-title>
          <source>Br J Dermatol</source>
          <year>2010</year>
          <volume>162</volume>
          <issue>4</issue>
          <fpage>717</fpage>
          <lpage>23</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-2133.2009.09581.x</pub-id>
          <?supplied-pmid 19995368?>
          <pub-id pub-id-type="pmid">19995368</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gonçalves</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Camargo-Kosugi</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Bonetti</surname>
              <given-names>TC</given-names>
            </name>
            <name>
              <surname>Invitti</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Girão</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Silva</surname>
              <given-names>ID</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>p27kip1 overexpression regulates VEGF expression, cell proliferation and apoptosis in cell culture from eutopic endometrium of women with endometriosis</article-title>
          <source>Apoptosis</source>
          <year>2015</year>
          <volume>20</volume>
          <issue>3</issue>
          <fpage>327</fpage>
          <lpage>35</lpage>
          <pub-id pub-id-type="doi">10.1007/s10495-014-1079-8</pub-id>
          <?supplied-pmid 25534318?>
          <pub-id pub-id-type="pmid">25534318</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Minella</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Loeb</surname>
              <given-names>KR</given-names>
            </name>
            <name>
              <surname>Knecht</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Welcker</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Varnum-Finney</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Bernstein</surname>
              <given-names>ID</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cyclin E phosphorylation regulates cell proliferation in hematopoietic and epithelial lineages in vivo</article-title>
          <source>Genes Dev</source>
          <year>2008</year>
          <volume>22</volume>
          <issue>12</issue>
          <fpage>1677</fpage>
          <lpage>89</lpage>
          <pub-id pub-id-type="doi">10.1101/gad.1650208</pub-id>
          <?supplied-pmid 18559482?>
          <pub-id pub-id-type="pmid">18559482</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><resumptionToken>oai%3Apubmedcentral.nih.gov%3A4700587!2016-01-06!2016-01-07!pmc!</resumptionToken></ListRecords></OAI-PMH>